<SEC-DOCUMENT>0001193125-23-092237.txt : 20230405
<SEC-HEADER>0001193125-23-092237.hdr.sgml : 20230405
<ACCEPTANCE-DATETIME>20230405161238
ACCESSION NUMBER:		0001193125-23-092237
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		119
FILED AS OF DATE:		20230405
DATE AS OF CHANGE:		20230405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rigetti Computing, Inc.
		CENTRAL INDEX KEY:			0001838359
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266810
		FILM NUMBER:		23802671

	BUSINESS ADDRESS:	
		STREET 1:		775 HEINZ AVENUE
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		(510) 210-5550

	MAIL ADDRESS:	
		STREET 1:		775 HEINZ AVENUE
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Supernova Partners Acquisition Co II, Ltd.
		DATE OF NAME CHANGE:	20201230
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>d483086dposam.htm
<DESCRIPTION>POS AM
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:rgti="http://www.rigetti.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>POS AM</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="">
<h5><a href="#toc">Table of Contents</a></h5>
<div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" id="hidden73986025" contextRef="P01_01_2022To12_31_2022">POS AM</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2022To12_31_2022">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2022To12_31_2022">0001838359</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="hidden73986034" contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">CA</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="hidden73986036" contextRef="P01_01_2022To12_31_2022">CA</ix:nonNumeric><ix:footnote id="FN_254680" xml:lang="en-US">Weighted-average shares have been retroactively restated to give effect to the Business Combination. </ix:footnote ><ix:footnote id="FN_254681" xml:lang="en-US">Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible Series C-1 Preferred Stock, legacy Class A Common Stock, and legacy Class B Common Stock have been retroactively restated to give effect to the Business Combination.</ix:footnote ></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="rgti-20221231.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references><ix:resources><xbrli:context id="P01_01_2022To12_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn05_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-05-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P12_31_2022To12_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-31</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_11_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-08-11</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P09_14_2022To09_14_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-09-14</xbrli:startDate> <xbrli:endDate>2022-09-14</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_14_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-14</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P08_11_2022To08_11_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-11</xbrli:startDate> <xbrli:endDate>2022-08-11</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_01_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-01-01</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2022" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:DerivativeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:DerivativeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:DerivativeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:DerivativeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:DerivativeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:ClassOfInvestorsAxis" >rgti:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:WarrantsToPurchaseClassACommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FurnitureAndOtherAssetsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >rgti:FurnitureAndOtherAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ItHardwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >rgti:ItHardwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ProcessEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >rgti:ProcessEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_QuantumComputingFridgesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >rgti:QuantumComputingFridgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_USsrtStatementGeographicalAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:CommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis" >rgti:RigettiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >rgti:MeasurementInputProbabilityOfOccurringTheContingencyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis" >rgti:RigettiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:AmpereComputingLlcMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:RigettiComputingIncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >rgti:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:MarketBasedVestingAwardMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:TimeBasedVestingAwardMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:DomesticCountryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ResearchMemberusgaapTaxCreditCarryforwardAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:DomesticCountryMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis" >us-gaap:ResearchMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ResearchMemberusgaapTaxCreditCarryforwardAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis" >us-gaap:ResearchMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:StatusOfVestingAxis" >rgti:VestedCustomerWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_UnvestedCustomerWarrantsMemberRGTIStatusOfVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:StatusOfVestingAxis" >rgti:UnvestedCustomerWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimatedPeriodOfExpirationMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >rgti:EstimatedPeriodOfExpirationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SimulatedTradingDaysMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >rgti:SimulatedTradingDaysMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_TwothousandandtwentyfourMemberRGTIRevenuePerformanceObligationTransactionPriceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:RevenuePerformanceObligationTransactionPriceAxis" >rgti:TwothousandandtwentyfourMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RemainderoftwothousandandtwentythreeMemberRGTIRevenuePerformanceObligationTransactionPriceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:RevenuePerformanceObligationTransactionPriceAxis" >rgti:RemainderoftwothousandandtwentythreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_PromoteSponsorVestingSharesMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:PromoteSponsorVestingSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SponsorRedemptionBasedVestingSharesMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:SponsorRedemptionBasedVestingSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesCOneRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:SeriesCOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivatePlacementWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:CommercialPaperMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:CommercialPaperMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis" >us-gaap:CommercialPaperMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesCOnePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:SeriesCOnePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesCPreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_PreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:SupernovaAcquistionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementAxis" >rgti:SponsorAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:TrancheAxis" >rgti:TrancheTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:SupernovaAcquistionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementAxis" >rgti:SponsorAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:TrancheAxis" >rgti:TrancheOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:CommercialPaperMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:RigettiComputingIncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" >us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:DerivativeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:DerivativeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >us-gaap:DerivativeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FurnitureAndOtherAssetsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >rgti:FurnitureAndOtherAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ItHardwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >rgti:ItHardwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ProcessEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >rgti:ProcessEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_QuantumComputingFridgesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" >rgti:QuantumComputingFridgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_GBsrtStatementGeographicalAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >country:GB</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >rgti:MeasurementInputProbabilityOfOccurringTheContingencyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >rgti:MeasurementInputProbabilityOfOccurringTheContingencyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:RigettiComputingIncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:StatusOfVestingAxis" >rgti:VestedCustomerWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_UnvestedCustomerWarrantsMemberRGTIStatusOfVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:StatusOfVestingAxis" >rgti:UnvestedCustomerWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:RigettiHoldingsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivatePlacementWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CollaborativeResearchAndOtherProfessionalServicesMembersrtProductOrServiceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis" >rgti:CollaborativeResearchAndOtherProfessionalServicesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccessToQuantumComputingSystemsMembersrtProductOrServiceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis" >rgti:AccessToQuantumComputingSystemsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis" >us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TransferredOverTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis" >us-gaap:TransferredOverTimeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_USsrtStatementGeographicalAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EuropeMembersrtStatementGeographicalAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >srt:EuropeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesC1PreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >rgti:ConvertibleSeriesC1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesCPreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >rgti:ConvertibleSeriesCPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RestrictedStockUnitsRSUMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis" >rgti:RigettiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:AmpereComputingLlcMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >rgti:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_RestrictedStockMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:RestrictedStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:MarketBasedVestingAwardMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:TimeBasedVestingAwardMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:AccountsReceivableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:AccountsReceivableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:AccountsReceivableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CurrentYearMemberRGTIPeriodAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:PeriodAxis" >rgti:CurrentYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PreviousYearMemberRGTIPeriodAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:PeriodAxis" >rgti:PreviousYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_RigettiComputingIncMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:RigettiComputingIncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_GovernmentEntitiesMembersrtProductOrServiceAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis" >rgti:GovernmentEntitiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:ClassOfInvestorsAxis" >rgti:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:WarrantsToPurchaseClassACommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis" >dei:BusinessContactMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SeriesCOneRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:SeriesCOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >rgti:SponsorMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EuropeMembersrtStatementGeographicalAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >srt:EuropeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_USsrtStatementGeographicalAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerEMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerEMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerDMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMemberusgaapAwardTypeAxis_TwoThousandThirteenEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >rgti:TwoThousandThirteenEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:CommonStockPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:UnvestedCustomerWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_RGTICommonStockPurchaseAgreementMemberRGTIRGTIAgreementNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:RGTIAgreementNameAxis" >rgti:RGTICommonStockPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CollaborativeResearchAndOtherProfessionalServicesMembersrtProductOrServiceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis" >rgti:CollaborativeResearchAndOtherProfessionalServicesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_AccessToQuantumComputingSystemsMembersrtProductOrServiceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis" >rgti:AccessToQuantumComputingSystemsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis" >us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_TransferredOverTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis" >us-gaap:TransferredOverTimeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_USsrtStatementGeographicalAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_EuropeMembersrtStatementGeographicalAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >srt:EuropeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesC1PreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >rgti:ConvertibleSeriesC1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesCPreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >rgti:ConvertibleSeriesCPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_RestrictedStockUnitsRSUMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" >us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" >us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerDMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_RigettiComputingIncMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:RigettiComputingIncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_GovernmentEntitiesMembersrtProductOrServiceAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis" >rgti:GovernmentEntitiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_EuropeMembersrtStatementGeographicalAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >srt:EuropeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_USsrtStatementGeographicalAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis" >country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerDMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerFMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerFMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis" >us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis" >us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis" >rgti:CustomerBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2021To12_31_2021_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >rgti:UnvestedCustomerWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-02-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis" >rgti:RigettiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:AmpereComputingLlcMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VestingAxis" >us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >rgti:AtinitialrecognitionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >rgti:AtinitialrecognitionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >rgti:AtinitialrecognitionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >rgti:AtinitialrecognitionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >rgti:AtinitialrecognitionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >rgti:AtinitialrecognitionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivateWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:EventAxis" >rgti:ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:EventAxis" >rgti:ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_EstimatedPeriodOfExpirationMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >rgti:EstimatedPeriodOfExpirationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_SimulatedTradingDaysMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >rgti:SimulatedTradingDaysMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:TrancheAxis" >rgti:TrancheTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementAxis" >rgti:SponsorAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:SupernovaAcquistionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-31</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:SupernovaAcquistionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementAxis" >rgti:SponsorAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:TrancheAxis" >rgti:TrancheOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-31</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_01_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-01</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_01_2021_InitialSubscriptionAgreementMemberRGTIAgreementAxis_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SupernovaAcquistionMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:SupernovaAcquistionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:InvestorAxis" >rgti:PrivateInvestmentInPublicEquityInvestorsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementAxis" >rgti:InitialSubscriptionAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-01</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_23_2021_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SubsequentSubscriptionAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:SupernovaAcquistionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:InvestorAxis" >rgti:PrivateInvestmentInPublicEquityInvestorsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementAxis" >rgti:SubsequentSubscriptionAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-23</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheAMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis" >rgti:VentureCapitalMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >rgti:TrancheAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2021_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:CommonStockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >rgti:TrancheBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis" >rgti:VentureCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-31</xbrli:startDate> <xbrli:endDate>2021-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MaximumMembersrtRangeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >rgti:TrancheBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis" >rgti:VentureCapitalMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-31</xbrli:startDate> <xbrli:endDate>2021-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-31</xbrli:startDate> <xbrli:endDate>2021-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_PrimeRateMemberusgaapVariableRateAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis" >us-gaap:PrimeRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-31</xbrli:startDate> <xbrli:endDate>2021-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis" >rgti:VentureCapitalMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >rgti:TrancheBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-05-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-05-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >rgti:TrancheCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-31</xbrli:startDate> <xbrli:endDate>2022-01-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_31_2022To01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MinimumMembersrtRangeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >rgti:TrancheBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis" >rgti:VentureCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-31</xbrli:startDate> <xbrli:endDate>2022-01-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_31_2022To01_31_2022_PrimeRateMemberusgaapVariableRateAxis_TrancheCMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >rgti:TrancheCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis" >us-gaap:PrimeRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-31</xbrli:startDate> <xbrli:endDate>2022-01-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis" >rgti:TrancheCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis" >rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P08_11_2022To08_11_2022_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:CommonStockPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-11</xbrli:startDate> <xbrli:endDate>2022-08-11</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_11_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:CommonStockPurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-08-11</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_02_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_02_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_02_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_02_2022_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_02_2022_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_02_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:CustomerWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:CustomerWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:CustomerWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2022To06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheTwoMemberusgaapVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis" >rgti:RigettiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:AmpereComputingLlcMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VestingAxis" >us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-06-30</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2022To06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VestingAxis" >us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis" >rgti:RigettiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:AmpereComputingLlcMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-06-30</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis" >rgti:RigettiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:AmpereComputingLlcMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VestingAxis" >us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheTwoMemberusgaapVestingAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis" >rgti:RigettiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >rgti:AmpereComputingLlcMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="rgti:AgreementNameAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VestingAxis" >us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P02_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-02-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis" >us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-28</xbrli:startDate> <xbrli:endDate>2023-02-28</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn02_28_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:CommonStockWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-02-28</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:CeoAwardMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-12</xbrli:startDate> <xbrli:endDate>2022-12-12</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:CeoAwardMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis" >srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-12</xbrli:startDate> <xbrli:endDate>2022-12-12</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis_TwoThousandThirteenEquityIncentivePlanMemberusgaapPlanNameAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis" >rgti:TwoThousandThirteenEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:CeoAwardMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-12</xbrli:startDate> <xbrli:endDate>2022-12-12</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_12_2022_CeoAwardMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >rgti:CeoAwardMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-12</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P06_02_2022To06_02_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-06-02</xbrli:startDate> <xbrli:endDate>2022-06-02</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_StatusOfSharesOutstandingBeforeBusinessCombinationMemberRGTIEventAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="rgti:EventAxis" >rgti:StatusOfSharesOutstandingBeforeBusinessCombinationMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" >us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivatePlacementWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:TrinityWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001838359</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis" >rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >rgti:PrivatePlacementWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD" > <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_shares" > <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure" > <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Year" > <xbrli:measure>utr:Year</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Month" > <xbrli:measure>utr:Month</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Day" > <xbrli:measure>utr:Day</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD_per_Share" > <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit><xbrli:unit id="Unit_OperatingSegment" > <xbrli:measure>rgti:OperatingSegment</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Numberofemployees" > <xbrli:measure>rgti:Numberofemployees</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Y" > <xbrli:measure>utr:Y</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_D" > <xbrli:measure>utr:D</xbrli:measure> </xbrli:unit><ix:relationship fromRefs="Fact_73804545" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804546" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804547" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804549" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804558" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804559" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804565" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804566" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804567" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804572" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804579" toRefs="FN_254680"/><ix:relationship fromRefs="Fact_73804580" toRefs="FN_254680"/><ix:relationship fromRefs="Fact_73804581" toRefs="FN_254680"/><ix:relationship fromRefs="Fact_73804582" toRefs="FN_254680"/><ix:relationship fromRefs="Fact_73804634" toRefs="FN_254681"/><ix:relationship fromRefs="Fact_73804635" toRefs="FN_254681"/><ix:relationship fromRefs="Fact_73804636" toRefs="FN_254681"/><ix:relationship fromRefs="Fact_73804637" toRefs="FN_254681"/><ix:relationship fromRefs="Fact_73804741" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804742" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804970" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73804971" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805338" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805339" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805341" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805344" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805486" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805487" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805491" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805492" toRefs="FN_254682"/><ix:relationship fromRefs="Fact_73805710" toRefs="FN_254682"/></ix:resources></ix:header></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 10.6667px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">As filed with the U.S. Securities and Exchange Commission on April <div style="display:inline;">5</div>, 2023</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div></div></div><div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Registration No. 333-266810 </div></div></div></div><div style="font-size: 4pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 4pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="line-height: 1pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin-top: 4pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">UNITED STATES </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">SECURITIES AND EXCHANGE COMMISSION </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Washington, D.C. 20549 </div></div></div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center;;text-indent: 0px;"><div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin-top: 3pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">POST-EFFECTIVE </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">AMENDMENT NO. 1 </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">TO </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">FORM <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden73986025">S-1</span></div> </div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; letter-spacing: 0px; top: 0px;;display:inline;">REGISTRATION STATEMENT </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">UNDER </div></div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">THE SECURITIES ACT OF 1933 </div></div></div></div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center;;text-indent: 0px;"><div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 24pt; margin-top: 3pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 24pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2022To12_31_2022">RIGETTI COMPUTING, INC.</ix:nonNumeric> </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(Exact name of registrant as specified in its charter) </div></div></div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center;;text-indent: 0px;"><div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 34%;"></td>
<td style="vertical-align: bottom;"></td>
<td style="width: 32%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 32%;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="P01_01_2022To12_31_2022" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityPrimarySicNumber" contextRef="P01_01_2022To12_31_2022">7374</ix:nonNumeric></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="P01_01_2022To12_31_2022">88-0950636</ix:nonNumeric></div></div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(State or other jurisdiction of<br/>incorporation or organization)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Primary Standard Industrial<br/>Classification Code Number)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(I.R.S. Employer<br/>Identification No.)</div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_01_2022To12_31_2022">775 Heinz Avenue</ix:nonNumeric> </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_01_2022To12_31_2022">Berkeley</ix:nonNumeric>, <span style="-sec-ix-hidden:hidden73986036">CA</span> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_01_2022To12_31_2022">94710</ix:nonNumeric> </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_01_2022To12_31_2022">510</ix:nonNumeric>) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_01_2022To12_31_2022">210-5550</ix:nonNumeric></div> </div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices) </div></div></div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center;;text-indent: 0px;"><div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:ContactPersonnelName" contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Rick Danis</ix:nonNumeric> </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">General Counsel </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Rigetti Computing, Inc. </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">775 Heinz Avenue</ix:nonNumeric> </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Berkeley</ix:nonNumeric>, <span style="-sec-ix-hidden:hidden73986034">CA</span> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">94710</ix:nonNumeric> </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">510</ix:nonNumeric>) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">210-5550</ix:nonNumeric></div> </div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">(Name, address, including zip code, and telephone number, including area code, of agent for service) </div></div></div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center;;text-indent: 0px;"><div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Copies to: </div></div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Rupa Briggs </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Sarah Sellers </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Cooley LLP </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">55 Hudson Yards </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">New York, NY 10001 </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(212) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">479-6000</div> </div></div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center;;text-indent: 0px;"><div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Approximate date of commencement of proposed sale to the public: </div></div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 10.6667px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">From time to time after this registration statement becomes effective.</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">. </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.&#160;&#160;&#9746; </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;&#9744; </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;&#9744; </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;&#9744; </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accelerated</div> filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12b-2</div> of the Exchange Act. </div></div><div style="font-size: 3pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 3pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 16%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 59%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 20%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 2%;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Large&#160;accelerated&#160;filer</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#9744;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Accelerated&#160;filer</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#9744;</div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Non-accelerated filer</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#9746;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Smaller&#160;reporting&#160;company</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#9746;</div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Emerging&#160;growth&#160;company</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#9746;</div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act.&#160;&#160;&#9744; </div></div></div><div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 3pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section&#160;8(a), may determine. </div></div></div></div><div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="line-height: 1pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><span style="color:#ff4338"><span style="font-weight:bold">The information in this preliminary prospectus is not complete and may be changed. Neither we nor the selling securityholders may sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </span></span></p> <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="color:#ff4338"><span style="font-weight:bold">Subject to Completion, Dated April 5, 2023 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">PRELIMINARY PROSPECTUS </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g483086g00g02.jpg" alt="LOGO" />
 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman;font-weight:bold;text-align:center">UP TO 500,000 SHARES OF COMMON STOCK </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates to the offer and sale from time to time by Ampere Computing LLC or its permitted transferees (&#8220;Ampere&#8221; or the &#8220;selling stockholder&#8221;) of up to 500,000 shares (the &#8220;Shares&#8221;) of common stock, par value $0.0001 (the &#8220;common stock&#8221;), of the Company, issued upon the exercise of the vested portion of that certain warrant issued to the selling stockholder (the &#8220;Ampere Warrant&#8221;) pursuant to the warrant subscription agreement, dated as of October&#160;6, 2021, by and between Legacy Rigetti (as defined below) and Ampere (the &#8220;Warrant Subscription Agreement&#8221;), for an aggregate purchase price (including amounts for exercise) of $10,000,000, or $10.00 per share. The Shares consist of 500,000 outstanding shares of common stock issued in connection with the exercise of the vested portion of the Ampere Warrant and receipt by the Company of an aggregate $5,000,000 (including aggregate exercise price). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder may offer, sell or distribute all or a portion of the Shares publicly or through private transactions at prevailing market prices or at negotiated prices. We will not receive any of the proceeds from such sales of the Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will bear all costs, expenses and fees in connection with the registration of these Shares, including with regard to compliance with state securities or &#8220;blue sky&#8221; laws. The selling stockholder will bear all commissions and discounts, if any, attributable to their sale of Shares. See the section entitled &#8220;Plan of Distribution.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;RGTI&#8221;. On April&#160;4, 2023, the last reported sales price of our common stock was $0.6679 per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#8220;emerging growth company&#8221; as defined under U.S. federal securities laws and, as such, have elected to comply with reduced public company reporting requirements. This prospectus complies with the requirements that apply to an issuer that is an emerging growth company. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman;font-weight:bold">Investing in our securities involves a high degree of risks. You should review carefully the risks and uncertainties described in the section titled &#8220;<a href="#tx483086_6">Risk Factors</a>&#8220; beginning on page 16 of this prospectus, and under similar headings in any amendments or supplements to this prospectus. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">The date of this prospectus is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc">TABLE OF CONTENTS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:95%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Page</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_1">ABOUT THIS PROSPECTUS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_2">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_3">CERTAIN DEFINED TERMS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_4">PROSPECTUS SUMMARY</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_5">THE OFFERING</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_6">RISK FACTORS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_7">USE OF PROCEEDS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">65</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_8">DETERMINATION OF OFFERING PRICE</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">66</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_9">MARKET INFORMATION FOR SECURITIES AND DIVIDEND POLICY</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_10">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">68</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_11">BUSINESS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">88</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_12">MANAGEMENT</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">109</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_13">EXECUTIVE COMPENSATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">116</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_14">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">134</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_15">BENEFICIAL OWNERSHIP OF SECURITIES</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_16">SELLING STOCKHOLDER</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">139</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_17">DESCRIPTION OF SECURITIES</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_18">CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES FOR NON-U.S. HOLDERS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">153</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_19">PLAN OF DISTRIBUTION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">157</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_20">LEGAL MATTERS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_21">EXPERTS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#tx483086_23">WHERE YOU CAN FIND MORE INFORMATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in this prospectus. No one has been authorized to provide you with information that is different from that contained in this prospectus. This prospectus is dated as of the date set forth on the cover hereof. You should not assume that the information contained in this prospectus is accurate as of any date other than that date. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">i </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_1">ABOUT THIS PROSPECTUS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on Form <span style="white-space:nowrap">S-1</span> that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) using the &#8220;shelf&#8221; registration process. Under this shelf registration process, the selling stockholder may, from time to time, sell the Shares offered by them described in this prospectus. We will not receive any proceeds from the sale by the selling stockholder of the Shares offered by them described in this prospectus. We will not receive any proceeds from the sale of the Shares pursuant to this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor the selling stockholder have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the selling stockholder take responsibility for, or provide any assurance as to the reliability of, any other information that others may give you. Neither we nor the selling stockholder will make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to, or update or change information contained in, this prospectus. You should read both this prospectus and any applicable prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer you in the sections of this prospectus entitled &#8220;Where You Can Find More Information.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;2, 2022 (the &#8220;Closing Date&#8221;), we consummated the transactions contemplated by that certain Agreement and Plan of Merger dated as of October&#160;6, 2021, as amended on December&#160;23, 2021 and January 10, 2022 (as amended, the &#8220;Merger Agreement&#8221;), by and among Supernova, Supernova Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Supernova (&#8220;First Merger Sub&#8221;), Supernova Romeo Merger Sub, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of Supernova (&#8220;Second Merger Sub&#8221;), and Rigetti Holdings, Inc., a Delaware corporation (&#8220;Legacy Rigetti&#8221;). As contemplated by the Merger Agreement, on March&#160;1, 2022 Supernova was domesticated as a Delaware corporation and changed its name to &#8220;Rigetti Computing, Inc.&#8221; (the &#8220;Domestication&#8221;). On the Closing Date, (i)&#160;First Merger Sub merged with and into Legacy Rigetti, the separate corporate existence of First Merger Sub ceased and Legacy Rigetti survived as a wholly owned subsidiary of Rigetti Computing, Inc. (the &#8220;Surviving Corporation&#8221; and, such merger, the &#8220;First Merger&#8221;) and (ii)&#160;immediately following the First Merger, the Surviving Corporation merged with and into the Second Merger Sub, the separate corporate existence of the Surviving Corporation ceased and Second Merger Sub survived as a wholly owned subsidiary of Rigetti Computing, Inc. and changed its name to &#8220;Rigetti Intermediate LLC&#8221; (such merger transaction, the &#8220;Second Merger&#8221; and, together with the First Merger, the &#8220;Merger,&#8221; and, collectively with the Domestication, the PIPE Financing (as defined below) and the other transactions contemplated by the Merger Agreement, the &#8220;Business Combination&#8221;). The closing of the Business Combination is herein referred to as &#8220;the Closing.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the resale of the Shares as required by the Warrant Subscription Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context indicates otherwise, references in this prospectus to the &#8220;Company,&#8221; &#8220;Rigetti,&#8221; &#8220;Rigetti Computing,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar terms refer to Rigetti Computing, Inc. (f/k/a Supernova Partners Acquisition Company II, Ltd.) and its consolidated subsidiaries. References to &#8220;Supernova&#8221; refer to our predecessor company prior to the consummation of the Business Combination (the &#8220;Closing,&#8221; and the date of the consummation of the Business Combination, the &#8220;Closing Date&#8221;). References to &#8220;Legacy Rigetti&#8221; refer to Rigetti Holdings, Inc. prior to the Closing. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under &#8220;<span style="font-style:italic">Where You Can Find More Information.</span>&#8221; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_2">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. We have based these forward-looking statements on our current expectations and projections about future events. Any statements that refer to projections, forecasts or other characterizations of future events or circumstances are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or the negative of such terms or other similar expressions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this prospectus. We caution you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond our control. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements in this prospectus may include, for example, statements about: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the sufficiency of our cash resources, our expectation that we will need to raise additional capital by late 2024 or early 2025 and our ability to raise additional capital when needed; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to achieve milestones, technological advancements, including with respect to executing on our technology roadmap and developing practical applications; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the potential of quantum computing and estimated market size and market growth including with respect to our long-term business strategy for quantum computing as a service (&#8220;Quantum Computing as a Service,&#8221; or &#8220;QCaaS&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the success of our partnerships and collaborations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to accelerate our development of multiple generations of quantum processors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">customer concentration and the risk that a significant portion of our revenue currently depends on contracts with the public sector; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the outcome of any legal proceedings that may be instituted against us or others with respect to the Business Combination or other matters; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to execute on our business strategy, including monetization of our products; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our financial performance, growth rate and market opportunity; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to cure the current deficiency with respect to, and to regain compliance with and maintain, the listing of our common stock and public warrants on, the Nasdaq Capital Market, and the potential liquidity and trading of such securities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, our ability to grow and manage growth profitably, maintain relationships with customers and suppliers and retain our management and key employees; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">costs related to operating as a public company; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to remediate the material weaknesses in, and establish and maintain, effective internal controls over financial reporting; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in applicable laws or regulations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the possibility that we may be adversely affected by other economic, business, or competitive factors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the evolution of the markets in which we compete; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to implement our strategic initiatives, expansion plans and continue to innovate our existing services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">unfavorable conditions in our industry, the global economy or global supply chain (including any supply chain impacts from the ongoing military conflict involving Russia and Ukraine and sanctions related thereto), including inflation and financial and credit market fluctuations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in applicable laws or regulations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our success in retaining or recruiting, or changes required in, our officers, key employees or directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our estimates regarding expenses, profitability, future revenue, capital requirements and needs for additional financing; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability or decisions to expand or maintain our existing customer base; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the continuing effects of the COVID-19 pandemic and macroeconomic conditions, including worsening global economic conditions, disruptions to and volatility and uncertainty in the credit and financial markets, increases in inflation and interest rates, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures, on the foregoing. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Additional cautionary statements or discussions of risks and uncertainties that could affect our results or the achievement of the expectations described in forward-looking statements may also be contained in any accompanying prospectus supplement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should one or more of the risks or uncertainties described in this prospectus, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. Additional information concerning these and other factors that may impact the operations and projections discussed herein can be found in the section entitled &#8220;Risk Factors&#8221; and in our periodic filings with the SEC. Our SEC filings are available publicly on the SEC&#8217;s website at <span style="font-style:italic">www.sec.gov</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus and any accompanying prospectus supplement completely and with the understanding that our actual future results, levels of activity and performance as well as other events and circumstances may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_3">CERTAIN DEFINED TERMS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context otherwise requires, references in this prospectus to: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Board</span>&#8221; are to the board of directors of Rigetti Computing, Inc. following the consummation of the Business Combination; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Business Combination</span>&#8221; are to the Domestication, the Merger and other transactions contemplated by the Merger Agreement, collectively, including the PIPE Financing; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Closing</span>&#8221; are to the closing of the Business Combination; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Closing Date</span>&#8221; are to March&#160;2, 2022; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span>&#8220;<span style="font-weight:bold">common stock</span>&#8221; or &#8220;<span style="font-weight:bold">Common Stock</span>&#8221; are to the shares of common stock, par value $0.0001 per share, of Rigetti Computing, Inc.; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Domestication</span>&#8221; are to the transfer by way of continuation and deregistration of Supernova from the Cayman Islands and the continuation and domestication of Supernova as a corporation incorporated in the State of Delaware which was effectuated on March&#160;1, 2022; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Exchange Ratio</span>&#8221; are to 0.786989052873439, as calculated pursuant to the Merger Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">GAAP</span>&#8221; are to generally accepted accounting principles in the United States, as applied on a consistent basis; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">initial public offering</span>&#8221; or &#8220;<span style="font-weight:bold">IPO</span>&#8221; are to Supernova&#8217;s initial public offering that was consummated on March&#160;4, 2021; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Legacy Rigetti</span>&#8221; are to Rigetti Holdings, Inc., a Delaware corporation, and its consolidated subsidiaries since the consummation of the Rigetti Holding Company Reorganization on October&#160;5, 2021 and prior to the consummation of the Business Combination, and to Rigetti&#160;&amp; Co, Inc. and its consolidated subsidiaries prior to the consummation of the Rigetti Holding Company Reorganization on October&#160;5, 2021; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Legacy Rigetti Board</span>&#8221; are to the board of directors of Legacy Rigetti; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Legacy</span> <span style="font-weight:bold">Rigetti common stock</span>&#8221; are to the common stock of Legacy Rigetti; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Legacy Rigetti Preferred Stock</span>&#8221; are to, collectively, the shares of preferred stock, par value $0.000001 per share, of Legacy Rigetti, of which shares have been designated as Series C Preferred Stock and Series <span style="white-space:nowrap">C-1</span> Preferred Stock; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Merger Agreement</span>&#8221; are to that certain Merger Agreement, dated October&#160;6, 2021, by and among Supernova, Supernova Merger Sub, Inc., Supernova Romeo Merger Sub, LLC and Rigetti Holdings, Inc., and as amended on December&#160;23, 2021 and further amended on January&#160;10, 2022; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Nasdaq</span>&#8221; are to The Nasdaq Capital Market; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">NYSE</span>&#8221; are to the New York Stock Exchange; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">PIPE Financing</span>&#8221; are to the transactions consummated in connection with Closing pursuant to the Subscription Agreements, in which the PIPE Investors collectively subscribed for an aggregate of 14,641,244 shares of common stock for an aggregate purchase price of $147,510,000; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span>&#8220;<span style="font-weight:bold">private placement warrants</span>&#8221; or &#8220;<span style="font-weight:bold">Private Warrants</span>&#8221; are to the 4,450,000 private placement warrants that were issued to Supernova Sponsor as part of the closing of Supernova&#8217;s IPO, which are substantially identical to the public warrants sold as part of the units in Supernova&#8217;s IPO, subject to certain limited exceptions; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span>&#8220;<span style="font-weight:bold">public warrants</span>&#8221; or &#8220;<span style="font-weight:bold">Public Warrants</span>&#8221; are to the redeemable warrants (including those that underlie the Supernova units) that were offered and sold by Supernova in its IPO or the redeemable warrants of Rigetti issued as a matter of law upon the conversion thereof at the time of the Domestication, as context requires; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Rigetti assumed warrants</span>&#8221; are to the warrants to purchase Legacy Rigetti common stock which were assumed and converted into a warrant to purchase shares of common stock in connection with the Business Combination, with each Rigetti assumed warrant subject to the same terms and conditions as were applicable to the original Legacy Rigetti warrant and having an exercise price and number of shares of common stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Rigetti assumed options</span>&#8221; are to the options to purchase Legacy Rigetti common stock which were assumed and converted into an option to purchase shares of common stock in connection with the Business Combination, with each Rigetti assumed option subject to the same terms and conditions as were applicable to the original Legacy Rigetti option and having an exercise price and number of shares of common stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Rigetti assumed RSUs</span>&#8221; are to the restricted stock units to purchase Legacy Rigetti common stock which were assumed and converted into a restricted stock unit award to receive shares of common stock in connection with the Business Combination, with each Rigetti assumed RSU subject to the same terms and conditions as were applicable to the original Legacy Rigetti restricted stock unit award and the number of shares of common stock to which the Rigetti assumed RSU relates based on the Exchange Ratio and other terms contained in the Merger Agreement; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Rigetti Holding Company Reorganization</span>&#8221; are to the holding company reorganization pursuant to which (i)&#160;Rigetti&#160;&amp; Co, Inc. established Rigetti Holdings, Inc. and Rigetti Intermediate Merger Sub Inc., each as wholly owned subsidiaries of Rigetti&#160;&amp; Co, Inc., (ii) on October&#160;5, 2021, pursuant to an Agreement and Plan of Merger (the &#8220;Holding Company Merger Agreement&#8221;) by and among Rigetti&#160;&amp; Co, Inc., Rigetti Holdings, Inc. and Rigetti Intermediate Merger Sub, Inc., dated as of October&#160;5, 2021, Rigetti Intermediate Merger Sub, Inc. merged with and into Rigetti&#160;&amp; Co, Inc., with Rigetti&#160;&amp; Co, Inc. surviving such merger as a wholly owned subsidiary of Rigetti Holdings, Inc., with all of the outstanding equity securities of Rigetti&#160;&amp; Co, Inc. exchanged for identical equity securities of Rigetti Holdings, Inc. and (iii)&#160;on October&#160;6, 2021, Rigetti&#160;&amp; Co, Inc. was converted into a Delaware limited liability company and continues as &#8220;Rigetti&#160;&amp; Co, LLC&#8221;; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">SEC</span>&#8221; are to the Securities and Exchange Commission; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Securities Act</span>&#8221; are to the Securities Act of 1933, as amended; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Supernova</span> <span style="font-weight:bold">Class</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;A ordinary shares</span>&#8221; are to the Class&#160;A ordinary shares, par value $0.0001 per share, of Supernova, which were automatically converted, on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-for-one</span></span> basis, into shares of Rigetti common stock in connection with the Domestication; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Supernova</span> <span style="font-weight:bold">Class</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;B ordinary shares</span>&#8221; are to the Class&#160;B ordinary shares, par value $0.0001 per share, of Supernova which automatically converted in connection with the Domestication on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-for-one</span></span> basis, into shares of Rigetti common stock; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Supernova Sponsor</span>&#8221; are to Supernova Partners II LLC, a Cayman Islands exempted company; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Sponsor Support Agreement</span>&#8221; are to that certain Sponsor Agreement, dated as of October&#160;6, 2021, by and among Supernova Sponsor, Supernova and Legacy Rigetti, as amended and modified from time to time; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Sponsor Vesting Shares</span>&#8221; are to the 3,059,273 shares of common stock initially held by Supernova Sponsor and subject to vesting and forfeiture; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Subscription Agreements</span>&#8221; are to the Initial Subscription Agreements and the Subsequent Subscription Agreements, entered into by Supernova and each of the PIPE Investors in connection with the PIPE Financing; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Supernova</span>&#8221; are to Supernova Partners Acquisition Company II, Ltd., a Cayman Islands exempted company, prior to the consummation of the Business Combination; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Supernova Board</span>&#8221; are to Supernova&#8217;s board of directors; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Warrant Agreement</span>&#8221; or &#8220;<span style="font-weight:bold">warrant agreement</span>&#8221; are to the Warrant Agreement, dated March&#160;1, 2021, between Supernova and American Stock Transfer&#160;&amp; Trust Company, as warrant agent; and </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span>&#8220;<span style="font-weight:bold">warrants</span>&#8221; or &#8220;<span style="font-weight:bold">Warrants</span>&#8221; are to the public warrants and the private placement warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<span style="font-weight:bold">Warrant Subscription Agreement</span>&#8221; or &#8220;<span style="font-weight:bold">Forward Warrant Agreement</span>&#8221; are to that certain warrant subscription agreement, dated as of October&#160;6, 2021, by and between Ampere and Legacy Rigetti. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_4">PROSPECTUS SUMMARY </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">This summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should consider in making your investment decision. Before investing in our securities, you should carefully read this entire prospectus, including our consolidated financial statements and the related notes thereto and the information set forth in the sections titled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; Unless the context otherwise requires, we use the terms &#8220;Rigetti,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this prospectus to refer to Rigetti Computing, Inc. and our wholly owned subsidiaries. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We build quantum computers and the superconducting quantum processors that power them. We believe quantum computing represents one of the most transformative emerging capabilities in the world today. By leveraging quantum mechanics, we believe our quantum computers process information in fundamentally new, more powerful ways than classical computers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a vertically integrated company. We own and operate Fab-1, a unique wafer fabrication facility dedicated to prototyping and producing our quantum processors. Through Fab-1, we own the means of production of our breakthrough multi-chip quantum processor technology. We leverage our chips through a full-stack product development approach, from quantum chip design and manufacturing through cloud delivery. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have been deploying our quantum computers to end users over the cloud since 2017. We offer our full-stack quantum computing platform as a cloud service to a wide range of <span style="white-space:nowrap">end-users,</span> directly through our Rigetti QCS platform, and also through cloud service providers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have developed strong customer relationships and collaborative partnerships to accelerate the development of key technologies for high-value use cases that unlock strategic early markets. Our partners and customers include commercial enterprises such as Amazon Web Services, Ampere, Astex Pharmaceuticals, Deloitte, Microsoft, Nasdaq and Standard Chartered Bank, along with U.S. government organizations such as the Defense Advanced Research Project Agency (&#8220;DARPA&#8221;), the Department of Energy (&#8220;DOE&#8221;), and NASA. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are enabled by a deep technical team that includes global experts in quantum chip design and manufacturing, quantum computing systems architecture, quantum software, and quantum algorithms and applications. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Powered by the production of our scalable multi-chip quantum processors in <span style="white-space:nowrap">Fab-1</span> and our full-stack product development approach, our goal is to deliver quantum computing systems that demonstrate clear performance advantages over classical computing alternatives for multiple high-impact application areas. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Background </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Supernova was a blank check company incorporated on December&#160;22, 2020 in the Cayman Islands for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Closing Date, Rigetti consummated the Business Combination pursuant to the Merger Agreement. Supernova&#8217;s shareholders approved the Business Combination and Domestication at an extraordinary general meeting of shareholders held on February&#160;28, 2022 (the &#8220;Extraordinary General Meeting&#8221;). In connection with the Extraordinary General Meeting and the Business Combination, holders of 22,915,538 of Supernova&#8217;s Class&#160;A </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ordinary shares (&#8220;Supernova Class&#160;A ordinary shares&#8221;), or 66.4% of the shares with redemption rights, exercised their right to redeem their shares for cash at a redemption price of approximately $10.00 per share, for an aggregate redemption amount of $229,155,380. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;1, 2022, the business day prior to the Closing Date, Supernova effectuated the Domestication by filing a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filing a certificate of incorporation (the &#8220;Certificate of Incorporation&#8221;) and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which Supernova was domesticated and continues as a Delaware corporation. The board of directors of Rigetti (the &#8220;Board&#8221;) also adopted the Bylaws of the Company (the &#8220;Bylaws&#8221;) on March&#160;1, 2022, which became effective on that date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Domestication, Supernova changed its name from Supernova Partners Acquisition Company II, Ltd. to Rigetti Computing, Inc. As a result of and upon the effective time of the Domestication, among other things, (1)&#160;each then issued and outstanding Supernova Class&#160;A ordinary share converted automatically, on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-for-one</span></span> basis, into a share of common stock; (2)&#160;each then issued and outstanding Class&#160;B ordinary share, par value $0.0001 per share, of Supernova (&#8220;Supernova Class&#160;B ordinary share&#8221;) converted automatically, on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-for-one</span></span> basis, into a share of common stock; (3)&#160;each then issued and outstanding whole warrant of Supernova to purchase one Supernova Class&#160;A ordinary shares converted automatically into a warrant to acquire one share of common stock at an exercise price of $11.50 per share pursuant to the Warrant Agreement, dated March&#160;1, 2021 (the &#8220;warrant agreement&#8221;), between Supernova and American Stock Transfer&#160;&amp; Trust Company, as warrant agent; and (4)&#160;each then issued and outstanding unit of Supernova (the &#8220;Supernova Units&#8221;) was separated and converted automatically into one share of common stock and <span style="white-space:nowrap">one-fourth</span> of one warrant to purchase common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Closing Date, Rigetti consummated the First Merger and immediately following the First Merger, consummated the Second Merger. Immediately prior to the effective time of the First Merger, each share of Legacy Rigetti&#8217;s Series C preferred stock and Series <span style="white-space:nowrap">C-1</span> preferred stock (collectively, the &#8220;Legacy Rigetti Preferred Stock&#8221;), converted into shares of common stock of Legacy Rigetti (&#8220;Legacy Rigetti common stock&#8221;) in accordance with the Amended and Restated Certificate of Incorporation of Legacy Rigetti (such conversion, the &#8220;Legacy Rigetti Preferred Conversion&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the First Merger, among other things, (1)&#160;all outstanding shares of Legacy Rigetti common stock as of immediately prior to the Closing (including Legacy Rigetti common stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of calculated pursuant to the Merger Agreement and equal to 0.786989052873439 (the &#8220;Exchange Ratio&#8221;) for an aggregate of 78,959,579 shares of common stock, (2)&#160;each warrant to purchase Legacy Rigetti common stock was assumed and converted into a Rigetti assumed warrant, with each Rigetti assumed warrant subject to the same terms and conditions as were applicable to the original Legacy Rigetti warrant and having an exercise price and number of shares of common stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement, (3)&#160;each option to purchase Legacy Rigetti common stock was assumed and converted into an option to purchase shares of common stock (the &#8220;Rigetti assumed options&#8221;), with each Rigetti assumed option subject to the same terms and conditions as were applicable to the original Legacy Rigetti option and with an exercise price and number of shares of common stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement and (4)&#160;each Legacy Rigetti restricted stock unit award was assumed and converted into a restricted stock unit award to receive shares of common stock (the &#8220;Rigetti assumed RSU&#8221;), with each Rigetti assumed RSU subject to the same terms and conditions as were applicable to the original Legacy Rigetti restricted stock unit award and the number of shares of common stock to which the Rigetti assumed RSU relates based on the Exchange Ratio and other terms contained in the Merger Agreement. </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Merger Agreement, Supernova entered into Subscription Agreements (the &#8220;Initial Subscription Agreements&#8221;) with certain investors (together, the &#8220;Initial PIPE Investors&#8221;), pursuant to which the Initial PIPE Investors agreed to subscribe for and purchase, and Supernova agreed to issue and sell to the Initial PIPE Investors, an aggregate of 10,251,000 shares of common stock at a price of $10.00 per share, for aggregate gross proceeds of $102,510,000 (the &#8220;Initial PIPE Financing&#8221;). On December&#160;23, 2021, Supernova<span style="font-style:italic"> </span>entered into Subscription Agreements (the &#8220;Subsequent Subscription Agreements,&#8221; and together with the Initial Subscription Agreements, the &#8220;Subscription Agreements&#8221;) with two &#8220;accredited investors&#8221; (as such term is defined in Rule 501 of Regulation D) (the &#8220;Subsequent PIPE Investors,&#8221; and together with the Initial PIPE Investors, the &#8220;PIPE Investors&#8221;) pursuant to which the Subsequent PIPE Investors agreed to subscribe for and purchase, and Supernova agreed to issue and sell to the Subsequent PIPE Investors, an aggregate of 4,390,244 shares of common stock at a price of $10.25 per share, for aggregate gross proceeds of $45,000,000 (the &#8220;Subsequent PIPE Financing,&#8221; and together with the Initial PIPE Financing, the &#8220;PIPE Financing&#8221;). Pursuant to the Subscription Agreements, Rigetti agreed to provide the PIPE Investors with certain registration rights with respect to the shares purchased as part of the PIPE Financing. The PIPE Financing was consummated immediately prior to the Merger. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Ampere Warrant </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Merger Agreement, on October&#160;6, 2021, Legacy Rigetti entered into the Warrant Subscription Agreement with Ampere for the purchase of the Ampere Warrant for an aggregate purchase price (including amounts for exercise) of $10,000,000 pursuant to which the Ampere Warrant may be exercised by Ampere at an exercise price of $0.0001 per share for 1,000,000 shares of the Company&#8217;s common stock. The Warrant Subscription Agreement was assumed by the Company pursuant to the Merger Agreement in connection with the closing of the business combination pursuant to the Merger Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2022, pursuant to the Warrant Subscription Agreement, the Company issued the Ampere Warrant to Ampere upon receipt of an aggregate of $5&#160;million (including the exercise price), and upon such payment and issuance, 500,000 shares of common stock vested under the Ampere Warrant and were immediately exercised by Ampere pursuant to the terms of the Ampere Warrant. The purchase of the Ampere Warrant pursuant to the Warrant Subscription Agreement was conditioned upon, among other things, the consummation of the Business Combination pursuant to the Merger Agreement and the entry into a collaboration agreement between Legacy Rigetti and Ampere. Pursuant to the Warrant Subscription Agreement, Ampere is required to pay, subject to the satisfaction of certain conditions, an additional $4,999,950 (the &#8220;Additional Payment&#8221;) to the Company no later than the second anniversary of the date of the Warrant Subscription Agreement, and upon such payment, the 500,000 shares of common stock issuable upon the vesting and exercise of the unvested portion of the Ampere Warrant (the &#8220;Unexercised Warrant Shares&#8221;) will vest and be exercisable by Ampere pursuant to the terms of the Ampere Warrant. If the conditions to payment are not satisfied by the second anniversary of the date of the Warrant Subscription Agreement, the Company may reject Ampere&#8217;s payment of the Additional Payment and the Unexercised Warrant Shares will not vest or be exercisable and Ampere will have no further obligation with respect to the payment of the Additional Payment. The Ampere Warrant and the shares of common stock issued pursuant to the Ampere Warrant have not been registered under the Securities Act of 1933, as amended, and were issued in reliance on an exemption from such registration. We are registering the resale of the Shares as required by the registration rights contained in the Warrant Subscription Agreement. We cannot predict when or if the Additional Payment will be received by the Company and if the Unexercised Warrant Shares will vest and become exercisable, and it is possible that we may never receive the Additional Payment, that the Ampere Warrant will not be exercised for the additional 500,000 shares of common stock, and that the Unexercised Warrant Shares may never be issued. </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary Risk Factors </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of select risks and uncertainties that could materially adversely affect us and our business, financial condition and results of operations. Before you invest in our common stock, you should carefully consider all the information in this prospectus, including matters set forth under the heading &#8220;Risk Factors,&#8221; immediately following this prospectus summary. These risks include the following, among others: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Based on our estimates and current business plan, we expect that we will need to raise additional capital by late 2024 or early 2025 in order to continue our research and development efforts and achieve our business objectives. We cannot be sure that additional financing will be available. If we are unable to raise additional funding when needed, we may be required to delay, limit or substantially reduce our quantum computing development efforts. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We are in our early stages and have a limited operating history, which makes it difficult to forecast our future results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We have a history of operating losses and expect to incur significant expenses and continuing losses for the foreseeable future. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Even if the market in which we compete achieves its anticipated growth levels, our business could fail to grow at similar rates, if at all. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our ability to use net operating loss carryforwards and other tax attributes may be limited. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We have not produced quantum computers with high qubit counts and we face significant barriers in our attempts to produce quantum computers, including the need to invent and develop new technology. If we cannot successfully overcome those barriers, our business will be negatively impacted and could fail. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Any future generations of hardware, including any future generations developed to demonstrate narrow quantum advantage and broad quantum advantage and the anticipated release of an 84 qubit system, and 336 qubit system, each of which is an important anticipated milestone for our technology roadmap and commercialization, may not occur on our anticipated timeline or at all. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If our computers fail to achieve quantum advantage, our business, financial condition and future prospects may be harmed. Moreover, the standards by which we measure our progress may be based on assumptions and expectations that are not accurate or that may change as quantum computing evolves. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The quantum computing industry is competitive on a global scale and we may not be successful in competing in this industry or establishing and maintaining confidence in our long-term business prospects among current and future partners and customers. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We depend on a limited number of customers for a significant percentage of our revenue and the loss or temporary loss of a major customer for any reason could harm our financial condition. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A significant portion of our revenue depends on contracts with the public sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our business is currently dependent upon our relationship with our cloud providers. There are no assurances that we will be able to commercialize quantum computers from our relationships with cloud providers. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We rely on access to high performance third party classical computing through public clouds, high performance computing centers and <span style="white-space:nowrap">on-premises</span> computing infrastructure to deliver performant quantum solutions to customers. We may not be able to maintain high quality business relationships and connectivity with these resources which could make it harder for us to reach customers or deliver solutions in a cost-effective manner. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We depend on certain suppliers to source products. Failure to maintain our relationship with any of these suppliers, or a failure to replace any of these suppliers, could have a material adverse effect on our business, financial position, results of operations and cash flows. </p></td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our system depends on the use of certain development tools, supplies, equipment and production methods. If we are unable to procure the necessary tools, supplies and equipment to build our quantum systems, or are unable to do so on a timely and cost-effective basis, and in sufficient quantities, we may incur significant costs or delays which could negatively affect our operations and business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Even if we are successful in developing quantum computing systems and executing our strategy, competitors in the industry may achieve technological breakthroughs which render our quantum computing systems obsolete or inferior to other products. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We may be unable to reduce the cost of developing our quantum computers, which may prevent us from pricing our quantum systems competitively. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The quantum computing industry is in its early stages and volatile, and if it does not develop, if it develops slower than we expect, if it develops in a manner that does not require use of our quantum computing solutions, if it encounters negative publicity or if our solution does not drive commercial engagement, the growth of our business will be harmed. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We could suffer disruptions, outages, defects and other performance and quality problems with our quantum computing systems, our production technology partners or with the public cloud, data centers and internet infrastructure on which we rely. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; and other adverse consequences, which may adversely affect our business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We have identified material weaknesses in our internal control over financial reporting related to the lack of effective review controls over the accounting for complex financial instruments and to the design and operation of our overall closing and financial reporting processes, and we may identify additional material weaknesses in the future. The material weakness over accounting for complex financial instruments has resulted in errors in financial statements for prior periods. If we fail to remediate such material weaknesses, if we identify additional material weaknesses or if we otherwise fail to establish and maintain effective control over financial reporting, it may adversely affect our ability to accurately and timely report our financial results in the future, and may adversely affect investor confidence, our reputation, our ability to raise additional capital and our business operations and financial condition. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our failure to obtain, maintain and protect our intellectual property rights could impair our ability to protect and commercialize our proprietary products and technology and cause us to lose our competitive advantage. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">There can be no assurance that we will be able to regain compliance with the continued listing standards of Nasdaq. If we fail to cure our current deficiency and regain compliance with the listing requirements of the Nasdaq Capital Market or fail to comply with such listing requirements in the future or fail to cure any future deficiencies, we may be delisted and the price of our common stock and our ability to access the capital markets could be negatively impacted. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Sales of our securities, or perceptions of sales, by us or holders of our securities in the public markets or otherwise could cause the market price for our securities to decline and even in such case certain holders of our securities may still have an incentive to sell our securities. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Delaware law and our Certificate of Incorporation and Bylaws contain certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Unstable market and economic conditions, including the recent bank failure of Silicon Valley Bank, have had and may continue to have serious adverse consequences on our business, financial condition and share price. </p></td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our warrants, including our public warrants, private placement warrants and other warrants we have issued, are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our warrants are exercisable for common stock, the exercise of which would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The warrants may never be in the money, and they may expire worthless. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Corporate Information </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 775 Heinz Avenue, Berkeley, CA 94710 and our telephone number is (510) <span style="white-space:nowrap">210-5550.</span> Our corporate website address is <span style="font-style:italic">www.rigetti.com</span>. Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;Rigetti&#8221; and our other registered and common law trade names, trademarks and service marks are property of Rigetti Computing, Inc. This prospectus contains additional trade names, trademarks and service marks of others, which are the property of their respective owners. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the <sup style="font-size:75%; vertical-align:top">&#174;</sup> or <sup style="font-size:75%; vertical-align:top">&#8482;</sup> symbols. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Emerging Growth Company and Smaller Reporting Company Status </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;). As an emerging growth company, we are exempt from certain requirements related to executive compensation, including the requirements to hold a nonbinding advisory vote on executive compensation and to provide information relating to the ratio of total compensation of our Chief Executive Officer to the median of the annual total compensation of all of our employees, each as required by the Investor Protection and Securities Reform Act of 2010, which is part of the Dodd-Frank Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to <span style="white-space:nowrap">non-emerging</span> growth companies, and any such election to not take advantage of the extended transition period is irrevocable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Supernova previously elected to avail itself of the extended transition period and we will take advantage of the benefits of the extended transition period emerging growth company status permits. During the extended transition period, it may be difficult or impossible to compare our financial results with the financial results of another public company that complies with public company effective dates for accounting standard updates because of the potential differences in accounting standards used. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will remain an emerging growth company under the JOBS Act until the earliest of (a)&#160;December 31, 2026 (the last day of the fiscal year following the fifth anniversary of the consummation of the IPO), (b) the last date of our fiscal year in which we have a total annual gross revenue of at least $1.07&#160;billion, (c)&#160;the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the rules of the SEC with at least $700.0&#160;million of outstanding securities held by <span style="white-space:nowrap">non-affiliates</span> or (d)&#160;the date on which we have issued more than $1.0&#160;billion in <span style="white-space:nowrap">non-convertible</span> debt securities during the previous three years. </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as the market value of our voting and <span style="white-space:nowrap">non-voting</span> common stock held by <span style="white-space:nowrap">non-affiliates</span> is less than $250.0&#160;million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0&#160;million during the most recently completed fiscal year and the market value of our voting and <span style="white-space:nowrap">non-voting</span> common stock held by <span style="white-space:nowrap">non-affiliates</span> is less than $700.0&#160;million measured on the last business day of our second fiscal quarter. </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_5">THE OFFERING </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Issuer </p></td>
<td>Rigetti Computing, Inc. </td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Resale of common stock </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Shares of common stock offered by the selling stockholder </p></td>
<td>We are registering the resale by the selling stockholder, or its permitted transferees, an aggregate of up to 500,000 outstanding shares of common stock issued upon exercise of the vested portion of the Ampere Warrant. </td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </p></td>
<td>We will not receive any of the proceeds from the sale of the Shares by the selling stockholder. </td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Market for common stock and public warrants </p></td>
<td>Our common stock is currently traded on Nasdaq under the symbol &#8220;RGTI&#8221;. </td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="vertical-align:TOP">
<td style="width:38%"> <p style=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </p></td>
<td>Before investing in our securities, you should carefully read and consider the information set forth in &#8220;Risk Factors&#8221; beginning on page 16. </td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For additional information concerning the offering, see &#8220;<span style="font-style:italic">Plan of Distribution</span>&#8221; beginning on page 161. </p>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_6">RISK FACTORS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below together with all of the other information contained in this prospectus, including our financial statements and related notes appearing at the end of this prospectus and in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; before deciding to invest in our common stock. If any of the events or developments described below were to occur, our business, prospects, operating results and financial condition could suffer materially, the trading price of our common stock could decline, and you could lose all or part of your investment. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Our Financial Condition and Status as an Early-Stage Company </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Based on our estimates and current business plan, we expect that we will need to raise additional capital by late 2024 or early 2025 in order to continue our research and development efforts and achieve our business objectives. We will require a significant amount of cash for expenditures as we invest in ongoing research and development and business operations and may need additional capital sooner than planned to pursue our business objectives and respond to business opportunities, challenges or unforeseen circumstances, and we cannot be sure that additional financing will be available. If we are unable to raise additional funding when needed, we may be required to delay, limit or substantially reduce our quantum computing development efforts. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business and future plans for expansion are capital-intensive, and the specific timing of cash inflows and outflows may fluctuate substantially from period to period. We will require a significant amount of cash for expenditures as we invest in ongoing research and development and business operations. For example, in addition to our continuing investment in our technology roadmap we may continue to invest in the expansion of and upgrades to our Fab-1 facility. In addition to increased electrical utility fees going forward, we may be required to pay additional amounts in taxes, penalties or otherwise related to the electrical utility fees that were unpaid and unrecognized in prior periods as discussed in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in this prospectus. We have incurred and expect to incur costs related to, among other things, the reduction in workforce that we announced in February 2023 and our recent management transitions, in addition to expenses relating to the remediation of our material weaknesses in internal controls over financial reporting. The actual amounts we may be required to spend on these and other matters may be greater and more significant than our expectations. We believe that our existing cash, cash equivalents and marketable securities should be sufficient to meet our anticipated operating cash needs for at least the next 12 months based on our current business plan, and expectations and assumptions considering current macroeconomic conditions. Based on our estimates and current business plan, we expect that we will need to obtain additional capital by late 2024 or early 2025 in order to continue our research and development efforts and achieve our business objectives. Our operating plan may change because of factors currently unknown, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations or other transactions. In addition, we may seek additional capital even if we believe that we have sufficient funds for current or future operating plans. Such financings may result in dilution to stockholders, issuance of securities with priority as to liquidation and dividend and other rights more favorable than common stock, imposition of debt covenants and repayment obligations or other restrictions that may adversely affect our business. Any funds we raise may not be sufficient to enable us to continue to implement our long-term business strategy. Further, our ability to raise additional capital may be adversely impacted by worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide resulting from, the continuing impacts of the COVID-19 pandemic, recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures and military conflict with Russia and Ukraine and the related sanctions imposed against Russia. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. A severe or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prolonged economic downturn could result in a variety of risks to our business, including weakened demand for our products and services and our ability to raise additional capital when needed on acceptable terms, if at all. If the equity and credit markets continue to deteriorate, it may make any necessary debt or equity financing more difficult, more costly, and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could impair our ability to achieve our growth strategy, could harm our financial performance and stock price and could require us to delay or abandon our business plans. We cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business. There can be no assurance that financing will be available to us on favorable terms, or at all. The inability to obtain financing when needed may make it more difficult for us to operate our business or implement our growth plans and we may be required to delay, limit or substantially reduce our quantum computing development efforts. In addition, our ability to raise additional capital through the sale of securities could be significantly impacted by the resale of our securities by holders of our securities which could result in a significant decline in the trading price of our securities and potentially hinder our ability to raise capital at terms that are acceptable to us or at all. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are in our early stages and have a limited operating history, which makes it difficult to forecast our future results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business was founded in 2013 and has operated quantum computers over the cloud since 2017. As a result of our limited operating history, our ability to accurately forecast the future results of operations is limited and subject to a number of uncertainties, including our ability to plan for and model future growth. Our ability to generate revenues will largely be dependent on our ability to develop and produce quantum computers with increasing numbers of quantum bits (&#8220;qubits&#8221;) and with increasing levels of performance. As of April&#160;5, 2023 the highest number of qubits we have externally deployed is a quantum computer with 80 qubits with 94.5% median fidelities As a result, our scalable business model has not been formed and our technology roadmap may not be realized as quickly as hoped, or even at all. We have in the past failed to meet publicly announced milestones and may fail to meet projected technological milestones in the future. In addition, we have in the past changed our technology roadmap, including anticipated milestones and timing thereof. For example, in 2018, we announced that we planned to build and deploy a <span style="white-space:nowrap">128-qubit</span> system over the subsequent twelve months, but have not to date built a <span style="white-space:nowrap">128-qubit</span> system. In addition, in 2022 we updated our technology roadmap, including anticipated timing for the 84Q Ankaa system, the 336Q Lyra system, 1,000+ qubit system, 4,000+ qubit system and incremental milestones relating to applications, access and production, Quantum Cloud Services (&#8220;Quantum Cloud Services&#8221; or &#8220;QCS&#8221;), quantum processing units and chip fabrication. We revised our technology roadmap in February 2023 to reflect our updated business strategy, including our plan to first concentrate on the goal of delivering the <span style="white-space:nowrap">Ankaa-1</span> <span style="white-space:nowrap">84-qubit</span> system, then prioritize increasing the performance of the anticipated <span style="white-space:nowrap">Ankaa-1</span> <span style="white-space:nowrap">84-qubit</span> system by focusing efforts on improving performance with an anticipated <span style="white-space:nowrap">Ankaa-2</span> <span style="white-space:nowrap">84-qubit</span> system, and thereafter scale to develop the anticipated Lyra <span style="white-space:nowrap">336-qubit</span> system, and after our internal deployment of Ankaa-1 in March 2023, we further refined this plan to reflect that we plan to continue to work to improve Ankaa-1 performance before the potential external release of the system to select customers. We may further update the technology roadmap in the future, including anticipated milestones and anticipated timeline for milestones. Furthermore, we may be unable to achieve the milestones in our technology roadmap on their announced anticipated timeline or at all. The development of our scalable business model will likely require the incurrence of a substantially higher level of costs than incurred to date, while our revenues will not substantially increase unless and until more powerful, scalable, higher performing computers are produced, which requires a number of technological advancements which may not occur on the currently anticipated timetable or at all. As a result, our historical results should not be considered indicative of our future performance. Further, in future periods, our growth could slow or decline for a number of reasons, including but not limited to slowing demand for our Quantum Cloud Services (&#8220;Quantum Cloud Services&#8221; or &#8220;QCS&#8221;), increased competition, changes to technology, inability to scale up or improve performance of our technology, a decrease in the growth of the market, or our failure, for any reason, to continue to take advantage of growth opportunities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also encountered, and will continue to encounter, risks and uncertainties frequently experienced by growing companies in rapidly changing industries. If our assumptions regarding these risks and uncertainties and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our future growth are incorrect or change, or if we do not address these risks successfully, our operating and financial results could differ materially from our expectations, and our business could suffer. Our success as a business ultimately relies upon fundamental research and development breakthroughs in the coming years. There is no certainty these research and development milestones will be achieved as quickly as hoped, or even at all. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have a history of operating losses and expect to incur significant expenses and continuing losses for the foreseeable future. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incurred net losses of $71.5&#160;million and $41.7&#160;million for the year ended December&#160;31, 2022 and the twelve months ended December&#160;31, 2021, respectively, and $38.2&#160;million for the eleven months ended December&#160;31, 2021. As of December&#160;31, 2022, we had an accumulated deficit of $278.7&#160;million. We believe that we will continue to incur operating and net losses each quarter until at least the time we begin generating significant revenue from our narrow or broad quantum advantage quantum computers, which may never occur. Even with significant production, our services may never become profitable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect the rate at which we will incur losses to be significantly higher in future periods as we, among other things, continue to incur significant expenses in connection with the design, development and manufacturing of our quantum computers; and as we expand our research and development activities; invest in manufacturing capabilities; build up inventories of components for our quantum computers; increase our sales and marketing activities; develop our infrastructure; and increase our general and administrative functions to support our growing operations and our being a public company. We may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in revenues, which would further increase our losses. If we are unable to achieve and/or sustain profitability, or if we are unable to achieve the growth that we expect from these investments, it could have a material effect on our business, financial condition or results of operations. Our business model is unproven and may never allow us to cover our costs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our operating results may be adversely affected by unfavorable economic and market conditions. We have recorded a charge for goodwill impairment and may in the future be required to record significant charges for impairment of other assets or investments. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An adverse change in market conditions, including a sustained decline in our stock price, negative changes to the Company&#8217;s position in the market, or lack of growth in demand for our products and services could be considered to be an impairment triggering event. Such changes in the future could impact valuation assumptions relating to the recoverability of assets and may result in impairment charges to our long-lived assets, other assets or investments, which would negatively impact our operating results and harm our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are inherent uncertainties in management&#8217;s estimates, judgments and assumptions used in assessing recoverability of goodwill, intangible, and other long-lived assets. Any material changes in key assumptions, including failure to meet business plans, a deterioration in the U.S. and global financial markets, an increase in interest rates or an increase in the cost of equity financing by market participants within the industry or other unanticipated events and circumstances, may decrease our projected cash flows or increase discount rates and could potentially result in an impairment charge. From time to time, we may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, in assessing our goodwill in connection with the preparation of the financial statements for the fiscal year ended December&#160;31, 2022, we concluded indicators of impairment were present due to the current macroeconomic conditions, including continued declines in our stock price. Based upon the results of the impairment test, we recorded a goodwill impairment charge of $5.4&#160;million within the consolidated statement of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may not be able to scale our business quickly enough to meet customer and market demand, which could result in lower profitability or cause us to fail to execute on our business strategies. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to grow our business, we will need to continually evolve and scale our business and operations to meet customer and market demand. Quantum computing technology has never been sold at large-scale commercial levels. Evolving and scaling our business and operations places increased demands on our management as well as our financial and operational resources to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">attract new customers and grow our customer base; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">maintain and increase the rates at which existing customers use our platform, sell additional products and services to our existing customers, and reduce customer churn; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">invest in our platform and product offerings; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">effectively manage organizational change; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">accelerate and/or refocus research and development activities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expand manufacturing and supply chain capacity; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increase sales and marketing efforts; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">broaden customer-support and services capabilities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">maintain or increase operational efficiencies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">implement appropriate operational and financial systems; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">establish and maintain effective financial disclosure controls and procedures and remediate material weaknesses thereof. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Commercial traction of quantum computing technology may never occur. As noted above, there are significant technological challenges associated with developing, producing, marketing and selling services in the advanced technology industry, including our services, and we may not be able to resolve all of the difficulties that may arise in a timely or cost-effective manner, or at all. We may not be able to cost effectively manage production at a scale or quality consistent with customer demand in a timely or economical manner. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to scale is dependent also upon components we must source from multiple industries including: from the electronics industry with <span style="white-space:nowrap">low-noise</span> microwave components, CPUs, GPUs, FPGAs; cryogenic industry with dilution refrigerators and associated helium gas products; and from the semiconductor industry with silicon wafers and other specialty materials, tooling and measurement equipment. Shortages or supply interruptions in any of these components will adversely impact our ability to deliver revenues. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If large-scale development of our quantum computers commences, our computers may contain defects in design and manufacture that may cause them to not perform as expected or that may require repair and design changes. Our quantum computers are inherently complex and incorporate technology and components that have not been used for other applications and that may contain defects and errors, particularly when first introduced. We have a limited frame of reference from which to evaluate the long-term performance of our computers. There can be no assurance that we will be able to detect and fix any defects in our quantum computers in a timely manner that does not disrupt our services to our customers. If our technology fails to perform as expected, customers may seek out a competitor or turn away from quantum computing entirely, each of which could adversely affect our sales and brand and could adversely affect our business, prospects and results of operations. If defects in our technology lead to erroneous outputs, third parties relying on those outputs may draw from them erroneous conclusions, creating a risk that we will be liable to those third parties. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we cannot evolve and scale our business and operations effectively, we may not be able to execute our business strategies in a cost-effective manner and our business, financial condition, profitability and results of operations could be adversely affected. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Even if the market in which we compete achieves its anticipated growth levels, our business could fail to grow at similar rates, if at all. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success will depend upon our ability to expand, scale our operations, and increase our sales and support capability. Even if the market in which we compete meets the size estimates and growth forecasted, our business could fail to grow at similar rates, if at all. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our growth is dependent upon our ability to successfully expand our solutions and services, retain customers, bring in new customers and retain critical talent. Unforeseen issues associated with scaling up and constructing quantum computing technology at commercially viable levels could negatively impact our business, financial condition and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our growth is dependent upon our ability to successfully market and sell our quantum computing services and solutions. We do not have experience with the large-scale production and sale of quantum computing technology. Our growth and long-term success will depend upon the development of our sales and retention capabilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, because of our unique technology, our customers will require particular support and service functions, some of which are not currently available, and may never be available. If we experience delays in adding such support capacity or servicing our customers efficiently, or experiences unforeseen issues with the reliability of our technology, we could overburden our servicing and support capabilities. Similarly, increasing the number of our products and services would require us to rapidly increase the availability of these services. Failure to adequately support and service our customers may inhibit our growth and ability to expand. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no assurance that we will be able to ramp our business to meet our sales, manufacturing, installation, servicing and quantum computing targets globally, that expected growth levels will prove accurate or that the pace of growth or coverage of our customer infrastructure network will meet customer expectations. For example, our competitors may achieve certain narrow and/or broad quantum milestones faster than us, which may negatively impact our business and prospects. Failure to grow at rates similar to that of the quantum computing industry may adversely affect our operating results and ability to effectively compete within the industry. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may not manage growth effectively, including with respect to our employee base, and managing our operations successfully. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure to manage growth effectively could harm our business, results of operations and financial condition. We anticipate that a period of significant expansion will be required to address potential growth. This expansion will place a significant strain on our management, operational and financial resources. For example, the expansion of our Fab 1 facility is ongoing and we may not complete the expansion on terms originally anticipated, in a timely manner or at all, which could have a material impact on our business, financial condition or results of operations. Expansion will require significant cash investments and management resources and there is no guarantee that they will generate additional sales of our products or services, or that we will be able to avoid cost overruns or be able to hire additional personnel to support us. In addition, we will also need to ensure our compliance with regulatory requirements in various jurisdictions applicable to the sale, installation and servicing of our products. To manage the growth of our operations and personnel, we must establish appropriate and scalable operational and financial systems, procedures and controls and establish and maintain a qualified finance, administrative and operations staff. The reduction in workforce that we announced in February 2023 may impair our ability to manage growth and maintain operations effectively, due to factors such as loss of institutional knowledge and expertise, employee attrition beyond our intended reduction in force, a reduction in morale among our remaining employees, greater-than-anticipated costs incurred in connection with implementing the restructuring, and the risk that we may not achieve the benefits from the restructuring to the extent or as quickly as we anticipate, all of which may have a material adverse effect on our business, results of operations or financial condition. We may be unable to acquire the necessary capabilities and personnel required to manage growth or to identify, manage and exploit potential strategic relationships and market opportunities. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our recent updates to our business plan and workforce reduction may not have the anticipated benefits and we may incur additional costs or other difficulties. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2023, we announced an updated business plan and implemented a workforce reduction. The objective of these initiatives is to focus our organization and its resources on nearer-term strategic priorities. We believe these changes were needed to streamline our organization and reallocate our resources to better align with our current strategic goals. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, the changes to our business strategy and the reduction in workforce may yield unintended consequences and costs, such as the loss of institutional knowledge and expertise, attrition beyond our intended <span style="white-space:nowrap"><span style="white-space:nowrap">reduction-in-force,</span></span> a reduction in morale among our remaining employees, and the risk that we may not achieve the anticipated benefits, all of which may have an adverse effect on our development activities, ability to progress our technology roadmap, and results of operations or financial condition. We may also incur other charges, costs, future cash expenditures or impairments not currently contemplated due to events that may occur as a result of, or in connection with, the revised business plan and reduction in workforce. In addition, we may be unsuccessful in distributing the duties and obligations of departed employees among our remaining employees. In addition, our management may need to divert a disproportionate amount of its attention away from our <span style="white-space:nowrap"><span style="white-space:nowrap">day-to-day</span></span> strategic and operational activities and devote a substantial amount of time to managing these organizational changes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also discover that the reductions in workforce and cost cutting measures will make it difficult for us to pursue new opportunities and initiatives and require us to hire qualified replacement personnel, which may require us to incur additional and unanticipated costs and expenses. Moreover, there is no assurance we will be successful in our pursuit of any of our new goals. Our failure to successfully accomplish any of the above activities and goals may have a material adverse impact on our business, financial condition, and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have a credit facility secured by substantially all of our assets under which we have borrowed and may in the future borrow additional amounts; any indebtedness thereunder could adversely affect our financial position and our ability to raise additional capital and prevent us from fulfilling our obligations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;10, 2021, we entered into a Loan and Security Agreement (as amended from time to time, the &#8220;Loan Agreement&#8221;) with Trinity Capital Inc. (&#8220;Trinity&#8221;). The credit facility had an available borrowing capacity of $32.0&#160;million. As of December&#160;31, 2022, we had total outstanding indebtedness of approximately $30.7&#160;million consisting of outstanding borrowings under the Loan Agreement. Any future additional borrowings under this agreement are at the sole discretion of the lender. This and future indebtedness incurred under the Loan Agreement may: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">limit our ability to borrow additional funds for working capital, capital expenditures, acquisitions, or other general business purposes; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">require us to use a portion of our cash flow from operations to make debt service payments instead of other purposes, thereby reducing the amount of cash flow available for future working capital, capital expenditures, acquisitions, or other general business purposes; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expose us to the risk of increased interest rates as following the consummation of our initial public offering borrowings under the Loan Agreement are subject to interest at the greater of (i)&#160;a floating per annum rate equal to 7.5% above the prime rate, or (ii)&#160;a fixed per annum rate equal to 11.0%, also paid on a monthly basis; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">limit our flexibility to plan for, or react to, changes in our business and industry; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increase our vulnerability to the impact of adverse economic, competitive and industry conditions; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increase our cost of borrowing. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The credit facility is secured by substantially all of our assets. In addition, the Loan Agreement contains, and the agreements governing our future indebtedness may contain, restrictive covenants that may limit our ability to engage in activities that may be in our long-term best interest. These restrictive covenants include, among others, financial reporting requirements and limitations on indebtedness, liens, mergers, consolidations, liquidations and dissolutions, sales of assets, dividends and other restricted payments, investments (including acquisitions) and transactions with affiliates. Our failure to comply with those covenants could result in an event of default which, if not cured or waived, could result in the acceleration of substantially all of our debt and potentially the foreclosure on our assets in the event we are unable to repay all amounts owed. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our ability to use net operating loss carryforwards and other tax attributes may be limited. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred losses during our history, do not expect to become profitable in the near future and may never achieve profitability. To the extent that we continue to generate taxable losses, unused losses will carry forward to offset future taxable income, if any, until such unused losses expire, if at all. As of December&#160;31, 2022 we had U.S. federal net operating loss carryforwards of approximately $234.7&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under current law, U.S. federal net operating loss carryforwards generated in taxable periods beginning after December&#160;31, 2017, may be carried forward indefinitely, but the deductibility of such net operating loss carryforwards is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to current federal law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), our federal net operating loss carryforwards and other tax attributes may become subject to an annual limitation in the event of certain cumulative changes in our ownership. An &#8220;ownership change&#8221; pursuant to Section&#160;382 of the Code generally occurs if one or more stockholders or groups of stockholders who own at least 5% of a company&#8217;s stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Our ability to utilize our net operating loss carryforwards and other tax attributes to offset future taxable income or tax liabilities may be limited as a result of ownership changes, including changes in connection with the Business Combination or other transactions. Similar rules may apply under state tax laws. We have not yet determined the amount of the cumulative change in our ownership resulting from the Business Combination or other transactions, or any resulting limitations on our ability to utilize our net operating loss carryforwards and other tax attributes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we earn taxable income, such limitations could result in increased future income tax liability and our future cash flows could be adversely affected. We have recorded a valuation allowance related to our net operating loss carryforwards and other deferred tax assets due to the uncertainty of the ultimate realization of the future benefits of those assets. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Our Business and Industry </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have not produced quantum computers with high qubit counts or at volume and we face significant barriers in our attempts to produce quantum computers, including the need to invent and develop new technology. If we cannot successfully overcome those barriers, our business will be negatively impacted and could fail. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Producing quantum computers is a difficult undertaking. There are significant engineering challenges that we must overcome to build our quantum computers. We are still in the development stage and face significant challenges in completing development of our quantum computers and in producing quantum computers in sufficient volumes. Some of the development challenges that could prevent the introduction of our quantum computers include, but are not limited to, failure to find scalable ways to manipulate qubits, failure to reduce error rates, failure to transition quantum systems to leverage <span style="white-space:nowrap">low-cost</span> components, and failure to realize multi-chip quantum computer technology. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we complete development and achieve volume production of our quantum computers, if the cost, accuracy, performance characteristics or other specifications of the quantum computer fall short of our expectations, our business, financial condition and results of operations would be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Any future generations of hardware and software developed to demonstrate narrow quantum advantage and broad quantum advantage, and the anticipated release of an 84 qubit system and a subsequent 84 qubit system with reduced error rates, and the potential later release of a 336 qubit system, each of which is an important anticipated milestone for our technology roadmap and commercialization, may not occur on our anticipated timeline or at all. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our successful execution of our technology roadmap is based on the development of multiple generations of quantum computing systems, including hardware that demonstrates narrow quantum advantage and broad quantum advantage, and the anticipated release of an 84 qubit system and a subsequent 84 qubit system with error rates reduced to 1% or lower, in addition to the potential release of a 336 qubit system. The future success of our technology roadmap will depend upon our ability to continue to increase the number of qubits and decrease error rates in each subsequent generation of our quantum computer. If we are unable to achieve the increase in the number of qubits or decrease in error rates on the timeframe that we anticipate, the availability of future generations of quantum computer systems may be materially delayed, or may never occur. In the past we have failed to meet publicly announced milestones and may fail to meet projected milestones in the future. If our technology roadmap is delayed or never achieved, this would have a material impact on our business, financial condition or results of operations. See &#8220;<span style="font-style:italic">We are in our early stages and have a limited operating history, which makes it difficult to forecast our future results of operations</span>.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If our computers fail to achieve quantum advantage, our business, financial condition and future prospects may be harmed. Moreover, the standards by which we measure our progress may be based on assumptions and expectations that are not accurate or that may change as quantum computing evolves. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantum advantage refers to the moment when a quantum computer can compute faster than traditional computers, while quantum supremacy is achieved once quantum computers are powerful enough to complete calculations that traditional supercomputers cannot perform at all. Narrow quantum advantage is when a quantum computer is able to solve practical problems in production workloads with improved accuracy, speed or cost. Broad quantum advantage is when quantum advantage is seen in many applications and developers prefer quantum computers to a traditional computer. No current quantum computers, including our quantum hardware, have reached broad quantum advantage, and may never reach such advantage. Achieving narrow quantum advantage and broad quantum advantage will be critical to the success of any quantum computing company, including ours. However, achieving quantum advantage would not necessarily lead to commercial viability of the technology that accomplished such advantage, nor would it mean that such system could outperform classical computers in tasks other than the one used to determine a quantum advantage. In addition, the definitions and expectations with respect to what constitutes quantum advantage, including the anticipated stages of quantum technology maturation, may continue to evolve and may also diverge from others in the industry. Quantum computing technology, including narrow quantum advantage and broad quantum advantage, may take years or decades to be realized, if ever. In addition, the standards by which we measure our progress may be based on assumptions and expectations that are not accurate or that may change as quantum computing evolves. For example, CLOPS as a speed test was originally developed by IBM in October 2021. To our knowledge, CLOPS as a speed test has not been investigated or verified by any independent third party. In addition, while we have applied CLOPS in testing the speed of our <span style="white-space:nowrap"><span style="white-space:nowrap">Aspen-M-2</span></span> and <span style="white-space:nowrap">Aspen-11</span> systems, there is no guarantee that we applied the test in the same way as IBM and, as a result, any variability in the application of the test as between Rigetti, IBM or others in the industry that may apply CLOPS in the future could render CLOPS scores incomparable and actual relative performance may materially differ from reported results. Other than IBM, others in the industry have not announced CLOPS as a speed test. As a result, the speed of other competitors as measured by CLOPS is not currently known. In addition, the solution accuracy provided by quantum computers is another key factor, and a quantum computer that may be slower may be preferable to users if it provides a </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
more accurate answer for certain applications. Moreover, the relative leads reflected by speed tests such as CLOPS can change as new generations of quantum computers are introduced by industry participants and, consequently, any advantages cannot be considered permanent and can be expected to change from time to time. Current CLOPS tests may not be indicative of the results of future tests. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we cannot develop quantum computers that have quantum advantage, customers may not continue to purchase our products and services. If other companies&#8217; quantum computers reach narrow quantum advantage or broad quantum advantage prior to the time we reach such capabilities, it could lead to a loss of customers. If any of these events occur, it could have a material adverse effect on our business, financial condition or results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may expend our resources to pursue particular products, designs, sectors or investments and we may fail to capitalize on such products, designs, sectors or investments and/or forego other products, designs, sectors or investments that may have been more profitable or for which there may have been a greater likelihood of success. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we have limited financial and operational resources, we must prioritize our research and development for use of quantum computing within certain products, designs, sectors or investments. Correctly prioritizing our research and development activities is particularly important for us due to the breadth of companies building or seeking to build universal, gate-model quantum computing systems that can meet the requirements for solving commercial problems. As a result, we may forego or delay pursuit of opportunities in other products, designs, sectors or investments that later prove to have greater commercial potential and ability to achieve quantum advantage. For example, although we currently believe that quantum machine learning for finance is poised to be an early domain of quantum advantage through rapid value capture from quick integration, the risks associated with developing a product that can compute algorithms that scale efficiently to real-world size applications and will be applicable to multiple use cases and competition in creating such a product, among others, could outweigh the benefits. In addition, in February 2023, we announced an updated business strategy and revisions to our technology roadmap reflecting a nearer term reprioritization and focus on lower qubit systems than our prior business strategy and technology roadmap. We may fail to capitalize on the products, designs, sectors, or investments we choose to pursue, and our resource allocation decisions may cause us to or forego viable or more profitable products, designs, sectors or investments, which would have an adverse effect on our business, prospects and financial results. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The quantum computing industry is competitive on a global scale and we may not be successful in competing in this industry or establishing and maintaining confidence in our long-term business prospects among current and future partners and customers. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The markets in which we operate are rapidly evolving and highly competitive. As the marketplace continues to mature and new technologies and competitors enter, we expect competition to intensify. Our current competitors include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">large, well-established tech companies that generally compete across our products, including Quantinuum, Google, Microsoft, Amazon, Intel and IBM; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">large research organizations funded by sovereign nations such as China, Russia, Canada, Australia and&#160;the United Kingdom, and those in the European Union as of the date of this prospectus and we believe additional countries in the future; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">less-established public and private companies with competing technology, including companies located outside the United States; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">new or emerging entrants seeking to develop competing technologies. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We compete based on various factors, including technology, performance, multi-cloud availability, brand recognition and reputation, customer support and differentiated capabilities, including ease of administration and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
use, scalability and reliability, data governance and security. Many of our competitors have substantially greater brand recognition, customer relationships, and financial, technical and other resources, including an experienced sales force and sophisticated supply chain management. They may be able to respond more effectively than us to new or changing opportunities, technologies, standards, customer requirements and buying practices. In addition, many countries are focused on developing quantum computing solutions either in the private or public sector and may subsidize quantum computers which may make it difficult for us to compete. Many of these competitors do not face the same challenges we do in growing our business. In addition, other competitors might be able to compete with us by bundling their other products in a way that does not allow us to offer a competitive solution. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we must be able to achieve our objectives in a timely manner lest quantum computing lose ground to competitors, including competing technologies. For example, our competitors may achieve certain narrow and/or broad quantum milestones faster than us, which may negatively impact our business and prospects. Because there are a large number of market participants, including certain sovereign nations, focused on developing quantum computing technology, we must dedicate significant resources to achieving any technical objectives on the timelines established by our management team. Any failure to achieve objectives in a timely manner could adversely affect our business, operating results and financial condition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all of these reasons, competition may negatively impact our ability to maintain and grow consumption of our platform or put downward pressure on our prices and gross margins, any of which could materially harm our reputation, business, results of operations, and financial condition. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We depend on a limited number of customers for a significant percentage of our revenue and the loss or temporary loss of a major customer for any reason could harm our financial condition. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have historically generated most of our revenue from a limited number of customers. Our three largest customers, which differed by period, collectively accounted for 66% of our revenue for the fiscal year ended December&#160;31, 2022, and 66% of our revenue for the eleven months ended December&#160;31, 2021. As a consequence of the concentrated nature of our customer base, our quarterly revenue and results of operations may fluctuate from quarter to quarter and are difficult to estimate, and any delay, reduction or cancellation of orders or services rendered or any acceleration or delay in anticipated purchases or grants and awards by our larger customers could materially affect our revenue and results of operations in any quarterly period. For further information regarding our customer concentration, refer to Note 2 to the notes to our audited consolidated financial statements for the year ended December&#160;31, 2022, included elsewhere in this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be unable to sustain or increase our revenue from our larger customers, grow revenues with new or other existing customers, or offset the discontinuation of concentrated purchases by our larger customers with purchases by new or existing customers. These larger customers could also reduce or discontinue their purchases of our products and services in the event they transition to internally developed products and services or determine to divide their purchases of our products and services between us and a second source. We expect that such concentrated purchases will continue to contribute materially to our revenue for the foreseeable future and that our results of operations may fluctuate materially as a result of such larger customers&#8217; buying patterns or funding cycles. The loss or temporary loss of such customers, or a significant delay or reduction in their purchases, could materially harm our business, financial condition, results of operations and prospects. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">A significant portion of our revenue currently depends on contracts with the public sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We derive a significant portion of our revenue from contracts with U.S. federal and foreign governments and government agencies, and we believe that the success and growth of our business will continue to depend on our successful procurement of government contracts. We have historically derived, and expect to continue to derive, a significant portion of our revenue from contracts with agencies of the U.S. federal and foreign </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
governments, either directly by us or through other government contractors. In the year ended December&#160;31, 2022 and the eleven months ended December&#160;31, 2021, sales to government entities comprised 81.3% and 80.0% of our total revenue, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Contracts with government agencies are subject to a number of challenges and risks. The bidding process for government contracts can be highly competitive, expensive, and time-consuming, often requiring significant upfront time and expense without any assurance that these efforts will generate revenue. We also must comply with laws and regulations relating to the formation, administration, and performance of contracts, which provide public sector customers rights, many of which are not typically found in commercial contracts. In addition, our perceived relationship with the U.S. government could adversely affect our business prospects in certain <span style="white-space:nowrap">non-U.S.</span> geographies or with certain <span style="white-space:nowrap">non-U.S.</span> governments. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, our business, financial condition, results of operations, and growth prospects may be adversely affected by certain events or activities, including, but not limited to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Changes in government fiscal or procurement policies, or decreases in government funding available for procurement of goods and services generally, or for our federal government contracts specifically; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Changes in government programs or applicable requirements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Restrictions in the grant of personnel security clearances to our employees; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Ability to maintain facility clearances required to perform on classified contracts for U.S. federal government and foreign government agencies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Changes in the political environment, including before or after a change to the leadership within the government administration, and any resulting uncertainty or changes in policy or priorities and resultant funding; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Changes in the government&#8217;s attitude towards the capabilities that we offer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Changes in the government&#8217;s attitude towards us as a company or our platforms; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Appeals, disputes, or litigation relating to government procurement, including but not limited to bid protests by unsuccessful bidders on potential or actual awards of contracts to us or our partners by the government; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The adoption of new laws or regulations or changes to existing laws or regulations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Budgetary constraints, including automatic reductions as a result of &#8220;sequestration&#8221; or similar measures and constraints imposed by any lapses in appropriations for the federal government or certain of its departments and agencies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Influence by, or competition from, third parties with respect to pending, new, or existing contracts with government customers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Changes in political or social attitudes with respect to security or data privacy issues; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Potential delays or changes in the government appropriations or procurement processes, including as a result of events such as war, incidents of terrorism, natural disasters, and public health concerns or epidemics, such as the coronavirus pandemic; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Increased or unexpected costs or unanticipated delays caused by other factors outside of our control. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, following the second quarter 2022, we announced that we anticipate lower-than-expected new government contract opportunities and what we believe to be slower than anticipated timing of government funding and appropriations with respect to relevant projects in 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such of the foregoing events or activities, among others, could cause governments and governmental agencies to delay or refrain from entering into contracts with us and/or purchasing our computers in the future, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reduce the size or timing of payments with respect to our services to, or purchases from, existing or new government customers, or otherwise have an adverse effect on our business, results of operations, financial condition, and growth prospects. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our business is currently dependent upon our relationship with our cloud providers. There are no assurances that we will be able to commercialize quantum computers from our relationships with cloud providers. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently offer access to quantum computing as a service (&#8220;Quantum Computing as a Service&#8221; or &#8220;QCaaS&#8221;), both directly to our end users with our own Quantum Cloud Services and indirectly to end users through public cloud providers such as Amazon Braket and Microsoft Azure Quantum who integrate our QCS into their own quantum computing platforms. These public cloud partners operate a service in direct competition with our providing direct access to QCS. Currently, a majority of our QCaaS business is run through the AWS service, and we intend to partner with additional partners to provide access to our QCaaS. Cloud computing partnerships could be terminated, or not scale as anticipated, or even at all. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is risk that one or more of the public cloud providers, such as AWS and Azure, could use their respective control of their public clouds to control market pricing of the services, restrict access, embed innovations or privileged interoperating capabilities in competing products, bundle competing products and leverage their public cloud customer relationships to exclude us from opportunities. Further, they have the resources to acquire or partner with existing and emerging providers of competing technology and thereby accelerate adoption of those competing technologies. All of the foregoing could make it difficult or impossible for us to provide products and services that compete favorably with those of the public cloud providers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, if our contractual and other business relationships with our partners are terminated, either by the counterparty or by us, suspended or suffer a material change to which we are unable to adapt, such as the elimination of services or features on which we depend, we would be unable to provide our QCaaS business at the same scale and would experience significant delays and incur additional expense in transitioning customers to a different public cloud provider. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, our customer agreement with AWS remains in effect until (i)&#160;terminated for convenience, which we may do for any reason by providing AWS notice and closing our account and which AWS may do for any reason by providing us at least 30 days&#8217; notice or (ii)&#160;terminated for cause, which either party may do if the other party has an uncured material breach and which AWS may do immediately upon notice. Although alternative data center providers could host our business on a substantially similar basis to AWS, transitioning the cloud infrastructure currently hosted by AWS to alternative providers could potentially be disruptive, and we could incur significant <span style="white-space:nowrap">one-time</span> costs. If we are unable to renew our agreement with AWS on commercially acceptable terms, our agreement with AWS is prematurely terminated, or it adds additional infrastructure providers, we may experience costs or downtime in connection with the transfer to, or the addition of, new data center providers. If AWS or other infrastructure providers increase the costs of their services, our business, financial condition, or results of operations could be materially and adversely affected. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any material change in our contractual and other business relationships with our partners, could result in reduced use of our systems, increased expenses, including service credit obligations, and harm to our brand and reputation, any of which could have a material adverse effect on our business, financial condition and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We rely on access to high performance third party classical computing through public clouds, high performance computing centers and <span style="white-space:nowrap">on-premises</span> computing infrastructure to deliver performant quantum solutions to customers. We may not be able to maintain high quality relationships and connectivity with these resources which could make it harder for us to reach customers or deliver solutions in a cost-effective manner. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our QCS incorporates high performance classical computing through public clouds to provide services to end users and our partners. These services are predominantly on AWS. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any material change in our contractual and other business relationships with AWS or other cloud provider, could result in reduced use of our systems, increased expenses, including service credit obligations, and harm our brand and reputation, any of which could have a material adverse effect on our business, financial condition and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, if our contractual and other business relationships with our partners are terminated, either by the counterparty or by us, suspended or suffer a material change to which we are unable to adapt, such as the elimination of services or features on which we depend, we would be unable to provide our QCaaS business at the same scale and would experience significant delays and incur additional expense in transitioning customers to a different public cloud provider. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We depend on certain suppliers to source products. Failure to maintain our relationship with any of these suppliers, or a failure to replace any of these suppliers, could have a material adverse effect on our business, financial position, results of operations and cash flows. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We buy our products and supplies from suppliers that manufacture and source products from the United States and abroad. We enter into agreements with many of our suppliers that provide us with exclusive or restrictive distribution rights, limiting our competitors&#8217; ability to source materials from such suppliers. Our ability to identify and develop relationships with qualified suppliers and enter into exclusive or restrictive distribution rights agreements with suppliers who can satisfy our standards for quality and our need to access products and supplies in a timely and efficient manner is a significant challenge. Any failure to maintain our relationship with any of our top ten largest suppliers, or a failure to replace any such supplier that is lost, could have a material adverse effect on our business, financial position, results of operations and cash flows. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be required to replace a supplier if their products do not meet our quality or safety standards. In addition, our suppliers could discontinue selling products at any time for reasons that may or may not be in our control or the suppliers&#8217; control, including shortages of raw materials, environmental and social supply chain issues, pandemic, labor disputes or weather conditions. Disruptions in transportation lines or the ongoing military conflict involving Russia and Ukraine may also cause global supply chain issues that affect us or our suppliers. We generally have multiple sources of supply, however, in some cases, materials are provided by a single supplier. For example, our small and <span style="white-space:nowrap">mid-size</span> cryogenic refrigerators have been provided by a single supplier and we have begun to source from a second supplier. In addition, we expect that larger cryogenic refrigerators required in connection with the potential development of systems greater than 100 qubits will be provided by a single supplier, at least for an initial period of time. We cannot assure that any of our suppliers or potential suppliers will have the capacity to supply larger cryogenic refrigerators on the terms, timing or scale that we expect. The loss of, or substantial decrease in the availability of, products from our suppliers, or the loss of a key supplier, temporarily or permanently, could result in a material shortage of products, which could lead to price escalations that we may be unable to offset by our prices to our customers. When supply chain issues are later resolved and prices return to normal levels, we may be required to reduce the prices at which we sell our products to our customers in order to remain competitive. In addition, even where these risks do not materialize, we may incur costs as we prepare contingency plans to address such risks. Our operating results and inventory levels could suffer if we are unable to promptly replace a supplier who is unwilling or unable to satisfy our requirements with a supplier providing similar products. In addition, our suppliers&#8217; ability to deliver products may also be affected by raw material and commodity cost volatility or financing constraints caused by credit market conditions, which could materially and negatively impact our net sales and operating costs, at least until alternate sources of supply are arranged. Any delay or unavailability of key products required for our development activities could delay or prevent us from further developing our systems and applications on our expected timelines or at all. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, our business, financial position, results of operations and cash flows could be materially and adversely affected by our inability to continue sourcing products from our suppliers. A weak or declining economy could strain our suppliers, possibly resulting in supply disruption. In addition, there is a risk that our </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
current or future suppliers, service providers, manufacturers or other partners may not survive such difficult economic times, which could directly affect our ability to attain our operating goals on schedule and on budget. Although we seek to have alternate sources and recover increases in input costs through price increases in our products, shortages, supply chain interruptions or regulatory changes or other governmental actions could result in the need to change suppliers or incur cost increases that cannot, in the short term, or in some cases even in the long-term, be offset by our prices. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may face unknown supply chain issues that could delay the development or introduction of our products and negatively impact our business and operating results. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are reliant on third-party suppliers for components necessary to develop and manufacture our quantum computing solutions. Any of the following factors (and others) could have an adverse impact on the availability of these components: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our inability to enter into agreements with suppliers on commercially reasonable terms, or at all; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulties of suppliers ramping up their supply of materials to meet our requirements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a significant increase in the price of one or more components, including due to industry consolidation occurring within one or more component supplier markets or as a result of decreased production capacity at manufacturers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any reductions or interruption in supply, including disruptions on our global supply chain as a result of the <span style="white-space:nowrap">COVID-19</span> pandemic, which we have experienced, and may in the future experience or as a result of the ongoing military conflict between Russia and Ukraine and the related sanctions imposed against Russia (including as a result of disruptions in global shipping, the transport of products, energy supply, cybersecurity incidents and banking systems as well as our ability to control input costs) or otherwise; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">financial problems of either manufacturers or component suppliers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">significantly increased freight charges, raw material costs, rising electrical power costs and other expenses associated with our business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">other factors beyond our control or which we do not presently anticipate, could also affect our suppliers&#8217; ability to deliver components to us on a timely basis; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a failure to develop our supply chain management capabilities and recruit and retain qualified professionals; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a failure to adequately authorize procurement of inventory by our contract manufacturers; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a failure to appropriately cancel, reschedule or adjust our requirements based on our business needs. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of the aforementioned factors were to materialize, it could cause us to halt production of our quantum computing solutions and/or entail higher manufacturing costs, any of which could materially adversely affect our business, operating results, and financial condition and could materially damage customer relationships. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our systems depend on the use of certain development tools, supplies, equipment and production methods. If we are unable to procure the necessary tools, supplies and equipment to build our quantum systems, or are unable to do so on a timely and cost-effective basis, and in sufficient quantities, we may incur significant costs or delays which could negatively affect our operations and business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are limited suppliers to sources of materials which may be necessary for the production of our technology. We are currently reliant on a single or small number of suppliers for certain resources. While we are currently looking to engage additional suppliers, there is no guarantee we will be able to establish or maintain relationships with such additional suppliers on terms satisfactory to us. Reliance on any single supplier increases the risks associated with being unable to obtain the necessary components because the supplier may have </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
manufacturing constraints, can be subject to unanticipated shutdowns and/or may be affected by natural disasters and other catastrophic events. Some of these factors may be completely out of our and our suppliers&#8217; control. Failure to acquire sufficient quantities of the necessary components in a timely or cost-effective manner could materially harm our business. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Even if we are successful in developing quantum computing systems and executing our strategy, competitors in the industry may achieve technological breakthroughs which render our quantum computing systems obsolete or inferior to other products. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our continued growth and success depends on our ability to innovate and develop quantum computing technology in a timely manner and effectively market these products. Without timely innovation and development, our quantum computing solutions could be rendered obsolete or less competitive by changing customer preferences or because of the introduction of a competitor&#8217;s newer technologies. We believe that many competing technologies will require a technological breakthrough in one or more problems related to science, fundamental physics or manufacturing. While it is uncertain whether such technological breakthroughs will occur in the next several years that does not preclude the possibility that such technological breakthroughs could eventually occur. Any technological breakthroughs which render our technology obsolete or inferior to other products, could have a material effect on our business, financial condition or results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may be unable to reduce the cost of developing our quantum computers, which may prevent us from pricing our quantum systems competitively. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The success of our business is dependent upon the cost per qubit decreasing over the next several years as our quantum computers advance, which is based on achieving anticipated economies of scale related to demand for our computer systems, technological innovation and negotiations with third-party parts suppliers. If we do not achieve economies of scale or if the anticipated cost savings do not materialize, we may be unable to achieve a lower cost per qubit, which would make our quantum computing solution less competitive than those produced by our competitors and could have a material adverse effect on our business, financial condition or results of operations. Due to macroeconomic headwinds, we have experienced and may continue to experience increased costs, including with respect to labor and products. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The quantum computing industry is in its early stages and volatile, and if it does not develop, if it develops slower than we expect, if it develops in a manner that does not require use of our quantum computing solutions, if it encounters negative publicity or if our solution does not drive commercial engagement, the growth of our business will be harmed. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The nascent market for quantum computers is still rapidly evolving, characterized by rapidly changing technologies, competitive pricing and competitive factors, evolving government regulation and industry standards, and changing customer demands and behaviors. If demand for quantum computers in general does not develop as expected, or develops more slowly than expected, our business, prospects, financial condition and operating results could be harmed. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our growth and future demand for our products is highly dependent upon the adoption by developers and customers of quantum computers, as well as on our ability to demonstrate the value of quantum computing to our customers. Delays in future generations of our quantum computers or technical failures at other quantum computing companies could limit acceptance of our solution. Negative publicity concerning our solution or the quantum computing industry as a whole could limit acceptance of our solution. We believe quantum computing will solve many large-scale problems. However, such problems may never be solvable by quantum computing technology. If our clients and partners do not perceive the benefits of our solution, or if our solution does not drive member engagement, then demand for our products may not develop at all, or it may develop slower than we expect. If any of these events occur, it could have a material adverse effect on our business, financial condition or results of operations. If progress towards quantum advantage ever slows relative </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to expectations, it could adversely impact revenues and customer confidence to continue to pay for testing, access and &#8220;quantum readiness.&#8221; This would harm or even eliminate revenues in the period before quantum advantage. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We could suffer disruptions, outages, defects and other performance and quality problems with our quantum computing systems, our production technology partners or with the public cloud, data centers and internet infrastructure on which we rely. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business depends on our quantum computing systems being available. We have experienced, and may in the future further experience, disruptions, outages, defects and other performance and quality problems with our systems. We have also experienced, and may in the future further experience, disruptions, outages, defects and other performance and quality problems with the public cloud and internet infrastructure on which our systems rely. These problems can be caused by a variety of factors, including failed introductions of new functionality, vulnerabilities and defects in proprietary and open-source software, hardware components, human error or misconduct, capacity constraints, design limitations or denial of service attacks or other security-related incidents. We do not have a contractual right with our public cloud providers that compensates us for any losses due to availability interruptions in the public cloud. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any disruptions, outages, defects and other performance and quality problems with our quantum computing systems or with the public cloud and internet infrastructure on which we rely, could result in reduced use of our systems, increased expenses, including service credit obligations, and harm to our brand and reputation, any of which could have a material adverse effect on our business, financial condition and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we cannot successfully execute on our strategy, including in response to changing customer needs and new technologies and other market requirements, or achieve our objectives in a timely manner, our business, financial condition and results of operations could be harmed. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The quantum computing market is characterized by rapid technological change, changing user requirements, uncertain product lifecycles and evolving industry standards. We believe that the pace of innovation will continue to accelerate as technology changes and different approaches to quantum computing mature on a broad range of factors, including system architecture, error correction, performance and scale, ease of programming, user experience, markets addressed, types of data processed, and data governance and regulatory compliance. Our future success depends on our ability to continue to innovate and increase customer adoption of our quantum solutions. If we are unable to enhance our quantum computing system to keep pace with these rapidly evolving customer requirements, or if new technologies emerge that are able to deliver competitive products at lower prices, more efficiently, with better functionality, more conveniently, or more securely than our platform, our business, financial condition and results of operations could be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are highly dependent on our ability to attract and retain senior executive leadership and other key employees, such as quantum physicists, software engineers and other key technical employees, which is critical to our success. If we fail to retain talented, highly qualified senior management, engineers and other key employees or attract them when needed, such failure could negatively impact our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future success is highly dependent on our ability to attract and retain our executive officers, key employees and other qualified personnel. As we build our brand and become more well known, there is increased risk that competitors or other companies may seek to hire our personnel. The loss of the services provided by these individuals will adversely impact the achievement of our business strategy. These individuals could leave our employment at any time, as they are &#8220;at will&#8221; employees. A loss of a member of senior management, or an engineer or other key employee particularly to a competitor, could also place us at a competitive disadvantage. Effective succession planning is also important to our long-term success. Failure to ensure effective transfer of knowledge and smooth transitions involving key employees could hinder our strategic planning and execution. For example, our former President and Chief Executive Officer, Dr.&#160;Chad Rigetti, resigned in the fourth quarter of 2022 and has been replaced by our current President and Chief Executive Officer, Dr.&#160;Subodh Kulkarni, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
following a transition period with an interim President and Chief Executive Officer. In addition, we recently announced the departure of our former Chief Financial Officer, Brian Sereda, and the appointment of Jeffrey Bertelsen as our new Chief Financial Officer, in addition to the departure of our former Chief Technology Officer, Michael Harburn, and promotion of David Rivas to such position. An inadequate transition in our management may cause disruption to our business due to, among other things, diverting management&#8217;s attention away from the operations of the business or causing a deterioration in morale. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the reduction in workforce that we announced in February 2023 may yield unintended consequences and costs, such as the loss of institutional knowledge and expertise, employee attrition beyond our intended reduction in force, a reduction in morale among our remaining employees, greater-than-anticipated costs incurred in connection with implementing the restructuring, and the risk that we may not achieve the benefits from the restructuring to the extent or as quickly as we anticipate, all of which may have a material adverse effect on our business, results of operations or financial condition. These restructuring initiatives could place substantial demands on our management and employees, which could lead to the diversion of our management&#8217;s and employees&#8217; attention from other business priorities. In addition, we may discover that the workforce reduction and other restructuring efforts will make it difficult for us to pursue new opportunities and initiatives and require us to hire qualified replacement personnel, which may require us to incur additional and unanticipated costs and expenses. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future success also depends on our continuing ability to attract, develop, motivate, and retain highly qualified and skilled employees. The market for highly skilled workers and leaders in the quantum computing industry is extremely competitive. In particular, hiring qualified personnel specializing in supply chain management, engineering and sales, as well as other technical staff and research and development personnel is critical to our business and the development of our quantum computing systems. Some of these professionals are hard to find and we may encounter significant competition in our efforts to hire them. Many of the other companies with which we compete for qualified personnel have greater financial and other resources than we do. The effective operation of our supply chain, including the acquisition of critical components and materials, the development of our quantum computing technologies, the commercialization of our quantum computing technologies and the effective operation of our managerial and operating systems all depend upon our ability to attract, train and retain qualified personnel in the aforementioned specialties. Additionally, changes in immigration and work permit laws and regulations or the administration or interpretation of such laws or regulations could impair our ability to attract and retain highly qualified employees. If we cannot attract, train and retain qualified personnel in this competitive environment, we may experience delays in the development of our quantum computing technologies and be otherwise unable to develop and grow our business as projected, or even at all. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our future growth and success depends on our ability to sell effectively to government entities and large enterprises. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our potential customers tend to be government agencies and large enterprises. Therefore, our future success will depend on our ability to effectively sell our products to such customers. Sales to these <span style="white-space:nowrap">end-customers</span> involve risks that may not be present (or that are present to a lesser extent) with sales to <span style="white-space:nowrap">non-governmental</span> agencies or smaller customers. These risks include, but are not limited to, (i)&#160;increased purchasing power and leverage held by such customers in negotiating contractual arrangements with us and (ii)&#160;longer sales cycles and the associated risk that substantial time and resources may be spent on a potential <span style="white-space:nowrap">end-customer</span> that elects not to purchase our solutions. Sales to government agencies are typically under fixed fee development contracts, which involve additional risks. See &#8220;&#8212;<span style="font-style:italic">If our cost and time estimates for fixed fee arrangements do not accurately anticipate the cost of servicing those arrangements, we could experience losses on these arrangements or our profitability could be reduced. </span>&#8221; In addition, government contracts generally include the ability of government agencies to terminate early which, if exercised, would result in a lower contract value and lower than anticipated revenues generated by such arrangement. See &#8220;&#8212;<span style="font-style:italic">Contracts with U.S. government entities subject us to risks including early termination, audits, investigations, sanctions and penalties</span>.&#8221; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">32 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government agencies and large organizations often undertake a significant evaluation process that results in a lengthy sales cycle. Our contracts with government agencies are typically structured in phases, with each phase subject to satisfaction of certain conditions. As a result, the actual scope of work performed pursuant to any such contracts, in addition to related contract revenue, could be less than total contract value. In addition, product purchases by such organizations are frequently subject to budget constraints, multiple approvals and unanticipated administrative, processing and other delays. Finally, these organizations typically have longer implementation cycles, require greater product functionality and scalability, require a broader range of services, demand that vendors take on a larger share of risks, require acceptance provisions that can lead to a delay in revenue recognition and expect greater payment flexibility. All of these factors can add further risk to business conducted with these potential customers and could lead to lower revenue results than originally anticipated. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may not be able to accurately estimate the future supply and demand for our quantum computers, which could result in a variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is difficult to predict our future revenues and appropriately budget for our expenses, and we may have limited insight into trends that may emerge and affect our business. We anticipate being required to provide forecasts of our demand to our current and future suppliers prior to the scheduled delivery of products to potential customers. Currently, there is no historical basis for making judgments on the demand for our quantum computers or our ability to develop, manufacture, and deliver quantum computers, or our profitability, if any, in the future. If we overestimate our requirements, our suppliers may have excess inventory, which indirectly would increase our costs. If we underestimate our requirements, our suppliers may have inadequate inventory, which could interrupt manufacturing of our products and result in delays in shipments and revenues. In addition, lead times for materials and components that our suppliers order may vary significantly and depend on factors such as the specific supplier, contract terms and demand for each component at a given time. If we fail to order sufficient quantities of product components in a timely manner, the delivery of quantum computers and related compute time to our potential customers could be delayed, which would harm our business, financial condition and operating results. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Because our success depends, in part, on our ability to expand sales internationally, our business will be susceptible to risks associated with international operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently maintain offices and have sales personnel in the United States, the United Kingdom, Australia and Canada. In the year ended December&#160;31, 2022 and the eleven months ended December&#160;31, 2021, our <span style="white-space:nowrap">non-U.S.</span> revenue was approximately 15.0% and 28.9% of our total revenue, respectively. Depending on customer opportunities and our ability to access quantum engineering talent, we may continue to expand our international operations, which may include opening offices in new jurisdictions. Any additional international expansion efforts that we are undertaking and may undertake may not be successful. In addition, conducting international operations subjects us to new risks, some of which we have not generally faced in the United States or other countries where we currently operate. These risks include, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">unexpected costs and errors in the localization of our platform and solutions, including translation into foreign languages and adaptation for local culture, practices and regulatory requirements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">lack of familiarity and burdens of complying with foreign laws, legal standards, privacy and cybersecurity standards, regulatory requirements, tariffs and other barriers, and the risk of penalties to our customers and individual members of management or employees if our practices are deemed to not be in compliance; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">practical difficulties of enforcing intellectual property rights in countries with varying laws and standards and reduced or varied protection for intellectual property rights in some countries; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an evolving legal framework and additional legal or regulatory requirements for data privacy and cybersecurity, which may necessitate the establishment of systems to maintain data in local markets, requiring us to invest in additional data centers and network infrastructure, and the implementation of </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">33 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
additional employee data privacy documentation (including locally-compliant data privacy notice and policies), all of which may involve substantial expense and may cause us to need to divert resources from other aspects of our business, all of which may adversely affect our business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">unexpected changes in regulatory requirements, taxes, trade laws, tariffs, export quotas, custom duties or other trade restrictions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulties in managing systems integrators and technology partners; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">differing technology standards; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">different pricing environments, longer sales cycles, longer accounts receivable payment cycles and difficulties in collecting accounts receivable; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increased financial accounting and reporting burdens and complexities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">difficulties in managing and staffing international operations including the proper classification of independent contractors and other contingent workers, differing employer/employee relationships and local employment laws; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increased costs involved with recruiting and retaining an expanded employee population outside the United States through cash and equity-based incentive programs and unexpected legal costs and regulatory restrictions in issuing our shares to employees outside the United States; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">global political and regulatory changes that may lead to restrictions on immigration and travel for our employees; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">fluctuations in exchange rates that may decrease the value of foreign-based revenue; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">potentially adverse tax consequences, including the complexities of foreign value added tax (or other tax) systems, restrictions on the repatriation of earnings, and transfer pricing requirements; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">permanent establishment risks and complexities in connection with international payroll, tax and social security requirements for international employees. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, operating in international markets also requires significant management attention and financial resources. We cannot be certain that the investment and additional resources required in establishing operations in other countries will produce desired levels of revenue or profitability. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compliance with laws and regulations applicable to our global operations also substantially increases our cost of doing business in foreign jurisdictions. We have limited experience in marketing, selling and supporting our platform outside of the United States. Our limited experience in operating our business internationally increases the risk that any potential future expansion efforts that we may undertake will not be successful. If we invest substantial time and resources to expand our international operations and are unable to do so successfully and in a timely manner, our business, financial condition, revenues, results of operations or cash flows will suffer. We may be unable to keep current with changes in government requirements as they change from time to time. Failure to comply with these regulations could harm our business. In many countries, it is common for others to engage in business practices that are prohibited by our internal policies and procedures or other regulations applicable to us. Although we have implemented policies and procedures designed to ensure compliance with these laws and policies, there can be no assurance that all of our employees, contractors, partners and agents will comply with these laws and policies. Violations of laws or key control policies by our employees, contractors, partners or agents could result in delays in revenue recognition, financial reporting misstatements, enforcement actions, reputational harm, disgorgement of profits, fines, civil and criminal penalties, damages, injunctions, other collateral consequences or the prohibition of the importation or exportation of our solutions and could harm our business, financial condition, revenues, results of operations or cash flows. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">34 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our international sales and operations subject us to additional risks and costs, including the ability to engage with customers in new geographies, exposure to foreign currency exchange rate fluctuations, that can adversely affect our business, financial condition, revenues, results of operations or cash flows. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We derive a significant portion of revenue from our customers in the United States. We may expand our international operations if we are able to achieve narrow or broad quantum advantage. However, there are a variety of risks and costs associated with our international sales and operations, which may include making additional investments prior to the proven adoption of our solutions, the cost of conducting our business internationally and hiring and training international employees and the costs associated with complying with local law. Furthermore, we cannot predict the rate at which our platform and solutions will be accepted in international markets by potential customers. We currently have sales, customer support and engineering personnel outside the United States in the United Kingdom, Australia and Canada, and have established an entity in Germany; however, our sales, support and engineering organization outside the United States is smaller than our U.S. sales organization. We believe our ability to attract new customers to subscribe to our platform or to attract existing customers to renew or expand their use of our platform is directly correlated to the level of engagement we obtain with the customer. To the extent we are unable to effectively engage with <span style="white-space:nowrap">non-U.S.</span> customers due to our limited sales force capacity, we may be unable to effectively grow in international markets. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given our international presence, we are exposed to the effects of fluctuations in currency exchange rates. While we have primarily transacted with customers in U.S. dollars, we expect to continue to generate some revenues, denominated in foreign currencies. Additionally, fluctuations in the value of the U.S. dollar and foreign currencies may make our subscriptions more expensive for international customers, which could harm our business. Additionally, we incur expenses for employee compensation and other operating expenses at our <span style="white-space:nowrap">non-U.S.</span> locations in the local currency for such locations. Fluctuations in the exchange rates between the U.S. dollar and other currencies could result in an increase to the U.S. dollar equivalent of such expenses. These fluctuations could cause our results of operations to differ from our expectations or the expectations of our investors. Additionally, such foreign currency exchange rate fluctuations could make it more difficult to detect underlying trends in our business and results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our international operations may subject us to greater than anticipated tax liabilities. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of taxes we pay in different jurisdictions depends on the application of the tax laws of various jurisdictions, including the United States, to our international business activities, changes in tax rates, new or revised tax laws or interpretations of existing tax laws and policies, and our ability to operate our business in a manner consistent with our corporate structure and intercompany arrangements. The taxing authorities of the jurisdictions in which we operate may challenge our methodologies for pricing intercompany transactions pursuant to our intercompany arrangements or disagree with our determinations as to the income and expenses attributable to specific jurisdictions. If such a challenge or disagreement were to occur, and our position was not sustained, we could be required to pay additional taxes, interest, and penalties, which could result in <span style="white-space:nowrap">one-time</span> tax charges, higher effective tax rates, reduced cash flows, and lower overall profitability of our operations. Our financial statements could fail to reflect adequate reserves to cover such a contingency. Similarly, a taxing authority could assert that we are subject to tax in a jurisdiction where we believe we have not established a taxable connection, often referred to as a &#8220;permanent establishment&#8221; under international tax treaties, and such an assertion, if successful, could increase our expected tax liability in one or more jurisdictions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our quantum computing systems may not be compatible with some or all industry-standard software and hardware in the future, which could harm our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have focused our efforts on creating quantum computing hardware, the operating system for such hardware, a suite of <span style="white-space:nowrap">low-level</span> software programs that optimize execution of quantum algorithms on our hardware, application programing interfaces (&#8220;APIs&#8221;) to access our systems, software development kits (&#8220;SDKs&#8221;) for system and application developers, and quantum programming languages for <span style="white-space:nowrap">low-</span> and high-level </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">35 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
application developers. The industry is rapidly evolving, and customers have many choices for programming languages, application libraries, APIs, and SDKs, some of which may not be compatible with our own languages, APIs or SDKs. Our quantum computing solutions are designed today to be compatible with most major quantum software development kits, including Qiskit, Cirq, and Open QASM, all of which are open source. If a proprietary (not open source) software toolset became the standard for quantum application development in the future by a competitor, usage of our hardware might be limited as a result which would have a negative impact on the Company. Similarly, if a piece of hardware became a necessary component for quantum computing (for instance, quantum networking) and we cannot integrate with, the result might have a negative impact on the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our customers are unable to achieve compatibility between other software and hardware and our hardware, it could impact our relationships with such customers or with customers, generally, if the incompatibility is more widespread. In addition, the mere announcement of an incompatibility problem relating to our products with higher level software tools could cause us to suffer reputational harm and/or lead to a loss of customers. Any adverse impacts from the incompatibility of our quantum computing solutions could adversely affect our business, operating results and financial condition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may rely heavily on future collaborative partners and third parties to develop key, relevant algorithms and programming to make our quantum systems commercially viable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into, and may enter into, strategic partnerships to develop and commercialize our current and future research and development programs with other companies to accomplish one or more of the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">obtain expertise; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">obtain sales and marketing services or support; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">obtain equipment and facilities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">develop relationships with potential future customers; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">generate revenue. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not be successful in establishing or maintaining suitable partnerships, and we may not be able to negotiate collaboration agreements having terms satisfactory to the Company, or at all. Failure to make or maintain these arrangements or a delay or failure in a collaborative partner&#8217;s performance under any such arrangements could harm our business and financial condition. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; and other adverse consequences, which may adversely affect our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of our business, we and the third parties upon which we rely, process proprietary, confidential, and sensitive data, including personal data, intellectual property, and trade secrets (collectively, sensitive information). Cyber-attacks, malicious internet-based activity, online and offline fraud, <span style="white-space:nowrap"><span style="white-space:nowrap">denial-of-service</span></span> attacks, ransomware attacks, business email compromises, computer malware, viruses, and social engineering (including phishing) and other similar activities threaten the confidentiality, integrity, and availability of our sensitive information and information technology systems, and those of the third parties upon which we rely. Such threats are prevalent in the technology industry and our customers&#8217; industries and continue to rise, are increasingly difficult to detect, and come from a variety of sources, including traditional computer &#8220;hackers,&#8221; threat actors, &#8220;hacktivists,&#8221; organized criminal threat actors, personnel (such as through theft or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">36 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
misuse), sophisticated nation states, and nation-state-supported actors. The techniques may be used to sabotage or to obtain unauthorized access to our platform, systems, networks, or physical facilities where our quantum computers are stored, and we may be unable to implement adequate preventative measures or stop security breaches while they are occurring. U.S. law enforcement agencies have indicated to us that quantum computing technology is of particular interest to certain malicious cyber threat actors. In addition, our cybersecurity risk could be increased as a result of the ongoing military conflict between Russia and Ukraine and the related sanctions imposed against Russia. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some actors now engage and are expected to continue to engage in cyber-attacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities. During times of war and other major conflicts, we, the third parties upon which we rely, may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our goods and services. We and the third parties upon which we rely are subject to a variety of evolving threats, including but not limited to social-engineering attacks (including through phishing attacks), malicious code (such as viruses and worms), malware (including as a result of advanced persistent threat intrusions), <span style="white-space:nowrap"><span style="white-space:nowrap">denial-of-service</span></span> attacks (such as credential stuffing), credential harvesting, personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, server malfunctions, software or hardware failures, loss of data or other information technology assets, adware, telecommunications failures, earthquakes, fires, floods, and other similar threats. In particular, severe ransomware attacks are becoming increasingly prevalent and can lead to significant interruptions in our operations, loss of sensitive data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on third-party service providers and technologies to operate critical business systems to process sensitive information in a variety of contexts. Our platform is built to be accessed through third-party public cloud providers such as AWS. These providers may also experience breaches and attacks to their products which may impact our systems. Data security breaches may also result from <span style="white-space:nowrap">non-technical</span> means, such as actions by an employee with access to our systems. Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. If our third-party service providers experience a security incident or other interruption, we could experience adverse consequences. While we may be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of the previously identified or similar threats could cause a security incident or other interruption that could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our sensitive information or our information technology systems, or those of the third parties upon whom we rely. A security incident or other interruption could disrupt our ability (and that of third parties upon whom we rely) to provide our platform/products/services. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may expend significant resources or modify our business activities to try to protect against security incidents. Certain data privacy and security obligations may require us to implement and maintain specific security measures or industry-standard or reasonable security measures to protect our information technology systems and sensitive information. While we and our third-party cloud providers have implemented security measures designed to protect against security breaches, these measures could fail or may be insufficient, resulting in the unauthorized disclosure, modification, misuse, destruction, or loss of sensitive or confidential information. We take steps to detect and remediate vulnerabilities, but we may not be able to detect and remediate all vulnerabilities because the threats and techniques used to exploit the vulnerability change frequently and are often sophisticated in nature. Therefore, such vulnerabilities could be exploited but may not be detected until after a security incident has occurred. These vulnerabilities pose material risks to our business. Further, we may experience delays in developing and deploying remedial measures designed to address any such identified vulnerabilities. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">37 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Applicable data privacy and security obligations may require us to notify relevant stakeholders of security incidents. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences. Actual or perceived breaches of our security measures or the accidental loss, inadvertent disclosure or unapproved dissemination of proprietary information or sensitive or confidential data about the Company, our partners, our customers or third parties could expose us and the parties affected to a risk of loss or misuse of this information, resulting in litigation and potential liability, paying damages, regulatory inquiries or actions, damage to our brand and reputation or other harm to our business. Our efforts to prevent and overcome these challenges could increase our expenses and may not be successful. If we fail to detect or remediate a security breach in a timely manner, or a breach otherwise affects our customers, or if we suffer a cyber-attack that impacts our ability to operate our platform, we may experience adverse consequences, such as government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional reporting requirements and/or oversight; restrictions on processing sensitive information (including personal data); litigation (including class claims); indemnification obligations; negative publicity; material damage to our reputation; monetary fund diversions; interruptions in our operations (including availability of data); financial loss; and other similar harms. Security incidents and attendant consequences may cause customers to stop using our services, deter new customers from using our services, and negatively impact our ability to grow and operate our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to experiencing a security incident, third parties may gather, collect, or infer sensitive information about us from public sources, data brokers, or other means that reveals competitively sensitive details about our organization and could be used to undermine our competitive advantage or market position. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Unfavorable conditions in our industry or the global economy, could limit our ability to grow our business and negatively affect our results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our results of operations have varied and may continue to vary based on the impact of changes in our industry or the global economy on us or our customers and potential customers. Negative conditions in the general economy both in the United States and abroad, including conditions resulting from changes in gross domestic product growth, financial and credit market fluctuations, international trade relations, pandemics (such as the <span style="white-space:nowrap">COVID-19</span> pandemic), political turmoil, natural catastrophes, warfare, and terrorist attacks on the United States or elsewhere, could cause a decrease in business investments, including the progress on development of quantum technologies, and negatively affect the growth of our business. In addition, in challenging economic times, our current or potential future customers may experience cash flow problems and as a result may modify, delay or cancel plans to purchase our products and services. Additionally, if our customers are not successful in generating sufficient revenue or are unable to secure financing, they may not be able to pay, or may delay payment of, accounts receivable due to it. Moreover, our key suppliers may reduce their output or become insolvent, thereby adversely impacting our ability to manufacture our products. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, uncertain economic conditions may make it more difficult for us to raise funds through borrowings or private or public sales of debt or equity securities. We cannot predict the timing, strength or duration of any economic slowdown, instability or recovery, generally or within any particular industry. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government actions and regulations, such as tariffs and trade protection measures, may limit our ability to obtain products from our suppliers or sell our products and services to customers. Political challenges between the United States and countries in which our suppliers are located, and changes to trade policies, including tariff </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">38 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
rates and customs duties, trade relations between the United States and those countries and other macroeconomic issues could adversely impact our business. The United States administration has announced tariffs on certain products imported into the United States, and some countries have imposed tariffs in response to the actions of the United States. There is also a possibility of future tariffs, trade protection measures or other restrictions imposed on our products or on our customers by the United States or other countries that could have a material adverse effect on our business. Our technology may be deemed a matter of national security and as such our customer base may be tightly restricted. We may accept government grants that place restrictions on the business&#8217; ability to operate. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Unstable market and economic conditions have had and may continue to have serious adverse consequences on our business, financial condition and share price. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The global economy, including credit and financial markets, has experienced extreme volatility and disruptions, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates, increases in inflation rates, higher interest rates, bank failures and uncertainty about economic stability. For example, recent bank failures have resulted in volatility in the capital markets. Similarly, the ongoing military conflict between Russia and Ukraine has created extreme volatility in the global capital markets and is expected to have further global economic consequences, including disruptions of the global supply chain and energy markets. Any volatility and disruptions may have adverse consequences on us or the third parties on whom we rely. If general economic conditions were to deteriorate or remain uncertain for an extended period of time, our liquidity and ability to repay our outstanding debt may be harmed and the trading price of our common stock could decline. Significant decline of stock price has caused, and may cause in the future, a triggering event for impairment testing of fair-valued assets, including goodwill and other long-lived assets. For example, in assessing our goodwill in connection with the preparation of the financial statements for the fourth quarter and fiscal year ended December&#160;31, 2022, we concluded indicators of impairment were present due to the current macroeconomic conditions, including continued declines in our stock price. Based upon the results of the impairment test, we recorded a goodwill impairment charge of $5.4&#160;million within the consolidated statement of operations for the twelve months ended December&#160;31, 2022. If the equity and credit markets deteriorate, including as a result of political unrest or war, it may make any necessary debt or equity financing more difficult to obtain in a timely manner or on favorable terms, more costly or more dilutive, and we could be forced to delay, reduce or eliminate our research and development programs and other efforts. Increased inflation rates have and are expected to adversely affect us by increasing our costs, including labor and employee benefit costs, and costs for equipment and system components associated with system development. In addition, higher inflation could also increase our customers&#8217; operating costs, which could result in reduced budgets for our customers and potentially less demand for our systems. Any significant increases in inflation and related increase in interest rates could have a material adverse effect on our business, results of operations and financial condition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March 10, 2023, the California Department of Financial Protection and Innovation closed Silicon Valley Bank (&#8220;SVB&#8221;) and appointed Federal Deposit Insurance Corporation (the &#8220;FDIC&#8221;) receiver. On March 12, 2023, the Department of the Treasury, the Federal Reserve, and the FDIC jointly released a statement that depositors at SVB and Signature Bank would have access to their funds, even those in excess of the standard FDIC insurance limits, under a systemic risk exception. As of March 14, 2023, we had approximately $1.0 million of cash with SVB, our sole depositor. We are making arrangements to open accounts with a new financial institution and could experience disruption with customer receivables and vendor payments during the transition process. The majority of our other cash, cash equivalents and investments, consisting of a variety of short-term and high-credit treasury and corporate bonds and other liquid investments, is held in custodial accounts with U.S. Bank for which SVB Asset Management is the advisor. Despite our proactive measures and the measures taken by the United States federal government, there is great uncertainty in the markets regarding the stability of regional banks and the safety of deposits in excess of the FDIC insured deposit limits. The ultimate outcome of these events, and whether further regulatory actions will be taken, cannot be predicted. These events may have a material adverse effect on our liquidity and financial condition if our ability to access funds at SVB and our ability to transfer our </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">39 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other cash, cash equivalents and investments to other financial institutions are impaired. In addition, if in the future a financial institution in which we hold funds fails or is subject to significant adverse conditions in the financial or credit markets, we could be subject to a risk of loss of all or a portion of such uninsured funds or be subject to a delay in accessing all or a portion of such uninsured funds. Any such loss or lack of access to these funds could adversely impact our short-term liquidity and ability to meet our operating expense obligations. Further, these events may make equity or debt financing more difficult to obtain, and additional equity or debt financing might not be available on reasonable terms, if at all; difficulties obtaining equity or debt financing could have a material adverse effect on our financial condition, as well as our ability to continue to grow our operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If our cost and time estimates for fixed fee arrangements do not accurately anticipate the cost of servicing those arrangements, we could experience losses on these arrangements and our profitability could be reduced. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our development contracts are typically fixed fee arrangements invoiced on a milestone basis. If we underestimate the amount of effort required to deliver on a contract and/or the period of time required to achieve the milestone, our profitability could be reduced. If the actual costs of completing the contract exceed the agreed upon fixed price, we would incur a loss on the arrangement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"></span><span style="font-weight:bold"><span style="font-style:italic">We have identified material weaknesses in our internal control over financial reporting related to the lack of effective review controls over the accounting for complex financial instruments and to the design and operation of our overall closing and financial reporting processes, and we may identify additional material weaknesses in the future. The material weakness over accounting for complex financial instruments has resulted in errors in financial statements for prior periods. If we fail to remediate such material weaknesses, if we identify additional material weaknesses or if we otherwise fail to establish and maintain effective control over financial reporting, it may adversely affect our ability to accurately and timely report our financial results in the future, and may adversely affect investor confidence, our reputation, our ability to raise additional capital and our business operations and financial condition. </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As previously disclosed, in connection with our unaudited condensed consolidated financial statements for the nine months ended October 31, 2021, we identified a material weakness in our internal control over financial reporting related to the lack of effective review controls over the accounting for complex financial instruments. Specifically, the controls failed to identify an error in the accounting for complex warrant instruments. The error related to the Company not properly accounting for the liability associated with the warrants to purchase common stock issued to Trinity Capital Inc. that was subsequently cancelled and reissued for a new warrant in connection with an amendment to the Loan Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in connection with the preparation of the financial statements for the second quarter of 2022, we also identified and corrected an immaterial error related to the revaluation of the liability associated with the same warrants issued to Trinity Capital. The error was made in the previously issued unaudited condensed consolidated financial statements as of and for the period ended March&#160;31, 2022. We corrected the immaterial error in our condensed consolidated financial statements as of and for the period ended June&#160;30, 2022 and restated our financial statements for the quarters ended March&#160;31, 2022 and June&#160;30, 2022 as described below, and reversed such prior correction and instead reflected such correction in the restated financial statements for the quarter ended March&#160;31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the preparation of the financial statements for the third quarter of 2022, we discovered that the previously identified material weakness led to additional material errors related to the valuation of the Earn-out liability and the private placement warrant liability that affected the previously issued unaudited </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">40 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
condensed consolidated financial statements as of and for the periods ended March 31, 2022 and June 30, 2022. These errors were corrected in the unaudited condensed consolidated financial statements as of and for the periods ended March 31, 2022 and June 30, 2022 through a restatement of previously filed financial statements for such periods. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management previously concluded that this material weakness in our internal control over financial reporting was due to the fact that at the time we initially identified the material weakness, we did not have sufficient accounting resources and did not have the necessary business processes and related internal controls formally designed and implemented to address the accounting and financial reporting requirements related to these complex instruments. This material weakness continued to exist as of December 31, 2022 due to the reasons described above and due to the shorter period of time that has elapsed since the identification of the additional errors in prior periods related to the material weakness discussed above. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, in connection with the preparation of the financial statements for the year ended December 31, 2022 appearing elsewhere in this prospectus, we identified a material weakness in our internal control over financial reporting related to the design and operation of our overall closing and financial reporting processes, including the timely preparation of account reconciliations, effective segregation of duties, and a lack of timely review over the financial statement close process. We have concluded that this material weakness is due to the fact that, between the date the company went public pursuant to the Business Combination and December&#160;31, 2022, the company had limited resources and did not have the necessary business processes and related internal controls formally designed and implemented coupled with the appropriate resources with the appropriate level of experience and technical expertise to oversee our closing and financial reporting processes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the foregoing, management concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of the end of the quarterly periods ended March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022. Our management is in the process of undertaking a remediation plan and is taking steps to remediate the material weaknesses. The material weaknesses will not be considered remediated until such time as management designs and implements effective controls that operate for a sufficient period of time and concludes, through testing, that these controls are effective. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management will continue to monitor the effectiveness of our remediation plan and will make the changes it determines to be appropriate. Although we intend to complete this remediation process as quickly as practicable, we cannot at this time estimate how long it will take, and our initiatives may not prove to be successful in remediating the material weaknesses. Furthermore, we cannot ensure that the measures we have taken to date, and actions we may take in the future, will be sufficient to remediate in a timely manner or at all the control deficiencies that led to our material weaknesses in our internal controls over financial reporting or that they will prevent or avoid potential future material weaknesses due to a failure to implement and maintain adequate internal control over financial reporting or circumvention of these controls. In addition, even if we are successful in strengthening our controls and procedures, in the future these controls and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our financial statements. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any failure to remediate the material weaknesses or otherwise develop or maintain effective controls or any difficulties encountered in their implementation or improvement could limit our ability to prevent or detect a misstatement of our accounts or disclosures that could result in additional material misstatements of our annual or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to the listing requirements of the Nasdaq. For example, in connection with the identification of the material weakness related to the lack of effective review controls over the accounting for complex financial instruments as described above, we were unable to file our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 by the deadline prescribed by the SEC and, as a result, we are not eligible to utilize a Form S-3 registration statement. In addition, we could be subject to sanctions or investigations by the SEC, the Nasdaq Stock Market or other regulatory authorities as well </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">41 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as shareholder litigation which would require additional financial and management resources, and investors may lose confidence in our financial reporting and our stock price may decline as a result. Further, B. Riley has the right to terminate the Purchase Agreement under specified circumstances, including if the related registration statement is unavailable for a specified period of time, including as a result of errors or missing information in our SEC filings. If we fail to make timely and complete filings with the SEC in the future, B.&#160;Riley Principal Capital II, LLC (&#8220;B.&#160;Riley&#8221;) may terminate the Common Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;) we entered with B. Riley on August&#160;11, 2022 under specified circumstances. As a result, our ability to obtain any additional financing, or additional financing on favorable terms, could be materially and adversely affected, which in turn, could materially and adversely affect our business, financial condition and the market value of our common stock and require us to incur additional costs to improve our internal control systems and procedures. In addition, perceptions of the Company among customers, suppliers, lenders, investors, securities analysts and others could also be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have been, and may in the future be, adversely affected by the global <span style="white-space:nowrap">COVID-19</span> pandemic, its various strains or future pandemics. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face various risks related to epidemics, pandemics, and other outbreaks, including the recent <span style="white-space:nowrap">COVID-19</span> pandemic, including newly discovered strains of the virus. In response to the <span style="white-space:nowrap">COVID-19</span> pandemic, governments have implemented significant measures, including, but not limited to, business closures, quarantines, travel restrictions, <span style="white-space:nowrap"><span style="white-space:nowrap">shelter-in-place,</span></span> <span style="white-space:nowrap"><span style="white-space:nowrap">stay-at-home</span></span> and other social distancing directives, intended to control the spread of the virus. Companies have also taken precautions, such as requiring employees to work remotely, imposing travel restrictions and temporarily closing businesses. To the extent that these restrictions remain in place, additional prevention and mitigation measures are implemented in the future, or there is uncertainty about the effectiveness of these or any other measures to contain or treat <span style="white-space:nowrap">COVID-19</span> or future pandemics, there is likely to be an adverse impact on our potential customers, our employees and global economic conditions, and consumer confidence and spending, which could materially and adversely affect our operations and demand for our products. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The spread of <span style="white-space:nowrap">COVID-19</span> has and may continue to impact our suppliers by disrupting the manufacturing, delivery and the overall supply chain of parts required to manufacture our quantum computers. In addition, various aspects of our business cannot be conducted remotely, such as the fabrication of quantum processors and the assembly of our quantum computers. Future measures by government authorities may remain in place for a significant period of time and they are likely to adversely affect our future manufacturing plans, sales and marketing activities, business and results of operations. We may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, suppliers, vendors and business partners. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the fluid nature of the <span style="white-space:nowrap">COVID-19</span> pandemic, uncertainties regarding the related economic impact are likely to result in sustained market turmoil, which could also negatively impact our business, financial condition and cash flows. During 2020, we scaled back our recruiting efforts to control costs and experienced weeklong onsite work stoppages due to quarantining related to the <span style="white-space:nowrap">COVID-19</span> pandemic. The extent of <span style="white-space:nowrap">COVID-19&#8217;s</span> effect on our operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic, all of which are uncertain and difficult to predict considering the rapidly evolving landscape. As a result, it is not currently possible to ascertain the overall impact of <span style="white-space:nowrap">COVID-19</span> on our business. However, if the pandemic continues to persist as a severe worldwide health crisis, the disease could negatively impact our business, financial condition results of operations and cash flows, and may also have the effect of heightening many of the other risks described in this &#8220;Risk Factors&#8221; section. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even after the <span style="white-space:nowrap">COVID-19</span> pandemic has subsided, we may continue to experience an adverse impact to our business as a result of <span style="white-space:nowrap">COVID-19&#8217;s</span> global economic impact, including any recession that has occurred or may occur in the future. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">42 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our facilities or operations could be damaged or adversely affected as a result of prolonged power outages, natural disasters and other catastrophic events. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our facilities or operations could be adversely affected by power outages as well as events outside of our control, such as natural disasters and other calamities. We cannot assure you that any backup systems will be adequate to protect us from the effects of fire, floods, typhoons, earthquakes, power loss resulting from such natural disasters, telecommunications failures, <span style="white-space:nowrap">break-ins,</span> war, riots, terrorist attacks or similar events. Any of the foregoing events may give rise to interruptions, breakdowns, system failures, technology platform failures or internet failures, which could cause delays in development and fabrication, the loss or corruption of data or malfunctions of software or hardware as well as adversely affect our ability to provide services. A significant power outage may disrupt our operations and could have a material adverse impact on our business, financial condition, results of operations and cash flows </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, the British National Grid recently warned that the United Kingdom, where we have significant operations, could face planned power cuts to homes and businesses throughout the winter of 2022 and 2023 if the country is unable to import electricity from Europe and it struggles to attract enough gas imports to fuel its <span style="white-space:nowrap">gas-fired</span> power plants. A significant power outage could have a material adverse impact on our business, financial condition, results of operations and cash flows. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Litigation and Government Regulation </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are subject to stringent and evolving U.S. state, federal and foreign laws and regulations, rules, contractual obligations, policies and other obligations related to privacy, data use and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; and otherwise could adversely affect us and our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of business, we collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, transmit, and share (collectively, &#8220;processing&#8221;) personal data and other sensitive information, including proprietary and confidential business data, trade secrets, and intellectual property. We are, therefore, subject to numerous data privacy and security obligations, such as state and federal laws and regulations, guidance, industry standards, external and internal privacy and security policies, contractual requirements, and other obligations related to privacy, data use and security. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, federal, state, and local governments have enacted numerous data privacy and security laws, including data breach notification laws, personal data privacy laws, consumer protection laws (e.g., Section&#160;5 of the Federal Trade Commission Act), and other similar laws (e.g., wiretapping laws). In addition, several states have enacted privacy or security breach legislation requiring varying levels of consumer notification in the event of a security breach. For example, the California Consumer Privacy Act (&#8220;CCPA&#8221;), applies to personal information of consumers, business representatives, and employees, and requires businesses to provide specific disclosures in privacy notices and grants consumers resident in California new rights with respect to the collection of their personal data. The CCPA provides for civil penalties of up to $7,500 per violation and allows private litigants affected by certain data breaches to recover significant statutory damages. In addition, the California Privacy Rights Act of 2020 (&#8220;CPRA&#8221;) expands the CCPA&#8217;s requirements, including by adding a new right for individuals to correct their personal information and establishing a new regulatory agency to implement and enforce the law. Several other states such as Virginia and Colorado, have also passed comprehensive privacy laws, and similar laws are being considered in several other states, as well as at the federal and local levels. These developments further complicate compliance efforts, and increase legal risk and compliance costs for us, and the third parties upon whom we rely. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Outside of the United States, foreign governments are raising similar privacy and data security concerns. In particular, the United Kingdom&#8217;s GDPR (&#8220;UK GDPR&#8221;) imposes strict requirements for processing personal data. For example, under the UK GDPR, companies may face temporary or definitive bans on data processing and other corrective actions; fines of up to 17.5&#160;million pounds or 4% of annual global revenue, whichever is greater; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">43 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or private litigation related to processing of personal data brought by classes of data subjects or consumer protection organizations authorized at law to represent their interests. In Canada, the Personal Information Protection and Electronic Documents Act (&#8220;PIPEDA&#8221;) and various related provincial laws, as well as Canada&#8217;s Anti-Spam Legislation (&#8220;CASL&#8221;), may apply to our operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of business, we may transfer personal data from the United Kingdom (UK), Canada, Australia and other jurisdictions to the United States or other countries. The UK and other jurisdictions have enacted laws requiring data to be localized or limiting the transfer of personal data to other countries. In particular, the UK has significantly restricted the transfer of personal data to the United States and other countries whose privacy laws it believes are inadequate. Other jurisdictions may adopt similarly stringent interpretations of their data localization and cross-border data transfer laws. Although there are currently various mechanisms that may be used to transfer personal data from the UK to the United States in compliance with law, such as the UK&#8217;s international data transfer addendum, these mechanisms are subject to legal challenges, and there is no assurance that we can satisfy or rely on these measures to lawfully transfer personal data to the United States. If there is no lawful manner for us to transfer personal data from the UK or other jurisdictions to the United States, or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our business or data processing activities to other jurisdictions at significant expense, increased exposure to regulatory actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against our processing or transferring of personal data necessary to operate our business. Additionally, companies that transfer personal data out of the UK to other jurisdictions, particularly to the United States, are subject to increased scrutiny from regulators, individual litigants, and activist groups. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also bound by contractual obligations related to data privacy and security, and our efforts to comply with such obligations may not be successful. For example, certain privacy laws, such as the UK GDPR CCPA, require our customers to impose specific contractual restrictions on their service providers. We publish privacy policies, marketing materials and other statements, such as compliance with certain certifications or self-regulatory principles, regarding data privacy and security. If these policies, materials or statements are found to be deficient, lacking in transparency, deceptive, unfair, or misrepresentative of our practices, we may be subject to investigation, enforcement actions by regulators or other adverse consequences. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Obligations related to data privacy and security are quickly changing, becoming increasingly stringent, and creating regulatory uncertainty. Additionally, these obligations may be subject to differing applications and interpretations, which may be inconsistent or conflict among jurisdictions. Preparing for and complying with these obligations requires us to devote significant resources, which may necessitate changes to our services, information technologies, systems, and practices and to those of any third parties that process personal data on our behalf. In addition, these obligations may require us to change our business model. We may at times fail (or be perceived to have failed) in our efforts to comply with our data privacy and security obligations. Moreover, despite our efforts, our personnel or third parties on whom we rely may fail to comply with such obligations, which could negatively impact our business operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we or the third parties on which we rely fail, or are perceived to have failed, to address or comply with applicable data privacy and security obligations, we could face significant consequences, including but not limited to: government enforcement actions (e.g., investigations, fines, penalties, audits, inspections, and similar); litigation (including class-action claims); additional reporting requirements and/or oversight; bans on processing personal data; orders to destroy or not use personal data; and imprisonment of company officials. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of these events could have a material adverse effect on our reputation, business, or financial condition, including but not limited to: loss of customers; interruptions or stoppages in our business operations; interruptions or stoppages of data collection needed to train our algorithms; inability to process personal data or to operate in certain jurisdictions; limited ability to develop or commercialize our products; expenditure of time and resources to defend any claim or inquiry; adverse publicity; or substantial changes to our business model or operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">44 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Contracts with U.S. government entities subject us to risks including early termination, audits, investigations, sanctions and penalties. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have several contracts with various government entities, including contracts with NASA, the Defense Advanced Research Project Agency and the Department of Energy, among others, and we may enter into additional contracts with U.S. government entities in the future, which subjects our business to statutes and regulations applicable to companies doing business with the government, including the Federal Acquisition Regulation. These government contracts customarily contain provisions that give the government substantial rights and remedies, many of which are not typically found in commercial contracts and which are unfavorable to contractors. For instance, most U.S. government agencies include provisions that allow the government to unilaterally terminate or modify contracts for convenience, and in that event, the counterparty to the contract may generally recover only its incurred or committed costs and settlement expenses and profit on work completed prior to the termination. If the government terminates a contract for default, the defaulting party may be liable for any extra costs incurred by the government in procuring undelivered items from another source. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, government contracts normally contain additional requirements that may increase our costs of doing business, reduce our profits, and expose us to liability for failure to comply with these terms and conditions. These requirements include, for example: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">specialized disclosure and accounting requirements unique to government contracts; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">financial and compliance audits that may result in potential liability for price adjustments, recoupment of government funds after such funds have been spent, civil and criminal penalties, or administrative sanctions such as suspension or debarment from doing business with the U.S. government; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">public disclosures of certain contract and company information; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">mandatory socioeconomic compliance requirements, including labor requirements, <span style="white-space:nowrap">non-discrimination</span> and affirmative action programs and environmental compliance requirements. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government contracts are also generally subject to greater scrutiny by the government, which can initiate reviews, audits and investigations regarding our compliance with government contract requirements. In addition, if we fail to comply with government contracting laws, regulations and contract requirements, our contracts may be subject to termination, and we may be subject to financial and/or other liability under our contracts, the Federal Civil False Claims Act (including treble damages and other penalties), or criminal law. In particular, the False Claims Act&#8217;s &#8220;whistleblower&#8221; provisions also allow private individuals, including present and former employees, to sue on behalf of the U.S. government. Any penalties, damages, fines or suspension could adversely affect our ability to operate our business and our financial results. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are subject to U.S. and foreign anti-corruption, anti-bribery and similar laws, and <span style="white-space:nowrap">non-compliance</span> with such laws can subject us to criminal or civil liability and harm our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, and other anti-bribery, and anti-corruption laws in countries in which we conduct activities. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit companies, their employees, and their third-party intermediaries from authorizing, promising, offering, providing, soliciting, or accepting, directly or indirectly, improper payments or benefits to or from any person whether in the public or private sector. We may engage with partners and third-party intermediaries to market our services and to obtain necessary permits, licenses, and other regulatory approvals. In addition, we or our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We can be held liable for the corrupt or other illegal activities of these third-party intermediaries, and of our employees, representatives, contractors, partners, and agents, even if we do not explicitly authorize such activities. We cannot provide any assurance that all of our employees and agents will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">45 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Detecting, investigating, and resolving actual or alleged violations of anti-corruption laws can require a significant diversion of time, resources, and attention from senior management. In addition, noncompliance with anti-corruption or anti-bribery laws could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, enforcement actions, fines, damages, other civil or criminal penalties, injunctions, suspension or debarment from contracting with certain persons, reputational harm, adverse media coverage, and other collateral consequences. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are subject to governmental export and import controls that could impair our ability to compete in international markets due to licensing requirements and subject us to liability if we are not in compliance with applicable laws. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our products and technologies are subject to U.S. export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, and various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Controls. U.S. export control and economic sanctions laws include restrictions or prohibitions on the sale or supply of certain products, technologies, and services to U.S. Government embargoed or sanctioned countries, governments, persons and entities. In addition, certain products and technology may be subject to export licensing or approval requirements. Exports of our products and technology must be made in compliance with export control and sanctions laws and regulations. If we fail to comply with these laws and regulations, we and certain of our employees could be subject to substantial civil or criminal penalties, including the possible loss of export or import privileges; fines, which may be imposed on us and responsible employees or managers; and, in extreme cases, the incarceration of responsible employees or managers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, changes in our products or technologies or changes<span style="font-weight:bold"> </span>in applicable export or import laws and regulations may create delays in<span style="font-weight:bold"> </span>the introduction and sale of our products and technologies in international markets or, in some cases, prevent the export or import of our products and technologies to certain countries, governments or persons altogether. Any change in export or import laws and regulations, shift in the enforcement or scope of existing laws and regulations, or change in the countries, governments, persons or technologies targeted by such laws and regulations, could also result in decreased use of our products and technologies, or in our decreased ability to export or sell our products and technologies to existing or potential customers. Any decreased use of our products and technologies or limitation on our ability to export or sell our products and technologies would likely adversely affect our business, financial condition and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to incur significant costs in complying with these regulations. Regulations related to quantum computing are currently evolving and we face risks associated with changes to these regulations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our business is exposed to risks associated with litigation, investigations and regulatory proceedings. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may in the future face legal, administrative and regulatory proceedings, claims, demands and/or investigations involving stockholder, consumer, competition and/or other issues relating to our business on a global basis. Litigation and regulatory proceedings are inherently uncertain, and adverse rulings could occur, including monetary damages, or an injunction stopping us from engaging in certain business practices, or requiring other remedies, such as compulsory licensing of patents. An unfavorable outcome or settlement may result in a material adverse impact on our business, results of operations, financial position and overall trends. In addition, regardless of the outcome, litigation can be costly, time-consuming, and disruptive to our operations. Any claims or litigation, even if fully indemnified or insured, could damage our reputation and make it more difficult to compete effectively or to obtain adequate insurance in the future. In addition, the laws and regulations our business is subject to are complex and change frequently. We may be required to incur significant expense to comply with changes in, or remedy violations of, these laws and regulations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, while we maintain insurance for certain potential liabilities, such insurance does not cover all types and amounts of potential liabilities and is subject to various exclusions as well as caps on amounts </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">46 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recoverable. Even if we believe a claim is covered by insurance, insurers may dispute our entitlement to recovery for a variety of potential reasons, which may affect the timing and, if the insurers prevail, the amount of our recovery. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may become subject to product liability claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may become subject to product liability claims, even those without merit, which could harm our business prospects, operating results, and financial condition. We may face inherent risk of exposure to claims in the event our quantum computers do not perform as expected or malfunction. A successful product liability claim against us could require us to pay a substantial monetary award. Moreover, a product liability claim could generate substantial negative publicity about our quantum computers and business and inhibit or prevent commercialization of other future quantum computers, which would have material adverse effects on our brand, business, prospects and operating results. Any insurance coverage might not be sufficient to cover all potential product liability claims. Any lawsuit seeking significant monetary damages either in excess of our coverage, or outside of our coverage, may have a material adverse effect on our reputation, business and financial condition. We may not be able to secure additional product liability insurance coverage on commercially acceptable terms or at reasonable costs when needed, particularly if we do face liability for our products and are forced to make a claim under our policy. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are subject to requirements relating to environmental and safety regulations and environmental remediation matters which could adversely affect our business, results of operations and reputation. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to numerous federal, state and local environmental laws and regulations governing, among other things, solid and hazardous waste storage, treatment and disposal, and remediation of releases of hazardous materials. There are significant capital, operating and other costs associated with compliance with these environmental laws and regulations. Environmental laws and regulations may become more stringent in the future, which could increase costs of compliance or require us to manufacture with alternative technologies and materials. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Federal, state and local authorities also regulate a variety of matters, including, but not limited to, health, safety and permitting in addition to the environmental matters discussed above. New legislation and regulations may require us to make material changes to our operations, resulting in significant increases to the cost of production. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our manufacturing process will have hazards such as but not limited to hazardous materials, machines with moving parts, and high voltage and/or high current electrical systems typical of large manufacturing equipment and related safety incidents. There may be safety incidents that damage machinery or product, slow or stop production, or harm employees. Consequences may include litigation, regulation, fines, increased insurance premiums, mandates to temporarily halt production, workers&#8217; compensation claims, or other actions that impact our brand, finances, or ability to operate. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Changes in tax laws or regulations that are applied adversely to us may have a material adverse effect on our business, cash flow, financial condition, or results of operations. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New tax laws, statutes, rules, regulations, or ordinances could be enacted at any time. For instance, the recently enacted Inflation Reduction Act imposes, among other rules, a 15% minimum tax on the book income of certain large corporations and a 1% excise tax on certain corporate stock repurchases. Further, existing tax laws, statutes, rules, regulations, or ordinances could be interpreted differently, changed, repealed, or modified at any time. Any such enactment, interpretation, change, repeal, or modification could adversely affect us, possibly with retroactive effect. In particular, changes in corporate tax rates, the realization of our net deferred tax assets, the taxation of foreign earnings, and the deductibility of expenses under the Tax Cuts and Jobs Act, as amended by </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">47 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Coronavirus Aid, Relief, and Economic Security Act or any future tax reform legislation, could have a material impact on the value of our deferred tax assets, result in significant <span style="white-space:nowrap">one-time</span> charges, and increase our future tax expenses. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Intellectual Property </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our failure to obtain, maintain and protect our intellectual property rights could impair our ability to protect and commercialize our proprietary products and technology and cause us to lose our competitive advantage. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success depends, in significant part, on our ability to obtain, maintain, enforce and defend our intellectual property rights, including patents and trade secrets. We rely upon a combination of the intellectual property protections afforded by patent, copyright, trademark and trade secret laws in the United States and other jurisdictions, as well as license agreements and other contractual protections, to establish, maintain and enforce rights in our proprietary technologies. In addition, we seek to protect our intellectual property rights through nondisclosure and invention assignment agreements with our employees and consultants, and through <span style="white-space:nowrap">non-disclosure</span> agreements with business partners and other third parties. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, we may not be able to prevent unauthorized use of our intellectual property. Our trade secrets may also be compromised, which could cause us to lose our competitive advantage. Third parties may attempt to copy or otherwise obtain, use or infringe our intellectual property. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Monitoring and detecting unauthorized use of our intellectual property is difficult and costly, and the steps we have taken or will take to prevent infringement or misappropriation may not be sufficient. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive and could divert management&#8217;s attention, which could harm our business, results of operations, and financial condition. In addition, existing intellectual property laws and contractual remedies may afford less protection than needed to safeguard our intellectual property portfolio, and third parties may develop competitive offerings in a manner that leaves us with limited means to enforce our intellectual property rights against them. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patent, copyright, trademark and trade secret laws vary significantly throughout the world. A number of foreign countries do not protect intellectual property rights to the same extent as do the laws of the United States. Therefore, our intellectual property rights may not be as strong or as easily enforced outside of the United States and efforts to protect against the unauthorized use of our intellectual property rights, technology and other proprietary rights may be more expensive and difficult outside of the United States. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Failure to adequately protect our intellectual property rights could result in our competitors using our intellectual property to offer products, potentially resulting in the loss of some of our competitive advantage and a decrease in our revenue, which would adversely affect our business, financial condition and operating results. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our inability to secure patent protection or enforce our patent rights could have a material adverse effect on our ability to prevent others from commercializing similar products or technology. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The application and registration of patents involves complex legal and factual questions. As a result, we cannot be certain that the patent applications that we file will result in patents being issued, or that our patents and any future patents that do issue will afford protection against competitors with similar technology. Numerous patents and pending patent applications owned by others exist in the fields in which we have developed and are developing our technology, and this may make it difficult for us to obtain certain patent coverage on our own. Any of our existing or pending patents may also be challenged by others on the basis that they are otherwise invalid or unenforceable. Furthermore, patent applications filed in foreign countries are subject to laws, rules and procedures that differ from those of the United States, and thus we cannot be certain that foreign patent applications related to issued U.S. patents will be issued. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if our patent applications succeed, it is still uncertain whether these patents will be contested, circumvented, invalidated or limited in scope in the future. The rights granted under any issued patents may not </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">48 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provide us with meaningful protection or competitive advantages. The intellectual property rights of others could bar us from licensing and exploiting any patents that issue from our pending applications, and the claims under any patents that issue from our patent applications may not be broad enough to prevent others from developing technologies that are similar or that achieve results similar to ours. In addition, patents issued to us may be infringed upon or designed around by others and others may obtain patents that it needs to license or design around, either of which would increase costs and may adversely affect our business, prospects, financial condition and operating results. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may face patent infringement and other intellectual property claims that could be costly to defend, result in injunctions and significant damage awards, or limit our ability to use certain key technologies in the future, all of which could harm our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success depends, in part, on our ability to develop and commercialize our products, services and technologies without infringing, misappropriating or otherwise violating the intellectual property rights of third parties. However, we may not be aware that our products, services or technologies are infringing, misappropriating or otherwise violating third-party intellectual property rights and such third parties may bring claims alleging such infringement, misappropriation or violation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, there may be issued patents of which we are unaware, held by third parties that, if found to be valid and enforceable, could be alleged to be infringed by our current or future products, services or technologies. Also, because patent applications can take years to issue and are often afforded confidentiality for some period of time, there may currently be pending applications, unknown to us, that later result in issued patents that could cover our current or future products, services or technologies. The strength of our defenses will depend on the rights asserted, the interpretation of these rights, and our ability to invalidate the asserted rights. However, we could be unsuccessful in advancing <span style="white-space:nowrap">non-infringement</span> and/or invalidity arguments in our defense. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Companies that have developed and are developing technology are often required to defend against litigation claims based on allegations of infringement, misappropriation or other violations of intellectual property rights. Our products, services or technologies may not be able to withstand third-party claims against their use. In addition, as compared to us, many companies have the capability to dedicate substantially greater resources to enforce their intellectual property rights and to defend claims that may be brought against them. If a third party is able to obtain an injunction preventing us from using or accessing such third-party intellectual property rights, or if we cannot license or develop alternative technology for any infringing aspect of our business, we may be forced to limit or stop sales of our products, services or technologies or cease business activities related to such intellectual property. Although we carry general liability insurance, our insurance may not cover potential claims of this type or may not be adequate to indemnify us for all liability that may be imposed. We cannot predict the outcome of lawsuits and cannot ensure that the results of any such actions will not have an adverse effect on our business, financial condition or results of operations. Even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and harm our business and operating results. Further, there could be public announcements of the intellectual property litigation, and if securities analysts, investors or others perceive the potential impact to be negative or risks to be substantial, it could have an adverse effect on the price of our common stock. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Any intellectual property litigation to which we might become a party, or for which we are required to provide indemnification, regardless of the merit of the claim or our defenses, may require us to do one or more of the following: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">cease selling or using solutions or services that incorporate the intellectual property rights that allegedly infringe, misappropriate or violate the intellectual property of a third party; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">make substantial payments for legal fees, settlement payments or other costs or damages; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">obtain a license, which may not be available on reasonable terms or at all, to sell or use the relevant technology; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">49 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">redesign the allegedly infringing solutions to avoid infringement, misappropriation or violation, which could be costly, time-consuming or impossible; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">indemnify third parties using our products or services. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The occurrence of infringement claims may grow as the market for our products, services and technologies grows. Accordingly, our exposure to damages resulting from infringement claims could increase and this could further exhaust our financial and management resources. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We rely on certain open-source software in our quantum systems. If licensing terms change, our business may be adversely affected. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our platform utilizes software licensed to us by third-party authors under &#8220;open-source&#8221; licenses and we expect to continue to utilize open-source software in the future. The use of open-source software may entail greater risks than the use of third-party commercial software, as open-source licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. To the extent that our platform depends upon the successful operation of the open-source software we use, any undetected errors or defects in this open-source software could prevent the deployment or impair the functionality of our platform, delay new solution introductions, result in a failure of our platform and injure our reputation. For example, undetected errors or defects in open-source software could render us vulnerable to breaches or security attacks, and, in conjunction, make our systems more vulnerable to data breaches. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, some open-source licenses require the release of proprietary source code combined with, linked to or distributed with such open-source software to be released to the public. If we combine, link or distribute our proprietary software with open-source software in a specific manner, we could, under some open-source licenses, be required to release the source code of our proprietary software to the public. This would allow our competitors to create similar solutions with lower development effort and time and ultimately put us at a competitive disadvantage. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we monitor our use of open-source software to avoid subjecting our platform to conditions we do not intend to attach to such platform or our proprietary code, we cannot assure you that our processes for controlling such use will be effective. If we are held to have breached the terms of an open-source software license, we could be required to seek licenses from third parties to continue operating using our solution on terms that are not economically feasible, to <span style="white-space:nowrap">re-engineer</span> our solution or the supporting computational infrastructure to discontinue use of code, or to make generally available, in source code form, portions of our proprietary code. This could allow our competitors to create similar solutions with lower development effort and time and ultimately put us at a competitive disadvantage. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Some of our intellectual property has been or may be conceived or developed through government-funded research and thus may be subject to federal regulations providing for certain rights for the U.S. government or imposing certain obligations on us, such as a license to the U.S. government under such intellectual property, <span style="white-space:nowrap">&#8220;march-in&#8221;</span> rights, certain reporting requirements and a preference for U.S.-based companies, and compliance with such regulations may limit our exclusive rights and our ability to contract with <span style="white-space:nowrap">non-U.S.</span> manufacturers. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, the U.S. government may have certain rights to intellectual property embodied in our current or future product candidates pursuant to the Bayh-Dole Act of 1980, or the Patent and Trademark Law Amendments Act. These U.S. government rights include a <span style="white-space:nowrap">non-exclusive,</span> <span style="white-space:nowrap">non-transferable,</span> irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right, under certain limited circumstances, to require the licensor to grant exclusive, partially exclusive or <span style="white-space:nowrap">non-exclusive</span> licenses to any of these inventions to a third party if it determines that (1)&#160;adequate steps have not been taken to commercialize the invention, (2)&#160;government action is necessary to meet public health or safety needs or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">50 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(3)&#160;government action is necessary to meet requirements for public use under federal regulations (also referred to as <span style="white-space:nowrap">&#8220;march-in&#8221;</span> rights). The U.S. government also has the right to take title to these inventions if the licensor fails to disclose the invention to the government or fails to file an application to register the intellectual property within specified time limits. Intellectual property generated under a government funded program is also subject to certain reporting requirements, compliance with which may require us to expend substantial resources. In addition, the U.S. government requires that any products embodying any of these inventions or produced through the use of any of these inventions be manufactured substantially in the United States, and some of our license agreements require that we comply with this requirement. This preference for U.S. industry may be waived by the federal agency that provided the funding if the owner or assignee of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture the products substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible. To the extent any of our owned or licensed future intellectual property is also generated through the use of U.S. government funding, the provisions of the Bayh-Dole Act may similarly apply. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Additional Risks Related to Ownership of Our Securities </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The price of our common stock and public warrants has been and may continue to be volatile. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The price of our common stock and public warrants has been and may continue to be volatile. From March&#160;2, 2022, the date our common stock and public warrants began trading on Nasdaq, through April 4, 2023, our stock price fluctuated from a high of $11.368 to a low of $0.464, and the price of our public warrants fluctuated from a high of $2.20 to a low of $0.0351. As a result of this volatility, investors in our common stock may not be able to sell their shares at or above the prices they paid. Further, as a result of this volatility it may be difficult for us to attract new investments, including additional offerings of our securities, on terms we consider reasonable, or at all. The price of our common stock and public warrants may fluctuate due to a variety of factors, including, without limitation: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our ability to meet our technological milestones, including any delays; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in the industries in which we and our customers operate; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">variations in our operating performance and the performance of our competitors in general; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">material and adverse impact of the <span style="white-space:nowrap">COVID-19</span> pandemic or the ongoing military conflict between Russia and Ukraine and the related sanctions imposed against Russia on the markets and the broader global economy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">actual or anticipated fluctuations in our quarterly or annual operating results; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">publication of research reports by securities analysts about us or our competitors or our industry; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the public&#8217;s reaction to our press releases, our other public announcements and our filings with the SEC; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our failure or the failure of our competitors to meet analysts&#8217; projections or guidance that we or our competitors may give to the market; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">additions and departures of key personnel; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in laws and regulations affecting our business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">commencement of, or involvement in, litigation involving the Company; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in our capital structure, such as future issuances of securities or the incurrence of additional debt; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the volume of shares of our common stock available for public sale, including the significant percentage of shares of our common stock that may be offered for resale; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">51 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the public&#8217;s response to press releases or other public announcements by us or third parties, including our filings with the SEC; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">guidance, if any, that we provide to the public, any changes in this guidance or our failure to meet this guidance, including with respect to our technology roadmap; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the development and sustainability of an active trading market for our stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">actions by institutional or activist stockholders; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in accounting standards, policies, guidelines, interpretations or principles; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">other events or factors, including recessions, increases in inflation and interest rates, disruptions to banking systems, foreign currency fluctuations, international tariffs, social, political and economic risks, natural disasters, acts of war (including the conflict involving Russia and Ukraine), terrorism or responses to such events. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These market and industry factors may materially reduce the market price of our common stock and our public warrants regardless of the operating performance of the Company. In the past, following periods of market volatility, stockholders have instituted securities class action litigation. If we are involved in securities litigation, it could have a substantial cost and divert resources and the attention of executive management from our business regardless of the outcome of such litigation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may fail to comply with the rules that apply to public companies, including Section&#160;404 of the Sarbanes-Oxley Act, which could result in sanctions or other penalties that would adversely impact our business. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, and particularly after we are no longer an &#8220;emerging growth company,&#8221; we will incur significant legal, accounting, and other expenses that we did not incur as a private company, including costs resulting from public company reporting obligations under the Securities Act or the Exchange Act, and regulations regarding corporate governance practices. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the rules of the SEC, the listing requirements of the Nasdaq, and other applicable securities rules and regulations impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. We have begun to hire additional accounting, finance, and other personnel in connection with our becoming, and our efforts to comply with the requirements of being, a public company, and our management and other personnel will need to devote a substantial amount of time towards maintaining compliance with these requirements. These requirements will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. We are currently evaluating these rules and regulations and cannot predict or estimate the amount of additional costs we may incur or the timing of such costs. These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We cannot predict or estimate the amount of additional costs we will incur as a result of recently becoming a public company or the timing of such costs. Any changes we make to comply with these obligations may not be sufficient to allow us to satisfy our obligations as a public company on a timely basis, or at all. These reporting requirements, rules and regulations, coupled with the increase in potential litigation exposure associated with being a public company, could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors or board committees or to serve as executive officers, or to obtain certain types of insurance, including directors&#8217; and officers&#8217; insurance, on acceptable terms. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Sarbanes-Oxley Act Section&#160;404, we will be required to furnish a report by our management on our internal control over financial reporting in our Annual Reports on Form <span style="white-space:nowrap">10-K</span> with the SEC. In order to continue to maintain effective internal controls to support growth and public company requirements, we will </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">52 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
need additional financial personnel, systems and resources. However, while we remain an emerging growth company, we are not required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Sarbanes-Oxley Act Section&#160;404 within the prescribed period, we will be engaged in a process to enhance our documentation and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants, adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented, and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude in the future, within the prescribed timeframe or at all, that our internal control over financial reporting is effective as required by Sarbanes-Oxley Act Section&#160;404. We have identified material weaknesses with respect to our internal control over financial reporting. See <span style="font-style:italic">We have identified material weaknesses in our internal control over financial reporting related to the lack of effective review controls over the accounting for complex financial instruments and to the design and operation of our overall closing and financial reporting processes, and we may identify additional material weaknesses in the future. The material weakness over accounting for complex financial instruments has resulted in errors in financial statements for prior periods. If we fail to remediate such material weaknesses, if we identify additional material weaknesses or if we otherwise fail to establish and maintain effective control over financial reporting, it may adversely affect our ability to accurately and timely report our financial results in the future, and may adversely affect investor confidence, our reputation, our ability to raise additional capital and our business operations and financial condition</span>. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have incurred and will continue to incur substantial costs as a result of operating as a public company, and our management will continue to devote substantial time to new compliance initiatives. In addition, key members of our management team have limited experience managing a public company. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we incur substantial legal, accounting, and other expenses that we did not incur as a private company. For example, we are subject to the reporting requirements of the Exchange Act, the applicable requirements of the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the rules and regulations of the SEC and the listing standards of Nasdaq. The Exchange Act requires, among other things, that we file annual, quarterly, and current reports with respect to our business, financial condition and results of operations. Compliance with these rules and regulations increase our legal and financial compliance costs and increase demand on our systems, particularly after we are no longer an emerging growth company. In addition, as a public company, we may be subject to shareholder activism, which can lead to additional substantial costs, distract management and impact the manner in which we operate our business in ways we cannot currently anticipate. As a result of disclosure of information in this prospectus and in filings required of a public company, our business and financial condition are more visible, which may result in threatened or actual litigation, including by competitors. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain members of our management team have limited experience managing a publicly traded company, interacting with public company investors, and complying with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently manage the transition to being a public company subject to significant regulatory oversight and reporting obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents will require significant attention from our senior management and could divert their attention away from the <span style="white-space:nowrap"><span style="white-space:nowrap">day-to-day</span></span> management of the business, which could adversely affect our business, financial condition, and results of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">53 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Concentration of ownership among our executive officers, directors and their respective affiliates may limit other stockholders&#8217; ability to influence corporate matters and delay or prevent a third party from acquiring control over us. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current executive officers and directors and their respective affiliates beneficially own, in the aggregate, approximately 24.6% of our outstanding common stock as of March 1, 2023. This significant concentration of ownership may have a negative impact on the trading price for our common stock because investors often perceive disadvantages in owning stock in companies where there is a concentration of ownership in a small number of stockholders. In addition, these stockholders will be able to exercise influence over all matters requiring stockholder approval, including the election of directors and approval of corporate transactions, such as a merger or other sale of us or our assets. This concentration of ownership could limit other stockholders&#8217; ability to influence corporate matters and may have the effect of delaying or preventing a change in control, including a merger, consolidation or other business combination, or discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control, even if that change in control would benefit the other stockholders. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We do not intend to pay cash dividends for the foreseeable future. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently intend to retain future earnings, if any, to finance the further development and expansion of our business and do not intend to pay cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as our board of directors deems relevant. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our quarterly operating results have and may fluctuate significantly and could fall below the expectations of securities analysts and investors due to seasonality and other factors, some of which are beyond our control, resulting in a decline in our stock price. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our quarterly operating results have and may fluctuate significantly because of several factors, including: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">labor availability and costs for hourly and management personnel; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">profitability of our products, especially in new markets and due to seasonal fluctuations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in interest rates; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">impairment of long-lived assets; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">macroeconomic conditions, both nationally and locally; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">negative publicity relating to products we serve; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in consumer preferences and competitive conditions; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expansion to new markets. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our securities. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities research analysts have and may establish and publish their own periodic projections for us. These projections may vary widely and may not accurately predict the results we actually achieve. Our share price may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades our stock or publishes inaccurate or unfavorable research about our business, our share price could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, our share price or trading volume could decline. If analysts cease coverage of us, the market price and volume for our securities could be adversely affected. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">54 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">There can be no assurance that we will regain compliance with the continued listing standards of Nasdaq. If we fail to cure our current deficiency and regain compliance with the listing requirements of the Nasdaq Capital Market or fail to comply with such listing requirements in the future or fail to cure any future deficiencies, we may be delisted and the price of our common stock and our ability to access the capital markets would be negatively impacted. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is currently listed for quotation on the Nasdaq Capital Market. To maintain the listing of our common stock on the Nasdaq Capital Market, we are required to meet certain listing requirements, including, among others: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a minimum closing bid price of $1.00 per share, and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a market value of publicly held shares (excluding shares held by our officers, directors and 10% or more stockholders) of at least $1.0&#160;million. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the above requirements, we must meet at least one of the following requirements: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">stockholders&#8217; equity of at least $2.5&#160;million; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a market value of listed securities of at least $35&#160;million; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">net income from continuing operations of $500,000. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&#160;25, 2023, we received a letter from the Listing Qualifications Department of Nasdaq, indicating that, based on the closing bid price for the previous 30 consecutive business days, the listing of our common stock was not in compliance with Nasdaq Listing Rule 5550(a)(2) to maintain a minimum bid price of $1.00 per share (the &#8220;Bid Price Rule&#8221;). Under Nasdaq Listing Rule 5810(c)(3)(A), we were given a period of 180 calendar days, or until July&#160;24, 2023 (the &#8220;Compliance Date&#8221;), to regain compliance with the Bid Price Rule. If at any time during this <span style="white-space:nowrap">180-day</span> period the closing bid price of our common stock is at least $1.00 for a minimum of ten consecutive business days, we will regain compliance. If we are unable to regain compliance before the Compliance Date, we may be eligible for an additional 180 calendar days to satisfy the Bid Price Rule. To qualify, we will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market with the exception of the Bid Price Rule, and will need to provide written notice of our intention to cure the deficiency during such additional compliance period, by effecting a reverse stock split, if necessary. However, if it appears to Nasdaq staff that we will not be able to cure the deficiency, or if we are otherwise not eligible for the additional compliance period, and we do not regain compliance by the Compliance Date, the Nasdaq Capital Market will provide written notification to us that our common stock is subject to delisting. At that time, we may appeal the delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if the Company does appeal the delisting determination by Nasdaq to the panel, such appeal would be successful. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that we will be able to regain compliance with respect to the current deficiency including by effecting a reverse share split, or that we will be able to maintain compliance with the Nasdaq Capital Market continued listing requirements in the future or regain compliance with respect to any future deficiencies. This could impair the liquidity and market price of our common stock. In addition, the delisting of our common stock from a national exchange would have a material adverse effect on our access to capital markets, and any limitation on market liquidity or reduction in the price of our common stock as a result of that delisting would adversely affect our ability to raise capital on terms acceptable to us, or at all. We intend to actively monitor the closing bid price of our listed common stock and, as appropriate, will consider available options to resolve the deficiency and regain compliance with the Bid Price Rule, including potentially seeking to effect a reverse share split, if necessary. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">55 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">&#8220;Penny stock&#8221; rules may make buying or selling our securities difficult which may make our stock less liquid and make it harder for investors to buy and sell our securities. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Trading in our securities is subject to the SEC&#8217;s &#8220;penny stock&#8221; rules and it is anticipated that trading in our securities will continue to be subject to the penny stock rules for the foreseeable future. The SEC has adopted regulations that generally define a penny stock to be any equity security that has a market price of less than $5.00 per share, subject to certain exceptions. These rules require that any broker-dealer who recommends our securities to persons other than prior customers and accredited investors must, prior to the sale, make a special written suitability determination for the purchaser and receive the purchaser&#8217;s written agreement to execute the transaction. Unless an exception is available, the regulations require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule explaining the penny stock market and the risks associated with trading in the penny stock market. In addition, broker-dealers must disclose commissions payable to both the broker-dealer and the registered representative and current quotations for the securities they offer. The additional burdens imposed upon broker-dealers by these requirements may discourage broker-dealers from recommending transactions in our securities, which could severely limit the liquidity of our securities and consequently adversely affect the market price for our securities. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Sales of our securities, or the perception of such sales, by us or holders of our securities in the public market or otherwise could cause the market price for our securities to decline and even in such case certain holders of our securities may still have an incentive to sell our securities. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The sale of our securities in the public market or otherwise, or the perception that such sales could occur, could harm the prevailing market price of shares of our securities. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell securities in the future at a time and at a price that it deems appropriate. Resales of our securities may cause the market price of our securities to drop significantly, even if our business is doing well. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of our common stock could decline if holders of our shares sell them, including pursuant to the resale registration statements, or are perceived by the market as intending to sell them. As such, sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to registration rights we have with certain holders of our securities, we filed a resale shelf registration statement covering the resale of up to an aggregate of 96,941,181 shares of our common stock, which was declared effective on June&#160;1, 2022. We filed the registration statement, of which this prospectus forms a part, to register the resale of 500,000 shares of our common stock issued upon exercise of the vested portion Ampere Warrant, which registration statement, of which this prospectus forms a part, was declared effective on August&#160;25, 2022. As of March 1, 2023, the number of shares of our common stock that have been registered for resale by holders represented approximately 61.58% of our shares outstanding (after giving effect to the issuance of shares upon exercise of outstanding public warrants, private placement warrants, the exercise or settlement of outstanding warrants, options or restricted stock units of Legacy Rigetti assumed in the Business Combination and exercise of the Ampere Warrant in full). In addition, on August&#160;11, 2022, we entered into the Purchase Agreement and a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;) with B. Riley Principal Capital II, LLC. Pursuant to the Purchase Agreement, subject to the satisfaction of the conditions set forth in the Purchase Agreement, we have the right to sell shares of our common stock in an aggregate amount up to the lesser of (i) $75.0&#160;million and (ii)&#160;an amount not to exceed 23,648,889 shares of our common stock, subject to certain limitations and conditions. We filed a registration statement on Form <span style="white-space:nowrap">S-1</span> under the Securities Act to register the resale of shares of common stock sold pursuant to the Purchase Agreement, which became effective on September&#160;14, 2022. Given this substantial number of shares available for resale, the sale of shares by such holders, or the perception in the market that holders of a large number of shares intend to sell shares, could increase the volatility of the market price of our common stock or result in a significant decline in the public trading price of our common stock. Even if our trading price is significantly below $10.00, the offering price for </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">56 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the units offered in Supernova&#8217;s IPO, certain holders of our securities may still have an incentive to sell shares of our common stock because they purchased the shares at prices lower than the public investors or the current trading price of our common stock. Further, the purchase price for the shares that we may sell to B. Riley under our committed equity financing will fluctuate based on the price of our common stock. Depending on market liquidity at the time, sales of such shares may cause the trading price of our common stock to fall. If and when we do sell shares to B. Riley, after B. Riley has acquired the shares, B. Riley may resell all, some, or none of those shares at any time or from time to time in its discretion. Therefore, sales to B. Riley by us could result in substantial dilution to the interests of other holders of our common stock. Additionally, the sale of a substantial number of shares of our common stock to B. Riley, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales. The decision to sell any shares of our common stock to sell to B. Riley under the committed equity financing will depend on market conditions, the trading prices of our common stock and other considerations, and we cannot guarantee the extent to which we may utilize the committed equity financing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Future issuances of debt securities and equity securities may adversely affect us, including the market price of our common stock and may be dilutive to existing stockholders. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that significant additional capital will be needed in the near future to continue our planned operations. In the future, we may incur debt or issue equity ranking senior to our common stock. Those securities will generally have priority upon liquidation. Such securities also may be governed by an indenture or other instrument containing covenants restricting our operating flexibility. Additionally, any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of our common stock. Because our decision to issue debt or equity in the future will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, nature or success of our future capital raising efforts. As a result, future capital raising efforts may reduce the market price of our common stock and be dilutive to existing stockholders. In addition, our ability to raise additional capital through the sale of equity or convertible debt securities could be significantly impacted by the resale of shares of common stock by selling securityholders which could result in a significant decline in the trading price of our common stock and potentially hinder our ability to raise capital at terms that are acceptable to us or at all. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may issue additional shares of common stock from time to time, including under our equity incentive plans or employee stock purchase plan, or preferred stock. Common stock reserved for future issuance under our equity incentive plans will become eligible for sale in the public market once those shares are issued, subject to provisions relating to various vesting agreements and, in some cases, limitations on volume and manner of sale applicable to affiliates under Rule 144, as applicable. The aggregate number of shares of our common stock initially reserved for future issuance under the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) is 18,332,215 shares. We have filed a registration statement on Form <span style="white-space:nowrap">S-8</span> under the Securities Act, which became effective on June&#160;10, 2022, to register the issuance of the 18,332,215 shares reserved under the 2022 Plan, the issuance of common stock under the Rigetti Computing, Inc. 2022 Employee Stock Purchase Plan (the &#8220;Employee Stock Purchase Plan&#8221;), which has an initial reserve of 3,055,370 shares, the resale of up to 18,367,696 shares subject to equity awards issued under the Rigetti &amp; Co, Inc. 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;) and the resale of up to 2,053 shares subject to equity awards issued under QxBranch, Inc. 2018 Equity Compensation Plan (the &#8220;QxBranch Plan&#8221;). We have also filed post-effective amendments to this registration statement on Form <span style="white-space:nowrap">S-8,</span> which became effective on June&#160;15, 2022 and August&#160;19, 2022, to add the reoffer of &#8220;control securities&#8221; the reoffer of acquired by certain executive officers under, and since the filing of, the original registration statement on Form <span style="white-space:nowrap">S-8.</span> In addition, we may file one or more registration statements on Form <span style="white-space:nowrap">S-8</span> under the Securities Act to register additional shares of common stock or securities convertible into or exchangeable for shares of common stock issued pursuant to our equity incentive plans and employee stock purchase plan, including additional registration statements on Form <span style="white-space:nowrap">S-8</span> to register additional shares of common stock pursuant to the &#8220;evergreen&#8221; provision under the 2022 Plan, which provides for an annual increase under such plan on January&#160;1 of each year for a period of ten years commencing on January&#160;1, 2023 and ending on (and including) January&#160;1, 2032 by an amount equal to (i) 5% of the total number of shares of our capital stock </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">57 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
outstanding on a fully diluted basis on December&#160;31 of the preceding year or (ii)&#160;a lesser amount determined by our board of directors, and the &#8220;evergreen&#8221; provision under the Employee Stock Purchase Plan, which provides for an annual increase under such plan on January&#160;1 of each year for a period of ten years commencing on January&#160;1, 2023 and ending on (and including) January&#160;1, 2032 by an amount equal to the lesser of (i) 1% of the total number of shares of our capital stock outstanding on a fully diluted basis on December 31st of the preceding calendar year, (ii) 3,055,370 shares of common stock or (iii)&#160;a lesser amount determined by our board of directors. Any such Form <span style="white-space:nowrap">S-8</span> registration statements will automatically become effective upon filing. Accordingly, shares registered under such registration statements may be immediately available for sale in the open market. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of shares of our common stock in the public market could occur at any time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such issuances of additional shares of common stock or preferred stock: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">may significantly dilute the equity interests of our investors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">could cause a change in control if a substantial number of shares of our common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">may adversely affect prevailing market prices for our common stock. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are currently an &#8220;emerging growth company&#8221; and &#8220;smaller reporting company&#8221; within the meaning of the Securities Act, and to the extent we have taken advantage of certain exemptions from disclosure requirements available to emerging growth companies or smaller reporting companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#8220;emerging growth company&#8221; within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies&#8221; including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result, our shareholders may not have access to certain information they may deem important. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our common stock held by <span style="white-space:nowrap">non-affiliates</span> exceeds $700&#160;million as of June&#160;30, in which case we would no longer be an emerging growth company as of the following fiscal year. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <span style="white-space:nowrap">non-emerging</span> growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">58 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Delaware law and our Certificate of Incorporation and Bylaws contain certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation and bylaws of the Company (the &#8220;Bylaws&#8221;) and the General Corporation Law of the State of Delaware (&#8220;DGCL&#8221;) contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition deemed undesirable by the board of directors of Rigetti (the &#8220;Board&#8221;) and therefore depress the trading price of our common stock. These provisions could also make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members of the Board or taking other corporate actions, including effecting changes in our management. Among other things, the Certificate of Incorporation and Bylaws include provisions regarding: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">providing for a classified board of directors with staggered, three-year terms; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the ability of the Board to issue up to 10,000,000 shares of preferred stock, including &#8220;blank check&#8221; preferred stock, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change of control; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that the authorized number of directors may be changed only by resolution of the Board; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that, subject to the rights of the holders of any series of preferred stock, any individual director or directors may be removed only with cause by the affirmative vote of the holders of at least 66 2/3% of the voting power of all of the then-outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent or electronic transmission; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder&#8217;s notice; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that special meetings of our stockholders may be called by the chairperson of the Board, the chief executive officer or by the Board pursuant to a resolution adopted by a majority of the total number of authorized directors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">not provide for cumulative voting rights, therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in the Board or management. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">59 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Certificate of Incorporation designates the Court of Chancery of the State of Delaware or the United States federal district courts as the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, stockholders, employees or agents. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for state law claims for (i)&#160;any derivative action or proceeding brought on our behalf; (ii)&#160;any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer or other employee, or stockholder of Rigetti to Rigetti or our stockholders, (iii)&#160;any action or claim against the Company or any current or former director, officer or other employee or stockholder of the Company, arising out of or pursuant to any provision of the DGCL or the Certificate of Incorporation or the Bylaws, (iv)&#160;any action seeking to interpret, apply, enforce or determine the validity of the Certificate of Incorporation or the Bylaws; (v)&#160;any action or claim as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; and (vi)&#160;any action against the Company or any current or former director, officer or other employee or stockholder of the Company, governed by the internal-affairs doctrine of the law of the State of Delaware, in all cases to the fullest extent permitted by law. The foregoing provisions will not apply to any claims as to which the Delaware Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of such court, which is rested in the exclusive jurisdiction of a court or forum other than such court (including claims arising under the Exchange Act), or for which such court does not have subject matter jurisdiction, or to any claims arising under the Securities Act and, unless we consent in writing to the selection of an alternative forum, the United States federal district courts will be the sole and exclusive forum for resolving any action asserting a claim arising under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules or regulations thereunder. Accordingly, both state and federal courts have jurisdiction to entertain such Securities Act claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, the Certificate of Incorporation provides that, unless we consent in writing to the selection of an alternative forum, United States federal district courts shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. There is uncertainty as to whether a court would enforce the forum provision with respect to claims under the federal securities laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This choice of forum provision in our Certificate of Incorporation may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other companies&#8217; charter documents has been challenged in legal proceedings. It is possible that a court could find these types of provisions to be inapplicable or unenforceable, and if a court were to find the choice of forum provision contained in the Certificate of Incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations and financial condition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, investors cannot waive compliance with the federal securities laws and rules and regulations thereunder. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our warrants, including our public warrants, private placement warrants and other warrants we have issued, are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to complex securities laws and regulations and accounting principles and interpretations. The preparation of our financial statements requires us to interpret accounting principles and guidance and to make </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">60 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses incurred during the reporting periods. We base our interpretations, estimates and judgments on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for the preparation of our financial statements. GAAP presentation is subject to interpretation by the SEC, the Financial Accounting Standards Board and various other bodies formed to interpret and create appropriate accounting principles and guidance. If one of these bodies disagrees with our accounting recognition, measurement or disclosure or any of our accounting interpretations, estimates or assumptions, it may have a significant effect on our reported results and may retroactively affect previously reported results. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&#160;12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled &#8220;Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (&#8220;SPACs&#8221;)&#8221; (the &#8220;SEC Statement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement governing our warrants. As a result of the SEC Statement, Rigetti reevaluated the accounting treatment of the 8,625,000 public warrants and 4,450,000 private placement warrants, and determined to classify the warrants as derivative liabilities measured at fair value, with changes in fair value each period reported in earnings. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, included in Rigetti&#8217;s balance sheet as of December&#160;31, 2022 contained in this prospectus are derivative liabilities related to embedded features contained within our warrants. Accounting Standards Codification 815, Derivatives and Hedging (&#8220;ASC 815&#8221;), provides for the remeasurement of the fair value of such derivatives at each balance sheet date, with a resulting <span style="white-space:nowrap">non-cash</span> gain or loss related to the change in the fair value being recognized in earnings in the statements of operations. As a result of the recurring fair value measurement, our financial statements and results of operations may fluctuate quarterly, based on factors, which are outside of our control. Due to the recurring fair value measurement, we expect that we will recognize <span style="white-space:nowrap">non-cash</span> gains or losses on our warrants each reporting period and that the amount of such gains or losses could be material. The impact of changes in fair value on earnings may have an adverse effect on the market price of our securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No assurance can be given that additional guidance or new regulations or accounting principles and interpretations will not be released that would require us to reclassify our warrants as liabilities measured at fair value, with changes in fair value reported each period in earnings and/or require a restatement of our financial statements with respect to treatment of the warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such restatement of our financial results could, among other potential adverse effects: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">result in us incurring substantial costs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">affect our ability to timely file our periodic reports until the restatement is completed; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">divert the attention of our management and employees from managing our business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">result in material changes to our historical and future financial results; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">result in investors losing confidence in our operating results; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">subject us to securities class action litigation; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">cause our stock price to decline. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, in connection with the preparation of our Report on Form <span style="white-space:nowrap">10-Q</span> for the quarterly period ended September&#160;30, 2022, the audit committee of our board of directors, based on the recommendation of, and after </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">61 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consultation with, our management, and as discussed with our independent registered public accounting firm, concluded that our previously issued unaudited interim condensed consolidated financial statements for the quarters ended March&#160;31, 2022 and June&#160;30, 2022 could no longer be relied upon and require restatement in order to revise the volatility assumption in the valuation methodology with respect to Sponsor Vesting Shares, revise the fair value for our private placement warrants and correct an immaterial error related to the valuation of the warrant liability with respect to the warrants issued to Trinity Capital Inc., in addition to other matters. As a result, we filed amendments to our Reports Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022 restating our financial statements for such periods and were unable to file our Report on Form 10-Q for the quarter ended September 30, 2022 by the prescribed deadline. See &#8220;<span style="font-style:italic">We have identified material weaknesses in our internal control over financial reporting related to the lack of effective review controls over the accounting for complex financial instruments and to the design and operation of our overall closing and financial reporting processes, and we may identify additional material weaknesses in the future. The material weakness over accounting for complex financial instruments has resulted in errors in financial statements for prior periods. If we fail to remediate such material weaknesses, if we identify additional material weaknesses or if we otherwise fail to establish and maintain effective control over financial reporting, it may adversely affect our ability to accurately and timely report our financial results in the future, and may adversely affect investor confidence, our reputation, our ability to raise additional capital and our business operations and financial condition</span>.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our warrants are exercisable for common stock, the exercise of which would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the Business Combination being consummated, outstanding warrants to purchase an aggregate of 13,074,972 shares of common stock became exercisable in accordance with the terms of the warrant agreement. These warrants became exercisable on April&#160;1, 2022. The exercise price of these warrants is $11.50 per share, or approximately $150.4&#160;million, assuming none of the warrants are exercised through &#8220;cashless&#8221; exercise. To the extent such warrants are exercised, additional shares of common stock will be issued, which will result in dilution to the holders of common stock and increase the number of shares eligible for resale in the public market. We believe the likelihood that warrant holders will exercise their warrants, and therefore the amount of cash proceeds that we would receive, is dependent upon the trading price of our common stock. If the trading price for our common stock is less than $11.50 per share, we believe holders of our public warrants and private placement warrants will be unlikely to exercise their warrants. On April&#160;4, 2023, the last reported sales price of our common stock was $0.6679&#160;per share. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of substantial numbers of such shares in the public market or the fact that such Warrants may be exercised could adversely affect the market price of common stock. However, there is no guarantee that the Public Warrants will ever be in the money prior to their expiration, and as such, the warrants may expire worthless. See &#8220;<span style="font-style:italic">The warrants may never be in the money, and they may expire worthless and the terms of the public warrants may be amended in a manner adverse to a holder if holders of at least 50% of the then outstanding public warrants approve of such amendment</span>.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The warrants may never be in the money, and they may expire worthless and the terms of the public warrants may be amended in a manner adverse to a holder if holders of at least 50% of the then outstanding public warrants approve of such amendment. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price for our warrants is $11.50 per share of common stock. We believe the likelihood that warrant holders will exercise their public warrants and private placement warrants, and therefore the amount of cash proceeds that we would receive, is dependent upon the trading price of our common stock. If the trading price for our common stock is less than $11.50 per share, we believe warrant holders will be unlikely to exercise their warrants. There is no guarantee that the warrants will be in the money following the time they become exercisable and prior to their expiration, and as such, the warrants may expire worthless. Our warrants became exercisable on April&#160;1, 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">62 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrants were issued in registered form under a warrant agreement between American Stock Transfer&#160;&amp; Trust Company, as warrant agent, and Supernova. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision or correct any mistake, but requires the approval by the holders of at least 50% of the then-outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least 50% of the then-outstanding public warrants approve of such amendment and, solely with respect to any amendment to the terms of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants, 50% of the number of the then outstanding private placement warrants. Although our ability to amend the terms of the public warrants with the consent of at least 50% of the then-outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash, shorten the exercise period or decrease the number of shares of common stock purchasable upon exercise of a warrant. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to the holder, thereby making such warrants worthless. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of the common stock equals or exceeds $18.00 per share (as adjusted for share subdivisions, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 <span style="white-space:nowrap">trading-day</span> period ending on the third trading day prior to the date we send the notice of redemption to the warrant holders. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of the outstanding warrants could force you to: (i)&#160;exercise your warrants and pay the exercise price therefore at a time when it may be disadvantageous for you to do so; (ii)&#160;sell your warrants at the then-current market price when you might otherwise wish to hold your warrants; or (iii)&#160;accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, is likely to be substantially less than the market value of your warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may redeem your warrants at any time after they become exercisable and prior to their expiration at a price of $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption for a number of shares of common stock determined based on the redemption date and the fair market value of our common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The value received upon exercise of the warrants (1)&#160;may be less than the value the holders would have received if they had exercised their warrants at a later time where the underlying share price is higher and (2)&#160;may not compensate the holders for the value of the warrants, including because the number of shares of common stock received is capped at 0.361 per share of common stock per warrant (subject to adjustment) irrespective of the remaining life of the warrants. None of the private placement warrants will be redeemable by us, subject to certain circumstances, so long as they are held by Supernova Partners II LLC (&#8220;Supernova Sponsor&#8221;) or its permitted transferees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The warrant agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with us. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrant agreement provides that, subject to applicable law, (i)&#160;any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii)&#160;that we irrevocably submit to such jurisdiction, which jurisdiction will be the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">63 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exclusive forum for any such action, proceeding or claim. Under the warrant agreement, we also agree that we will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, these provisions of the warrant agreement do not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of the public warrants or private placement warrants will be deemed to have notice of and to have consented to the forum provisions in our warrant agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any action, the subject matter of which is within the scope of the forum provisions of the warrant agreement, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a &#8220;foreign action&#8221;) in the name of any holder of the public warrants or private placement warrants, such holder will be deemed to have consented to: (x)&#160;the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an &#8220;enforcement action&#8221;), and (y)&#160;having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder&#8217;s counsel in the foreign action as agent for such warrant holder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <span style="white-space:nowrap"><span style="white-space:nowrap">choice-of-forum</span></span> provision may limit a warrant holder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and board of directors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may be subject to securities litigation, which is expensive and could divert management attention. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of our common stock may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert management&#8217;s attention from other business concerns, which could seriously harm our business. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">64 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_7">USE OF PROCEEDS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are filing the registration statement of which this prospectus forms&#160;a part to permit the selling stockholder to resell the Shares, as described in the section titled &#8220;Selling Stockholder&#8221;. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder will receive all of the net proceeds from sales of the Shares sold pursuant to this prospectus. We will not receive any proceeds from the resale of any Shares offered by this prospectus by the selling stockholder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, the Selling Stockholder is required to pay, subject to the satisfaction of certain conditions, the Additional Payment to the Company no later than the second anniversary of the date of the Warrant Subscription Agreement, and upon such payment, the Unexercised Warrant Shares will vest and be exercisable by the Selling Stockholder pursuant to the terms of the Ampere Warrant. If the conditions to payment are not satisfied by the second anniversary of the date of the Warrant Subscription Agreement, the Company may reject Ampere&#8217;s payment of the Additional Payment and the Unexercised Warrant Shares will not vest or be exercisable and Ampere will have no further obligation with respect to the payment of the Additional Payment. We expect to use the proceeds from the payments from the Ampere Warrant for general corporate purposes. We cannot predict when or if we will receive the Additional Payment, and if the Unexercised Warrant Shares will vest and be exercisable, and it is possible that we may never receive the Additional Payment, that the Ampere Warrant will not be exercised for the additional 500,000 shares of common stock, and that the Unexercised Warrant Shares may never be issued. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, and not the selling stockholder, will pay the costs, expenses and fees in connection with the registration and sale of the Shares covered by this prospectus, but the selling stockholder will pay all discounts, commissions or brokers&#8217; fees or fees of similar securities industry professionals and transfer taxes, if any, attributable to sales of the Shares. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">65 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_8">DETERMINATION OF OFFERING PRICE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot currently determine the price or prices at which the Shares may be sold by the selling stockholder under this prospectus. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">66 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_9">MARKET INFORMATION FOR SECURITIES AND DIVIDEND POLICY </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Market Information </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock and public warrants are currently listed on Nasdaq under the symbols &#8220;RGTI&#8221; and &#8220;RGTIW,&#8221; respectively. Prior to the consummation of the Business Combination, Supernova Class&#160;A common shares and public warrants were listed on The New York Stock Exchange under the symbols &#8220;SNII&#8221; and &#8220;SNIIW,&#8221; respectively. As of March 22, 2023, there were 209 holders of record of our common stock, 1 holder of record of the public warrants and 4 holders of record of the private placement warrants. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Dividend Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid any dividends on shares of our common stock. We anticipate that we will retain all of our future earnings, if any, for use in the operation and expansion of our business and do not anticipate paying cash dividends in the foreseeable future. Any decision to declare and pay dividends in the future will be made at the sole discretion of our Board and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions and other factors that our Board may deem relevant. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">67 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_10">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section should be read in conjunction with the consolidated financial statements and notes thereto included elsewhere in this prospectus. This discussion and analysis contains forward-looking statements, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words &#8220;believe,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;target,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;will,&#8221; &#8220;continue,&#8221; &#8220;project,&#8221; and the like, and/or future tense or conditional constructions (&#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties, including those we describe under &#8220;Risk Factors&#8221; and elsewhere in this prospectus that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">For purposes of this discussion, &#8220;Rigetti,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Rigetti Computing, Inc. and its subsidiaries unless the context otherwise requires. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;2, 2022 (the &#8220;Closing Date&#8221;), we consummated the transactions contemplated by that certain Agreement and Plan of Merger dated as of October&#160;6, 2021, as amended on December&#160;23, 2021 and January&#160;10, 2022 (as amended, the &#8220;Merger Agreement&#8221;), by and among Supernova Partners Acquisition Company II, Ltd., a Cayman Islands exempted company (&#8220;Supernova&#8221;), Supernova Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Supernova (the &#8220;First Merger Sub&#8221;), Supernova Romeo Merger Sub, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of Supernova (the &#8220;Second Merger Sub&#8221;), and Rigetti Holdings, Inc., a Delaware corporation (&#8220;Legacy Rigetti&#8221;). As contemplated by the Merger Agreement, on March&#160;1, 2022 Supernova was domesticated as a Delaware corporation and changed its name to &#8220;Rigetti Computing, Inc.&#8221; (the &#8220;Domestication&#8221;). On the Closing Date, (i)&#160;First Merger Sub merged with and into Legacy Rigetti, the separate corporate existence of First Merger Sub ceased and Legacy Rigetti survived as a wholly owned subsidiary of Rigetti Computing, Inc. (the &#8220;Surviving Corporation&#8221; and, such merger, the &#8220;First Merger&#8221;), and (ii)&#160;immediately following the First Merger, the Surviving Corporation merged with and into the Second Merger Sub, the separate corporate existence of the Surviving Corporation ceased and Second Merger Sub survived as a wholly owned subsidiary of Rigetti Computing, Inc. and changed its name to &#8220;Rigetti Intermediate LLC&#8221; (such merger transaction, the &#8220;Second Merger&#8221; and, together with the First Merger, the &#8220;Merger&#8221;, and, collectively with the Domestication, the &#8220;PIPE Financing&#8221; (as defined below) and the other transactions contemplated by the Merger Agreement, the &#8220;Business Combination&#8221;). The closing of the Business Combination is herein referred to as &#8220;the Closing.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We build quantum computers and the superconducting quantum processors that power them. We believe quantum computing represents one of the most transformative emerging capabilities in the world today. By leveraging quantum mechanics, we believe our quantum computers process information in fundamentally new, more powerful ways than classical computers. When scaled, it is anticipated that these systems will be poised to solve problems of staggering computational complexity at unprecedented speed. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With the goal of unlocking this opportunity, we have developed the world&#8217;s first multi-chip quantum processor for scalable quantum computing systems. We believe that this patented and patent pending, modular chip architecture is the building block for new generations of quantum processors that we expect to achieve a clear advantage over classical computers. Our long-term business model centers on revenue generated from quantum computing systems made accessible via the cloud in the form of Quantum Computing as a Service (&#8220;QCaaS&#8217;) products. However, the substantial majority of our revenues are derived from development contracts, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">68 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and we anticipate this market opportunity will exist for at least the next several years as we work to ramp up our QCaaS business. Additionally, we are working to further develop a revenue stream and forging important customer relationships by entering into technology development contracts with various partners. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a vertically integrated company. We own and <span style="white-space:nowrap">operate&#160;Fab-1,&#160;a</span> dedicated and integrated laboratory and manufacturing facility, through which we own the means of producing our breakthrough multi-chip quantum processor technology. We leverage our chips through a full-stack product development approach, from quantum chip design and manufacturing through cloud delivery. We believe this full-stack development approach offers both the fastest and lowest risk path to building commercially valuable quantum computers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have been generating revenue since 2018 through partnerships with government agencies and commercial organizations; however, we have not yet generated profits. We have incurred significant operating losses since inception. Our net losses were $71.5&#160;million and $38.2&#160;million for the year ended December&#160;31, 2022, and 11 months ended December&#160;31, 2021, respectively. We expect to continue to incur additional losses for the foreseeable future as we invest in research development and infrastructure in line with our long-term business strategy. As of December&#160;31, 2022, we had an accumulated deficit of $278.7&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on our estimates and current business plan, we expect that we will need to obtain additional capital by late 2024 or early 2025 in order to continue our research and development efforts and achieve our business objectives. There is no assurance that additional financing will be available. If we are unable to raise additional funding when needed, we may be required to delay, limit or substantially reduce our quantum computing development efforts. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February&#160;2023, we announced an updated business strategy, including revisions to our technology roadmap. In connection with this updated strategy, we have implemented a workforce reduction in order to focus the organization and our resources on nearer-term strategic priorities. In March 2023, we further refined our business strategy after internally deploying Ankaa-1, our 84-qubit system delivering denser qubit spacing and tunable couplers, within our company for testing. We plan to concentrate on refining the performance of <span style="white-space:nowrap">Ankaa-1.</span> Upon the anticipated external launch of the Ankaa-1 84-qubit system, which is expected to be to select customers, we plan to continue efforts to improve the performance of the system with the goal of reaching at least 98% 2-qubit gate fidelity to support the anticipated Ankaa-2 84-qubit system. We then plan to launch the anticipated Ankaa-2 84 qubit system, continuing to work to improve performance with the goal of reaching at least 99% gate fidelity on Ankaa-2. If these targets are achieved, we plan to shift focus to scaling to develop Lyra, an anticipated 336-qubit system. We believe that this business plan should enable us to concentrate our software application development strategy on what we believe to be the highest likelihood applications for demonstrating nearer term narrow quantum advantage. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The reduction in workforce impacted approximately 50 employees or 28% of our workforce. We began implementing activities with respect to the revised business plan and reduction in workforce in February 2023. Affected employees were offered separation benefits, including severance payments and temporary healthcare coverage assistance. We currently expect to incur restructuring charges of approximately $1.4&#160;million for severance payments and temporary healthcare coverage for effected employees. Such restructuring charges are expected to be incurred and recorded in the first quarter of 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">The Business Combination and PIPE Financing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;6, 2021, SNII entered into the Merger Agreement by and among Supernova, First Merger Sub, Second Merger Sub, and Legacy Rigetti. On March&#160;2, 2022, the Business Combination was consummated. While the legal acquirer in the Merger Agreement was Supernova, for financial accounting and reporting purposes under United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;), Rigetti was the accounting acquirer and the Merger was accounted for as a &#8220;reverse recapitalization.&#8221; A reverse recapitalization does not result in a new basis of accounting, and financial statements of Rigetti represent the continuation of the financial </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">69 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements of Legacy Rigetti in many respects. Under this method of accounting, Supernova was treated as the &#8220;acquired&#8221; company for financial reporting purposes. For accounting purposes, Rigetti was deemed to be the accounting acquirer in the transaction and, consequently, the transaction was treated as a recapitalization of Rigetti (i.e., a capital transaction involving the issuance of stock by Supernova for the stock of Rigetti). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the Business Combination, all of the shares of Legacy Rigetti Common Stock outstanding immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti preferred stock conversion) were converted into the right to receive an aggregate of 78,959,579 shares of our Common Stock, par value $0.0001 per share (&#8220;Common Stock&#8221;). Additionally, each issued and outstanding share of Supernova Class&#160;A and Class&#160;B Common Stock held by Supernova automatically converted to 20,209,462 shares of Common Stock (of which 3,059,273 shares are subject to vesting under certain conditions). Upon consummation of the Business Combination, the most significant change in our reported financial position and results of operations was an increase in cash of $205.0&#160;million (as compared to Rigetti&#8217;s balance sheet at December&#160;31, 2021), including $225.6&#160;million of proceeds from the Business Combination and PIPE Financing net of transaction costs incurred by us of $20.6&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional direct and incremental transaction costs were also incurred by Rigetti in connection with the Business Combination. Generally, costs (e.g., SPAC shares) are recorded as a reduction to additional <span style="white-space:nowrap">paid-in</span> capital. Costs allocated to liability-classified instruments that are subsequently measured at fair value through earnings (e.g., certain SPAC warrants) are expensed. Rigetti&#8217;s transaction costs totaled $20.6&#160;million, of which $19.7&#160;million was allocated to equity-classified instruments and recorded as a reduction to additional <span style="white-space:nowrap">paid-in</span> capital, and the remaining $0.9&#160;million was allocated to liability-classified instruments that are subsequently measured at fair value through earnings and recognized as expense in the consolidated statements of operations during the year ended December&#160;31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the Business Combination, we became subject to the reporting requirements under the Securities Exchange Act of 1934, as amended, and listing standards of the Nasdaq Capital Market, which has and will necessitate us to hire additional personnel and implement procedures and processes to address such public company requirements. We expect to incur additional ongoing expenses as a public company for, among other things, directors&#8217; and officers&#8217; liability insurance, director fees, and additional internal and external accounting, legal and administrative resources. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future results of consolidated operations and financial position may not be comparable to historical results as a result of the Business Combination. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Macroeconomic Considerations </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unfavorable conditions in the economy in the United States and abroad may negatively affect the growth of our business and our results of operations. For example, macroeconomic events, including the COVID-19 pandemic, rising inflation, the U.S. Federal Reserve raising interest rates, the Russia-Ukraine war, and recent bank failures have led to economic uncertainty globally. The effect of macroeconomic conditions may not be fully reflected in our results of operations until future periods. If, however, economic uncertainty increases or the global economy worsens, our business, financial condition and results of operations may be harmed. For further discussion of the potential impacts of macroeconomic events on our business, financial condition, and operating results, see the section titled &#8220;Risk Factors,&#8221; including the risk factor titled <span style="font-style:italic">&#8220;Unstable market and economic conditions have had and may continue to have serious adverse consequences on our business, financial condition and share price.&#8221;</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specifically, the <span style="white-space:nowrap">COVID-19</span> pandemic has limited and could further limit the ability of suppliers and business partners to perform, including third-party suppliers&#8217; ability to provide components, services and materials. We have experienced and may experience further increases in the cost of raw materials. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">70 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, during the year ended December&#160;31, 2022, we experienced supply chain challenges, which we largely attribute to the <span style="white-space:nowrap">COVID-19</span> pandemic and the general disruptions resulting from the ongoing conflict between Ukraine and Russia and related sanctions, as well as increases in costs of component parts, labor and raw materials, which we largely attribute to rising inflation and high demand as a result of restricted supply. We expect these increased costs to remain high as the <span style="white-space:nowrap">COVID-19</span> pandemic, the Ukraine-Russia conflict and their respective effects persist. As global economic conditions recover from the <span style="white-space:nowrap">COVID-19</span> pandemic, the Ukraine-Russia conflict and the related sanctions, business activity may not recover as quickly as anticipated, and it is not possible at this time to estimate the long-term impact that these and related events could have on our business, as the impact will depend on future developments, which are highly uncertain and cannot be predicted. For instance, product demand may be reduced due to an economic recession, a decrease in corporate capital expenditures, prolonged unemployment, rising inflation and interest rates, labor shortages, reduction in consumer confidence, adverse geopolitical and macroeconomic events, or any similar negative economic condition. In addition, global economic conditions have been worsening, with disruptions to, and volatility and uncertainty in, the credit and financial markets in the U.S. and worldwide resulting from the effects of <span style="white-space:nowrap">COVID-19</span> and increases in inflation, interest rates and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures. If these conditions persist and deepen, we could experience an inability to access additional capital or our liquidity could otherwise be impacted. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs and other efforts. However, like many other companies, we are taking actions to monitor our operations to account for the increases in cost of capital. Specifically, this includes efforts to enhance our operational efficiency, maximize our R&amp;D spend through strategic collaborations, and being highly selective in hiring <span style="white-space:nowrap">top-tier</span> talent. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Change in Fiscal Year </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2021, the board of directors of Legacy Rigetti (the &#8220;Legacy Rigetti Board&#8221;) approved a change in fiscal year end from January&#160;31 to December&#160;31, effective December&#160;31, 2021. As a result of this change, our fiscal year begins on January&#160;1 and ends on December&#160;31 of each year, starting on January&#160;1, 2022. For fiscal year 2021, this covers a period of 11 months starting from February&#160;1, 2021 and ending on December&#160;31, 2021. See below &#8220;Result of Operations&#8221; regarding comparability of prior periods relating to the change in fiscal year. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Key Components of Results of Operations </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generate revenue through our development contracts, as well as from our QCaaS offerings and other services including training and provision of quantum computing components. Development contracts are generally multi-year, <span style="white-space:nowrap">non-recurring</span> arrangements pursuant to which we provide professional services regarding collaborative research in practical applications of quantum computing to technology and business problems within the customer&#8217;s industry or organization and assists the customer in developing quantum algorithms and applications to assist customers in areas of business interest. QCaaS revenue is recognized on a ratable basis over the contract term or on a usage basis, which generally ranges from three months to two years. Revenue related to development contracts and other services is recognized as the related milestones are completed or over time, as the work required to complete milestones deemed probable of being met is completed. Revenue related to the sale of custom quantum computing components is recognized at a point in time upon acceptance by the customer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cost of Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenue consists primarily of all direct and indirect cost associated with providing QCaaS offerings and development contracts and other services, including employee salaries and related taxes, bonuses, and benefit costs of program management and personnel associated with the delivery of goods and services to customers and <span style="white-space:nowrap">sub-contract</span> costs for work performed by third parties. Cost of revenue also includes an allocation of facility costs, depreciation and amortization directly related to providing the QCaaS offerings and development contracts and other services. Cost of revenue is expected to increase with any growth in revenues as we expand our operations, enhance our service offerings and expand our customer base. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">71 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our operating expenses consist of sales and marketing, general and administrative and research and development expenses. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Research and Development </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development costs are expensed as incurred. Research and development expenses include compensation, employee benefits, stock-based compensation, outside consultant fees, facility costs, depreciation and amortization, materials and components purchased for research and development. We expect research and development expenses to increase as we invest in the enhancement of our product offerings. We do not currently capitalize any research and development expenditures. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Sales and Marketing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales and marketing expenses consist primarily of compensation including stock-based compensation, employee benefits, outside consultant&#8217;s fees, travel and marketing promotion costs. We expect selling and marketing expenses to increase after we achieve narrow and broad quantum advantage, and subsequently enhance our service offerings, expand our customer base, and implement new marketing strategies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General and Administrative </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses include compensation, employee benefits, stock-based compensation, insurance, facility costs), professional service fees, and other general overhead costs other than those associated with providing QCaaS offerings and development contracts and other services. We expect our general and administrative expenses to increase as we continue to grow our business. We also expect to incur additional expenses as a result of operating as a public company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Provision for Income Taxes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. We have recorded a full valuation allowance against our deferred tax assets. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Results of Operations </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described above in &#8220;&#8212;Change in Fiscal Year,&#8221; the board of Legacy Rigetti changed the fiscal year from January&#160;1 to December&#160;31, effective December&#160;31, 2021. Accordingly, the fiscal year ended December&#160;31, 2021 covers a period of 11 months from February&#160;1, 2021 to December&#160;31, 2021 (&#8220;fiscal year 2021&#8221;). Financial statements for the fiscal year ended December&#160;31, 2022 include the 12 months ended December&#160;31, 2022 (&#8220;fiscal year 2022&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The comparability of our results of operations for fiscal year 2022 with fiscal year 2021 is affected by the change in fiscal year since fiscal year 2021 includes an <span style="white-space:nowrap">11-month</span> period versus a <span style="white-space:nowrap">12-month</span> period for fiscal year 2022. For comparability purposes, to supplement the discussion of our historical results of operations for fiscal year 2022 and comparative period in 2021, we have included a discussion of unaudited supplemental recast </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">72 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information for the 12 months ended December&#160;31, 2021. The unaudited supplemental recast information for the <span style="white-space:nowrap">12-month</span> period ended December&#160;31, 2021 includes historical consolidated results of operations for fiscal year 2021 and one month of results of operations for January 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All dollar amounts in tables, except share and per share amounts, are presented in thousands unless otherwise noted. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Year ended December&#160;31, 2022 compared to 11 months ended December&#160;31, 2021 and Supplemental Information &#8211; Year ended December&#160;31, 2022 compared to Unaudited 12 months ended December&#160;31, 2021 </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables set forth our results of operations for fiscal year 2022 compared to fiscal year 2021 and supplemental information comparing fiscal year 2022 to the unaudited 12 month period ended December&#160;31, 2021: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:34%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="14" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">Fiscal Year</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="14" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">Supplemental Information</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">Year Ended<br />December&#160;31,</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">11&#160;Months<br />Ended<br />December&#160;31,</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">Year&#160;Ended<br />December&#160;31, 2022<br />versus<br />11 Months Ended<br />December&#160;31,&#160;2021</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">Year Ended<br />December&#160;31,</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">12&#160;Months<br />Ended<br />December&#160;31,</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">Year Ended<br />December&#160;31, 2022<br />versus<br />12 Months Ended<br />December&#160;31, 2021</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">2022</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">2021</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">$&#160;Change</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">%&#160;Change</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">2022</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">2021</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7.5pt"><span style="font-weight:bold">$&#160;Change</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center">(unaudited)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center">(unaudited)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center">(unaudited)</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Revenue:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 4,906</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">60</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 8,633</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 4,469</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,873</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,623</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,873</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,770</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,103</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">62</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total gross profit</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,229</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,573</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,656</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,229</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,863</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,366</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">49</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating expenses:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Research and development</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,952</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">26,928</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">123</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,952</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,798</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31,154</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">108</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Sales and marketing</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,475</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,873</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">156</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,557</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,791</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">148</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">General and administrative</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">47,632</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,299</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">36,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">322</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">47,632</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,094</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">34,538</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">264</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Goodwill impairment</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">119,309</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40,702</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">78,607</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">193</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">119,309</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44,449</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">74,860</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">168</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Loss from operations</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(109,080</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(34,129</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(74,951</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">220</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(109,080</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(37,586</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(71,494</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">190</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other (expense) income, net:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest expense</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,286</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,465</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,821</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">114</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,286</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,465</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,821</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">114</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,433</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,423</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,433</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of derivative warrant liabilities</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,132</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,664</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,796</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,132</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,664</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,796</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of <span style="white-space:nowrap">earn-out</span> liability</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,207</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,207</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,207</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,207</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Transaction cost</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(927</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(927</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(927</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(927</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">nm</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(23</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total other income (expense), net</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,559</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,112</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">41,671</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,559</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,141</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">41,700</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net loss before provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(71,521</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(38,241</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(33,280</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(71,521</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(41,727</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(29,794</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net loss</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(71,521</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(38,241</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(33,280</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(71,521</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(41,727</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(29,794</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">*nm &#8211; not meaningful </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">73 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue increased $4.9&#160;million, or 60%, to $13.1&#160;million for the year ended December&#160;31, 2022, up from $8.2&#160;million for the 11 months ended December&#160;31, 2021. The period over period increase was attributable to a $5.3&#160;million increase in revenue from extension of three government contracts into <span style="white-space:nowrap">year-two</span> and year-three phases, a $0.7&#160;million increase from a <span style="white-space:nowrap">non-governmental</span> QCaaS customer, and other increases in revenue from existing projects totaling $0.4&#160;million. These increases were offset in part by a $0.9&#160;million decrease in revenue from a U.S. government contract that is nearing completion and a $0.6&#160;million decrease in revenue from other customers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our development contracts are fixed price milestone or cost share-based contracts and the timing and amounts of revenue recognized in each quarter vary based on the delivery of the associated milestones and/or work performed. We expect to continue to generate the majority of our revenue from development contracts over at least the next several years and that revenue will vary in timing and size as we work to ramp up our QCaaS business for the longer term. There may be some near-term reduction in revenue as we align to our new strategy announced in February 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue increased $4.5&#160;million, or 52%, to $13.1&#160;million for the year ended December&#160;31, 2022, up from $8.6&#160;million for the unaudited 12 months ended December&#160;31, 2021. The period over period increase was primarily attributable to the reasons discussed in the section above, offset in part by one more month of activity in the 2021 comparison period. We earned $0.4&#160;million of revenue in January 2021 which was included in the unaudited 12 months ended December&#160;31, 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cost of Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenue increased by $1.3&#160;million, or 77%, to $2.9&#160;million for the year ended December&#160;31, 2022, as compared to $1.6&#160;million for the 11 months ended December&#160;31, 2021. The increase was mainly attributable to an increase in employee-related costs of $0.4&#160;million and subcontractor costs of $0.9&#160;million associated with specific projects and collaborative development contract services work with government agencies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect subcontractor costs to increase and employee-related costs to decline in the near term as a result of the reorganization efforts, including the reduction in workforce, that we announced in February 2023. In addition, we have incurred and may continue to incur increased costs associated with equipment, system components and labor due to current global economic conditions, including inflation, labor shortages and supply conditions. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenue increased by $1.1&#160;million, or 62%, to $2.9&#160;million for the year ended December&#160;31, 2022, as compared to $1.8&#160;million for the unaudited 12 months ended December&#160;31, 2021. The increase was mainly attributable to the reasons described in the section above and one more month in the 2021 comparison period. We incurred $0.2&#160;million of employee-related costs in January 2021 which was included in the unaudited 12 month periods ended December&#160;31, 2021. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">74 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Research and Development Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased by $33.0&#160;million, or 123%, to $60.0&#160;million for the year ended December&#160;31, 2022, from $26.9&#160;million for the 11 months ended December&#160;31, 2021. The period over period increase was primarily attributable to the following factors and one less month of activity in the 2021 comparison period: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $22.6&#160;million increase in employee-related costs for the year ended December&#160;31, 2022 due to an increase in headcount and resulting wage increase of $9.5&#160;million, a $13.1&#160;million increase in stock-based compensation expense, which includes annual refresh grants of restricted stock to employees in the year ended December&#160;31, 2022 and a <span style="white-space:nowrap">one-time</span> cumulative recognition of previously deferred stock-based compensation expense of $1.6&#160;million related to the satisfaction of the liquidity condition with respect to outstanding stock units recognized as a result of the close of the Business Combination in March 2022. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $7.4&#160;million increase associated with the ongoing and expanded investment in research and development efforts, including a $3.5&#160;million increase in software subscription costs, a $2.0&#160;million increase in depreciation, a $0.9&#160;million increase in equipment spares and materials costs, a $0.3&#160;million increase in other costs, a $0.4&#160;million increase in other expenses relates to travel and meal costs, and a $0.3&#160;million increase in consultant fees. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $3.0&#160;million increase in facility costs, including a $1.3&#160;million <span style="white-space:nowrap">one-time</span> catch up for electricity usage at our Berkeley facility from February 2019 to December&#160;31, 2021, which was an <span style="white-space:nowrap"><span style="white-space:nowrap">out-of-period</span></span> adjustment; additional electricity usage of $0.7&#160;million, and an increase in operating lease expense of $1.0&#160;million due to an expansion of office space. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect research and development expenses to remain consistent during the next two years as a result of anticipated increase in expenses as we shift our focus to further developing the <span style="white-space:nowrap">Ankaa-1</span> <span style="white-space:nowrap">84-qubit</span> system and improving performance with the anticipated <span style="white-space:nowrap">Ankaa-2</span> <span style="white-space:nowrap">84-qubit</span> system, offset by our reorganization efforts announced in February 2023. Thereafter our plan is to shift to development of the anticipated Lyra <span style="white-space:nowrap">336-qubit</span> system, working towards the goal of achieving narrow quantum advantage. We expect research and development expenses to increase as and if we near the point of achieving narrow quantum advantage. Our ability to limit research and development costs in the nearer term will be impacted by increasing costs for labor, including stock-based compensation expenses in order to attract and retain qualified personnel, equipment and component costs impacted by the current macroeconomic environment, including supply chain constraints, and labor shortages. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased by $31.2&#160;million, or 108%, to $60.0&#160;million for the year ended December&#160;31, 2022, from $28.8&#160;million for the unaudited 12 months ended December&#160;31, 2021. The increase was primarily attributable to the reasons discussed in the section above and one more month of expenses included in the 2021 comparison period specifically related to the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$1.6&#160;million of employee-related costs, including $1.4&#160;million for wages and $0.2&#160;million for stock-based compensation expense. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$0.2&#160;million of depreciation expense. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Sales and Marketing Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales and marketing increased $3.9&#160;million, or 156%, to $6.3&#160;million for the year ended December&#160;31, 2022, from $2.5&#160;million for the 11 months ended December&#160;31, 2021. The period over period increase was primarily </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">75 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
attributable to a $0.8&#160;million increase in employee related costs, a $2.0&#160;million increase in stock-based compensation of which $0.4&#160;million was related to the satisfaction of the liquidity condition with respect to outstanding stock units recognized as a result of the close of the Business Combination in March 2022, a $1.1&#160;million increase for consultants and other spending for sales development activities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect selling and marketing expenses to marginally decrease or stay consistent during the next few years due to the reduction in workforce we implemented in February 2023 and other cost control efforts. We expect sales and marketing expenses to increase if and when we near the point of narrow quantum advantage. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales and marketing increased $3.8&#160;million, or 148%, to $6.3&#160;million for the year ended December&#160;31, 2022, from $2.6&#160;million for the unaudited 12 months ended December&#160;31, 2021. The increase was primarily driven by the reasons discussed in the section above and one more month of activity in the 2021 comparison period. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General and Administrative Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $36.3&#160;million, or 322%, to $47.6&#160;million for the year ended December&#160;31, 2022, from $11.3&#160;million for the 11 months ended December&#160;31, 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The increase was attributable to the following factors: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $27.9&#160;million increase in stock-based compensation expense, including <span style="white-space:nowrap">a&#160;one-time</span> cumulative recognition of previously deferred stock-based compensation expense of $6.9&#160;million related to the satisfaction of the liquidity condition with respect to outstanding stock units recognized as a result of the closing of the Business Combination. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $7.8&#160;million increase in other expenses, including $4.6&#160;million in legal and accounting costs related to public company reporting requirements, investor relation costs, other software acquisition costs, and a $3.2&#160;million increase in consultant costs. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $2.7&#160;million increase for directors&#8217; and officers&#8217; insurance and other office expenses attributable to a return to <span style="white-space:nowrap">in-person</span> office work related to the <span style="white-space:nowrap">Covid-19</span> pandemic; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $1.8&#160;million increase for transaction bonuses awarded to employees in recognition of the closing of the Business Combination, </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $1.8&#160;million increase in employee related costs as a result of operating as a public company and the build out of our information security team, including higher executive salaries and increased headcount. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $0.5&#160;million increase in depreciation expense. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These costs were partially offset by the gain in change in fair value of our Forward Warrant Agreement of $5.8&#160;million which was entered into with Ampere in October 2021 as part of our strategic collaboration agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect general and administrative expenses to decrease or stay consistent during the next few years due to the reduction in workforce we implemented in February 2023 and other efforts to control costs. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $34.5&#160;million, or 264%, to $47.6&#160;million for the year ended December&#160;31, 2022, from $13.1&#160;million for the unaudited 12 months ended December&#160;31, 2021. The increase was attributable to the reasons described in the section above and one more month of activity in the 2021 comparison period. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">76 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company incurred the following costs totaling $1.8&#160;million in January 2021 which were included in the unaudited 12 months ended December&#160;31, 2021: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$0.5&#160;million in other expenses including legal and accounting costs related to private company financing initiatives, audit, third party consulting services, preparing the company to go public and other software acquisition costs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$0.5&#160;million in employee related costs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$0.3&#160;million in other costs attributable to return to office work; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$0.2&#160;million in depreciation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$0.1&#160;million in stock-based compensation expense. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$0.2&#160;million in other costs </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Goodwill impairment </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Goodwill impairment increased by $5.4&#160;million for the year ended December&#160;31, 2022, when compared to the 11&#160;months ended December&#160;31, 2021. We test for goodwill impairment on the first of November each year and at interim dates when indicators of impairment exist. When assessing goodwill for possible impairment, we first consider qualitative factors, including but not limited to macroeconomic conditions, industry and market considerations, our overall performance and events directly affecting us. It was noted during our annual goodwill impairment assessment on November&#160;1, 2022 that the Company had experienced a sustained decline in stock price, however, we determined at that time that our goodwill was not impaired. Subsequently, our stock price continued to decline, resulting in a triggering event that required us to evaluate goodwill for possible impairment as of December&#160;31, 2022. After adjusting the Company&#8217;s stock market capitalization for a control premium based on market comparable transactions, we determined that the fair value of the Company was less than its carrying value or stockholder&#8217;s equity, resulting in a <span style="white-space:nowrap">non-cash</span> goodwill impairment charge of $5.4&#160;million for the year ended December&#160;31, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As the goodwill impairment occurred during the year ended December&#160;31, 2022, the increase in impairment during the year ended December&#160;31, 2022 as compared to the unaudited 12 months ended December&#160;31, 2021 is related to the matter described in the above section. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Other Income (Expense), net </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Interest Expense </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense was $5.3&#160;million and $2.5&#160;million for the year ended December&#160;31, 2022 and the 11 months ended December&#160;31, 2021, respectively. The increase in expense was a result of the Loan Agreement we entered into with Trinity Capital Inc. (&#8220;Trinity&#8221;) in March 2021 (as amended from time to time, the &#8220;Loan Agreement&#8221;). The period over period increase was a combination of the Federal Reserve increasing interest rates in response to inflation and a longer interest period during the year ended December&#160;31, 2022. For the year ended December&#160;31, 2022, interest expense was based on the overall borrowings under the Loan Agreement of $32.0&#160;million with higher interest rates. For the 11 months ended December&#160;31, 2021 interest expense reflected lower borrowings and interest rates, with borrowings ranging from $12.0&#160;to $27.0&#160;million. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">77 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The increase in interest expense during the year ended December&#160;31, 2022 as compared to the unaudited 12 months ended December&#160;31, 2021 is related to the matter described in the above section. As the Loan Agreement was entered into in March 2021, no interest costs were incurred in January 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Interest Income </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income was $2.4&#160;million and virtually nil for the year ended December&#160;31, 2022, and the 11 months ended December&#160;31, 2021, respectively. The increase in interest income was a result of the <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sales</span></span> investments we hold and the increase in interest rates on deposits due to Federal Reserve rate increases. As of December&#160;31, 2022, investment securities in our Trust Account consisted of $36.3&#160;million in money market funds, $58.2&#160;million in United States Treasury securities, $3.6&#160;million in corporate bonds and $23.1&#160;million in commercial paper. We earned interest on such investments. We did not hold <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sales</span></span> investments and did not earn interest on such investments during the 11 months ended December&#160;31, 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The period over period increase was attributable to the reasons explained in the section above and one more month of interest income recognized in the unaudited 12 months ended December&#160;31, 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Change in Fair Value of Warrant Liabilities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A discussion of change in fair value of warranty liabilities is included in Note 13 to our consolidated financial statements for the year ended December&#160;31, 2022, included elsewhere in this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Change in Fair Value of <span style="white-space:nowrap">Earn-out</span> Liability </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A discussion of change in fair value of <span style="white-space:nowrap">earn-out</span> liability is included in Note 2, Sponsor <span style="white-space:nowrap">Earn-Out</span> Liability, to our consolidated financial statements for the year ended December&#160;31, 2022, included elsewhere in this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Transaction Costs </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A portion of transaction costs arising from the Business Combination were allocated to liability-classified instruments that are subsequently measured at fair value through earnings. Transaction costs allocated to these instruments must be expensed as incurred. We incurred and expensed total transaction costs of $0.9&#160;million allocated to liability-classified instruments for the year ended December&#160;31, 2022. We did not incur any transaction costs for the 11 months ended December&#160;31, 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As no transaction costs were incurred during the unaudited 12 months ended December&#160;31, 2021, the increase in transaction costs during the year ended December&#160;31, 2022 is related to the matter described in the section above.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Liquidity and Capital Resources </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred net losses since inception, and experienced negative cash flows from operations. Prior to the Business Combination, we financed our operations primarily through the issuance of preferred stock, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">78 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
warrants, convertible notes, venture backed debt and revenues. During the year ended December&#160;31, 2022, we incurred a net loss of $71.5&#160;million. As of December&#160;31, 2022, we had an accumulated deficit of $278.7&#160;million, and we expect to incur additional losses for the foreseeable future. In connection with the closing of the Business Combination on March&#160;2, 2022, we received net proceeds of $225.6&#160;million. We believe that our existing balances of cash, cash equivalents and marketable securities should be sufficient to meet our anticipated operating cash needs for at least the next 12 months, based on our current business plan, and expectations and assumptions considering current macroeconomic conditions. Based on our estimates and current business plan, we expect that we will need to obtain additional capital by late 2024 or early 2025 in order to continue our research and development efforts and achieve our business objectives. We cannot be sure that additional financing will be available. If we are unable to raise additional funding when needed, we may be required to delay, limit or substantially reduce our quantum computing development efforts. We have based these estimates on assumptions that may prove to be wrong and we could use our available capital resources sooner than we currently expect, and future capital requirements and the adequacy of available funds will depend on many factors, including those described in the section titled &#8220;Risk Factors&#8221; in this prospectus. Global economic conditions have been worsening, with disruptions to, and volatility in, the credit and financial markets in the U.S. and worldwide resulting from the continuing effects of <span style="white-space:nowrap">COVID-19</span> pandemic, disruptions in banking systems, international conflicts and otherwise. If these conditions persist and deepen, we could experience an inability to access additional capital or our liquidity could otherwise be impacted. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs and/or other efforts.&#160;A recession or additional market corrections resulting from the impact of the continuing effects of the <span style="white-space:nowrap">COVID-19</span> pandemic and macroeconomic conditions could materially affect our business and the value of our securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our short-term cash requirements include capital expenditures for materials and components for research and development and quantum computing fridges; working capital requirements; and strategic collaborative arrangements and investments. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our long-term requirements include expenditures for the planned expansion of our quantum chip fabrication facility; planned development of multiple generations of quantum processors; and anticipated additional investments to scale our QCaaS offering. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will require a significant amount of cash for expenditures as we invest in ongoing research and development and business operations. Until such time as we can generate significant revenue from sales of our development contracts and other services, including our QCaaS offering, we expect to finance our cash needs primarily through our Loan Agreement with Trinity, our arrangements with Ampere, our committed equity financing with B. Riley, and other potential securities financings or other capital sources, including development contract revenue with government agencies and strategic partnerships. To the extent that we raise additional capital through the sale of equity or convertible debt securities, including through the use of our committed equity financing with B. Riley, the ownership interest of our stockholders will be, or could be, diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, or substantially reduce our quantum computing development efforts. Our future capital requirements and the adequacy of available funds will depend on many factors, including those set forth in the section titled &#8220;Risk Factors&#8221; included in this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, actual sales, if any, of shares of our Common Stock to B. Riley pursuant to the committed equity financing will depend on a variety of factors to be determined by us from time to time, including, among other things, market conditions, the trading price of our Common Stock and determinations by us as to appropriate sources of funding for our business and operations. We cannot guarantee the extent to which we may utilize the committed equity financing. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">79 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Loan and Security Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;10, 2021, we entered into the Loan Agreement with Trinity for term loans with a principal amount of $12.0&#160;million, bearing an interest rate at the greater of 7.5% plus the prime rate published by the Wall Street Journal or 11.0%. In addition, we are required to pay a final payment fee equal to 2.75% of the aggregate amount of all term loan advances. The term loans under the Loan Agreement are secured by all of our assets. The Loan Agreement contains customary representations, warranties and covenants, but does not include any financial covenants. The negative covenants include restrictions on the ability to incur indebtedness, pay dividends, execute fundamental change transactions, and other specified actions. In connection with entry into the Loan Agreement, we issued a warrant to purchase shares of our Common Stock to Trinity. The Guarantor of the loan is Rigetti Holdings, Inc. and the loan is secured by substantially all of our assets. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;18, 2021, we entered into a first amendment to the Loan Agreement, which modified certain financial covenants, including an additional good faith deposit of $20,000 and adding a tranche B to the Loan Agreement in an aggregate amount of $15.0&#160;million, consisting of two advances of $8.0&#160;million and $7.0&#160;million each. In connection with such amendment, the maturity date was modified to be the date equal to 48 months from the first payment date of each specific cash advance. In connection with such amendment, we cancelled the initial warrants and issued a warrant to purchase 995,099 shares of our Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;21, 2021, we entered into a second amendment to the Loan Agreement, which modified the date requiring us to deliver evidence of completion of the PIPE transaction and execution of a definitive merger agreement with a special purpose acquisition company to October&#160;31, 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the second amendment, the maturity date was modified to be the date equal to 48 months from the first payment date of each specific cash advance. Subject to an interest only period of 18 months following each specific cash advance date, the term loan incurs interest at the greater of a variable interest rate based on prime rate or 11% per annum, payable monthly. Interest-only payments are due monthly immediately following an advance for a period of 18 months and, beginning on the 19th month, principal and interest payments are due monthly. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2022, we entered into the third amendment to the Loan Agreement to increase the debt commitment by $5.0&#160;million to $32.0&#160;million. The amendment allows us to draw an additional $5.0&#160;million immediately with an additional $8.0&#160;million to be drawn at the sole discretion of the lender. We drew the additional $5.0&#160;million upon signing the amendment. Other modifications per the amendment included an extension of the requirement to raise an additional $75.0&#160;million of equity and a defined exit fee for the additional $5.0&#160;million to be at 20% of the advanced funds under the amendment. In conjunction with the amendment, we also guaranteed payment of all monetary amounts owed and performance of all covenants, obligations and liabilities. As of December&#160;31, 2022, the total principal amount outstanding under the Loan Agreement was approximately $30.7&#160;million. We use borrowings under the Loan Agreement for working capital purposes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Loan Agreement is secured by a first-priority security interest in substantially all of our assets. As of the date of this prospectus, we are in compliance with all covenants under the Loan Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our cash commitments as of December&#160;31, 2022 were primarily as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:61%"></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold"><span style="white-space:nowrap">Short-Term</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold"><span style="white-space:nowrap">Long-Term</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing obligations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,491</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,218</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated cash interest on financing obligations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,683</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,447</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,236</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease obligations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,839</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,417</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span>$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold"></span>48,231</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold"></span>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,360</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">34,871</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">80 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financing obligations consist of cash principal payments related to the Loan and Security Agreement and are presented gross. These balances on the consolidated balance sheet are presented net of issuance costs. Estimated cash interest on financing obligations are based on the interest rate on the Loan and Security Agreement as of February 2023 of 15.25%. Operating lease obligations consist of obligations under <span style="white-space:nowrap">non-cancelable</span> operating leases for our offices and facilities. The cash requirements in the table above are associated with contracts that are enforceable and legally binding and that specify all significant terms, including fixed or minimum services to be used, fixed, minimum or variable price provisions, and the approximate timing of the actions under the contracts. The table does not include obligations under agreements that we can cancel without a significant penalty. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Summary of Historical Cash Flows </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our cash flows for the periods indicated: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:34%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="10" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Fiscal Year </span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="10" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Supplemental Information</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year&#160;Ended<br />December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">11 Months<br />Ended<br />December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year Ended<br />December 31,<br />2022 versus<br />11&#160;Months&#160;Ended<br />December&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year Ended<br />December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">12 Months<br />Ended<br />December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year Ended<br />December 31,<br />2022 versus<br />12&#160;Months&#160;Ended<br />December&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change </span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center">(Unaudited)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center">(Unaudited)</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(62,689</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(29,044</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(33,645</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(62,689</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(30,642</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(32,047</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(107,024</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,008</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(100,016</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(107,024</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,354</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(99,670</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">215,454</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,583</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">189,871</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">215,454</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,601</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">189,853</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Cash Flows Used in Operating Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our cash flows from operating activities are significantly affected by our ability to achieve significant growth to offset expenditures related to research and development, sales and marketing, and general and administrative activities. Our operating cash flows are also affected by our working capital needs to support growth in personnel-related expenditures and fluctuations in accounts payable and other current assets and liabilities. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Year ended December&#160;31, 2022 vs. 11 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities increased by $33.6&#160;million, or 116%, when comparing the year ended December&#160;31, 2022 to the 11 months ended December&#160;31, 2021. The increase in spending was primarily due to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an increase in headcount and payroll related costs of $20.8&#160;million as a result of investments in research and development efforts combined with upgrading internal and external resources to operate as a public company including a <span style="white-space:nowrap">one-time</span> bonus related to the business combination of $2.1&#160;million; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $6.3&#160;million increase in legal and accounting costs related to enhanced public reporting requirements, investor relation costs, and other software acquisition costs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a $3.3&#160;million prepayment of insurance premiums for directors and officers liability insurance; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$2.8&#160;million in additional interest costs related to increased borrowing amounts associated with the Loan Agreement; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">transaction costs of $1.0&#160;million incurred in connection with the closing of the Business Combination. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">81 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities during the year ended December&#160;31, 2022 was $62.7&#160;million, resulting primarily from a net loss of $71.5&#160;million, adjusted for <span style="white-space:nowrap">non-cash</span> charges of $11.2 million. These <span style="white-space:nowrap">non-cash</span> charges were partially offset by changes in operating assets and liabilities during the period. Changes in operating assets and liabilities accounted for $2.3&#160;million of cash used in operations. The changes primarily consisted of an increase in accounts receivable of $4.7&#160;million; an increase in prepaid and current assets of $1.1&#160;million; a decrease in accounts payable of $0.7&#160;million, and a decrease in other liabilities of $0.3&#160;million; offset by an increase in accrued expenses and other current liabilities of $4.5&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities during the 11 months ended December&#160;31, 2021 was $29.0&#160;million, resulting primarily from a net loss of $38.2&#160;million, adjusted for <span style="white-space:nowrap">non-cash</span> charges of $9.0 million. Changes in operating assets and liabilities accounted for $0.2&#160;million of cash provided by operations, which primarily consisted of an increase in prepaid and current assets of $0.3&#160;million; an increase in deferred revenue of $0.5&#160;million, an increase in accounts receivable of $1.1&#160;million, offset by an increase in accounts payable, accrued expenses and other liabilities of $1.1&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the reorganization efforts announced in February 2023, we transitioned to a newly appointed CFO and CTO and are implementing a workforce reduction in order to focus the organization and its resources on nearer-term strategic priorities. As a result of the reorganization, we expect to incur costs related to management transition, and reduce operating expenses in activities outside of focus areas in the nearer term and prioritize cash resources. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic"><span style="text-decoration:underline">Supplemental Information - Year ended December&#160;31, 2022 vs. Unaudited 12 months ended December&#160;31, 2021 </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities increased by $32.0&#160;million, or 105%, when comparing the year ended December&#160;31, 2022 to the unaudited 12 months ended December&#160;31, 2021. The increase in spending was primarily due to reasons explained in the section above. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Cash Flows Used in Investing Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities during the year ended December&#160;31, 2022 was $107.0&#160;million, resulting from the addition of $22.7&#160;million in property and equipment and the addition of $84.3&#160;million in <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities. Investments in property and equipment during this period relate primarily to process computing equipment, quantum computing fridges, and development tools for our chip fabrication facility. Investments in <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities consist of U.S Treasury securities, commercial paper, and corporate bonds that have a maturity of one year or less. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities during the 11 months ended December&#160;31, 2021, and unaudited 12 months ended December&#160;31, 2021 was $7.0&#160;million and $7.4&#160;million, respectively, and is attributable to additions to property and equipment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities during the year ended December&#160;31, 2022, increased by $100.0&#160;million and $99.6&#160;million compared to the 11 months and unaudited 12 months ended December&#160;31, 2021, respectively, largely as a result of increased investment in <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities and research and development infrastructure, including additional investments for electricity upgrades. Investments in our Fab 1 facility and quantum computing fridges will continue to be made to the extent necessary to support our new strategic direction referred to above. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Cash Flows provided by Financing Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities during the year ended December&#160;31, 2022 was $215.5&#160;million, reflecting proceeds of $225.6&#160;million from the Business Combination and PIPE Investment net of transaction costs, additional proceeds from the issuance of debt and warrants of $5.0&#160;million associated with the Loan Agreement, less principal payments of $1.3&#160;million, debt issuance costs and exit fees totaling $1.1&#160;million; and proceeds from issuance of Common Stock upon exercise of stock options and warrants of $6.1&#160;million. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">82 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities was the same for the 11 months ended December&#160;31, 2021 and unaudited 12 months ended December&#160;31, 2021 for a total of $25.6&#160;million, mainly reflecting proceeds from the issuance of debt totaling $27.0&#160;million less cash payments for debt issuance costs of $0.3&#160;million, proceeds from issuance of Common Stock upon exercise of stock options and warrants for a total $0.3&#160;million, and payment of deferred offering costs of $1.5&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities during the year ended December&#160;31, 2022 increased by $189.9&#160;million as compared to both the 11 months and unaudited 12 months ended December&#160;31, 2021, largely from the close of the Business Combination and PIPE Investment net of transaction costs, and additional proceeds from the issuance of debt and warrants during the year ended December&#160;31, 2022. We expect to continue finance our cash needs primarily through our arrangements with Ampere, our committed equity financing with B. Riley, and other potential securities financings or capital sources. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Critical Accounting Policies and Estimates </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations is based on our consolidated financial statements included in this prospectus, which have been prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. We also make estimates and assumptions that affect revenue and expenses during the reporting periods. Our estimates are based on historical experience and on various other factors that we believe are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are described in the Notes to our consolidated financial statements for the year ended December&#160;31, 2022, included elsewhere in this prospectus, we believe the following critical accounting policies and estimates are most important to understanding and evaluating our reported financial results. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Public and Private Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Business Combination, Supernova issued&#160;4,450,000&#160;private placement warrants (&#8220;Private Warrants&#8221;) and 8,625,000&#160;public warrants (&#8220;Public Warrants&#8221; and collectively, &#8220;Warrants&#8221;). Each whole warrant entitles the holder to purchase one share of our Common Stock at a price of $11.50 per share, subject to adjustments and will expire five years after the Merger or earlier upon redemption or liquidation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a <span style="white-space:nowrap"><span style="white-space:nowrap">fixed-for-fixed</span></span> option on equity shares. Therefore, the Private Warrants are not considered indexed to our stock and should be classified as a liability. Since the Private Warrants meet the definition of a derivative, we recorded the Private Warrants as liabilities in the consolidated balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date. The fair value of the Private Warrants was measured using the Black-Scholes option-pricing model at each measurement date. The Public Warrants also fail to meet the indexation guidance in ASC 815 and are accounted for as liabilities as the Public Warrants include a provision whereby in a scenario in which there is not an effective registration statement, the warrant holders have a cap, 0.361 shares of Common Stock per warrant (subject to adjustment), on the issuable number of shares in a cashless exercise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subsequent to the separate listing and trading of the Public Warrants, the fair value of the Public Warrants has been measured based on the observable listed prices for such warrants and the fair value of the Private Warrants are measured using a Monte Carlo Pricing Model. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">83 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the consummation of the Business Combination, we recorded a liability related to the Private Warrants of $9.6&#160;million, with an offsetting entry to additional <span style="white-space:nowrap">paid-in</span> capital. As of December&#160;31, 2022, the fair value of the Private Warrants decreased to $1.1&#160;million, with the gain on the change in fair value of derivative warrant liabilities recorded in the consolidated statements of operations for the year ended December&#160;31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similarly, on the consummation of the Business Combination, we recorded a liability related to the Public Warrants of $16.3&#160;million, with an offsetting entry to additional <span style="white-space:nowrap">paid-in</span> capital. As of December&#160;31, 2022, the fair value of the Public Warrants decreased to $0.7&#160;million with the gain on the change in fair value of derivative warrant liabilities recorded in the consolidated statements of operations for the year ended December&#160;31, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Other Derivative Warrant Liabilities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;) at the initial recognition date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the Public and Private Warrants noted above, we also issued a total of 783,129 Common Stock warrants in conjunction with the Loan Agreement in 2021. Such derivative warrant liabilities are classified as <span style="white-space:nowrap">non-current</span> as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. We utilized the Black-Scholes model to determine the inception date fair value of the warrants of approximately $2.7&#160;million which was recorded as part of Debt Issuance Cost. The outstanding Common Stock warrants were subsequently remeasured at each reporting period using the Black-Scholes model with the change in fair value recorded as a component of other income in the Company&#8217;s consolidated statements of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;2, 2022, the 783,129 Common Stock warrants that were issued in connection with the Loan Agreement were exercised and the $6.4&#160;million warrant liability was reclassified to equity. We recorded a loss of $2.0&#160;million from the change in the fair value of the warrant liability for the year ended December&#160;31, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Earn-Out&#160;Liability</span> </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At Business Combination Closing, Supernova Sponsor subjected certain shares (&#8220;Sponsor Vesting Shares&#8221;) of Common Stock held by Supernova Sponsor and its permitted transferees (the &#8220;Sponsor Holders&#8221;) to forfeiture and vesting as of the Closing if thresholds related to the weighted average price of Common Stock are not met for the duration of various specified consecutive day trading periods during the five-year period following the Closing (the <span style="white-space:nowrap">&#8220;Earn-out</span> Triggering Events&#8221;). Any such shares held by the Sponsor Holders that remain unvested after the fifth anniversary of the Closing will be forfeited. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor Vesting Shares are accounted for as liability classified instruments because the <span style="white-space:nowrap">Earn-Out</span> Triggering Events that determine the number of Sponsor Vesting Shares to be earned back by the Sponsor Holders include outcomes that are not solely indexed to our Common Stock. The aggregate fair value of the Sponsor Vesting Shares at the time of the Business Combination Closing was estimated using a Monte Carlo simulation model and was determined to be $20.4&#160;million. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the <span style="white-space:nowrap">Earn-Out</span> Triggering Events were not achieved for any of the tranches, and as such, the Company adjusted the carrying amount of the liability to its estimated fair value of $1.2&#160;million. The change in the fair value of $19.2&#160;million is included in change in fair value of <span style="white-space:nowrap">earn-out</span> liability in the consolidated statements of operations for the year ended December&#160;31, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Forward Warrant Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the execution of the Merger Agreement in October 2021, we entered into the Forward Warrant Agreement with Ampere for the purchase of a warrant for an aggregate purchase price (including </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">84 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amounts from exercise) of $10.0&#160;million. The Forward Warrant Agreement provides for the issuance of a warrant for the purchase of an aggregate of 1,000,000 shares of Common Stock at an exercise price of $0.0001. The purchase of the warrant was conditioned upon, among other things, the consummation of the Business Combination and the entry into a collaboration agreement between Ampere and us. The collaboration agreement was entered into in January 2022. Ampere was required to pay $5.0&#160;million to us no later than the later of (i)&#160;the Closing and (ii)&#160;June&#160;30, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2022, pursuant to the Warrant Subscription Agreement, we issued the warrant to Ampere upon receipt of an aggregate of $5.0&#160;million (including the exercise price), and upon such payment and issuance, 500,000 shares of our Common Stock vested under the warrant and were immediately exercised by Ampere pursuant to the terms of the warrant. Ampere is required to pay an additional $5.0&#160;million to us no later than the closing date of the listing of Ampere&#8217;s capital stock, provided that if the listing has not occurred by the second anniversary of the warrant subscription agreement, Ampere is not obligated to make the additional payment and we are not obligated to issue the warrants. The warrant subscription agreement further provides that we will use commercially reasonable efforts to file a registration statement to register the resale of the shares issued or issuable pursuant to the warrant and upon such payment the warrant will vest and be exercisable by Ampere with respect to 500,000 shares of Common Stock pursuant to the terms of the warrant. We filed such registration statement and it became effective in the year ended December&#160;31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We evaluated the Forward Warrant Agreement as a derivative in accordance with the guidance of ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;. We calculated fair value of the Forward Warrant Agreement by using the Forward Contract Pricing methodology at inception and at the end of December&#160;31, 2022. The fair value of the Forward Warrant Agreement was estimated based on the following key inputs and assumptions 1) Assumed holding period 2) Related risk-free rate and 3) Likelihood of the outcome of the various contingencies specified in the agreement. Based on these inputs and assumption, we calculated the fair value of the Forward Warrant Agreement to be a $2.2&#160;million derivative asset at December&#160;31, 2022 and a $0.2&#160;million derivative liability at December&#160;31, 2021. We have included the derivative asset separately as a forward contract asset and the derivative liability as a forward contract liability in the accompanying consolidated balance sheets as of December&#160;31, 2022 and December&#160;31, 2021, respectively. The change in fair value is recorded as part of general and administrative expense in our consolidated statements of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Revenue Recognition </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue consists primarily of our contracts that provide access to Rigetti quantum computing systems, collaborative research services, professional services, and the sale of custom quantum computing components. Access to Rigetti quantum computing systems can be purchased as a quantum computing subscription, or on a usage basis for a specified quantity of hours. Revenue related to subscription-based access to Rigetti quantum computing systems (i.e., quantum computing subscriptions) is recognized on a ratable basis over the subscription term, which can range from three months to two years. Revenue related to usage-based access to Rigetti quantum computing systems is recognized over time as the systems are accessed using an output method based on compute credit hours expended. Revenue related to collaborative research services and professional services is recognized over time based on completed milestones or hours or costs incurred as appropriate. Revenue for partially completed milestones deemed probable of being met is recognized using an input measure based on actual labor hours incurred to date relative to total estimated labor hours needed to complete the milestone. Revenue related to cost share contracts is recognized as the reimbursable costs are incurred. For Fixed price Milestone based contracts, revenue is recognized based on the input measure explained above as control is expected to transfer over the time period a milestone is completed. Revenue related to the sale of custom quantum computing components is recognized at a point in time upon acceptance by the customer. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our fixed fee development contracts vary in term from one to five years, with the majority of such contracts having a term of 18 months to two years. When establishing the pricing for our fixed fee arrangements, we determine the pricing based on estimated costs to complete and expected margins taking into account the scope </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">85 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of work outlined within the contract being evaluated and our historical experience with similar services and contracts. Actual costs incurred over the period in which these contracts are fulfilled could vary from these estimates and therefore, these estimates are subject to uncertainty. On a quarterly basis, management reviews the progress with respect to each contract and its related milestones and evaluates whether any changes in estimates exists. As a result of the quarterly reviews, revisions in the estimated effort to complete the contract are reflected in the period in which the change is identified. These revisions may impact the overall progress related to transfer of control and therefore, result in either increases or decreases in revenues as well as increase or decreases in fulfillment costs and contract margins. In accordance, with ASC No.&#160;250, Accounting Changes and Error Corrections, any changes in estimates are reflected in our consolidated statements of operations in the period in which the circumstances that give rise to the revision become known to management. To date, we have not experienced any changes in estimates that have had a material impact on our results from operations or financial position. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When our contracts with customers contain multiple performance obligations, the transaction price is allocated on a relative standalone selling price basis to each performance obligation. We typically determine standalone selling price based on observable selling prices of our products and services. In instances where standalone selling price is not directly observable, standalone selling price is determined using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, we will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transaction price is the amount of consideration to which we expect to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price, which includes fixed consideration and estimates of variable consideration. The amount of variable consideration included in the transaction price is constrained and is included only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our contracts with customers may include renewal or other options at fixed prices. Determining whether such options are considered distinct performance obligations that provide the customer with a material right and therefore should be accounted for separately requires significant judgment. Judgment is required to determine the standalone selling price for each renewal option to determine whether the renewal pricing is reflective of standalone selling price or is reflective of a discount that would provide the customer with a material right. Based on our assessment of standalone selling prices, we determined that there were no significant material rights provided to our customers requiring separate recognition. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Goodwill Impairment Review </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2022, we tested our goodwill for impairment. See&#160;Note 5 &#8211; Goodwill of our consolidated financial statements for the year ended December&#160;31, 2022 included elsewhere in this prospectus for additional information on how the impairment was measured. We have determined that the Company is a single reporting unit. As such, management estimated the fair value of the Company based on its market capitalization as of December&#160;31, 2022, as adjusted for a control premium based on recent market comparable transactions.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on our analysis, we determined that the carrying value of the Company (stockholder&#8217;s equity) exceeded its fair value. As a result, we recorded a <span style="white-space:nowrap"><span style="white-space:nowrap">non-tax-deductible</span></span> goodwill impairment charge of $5.4&#160;million for the year ended December&#160;31, 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">86 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Recently Issued Accounting Pronouncements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 of our consolidated financial statements for the year ended December&#160;31, 2022 included elsewhere in this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Emerging Growth Company and Smaller Reporting Company Status </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2012, the JOBS Act was enacted. Section&#160;107 of the JOBS Act provides that an &#8220;emerging growth company&#8221; may take advantage of the extended transition period provided in Section&#160;7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. Therefore, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. Following the Business Combination, we still qualify as an emerging growth company and plan to take advantage of the extended transition period that emerging growth company status permits. During the extended transition period, it may be difficult or impossible to compare our financial results with the financial results of another public company that complies with public company effective dates for accounting standard updates because of the potential differences in accounting standards used. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will remain an emerging growth company under the JOBS Act until the earliest of (a)&#160;December 31, 2026, the last day of our first fiscal year following the fifth anniversary of the completion of SNII&#8217;s initial public offering, (b)&#160;the last date of our fiscal year in which we have total annual gross revenue of at least $1.24&#160;billion, (c)&#160;the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the rules of the SEC with at least $700.0&#160;million of outstanding securities held by <span style="white-space:nowrap">non-affiliates</span> or (d)&#160;the date on which we have issued more than $1.0&#160;billion in <span style="white-space:nowrap">non-convertible</span> debt securities during the previous three years. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as the market value of our voting and <span style="white-space:nowrap">non-voting</span> Common Stock held by <span style="white-space:nowrap">non-affiliates</span> is less than $250.0&#160;million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0&#160;million during the most recently completed fiscal year and the market value of our voting and <span style="white-space:nowrap">non-voting</span> Common Stock held by <span style="white-space:nowrap">non-affiliates</span> is less than $700.0&#160;million measured on the last business day of our second fiscal quarter. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">87 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_11">BUSINESS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">OUR MISSION IS TO BUILD THE WORLD&#8217;S MOST POWERFUL COMPUTERS TO HELP SOLVE HUMANITY&#8217;S MOST IMPORTANT AND PRESSING PROBLEMS. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Today, many of the world&#8217;s most important computational challenges remain intractable, lying beyond the capabilities of traditional supercomputers and cloud infrastructure. We build and operate quantum computers. We believe quantum computing represents one of the most transformative emerging capabilities in the world today. By leveraging quantum mechanics, our quantum computers process information in fundamentally new, more powerful ways compared to classical computing. When scaled, we believe these systems are poised to solve problems of staggering computational complexity at unprecedented speed. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability of scalable quantum computers is expected to enable scientists and engineers to address problems in areas like climate change, fusion energy, quantitative finance, drug development and discovery, materials science, and artificial intelligence. A July 2021 Boston Consulting Group report predicts that fully fault tolerant quantum computers could ultimately produce between $450 billion and $850&#160;billion in annual value creation on an operating income basis for end users after 2040. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To unlock this opportunity, we have developed the world&#8217;s first multi-chip quantum processor for scalable quantum computing systems. We expect this patented and patent pending, modular chip architecture to be the building block for new generations of quantum processors that we expect to achieve a clear advantage over classical computers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a vertically integrated company. We own and operate <span style="white-space:nowrap">Fab-1,</span> a unique wafer fabrication facility dedicated to prototyping and producing our quantum processors. Through <span style="white-space:nowrap">Fab-1,</span> we own the means of production of our breakthrough multi-chip quantum processor technology. We leverage our chips through a full-stack product development approach, from quantum chip design and manufacturing through cloud delivery. We believe this full-stack development approach offers both the fastest and lowest risk path to building commercially valuable quantum computers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have been deploying our quantum computers to end users over the cloud since 2017. We offer our full-stack quantum computing platform as a cloud service to a wide range of <span style="white-space:nowrap">end-users,</span> directly through our Rigetti QCS platform, and also through cloud service providers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have developed strong customer relationships and collaborative partnerships to accelerate the development of key technologies for high-value use cases to potentially unlock strategic market opportunities. Our partners and customers include commercial enterprises such as Amazon Web Services, Ampere, Astex Pharmaceuticals, Deloitte, Microsoft, Nasdaq and Standard Chartered Bank, along with U.S. government organizations such as DARPA, DOE, and NASA. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company is enabled by a deep technical team that includes global experts in quantum chip design and manufacturing, quantum computing systems architecture, quantum software, and quantum algorithms and applications. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Powered by the production of our scalable multi-chip quantum processors in <span style="white-space:nowrap">Fab-1</span> and our full-stack product development approach, we are working to develop quantum computing systems that demonstrate clear performance advantages over classical computing alternatives for multiple high-impact application areas. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Potential Market Opportunity </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Demand for computing power capable of solving computationally complex problems is increasing. Many of these types of problems are approached through the use of High Performance Computing (&#8220;HPC&#8221;), which relies </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">88 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
primarily on large classical computers located either in the cloud or <span style="white-space:nowrap">on-premise.</span> Company management estimates the global market for HPC to be approximately $54&#160;billion by 2027. We believe our quantum computers will be able to solve many computational problems with greater speed and at a lower cost than today&#8217;s high performance computers, thereby unlocking considerable value for the users of current HPC systems. Furthermore, we believe that quantum computing will be applicable to many use cases that today lie within the realm of the much larger cloud computing market. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Advanced scientific and technical computing applied in fields like drug discovery, materials science, computational fluid dynamics, machine learning, and quantitative finance have underpinned many of society&#8217;s greatest scientific and industrial advancements over the past half-century. Yet, despite the availability of the latest cloud and supercomputing capabilities, these and many other fields remain constrained by the intractable nature of their thorniest problems. Typically, the computational limits of classical computers are reached because of either the size or complexity of the required calculations. In certain cases, algorithms have been developed that in theory solve a particular computation problem; however, classical computers are limited in their ability to implement and process such algorithms. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For decades, classical computing power increased exponentially as the number of transistors on a microchip were doubling about every two years, while the cost of computing simultaneously decreased significantly. Over the past ten years, this rate of progress in classical computing power has significantly slowed as physical limits on the miniaturization of transistors in nano-scale devices are being reached. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Stages of Evolution of Quantum Computing Maturation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that market demand for our quantum computers will grow in phases that map to the increasing capabilities of our commercially available quantum computing systems similar to that of classical computer technology. With each new phase, we expect quantum computers to solve an ever-increasing breadth of high-impact commercial problems and to do so with greater speed and accuracy. Qubits do not need the latest semiconductor lithography node and, in fact, can be made using 1990&#8217;s era lithography. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Emerging Quantum Advantage (&#8220;eQA&#8221;) Phase </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This phase is characterized by the availability of practical, fully functional and operational quantum computers, whose capabilities do not yet enable them to demonstrate clear performance advantages relative to traditional computers. Currently, our quantum computers are of sufficient scale and capability to be useful in applied research for quantum algorithm development, the exploration of potential applications of quantum computing, and for understanding the skill gaps an organization must resolve in order to be prepared to take advantage of quantum computing capabilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We consider the eQA phase to have begun three years ago, and during this time we have worked with business and government researchers, commercial software developers and academic institutions who access our quantum computers via cloud-based services. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We anticipate that indications that this phase is coming to a close will occur when there are repeated demonstrations solving practical problems, of substantial commercial or customer value, with a level of performance that is competitive with the best available classical computing performance. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Narrow Quantum Advantage (&#8220;nQA&#8221;) Phase </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If and when our quantum computing processing capabilities have scaled to the point where they can be used to solve practical, operationally relevant problems with improved accuracy, speed or cost over classical computers, we believe we will have reached the phase of nQA. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">89 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the nQA phase, we expect that large enterprises and government organizations would increase their investment in quantum computing as the superior computational capabilities of the technology will have progressed from projected to verifiably advantaged for certain applications. In addition to quantum-based research and development, quantum machine learning (&#8220;QML&#8221;) is likely to emerge as a strong avenue for growth as it can be leveraged in a wide range of business and scientific applications. Research into quantum simulation and quantum optimization opportunities is predicted to increase in the nQA phase. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Broad Quantum Advantage (&#8220;bQA&#8221;) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will consider the phase of bQA to have begun if and when our quantum computing processing abilities have scaled to the point where they can be used to solve practical problems that would be physically impossible to solve on any classical computer. At such point, with both scaled qubit counts and strong error correction capabilities, we believe our quantum computers would be suitable for many applications of quantum machine learning and begin to be used for a growing number of quantum simulation and quantum optimization problems. In the event we demonstrate bQA, we expect many new potential clients to emerge as the range and value of the problems that are addressable by our quantum computing systems significantly increases. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Large-Scale Fault Tolerant Quantum Computing (&#8220;lFTQC&#8221;) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will consider the phase of lFTQC to begin when systems are available with hundreds of logical qubits, which can be universally controlled and measured with substantially error-free operation through the full course of a quantum computation. It is currently believed in the quantum computing industry that this likely requires systems with 10,000 to 1,000,000 physical qubits. We believe our scalable multi-chip architecture paves the way to scale up to these large systems. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We anticipate the beginning of the large-scale fault tolerant phase to be likely at least a decade away. As quantum computing further matures through this phase, systems will likely continue to grow in scale and performance, culminating in full-scale fault tolerance that operates using potentially thousands of effectively perfect logical qubits. This ultimate goal of full-scale fault tolerance represents the largest commercial opportunity at an estimated $850&#160;billion per year in potential annual value creation for end users and technology providers. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Business Strategy </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our approach to developing and sustaining strong competitive advantage relies on a four-pronged strategy: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Create high performance quantum computing systems through full-stack product development.</span></span><span style="font-weight:bold"> </span>From the outset, we have approached the market opportunity with a strategy to build quantum computers, the superconducting processors that power them, and the software required to access and program these systems. We believe that vertical integration, from chip manufacturing through cloud delivery, unlocks the fastest and lowest risk path to broad commercialization and the largest, long-term market opportunity. This was underscored by our announcement of the industry&#8217;s first multi-chip quantum processor for scalable quantum computers, a capability realized through many innovations from <span style="white-space:nowrap">Fab-1.</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Leverage cloud to provide broad access to our quantum computers.</span></span><span style="font-weight:bold"> </span>We have been providing cloud access to our quantum computers since 2017 and have since expanded the availability of our machines through distribution agreements with other solution providers including Amazon Braket, Microsoft, Oak Ridge National Laboratory (&#8220;ORNL&#8221;) and Strangeworks. Cloud services efficiently simplify access to our quantum computers and allow for pricing that enables a broad range of scientific, commercial and academic developers to readily participate in the development of quantum computing algorithms, applications and software development tools. Collectively, these cloud services provide a range of choices and capabilities designed to meet the diverse needs of large and small organizations alike. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">90 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Develop deep partnerships that accelerate the development and commercialization of quantum computing.</span></span> We have formed commercial partnerships with business and government entities that are designed to advance their mutual understanding of the opportunities, challenges and solutions necessary for quantum computing to excel in specific real-world applications. Examples of these partnerships include our contracted relationships with DARPA, the DOE&#8217;s Fermi National Accelerator Laboratory (&#8220;Fermilab&#8221;) and ORNL. We believe these types of highly collaborative, multi-year relationships will yield specialized and proprietary market insights and technological advancements. We expect the number and scope of these types of partnerships to expand as the capabilities of our quantum computers continue to grow. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Advance our technology leadership position</span></span><span style="font-style:italic">.</span> We have invested heavily in a world-class and multidisciplinary team of scientists, hardware and software engineers, system designers and algorithm and application developers to rapidly innovate, invent, engineer and commercialize our quantum computing technologies. We have also developed numerous proprietary technologies required to create quantum computing chips, quantum computer systems, software and cloud-based services and we rigorously protect our unique intellectual property through a portfolio of 165 patents issued and pending (as of April&#160;5, 2023). We intend to continue deeply investing in finding and fostering the talent required to remain at the forefront of quantum computing innovation, while protecting our growing base of intellectual property. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2023, we updated our business strategy and revised our technology roadmap to focus on nearer-term priorities and focus efforts to achieve narrow quantum advantage. We made further refinements following our internal deployment for testing in March 2023 of Ankaa-1, our 84-qubit system delivering denser qubit spacing and tunable couplers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We now plan to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Concentrate on refining the performance of Ankaa-1. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Upon the anticipated external launch of the <span style="white-space:nowrap">Ankaa-1</span> <span style="white-space:nowrap">84-qubit</span> system, which is expected to be to select customers, continue efforts to improve the performance of the system with the goal of reaching at least 98% <span style="white-space:nowrap">2-qubit</span> gate fidelity to support the anticipated <span style="white-space:nowrap">Ankaa-2</span> <span style="white-space:nowrap">84-qubit</span> system. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Launch the anticipated Ankaa-2 84 qubit system, continuing to work to improve performance with the goal of reaching at least 99% gate fidelity on Ankaa-2. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If the above targets are achieved, we plan to shift focus to scaling to develop Lyra, an anticipated <span style="white-space:nowrap">336-qubit</span> system. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Business Model&#160;&amp; Services </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, we generate the majority of our revenues from technology development contracts with various partners. We believe our longer term business model will be more weighted towards recurring revenues generated from quantum computing systems made accessible via the cloud in the form of QCaaS products. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Quantum Computing as a Service (QCaaS) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We design, build, own, and operate quantum computers and sell access to these systems through cloud-based services, commonly referred to as QCaaS. This approach enables us to serve a wide range of customers without the complexity and cost associated with shipping, operating and servicing complex and cryogenic computing equipment on customer premises. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Rigetti Quantum Cloud Services </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company&#8217;s flagship product is Rigetti Quantum Cloud Services. QCS is a platform to deliver high-performance quantum computing over the cloud. QCS features a hybrid quantum-classical computing </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">91 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
environment that incorporates Rigetti quantum computers operating in tandem with cloud infrastructure. It provides support for a broad range of programming capabilities, the ability to integrate over public or private clouds, and high-speed connectivity to auxiliary classical computing resources. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The product is designed to meet the needs of a diverse set of customers that all benefit from the high-performance nature of its core computational capabilities. Central to QCS are two very powerful sets of technologies developed by our quantum processing units (&#8220;QPUs&#8221;), and our quantum operating system, as described below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Rigetti Quantum Processing Units</span></span>. At the heart of QCS are the proprietary QPUs that perform quantum computations. Our QPUs contain fabricated silicon-based chips featuring superconducting qubits. These high-performance chips provide fast gate times, low latency conditional logic, and fast program execution times. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rigetti QPUs are designed and fabricated at <span style="white-space:nowrap">Fab-1,</span> leveraging novel manufacturing methods to create <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">state-of-the-art</span></span></span> superconducting qubits. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Production versions of QCS currently utilize our <span style="white-space:nowrap">Aspen-M</span> series chips with 80 qubits. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Quantum Operating System Software</span></span>. QCS&#8217;s computing environment is powered by a distributed quantum operating system that natively supports both public and private cloud architectures. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The operating system software includes a rich set of quantum application and software development tools designed to unlock the capabilities of the quantum computing ecosystem by: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Enabling customers to access Rigetti QPUs through a broad range of quantum application software, development frameworks and algorithm libraries; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Providing software and algorithm developers with the performance and fine-grained control required to expedite a new era of computational breakthroughs; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Facilitating the implementation of high performance public and private clouds with <span style="white-space:nowrap">ultra-low</span> latency connectivity between classical hardware and Rigetti QPUs. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">92 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g483086g11g01.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">Rigetti&#8217;s quantum computing facility in Berkeley, California includes both research and development and production quantum processing units, which are each housed in a cryogenic refrigerator. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Direct QCaaS Distribution </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide access on a commercial basis to our quantum computers over QCS, directly engaging with enterprises and government organizations making significant investments in quantum computing research, development and readiness. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe many of these customers will have performance, customization and integration requirements best met by our ability to engage deeply, and directly, with these kinds of clients. We believe the company&#8217;s full-stack product development approach, and strategy of forging collaborative customer partnerships, positions the company to be a highly valued and long-term provider of quantum computing services to these organizations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, these direct customer relationships have been with customers using QCS for general quantum computing research, algorithm development, algorithm benchmarking and software development activities. They represent a cross section of industries, government agencies and partners in the quantum computing ecosystem. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Indirect QCaaS Distribution </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are a large and growing number of providers of classical computing services over the cloud. This creates an opportunity for us to efficiently reach a broad set of <span style="white-space:nowrap">end-users,</span> indirectly, by partnering with cloud computing service providers, who in turn sell access to our quantum computer systems to their own customers. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">93 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indirect distribution model is enabled by the same QCS platform used in the direct distribution model, providing us with powerful business leverage in addressing the needs of customers in different market segments. In this instance, we can capitalize on our full-stack product development capabilities to meet the unique requirements of cloud-service providers. For example, one cloud provider or HPC operator might need deep and high-performance integration with a specific Machine Learning service they provide, while another might desire a fast and easy way for small customers to be introduced to quantum computing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have signed a distribution agreement with Amazon&#8217;s Braket service and Microsoft&#8217;s Azure Quantum Service, providing access to our quantum computing systems to AWS and Azure customers. We have also signed a distribution agreement with ORNL, a U.S. government entity that provides <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">state-of-the-art</span></span></span> computational infrastructure to government researchers. Similarly, we have signed a distribution agreement with Strangeworks, a provider of quantum computing enablement software, services and computational resources. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Key Technology Development Partnerships </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We enter into multi-year development partnerships with organizations that have specialized technical expertise and a strong interest in advancing their understanding and application of quantum computing technology. These partnerships can provide us with deep insight into the unique requirements of market leaders in key industries; advance our engineering and product development capabilities; and lead to the creation of new hardware and software products. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Examples of our development partnerships include contracts with: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Fermilab and the U.S. DOE&#8217;s Superconducting Quantum Materials and Systems Center (&#8220;SQMS&#8221;), to advance the development of scalable and high performance quantum processors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">DARPA and National Aeronautics and Space Administration (&#8220;NASA&#8221;) to create quantum computing systems, software and algorithms for optimization applications; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Innovate UK, as part of the British government&#8217;s effort to accelerate commercialization of quantum computing in the United Kingdom and to pursue practical applications in machine learning, molecular simulation and financial optimization. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to add new development partnerships as the capabilities of our quantum computer systems grow and the market&#8217;s readiness and interest in quantum computing continues to mature. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">94 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Rigetti Foundry Services </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rigetti Foundry Services leverages the company&#8217;s <span style="white-space:nowrap">US-based</span> <span style="white-space:nowrap">in-house</span> fabrication facility to deliver superconducting quantum chips to advance and accelerate quantum information science and technology research and development efforts. Customers include researchers spanning academia, defense laboratories, and national laboratories. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g483086g12g01.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">A Rigetti employee inspects a silicon wafer with superconducting quantum integrated circuits that was fabricated at Rigetti&#8217;s <span style="white-space:nowrap">Fab-1</span> facility. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Professional Services </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In certain engagements, we provide professional services that enhance and advance our customers&#8217; ability to consume our core products and services. Our engineers can augment a client&#8217;s internal capabilities with expertise in algorithm development, benchmarking, quantum application programming and software development. These <span style="white-space:nowrap">fee-based</span> services can enhance our customer&#8217;s readiness for quantum, accelerate our customer&#8217;s timelines for meaningful discoveries, and increase our depth of knowledge about key application domains and customer requirements for quantum computing in different industries. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Key Applications </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantum computing is expected to drive value across many different applications and industries. We believe that many of the principal benefits in these areas will spring from four different types of computational problems that are particularly well suited to quantum computing: optimization, machine learning, simulation and quantum mechanical system simulation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Optimization </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The computational properties of a quantum computer inherently support the problem-solving requirements of extremely complex optimization calculations because quantum computers possess the ability to </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">95 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
simultaneously evaluate very large numbers of variables, and each additional qubit in a quantum computer exponentially scales our information processing capacity. We believe that quantum computers could allow highly accurate optimization models to be continuously refreshed to reflect the impact of changing conditions on available solutions, ultimately leading to better and more responsive plans and decision-making. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of the world&#8217;s largest and most valuable industries could potentially benefit from enhanced optimization enabled by quantum computing. In financial services, optimization could be applied to portfolio management, algorithmic trading and risk assessment. In telecommunications, optimization could be applied to call routing and network capacity planning. In manufacturing, optimization could help with workforce, warehouses and supply chain planning. In transport, there are logistics applications like fleet routing, driver scheduling, and package loading and delivery that could benefit from further optimization. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These types of problems can quickly overwhelm classical computers due to the large numbers of variables that need to be evaluated, which exponentially scales the computational power required with each additional<span style="font-style:italic"> </span>possibility to be considered. For example, in a vehicle routing problem involving roundtrips to just 10 destinations there can be more than 300,000 permutations to be considered; with 15 destinations, the number of possible routes exceeds 87&#160;billion. If you factor in other real-world considerations such as delivery cost, fleet size, driver availability, or service level agreements, you can see the intractable nature of these kinds of problems in full display. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the most active fields of quantum algorithm research is the area of constrained combinatorial optimization. These mathematical equations can arrive at approximate results with a <span style="white-space:nowrap"><span style="white-space:nowrap">close-to-optimal</span></span> solution across many possible <span style="white-space:nowrap">outcomes-a</span> result that would create high value in many different industries, particularly when the exact solution is unknowable utilizing a classical computer. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are exploring the application of our quantum computers for high value optimization problems including a partnership with NASA and DARPA for secure dynamic message scheduling using high-demand space and national security assets. In January 2022, we were selected to deliver hardware, software and benchmarks for Phase 2 of DARPA&#8217;s ONISQ program to develop quantum computers capable of solving complex scheduling optimization problems, with a focus on quantum advantage for currently available or soon to be available quantum processors. The award was based upon us successfully completing our performance milestones in Phase&#160;I of the program, and is targeting Rigetti&#8217;s <span style="white-space:nowrap">Aspen-M</span> 80 processor, and our next generation Ankaa processor. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2022, we were selected to lead a program to develop benchmarks for quantum application performance on large-scale quantum computers as part of DARPA&#8217;s Quantum Benchmarking Program. The goal of this program is to <span style="white-space:nowrap">re-invent</span> key quantum computing metrics, make those metrics testable, and estimate the required quantum and classical resources needed to reach critical performance thresholds </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Machine Learning </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Machine learning is a well-established field, with broad application, that today is already having a transformative impact on a myriad of markets. The potential market opportunity for machine-learning is currently estimated at $16&#160;billion with<span style="font-style:italic"> </span>expected compound annual growth rates through 2028 of 39%, according to market research from Fortune Business Insights. Boston Consulting Group projects that machine learning applications with fully fault tolerant quantum computers could produce $150&#160;billion to $220&#160;billion in annual potential value creation for end users and technology providers. At the core of any machine learning application is a series of computations, typically expressed in linear algebra, applied to vast amounts of data in order to do things such as reliably classifying objects and making data-driven predictions. Today, cloud computing and HPC have been the predominant sources of the computational capabilities required to create effective machine learning algorithms, models and data analysis applications. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">But, the efficiency of <span style="white-space:nowrap">HPC-powered</span> machine learning algorithms is limited when faced with richer and larger data sets. For that reason, computer scientists have looked toward the computational promise of quantum </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">96 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
computers, and the development of quantum-based algorithms, as a means of both accelerating current machine learning algorithms and creating new approaches that are currently impossible on classical computers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given these factors, the emerging field of QML is the focus of much of the current research and development occurring on quantum computers today. We already see emerging machine learning algorithms that take advantage of the unique capabilities of quantum computing to tackle the complex linear algebra problems at the heart of many machine learning tasks. In fact, recent research has emerged demonstrating that quantum algorithms could work better than classical ones for critical machine learning classification problems. As algorithmic research continues to progress, some of these quantum algorithms are improving to the point where their benefits may be realized on smaller scale quantum computers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research has also demonstrated the promising application of QML, for Generative Adversarial Networks, (&#8220;GANs&#8221;), a deep learning technique where a neural network is used to generate highly accurate and new examples that could plausibly have come from an original dataset. The potential utilization of quantum computing for GANs alone is <span style="white-space:nowrap">far-reaching</span> and could be impactful in large markets like: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">healthcare - for medical image analysis used to detect and categorize tumors and predict their growth; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">drug discovery - for generating molecular structure candidates for medicines to target or cure diseases; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">finance and banking - for creating models that can detect financial fraud based upon predictive patterns rather than rules determined by previously observed behaviors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">defense and intelligence - for reliably enhancing low resolution satellite imagery into high resolution photography. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2022, we previously partnered with researchers at a U.S. government agency on a generative modeling application for weather forecasting. In this instance, we leveraged a combination of classical and QML techniques to produce high-quality synthetic weather radar data. Meteorological scoring metrics for storm prediction were in some cases augmented using the QML relative to the purely classical implementation. With additional refinement to the underlying methods, combined with the current pace of scaling and performance improvements in quantum hardware, the researchers believe the synthetic weather data application could be a strong candidate for quantum advantage and operational deployment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we believe QML for finance is poised to be an early domain of quantum advantage. We recently partnered with Standard Chartered using QML to provide a deeper understanding of QML capabilities and the value of their datasets. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Simulation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Classical computers have been used for decades in critical applications that model real-world processes or systems in order to study their behaviors over time. These computer-based simulations have had an enormous impact on fields like pharmaceuticals, material science, finance, logistics, aerospace, defense and computer-aided design and engineering. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The global market for simulation software alone is projected to grow from $12.7&#160;billion in 2020 to $26.9&#160;billion in 2026 according to Markets&#160;&amp; Markets. BCG projects that simulation applications with fully fault tolerant quantum computers could produce $160&#160;billion to $330&#160;billion in annual potential value creation for end users and technology providers over the next 15 to 30 years. Simulations are essentially mathematical models of a system and hence are logical candidates to benefit from quantum computing. Many important systems, such as molecular structures, cannot be accurately modeled due to the level of complexity associated with representing the properties and behaviors of the key elemental components. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that quantum computers possess inherent advantages that will allow them to accurately model systems with large numbers of variables that are far outside the reach of classical computers today. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">97 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Quantum Mechanical System Simulations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The essential building blocks of nature, whose understanding has been the driver of many breakthrough innovations in pharmaceuticals, healthcare, energy, and material science, are the microscopic systems of molecules, atoms and subatomic particles like electrons and protons. The properties and behaviors of these quantum mechanical systems can be expressed in mathematical rules that have been verified experimentally with high degrees of accuracy, but the complexity associated with such calculations, and their applicability to existing and potential molecular and atomic structures, has proven to be outside the realm of capability for today&#8217;s classical computers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Scientists have not found a way to rapidly and accurately model most quantum mechanical systems on a computational device that itself is not quantum in nature. Conversely, we believe quantum computers have the potential to efficiently model the relevant set of potential interactions between quantum mechanical elements because they natively reflect the essential properties of quantum systems and behaviors like entanglement, superposition and wave functions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Drug discovery is among the fields where research into the applicability of quantum computing for simulating quantum mechanical systems is producing considerable enthusiasm. With the growing high costs to develop new drugs, a quantum-based approach that could help pharmaceutical companies evaluate thousands of potential compounds for a targeted therapeutic, and avoid failed outcomes in costly clinical trials, would have an enormously positive economic and societal effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other high potential impact areas for quantum mechanical simulations include the design of chemical catalysts, computational fluid dynamics in aerospace engineering, and nuclear fusion for clean energy. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have several active partnerships with clients developing simulations of quantum mechanical systems. One such partnership is with Astex Pharmaceuticals, a United Kingdom-based company, which is working with our quantum computers on approaches that may speed up the process of drug discovery. We are also partnering with two U.S. DOE agencies on simulation applications in the areas of nuclear fusion and high energy physics. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Technology </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Introduction to Quantum Computing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantum computers encode and process data using a new kind of information storing electrical circuit called a quantum bit, or qubit. By leveraging the quantum mechanical principle of superposition, qubits can represent complex mathematical combinations of <span style="font-style:italic">both</span> zero and one at the same time. In contrast, classical computers are composed of transistors, electronic devices that hold binary zero or one states, therefore requiring billions of transistors in order to execute complex algorithms. This qubit property of superposition creates unique capabilities. By enabling qubits to encode more information than classical bits, it allows for a quantum computer&#8217;s power to scale exponentially, rather than linearly as with traditional computers based on transistors. Additionally, it makes it possible to construct algorithms that can evaluate all possible solutions to a problem simultaneously, rather than sequentially as is the case with classical computing. Furthermore, making qubits does not require expensive, continually shrinking lithography in order to improve performance, as transistor-based computers do. Qubits can be made using trailing edge semiconductor tools, so computer performance is decoupled from chip manufacturing cost. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These properties enable quantum computers to excel at solving problems with a large number of variables, highly complex and numerous solutions, or strong correlations or interactions. Many of these problems are currently intractable due to the scaling limits of classical computers and thus represent opportunities for computational advancement across many industries, including finance, pharma and biotechnology, energy, logistics, aerospace, defense and intelligence, and basic research and development. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">98 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">How Quantum Computers Compute </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To execute a quantum computation, classical data, which represents the problem to be solved and the algorithm, is translated into control sequences, or quantum logic gates, and applied to the qubits in the quantum computer. These<span style="font-style:italic"> </span>sequences are called quantum circuits. Once the circuit has been executed on the quantum computer, the qubits are measured, resulting in classical data flowing out of the quantum computer and back into classical memory. The level of performance of a quantum computer in executing these circuits and solving computational problems is dictated by many factors. These include the <span style="font-style:italic">scale</span>, or number of qubits available in the quantum processor to encode the problem and algorithm, with more qubits enabling exponentially more complex and challenging problems to be represented; the <span style="font-style:italic">fidelity</span> of the quantum logic gates from which circuits are composed, which determines how often errors occur when the circuit is executed; the <span style="font-style:italic">gate speed</span>, which shapes the time taken to execute a given circuit; the <span style="font-style:italic"><span style="white-space:nowrap">co-processing</span></span> technology and integration, which determines the rate at which classical data representing the problem and algorithm can be loaded into the quantum computer, and the rate at which it flows back out upon completion of the circuit execution; and <span style="font-style:italic"><span style="white-space:nowrap">re-programmability</span></span>, or the speed with which the specific quantum circuit being executed may be updated to move on to the next step in a computational process. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Several candidate physical systems, or modalities, have been proposed or are being pursued, to form the basic physical qubits in quantum computers. These include, first and foremost, the superconducting qubit technology leveraged by us. They also include approaches based on trapped ions, trapped neutral atoms, and photonics. There is a varying degree of promise, potential and risk in building machines capable of meeting the above requirements for broad commercial utility. As outlined below, it is widely believed that superconducting qubit technology is the most mature, the most advanced, and most likely to ultimately lead to broad commercial success. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Requirements for Practical Workloads: Path to Quantum Advantage </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unlocking the broad commercial market for quantum computing calls for quantum computers that are able to solve practical commercial problems better, faster, or cheaper than the best alternative classical computing solution, including even the most powerful supercomputers. This inflection point is referred to as <span style="font-style:italic">quantum advantage</span>. Achieving quantum advantage imposes requirements on the quantum computer itself, the most important of which relate to the above performance factors of <span style="font-style:italic">scale</span>, <span style="font-style:italic">fidelity</span>, <span style="font-style:italic">speed</span>, <span style="font-style:italic"><span style="white-space:nowrap">co-processing</span></span>, and <span style="font-style:italic"><span style="white-space:nowrap">re-programmability</span></span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Scale</span></span>. In order for quantum computers to solve problems out of reach for classical computers, such as modeling molecules with many electrons in order to enhance drug discovery, they require a significant number of high-performing qubits, likely starting at between a few hundred to 1,000 qubits. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Fidelity</span></span>. A gate fidelity estimates the reliability of an operation. For instance, a <span style="white-space:nowrap">two-qubit</span> gate with a gate fidelity of 99% means that 99 out of 100 times the operation will provide the correct result. Errors can be caused by imperfect control, natural manufacturing variations, finite qubit lifetimes (coherence) or other sources. Overall, high fidelities of over 99% are likely necessary to enable performance benefits on practical workloads. An error per operation is defined as <span style="white-space:nowrap">(1-fidelity).</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Speed</span></span>. Speed is a crucial metric for all types of computers, both quantum and classical. Since quantum algorithms are ultimately composed of logic gates applied sequentially to qubits in a quantum computer, the speed with which these gates can be executed translates directly into processing speed and workload throughput. Therefore, faster quantum processing speeds can result in a larger number of addressable problems and larger market opportunity, as well as a more direct path to outperforming classical alternatives and a higher intrinsic revenue potential per unit time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Co-processing</span></span></span>. Hybrid architectures that leverage quantum computers as <span style="white-space:nowrap">co-processors,</span> pioneered by us since the company&#8217;s inception, have now become widely adopted in the quantum computing industry. Quantum </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">99 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<span style="white-space:nowrap">co-processing</span> delivered over the cloud, such as Rigetti Quantum Cloud Services platform, is the predominant framework for building and using quantum computers today. In this paradigm, quantum processors are tightly integrated with classical computing systems and infrastructure to ensure the rate of data flowing in and out of the quantum processor can meet the needs of commercial applications. Effective implementation of <span style="white-space:nowrap">co-processing</span> hinges on both the intrinsic technological features of the specific qubit technology, as well as product innovations and system architectures aimed to prioritize this capability. For example, just as in classical computing<span style="font-style:italic"> </span>architecture, fast gate speeds, coupled with a network architecture that achieves low network latency for data flow, are some requirements for high performance <span style="white-space:nowrap">co-processing.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Reprogrammability</span></span>. Reprogrammable quantum computers are general purpose machines that should be able to run any quantum algorithm, provided the machine has the scale, fidelity, and other attributes needed to support the particular problem instance. While gate-model quantum computers, such as those made by us, IBM, IonQ and Google, are typically reprogrammable, different technology approaches and architecture choices lead to varying constraints in applying this capability in a practical setting. Specifically, the ability to dynamically reprogram the quantum processor during the execution of a quantum circuit or within the coherence time of its qubits is of particular importance for many anticipated applications and use cases. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While research and development funding and investments into quantum computing have accelerated, we believe that long-term commercial demand for quantum computing systems hinges on the ability to meet the above criteria for running practical workloads. Multiple quantum hardware modalities are being pursued. Among these, we believe the superconducting qubit is the only such modality that has, to date, demonstrated viability across all these requisite metrics. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our Superconducting Quantum Processors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Introduction to Superconducting Qubits </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We build and operate quantum computers based on superconducting qubits. Superconducting qubits are silicon-based electronic devices that encode information in quantum states associated with currents and voltages. Superconducting qubits benefit from the fact that their basic properties can be engineered through well-established semiconductor industry design and manufacturing techniques. This enables chip design and architecture tradeoffs to be made to overcome various practical constraints in building commercial quantum computing systems. They are also improving along these key metrics faster than approaches based on other qubit modalities, such as ion traps, photonics and neutral atoms. As an example, in June 2011, the largest algorithms demonstrated on programmable, gate model quantum computers across these modalities were in the range of a few qubits. In the ensuing <span style="white-space:nowrap">ten-year</span> period from 2011 to 2021, superconducting systems have successfully scaled up to the range of 30 to 60 or more qubits, including demonstrations of quantum supremacy. This rate of scaling has easily outpaced other approaches. We believe this leadership results in part from an intrinsic advantage: superconducting qubits have many inherent similarities to traditional silicon-based chips. As a result, progress in superconducting quantum computers may be achieved by leveraging the existing capabilities - expertise, technologies, workforces, and supply chains, for example - of the semiconductor manufacturing industry, rather than needing to establish such capabilities anew. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Rigetti Quantum Processors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rigetti quantum processors are based on transmon-style superconducting qubits. Quantum logic gates are actuated by applying electronic signals to the qubits. Chips are packaged, connected to input and output circuitry, and operated in a <span style="white-space:nowrap">low-temperature</span> environment. Control and readout signals are generated and processed in a control system operating at room temperature. This control system is subsequently integrated with, or networked into, auxiliary classical computing hardware to enable <span style="white-space:nowrap">co-processing</span> system requirements. Our competitive advantage begins at the chip level and extends through the full-stack, with a distinct focus on fabricating scalable hardware meeting the requirements for practical workloads. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">100 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Scale </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Achieving the scale of quantum processor needed for practical workloads is perhaps the hardest requirement of all. To address this, we have developed a unique patented and patent-pending multi-chip quantum processor technology. This approach leverages techniques long used in classical computer microprocessors and memory (&#8220;RAM&#8221;). Our scalable processor architecture enables multiple core processor chips, each having many qubits, within a multi-chip assembly to function cohesively as a single, large quantum computer-without introducing additional error sources, network latency or other overhead. Using our modular chip architecture, larger quantum processors may be constructed by assembling more core processors together. From a manufacturing perspective, this enables a single type of core processor chip to support multiple quantum processor generations of increasing scale and performance. We believe that this solution facilitates rapid scaling and can enable even faster development cycles in future chip generations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to accelerating the pace of scaling, we believe our proprietary modular chip architecture has significant manufacturability and cost benefits. For example, rather than producing large, complex individual chips with 1,000 qubits, we may fabricate 10 chips with 100 qubits each, and use our multi-chip technology to assemble them together to produce a 1,000 qubit quantum processor. This solution makes it much easier to produce large processor chips with high yield. As a result, we believe our modular approach to be fundamentally more manufacturable, predictable, and scalable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our multi-chip technology incorporates several advances in integrated circuit design, architecture, and silicon device manufacturing. These advances include superconducting multi-chip bonding technology for chip-level 3D integration, superconducting through-silicon via process technology and interchip coupling technology that enables high-fidelity <span style="white-space:nowrap">two-qubit</span> logic gates between qubits disposed on different silicon dies. These innovations have resulted from our investment in more than five years of technology development to establishing the essential capabilities to produce quantum processors meeting the requirements for broad commercial utility. We believe our approach to scaling quantum computers will accelerate us toward quantum advantage systems. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">101 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g483086g18g01.jpg" alt="LOGO" />
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">Rigetti&#8217;s proprietary multi-chip architecture enables larger quantum processors to be constructed by assembling individual chips together, thereby supporting multiple quantum processor generations of increasing scale and performance </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Fab-1</span></span></span>. We have developed, own and operate the distinctive manufacturing capabilities needed to produce quantum processors in our proprietary scalable architecture. In 2017, we became the first company to build a dedicated and integrated Fab for producing quantum processors. In addition to vertically integrating the process capabilities to produce our proprietary chips, <span style="white-space:nowrap">Fab-1</span> delivers a high mix of development chips to internal teams. This <span style="white-space:nowrap">in-house</span> fabrication capability allows for rapid <span style="white-space:nowrap"><span style="white-space:nowrap">design-fab-test</span></span> cycles of learning, enabling an innovation cycle we estimate to be two to five times faster than a typical MEMS or semiconductor foundry. In <span style="white-space:nowrap">Fab-1,</span> our engineers focus their efforts on rapidly exploring then optimizing new chip designs and establishing repeatable manufacturing processes. <span style="white-space:nowrap">Fab-1</span> also includes semi-automated chip testing and characterization capabilities. Additionally, by leveraging traditional semiconductor tools and processes, <span style="white-space:nowrap">Fab-1</span> builds on expertise from the existing semiconductor industry, a distinct advantage over other qubit modalities. This <span style="white-space:nowrap">in-house</span> fab capability has enabled us to accumulate the <span style="white-space:nowrap">hands-on</span> experience and intellectual property, including <span style="white-space:nowrap">know-how,</span> patents, and trade secrets, to produce quantum computer chips within our scalable, proprietary architecture. Furthermore, we believe <span style="white-space:nowrap">Fab-1</span> has enough wafer capacity to supply all of our chip needs for at least the next four years. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Cooling</span></span>. Like all high-performance computing systems, Rigetti quantum computers require an advanced cooling system. In this case, commercially available dilution refrigerators maintain chip temperatures at around 0.02 Kelvin. Cooling power requirements and associated electricity costs will scale approximately linearly with qubit count, while expected computational utility increases exponentially. As a result, we expect the electricity </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">102 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
costs to run the cooling systems of our quantum computers to make up an ever-decreasing fraction of the overall revenue generated from each machine. In addition, we work closely with refrigerator vendors and anticipate the commercial availability of dilution refrigerator systems with the capabilities to support our product roadmap. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Fidelity </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Improvements to the coherence times of superconducting qubits, combined with methods for ever-faster and more precise quantum logic gates, have kept superconducting qubits on a pace of continuous fidelity improvement for approximately two decades. Over the last several years, algorithms have been developed on processors with average <span style="white-space:nowrap">two-qubit</span> gate fidelities of <span style="white-space:nowrap">95-98%.</span> As processors scale to broad quantum advantage, fidelity will need to improve, likely to 99% and beyond. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are focused on delivering advances to fidelity through a systematic engineering approach centered on our <span style="white-space:nowrap"><span style="white-space:nowrap">design-fab-test</span></span> flywheel powered by our <span style="white-space:nowrap">in-house</span> design and manufacturing. Uniquely, our modular processor technology enables improvements to fidelity to be achieved separately from efforts to increase scale; fidelity advancements can be developed on the individual core processor chips, and these improvements can be rapidly integrated into scaled processors through our multi-chip integration technology. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercially available <span style="white-space:nowrap">80-qubit</span> Aspen systems typically have similar gate fidelities to its <span style="white-space:nowrap">32-qubit</span> systems. Significantly, our <span style="white-space:nowrap">80-qubit</span> multi-chip processors leverage our interchip coupling technology to form an <span style="white-space:nowrap">80-qubit</span> lattice of similar fidelity to the <span style="white-space:nowrap">40-qubit</span> chips on which they are based. Looking forward, we plan to combine core elements of this multi-chip scaling technology with the expected higher performance and connectivity of our next generation chips. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently see higher performance in test devices of our next generation core quantum processor, the <span style="white-space:nowrap">Ankaa-1</span> 84 qubit system, which we recently deployed internally within the company in March 2023 for testing. This next-generation chip design uses tunable couplers to enable active cancellation of unwanted interactions between qubits to improve control and decrease error. Recent tests on a <span style="white-space:nowrap">9-qubit</span> system utilizing these new chips have demonstrated mean <span style="white-space:nowrap">two-qubit</span> gate fidelities of 98.3%, median fidelities of 98.1% and maximum fidelities of 99.6%. As development has progressed, we continue to see high <span style="white-space:nowrap">two-qubit</span> gate fidelities around 99% on test devices. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Speed </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the strengths of superconducting qubit technology, and our technology in particular, is that gate operations on superconducting processors are faster than other commercially available modalities today. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The speed of gate operations in superconducting qubits are determined by the intentional design of circuit elements <span style="white-space:nowrap">on-chip</span> and their optimized parameters, rather than relying on atomic properties. Our slowest class of gate operations, <span style="white-space:nowrap">two-qubit</span> entangling gates, have a median duration of less than 200 nanoseconds. Moreover, for future computer systems from us, high quality entangling gates as fast as 36 nanoseconds have recently been achieved through the introduction of an additional circuit element to tune the interaction strength between qubits, showcasing the value of engineered approaches. We believe that superconducting processors&#8217; speed advantage will result in a larger market for superconducting quantum computers compared to other modalities, as there are a multitude of high value use cases that require timely results, such as real-time decision making, risk calculations, and more. As in conventional computing, faster gate speeds also equate to higher throughput in commercial deployment and therefore greater potential revenue opportunity. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2022, we announced speed test results for Circuit layer operations per second, or CLOPS, for our Aspen 11 and <span style="white-space:nowrap">Aspen-M</span> series processors. CLOPs is a quantum computer performance metric initially developed and published by IBM in October 2021. Conducting tests based on 100 shots, as set forth in the original published definition, the <span style="white-space:nowrap">40-qubit</span> <span style="white-space:nowrap">Aspen-11</span> system demonstrated a CLOPS of 844, while the <span style="white-space:nowrap">80-qubit</span> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">103 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<span style="white-space:nowrap">Aspen-M</span> system demonstrated a CLOPS of 892. These results suggest that our current systems perform as well or better on this CLOPS speed test as the number of qubits in the system increases. To reflect what users can potentially expect in typical use cases, we also evaluated CLOPS using 1000 shots. In this case, <span style="white-space:nowrap">Aspen-11</span> performed at 7512 CLOPS and <span style="white-space:nowrap">Aspen-M</span> performed at 8333 CLOPS, demonstrating that comparable or better system speed persists at both higher shot counts and higher qubit counts. In July and August, 2022, we successfully achieved a CLOPS performance greater than 4,000 on both our <span style="white-space:nowrap">80-qubit</span> <span style="white-space:nowrap"><span style="white-space:nowrap">Aspen-M-2</span></span> system and our <span style="white-space:nowrap">40-qubit</span> <span style="white-space:nowrap">Aspen-11</span> system, respectively, representing a 4.5 times acceleration since February. These speed tests were conducted using our production QCS environment. CLOPS, characterizes quantum processing speeds inclusive of gate speeds, reprogrammability, and <span style="white-space:nowrap">co-processing</span> capabilities, among other factors. CLOPS is calculated as M &#215; K &#215; S &#215; D / time taken where: M = number of templates = 100; K = number of parameter updates = 10; S = number of shots = 100 or 1000; and D = number of QV layers = log2 QV. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Co-processing</span> </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is widely believed that unlocking the commercial value of quantum computing requires quantum computers to be tightly integrated with classical computing systems and technology. High-performance <span style="white-space:nowrap">co-processing</span> integration accelerates the path to quantum advantage by enabling both quantum and classical computing resources to work in tandem to address computational bottlenecks best suited to their particular strengths. This approach also facilitates adoption and usability by end users who are more familiar with classical programming. The inherent speed with which superconducting processors can execute circuits and be dynamically <span style="white-space:nowrap">re-programmed</span> makes them ideally suited to high-speed <span style="white-space:nowrap">co-processing</span> integration. Other modalities have not demonstrated the gate speeds necessary to support high-performance <span style="white-space:nowrap">co-processing.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have invented and patented capabilities at the hardware and software level, such as parametric code compilation, to enable high performance <span style="white-space:nowrap">co-processing</span> on a cloud platform. Parametric code compilation supports running faster hybrid algorithms through memory registers shared between classical programs and embedded logic on a QPU control system. This means that users can run algorithms without incurring latency that would otherwise be caused by updating parameters at each step. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Reprogrammability </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our systems are dynamically reprogrammable. Instructions are streamed into the quantum computer or updated within the execution time of the quantum logic circuit. This allows our machines to effectively run<span style="font-style:italic"> </span>both the hybrid variational algorithms that underpin current use cases and quantum error correction routines in future systems. In a production setting, dynamic reprogrammability translates to higher customer job throughput per unit time. Since many applications are expected to require streamed data processing or error correction, we believe this dynamic reprogrammability is central to unlocking the full market potential of quantum computing systems, especially in comparison to alternative modalities that are unable to implement high speed <span style="white-space:nowrap">re-programming.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our quantum computers are orchestrated with a control system operated at room temperature. In our architecture, reprogramming the quantum processor occurs exclusively within this control system. Unlike photonics, for example, reprogramming the system to run a new quantum circuit does not require slow <span style="white-space:nowrap">on-chip</span> updates, but only requires changes to the sequence of signals applied to the chip. Our QPUs today support dynamic programming protocols within microsecond feedback loops. For example, <span style="white-space:nowrap">re-setting</span> registers of qubits conditional on the outcomes of previous measurements, can increase overall quantum circuit throughput by 5x relative to <span style="white-space:nowrap">non-dynamic</span> implementations of the same workload. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The QPU control system includes hardware for networking, classical microprocessors, FPGAs for control and readout pulse sequencing, and analog signal processing. The integrated system is designed and built to meet the requirements for <span style="white-space:nowrap">co-processing</span> and reprogrammability over the cloud. This capability enables high-speed data flow within the quantum processor, and between the quantum processor and auxiliary classical compute and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">104 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
networking infrastructure. Our systems are thus enabled for high-performance hybrid quantum-classical computing, the implementation of high-throughput quantum programs for practical workloads, and the dynamic control flow and feedback that underpins practical quantum error correction. The control system drives the quantum processor, calibrates and operates gates, and measures qubit states at the end of a computation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Quantum Error Correction </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Direct improvements to qubits and gate fidelities are currently the primary means of advancing the performance of quantum computers. However, at the scale of a few hundred qubits and beyond, a method called quantum error correction can be applied to further accelerate this rate of progress. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In quantum error correction, a large number of individual physical qubits can be transformed, through repeated application of gate and readout operations designed to detect and fix physical errors, into single &#8220;logical&#8221; qubits, whose properties are exponentially improved relative to the constituent physical qubits. While the methodology of quantum error correction is well-established in the field of quantum computing, systems capable of running such codes at a commercially useful scale are not currently available. Eventually, solving certain classes of problems will require the ability to compute with tens to hundreds or even thousands of logical qubits. This makes the ability to build large qubit count processors at this commercial scale an even more crucial capability. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, because errors must be identified at a specific physical location within the quantum processor in order to be corrected, those errors must also be well-localized within small regions of the quantum processor. For example, a qubit in one region must not induce errors on some distant qubit, but rather be constrained to influencing errors on nearby qubits. This essential requirement underpins modern quantum error correction theory and practice. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Turning to the processor&#8217;s physical qubit array, the necessity of localizing errors has led to the predominance of nearest-neighbor connectivity graphs in quantum processor design. Our quantum processors meet these essential requirements with a nearest-neighbor, planar connectivity graph. Planar codes are expected to show a high error threshold of approximately 1% error probability per operation. This means that if error rates are below the required threshold (e.g. 1%), then increasing the redundancy (<span style="font-style:italic">i.e.</span>, the number of physical qubits making up a single logical qubit) results in an exponential reduction in logical error. In other words, adding a small number of additional physical qubits per logical qubit will provide exponential improvements. Notably, codes for other modalities, such as Bacon-Shor codes for trapped ion qubits, lack such a threshold behavior and is one reason why we believe superconducting quantum computers to be superior to trapped ion modalities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We aim to deliver the physical qubit count needed, with the requisite nearest-neighbor connectivity, to enable developers and customers to benefit from this exponential error reduction. In contrast to known approaches for other qubit modalities, our systems are expected to be able to run the same code family at multiple different levels of redundancy without requiring additional complexity such as code concatenation. This approach enables developers to scale the effective error rate and associated overheads up and down as dictated by their <span style="white-space:nowrap">use-case</span> requirements. For example, the smallest surface code logical qubit for superconducting processors is 17:1 physical qubits to logical qubits, in comparison to 16:1 for trapped ions. However, for complex applications, the ability to pack more physical qubits into the code (such as 100:1 or 1000:1) is critical because it allows developers to further reduce errors for algorithms based on many quantum gates where errors are more likely to accumulate. In comparison to trapped ions, we believe superconducting processors are better positioned to scale up to the large number of qubits required to run these valuable large codes while also having the fast gate speeds for them to be useful. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our processor architecture, software tools, and cloud services platform are designed to enable users and partners to directly construct, test and deploy error correction and error mitigation protocols, and to tailor such codes to specific computational tasks through software. This capability is enabled by the <span style="white-space:nowrap">re-programmability,</span> <span style="white-space:nowrap">co-processing</span> integration, and system design we have established. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">105 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Intellectual Property </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our intellectual property portfolio plays a strategic role in advancing our innovation and leadership in quantum computing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our patent portfolio seeks to protect our current developments and the intellectual property space for the company&#8217;s technology roadmap and anticipated areas of development. We rely upon a combination of protections afforded to owners of patents, copyrights, trade secrets, and trademarks, along with confidentiality and proprietary rights agreements with employees, consultants, contractors, vendors and business partners to establish and protect our intellectual property rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of April&#160;5, 2023, we have 165 issued and pending patents that are designed to protect our full-stack technology across hardware, software, and services. These patents cover a broad range of key technology areas of the business including (i)&#160;quantum computing systems, software and access; (ii)&#160;quantum processor hardware; (iii)&#160;algorithms and applications for problem solving; and (iv)&#160;chip design&#160;&amp; fabrication. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We pursue international registration of our domain names and trademarks. We are the registered holder of a variety of domain name registrations, including &#8220;rigetti.com.&#8221; Our trademark registrations include &#8220;Rigetti&#8221; in the US, U.K. and EU. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Sales&#160;&amp; Marketing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During this period of eQA, our <span style="white-space:nowrap"><span style="white-space:nowrap">go-to-market</span></span> strategy is focused on being a leader in the key market segments driving the early application of quantum computing. Our sales and marketing efforts are focused on technology development and distribution partnerships with the leading organizations in these markets. In the U.S. government, for example, the Department of Defense, the DOE and the Intelligence Community have each been making significant investments in quantum computing, and we have technology development partnerships with leading agencies and national laboratories. We are pursuing similar arrangements with customers in other important vertical market segments, like finance, where we are developing specific expertise in several application areas and are collaborating with Nasdaq and Standard Chartered Bank. We also have distribution relationships with customers like Amazon Web Services, Microsoft, ORNL and Strangeworks. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we work to develop new generations of our hardware with the goal of continuing to scale and achieve nQA and then BQA, we anticipate increasing our investment in both sales and marketing to expand the number of enterprise companies directly licensing our QCS platform. However, with the reorganization and reduction in force announced in February 2023, we anticipate that the costs will decrease in the near term until we achieve narrow quantum advantage, at which point we expect costs to increase. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Customers&#160;&amp; Key Partners </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the realization of quantum computing&#8217;s promise requires strong relationships across an ecosystem of innovative and quantum-committed organizations and have been developing commercial relationships and collaborative partnerships with organizations that possess a keen understanding of specific industry problems and deep technical expertise in key scientific and engineering disciplines. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, we have focused on developing a range of client relationships and research partnerships with: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="white-space:nowrap">enterprise-sized</span> organizations working on quantum-assisted breakthroughs in applications areas like drug discovery, network optimization, financial modeling, weather forecasting and fusion energy with organizations like Astex Pharmaceuticals, Deloitte, NASA, Nasdaq, Standard Chartered Bank, the U.S. DOE and certain military branches within the U.S. Department of Defense; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">materials science researchers and quantum algorithm developers at renowned laboratories like Fermilab, Lawrence Livermore National Laboratory, MIT Lincoln Laboratory, NASA Quantum Artificial Intelligence Laboratory and ORNL; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">106 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">quantum-focused software and algorithm companies like 1Qbit, Phasecraft, Riverlane, <span style="white-space:nowrap">Q-CTRL</span> and Zapata; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Cloud service providers like Amazon Web Services, Microsoft Azure, and Strangeworks; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We also enter into multi-year technology development partnerships with organizations that possess specialized technical expertise and strong interests in advancing the development of quantum computing (as referenced in <span style="font-style:italic">Business - Key Technology Development Partnerships</span>). These organizations include DARPA, SQMS, and Innovate UK. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Competition </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The quantum computing market is evolving and highly competitive. With the introduction of new innovations and the potential entry of new competitors into the market, we expect competition to increase in the future, which could harm our business, results of operations, or financial condition. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current and prospective competitors include companies engaged in the research, development, and operation of quantum computing capabilities. Major companies now developing both quantum hardware and software include IBM, Google, Microsoft, IonQ, Quantinuum, PsiQuantum, Xanadu and ColdQuanta. In addition, because of the importance of quantum computing, most large public cloud providers and traditional chip makers are researching and investing in quantum computing initiatives, in some cases seeking to build quantum computers. For example, Amazon and Intel are engaged in the research and development of quantum computers. A number of development-stage companies are also seeking to build quantum computers, quantum software and applications, and quantum cloud computing services. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our primary direct competition will come from other companies building or seeking to build universal, gate-model quantum computing systems that can meet the requirements for solving commercial problems. We believe competition will be based on a number of factors, including: different approaches to building quantum computers; quantum computer system performance, including scale, speed, and fidelity; system accessibility and ease of use; supported software and applications; compatibility with existing classical workflows; rate of technological innovation; ability to create value through long-term partnerships; <span style="white-space:nowrap">end-user</span> support and customer experience; solutions and insight delivery; price; brand recognition and trust; financial resources; and access to key personnel. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that we are favorably positioned to compete on the basis of these factors. However, we face various risks relating to competition as described in &#8220;<span style="font-style:italic">Risk Factors-Risks Related to Rigetti&#8217;s Business and <span style="white-space:nowrap">Industry-The</span> quantum computing industry is competitive on a global scale and Rigetti may not be successful in competing in this industry or establishing and maintaining confidence in our long-term business prospects among current and future partners and customers</span>.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Regulatory </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">U.S. government contracts, grants, and agreements are subject to regulations and procurement laws. The majority of our current programs are subject to Title 2 of the Code of Federal Regulations, covering Grants and Agreements. We also perform programs authorized under Other Transaction Authority and the Federal Acquisition Regulation. Several of our agreements are also subject to agency level acquisition regulation supplements, including the Defense Federal Acquisition Regulation Supplement and the Department of Energy Acquisition Regulation. These regulations mandate uniform policies and procedures for the administration of government funded programs. This includes requiring compliance with eligibility and responsibility requirements, contractor qualifications, financial and reporting requirements, as well as subjecting the company audits and to other government reviews covering issues such as cost, performance, internal controls and accounting practices. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">107 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Employees&#160;&amp; Core Values </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our deep and talented workforce is the key to our success. As of March 1, 2023, we employ&#160;144 people globally, the majority of whom are employed in areas of quantum physics, chip and hardware engineering and software development. Most of our employees are based in the United States with the remainder based in the United Kingdom, Australia and Canada. In addition, we also engage a small number of consultants and contractors to enhance our research and development and selling general and administrative areas of our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, we have not experienced any work stoppages and maintain good working relationships with our employees. None of our employees are subject to a collective bargaining agreement or are represented by labor unions at this time. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Facilities </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate headquarters is located in Berkeley, California, where the Company leases 15,625 square feet pursuant to a lease that expires October&#160;31, 2025. Our Fab-1 facility is located in Fremont, California, where the company leases approximately 53,800 square feet pursuant to a lease that expires September&#160;30, 2029. We also have offices for our international operations in the United Kingdom and Australia. We believe that our current facilities are suitable and adequate to meet our current needs. We intend to add new facilities or expand existing facilities as we add employees, and we believe that suitable additional or substitute space will be available as needed to accommodate any such expansion of our operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Corporate Information </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rigetti Computing, Inc., formerly known as Supernova Partners Acquisition Company II, Ltd., was incorporated on December&#160;22, 2020 as a Cayman Islands exempted company and a special purpose acquisition company. On October&#160;6, 2021, Supernova entered into the Merger Agreement. Pursuant to the Merger Agreement, on March&#160;1, 2022, Supernova effected a domestication after which it continues as a Delaware corporation, changing its name to &#8220;Rigetti Computing, Inc.&#8221; On March&#160;2, 2022, pursuant to the Merger Agreement, First Merger Sub merged with and into Legacy Rigetti, the separate corporate existence of First Merger Sub ceasing and Legacy Rigetti being the surviving corporation and (ii)&#160;immediately following the First Merger, Legacy Rigetti merged with and into the Second Merger Sub, with the separate corporate existence of Legacy Rigetti ceasing and the Second Merger Sub being the surviving entity and changing its name to &#8220;Rigetti Intermediate LLC&#8221;. Our principal executive offices are located at 775 Heinz Avenue, Berkeley, CA 94710 and our telephone number is (510) <span style="white-space:nowrap">210-5550.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Legal Proceedings </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we may become involved in actions, claims, suits and other legal proceedings arising from the ordinary course of business. Our management believes we are not currently a party to any actions, claims, suits or other legal proceedings, the outcome of which, if determined adversely to the company, would have a material adverse effect on its results of operations, financial condition or cash flows. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">108 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_12">MANAGEMENT </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Executive Officers and Directors </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The brief biographies below include information, as of April 5, 2023, regarding the specific and particular experience, qualifications, attributes and skills for each member of our board of directors. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:33%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:63%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Position</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><span style="font-weight:bold"><span style="font-style:italic">Executive Officers</span></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Subodh Kulkarni</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">58</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">President, Chief Executive Officer and Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Jeff Bertelsen</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">60</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Rick Danis</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">53</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">General Counsel and Corporate Secretary</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">David Rivas</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">62</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Chief Technology Officer</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><span style="font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Non-Employee&#160;Directors</span></span></span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Alissa Fitzgerald</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">53</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Ray Johnson</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">67</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">David Cowan</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">57</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Cathy McCarthy</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">75</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Michael Clifton</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">43</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">H. Gail Sandford</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center">59</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Executive Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Subodh Kulkarni.</span> Dr.&#160;Subodh Kulkarni has served as President, Chief Executive Officer and director of Rigetti since December 2022. Dr.&#160;Kulkarni previously served as president, chief executive officer, and member of the board of directors of CyberOptics Corporation (&#8220;CyperOptics&#8221;), a developer and manufacturer of high precision sensors and inspection systems for the semiconductor and electronics industry. He held these roles from 2014 until CyberOptics was acquired by Nordson Corporation in November 2022. Prior to CyberOptics, Dr.&#160;Kulkarni was chief executive officer of Prism Computational Sciences, a developer of software tools for scientific and commercial applications in the semiconductor industry. Earlier in his career, he held additional leadership positions, including chief technology officer and senior vice president of OEM/Emerging business, global commercial business, R&amp;D and manufacturing at Imation, a global scalable storage and data security company. Dr.&#160;Kulkarni began his career in research and management positions with 3M Corporation and IBM. He received his B.S. in chemical engineering from the Indian Institute of Technology, Mumbai, and later obtained a M.S. and Ph.D. in chemical engineering from MIT. Dr.&#160;Kulkarni currently serves on the board of directors of KeyTronic Corporation (Nasdaq: KTCC), an electronics manufacturing services company, as well as chairman of the board of directors of Prism Computational Sciences. We believe Dr.&#160;Kulkarni is well qualified to serve on our Board because of his prior leadership and officer positions at technology and software companies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Jeff Bertelsen. </span>Mr.&#160;Bertelsen was most recently Chief Financial Officer and Chief Operating Officer of CyberOptics Corporation, a developer and manufacturer of high precision sensors and inspection systems for the semiconductor and electronics industry. Mr.&#160;Bertelsen joined CyberOptics as Vice President&#8212;Finance and Chief Financial Officer in 2005. In February 2014, Mr.&#160;Bertelsen was appointed Chief Operating Officer of CyberOptics, and also retained his positions as Vice President&#8212;Finance and Chief Financial Officer. Mr.&#160;Bertelsen was also appointed Secretary of CyberOptics in February 2016. Before joining CyberOptics, Mr.&#160;Bertelsen held various positions with Computer Network Technology Corporation, a provider of storage networking equipment and solutions (&#8220;CNT&#8221;), as Vice President, Finance, Corporate Controller and Treasurer and Assistant Secretary. Prior to joining CNT, Mr.&#160;Bertelsen was a Certified Public Accountant with KPMG LLP. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Rick Danis.</span> Mr.&#160;Danis has served as General Counsel and Corporate Secretary of Rigetti since immediately following the consummation of the Business Combination and served as Legacy Rigetti&#8217;s General Counsel and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">109 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Corporate Secretary from July 2019 until the consummation of the Business Combination. Prior to joining Legacy Rigetti, Mr.&#160;Danis served as Chief Legal Officer and corporate secretary at Kymeta Corporation from May 2018 to July 2019. Mr.&#160;Danis also served as Senior Vice President and Assistant General Counsel at Funko from December 2017 to May 2018 and as General Counsel and Corporate Secretary at publicly traded Rightside Group, Ltd. from August 2014 until August 2017. In addition, Mr.&#160;Danis has served as a director on the board of F3 Nation, Inc. since January 2020. In all, Mr.&#160;Danis has over 25 years of experience practicing law, almost exclusively <span style="white-space:nowrap">in-house</span> at technology companies. Mr.&#160;Danis received a B.B.A. in accounting from Ohio University and a J.D. from DePaul University College of Law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">David Rivas</span>. Mr.&#160;Rivas has served as Chief Technology Officer since February 2023 and previously was Senior Vice President, Systems and Services at Rigetti since March 2019, where he oversaw the engineering and operations of Rigetti&#8217;s Quantum Cloud Services platform. Mr.&#160;Rivas served as Vice President Engineering at Bolt Threads from March 2017- February 2018. He served as President and COO and later as CEO of Stage 3 Systems from 2013-2015. He held several roles at Nokia from 2007-2012 including Vice President, Emerging Products and Vice President, Product&#160;&amp; Technology Management. From October 2003- February 2006 he served as Chief Technology Officer - Client Systems Group at Sun Microsystems. He holds a B.S. and M.S. in electrical and computer engineering, both from the University of California, San Diego. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Non-Employee</span> Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Alissa M. Fitzgerald.</span> Dr.&#160;Fitzgerald has served as a member of the Board since March 2022 and previously served as a member of the Legacy Rigetti Board from April 2018 until the consummation of the Business Combination. She has also served as the Chief Executive Officer and Managing Member of A.M. Fitzgerald&#160;&amp; Associates, LLC, a consulting services firm for micro electromechanical systems (MEMS) product development and technology since 2003. She had previously worked in engineering or management positions at several technology companies. She currently serves as a member of the board of directors of Transducer Research Foundation since 2016 and served as a board director for the MEMS Industry Group (MIG) from 2008 to 2014. Dr.&#160;Fitzgerald received a PhD. in aeronautics and astronautics from Stanford University and an M.S. and B.S. in aeronautics and astronautics from the Massachusetts Institute of Technology. We believe Dr.&#160;Fitzgerald is qualified to serve as a member of the Board because of her extensive experience as a senior executive and substantial knowledge in semiconductor and electronics technology. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Dr.</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;Ray</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;O. Johnson.</span> Dr.&#160;Johnson has served as a member of the Board since March 2022 and previously served as a member of the Legacy Rigetti Board from August 2019 until the consummation of the Business Combination. He has served as Chief Executive Officer of the Technology Innovation Institute since August 2021, and also has served as Operating Partner at Bessemer Venture Partners since July 2020, after joining Bessemer Venture Partners as an Executive In Residence in June 2015. Prior to that, Dr.&#160;Johnson served as Senior Vice President and Chief Technology Officer of the Lockheed Martin Corporation from July 2006 to February 2015. He also served as Senior Vice President and Chief Operating Officer of Modern Technology Solutions, Inc. from June 2005 to July 2006 and as Senior Vice President and Business Unit General Manager at SAIC from January 1996 to June 2005. Dr.&#160;Johnson is also a member of the board of directors of Xanadu Quantum Technologies. Dr.&#160;Johnson received a B.S. in electrical engineering from Oklahoma State University and a PhD. and M.S. in electrical engineering from the U.S. Air Force Institute of Technology. We believe Dr.&#160;Johnson is qualified to serve as a member of the Board because of his integral involvement in the technology industry, generally, and management roles at global venture capital firms. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">David Cowan.</span> Mr.&#160;Cowan has served as a member of the Board since March 2022 and previously served as a member of the Legacy Rigetti Board from April 2021 until the consummation of the Business Combination. Mr.&#160;Cowan is a partner at Bessemer Venture Partners, a venture capital investment firm. Mr.&#160;Cowan is or has been a member of the board of directors of a number of portfolio companies of Bessemer Venture Partners, including Xanadu Quantum Technologies. Mr.&#160;Cowan is also a member of the board of directors of Rocket Lab </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">110 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
USA, Inc. Mr.&#160;Cowan holds an A.B. in Computer Science and Mathematics from Harvard University and an MBA from Harvard Business School. We believe Mr.&#160;Cowan is qualified to serve as a member of the Board because of his integral involvement in the technology industry, generally, and his experience in the venture capital industry. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Cathy McCarthy. </span>Ms.&#160;McCarthy has served as a member of the Board since March 2022 and, has served as Chair of the Board since July&#160;15, 2022. Ms.&#160;McCarthy previously served as a member of Legacy Rigetti Board from July 2021 until the consummation of the Business Combination. Ms.&#160;McCarthy is currently President and CEO of Cross Tack Consulting, a strategy consulting firm. Ms.&#160;McCarthy previously served as Chief Executive Officer and as Chief Financial Officer of SM&amp;A, a publicly traded company specializing in business capture and program services support services to government contractors. Ms.&#160;McCarthy served on the board of directors, compensation committee and audit committee of Solta Medical, Inc., prior to its merger with Valeant Pharmaceuticals International, Inc. She currently serves as a board member and audit committee chair of the Middleby Corporation, a publicly-traded leader in the foodservice equipment industry. Ms.&#160;McCarthy began her career at Mellon Bank, N.A., where she was Vice President of several lending departments and was responsible for oversight of highly leveraged and distress assets.&#160;We believe Ms.&#160;McCarthy is qualified to serve as a member of the Board because of her extensive experience and prior public board and audit committee experience. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Michael Clifton</span>. Mr.&#160;Clifton has served as a member of the Board since March 2022 and previously served as the Chief Financial Officer and a director of Supernova since its inception. Mr.&#160;Clifton currently serves as a Partner at Falfurrias Management where he helps lead Falfurrias Growth Partners. Prior to that, he was Chief Financial Officer and/or a director of Supernova Partners Acquisition Company I Inc. and Supernova Partners Acquisition Company III Ltd. Prior to that he was a senior investment professional at The Carlyle Group from 2010 to 2020 as a member of its flagship U.S. Buyout team where he helped lead Carlyle&#8217;s investing activities in the technology and business services sectors. During his tenure he worked on transactions involving companies in multiple sectors, including enterprise software, financial technology, semiconductors, and IT services. He has served on four private boards and has been a board observer of a public company. Over his career, Mr.&#160;Clifton has been involved in several leveraged buyouts, growth investments, and carve-outs. Mr.&#160;Clifton has substantial public market experience and has helped lead the public offerings of three companies. Prior to joining Carlyle, Mr.&#160;Clifton worked at two middle market private equity firms, as well as in the M&amp;A group of Bank of America Securities. He earned a Bachelor of Arts, cum laude, in classics from Davidson College, and an MBA with High Distinction from the Harvard Business School where he was a Baker Scholar. We believe Mr.&#160;Clifton is qualified to serve on the Board due to his corporate finance experience and experience investing in technology companies, including semiconductor businesses. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">H. Gail Sandford.</span> Ms. Sandford has served as a member of the Board since March 2022. Currently Ms. Sandford holds the position as Principal Director, Business Transformation Office at The Aerospace Corporation. Prior to joining The Aerospace Corporation, Ms. Sandford served as Chief Operations Officer of Recros Medica, an aesthetic medical device startup from 2017 to 2022, and as Chief Operations Officer of PFMG Solar, a leading solar developer in the municipal and school market from 2011 to 2017. Previously, Ms. Sandford served as Vice President at SM&amp;A, a publicly traded consulting firm specializing in business capture and program support services for clients in aerospace, defense, homeland security, and information services, and as Director of Proprietary Programs at Boeing, where she led a program to deliver a novel classified space system. Ms.&#160;Sandford holds a B.S. in physics from North Georgia College, an M.S. in engineering from The George Washington University, and an MBA from the University of Southern California. We believe Ms. Sandford is qualified to serve on the Board due to her experience in managing large, complex technical programs and her significant government contract experience. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Family Relationships </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our directors or executive officers. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">111 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Composition </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business and affairs are organized under the direction of the Board. The Board will meet on a regular basis and additionally as required. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of the Bylaws, the Board may establish the authorized number of directors from time to time by resolution. The Board consists of seven members. In accordance with the Certificate of Incorporation, the Board is divided into three classes with staggered three-year terms. At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following election. The Board is divided among the three classes as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Class&#160;I directors are Subodh Kulkarni, Ray Johnson and H. Gail Sandford, and their terms will expire at the annual meeting of stockholders to be held in 2023; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Class&#160;II directors are Alissa Fitzgerald and David Cowan, and their terms will expire at the annual meeting of stockholders to be held in 2024; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Class&#160;III directors are Cathy McCarthy and Michael Clifton and their terms will expire at the annual meeting of stockholders to be held in 2025. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As nearly as possible, each class will continue to consist of <span style="white-space:nowrap">one-third</span> of the directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The division of the Board into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Independence </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Nasdaq Stock Market (&#8220;Nasdaq&#8221;) listing standards, a majority of the members of a listed company&#8217;s Board must qualify as &#8220;independent,&#8221; as affirmatively determined by the Board. The Board consults with the Company&#8217;s counsel to ensure that the Board&#8217;s determinations with respect to independence are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on information provided by each director concerning his or her background, employment and affiliations, the Board determined that none of our directors, other than Mr. Kulkarni, has any relationships that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director, and that each of our directors, other than Mr. Kulkarni, is &#8220;independent&#8221; as that term is defined under the Nasdaq listing standards. In addition, our Board previously determined that Peter Pace, who served as a director and chair of the Board during 2022, including as a member of the audit committee and the compensation committee, and resigned effective July 2022, was &#8220;independent&#8221; as that term is defined under the Nasdaq listing standards. In making these determinations, the Board considered the current and prior relationships that each non-employee director has with Rigetti and all other facts and circumstances our Board deemed relevant in determining their independence, including the beneficial ownership of securities of Rigetti by each non-employee director and the transactions described in the section titled &#8220;<span style="font-style:italic">Certain</span><span style="font-style:italic"> </span><span style="font-style:italic">Relationships</span><span style="font-style:italic"> </span><span style="font-style:italic">and</span><span style="font-style:italic"> </span><span style="font-style:italic">Related</span><span style="font-style:italic"> </span><span style="font-style:italic">Person</span><span style="font-style:italic"> </span><span style="font-style:italic">Transaction</span><span style="font-style:italic">s</span>.&#8221; The Board also determined that each member of our Audit, Compensation and Nominating and Corporate Governance Committees satisfies the independence standards for such committees established by the SEC and the Nasdaq listing standards, as applicable. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Role of the Board in Risk Oversight/Risk Committee </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the key functions of the Board is the informed oversight of our risk management process. The Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various standing committees of the Board that address risks </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">112 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
inherent in their respective areas of oversight. In particular, the Board is responsible for monitoring and assessing strategic risk exposure and the Board&#8217;s audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management will take to monitor and control such exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The Board&#8217;s audit committee also monitors compliance with legal and regulatory requirements and assesses cybersecurity risks, including through its standing subcommittee focused on cybersecurity. The Board&#8217;s compensation committee also assesses and monitor whether our compensation plans, policies and programs comply with applicable legal and regulatory requirements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Committees of the Board </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board adopted a charter for each of its committees, which comply with the applicable requirements of current SEC and Nasdaq rules. We intend to comply with future requirements to the extent applicable. Copies of the charters for each committee are available on the investor relations portion of our website. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Audit Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audit committee consists of Cathy McCarthy, H. Gail Sandford, Alissa Fitzgerald and Michael Clifton, each of whom the Board has determined satisfies the independence requirements under Nasdaq listing standards and <span style="white-space:nowrap">Rule&#160;10A-3(b)(1)</span> of the Exchange Act. The chair of the audit committee is Ms. McCarthy. The Board has determined that Ms. McCarthy is an &#8220;audit committee financial expert&#8221; within the meaning of SEC regulations. Each member of the audit committee can read and understand fundamental financial statements in accordance with applicable requirements. In arriving at these determinations, the Board examined each audit committee member&#8217;s scope of experience and the nature of their employment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary purpose of the audit committee is to discharge the responsibilities of the Board with respect to the corporate accounting and financial reporting processes, systems of internal control and financial statement audits, and to oversee the independent registered public accounting firm. Specific responsibilities of the audit committee include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">oversee our accounting and financial reporting processes, systems of internal control, financial statement audits and the integrity of our financial statements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">manage the selection, engagement terms, fees, qualifications, independence, and performance of the registered public accounting firms engaged as our independent outside auditors for the purpose of preparing or issuing an audit report or performing audit services (the &#8220;Auditors&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">maintain and foster an open avenue of communication with our management, internal audit group (if any) and Auditors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">review any reports or disclosures required by applicable law and stock exchange listing requirements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">oversee the design, implementation, organization and performance of our internal audit function (if any); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">help our Board oversee our legal and regulatory compliance, including risk assessment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">oversee our technology security and data privacy programs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">prepare the audit committee report required by the SEC to be included in our annual proxy statement, and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide regular reports and information to the Board. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Compensation Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation committee consists of Ray Johnson and Michael Clifton. The chair of the compensation committee is Mr. Clifton. The Board has determined that each member of the compensation committee is </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">113 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
independent under the Nasdaq listing standards and a <span style="white-space:nowrap">&#8220;non-employee</span> director&#8221; as defined in Rule <span style="white-space:nowrap">16b-3</span> promulgated under the Exchange Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary purpose of the compensation committee is to discharge the responsibilities of the Board in overseeing the compensation policies, plans and programs and to review and determine the compensation to be paid to executive officers, directors and other senior management, as appropriate. Specific responsibilities of the compensation committee include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">help the Board oversee our compensation policies, plans and programs with a goal to attract, incentivize, retain and reward top quality executive management and employees; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">review and determine the compensation to be paid to our executive officers and directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">when required, review and discuss with management our compensation disclosures in the &#8220;Compensation Discussion and Analysis&#8221; section of our annual reports, registration statements, proxy statements or information statements filed with the SEC; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">when required, prepare and review the Committee report on executive compensation included in our annual proxy statement; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">review and ensure our talent management strategies are aligned to best practices and ensure we attract, retain and develop top talent. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Nominating and Corporate Governance Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The nominating and corporate governance committee consists of Alissa Fitzgerald, H. Gail Sandford, and David Cowan. The chair of the nominating and corporate governance committee is Ms. Sandford. The Board has determined that each member of the nominating and corporate governance committee is independent under the Nasdaq listing standards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specific responsibilities of the nominating and corporate governance committee include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">help the Board oversee our corporate governance functions and develop, update as necessary and recommend to the Board the governance principles applicable to Rigetti; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">identify, evaluate and recommend and communicate with candidates qualified to become Board members or nominees for directors of the Board consistent with criteria approved by the Board; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">make other recommendations to the Board relating to the directors of Rigetti. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation Committee Interlocks and Insider Participation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the members of our compensation committee has ever been an executive officer or employee of Rigetti. None of our executive officers currently serve, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more executive officers that serve as a member of the Board or compensation committee. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Code of Business Conduct and Ethics </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board adopted a Code of Business Conduct and Ethics (the &#8220;Code of Conduct&#8221;) applicable to all of our employees, executive officers and directors. The Code of Conduct is available at the investors section of our website at https://www.rigetti.com/investor-information. Information contained on or accessible through the website is not a part of this prospectus, and the inclusion of the website address in this prospectus is an inactive textual reference only. Any amendments to the Code of Conduct, or any waivers of its requirements, are expected to be disclosed on our website at the above location to the extent required by applicable rules and exchange requirements, including in order to satisfy Item 5.05 of Form 8-K. The reference to our website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this prospectus. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">114 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Corporate Governance Guidelines </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board has adopted the Rigetti Computing, Inc. Corporate Governance Guidelines for the conduct and operation of the Board in order to give directors a flexible framework for effectively pursuing our objectives for the benefit of our stockholders. The Corporate Governance Guidelines set forth the practices the Board intends to follow with respect to board composition and selection, board meetings and involvement of senior management, Chief Executive Officer performance evaluation and management succession planning and board committees and compensation. The Corporate Governance Guidelines are available in the investors section of our website at https://www.rigetti.com/investor-information. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Limitation on Liability and Indemnification of Directors and Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation limits a directors&#8217; liability to the fullest extent permitted under the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for any transaction from which the director derives an improper personal benefit; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for any unlawful payment of dividends or redemption of shares; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for any breach of a director&#8217;s duty of loyalty to the corporation or our stockholders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of the directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delaware law and the Bylaws provide that the Company will, in certain situations, indemnify our directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment, or reimbursement of reasonable expenses (including attorneys&#8217; fees and disbursements) in advance of the final disposition of the proceeding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Company entered into separate indemnification agreements with our directors and officers. These agreements, among other things, require the Company to indemnify our directors and officers for certain expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as one of our directors or officers or any other company or enterprise to which the person provides services at our request. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors and officers. We believe these provisions in the Charter and Bylaws and these indemnification agreements are necessary to attract and retain qualified persons as directors and officers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, or control persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">115 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_13">EXECUTIVE COMPENSATION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Unless the context otherwise requires, any reference in this section of this prospectus to &#8220;Rigetti,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or &#8220;the Company&#8221; refers to Legacy Rigetti and its consolidated subsidiaries prior to the consummation of the Business Combination and to Rigetti and its consolidated subsidiaries following the Business Combination. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the fiscal year ended December&#160;31, 2022 (&#8220;fiscal year 2022&#8221;), our named executive officers were: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Subodh Kulkarni, Current President and Chief Executive Officer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Rick Danis, Rigetti&#8217;s Former Interim President and Chief Executive Officer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Chad Rigetti, Former President and Chief Executive Officer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Brian Sereda, Former Chief Financial Officer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Michael Harburn, Former Chief Technology Officer; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Taryn Naidu, Former Chief Operating Officer </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Kulkarni joined Rigetti as President and Chief Executive Officer in December 2022 and was not a named executive officer for fiscal year 2021. On November&#160;12, 2022, the board accepted the resignation of Dr.&#160;Rigetti as the Company&#8217;s President and Chief Executive Officer and appointed Rick Danis as the Interim President and Chief Executive Officer. Dr. Rigetti continued as a director and non-executive employee of Rigetti until December 15, 2022. On February&#160;9, 2023, Mr.&#160;Harburn&#8217;s employment with Rigetti ended and Mr.&#160;Sereda ceased serving as Chief Financial Officer of Rigetti. On April&#160;18, 2022, Mr.&#160;Naidu&#8217;s employment with Rigetti terminated. Dr.&#160;Rigetti, Mr.&#160;Sereda and Mr.&#160;Naidu were also named executive officers for the <span style="white-space:nowrap">11-months</span> ended December&#160;31, 2021 (&#8220;fiscal year 2021&#8221;). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation of our named executive officers for the fiscal years ended December&#160;31, 2021 and December&#160;31, 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:39%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name, Principal Position</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Fiscal<br />Year</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Salary(1)<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Bonus(2)<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Stock<br />Awards(3)<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option<br />Awards(4)<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold"><span style="white-space:nowrap">Non-Equity</span><br />Incentive Plan<br />Compensation(5)<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">All Other<br />Compensation(6)<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total<br />($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman;font-weight:bold">Subodh Kulkarni(7)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-size:9pt">2022</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-size:9pt">16,619</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-size:9pt">&#8212;&#160;&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-size:9pt">&#8212;&#160;&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-size:9pt">1,527,975</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-size:9pt">&#8212;&#160;&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-size:9pt">&#8212;&#160;&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-size:9pt">1,544,594</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-size:9pt">&#160;</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><span style="font-style:italic">President and CEO</span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman;font-weight:bold">Rick Danis(8)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">393,962</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">460,309</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,220,086</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,076,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><span style="font-style:italic">Former Interim President and CEO, General Counsel and Secretary</span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman;font-weight:bold">Chad Rigetti(9)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">411,053</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">402,350</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">36,454,550</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">168,957</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,436,910</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><span style="font-style:italic">Former President and CEO</span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">320,833</td>
<td style="white-space:nowrap;vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,300</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,998,877</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">584</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,377,594</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman;font-weight:bold">Brian Sereda(10)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">344,080</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">768,694</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">384</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,138,158</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><span style="font-style:italic">Former Chief Financial Officer</span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">121,875</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">75,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,010,271</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,226,806</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman;font-weight:bold">Michael Harburn(11)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">329,659</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,335,189</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">384</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,665,232</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><span style="font-style:italic">Former Chief Technology Officer</span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman;font-weight:bold">Taryn Naidu(12)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">329,659</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,335,189</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">384</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,065,232</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><span style="font-style:italic">Former Chief Operating Officer</span></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">258,098</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,378,794</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">45,540</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,343</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,686,775</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Salary amounts represent actual amounts earned during fiscal year 2022. See &#8220;<span style="font-style:italic">Narrative Disclosure to Summary Compensation Table&#8212;Base Salaries</span>&#8221; below. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">116 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This column reflects amounts awarded as discretionary bonuses in 2022. See &#8220;<span style="font-style:italic">Narrative Disclosure to Summary Compensation Table&#8212;Bonuses</span>&#8221; below. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This column reflects the aggregate grant date fair value of the transaction stock awards and restricted stock units granted to the named executive officer during fiscal year 2022 and fiscal year 2021 under the 2013 Plan and 2022 Plan. The aggregate grant date fair value is computed in accordance with ASC Topic 718 for stock-based compensation transactions. Assumptions used in the calculation of these amounts are included in the notes to our financial statements included elsewhere in this prospectus. This amount does not reflect the actual economic value that may be realized by the named executive officer. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This column reflects the aggregate grant date fair value of the option awards granted during fiscal year 2022 computed in accordance with ASC Topic 718 for stock-based compensation transactions. Assumptions used in the calculation of these amounts are included in the notes to our audited financial statements included elsewhere in this prospectus. These amounts do not reflect the actual economic value that will be realized by the named executive officer upon the vesting of the stock options, the exercise of the stock options, or the sale of the common stock underlying such stock options. The amounts reported for 2022 for Mr. Kulkarni include the aggregate grant-date fair value of a time-vesting option awarded to the Mr. Kulkani in December 2022, calculated in accordance with Topic 718. Mr. Kulkani was also granted a performance-vesting option in December 2022 that is subject to time-based vesting and performance conditions as defined under applicable accounting standards. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">See &#8220;&#8212;Narrative to Summary Compensation <span style="white-space:nowrap">Table&#8212;Non-Equity</span> Incentive Plan Compensation&#8221; below for a description of the material terms of the program for fiscal year 2021 pursuant to which this compensation was awarded. The amounts shown for <span style="white-space:nowrap">non-equity</span> incentive plan compensation represent amounts earned for the fiscal years presented, whether or not actually paid during such year.<sup style="font-size:75%; vertical-align:top"> </sup> </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This column reflects the aggregate value of other categories of payment, consisting of (i)&#160;for Mr.&#160;Danis, $384 for life insurance premiums for fiscal year 2022, and $1,968 for professional membership fees for fiscal year 2022; (ii) Dr.&#160;Rigetti, $584 for life insurance premiums for each of fiscal year 2022 and fiscal year 2021, respectively, and $168,957 for reimbursement for legal fees paid in connection with negotiation of separation from the Company in fiscal year 2022; (iii) for Mr.&#160;Sereda, $384 and $160 for life insurance premiums for fiscal year 2022 and fiscal year 2021, respectively; (iv)&#160;for Mr.&#160;Harburn, $384 for life insurance premiums for fiscal year 2022; and (v)&#160;for Mr.&#160;Naidu, $384 and $552 for life insurance premiums for fiscal year 2022 and fiscal year 2021, respectively, and $3,791 for professional membership fees for fiscal year 2021. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Dr.&#160;Kulkarni joined Rigetti as Chief Financial Officer in December 2022. Dr.&#160;Kulkarni was not a named executive officer for fiscal year 2021. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">On November&#160;12, 2022, Mr.&#160;Danis was appointed Interim President and Chief Executive Officer. On December&#160;12, 2022, Mr.&#160;Danis stepped down from such position and continued with the Company in his role as the Company&#8217;s General Counsel and Corporate Secretary. Mr. Danis was not a named executive officer in 2021. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">On November&#160;12, 2022, the board accepted the resignation of Dr.&#160;Rigetti as the Company&#8217;s President and Chief Executive Officer. Dr.&#160;Rigetti continued as a director and <span style="white-space:nowrap">non-executive</span> employee of Rigetti until December&#160;15, 2022. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(10)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Sereda ceased serving as Chief Financial Officer of Rigetti on February&#160;9, 2023 and his employment ended with Rigetti on March&#160;27, 2023. Mr.&#160;Sereda joined Rigetti as Chief Financial Officer in August 2021. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(11)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Harburn&#8217;s employment with Rigetti ended on February&#160;9, 2023. Mr.&#160;Harburn was not a named executive officer in 2021. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(12)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">On April&#160;18, 2022, Mr.&#160;Naidu&#8217;s employment with Rigetti terminated. Mr.&#160;Naidu is included as a named executive officer for 2022 because he would have been required to be included but for the fact that he was not serving as an executive officer at the end of the 2022. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">117 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Narrative Disclosure to Summary Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Base Salaries </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our named executive officers receive a base salary to compensate them for the services they provide to our company. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role and responsibilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&#160;Kulkarni had an annual base salary of $585,000 commencing on December&#160;7, 2022. Mr.&#160;Rigetti had an annual base salary of $446,000 in fiscal year 2022 and $350,000 for fiscal year 2021. Mr.&#160;Danis had an annual base salary of $309,000 for fiscal year 2022 which was increased to $392,333 from November 12, 2022 to December 12, 2022, which was the duration of his position as Interim President and Chief Executive Officer. Mr.&#160;Sereda has an annual base salary of $348,000 in fiscal year 2022 and $325,000 in fiscal year 2021. Mr.&#160;Harburn had an annual base salary of $345,000 for fiscal year 2022. Mr. Naidu had an annual base salary of $379,000 for fiscal year 2022. Mr. Naidu had a base salary of $275,000 from February 1, 2021 to July 14, 2021 and a base salary of $284,625 commencing on July 15, 2021 for fiscal year 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The actual salaries earned by each named executive officer for fiscal year 2022 and fiscal year 2021 (the <span style="white-space:nowrap">11-month</span> period from February&#160;1, 2021 to December&#160;31, 2021) are set forth in the &#8220;<span style="font-style:italic">Summary Compensation Table</span>&#8221; above in the column titled &#8220;<span style="font-style:italic">Salary</span>.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Bonuses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Transaction Cash Bonuses. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In recognition of contributions in connection with the Business Combination, the Legacy Rigetti Board approved cash bonuses that were paid to Dr. Rigetti, Mr. Naidu, Mr. Danis and Mr. Sereda in the amount of $400,000, $400,000, $350,000 and $25,000, respectively, in connection with the closing of the Business Combination in fiscal year 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Discretionary Bonuses. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In fiscal year 2022, Dr.&#160;Rigetti received a discretionary bonus of $2,350. In fiscal year 2021, Dr.&#160;Rigetti received a discretionary bonus of $700 in March 2021 and $600 in May 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Mr.&#160;Sereda Signing Bonus. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2021, Mr.&#160;Sereda received a <span style="white-space:nowrap">sign-on</span> bonus in an aggregate amount of $75,000 as an incentive for him to join the Company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap">Non-Equity</span> Incentive Plan Compensation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For fiscal year 2022, we did not have an annual performance-based cash bonus program. In 2021, the Legacy Rigetti Board implemented an annual performance-based cash bonus program in which each of the named executive officers participate. Mr. Sereda was eligible for a performance-based cash bonus under the Company&#8217;s 2021 performance bonus program pursuant to his offer letter, which is described in &#8220;Employment Arrangements with Executive Officers&#8212;Brian Sereda.&#8221; Under the performance bonus program for fiscal year 2021, each named executive officer was eligible to be considered for a cash performance bonus based on (1) a target bonus, as a percentage of base salary, and (2) the achievement of 2021 corporate goals established by the Legacy Rigetti Board in its sole discretion. Each named executive officer for fiscal year 2021 was assigned a maximum target performance bonus of 16% of current base salary with respect to Dr. Rigetti and Mr. Naidu ($350,000 and $284,625 for Dr. Rigetti and Mr. Naidu, respectively) and base salary actually received in fiscal year 2021 with respect to Mr. Sereda. The payout amounts under the 2021 performance bonus program were $56,000 for Dr.&#160;Rigetti, $45,540 for Mr. Naidu and $19,500 for Mr. Sereda. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">118 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Equity-Based Incentive Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our equity award program is the primary vehicle for offering long-term incentives to our executives. We believe that equity awards provide our executive officers with a strong link to long-term performance, create an ownership culture and help to align the interests of Rigetti&#8217;s executive officers and stockholders. To date, we have historically granted stock options, both incentive stock options and nonstatutory stock options, restricted stock units (&#8220;RSUs&#8221;) and stock awards to our executive officers. We believe that our equity awards are an important retention tool for our executive officers, as well as for our other employees. We grant equity awards broadly to our employees, including to our <span style="white-space:nowrap">non-executive</span> employees. The Board is responsible for approving equity grants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the closing of the Business Combination on March 2, 2022, all of the equity incentive awards that we have granted to executive officers were made pursuant to the 2013 Plan. Following the closing of the Business Combination, all of the equity incentive awards have been and will continue to be granted under the terms of the 2022 Plan. The material terms of the equity awards granted to our named executive officers prior to December 31, 2022 are set forth in the section titled &#8220;Outstanding Equity Awards as of December 31, 2022.&#8221; All options are granted with an exercise price per share that is no less than the fair market value of our common stock on the date of grant of such award. Stock option awards and RSU awards generally vest over a four year period with a <span style="white-space:nowrap">one-year</span> cliff and may be subject to acceleration of vesting and exercisability under certain termination and change in control events. See &#8220;&#8212;<span style="font-style:italic">Outstanding Equity Awards as of December</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;31, 2022</span>.&#8221; Upon the closing of the Business Combination, outstanding Legacy Rigetti options and Legacy Rigetti restricted stock unit awards under the 2013 Plan were assumed by us and converted into options to purchase common stock and RSUs for common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">CEO Award </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 12, 2022, Mr. Kulkarni was granted an option to purchase up to 1,250,000 shares of common stock, at an exercise price of $0.9638 per share, and an option to purchase up to 500,000 shares of common stock, at an exercise price of $0.9638 per share. Mr. Kulkarni&#8217;s grant included his initial grant provided upon his commencement of employment. See &#8220;&#8212;Employment Arrangements&#8212;Dr. Subodh Kulkarni&#8221; for additional information on the vesting conditions for Mr. Kulkarni&#8217;s grants. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Interim CEO Award </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 9, 2022, Mr. Danis was awarded 147,058 RSUs in connection with his service as Interim CEO. The RSUs vest one-third on each of December 31, 2022, January 31, 2023 and February 28, 2023, subject to Mr.&#160;Danis&#8217;s continuous service as of the applicable vesting date. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Rigetti 2022 Alignment RSU Awards and Annual RSU Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;10, 2022, 5,132,962 RSUs in the aggregate were granted to employees of Rigetti as alignment awards for the purpose of better aligning executive and employee equity ownership in the company with similarly situated companies (collectively the &#8220;Alignment RSUs&#8221;), of 2,857,444, 164,685, 8,791 and 207,178 Alignment RSUs were granted to Dr. Rigetti, Mr. Danis, Mr. Sereda and Mr. Harburn, respectively. The Alignment RSUs vest (i) 50% in 12 equal monthly installments on the last day of each month commencing March 31, 2022 and (ii)&#160;50% vested or shall vest in 48 equal monthly installments on the last day of each month commencing March&#160;31, 2022, subject to continuous service of the named executive officer on each such date. Dr. Rigetti was employed by the Company until December 15, 2022 and as of this date, 1,339,426 of his Alignment RSUs had vested. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, on June&#160;10, 2022, 1,232,300 RSUs in the aggregate were granted to employees of Rigetti as 2022 annual equity awards (the &#8220;Rigetti 2022 Annual RSUs&#8221;), of which 334,700, 102,800, 128,600 and 107,900 Rigetti 2022 Annual RSUs were granted to Dr. Rigetti, Mr. Danis, Mr. Sereda and Mr. Harburn, respectively. The Rigetti 2022 Annual RSUs vest in 48 equal installments commencing on March 31, 2022, subject to continuous service of the named executive officer on each such date. Dr. Rigetti was employed by the Company until December 15, 2022 and as of this date, 62,756 of his Rigetti 2022 Annual RSUs had vested. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">119 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-style:italic">Transaction </span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-style:italic">Bonus </span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-style:italic">Stock Awards</span><span style="font-weight:bold"><span style="font-style:italic"> </span></span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;10, 2022, 120,000 shares of common stock in the aggregate were granted to employees as transaction bonus stock awards, of which 45,000, 25,000 and 5,000 individual stock awards were granted to Dr. Rigetti, Mr.&#160;Danis and Mr. Sereda, respectively. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-style:italic">2022</span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-style:italic"> Legacy Rigetti RSUs</span><span style="font-weight:bold"><span style="font-style:italic"> </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January 25, 2022, the Legacy Rigetti awarded 4,963,063 RSUs in the aggregate to employees of Legacy Rigetti, of which 2,174,346, 125,315, 6,689, 157,650 and 338,199 were granted to Dr. Rigetti, Mr. Danis, Mr.&#160;Sereda, Mr. Harburn and Mr. Naidu, respectively. These RSUs were granted pursuant to the terms of the 2013 Plan and for the purpose of better aligning executive and employee equity ownership in the company with similarly situated companies. The RSUs vest in 48 equal monthly installments commencing February 25, 2022, subject to continuous service of the named executive officer on each such date. Upon the closing of the Business Combination, these RSUs were assumed and converted into RSUs to acquire common stock. Dr. Rigetti was employed by the Company until December 15, 2022 and as of this date, 1,132,469 of his RSUs had vested. Mr.&#160;Naidu was employed by the Company until April 18, 2022 and as of this date, 35,228 of his RSUs had vested. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 21, 2021, Legacy Rigetti awarded RSUs to each of Dr. Rigetti and Mr. Naidu in the amounts of 1,044,905, and 378,082, respectively. On August 18, 2021, Rigetti awarded RSUs to Mr. Sereda in the amount of 1,048,875. The RSUs are subject to time-based vesting requirements and liquidity-event vesting requirements. The RSU awards to Dr. Rigetti and Mr. Naidu vest in 48 equal installments commencing on May 21, 2021, subject to continuous service of the named executive officer on each such date. Dr. Rigetti was employed by the Company until December 15, 2022 and as of this date, 413,608 of his RSUs had vested. Mr. Naidu was employed by the Company until April 18, 2022 and as of this date, 86,643 of his RSUs had vested. 25% of the RSU award to Mr. Sereda vested on August 12, 2022, and the remainder vests in 36 equal monthly installments, subject to continuous service of Mr. Sereda on each such date. The liquidity-event vesting requirement was satisfied upon the consummation of the Business Combination. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Reimbursement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rigetti reimbursed Dr.&#160;Rigetti for legal fees paid in the amount of $168,957 in connection with internal matters and the negotiation of his separation from the Company in fiscal 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">120 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Outstanding Equity Awards as of December&#160;31, 2022 </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information regarding outstanding equity awards held by our named executive officers as of December&#160;31, 2022. All awards were granted pursuant to the 2013 Plan and 2022 Plan. See the section titled <span style="font-style:italic">&#8220;&#8212;Equity Incentive Plans-2013 Plan</span>&#8221; and &#8220;<span style="font-style:italic">&#8212;Equity Incentive Plans-</span> <span style="font-style:italic">Rigetti Computing, Inc. 2022 Equity Incentive Plan</span>&#8221; below for additional information. Mr. Naidu&#8217;s employment with the Company ended on April 18, 2022 and his post-termination exercise period expired on July 18, 2022. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:30%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="18" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option Awards</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="10" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Stock Awards</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Grant Date</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number of<br />Securities<br />Underlying<br />Unexercised<br />Options (#)<br />Exercisable</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number of<br />Securities<br />Underlying<br />Unexercised<br />Options (#)<br />Unexercisable</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Equity</span><br /><span style="font-weight:bold">incentive<br />plan&#160;awards:<br />number of<br />securities<br />underlying<br />unexercised<br />unearned<br />options&#160;(#)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option<br />Exercise<br />Price</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Option<br />Expiration<br />Date</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of<br />shares&#160;or&#160;units<br />that have</span><br /><span style="font-weight:bold">not</span><br /><span style="font-weight:bold">vested(#)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Market<br />value of<br />shares of<br />units of<br />stock that<br />have not<br />vested&#160;($)(1)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Subodh Kulkarni</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12/12/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,250,000&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(2)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.9640</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12/12/2032</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12/12/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">500,000&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(3)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.9640</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12/12/2032</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Rick Danis</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5/22/2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">162,573</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">83,245&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(4)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5/21/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9/20/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,430&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(5)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9/19/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7/15/2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">42,792</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,037&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(6)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7/14/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4/21/2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">79,110&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(8)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57,687</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/25/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">53,524&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(9)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">39,030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6/10/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">78,912&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(10)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57,543</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6/10/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">81,384&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(11)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,345</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12/09/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">49,019&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(7)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">98,039</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Chad Rigetti(22)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5/22/2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,657,887&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(12)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5/21/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7/13/2016</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,360</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7/13/2026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5/16/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,416</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5/16/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12/14/2017</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">944</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12/14/2027</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4/04/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,023</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4/4/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7/11/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">786</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7/11/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9/26/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,495</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9/26/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/29/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">629</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/29/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/29/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">708</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/29/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10/30/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">393</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10/30/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10/30/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">865</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10/30/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10/30/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">472</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10/30/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/20/2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">393</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/19/2031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Brian Sereda</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8/18/2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">699,250&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(13)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">509,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/25/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,157&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(14)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,760</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6/10/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,960&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(11)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,075</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6/10/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">101,809&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(11)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">74,239</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Michael Harburn</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5/22/2020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">204,678</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">71,215&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(15)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5/21/2030</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7/11/2018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,592</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,148&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(16)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7/11/2028</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4/4/2019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,888</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,805&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(17)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.2720</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4/3/2029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4/21/2021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">188,230&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(8)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">137,257</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1/25/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">121,522&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(14)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">88,614</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6/10/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">164,016&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(11)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">119,600</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6/10/2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">85,421&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(11)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">62,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The market value of unvested shares is calculated by multiplying the number of unvested shares by the closing market price of our common stock on Nasdaq on December&#160;30, 2022, the last trading day of fiscal year 2022, which was $0.7292 per share. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">One-third</span> (1/3rd) of the shares subject to the option vest on December&#160;12, 2023, and the remaining shares subject to the option shall vest in twenty-four (24)&#160;equal monthly installments thereafter, subject to Dr.&#160;Kulkarni&#8217;s continuous service through each such vesting date (the &#8220;time-based vesting requirement&#8221;). </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">121 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This option is subject to the aforementioned time-based vesting requirement and a performance-based vesting requirement. The performance-based vesting requirement uses the Company&#8217;s stock price as vesting hurdles over a five-year period. There are two vesting hurdles at $5 and $10 per share, with each hurdle price applying to 50% of the shares underlying the option granted. A hurdle is met when the Company&#8217;s closing trading stock price equals or exceeds the hurdle amount for any twenty (20)&#160;trading days during any consecutive thirty (30)&#160;trading day period. To the extent that the performance-based vesting requirement is satisfied prior to the termination of Dr.&#160;Kulkarni&#8217;s continuous service, the option will vest and become exercisable without regard to the time-based vesting requirement. The option will not vest and become exercisable unless and until the performance-based vesting requirement has been satisfied, even if the <span style="white-space:nowrap">time-based</span> vesting requirement has been satisfied. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">14.44808% of this option vested and became exercisable on July&#160;23, 2020, with the remainder vesting in 48&#160;equal monthly installments thereafter, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">20% of this option vested and became exercisable on July&#160;23, 2020, with the remainder vesting in 48 equal monthly installments thereafter, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This option vests and becomes exercisable in equal monthly installments over a period of four years commencing August&#160;15, 2020, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The RSU vests in three equal monthly installments commencing on December&#160;31, 2022, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The RSU vests in 48 equal installments commencing on May&#160;21, 2021, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The RSU vests (i)&#160;50% in 12 equal monthly installments on the last day of each month commencing February&#160;28, 2022 and (ii)&#160;50% vested or shall vest in 48 equal monthly installments on the last day of each month commencing February&#160;28, 2022, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(10)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The RSU vests (i)&#160;50% in 12 equal monthly installments on the last day of each month commencing March&#160;31, 2022 and (ii)&#160;50% vested or shall vest in 48 equal monthly installments on the last day of each month commencing March&#160;31, 2022, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(11)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The RSU vests in 48 equal installments commencing on March&#160;31, 2022, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(12)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">25% of this option vested and became exercisable on February&#160;18, 2021, with the remainder vesting in 48&#160;equal monthly installments thereafter, subject to continuous service on each such date, until Dr.&#160;Rigetti&#8217;s departure on December&#160;15, 2022. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(13)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">25% of the RSU vested on August&#160;12, 2022, and the remainder shall vest in 36 equal monthly installments, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(14)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The RSU shall vest in 48 equal monthly installments commencing February&#160;25, 2022, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(15)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">11.49988% of this option vested and became exercisable on February&#160;18, 2020, with the remainder vesting in 48 equal monthly installments thereafter, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(16)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">20% of this option vested and became exercisable on July&#160;18, 2019, with the remainder vesting in 48 equal monthly installments thereafter, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(17)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This option vests and became exercisable in equal monthly installments over a period of five years commencing April&#160;1, 2019, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(18)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">6.99996% of this option vested and became exercisable on February&#160;18, 2020, with the remainder vesting in 48 equal monthly installments thereafter, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(19)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">20% of this option vested and became exercisable on March&#160;18, 2020, with the remainder vesting in 48&#160;equal monthly installments thereafter, subject to continuous service on each such date. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(20)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Dr.&#160;Kulkarni was appointed the Company&#8217;s President and Chief Executive Officer on December&#160;12, 2022. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(21)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mr.&#160;Danis served as the Company&#8217;s Interim President and Chief Executive Officer from November&#160;12, 2022 to December&#160;12, 2022. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(22)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Dr. Rigetti resigned as the Company&#8217;s President and Chief Executive Officer on November&#160;12, 2022 and served as a director and non-executive employee of the Company until December&#160;15, 2022. The shares included in this table represent the shares vested with respect to option awards held by Dr.&#160;Rigetti as of the last date of his employment with the Company on December&#160;15, 2022. Dr.&#160;Rigetti&#8217;s post-termination exercise period for option awards expired on March&#160;15, 2023. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">122 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Health and Welfare and Retirement Benefits; Perquisites </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of Rigetti&#8217;s named executive officers are eligible to participate in Rigetti&#8217;s employee benefit plans, including medical, dental, vision, disability and life insurance plans, in each case on the same basis as all of Rigetti&#8217;s other full-time employees. We pay the premiums for medical, dental, vision, group term life, disability and accidental death and dismemberment insurance for all of our employees, including our named executive officers. We generally do not provide perquisites or personal benefits to our named executive officers, except in limited circumstances. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">401(k) Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our named executive officers are eligible to participate in a defined contribution retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees may defer eligible compensation on a <span style="white-space:nowrap">pre-tax</span> or <span style="white-space:nowrap">after-tax</span> (Roth) basis, up to the statutorily prescribed annual limits on contributions under the Code. Contributions are allocated to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217; directions. The 401(k) plan is intended to be qualified under Section&#160;401(a) of the Code with the 401(k) plan&#8217;s related trust intended to be tax exempt under Section&#160;501(a) of the Code. As a <span style="white-space:nowrap">tax-qualified</span> retirement plan, contributions to the 401(k) plan (except for Roth contributions) and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Employment Arrangements with Executive Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of Dr.&#160;Kulkarni, Mr.&#160;Danis and Mr.&#160;Harburn are, and each of Dr.&#160;Rigetti, Mr.&#160;Sereda and Mr.&#160;Naidu was, an <span style="white-space:nowrap">at-will</span> employee. Except as set forth below, as of the date of this prospectus, we have not entered into any employment agreements or offer letters with our named executive officers. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Dr.&#160;Subodh Kulkarni </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2022, we entered into an executive employment agreement with Dr.&#160;Kulkarni. Pursuant to the executive employment agreement, Dr.&#160;Kulkarni will perform the Chief Executive Officer&#8217;s duties; provided that, for the initial period beginning on the December&#160;12, 2022 and continuing through January&#160;8, 2023, Dr.&#160;Kulkarni will perform the Chief Executive Officer&#8217;s duties within a time commitment averaging approximately fifty percent (50%) of that of a full-time professional while Dr.&#160;Kulkarni provides transition consulting services to CyberOptics. Pursuant to the executive employment agreement, Dr.&#160;Kulkarni will receive an annual base salary of $585,000 (prorated for the period described in the foregoing sentence) and will be eligible: (i)&#160;to participate in the Company&#8217;s benefit plans; (ii)&#160;to receive awards of stock options, restricted stock, restricted stock units or other equity awards pursuant to any plans or arrangements which the Company may have in effect from time to time; (iv)&#160;to receive <span style="white-space:nowrap">a&#160;one-time&#160;relocation</span> benefit in the gross amount of $130,000 if Dr.&#160;Kulkarni relocates to the Bay Area, California by no later than 120 days following December&#160;12, 2022, which will be paid in lump sum within thirty (30)&#160;days after completion of the relocation; and (iii)&#160;starting with calendar year 2023, a discretionary annual cash bonus of a target amount equal to $290,000, subject to review and adjustment by the Company and dependent on his continuous performance of services to the Company through the last date of the applicable performance period and the actual achievement by him and the Company of applicable performance targets and goals set by the Board or the Compensation Committee of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreement also provides for the grant of an option to purchase up to 1,250,000 shares of common stock (the &#8220;Dr.&#160;Kulkarni Initial Option&#8221;), which award was granted on December&#160;12, 2022 pursuant to the form of option award agreement previously adopted and disclosed by the Company.&#160;The Dr.&#160;Kulkarni Initial Option will have an exercise price equal to the closing price per share of the Company&#8217;s common stock on the grant date, and will vest in accordance with the following schedule: 12/36ths of the total shares subject to the Dr.&#160;Kulkarni Initial Option will vest on the one year anniversary of the vesting commencement date, and 1/36th of the total shares subject to the Dr.&#160;Kulkarni Initial Option will vest each month </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">123 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereafter on the same day of the month as the vesting commencement date (or if there is no corresponding day, on the last day of the month), in each case, subject to Dr.&#160;Kulkarni&#8217;s continuous service through each such date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the executive employment agreement provides for the grant of an option to purchase up to 500,000 shares of common stock (the &#8220;Dr.&#160;Kulkarni Performance Options&#8221;), which award was granted on December&#160;12, 2022 pursuant to the form of option award agreement previously adopted and disclosed by the Company. The Dr.&#160;Kulkarni Performance Option will have an exercise price equal to the closing price per share of the Company&#8217;s common stock on the grant date, and will be subject to a time-based vesting requirement (the &#8220;Dr.&#160;Kulkarni Time-Based Vesting Requirement&#8221;) and a performance-based vesting requirement (the &#8220;Dr.&#160;Kulkarni Performance-Based Vesting Requirement&#8221;). To the extent that the Dr.&#160;Kulkarni Performance-Based Vesting Requirement is satisfied prior to the termination of Dr.&#160;Kulkarni&#8217;s continuous service, the Dr.&#160;Kulkarni Performance Option will vest and become exercisable without regard to the Time-Based Vesting Requirement. However, the Dr.&#160;Kulkarni Performance Option will not vest and become exercisable unless and until the Dr.&#160;Kulkarni Performance-Based Vesting Requirement has been satisfied, even if the T Dr.&#160;Kulkarni <span style="white-space:nowrap">ime-Based</span> Vesting Requirement has been satisfied. The Dr.&#160;Kulkarni Time-Based Vesting Requirement will be satisfied as follows: 12/36ths of the total shares subject to the Performance Option will satisfy the Dr.&#160;Kulkarni Time-Based Vesting Requirement on the one year anniversary of the vesting commencement date, and 1/36th of the total shares subject to the Dr.&#160;Kulkarni Performance Option will satisfy the Dr.&#160;Kulkarni Time-Based Vesting Requirement each month thereafter on the same day of the month as the vesting commencement date (or if there is no corresponding day, on the last day of the month), in each case, subject to Mr.&#160;Kulkarni&#8217;s continuous service through each such date. The Dr.&#160;Kulkarni Performance-Based Vesting Requirement will be satisfied with respect to 250,000 shares to the extent that the closing price per share of the Company&#8217;s common stock is $5.00 or higher and, with respect to the other 250,000 shares, the closing price per share of the Company&#8217;s common stock is $10.00 or higher, for any twenty trading days during any consecutive thirty trading day period during the five-year period beginning on the December&#160;12, 2022 and ending on the fifth anniversary thereof. Any portion of the Dr.&#160;Kulkarni Performance Option that has not satisfied the Dr.&#160;Kulkarni Performance-Based Vesting Requirement on or prior to the fifth anniversary of the December&#160;12, 2022 will be forfeited. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Rick Danis </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Executive Employment Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2022, we entered into an executive employment agreement with Mr.&#160;Danis, which was amended and restated on February&#160;2, 2022 and became effective upon and concurrent with the Closing of the Business Combination. Pursuant to the executive employment agreement, Mr.&#160;Danis receives an annual base salary of $309,000 and is eligible: (i)&#160;to participate in Rigetti&#8217;s benefit plans; (ii)&#160;subject to the approval of the Board, to receive restricted stock units to acquire shares of common stock (the &#8220;PSU Awards&#8221;), if certain performance-based milestones established by Rigetti are satisfied in the future and provided that Mr.&#160;Danis remains continuously employed by Rigetti through the date that the Board or the Compensation Committee grants such PSU Awards (subject to continued employment for a three-year period); (iii) to receive awards of stock options, restricted stock, restricted stock units or other equity awards pursuant to any plans or arrangements which Rigetti may have in effect from time to time; and (iv)&#160;a discretionary annual cash bonus of a target amount equal to 25% of the base salary, subject to review and adjustment by the Board. Mr.&#160;Danis is entitled to certain severance benefits as described below in &#8220;&#8212;Potential Payments Upon Termination or Change in Control.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreement also provided for the grant of an initial restricted stock unit award to purchase 164,685 (the &#8220;Mr.&#160;Danis Initial RSU Award&#8221;) shares of common stock, which was approved by the Board, contingent upon and subject to the filing and effectiveness of a registration statement on Form <span style="white-space:nowrap">S-8</span> (the &#8220;Form <span style="white-space:nowrap">S-8&#8221;)</span> with respect to the 2022 Plan, following the Closing and which will be granted upon the effectiveness of the Form <span style="white-space:nowrap">S-8.</span> </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">124 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This award vests in accordance with the following schedule: (i) 50% of the total number of Mr.&#160;Danis Initial RSU Awards will vest in substantially equal installments (rounded down, except for the final scheduled vesting installment) at the end of each month following the vesting commencement date over a period of 12 months and (ii)&#160;the remaining 50% of the total number of Mr.&#160;Danis Initial RSU Awards will vest in in substantially equal installments (rounded down, except for the final scheduled vesting installment) at the end of each month following the vesting commencement date over a period of four years, with prongs (i)&#160;and (ii) occurring concurrently, such that, at the end of the <span style="white-space:nowrap">12-month</span> period immediately following the vesting commencement date, 62.5% of the total number of Initial RSU Awards will have vested (subject to the Executive&#8217;s Continuous Service (as defined in the 2022 Plan) on such vesting date). The executive employment agreement also provided that, contingent upon the occurrence of the Closing and Mr.&#160;Danis&#8217; continued employment with Rigetti through such date, Mr.&#160;Danis shall receive a cash bonus between $50,000 and $500,000, determined by the Board based on the gross proceeds of the transactions contemplated by the Merger Agreement, in recognition of his contributions to Rigetti and 25,000 shares of common stock subject to the approval of the Board or the Compensation Committee of the Board and Mr.&#160;Danis&#8217; continued employment with Rigetti through such date. In addition, the executive employment agreement provides that Mr.&#160;Danis will receive Rigetti 2022 Annual RSUs (as defined below) to purchase 334,700 shares of common stock, which will vest monthly over four years, provided that Mr.&#160;Danis is continuously employed for such period, or vesting 100% upon a Change in Control (as defined in the 2022 Plan). The executive employment agreement further provides that Rigetti will reimburse Mr.&#160;Danis for reasonable business expenses in accordance with the company&#8217;s standard expense reimbursement policy, as the same may be modified from time to time. In addition, Mr.&#160;Danis is eligible to receive certain employee benefits, including medical, vision, dental, life insurance, and participation in a Section&#160;401(k) retirement plan (as described above). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Interim CEO Letter Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&#160;1, 2022, the Company entered into a letter agreement (the &#8220;Interim CEO Letter&#8221;) with Mr.&#160;Danis, governing the terms of his service as the Company&#8217;s Interim President and Chief Executive Officer from November&#160;12, 2022 to December&#160;12, 2022 (the &#8220;Interim CEO Period&#8221;). During the Interim CEO Period, Mr.&#160;Danis&#8217; base salary increased to $83,333 per month. Mr.&#160;Danis was also eligible to receive <span style="white-space:nowrap">a&#160;one-time&#160;bonus</span> in the amount of $67,109.47, provided that, all of the stock options held by Mr.&#160;Danis as of the date of the Interim CEO Letter were exercised prior to the three-month anniversary of the date of the Interim CEO Letter. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Interim CEO Letter, subject to the approval of the Board or an authorized committee thereof, Mr.&#160;Danis is eligible to receive the following restricted stock unit (&#8220;RSU&#8221;) awards: (i)&#160;a RSU award having a grant date fair value equal to $150,000 following the entry of the Interim CEO Letter (the &#8220;Initial RSU Award&#8221;); (ii) a RSU award having a grant date fair value equal to $250,000 following the end of the Interim CEO Period (the &#8220;End of Term RSU Award&#8221;); and (iii)&#160;a RSU award having a grant date fair value equal to $50,000 on each monthly anniversary of November&#160;12, 2022 starting with March&#160;12, 2023 (each, an &#8220;Additional RSU Award&#8221;). Each of such RSU awards will be governed by the Company&#8217;s 2022 Equity Incentive Plan and a RSU award agreement adopted thereunder. The Initial RSU Award of 147,058 RSUs was granted on December 9, 2022. Subject to Mr.&#160;Danis&#8217; continued service with the Company through each applicable vesting date, the Initial RSU Award vests in three equal monthly installments following the vesting commencement date; the End of Term RSU Award will vest in twelve equal monthly installments following the vesting commencement date; and each Additional RSU Award will fully vest at the end of the month following the applicable vesting commencement date. In the event of a change in control of the Company, the vesting of such RSU awards will be accelerated in full immediately prior to the consummation of such change in control, subject to Mr.&#160;Danis&#8217; continued service with the Company through such date. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">125 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Chad Rigetti </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Executive Employment Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2022, we entered into an executive employment agreement with Dr.&#160;Rigetti, which was amended and restated on February&#160;2, 2022 and became effective upon and concurrent with the Closing of the Business Combination. Dr.&#160;Rigetti resigned as the Company&#8217;s President and Chief Executive Officer on November&#160;12, 2022 and resigned from the Board on December&#160;15,&#160;2022. Pursuant to the executive employment agreement, Dr.&#160;Rigetti received an annual base salary of $446,000 and was eligible: (i)&#160;to participate in Rigetti&#8217;s benefit plans; (ii)&#160;subject to the approval of the Board, to receive PSU Awards, if certain performance-based milestones established by Rigetti are satisfied in the future and provided that Dr.&#160;Rigetti has remained continuously employed by Rigetti through the date that the Board or the Compensation Committee grants such PSU Awards (subject to continued employment for a three-year period); (iii) to receive awards of stock options, restricted stock, restricted stock units or other equity awards pursuant to any plans or arrangements which Rigetti may have in effect from time to time; and (iv)&#160;a discretionary annual cash bonus of a target amount equal to 25% of the base salary, subject to review and adjustment by the Board. Dr.&#160;Rigetti was entitled to certain severance benefits as described below in &#8220;&#8212;Potential Payments Upon Termination or Change in Control.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreement also provided for the grant of an initial restricted stock unit award to purchase 2,857,444 (the &#8220;Dr.&#160;Rigetti Initial RSU Award&#8221;) shares of common stock, which was approved by the Board, contingent upon and subject to the filing and effectiveness of the Form <span style="white-space:nowrap">S-8</span> with respect to the 2022 Plan, following the Closing and which will be granted upon the effectiveness of the Form <span style="white-space:nowrap">S-8.</span> Dr. Rigetti Initial RSU Award was granted on June 10, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This award vested in accordance with the following schedule: (i) 50% of the total number of Dr.&#160;Rigetti Initial RSU Awards will vest in substantially equal installments (rounded down, except for the final scheduled vesting installment) at the end of each month following the vesting commencement date over a period of 12&#160;months and (ii)&#160;the remaining 50% of the total number of Dr.&#160;Rigetti Initial RSU Awards will vest in in substantially equal installments (rounded down, except for the final scheduled vesting installment) at the end of each month following the vesting commencement date over a period of four years, with prongs (i)&#160;and (ii) occurring concurrently, such that, at the end of the <span style="white-space:nowrap">12-month</span> period immediately following the vesting commencement date, 62.5% of the total number of Initial RSU Awards will have vested (subject to the Executive&#8217;s Continuous Service (as defined in the 2022 Plan) on such vesting date). The executive employment agreement also provided that, contingent upon the occurrence of the Closing and Dr.&#160;Rigetti&#8217;s continued employment with Rigetti through such date, Dr.&#160;Rigetti would receive a cash bonus between $50,000 and $750,000, determined by the Board based on the gross proceeds of the transactions contemplated by the Merger Agreement, in recognition of his contributions to Rigetti and 45,000 shares of common stock subject to the approval of the Board or the Compensation Committee of the Board and Dr.&#160;Rigetti&#8217;s continued employment with Rigetti through such date. The transaction cash bonus and transaction bonus stock awards to Mr. Rigetti were granted in fiscal year 2022. In addition, the executive employment agreement provides that Dr.&#160;Rigetti would receive Rigetti 2022 Annual RSUs to purchase 334,700 shares of common stock, which vested monthly over four years, provided that Dr.&#160;Rigetti is continuously employed for such period, or vesting 100% upon a Change in Control (as defined in the 2022 Plan). The Rigetti 2022 Annual RSUs to Mr. Rigetti were granted on June 10, 2022. The executive employment agreement further provided that Rigetti would reimburse Dr.&#160;Rigetti for reasonable business expenses in accordance with the company&#8217;s standard expense reimbursement policy, as the same may be modified from time to time. In addition, Dr.&#160;Rigetti was eligible to receive certain employee benefits, including medical, vision, dental, life insurance, and participation in a Section&#160;401(k) retirement plan (as described above). On November 12, 2022, the board accepted the resignation of Dr. Rigetti as the Company&#8217;s President and Chief Executive Officer. Dr. Rigetti continued as a director and non-executive employee of Rigetti until December 15, 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">126 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Separation Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with Dr.&#160;Rigetti&#8217;s resignation as the Company&#8217;s President and Chief Executive Officer, we entered into a Separation Agreement with Dr.&#160;Rigetti on February&#160;14, 2023 (the &#8220;Separation Agreement&#8221;), under which Dr.&#160;Rigetti is entitled to: (i)&#160;cash severance of $446,000, which is an amount equal to 12 months of Dr.&#160;Rigetti&#8217;s base salary in effect as of the Separation Date, payable in installments commencing on the Company&#8217;s first regular payroll date that is at least sixty (60)&#160;days following the Separation Date (but no earlier than the effective date of the Separation Agreement), provided that on the first payment date, the Company will make a <span style="white-space:nowrap">catch-up</span> payment equal to the aggregate amount of cash severance payments that would have been paid to him through such date had the payments commenced on the first regularly scheduled payroll date following the Separation Date, and (ii)&#160;provided Dr.&#160;Rigetti timely elects continued coverage under COBRA, payment of COBRA premiums to continue health insurance coverage for him and his eligible dependents until the earliest of (a)&#160;twelve (12)&#160;months following the Separation Date, (b)&#160;the date when Dr.&#160;Rigetti becomes eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment, or (c)&#160;the date when Dr.&#160;Rigetti ceases to be eligible for COBRA continuation coverage for any reason, including plan termination, or a taxable payment in lieu of such payment if determined necessary by the Company to comply with law. The Separation Agreement additionally includes a customary general release of claims by Dr.&#160;Rigetti in favor of the Company and certain related parties. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Brian Sereda </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered into an offer letter agreement with Mr.&#160;Sereda as Chief Financial Officer on July&#160;1, 2021, pursuant to which Mr.&#160;Sereda is entitled to an annual base salary of $325,000. In addition, Mr.&#160;Sereda received a start bonus in the amount of $75,000 that is subject to repayment if Mr.&#160;Sereda&#8217;s employment with Rigetti is terminated for any reason prior to the <span style="white-space:nowrap">one-year</span> anniversary of his start date. Pursuant to the offer letter agreement, Mr.&#160;Sereda received 1,048,875 RSUs for shares of common stock. The offer letter agreement provides that Mr.&#160;Sereda is eligible to receive an annual performance-based cash bonus for each fiscal year under Rigetti&#8217;s performance-based bonus program with a target bonus opportunity of 16% of his base salary actually paid based on the achievement of performance criteria established by the Board, the compensation committee of the Board (or their designee) for fiscal year 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2022, we entered into an executive employment agreement with Mr.&#160;Sereda, which was amended and restated on February&#160;2, 2022 and became effective upon and concurrent with the Closing of the Business Combination and which replaced Mr.&#160;Sereda&#8217;s existing offer letter agreement. Pursuant to the executive employment agreement, Mr.&#160;Sereda will receive an annual base salary of $348,000 and will be eligible: (i)&#160;to participate in Rigetti&#8217;s benefit plans; (ii)&#160;subject to the approval of the Board, to receive PSU&#8217;s, if certain performance-based milestones established by Rigetti are satisfied in the future and provided that Mr.&#160;Sereda has remained continuously employed by Rigetti through the date that the Board or the Compensation Committee grants such PSU Awards (subject to continued employment for a three-year period); (iii) to receive awards of stock options, restricted stock, restricted stock units or other equity awards pursuant to any plans or arrangements which Rigetti may have in effect from time to time; and (iv)&#160;a discretionary annual cash bonus of a target amount equal to 25% of the base salary, subject to review and adjustment by the Board. Mr.&#160;Sereda is entitled to certain severance benefits as described below in &#8220;-<span style="font-style:italic">Potential Payments Upon Termination or Change in Control.</span>&#8221;<span style="font-weight:bold"><span style="font-style:italic"> </span></span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreement also provided for the grant of an initial restricted stock unit award to purchase 8,791 (the &#8220;Sereda Initial RSU Award&#8221;) shares of common stock, which was approved by the Board, contingent upon and subject to the filing and effectiveness of the Form <span style="white-space:nowrap">S-8</span> with respect to the 2022 Plan, following the Closing and were granted upon the effectiveness of the Form <span style="white-space:nowrap">S-8</span> on June 10, 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">127 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This award vests in accordance with the following schedule: <span style="white-space:nowrap">one-forty</span> eighth (1/48th) of the total number of Sereda Initial RSU Awards (rounded down, except for the final scheduled vesting installment) will satisfy time-based vesting each month following the vesting commencement date over a period of four years. The executive employment agreement also provided that, contingent upon the occurrence of the Closing and Mr.&#160;Sereda&#8217;s continued employment with Rigetti through such date, Mr.&#160;Sereda would receive a bonus between $0 and $25,000, determined by the Board based on the gross proceeds of the transactions contemplated by the Merger Agreement, in recognition of his contributions to Rigetti and 5,000 shares of common stock subject to the approval of the Board or the Compensation Committee of the Board and Mr.&#160;Sereda&#8217;s continued employment with Rigetti through such date. The transaction cash bonus and transaction bonus stock awards were granted to Mr. Sereda in fiscal year 2022. In addition, the executive employment agreement provides that Mr.&#160;Sereda would receive Rigetti 2022 Annual RSUs to purchase 128,600 shares of common stock, which vest monthly over four years, provided that Mr.&#160;Sereda is continuously employed for such period, or vesting 100% upon a Change in Control (as defined in the 2022 Plan). The Rigetti 2022 Annual RSUs were granted on June 10, 2022. The executive employment agreement further provides that Rigetti will reimburse Mr.&#160;Sereda for reasonable business expenses in accordance with Rigetti&#8217;s standard expense reimbursement policy, as the same may be modified from time to time. In addition, Mr.&#160;Sereda is eligible to receive certain employee benefits, including medical, vision, dental, life insurance, and participation in a Section&#160;401(k) retirement plan (as described above). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Michael Harburn </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2022, we entered into an executive employment agreement with Mr.&#160;Harburn, which was amended and restated on February&#160;2, 2022 and became effective upon and concurrent with the Closing of the Business Combination. Pursuant to the executive employment agreement, Mr.&#160;Harburn received an annual base salary of $345,000 and was eligible: (i)&#160;to participate in Rigetti&#8217;s benefit plans; (ii)&#160;subject to the approval of the Board, to receive PSU Awards, if certain performance-based milestones established by Rigetti are satisfied in the future and provided that Mr.&#160;Harburn has remained continuously employed by Rigetti through the date that the Board or the Compensation Committee grants such PSU Awards (subject to continued employment for a three-year period); (iii) to receive awards of stock options, restricted stock, restricted stock units or other equity awards pursuant to any plans or arrangements which Rigetti may have in effect from time to time; and (iv)&#160;a discretionary annual cash bonus of a target amount equal to 25% of the base salary, subject to review and adjustment by the Board. Mr.&#160;Harburn is entitled to certain severance benefits as described below in &#8220;&#8212;Potential Payments Upon Termination or Change in Control.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreement also provided for the grant of an initial restricted stock unit award to purchase 207,178 (the &#8220;Mr.&#160;Harburn Initial RSU Award&#8221;) shares of common stock, which was approved by the Board, contingent upon and subject to the filing and effectiveness of the Form <span style="white-space:nowrap">S-8</span> with respect to the 2022 Plan, following the Closing and which was granted upon the effectiveness of the Form <span style="white-space:nowrap">S-8</span> on June 10, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This award vested in accordance with the following schedule: <span style="white-space:nowrap">(i)&#160;one-forty</span> eighth (1/48<sup style="font-size:75%; vertical-align:top">th</sup>) of the total number of Mr.&#160;Harburn Initial RSU Awards (rounded down, except for the final scheduled vesting installment) will satisfy time-based vesting each month following the vesting commencement date over a period of four years. The executive employment agreement also provides that Mr.&#160;Harburn would receive Rigetti 2022 Annual RSUs (as defined below) to purchase 102,900 shares of common stock, which vested monthly over four years, provided that Mr.&#160;Harburn is continuously employed for such period, or vesting 100% upon a Change in Control (as defined in the 2022 Plan). The Rigetti 2022 Annual RSUs were granted on June 10, 2022. The executive employment agreement further provided that Rigetti would reimburse Mr.&#160;Harburn for reasonable business expenses in accordance with the company&#8217;s standard expense reimbursement policy, as the same may be modified from time to time. In addition, Mr.&#160;Harburn was eligible to receive certain employee benefits, including medical, vision, dental, life insurance, and participation in a Section&#160;401(k) retirement plan (as described above). On February 9, 2023, Mr. Harburn&#8217;s employment with the Company ended. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">128 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Taryn Naidu </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We originally entered into an offer letter with Mr.&#160;Naidu in March 2019. Pursuant to this offer letter, Mr.&#160;Naidu was granted an option to purchase 157,397 shares of common stock at an original exercise price of $7.09 per share (not reflecting the Exchange Ratio) on April&#160;4, 2019, such exercise price being reduced to $0.272 per share by a unanimous written consent of the Legacy Rigetti Board on May&#160;22, 2020 in connection with the Repricing. In connection with the Repricing on May&#160;22, 2020, Mr.&#160;Naidu was also granted a &#8220;refresh&#8221; option to purchase 647,032 shares of common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2022, we entered into an executive employment agreement with Mr.&#160;Naidu, which was amended and restated on February&#160;2, 2022 and which became effective contingent upon and concurrent with the Closing of the Business Combination. Pursuant to the executive employment agreement and prior to the termination of Mr.&#160;Naidu&#8217;s employment on April&#160;18, 2022, Mr.&#160;Naidu was entitled to receive an annual base salary of $379,000 and was eligible: (i)&#160;to participate in Rigetti&#8217;s benefit plans; (ii)&#160;subject to the approval of the Board, to receive PSU Awards if certain performance-based milestones established by Rigetti are satisfied in the future and provided that Mr.&#160;Naidu remained continuously employed by Rigetti through the date that the Board or the Compensation Committee were to grant such PSU Awards (subject to continued employment for a three-year period); (iii) to receive awards of stock options, restricted stock, restricted stock units or other equity awards pursuant to any plans or arrangements which Rigetti may have in effect from time to time; and (iv)&#160;a discretionary annual cash bonus of a target amount equal to 25% of the base salary, subject to review and adjustment by the Board. Under certain circumstances, Mr.&#160;Naidu was entitled to certain severance benefits as described below in &#8220;&#8212;Potential Payments Upon Termination or Change in Control.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive employment agreement also provided for the grant of an initial restricted stock unit award to purchase 444,450 (the &#8220;Naidu Initial RSU Award&#8221;) shares of common stock, which was approved by the Board, contingent upon and subject to the filing and effectiveness of the <span style="white-space:nowrap">Form&#160;S-8&#160;with</span> respect to the 2022 Plan, following the Closing and which was to be granted upon the effectiveness of the <span style="white-space:nowrap">Form&#160;S-8.&#160;The</span> executive employment agreement also provided that to be eligible for the Naidu Initial RSU Award, Mr.&#160;Naidu was required to be employed by the Company when the Board or the Compensation Committee grants the Naidu Initial RSU Award. This award would have vested in accordance with the following schedule: (i) 50% of the total number of Initial RSU Awards vest in substantially equal installments (rounded down, except for the final<span style="font-style:italic"></span>&#160;scheduled vesting installment) at the end of each month following the vesting commencement date over a period of 12 months and (ii)&#160;the remaining 50% of the total number of Naidu Initial RSU Awards vest in substantially equal installments (rounded down, except for the final scheduled vesting installment) at the end of each month following the vesting commencement date over a period of four years, with prongs (i)&#160;and (ii)&#160;occurring concurrently, such that, at the end of <span style="white-space:nowrap">the&#160;12-month&#160;period</span> immediately following the vesting commencement date, 62.5% of the total number of Naidu Initial RSU Awards were to have vested (subject to the Executive&#8217;s Continuous Service (as defined in the 2022 Plan) on such vesting date). The executive employment agreement also provided that, contingent upon the occurrence of the Closing and Mr.&#160;Naidu&#8217;s continued employment with Rigetti through such date, Mr.&#160;Naidu would be entitled to receive a bonus between $50,000 and $750,000, determined by the Board based on the gross proceeds of the transactions contemplated by the Merger Agreement, in recognition of his contributions to Rigetti and 45,000 shares of common stock subject to the approval of the Board or the Compensation Committee of the Board and Mr.&#160;Naidu&#8217;s continued employment with Rigetti through such date. In addition, the executive employment agreement provided that Mr.&#160;Naidu would receive Rigetti 2022 Annual RSUs to purchase 161,300 shares of common stock, contingent upon and subject to the filing and effectiveness of the <span style="white-space:nowrap">Form&#160;S-8&#160;with</span> respect to the 2022 Plan, which would have vested monthly over four years, provided that Mr.&#160;Naidu is continuously employed for such period, or vesting 100% upon a Change in Control (as defined in the 2022 Plan). The executive employment agreement also provided that to be eligible for the Rigetti 2022 Annual RSUs, Mr.&#160;Naidu was required to be employed by the Company when the Board or the Compensation Committee grants the Rigetti 2022 Annual RSUs. The executive employment agreement further provided that Rigetti would reimburse Mr.&#160;Naidu for reasonable business expenses in accordance with Rigetti&#8217;s standard expense reimbursement policy, as the same may be modified from time to </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">129 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
time. In addition, Mr.&#160;Naidu was eligible to receive certain employee benefits, including medical, vision, dental, life insurance, and to participate in a Section&#160;401(k) retirement plan (as described above). On April&#160;18, 2022, Mr.&#160;Naidu&#8217;s employment with Rigetti was terminated. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Potential Payments Upon Termination or Change in Control </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of Dr.&#160;Kulkarni, Mr.&#160;Danis and Mr.&#160;Sereda is entitled, and each of Dr.&#160;Rigetti prior to his resignation, Mr.&#160;Harburn prior to his departure, and Mr.&#160;Naidu prior to his termination, was entitled, to the following severance benefits pursuant to his respective employment agreement if his employment is terminated by Rigetti without &#8220;Cause&#8221; or by the executive for &#8220;Good Reason,&#8221; and provided such executive officer timely executes and does not revoke a release of claims in Rigetti&#8217;s favor, (a)&#160;continuing payments of his then-current annual base salary for twelve months; (b)&#160;payment of the premiums necessary to continue health insurance coverage for himself and his eligible dependents under Rigetti&#8217;s group health plans pursuant to COBRA or similar state insurance laws, for up to twelve months; and (c)&#160;Accrued Obligations (as defined in the respective executive employment agreement), which include accrued but unpaid salary through the date of termination, unreimbursed expenses, and benefits owed to such executive officer under retirement or health plans in which such executive officer was a participant. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the named executive officer&#8217;s employment is terminated by Rigetti other than for &#8220;Cause,&#8221; death or disability or by such executive officer for &#8220;Good Reason&#8221; within three months prior to or twelve months after a Change in Control (as defined in the 2022 Plan), then, in lieu of and not in addition to any other severance benefit, (i) 100% of the then-unvested portion of each of his outstanding equity awards will become fully vested; (ii)&#160;Rigetti will pay such executive officer a lump sum equal to his then current annual base salary; (iii)&#160;subject to such executive officer making certain elections, Rigetti will pay certain COBRA premiums necessary to continue his and his covered dependents&#8217; health insurance coverage; and (iv)&#160;Rigetti will pay a bonus to such executive officer equivalent to a pro rata share of his full Target Amount (as defined in the respective executive employment agreement), for the portion of the performance year completed when his termination occurs. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under each of the named executive officer&#8217;s employment agreement, &#8220;Cause&#8221; means that we have determined in our sole discretion that the executive officer has engaged in any of the following: (i)&#160;his material breach of any covenant or condition under the executive employment agreement or any other agreement between the parties, and, to the extent curable, such executive officer has not cured such breach after the expiration of ten (10)&#160;days after written notice from us of such breach; (ii)&#160;his material act constituting dishonesty, fraud, immoral or disreputable conduct in connection with his duties to us; (iii)&#160;any conduct which constitutes a felony or a crime of moral turpitude under applicable law; (iv)&#160;material violation of our policy or any act of misconduct; (v)&#160;refusal to follow or implement a clear and reasonable directive of the Company; (vi)&#160;negligence or incompetence in the performance of Rigetti&#8217;s duties or failure to perform such duties in a manner satisfactory to us after the expiration of ten (10)&#160;days without cure after written notice of such failure; or (vii)&#160;his breach of fiduciary duty to the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under each named executive officer&#8217;s employment agreement, &#8220;Good Reason&#8221; means the occurrence of any of the following events without such executive officer&#8217;s consent: (i)&#160;a material reduction in his base salary, other than a reduction applied in a similar proportional amount to all similarly situated executives; (ii)&#160;a material breach of the executive employment agreement by Rigetti; (iii)&#160;a material reduction in the his duties, authority and responsibilities relative to the his duties, authority, and responsibilities in effect immediately prior to such reduction; or (iv)&#160;the relocation of his principal place of employment, without his consent, in a manner that lengthens his <span style="white-space:nowrap">one-way</span> commute distance by twenty-five (25)&#160;or more miles from his then-current principal place of employment immediately prior to such relocation; not to include a requirement to return to <span style="white-space:nowrap">in-person</span> work, in which circumstance Good Reason will not apply; provided, however, that, any such termination by such executive officer shall only be deemed for Good Reason pursuant to this definition if: (1)&#160;such executive officer gives Rigetti written notice of his intent to terminate for Good Reason within thirty (30)&#160;days following the first occurrence of the condition(s) that his believes constitute(s) Good Reason, which notice shall describe such </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">130 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
condition(s); (2) Rigetti fails to remedy such condition(s) within thirty (30)&#160;days following receipt of the written notice (the &#8220;Cure Period&#8221;); and (3)&#160;such executive officer voluntarily terminates employment within thirty (30)&#160;days following the end of the Cure Period, or the parties agree in writing to extend such Cure Period. With respect to the executive employment agreements entered into by and between Rigetti and each of Dr.&#160;Rigetti and Messrs. Naidu and Sereda, &#8220;Good Reason&#8221; shall also mean the occurrence of a material change in the executive officer&#8217;s reporting relationship, other than such change made directly in connection with organizational changes resulting from a Change in Control (as defined in the executive employment agreements). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Compensation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation of Legacy Rigetti&#8217;s directors for fiscal year 2022. Dr.&#160;Rigetti, our Chief Executive Officer, did not receive additional compensation for his service as a director in fiscal year 2022, and therefore is not included in the Director Compensation table below. All compensation paid to Dr.&#160;Rigetti is reported above in the &#8220;<span style="font-style:italic">Summary Compensation Table</span>.&#8221; </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Cash(1)&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Stock&#160;Awards(2)&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">All Other<br />Compensation&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total&#160;($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alissa Fitzgerald</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">124,167</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">349,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">474,153</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ray Johnson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">349,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">393,319</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Cowan</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,083</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">349,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">387,069</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cathy McCarthy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">146,425</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">349,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">496,411</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Clifton</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">349,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">388,319</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Gail Sandford</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40,583</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">349,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">390,569</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General Peter Pace(3)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,064</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">349,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">382,050</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This column represents cash compensation for their service as a director during the fiscal year ended December&#160;31, 2022. Cash compensation for non-employee directors for fiscal year 2022 was determined pursuant to the Non-Employee Director Compensation Policy described below. Ms. Fitzgerald and Ms.&#160;McCarthy were each awarded additional cash compensation of $75,000 in connection with their significant time and commitment to performing services as non-employee directors of the Board during fiscal year 2022. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">This column reflects the aggregate grant date fair value of the restricted stock units granted to the director during fiscal year 2022 under the 2013 Plan and 2022 Plan, as applicable. The aggregate grant date fair value is computed in accordance with ASC Topic 718 for stock-based compensation transactions. Assumptions used in the calculation of these amounts are included in the notes to our financial statements included elsewhere in this prospectus. This amount does not reflect the actual economic value that may be realized by the director. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">General Peter Pace resigned as a director of the Company, effective July&#160;15, 2022. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The table below shows for each <span style="white-space:nowrap">non-employee</span> director who was serving, and held outstanding equity awards, as of December&#160;31,&#160;2022. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:57%"></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares<br />Underlying<br />Options<br />Outstanding<br />(Vested) at<br />Fiscal<br />Year End</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares<br />Underlying<br />Options<br />Outstanding<br />(Unvested)&#160;at<br />Fiscal<br />Year End</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Unvested<br />Stock<br />Awards&#160;at<br />Fiscal<br />Year End</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alissa Fitzgerald</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">241,445</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">53,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67,436</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ray Johnson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">203,320</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">91,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67,436</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Cowan</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67,436</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cathy McCarthy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">221,340</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Clifton</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67,436</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Gail Sandford</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67,436</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General Peter Pace*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">131 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">General Peter Pace resigned as a director of the Company, effective July&#160;15, 2022. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Non-Employee</span> Director Compensation Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s amended non-employee director compensation policy, effective as of June 8, 2022, consists of annual cash retainers of $40,000 for each non-employee director and an additional $25,000 for the chairperson of the Board; an additional $20,000 and $10,000 for the chairperson and each member of the audit committee of the Board, respectively; an additional $12,000 and $6,000 for the chairperson and each member of the compensation committee of the Board, respectively; and an additional $9,000 and $4,500 for the chairperson and each member of the nominating and corporate governance committee of the Board, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For each member of the Board who is not also serving as an employee of or consultant to the Company or any of its subsidiaries (each such member, an &#8220;Eligible Director&#8221;) and who is (i)&#160;serving on the Board immediately following the effective date of the non-employee director compensation policy (the &#8220;Effective Date&#8221;) or (ii)&#160;first elected or appointed to the Board following the Effective Date, (A)&#160;on the date on which a registration statement on Form S-8 is filed and effective covering the RSUs (&#8220;Form S-8&#8221;), with respect to clause (i)&#160;and (B)&#160;on the date of such director&#8217;s initial election or appointment to the Board (or, if such date is not a market trading day, the first market trading day thereafter or, if there is not a Form S-8 on the date of such initial election or appointment, then the date on which a <span style="white-space:nowrap">Form&#160;S-8</span> is filed and effective), with respect to clause (ii), the director will be automatically, and without further action by the Board or its Compensation Committee, granted RSUs with respect to shares of common stock with an aggregate Fair Market Value (as defined in the Plan) as of the grant date equal to $210,000 (the &#8220;Director Initial RSU Grant&#8221;); provided that such director remains in Continuous Service (as defined in the 2022 Plan) through the grant date. The grant of any Director Initial RSU Grant pursuant to clause (i)&#160;above is contingent upon, subject to and effective upon the filing and effectiveness of a Form S-8. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Director Initial RSU Grant will vest over a three-year period, with one-third (1/3)&#160;of the Initial RSU Grant vesting on the first anniversary of the grant date, one-third (1/3)&#160;of the Initial RSU Grant vesting on the second anniversary of the grant date and the remaining one-third (1/3)&#160;of the Initial RSU Grant vesting on the third anniversary of the grant date, such that the Initial RSU Grant is fully vested on the third anniversary of the date of grant, subject to the Eligible Director&#8217;s Continuous Service through each such vesting date. On June&#160;10, 2022, each non-employee director of the Board was granted a Director Initial RSU Grant of 40,462 RSUs. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amended non-employee director compensation policy also provides for annual grants of RSUs to each director equivalent to $140,000 starting in 2022 and in future years, will vest in full on the earlier of (i)&#160;the date of the following year&#8217;s Annual Meeting (or the date immediately prior to the next Annual Meeting if the Eligible Director&#8217;s service as a director ends at such Annual Meeting due to the director&#8217;s failure to be re-elected or the director not standing for re-election); or (ii)&#160;the one-year anniversary measured from the date of grant, in each case. In the event of a Change in Control (as defined in the 2022 Plan), any unvested portion of the RSUs would vest immediately prior to the consummation of such Change in Control. On June&#160;10, 2022, each non-employee director of the Board was granted an annual grant of 26,974 RSUs. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will reimburse Eligible Directors for ordinary, necessary and reasonable out-of-pocket travel expenses to cover in-person attendance at and participation in Board and committee meetings; provided, that the Eligible Director timely submit to the Company appropriate documentation substantiating such expenses in accordance with the Company&#8217;s travel and expense Policy, as in effect from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The description of the amended non-employee director compensation policy is not complete and is subject to and qualified in its entirety by reference to the amended non-employee director compensation policy, a copy of which is included as Exhibit 10.22 to this prospectus. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">132 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Emerging Growth Company Status </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As an emerging growth company, we are exempt from certain requirements related to executive compensation, including the requirements to hold a nonbinding advisory vote on executive compensation or golden parachute payments, and to provide information relating to the ratio of total compensation of our CEO to the median of the annual total compensation of all of our employees, each as required by the Investor Protection and Securities Reform Act of 2010, which is part of the Dodd-Frank Wall Street Reform and Consumer Protection Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as the market value of our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">133 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_14">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than compensation arrangements for our directors and executive officers, which are described elsewhere in this prospectus, below is a description of transactions since January&#160;1, 2021 to which Rigetti was a party or will be a party, in which: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the amounts involved exceeded or will exceed $120,000; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any of our directors, executive officers or holders of more than 5% of the company&#8217;s capital stock, or any member of the immediate family of, or person sharing the household with, the foregoing persons, had or will have a direct or indirect material interest. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Supernova Class B Ordinary Shares </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&#160;22, 2020, Supernova Sponsor paid $25,000, or approximately $0.004 per share, to cover certain offering and formation costs in consideration of 5,750,000 Supernova Class B ordinary shares. On January&#160;14, 2021, Supernova effected a share dividend, resulting in 7,187,500 Supernova Class B ordinary shares outstanding. On February&#160;22, 2021, the Supernova Sponsor transferred 28,750 Supernova Class B ordinary shares to each of Supernova&#8217;s six former independent director nominees. On March&#160;1, 2021, Supernova effected a share dividend, resulting in 8,625,000 Supernova Class B ordinary shares. In connection with the consummation of the Business Combination, the Supernova Class B ordinary shares were converted into 8,625,000 shares of common stock. In August 2022, Supernova Sponsor effected a liquidating pro rata distribution of its shares of common stock to its members, pursuant to which Mr. Clifton, one of our directors, received 1,052,250 of common stock, of which 382,409 shares are subject to vesting conditions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Private Placement Warrants </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March 4, 2021, Supernova Sponsor purchased an aggregate of 4,450,000 private placement warrants for a purchase price of $2.00 per whole warrant, or $8,900,000 in the aggregate, in a private placement that occurred simultaneously with the closing of Supernova&#8217;s IPO. Each private placement warrant entitles the holder to purchase one share of common stock at $11.50 per share, subject to adjustment. The private placement warrants (including the common stock issuable upon exercise thereof) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of the Business Combination. In connection with the consummation of the Business Combination, the Supernova private placement warrants were converted into 4,450,000 private placement warrants of the Company to purchase one share of common stock at an exercise price of $11.50. In August 2022, Supernova Sponsor effected a liquidating pro rata distribution of its private placement warrants to its members, pursuant to which Mr. Clifton, one of our directors, received 556,250 private placement warrants. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Expense Reimbursement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&#160;22, 2020, Supernova Sponsor agreed to loan Supernova an aggregate of up to $300,000 to cover expenses related to Supernova&#8217;s IPO pursuant to a promissory note (the &#8220;Note&#8221;). This Note was non-interest bearing and payable upon the completion of the IPO. Supernova borrowed $275,000 under the Note and repaid the Note in full on March&#160;4, 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Subscription Agreements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the closing of the Business Combination, (i) Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P. purchased 9,481,710 and 10,100,508 shares of common stock in the PIPE Financing, for a purchase price of $10.00 per share pursuant to separate Subscription Agreements, each dated October&#160;6, 2021, and (ii) 62,500 shares of common stock were issued to one of our directors, Mr. Clifton, pursuant to the PIPE Financing. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">134 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Rigetti Holders Support Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;6, 2021, in connection with the execution of the Merger Agreement, Supernova entered into the Rigetti Holders Support Agreement with Legacy Rigetti and certain stockholders of Legacy Rigetti pursuant to which such stockholders agreed to vote to adopt and approve, upon the registration statement on Form S-4 being declared effective, the Merger Agreement and all other documents and transactions contemplated thereby. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Sponsor Support Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;6, 2021, in connection with the execution of the Merger Agreement, Supernova entered into a sponsor support agreement (the &#8220;Sponsor Support Agreement&#8221;) with the Supernova Sponsor, Legacy Rigetti and Supernova&#8217;s directors and officers. Pursuant to the Sponsor Support Agreement, the Supernova Sponsor and Supernova&#8217;s directors and officers (&#8220;Sponsor Holders&#8221;), among other things, agreed to vote all of their shares of Supernova capital stock in favor of the approval of the Business Combination. In addition, pursuant to the Sponsor Support Agreement, (i)&#160;2,479,000 shares of common stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the five year period following the Closing, the volume weighted average price of common stock equals or exceeds $12.50 for any twenty trading days within a period of thirty consecutive trading days, and (ii)&#160;580,273 shares of common stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the five year period following the Closing, the volume weighted average price of common stock equals or exceeds $15.00 for any twenty trading days within a period of thirty consecutive trading days. Any such shares held by the Sponsor Holders that remain unvested after the fifth anniversary of the Closing will be forfeited. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation Arrangements, Stock Option Grants and Indemnification for Executive Officers and Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have employment arrangements with our executive officers that, among other things, provide for certain change in control benefits, as well as severance benefits for executive officers. For a description of these agreements with our named executive officers, see &#8220;Executive Compensation.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have granted stock options, restricted stock units and stock awards to our executive officers and our directors. For a description of these equity awards to our named executive officers and directors, see &#8220;Executive Compensation.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Amended and Restated Registration Rights Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Closing, we, Supernova Sponsor, Supernova directors and officers, Legacy Rigetti directors and officers and certain of Legacy Rigetti securityholders entered into an amended and restated registration rights agreement. Pursuant to the agreement, we agreed that we would file with the SEC a registration statement registering the resale of certain securities held by or issuable to such holders, and we will use reasonable best efforts to have such registration statement declared effective as soon as practicable after the filing thereof. In certain circumstances, certain holders can demand up to two underwritten offerings in any 12 month period, and certain holders are entitled to piggyback registration rights. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Indemnification Agreements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into indemnification agreements with each of our directors and executive officers in addition to the indemnification provided in the Bylaws. The indemnification agreements require us to indemnify our directors to the fullest extent permitted by Delaware law. See &#8220;Directors, Executive Officers and Corporate Governance&#8212;Limitation on Liability and Indemnification of Directors and Officers&#8221; for information about indemnification agreements and director and officer liability insurance which the Company maintains. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">135 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Related Person Transactions Policy </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board adopted a written related person transactions policy that sets forth our policies and procedures regarding the identification, review, consideration and oversight of &#8220;related person transactions.&#8221; For purposes of our policy only, a &#8220;related person transaction&#8221; is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which we or any of our subsidiaries are participants involving an amount that exceeds $120,000, in which any &#8220;related person&#8221; has a material interest. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions involving compensation for services provided to us by an employee, consultant or director will not be considered related person transactions under this policy. A related person is any executive officer, director, nominee to become a director or a holder of more than 5% of any class of our voting securities (including our common stock), including any of their immediate family members and affiliates and entities owned or controlled by any related person. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, the related person in question or, in the case of transactions with a holder of more than 5% of any class of our voting securities, an officer with knowledge of the proposed related person transaction, must present information regarding the proposed related person transaction to our audit committee (or, where review by our audit committee would be inappropriate, to another independent body of our Board) for review. To identify related person transactions in advance, we will rely on information supplied by our executive officers, directors and certain significant stockholders. In considering related person transactions, our audit committee will take into account the relevant available facts and circumstances, which may include, but are not limited to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the risks, costs, and benefits to us; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the impact on a director&#8217;s independence in the event the related person is a director, immediate family member of a director or an entity with which a director is affiliated; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the terms of the transaction; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the availability of other sources for comparable services or products; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the terms available to or from, as the case may be, unrelated third parties. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee will approve only those transactions that it determines are fair to and in the best interests of the Company. All of the transactions described above were entered into prior to the adoption of such policy. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">136 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_15">BENEFICIAL OWNERSHIP OF SECURITIES </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information known to the Company regarding the beneficial ownership of common stock as of March 1, 2023, by: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each person known by the Company to be the beneficial owner of more than 5% of outstanding shares of common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each of the Company&#8217;s named executive officers, including its former Chief Operating Officer, and directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">all executive officers and directors of the Company as a group, excluding its former Chief Operating Officer. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The beneficial ownership percentages set forth in the table below are based on 126,964,206 shares of common stock issued and outstanding as of March 1, 2023. Unless otherwise noted in the footnotes to the following table, and subject to applicable community property laws, the persons and entities named in the table have sole voting and investment power with respect to the securities they beneficially owned. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:55%"></td>

<td style="vertical-align:bottom;width:14%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:14%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name of Beneficial Owner<sup style="font-size:75%; vertical-align:top">1</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of&#160;Shares&#160;of<br />Common&#160;Stock&#160;Beneficially<br />Owned</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">% of<br />Ownership</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Directors and Named Executive Officers</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subodh Kulkarni<sup style="font-size:75%; vertical-align:top">(2)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rick Danis<sup style="font-size:75%; vertical-align:top">(3)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">646,101</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Sereda<sup style="font-size:75%; vertical-align:top">(4)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">275,579</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chad Rigetti<sup style="font-size:75%; vertical-align:top">(5)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,144,379</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taryn Naidu<sup style="font-size:75%; vertical-align:top">(6)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">796,326</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mike Harburn<sup style="font-size:75%; vertical-align:top">(7)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">445,118</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Cowan<sup style="font-size:75%; vertical-align:top">(8)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alissa Fitzgerald<sup style="font-size:75%; vertical-align:top">(9)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">221,097</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ray Johnson<sup style="font-size:75%; vertical-align:top">(10)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">247,765</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cathy McCarthy<sup style="font-size:75%; vertical-align:top">(11)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">73,780</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#160;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Clifton<sup style="font-size:75%; vertical-align:top">(12)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,671,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1.3</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H. Gail Sandford</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">All current executive officers and directors as a group (8&#160;persons)</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,313,527</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2.6</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Five Percent Holders</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AVG Entities<sup style="font-size:75%; vertical-align:top">(13)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,588,642</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5.9</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Bessemer Venture Partners<sup style="font-size:75%; vertical-align:top">(14)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,582,218</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Insurance Company of the West<sup style="font-size:75%; vertical-align:top">(15)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,178,816</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7.2</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Unless otherwise noted, the mailing address of each of those listed in the table above is 775 Heinz Avenue, Berkeley, CA, 94710. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Dr.&#160;Kulkarni was appointed President and Chief Executive Officer on December&#160;12, 2022 and as a director of the Board on December&#160;15, 2022. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">137 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 335,503 shares of common stock, 92,576 shares of common stock subject to outstanding stock options that are exercisable within 60 days of March 1, 2023 and 218,022 shares of common stock issuable upon the settlement of restricted stock units releasable within 60 days of March 1, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 151,312 shares of common stock and 124,267 shares of common stock issuable upon the settlement of restricted stock units releasable within 60 days of March 1, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Information based on a Schedule 13D/A filed by Dr. Rigetti on January 26, 2023 with the SEC. Includes 2,669,371 shares vested and issuable upon exercise of options as of January 26, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Information provided for Mr. Naidu is as of the date of his termination of April 18, 2022. Consists of 199,075 shares of common stock held by Mr. Naidu, the former Chief Operating Officer of Rigetti, or his affiliated entity AlphaNuma LLC, and 453,135 shares of common stock subject to outstanding stock options that were exercisable at the time of Mr. Naidu&#8217;s termination, 121,871 shares of common stock issuable upon the settlement of restricted stock units that were releasable at the time of Mr. Naidu&#8217;s termination and 22,245 shares subject to the exercise of warrants of the Company. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Information provided for Mr. Harburn is as of his resignation date of February 9, 2022. Consists of 136,368 shares of common stock, 275,607 shares of common stock subject to outstanding stock options that were exercisable at the time of Mr. Harburn&#8217;s termination and 33,143 shares of common stock issuable upon the settlement of restricted stock units at the time of Mr. Harburn&#8217;s termination. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">David Cowan, a member of the Board, is a partner at Bessemer Venture Partners. Mr. Cowan disclaims beneficial ownership interest of the securities held by the Bessemer Entities (as defined below) referred to in footnote 14 below, except to the extent of his pecuniary interest, if any, in such securities through an indirect interest in the Bessemer Entities. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 221,097 shares of common stock subject to outstanding stock options that are exercisable within 60 days of March 1, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(10)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 22,788 shares of common stock and 224,977 shares of common stock subject to outstanding stock options that are exercisable within 60 days of March 1, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(11)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 73,780 shares of common stock. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(12)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 1,114,750 shares of common stock and 556,250 issuable upon the exercise of 556,250 private placement warrants to purchase common stock. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(13)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 860,629 shares of common stock held by AVG - BIV Rigetti Trust1 2020, (ii) 1,022,123 shares of common stock held by AVG - BIV Rigetti Trust2 2020, (iii) 5,585,461 shares of common stock held by AVG - BIV Rigetti Trust3 2020, (iv) 20,429 shares of common stock held by AVGF-BIV 2 Rigetti 2017, LLC, and (v) 100,000 shares of common stock purchased by Alumni Ventures &#8211; Rigetti Trust 2022 in the PIPE Financing. Alumni Ventures Group, LLC is the manager of each of the funds, and has power to vote or direct the voting of shares held by each fund. The address of Alumni Ventures Group, LLC and the funds is 670 N. Commercial Street, Suite 403, Manchester, NH 03101. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(14)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 9,481,710 shares of common stock held by Bessemer Venture Partners X Institutional L.P., or Bessemer Institutional, and 10,100,508 shares of common stock held by Bessemer Venture Partners X L.P., or Bessemer X, and together with Bessemer Institutional, the Bessemer Entities, and (ii) 968,400 shares of common stock purchased by Bessemer Institutional and 1,031,600 shares of common stock purchased by Bessemer X in the PIPE Financing. Deer X &amp; Co. L.P., or Deer X L.P., is the general partner of the Bessemer Entities. Deer X &amp; Co. Ltd., or Deer X Ltd., is the general partner of Deer X L.P. Adam Fisher, Robert P. Goodman, David Cowan, Jeremy Levine, Byron Deeter, Ethan Kurzweil, Alex Ferrara, Brian Feinstein and Stephen Kraus are the directors of Deer X Ltd. and hold the voting and dispositive power for the Bessemer Entities. Investment and voting decisions with respect to the securities held by the Bessemer Entities are made by the directors of Deer X Ltd. acting as an investment committee. Mr. Cowan disclaims beneficial ownership interest of the securities of the Company held by the Bessemer Entities except to the extent of his pecuniary interest, if any, in such securities through an indirect interest in the Bessemer Entities. The address for the Bessemer Entities is c/o Bessemer Venture Partners, 1865 Palmer Avenue, Suite 104, Larchmont, NY 10538. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(15)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 9,178,816 shares of common stock held by Insurance Company of the West. The address for Insurance Company of the West is 15025 Innovation Drive, San Diego, CA 92128. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">138 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_16">SELLING STOCKHOLDER </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;6, 2021, Legacy Rigetti entered into the Warrant Subscription Agreement with Ampere for the purchase of the Ampere Warrant for an aggregate purchase price (including amounts for exercise) of $10,000,000 pursuant to which the Ampere Warrant may be exercised by Ampere at an exercise price of $0.0001 per share for 1,000,000 shares of common stock. The Warrant Subscription Agreement was assumed by the Company pursuant to the Merger Agreement in connection with the closing of the Business Combination. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2022, pursuant to the Warrant Subscription Agreement, the Company issued the Ampere Warrant upon receipt of an aggregate of $5&#160;million (including the exercise price), and upon such payment and issuance, 500,000 shares of the Company&#8217;s common stock vested under the warrant and were immediately exercised by Ampere pursuant to the terms of the Ampere Warrant. The purchase of the Ampere Warrant pursuant to the Warrant Subscription Agreement was conditioned upon, among other things, the consummation of the Business Combination pursuant to the Merger Agreement and the entry into a collaboration agreement between Legacy Rigetti and Ampere. Pursuant to the Warrant Subscription Agreement, Ampere is required to pay, subject to the satisfaction of certain conditions, the Additional Payment of $4,999,950 to the Company no later than the second anniversary of the date of the Warrant Subscription Agreement, and upon such payment, the Unexercised Warrant Shares will vest and be exercisable by Ampere at an exercise price of $0.0001 per share pursuant to the terms of the Ampere Warrant. If the conditions to payment are not satisfied by the second anniversary of the date of the Warrant Subscription Agreement, the Company may reject Ampere&#8217;s payment of the Additional Payment and the Unexercised Warrant Shares will not vest or be exercisable and Ampere will have no further obligation with respect to the payment of the additional $4,999,950. We cannot predict when or if the Additional Payment will be received by the Company and if the Unexercised Warrant Shares will vest and become exercisable, and it is possible that we may never receive the Additional Payment, that the Ampere Warrant will not be exercised for the additional 500,000 shares of common stock, and that the Unexercised Warrant Shares may never be issued.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Warrant Subscription Agreement, we have agreed to keep the registration statement of which this prospectus constitutes a part effective through the earliest of (i)&#160;three years from the date the initial registration statement covering the registrable securities under the Subscription Agreements is declared effective, (ii)&#160;the date on which subscriber no longer owns the Ampere Warrant or (iii)&#160;the first date on which subscribers can sell the Ampere Warrant (or shares received in exchange therefor) without any condition or limitation under Rule 144. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the resale of the Shares to permit the selling stockholder below to resell or otherwise dispose of the Shares in the manner contemplated under &#8220;Plan of Distribution&#8221; in this prospectus (as may be supplemented and amended). As used in this prospectus, the term &#8220;selling securityholder&#8221; includes the selling securityholder listed in the table below, and the pledgees, donees, transferees, assignees, successors, designees, <span style="white-space:nowrap"><span style="white-space:nowrap">successors-in-interest</span></span> and others who later come to hold any of the selling securityholder&#8217;s interest in the common stock or warrants other than through a public sale. Throughout this prospectus, when we refer to the common stock being registered on behalf of the selling stockholder, we are referring to the Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder may sell some, all or none of their Shares. We do not know how long the selling stockholder will hold the Shares before selling them, and we currently have no agreements, arrangements or understandings with the selling stockholder regarding the sale or other disposition of any of the Shares. The Shares covered hereby may be offered from time to time by the selling stockholder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the number of our outstanding common stock beneficially owned by the selling stockholder as of March 1, 2023, the number of Shares that may be offered under this prospectus and the number and percentage of our outstanding common stock beneficially owned by the selling stockholder assuming all of the Shares covered hereby are sold. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to our shares of common stock. Generally, a person </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">139 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#8220;beneficially owns&#8221; shares of common stock if the person has or shares with others the right to vote those shares or to dispose of them, or if the person has the right to acquire voting or disposition rights within 60&#160;days. The number of shares in the column &#8220;Number Registered for Resale&#8221; represents all of the shares that the selling stockholder may offer and sell from time to time under this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All information contained in the table below and the footnotes thereto is based upon information provided to us by the selling stockholder as of August&#160;16, 2022. The selling stockholder may have sold or transferred, in transactions exempt from the registration requirements of the Securities Act, some or all of its shares or other securities since the date on which the information in the table below is presented. Information about the selling stockholder may change over time. The percentage of shares owned after the offering is based on 126,964,206 shares of common stock outstanding as of&#160;March 1, 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:56%"></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="14" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares of Common Stock</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number<br />Beneficially<br />Owned<br />Prior to<br />Offering</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number<br />Registered<br />for Sale<br />Hereby</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number<br />Beneficially<br />Owned<br />After<br />Offering</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Percent<br />Owned<br />After<br />Offering</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ampere Computing LLC<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Less than one percent. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of 500,000 shares issued and outstanding in connection with the exercise of the vested portion of the Ampere Warrant. Ren&#233;e J. James is the Chairman and Chief Executive Officer of Ampere and has voting and investment control of the shares held by Ampere. While Ms. James may be deemed to be the beneficial owner of the shares held by Ampere, she disclaims such beneficial ownership. The registered address of Ampere Computing LLC is 4655&#160;Great America Parkway, Suite 601, Santa Clara, CA 95054. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">140 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_17">DESCRIPTION OF SECURITIES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The following summary of the material terms of our securities is not intended to be a complete summary of the rights and preferences of such securities, and is qualified by reference to our certificate of incorporation, our Bylaws and the warrant-related documents described herein and filed as exhibits to the registration statement of which this prospectus forms a part. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Authorized Capitalization </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation authorizes the issuance of 1,000,000,000 shares of common stock, $0.0001 par value per share, and 10,000,000 shares of preferred stock, $0.0001 par value per share. As of March 1, 2023, there were approximately 126,964,206 shares of common stock and no shares of preferred stock issued and outstanding. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Voting Rights </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of common stock will be entitled to one (1)&#160;vote for each share of common stock held of record by such holder on all matters voted upon by our stockholders, provided, however, that, except as otherwise required in the Certificate of Incorporation or by applicable law, the holders of common stock will not be entitled to vote on any amendment to the Certificate of Incorporation that alters or changes the powers, preferences, rights or other terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation (including any certificate of designation relating to any series of preferred stock) or pursuant to the DGCL. When a quorum is present, the affirmative vote of a majority of the voting power of the shares present in person, by remote communication, if applicable, or represented by proxy at the meeting and entitled to vote generally on the subject matter is required to take action, unless otherwise specified by law, the Bylaws or the Certificate of Incorporation, and except for the election of directors, which is determined by a plurality vote. There are no cumulative voting rights. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Dividend Rights </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of the holders of preferred stock and any other provisions of the Certificate of Incorporation, as it may be amended from time to time, holders of common stock will be entitled to receive such dividends and other distributions in cash, stock or property of the Company when, as and if declared thereon by the Board, in its discretion, from time to time out of assets or funds of the Company legally available therefor. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Rights upon Liquidation, Dissolution and <span style="white-space:nowrap">Winding-Up</span> </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of holders of preferred stock, in the event of any liquidation, dissolution or winding up of our affairs, whether voluntary or involuntary, after payment or provision for payment of our debts and any other payments required by law and amounts payable upon shares of preferred stock ranking senior to the shares of common stock upon such dissolution, liquidation or winding up, if any, the Company&#8217;s remaining net assets will be distributed to the holders of common stock and the holders of any other class or series of capital stock ranking equally with the common stock upon such dissolution, liquidation or winding up, equally on a per share basis. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Rights </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of holders of common stock will be subject to those of the holders of preferred stock that the Company may issue in the future. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">141 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Election of Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board is divided into three classes, Class&#160;I, Class&#160;II and Class&#160;III, with members of each class serving staggered three-year terms with only one class of directors being elected in each year. Under the Bylaws, the election of directors is determined by plurality vote. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Preferred Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has the authority to issue shares of preferred stock from time to time on terms it may determine, to divide shares of preferred stock into one or more series and to fix the designations, preferences, privileges, and restrictions of preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption, liquidation preference, sinking fund terms and the number of shares constituting any series or the designation of any series to the fullest extent permitted by the DGCL. The issuance of preferred stock could have the effect of decreasing the trading price of our common stock, restricting dividends on the capital stock, diluting the voting power of the holders of common stock, impairing the liquidation rights of the capital stock, or delaying or preventing a change in control of the company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Warrants </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March 1, 2023, there were 13,074,972 warrants outstanding, consisting of public warrants and private placement warrants. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Public Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each whole public warrant entitles the registered holder to purchase one share of common stock at a price of $11.50 per whole share, subject to adjustment as discussed below, at any time commencing 30 days after the completion of the Business Combination, except as discussed in the immediately succeeding paragraph. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of shares of common stock. This means only a whole warrant may be exercised at a given time by a warrant holder and only whole warrants trade. The warrants will expire five years after the Closing Date, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and we will not be obligated to issue a share of common stock upon exercise of a warrant unless the share of common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement for the registration, under the Securities Act, of the shares of common stock issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to maintain the effectiveness of such registration statement and a current prospectus relating to those shares of Rigetti common stock until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if shares of common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1) of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9) of the Securities Act and, in the event we so elect, we will </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">142 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not be required to file or maintain in effect a registration statement, but we will use our commercially reasonably efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Redemption of warrants when the price per share of common stock equals or exceeds $18.00.</span> Once the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with respect to the private placement warrants): </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in whole and not in part; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at a price of $0.01 per warrant; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon a minimum of 30 days&#8217; prior written notice of redemption to each warrant holder; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">if, and only if, the closing price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212;<span style="font-style:italic">Anti-dilution Adjustments</span>&#8221;) on the trading day prior to the date on which we send the notice of redemption to the warrant holders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of common stock is available throughout the <span style="white-space:nowrap">30-day</span> redemption period. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. Any such exercise would not be done on a &#8220;cashless&#8221; basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. However, the price of the shares of common stock may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212;<span style="font-style:italic">Anti-dilution Adjustments</span>&#8221;) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Redemption of warrants when the price per share of common stock equals or exceeds $10.00</span>. Once the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with respect to the private placement warrants): </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in whole and not in part; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at $0.10 per warrant; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon a minimum of 30 days&#8217; prior written notice of redemption<span style="font-style:italic"> provided</span> that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the &#8220;fair market value&#8221; of our shares of common stock except as otherwise described below; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">if, and only if, the closing price of shares of common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading &#8220;&#8212;<span style="font-style:italic">Anti-dilution Adjustments</span>&#8221;) on the trading day prior to the date on which we send the notice of redemption to the warrant holders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beginning on the date the notice of redemption is given until the warrants are redeemed or exercised, holders may elect to exercise their warrants on a cashless basis. The numbers in the table below represent the number of shares of common stock that a warrant holder will receive upon such cashless exercise in connection with a redemption by us pursuant to this redemption feature, based on the &#8220;fair market value&#8221; of shares of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">143 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock on the corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined for these purposes based on volume weighted average price of shares of common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding redemption date precedes the expiration date of the warrants, each as set forth in the table below. We will provide our warrant holders with the final fair market value no later than one business day after the <span style="white-space:nowrap">10-trading</span> day period described above ends. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The share prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a warrant or the exercise price of a warrant is adjusted as set forth under the heading &#8220;<span style="font-style:italic"> &#8212;Anti-dilution Adjustments</span>&#8221; below. If the number of shares issuable upon exercise of a warrant is adjusted, the adjusted share prices in the column headings will equal the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the exercise price of the warrant after such adjustment and the denominator of which is the price of the warrant immediately prior to such adjustment. In such an event, the number of shares in the table below shall be adjusted by multiplying such share amounts by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted. If the exercise price of a warrant is adjusted, in the case of an adjustment pursuant to the second paragraph under the heading &#8220;<span style="font-style:italic"> &#8212;Anti-dilution Adjustments</span>&#8221; below, the adjusted share prices in the column headings will equal the unadjusted share price less the decrease in the exercise price of a warrant pursuant to such exercise price adjustment. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:46%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="34" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Fair Market Value of Common Stock</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Redemption Date <br />(period to expiration of warrants)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold"></span>&#8804;<span style="font-weight:bold"></span><span style="font-weight:bold">&#160;10.00</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">11.00</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">12.00</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">13.00</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">14.00</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">15.00</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">16.00</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">17.00</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold"></span>&#8805;<span style="font-weight:bold"></span><span style="font-weight:bold">18.00</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">60 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.261</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.281</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.297</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.311</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.324</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.337</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.358</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">57 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.257</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.277</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.294</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.310</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.324</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.337</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.358</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">54 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.291</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.307</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.322</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.335</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.347</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.357</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">51 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.246</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.268</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.287</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.304</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.320</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.357</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">48 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.241</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.263</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.283</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.301</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.317</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.332</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.344</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.356</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">45 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.235</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.258</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.279</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.298</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.315</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.330</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.343</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.356</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">42 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.228</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.274</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.294</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.328</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.342</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.355</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">39 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.221</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.246</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.269</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.290</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.309</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.340</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.354</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">36 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.213</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.239</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.263</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.285</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.305</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.323</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.339</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.353</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">33 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.205</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.232</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.257</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.280</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.301</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.320</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.337</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.224</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.274</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.297</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.316</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.335</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.351</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">27 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.185</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.214</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.242</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.268</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.291</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.313</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.332</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.350</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">24 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.173</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.204</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.233</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.260</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.285</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.308</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.329</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.161</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.193</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.223</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.279</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.304</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.326</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.347</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">18 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.146</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.179</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.211</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.242</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.271</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.298</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.322</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.345</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.130</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.164</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.197</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.230</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.262</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.291</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.317</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.342</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.146</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.181</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.216</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.282</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.339</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.090</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.125</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.162</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.199</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.305</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.336</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.065</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.099</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.178</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.219</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.259</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.296</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.331</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.065</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.104</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.150</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.197</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.243</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.286</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.326</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">0 months</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.042</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.115</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.179</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.233</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.281</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.323</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption date is between two redemption dates in the table, the number of shares of common stock to be issued for each warrant exercised will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier and later redemption dates, as applicable, based on a 365 or <span style="white-space:nowrap">366-day</span> year, as applicable. For example, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">144 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
if the volume weighted average price of our shares of common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.277 shares of common stock for each whole warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the volume weighted average price of shares of common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 shares of common stock for each whole warrant. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than 0.361 shares of common stock per warrant (subject to adjustment). Finally, as reflected in the table above, if the warrants are out of the money and about to expire, they cannot be exercised on a cashless basis in connection with a redemption by us pursuant to this redemption feature, since they will not be exercisable for any shares of common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This redemption feature differs from the typical warrant redemption features used in many other blank check companies, which typically only provide for a redemption of warrants for cash (other than the private placement warrants) when the trading price for the shares of common stock exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the outstanding warrants to be redeemed when the shares of common stock are trading at or above $10.00 per public share, which may be at a time when the trading price of shares of common stock is below the exercise price of the warrants. We have established this redemption feature to provide us with the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under &#8220;<span style="font-style:italic"> &#8212;Redemption of warrants when the price per share of common stock equals or exceeds $18.00</span>.&#8221; Holders choosing to exercise their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their warrants based on an option pricing model with a fixed volatility input as of the of this prospectus. This redemption right provides us with an additional mechanism by which to redeem all of the outstanding warrants, and therefore have certainty as to our capital structure as the warrants would no longer be outstanding and would have been exercised or redeemed. We will be required to pay the applicable redemption price to warrant holders if we choose to exercise this redemption right and it will allow us to quickly proceed with a redemption of the warrants if we determine it is in our best interest to do so. As such, we would redeem the warrants in this manner when we believe it is in our best interest to update our capital structure to remove the warrants and pay the redemption price to the warrant holders. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As stated above, we can redeem the warrants when the shares of common stock are trading at a price starting at $10.00, which is below the exercise price of $11.50, because it will provide certainty with respect to our capital structure and cash position while providing warrant holders with the opportunity to exercise their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the warrants when the shares of common stock are trading at a price below the exercise price of the warrants, this could result in the warrant holders receiving fewer shares of common stock than they would have received if they had chosen to wait to exercise their warrants for shares of common stock if and when such shares of common stock were trading at a price higher than the exercise price of $11.50. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional shares of common stock will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the number of shares of common stock to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the shares of common stock pursuant to the warrant agreement, the warrants may be exercised for such security. At such time as the warrants become exercisable for a security other than the shares of common stock, we (or surviving company) will use our commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Redemption procedures. </span>A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">145 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effect to such exercise, such person (together with such person&#8217;s affiliates), to the warrant agent&#8217;s actual knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the shares of common stock issued and outstanding immediately after giving effect to such exercise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Anti-dilution Adjustments.</span> If the number of outstanding shares of common stock is increased by a capitalization or share dividend payable in shares of common stock, or by a <span style="white-space:nowrap">sub-division</span> of ordinary shares or other similar event, then, on the effective date of such capitalization or share dividend, <span style="white-space:nowrap">sub-division</span> or similar event, the number of shares of common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase shares of common stock at a price less than the &#8220;historical fair market value&#8221; (as defined below) will be deemed a share dividend of a number of shares of common stock equal to the product of (i)&#160;the number of shares of common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for shares of common stock) and (ii)&#160;one minus the quotient of (x)&#160;the price per share of common stock paid in such rights offering and (y)&#160;the historical fair market value. For these purposes, (i)&#160;if the rights offering is for securities convertible into or exercisable for shares of common stock, in determining the price payable for shares of common stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) &#8220;historical fair market value&#8221; means the volume weighted average price of shares of common stock as reported during the 10 trading day period ending on the trading day prior to the first date on which the shares of common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to all or substantially all of the holders of the shares of common stock on account of such shares of common stock (or other securities into which the warrants are convertible), other than (a)&#160;as described above and, (b)&#160;any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions paid on the shares of common stock during the <span style="white-space:nowrap">365-day</span> period ending on the date of declaration of such dividend or distribution does not exceed $0.50 (as adjusted to appropriately reflect any other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of shares of common stock issuable on exercise of each warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50 per share, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of common stock in respect of such event. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the number of outstanding shares of common stock is decreased by a consolidation, combination or reclassification of shares of common stock or other similar event, then, on the effective date of such consolidation, combination, reclassification or similar event, the number of shares of common stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares of common stock. Whenever the number of shares of common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x)&#160;the numerator of which will be the number of shares of common stock purchasable upon the exercise of the warrants immediately prior to such adjustment and (y)&#160;the denominator of which will be the number of shares of common stock so purchasable immediately thereafter. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case of any reclassification or reorganization of the outstanding shares of common stock (other than those described above or that solely affects the par value of such shares of common stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our outstanding shares of common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">146 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions specified in the warrants and in lieu of the shares of common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of common stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. However, if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each warrant will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders in such consolidation or merger that affirmatively make such election, and if a tender, exchange or redemption offer has been made to and accepted by such holders (other than a tender, exchange or redemption offer made by the company in connection with redemption rights held by shareholders of the company as provided for in the company&#8217;s amended and restated memorandum and articles of association or as a result of the redemption of shares of common stock by the company if a proposed initial business combination is presented to the shareholders of the company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule <span style="white-space:nowrap">13d-5(b)(1)</span> under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule <span style="white-space:nowrap">12b-2</span> under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule <span style="white-space:nowrap">13d-3</span> under the Exchange Act) more than 50% of the issued and outstanding shares of common stock, the holder of a warrant will be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the shares of common stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustment (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in the warrant agreement. If less than 70% of the consideration receivable by the equityholders of Rigetti in such a transaction is payable in the form of shares of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established <span style="white-space:nowrap"><span style="white-space:nowrap">over-the-counter</span></span> market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrants have been issued in registered form under a warrant agreement between American Stock Transfer&#160;&amp; Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder for the purpose of (i)&#160;curing any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in this prospectus, or defective provision (ii)&#160;amending the provisions relating to cash dividends on ordinary shares as contemplated by and in accordance with the warrant agreement or (iii)&#160;adding or changing any provisions with respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants, provided that the approval by the holders of at least 50% of the then-outstanding public warrants is required to make any change that adversely affects the interests of the registered holders. You should review a copy of the warrant agreement, which is filed as an exhibit to the registration statement of which this prospectus is a part, for a complete description of the terms and conditions applicable to the warrants. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">147 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrant holders do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive shares of common stock. After the issuance of shares of common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional warrants will be issued upon separation of the units and only whole warrants will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of shares of common stock to be issued to the warrant holder. We have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. See &#8220;<span style="font-style:italic">Risk Factors&#8212;The warrant agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with us.</span>&#8221; This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Private Placement Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as described below, the private placement warrants have terms and provisions that are identical to those of the public warrants. The private placement warrants (including the shares of common stock issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of the Business Combination (except pursuant to limited exceptions, to our officers and directors and other persons or entities affiliated with the initial purchasers of the private placement warrants) and they will not be redeemable by us so long as they are held by Supernova Sponsor or its permitted transferees. Supernova Sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other than Supernova Sponsor or its permitted transferees, the private placement warrants will be redeemable by us in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in Supernova&#8217;s initial public offering. Any amendment to the terms of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants will require a vote of holders of at least 50% of the number of the then outstanding private placement warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If holders of the private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number of shares of common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by the excess of the &#8220;Sponsor fair market value&#8221; (defined below) over the exercise price of the warrants by (y)&#160;the Sponsor fair market value. For these purposes, the &#8220;Sponsor fair market value&#8221; shall mean the average reported closing price of the shares of common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Dividends </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not paid any cash dividends on our common stock to date. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements, general financial condition, contractual restrictions and other factors that our Board may deem relevant and will be within the discretion of our Board at such time. In addition, our ability to pay dividends may be limited by covenants of any existing and future outstanding indebtedness that we or our subsidiaries incur. We do not anticipate declaring any cash dividends to holders of common stock in the foreseeable future. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">148 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain Anti-Takeover Provisions of Delaware Law and our Second Amended and Restated Certificate of Incorporation and Bylaws </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Section&#160;203 of the Delaware General Corporation Law </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to Section&#160;203 of the DGCL, which generally prohibits a publicly held Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, those shares owned (1)&#160;by persons who are directors and also officers and (2)&#160;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&#160;203 defines a &#8220;business combination&#8221; to include the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any merger or consolidation involving the corporation and the interested stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through the corporation. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&#160;203 defines an &#8220;interested stockholder&#8221; as an entity or person who, together with the person&#8217;s affiliates and associates, beneficially owns or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Delaware corporation may &#8220;opt out&#8221; of these provisions with an express provision in its original certificate of incorporation or an express provision in an amended and restated certificate of incorporation or amended and restated bylaws resulting from a stockholders&#8217; amendment approved by at least a majority of the outstanding voting shares. We have not opted out of these provisions. As a result, mergers or other takeover or change in control attempts of us may be discouraged or prevented. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Certificate of Incorporation and Bylaws </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Among other things, our Certificate of Incorporation and Bylaws: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">providing for a classified board of directors with staggered, three-year terms; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the ability of the Board to issue up to 10,000,000 shares of preferred stock, including &#8220;blank check&#8221; preferred stock, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change of control; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">149 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that the authorized number of directors may be changed only by resolution of the Board; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that, subject to the rights of the holders of any series of preferred stock, any individual director or directors may be removed only with cause by the affirmative vote of the holders of at least 66 2/3% of the voting power of all of the then-outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent or electronic transmission; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder&#8217;s notice; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provide that special meetings of our stockholders may be called by the chairperson of the Board, the chief executive officer or by the Board pursuant to a resolution adopted by a majority of the total number of authorized directors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">not provide for cumulative voting rights, therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The combination of these provisions will make it more difficult for the existing stockholders to replace our Board as well as for another party to obtain control of us by replacing our Board. Because our Board has the power to retain and discharge its officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated preferred stock makes it possible for our Board to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions are intended to enhance the likelihood of continued stability in the composition of our Board and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and to discourage certain<span style="font-style:italic"> </span>tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control or management. As a consequence, these provisions may also inhibit fluctuations in the market price of our stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Exclusive Forum of Certain Actions </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation requires, unless the we consent in writing to the selection of an alternative forum, that Court of Chancery of the State of Delaware (or, if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware) and any appellate court therefrom is the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (i)&#160;derivative actions brought on behalf of the Company; (ii)&#160;actions against current or former directors, officers or other employees or stockholders of the Company for breach of fiduciary duty to the Company or the Company&#8217;s stockholders; (iii)&#160;actions against the Company or any current or former director, officer or other employee or stockholder of the Company, arising out of or pursuant to any provision of the DGCL or the Certificate of Incorporation or the Bylaws,: (iv) actions to interpret, apply, enforce or determine the validity of the Certificate of Incorporation or the Bylaws; (v)&#160;actions as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware; and (vi)&#160;actions against the Company or any current or former director, officer or other employee or stockholder of the Company, governed by the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">150 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
internal-affairs doctrine of the law of the State of Delaware, in all cases to the fullest extent permitted by law and subject to the court having personal jurisdiction over the indispensable parties named as defendants. However, this provision will not apply to claims or actions brought to enforce a duty or liability created by the Securities Act or Exchange Act, or any other claim for which the federal courts have exclusive jurisdiction. The Certificate of Incorporation further provides that unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause or causes of action arising under the Securities Act, including all causes of action asserted against any defendant named in such complaint. Additionally, the Certificate of Incorporation provides that any person or entity holding, owning or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to these provisions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we believe this provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, the provision may have the effect of discouraging lawsuits against our directors and officers. Additionally, we cannot be certain that a court will decide that this provision is either applicable or enforceable, and if a court were to find the choice of forum provision contained in the amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results and financial condition. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Amendment to Certificate of Incorporation and Bylaws </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The DGCL provides generally that the affirmative vote of a majority of the outstanding stock entitled to vote on amendments to a corporation&#8217;s certificate of incorporation or bylaws is required to approve such amendment, unless a corporation&#8217;s certificate of incorporation or bylaws, as the case may be, requires a greater percentage. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation provides, in addition to the votes required by law, that the following provisions therein may be amended, altered, repealed or rescinded only by the affirmative of the holders of at least <span style="white-space:nowrap">sixty-six</span> and <span style="white-space:nowrap">two-thirds</span> percent (66 2/3%) of the voting power of all of the then-outstanding shares of capital stock of Rigetti common stock and preferred stock entitled to vote generally in the election of directors, voting together as a single class, including provisions regarding the classified board structure, the size of the Board, the election and removal of directors to the Board, the filling of vacancies, the limited liability of directors and officers of Rigetti and exclusive forums for certain actions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Bylaws may be amended or repealed (A)&#160;by the affirmative vote of a majority of the entire Board then in office, without the assent or vote of any stockholder (subject to any bylaw requiring the affirmative vote of a larger percentage of the members of the Board) or (B)&#160;without the approval of the Board, by the affirmative vote of the holders of any class or series of stock of Rigetti required by law or by the Certificate of Incorporation, such action by stockholders requiring the affirmative vote of the holders of at least <span style="white-space:nowrap">sixty-six</span> and <span style="white-space:nowrap">two-thirds</span> percent (66 2/3%) of the voting power of all of the then-outstanding shares of the capital stock of Rigetti entitled to vote generally in the election of directors, voting together as a single class. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Limitations of Liability and Indemnification </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#8220;Management&#8212;Limitation on Liability and Indemnification of Directors and Officers.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Rule 144 </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Rule 144 under the Securities Act (&#8220;Rule 144&#8221;), a person who has beneficially owned restricted shares of our common stock or our warrants for at least six months would be entitled to sell their securities provided that (i)&#160;such person is not deemed to have been our affiliate at the time of, or at any time during the three months preceding, a sale and (ii)&#160;we are subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports under Section&#160;13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as we are required to file reports) preceding the sale. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">151 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Persons who have beneficially owned restricted shares of our common stock or our warrants for at least six months but who are our affiliates at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">1% of the total number of our common stock then outstanding; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the average weekly reported trading volume of our common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales by our affiliates under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information about us. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rule 144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the issuer of the securities that was formerly a shell company has ceased to be a shell company; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the issuer of the securities is subject to the reporting requirements of Section&#160;13 or 15(d) of the Exchange Act; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form <span style="white-space:nowrap">8-K</span> reports; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Transfer Agent and Warrant Agent </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent for common stock and warrant agent for the warrants is American Stock Transfer&#160;&amp; Trust Company. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Listing of Securities </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock and public warrants are listed on the Nasdaq Capital Market under the symbols &#8220;RGTI&#8221; and &#8220;RGTIW,&#8221; respectively. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">152 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_18">CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES FOR <span style="white-space:nowrap">NON-U.S.</span> HOLDERS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of certain material U.S. federal income tax consequences applicable <span style="white-space:nowrap">to&#160;non-U.S.&#160;holders</span> (as defined below) with respect to their ownership and disposition of shares of our common stock, but does not purport to be a complete analysis of all potential tax effects. This discussion is based on current provisions of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) existing and proposed U.S. Treasury Regulations promulgated thereunder, current administrative rulings and judicial decisions, all as in effect as of the date of this prospectus and, all of which are subject to change or to differing interpretation, possibly with retroactive effect. Any such change or differing interpretation could alter the tax consequences <span style="white-space:nowrap">to&#160;non-U.S.&#160;holders</span> described in this prospectus. There can be no assurance that the Internal Revenue Service, which we refer to as the IRS, will not challenge one or more of the tax consequences described herein. We assume in this discussion that <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> holds shares of our common stock as a capital asset within the meaning of Section&#160;1221 of the Code, which is generally property held for investment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a <span style="white-space:nowrap">particular&#160;non-U.S.&#160;holder</span> in light of <span style="white-space:nowrap">that&#160;non-U.S.&#160;holder&#8217;s</span> individual circumstances nor does it address any U.S. state, local <span style="white-space:nowrap">or&#160;non-U.S.&#160;tax</span> considerations, the alternative minimum tax, the Medicare tax on net investment income, the rules regarding qualified small business stock within the meaning of Section&#160;1202 of the Code, or any other aspect of any U.S. federal tax other than the income tax. This discussion also does not consider any specific facts or circumstances that may apply to a <span style="white-space:nowrap">non-U.S.</span> holder and does not address the special tax rules applicable to <span style="white-space:nowrap">particular&#160;non-U.S.&#160;holders,</span> such as: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">insurance companies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="white-space:nowrap">tax-exempt&#160;or</span> governmental organizations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">financial institutions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">brokers or dealers in securities; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">regulated investment companies; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">pension plans; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">&#8220;qualified foreign pension funds,&#8221; or entities wholly owned by a &#8220;qualified foreign pension fund&#8221;; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">persons deemed to sell our common stock under the constructive sale provisions of the Code; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">persons that hold our common stock as part of a straddle, hedge, conversion transaction, synthetic security or other integrated investment; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">certain U.S. expatriates. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> means a beneficial owner of our common stock that is for U.S. federal income tax purposes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="white-space:nowrap">a&#160;non-resident&#160;alien</span> individual; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a corporation or other organization taxable as a corporation for U.S. federal income tax purposes that is created or organized in or under laws other than the laws of the United States, any state thereof, or the District of Columbia; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an estate the income of which is not subject to U.S. federal income tax on a net income basis; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a trust the income of which is not subject to U.S. federal income tax on a net income basis and that (1)&#160;is not subject to the primary supervision of a court within the United States or over which no U.S. persons have authority to control all substantial decisions and (2)&#160;has not made an election to be treated as a U.S. person </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">153 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">This discussion does not address the tax treatment of partnerships or other entities that are pass-through entities for U.S. federal income tax purposes or persons that hold their common stock through partnerships or other pass-through entities. A partner in a partnership or other pass-through entity that will hold our common stock should consult his, her or its tax advisor regarding the tax consequences of acquiring, holding and disposing of our common stock through a partnership or other pass-through entity, as applicable. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is for general information only and is not tax advice. Accordingly, all prospective <span style="white-space:nowrap">non-U.S.</span> holders of our common stock should consult their tax advisors with respect to the U.S. federal, state, local <span style="white-space:nowrap">and&#160;non-U.S.&#160;tax</span> consequences of the purchase, ownership and disposition of our common stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Distributions on Our Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions, if any, on our common stock will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as <span style="white-space:nowrap">a&#160;tax-free&#160;return</span> of <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder&#8217;s</span> investment, up to such holder&#8217;s tax basis in the common stock. Any remaining excess will be treated as capital gain, subject to the tax treatment described below in &#8220;Gain on Sale or Other Taxable Disposition of Our Common Stock.&#8221; Any such distributions will also be subject to the discussions below under the sections titled &#8220;Backup Withholding and Information Reporting&#8221; and &#8220;Withholding and Information Reporting Requirements&#8212;FATCA.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion in the following two paragraphs in this section, dividends paid to <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder&#8217;s country of residence. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends that are treated as effectively connected with a trade or business conducted by <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> within the United States and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder</span> within the United&#160;States, are generally exempt from the 30% withholding tax if <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder</span> satisfies applicable certification and disclosure requirements. However, such U.S. effectively connected income, net of specified deductions and credits, is taxed at the same U.S. federal income tax rates applicable to United States persons (as defined in the Code). Any U.S. effectively connected income received by <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> that is a corporation may also, under certain circumstances, be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder&#8217;s country of residence. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">A&#160;non-U.S.&#160;holder</span> of our common stock who claims the benefit of an applicable income tax treaty between the United States and such holder&#8217;s country of residence generally will be required to provide a properly executed IRS <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">Form&#160;W-8BEN&#160;or&#160;W-8BEN-E&#160;(or</span></span></span> successor form), as applicable, to the applicable withholding agent and satisfy applicable certification and other requirements. <span style="white-space:nowrap">Non-U.S.</span> holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty. <span style="white-space:nowrap">A&#160;non-U.S.&#160;holder</span> that is eligible for a reduced rate of U.S. withholding tax under an income tax treaty may obtain a refund or credit of any excess amounts withheld by timely filing a U.S. tax return with the IRS. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Gain on Sale or Other Taxable Disposition of Our Common Stock </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussions below under &#8220;Backup Withholding and Information Reporting&#8221; and &#8220;Withholding and Information Reporting Requirements&#8212;FATCA,&#8221; <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> generally will not be subject to any U.S. federal income tax on any gain realized upon such holder&#8217;s sale or other taxable disposition of shares of our common stock unless: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the gain is effectively connected with <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder&#8217;s</span> conduct of a U.S. trade or business and, if an applicable income tax treaty so provides, is attributable to a permanent establishment or a fixed-base maintained by <span style="white-space:nowrap">such&#160;non-U.S.&#160;holder</span> in the United States, in which case the <span style="white-space:nowrap">non-U.S.</span> holder generally </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">154 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
will be taxed on a net income basis at the U.S. federal income tax rates applicable to United States persons (as defined in the Code) and, if the <span style="white-space:nowrap">non-U.S.</span> holder is a foreign corporation, the branch profits tax described above in &#8220;Distributions on Our Common Stock&#8221; also may apply; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="white-space:nowrap">the&#160;non-U.S.&#160;holder</span> is a nonresident alien individual who is present in the United States for a period or periods aggregating 183 days or more in the taxable year of the disposition and certain other conditions are met, in which case <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder</span> will be subject to a 30% tax on the net gain derived from the disposition, which may be offset by certain U.S. source capital losses of <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder,</span> if any (even though the individual is not considered a resident of the United States), provided that the <span style="white-space:nowrap">non-U.S.</span> holder has timely filed U.S. federal income tax returns with respect to such losses; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">we are, or have been, at any time during the five-year period preceding such sale of other taxable disposition (or <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder&#8217;s</span> holding period, if shorter) a &#8220;U.S. real property holding corporation,&#8221; unless our common stock is regularly traded on an established securities market as defined for purposes of applicable Treasury Regulations and <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder</span> holds no more than 5% of our outstanding common stock, directly or indirectly, actually or constructively, during the shorter of <span style="white-space:nowrap">the&#160;5-year&#160;period</span> ending on the date of the disposition or the period that <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder</span> held our common stock. Generally, a corporation is a U.S. real property holding corporation only if the fair market value of its U.S. real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business. Although there can be no assurance, we do not believe that we are, or have been, a U.S. real property holding corporation, or that we are likely to become one in the future. No assurance can be provided that our common stock will be regularly traded on an established securities market for purposes of the rules described above. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Backup Withholding and Information Reporting </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We must report annually to the IRS and to <span style="white-space:nowrap">each&#160;non-U.S.&#160;holder</span> the gross amount of the distributions on our common stock paid to such holder and the tax withheld, if any, with respect to such distributions. <span style="white-space:nowrap">Non-U.S.</span> holders may have to comply with specific certification procedures to establish that the holder is not a United States person (as defined in the Code) in order to avoid backup withholding at the applicable rate with respect to distributions on our common stock. Dividends paid <span style="white-space:nowrap">to&#160;non-U.S.&#160;holders</span> subject to withholding of U.S. federal income tax, as described above in &#8220;Distributions on Our Common Stock,&#8221; generally will be exempt from U.S. backup withholding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information reporting and backup withholding will generally apply to the proceeds of a disposition of our common stock by <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> effected by or through the U.S. office of any broker, U.S. or foreign, unless the holder certifies its status as <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> and satisfies certain other requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> where the transaction is effected outside the United States through <span style="white-space:nowrap">a&#160;non-U.S.&#160;office</span> of a broker. However, for information reporting purposes, dispositions effected through <span style="white-space:nowrap">a&#160;non-U.S.&#160;office</span> of a broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Non-U.S.&#160;holders</span> should consult their tax advisors regarding the application of the information reporting and backup withholding rules to them. Copies of information returns may be made available to the tax authorities of the country in which <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder</span> resides or is incorporated under the provisions of a specific treaty or agreement. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to <span style="white-space:nowrap">a&#160;non-U.S.&#160;holder</span> can be refunded or credited against <span style="white-space:nowrap">the&#160;non-U.S.&#160;holder&#8217;s</span> U.S. federal income tax liability, if any, provided that an appropriate claim is filed with the IRS in a timely manner. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Withholding and Information Reporting Requirements&#8212;FATCA </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Foreign Account Tax Compliance Act and guidance issued thereunder (&#8220;FATCA&#8221;) imposes withholding taxes on certain types of payments made to &#8220;foreign financial institutions&#8221; and certain other foreign </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">155 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entities (including financial intermediaries). FATCA generally imposes withholding at a rate of 30% on payments to certain foreign entities of dividends on our common stock and certain other withholdable payments, unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied or the entity otherwise qualifies for an exemption. An intergovernmental agreement between the United States and an applicable foreign country may modify these requirements. Such withholding may apply to gross proceeds from the sale or other disposition of our common stock, although under proposed U.S. Treasury Regulations, no withholding would apply to such gross proceeds. The preamble to the proposed regulations specifies that taxpayers (including withholding agents) are permitted to rely on the proposed regulations pending finalization. You should consult your tax advisor regarding the application of FATCA. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">The preceding discussion of U.S. federal tax consequences is for general information only. It is not tax advice. Each prospective investor should consult its own tax advisor regarding the particular U.S. federal, state and local <span style="white-space:nowrap">and&#160;non-U.S.&#160;tax</span> consequences of purchasing, holding and disposing of our common stock, including the consequences of any proposed change in applicable laws. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">156 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_19">PLAN OF DISTRIBUTION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are registering the resale by the selling stockholder or its permitted transferees from time to time of up to 500,000 shares of common stock issued pursuant to the exercise of the vested portion of the Ampere Warrant purchased by the selling stockholder pursuant to the Warrant Subscription Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to pay all fees and expenses incident to the registration of the securities to be offered and sold pursuant to this prospectus. The selling stockholder will bear all commissions and discounts, if any, attributable to its sale of securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any of the proceeds from the sale of the securities by the selling stockholder. The aggregate proceeds to the selling stockholder will be the purchase price of the securities less any discounts and commissions borne by the selling stockholder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock owned by the selling stockholder covered by this prospectus may be offered and sold from time to time by the selling stockholder. The selling stockholder will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in <span style="white-space:nowrap"><span style="white-space:nowrap">the&#160;over-the-counter&#160;market</span></span> or otherwise, at prices and under terms then prevailing or at prices related to the then current market price or in negotiated transactions. The selling stockholder may sell their securities by one or more of, or a combination of, the following methods:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">ordinary brokerage transactions and transactions in which the broker solicits purchasers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an <span style="white-space:nowrap"><span style="white-space:nowrap">over-the-counter</span></span> distribution in accordance with the rules of Nasdaq; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">through trading plans entered into by a selling stockholder pursuant to Rule <span style="white-space:nowrap">10b5-1</span> under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of its securities on the basis of parameters described in such trading plans; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">short sales; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">distribution to employees, members, limited partners or stockholders of the selling stockholder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">through the writing or settlement of options or other hedging transaction, whether through an options exchange or otherwise; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">by pledge to secured debts and other obligations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">delayed delivery arrangements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to or through underwriters or broker-dealers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in &#8220;at the market&#8221; offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in privately negotiated transactions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in options transactions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">through a combination of any of the above methods of sale; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">any other method permitted pursuant to applicable law. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">157 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, any securities that qualify for sale pursuant to Rule 144 or another exemption from registration under the Securities Act or other such exemption may be sold under Rule 144 rather than pursuant to this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of distribution. In connection with distributions of the securities or otherwise, the selling stockholder may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of the securities in the course of hedging the positions they assume with selling the stockholder. The selling stockholder may also sell the securities short and redeliver the securities to close out such short positions. The selling stockholder may also enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The selling stockholder may also pledge securities to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution, may effect sales of the pledged securities pursuant to this prospectus (as supplemented or amended to reflect such transaction). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In effecting sales, broker-dealers or agents engaged by the selling stockholder may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the selling stockholder in amounts to be negotiated immediately prior to the sale. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In offering the securities covered by this prospectus, the selling stockholder and any broker-dealers who execute sales for the selling stockholder may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. Any profits realized by the selling stockholder and the compensation of any broker-dealer may be deemed to be underwriting discounts and commissions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If at the time of any offering made under this prospectus a member of FINRA participating in the offering has a &#8220;conflict of interest&#8221; as defined in FINRA Rule 5121 (&#8220;Rule 5121&#8221;), that offering will be conducted in accordance with the relevant provisions of Rule 5121. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to comply with the securities laws of certain states, if applicable, the securities must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have advised the selling stockholder that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of securities in the market and to the activities of the selling stockholder and its affiliates. In addition, we will make copies of this prospectus available to the selling stockholder for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholder may indemnify any broker-dealer that participates in transactions involving the sale of the securities against certain liabilities, including liabilities arising under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the time a particular offer of securities is made, if required, a prospectus supplement will be distributed that will set forth the number of securities being offered and the terms of the offering, including the name of any underwriter, dealer or agent, the purchase price paid by any underwriter, any discount, commission and other item constituting compensation, any discount, commission or concession allowed or reallowed or paid to any dealer, and the proposed selling price to the public. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the selling stockholder against certain liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares offered by this prospectus. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">158 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Warrant Subscription Agreement, we have agreed to keep the registration statement of which this prospectus constitutes a part effective through the earliest of (i)&#160;three years from the date the initial registration statement covering the registrable securities under the Subscription Agreements is declared effective, (ii)&#160;the date on which subscriber no longer owns the Ampere Warrant or (iii)&#160;the first date on which subscriber can sell the Ampere Warrant (or shares received in exchange therefor) without any condition or limitation under Rule 144. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">159 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_20">LEGAL MATTERS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of any securities offered by this prospectus will be passed upon for us by Cooley LLP. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_21">EXPERTS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Rigetti Computing, Inc. as of December&#160;31, 2022 and 2021, and for the year ended December 31, 2022 and eleven months ended December&#160;31, 2021, included in this Prospectus and in the Registration Statement have been so included in reliance on the report of BDO USA, LLP, an independent registered public accounting firm, appearing elsewhere herein and in the Registration Statement, given on the authority of said firm as experts in auditing and accounting. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_23">WHERE YOU CAN FIND MORE INFORMATION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <span style="white-space:nowrap">S-1</span> under the Securities Act, with respect to the securities being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all of the information in the registration statement and its exhibits. For further information with respect to Rigetti and the securities offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference. You can read our SEC filings, including the registration statement, over the internet at the SEC&#8217;s website at <span style="font-style:italic">www.sec.gov</span>. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate website address is www.rigetti.com. We make available on our website, free of charge, our Annual Reports on Form 10-K, our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding our filings at www.sec.gov. We use our corporate website as a channel of distribution of material company information. For example, financial and other material information regarding our company is routinely posted on and accessible on our website. Accordingly, investors should monitor this channel, in addition to following our press releases, SEC filings and public conference calls and webcasts. The information found on our website is not incorporated by reference into this prospectus or any reports we file with or furnish to the SEC. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">160 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>
<div style='display: none'><ix:header><ix:hidden><ix:nonNumeric name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="hidden73805686" contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis">http://fasb.org/us-gaap/2022#Liabilities</ix:nonNumeric><ix:nonNumeric name="rgti:NumberOfTradingDaysForDeterminingTheSharePrice" id="hidden73805545" contextRef="P12_31_2022To12_31_2022">P20D</ix:nonNumeric><ix:nonNumeric name="rgti:NumberOfTradingDaysForDeterminingTheSharePrice" id="hidden73805546" contextRef="P12_31_2022To12_31_2022">P20D</ix:nonNumeric><ix:nonNumeric name="rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" id="hidden73805503" contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis">P30D</ix:nonNumeric><ix:nonNumeric name="rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" id="hidden73805504" contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis">P30D</ix:nonNumeric><ix:nonNumeric name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="hidden73805685" contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis">http://fasb.org/us-gaap/2022#Assets</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="rgti-20221231.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references></ix:header></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div id="index" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 96%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin426335_1">Report of Independent Registered Public Accounting Firm (BDO USA, LLP, Spokane, Washington, PCAOB ID #243)</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F-2</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin426335_2">Consolidated Balance Sheets as of December&#160;31, 2022 and 2021</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F-3</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin426335_3">Consolidated Statements of Operations for the Year Ended December&#160;31, 2022 and for the Eleven Months Ended December&#160;31, 2021</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F-4</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin426335_4">Consolidated Statements of Comprehensive Loss for the Year Ended December 31, 2022 and for the Eleven Months Ended December 31, 2021 </a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F-5</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin426335_5">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) for the Year Ended December&#160;31, 2022 and for the Eleven Months Ended December&#160;31, 2021</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F-6</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin426335_6">Consolidated Statements of Cash Flows for the Year Ended December&#160;31, 2022 and for the Eleven Months Ended December&#160;31, 2021</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F-7</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin426335_7">Notes to Consolidated Financial Statements</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">F-8</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-1 </div></div></div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin426335_1">Report of Independent Registered Public Accounting Firm </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shareholders and Board of Directors </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rigetti Computing, Inc. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Berkeley, California </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Opinion on the Consolidated Financial Statements </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">We have audited the accompanying consolidated balance sheets of Rigetti Computing, Inc. (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, redeemable convertible preferred stock and stockholders&#8217; equity (deficit), and cash flows for the year ended December 31, 2022 and for the eleven months ended December 31, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for the year ended December 31, 2022 and the eleven months ended December 31, 2021<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">,</div></div> in conformity with accounting principles generally accepted in the United States of America. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in Accounting Principle </div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As discussed in Notes 2 and 8 to the consolidated financial statements, the Company has changed its accounting method for accounting for leases in 2022 due to the adoption of Topic 842: Leases. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis for Opinion</div></div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>BDO USA, LLP</div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have served as the Company&#8217;s auditor since 2021. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Spokane, Washington </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">March 27, 2023 </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 6pt; margin-top: 8pt; margin-bottom: 0pt; text-align: center;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-2 </div></div> </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div id="fin426335_2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 9.5pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9.5pt; letter-spacing: 0px; top: 0px;;display:inline;">RIGETTI COMPUTING, INC. </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 9.5pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9.5pt; letter-spacing: 0px; top: 0px;;display:inline;">CONSOLIDATED BALANCE SHEETS </div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 9.5pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9.5pt; letter-spacing: 0px; top: 0px;;display:inline;">(In thousands, except share and per share amounts) </div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:77%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current assets:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">57,888</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,729</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> investments</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">84,923</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:MarketableSecuritiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction>&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,235</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,543</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,450</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,351</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Forward contract&#8212;assets</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ForwardContractAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,229</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ForwardContractAssetsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction>&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredCostsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">742</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredCostsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,449</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current assets</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">154,467</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,072</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">39,530</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,497</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets, net</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,316</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RestrictedCash" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">317</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">129</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">165</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,377</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total assets</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">203,442</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">46,428</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="font-size:1pt">
<td style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities, redeemable convertible preferred stock and stockholders&#8217; equity (deficit)</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current liabilities:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,938</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,971</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,205</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,806</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">961</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">985</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Debt&#8212;current portion</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,303</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">575</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Operating lease liabilities&#8212;current</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,345</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Forward contract&#8212;liabilities</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ForwardContractLiabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction>&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ForwardContractLiabilities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">230</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">21,752</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,567</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt - net of current portion</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:DebtNetOfCurrentPortion" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">20,635</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:DebtNetOfCurrentPortion" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">24,216</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities - noncurrent</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,858</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,767</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,355</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-out</div> liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,206</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">295</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">53,218</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">36,433</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commitments and contingencies (Note 9)</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction>&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redeemable convertible preferred stock*, par value $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction> shares and <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">80,974,757</ix:nonFraction> shares authorized at December&#160;31, 2022 and December&#160;31, 2021, respectively; <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">77,696,679</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2022 and December&#160;31, 2021, respectively</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero" id="Fact_73804637">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804636">81,523</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stockholders&#8217; equity (deficit):</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stock, par value $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction> shares and <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction> shares authorized at December&#160;31, 2022 and December&#160;31, 2021, respectively; <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2022 and December&#160;31, 2021, respectively</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PreferredStockValueOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PreferredStockValueOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock*, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,000,000,000</ix:nonFraction> shares and <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">134,050,472</ix:nonFraction> shares authorized at December&#160;31, 2022 and December&#160;31, 2021, respectively; <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">125,257,233</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">18,221,069</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;21, 2022 and December&#160;31, 2021, respectively</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804635">12</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804634">2</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">429,025</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">135,549</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated other comprehensive gain (loss)</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">161</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">52</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated deficit</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">278,652</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">207,131</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total stockholders&#8217; equity (deficit)</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">150,224</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,528</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9.5pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities, redeemable convertible preferred stock and stockholders&#8217; equity (deficit)</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">203,442</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">46,428</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left;">*</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9.5pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;C-1</div> Preferred Stock, legacy Class&#160;A Common Stock, and legacy Class&#160;B Common Stock have been retroactively restated to give effect to the Business Combination. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman;text-align:center">The accompanying notes are an integral part of these consolidated financial statements. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-3 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> <div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div id="fin426335_3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RIGETTI COMPUTING, INC. </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CONSOLIDATED STATEMENTS OF OPERATIONS </div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(In thousands, except for share and per share amounts) </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 72%;"></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,102</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,196</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,873</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,623</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gross profit</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,229</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,573</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1pt">
<td style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">59,952</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">26,928</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,348</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,475</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">47,632</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,299</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill impairment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,377</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">119,309</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">40,702</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from operations</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">109,080</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">34,129</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other income (expense), net:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest expense</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,286</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,465</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,433</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">22,132</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,664</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">earn-out</div> liability</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">19,207</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transaction costs</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:TransactionCosts" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">927</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:TransactionCosts" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Other income</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other income (expense), net</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">37,559</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">4,112</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss before provision for income taxes</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,521</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,241</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Provision for income taxes</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,521</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,241</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Net loss per share attributable to common stockholders - basic and diluted</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">0.70</ix:nonFraction></ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">1.64</ix:nonFraction></ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Weighted average shares used in computing net loss per share attributable to common <br/>stockholders&#8212;basic and diluted*</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_73804579"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804581">102,300,852</ix:nonFraction></ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_73804580"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804582">23,337,127</ix:nonFraction></ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left;">*</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Weighted-average shares have been retroactively restated to give effect to the Business Combination. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">The accompanying notes are an integral part of these consolidated financial statements. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-4 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> <div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div id="fin426335_4" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RIGETTI COMPUTING, INC. </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS </div></div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(In thousands) </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 74%;"></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:74%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,521</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,241</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other comprehensive gain (loss):</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency translation gain (loss)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">101</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in unrealized loss on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">314</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Comprehensive loss</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,734</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,246</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">The accompanying notes are an integral part of these consolidated financial statement </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-5 </div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div> <div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div id="fin426335_5" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RIGETTI COMPUTING, INC. </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) </div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(In thousands) </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 53%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align: bottom;"></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Redeemable&#160;Convertible<br/>Preferred&#160;Stock*</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common&#160;Stock*</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-In</div><br/>Capital</div></div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Other<br/>Comprehensive<br/>Gain (Loss)</div></div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Deficit</div></div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/>Stockholders&#8217;<br/>Equity</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Deficit)</div></div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="30" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(In thousands, except share and per share data)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 53%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align: bottom;"></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-size: 0px;">
<td style="width:46%"></td>
<td style="vertical-align:bottom"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="vertical-align:bottom"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;"><div style="font-size: 8pt;;font-weight:bold;display:inline;">Balance, January&#160;31, 2021</div></div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn01_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804565">77,696,679</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn01_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804567">81,523</ix:nonFraction></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn01_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804566">16,582,525</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn01_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804572">2</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn01_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">133,406</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn01_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">57</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn01_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">168,890</ix:nonFraction>)</td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn01_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">35,425</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;"></div>)</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock upon exercise of stock options</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P02_01_2021To12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804970">1,404,966</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P02_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">375</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">375</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock upon exercise of common stock warrants</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" contextRef="P02_01_2021To12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73805486">233,578</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" contextRef="P02_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="P02_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,765</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,765</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency translation loss</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="P02_01_2021To12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P02_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,241</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,241</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;"><div style="font-size: 8pt;;font-weight:bold;display:inline;">Balance, December&#160;31, 2021</div></div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804547">77,696,679</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804559">81,523</ix:nonFraction></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804546">18,221,069</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804558">2</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">135,549</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">52</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">207,131</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,528</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; line-height: 9pt;;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock upon conversion of legacy Series C and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock in connection with the Business Combination (Note 3)</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="rgti:ReclassificationOfTemporaryEquityShares" contextRef="P01_01_2022To12_31_2022_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" sign="-" format="ixt:num-dot-decimal" id="Fact_73805338">77,696,679</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" contextRef="P01_01_2022To12_31_2022_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal" id="Fact_73804742">81,523</ix:nonFraction></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:ReclassificationOfTemporaryEquityShares" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73805339">57,380,563</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804741">6</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">81,517</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">81,523</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock upon exercise of stock options</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804971">2,768,568</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,020</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,020</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock upon exercise of common stock warrants</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73805487">4,818,630</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,048</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,048</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73805344">34,850,706</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73805341">3</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">159,535</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">159,538</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock upon release of RSUs</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73805492">7,046,689</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73805491">1</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Reclassification of loan and security agreement warrants to equity</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,370</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,370</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Settlement of the first tranche of forward contract</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="rgti:AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3,305</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="rgti:AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3,305</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Capitalization of deferred costs to equity upon share issuance</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,520</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,520</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock pursuant to the Common Stock Purchase Agreement - B. Riley</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="rgti:IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73805710">171,008</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">44,812</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">44,812</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Foreign currency translation gain</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">101</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">101</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in unrealized loss on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="rgti:IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" contextRef="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">314</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="rgti:IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">314</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 9pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss</div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,521</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,521</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; line-height: 8pt; font-size: 8pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 8pt; font-size: 8pt;;font-weight:bold;display:inline;">Balance, December&#160;31, 2022</div></div></div> </td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="border-right: 0.75pt solid rgb(0, 0, 0); white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_73804545">125,257,233</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal" id="Fact_73804549">12</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">429,025</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">161</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div>)</td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">278,652</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div>)</td>
<td style="vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">150,224</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 8pt; font-size: 8pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"><br/></div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left;">*</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><ix:footnote id="FN_254682" xml:lang="en-US">Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;C-1</div> Preferred Stock, legacy Class&#160;A Common Stock, and legacy Class&#160;B Common Stock have been retroactively restated to give effect to the Business Combination.</ix:footnote> </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">The accompanying notes are an integral part of these consolidated financial statements </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-6 </div> </div> </div> </div> <div></div> </div> <div> <div style="background-color:white;display: inline;"> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div id="fin426335_6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RIGETTI COMPUTING, INC. </div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">CONSOLIDATED STATEMENTS OF CASH FLOWS</div></div> </div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(In thousands) </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 74%;"></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December 31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 74%;"></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align: top; width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash flows from operating activities</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,521</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,241</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align: top; width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Adjustments to reconcile net loss to net cash used in operating activities:</div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Depreciation and amortization</div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,017</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Depreciation" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,651</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align: top; width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">44,812</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,765</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of earnout liability</div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">19,207</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align: top; width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative warrant liabilities</div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">22,132</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,664</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of forward contract</div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:ChangeInFairValueOfForwardContract" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5,764</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ChangeInFairValueOfForwardContract" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">230</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Accretion of available-for-sale securities<br/></div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; text-align: right; line-height: normal;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">949</ix:nonFraction></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal; text-align: right;">&#160;<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction> &#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div> </td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt issuance costs</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">917</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">513</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt commitment fee asset</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:AmortizationOfDebtCommitmentFeeAsset" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">266</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:AmortizationOfDebtCommitmentFeeAsset" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">94</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Accretion of debt end of term liabilities</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:AccretionOfDebtEndOfTermLiabilities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">285</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:AccretionOfDebtEndOfTermLiabilities" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">122</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-cash</div> lease expense</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:NonCashLeaseExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">537</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:NonCashLeaseExpense" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill impairment</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,377</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Changes in operating assets and liabilities:</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,692</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,063</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,099</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">315</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other assets</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">34</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">35</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">24</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">493</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">707</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">389</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,456</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,554</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other liabilities</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">295</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">87</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 74%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net cash used in operating activities</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">62,689</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">29,044</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 74%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash flows from investing activities</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchases of property and equipment</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,737</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,008</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchases of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">84,287</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 74%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net cash used in investing activities</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">107,024</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">7,008</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 74%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash flows from financing activities</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from Business Combination, net of transaction costs paid</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">225,604</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transaction costs paid directly by Rigetti</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="rgti:TransactionCostsPaid" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,842</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:TransactionCostsPaid" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of notes payable</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">27,000</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments on principal of notes payable</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,291</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><br/></td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments on debt issuance costs</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">85</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">247</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payment on loan and security agreement exit fees</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="rgti:PaymentOfLoanAndSecurityAgreementExitFees" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,000</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><br/></td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payments on deferred offering costs</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:PaymentOfDeferredOfferingCosts" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="rgti:PaymentOfDeferredOfferingCosts" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,548</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from issuance of common stock upon exercise of stock options and warrants</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,068</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">378</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 74%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net cash provided by financing activities</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">215,454</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25,583</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 74%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Effect of changes in exchange rate on cash and restricted cash</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">101</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net increase (decrease) in cash, cash equivalents, and restricted cash</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">45,842</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">10,474</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash, cash equivalents, and restricted cash at beginning of period</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,046</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn01_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,520</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 74%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash, cash equivalents, and restricted cash at end of period</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">57,888</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,046</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 74%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Supplemental disclosure of cash flow information:</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash paid for interest</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,819</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,489</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Supplemental disclosure of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> financing activity:</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Initial fair value of earn-out liability acquired in merger</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:InitialFairValueOfEarnoutLiabilityAcquiredInMergera" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">20,413</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs in accounts payable and accrued expenses</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,900</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of loan and security agreement warrant liability</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:FairValueOfLoanAndSecurityAgreementAndWarrantLiability." contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:FairValueOfLoanAndSecurityAgreementAndWarrantLiability." contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,691</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Initial fair value of private placement and public warrants liability acquired in merger</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,932</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Reclassification of loan and security agreement warrants to equity</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:ExerciseOfLoanAndSecurityAgreementWarrants" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,370</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:ExerciseOfLoanAndSecurityAgreementWarrants" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Settlement of the first tranche of forward contract</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:SettlementOfTheFirstTrancheOfForwardContract" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,305</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:SettlementOfTheFirstTrancheOfForwardContract" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalization of deferred costs to equity upon share issuance</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:CapitalizationOfDeferredCostsToEquityUponShareIssuance" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,520</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:CapitalizationOfDeferredCostsToEquityUponShareIssuance" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchases of property and equipment recorded in accounts payable</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">673</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchases of property and equipment recorded in accrued expense</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">639</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Unrealized loss on short term investments</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">314</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets recorded on adoption of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:RightOfUseAssetsRecordedOnAdoptionOfAsu201602" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,270</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:RightOfUseAssetsRecordedOnAdoptionOfAsu201602" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities recorded on adoption of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,620</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="rgti:OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 8pt;">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); width: 74%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Lease liabilities arising from obtaining <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,892</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 7%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="rgti:LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">The accompanying notes are an integral part of these consolidated financial statements </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-7 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin426335_7" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RIGETTI COMPUTING, INC. </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </div></div></div></div><ix:nonNumeric name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804525"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">1. DESCRIPTION OF BUSINESS </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rigetti Computing, Inc. and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Rigetti&#8221;), builds quantum computers and the superconducting quantum processors that power them. Through the Company&#8217;s Quantum Computing as a Service (&#8220;QCaaS&#8221;) platform, the Company&#8217;s machines can be integrated into any public, private or hybrid cloud. The Company offers product types of Platform, Research and Software Tools usage in application areas of benchmarking, chemical simulation, education/entertainment, machine learning, and optimization. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is located and headquartered in Berkeley, California. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Munich, Germany. The Company&#8217;s revenue is derived primarily from operations in the United States and the United Kingdom. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Basis of Presentation </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;2, 2022 (the &#8220;Closing Date&#8221;), a merger transaction between Rigetti Holdings, Inc. (&#8220;Legacy Rigetti&#8221;) and Supernova Partners Acquisition Company II, Ltd. (&#8220;SNII&#8221;) was completed (the &#8220;Business Combination&#8221;, see Note 3). In connection with the closing of the Business Combination, the Company changed its name to Rigetti Computing, Inc. and all of SNII Class&#160;A ordinary shares and SNII Class&#160;B ordinary shares automatically converted into shares of Common Stock, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn03_02_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn03_02_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction>, of the Company (the &#8220;Common Stock&#8221;) on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis. The SNII Public Warrants and the Private Warrants held by SNII became warrants for Common Stock. The Company&#8217;s Common Stock and Public Warrants trade on the Nasdaq Capital Market under the ticker symbols &#8220;RGTI&#8221; and &#8220;RGTIW,&#8221; respectively. For more information on this transaction, see Note 3. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company determined that Legacy Rigetti was the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification (ASC) 805, Business Combination. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The determination was primarily based on the following facts: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Former Legacy Rigetti stockholders have a controlling voting interest in the Company; </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The Company&#8217;s board of directors as of immediately after the closing is comprised of eight board members, six seats occupied by previous Rigetti board members and one seat being occupied by a previous Supernova representative. The final eighth seat was filled by an individual who did not have ties to either Rigetti or Supernova <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-merger;</div> and </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Legacy Rigetti management continues to hold executive management roles for the post-combination company and be responsible for the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-to-day</div></div> operations. </div></td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Rigetti issuing stock for the net assets of SNII, accompanied by a recapitalization. The primary asset acquired from SNII was cash. Separately, the Company also assumed warrants that were deemed to be derivatives and meet liability classification subject to fair value adjustment measurements upon closing of the Business Combination (the &#8220;Closing&#8221;). No goodwill or other intangible assets were recorded as a result of the Business Combination.</div></div><br/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">While SNII was the legal acquirer in the Business Combination, because Legacy Rigetti was deemed the accounting acquirer, the historical financial statements of Legacy Rigetti became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the financial statements included in this report reflect (i)&#160;the historical operating results of Legacy Rigetti prior to the Business Combination; (ii)&#160;the combined results of SNII and Legacy Rigetti following the closing of the Business Combination; (iii)&#160;the assets and liabilities of Legacy Rigetti at their historical cost; and (iv)&#160;the Company&#8217;s equity structure for all periods presented. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><br/></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-8</ix:exclude></div> </ix:nonNumeric></div></div><ix:continuation id="TextSelection_73804525" continuedAt="TextSelectionAppend_73804525_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804525_1" continuedAt="TextSelectionAppend_73804525_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804525_2" continuedAt="TextSelectionAppend_73804525_3"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a><br/></div> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804525_3"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The equity structure has been retroactively restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company&#8217;s Common Stock, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> par value per share, issued to Legacy Rigetti shareholders and Legacy Rigetti convertible preferred shareholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Rigetti redeemable convertible preferred stock and Legacy Rigetti Common Stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying consolidated financial statements of the Company and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. All dollar amounts in tables, except share and per share amounts, in the notes to the consolidated financial statements are presented in thousands unless otherwise noted. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Risks and Uncertainties</div></div> &#8212; The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including, but not limited to, the need for successful development of products, the need for additional capital (or financing) to fund operating losses, competition from substitute products and services from larger companies, protection of proprietary technology, patent litigation, dependence on key individuals, and risks associated with changes in information technology. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Based on our forecasts, we believe that our existing cash and cash equivalents and available for sale investments will be sufficient to meet our anticipated operating cash needs for at least the next 12 months from the issuance of these financial statements based on our current business plan and expectations and assumptions considering current macroeconomic conditions. </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> and Macroeconomic Conditions</div></div> &#8212; As of December&#160;31, 2022, and December&#160;31, 2021, the Company&#8217;s financial position was not significantly impacted by the effects of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19.</div> However, the duration and intensity of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and any resulting disruption to the Company&#8217;s operations remains somewhat uncertain. Global economic conditions have been worsening, with disruptions to, and volatility in, the credit and financial markets, disruption to banking systems, and rising inflation and interest rates in the U.S. and worldwide resulting from the effects of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> and otherwise. If these conditions persist and deepen, the Company could experience an inability to access additional capital or our liquidity could otherwise be impacted. If the Company is unable to raise capital when needed or on attractive terms, it would be forced to delay, reduce or eliminate its research and development programs and other efforts. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in Fiscal Year</div></div> &#8212; In October 2021, the board of directors of Rigetti approved a change to Rigetti&#8217;s fiscal <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> from January&#160;31 to December&#160;31, effective December&#160;31, 2021. The Company believes the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> change is important and useful to its financial statement users to allow for increased comparability with its industry peers. As a result of this change, the Company&#8217;s fiscal year now begins on January&#160;1 and ends on December&#160;31 of each year, starting on January&#160;1, 2022. Rigetti&#8217;s fiscal year 2021 covers a period of 11 months starting from February&#160;1, 2021 and ending on December&#160;31, 2021.</div></div></ix:continuation> <ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804411"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </div></div></div></div> <ix:nonNumeric name="rgti:EmergingGrowthCompanyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804507"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Emerging Growth Company</div></div> &#8212; Following the Business Combination, the Company qualifies as an emerging growth company (&#8216;&#8216;EGC&#8217;&#8217;) as defined in the Jumpstart our Business Startups (&#8216;&#8216;JOBS&#8217;&#8217;) Act. The JOBS Act permits companies with EGC status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company intends to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the </div></div></ix:nonNumeric> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <ix:exclude> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-9 </div> </ix:exclude></ix:nonNumeric></div></div> <ix:continuation id="TextSelection_73804411" continuedAt="TextSelectionAppend_73804411_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_73804411_1" continuedAt="TextSelectionAppend_73804411_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_2" continuedAt="TextSelectionAppend_73804411_3"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation></div></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_3" continuedAt="TextSelectionAppend_73804411_4"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"></div><ix:continuation id="TextSelection_73804507"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">earlier of the date the Company (i)&#160;is no longer an EGC or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates. </div></div></div></ix:continuation><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><ix:nonNumeric name="us-gaap:UseOfEstimates" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804504"></ix:nonNumeric></div><ix:continuation id="TextSelection_73804504"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div> &#8212; The </div> preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Such management estimates include, but are not limited to, the fair value of share-based awards, the fair value of the convertible preferred stock warrants, the fair value of the Forward Warrant Agreement (as defined below) , the fair value of derivative warrant liabilities, the fair value of Sponsor Vesting Shares issued in connection with the business combination (See Note 3), goodwill and intangible assets, accrued liabilities and contingencies, depreciation and amortization periods, revenue recognition and accounting for income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from those estimates.</div></ix:continuation><div style="margin-top: 1em; margin-bottom: 1em"></div><div style="margin-top: 1em; margin-bottom: 1em"></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></div><div style="margin-top: 1em; margin-bottom: 1em"></div><ix:nonNumeric name="us-gaap:ConsolidationPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principals of Consolidation</div></div> &#8212;The consolidated financial statements include the accounts of Rigetti and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reclassifications</div></div> &#8212; Certain amounts reported previously have been reclassified to conform to current presentation, with no effect on stockholders&#8217; equity or net loss as previously presented. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Segments</div></div> &#8212; Operating segments are defined as components of an entity for which discrete financial information is available and that information is regularly reviewed by the Chief Operating Decision Maker (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM, who has ultimate responsibility for the operating performance of the Company and the allocation of resources. The Company&#8217;s CODM reviews financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in <ix:nonFraction name="us-gaap:NumberOfOperatingSegments" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_OperatingSegment" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> operating and <ix:nonFraction name="us-gaap:NumberOfReportableSegments" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_OperatingSegment" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> reportable segment. </div> </ix:nonNumeric><ix:nonNumeric name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign Currency</div></div> &#8212; The Company&#8217;s reporting currency is the US dollar. The functional currencies of the Company&#8217;s foreign subsidiaries are the local currencies (UK pounds sterling, Australian dollar and Canadian Dollar), which are the monetary unit of account of the principal economic environment in which the Company&#8217;s foreign subsidiaries operate. All assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollars is reflected as a foreign currency cumulative translation adjustment and reported as a component of accumulated other comprehensive gain (loss). Foreign currency transaction gains and losses resulting from or expected to result from transactions denominated in a currency other than the functional currency are recognized in other income (expense), net in the consolidated statements of operations and are de minimis for the year ended December 31, 2022 and 11 months ended December 31, 2021. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> </ix:nonNumeric> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><br/></div> <ix:nonNumeric name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Comprehensive Loss</div></div> &#8212; Comprehensive loss consists of two components including net loss and other comprehensive loss. The Company&#8217;s other comprehensive loss consists of foreign currency translation adjustments that result from consolidation of its foreign subsidiaries and unrealized loss on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities. </div></div> </ix:nonNumeric> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804901"></ix:nonNumeric></div><ix:continuation id="TextSelection_73804901" continuedAt="TextSelectionAppend_73804901_1"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash, Cash Equivalents and Restricted Cash</div></div> &#8212; As of December&#160;</div>31, 2022 and December&#160;31, 2021, cash consists primarily of checking and savings deposits. As of December&#160;31, 2022, cash equivalents consist primarily of money market funds. There were <ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> cash equivalents as of December&#160;31, 2021. The Company considers all highly liquid investment securities with remaining maturities at the date of purchase of three months or less to be cash equivalents. These cash equivalents are stated at cost, which approximates fair value.</div><div style="margin-top: 1em; margin-bottom: 1em"></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-10</ix:exclude></div></div></div> </ix:continuation><ix:continuation id="TextSelectionAppend_73804901_1" continuedAt="TextSelectionAppend_73804901_2"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> </ix:continuation></div></div><ix:continuation id="TextSelectionAppend_73804901_2" continuedAt="TextSelectionAppend_73804901_3"><ix:continuation id="TextSelectionAppend_73804411_4" continuedAt="TextSelectionAppend_73804411_5"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_5" continuedAt="TextSelectionAppend_73804411_6"><ix:exclude><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_6" continuedAt="TextSelectionAppend_73804411_7"><ix:continuation id="TextSelectionAppend_73804901_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></div><div style="margin-top: 1em; margin-bottom: 1em"></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s restricted cash balance includes cash whose use is limited by contractual provisions. As of December&#160;31, 2022, there was <ix:nonFraction name="us-gaap:RestrictedCash" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction> restricted cash. As of December&#160;31, 2021, restricted cash consists of cash secured as collateral for letters of credit in favor of the Company&#8217;s landlord and its corporate credit card program. </div><ix:nonNumeric name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805089"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Cash" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">21,542</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Cash" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,729</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash <div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>quivalents</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">36,346</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">317</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents and restricted cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">57,888</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,046</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric></ix:continuation><ix:continuation id="TextSelection_73805089"> </ix:continuation> <ix:nonNumeric name="us-gaap:InvestmentPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investments </div></div>&#8212;<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>The Company classifies its investments in fixed income securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments. The Company&#8217;s investments consist of U.S Treasury securities, commercial paper, and corporate bonds that have a maturity of one year or less. These investments are recorded in the consolidated balance sheets at fair value. The fair value of our underlying investments is based on observable inputs and classified as Level&#160;1 and Level&#160;2. Unrealized gains and losses on these investments are included as a separate component of Accumulated Other Comprehensive Loss. The Company evaluates its investments to assess whether those with unrealized loss positions are other than temporarily impaired. Impairments are considered other than temporary if they are related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of the cost basis. Realized gains and losses and declines in value determined to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the statements of operations. See Note 15 for further information on fair value. </div> </ix:nonNumeric><ix:nonNumeric name="us-gaap:TradeAndOtherAccountsReceivablePolicy" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accounts Receivable</div></div> &#8212; Accounts receivable are recorded at invoice value, net of allowance for doubtful accounts. Unbilled receivables are included in accounts receivable and include amounts that were invoiced subsequent to the period end for which revenue was recognized in advance of the right to invoice. On a periodic basis, management evaluates its accounts receivable and determines whether to provide an allowance or if any accounts should be written off based on a past history of write-offs, collections, and current credit conditions. A receivable is considered past due if the Company has not received payments based on agreed-upon terms. As of December&#160;31, 2022 and December&#160;31, 2021, the Company does not have any allowances for doubtful accounts. </div> </ix:nonNumeric><ix:nonNumeric name="rgti:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Prepaid Expenses and Other Current Assets </div></div>&#8212; Prepaid expenses and other current assets include prepaid software, prepaid insurance, other prepaid expenses, all of which are expected to be recognized or realized within the next 12 months. </div> </ix:nonNumeric> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;<br/></div> </ix:continuation></div></div></div></div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_7" continuedAt="TextSelectionAppend_73804411_8"><ix:nonNumeric name="rgti:DeferredOfferingCostsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804910"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deferred Offering Costs</div></div> &#8212;The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with the Business Combination or issuance of shares under a registration statement filed with the SEC. After consummation of the Business Combination or issuance of shares, costs allocated to equity-classified instruments are recorded as a reduction to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. Costs allocated to liability-classified instruments are expensed. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The </div></div> Company incurred $<ix:nonFraction name="rgti:OfferingCostsIncurred" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction>&#160;million of offering costs for the year ended December&#160;31, 2022, which related to filing new registration statements with the SEC after the close of the Business Combination. These costs are incremental to those disclosed in Note 3. A portion of the offering costs amounting to $<ix:nonFraction name="rgti:OfferingCostsIncurred" contextRef="P01_01_2022To12_31_2022_RGTICommonStockPurchaseAgreementMemberRGTIRGTIAgreementNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million relates to the Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC. As of December&#160;31, 2022, while the registration statement related to the Common Stock Purchase Agreement with B. Riley Principal Capital II, </div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-11</ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></ix:continuation></div> </div> <ix:continuation id="TextSelection_73804910" continuedAt="TextSelectionAppend_73804910_1"><ix:continuation id="TextSelectionAppend_73804411_8" continuedAt="TextSelectionAppend_73804411_9"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_9" continuedAt="TextSelectionAppend_73804411_10"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation> </ix:continuation><div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_10" continuedAt="TextSelectionAppend_73804411_11"><ix:continuation id="TextSelectionAppend_73804910_1"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;">LLC was filed with the SEC, there were no shares issued other than the commitment shares referred to in Note&#160;12. As such $<ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million of the offering costs were classified as deferred offering costs. As of December&#160;31, 2021, the Company had recorded deferred offering costs of $<ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.4</ix:nonFraction>&#160;million, all of which are related to the Business Combination as discussed in Note 3. </div> </ix:continuation><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Property and Equipment, Net </div></div>&#8212; Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets. The Company uses an estimated useful life of three years for furniture and other assets and information technology hardware (&#8220;IT hardware&#8221;), seven years for process equipment, and three to ten years for quantum computing fridges. Leasehold improvements are amortized over the shorter of the lease-term or the estimated useful life of the related asset. Expenditures for repairs and maintenance are expensed as incurred. Upon disposition, the cost and related accumulated depreciation are removed and any resulting gain or loss is reflected in other income (expense) in the consolidated statements of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Long-lived assets, which consist of property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset (asset group) may not be recoverable. When such events or changes in circumstances occur, the Company performs an undiscounted cash flow analysis to determine if an impairment exists and, if so, an impairment loss would be recorded based on the excess of the carrying amount of the asset (asset group) over its fair value. During the year ended December&#160;31, 2022 the Company determined there was a triggering event and an undiscounted cash flow analysis was performed. Based on the results of this analysis, the Company&#8217;s long-lived assets were not impaired and no impairment charge was recorded. During the 11 months ended December&#160;31, 2021 no triggering events were noted. </div> </ix:nonNumeric><ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill </div></div>&#8212; Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed in a business combination. Goodwill has an indefinite useful life and is not amortized. The Company reviews its goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value of the Company may exceed its fair value. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the Company is less than its carrying amount, including goodwill. If that is the case, the Company performs a quantitative impairment test, and, if the carrying amount of the Company exceeds its fair value, then the Company will recognize an impairment charge for the amount by which its carrying amount exceeds its fair value, not to exceed the carrying amount of the goodwill. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company determined a triggering event existed in the fourth quarter of 2022 resulting from the sustained decline in the Company&#8217;s stock price. A quantitative impairment test was performed and as a result, the Company recognized a $<ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.4</ix:nonFraction>&#160;million goodwill impairment charge for the year ended December&#160;31, 2022. </div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"></div> <ix:nonNumeric name="rgti:DeferredFinancingCostsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deferred Financing Costs</div></div> &#8212; The incremental cost, including the fair value of warrants, directly associated with obtaining <div style="letter-spacing: 0px; top: 0px;;display:inline;">debt</div> financing is capitalized as deferred financing costs upon the issuance of the debt and amortized over the term of the related debt agreement using the effective-interest metho<div style="letter-spacing: 0px; top: 0px;;display:inline;">d</div> with such amortized amounts included as a component of interest expense in the consolidated statements of operations. Unamortized deferred financing costs are presented on the consolidated balance sheets as a direct deduction from the carrying amount of the related de<div style="display:inline;">b</div>t<div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:rgba(255, 255, 255, .0);;display:inline;">obligation.<div style="letter-spacing: 0px; top: 0px;;display:inline;"></div> </div></div></div></div> <div style="background-color:rgba(255, 255, 255, .0);;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:rgba(255, 255, 255, .0);;display:inline;">&#160;</div></div></div><br/></div></ix:nonNumeric> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"></div> <ix:nonNumeric name="rgti:PublicAndPrivateWarrantsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805415"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public and Private Warrants</div></div> &#8212; At the Closing Date of the Business Combination, SNII </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> had 4,450,000 Private Warrants and&#160;</div><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">8,625,000</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;Public warrants outstanding. Each whole warrant entitles the holder to purchase one share of the Company&#8217;s Common Stock at a price of $</div><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2022_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction></ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> per share, subject to adjustments, and will expire </div><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durwordsen"><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn12_31_2022_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durwordsen">five years</ix:nonNumeric></ix:nonNumeric><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> after the Business Combination or earlier upon redemption or liquidation.</div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">fixed-for-fixed</div></div> option on equity shares. Therefore, the Private Warrants are not considered indexed to the Company&#8217;s stock and should be </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-12</ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></ix:continuation></div> </div> <ix:continuation id="TextSelection_73805415" continuedAt="TextSelectionAppend_73805415_1"><ix:continuation id="TextSelectionAppend_73804411_11" continuedAt="TextSelectionAppend_73804411_12"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_12" continuedAt="TextSelectionAppend_73804411_13"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> </ix:continuation><div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_13" continuedAt="TextSelectionAppend_73804411_14"><ix:continuation id="TextSelectionAppend_73805415_1"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">classified as a liability. Since the Private Warrants meet the definition of a derivative, the Company recorded the Private Warrants as liabilities in the consolidated balance sheet at fair value upon the closing, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date. The fair value of the Private Warrants are measured using the Black-Scholes option-pricing model. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Public Warrants also fail to meet the indexation guidance in ASC 815 and are accounted for as liabilities because they include a provision whereby if there is not an effective registration statement, the warrant holders have a cap of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="3" scale="0" format="ixt:num-dot-decimal">0.361</ix:nonFraction> shares of Common Stock per warrant (subject to adjustment), on the issuable number of shares in a cashless exercise. Subsequent to the separate listing and trading of the Public Warrants, their fair value has been measured based on the observable listed prices for such warrants. Upon consummation of the Business Combination, the Company recorded a liability related to the Public Warrants of $<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">16.3</ix:nonFraction>&#160;million, with an offsetting entry to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. On December&#160;31, 2022, the fair value of the Public Warrants decreased to $<ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction>&#160;million with the corresponding gain from the change in fair value recorded in the consolidated statement of operations for the year ended December&#160;31, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See Note 13 and 15 for further information on fair value. </div> </ix:continuation> <ix:nonNumeric name="us-gaap:DerivativesPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative Warrant Liabilities </div></div>&#8212; The<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;) at the initial recognition date. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than the Public and Private Warrants noted above, the Company also issued warrants to Trinity Capital which are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period until exercised. The fair value of the warrant liabilities issued were initially measured using the Black- Scholes model and are subsequently remeasured at each reporting period with changes recorded as a component of other (expense) income in the Company&#8217;s consolidated statements of operations. During the year ended December&#160;31, 2022 these warrants were exercised and are no longer outstanding. </div> </ix:nonNumeric> <ix:nonNumeric name="rgti:BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805483"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Liability &#8212;</div></div> At the closing of the Business Combination, the SPAC Sponsor subjected certain Sponsor Vesting Shares to forfeiture and vesting as of the Closing Date if thresholds related to the weighted average price of Common Stock are not met for the duration of various specified consecutive day trading periods during the <ix:nonNumeric name="rgti:PeriodOfEarnoutShares" contextRef="P01_01_2022To12_31_2022_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" format="ixt-sec:durwordsen">five-year</ix:nonNumeric> period following the Closing (the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Earn-Out</div> Triggering Events&#8221;). Any such shares held by the Sponsor that remain unvested after the fifth anniversary of the Closing will be forfeited. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These Sponsor Vesting Shares are accounted for as liability classified instruments because the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Triggering Events that determine the number of Sponsor Vesting Shares to be earned back by the Sponsor include outcomes that are not solely indexed to the Common Stock of the Company. The aggregate fair value of the Sponsor Vesting Shares on the Closing Date was estimated using a Monte Carlo simulation model and was determined to be $20.4&#160;million at the Closing Date. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2022, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Triggering Events were not achieved for any of the tranches, and as such, the Company adjusted the carrying amount of the liability to its estimated fair value of $1.2&#160;million. The change in the fair value of $19.2&#160;million for the year ended December&#160;31, 2022 is included in gain on fair value change, net in the condensed consolidated statements of operations. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-13</ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></ix:continuation></div> </div> <ix:continuation id="TextSelection_73805483" continuedAt="TextSelectionAppend_73805483_1"><ix:continuation id="TextSelectionAppend_73804411_14" continuedAt="TextSelectionAppend_73804411_15"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_15" continuedAt="TextSelectionAppend_73804411_16"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation></ix:continuation></div> </div> <div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_16" continuedAt="TextSelectionAppend_73804411_17"><ix:continuation id="TextSelectionAppend_73805483_1"><ix:nonNumeric name="rgti:DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant inputs into the respective valuation models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows:</div></div></div> <div style="null;text-indent: 0px;"> <div> <div style="display: inline; background-color: white;"> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 54%;"></td>
<td style="width: 20%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 20%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Assumptions</div></div></div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"> <div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial Recognition on<br/>March 2, 2022</div></div></div> </div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"> <div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></div> </div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Price</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn03_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:num-dot-decimal">9.43</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:num-dot-decimal">0.73</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Simulated trading days</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn03_02_2022_SimulatedTradingDaysMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_D" decimals="0" scale="0" format="ixt:num-dot-decimal">1,198</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_SimulatedTradingDaysMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_D" decimals="0" scale="0" format="ixt:num-dot-decimal">1,050</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility (annual)</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn03_02_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">30.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">109.30</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn03_02_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">1.74</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">4.04</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Estimated time to expiration (years)</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn03_02_2022_EstimatedPeriodOfExpirationMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_Y" decimals="3" scale="0" format="ixt:num-dot-decimal">5.000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_EstimatedPeriodOfExpirationMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_Y" decimals="3" scale="0" format="ixt:num-dot-decimal">4.170</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> </div> </div> </div> </ix:nonNumeric> </ix:continuation> <ix:nonNumeric name="us-gaap:RevenueRecognitionPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804926"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue Recognition</div></div> &#8212; The Company recognizes revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Revenue from Contracts with Customers </div></div>and accounts for certain contract costs in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;340-40,</div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Other Assets and <div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred</div> Costs&#8212;Contracts with Customers.</div></div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes revenue from contracts <div style="letter-spacing: 0px; top: 0px;;display:inline;">with</div> customers by applying the following five-step model: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identify the contract with a customer </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identify the performance obligations in the contract </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Determine the transaction price </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocate the transaction price to the performance obligations in the contract </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recognize revenue when (or as) performance obligations are satisfied </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company generates revenue through its Quantum Computing as a Service (&#8220;QCaaS&#8221;) and development contracts and other services. Access to Rigetti quantum computing systems can be purchased as a quantum computing subscription, or on a usage basis for a specified quantity of hours. Revenue related to subscription-based access to (&#8220;QCaaS&#8221;) is recognized over time as access to the systems is provided on a ratable basis over the subscription term, which can range from six months to two years. This time-based input measure of progress provides a faithful depiction of the transfer of the services because the benefits the customer obtains generally equals the benefit from its access to the systems throughout the subscription term. Revenue related to usage-based access to Rigetti quantum computing systems is recognized over time as the systems are accessed using an output method based on compute credit hours expended. This output method provides a faithful depiction of the transfer of the services because the customer has purchased a specified quantity of hours of usage that diminishes each time an hour is expended and therefore each hour of access to the systems is considered a discrete delivery of underlying services in these arrangements. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Development contracts are generally multi-year, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> arrangements in which the Company provides professional services regarding practical applications of quantum computing to technology and business problems within the customer&#8217;s industry or organization and assists the customer in developing quantum algorithms and applications that will provide commercial value to the customer in areas of business interest. Development contracts are typically fixed fee arrangements invoiced on a milestone basis but may also be invoiced on a time and materials or cost reimbursement basis in certain cases. Revenue related to development contracts and other services is recognized over time based on completed milestones or hours or costs incurred as appropriate. Revenue for partially completed milestones deemed probable of being met is recognized using an input measure based on actual labor hours incurred to date relative to total estimated labor hours needed to complete the milestone. This input measure of progress provides a faithful depiction of the transfer of the services because it closely depicts the Company&#8217;s efforts or inputs to the satisfaction of the performance obligation. Revenue related to the sale of custom quantum computing components is recognized at a point in time upon acceptance by the customer. </div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">When the Company&#8217;s contracts with customers contain multiple performance obligations, the transaction price is allocated on a relative standalone selling price basis to each performance obligation. The Company typically </div></div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"><ix:exclude>F-14</ix:exclude></div> </ix:nonNumeric></ix:continuation></div> </div> </div> <ix:continuation id="TextSelection_73804926" continuedAt="TextSelectionAppend_73804926_1"><ix:continuation id="TextSelectionAppend_73804411_17" continuedAt="TextSelectionAppend_73804411_18"><div></div></ix:continuation></ix:continuation> </div> <div> <div style="background-color:white;display: inline;"> <ix:continuation id="TextSelectionAppend_73804926_1" continuedAt="TextSelectionAppend_73804926_2"><ix:continuation id="TextSelectionAppend_73804411_18" continuedAt="TextSelectionAppend_73804411_19"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_73804411_19" continuedAt="TextSelectionAppend_73804411_20"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_20" continuedAt="TextSelectionAppend_73804411_21"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> </ix:continuation><div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_21" continuedAt="TextSelectionAppend_73804411_22"><ix:continuation id="TextSelectionAppend_73804926_2"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">determines standalone selling price based on observable selling prices of our products and services. In instances where standalone selling price is not directly observable, standalone selling price is determined using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price, which includes fixed consideration and estimates of variable consideration. The amount of variable consideration included in the transaction price is constrained and is included only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s contracts with customers may include renewal or other options at fixed prices. Determining whether such options are considered distinct performance obligations that provide the customer with a material right and therefore should be accounted for separately requires significant judgment. Judgment is required to determine the standalone selling price for each renewal option to determine whether the renewal pricing is reflective of standalone selling price or is reflective of a discount that would provide the customer with a material right. Based on the Company&#8217;s assessment of standalone selling prices, the Company determined that there were no significant material rights provided to its customers requiring separate recognition. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The timing of revenue recognition may not align with the right to invoice the customer. The Company records accounts receivable when it has the unconditional right to issue an invoice and receive payment, regardless of whether revenue has been recognized. If revenue has not yet been recognized, a contract liability (deferred revenue) is also recorded. If revenue is recognized in advance of the right to invoice, a contract asset or unbilled receivable is recorded, depending on whether the Company&#8217;s right to consideration is considered conditional or unconditional. Unbilled receivables are included within accounts receivable in the consolidated balance sheets. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In instances where the timing of revenue recognition differs from the timing of the right to invoice, the Company has determined that a significant financing component generally does not exist. The primary purpose of the Company&#8217;s invoicing terms is to provide customers with simplified and predictable ways of purchasing the products and services and not to receive financing from or provide financing to the customer. Additionally, the Company has elected the practical expedient that permits an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment terms on invoiced amounts are typically net 30 days. The Company does not offer rights of return for its products and services in the normal course of business, and contracts generally do not include service-type warranties that provide any incremental service to the customer beyond providing assurance that the goods and services conform to applicable specifications or customer-specific or subjective acceptance provisions. The Company also excludes from revenue government-assessed and imposed taxes on revenue-generating activities that are invoiced to customers. </div> </ix:continuation> <ix:nonNumeric name="rgti:CostsOfObtainingAndFulfillingContractsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Costs of Obtaining and Fulfilling Contracts</div></div> &#8212; The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less. The Company capitalizes incremental costs incurred to fulfill its contracts that (i)&#160;relate directly to the contract, (ii)&#160;are expected to generate resources that will be used to satisfy the Company&#8217;s performance obligation(s) under the contract, and (iii)&#160;are expected to be recovered through revenue generated under the contract. </div></div> </ix:nonNumeric> <ix:nonNumeric name="us-gaap:CostOfSalesPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804919"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost of Revenue</div></div> &#8212; Cost of revenue consists primarily of all direct and indirect cost associated with providing QCaaS offerings and development contracts and other services, including employee salaries and employee </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-15</ix:exclude></div> </ix:nonNumeric></ix:continuation></div> </div> <ix:continuation id="TextSelection_73804919" continuedAt="TextSelectionAppend_73804919_1"><ix:continuation id="TextSelectionAppend_73804411_22" continuedAt="TextSelectionAppend_73804411_23"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_73804411_23" continuedAt="TextSelectionAppend_73804411_24"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_24" continuedAt="TextSelectionAppend_73804411_25"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation></ix:continuation></div> </div> </div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_25" continuedAt="TextSelectionAppend_73804411_26"><ix:continuation id="TextSelectionAppend_73804919_1"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">related costs, including compensation, bonuses, employee taxes and benefit costs of program management and personnel associated with the delivery of goods and services to customers. Cost of revenue also includes an allocation of facility costs, depreciation and amortization directly related to providing the QCaaS offerings and development contracts and other services.</div></div></div></ix:continuation> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><ix:nonNumeric name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Research and Development </div></div>&#8212; Research and development costs are expensed as incurred. Research and development expenses include compensation, employee benefits, stock-based compensation, outside consultant fees, allocation of facility costs, depreciation and amortization, materials and components purchased for research and development. </div> </ix:nonNumeric><ix:nonNumeric name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">General and Administrative</div></div> &#8212; General and administrative expenses include compensation, employee benefits, stock-based compensation, legal, insurance, finance administration and human resources, an allocation of facility costs (including leases), bad debt costs, professional service fees, and an allocation of other general overhead costs including depreciation and amortization to support Rigetti&#8217;s operations, which consists of operations other than associated with providing QCaaS offerings and development contracts and other services. </div> </ix:nonNumeric><ix:nonNumeric name="rgti:SalesAndMarketingPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sales and Marketing &#8212;</div></div> Sales and marketing expenses consist primarily of compensation including stock-based compensation, employee benefits of sales and marketing employees, outside consultants fees, travel and marketing and promotion costs. </div> </ix:nonNumeric><ix:nonNumeric name="rgti:CapitalizedSoftwarePolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capitalized Software &#8212;</div></div> The Company capitalizes the costs to develop <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">its&#160;internal-use&#160;software</div> when preliminary development efforts are successfully completed, management has authorized and committed project funding, and it is probable that the project will be completed and the software will be used as intended. Such costs are included in property and equipment in the consolidated balance sheets and are amortized on a straight-line basis over the estimated useful life of the related asset. These capitalized costs are primarily related to the software infrastructure supporting the quantum computing services purchased by customers. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. During the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, <ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAdditions" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAdditions" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> capitalized software has been recorded. </div> </ix:nonNumeric> <ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes </div></div>&#8212; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of December&#160;31, 2022 and December&#160;31, 2021, the Company has recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of income tax positions only if it is more likely than not that those positions will be sustained. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in income tax expense.</div></div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804451"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Loss Per Share</div></div> &#8212; Basic net loss per common share is computed by dividing the net loss available to Common Stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to Common Stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-16</ix:exclude></div> </ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_73804451" continuedAt="TextSelectionAppend_73804451_1"><ix:continuation id="TextSelectionAppend_73804411_26" continuedAt="TextSelectionAppend_73804411_27"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_27" continuedAt="TextSelectionAppend_73804411_28"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_28" continuedAt="TextSelectionAppend_73804411_29"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> </ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_29" continuedAt="TextSelectionAppend_73804411_30"><ix:continuation id="TextSelectionAppend_73804451_1"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">of common shares and potential common shares outstanding when the impact is not antidilutive. Potential common shares from stock options, unvested restricted stock units and Common Stock warrants are computed using the treasury stock method, while those from convertible Series C and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock are computed using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. Contingently issuable shares are included in basic net loss per share only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration shall be considered outstanding common shares and included in the computation of basic net loss per share. </div></div></ix:continuation><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></div><div style="margin-top: 1em; margin-bottom: 1em"></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></div><div style="margin-top: 1em; margin-bottom: 1em"></div><ix:nonNumeric name="us-gaap:CompensationRelatedCostsPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock-Based Compensation</div></div> &#8212; The Company accounts for share-based compensation in accordance with ASC 718, Compensation &#8211; Stock Compensation. The Company&#8217;s share-based compensation awards are all equity-classified and consist of stock options, restricted stock units (&#8220;RSU&#8221;) and restricted stock awards (&#8220;RSA&#8221;). Most stock options have service vesting conditions ranging from <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" contextRef="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_MinimumMembersrtRangeAxis" format="ixt-sec:duryear">1</ix:nonNumeric> to <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" contextRef="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_MaximumMembersrtRangeAxis" format="ixt-sec:duryear">5</ix:nonNumeric> years. RSAs are fully vested on grant date. RSUs granted under the Rigetti&#160;&amp; Co., Inc. 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;) have a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" contextRef="P01_01_2022To12_31_2022_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMemberusgaapAwardTypeAxis_TwoThousandThirteenEquityIncentivePlanMemberusgaapPlanNameAxis" format="ixt-sec:duryear">4</ix:nonNumeric>-year</div> service vesting condition and a performance condition linked to the occurrence of a liquidity event defined as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">change-in-control</div></div> event, successful initial public offering or successful merger with a special purpose acquisition company, which was satisfied at the Closing. RSUs granted under the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) have a service vesting condition only. The Company occasionally issues awards that might have different vesting conditions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compensation expense is based on the grant-date fair value of the awards and recognized over the requisite service period using a straight-line method for awards that have a service only condition. Compensation expense for awards with service and performance and/or market conditions is recognized using a graded vesting method. Compensation expense for RSAs is recognized fully on grant date. Compensation expenses for awards with a market condition are recognized over the requite service period regardless of whether the market condition is met unless the service requirement is not met. The Company has elected to account for forfeitures of employee stock awards as they occur. </div> </ix:nonNumeric> <ix:nonNumeric name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div>&#8212; The Company reports all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis... Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 1&#8212;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 2&#8212;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 3&#8212;Inputs are unobservable for the asset or liability. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety. </div></div></div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804468"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentrations of Credit Risk</div></div> &#8212; Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments in the form of commercial paper and corporate bonds, and trade accounts receivable. The Company&#8217;s cash and cash equivalents and short-term investments are placed with high-credit-quality financial institutions, and at times exceed federally insured limits. To date, the Company has not experienced any credit loss relating to its cash and cash equivalents or short-term investments. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-17</ix:exclude></div> </ix:nonNumeric></ix:continuation></div></div> <ix:continuation id="TextSelection_73804468" continuedAt="TextSelectionAppend_73804468_1"><ix:continuation id="TextSelectionAppend_73804411_30" continuedAt="TextSelectionAppend_73804411_31"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_73804411_31" continuedAt="TextSelectionAppend_73804411_32"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_32" continuedAt="TextSelectionAppend_73804411_33"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation></ix:continuation></div></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_33" continuedAt="TextSelectionAppend_73804411_34"><ix:continuation id="TextSelectionAppend_73804468_1"><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-bottom: 0pt; text-indent: 0px; margin-top: 1em"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant </div></div> customers that represent <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction></ix:nonFraction>% or more of revenue are set forth in the <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">following tables: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year<br/>Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the 11<br/>months<br/>ended<br/>December&#160;31,</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer A</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">33</ix:nonFraction>%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">16</ix:nonFraction>%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer B</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">18</ix:nonFraction>%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer C</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">15</ix:nonFraction>%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">15</ix:nonFraction>%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer D</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">14</ix:nonFraction>%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">29</ix:nonFraction>%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer E</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerEMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">11</ix:nonFraction>%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer F</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">*</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerFMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">17</ix:nonFraction>%</td></tr></table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*Customer accounted for less than 10% of revenue in the respective period </div></div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> </ix:nonNumeric> <ix:nonNumeric name="rgti:DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer A</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">65</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer B</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">13</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">35</ix:nonFraction>%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer C</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction>%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">34</ix:nonFraction>%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer D</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">29</ix:nonFraction>%</td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*Customer accounted for less than 10% of accounts receivable in the respective period</div></div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales to government entities comprised <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_GovernmentEntitiesMembersrtProductOrServiceAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">81.3</ix:nonFraction>% and <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_GovernmentEntitiesMembersrtProductOrServiceAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">80.0</ix:nonFraction>% of the Company&#8217;s total revenue for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. </div></ix:continuation> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804433"></ix:nonNumeric></div><ix:continuation id="TextSelection_73804433" continuedAt="TextSelectionAppend_73804433_1"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recently Adopted Accounting Pronouncements </div></div>&#8212; In February 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-0</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2,</div> Leases and related subsequently issued ASUs (collectively, &#8220;Topic 842&#8221;), which supersedes Topic 840. From a lessee perspective, the core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (&#8220;ROU&#8221;) asset representing its right to use the underlying asset for the lease term. There continues to be a differentiation between finance leases (which replace capital leases as so identified under Topic 840) and operating leases. However, the principal difference from the previous guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the statement of financial position. The updated guidance also requires additional quantitative and qualitative disclosures and allows various practical expedients.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/><div style="margin-top: 1em; margin-bottom: 1em"></div> </ix:continuation><ix:continuation id="TextSelectionAppend_73804433_1" continuedAt="TextSelectionAppend_73804433_2"><ix:exclude> </ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_73804433_2" continuedAt="TextSelectionAppend_73804433_3"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted Topic 842 effective January&#160;1, 2022, using the modified retrospective transition option of applying the new standard at the adoption date for all leases with an original term greater than 12 months. The Company elected the package of practical expedients requiring no reassessment of (i)&#160;whether any expired or existing contracts are or contain leases, (ii)&#160;the lease classification of any expired or existing leases, or (iii)&#160;initial direct costs for any existing leases. Adoption of the standard had a material impact on the Company&#8217;s consolidated balance sheet by recognizing operating lease ROU assets and operating lease liabilities but did not<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>have an impact on its consolidated statement of operations or cash flows on the date of adoption. The adoption of Topic 842 was recorded as of January&#160;1, 2022 and resulted in the recognition of operating lease ROU assets and operating lease liabilities of $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn01_01_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.3</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="PAsOn01_01_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.6</ix:nonFraction>&#160;million respectively and a $<ix:nonFraction name="rgti:IncreaseDecreaseInDeferredRent" contextRef="PAsOn01_01_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction>&#160;million adjustment to deferred rent, with <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn01_01_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction> impact to accumulated deficit as of January&#160;1, 2022. The period ended December&#160;31, 2021 continues to be reported in accordance with the Company&#8217;s historic accounting under previous lease guidance, Topic 840.</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company determines if an arrangement includes a lease at inception. Operating leases are included in the Company&#8217;s balance sheet as operating lease ROU assets and operating lease liabilities as of December&#160;31, 2022. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-18</ix:exclude></div></div></div> </ix:continuation><ix:continuation id="TextSelectionAppend_73804433_3" continuedAt="TextSelectionAppend_73804433_4"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> </ix:continuation></div></div><ix:continuation id="TextSelectionAppend_73804433_4" continuedAt="TextSelectionAppend_73804433_5"><ix:continuation id="TextSelectionAppend_73804411_34" continuedAt="TextSelectionAppend_73804411_35"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_35" continuedAt="TextSelectionAppend_73804411_36"><ix:exclude><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_36" continuedAt="TextSelectionAppend_73804411_37"><ix:continuation id="TextSelectionAppend_73804433_5"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. In determining the net present value of its lease payments, the Company uses an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date, or the date of adoption of Topic 842. The operating lease ROU assets also include any lease payments made less lease incentives. The Company&#8217;s leases may include options to extend or terminate the lease, which is considered in the lease term when it is reasonably certain that the Company will exercise any such options. Lease expense is recognized on a straight-line basis over the expected lease term, taking into account adjustments for provisions such as free rent, escalating base monthly rental payments or deferred payment terms such as rent holidays that defer the commencement date of required payments. The Company has elected not to apply the recognition requirements of Topic 842 for short-term leases. The Company considers leases with a term of 12 months or less at the date of commencement to be short-term. </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2021, the FASB issued&#160;ASU No. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04,&#160;Earnings</div> Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-50),</div> Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#160;(&#8220;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#8221;).</div> The guidance in&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#160;clarifies</div> and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December&#160;15, 2021.The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Company&#160;adopted&#160;ASU&#160;2021-04&#160;as</div> of&#160;January 1, 2022. The adoption of&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#160;did</div> not have an impact on the Company&#8217;s financial position and results of operations. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,&#160;Income</div> Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> removes certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. The Company adopted this ASU on January&#160;1, 2022. Adoption did not have a significant impact on the Company&#8217;s financial statements or related disclosures. </div></div></ix:continuation> <ix:nonNumeric name="rgti:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805851"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recently Issued Accounting Pronouncements Not Yet Adopted </div></div>&#8212; In June 2022, the FASB issued&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2022-03,&#160;ASC</div> Subtopic 820&#160;&#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The FASB issued this update (1)&#160;to clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2)&#160;to amend a related illustrative example, and (3)&#160;to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The ASU is effective for the Company after December&#160;15, 2024, and interim periods within those fiscal years, with early adoption permitted. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In August 2020, the FASB issued&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06,</div> Debt - (Topic 815) (&#8220;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06&#8221;),</div> which simplifies an issuer&#8217;s accounting for convertible instruments and its application of the derivatives scope exception for contracts in its own equity. The amendments in&#160;ASU No. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06&#160;are</div> effective for public companies, other than smaller reporting companies, for fiscal years beginning after December&#160;15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December&#160;15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December&#160;15, 2020, including interim periods within those fiscal years. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In April 2019, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU&#160;2019-04,&#160;Codification&#160;Improvements</div> to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-19</ix:exclude></div> </ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_73805851" continuedAt="TextSelectionAppend_73805851_1"><ix:continuation id="TextSelectionAppend_73804411_37" continuedAt="TextSelectionAppend_73804411_38"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_38" continuedAt="TextSelectionAppend_73804411_39"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804411_39" continuedAt="TextSelectionAppend_73804411_40"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation></ix:continuation></div></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804411_40"><ix:continuation id="TextSelectionAppend_73805851_1"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU&#160;No.&#160;2019-04&#160;was</div> issued as part of the FASB&#8217;s ongoing project to improve upon its Accounting Standards Codification (ASC), and to clarify and improve areas of guidance related to recently issued standards on credit losses, hedging, and recognition and measurement. For entities that have not yet adopted the guidance in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Update&#160;2016-13,&#160;the</div> effective dates and the transition requirements for these amendments are the same as the effective date and transition requirements in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Update&#160;2016-13.&#160;The</div> amendments related to ASC 326 are effective for the Company as of January&#160;1, 2023.&#160;The adoption of the ASU is not expected to have a material impact on its consolidated financial statements. </div></div></ix:continuation></ix:continuation> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></div> <div style="margin-top: 1em; margin-bottom: 1em"></div> <ix:nonNumeric name="us-gaap:BusinessCombinationDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805379"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">3. BUSINESS COMBINATION </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed in Note 1, on March&#160;2, 2022, the Business Combination was completed. Pursuant to the Company&#8217;s certificate of incorporation, as amended on March&#160;2, 2022, the Company is authorized to issue <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,000,000,000</ix:nonFraction> shares of Common Stock and <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction>, of the Company (the &#8220;Preferred Stock&#8221;). The holders of shares of Common Stock are entitled to <div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:CommonStockNumberOfVotesPerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_pure" decimals="0" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></div> vote for each share of Common Stock held. The Preferred Stock is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting.</div> <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction> shares of Preferred Stock were issued and outstanding as of December&#160;31, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;1, 2022, prior to the Closing, as contemplated by the Merger Agreement and following approval by SNII&#8217;s shareholders at an extraordinary general meeting of shareholders held on February&#160;28, 2022 (the &#8220;Extraordinary General Meeting&#8221;), SNII filed a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filed a certificate of incorporation (the &#8220;Certificate of Incorporation&#8221;) and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which SNII was domesticated and continues as a Delaware corporation, changing its name to &#8220;Rigetti Computing, Inc.&#8221;<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div> <ix:exclude> </ix:exclude> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of and upon the effective time of the Domestication (which occurred on March&#160;1, 2022), among other things:(1) each then issued and outstanding Class&#160;A ordinary share, par value $<ix:nonFraction name="rgti:CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share, of SNII (&#8220;SNII Class&#160;A ordinary share&#8221;) converted automatically, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into a share of Common Stock; (2)&#160;each then issued and outstanding Class&#160;B ordinary share, par value $<ix:nonFraction name="rgti:CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share, of SNII (&#8220;SNII Class&#160;B ordinary share&#8221;) converted automatically, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into a share of Common Stock; (3)&#160;each then issued and outstanding whole warrant of SNII to purchase one SNII Class&#160;A ordinary share converted automatically into a Public Warrant to acquire one share of Common Stock at an exercise price of $<ix:nonFraction name="rgti:ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction> per share pursuant to the Warrant Agreement, dated March&#160;1, 2021, between SNII and American Stock Transfer&#160;&amp; Trust Company, as warrant agent; (4)&#160;and each then issued and outstanding unit of SNII (the &#8220;SNII Units&#8221;) was separated and converted automatically into one share of Common Stock and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-fourth</div> of <ix:nonFraction name="rgti:ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="0" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> Warrant. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immediately prior to the effective time of the Business Combination, each share of Legacy Rigetti&#8217;s Series C preferred stock and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock (collectively, the &#8220;Legacy Rigetti Preferred Stock&#8221;) with Par Value of $<ix:nonFraction name="rgti:TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="6" scale="0" format="ixt:num-dot-decimal">0.000001</ix:nonFraction> converted into shares of Common Stock of Legacy Rigetti (&#8220;Legacy Rigetti Common Stock&#8221;) in accordance with the Amended and Restated Certificate of Incorporation of Legacy Rigetti (such conversion, the &#8220;Legacy Rigetti Preferred Conversion&#8221;). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the Business Combination, among other things (1)&#160;all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (in<div style="background-color:#ffffff;;display:inline;">cluding Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of </div><div style="background-color:#ffffff;;display:inline;"><ix:nonFraction name="rgti:CommonStockSharesExchangeRatio" contextRef="PAsOn12_31_2022" unitRef="Unit_pure" decimals="4" scale="0" format="ixt:num-dot-decimal">0.7870</ix:nonFraction></div><div style="background-color:#ffffff;;display:inline;"> (the &#8220;Exchange Ratio&#8221;) for an aggregate of </div><div style="background-color:#ffffff;;display:inline;"><ix:nonFraction name="rgti:CommonStockSharesIssuedAsAResultOfExchange" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">78,959,579</ix:nonFraction></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;">&#160;</div></div><div style="background-color:#ffffff;;display:inline;">shares of Common Stock; (2)&#160;each warrant to purchase Legacy Rigetti Common Stock converted into a warrant to purchase shares of Common Stock (&#8220;Assumed Warrant&#8221;), with each Assumed Warrant subject to the same terms and conditions as were applicable to the original Legacy Rigetti warrant and having an exercise price and number of shares of Common Stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement; (3)&#160;each option to purchase Legacy Rigetti Common Stock converted into an option to purchase shares of Common Stock (&#8220;Assumed Option&#8221;), with each Assumed Option subject to the same terms and conditions as were applicable to the original Legacy Rigetti</div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-20</ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></div></div><ix:continuation id="TextSelection_73805379" continuedAt="TextSelectionAppend_73805379_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805379_1" continuedAt="TextSelectionAppend_73805379_2"><ix:exclude><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805379_2" continuedAt="TextSelectionAppend_73805379_3"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">option and with an exercise price and number of shares of Common Stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement, and; (4)&#160;each Legacy Rigetti restricted stock unit award converted into a restricted stock unit award to receive shares of Common Stock (&#8220;Assumed RSU Award&#8221;), with each Assumed RSU Award subject to the same terms and conditions as were applicable to the Legacy Rigetti restricted stock unit award, and with the number of shares of Common Stock to which the Assumed RSU Award converted based on the Exchange Ratio and other terms contained in the Merger Agreement. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connectio</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">n with the execution of the Merger Agreement, SNII entered into a sponsor support agreement (the &#8220;Sponsor Support Agreement&#8221;) with the Sponsor, Legacy Rigetti and SNII&#8217;s directors and officers. Pursuant to the Sponsor Support Agreement, the Sponsor and SNII&#8217;s directors and officers (&#8220;Sponsor Holders&#8221;), among other things, agreed to vote all of their shares of SNII capital stock in favor of the approval of the Business Combination. In addition, pursuant to the Sponsor Support Agreement, (i) </div><ix:nonFraction name="rgti:SharesSubjectToVestingBasedOnCertainConditions" contextRef="PAsOn12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,479,000</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="rgti:SharesSubjectToVestingMaximumPeriod" contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis" format="ixt-sec:durwordsen">five year</ix:nonNumeric> </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">period following the Closing, the volume weighted average price of Common Stock equals or exceeds $</div><ix:nonFraction name="rgti:VolumeWeightedAveragePricePerShare" contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">12.50</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> for any </div><span style="-sec-ix-hidden:hidden73805546">twenty trading days</span><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> within a period of </div><span style="-sec-ix-hidden:hidden73805503">thirty consecutive trading days</span><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, and (ii) </div><ix:nonFraction name="rgti:SharesSubjectToVestingBasedOnCertainConditions" contextRef="PAsOn12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">580,273</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the </div><ix:nonNumeric name="rgti:SharesSubjectToVestingMaximumPeriod" contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis" format="ixt-sec:durwordsen">five year</ix:nonNumeric><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> period following the Closing, the volume weighted average price of Common Stock equals or exceeds $</div><ix:nonFraction name="rgti:VolumeWeightedAveragePricePerShare" contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">15.00</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> for any</div><span style="-sec-ix-hidden:hidden73805545"> twenty trading days</span><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> within a period of </div><span style="-sec-ix-hidden:hidden73805504">thirty consecutive trading days</span><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">. Any such shares held by the Sponsor Holders that remain unvested after the fifth anniversary of the Closing will be forfeited. (Refer to Note 2 for related significant accounting policy for the Sponsor </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Liability).</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div> <ix:exclude> </ix:exclude><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Concurrently with the execution of the Merger Agreement, SNII entered into Subscription Agreements (the &#8220;Initial Subscription Agreements&#8221;) with certain investors (together, the &#8220;Initial PIPE Investors&#8221;), pursuant to which the Initial PIPE Investors agreed to subscribe for and purchase, and SNII agreed to issue and sell to the Initial PIPE Investors, an aggregate of <ix:nonFraction name="us-gaap:CommonStockSharesSubscribedButUnissued" contextRef="PAsOn12_01_2021_InitialSubscriptionAgreementMemberRGTIAgreementAxis_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SupernovaAcquistionMemberdeiLegalEntityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">10,251,000</ix:nonFraction> shares of Common Stock at a price of $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn12_01_2021_InitialSubscriptionAgreementMemberRGTIAgreementAxis_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SupernovaAcquistionMemberdeiLegalEntityAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">10.00</ix:nonFraction> per share, for aggregate gross proceeds of $<ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="PAsOn12_01_2021_InitialSubscriptionAgreementMemberRGTIAgreementAxis_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SupernovaAcquistionMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">102.5</ix:nonFraction> Million (the &#8220;Initial PIPE Financing&#8221;). <div style="letter-spacing: 0px; top: 0px;;display:inline;">On December 23, 2021, SNII entered into Subscription Agreements (the &#8220;Subsequent Subscription Agreements&#8221;, and together with the Initial Subscription Agreements, the &#8220;Subscription Agreements&#8221;) with two&#160;investors (the &#8220;Subsequent PIPE Investors&#8221;, and together with the Initial PIPE Investors, the &#8220;PIPE Investors&#8221;) pursuant to which the Subsequent PIPE Investors agreed to subscribe for and purchase, and SNII agreed to issue and sell to the Subsequent PIPE Investors, an aggregate of&#160;</div><ix:nonFraction name="us-gaap:CommonStockSharesSubscribedButUnissued" contextRef="PAsOn12_23_2021_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SubsequentSubscriptionAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">4,390,244</ix:nonFraction> shares of Common Stock at a price of $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn12_23_2021_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SubsequentSubscriptionAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">10.25</ix:nonFraction> per share, for aggregate gross proceeds of $<ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="PAsOn12_23_2021_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SubsequentSubscriptionAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">45.0</ix:nonFraction> Million (the &#8220;Subsequent PIPE Financing&#8221;, and together with the Initial PIPE Financing, the &#8220;PIPE Financing&#8221;). Pursuant to the Subscription Agreements, Rigetti agreed to provide the PIPE Investors with certain registration rights with respect to the shares purchased as part of the PIPE Financing. The PIPE Financing was consummated immediately prior to the Merger. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Business Combination is accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, SNII was treated as the &#8220;acquired&#8221; company for financial reporting purposes. </div></div><br/></div> </ix:continuation></div></div></div></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805379_3" continuedAt="TextSelectionAppend_73805379_4"><ix:nonNumeric name="rgti:DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;">In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $<ix:nonFraction name="rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">225.6</ix:nonFraction>&#160;million. The table below shows the net proceeds from business combination and PIPE financing: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;SNII trust and cash (net of redemption)</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CashReceivedFromTrustNetOfRedemptions" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">77,769</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;PIPE</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CashReceivedFromPrivateInvestmentInPublicEquity" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">147,510</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;SNII operating account</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AggregateTransactionCostsPaid" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">325</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Net Proceeds from Business Combination and PIPE</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">225,604</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction costs consist of direct legal, accounting and other fees relating to the consummation of the Merger. Legacy Rigetti transaction costs specific and directly attributable to the business combination totaled </div></div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-21</ix:exclude></div></div></div><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_73805379_4" continuedAt="TextSelectionAppend_73805379_5"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805379_5" continuedAt="TextSelectionAppend_73805379_6"><ix:exclude><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805379_6" continuedAt="TextSelectionAppend_73805379_7"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$<ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">20.65</ix:nonFraction>&#160;million. These costs were initially capitalized as incurred in deferred offering assets on the consolidated balance sheets. Upon the Closing, transaction costs related to the issuance of shares were recognized in stockholders&#8217; equity (deficit) while costs associated with the Public Warrants, Private Warrants and Sponsor Vesting Shares were expensed in the consolidated statements of operations. Of the total transaction cost of<div style="letter-spacing: 0px; top: 0px;;display:inline;"><br/></div>$<ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">20.65</ix:nonFraction>&#160;million, $<ix:nonFraction name="rgti:AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">19.75</ix:nonFraction>&#160;million was recorded to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital as a reduction of proceeds and the remaining $<ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction>&#160;million was recognized in the consolidated statements of operations during the year ended December&#160;31, 2022. Transaction cost paid through cash during the year ended December&#160;31, 2022, equals $<ix:nonFraction name="rgti:PaymentOfTransactionCostsThroughCash" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">16.7</ix:nonFraction>&#160;million. For the year ended December&#160;31, 2022, the Company also paid a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-time</div> bonus to certain employees related to the business combination of $<ix:nonFraction name="rgti:OneTimeBonus" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.1</ix:nonFraction>&#160;million. </div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_73805379_7" continuedAt="TextSelectionAppend_73805379_8"><ix:exclude> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805379_8"><ix:nonNumeric name="rgti:DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The number of shares of Common Stock issued immediately following the consummation of the Business Combination was as follows: </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:79%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div>SNII Class&#160;A, outstanding prior to Business Combination</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_StatusOfSharesOutstandingBeforeBusinessCombinationMemberRGTIEventAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">34,500,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: redemption of SNII Class&#160;A ordinary shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:RedemptionOfCommonStockSharesOfThePredecessorCompany" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">22,915,538</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div>SNII Class&#160;A ordinary shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CommonStockSharesNewlyIssuedInThePredecessorCompany" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">11,584,462</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;SNII Class&#160;B ordinary shares*</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CommonStockSharesNewlyIssuedInThePredecessorCompany" contextRef="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">8,625,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in PIPE</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">14,641,244</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Business Combination and PIPE shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">34,850,706</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;Legacy Rigetti**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CommonStockSharesIssuedInTheNewCompany" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">18,221,069</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;exercise of Legacy Rigetti stock options immediately prior to the closing**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,123,539</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;exercise of Legacy Rigetti warrants immediately prior to the closing**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,234,408</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;upon conversion of Legacy Rigetti Series C preferred stock**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" contextRef="P01_01_2022To12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">54,478,261</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;upon conversion of Legacy Rigetti Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" contextRef="P01_01_2022To12_31_2022_SeriesCOneRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,902,302</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares of Common Stock immediately after Business Combination</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">113,810,285</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">*</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes (i) <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2022_PromoteSponsorVestingSharesMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,479,000</ix:nonFraction> shares of Common Stock held by the Sponsor (the &#8220;Promote Sponsor Vesting Shares&#8221;) and (ii) <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="PAsOn12_31_2022_SponsorRedemptionBasedVestingSharesMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">580,273</ix:nonFraction> shares of Common Stock held by the Sponsor (&#8220;Sponsor Redemption-Based Vesting Shares&#8221;). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">**</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">(i) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of <ix:nonFraction name="rgti:CommonStockSharesExchangeRatio" contextRef="PAsOn12_31_2022" unitRef="Unit_pure" decimals="4" scale="0" format="ixt:num-dot-decimal">0.7870</ix:nonFraction> (the &#8220;Exchange Ratio&#8221;). (ii) the conversion ratio to Legacy Rigetti Common Stock for the Legacy Series C Preferred Stock was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" contextRef="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction>-for-one</div></div> and for Legacy <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;C-1</div> Preferred Stock was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" contextRef="PAsOn12_31_2022_SeriesCOneRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt-sec:numwordsen">eight</ix:nonFraction>-for-one.</div></div> </div></td></tr></table></ix:nonNumeric> </ix:continuation> <ix:nonNumeric name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805697"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4. INVESTMENTS </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, investment securities in the Company&#8217;s Trust Account consisted of $<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">36.3</ix:nonFraction>&#160;million in money market funds, $<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">58.2</ix:nonFraction>&#160;million in United States Treasury securities, $<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">3.6</ix:nonFraction>&#160;million in corporate bonds and $<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">23.1</ix:nonFraction>&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">million in commercial paper. The money market funds are classified as cash equivalents in the consolidated balance sheets. The Company classifies its investments in fixed income securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale.</div></div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> marketable securities are recorded at their estimated fair value. <ix:nonNumeric name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805700">The amortized cost, gross unrealized holding loss included in other comprehensive income, and fair value of the</ix:nonNumeric> </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-22</ix:exclude></div></div></div><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:nonNumeric></div></div><ix:continuation id="TextSelection_73805697" continuedAt="TextSelectionAppend_73805697_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805697_1" continuedAt="TextSelectionAppend_73805697_2"><ix:exclude><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805697_2" continuedAt="TextSelectionAppend_73805697_3"><ix:continuation id="TextSelection_73805700"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">investment securities on December&#160;31, 2022 are presented in the table below. The Company did not hold investment securities at December&#160;31, 2021. </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 49%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized&#160;Cost&#160;as&#160;of<br/>December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross&#160;Unrealized<br/>Holding Loss</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;Value&#160;as&#160;of<br/>December&#160;31,&#160;2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash <div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>quivalents</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money Market Funds</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">36,346</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" contextRef="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">36,346</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments:</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States Treasury Securities</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">58,514</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" contextRef="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">304</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">58,210</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,581</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" contextRef="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,571</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commercial Papers</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">23,142</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">23,142</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">121,583</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">314</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">121,269</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:continuation> </ix:continuation></div></div><ix:continuation id="TextSelectionAppend_73805697_3" continuedAt="TextSelectionAppend_73805697_4"><ix:exclude> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805697_4"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the Company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities have final maturities of <ix:nonNumeric name="rgti:DebtSecuritiesAvailableForSaleMaturityYear" contextRef="P01_01_2022To12_31_2022">one year or less</ix:nonNumeric>. The Company reviews the individual securities that have unrealized losses in its short-term investment portfolio on a regular basis. The Company evaluates whether it has the intention to sell any of these investments and whether it is more likely than not that it will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met as of December&#160;31, 2022. The Company additionally evaluates whether the decline in fair value of the securities below their amortized cost basis is related to credit losses or other factors. Based on this evaluation, the Company determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-credit-related</div> factors. Accordingly, the Company determined that the unrealized losses were not other-than-temporary and that recording an impairment was therefore unnecessary for its short-term investments as of December&#160;31, 2022. All of the Company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities have been in an unrealized loss position for less than one year because they were all acquired in 2022. The Company did <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>t have any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities as of December&#160;31, 2021. </div></ix:continuation><ix:nonNumeric name="us-gaap:GoodwillDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">5. GOODWILL </div></div><ix:nonNumeric name="us-gaap:ScheduleOfGoodwillTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the change in the carrying amount of goodwill for the Company for the year ended December&#160;31, 2022: </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 86%;"></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 86%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">January 1, 2021</div></div></div></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn01_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,377</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 86%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Change</div><br/></div></div></div></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 86%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:86%"></td>
<td style="vertical-align: bottom; width: 6%;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December&#160;31, 2021</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,377</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment charge</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,377</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 86%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December&#160;31, 2022</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 86%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div></ix:nonNumeric> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On the Company&#8217;s annual goodwill impairment testing date of November&#160;1, 2022 management performed an impairment evaluation of goodwill after assessing qualitative factors that indicated a possible impairment of goodwill. Under the qualitative assessment, management considers relevant events and circumstances including but not limited to macroeconomic conditions, industry and market considerations, overall Company performance and events directly affecting the Company. It was noted during our assessment that the Company has experienced a sustained decline in stock price, however as of November&#160;1, 2022 the Company determined that goodwill was not impaired. Subsequently in December 2022, the Company&#8217;s stock price continued to decline, resulting in a triggering event to evaluate goodwill for impairment as of December&#160;31, 2022. As a result, further quantitative analysis was conducted to determine the extent to which, if any, the Company&#8217;s carrying value exceeded its fair value as of December&#160;31, 2022. The quantitative analysis used fair value based on market capitalization adjusted for a control premium based on market comparable transactions. This quantitative analysis resulted in the Company&#8217;s fair value being significantly below its carrying value, resulting in a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> goodwill impairment charge of $<ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.4</ix:nonFraction>&#160;million being recorded for the year ended December&#160;31, 2022. </div></div></ix:nonNumeric> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-2<div style="letter-spacing: 0px; top: 0px;;display:inline;">3</div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div> <div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6. REVENUE RECOGNITION </div></div></div></div> <ix:nonNumeric name="us-gaap:DisaggregationOfRevenueTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables depict the disaggregation of revenue according to the type of good or service and timing of transfer of goods or services for the year ended December&#160;31, 2022, and the 11 months ended December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 62%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Type of Goods or Service</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Collaborative research and other professional services</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P01_01_2022To12_31_2022_CollaborativeResearchAndOtherProfessionalServicesMembersrtProductOrServiceAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,917</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P02_01_2021To12_31_2021_CollaborativeResearchAndOtherProfessionalServicesMembersrtProductOrServiceAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,849</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Access to quantum computing systems</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P01_01_2022To12_31_2022_AccessToQuantumComputingSystemsMembersrtProductOrServiceAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,185</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P02_01_2021To12_31_2021_AccessToQuantumComputingSystemsMembersrtProductOrServiceAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,347</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,102</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,196</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Timing of Revenue Recognition</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue recognized at a point in time</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P01_01_2022To12_31_2022_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P02_01_2021To12_31_2021_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue recognized over time</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P01_01_2022To12_31_2022_TransferredOverTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,102</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P02_01_2021To12_31_2021_TransferredOverTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,196</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,102</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,196</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> </ix:nonNumeric> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <ix:nonNumeric name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Selected consolidated balance sheet line items that reflect accounts receivable, contract assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021 were as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 65%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 65%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trade receivables</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,143</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">962</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unbilled receivables</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:UnbilledReceivablesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">92</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:UnbilledReceivablesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">581</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">961</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">985</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <ix:nonNumeric name="rgti:ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in deferred revenue from contracts with customers were as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"></td>
<td style="width: 14%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 14%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 62%;"></td>
<td style="width: 14%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 14%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at beginning of period</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">985</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="PAsOn01_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">492</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferral of revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:DeferralOfRevenue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">545</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:DeferralOfRevenue" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">904</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recognition of deferred revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:RecognitionOfDeferredRevenues" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">569</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:RecognitionOfDeferredRevenues" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">411</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at end of period</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">961</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">985</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Remaining performance obligations represent the portion of the transaction price that has not yet been satisfied or achieved. As of December&#160;31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $<ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">9.7</ix:nonFraction>&#160;million. The Company expects to recognize estimated revenues related to performance obligations that are unsatisfied (or partially satisfied) in the amounts of approximately $<ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="PAsOn12_31_2022_RemainderoftwothousandandtwentythreeMemberRGTIRevenuePerformanceObligationTransactionPriceAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.9</ix:nonFraction>&#160;million during the year ended December&#160;31, 2023, and $<ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="PAsOn12_31_2022_TwothousandandtwentyfourMemberRGTIRevenuePerformanceObligationTransactionPriceAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.8</ix:nonFraction>&#160;million during the years ended December&#160;31, 2024 and December&#160;31, 2025. <br/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred Contract Acquisition and Fulfillment Costs&#8212;The Company has not identified any costs that are incremental to the acquisition of customer contracts that would be capitalized as deferred costs on the balance sheet in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40.</div> Incremental costs incurred to fulfill the Company&#8217;s contracts that meet the capitalization criteria in ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40</div> have historically been immaterial. Accordingly, the Company has not capitalized any contract fulfillment costs as of December&#160;31, 2022 and December&#160;31, 2021. </div></div> </ix:nonNumeric> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-2<div style="display:inline;">4</div></div></div></div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div> </div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></div> <div style="margin-top: 1em; margin-bottom: 1em"></div> <ix:nonNumeric name="rgti:SupplementalFinancialStatementInformationTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">7. SUPPLEMENTAL FINANCIAL STATEMENTS INFORMATION </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Property and Equipment, Net </div></div> <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment as of December&#160;31, 2022 and December&#160;31, 2021 are composed of the following: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Quantum computing fridges</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022_QuantumComputingFridgesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,218</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2021_QuantumComputingFridgesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">17,190</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Process equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022_ProcessEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">23,330</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2021_ProcessEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">16,170</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,561</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2021_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,297</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IT Hardware</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022_ItHardwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,035</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2021_ItHardwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,428</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and other assets</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022_FurnitureAndOtherAssetsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,246</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2021_FurnitureAndOtherAssetsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,246</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">65,390</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">41,330</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation and amortization</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">25,860</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18,832</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment - net</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">39,530</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">22,497</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022 and December&#160;31, 2021, <ix:nonFraction name="rgti:PercentageOfTotalGrossPropertyAndEquipment" contextRef="PAsOn12_31_2022_USsrtStatementGeographicalAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">98</ix:nonFraction>% of the total gross property and equipment was located in the United States, and <ix:nonFraction name="rgti:PercentageOfTotalGrossPropertyAndEquipment" contextRef="PAsOn12_31_2021_GBsrtStatementGeographicalAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">2</ix:nonFraction>% of the total gross property and equipment was located in the United Kingdom. Total depreciation and amortization expense for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $<ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.0</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.7</ix:nonFraction>&#160;million, respectively. </div> <ix:nonNumeric name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued Expenses and Other Current Liabilities </div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Utilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedUtilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,818</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Professional&#160;&amp; subscription fees</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,044</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,377</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and other taxes</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AccruedPropertyAndOtherTaxes" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,161</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AccruedPropertyAndOtherTaxes" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">571</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subcontractor cost</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AccruedSubcontractorCost" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">804</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payroll and other payroll costs</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">781</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedPayrollTaxesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">962</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AccruedPropertyPlantAndEquipmentCost" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">639</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">626</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;">Accrued interest</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">314</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">248</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AccruedDeferredOfferingCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">18</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AccruedDeferredOfferingCosts" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">648</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,205</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,806</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805799"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">8. LEASES </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company leases a building, offices and equipment under various lease agreements with terms extending through 2029. Under the terms of the building and office leases the Company bears the costs for certain insurance, property taxes and maintenance, and the lease agreements provide for increasing rental payments at fixed intervals. <br/></div> </ix:nonNumeric></div> </div> </div> </div> </div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelection_73805799" continuedAt="TextSelectionAppend_73805799_1"><ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805798"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Components of lease costs, the weighted average remaining lease term and weighted average discount rate were as follows as of and for the year ended December&#160;31, 2022: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"></td>
<td style="width: 15%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div>Lease cost<div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 78%;"></td>
<td style="width: 15%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-size: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,513</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term lease cost</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">36</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Sub-lease income</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">194</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease cost</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,355</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr> </table> </ix:nonNumeric></ix:continuation></div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_73805798" continuedAt="TextSelectionAppend_73805798_1"><ix:continuation id="TextSelectionAppend_73805799_1" continuedAt="TextSelectionAppend_73805799_2"> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-2<div style="display:inline;">5</div></ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:continuation></ix:continuation></div> </div> <ix:continuation id="TextSelectionAppend_73805798_1" continuedAt="TextSelectionAppend_73805798_2"><ix:continuation id="TextSelectionAppend_73805799_2" continuedAt="TextSelectionAppend_73805799_3"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805799_3" continuedAt="TextSelectionAppend_73805799_4"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation> </ix:continuation><div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805799_4"><ix:continuation id="TextSelectionAppend_73805798_2"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash paid for amounts included in the measurement of lease liabilities:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating cash flows from operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">$<ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,128</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets obtained in exchange for new and modified operating lease liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">$<ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,892</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average remaining lease term - operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="PAsOn12_31_2022" format="ixt-sec:duryear">5.87</ix:nonNumeric>&#160;years</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate - operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center; text-indent: 0px;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="PAsOn12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">7.93</ix:nonFraction><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0px;;text-align:center;">&#160;</td> </tr> </table> </ix:continuation> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the net present value of its lease payments, the Company used an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date or the date of Adoption of Topic 842. As of December&#160;31, 2022, the maturities of the Company&#8217;s operating lease liabilities were as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,422</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,288</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,198</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,524</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,566</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,841</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease payments</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">12,839</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Imputed interest</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,636</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Present value of lease liabilities</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,203</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,345</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, noncurrent</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">7,858</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">10,203</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the adoption of Topic 842 on January&#160;1, 2022, the Company accounted for its leases under Topic 840. The Company recognized rent expense on a straight-line basis over the lease term, taking into account adjustments for provisions such as free or escalating monthly rental payments or deferred payment terms such as rent holidays that defer the commencement date of required payments. The Company recorded the difference between cash rent payments and the recognition of rent expense as deferred rent. Rent expense under the Company&#8217;s operating leases was $<ix:nonFraction name="rgti:OperatingLeaseRentExpenses" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.5</ix:nonFraction>&#160;million for the 11 months ended December&#160;31, 2021.<br/></div> <ix:nonNumeric name="rgti:ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future minimum lease payments under non-cancelable operating leases as of December 31, 2021 are <div style="letter-spacing: 0px; top: 0px;;display:inline;">as</div> follows: </div></div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 87%;"></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,808</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">901</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">928</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">956</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">81</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total minimum future lease payments</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,674</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr> </table> </ix:nonNumeric> </ix:continuation> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-2<div style="display:inline;">6</div></div></div></div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div> </div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9. COMMITMENTS AND CONTINGENCIES</div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is periodically involved in legal proceedings, legal actions and claims arising in the normal course of business. Management believes that the outcome of such legal proceedings, legal actions and claims will not have a significant adverse effect on the Company&#8217;s financial position, results of operations or cash flows.</div> </ix:nonNumeric><ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805151"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">10. DEBT </div></div></div><br/></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2021, the Company entered into an agreement (the &#8220;Loan Agreement&#8221;) with Trinity Capital Inc. (&#8220;Trinity&#8221;) to secure a debt commitment of $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="PAsOn03_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheAMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">12.0</ix:nonFraction>&#160;million (the &#8220;Tranche A&#8221;) which was drawn at the closing. The term loan is collateralized by a first-priority, senior secured interest in substantially all of the Company&#8217;s assets. In conjunction with the Loan Agreement, the Company issued Trinity a warrant to purchase shares of Common Stock (the &#8220;Trinity Warrants&#8221;) which is recorded at fair value using the Black-Scholes model, see Note 15 for the fair value assumptions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreement contains customary representations, warranties and covenants; however, the debt agreement does not include any financial covenants. In May 2021, the debt agreement was modified to increase the overall debt commitment by $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">15.0</ix:nonFraction>&#160;million (the &#8220;Tranche B&#8221; or the &#8220;Amendment&#8221;) and $<ix:nonFraction name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.0</ix:nonFraction>&#160;million of the additional commitment was drawn at the closing and the remaining commitment of $<ix:nonFraction name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.0</ix:nonFraction>&#160;million was available at the Company&#8217;s option at any time through March&#160;10, 2022 subject to certain conditions. The Company drew the $<ix:nonFraction name="rgti:WithdrawnCreditFacility" contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">7.0</ix:nonFraction>&#160;million in November 2021. In conjunction with the Amendment, the Company cancelled the Initial Warrants and issued <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">995,099</ix:nonFraction> (<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn12_31_2022_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">783,129</ix:nonFraction> shares post conversion upon the closing of the Business Combination) warrant shares to purchase the Common Stock which was an incremental cost allocated between Tranche A and Tranche B, see Note 13 for further information on these warrants. The Amendment to the debt agreement was considered a modification for accounting purposes. The Company capitalized $<ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="PAsOn05_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.8</ix:nonFraction>&#160;million of debt issuance costs which consist of incremental costs incurred for the lenders and third-party legal firms as well as the fair value of the warrant issued in conjunction with the term loan. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Amendment, the maturity date was modified to be the date equal to <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MaximumMembersrtRangeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis" format="ixt-sec:durmonth">48</ix:nonNumeric> months from the first payment date of each specific cash advance. Subject to an interest only period of <ix:nonNumeric name="us-gaap:DebtInstrumentPaymentTerms" contextRef="P01_31_2022To01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MinimumMembersrtRangeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis">19 months</ix:nonNumeric> following each specific cash advance date, the term loan incurs interest at a rate of the greater of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">11</ix:nonFraction>% <div style="letter-spacing: 0px; top: 0px;;display:inline;">or </div>the <ix:nonNumeric name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_PrimeRateMemberusgaapVariableRateAxis">US Prime Rate plus <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_PrimeRateMemberusgaapVariableRateAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">7.50</ix:nonFraction>% per annum</ix:nonNumeric>, <ix:nonNumeric name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">payable monthly</ix:nonNumeric>. The Term Loan includes certain negative covenants, primarily consisting of restrictions on the Company&#8217;s ability to incur indebtedness, pay dividends, execute fundamental change transactions, and other specified actions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2022, the debt agreement was modified to increase the overall debt commitment by $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million (the &#8220;Tranche C&#8221; or the &#8220;Third Amendment&#8221;) which was drawn on January&#160;27, 2022. Subject to an interest only period of <ix:nonNumeric name="us-gaap:DebtInstrumentPaymentTerms" contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis">19 months</ix:nonNumeric>, Tranche C incurs interest at a rate of the greater of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">11</ix:nonFraction>% and the <ix:nonNumeric name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" contextRef="P01_31_2022To01_31_2022_PrimeRateMemberusgaapVariableRateAxis_TrancheCMemberusgaapDebtInstrumentAxis">US Prime Rate plus <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="P01_31_2022To01_31_2022_PrimeRateMemberusgaapVariableRateAxis_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">7.50</ix:nonFraction>% per annum</ix:nonNumeric>, <ix:nonNumeric name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis">payable monthly</ix:nonNumeric>, until the maturity date, <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" format="ixt:date-monthname-day-year-en">February 1, 2026</ix:nonNumeric>. Other modifications per the amendment included an extension of the requirement to raise an additional $<ix:nonFraction name="us-gaap:DebtInstrumentRepurchaseAmount" contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">75</ix:nonFraction>&#160;million of equity until April&#160;1, 2022, and a defined exit fee for the additional $<ix:nonFraction name="us-gaap:DebtInstrumentFeeAmount" contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million to be at <ix:nonFraction name="rgti:PercentageOfadvancedFundsUnderTheAmendment" contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% of the advanced funds under the amendment. The company met the requirement to raise additional equity of $<ix:nonFraction name="us-gaap:DebtInstrumentRepurchaseAmount" contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">75</ix:nonFraction><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million through the business combination mentioned in Note 3. The Company paid an exit fee of $</div><ix:nonFraction name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.0</ix:nonFraction>&#160;million which is <ix:nonFraction name="rgti:PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:num-dot-decimal">20</ix:nonFraction><div style="letter-spacing: 0px; top: 0px;;display:inline;">% of the Tranche C amount upon the consummation of the merger. The exit fee was capitalized as a debt issuance cost and is amortized using the effective interest method over the life of Tranche C. The exit fee is not applicable to Tranche A and Tranche B. In conjunction with the amendment, the Company also guaranteed payment of all monetary amounts owed and performance of all covenants, obligations and liabilities.&#160;</div> </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In addition, the Company is required to pay a final payment fee equal to <ix:nonFraction name="rgti:DebtInstrumentPaymentFeepercentage" contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">2.75</ix:nonFraction>% of the aggregate amount of all term loan advances. The final payment fee is being accreted and amortized into interest expense using the effective interest rate method over the term of the loan. The effective interest was between <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MinimumMembersrtRangeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">20.75</ix:nonFraction><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% </div></div> &#8211; <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MaximumMembersrtRangeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">26.83</ix:nonFraction>% for all tranches of the debt as of December&#160;31, 2022.<br/></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-2<div style="display:inline;">7</div></ix:exclude></div></div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_73805151" continuedAt="TextSelectionAppend_73805151_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805151_1" continuedAt="TextSelectionAppend_73805151_2"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805151_2" continuedAt="TextSelectionAppend_73805151_3"></ix:continuation></div> </div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805151_3"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><ix:nonNumeric name="us-gaap:ScheduleOfDebtTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the debt is classified as Level 2. Given the maturity and variable interest rate on the debt, the book value approximates its fair value. Long term debt and the unamortized discount balances are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 74%;"></td>
<td style="width: 5%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 5%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding principal amount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,709</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">27,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Add: accreted liability of final payment fee</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AccruedFinalPaymentFee" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">407</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:AccruedFinalPaymentFee" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">125</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: unamortized debt discount, long term</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">990</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,618</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: current portion of long term debt-principal</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:CurrentPortionOfLongTermDebtGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">9,491</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:CurrentPortionOfLongTermDebtGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,291</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Debt&#8212;net of current portion</div><br/></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">20,635</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">24,216</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Current portion of long term debt&#8212;principal</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CurrentPortionOfOutstandingPrincipalAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,491</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:CurrentPortionOfOutstandingPrincipalAmount" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,291</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: current portion of unamortized debt discount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,188</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">716</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt&#8212;current portion</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,303</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">575</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the year ended December&#160;31, 2022, the Company recorded interest expense of $</div><ix:nonFraction name="us-gaap:InterestExpense" contextRef="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.3</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, which includes the accretion of the end of term liability of $</div><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, the amortization of commitment fee asset of $</div><ix:nonFraction name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" contextRef="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.3</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million and the amortization of debt issuance cost of $</div><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.9</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, respectively. The unamortized debt discount of $</div><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.2</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million as of December&#160;31, 2022 is offset against the carrying value of the term loan in the consolidated balance sheet.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the 11 months ended December&#160;31, 2021, the Company recorded interest expense of $</div><ix:nonFraction name="us-gaap:InterestExpense" contextRef="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.5</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, which includes the accretion of the end of term liability of $</div><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, the amortization of commitment fee asset of $</div><ix:nonFraction name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" contextRef="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.1</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million and the amortization of debt issuance cost of $</div><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.5</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million. The unamortized debt discount of $</div><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="PAsOn12_01_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million as of December&#160;31, 2021 is offset against the carrying value of the term loan in the consolidated balance sheet.</div></div> <ix:nonNumeric name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Scheduled principal payments on total outstanding debt as of December&#160;31, 2022 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 85%;"></td>
<td style="vertical-align: bottom; width: 6%;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,491</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,007</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,020</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">191</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">30,709</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scheduled principal payments on total outstanding debt as of December 31, 2021 are as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">702</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,682</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,008</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">6,608</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">27,000</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr> </table> </ix:nonNumeric></ix:continuation> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-2<div style="display:inline;">8</div></div></div></div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div> </div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="rgti:RedeemableConvertiblePreferredStockTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">11. REDEEMABLE CONVERTIBLE PREFERRED STOCK </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Legacy Rigetti was authorized to issue <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2022_SeriesCPreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">73,389,000</ix:nonFraction> shares of Series C preferred stock and <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2022_SeriesCOnePreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">62,537,577</ix:nonFraction> shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock with a par value of $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_PreferredStockMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.000001</ix:nonFraction> per share for each class of preferred Stock. Legacy Rigetti&#8217;s board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, option or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Immediately prior to the effective time of the Business Combination (Note&#160;3), all Legacy Rigetti preferred stock outstanding converted into shares of Common Stock of Legacy Rigetti (the shares in this note do not factor in the exchange ratio). </div> </ix:nonNumeric> <ix:nonNumeric name="rgti:CommonStockTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804809"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">12. COMMON STOCK </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As discussed in Note 3, on March&#160;2, 2022, the Company consummated a Business Combination which has been accounted for as a reverse recapitalization. Pursuant to the certificate of incorporation as amended on March&#160;2, </div>2022, the Company is authorized to issue <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,000,000,000</ix:nonFraction> shares of Common Stock and <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn03_02_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction> shares of Preferred Stock. The holders of shares of Common Stock are entitled to <ix:nonNumeric name="us-gaap:CommonStockVotingRights" contextRef="P01_01_2022To12_31_2022">one vote</ix:nonNumeric> for each share of Common Stock held. The Preferred Stock is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting.</div> <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction> shares of Preferred Stock were issued and outstanding as of December&#160;31, 2022.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, and after payment to the holders of shares of Preferred Stock of their liquidation preferences, the holders of the Common Stock are entitled to the entire remaining assets of the Company on a pro rata basis. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the warrants and stock-based awards outstanding prior to March&#160;2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. </div> <ix:nonNumeric name="us-gaap:ScheduleOfConversionsOfStockTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company has reserved the following shares of Common Stock for issuance upon the conversion, exercise or vesting of the underlying instruments: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common&#160;Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="PAsOn12_31_2022_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">17,243,811</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Stock-Based Awards&#8212;RSUs Outstanding</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="PAsOn12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">11,332,591</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Stock-Based Awards&#8212;Options Outstanding</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="PAsOn12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">8,845,903</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">37,422,305</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock Purchase Agreement </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Company entered into a Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC (&#8220;B.&#160;Riley&#8221;) on August&#160;11, 2022 pursuant to which the Company may issue and sell to B. Riley the lesser of i)&#160;$</div><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="PAsOn08_11_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">75.0</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million in aggregate gross purchase price of newly issued shares of the Company&#8217;s Common Stock or ii)&#160;an amount not to exceed </div><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn08_11_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">23,648,889</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock (such number of shares equal to approximately </div><ix:nonFraction name="rgti:PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" contextRef="P08_11_2022To08_11_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">19.99</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the aggregate number of shares of Common Stock issued and outstanding immediately prior to the execution of the agreement and inclusive of </div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="P08_11_2022To08_11_2022_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">171,008</ix:nonFraction><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock issued to B. Riley on August&#160;11, 2022 as consideration for entering into the Common Stock Purchase Agreement).&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In consideration of the parties entering into the foregoing agreement, the parties also entered into a Registration Rights Agreement on August&#160;11, 2022 pursuant to which the Company provides B. Riley with registration rights with respect to such Common Stock and pursuant to which the Company has filed a registration statement covering the resale of such Common Stock. </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the initial satisfaction of the conditions to B. Riley&#8217;s purchase obligation set forth in the Purchase Agreement, on September&#160;14, 2022 (the &#8220;Commencement Date&#8221;) the Company will have the right, but not the </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="display:inline;">29</div></ix:exclude></div></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_73804809" continuedAt="TextSelectionAppend_73804809_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804809_1" continuedAt="TextSelectionAppend_73804809_2"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804809_2"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">obligation, from time to time at the Company&#8217;s sole discretion over the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">24-month</div> period from and after the Commencement, to direct B. Riley to purchase a specified amount of shares not to exceed the lesser of (i)&#160;1,000,000 shares of Common Stock </div> and (ii) <ix:nonFraction name="rgti:PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" contextRef="P09_14_2022To09_14_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% of the total aggregate number (or volume) of shares of Common Stock traded on The Nasdaq Capital Market (&#8220;Nasdaq&#8221;) during the applicable period beginning at the official open (or &#8220;commencement&#8221;) of the regular trading session on the applicable purchase date for such purchase and ending at such time that the total aggregate volume of shares of common stock traded on Nasdaq reaches the Purchase Share Volume Maximum (as defined herein) for such purchase (as applicable) (such period for each purchase, the &#8220;Purchase Valuation Period&#8221;). &#8220;Purchase Share Volume Maximum&#8221; means, with respect to a purchase made pursuant to the Purchase Agreement, the number of shares of Common Stock equal to the quotient obtained by dividing the (i)&#160;total number of shares of Common Stock to be purchased by B. Riley in the relevant purchase (the &#8220;Purchase Share Amount&#8221;), by (ii) <ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="PAsOn09_14_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.20</ix:nonFraction> (subject to certain adjustments). <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not identify any feature that needs to be bifurcated and recorded as a derivative within the Purchase Agreement. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recorded $<ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.7</ix:nonFraction><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">million of additional paid-in capital with a corresponding entry to the deferred offering cost asset in the accompanying consolidated balance sheet as of December 31, 2022 with respect to the fair value of the<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="P01_01_2022To12_31_2022_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">171,008</ix:nonFraction> <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">common stock commitment shares issued to B. Riley which will be offset against future proceeds from the sale of the Company&#8217;s common stock under the Purchase Agreement. The Company did not issue or sell any shares to B. Riley under the Purchase Agreement during the year ended December 31, 2022 other than the </div><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">171,008</ix:nonFraction> <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">shares issued as consideration for entering into the Purchase Agreement.</div></div> </ix:continuation></div> </div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="rgti:WarrantsTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804522"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13. WARRANTS </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the number and corresponding strike price of Rigetti warrants outstanding prior to March&#160;2, 2022, the date of the Business Combination, to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Liability Classified Warrants </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public Warrants </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Public Warrant entitles the holder to the right to purchase one share of Common Stock at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction> per share. No fractional shares will be issued upon exercise of the Public Warrants. The Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $<ix:nonFraction name="us-gaap:SharePrice" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, and (ii)&#160;the last reported sale price of the Company&#8217;s Common Stock equals or exceeds $<ix:nonFraction name="us-gaap:SharePrice" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">18.00</ix:nonFraction> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any <ix:nonNumeric name="rgti:NumberOfTradingDaysForDeterminingTheSharePrice" contextRef="P01_01_2022To12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">20</ix:nonNumeric> trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" contextRef="P01_01_2022To12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">30</ix:nonNumeric>-trading</div> day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders. Upon issuance of a redemption notice by the Company, the warrant holders have a period of <ix:nonNumeric name="rgti:WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" contextRef="P01_01_2022To12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">30</ix:nonNumeric> days to exercise for cash, or on a cashless basis. As of December&#160;31, 2022, there were <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">8,625,000</ix:nonFraction> Public Warrants issued and outstanding (Refer to Note 15 for fair value measurement). </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Private Warrants </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Warrants may not be redeemed by the Company so long as the Private Warrants are held by the initial purchasers, or such purchasers&#8217; permitted transferees. The Private Warrants have terms and provisions identical to those of the Public Warrants, including as to exercise price, exercisability and exercise period, except if the Private Warrants are held by someone other than the initial purchasers&#8217; permitted transferees, then the Private Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. On August 18, 2022, the Private Placement Warrants were transferred from the initial purchasers to permitted transferees and remain unredeemable by the Company as of December&#160;31, 2022. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-3<div style="display:inline;">0</div></ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_73804522" continuedAt="TextSelectionAppend_73804522_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804522_1" continuedAt="TextSelectionAppend_73804522_2"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804522_2" continuedAt="TextSelectionAppend_73804522_3"><ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" contextRef="P01_01_2022To12_31_2022_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" escape="true"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Private Warrant was measured using the Black Scholes model approach. Significant inputs into the respective models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 61%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Assumptions</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial&#160;Recognition<br/>on March 2, 2022</div></div></div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 61%;"></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock Price</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">0.73</ix:nonFraction></div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">9.43</ix:nonFraction></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike Price</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction></div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility (annual)</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">109.26</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">30.66</ix:nonFraction>%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">4.04</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">1.74</ix:nonFraction>%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated time to expiration (years)</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_Y" decimals="3" scale="0" format="ixt:num-dot-decimal">4.172</ix:nonFraction></div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_Y" decimals="3" scale="0" format="ixt:num-dot-decimal">5.000</ix:nonFraction></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>%</div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> </ix:nonNumeric> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Trinity Warrants </div></div></div></div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Trinity Warrants were issued in March of 2021 for the purchase of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn03_31_2021_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">313,252</ix:nonFraction> shares of Common Stock, and additional warrants to purchase <ix:nonFraction name="rgti:Classofwarrantorrightissuedduringperiodwarrants" contextRef="P01_01_2022To12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">469,877</ix:nonFraction> shares of Common Stock were issued in connection with the Tranche B Amendment, see Note 10. Therefore, there were total of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">783,129</ix:nonFraction> Common Stock warrants issued in conjunction with the Loan and Security Agreement in 2021. The Company utilized a Black-Scholes model to determine the grant date fair value of the warrants which was approximately $<ix:nonFraction name="rgti:Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" contextRef="P01_01_2022To12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.7</ix:nonFraction>&#160;million and was recorded as a debt issuance cost. The outstanding Common Stock warrants were subsequently remeasured at each reporting period using the Black-Scholes models with changes recorded as a component of other income in the Company&#8217;s consolidated statement of <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">operations. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The liability related </div></div>to the Trinity Warrants was $<ix:nonFraction name="us-gaap:IncreaseDecreaseInDerivativeLiabilities" contextRef="P06_02_2022To06_02_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">6.4</ix:nonFraction>&#160;million as of June&#160;2, 2022, at which time all <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="PAsOn06_02_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">783,129</ix:nonFraction> warrants outstanding were exercised and the fair value of the warrant liability was reclassified to equity. The Company recorded a loss for the change in the fair value of the warrant liability in the consolidated statements of operations for the year ended December&#160;31, 2022 and the 11 months ended December&#160;31, 2021, of $<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2022To12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.0</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P02_01_2021To12_31_2021_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.7</ix:nonFraction>&#160;million, respectively.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The warrant issued in conjunction with the Loan and Security Agreement was classified as a liability under ASC&#160;480, &#8220;Distinguishing Liabilities from Equity&#8221;. See Deferred Financing Cost disclosure at Note 2 Summary of Significant Accounting Policies. </div> <ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant inputs into the Black Scholes model used to value the Trinity Warrant liabilities at June&#160;2, 2022, the exercise date, are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 82%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 82%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Assumptions - Trinity Warrant Liability</div></div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;2,&#160;2022</div></div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">8.23</ix:nonFraction></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_02_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">0.27</ix:nonFraction></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility (annual)</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_02_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">105.10</ix:nonFraction>%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_02_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">2.94</ix:nonFraction>%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated time to expiration (years)</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_02_2022_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_Y" decimals="3" scale="0" format="ixt:num-dot-decimal">9.000</ix:nonFraction></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_02_2022_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>%</div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Equity Classified Warrants </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C Preferred Stock Financing Warrants </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In conjunction with a prior Series C Preferred Stock Financing the Company issued a total of&#160;</div><ix:nonFraction name="rgti:Classofwarrantsorrightswarrantsissuedduringtheperiodunits" contextRef="P01_01_2022To12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">5,248,183</ix:nonFraction> Warrants to purchase Class&#160;A Common Stock to the Series C investors. The Warrants have a $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> exercise price per share and have a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:duryear">10</ix:nonNumeric>-year</div> term to expiration. The Warrants can be exercised for cash or on a cashless basis. The Company determined that the Warrants met the requirements for equity classification under ASC 480 and ASC<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>815. The Company estimated the fair value of the Warrants using the Black-Scholes model and allocated approximately $<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.2</ix:nonFraction>&#160;million in proceeds from the Series C Preferred Stock to the value of the Warrants on a relative fair value basis, which was recorded to additional paid in <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">capital. </div></div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-3<div style="display:inline;">1</div></ix:exclude></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></ix:continuation></div> </div> <ix:continuation id="TextSelectionAppend_73804522_3" continuedAt="TextSelectionAppend_73804522_4"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> </ix:continuation><ix:continuation id="TextSelectionAppend_73804522_4" continuedAt="TextSelectionAppend_73804522_5"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804522_5" continuedAt="TextSelectionAppend_73804522_6"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804522_6" continuedAt="TextSelectionAppend_73804522_7"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Customer Warrants </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In February 2020, the Company issued a Warrant to purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,680,607</ix:nonFraction> shares of Class&#160;A Common Stock to a customer in conjunction with a revenue arrangement (the &#8220;Customer Warrants&#8221;). The Customer Warrants have a $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="3" scale="0" format="ixt:num-dot-decimal">1.152</ix:nonFraction> exercise price per share and have a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:duryear">10</ix:nonNumeric>-year</div> term to expiration. The Warrants vest upon the achievement of certain performance conditions (i.e., sales milestones) defined in the agreement, and upon a change of control, either <ix:nonFraction name="rgti:Classofwarrantsvestingpercentage" contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis_MinimumMembersrtRangeAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:num-dot-decimal">50</ix:nonFraction>% or <ix:nonFraction name="rgti:Classofwarrantsvestingpercentage" contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis_MaximumMembersrtRangeAxis" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the then unvested Customer Warrants will become fully vested, dependent on the acquiring party in the change of control transaction. The Warrants can be exercised for cash or on a cashless basis. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company followed the guidance in ASC 718 and ASC 606 for the accounting of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> consideration payable to a customer. The Company determined that the Customer Warrants met the requirements for equity classification under ASC 718 and measured the Customer Warrants based on their grant date fair value, estimated to be $<ix:nonFraction name="rgti:ClassOfWarrantOrRightGrandDateFairValue" contextRef="PAsOn02_28_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction>&#160;million. The Company recorded this amount as a deferred asset and additional paid in capital as of the issuance date, as the Company believes it is probable that all performance conditions (i.e., sales milestones) in the Customer Warrants will be met.&#160;</div> <ix:nonNumeric name="rgti:DisclosureOfVestingStatusOfWarrantsTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804983"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The vesting status of the Customer Warrant is as follows at December&#160;31, 2022 and December&#160;31, 2021:</div></div><br/></div> </ix:nonNumeric></ix:continuation></div> </div> </div> </div> <div><div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804522_7"><ix:continuation id="TextSelection_73804983"><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 76%; border: 0px; margin: 0px auto; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested Customer warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2022_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,340,297</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2021_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,072,237</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested Customer warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2022_UnvestedCustomerWarrantsMemberRGTIStatusOfVestingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,340,310</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2021_UnvestedCustomerWarrantsMemberRGTIStatusOfVestingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,608,370</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,680,607</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,680,607</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:continuation> </ix:continuation> <ix:nonNumeric name="rgti:ForwardWarrantAgreementDisclosure" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804851"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">14. FORWARD WARRANT AGREEMENT </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the execution of the Merger Agreement in October 2021, Rigetti entered into a warrant subscription agreement (&#8220;Forward Warrant Agreement&#8221;) with a strategic partner, Ampere Computing LLC (&#8220;Ampere&#8221;) for the purchase of a warrant for an aggregate purchase price (including amounts from exercise) of $</div><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="P01_01_2022To12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million. The Forward Warrant Agreement provides for the issuance of a warrant for the purchase of an aggregate of <ix:nonFraction name="rgti:StockIssuedDuringPeriodWarrantsIssued" contextRef="P01_01_2022To12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction> shares of Common Stock at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction>. The purchase of the warrant was conditioned upon, among other things, the consummation of the Business Combination and the entry into a collaboration agreement between Rigetti and Ampere. The parties entered into the collaboration agreement in January 2022. Ampere was required to pay $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="P01_01_2021To12_31_2021_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million to Rigetti no later than the later of (i)&#160;the Closing and (ii)&#160;June&#160;30, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2022, pursuant to the Warrant Subscription Agreement, the Company issued the warrant to Ampere upon receipt of an aggregate of $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="P06_30_2022To06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million (including the exercise price), and upon such payment and issuance, <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="PAsOn06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction> shares of the Company&#8217;s Common Stock vested under the warrant and were immediately exercised by Ampere pursuant to the terms of the warrant. Ampere is required to pay an additional $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" contextRef="P06_30_2022To06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheTwoMemberusgaapVestingAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.0</ix:nonFraction>&#160;million to Rigetti no later than the closing date of the listing of Ampere&#8217;s capital stock, provided that if the listing has not occurred by the second anniversary of the Warrant Subscription Agreement, Ampere is not obligated to make the additional payment. Upon the payment of such additional amounts, the warrant will vest and be exercisable with respect to the remaining <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="PAsOn06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheTwoMemberusgaapVestingAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction> shares underlying the warrant. The Warrant Subscription Agreement further provides that the Company will use commercially reasonable efforts to file a registration statement to register the resale of the remaining shares underlying the warrant. The Company filed a registration statement registering the resale of the initial <ix:nonFraction name="rgti:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" contextRef="P01_01_2022To12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction> shares issued under the warrant during the year ended December&#160;31, 2022.<br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated the Forward Warrant Agreement as a derivative in conjunction with the guidance of ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;. The Company calculated the fair value of the Forward Warrant </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="background: none; letter-spacing: 0px; top: 0px; text-decoration: none;;display:inline;"> </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-3<div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div></ix:exclude></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_73804851" continuedAt="TextSelectionAppend_73804851_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804851_1" continuedAt="TextSelectionAppend_73804851_2"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804851_2"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Agreement by using the Forward Contract Pricing methodology at inception and at December&#160;31, 2022. The fair value of the Forward Warrant Agreement was estimated based on the following key inputs and assumptions 1) Assumed holding period 2) Related risk-free rate and 3) Likelihood of the outcome of the various contingencies outlined below. Based on these inputs and assumption, the Company calculated the fair value of the Forward Warrant Agreement to be a </div></div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> $</div><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.2</ix:nonFraction>&#160;million <span style="-sec-ix-hidden:hidden73805685">derivative asset</span> and a ($<ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.2</ix:nonFraction> million) <span style="-sec-ix-hidden:hidden73805686">derivative liability</span> <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at December&#160;31, 2022 and December&#160;31, 2021, respectively. The Company has included the derivative asset as a forward contract asset and the derivative liability separately in other liabilities (current) on the balance sheet line in the accompanying consolidated balance sheets as of December&#160;31, 2022 and December&#160;31, 2021, respectively. The change in fair value is recorded as part of the general and administrative operating activities in the Company&#8217;s consolidated statements of operations. <ix:nonNumeric name="rgti:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804854">The following table represents key valuation assumptions as of the year ended December&#160;31, 2022 and 11 months ended December 31, 2021:</ix:nonNumeric> </div></div></div> <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <ix:continuation id="TextSelection_73804854">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 64%;"></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Assumptions</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Holding period (in years)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_Y" decimals="3" scale="0" format="ixt:num-dot-decimal">0.767</ix:nonFraction></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis" unitRef="Unit_Y" decimals="1" scale="0" format="ixt:num-dot-decimal">0.5</ix:nonFraction>-<ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_Y" decimals="2" scale="0" format="ixt:num-dot-decimal">1.13</ix:nonFraction></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk free rate</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.69</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.19</ix:nonFraction>%-<ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.43</ix:nonFraction>%</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Probability of occurring the contingency</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">50</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">50</ix:nonFraction>%-<ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>%</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying value per share</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$<ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">0.73</ix:nonFraction></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$<ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">10.29</ix:nonFraction></div></td></tr></table></ix:continuation> </ix:continuation> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804518"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15. FAIR VALUE MEASUREMENTS</div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 87%;"></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric></div></div> </div></div><div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto;text-indent: 0px;"><ix:continuation id="TextSelection_73804518" continuedAt="TextSelectionAppend_73804518_1"><ix:nonNumeric name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value measurements of financial assets and liabilities that <div style="letter-spacing: 0px; top: 0px;;display:inline;">are </div>measured at fair value at December&#160;31, 2022 and December&#160;31, 2021 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 68%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:68%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash equivalents: </div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money Market Funds</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">36,346</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States Treasury Securities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">58,210</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,571</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commercial Paper</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">23,142</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward warrant agreement</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ForwardWarrantAgreementFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ForwardWarrantAgreementFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ForwardWarrantAgreementFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,229</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">94,556</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">26,713</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,229</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Public Warrants</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">699</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Private Warrants</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;;text-align:right;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,068</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-out</div> liability</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ContingentEarnOutLiabilityFairValueDisclosure" contextRef="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ContingentEarnOutLiabilityFairValueDisclosure" contextRef="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:ContingentEarnOutLiabilityFairValueDisclosure" contextRef="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,206</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">699</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,274</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;;text-indent: 0px;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Trinity Warrants</div><br/></div></td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$<div style="display:inline;">&#160; &#160; &#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$<div style="display:inline;">&#160; &#160; &#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,355</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward warrant agreement</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">230</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Liabilities</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; width: 4%;"><div style="font-weight:bold;display:inline;">&#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,585</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company has recorded the following <div style="letter-spacing: 0px; top: 0px;;display:inline;">financial </div>instruments subject to fair value measurements: 1) Derivative warrant liabilities&#8212;Public Warrants liability and Private Warrants, 2) Forward Warrant Agreement, and 3) Earnout liability. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-3<div style="letter-spacing: 0px; top: 0px;;display:inline;">3</div></ix:exclude></div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:continuation></div></div><ix:continuation id="TextSelectionAppend_73804518_1" continuedAt="TextSelectionAppend_73804518_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73804518_2" continuedAt="TextSelectionAppend_73804518_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a><br/></div> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804518_3" continuedAt="TextSelectionAppend_73804518_4"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company also has long-term debt and a line of credit that provides for variable interest, and therefore, the carrying value approximates the fair value. The carrying values as of December 31, 2022 and December 31, 2021, represent the original principal amounts borrowed less principal payments and debt issuance costs. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Public Warrants has been measured based on the observable listed prices for such warrants, a Level&#160;1 measurement. The Company&#8217;s money market funds and U.S. Treasury securities are classified within Level I due to the highly liquid nature of these assets with quoted prices in active markets. The investments in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities (i.e., commercial paper and corporate debt securities) and corporate debt issued by the Company are classified within Level II. The fair value of the Company&#8217;s Level II financial assets and liabilities is determined by using inputs based quoted market prices for similar instruments. All other financial instruments are classified as Level&#160;3 liabilities as they all include unobservable inputs. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Warrants were initially measured at fair value using a Black Scholes model. The Company estimated the fair value of the Forward Warrant Agreement using a forward analysis with unobservable inputs which included selected risk-free rate and probability outcomes. The Company has further discussed the key aspects of the fair value measurements described above in Notes 13 and 14 to the financial statements. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate fair value of the Sponsor Vesting Shares on the Closing date was estimated using a Monte Carlo simulation model. The Company has further discussed the key aspect of the valuation inputs in Note 2 significant accounting policy for Sponsor <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Liability. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2021, the Company recorded a derivative warrant liability for the Trinity Warrants at fair value using a Black-Scholes option model with unobservable inputs including volatility. The Company estimates the volatility of its ordinary share warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s ordinary shares that matches the expected remaining life of the warrants. On June&#160;2, 2022, all outstanding Trinity Warrants were exercised into shares of the Company&#8217;s Common Stock </div></div><br/></div> </ix:continuation></div></div> </div></div></div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804518_4"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There have been no changes in fair value measurement techniques (other than the change in valuation assumptions described in Note 1) during the year ended December&#160;31, 2022. There were no transfers between Level&#160;1 or Level&#160;2, or transfers in or out of Level&#160;3 of the fair value hierarchy during the year end December&#160;31, 2022. The fair value estimates are based on pertinent information available to management as of December 31, 2022 and December 31, 2021. Although management is not aware of any factors, other than those noted above, that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for the purpose of these financial statements. Current estimates of fair value may differ from the amounts presented.</div></div></div> <ix:nonNumeric name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805283"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of the changes in the fair value of the Company&#8217;s Level&#160;3 financial instruments as of December&#160;31, 2022 and December&#160;31, 2021 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">warrant&#160;liability&#160;-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Trinity Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">warrant&#160;liability&#160;-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward<br/>Warrant</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Agreement</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-out</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">liability</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;January 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" contextRef="P01_01_2021To12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,691</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">400</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair values</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="P01_01_2021To12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,664</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">170</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 45%;"></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 8%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;December 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2020_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,355</ix:nonFraction></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">230</ix:nonFraction></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Initial measurement on March&#160;2, 2022 upon Business Combination (Note 3)</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" contextRef="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">9,612</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" contextRef="P01_01_2022To12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">20,413</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair values</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,015</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">8,544</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="P01_01_2022To12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">5,764</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="P01_01_2022To12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">19,207</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Exercise of warrants</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">6,370</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="P01_01_2022To12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,305</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;December 31, 2022</div><br/></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,068</ix:nonFraction></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,229</ix:nonFraction></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div>)</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,206</ix:nonFraction></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr>
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;;text-align:right;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td> </tr> </table> </ix:nonNumeric></ix:continuation> <ix:continuation id="TextSelection_73805283"><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:continuation> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-3<div style="letter-spacing: 0px; top: 0px;;display:inline;">4</div></div></div></div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div> </div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805145"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">16. EQUITY PLANS </div></div></div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2013 Equity Incentive Plan</div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2013, the Company adopted the 2013 Plan which provides for the grant of qualified incentive stock options (&#8220;ISO&#8221;) and nonqualified stock options (&#8220;NSO&#8221;), restricted stock, restricted stock units (&#8220;RSU&#8221;) or other awards to the Company&#8217;s employees, officers, directors, advisors, and outside consultants. After the Closing Date and consummation of the Business Combination effective March&#160;2, 2022, no additional awards were issued under the 2013 Plan. Awards outstanding under the 2013 Plan will continue to be governed by such plan; however, the Company will not grant any further awards under the 2013 Plan. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 Equity Incentive Plan</div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination (Note 3), the shareholders approved the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) in February, 2022, which became effective immediately upon the Closing Date. The 2022 Plan provides for the grant of ISOs, NSOs, stock appreciation rights, restricted stock awards (&#8220;RSA&#8221;), restricted stock unit awards, performance awards and other forms of awards to employees, directors, and consultants, including employees and consultants of the Company&#8217;s affiliates. The aggregate number of shares of common stock reserved for issuance under the 2022 Plan is <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="PAsOn12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">18,332,215</ix:nonFraction> shares as of December&#160;31, 2022. As of December&#160;31, 2022, <ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="PAsOn12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">4,748,116</ix:nonFraction> shares were available for future issuance under the 2022 Plan. The number of shares reserved for issuance under the 2022 Plan will automatically increase on January 1st of each year for a period of nine years commencing on January&#160;1, 2023 and ending on (and including) January&#160;1, 2032, in an amount equal to <ix:nonFraction name="rgti:PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">5</ix:nonFraction>% of the common stock of all classes outstanding on December&#160;31 of the preceding year; provided, however, that the board of directors of the Company may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of Common Stock. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock Options</div></div></div></div> <ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of activity related to stock option is summarized as below:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 54%;"></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 6%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;Options</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Exercise</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Contractual</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life&#160;(in&#160;years)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intrinsic<br/>Value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Outstanding&#8212;December 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">11,468,275</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.36</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,750,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.96</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">2,768,568</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.27</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited and expired</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,603,804</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.27</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 54%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Outstanding&#8212;December 31, 202<div style="display:inline;">2</div></div><br/></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">8,845,903</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.38</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="P01_01_2022To12_31_2022" format="ixt-sec:duryear">7.2</ix:nonNumeric></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">3,103</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; width: 54%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 0pt; font-family: &quot;Times New Roman&quot;; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; padding-bottom: 0.375pt; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Exercisable&#8212;December 31, 2022</div><br/></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="PAsOn12_31_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">5,464,027</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.40</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="P01_01_2022To12_31_2022" format="ixt-sec:duryear">7.2</ix:nonNumeric></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,780</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;12, 2022 the Company granted to the CEO an equity award (&#8220;CEO award&#8221;) under its 2022 Plan that consisted of options to purchase a total of <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis_TwoThousandThirteenEquityIncentivePlanMemberusgaapPlanNameAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,750,000</ix:nonFraction> shares of its common stock with an exercise price of $<ix:nonFraction name="rgti:StockOptionCommonShareExercisePrice" contextRef="PAsOn12_12_2022_CeoAwardMemberusgaapAwardTypeAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.96</ix:nonFraction> per share. Of the total stock options granted to the CEO, <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,250,000</ix:nonFraction> have time-based vesting over <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis" format="ixt-sec:duryear">3</ix:nonNumeric> years and the remaining <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction> have market-based vesting conditions. Compensation expense for the CEO award for the year ending December&#160;31, 2022 was insignificant. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted-average grant date fair value of options granted during the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.81</ix:nonFraction> and $<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">3.43</ix:nonFraction> respectively. The total intrinsic value of options exercised during the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 is $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">9.9</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">5.7</ix:nonFraction>&#160;million, respectively. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2022, there was $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.4</ix:nonFraction>&#160;million of unrecognized compensation cost related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-vested</div> stock options granted under the 2013 and 2022 Plan, which is expected to be recognized over a weighted-average period o</div>f approximately <ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="P01_01_2022To12_31_2022" format="ixt-sec:duryear">1.96</ix:nonNumeric> years.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><br/></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-3<div style="letter-spacing: 0px; top: 0px;;display:inline;">5</div></ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_73805145" continuedAt="TextSelectionAppend_73805145_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_73805145_1" continuedAt="TextSelectionAppend_73805145_2"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805145_2" continuedAt="TextSelectionAppend_73805145_3"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="null;text-indent: 0px;;font-style:italic;display:inline;">Restricted Stock Units</div></div></div></div></div> <ix:nonNumeric name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of activity related to RSUs is summarized as below:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSUs</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Fair<br/>Value&#160;Per&#160;Share</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-vested</div> shares at December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="PAsOn12_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">5,388,455</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">3.93</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">17,782,607</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">4.92</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">7,007,789</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">4.99</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">4,830,682</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">5.03</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-vested</div> shares at December&#160;31, 2022</div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="PAsOn12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">11,332,591</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">4.36</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:right;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;2, 2022, the performance condition of all outstanding RSUs was met due to the closing of the Business Combination. As a result, the Company recorded a cumulative <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">catch-up</div> compensation expense for the vesting period that was satisfied as of March&#160;2, 2022 and continues amortizing compensation expenses for unvested RSUs over their remaining vesting period.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fair value of the RSUs vested during the twelve months ending December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">35.0</ix:nonFraction>&#160;million and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="P02_01_2021To12_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">0</ix:nonFraction> respectively.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock-based compensation <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">expense related to RSUs granted to employees was $</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">42.7</ix:nonFraction></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;million and $</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P02_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">0</ix:nonFraction></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> for the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. As of</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31, 2022, the unrecognized compensation expense related to unvested RSUs was approximately $</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="PAsOn12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">41.9</ix:nonFraction></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;million which is expected to be recognized over a weighted-average period of approximately </div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis" format="ixt-sec:duryear">2.85</ix:nonNumeric></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> years.</div></div> <br/></div> </ix:continuation></div> </div> </div> </div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805145_3" continuedAt="TextSelectionAppend_73805145_4"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Restricted Stock Awards</div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the twelve months ended December&#160;31, 2022, <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="P01_01_2022To12_31_2022_RestrictedStockMemberusgaapAwardTypeAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">120,000</ix:nonFraction> restricted stock awards (&#8220;RSAs&#8221;) were issued and vested immediately on the grant date as part of transaction bonuses in recognition of efforts in connection with the Business Combination. The total compensation expense related to RSAs was $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_RestrictedStockMemberusgaapAwardTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">0.6</ix:nonFraction>&#160;million for the twelve months ended December&#160;31, 2022.</div><ix:nonNumeric name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below summarizes the total stock-based compensation expenses for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">14,092</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P02_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">975</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Selling and marketing expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,109</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P02_01_2021To12_31_2021_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">106</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">28,611</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P02_01_2021To12_31_2021_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">684</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total stock-based compensation expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">44,812</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,765</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Common Stock and Options</div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model that uses the assumptions noted in the table below. Expected volatility for the Company&#8217;s Common Stock was determined based on an average of the historical volatility of a peer group of similar public companies. The expected term of options granted was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><ix:exclude>F-3<div style="letter-spacing: 0px; top: 0px;;display:inline;">6</div></ix:exclude></div> </ix:continuation></div></div><ix:continuation id="TextSelectionAppend_73805145_4" continuedAt="TextSelectionAppend_73805145_5"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805145_5" continuedAt="TextSelectionAppend_73805145_6"><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805145_6" continuedAt="TextSelectionAppend_73805145_7"><ix:exclude> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805145_7"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">upon which to estimate expected term. The assumed dividend yield is based upon the Company&#8217;s expectation of not paying dividends in the foreseeable future. The risk-free rate is based upon the U.S. Treasury yield curve in effect at the time of grant for the period equivalent to the expected life of the option.</div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In determining the exercise prices for options granted, the Company&#8217;s board of directors has considered the fair value of the Common Stock as of the grant date. Before the Company&#8217;s common stock was publicly traded, the fair value of the Common Stock has been determined by the board of directors at each award grant date based upon a variety of factors, including the results obtained from an independent third-party valuation, the Company&#8217;s financial position and historical financial performance, the status of technological developments within the Company&#8217;s products, the composition and ability of the current engineering and management team, an evaluation or benchmark of the Company&#8217;s competition, the current business climate in the marketplace, the illiquid nature of the Common Stock, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">arm&#8217;s-length</div> sales of the Company&#8217;s capital stock (including redeemable convertible preferred stock), the effect of the rights and preferences of the preferred shareholders, and the prospects of a liquidity event, among others.</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock options issued in 2022, including the options that are based on market conditions, did not have significant </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">impact on the stock-based compensation expense during the year ended December 31, 2022. The range of assumptions used in the Black-Scholes option-pricing model for time based options issued to employees and in Monte Carlo simulation model for market based options during the 12 months ended December 31, 2022 and 11 months ended December 31, 2021 are as follows: </div></div></div> <ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width:55%"></td>
<td style="vertical-align: bottom; width: 12%;"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align: bottom; width: 12%;"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align: bottom; width: 12%;"></td>
<td style="width:12%;"></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12&#160;Months&#160;ended&#160;December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">ended<br/>December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Time&#160;based&#160;vesting</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Market&#160;based&#160;vesting<br/>awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-size: 0px;">
<td style="width: 55%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align: bottom; width: 12%;"></td>
<td style="width:12%;"></td>
<td></td>
<td></td></tr>
<tr style="font-size: 0px;">
<td style="width: 55%;"></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 12%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align: bottom; width: 12%;"></td>
<td style="width:12%;"></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">150</ix:nonFraction></div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%&#160;</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">150</ix:nonFraction></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div>&#160;</div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">46.8</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.77</ix:nonFraction></div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.76</ix:nonFraction><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">1.07</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction></div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; text-indent: 0px; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (in years)</div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis" format="ixt-sec:duryear">5.85</ix:nonNumeric></div></div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis" format="ixt-sec:duryear">5.0</ix:nonNumeric></div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: right;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="P02_01_2021To12_31_2021" format="ixt-sec:duryear">6.1</ix:nonNumeric>&#160;years<div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: center;"><div style="font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Exercise price/Stock price</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="PAsOn12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.96</ix:nonFraction></div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="PAsOn12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.96</ix:nonFraction></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.21</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr></table> </ix:nonNumeric> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="clear:both;max-height:0pt;"></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> </ix:continuation> <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804827"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">17. NET LOSS PER SHARE </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the weighted average shares outstanding prior to March&#160;2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><ix:nonNumeric name="rgti:ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of basic and diluted net loss per share of Common Stock for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11 Months<br/>ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:NetIncomeLossRelationToCommonStock" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,521</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:NetIncomeLossRelationToCommonStock" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,241</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average Class&#160;A Common Stock outstanding</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">102,300,852</ix:nonFraction></ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">23,337,127</ix:nonFraction></ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss per share for Class&#160;A Common Stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#8212; Basic</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">0.70</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">1.64</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#8212; Diluted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">0.70</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:num-dot-decimal">1.64</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> </ix:nonNumeric> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There </div></div>are <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">3,059,273</ix:nonFraction> shares of contingently <div style="letter-spacing: 0px; top: 0px;;display:inline;">issuable </div>Common Stock pursuant to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">earn-out</div> arrangement that were not included in the computation of basic net loss per share since the contingencies for the issuance of <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">these </div></div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-37</ix:exclude></div></div><br/></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></div></div> <ix:continuation id="TextSelection_73804827" continuedAt="TextSelectionAppend_73804827_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_73804827_1" continuedAt="TextSelectionAppend_73804827_2"><ix:exclude><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73804827_2" continuedAt="TextSelectionAppend_73804827_3"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;">shares have not been met as of December&#160;31, 2022. The weighted-average common shares outstanding for the twelve months ended December&#160;31, 2022 and December&#160;31, 2021 include <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,541,856</ix:nonFraction></ix:nonFraction> and <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">5,116,058</ix:nonFraction></ix:nonFraction> weighted-average shares of warrants with an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction></ix:nonFraction>, respectively. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s potential dilutive securities, which include stock options, restricted stock units, convertible preferred stock and warrants have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. </div></div><br/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73804832"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company excluded the following potential common shares from the computation of diluted net loss per share as of December&#160;31, 2022 and December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31,</div></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesC1PreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesC1PreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">23,218,320</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible Series C Preferred Stock</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesCPreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesCPreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">54,478,033</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock Warrants</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">14,444,127</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,822,319</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Options</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">8,845,903</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">11,468,227</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted Stock Units</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RestrictedStockUnitsRSUMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">11,332,591</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_RestrictedStockUnitsRSUMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">34,622,621</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">90,986,899</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> </ix:nonNumeric></ix:continuation></div></div> </div></div> <div><div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_73804832"><ix:continuation id="TextSelectionAppend_73804827_3">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 1px;">
<td></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The number of outstanding shares as of December&#160;31, 2021 have been retrospectively adjusted to reflect the Exchange Ratio. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The number of outstanding warrants as of December&#160;31, 2022 and December&#160;31, 2021 does not include <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2022To12_31_2022_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,340,310</ix:nonFraction> and <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P02_01_2021To12_31_2021_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">1,608,359</ix:nonFraction> shares, respectively, of Unvested Customer Warrants. </div></td></tr></table> </ix:continuation></ix:continuation> <ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805121"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">18. INCOME TAXES </div></div> <ix:nonNumeric name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents domestic and foreign components of loss before income taxes for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;ended</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Domestic</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">67,677</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">36,787</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">3,844</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,454</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">71,521</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">38,241</ix:nonFraction>)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not pay any income taxes for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021. </div></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-3<div style="letter-spacing: 0px; top: 0px;;display:inline;">8</div></ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:nonNumeric></div></div><ix:continuation id="TextSelection_73805121" continuedAt="TextSelectionAppend_73805121_1"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805121_1" continuedAt="TextSelectionAppend_73805121_2"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a><br/></div> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805121_2" continuedAt="TextSelectionAppend_73805121_3"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of <ix:nonNumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805117">the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021, are as follows: </ix:nonNumeric></div></div></div><ix:continuation id="TextSelection_73805117"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 9%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred <div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div>ax <div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>ssets:</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">61,313</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">46,553</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals and reserves</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">160</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">147</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,233</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">744</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,509</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">32</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">ROU <div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div>iability</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="rgti:DeferredTaxAssetsRightOfUseLiabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">2,507</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross deferred assets <div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">80,733</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">47,487</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred <div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div>ax <div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div>iabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ROU <div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>sset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:DeferredTaxLiabilitiesRightOfUseAssets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,289</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Depreciation and amortization</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:DeferredTaxLiabilitiesDepreciationAndAmortization" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">2,063</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="rgti:DeferredTaxLiabilitiesDepreciationAndAmortization" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" sign="-" format="ixt:num-dot-decimal">1,420</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total deferred tax liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,352</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">1,420</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total net deferred tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">76,381</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">46,067</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">76,381</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">46,067</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Net deferred tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:continuation> </ix:continuation></div></div> </div></div><div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805121_3" continuedAt="TextSelectionAppend_73805121_4"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The effective<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">tax rate differs from the statutory rate, primarily due to </div><ix:nonNumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805116"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Company&#8217;s history of incurring losses which have not been benefited and other permanent differences.&#160;</div><br/></ix:nonNumeric></div><ix:continuation id="TextSelection_73805116"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"></td>
<td style="width: 22%; vertical-align: bottom;"></td>
<td></td>
<td style="width: 21%; vertical-align: bottom;"></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;Ended<br/>December&#160;31,&#160;2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,&#160;2021</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt; width: 55%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Component</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rate Impact</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rate Impact</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total pre-tax book income</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">21</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">21</ix:nonFraction>%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State and local income taxes</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">11</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Fair market value adjustments</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">14</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Non-deductible executive compensation</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" sign="-" format="ixt:num-dot-decimal">4</ix:nonFraction>)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill impairment</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="rgti:EffectiveIncomeTaxRateReconciliationGoodwillImpairment" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" sign="-" format="ixt:num-dot-decimal">2</ix:nonFraction>)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:EffectiveIncomeTaxRateReconciliationGoodwillImpairment" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction <div style="letter-spacing: 0px; top: 0px;;display:inline;">c</div>osts</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:EffectiveIncomeTaxRateReconciliationTransactionCosts" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">3</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="rgti:EffectiveIncomeTaxRateReconciliationTransactionCosts" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Change in valuation allowance</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" sign="-" format="ixt:num-dot-decimal">42</ix:nonFraction>)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" sign="-" format="ixt:num-dot-decimal">21</ix:nonFraction>)%</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total:</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">0</ix:nonFraction>%</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr></table></ix:continuation> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net U.S. federal and state deferred tax assets have been fully offset by a valuation allowance. The net change in the total valuation allowance was an increase of approximately $<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">30.3</ix:nonFraction><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>million and $<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">8.0</ix:nonFraction><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>million for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">As of December&#160;31, 2022, the Company had net operating loss carryforwards for federal income tax purposes of $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">230.9</ix:nonFraction>&#160;million, of which $<ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">189.4</ix:nonFraction><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>million does not expire; federal research and development tax credits of $<ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" contextRef="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ResearchMemberusgaapTaxCreditCarryforwardAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction>&#160;million, which will start to expire in <div style="letter-spacing: 0px; top: 0px;;display:inline;">2035</div>; net operating loss carryforwards for state income tax purposes of $<ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">168.1</ix:nonFraction><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>million, which will start to expire in 2033; and state research and development tax credits of $<ix:nonFraction name="us-gaap:TaxCreditCarryforwardAmount" contextRef="PAsOn12_31_2022_ResearchMemberusgaapTaxCreditCarryforwardAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">2.3</ix:nonFraction>&#160;million, which do&#160;not expire.</div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Utilization of the net operating losses and credits may be subject to substantial annual limitation due to federal and state ownership change limitations provided by the Internal Revenue Code and similar state provisions. Such </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="display:inline;">39</div></ix:exclude></div></div></div> <ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude> </ix:continuation></div></div><ix:continuation id="TextSelectionAppend_73805121_4" continuedAt="TextSelectionAppend_73805121_5"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_73805121_5" continuedAt="TextSelectionAppend_73805121_6"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_73805121_6"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">annual limitations could result in the expiration of the net operating losses and credits before their utilization. The Company has not performed a Section&#160;382 analysis to determine if an ownership change occurred and whether the use of net operating loss carryforwards and credits carryforwards will be limited to offset future taxable income. For financial statement purposes, the Company has included the federal and state net operating losses and credits in the deferred tax assets with a full valuation allowance. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company files U.S., various state income tax returns as well as foreign income tax returns within Australia, Canada and the United Kingdom with varying statutes of limitations. The tax years from inception in 2013 forward remain open to examination due to the carryover of unused net operating losses and tax credits. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company had unrecognized tax benefits of $<ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">4.7</ix:nonFraction>&#160;million as of December&#160;31, 2022 all of which is offset by a full valuation allowance. These unrecognized tax benefits, if recognized, would <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction>t affect the effective tax rate. There were <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt-sec:numwordsen">no </ix:nonFraction>interest or penalties accrued as of December&#160;31, 2022. </div> <ix:nonNumeric name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true" continuedAt="TextSelection_73805115"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">A reconciliation of the beginning and ending amounts of unrecognized income tax benefits during the year is as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 68%; border: 0px; margin: 0px auto; text-indent: 0px; border-spacing: 0px;">
<tr style="font-size: 0px;;text-indent: 0px;">
<td style="width:87%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance at January&#160;1, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="PAsOn01_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,672</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Current year increase (decrease)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="P01_01_2022To12_31_2022_CurrentYearMemberRGTIPeriodAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;">
<td>Prior year adjustment&#8212;increase (decrease)&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextRef="P01_01_2022To12_31_2022_PreviousYearMemberRGTIPeriodAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:fixed-zero">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px;text-indent: 0px;">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">4,672</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px;text-indent: 0px;">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> </ix:nonNumeric></ix:continuation><ix:continuation id="TextSelection_73805115"> </ix:continuation> </div></div> </div></div></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:SegmentReportingDisclosureTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">19. SEGMENTS </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div><ix:nonNumeric name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, and 11 months ended 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 52%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended <br/>December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11 Months Ended <br/>December&#160;31, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2022To12_31_2022_USsrtStatementGeographicalAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">11,137</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_USsrtStatementGeographicalAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">85.0</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P02_01_2021To12_31_2021_USsrtStatementGeographicalAxis" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">5,826</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_USsrtStatementGeographicalAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">71.1</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Europe</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2022To12_31_2022_EuropeMembersrtStatementGeographicalAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">1,965</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_EuropeMembersrtStatementGeographicalAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">15.0</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P02_01_2021To12_31_2021_EuropeMembersrtStatementGeographicalAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal">2,370</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_EuropeMembersrtStatementGeographicalAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">28.9</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">13,102</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">100.0</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P02_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-3" scale="3" format="ixt:num-dot-decimal">8,196</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P02_01_2021To12_31_2021_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">100.0</ix:nonFraction>%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenues from external customers are attributed to individual countries based on the physical location in which the services are provided or the particular customer location with whom the Company has contracted.</div> </ix:nonNumeric><ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" contextRef="P01_01_2022To12_31_2022" escape="true"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">20. SUBSEQUENT EVENTS</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In February 2023, the Company announced an updated business strategy, including revisions to the Company&#8217;s technology roadmap. In connection with this updated strategy, the Company has implemented a workforce reduction in order to focus the organization and its resources on nearer-term strategic priorities. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reduction</div></div><div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;">&#160;in workforce impacted approximately </div><ix:nonFraction name="rgti:NumberOfEmployees" contextRef="P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_Numberofemployees" decimals="0" scale="0" format="ixt:num-dot-decimal">50</ix:nonFraction> <div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;">employees or approximately </div><ix:nonFraction name="rgti:PercentageOfReductionInEmployees" contextRef="P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">28</ix:nonFraction><div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;">% of the Company&#8217;s workforce. The Company began implementing activities with respect to the revised business plan, updated technology roadmap and reduction in workforce in February 2023. Affected employees were offered separation benefits, including severance payments and temporary healthcare coverage assistance. The Company currently expects to incur restructuring charges of approximately $</div><ix:nonFraction name="us-gaap:RestructuringCharges" contextRef="P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">1.4</ix:nonFraction>&#160;<div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;">million for severance payments and temporary healthcare coverage to employees with respect to eliminated positions. Such restructuring charges are expected to be incurred and recorded in the first quarter of 2023.</div></div> </ix:nonNumeric> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-4<div style="letter-spacing: 0px; top: 0px;;display:inline;">0</div></div> <div style="margin-top: 1em; margin-bottom: 1em"></div> </div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PART II </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INFORMATION NOT REQUIRED IN PROSPECTUS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;13.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Expenses of Issuance and Distribution. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth all costs and expenses, other than underwriting discounts and commissions, payable by us in connection with the sale of the securities being registered. All amounts shown are estimates except for the SEC registration fee. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:82%"></td>

<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">406.03</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accountants&#8217; fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">150,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">175,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,093.97</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">340,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Previously paid. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Discounts, concessions, commissions and similar selling expenses attributable to the sale of shares of common stock covered by this prospectus will be borne by the selling stockholders. We will pay all expenses (other than discounts, concessions, commissions and similar selling expenses) relating to the registration of the shares with the SEC, as estimated in the table above. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;14.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Indemnification of Directors and Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;145(a) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party to or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), because he or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding, if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;145(b) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor because the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made with respect to any claim, issue or matter as to which he or she shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, he or she is fairly and reasonably entitled to indemnity for such expenses that the Court of Chancery or other adjudicating court shall deem proper. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;145(g) of the DGCL provides, in general, that a corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify the person against such liability under Section&#160;145 of the DGCL. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, our charter eliminates our directors&#8217; liability to the fullest extent permitted under the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for any transaction from which the director derives an improper personal benefit; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for any unlawful payment of dividends or redemption of shares; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for any breach of a director&#8217;s duty of loyalty to the corporation or its stockholders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of the Company&#8217;s directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have entered into separate indemnification agreements with our directors and officers. These agreements, among other things, require us to indemnify our directors and officers for certain expenses, including attorneys&#8217; fees, judgments, fines, and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as one of our directors or officers or any other company or enterprise to which the person provides services at our request. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors and officers. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;15.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Recent Sales of Unregistered Securities</span><span style="font-weight:bold"><span style="font-style:italic">.</span></span><span style="font-weight:bold"> </span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following list sets forth information regarding all unregistered securities sold by us since inception on December&#160;22, 2020. None of the following transactions involved any underwriters, underwriting discounts or commissions, or any public offering. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Class&#160;B Ordinary Shares </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&#160;22, 2020 the Company issued an aggregate of 5,750,000 Supernova Class&#160;B ordinary shares to Supernova Partners II LLC for an aggregate purchase price of $25,000, or approximately $0.004 per share, to cover certain offering and formation costs. On January&#160;14, 2021, Supernova effected a share dividend resulting in there being an aggregate of 7,187,500 Class&#160;B ordinary shares outstanding, and on March&#160;1, 2021, Supernova effected a second share dividend resulting in there being an aggregate of 8,625,000 Supernova Class&#160;B ordinary shares outstanding. Such securities were issued pursuant to the exemption from registration contained in Section&#160;4(a)(2) of the Securities Act. Supernova Sponsor is an accredited investor for purposes of Rule 501 of Regulation D under the Securities Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Private Placement Warrants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Supernova Partners II LLC purchased 4,450,000 private placement warrants at a price of $2.00 per warrant in a private placement that occurred concurrently with the closing of Supernova&#8217;s initial public offering and generated gross proceeds of $8,900,000. Each private placement warrant is exercisable for one share of common stock at a price of $11.50 per share. The private placement warrants are <span style="white-space:nowrap">non-redeemable</span> and exercisable on a cashless basis so long as they are held by Supernova Partners II LLC or its permitted transferees. The sale of the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
private placement warrants was made pursuant to the exemption from registration contained in Section&#160;4(a)(2) of the Securities Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">PIPE Financing Subscription Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;2, 2022, subscribers purchased from the Company an aggregate of 10,251,000 shares of common stock, for a purchase price of $10.00 per share and an aggregate purchase price of $102.51&#160;million, pursuant to individual subscription agreements, each dated as of October&#160;6, 2021, entered into in connection with the Business Combination. The sale of the shares of common stock to the subscribers was made pursuant to the exemption from registration contained in Section&#160;4(a)(2) of the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;2, 2022, two &#8220;accredited investors&#8221; (as such term is defined in Rule 501 of Regulation D) purchased from the Company an aggregate of 4,390,244 shares of common stock, for a purchase price of $10.25&#160;per share and an aggregate purchase price of $45.0&#160;million, pursuant to individual subscription agreements, each dated as of December&#160;23, 2021, in connection with the Business Combination. The sale of the shares of common stock to the two subscribers was made pursuant to the exemption from registration contained in Section&#160;506(c) of the Securities Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Warrant Subscription Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2022, pursuant to the Warrant Subscription Agreement, the Company issued the Ampere Warrant upon receipt of an aggregate of $5&#160;million (including the exercise price), and upon such payment and issuance, 500,000 shares of the Company&#8217;s common stock vested under the warrant and were immediately exercised by Ampere pursuant to the terms of the warrant. Pursuant to the Warrant Subscription Agreement, Ampere is required to pay, subject to the satisfaction of certain conditions, an additional $4,999,950 to the Company no later than the second anniversary of the date of the Warrant Subscription Agreement, and upon such payment, the Unexercised Warrant Shares will vest and be exercisable by Ampere pursuant to the terms of the warrant. If the conditions to payment are not satisfied by the second anniversary of the date of the Warrant Subscription Agreement, the Company may reject Ampere&#8217;s payment of the additional $4,999,950 and the Unexercised Warrant Shares will not vest or be exercisable and Ampere will have no further obligation with respect to the payment of the additional $4,999,950. The Ampere Warrant and the 500,000 outstanding shares of common stock issued upon exercise of the Ampere Warrant were issued pursuant to the exemption from registration contained in Section&#160;4(a)(2) of the Securities Act. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Committed Equity Facility </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;11, 2022, the Company entered into a Common Stock Purchase Agreement (the &#8220;Committed Equity Purchase Agreement&#8221;) and a Registration Rights Agreement with B. Riley Principal Capital II, LLC (&#8220;B.&#160;Riley&#8221;). Pursuant to the Committed Equity Purchase Agreement, subject to the satisfaction of the conditions set forth therein, the Company will have the right to sell to B. Riley up to $75,000,000 of newly issued shares (the &#8220;Committed Equity Shares&#8221;) of its common stock (subject to certain conditions and limitations contained in the Committed Equity Purchase Agreement), from time to time during the term of the Purchase Agreement. Sales of common stock pursuant to the Committed Equity Purchase Agreement, and the timing of any sales, are solely at the Company&#8217;s option, and it is under no obligation to sell any securities to B. Riley under the Committed Equity Purchase Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As consideration for B. Riley&#8217;s commitment to purchase shares of common stock at the Company&#8217;s direction upon the terms and subject to the conditions set forth in the Committed Equity Purchase Agreement, upon execution of the Committed Equity Purchase Agreement, the Company issued 171,008 shares of common stock to B. Riley (the &#8220;Commitment Shares&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the Committed Equity Purchase Agreement, B. Riley represented to the Company among other things, that it is an &#8220;accredited investor&#8221; (as such term is defined in Rule 501(a) of Regulation D under the Securities </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Act). The Committed Equity Shares and the Commitment Shares are being issued and sold by the Company to B.&#160;Riley in reliance upon the exemptions from the registration requirements of the Securities Act afforded by Section&#160;4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;16.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Exhibits and Financial Statement Schedules</span><span style="font-weight:bold"><span style="font-style:italic">.</span></span><span style="font-weight:bold"> </span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Exhibits. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exhibits listed below are filed as part of this registration statement </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:45%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="9" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Incorporated by Reference</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Schedule/<br />Form</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">File No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Exhibit</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Filing Date</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;2.1+</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312521292696/d228756dex21.htm">Agreement and Plan of Merger, dated as of October&#160;6, 2021, by and among Supernova Partners Acquisition Company II, Ltd., Supernova Merger Sub, Inc., Supernova Romeo Merger Sub, LLC and Rigetti Holdings, Inc.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">2.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October&#160;6,&#160;2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;2.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312521366325/d260312dex21.htm">First Amendment to Agreement and Plan of Merger, dated as of December&#160;23, 2021, by and among Supernova Partners Acquisition Company II, Ltd., Supernova Merger Sub, Inc., Supernova Romeo Merger Sub, LLC and Rigetti Holdings, Inc.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">2.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">December&#160;23,<br />2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;2.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522005796/d254318dex21.htm">Second Amendment to Agreement and Plan of Merger, dated as of January&#160;10, 2022, by and among Supernova Partners Acquisition Company&#160;II, Ltd., Supernova Merger Sub, Inc., Supernova Romeo Merger Sub, LLC and Rigetti Holdings, Inc.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">2.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">January&#160;10,&#160;2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex31.htm">Certificate of Incorporation of Rigetti Computing, Inc.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">3.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;3.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522284708/d418381dex31.htm">Amended and Restated Bylaws of Rigetti Computing, Inc. </a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">3.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">November&#160;14,&#160;2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex41.htm">Specimen Common Stock Certificate.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">4.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex42.htm">Specimen Warrant Certificate.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">4.2</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312521069319/d107027dex41.htm">Warrant Agreement between American Stock Transfer &amp; Trust Company, LLC and Supernova Partners Acquisition Company II, Ltd., dated March&#160;1, 2021.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">4.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">March&#160;4, 2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;&#160;&#160;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522225317/d222120dex51.htm">Opinion of Cooley LLP</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-1/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-266810</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">5.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">August 19, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex101.htm">Amended and Restated Registration Rights Agreement, dated March 2, 2022, by and among New Rigetti, the Sponsor and the other holders party thereto.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.1</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312521292696/d228756dex102.htm">Form of Subscription Agreement for PIPE Financing.</a></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.2</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October&#160;6, 2021</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:45%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="9" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Incorporated by Reference</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Schedule/<br />Form</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">File No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Exhibit</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Filing Date</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312521292696/d228756dex103.htm">Sponsor Support Agreement, dated as of October 6, 2021, by and among Supernova Partners Acquisition Company II, Ltd., Rigetti Holdings, Inc., Supernova Partners II LLC and certain other parties thereto.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">October&#160;6, 2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312521292696/d228756dex104.htm">Rigetti Holders Support Agreement, dated as of October 6, 2021, by and among Supernova Partners Acquisition Company II, Ltd., Rigetti Holdings, Inc. and certain other parties thereto.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">October&#160;6, 2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312521069319/d107027dex101.htm">Letter Agreement, dated as of March&#160;1, 2021, among Supernova, the Sponsor and Supernova&#8217;s officers and directors.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">March&#160;4, 2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312521362173/d248645dex1014.htm">Loan and Security Agreement dated March&#160;10, 2021, by and between Rigetti and Trinity Capital Inc.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.14</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8,&#160;2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312521362173/d248645dex1015.htm">Amendment No.&#160;1 to Trinity Loan and Security Agreement dated May 18, 2021, by and between Rigetti and Trinity Capital Inc.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.15</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.8</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312521362173/d248645dex1016.htm">Amendment No.&#160;2 to Trinity Loan and Security Agreement dated October 21, 2021, by and between Rigetti and Trinity Capital Inc.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.16</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.9</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522021446/d248645dex1017.htm">Amendment No.&#160;3 to Trinity Loan and Security Agreement dated January&#160;27, 2022, by and between Rigetti &amp; Co. LLC and Trinity Capital Inc.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.17</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.10</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522030892/d248645dex1018.htm">Guaranty Agreement dated January&#160;27, 2022, by and between Rigetti Holdings, Inc. and Trinity Capital Inc.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.18</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.11</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312521362173/d248645dex1019.htm">Amended and Restated Warrant to Purchase Stock, dated March&#160;9, 2021, issued to Trinity Capital Inc. by Rigetti &amp; Co, Inc.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.21</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.12</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312521362173/d248645dex1017.htm">Manufacturing Agreement dated May&#160;28, 2020, by and between Rigetti and Sparqtron Corporation.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.19</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.13#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522151893/d336452dex1021.htm">Rigetti&#160;&amp; Co, Inc. 2013 Equity Incentive Plan, as amended.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">10-Q</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.21</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">May&#160;16, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.14#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312522008927/d248645dex1020.htm">Form of Stock Option Grant Notice and Form of Stock Option Agreement under Rigetti &amp; Co, Inc. 2013 Equity Incentive Plan.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.22</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:45%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="9" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Incorporated by Reference</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Schedule/<br />Form</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">File No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Exhibit</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Filing Date</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.15#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312522008927/d248645dex1021.htm">Form of Restricted Stock Unit Grant Notice and Form of Restricted Stock Unit Agreement under Rigetti &amp; Co, Inc. 2013 Equity Incentive Plan.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.23</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.16#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex1016.htm">Rigetti Computing, Inc. 2022 Equity Incentive Plan.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.16</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.17#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex1017.htm">Form of Stock Option Grant Package under 2022 Equity Incentive Plan.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.17</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.18#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex1018.htm">Form of RSU Grant Package under 2022 Equity Incentive Plan.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.18</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.19#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex1019.htm">Form of Stock Award Grant Package under 2022 Equity Incentive Plan.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.19</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.20#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex1020.htm">Rigetti Computing, Inc. 2022 Employee Stock Purchase Plan.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.20</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.21#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex1021.htm">Form of Indemnification Agreement by and between the Company and its directors and officers.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.21</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.22#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522218918/d363252dex102.htm"><span style="white-space:nowrap">Non-Employee</span> Director Compensation Policy. </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">10-Q</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">August&#160;11, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">10.23</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312521362173/d248645dex1012.htm">Lease Agreement dated August&#160;9, 2016 by and between Rigetti and Prologis Limited Partnership I, as amended.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.12</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8,&#160;2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.24</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001838359/000119312521362173/d248645dex1013.htm">Lease Agreement dated April 15, 2015, by and among Rigetti, Temescal, LP and Contra Costa Industrial Park, Ltd., as amended.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.13</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.25#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522030892/d248645dex1024.htm">Amended&#160;&amp; Restated Employment Agreement, dated February 2, 2022, between Rigetti Holdings, Inc. and Chad Rigetti.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.24</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.26#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522030892/d248645dex1025.htm">Amended&#160;&amp; Restated Employment Agreement, dated February 2, 2022, between Rigetti Holdings, Inc. and Brian Sereda.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.25</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8,&#160;2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.27#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522030892/d248645dex1026.htm">Amended&#160;&amp; Restated Employment Agreement, dated February 2, 2022, between Rigetti Holdings, Inc. and Taryn Naidu.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.26</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.28#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522030892/d248645dex1028.htm">Amended&#160;&amp; Restated Employment Agreement, dated February&#160;2, 2022, between Rigetti Holdings, Inc. and Mike Harburn.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.28</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:46%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="11" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Incorporated by Reference</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Schedule/<br />Form</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">File No.</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Exhibit</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Filing Date</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.29#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522030892/d248645dex1029.htm">Amended&#160;&amp; Restated Employment Agreement, dated February 2, 2022, between Rigetti Holdings, Inc. and Rick Danis.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-4/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-260692</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.29</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;8, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.30*#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d483086dex1030.htm">Amended and Restated Employment Agreement, dated as of March 2, 2023, between Rigetti Computing, Inc. and David Rivas. </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.31</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522188287/d359677dex992.htm">Warrant Subscription Agreement, dated as of October&#160;6, 2021, between Rigetti Holdings, Inc. and Ampere Computing LLC.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">July&#160;6, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.32</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522188287/d359677dex993.htm">Warrant, dated as of June&#160;30, 2022, issued by Rigetti Computing, Inc.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">99.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">July&#160;6, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.33</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522218918/d363252dex105.htm">Common Stock Purchase Agreement, dated as of August&#160;11, 2022, by and between Rigetti Computing, Inc. and B. Riley Capital&#160;II, LLC. </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">10-Q</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">August&#160;11, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.34</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522218918/d363252dex106.htm">Registration Rights Agreement, dated as of August&#160;11, 2022, by and between Rigetti Computing, Inc. and B. Riley Capital II, LLC. </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">10-Q</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">August&#160;11,&#160;2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.35#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522297563/d388782dex101.htm">Interim President and Chief Executive Officer Letter Agreement for Rick Danis, dated as of December 1, 2022 </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right">001-40140</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">December&#160;2,&#160;2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.36#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522300553/d431423dex101.htm">Executive Employment Agreement, dated December 7, 2022, by and between Rigetti Computing, Inc. and Dr. Subodh Kulkarni. </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right">8-K</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top">001-40140</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">December&#160;8,&#160;2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.37#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312523031410/d406416dex101.htm">Executive Employment Agreement, dated February 9, 2023, by and between Rigetti Computing, Inc. and Jeffrey Bertelsen </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right">8-K</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top">001-40140</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;10,&#160;2023</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;10.38#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312523040758/d440145dex101.htm">Separation Agreement for Chad Rigetti, dated as of February 14, 2023 </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right">8-K</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top">001-40140</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">February&#160;16,&#160;2023</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;21.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522067932/d506107dex211.htm">List of Subsidiaries of Rigetti Computing, Inc.</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">8-K</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">001-40140</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">21.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">March&#160;7, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;23.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d483086dex231.htm">Consent of BDO USA LLP </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;23.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522225317/d222120dex51.htm">Consent of Cooley LLP (included in Exhibit&#160;5.1) </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-1/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-266810</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">23.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">August 19, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;&#160;24.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522218934/d222120ds1.htm#tx222120_24">Power of Attorney </a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right">S-1</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-266810</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">24.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">August&#160;12, 2022</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">101.INS*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Instance Document</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">101.SCH*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Schema Document</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">101.CAL*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Calculation Linkbase Document</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:6%"></td>
<td style="width:44%"></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td></td></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="9" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Incorporated by Reference</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Schedule/<br />Form</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">File No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Exhibit</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Filing Date</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">101.DEF*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Definition Linkbase Document</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">101.LAB*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Label Linkbase Document</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">101.PRE*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Inline XBRL Taxonomy Extension Presentation Linkbase Document</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">104*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit&#160;101)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="4"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">107</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1838359/000119312522225317/d222120dexfilingfees.htm">Filing Fee Table</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:top" align="right"><span style="white-space:nowrap">S-1/A</span></td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap">333-266810</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">107</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top" align="center">August 19, 2022</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed herewith. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">+</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of <span style="white-space:nowrap">Regulation&#160;S-K.</span> A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">#</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Indicates management contract or compensatory plan or arrangement. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Financial Statement Schedules. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;17.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Undertakings</span><span style="font-weight:bold"><span style="font-style:italic">.</span></span><span style="font-weight:bold"> </span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(a)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The undersigned registrant hereby undertakes as follows: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(i)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(ii)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20&#160;percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(iii)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">provided</span>,<span style="font-style:italic"> however</span>, that: Paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(i)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(ii)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii) or (x)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">That, for the purpose of determining any liability under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(i)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(ii)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(iii)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or our securities provided by or on behalf of the undersigned registrant; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(iv)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(b)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the undersigned pursuant to the foregoing provisions, or otherwise, the undersigned has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td align="left" style="vertical-align:top">
that a claim for indemnification against such liabilities (other than the payment by the undersigned of expenses incurred or paid by a director, officer or controlling person of the undersigned in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the undersigned will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. </td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx483086_24"><span id="sig"></span>SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Berkeley, State of California, on this 5th day of April, 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:92%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">RIGETTI COMPUTING, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Subodh Kulkarni</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Subodh Kulkarni</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:35%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td style="width:18%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Signature</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Subodh Kulkarni</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Chief&#160;Executive&#160;Officer&#160;and&#160;Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">April&#160;5, 2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Subodh Kulkarni</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">(Principal Executive Officer)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeffrey Bertelsen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">April&#160;5, 2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Jeffrey Bertelsen</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">(Principal Financial Officer and Principal Accounting Officer)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">April&#160;5, 2023 </p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Michael Clifton</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">April&#160;5, 2023 </p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">David Cowan</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">April&#160;5, 2023 </p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Alissa Fitzgerald</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">April&#160;5, 2023 </p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Ray Johnson</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Chair of the Board of Directors</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">April&#160;5, 2023 </p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Cathy McCarthy</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">April&#160;5, 2023 </p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">H. Gail Sandford</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:45%;border:0">


<tr>

<td style="width:10%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:89%"></td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">*By:</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">/s/ Rick Danis</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Rick Danis</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Attorney-in-Fact</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-11 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>2
<FILENAME>d483086dex1030.htm
<DESCRIPTION>EX-10.30
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.30</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.30 </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL> E<SMALL>XECUTIVE</SMALL> E<SMALL>MPLOYMENT</SMALL>
A<SMALL>GREEMENT</SMALL> </B>dated as of March 2, 2023 (&#147;<B><I>Agreement</I></B>&#148;) is by and between David Rivas (&#147;<B><I>Executive</I></B>&#148;) and <B>R<SMALL>IGETTI</SMALL> C<SMALL>OMPUTING</SMALL>, I<SMALL>NC</SMALL>. </B>(the
&#147;<B><I>Company</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL>, </B>the Executive and the Company executed a certain Executive Employment
Agreement on February&nbsp;2, 2022 (the &#147;<B><I>Prior Agreement</I></B>&#148;) and now wish to amend and restate the Prior Agreement on the terms and conditions set forth herein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company desires to employ Executive as Chief Technology Officer (&#147;<B><I>CTO</I></B>&#148;) effective on
February&nbsp;9, 2023, subject to Executive&#146;s signature below (the &#147;<B>Effective Date</B>&#148;) and provide Executive with certain compensation and benefits in return for Executive&#146;s services, and Executive agrees to continue to be
employed by the Company in such capacity and to receive the compensation and benefits on the terms and conditions set forth herein; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>N<SMALL>OW</SMALL>, T<SMALL>HEREFORE</SMALL>, </B>in consideration of the mutual promises and covenants contained herein, the parties agree
to the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Employment by the Company. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Position</B>. Subject to the terms set forth herein, the Company agrees to employ Executive in the
position of CTO, and Executive hereby accepts such continued employment on the terms and conditions set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Duties</B>. As CTO, Executive will report to the Chief Executive Officer of the Company (the
&#147;<B><I>CEO</I></B>&#148;), performing such duties as are normally associated with the position and such duties as are assigned from time to time, subject to the oversight and direction of the CEO. Executive shall make such business trips to
such places as may be reasonably necessary or advisable for the efficient operations of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.3</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Company Policies and Benefits</B>. The employment relationship between the parties shall also be subject
to the Company&#146;s personnel policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company&#146;s sole discretion. Executive will be eligible to participate on the same basis as similarly
situated employees in the Company&#146;s benefit plans in effect from time to time during Executive&#146;s employment. All matters of eligibility for coverage or benefits under any benefit plan shall be determined in accordance with the provisions
of such plan. The Company reserves the right to change, alter, or terminate any benefit plan in its sole discretion. Notwithstanding the foregoing, in the event that the terms of this Agreement differ from or are in conflict with the Company&#146;s
general employment policies or practices, this Agreement shall control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.4</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Vacation. </B>While this
Agreement is in effect, Executive shall also receive unlimited paid time off subject to the Company&#146;s vacation policies and procedures as in effect or amended from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.5</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Indemnification. </B>Subject to applicable law,
Executive will be provided indemnification to the maximum extent permitted by the Company&#146;s Certificate of Incorporation or Bylaws, all as amended, including, if applicable, any directors and officers insurance policies, with such
indemnification to be on terms determined by the Board or any of its committees. Such indemnification shall be documented in an Indemnification Agreement provided after the Closing Date subject to approval by the Board. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Compensation. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Salary</B>. Executive shall receive for Executive&#146;s services to be rendered under this Agreement an
initial base salary of $345,000 on&nbsp;an&nbsp;annualized basis, subject to review and adjustment by the Company in its sole discretion, payable subject to standard federal and state payroll withholding requirements in accordance with the
Company&#146;s standard payroll practices (&#147;<B><I>Base Salary</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Annual Bonus.
</B>While this Agreement is in effect, Executive shall be eligible for a discretionary annual cash bonus of a target amount equal to 25% of Base Salary (&#147;<B><I>Target Amount</I></B>&#148;), subject to review and adjustment by the Company in its
reasonable discretion, payable subject to standard federal and state payroll withholding requirements. Whether or not Executive earns any bonus will be dependent upon (a)&nbsp;Executive&#146;s continuous performance of services to the Company
through the last date of the applicable performance period, unless otherwise provided for in this Agreement; and (b)&nbsp;the actual achievement by Executive and the Company of the applicable performance targets and goals set by the Board or its
Compensation Committee. The annual period over which performance is measured for purposes of this bonus is January 1 through December 31. The Board or its Compensation Committee will determine in its reasonable discretion the extent to which
Executive and the Company have achieved the performance goals upon which the bonus is based and the amount of the bonus, which could be above or below the Target Amount (and may be zero). The bonus, if awarded, will be paid no later than
March&nbsp;15 of the calendar year immediately following the calendar year for which the bonus is being measured. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Equity. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the approval of the Board or the Compensation Committee, as soon as practicable following the
commencement of the Executive&#146;s employment with the Company, the Company will grant Executive performance stock units for 600,000 shares of common stock in the Company (the &#147;<B><I>Performance Stock</I></B>&#148;). The anticipated
Performance Stock will be governed by the terms and conditions of the Plan and a written award agreement between the Company and Executive, which will govern and control the Performance Stock in all respects, and will include the vesting terms and
conditions set forth in Schedule 1 hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Executive is also eligible to receive additional restricted stock
units to acquire shares of Company common stock (the &#147;<B><I>PSU Awards</I></B>&#148;), if certain performance-based milestones established by the Company are satisfied in the future and provided that Executive has remained continuously employed
by the Company through the date that the Board or the Compensation Committee grants such PSU Awards. The PSU Awards, if granted, will be issued subject to the terms and conditions of the Plan and a restricted stock unit award agreement in a form
satisfactory to the Company and shall vest in accordance with the terms therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Executive will also be eligible to receive awards of stock
options, restricted stock, restricted stock units or other equity awards pursuant to any plans or arrangements the Company may have in effect from time to time. The Board or a committee of the Board shall determine in its discretion whether
Executive shall be granted any such equity awards and the terms of any such award in accordance with the terms of any applicable plan or arrangement that may be in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.4</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Expense Reimbursement</B>. The Company will reimburse Executive for reasonable business expenses in
accordance with the Company&#146;s standard expense reimbursement policy, as the same may be modified by the Company from time to time. For the avoidance of doubt, to the extent that any reimbursements payable to Executive are subject to the
provisions of Section&nbsp;409A of the Code: (a)&nbsp;any such reimbursements will be paid no later than December 31 of the year following the year in which the expense was incurred, (b)&nbsp;the amount of expenses reimbursed in one year will not
affect the amount eligible for reimbursement in any subsequent year, and (c)&nbsp;the right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Confidential Information and Invention Assignment Obligations. </B>As a condition
of continued employment, Executive agrees to execute and abide by a Confidential Information and Invention Assignment Agreement attached as Exhibit A (&#147;<B><I>Proprietary Information Agreement</I></B>&#148;), which may be amended by the parties
from time to time without regard to this Agreement. The Proprietary Information Agreement contains provisions that are intended by the parties to survive and do survive termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Outside Activities during Employment</B>. During the term of Executive&#146;s
employment with the Company, Executive will work on a full-time basis for the Company and will devote Executive&#146;s best efforts and substantially all of Executive&#146;s business time and attention to the business of the Company. Except with the
prior written consent of the Board, including consent given to Executive prior to the signing of this Agreement, Executive will not, while employed by the Company, undertake or engage in any other employment, occupation or business enterprise that
would interfere with Executive&#146;s responsibilities and the performance of Executive&#146;s duties hereunder except for (i)&nbsp;reasonable time devoted to volunteer services for or on behalf of such religious, educational, <FONT
STYLE="white-space:nowrap">non-profit</FONT> and/or other charitable organization as Executive may wish to serve, (ii)&nbsp;reasonable time devoted to activities in the <FONT STYLE="white-space:nowrap">non-profit</FONT> and business communities
consistent with Executive&#146;s duties; and (iii)&nbsp;such other activities as may be specifically approved by the Board, and such approval shall not be unreasonably withheld. This restriction shall not, however, preclude Executive (x)&nbsp;from
owning less than one percent (1%) of the total outstanding shares of a publicly traded company, or (y)&nbsp;from employment or service in any capacity with Affiliates of the Company. As used in this Agreement, &#147;<B><I>Affiliates</I></B>&#148;
means an entity under common management or control with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;No
Conflict with Existing Obligations</B>. Executive represents that Executive&#146;s performance of all the terms of this Agreement does not and will not breach any agreement or obligation of any kind made prior to Executive&#146;s employment by the
Company, including agreements or obligations Executive may have with prior employers or entities for which Executive has provided services. Executive has not entered into, and Executive agrees that Executive will not enter into, any agreement or
obligation, either written or oral, in conflict herewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Termination of Employment</B>.
The parties acknowledge that Executive&#146;s employment relationship with the Company is <FONT STYLE="white-space:nowrap">at-will,</FONT> meaning either the Company or Executive may terminate Executive&#146;s employment at any time, with or without
cause or advance notice. The provisions in this Section govern the amount of compensation, if any, to be provided to Executive upon termination of employment and do not alter Executive&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> status.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.1</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination by the Company without Cause or for Good Reason. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have the right to terminate Executive&#146;s employment with the Company pursuant to this
<B>Section</B><B></B><B>&nbsp;6.1 </B>at any time, in accordance with <B>Section</B><B></B><B>&nbsp;6.6</B>, without &#147;Cause&#148; (as defined in <B>Section</B><B></B><B>&nbsp;6.3(b) </B>below) by giving notice as described in
<B>Section</B><B></B><B>&nbsp;7.1 </B>of this Agreement. A&nbsp;termination pursuant to <B>Section</B><B></B><B>&nbsp;6.5 </B>below is not a termination without &#147;Cause&#148; for purposes of receiving the benefits described in <B>Sections 6.1
</B>or <B>Section</B><B></B><B>&nbsp;6.2</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If the Company terminates Executive&#146;s employment at any
time without Cause or Executive terminates employment with the Company for Good Reason and <I>provided </I>that such termination constitutes a &#147;separation from service&#148; (as defined under Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h),</FONT> without regard to any alternative definition thereunder, a &#147;<B><I>Separation from Service</I></B>&#148;), then Executive shall be entitled to receive the Accrued Obligations
(defined below). If Executive complies with the obligations in <B>Section</B><B></B><B>&nbsp;6.1(c) </B>below, Executive shall also be eligible to receive the following &#147;<B><I>Severance Benefits</I></B>&#148;: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Company will pay Executive an amount equal to Executive&#146;s then current Base Salary for twelve
(12)&nbsp;months, less all applicable withholdings and deductions, paid in equal installments on the Company&#146;s normal payroll schedule following the termination date, with the first payment beginning on the Severance Pay Commencement Date (as
defined in <B>Section</B><B></B><B>&nbsp;6.1(c) </B>below), and the remaining installments occurring on the Company&#146;s regularly scheduled payroll dates thereafter; <I>provided </I>that on the Severance Pay Commencement Date, the Company will
pay in a lump sum the aggregate amount of the cash severance payments that the Company would have paid Executive through such date had the payments commenced on the effective date of termination through the Severance Pay Commencement Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;If Executive timely elects continued coverage under COBRA for Executive and Executive&#146;s covered dependents
under the Company&#146;s group health plans following such termination, then the Company shall pay the COBRA premiums necessary to continue Executive&#146;s and Executive&#146;s covered dependents&#146; health insurance coverage in effect for
Executive (and Executive&#146;s covered dependents) on the termination date until the earliest of: (i) twelve (12)&nbsp;months following the termination date (the &#147;<B><I>COBRA Severance Period</I></B>&#148;); (ii) the date when Executive
becomes eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment; or (iii)&nbsp;the date Executive ceases to be eligible for COBRA continuation coverage for any reason, including plan
termination (such period from the termination date through the earlier of (i)-(iii), (the &#147;<B><I>COBRA Payment Period</I></B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if at any time the Company determines that its payment of COBRA premiums on
Executive&#146;s behalf would result in a violation of applicable law (including, but not limited to, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of paying
COBRA premiums pursuant to this Section, the Company shall pay Executive on the last day of each remaining month of the COBRA Payment Period, a fully taxable cash payment equal to the COBRA premium for such month, subject to applicable tax
withholding (such amount, the &#147;<B><I>Special Severance Payment</I></B>&#148;), for the remainder of the COBRA Payment Period. Nothing in this Agreement shall deprive Executive of Executive&#146;s rights under COBRA or ERISA for benefits under
plans and policies arising under Executive&#146;s employment by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Executive will be paid all of
the Accrued Obligations on the Company&#146;s first payroll date after Executive&#146;s date of termination from employment or earlier if required by law. Executive shall receive the Severance Benefits pursuant to
<B>Section</B><B></B><B>&nbsp;6.1(b) </B>or the Change in Control Severance Benefits (defined below) pursuant to <B>6.2(a) </B>of this Agreement, as applicable, if: (i)&nbsp;Executive executes and does not revoke a separation agreement containing an
effective, general release of claims in favor of the Company and its affiliates and representatives but no other post-employment obligations other than an obligation to continue to abide and be bound by any post-employment obligations set forth in
agreements previously entered into with the Company or its affiliates, such as this Agreement or any proprietary rights agreement), in a form acceptable to the Company (the &#147;<B><I>Release</I></B>&#148;) and the Release is enforceable and
effective as provided in the Release on or before the date that is the sixtieth (60<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day following the effective date of termination (such
60<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day, the &#147;<B><I>Severance Pay Commencement Date</I></B>&#148;); (ii) if Executive holds any other positions with the Company, Executive resigns such position(s) to be effective no later
than the date of Executive&#146;s termination date (or such other date as requested by the Board); (iii) Executive returns all Company property on or before the Severance Pay Commencement Date; (iv) Executive complies with Executive&#146;s
post-termination obligations under this Agreement and the Proprietary Information Agreement; and (v)&nbsp;Executive complies with the terms of the Release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, &#147;<B><I>Accrued Obligations</I></B>&#148; are (i) Executive&#146;s accrued but
unpaid salary through the date of termination, (ii)&nbsp;any unreimbursed business expenses incurred by Executive payable in accordance with the Company&#146;s standard expense reimbursement policies, and (iii)&nbsp;benefits owed to Executive under
any qualified retirement plan or health and welfare benefit plan in which Executive was a participant in accordance with applicable law and the provisions of such plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Severance Benefits provided to Executive pursuant to this <B>Section</B><B></B><B>&nbsp;6.1 </B>are in lieu
of, and not in addition to, any benefits to which Executive may otherwise be entitled under any Company severance plan, policy or program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, &#147;<I>Good Reason</I>&#148; shall mean the occurrence of any of the following
events without Executive&#146;s consent: (i)&nbsp;a material reduction in Executive&#146;s Base Salary, other than a reduction applied in a similar proportional amount to all similarly situated executives; (ii)&nbsp;a material breach of this
Agreement by the Company; (iii)&nbsp;a material reduction in the Executive&#146;s duties, authority and responsibilities relative to the Executive&#146;s duties, authority, and responsibilities in effect immediately prior to such reduction; or (iv)
the relocation of Executive&#146;s principal place of employment, without Executive&#146;s consent, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">a manner that lengthens Executive&#146;s <FONT STYLE="white-space:nowrap">one-way</FONT> commute distance by
twenty-five (25)&nbsp;or more miles from Executive&#146;s then-current principal place of employment immediately prior to such relocation; not to include a requirement to return to <FONT STYLE="white-space:nowrap">in-person</FONT> work as set forth
in <B>Section</B><B></B><B>&nbsp;1.3</B>, in which circumstance Good Reason will not apply; <I>provided, however, </I>that, any such termination by Executive shall only be deemed for Good Reason pursuant to this definition if: (1)&nbsp;Executive
gives the Company written notice of Executive&#146;s intent to terminate for Good Reason within thirty (30)&nbsp;days following the first occurrence of the condition(s) that Executive believes constitute(s) Good Reason, which notice shall describe
such condition(s); (2) the Company fails to remedy such condition(s) within thirty (30)&nbsp;days following receipt of the written notice (the &#147;<B><I>Cure Period</I></B>&#148;); and (3)&nbsp;Executive voluntarily terminates employment within
thirty (30)&nbsp;days following the end of the Cure Period, or the parties agree in writing to extend such Cure Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>6.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Termination by the Company without Cause or for Good Reason Coincident with a
Change in Control</B>. If Executive&#146;s employment by the Company is terminated by the Company or any successor entity without &#147;Cause&#148; (and not due to Disability or death) or by Executive for Good Reason, in either case, within three
(3)&nbsp;months prior to or within twelve (12)&nbsp;months following the effective date of a &#147;<B><I>Change in Control</I></B>&#148; (as defined in the Plan), and, in either case, provided that such termination constitutes a Separation from
Service, without regard to any alternative definition thereunder, then in addition to paying or providing Executive with the Accrued Obligations, and subject to compliance with <B>Section</B><B></B><B>&nbsp;6.1(c)</B>, the following additional
benefits shall be provided in lieu of, and not in addition to, the Severance Benefits provided for in <B>Section</B><B></B><B>&nbsp;6.1(b) </B>(the &#147;<B><I>Change in Control Severance Benefits</I></B>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company will pay Executive a lump sum equal to Executive&#146;s then current annual Base Salary, less all
applicable withholdings and deductions, paid on the Severance Pay Commencement Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If Executive timely
elects continued coverage under COBRA for Executive and Executive&#146;s covered dependents under the Company&#146;s group health plans following such termination, then the Company shall pay the COBRA premiums necessary to continue Executive&#146;s
and Executive&#146;s covered dependents&#146; health insurance coverage in effect for Executive (and Executive&#146;s covered dependents) on the termination date during the COBRA Payment Period. Notwithstanding the foregoing, if at any time the
Company determines that its payment of COBRA premiums on Executive&#146;s behalf would result in a violation of applicable law (including, but not limited to, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care
and Education Reconciliation Act), then in lieu of paying COBRA premiums pursuant to this Section, the Company shall pay Executive on the last day of each remaining month of the COBRA Payment Period, the Special Severance Payment, for the remainder
of the COBRA Payment Period. Nothing in this Agreement shall deprive Executive of Executive&#146;s rights under COBRA or ERISA for benefits under plans and policies arising under Executive&#146;s employment by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company will pay a bonus equivalent to a pro rata share of Executive&#146;s full Target Amount, for the
portion of the performance year completed when Executive&#146;s termination occurs. This bonus will be payable subject to standard federal and state payroll withholding requirements in a lump sum payment on the Severance Pay Commencement Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the terms of any equity plan or award agreement
to the contrary, the time-based vesting conditions applicable to 100% of Executive&#146;s then outstanding stock options and/or other equity awards subject to time-based vesting requirements as of Executive&#146;s termination date shall be
accelerated as of the date of termination, and, with respect to any performance-based equity awards, and unless otherwise provided by the applicable award agreement, any performance-based vesting objectives will be deemed achieved at the higher of
target or actual performance. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.3</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination by the Company for Cause. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have the right to terminate Executive&#146;s employment with the Company at any time, in
accordance with <B>Section</B><B></B><B>&nbsp;6.6</B>, for Cause by giving notice as described in <B>Section</B><B></B><B>&nbsp;7.1 </B>of this Agreement. In the event Executive&#146;s employment is terminated at any time for Cause, Executive will
not receive Severance Benefits, Change in Control Severance Benefits, or any other severance compensation or benefits, except that, pursuant to the Company&#146;s standard payroll policies, the Company shall pay to Executive the Accrued Obligations.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<B><I>&#147;Cause&#148; </I></B>for termination shall mean that the Company has determined in its sole
discretion that Executive has engaged in any of the following: (i)&nbsp;Executive&#146;s material breach of any covenant or condition under this Agreement or any other agreement between the parties; (ii)&nbsp;Executive&#146;s material act
constituting dishonesty or fraudulent conduct in connection with Executive&#146;s duties to the Company; (iii)&nbsp;any conduct which constitutes a felony or a crime of moral turpitude under applicable law; (iv)&nbsp;material violation of any
Company policy; (v)&nbsp;refusal to follow or implement a clear and reasonable directive of Company, or any act of willful or intentional misconduct in relation to the Executive&#146;s duties to the Company; (vi)&nbsp;repeated or willful failure by
Executive to perform Executive&#146;s duties in a manner satisfactory to the Company; or (vii)&nbsp;Executive&#146;s breach of fiduciary duty to the Company; <I>provided </I>that <B>Sections 6.3(b)(i), (iv) </B>and <B>(vi)</B><B></B>&nbsp;shall only
provide the basis for a Cause termination if the Executive has not cured such breach, violation or conduct, to the extent curable, after the expiration of ten (10)&nbsp;days following the Company providing Executive with written notice of such basis
for Cause. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.4</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Resignation by Executive. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Executive may resign from Executive&#146;s employment with the Company at any time, in accordance with
<B>Section</B><B></B><B>&nbsp;6.6</B>, by giving notice as described in <B>Section</B><B></B><B>&nbsp;7.1</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event Executive resigns from Executive&#146;s employment with the Company for any reason other than Good
Reason in accordance with <B>Sections 6.1 or 6.2</B>, Executive will not receive Severance Benefits, Change in Control Severance Benefits, or any other severance compensation or benefits, except that, pursuant to the Company&#146;s standard payroll
policies, the Company shall pay to Executive the Accrued Obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.5</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Termination by Virtue of Death or Disability of Executive. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In the event of Executive&#146;s death while employed pursuant to this Agreement, all obligations of the parties
hereunder shall terminate, in accordance with <B>Section</B><B></B><B>&nbsp;6.6</B>, and the Company shall, pursuant to the Company&#146;s standard payroll policies, pay to Executive&#146;s legal representatives all Accrued Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Subject to applicable state and federal law, the Company shall at all times have the right, upon written notice to
Executive, and in accordance with <B>Section</B><B></B><B>&nbsp;6.6</B>, to terminate Executive&#146;s employment based on Executive&#146;s Disability. Termination by the Company of Executive&#146;s employment based on
&#147;<B><I>Disability</I></B>&#148; shall mean termination because Executive is unable due to a physical or mental condition to perform the essential functions of Executive&#146;s position with or without reasonable accommodation for 180 days in
the aggregate during any twelve (12)&nbsp;month period or based on the written certification by two licensed physicians of the likely continuation of such condition for such period. This definition shall be interpreted and applied consistent with
the Americans with Disabilities Act, the Family and Medical Leave Act, and other applicable federal, state or local law. In the event Executive&#146;s employment is terminated by the Company based on Executive&#146;s Disability or Executive
voluntarily resigns due to such Disability, Executive will not receive Severance Benefits, Change in Control Severance Benefits, or any other severance compensation or benefit, except that, pursuant to the Company&#146;s standard payroll policies,
the Company shall pay to Executive the Accrued Obligations. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.6</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice; Effective Date of Termination. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Termination of Executive&#146;s employment pursuant to this Agreement shall be effective on the earliest of: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;immediately after the Company gives notice to Executive of Executive&#146;s termination, with or without Cause,
unless pursuant to <B>Section</B><B></B><B>&nbsp;6.3(b)(i)</B>, if curable, or <B>Section</B><B></B><B>&nbsp;6.3(b)(vi)</B>, in which case ten (10)&nbsp;days after notice if not cured or unless the Company specifies a later date, in which case,
termination shall be effective as of such later date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;immediately upon the Executive&#146;s death; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;ten (10)&nbsp;days after the Company gives notice to Executive of Executive&#146;s termination on account of
Executive&#146;s Disability, unless the Company specifies a later date, in which case, termination shall be effective as of such later date, <I>provided </I>that Executive has not returned to the full-time performance of Executive&#146;s duties
prior to such date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;ten (10)&nbsp;days after the Executive gives written notice to the Company of
Executive&#146;s resignation, <I>provided </I>that the Company may set a termination date at any time between the date of notice and the date of resignation, in which case the Executive&#146;s resignation shall be effective as of such other date.
Executive will receive compensation through any required notice period; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:16%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;for a termination for Good Reason,
immediately upon Executive&#146;s full satisfaction of the requirements of <B>Section</B><B></B><B>&nbsp;6.1(f)</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event of a termination for Cause, written confirmation shall specify the subsection(s) of the definition of
Cause relied on to support the decision to terminate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>6.7</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Cooperation with Company after
Termination of Employment</B>. Following termination of Executive&#146;s employment for any reason, Executive agrees to provide reasonable cooperation to the Company in connection with its actual or contemplated defense, prosecution, or
investigation of any claims or demands by or against third parties, or other matters arising from events, acts, or failures to act that occurred during the period of Executive&#146;s employment by the Company. Such cooperation includes, without
limitation, making Executive available to the Company upon reasonable notice, without subpoena, to provide complete, truthful and accurate information in witness interviews, depositions and trial testimony. The Company will reimburse Executive for
reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses Executive incurs in connection with any such cooperation (excluding forgone wages, salary, or other compensation) and will make
reasonable efforts to accommodate Executive&#146;s scheduling needs and for more than de minimis service, the&nbsp;parties will agree on a mutually agreeable per diem rate. In addition, in the event Executive is receiving Severance Benefits or
Change in Control Severance Benefits, for twelve (12) months after Executive&#146;s employment with the Company ends for any reason, Executive agrees to reasonably cooperate with the Company in all matters relating to the transition of
Executive&#146;s work and responsibilities on behalf of the Company, including, but not limited to, any present, prior or subsequent relationships and the orderly transfer of any such work and institutional knowledge to such other persons as may be
designated by the Company. Such transition assistance described in the previous sentence shall not be subject to additional compensation, and the Company will make reasonable efforts to accommodate Executive&#146;s scheduling needs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>6.8</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Application of Section</B><B></B><B>&nbsp;409A</B>. It is intended that all of
the severance payments payable under this Agreement satisfy, to the greatest extent possible, the exemptions from the application of Section&nbsp;409A of the Code and the regulations and other guidance thereunder and any state law of similar effect
(collectively, &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;) provided under Treasury Regulations Sections <FONT STYLE="white-space:nowrap">1.409A-1(b)(4)</FONT> and <FONT STYLE="white-space:nowrap">1.409A-1(b)(9),</FONT>
and this Agreement will be construed in a manner that complies with Section&nbsp;409A. If not so exempt, this Agreement (and any definitions hereunder) will be construed in a manner that complies with Section&nbsp;409A, and incorporates by reference
all required definitions and payment terms. No severance payments will be made under this Agreement unless Executive&#146;s termination of employment constitutes a &#147;separation from service&#148; (as defined under Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h)).</FONT> For purposes of Section&nbsp;409A (including, without limitation, for purposes of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)(iii)),</FONT>
Executive&#146;s right to receive any installment payments under this Agreement (whether severance payments or otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall
at all times be considered a&nbsp;separate and distinct payment. If the Company determines that the severance benefits provided under this Agreement constitutes &#147;deferred compensation&#148; under Section&nbsp;409A and if Executive is a
&#147;specified employee&#148; of the Company, as such term is defined in Section&nbsp;409A(a)(2)(B)(i) of the Code at the time of&nbsp;Executive&#146;s Separation from Service, then, solely to the extent necessary to avoid the incurrence of the
adverse personal tax consequences under Section&nbsp;409A, the timing of the Severance will be delayed as follows: on the earlier to occur of (a)&nbsp;the date that is six months and one day after Executive&#146;s Separation from Service, and
(b)&nbsp;the date of Executive&#146;s death (such earlier date, the &#147;<B><I>Delayed Initial Payment Date</I></B>&#148;), the Company will (i)&nbsp;pay to Executive a lump sum amount equal to the sum of the severance benefits that Executive would
otherwise have received through the Delayed Initial Payment Date if the commencement of the payment of the severance benefits had not been delayed pursuant to this Section&nbsp;6.8 and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(ii)&nbsp;commence paying the balance of the severance benefits in accordance with the applicable payment schedule set forth in Section&nbsp;6. No interest shall be due on any amounts deferred
pursuant to this Section&nbsp;6.8. To the extent that any Severance Benefits are deferred compensation under Section&nbsp;409A of the Code, and are not otherwise exempt from the application of Section&nbsp;409A, then, if the period during which
Executive may consider and sign the Release spans two calendar years, the payment of any such Severance Benefit will not be made or begin until the later calendar year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>6.9</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Section 280G. </B>Notwithstanding any other provision of this Agreement to the
contrary, if payments made or benefits provided pursuant to this Agreement or otherwise from the Company or any person or entity are considered &#147;parachute payments&#148; under Section&nbsp;280G of the Code after the application of all
exemptions available under Code Section&nbsp;280G(b)(5)(A), then such parachute payments will be limited to the greatest amount that may be paid to Executive under Section&nbsp;280G of the Code without causing any loss of deduction to the Company
Group under such section, but only if, by reason of such reduction, the net after tax benefit to Executive will exceed the net after tax benefit if such reduction were not made. &#147;<B><I>Net after tax benefit</I></B>&#148; for purposes of this
Agreement will mean the sum of (i)&nbsp;the total amounts payable to the Executive under this Agreement, plus (ii)&nbsp;all other payments and benefits which the Executive receives or then is entitled to receive from the Company or otherwise that
would constitute a &#147;parachute payment&#148; within the meaning of Section&nbsp;280G of the Code, less (iii)&nbsp;the amount of federal, state and local taxes payable with respect to the foregoing calculated at the maximum marginal income tax
rate for each year in which the foregoing will be paid to Executive (based upon the rate in effect for such year as set forth in the Code at the time of termination of Executive&#146;s employment), less (iv)&nbsp;the amount of excise taxes imposed
with respect to the payments and benefits described in (i)&nbsp;and (ii) above by Section&nbsp;4999 of the Code. The determination as to whether and to what extent payments are required to be reduced in accordance with this Section&nbsp;6.9 will be
made at the Company&#146;s expense by a nationally recognized certified public accounting firm or other professional services firm, in either case, as may be designated by the Company prior to a change in control (the
&#147;<B><I>Firm</I></B>&#148;). In the event of any mistaken underpayment or overpayment under this Agreement, as determined by the Firm, the amount of such underpayment or overpayment will forthwith be paid to Executive or refunded to the Company,
as the case may be, with interest at one hundred twenty (120%) of the applicable Federal rate provided for in Section&nbsp;7872(f)(2) of the Code. Any reduction in payments required by this Section&nbsp;6.9 will occur in the following order:
(1)&nbsp;any cash severance, (2)&nbsp;cancellation of equity awards being taken into account at full value that were granted &#147;contingent on a change in ownership or control&#148; within the meaning of 280G of the Code in the reverse order of
date of grant of the awards (that is, the most recently granted equity awards will be cancelled first); (3) any other cash amount payable to Executive, (4)&nbsp;any benefit valued as a &#147;parachute payment,&#148; (5) the acceleration of vesting
of any equity awards that are options, and (6)&nbsp;the acceleration of vesting of any other equity awards. Within any such category of payments and benefits, a reduction will occur first with respect to amounts that are not &#147;deferred
compensation&#148; within the meaning of Section&nbsp;409A and then with respect to amounts that are. In the event that acceleration of compensation from equity awards is to be reduced, such acceleration of vesting will be canceled, subject to the
immediately preceding sentence, in the reverse order of the date of grant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General Provisions. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Notices</B>. Any notices hereunder must be in writing and shall be deemed
effectively given: (a)&nbsp;upon personal delivery to the party to be notified, (b)&nbsp;when sent by electronic mail if sent during normal business hours of the recipient, and if not, then on the next business day, (c)&nbsp;five (5) days after
having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d)&nbsp;one (1) business day after timely deposit for <FONT STYLE="white-space:nowrap">next-business-day</FONT> delivery with a nationally recognized
overnight courier, specifying <FONT STYLE="white-space:nowrap">next-business-day</FONT> delivery, with written verification of receipt. All communications shall be sent to the Company at its primary office location, or to <U>legal@rigetti.com</U>,
and to Executive at either Executive&#146;s address as listed on the Company payroll records, or Executive&#146;s Company-issued email address, or at such other address as the Company or Executive may designate by ten (10)&nbsp;days advance written
notice to the other. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.2</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Severability</B>. Whenever possible, each provision of
this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any
jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or
unenforceable provisions had never been contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.3</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Survival</B>.
Provisions of this Agreement which by their terms must survive the termination of this Agreement in order to effectuate the intent of the parties will survive any such termination for such period as may be appropriate under the circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.4</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Waiver</B>. If either party should waive any breach of any provisions of this
Agreement, it shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.5</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Complete Agreement</B>. This Agreement constitutes the entire agreement between
Executive and the Company with regard to the subject matter hereof. This Agreement is the complete, final, and exclusive embodiment of their agreement with regard to this subject matter and supersedes any prior oral discussions or written
communications and agreements, including the Prior Agreement. This Agreement is entered into without reliance on any promise or representation other than those expressly contained herein, and it cannot be modified or amended except in writing signed
by Executive and an authorized officer of the Company. The parties have entered into a separate Proprietary Information Agreement and have or may enter into separate agreements related to equity. These separate agreements govern other aspects of the
relationship between the parties, have or may have provisions that survive termination of Executive&#146;s employment under this Agreement, may be amended or superseded by the parties without regard to this Agreement and are enforceable according to
their terms without regard to the enforcement provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.6</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Counterparts</B>. This Agreement may be executed in separate counterparts, any
one of which need not contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement. The parties agree that facsimile and scanned image copies of signatures, including DocuSign, will suffice as
original signatures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.7</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Withholding Taxes. </B>The
Company will be entitled to withhold from any payment due to Executive hereunder any amounts required to be withheld by applicable tax laws or regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.8</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Headings</B>. The headings of the sections hereof are inserted for convenience
only and shall not be deemed to constitute a part hereof nor to affect the meaning thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.9</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Successors and Assigns</B>. The Company shall assign this Agreement and its
rights and obligations hereunder in whole, but not in part, to any Company or other entity with or into which the Company may hereafter merge or consolidate or to which the Company may transfer all or substantially all of its assets, if in any such
case said Company or other entity shall by operation of law or expressly in writing assume all obligations of&nbsp;the Company hereunder as fully as if it had been originally made a party hereto, but may not otherwise assign this Agreement or its
rights and obligations hereunder. Executive may not assign or transfer this Agreement or any rights or obligations hereunder, other than to Executive&#146;s estate upon Executive&#146;s death. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.10</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;&nbsp;&nbsp;Choice of Law</B>. All questions concerning the construction, validity and
interpretation of this Agreement will be governed by the laws of the State of California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>7.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dispute Resolution</B>. The parties recognize that litigation in federal or state
courts or before federal or state administrative agencies of disputes arising out of the Executive&#146;s employment with the Company or out of this Agreement, or the Executive&#146;s termination of employment or termination of this Agreement, may
not be in the best interests of either the Executive or the Company, and may result in unnecessary costs, delays, complexities, and uncertainty. Except where prohibited by law, the parties agree that any dispute between the parties arising out of or
relating to the negotiation, execution, performance or termination of this Agreement or the Executive&#146;s employment, including, but not limited to, any claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964,
as amended, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, Section&nbsp;1981 of the Civil Rights Act of 1966, as amended, the Family Medical Leave Act, the Executive
Retirement Income Security Act, and any similar federal, state or local law, statute, regulation, or any common law doctrine, whether that dispute arises during or after employment, shall be settled by binding arbitration in accordance with the
National Rules for the Resolution of Employment Disputes of the American Arbitration Association. The location for the arbitration shall be in Alameda County, California. Any award made by such panel shall be final, binding and conclusive on the
parties for all purposes, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof. The arbitrators&#146; fees and expenses and all administrative fees and expenses associated with the filing of
the arbitration shall be borne by the Company; <I>provided however</I>, that at the Executive&#146;s option, Executive may voluntarily pay up to <FONT STYLE="white-space:nowrap">one-half</FONT> the costs and fees. The parties acknowledge and agree
that their obligations to arbitrate under this Section survive the termination of this Agreement and continue after the termination of the employment relationship between Executive and the Company. The parties each further agree that the arbitration
provisions of this Agreement shall provide each party with its <B>exclusive remedy</B>, and each party expressly waives any right it might have to seek redress in any other forum, except as otherwise expressly provided in this Agreement. By election
arbitration as the means for final settlement of&nbsp;all claims, <B>the parties hereby waive their respective rights to, and agree not to, sue each other in any action in a Federal, State or</B> </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>local court with respect to such claims, but may seek to enforce in court an arbitration award rendered
pursuant to this Agreement. The parties specifically agree to waive their respective rights to a trial by jury, and further agree that no demand, request or motion will be made for trial by jury.</B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[SIGNATURES TO FOLLOW ON NEXT PAGE] </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the
parties have duly executed this Agreement as of the date first above written. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>RIGETTI COMPUTING, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><B>/</B>s/ Jackie Kaweck</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name: Jackie Kaweck</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title: SVP, HR</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>E<SMALL>XECUTIVE</SMALL></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><B>/</B>s/ David Rivas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">David Rivas</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:120pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[SIGNATURE PAGE TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT] </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule 1 </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Performance Stock </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Performance Stock will be subject to a time-based vesting requirement (the &#147;<B><I>Time-Based Vesting Requirement</I></B>&#148;) and a performance-based vesting requirement (the &#147;<B><I>Performance-Based Vesting Requirement</I></B>&#148;) as
set forth on this Schedule&nbsp;1. To the extent that the Performance-Based Vesting Requirement is satisfied prior to the termination of Executive&#146;s Continuous Service, the Performance Stock will vest without regard to the Time-Based Vesting
Requirement. However, the Performance Stock will not vest unless and until the Performance-Based Vesting Requirement has been satisfied, even if the Time-Based Vesting Requirement has been satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Time-Based Vesting Requirement</U>: The Time-Based Vesting Requirement will be satisfied as follows 1/48th of the total shares subject to
the Performance Stock will satisfy the Time-Based Vesting Requirement each month on the same day of the month as the vesting commencement date (or&nbsp;if&nbsp;there is no corresponding day, on the last day of the month), in each case, subject to
Executive&#146;s Continuous Service through each such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Performance-Based Vesting Requirement</U>: The Performance-Based Vesting
Requirement will be satisfied with respect to the corresponding number of shares indicated in the chart below to the extent that, during the five-year period beginning on the Effective Date and ending on the fifth (5<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>)&nbsp;anniversary thereof, the closing price per share of the Company&#146;s common stock for any twenty (20)&nbsp;trading days during any consecutive thirty (30)&nbsp;trading day period equals or
exceeds a price set forth in the chart below, subject to the certification of such achievement by the Compensation Committee. Any portion of the Performance Stock that has not satisfied the Performance-Based Vesting Requirement on or prior to the
fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) anniversary of the Effective Date will be forfeited without consideration. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="10" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="10" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:8pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">Closing Price</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:8pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">Shares to Vest</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="10" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:8pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">$2.00 or higher</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:8pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">300,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="10" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:8pt ;BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">$4.00 or higher</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:8pt ;BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">300,000</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Termination of Employment</U>: Upon a termination of the Executive&#146;s Continuous Service for any
reason, any portion of the Performance Stock that has satisfied the Time-Based Vesting Requirement on or prior to the date of such termination (including due to any applicable acceleration in connection with such termination in accordance with the
Agreement) shall remain outstanding and eligible to vest, to the extent not already vested, based on the satisfaction of the Performance-Based Vesting Requirement. Notwithstanding the foregoing, upon a termination of the Executive&#146;s Continuous
Service for Cause, the Performance Stock, whether or not vested, will immediately be forfeited without consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d483086dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Consent of Independent Registered Public Accounting Firm </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rigetti Computing, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Berkeley, California </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March&nbsp;27, 2023, relating to the
consolidated financial statements of Rigetti Computing, Inc., which is contained in that Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also consent to the reference to us under the
caption &#147;Experts&#148; in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ BDO USA, LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Spokane, Washington </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;5, 2023 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>rgti-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 05-April-2023 [05:05:55] {PM}-->
<schema targetNamespace="http://www.rigetti.com/20221231" elementFormDefault="qualified" xmlns:rgti="http://www.rigetti.com/20221231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.rigetti.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document - Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
<link:definition>1002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
<link:definition>1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
<link:definition>1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss" id="ConsolidatedStatementsOfComprehensiveLoss">
<link:definition>1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" id="ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit">
<link:definition>1006 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
<link:definition>1007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
<link:definition>1008 - Disclosure - Description of Business</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/BusinessCombination" id="BusinessCombination">
<link:definition>1010 - Disclosure - Business Combination</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/Investments" id="Investments">
<link:definition>1011 - Disclosure - Investments</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/Goodwill" id="Goodwill">
<link:definition>1012 - Disclosure - Goodwill</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/RevenueRecognition" id="RevenueRecognition">
<link:definition>1013 - Disclosure - Revenue Recognition</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformation" id="SupplementalFinancialStatementsInformation">
<link:definition>1014 - Disclosure - Supplemental Financial Statements Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/Leases" id="Leases">
<link:definition>1015 - Disclosure - Leases</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>1016 - Disclosure - Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/Debt" id="Debt">
<link:definition>1017 - Disclosure - Debt</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/RedeemableConvertiblePreferredStock" id="RedeemableConvertiblePreferredStock">
<link:definition>1018 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/CommonStock" id="CommonStock">
<link:definition>1019 - Disclosure - Common Stock</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/Warrants" id="Warrants">
<link:definition>1020 - Disclosure - Warrants</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ForwardWarrantAgreement" id="ForwardWarrantAgreement">
<link:definition>1021 - Disclosure - Forward Warrant Agreement</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/FairValueMeasurements" id="FairValueMeasurements">
<link:definition>1022 - Disclosure - Fair Value Measurements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/EquityPlans" id="EquityPlans">
<link:definition>1023 - Disclosure - Equity Plans</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/NetLossPerShare" id="NetLossPerShare">
<link:definition>1024 - Disclosure - Net Loss Per Share</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition>1025 - Disclosure - Income Taxes</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/Segments" id="Segments">
<link:definition>1026 - Disclosure - Segments</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>1027 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1028 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition>1029 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/BusinessCombinationTables" id="BusinessCombinationTables">
<link:definition>1030 - Disclosure - Business Combination (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/InvestmentsTables" id="InvestmentsTables">
<link:definition>1031 - Disclosure - Investments (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/GoodwillTables" id="GoodwillTables">
<link:definition>1032 - Disclosure - Goodwill (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/RevenueRecognitionTables" id="RevenueRecognitionTables">
<link:definition>1033 - Disclosure - Revenue Recognition (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables" id="SupplementalFinancialStatementsInformationTables">
<link:definition>1034 - Disclosure - Supplemental Financial Statements Information (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/LeasesTables" id="LeasesTables">
<link:definition>1035 - Disclosure - Leases (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/DebtTables" id="DebtTables">
<link:definition>1036 - Disclosure - Debt (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/CommonStockTables" id="CommonStockTables">
<link:definition>1037 - Disclosure - Common Stock (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/WarrantsTables" id="WarrantsTables">
<link:definition>1038 - Disclosure - Warrants (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementTables" id="ForwardWarrantAgreementTables">
<link:definition>1039 - Disclosure - Forward Warrant Agreement (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
<link:definition>1040 - Disclosure - Fair Value Measurements (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/EquityPlansTables" id="EquityPlansTables">
<link:definition>1041 - Disclosure - Equity Plans - (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/NetLossPerShareTables" id="NetLossPerShareTables">
<link:definition>1042 - Disclosure - Net Loss Per Share (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition>1043 - Disclosure - Income Taxes (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SegmentsTables" id="SegmentsTables">
<link:definition>1044 - Disclosure - Segments (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail" id="DescriptionOfBusinessAdditionalInformationDetail">
<link:definition>1045 - Disclosure - Description of Business - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
<link:definition>1046 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail" id="SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail">
<link:definition>1047 - Disclosure - Summary of Significant Accounting Policies - Summary of Cash Cash Equivalents and Short Term Investments (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail" id="SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail">
<link:definition>1048 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inputs Into the Respective Models (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail" id="SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail">
<link:definition>1049 - Disclosure - Summary of Significant Accounting Policies - Summary Of Earnings Per Share Basic And Diluted (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail" id="SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail">
<link:definition>1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Customers Accounts Receivable (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail" id="BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail">
<link:definition>1051 - Disclosure - Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail" id="BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail">
<link:definition>1052 - Disclosure - Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail" id="BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail">
<link:definition>1053 - Disclosure - Business Combination - Summary of Consummation of the Business Combination (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail" id="BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail">
<link:definition>1054 - Disclosure - Business Combination - Summary of Consummation of the Business Combination (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail" id="BusinessCombinationAdditionalInformationDetail">
<link:definition>1055 - Disclosure - Business Combination - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail" id="InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail">
<link:definition>1056 - Disclosure - Investments  - Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail" id="InvestmentsAdditionalInformationDetail">
<link:definition>1057 - Disclosure - Investments - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail" id="GoodwillSummaryOfScheduleOfGoodwillDetail">
<link:definition>1058 - Disclosure - Goodwill - Summary of Schedule of Goodwill (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/GoodwillAdditionalInformationDetail" id="GoodwillAdditionalInformationDetail">
<link:definition>1059 - Disclosure - Goodwill - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail" id="RevenueRecognitionAdditionalInformationDetail">
<link:definition>1060 - Disclosure - Revenue Recognition - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail" id="RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail">
<link:definition>1061 - Disclosure - Revenue Recognition - Summary of Disaggregation of Revenue (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail" id="RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail">
<link:definition>1062 - Disclosure - Revenue Recognition - Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail" id="RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail">
<link:definition>1063 - Disclosure - Revenue Recognition - Summary of Change in Contract with Customer, Asset and Liability (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail" id="SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail">
<link:definition>1064 - Disclosure - Supplemental Financial Statements Information - Summary Of  Property Plant And Equipment Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail" id="SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail">
<link:definition>1065 - Disclosure - Supplemental Financial Statements Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail" id="SupplementalFinancialStatementsInformationAdditionalInformationDetail">
<link:definition>1066 - Disclosure - Supplemental Financial Statements Information - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/LeasesAdditionalInformationDetail" id="LeasesAdditionalInformationDetail">
<link:definition>1067 - Disclosure - Leases - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail" id="LeasesSummaryOfComponentsOfLeaseCostsDetail">
<link:definition>1068 - Disclosure - Leases - Summary of Components of Lease Costs (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail" id="LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail">
<link:definition>1069 - Disclosure - Leases - Summary Of Lessee Operating Lease Liability Maturity (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail" id="LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail">
<link:definition>1070 - Disclosure - Leases - Summary of Maturities of the Company's Operating Lease Liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail" id="DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail">
<link:definition>1071 - Disclosure - Debt - Scheduled principal payments on total outstanding debt (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail" id="DebtLongTermDebtAndTheUnamortizedDiscountDetail">
<link:definition>1072 - Disclosure - Debt -  Long term debt and the unamortized discount (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/DebtAdditionalInformationDetail" id="DebtAdditionalInformationDetail">
<link:definition>1073 - Disclosure - Debt - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" id="RedeemableConvertiblePreferredStockAdditionalInformationDetail">
<link:definition>1074 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail" id="CommonStockSummaryOfConversionsOfStockDetail">
<link:definition>1075 - Disclosure - Common Stock - Summary of Conversions of Stock (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/CommonStockAdditionalInformationDetail" id="CommonStockAdditionalInformationDetail">
<link:definition>1076 - Disclosure - Common Stock - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/WarrantsAdditionalInformationDetail" id="WarrantsAdditionalInformationDetail">
<link:definition>1077 - Disclosure - Warrants - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail" id="WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail">
<link:definition>1078 - Disclosure - Warrants - Schedule Of Fair Value Of The Private Placement Warrant Measured Using Black Scholes Approach (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail" id="WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail">
<link:definition>1079 - Disclosure - Warrants - Schedule Of Fair Value Of The Trinity Warrant liabilities Measured Using Black Scholes Approach (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail" id="WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail">
<link:definition>1080 - Disclosure - Warrants - Summary of Vesting Status of the Customer Warrant (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail" id="ForwardWarrantAgreementAdditionalInformationDetail">
<link:definition>1081 - Disclosure - Forward Warrant Agreement - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail" id="ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail">
<link:definition>1082 - Disclosure - Forward Warrant Agreement - Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" id="FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
<link:definition>1083 - Disclosure - Fair Value Measurements - Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail" id="FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail">
<link:definition>1084 - Disclosure - Fair Value Measurements - Summary Of Change in Fair Value of Derivative Liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail" id="EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail">
<link:definition>1085 - Disclosure - Equity Plans - Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail" id="EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail">
<link:definition>1086 - Disclosure - Equity Plans - Schedule of Activity Related to Restricted Stock Units (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail" id="EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail">
<link:definition>1087 - Disclosure - Equity Plans -Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail" id="EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail">
<link:definition>1088 - Disclosure - Equity Plans -Schedule Of Share Based Payment Award Stock Options Valuation Assumptions (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail" id="EquityPlansAdditionalInformationDetail">
<link:definition>1089 - Disclosure - Equity Plans - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" id="NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail">
<link:definition>1090 - Disclosure - Net Loss Per Share - Schedule of Earnings Per Share Basic and Diluted (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" id="NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail">
<link:definition>1091 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail" id="NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail">
<link:definition>1092 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail" id="NetLossPerShareAdditionalInformationDetail">
<link:definition>1093 - Disclosure - Net Loss Per Share - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail" id="IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail">
<link:definition>1094 - Disclosure - Income Taxes - Summary of Domestic and Foreign Components of Loss Before Income Taxes (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" id="IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail">
<link:definition>1095 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets and Liabilities (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail" id="IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail">
<link:definition>1096 - Disclosure - Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail" id="IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail">
<link:definition>1097 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits Affecting the Effective Tax rate (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail" id="IncomeTaxesAdditionalInformationDetail">
<link:definition>1098 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail" id="SegmentsSummaryOfRevenueByGeographyDetail">
<link:definition>1099 - Disclosure - Segments - Summary of Revenue by Geography (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail" id="SubsequentEventsAdditionalInformationDetail">
<link:definition>1100 - Disclosure - Subsequent Events - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="rgti-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
<import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
<import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
<import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
<import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
<import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
<element name="ForwardContractAssetsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_ForwardContractAssetsCurrent" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ForwardContractLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_ForwardContractLiabilities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DebtNetOfCurrentPortion" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_DebtNetOfCurrentPortion" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_TransactionCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" substitutionGroup="xbrli:item" />
<element name="ReclassificationOfTemporaryEquityShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ReclassificationOfTemporaryEquityShares" substitutionGroup="xbrli:item" />
<element name="IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" substitutionGroup="xbrli:item" />
<element name="AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AmortizationOfDebtCommitmentFeeAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_AmortizationOfDebtCommitmentFeeAsset" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ChangeInFairValueOfForwardContract" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ChangeInFairValueOfForwardContract" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="AccretionOfDebtEndOfTermLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_AccretionOfDebtEndOfTermLiabilities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NonCashLeaseExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_NonCashLeaseExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PaymentOfDeferredOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PaymentOfDeferredOfferingCosts" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TransactionCostsPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_TransactionCostsPaid" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PaymentOfLoanAndSecurityAgreementExitFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PaymentOfLoanAndSecurityAgreementExitFees" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="FairValueOfLoanAndSecurityAgreementAndWarrantLiability." type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ExerciseOfLoanAndSecurityAgreementWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ExerciseOfLoanAndSecurityAgreementWarrants" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CapitalizationOfDeferredCostsToEquityUponShareIssuance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="SettlementOfTheFirstTrancheOfForwardContract" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_SettlementOfTheFirstTrancheOfForwardContract" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="InitialFairValueOfEarnoutLiabilityAcquiredInMergera" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="RightOfUseAssetsRecordedOnAdoptionOfAsu201602" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SupplementalFinancialStatementInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SupplementalFinancialStatementInformationAbstract" substitutionGroup="xbrli:item" />
<element name="SupplementalFinancialStatementInformationTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_SupplementalFinancialStatementInformationTextBlock" substitutionGroup="xbrli:item" />
<element name="RedeemableConvertiblePreferredStockTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_RedeemableConvertiblePreferredStockTextBlock" substitutionGroup="xbrli:item" />
<element name="CommonStockTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockTextBlock" substitutionGroup="xbrli:item" />
<element name="WarrantsTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_WarrantsTextBlock" substitutionGroup="xbrli:item" />
<element name="ForwardWarrantAgreementDisclosure" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ForwardWarrantAgreementDisclosure" substitutionGroup="xbrli:item" />
<element name="SalesAndMarketingPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_SalesAndMarketingPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="CostsOfObtainingAndFulfillingContractsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="DeferredOfferingCostsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DeferredOfferingCostsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="PublicAndPrivateWarrantsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PublicAndPrivateWarrantsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="CapitalizedSoftwarePolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CapitalizedSoftwarePolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="DeferredFinancingCostsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DeferredFinancingCostsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="EmergingGrowthCompanyPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_EmergingGrowthCompanyPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" substitutionGroup="xbrli:item" />
<element name="ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" substitutionGroup="xbrli:item" />
<element name="ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfVestingStatusOfWarrantsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" substitutionGroup="xbrli:item" />
<element name="PrivateWarrantMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_PrivateWarrantMember" substitutionGroup="xbrli:item" />
<element name="FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" substitutionGroup="xbrli:item" />
<element name="DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" substitutionGroup="xbrli:item" />
<element name="EventAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_EventAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="EventDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_EventDomain" substitutionGroup="xbrli:item" />
<element name="ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" substitutionGroup="xbrli:item" />
<element name="TrancheAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TrancheAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="TrancheDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TrancheDomain" substitutionGroup="xbrli:item" />
<element name="AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_AgreementAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="AgreementDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_AgreementDomain" substitutionGroup="xbrli:item" />
<element name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SummaryOfSignificantAccountingPoliciesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SummaryOfSignificantAccountingPoliciesLineItems" substitutionGroup="xbrli:item" />
<element name="PeriodOfEarnoutShares" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PeriodOfEarnoutShares" substitutionGroup="xbrli:item" />
<element name="OfferingCostsIncurred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_OfferingCostsIncurred" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncreaseDecreaseInDeferredRent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_IncreaseDecreaseInDeferredRent" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="RigettiComputingIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RigettiComputingIncMember" substitutionGroup="xbrli:item" />
<element name="NumberOfCustomersAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_NumberOfCustomersAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="NumberOfCustomersDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_NumberOfCustomersDomain" substitutionGroup="xbrli:item" />
<element name="CriteriaAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CriteriaAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="CriteriaDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CriteriaDomain" substitutionGroup="xbrli:item" />
<element name="ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" substitutionGroup="xbrli:item" />
<element name="SponsorMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SponsorMember" substitutionGroup="xbrli:item" />
<element name="PublicWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_PublicWarrantsMember" substitutionGroup="xbrli:item" />
<element name="PrivatePlacementWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_PrivatePlacementWarrantsMember" substitutionGroup="xbrli:item" />
<element name="ConditionAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ConditionAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="ConditionDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ConditionDomain" substitutionGroup="xbrli:item" />
<element name="RGTIAgreementNameAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RGTIAgreementNameAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="RgtiAgreementNameDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RgtiAgreementNameDomain" substitutionGroup="xbrli:item" />
<element name="RGTICommonStockPurchaseAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RGTICommonStockPurchaseAgreementMember" substitutionGroup="xbrli:item" />
<element name="TwoThousandThirteenEquityIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TwoThousandThirteenEquityIncentivePlanMember" substitutionGroup="xbrli:item" />
<element name="GovernmentEntitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_GovernmentEntitiesMember" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="SimulatedTradingDaysMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SimulatedTradingDaysMember" substitutionGroup="xbrli:item" />
<element name="EstimatedPeriodOfExpirationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_EstimatedPeriodOfExpirationMember" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" substitutionGroup="xbrli:item" />
<element name="ScheduleOfTransitionPeriodComparativeDataTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ScheduleOfTransitionPeriodComparativeDataTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="CustomerDMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CustomerDMember" substitutionGroup="xbrli:item" />
<element name="CustomerCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CustomerCMember" substitutionGroup="xbrli:item" />
<element name="CustomerEMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CustomerEMember" substitutionGroup="xbrli:item" />
<element name="CustomerFMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CustomerFMember" substitutionGroup="xbrli:item" />
<element name="CustomerAMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CustomerAMember" substitutionGroup="xbrli:item" />
<element name="CustomerBMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CustomerBMember" substitutionGroup="xbrli:item" />
<element name="ScheduleOfTransitionPeriodComparativeDataLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" substitutionGroup="xbrli:item" />
<element name="DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" substitutionGroup="xbrli:item" />
<element name="AggregateTransactionCostsPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_AggregateTransactionCostsPaid" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CashReceivedFromPrivateInvestmentInPublicEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CashReceivedFromPrivateInvestmentInPublicEquity" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CashReceivedFromTrustNetOfRedemptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CashReceivedFromTrustNetOfRedemptions" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PaymentOfTransactionCostsThroughCash" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PaymentOfTransactionCostsThroughCash" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" substitutionGroup="xbrli:item" />
<element name="StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesIssuedInTheNewCompany" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockSharesIssuedInTheNewCompany" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" substitutionGroup="xbrli:item" />
<element name="RedemptionOfCommonStockSharesOfThePredecessorCompany" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesNewlyIssuedInThePredecessorCompany" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" substitutionGroup="xbrli:item" />
<element name="StatusOfSharesOutstandingBeforeBusinessCombinationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" substitutionGroup="xbrli:item" />
<element name="SeriesCOneRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="SeriesCRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SeriesCRedeemableConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesExchangeRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_CommonStockSharesExchangeRatio" substitutionGroup="xbrli:item" />
<element name="ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" substitutionGroup="xbrli:item" />
<element name="PromoteSponsorVestingSharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_PromoteSponsorVestingSharesMember" substitutionGroup="xbrli:item" />
<element name="SponsorRedemptionBasedVestingSharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SponsorRedemptionBasedVestingSharesMember" substitutionGroup="xbrli:item" />
<element name="CommonStockNumberOfVotesPerShare" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_CommonStockNumberOfVotesPerShare" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesIssuedAsAResultOfExchange" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_CommonStockSharesIssuedAsAResultOfExchange" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" substitutionGroup="xbrli:item" />
<element name="VolumeWeightedAveragePricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_VolumeWeightedAveragePricePerShare" substitutionGroup="xbrli:item" />
<element name="NumberOfTradingDaysForDeterminingTheSharePrice" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_NumberOfTradingDaysForDeterminingTheSharePrice" substitutionGroup="xbrli:item" />
<element name="SharesSubjectToVestingMaximumPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_SharesSubjectToVestingMaximumPeriod" substitutionGroup="xbrli:item" />
<element name="SharesSubjectToVestingBasedOnCertainConditions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_SharesSubjectToVestingBasedOnCertainConditions" substitutionGroup="xbrli:item" />
<element name="NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" substitutionGroup="xbrli:item" />
<element name="OneTimeBonus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_OneTimeBonus" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" substitutionGroup="xbrli:item" />
<element name="SponsorAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SponsorAgreementMember" substitutionGroup="xbrli:item" />
<element name="InitialSubscriptionAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_InitialSubscriptionAgreementMember" substitutionGroup="xbrli:item" />
<element name="SubsequentSubscriptionAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SubsequentSubscriptionAgreementMember" substitutionGroup="xbrli:item" />
<element name="TrancheOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TrancheOneMember" substitutionGroup="xbrli:item" />
<element name="TrancheTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TrancheTwoMember" substitutionGroup="xbrli:item" />
<element name="SupernovaAcquistionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SupernovaAcquistionMember" substitutionGroup="xbrli:item" />
<element name="InvestorAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_InvestorAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="InvestorDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_InvestorDomain" substitutionGroup="xbrli:item" />
<element name="PrivateInvestmentInPublicEquityInvestorsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_PrivateInvestmentInPublicEquityInvestorsMember" substitutionGroup="xbrli:item" />
<element name="DebtSecuritiesAvailableForSaleMaturityYear" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DebtSecuritiesAvailableForSaleMaturityYear" substitutionGroup="xbrli:item" />
<element name="RevenuePerformanceObligationTransactionPriceAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RevenuePerformanceObligationTransactionPriceAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="RevenuePerformanceObligationTransactionPriceDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RevenuePerformanceObligationTransactionPriceDomain" substitutionGroup="xbrli:item" />
<element name="RemainderoftwothousandandtwentythreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RemainderoftwothousandandtwentythreeMember" substitutionGroup="xbrli:item" />
<element name="TwothousandandtwentyfourMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TwothousandandtwentyfourMember" substitutionGroup="xbrli:item" />
<element name="AccessToQuantumComputingSystemsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_AccessToQuantumComputingSystemsMember" substitutionGroup="xbrli:item" />
<element name="CollaborativeResearchAndOtherProfessionalServicesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CollaborativeResearchAndOtherProfessionalServicesMember" substitutionGroup="xbrli:item" />
<element name="RecognitionOfDeferredRevenues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_RecognitionOfDeferredRevenues" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DeferralOfRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_DeferralOfRevenue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="FurnitureAndOtherAssetsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_FurnitureAndOtherAssetsMember" substitutionGroup="xbrli:item" />
<element name="ItHardwareMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ItHardwareMember" substitutionGroup="xbrli:item" />
<element name="QuantumComputingFridgesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_QuantumComputingFridgesMember" substitutionGroup="xbrli:item" />
<element name="ProcessEquipmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ProcessEquipmentMember" substitutionGroup="xbrli:item" />
<element name="AccruedDeferredOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_AccruedDeferredOfferingCosts" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AccruedPropertyAndOtherTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_AccruedPropertyAndOtherTaxes" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AccruedSubcontractorCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_AccruedSubcontractorCost" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AccruedPropertyPlantAndEquipmentCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_AccruedPropertyPlantAndEquipmentCost" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PercentageOfTotalGrossPropertyAndEquipment" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_PercentageOfTotalGrossPropertyAndEquipment" substitutionGroup="xbrli:item" />
<element name="OperatingLeaseRentExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_OperatingLeaseRentExpenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="RigettiHoldingsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RigettiHoldingsMember" substitutionGroup="xbrli:item" />
<element name="CurrentPortionOfOutstandingPrincipalAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_CurrentPortionOfOutstandingPrincipalAmount" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="AccruedFinalPaymentFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_AccruedFinalPaymentFee" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CurrentPortionOfLongTermDebtGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_CurrentPortionOfLongTermDebtGross" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TrancheAMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TrancheAMember" substitutionGroup="xbrli:item" />
<element name="TrancheBMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TrancheBMember" substitutionGroup="xbrli:item" />
<element name="TrancheCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TrancheCMember" substitutionGroup="xbrli:item" />
<element name="LoanAndSecurityAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_LoanAndSecurityAgreementMember" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentPaymentFeepercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_DebtInstrumentPaymentFeepercentage" substitutionGroup="xbrli:item" />
<element name="WithdrawnCreditFacility" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_WithdrawnCreditFacility" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PercentageOfadvancedFundsUnderTheAmendment" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PercentageOfadvancedFundsUnderTheAmendment" substitutionGroup="xbrli:item" />
<element name="PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" substitutionGroup="xbrli:item" />
<element name="InvestorNameAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_InvestorNameAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="InvestorNameDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_InvestorNameDomain" substitutionGroup="xbrli:item" />
<element name="VentureCapitalMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_VentureCapitalMember" substitutionGroup="xbrli:item" />
<element name="CommonStockWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockWarrantsMember" substitutionGroup="xbrli:item" />
<element name="SeriesCOnePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SeriesCOnePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="EquityAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_EquityAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="EquityDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_EquityDomain" substitutionGroup="xbrli:item" />
<element name="PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" substitutionGroup="xbrli:item" />
<element name="PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" substitutionGroup="xbrli:item" />
<element name="AgreementNameAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_AgreementNameAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="AgreementNameDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_AgreementNameDomain" substitutionGroup="xbrli:item" />
<element name="CommonStockPurchaseAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CommonStockPurchaseAgreementMember" substitutionGroup="xbrli:item" />
<element name="WarrantsToPurchaseClassACommonStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_WarrantsToPurchaseClassACommonStockMember" substitutionGroup="xbrli:item" />
<element name="CustomerWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CustomerWarrantsMember" substitutionGroup="xbrli:item" />
<element name="TrinityWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TrinityWarrantsMember" substitutionGroup="xbrli:item" />
<element name="ClassOfInvestorsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ClassOfInvestorsAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="ClassOfInvestorsDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ClassOfInvestorsDomain" substitutionGroup="xbrli:item" />
<element name="Classofwarrantsorrightswarrantsissuedduringtheperiodunits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" substitutionGroup="xbrli:item" />
<element name="Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" substitutionGroup="xbrli:item" />
<element name="Classofwarrantsvestingpercentage" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_Classofwarrantsvestingpercentage" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightGrandDateFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_ClassOfWarrantOrRightGrandDateFairValue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="Classofwarrantorrightissuedduringperiodwarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_Classofwarrantorrightissuedduringperiodwarrants" substitutionGroup="xbrli:item" />
<element name="AtinitialrecognitionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_AtinitialrecognitionMember" substitutionGroup="xbrli:item" />
<element name="DisclosureofvestingstatusofwarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureofvestingstatusofwarrantsAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfVestingStatusOfWarrantsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureOfVestingStatusOfWarrantsTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="StatusOfVestingAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_StatusOfVestingAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="StatusOfVestingDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_StatusOfVestingDomain" substitutionGroup="xbrli:item" />
<element name="VestedCustomerWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_VestedCustomerWarrantsMember" substitutionGroup="xbrli:item" />
<element name="UnvestedCustomerWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_UnvestedCustomerWarrantsMember" substitutionGroup="xbrli:item" />
<element name="DisclosureofvestingstatusofwarrantsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DisclosureofvestingstatusofwarrantsLineItems" substitutionGroup="xbrli:item" />
<element name="StockIssuedDuringPeriodWarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_StockIssuedDuringPeriodWarrantsIssued" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" substitutionGroup="xbrli:item" />
<element name="RigettiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RigettiMember" substitutionGroup="xbrli:item" />
<element name="ForwardWarrantAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ForwardWarrantAgreementMember" substitutionGroup="xbrli:item" />
<element name="AmpereComputingLlcMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_AmpereComputingLlcMember" substitutionGroup="xbrli:item" />
<element name="MeasurementInputProbabilityOfOccurringTheContingencyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" substitutionGroup="xbrli:item" />
<element name="ContingentEarnOutLiabilityFairValueDisclosure" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_ContingentEarnOutLiabilityFairValueDisclosure" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ForwardWarrantAgreementFairValueDisclosure" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_ForwardWarrantAgreementFairValueDisclosure" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ContingentEarnOutLiabilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ContingentEarnOutLiabilityMember" substitutionGroup="xbrli:item" />
<element name="ForwardWarrantAgreementLiabilityFairValueDisclosureMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" substitutionGroup="xbrli:item" />
<element name="DerivativeWarrantLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_DerivativeWarrantLiabilitiesMember" substitutionGroup="xbrli:item" />
<element name="ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" substitutionGroup="xbrli:item" />
<element name="RestrictedStockUnitsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_RestrictedStockUnitsTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" substitutionGroup="xbrli:item" />
<element name="TimeBasedVestingAwardMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TimeBasedVestingAwardMember" substitutionGroup="xbrli:item" />
<element name="MarketBasedVestingAwardMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_MarketBasedVestingAwardMember" substitutionGroup="xbrli:item" />
<element name="StockOptionCommonShareExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_StockOptionCommonShareExercisePrice" substitutionGroup="xbrli:item" />
<element name="PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" substitutionGroup="xbrli:item" />
<element name="TwoThousandTwentyTwoEquityIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" substitutionGroup="xbrli:item" />
<element name="CeoAwardMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CeoAwardMember" substitutionGroup="xbrli:item" />
<element name="NetIncomeLossRelationToCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_NetIncomeLossRelationToCommonStock" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ConvertibleSeriesCPreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ConvertibleSeriesCPreferredStockMember" substitutionGroup="xbrli:item" />
<element name="ConvertibleSeriesC1PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_ConvertibleSeriesC1PreferredStockMember" substitutionGroup="xbrli:item" />
<element name="DeferredTaxLiabilitiesDepreciationAndAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxLiabilitiesRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_DeferredTaxLiabilitiesRightOfUseAssets" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetsRightOfUseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="rgti_DeferredTaxAssetsRightOfUseLiabilities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="EffectiveIncomeTaxRateReconciliationTransactionCosts" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" substitutionGroup="xbrli:item" />
<element name="EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" substitutionGroup="xbrli:item" />
<element name="EffectiveIncomeTaxRateReconciliationGoodwillImpairment" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" substitutionGroup="xbrli:item" />
<element name="PeriodAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_PeriodAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="PeriodDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_PeriodDomain" substitutionGroup="xbrli:item" />
<element name="CurrentYearMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_CurrentYearMember" substitutionGroup="xbrli:item" />
<element name="PreviousYearMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_PreviousYearMember" substitutionGroup="xbrli:item" />
<element name="SummaryOfIncomeTaxesInformationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SummaryOfIncomeTaxesInformationTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="SummaryOfIncomeTaxesInformationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_SummaryOfIncomeTaxesInformationLineItems" substitutionGroup="xbrli:item" />
<element name="NumberOfEmployees" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_NumberOfEmployees" substitutionGroup="xbrli:item" />
<element name="PercentageOfReductionInEmployees" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="rgti_PercentageOfReductionInEmployees" substitutionGroup="xbrli:item" />
<element name="WeightedAverageSharePriceAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_WeightedAverageSharePriceAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="WeightedAverageSharePriceDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="rgti_WeightedAverageSharePriceDomain" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>rgti-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 05-April-2023 [05:05:55] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.rigetti.com/role/ConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfOperations" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfComprehensiveLoss" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail" roleURI="http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail" roleURI="http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtLongTermDebtAndTheUnamortizedDiscountDetail" roleURI="http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail" />
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" xlink:label="loc_RGTI_EffectiveIncomeTaxRateReconciliationTransactionCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_RGTI_EffectiveIncomeTaxRateReconciliationTransactionCosts" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" xlink:label="loc_RGTI_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_RGTI_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" xlink:label="loc_RGTI_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_RGTI_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" use="optional" order="8" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCurrent" xlink:label="loc_us-gaap_DeferredCostsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_DeferredCostsCurrent" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardContractAssetsCurrent" xlink:label="loc_RGTI_ForwardContractAssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_RGTI_ForwardContractAssetsCurrent" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_RestrictedCash" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OtherAssets" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_Goodwill" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset" use="optional" order="12" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValueOutstanding" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DeferredRevenue" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DebtCurrent" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardContractLiabilities" xlink:label="loc_RGTI_ForwardContractLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_RGTI_ForwardContractLiabilities" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" order="26" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent" use="optional" order="27" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaap_OtherLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_OtherLiabilities" use="optional" order="28" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" use="optional" order="29" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtNetOfCurrentPortion" xlink:label="loc_RGTI_DebtNetOfCurrentPortion" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_RGTI_DebtNetOfCurrentPortion" use="optional" order="30" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" order="31" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_CommitmentsAndContingencies" use="optional" order="32" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValue" use="optional" order="33" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_GrossProfit" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_CostOfRevenue" use="optional" order="3" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" use="optional" order="4" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_SellingAndMarketingExpense" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_GoodwillImpairmentLoss" use="optional" order="8" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit" use="optional" order="10" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" use="optional" order="11" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" use="optional" order="12" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TransactionCosts" xlink:label="loc_RGTI_TransactionCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_RGTI_TransactionCosts" use="optional" order="13" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InterestExpense" use="optional" order="14" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InvestmentIncomeInterest" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_OtherIncome" use="optional" order="16" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_NetIncomeLoss" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" use="optional" order="3" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="2" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" use="optional" order="3" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable" use="optional" order="6" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromNotesPayable" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts" use="optional" order="8" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfDeferredOfferingCosts" xlink:label="loc_RGTI_PaymentOfDeferredOfferingCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RGTI_PaymentOfDeferredOfferingCosts" use="optional" order="9" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_RGTI_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RGTI_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TransactionCostsPaid" xlink:label="loc_RGTI_TransactionCostsPaid" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RGTI_TransactionCostsPaid" use="optional" order="11" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfLoanAndSecurityAgreementExitFees" xlink:label="loc_RGTI_PaymentOfLoanAndSecurityAgreementExitFees" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RGTI_PaymentOfLoanAndSecurityAgreementExitFees" use="optional" order="12" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" xlink:label="loc_RGTI_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_RGTI_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_Depreciation" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ShareBasedCompensation" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ChangeInFairValueOfForwardContract" xlink:label="loc_RGTI_ChangeInFairValueOfForwardContract" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RGTI_ChangeInFairValueOfForwardContract" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AmortizationOfDebtCommitmentFeeAsset" xlink:label="loc_RGTI_AmortizationOfDebtCommitmentFeeAsset" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RGTI_AmortizationOfDebtCommitmentFeeAsset" use="optional" order="21" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccretionOfDebtEndOfTermLiabilities" xlink:label="loc_RGTI_AccretionOfDebtEndOfTermLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RGTI_AccretionOfDebtEndOfTermLiabilities" use="optional" order="22" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" use="optional" order="24" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" order="26" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" use="optional" order="27" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" use="optional" order="28" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" use="optional" order="29" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_RGTI_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RGTI_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" use="optional" order="30" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NonCashLeaseExpense" xlink:label="loc_RGTI_NonCashLeaseExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_RGTI_NonCashLeaseExpense" use="optional" order="31" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GoodwillImpairmentLoss" use="optional" order="32" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" use="optional" order="33" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaap_LoansPayableCurrent" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentPortionOfOutstandingPrincipalAmount" xlink:label="loc_RGTI_CurrentPortionOfOutstandingPrincipalAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LoansPayableCurrent" xlink:to="loc_RGTI_CurrentPortionOfOutstandingPrincipalAmount" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LoansPayableCurrent" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" use="optional" order="2" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaap_LongTermLoansPayable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedFinalPaymentFee" xlink:label="loc_RGTI_AccruedFinalPaymentFee" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="loc_RGTI_AccruedFinalPaymentFee" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="loc_us-gaap_DeferredFinanceCostsNet" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentPortionOfLongTermDebtGross" xlink:label="loc_RGTI_CurrentPortionOfLongTermDebtGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="loc_RGTI_CurrentPortionOfLongTermDebtGross" use="optional" order="6" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" use="optional" order="6" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" order="8" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities" use="optional" order="1" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="loc_RGTI_DeferredTaxLiabilitiesDepreciationAndAmortization" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_RGTI_DeferredTaxLiabilitiesDepreciationAndAmortization" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="loc_RGTI_DeferredTaxLiabilitiesRightOfUseAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_RGTI_DeferredTaxLiabilitiesRightOfUseAssets" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredTaxAssetsGross" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredTaxAssetsNet" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance" use="optional" order="11" weight="-1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="loc_RGTI_DeferredTaxAssetsRightOfUseLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="loc_RGTI_DeferredTaxAssetsRightOfUseLiabilities" use="optional" order="12" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_RGTI_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CashReceivedFromTrustNetOfRedemptions" xlink:label="loc_RGTI_CashReceivedFromTrustNetOfRedemptions" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_RGTI_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:to="loc_RGTI_CashReceivedFromTrustNetOfRedemptions" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CashReceivedFromPrivateInvestmentInPublicEquity" xlink:label="loc_RGTI_CashReceivedFromPrivateInvestmentInPublicEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_RGTI_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:to="loc_RGTI_CashReceivedFromPrivateInvestmentInPublicEquity" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="loc_us-gaap_Cash" use="optional" order="3" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" use="optional" order="5" weight="1" />
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>rgti-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 05-April-2023 [05:05:55] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CoverPage" roleURI="http://www.rigetti.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.rigetti.com/role/ConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfOperations" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfComprehensiveLoss" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DescriptionOfBusiness" roleURI="http://www.rigetti.com/role/DescriptionOfBusiness" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognition" roleURI="http://www.rigetti.com/role/RevenueRecognition" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformation" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformation" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Debt" roleURI="http://www.rigetti.com/role/Debt" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RedeemableConvertiblePreferredStock" roleURI="http://www.rigetti.com/role/RedeemableConvertiblePreferredStock" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommonStock" roleURI="http://www.rigetti.com/role/CommonStock" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Warrants" roleURI="http://www.rigetti.com/role/Warrants" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ForwardWarrantAgreement" roleURI="http://www.rigetti.com/role/ForwardWarrantAgreement" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#FairValueMeasurements" roleURI="http://www.rigetti.com/role/FairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShare" roleURI="http://www.rigetti.com/role/NetLossPerShare" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxes" roleURI="http://www.rigetti.com/role/IncomeTaxes" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Segments" roleURI="http://www.rigetti.com/role/Segments" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionTables" roleURI="http://www.rigetti.com/role/RevenueRecognitionTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformationTables" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommonStockTables" roleURI="http://www.rigetti.com/role/CommonStockTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsTables" roleURI="http://www.rigetti.com/role/WarrantsTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ForwardWarrantAgreementTables" roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#FairValueMeasurementsTables" roleURI="http://www.rigetti.com/role/FairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansTables" roleURI="http://www.rigetti.com/role/EquityPlansTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareTables" roleURI="http://www.rigetti.com/role/NetLossPerShareTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesTables" roleURI="http://www.rigetti.com/role/IncomeTaxesTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SegmentsTables" roleURI="http://www.rigetti.com/role/SegmentsTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DescriptionOfBusinessAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail" roleURI="http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#InvestmentsAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail" roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail" roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail" roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformationAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail" roleURI="http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail" roleURI="http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtLongTermDebtAndTheUnamortizedDiscountDetail" roleURI="http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/DebtAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RedeemableConvertiblePreferredStockAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommonStockSummaryOfConversionsOfStockDetail" roleURI="http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommonStockAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/CommonStockAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/WarrantsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail" roleURI="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail" roleURI="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail" roleURI="http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ForwardWarrantAgreementAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail" roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" roleURI="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail" roleURI="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail" roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail" roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail" roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail" roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail" roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SegmentsSummaryOfRevenueByGeographyDetail" roleURI="http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SubsequentEventsAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SubsequentEvents" roleURI="http://www.rigetti.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtTables" roleURI="http://www.rigetti.com/role/DebtTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlans" roleURI="http://www.rigetti.com/role/EquityPlans" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombination" roleURI="http://www.rigetti.com/role/BusinessCombination" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationTables" roleURI="http://www.rigetti.com/role/BusinessCombinationTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommitmentsAndContingencies" roleURI="http://www.rigetti.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Investments" roleURI="http://www.rigetti.com/role/Investments" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#InvestmentsTables" roleURI="http://www.rigetti.com/role/InvestmentsTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#GoodwillSummaryOfScheduleOfGoodwillDetail" roleURI="http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesTables" roleURI="http://www.rigetti.com/role/LeasesTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/LeasesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail" roleURI="http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesSummaryOfComponentsOfLeaseCostsDetail" roleURI="http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Leases" roleURI="http://www.rigetti.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#GoodwillAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/GoodwillAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#GoodwillTables" roleURI="http://www.rigetti.com/role/GoodwillTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Goodwill" roleURI="http://www.rigetti.com/role/Goodwill" />
<roleRef xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm" roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_1423368" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_1423251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_CityAreaCode_1423251" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_1323693" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_AmendmentFlag_1323693" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1323696" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityRegistrantName_1323696" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_1323698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityCentralIndexKey_1323698" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_1323692" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_DocumentType_1323692" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1423363" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_DocumentInformationTable_1423363" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1423364" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_1423363" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1423364" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423365" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423364" xlink:to="loc_us-gaap_ClassOfStockDomain_1423365" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423365_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423364" xlink:to="loc_us-gaap_ClassOfStockDomain_1423365_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423442" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_1423363" xlink:to="loc_dei_LegalEntityAxis_1423442" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423445" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423442" xlink:to="loc_dei_EntityDomain_1423445" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423445_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423442" xlink:to="loc_dei_EntityDomain_1423445_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_2146632636" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_1423363" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_2146632636" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_2146632635" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_2146632636" xlink:to="loc_dei_AddressTypeDomain_2146632635" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_2146632635_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_2146632636" xlink:to="loc_dei_AddressTypeDomain_2146632635_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_2146632634" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_2146632635" xlink:to="loc_dei_BusinessContactMember_2146632634" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_1423252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_LocalPhoneNumber_1423252" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1423371" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1423371" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_1423370" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityTaxIdentificationNumber_1423370" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_1423376" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityAddressPostalZipCode_1423376" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_1423377" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityAddressAddressLine1_1423377" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_1423378" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityAddressCityOrTown_1423378" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_1423379" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityAddressStateOrProvince_1423379" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber_2146632637" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityPrimarySicNumber_2146632637" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_2146632633" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_ContactPersonnelName_2146632633" use="optional" order="25" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_136" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_136" xlink:to="loc_us-gaap_AssetsAbstract_137" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_AssetsCurrentAbstract_138" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCurrent" xlink:label="loc_us-gaap_DeferredCostsCurrent_1335848" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_DeferredCostsCurrent_1335848" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1329019" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1329019" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardContractAssetsCurrent" xlink:label="loc_rgti_ForwardContractAssetsCurrent_1423382" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_rgti_ForwardContractAssetsCurrent_1423382" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1329018" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1329018" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_146" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_AssetsCurrent_146" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_1701613" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_1701613" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1701611" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1701611" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_1329021" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_RestrictedCash_1329021" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_150" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_Assets_150" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1329020" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1329020" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2146632823" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2146632823" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_1329023" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_Goodwill_1329023" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets_1329022" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_OtherAssets_1329022" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_136" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_140" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1329024" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1329024" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_1329027" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_DebtCurrent_1329027" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_151" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_AccountsPayableCurrent_151" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue_1329026" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_DeferredRevenue_1329026" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2146632822" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2146632822" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardContractLiabilities" xlink:label="loc_rgti_ForwardContractLiabilities_1423383" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_rgti_ForwardContractLiabilities_1423383" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtNetOfCurrentPortion" xlink:label="loc_rgti_DebtNetOfCurrentPortion_1329028" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_rgti_DebtNetOfCurrentPortion_1329028" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaap_OtherLiabilities_1329030" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_OtherLiabilities_1329030" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_164" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_156" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_Liabilities_156" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_StockholdersEquityAbstract_141" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_163" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_StockholdersEquity_163" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_162" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_161" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_161" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_160" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_CommonStockValue_160" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1329033" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1329033" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_1423430" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_1423430" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1423425" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1423425" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_LiabilitiesCurrent_153" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2146632821" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2146632821" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_155" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_157" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_CommitmentsAndContingencies_157" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_159" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_PreferredStockValue_159" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_136" xlink:to="loc_us-gaap_StatementTable_133" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329072" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_133" xlink:to="loc_dei_LegalEntityAxis_1329072" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329073" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329072" xlink:to="loc_dei_EntityDomain_1329073" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329073_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329072" xlink:to="loc_dei_EntityDomain_1329073_default" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_133" xlink:to="loc_us-gaap_StatementClassOfStockAxis_134" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_134" xlink:to="loc_us-gaap_ClassOfStockDomain_135" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_135_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_134" xlink:to="loc_us-gaap_ClassOfStockDomain_135_default" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329032" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_135" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329032" use="optional" order="48" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_191" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_202" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_202" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_197" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_197" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_198" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_188" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_StatementTable_188" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_189" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_188" xlink:to="loc_us-gaap_StatementClassOfStockAxis_189" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_189" xlink:to="loc_us-gaap_ClassOfStockDomain_190" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_190_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_189" xlink:to="loc_us-gaap_ClassOfStockDomain_190_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329063" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_190" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329063" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329065" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_188" xlink:to="loc_dei_LegalEntityAxis_1329065" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329067" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329065" xlink:to="loc_dei_EntityDomain_1329067" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329067_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329065" xlink:to="loc_dei_EntityDomain_1329067_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_201" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_201" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_199" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_PreferredStockSharesIssued_199" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_200" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_200" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_205" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_CommonStockSharesIssued_205" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_206" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_206" use="optional" order="16" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_233" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_246" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_EarningsPerShareDiluted_248" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1329107" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1329107" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_1329113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1329107" xlink:to="loc_us-gaap_SellingAndMarketingExpense_1329113" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_237" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1329107" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_237" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2146632820" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1329107" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2146632820" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1329109" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1329107" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1329109" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1423459" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1423459" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TransactionCosts" xlink:label="loc_rgti_TransactionCosts_1423460" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_rgti_TransactionCosts_1423460" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1329122" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1329122" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_239" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_239" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_1329119" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_InterestExpense_1329119" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome_1329126" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_OtherIncome_1329126" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1329131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1329131" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_245" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1329134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1329134" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_NetIncomeLoss_242" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1329136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1329136" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_StatementTable_230" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_231" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_230" xlink:to="loc_us-gaap_StatementClassOfStockAxis_231" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_231" xlink:to="loc_us-gaap_ClassOfStockDomain_232" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_232_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_231" xlink:to="loc_us-gaap_ClassOfStockDomain_232_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_230" xlink:to="loc_dei_LegalEntityAxis_1329141" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329141" xlink:to="loc_dei_EntityDomain_1329142" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329142_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329141" xlink:to="loc_dei_EntityDomain_1329142_default" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_1329116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_OperatingExpenses_1329116" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_1329101" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_CostOfRevenue_1329101" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1329098" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1329098" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_OperatingIncomeLoss_238" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_EarningsPerShareBasic_247" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1329105" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_GrossProfit_1329105" use="optional" order="32" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1329165" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1329172" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1329165" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1329172" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1329167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1329165" xlink:to="loc_us-gaap_NetIncomeLoss_1329167" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1329164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1329165" xlink:to="loc_us-gaap_StatementTable_1329164" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329179" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1329164" xlink:to="loc_dei_LegalEntityAxis_1329179" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329180" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329179" xlink:to="loc_dei_EntityDomain_1329180" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329180_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329179" xlink:to="loc_dei_EntityDomain_1329180_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1329168" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1329165" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1329168" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1701644" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1329168" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1701644" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1329171" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1329168" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1329171" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_278" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_273" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StatementTable_273" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_274" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_274" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_274" xlink:to="loc_us-gaap_EquityComponentDomain_275" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_275_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_274" xlink:to="loc_us-gaap_EquityComponentDomain_275_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_279" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_CommonStockMember_279" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_280" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_281" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_RetainedEarningsMember_281" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1329198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1329198" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_1426616" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_PreferredStockMember_1426616" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_us-gaap_StatementClassOfStockAxis_276" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_276" xlink:to="loc_us-gaap_ClassOfStockDomain_277" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_277_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_276" xlink:to="loc_us-gaap_ClassOfStockDomain_277_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_277" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329194" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1423466" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_srt_RestatementAxis_1423466" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1423467" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_1423466" xlink:to="loc_srt_RestatementDomain_1423467" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1423467_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_1423466" xlink:to="loc_srt_RestatementDomain_1423467_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_290" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_NetIncomeLoss_290" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_285" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_SharesOutstanding_285" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockholdersEquity_284" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1333716" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1333716" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1333717" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1333717" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" xlink:label="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue_1423474" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue_1423474" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xlink:label="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares_1569160" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares_1569160" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xlink:label="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants_1569173" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants_1569173" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1333709" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1333709" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" xlink:label="loc_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares_1701947" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares_1701947" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ReclassificationOfTemporaryEquityShares" xlink:label="loc_rgti_ReclassificationOfTemporaryEquityShares_1423471" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_ReclassificationOfTemporaryEquityShares_1423471" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1569176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1569176" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" xlink:label="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares_1423475" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares_1423475" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" xlink:label="loc_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants_1569152" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants_1569152" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" xlink:label="loc_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract_1569174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract_1569174" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1569135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1569135" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_1329245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_1329245" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1336565" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1336565" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1569131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1569131" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" xlink:label="loc_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities_2146632805" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities_2146632805" use="optional" order="36" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334717" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_331" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_331" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_1332811" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_331" xlink:to="loc_us-gaap_InterestPaidNet_1332811" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_1332526" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_1332526" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AmortizationOfDebtCommitmentFeeAsset" xlink:label="loc_rgti_AmortizationOfDebtCommitmentFeeAsset_1332555" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_rgti_AmortizationOfDebtCommitmentFeeAsset_1332555" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ChangeInFairValueOfForwardContract" xlink:label="loc_rgti_ChangeInFairValueOfForwardContract_1332509" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_rgti_ChangeInFairValueOfForwardContract_1332509" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_1332435" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_Depreciation_1332435" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccretionOfDebtEndOfTermLiabilities" xlink:label="loc_rgti_AccretionOfDebtEndOfTermLiabilities_1332559" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_rgti_AccretionOfDebtEndOfTermLiabilities_1332559" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_1332484" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_1332484" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1332445" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_ShareBasedCompensation_1332445" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2146632794" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2146632794" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1710893" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1710893" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1423480" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1423480" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NonCashLeaseExpense" xlink:label="loc_rgti_NonCashLeaseExpense_2146632803" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_rgti_NonCashLeaseExpense_2146632803" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_1424488" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_1424488" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_337" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_337" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_1332579" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_1332579" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1332563" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1332563" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_336" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_336" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1332594" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1332594" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1332584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1332584" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_332" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" xlink:to="loc_us-gaap_ProfitLoss_332" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_339" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_339" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_341" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_341" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1332646" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1332646" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1701646" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1701646" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_349" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_349" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1332568" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_StatementTable_1332568" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1332569" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1332568" xlink:to="loc_dei_LegalEntityAxis_1332569" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1332570" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1332569" xlink:to="loc_dei_EntityDomain_1332570" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1332570_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1332569" xlink:to="loc_dei_EntityDomain_1332570_default" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_1332768" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_1332768" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfDeferredOfferingCosts" xlink:label="loc_rgti_PaymentOfDeferredOfferingCosts_1332777" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_PaymentOfDeferredOfferingCosts_1332777" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_347" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_347" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_1332772" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_1332772" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_343" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_343" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423483" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423483" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TransactionCostsPaid" xlink:label="loc_rgti_TransactionCostsPaid_1423484" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_TransactionCostsPaid_1423484" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfLoanAndSecurityAgreementExitFees" xlink:label="loc_rgti_PaymentOfLoanAndSecurityAgreementExitFees_1423485" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_PaymentOfLoanAndSecurityAgreementExitFees_1423485" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" xlink:label="loc_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants_1423486" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants_1423486" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." xlink:label="loc_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability._1332857" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability._1332857" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ExerciseOfLoanAndSecurityAgreementWarrants" xlink:label="loc_rgti_ExerciseOfLoanAndSecurityAgreementWarrants_1569178" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_ExerciseOfLoanAndSecurityAgreementWarrants_1569178" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xlink:label="loc_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses_1332842" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses_1332842" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_1701647" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_1701647" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" xlink:label="loc_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance_1569181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance_1569181" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1569182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1569182" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SettlementOfTheFirstTrancheOfForwardContract" xlink:label="loc_rgti_SettlementOfTheFirstTrancheOfForwardContract_1569180" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_SettlementOfTheFirstTrancheOfForwardContract_1569180" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" xlink:label="loc_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera_2146632680" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera_2146632680" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" xlink:label="loc_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger_2146632679" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger_2146632679" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" xlink:label="loc_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602_2146632798" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602_2146632798" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" xlink:label="loc_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602_2146632797" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602_2146632797" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xlink:label="loc_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets_2146632796" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets_2146632796" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" xlink:label="loc_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense_2146632795" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense_2146632795" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_348" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_348" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1332805" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1332805" use="optional" order="60" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DescriptionOfBusiness">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334423" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334420" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334423" xlink:to="loc_us-gaap_StatementTable_1334420" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334421" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334420" xlink:to="loc_dei_LegalEntityAxis_1334421" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334422" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334421" xlink:to="loc_dei_EntityDomain_1334422" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334422_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334421" xlink:to="loc_dei_EntityDomain_1334422_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_360" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334423" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_360" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334433" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_366" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334433" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_366" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334430" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334433" xlink:to="loc_us-gaap_StatementTable_1334430" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1392700" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334430" xlink:to="loc_dei_LegalEntityAxis_1392700" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1392701" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1392700" xlink:to="loc_dei_EntityDomain_1392701" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1392701_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1392700" xlink:to="loc_dei_EntityDomain_1392701_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognition">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1329444" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1329436" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329444" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1329436" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329437" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329436" xlink:to="loc_dei_LegalEntityAxis_1329437" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329439" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329437" xlink:to="loc_dei_EntityDomain_1329439" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329439_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329437" xlink:to="loc_dei_EntityDomain_1329439_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1329356" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329444" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1329356" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformation">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334782" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334779" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334782" xlink:to="loc_us-gaap_StatementTable_1334779" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334784" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334779" xlink:to="loc_dei_LegalEntityAxis_1334784" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334785" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334784" xlink:to="loc_dei_EntityDomain_1334785" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334785_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334784" xlink:to="loc_dei_EntityDomain_1334785_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334780" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334779" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334780" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334781" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334780" xlink:to="loc_us-gaap_ClassOfStockDomain_1334781" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334781_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334780" xlink:to="loc_us-gaap_ClassOfStockDomain_1334781_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupplementalFinancialStatementInformationTextBlock" xlink:label="loc_rgti_SupplementalFinancialStatementInformationTextBlock_1330546" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334782" xlink:to="loc_rgti_SupplementalFinancialStatementInformationTextBlock_1330546" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Debt">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335051" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335048" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1335051" xlink:to="loc_us-gaap_StatementTable_1335048" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335053" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335048" xlink:to="loc_dei_LegalEntityAxis_1335053" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335054" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1335053" xlink:to="loc_dei_EntityDomain_1335054" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335054_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1335053" xlink:to="loc_dei_EntityDomain_1335054_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1335049" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335048" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1335049" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335050" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335049" xlink:to="loc_us-gaap_ClassOfStockDomain_1335050" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335050_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335049" xlink:to="loc_us-gaap_ClassOfStockDomain_1335050_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1331477" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335051" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1331477" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RedeemableConvertiblePreferredStock">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1331551" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RedeemableConvertiblePreferredStockTextBlock" xlink:label="loc_rgti_RedeemableConvertiblePreferredStockTextBlock_1330631" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331551" xlink:to="loc_rgti_RedeemableConvertiblePreferredStockTextBlock_1330631" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331506" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331551" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331506" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331509" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331506" xlink:to="loc_dei_LegalEntityAxis_1331509" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331510" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331509" xlink:to="loc_dei_EntityDomain_1331510" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331510_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331509" xlink:to="loc_dei_EntityDomain_1331510_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommonStock">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_1331540" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockTextBlock" xlink:label="loc_rgti_CommonStockTextBlock_1330973" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1331540" xlink:to="loc_rgti_CommonStockTextBlock_1330973" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331531" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_1331540" xlink:to="loc_us-gaap_StatementTable_1331531" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331532" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331531" xlink:to="loc_dei_LegalEntityAxis_1331532" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331533" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331532" xlink:to="loc_dei_EntityDomain_1331533" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331533_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331532" xlink:to="loc_dei_EntityDomain_1331533_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Warrants">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333774" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WarrantsTextBlock" xlink:label="loc_rgti_WarrantsTextBlock_390" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333774" xlink:to="loc_rgti_WarrantsTextBlock_390" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1333769" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333774" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1333769" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333770" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1333769" xlink:to="loc_dei_LegalEntityAxis_1333770" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333771" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333770" xlink:to="loc_dei_EntityDomain_1333771" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333771_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333770" xlink:to="loc_dei_EntityDomain_1333771_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ForwardWarrantAgreement">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1331591" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331589" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331591" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331589" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331594" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331589" xlink:to="loc_dei_LegalEntityAxis_1331594" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331595" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331594" xlink:to="loc_dei_EntityDomain_1331595" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331595_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331594" xlink:to="loc_dei_EntityDomain_1331595_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementDisclosure" xlink:label="loc_rgti_ForwardWarrantAgreementDisclosure_1331187" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331591" xlink:to="loc_rgti_ForwardWarrantAgreementDisclosure_1331187" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/FairValueMeasurements">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334877" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334874" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334877" xlink:to="loc_us-gaap_StatementTable_1334874" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334878" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334874" xlink:to="loc_dei_LegalEntityAxis_1334878" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334879" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334878" xlink:to="loc_dei_EntityDomain_1334879" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334879_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334878" xlink:to="loc_dei_EntityDomain_1334879_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334875" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334874" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334875" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334876" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334875" xlink:to="loc_us-gaap_ClassOfStockDomain_1334876" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334876_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334875" xlink:to="loc_us-gaap_ClassOfStockDomain_1334876_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_408" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334877" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_408" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShare">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334569" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334566" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334569" xlink:to="loc_us-gaap_StatementTable_1334566" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334570" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334566" xlink:to="loc_dei_LegalEntityAxis_1334570" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334572" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334570" xlink:to="loc_dei_EntityDomain_1334572" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334572_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334570" xlink:to="loc_dei_EntityDomain_1334572_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334567" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334566" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334567" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334568" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334567" xlink:to="loc_us-gaap_ClassOfStockDomain_1334568" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334568_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334567" xlink:to="loc_us-gaap_ClassOfStockDomain_1334568_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1331099" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334569" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1331099" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxes">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333030" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1331666" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333030" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1331666" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333027" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1333030" xlink:to="loc_us-gaap_StatementTable_1333027" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333032" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333027" xlink:to="loc_dei_LegalEntityAxis_1333032" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333034" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333032" xlink:to="loc_dei_EntityDomain_1333034" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333034_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333032" xlink:to="loc_dei_EntityDomain_1333034_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333028" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333027" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333028" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333029" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333028" xlink:to="loc_us-gaap_ClassOfStockDomain_1333029" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333029_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333028" xlink:to="loc_us-gaap_ClassOfStockDomain_1333029_default" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Segments">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334461" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1331015" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334461" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1331015" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334458" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334461" xlink:to="loc_us-gaap_StatementTable_1334458" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334459" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334458" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334459" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334460" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334459" xlink:to="loc_us-gaap_ClassOfStockDomain_1334460" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334460_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334459" xlink:to="loc_us-gaap_ClassOfStockDomain_1334460_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334463" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334458" xlink:to="loc_dei_LegalEntityAxis_1334463" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334464" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334463" xlink:to="loc_dei_EntityDomain_1334464" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334464_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334463" xlink:to="loc_dei_EntityDomain_1334464_default" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334496" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_442" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_442" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_437" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_437" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SalesAndMarketingPolicyTextBlock" xlink:label="loc_rgti_SalesAndMarketingPolicyTextBlock_1331367" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_SalesAndMarketingPolicyTextBlock_1331367" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" xlink:label="loc_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock_1331353" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock_1331353" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredOfferingCostsPolicyTextBlock" xlink:label="loc_rgti_DeferredOfferingCostsPolicyTextBlock_1331321" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_DeferredOfferingCostsPolicyTextBlock_1331321" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_1331351" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_1331351" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicAndPrivateWarrantsPolicyTextBlock" xlink:label="loc_rgti_PublicAndPrivateWarrantsPolicyTextBlock_1423671" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_PublicAndPrivateWarrantsPolicyTextBlock_1423671" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_1331328" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_1331328" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1331319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1331319" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_1334548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_1334548" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="loc_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_1331340" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_1331340" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1331330" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1331330" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334493" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_StatementTable_1334493" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1392708" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334493" xlink:to="loc_dei_LegalEntityAxis_1392708" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1392710" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1392708" xlink:to="loc_dei_EntityDomain_1392710" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1392710_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1392708" xlink:to="loc_dei_EntityDomain_1392710_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_447" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_447" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1331347" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1331347" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CapitalizedSoftwarePolicyTextBlock" xlink:label="loc_rgti_CapitalizedSoftwarePolicyTextBlock_1331374" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_CapitalizedSoftwarePolicyTextBlock_1331374" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredFinancingCostsPolicyTextBlock" xlink:label="loc_rgti_DeferredFinancingCostsPolicyTextBlock_1331322" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_DeferredFinancingCostsPolicyTextBlock_1331322" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_1701735" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_1701735" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_1331362" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_1331362" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1423673" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1423673" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_1331396" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_1331396" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_1331316" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_1331316" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1331332" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1331332" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="loc_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2146632817" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2146632817" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_1331354" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_1331354" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_436" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_UseOfEstimates_436" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_rgti_EmergingGrowthCompanyPolicyTextBlock_435" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_EmergingGrowthCompanyPolicyTextBlock_435" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_448" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_448" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_446" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_446" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_441" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_441" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_1334542" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_1334542" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" xlink:label="loc_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock_1423674" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock_1423674" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1331355" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1331355" use="optional" order="36" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334735" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination_1423493" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination_1423493" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_454" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_454" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1331888" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1331888" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock_1423494" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock_1423494" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334732" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_us-gaap_StatementTable_1334732" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1434183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334732" xlink:to="loc_dei_LegalEntityAxis_1434183" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1434184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1434183" xlink:to="loc_dei_EntityDomain_1434184" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1434184_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1434183" xlink:to="loc_dei_EntityDomain_1434184_default" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock_1329467" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" xlink:to="loc_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock_1329467" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1329465" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1329465" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1329459" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1329459" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329460" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329459" xlink:to="loc_dei_LegalEntityAxis_1329460" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329461" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329460" xlink:to="loc_dei_EntityDomain_1329461" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329461_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329460" xlink:to="loc_dei_EntityDomain_1329461_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1329466" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1329466" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334819" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1334826" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334819" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1334826" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1334829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334819" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1334829" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334816" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334819" xlink:to="loc_us-gaap_StatementTable_1334816" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334820" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334816" xlink:to="loc_dei_LegalEntityAxis_1334820" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334821" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334820" xlink:to="loc_dei_EntityDomain_1334821" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334821_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334820" xlink:to="loc_dei_EntityDomain_1334821_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334817" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334816" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334817" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334818" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334817" xlink:to="loc_us-gaap_ClassOfStockDomain_1334818" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334818_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334817" xlink:to="loc_us-gaap_ClassOfStockDomain_1334818_default" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommonStockTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_1331550" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1331544" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_1331550" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1331544" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331546" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1331544" xlink:to="loc_dei_LegalEntityAxis_1331546" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331546" xlink:to="loc_dei_EntityDomain_1331547" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331547_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331546" xlink:to="loc_dei_EntityDomain_1331547_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:label="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock_1330990" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1331550" xlink:to="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock_1330990" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333785" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" xlink:label="loc_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock_1333806" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333785" xlink:to="loc_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock_1333806" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1333796" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333785" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1333796" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333785" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333786" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" xlink:to="loc_dei_LegalEntityAxis_1333786" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333787" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333786" xlink:to="loc_dei_EntityDomain_1333787" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333787_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333786" xlink:to="loc_dei_EntityDomain_1333787_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1333800" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1333800" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1333801" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1333800" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1333801" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1333801_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1333800" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1333801_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateWarrantMember" xlink:label="loc_rgti_PrivateWarrantMember_1569644" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1333801" xlink:to="loc_rgti_PrivateWarrantMember_1569644" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ForwardWarrantAgreementTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1331603" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331602" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331603" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331602" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331605" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331602" xlink:to="loc_dei_LegalEntityAxis_1331605" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331606" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331605" xlink:to="loc_dei_EntityDomain_1331606" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331606_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331605" xlink:to="loc_dei_EntityDomain_1331606_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1331195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331603" xlink:to="loc_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1331195" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/FairValueMeasurementsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334909" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1334910" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334909" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1334910" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334906" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334909" xlink:to="loc_us-gaap_StatementTable_1334906" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334923" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334906" xlink:to="loc_dei_LegalEntityAxis_1334923" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334925" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334923" xlink:to="loc_dei_EntityDomain_1334925" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334925_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334923" xlink:to="loc_dei_EntityDomain_1334925_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334907" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334906" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334907" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334908" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334907" xlink:to="loc_us-gaap_ClassOfStockDomain_1334908" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334908_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334907" xlink:to="loc_us-gaap_ClassOfStockDomain_1334908_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1334917" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334909" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1334917" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335223" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_1424001" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_1424001" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335220" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_StatementTable_1335220" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335225" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335220" xlink:to="loc_dei_LegalEntityAxis_1335225" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335226" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1335225" xlink:to="loc_dei_EntityDomain_1335226" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335226_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1335225" xlink:to="loc_dei_EntityDomain_1335226_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_1331576" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_1331576" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1332094" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1332094" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1331586" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1331586" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334579" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock_1331108" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334579" xlink:to="loc_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock_1331108" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334576" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334579" xlink:to="loc_us-gaap_StatementTable_1334576" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334577" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334576" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334577" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334578" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334577" xlink:to="loc_us-gaap_ClassOfStockDomain_1334578" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334578_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334577" xlink:to="loc_us-gaap_ClassOfStockDomain_1334578_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334582" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334576" xlink:to="loc_dei_LegalEntityAxis_1334582" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334582" xlink:to="loc_dei_EntityDomain_1334584" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334584_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334582" xlink:to="loc_dei_EntityDomain_1334584_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1331115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334579" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1331115" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335634" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1331708" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1331708" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1331707" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1331707" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1331710" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1331710" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1331709" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1331709" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335631" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_StatementTable_1335631" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2146632686" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335631" xlink:to="loc_dei_LegalEntityAxis_2146632686" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2146632685" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2146632686" xlink:to="loc_dei_EntityDomain_2146632685" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2146632685_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2146632686" xlink:to="loc_dei_EntityDomain_2146632685_default" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SegmentsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334471" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334468" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334471" xlink:to="loc_us-gaap_StatementTable_1334468" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334472" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334468" xlink:to="loc_dei_LegalEntityAxis_1334472" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334473" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334472" xlink:to="loc_dei_EntityDomain_1334473" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334473_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334472" xlink:to="loc_dei_EntityDomain_1334473_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1331019" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334471" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1331019" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:label="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_554" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1423427" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_554" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1423427" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:label="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_554" xlink:to="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_546" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_srt_RangeAxis_546" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_546" xlink:to="loc_srt_RangeMember_547" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_547_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_546" xlink:to="loc_srt_RangeMember_547_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_548" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_549" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_548" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_549" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_549_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_548" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_549_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_550" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_TypeOfArrangementAxis_550" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_551" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_550" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_551" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_551_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_550" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_551_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423443" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_dei_LegalEntityAxis_1423443" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423444" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423443" xlink:to="loc_dei_EntityDomain_1423444" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423444_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423443" xlink:to="loc_dei_EntityDomain_1423444_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_540" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_StatementClassOfStockAxis_540" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_541" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_540" xlink:to="loc_us-gaap_ClassOfStockDomain_541" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_541_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_540" xlink:to="loc_us-gaap_ClassOfStockDomain_541_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_567" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_541" xlink:to="loc_us-gaap_CommonClassBMember_567" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_555" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_541" xlink:to="loc_us-gaap_CommonClassAMember_555" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventAxis" xlink:label="loc_rgti_EventAxis_1423429" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_rgti_EventAxis_1423429" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventDomain" xlink:label="loc_rgti_EventDomain_1423431" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_EventAxis_1423429" xlink:to="loc_rgti_EventDomain_1423431" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventDomain" xlink:label="loc_rgti_EventDomain_1423431_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_EventAxis_1423429" xlink:to="loc_rgti_EventDomain_1423431_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" xlink:label="loc_rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember_1423432" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_EventDomain_1423431" xlink:to="loc_rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember_1423432" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_552" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_srt_TitleOfIndividualAxis_552" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_553" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_552" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_553" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_553_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_552" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_553_default" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_542" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_542" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_543" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_542" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_543" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_543_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_542" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_543_default" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_544" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_544" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_545" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_544" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_545" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_545_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_544" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_545_default" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheAxis" xlink:label="loc_rgti_TrancheAxis_2146632885" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_rgti_TrancheAxis_2146632885" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheDomain" xlink:label="loc_rgti_TrancheDomain_2146632886" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_TrancheAxis_2146632885" xlink:to="loc_rgti_TrancheDomain_2146632886" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheDomain" xlink:label="loc_rgti_TrancheDomain_2146632886_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_TrancheAxis_2146632885" xlink:to="loc_rgti_TrancheDomain_2146632886_default" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_2146632875" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_srt_RestatementAxis_2146632875" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_2146632876" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_2146632875" xlink:to="loc_srt_RestatementDomain_2146632876" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_2146632876_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_2146632875" xlink:to="loc_srt_RestatementDomain_2146632876_default" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementAxis" xlink:label="loc_rgti_AgreementAxis_2146632882" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_rgti_AgreementAxis_2146632882" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementDomain" xlink:label="loc_rgti_AgreementDomain_2146632883" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_AgreementAxis_2146632882" xlink:to="loc_rgti_AgreementDomain_2146632883" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementDomain" xlink:label="loc_rgti_AgreementDomain_2146632883_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_AgreementAxis_2146632882" xlink:to="loc_rgti_AgreementDomain_2146632883_default" use="optional" order="41" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_647" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_647" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_1332696" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_NumberOfReportableSegments_1332696" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts_1332724" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_DeferredOfferingCosts_1332724" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1332808" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1332808" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_634" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_StatementClassOfStockAxis_634" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_635" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_634" xlink:to="loc_us-gaap_ClassOfStockDomain_635" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_635_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_634" xlink:to="loc_us-gaap_ClassOfStockDomain_635_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_636" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_636" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_637" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_636" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_637" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_637_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_636" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_637_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1332787" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1332787" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1332788" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1332787" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1332788" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1332788_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1332787" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1332788_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1332790" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_srt_RangeAxis_1332790" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1332791" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1332790" xlink:to="loc_srt_RangeMember_1332791" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1332791_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1332790" xlink:to="loc_srt_RangeMember_1332791_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1332792" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1332791" xlink:to="loc_srt_MaximumMember_1332792" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1332793" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1332791" xlink:to="loc_srt_MinimumMember_1332793" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_639" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638" xlink:to="loc_us-gaap_TypeOfAdoptionMember_639" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_639_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638" xlink:to="loc_us-gaap_TypeOfAdoptionMember_639_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="loc_us-gaap_RetirementPlanNameAxis_1333008" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_RetirementPlanNameAxis_1333008" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="loc_us-gaap_RetirementPlanNameDomain_1333009" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_1333008" xlink:to="loc_us-gaap_RetirementPlanNameDomain_1333009" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="loc_us-gaap_RetirementPlanNameDomain_1333009_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_1333008" xlink:to="loc_us-gaap_RetirementPlanNameDomain_1333009_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1423681" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_srt_StatementScenarioAxis_1423681" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1423682" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1423681" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1423682" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1423682_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1423681" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1423682_default" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1332946" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1332946" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1332947" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1332946" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1332947" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1332947_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1332946" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1332947_default" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1332948" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1332947" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1332948" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:label="loc_us-gaap_RevenueFromRightsConcentrationRiskMember_1580587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1332947" xlink:to="loc_us-gaap_RevenueFromRightsConcentrationRiskMember_1580587" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1332678" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_dei_LegalEntityAxis_1332678" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1332680" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1332678" xlink:to="loc_dei_EntityDomain_1332680" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1332680_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1332678" xlink:to="loc_dei_EntityDomain_1332680_default" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiComputingIncMember" xlink:label="loc_rgti_RigettiComputingIncMember_1332681" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1332680" xlink:to="loc_rgti_RigettiComputingIncMember_1332681" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfCustomersAxis" xlink:label="loc_rgti_NumberOfCustomersAxis_1332957" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_NumberOfCustomersAxis_1332957" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfCustomersDomain" xlink:label="loc_rgti_NumberOfCustomersDomain_1332958" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_NumberOfCustomersAxis_1332957" xlink:to="loc_rgti_NumberOfCustomersDomain_1332958" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfCustomersDomain" xlink:label="loc_rgti_NumberOfCustomersDomain_1332958_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_NumberOfCustomersAxis_1332957" xlink:to="loc_rgti_NumberOfCustomersDomain_1332958_default" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CriteriaAxis" xlink:label="loc_rgti_CriteriaAxis_1423678" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_CriteriaAxis_1423678" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CriteriaDomain" xlink:label="loc_rgti_CriteriaDomain_1423679" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_CriteriaAxis_1423678" xlink:to="loc_rgti_CriteriaDomain_1423679" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CriteriaDomain" xlink:label="loc_rgti_CriteriaDomain_1423679_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_CriteriaAxis_1423678" xlink:to="loc_rgti_CriteriaDomain_1423679_default" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1332949" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1332949" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1332949" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1332949" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950_default" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_1332951" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950" xlink:to="loc_us-gaap_AccountsReceivableMember_1332951" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1332953" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950" xlink:to="loc_us-gaap_SalesRevenueNetMember_1332953" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1423717" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_AwardTypeAxis_1423717" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1423717" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1423717" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718_default" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" xlink:label="loc_rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember_1423720" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718" xlink:to="loc_rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember_1423720" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1423719" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1423719" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1423714" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1423714" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1423715" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1423714" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1423715" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1423715_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1423714" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1423715_default" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1423711" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1423711" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1423712" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1423711" xlink:to="loc_us-gaap_RelatedPartyDomain_1423712" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1423712_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1423711" xlink:to="loc_us-gaap_RelatedPartyDomain_1423712_default" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorMember" xlink:label="loc_rgti_SponsorMember_1423713" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1423712" xlink:to="loc_rgti_SponsorMember_1423713" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1333015" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1333015" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1333016" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1333015" xlink:to="loc_us-gaap_EquityComponentDomain_1333016" use="optional" order="62" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1333016_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1333015" xlink:to="loc_us-gaap_EquityComponentDomain_1333016_default" use="optional" order="63" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1423689" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1423689" use="optional" order="64" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1423689" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690" use="optional" order="65" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1423689" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690_default" use="optional" order="66" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicWarrantsMember" xlink:label="loc_rgti_PublicWarrantsMember_1423692" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690" xlink:to="loc_rgti_PublicWarrantsMember_1423692" use="optional" order="67" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivatePlacementWarrantsMember" xlink:label="loc_rgti_PrivatePlacementWarrantsMember_1423691" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690" xlink:to="loc_rgti_PrivatePlacementWarrantsMember_1423691" use="optional" order="68" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConditionAxis" xlink:label="loc_rgti_ConditionAxis_1423695" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_ConditionAxis_1423695" use="optional" order="69" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConditionDomain" xlink:label="loc_rgti_ConditionDomain_1423696" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_ConditionAxis_1423695" xlink:to="loc_rgti_ConditionDomain_1423696" use="optional" order="70" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConditionDomain" xlink:label="loc_rgti_ConditionDomain_1423696_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_ConditionAxis_1423695" xlink:to="loc_rgti_ConditionDomain_1423696_default" use="optional" order="71" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTIAgreementNameAxis" xlink:label="loc_rgti_RGTIAgreementNameAxis_2146632967" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_RGTIAgreementNameAxis_2146632967" use="optional" order="72" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_2146632969" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_RGTIAgreementNameAxis_2146632967" xlink:to="loc_rgti_RgtiAgreementNameDomain_2146632969" use="optional" order="73" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_2146632969_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_RGTIAgreementNameAxis_2146632967" xlink:to="loc_rgti_RgtiAgreementNameDomain_2146632969_default" use="optional" order="74" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTICommonStockPurchaseAgreementMember" xlink:label="loc_rgti_RGTICommonStockPurchaseAgreementMember_2146632970" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_RgtiAgreementNameDomain_2146632969" xlink:to="loc_rgti_RGTICommonStockPurchaseAgreementMember_2146632970" use="optional" order="75" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_1575832" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_PlanNameAxis_1575832" use="optional" order="76" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1575833" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1575832" xlink:to="loc_us-gaap_PlanNameDomain_1575833" use="optional" order="77" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1575833_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1575832" xlink:to="loc_us-gaap_PlanNameDomain_1575833_default" use="optional" order="78" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember_1575834" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1575833" xlink:to="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember_1575834" use="optional" order="79" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1580591" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_srt_ProductOrServiceAxis_1580591" use="optional" order="80" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1580592" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1580591" xlink:to="loc_srt_ProductsAndServicesDomain_1580592" use="optional" order="81" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1580592_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1580591" xlink:to="loc_srt_ProductsAndServicesDomain_1580592_default" use="optional" order="82" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_GovernmentEntitiesMember" xlink:label="loc_rgti_GovernmentEntitiesMember_1580593" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1580592" xlink:to="loc_rgti_GovernmentEntitiesMember_1580593" use="optional" order="83" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1332698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1332698" use="optional" order="84" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1423686" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1423686" use="optional" order="85" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_1332691" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_NumberOfOperatingSegments_1332691" use="optional" order="86" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1423687" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1423687" use="optional" order="87" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_1423698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_DerivativeLiabilities_1423698" use="optional" order="88" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1423694" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1423694" use="optional" order="89" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodOfEarnoutShares" xlink:label="loc_rgti_PeriodOfEarnoutShares_1423706" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_rgti_PeriodOfEarnoutShares_1423706" use="optional" order="90" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2146632807" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2146632807" use="optional" order="91" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1423688" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1423688" use="optional" order="92" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1423710" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1423710" use="optional" order="93" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OfferingCostsIncurred" xlink:label="loc_rgti_OfferingCostsIncurred_1569198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_rgti_OfferingCostsIncurred_1569198" use="optional" order="94" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_2146632809" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_OperatingLeaseLiability_2146632809" use="optional" order="95" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInDeferredRent" xlink:label="loc_rgti_IncreaseDecreaseInDeferredRent_2146632808" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_rgti_IncreaseDecreaseInDeferredRent_2146632808" use="optional" order="96" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_2146632816" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_RestrictedCash_2146632816" use="optional" order="97" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAdditions" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions_2146632811" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAdditions_2146632811" use="optional" order="98" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2146632810" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2146632810" use="optional" order="99" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_1423704" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_1423704" use="optional" order="100" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems_1423507" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1423519" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems_1423507" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1423519" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems_1423507" xlink:to="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423504" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" xlink:to="loc_dei_LegalEntityAxis_1423504" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423505" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423504" xlink:to="loc_dei_EntityDomain_1423505" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423505_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423504" xlink:to="loc_dei_EntityDomain_1423505_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1423508" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1423508" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1423509" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1423508" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1423509" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1423509_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1423508" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1423509_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1423514" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1423514" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_1423512" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_1423512" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SimulatedTradingDaysMember" xlink:label="loc_rgti_SimulatedTradingDaysMember_1423511" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_rgti_SimulatedTradingDaysMember_1423511" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1423510" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1423510" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EstimatedPeriodOfExpirationMember" xlink:label="loc_rgti_EstimatedPeriodOfExpirationMember_1423518" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_rgti_EstimatedPeriodOfExpirationMember_1423518" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" xlink:label="loc_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems_1424734" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfTransitionPeriodComparativeDataTable" xlink:label="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems_1424734" xlink:to="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1424747" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1424747" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1424749" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1424747" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1424749" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1424749_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1424747" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1424749_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1424751" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1424749" xlink:to="loc_us-gaap_SalesRevenueNetMember_1424751" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1424752" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" xlink:to="loc_srt_MajorCustomersAxis_1424752" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1424753" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_1424752" xlink:to="loc_srt_NameOfMajorCustomerDomain_1424753" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1424753_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_1424752" xlink:to="loc_srt_NameOfMajorCustomerDomain_1424753_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerDMember" xlink:label="loc_rgti_CustomerDMember_1568564" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerDMember_1568564" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerCMember" xlink:label="loc_rgti_CustomerCMember_1424757" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerCMember_1424757" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerEMember" xlink:label="loc_rgti_CustomerEMember_1581084" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerEMember_1581084" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerFMember" xlink:label="loc_rgti_CustomerFMember_1701742" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerFMember_1701742" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerAMember" xlink:label="loc_rgti_CustomerAMember_1424754" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerAMember_1424754" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerBMember" xlink:label="loc_rgti_CustomerBMember_1424755" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerBMember_1424755" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1424741" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1424741" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1424743" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1424741" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1424743" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1424743_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1424741" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1424743_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1424745" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1424743" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1424745" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1424735" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems_1424734" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1424735" use="optional" order="19" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems_1332325" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1332327" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems_1332325" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1332327" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems_1332325" xlink:to="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1334710" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_srt_MajorCustomersAxis_1334710" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1334711" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_1334710" xlink:to="loc_srt_NameOfMajorCustomerDomain_1334711" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1334711_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_1334710" xlink:to="loc_srt_NameOfMajorCustomerDomain_1334711_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerDMember" xlink:label="loc_rgti_CustomerDMember_1334749" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1334711" xlink:to="loc_rgti_CustomerDMember_1334749" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerBMember" xlink:label="loc_rgti_CustomerBMember_1332308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1334711" xlink:to="loc_rgti_CustomerBMember_1332308" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerCMember" xlink:label="loc_rgti_CustomerCMember_1332310" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1334711" xlink:to="loc_rgti_CustomerCMember_1332310" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerAMember" xlink:label="loc_rgti_CustomerAMember_1332305" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1334711" xlink:to="loc_rgti_CustomerAMember_1332305" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334714" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_dei_LegalEntityAxis_1334714" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334715" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334714" xlink:to="loc_dei_EntityDomain_1334715" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334715_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334714" xlink:to="loc_dei_EntityDomain_1334715_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1332303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1332303" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1332304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1332303" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1332304" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1332304_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1332303" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1332304_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1423742" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1332304" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1423742" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1334703" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1334703" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1334704" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1334703" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1334704" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1334704_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1334703" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1334704_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_1423741" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1334704" xlink:to="loc_us-gaap_AccountsReceivableMember_1423741" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423557" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423557" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423548" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423550" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423548" xlink:to="loc_dei_LegalEntityAxis_1423550" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423551" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423550" xlink:to="loc_dei_EntityDomain_1423551" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423551_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423550" xlink:to="loc_dei_EntityDomain_1423551_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AggregateTransactionCostsPaid" xlink:label="loc_rgti_AggregateTransactionCostsPaid_1423555" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_AggregateTransactionCostsPaid_1423555" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CashReceivedFromPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_CashReceivedFromPrivateInvestmentInPublicEquity_1423554" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_CashReceivedFromPrivateInvestmentInPublicEquity_1423554" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CashReceivedFromTrustNetOfRedemptions" xlink:label="loc_rgti_CashReceivedFromTrustNetOfRedemptions_1423553" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_CashReceivedFromTrustNetOfRedemptions_1423553" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfTransactionCostsThroughCash" xlink:label="loc_rgti_PaymentOfTransactionCostsThroughCash_1423572" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_rgti_PaymentOfTransactionCostsThroughCash_1423572" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423574" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423574" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" xlink:label="loc_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts_1423570" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts_1423570" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_1423571" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_1423571" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_1423569" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_1423569" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1423565" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1423565" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1423566" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1423565" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1423566" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1423566_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1423565" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1423566_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423562" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" xlink:to="loc_dei_LegalEntityAxis_1423562" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423563" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423562" xlink:to="loc_dei_EntityDomain_1423563" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423563_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423562" xlink:to="loc_dei_EntityDomain_1423563_default" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventAxis" xlink:label="loc_rgti_EventAxis_1426380" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" xlink:to="loc_rgti_EventAxis_1426380" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventDomain" xlink:label="loc_rgti_EventDomain_1426381" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_EventAxis_1426380" xlink:to="loc_rgti_EventDomain_1426381" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventDomain" xlink:label="loc_rgti_EventDomain_1426381_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_EventAxis_1426380" xlink:to="loc_rgti_EventDomain_1426381_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" xlink:label="loc_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember_1426382" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_EventDomain_1426381" xlink:to="loc_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember_1426382" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423581" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" xlink:to="loc_dei_LegalEntityAxis_1423581" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423582" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423581" xlink:to="loc_dei_EntityDomain_1423582" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423582_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423581" xlink:to="loc_dei_EntityDomain_1423582_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1423584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1423584" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423585" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423584" xlink:to="loc_us-gaap_ClassOfStockDomain_1423585" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423585_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423584" xlink:to="loc_us-gaap_ClassOfStockDomain_1423585_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1423586" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423585" xlink:to="loc_us-gaap_CommonClassAMember_1423586" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember_1423589" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423585" xlink:to="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember_1423589" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1423587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423585" xlink:to="loc_us-gaap_CommonClassBMember_1423587" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1423588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423585" xlink:to="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1423588" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity_1423594" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity_1423594" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedInTheNewCompany" xlink:label="loc_rgti_CommonStockSharesIssuedInTheNewCompany_1423595" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedInTheNewCompany_1423595" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" xlink:label="loc_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing_1423597" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing_1423597" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" xlink:label="loc_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing_1423596" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing_1423596" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity_1423593" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity_1423593" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" xlink:label="loc_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany_1423591" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany_1423591" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1423599" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_us-gaap_SharesOutstanding_1423599" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" xlink:label="loc_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany_1423592" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany_1423592" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" xlink:label="loc_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity_1423598" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity_1423598" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1423611" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" xlink:to="loc_us-gaap_SharesOutstanding_1423611" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesExchangeRatio" xlink:label="loc_rgti_CommonStockSharesExchangeRatio_1423612" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" xlink:to="loc_rgti_CommonStockSharesExchangeRatio_1423612" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" xlink:label="loc_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio_1423613" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" xlink:to="loc_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio_1423613" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" xlink:to="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423604" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" xlink:to="loc_dei_LegalEntityAxis_1423604" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423605" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423604" xlink:to="loc_dei_EntityDomain_1423605" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423605_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423604" xlink:to="loc_dei_EntityDomain_1423605_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1423607" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1423607" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423608" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423607" xlink:to="loc_us-gaap_ClassOfStockDomain_1423608" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423608_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423607" xlink:to="loc_us-gaap_ClassOfStockDomain_1423608_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PromoteSponsorVestingSharesMember" xlink:label="loc_rgti_PromoteSponsorVestingSharesMember_1423614" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423608" xlink:to="loc_rgti_PromoteSponsorVestingSharesMember_1423614" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorRedemptionBasedVestingSharesMember" xlink:label="loc_rgti_SponsorRedemptionBasedVestingSharesMember_1423615" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423608" xlink:to="loc_rgti_SponsorRedemptionBasedVestingSharesMember_1423615" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1423609" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423608" xlink:to="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1423609" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember_1423610" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423608" xlink:to="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember_1423610" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockNumberOfVotesPerShare" xlink:label="loc_rgti_CommonStockNumberOfVotesPerShare_1423986" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_CommonStockNumberOfVotesPerShare_1423986" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesExchangeRatio" xlink:label="loc_rgti_CommonStockSharesExchangeRatio_1424219" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_CommonStockSharesExchangeRatio_1424219" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedAsAResultOfExchange" xlink:label="loc_rgti_CommonStockSharesIssuedAsAResultOfExchange_1424226" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_CommonStockSharesIssuedAsAResultOfExchange_1424226" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1423640" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1423640" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" xlink:label="loc_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare_1424130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare_1424130" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VolumeWeightedAveragePricePerShare" xlink:label="loc_rgti_VolumeWeightedAveragePricePerShare_1424312" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_VolumeWeightedAveragePricePerShare_1424312" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice_1424324" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice_1424324" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SharesSubjectToVestingMaximumPeriod" xlink:label="loc_rgti_SharesSubjectToVestingMaximumPeriod_1424336" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_SharesSubjectToVestingMaximumPeriod_1424336" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SharesSubjectToVestingBasedOnCertainConditions" xlink:label="loc_rgti_SharesSubjectToVestingBasedOnCertainConditions_1424296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_SharesSubjectToVestingBasedOnCertainConditions_1424296" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaap_CommonStockSharesSubscribedButUnissued_1424376" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_CommonStockSharesSubscribedButUnissued_1424376" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1424380" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_1424380" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1423989" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1423989" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_1426242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_1426242" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" xlink:label="loc_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination_1424109" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination_1424109" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" xlink:label="loc_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations_1424112" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations_1424112" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1423641" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1423641" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1424053" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1424053" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1423980" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1423980" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaap_CommonStockSharesSubscriptions_1424383" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_CommonStockSharesSubscriptions_1424383" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1423623" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1423623" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423624" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423623" xlink:to="loc_us-gaap_ClassOfStockDomain_1423624" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423624_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423623" xlink:to="loc_us-gaap_ClassOfStockDomain_1423624_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1423625" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423624" xlink:to="loc_us-gaap_CommonClassAMember_1423625" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1423626" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1423624" xlink:to="loc_us-gaap_CommonClassBMember_1423626" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementAxis" xlink:label="loc_rgti_AgreementAxis_1423628" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_rgti_AgreementAxis_1423628" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementDomain" xlink:label="loc_rgti_AgreementDomain_1423629" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_AgreementAxis_1423628" xlink:to="loc_rgti_AgreementDomain_1423629" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementDomain" xlink:label="loc_rgti_AgreementDomain_1423629_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_AgreementAxis_1423628" xlink:to="loc_rgti_AgreementDomain_1423629_default" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorAgreementMember" xlink:label="loc_rgti_SponsorAgreementMember_1423630" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_AgreementDomain_1423629" xlink:to="loc_rgti_SponsorAgreementMember_1423630" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialSubscriptionAgreementMember" xlink:label="loc_rgti_InitialSubscriptionAgreementMember_1423631" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_AgreementDomain_1423629" xlink:to="loc_rgti_InitialSubscriptionAgreementMember_1423631" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SubsequentSubscriptionAgreementMember" xlink:label="loc_rgti_SubsequentSubscriptionAgreementMember_1423632" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_AgreementDomain_1423629" xlink:to="loc_rgti_SubsequentSubscriptionAgreementMember_1423632" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheAxis" xlink:label="loc_rgti_TrancheAxis_1423633" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_rgti_TrancheAxis_1423633" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheDomain" xlink:label="loc_rgti_TrancheDomain_1423634" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_TrancheAxis_1423633" xlink:to="loc_rgti_TrancheDomain_1423634" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheDomain" xlink:label="loc_rgti_TrancheDomain_1423634_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_TrancheAxis_1423633" xlink:to="loc_rgti_TrancheDomain_1423634_default" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheOneMember" xlink:label="loc_rgti_TrancheOneMember_1423635" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_TrancheDomain_1423634" xlink:to="loc_rgti_TrancheOneMember_1423635" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheTwoMember" xlink:label="loc_rgti_TrancheTwoMember_1423636" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_TrancheDomain_1423634" xlink:to="loc_rgti_TrancheTwoMember_1423636" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423620" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_dei_LegalEntityAxis_1423620" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423621" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423620" xlink:to="loc_dei_EntityDomain_1423621" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423621_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423620" xlink:to="loc_dei_EntityDomain_1423621_default" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupernovaAcquistionMember" xlink:label="loc_rgti_SupernovaAcquistionMember_1423627" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1423621" xlink:to="loc_rgti_SupernovaAcquistionMember_1423627" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorAxis" xlink:label="loc_rgti_InvestorAxis_1423637" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_rgti_InvestorAxis_1423637" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorDomain" xlink:label="loc_rgti_InvestorDomain_1423638" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_InvestorAxis_1423637" xlink:to="loc_rgti_InvestorDomain_1423638" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorDomain" xlink:label="loc_rgti_InvestorDomain_1423638_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_InvestorAxis_1423637" xlink:to="loc_rgti_InvestorDomain_1423638_default" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateInvestmentInPublicEquityInvestorsMember" xlink:label="loc_rgti_PrivateInvestmentInPublicEquityInvestorsMember_1423639" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_InvestorDomain_1423638" xlink:to="loc_rgti_PrivateInvestmentInPublicEquityInvestorsMember_1423639" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1423994" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1423994" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OneTimeBonus" xlink:label="loc_rgti_OneTimeBonus_1580599" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_OneTimeBonus_1580599" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" xlink:label="loc_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare_1424106" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare_1424106" use="optional" order="47" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1701704" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1701704" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_1701705" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_1701705" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1701707" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1701707" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701702" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701702" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1701708" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701702" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1701708" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1701708" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1701708" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_1701710" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_1701710" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_1701712" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" xlink:to="loc_us-gaap_CommercialPaperMember_1701712" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1701713" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1701713" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701711" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701711" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2146632790" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2146632790" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1701719" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1701719" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtSecuritiesAvailableForSaleMaturityYear" xlink:label="loc_rgti_DebtSecuritiesAvailableForSaleMaturityYear_2146632789" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" xlink:to="loc_rgti_DebtSecuritiesAvailableForSaleMaturityYear_2146632789" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701720" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701720" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1701722" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701720" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1701722" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1701722" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1701722" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701725" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701725" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_1701726" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" xlink:to="loc_us-gaap_CommercialPaperMember_1701726" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1701727" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1701727" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_1701724" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_1701724" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1329372" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1329367" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329372" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1329367" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1329368" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329367" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1329368" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1329369" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1329368" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1329369" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1329369_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1329368" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1329369_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RevenuePerformanceObligationTransactionPriceAxis" xlink:label="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis_1423534" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329367" xlink:to="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis_1423534" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RevenuePerformanceObligationTransactionPriceDomain" xlink:label="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis_1423534" xlink:to="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RevenuePerformanceObligationTransactionPriceDomain" xlink:label="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis_1423534" xlink:to="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RemainderoftwothousandandtwentythreeMember" xlink:label="loc_rgti_RemainderoftwothousandandtwentythreeMember_2146632758" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536" xlink:to="loc_rgti_RemainderoftwothousandandtwentythreeMember_2146632758" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwothousandandtwentyfourMember" xlink:label="loc_rgti_TwothousandandtwentyfourMember_2146632757" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536" xlink:to="loc_rgti_TwothousandandtwentyfourMember_2146632757" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329448" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329367" xlink:to="loc_dei_LegalEntityAxis_1329448" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329449" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329448" xlink:to="loc_dei_EntityDomain_1329449" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329449_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329448" xlink:to="loc_dei_EntityDomain_1329449_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_1423533" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329372" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_1423533" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1329529" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1329527" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329529" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1329527" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1329533" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329527" xlink:to="loc_srt_ProductOrServiceAxis_1329533" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1329534" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1329533" xlink:to="loc_srt_ProductsAndServicesDomain_1329534" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1329534_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1329533" xlink:to="loc_srt_ProductsAndServicesDomain_1329534_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccessToQuantumComputingSystemsMember" xlink:label="loc_rgti_AccessToQuantumComputingSystemsMember_1329539" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1329534" xlink:to="loc_rgti_AccessToQuantumComputingSystemsMember_1329539" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CollaborativeResearchAndOtherProfessionalServicesMember" xlink:label="loc_rgti_CollaborativeResearchAndOtherProfessionalServicesMember_1329538" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1329534" xlink:to="loc_rgti_CollaborativeResearchAndOtherProfessionalServicesMember_1329538" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1329541" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329527" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1329541" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1329541" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1329541" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_1329544" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_1329544" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaap_TransferredOverTimeMember_1329545" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542" xlink:to="loc_us-gaap_TransferredOverTimeMember_1329545" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1329548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329529" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1329548" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostLineItems" xlink:label="loc_us-gaap_CapitalizedContractCostLineItems_1329685" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_1329623" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329685" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_1329623" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTable" xlink:label="loc_us-gaap_CapitalizedContractCostTable_1329684" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329685" xlink:to="loc_us-gaap_CapitalizedContractCostTable_1329684" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329686" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CapitalizedContractCostTable_1329684" xlink:to="loc_dei_LegalEntityAxis_1329686" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329687" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329686" xlink:to="loc_dei_EntityDomain_1329687" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329687_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329686" xlink:to="loc_dei_EntityDomain_1329687_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_1329634" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329685" xlink:to="loc_us-gaap_DeferredRevenueCurrent_1329634" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_1329624" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329685" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_1329624" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostLineItems" xlink:label="loc_us-gaap_CapitalizedContractCostLineItems_1329696" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTable" xlink:label="loc_us-gaap_CapitalizedContractCostTable_1329695" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329696" xlink:to="loc_us-gaap_CapitalizedContractCostTable_1329695" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CapitalizedContractCostTable_1329695" xlink:to="loc_dei_LegalEntityAxis_1329698" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329699" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1329698" xlink:to="loc_dei_EntityDomain_1329699" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329699_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1329698" xlink:to="loc_dei_EntityDomain_1329699_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_1329664" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329696" xlink:to="loc_us-gaap_DeferredRevenueCurrent_1329664" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RecognitionOfDeferredRevenues" xlink:label="loc_rgti_RecognitionOfDeferredRevenues_1329667" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329696" xlink:to="loc_rgti_RecognitionOfDeferredRevenues_1329667" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferralOfRevenue" xlink:label="loc_rgti_DeferralOfRevenue_1329665" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329696" xlink:to="loc_rgti_DeferralOfRevenue_1329665" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1330618" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1330618" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1330620" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1330620" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1330621" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1330621" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333274" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" xlink:to="loc_dei_LegalEntityAxis_1333274" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333274" xlink:to="loc_dei_EntityDomain_1333275" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333275_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333274" xlink:to="loc_dei_EntityDomain_1333275_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1330607" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1330607" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1330607" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1330607" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FurnitureAndOtherAssetsMember" xlink:label="loc_rgti_FurnitureAndOtherAssetsMember_1330616" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_rgti_FurnitureAndOtherAssetsMember_1330616" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_1330613" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_1330613" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ItHardwareMember" xlink:label="loc_rgti_ItHardwareMember_1330614" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_rgti_ItHardwareMember_1330614" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_QuantumComputingFridgesMember" xlink:label="loc_rgti_QuantumComputingFridgesMember_1330610" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_rgti_QuantumComputingFridgesMember_1330610" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProcessEquipmentMember" xlink:label="loc_rgti_ProcessEquipmentMember_1330611" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_rgti_ProcessEquipmentMember_1330611" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334851" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedDeferredOfferingCosts" xlink:label="loc_rgti_AccruedDeferredOfferingCosts_2146632742" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_rgti_AccruedDeferredOfferingCosts_2146632742" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_1330634" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_1330634" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334848" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_StatementTable_1334848" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334849" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334848" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334849" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334850" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334849" xlink:to="loc_us-gaap_ClassOfStockDomain_1334850" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334850_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334849" xlink:to="loc_us-gaap_ClassOfStockDomain_1334850_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334853" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1334848" xlink:to="loc_dei_LegalEntityAxis_1334853" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334855" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334853" xlink:to="loc_dei_EntityDomain_1334855" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334855_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334853" xlink:to="loc_dei_EntityDomain_1334855_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedPropertyAndOtherTaxes" xlink:label="loc_rgti_AccruedPropertyAndOtherTaxes_2146632739" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_rgti_AccruedPropertyAndOtherTaxes_2146632739" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_1330664" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_1330664" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2146632746" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2146632746" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaap_InterestPayableCurrent_1330630" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_InterestPayableCurrent_1330630" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2146632740" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2146632740" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedUtilitiesCurrent" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_2146632753" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_2146632753" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedSubcontractorCost" xlink:label="loc_rgti_AccruedSubcontractorCost_2146632749" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_rgti_AccruedSubcontractorCost_2146632749" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedPropertyPlantAndEquipmentCost" xlink:label="loc_rgti_AccruedPropertyPlantAndEquipmentCost_2146632747" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_rgti_AccruedPropertyPlantAndEquipmentCost_2146632747" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330769" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330769" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334862" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" xlink:to="loc_dei_LegalEntityAxis_1334862" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334863" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334862" xlink:to="loc_dei_EntityDomain_1334863" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334863_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334862" xlink:to="loc_dei_EntityDomain_1334863_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1330731" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" xlink:to="loc_srt_StatementGeographicalAxis_1330731" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1330732" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1330731" xlink:to="loc_srt_SegmentGeographicalDomain_1330732" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1330732_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1330731" xlink:to="loc_srt_SegmentGeographicalDomain_1330732_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_country_US_1330734" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1330732" xlink:to="loc_country_US_1330734" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB" xlink:label="loc_country_GB_1330766" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1330732" xlink:to="loc_country_GB_1330766" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1330807" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330769" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1330807" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTotalGrossPropertyAndEquipment" xlink:label="loc_rgti_PercentageOfTotalGrossPropertyAndEquipment_1330777" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330769" xlink:to="loc_rgti_PercentageOfTotalGrossPropertyAndEquipment_1330777" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_2146632670" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2146632675" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_StatementTable_2146632675" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2146632674" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2146632675" xlink:to="loc_dei_LegalEntityAxis_2146632674" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2146632673" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2146632674" xlink:to="loc_dei_EntityDomain_2146632673" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2146632673_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2146632674" xlink:to="loc_dei_EntityDomain_2146632673_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiHoldingsMember" xlink:label="loc_rgti_RigettiHoldingsMember_2146632671" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_2146632673" xlink:to="loc_rgti_RigettiHoldingsMember_2146632671" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2146632669" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2146632669" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2146632668" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2146632668" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2146632667" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2146632667" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2146632666" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2146632666" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2146632665" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2146632665" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2146632664" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2146632664" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335140" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1331610" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1331610" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_StatementTable_1335137" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335137" xlink:to="loc_dei_LegalEntityAxis_1335141" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1335141" xlink:to="loc_dei_EntityDomain_1335142" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335142_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1335141" xlink:to="loc_dei_EntityDomain_1335142_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiComputingIncMember" xlink:label="loc_rgti_RigettiComputingIncMember_1335143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1335142" xlink:to="loc_rgti_RigettiComputingIncMember_1335143" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1335138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335137" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1335138" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335138" xlink:to="loc_us-gaap_ClassOfStockDomain_1335139" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335139_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335138" xlink:to="loc_us-gaap_ClassOfStockDomain_1335139_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1423809" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1423809" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1331619" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1331619" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_1331623" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebt_1331623" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1331607" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1331607" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1331614" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1331614" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335130" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1331653" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1331653" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentPortionOfOutstandingPrincipalAmount" xlink:label="loc_rgti_CurrentPortionOfOutstandingPrincipalAmount_1423786" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_rgti_CurrentPortionOfOutstandingPrincipalAmount_1423786" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaap_LongTermLoansPayable_1423785" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_LongTermLoansPayable_1423785" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_StatementTable_1335127" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335127" xlink:to="loc_dei_LegalEntityAxis_1335131" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335132" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1335131" xlink:to="loc_dei_EntityDomain_1335132" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335132_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1335131" xlink:to="loc_dei_EntityDomain_1335132_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1335128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335127" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1335128" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335128" xlink:to="loc_us-gaap_ClassOfStockDomain_1335129" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335129_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335128" xlink:to="loc_us-gaap_ClassOfStockDomain_1335129_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_1423787" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_1423787" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedFinalPaymentFee" xlink:label="loc_rgti_AccruedFinalPaymentFee_1331657" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_rgti_AccruedFinalPaymentFee_1331657" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaap_LoansPayableCurrent_1423788" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_LoansPayableCurrent_1423788" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_1331660" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_1331660" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentPortionOfLongTermDebtGross" xlink:label="loc_rgti_CurrentPortionOfLongTermDebtGross_1432171" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_rgti_CurrentPortionOfLongTermDebtGross_1432171" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaap_AccretionExpense_1332042" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_AccretionExpense_1332042" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1332049" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1332049" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_1332000" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_1332000" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331911" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331911" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331912" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331911" xlink:to="loc_us-gaap_ClassOfStockDomain_1331912" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331912_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331911" xlink:to="loc_us-gaap_ClassOfStockDomain_1331912_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1331896" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_srt_RangeAxis_1331896" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1331897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1331896" xlink:to="loc_srt_RangeMember_1331897" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1331897_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1331896" xlink:to="loc_srt_RangeMember_1331897_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1331899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1331897" xlink:to="loc_srt_MinimumMember_1331899" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1331898" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1331897" xlink:to="loc_srt_MaximumMember_1331898" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1331829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_DebtInstrumentAxis_1331829" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1331832" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1331829" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1331832" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1331832_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1331829" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1331832_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheAMember" xlink:label="loc_rgti_TrancheAMember_1331852" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1331832" xlink:to="loc_rgti_TrancheAMember_1331852" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheBMember" xlink:label="loc_rgti_TrancheBMember_1331892" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1331832" xlink:to="loc_rgti_TrancheBMember_1331892" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheCMember" xlink:label="loc_rgti_TrancheCMember_1423802" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1331832" xlink:to="loc_rgti_TrancheCMember_1423802" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1331860" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1331860" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1331862" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1331860" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1331862" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1331862_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1331860" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1331862_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_LoanAndSecurityAgreementMember" xlink:label="loc_rgti_LoanAndSecurityAgreementMember_1331863" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1331862" xlink:to="loc_rgti_LoanAndSecurityAgreementMember_1331863" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1331936" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1331936" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1331937" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1331936" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1331937" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1331937_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1331936" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1331937_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335066" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_dei_LegalEntityAxis_1335066" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335067" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1335066" xlink:to="loc_dei_EntityDomain_1335067" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335067_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1335066" xlink:to="loc_dei_EntityDomain_1335067_default" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorNameAxis" xlink:label="loc_rgti_InvestorNameAxis_1331951" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_rgti_InvestorNameAxis_1331951" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorNameDomain" xlink:label="loc_rgti_InvestorNameDomain_1331954" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_InvestorNameAxis_1331951" xlink:to="loc_rgti_InvestorNameDomain_1331954" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorNameDomain" xlink:label="loc_rgti_InvestorNameDomain_1331954_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_InvestorNameAxis_1331951" xlink:to="loc_rgti_InvestorNameDomain_1331954_default" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_1335069" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_1335069" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_1335070" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_1335069" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_1335070" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_1335070_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_1335069" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_1335070_default" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VentureCapitalMember" xlink:label="loc_rgti_VentureCapitalMember_1335071" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_1335070" xlink:to="loc_rgti_VentureCapitalMember_1335071" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1575827" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1575827" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1575828" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1575827" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1575828" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1575828_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1575827" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1575828_default" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockWarrantsMember" xlink:label="loc_rgti_CommonStockWarrantsMember_1575829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1575828" xlink:to="loc_rgti_CommonStockWarrantsMember_1575829" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_1568991" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_VariableRateAxis_1568991" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_1568992" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_1568991" xlink:to="loc_us-gaap_VariableRateDomain_1568992" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_1568992_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_1568991" xlink:to="loc_us-gaap_VariableRateDomain_1568992_default" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="loc_us-gaap_PrimeRateMember_1568993" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1568992" xlink:to="loc_us-gaap_PrimeRateMember_1568993" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtInstrumentPaymentFeepercentage" xlink:label="loc_rgti_DebtInstrumentPaymentFeepercentage_1332006" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_rgti_DebtInstrumentPaymentFeepercentage_1332006" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_1332023" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_InterestExpense_1332023" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1331994" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1331994" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1332003" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1332003" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1332001" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentTerm_1332001" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_1332047" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_1332047" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1575824" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1575824" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WithdrawnCreditFacility" xlink:label="loc_rgti_WithdrawnCreditFacility_1335074" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_rgti_WithdrawnCreditFacility_1335074" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1331998" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1331998" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_1332044" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_1332044" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_1331997" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_1331997" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_1423792" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_1423792" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="loc_us-gaap_DebtInstrumentPaymentTerms_1423790" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentPaymentTerms_1423790" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfadvancedFundsUnderTheAmendment" xlink:label="loc_rgti_PercentageOfadvancedFundsUnderTheAmendment_1580602" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_rgti_PercentageOfadvancedFundsUnderTheAmendment_1580602" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" xlink:label="loc_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger_1423798" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger_1423798" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_1580600" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_1580600" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1569027" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1569027" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1335082" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1335082" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_1580601" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_1580601" use="optional" order="62" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1423789" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1423789" use="optional" order="63" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1423793" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1423793" use="optional" order="64" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1568990" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1568990" use="optional" order="65" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1423821" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1423823" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1423821" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1423823" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1423822" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1423821" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1423822" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1423821" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1425169" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1425169" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1425170" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1425169" xlink:to="loc_us-gaap_ClassOfStockDomain_1425170" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1425170_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1425169" xlink:to="loc_us-gaap_ClassOfStockDomain_1425170_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCOnePreferredStockMember" xlink:label="loc_rgti_SeriesCOnePreferredStockMember_1425173" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1425170" xlink:to="loc_rgti_SeriesCOnePreferredStockMember_1425173" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_1425172" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1425170" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_1425172" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_1425193" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1425170" xlink:to="loc_us-gaap_PreferredStockMember_1425193" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423824" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" xlink:to="loc_dei_LegalEntityAxis_1423824" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423825" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423824" xlink:to="loc_dei_EntityDomain_1423825" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423825_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423824" xlink:to="loc_dei_EntityDomain_1423825_default" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockLineItems" xlink:label="loc_us-gaap_ConversionOfStockLineItems_1331043" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockTable" xlink:label="loc_us-gaap_ConversionOfStockTable_1331006" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331043" xlink:to="loc_us-gaap_ConversionOfStockTable_1331006" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EquityAxis" xlink:label="loc_rgti_EquityAxis_1335300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_rgti_EquityAxis_1335300" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EquityDomain" xlink:label="loc_rgti_EquityDomain_1335301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_EquityAxis_1335300" xlink:to="loc_rgti_EquityDomain_1335301" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EquityDomain" xlink:label="loc_rgti_EquityDomain_1335301_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_EquityAxis_1335300" xlink:to="loc_rgti_EquityDomain_1335301_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1331034" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1331034" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1331035" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1331034" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1331035" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1331035_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1331034" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1331035_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockWarrantsMember" xlink:label="loc_rgti_CommonStockWarrantsMember_1331036" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1331035" xlink:to="loc_rgti_CommonStockWarrantsMember_1331036" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331554" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_dei_LegalEntityAxis_1331554" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331555" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331554" xlink:to="loc_dei_EntityDomain_1331555" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331555_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331554" xlink:to="loc_dei_EntityDomain_1331555_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1331037" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_us-gaap_AwardTypeAxis_1331037" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1331037" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1331037" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1331040" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1331040" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1331039" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1331039" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331030" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331030" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331031" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331030" xlink:to="loc_us-gaap_ClassOfStockDomain_1331031" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331031_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331030" xlink:to="loc_us-gaap_ClassOfStockDomain_1331031_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1331044" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331043" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1331044" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommonStockAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockLineItems" xlink:label="loc_us-gaap_ConversionOfStockLineItems_1331053" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1423835" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1423835" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" xlink:label="loc_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket_1701471" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket_1701471" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1423839" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1423839" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaap_CommonStockSharesSubscriptions_1701482" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_CommonStockSharesSubscriptions_1701482" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1423838" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1423838" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts_2146632663" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_DeferredOfferingCosts_2146632663" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaap_CommonStockVotingRights_1331067" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_CommonStockVotingRights_1331067" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1331064" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1331064" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1701468" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1701468" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" xlink:label="loc_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement_1701486" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement_1701486" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1701487" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1701487" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_1701473" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_1701473" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockTable" xlink:label="loc_us-gaap_ConversionOfStockTable_1331048" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_ConversionOfStockTable_1331048" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameAxis" xlink:label="loc_rgti_AgreementNameAxis_1701483" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_rgti_AgreementNameAxis_1701483" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1701484" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_AgreementNameAxis_1701483" xlink:to="loc_rgti_AgreementNameDomain_1701484" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1701484_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_AgreementNameAxis_1701483" xlink:to="loc_rgti_AgreementNameDomain_1701484_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockPurchaseAgreementMember" xlink:label="loc_rgti_CommonStockPurchaseAgreementMember_1701485" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_AgreementNameDomain_1701484" xlink:to="loc_rgti_CommonStockPurchaseAgreementMember_1701485" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331049" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331049" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331050" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331049" xlink:to="loc_us-gaap_ClassOfStockDomain_1331050" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331050_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331049" xlink:to="loc_us-gaap_ClassOfStockDomain_1331050_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1331051" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1331050" xlink:to="loc_us-gaap_CommonClassAMember_1331051" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331558" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_dei_LegalEntityAxis_1331558" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331559" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331558" xlink:to="loc_dei_EntityDomain_1331559" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331559_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331558" xlink:to="loc_dei_EntityDomain_1331559_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTIAgreementNameAxis" xlink:label="loc_rgti_RGTIAgreementNameAxis_1701488" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_rgti_RGTIAgreementNameAxis_1701488" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_1701489" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_RGTIAgreementNameAxis_1701488" xlink:to="loc_rgti_RgtiAgreementNameDomain_1701489" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_1701489_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_RGTIAgreementNameAxis_1701488" xlink:to="loc_rgti_RgtiAgreementNameDomain_1701489_default" use="optional" order="27" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_906" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_906" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_1333915" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_1333915" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1333925" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1333925" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" xlink:label="loc_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits_1333916" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits_1333916" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1333923" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1333923" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" xlink:label="loc_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant_1333914" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant_1333914" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_1575813" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_1575813" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" xlink:label="loc_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered_1423862" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered_1423862" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1333922" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1333922" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_907" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_907" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_1423859" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_SharePrice_1423859" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsvestingpercentage" xlink:label="loc_rgti_Classofwarrantsvestingpercentage_1333927" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_Classofwarrantsvestingpercentage_1333927" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantOrRightGrandDateFairValue" xlink:label="loc_rgti_ClassOfWarrantOrRightGrandDateFairValue_1425925" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_ClassOfWarrantOrRightGrandDateFairValue_1425925" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_887" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_887" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_888" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_888" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_889" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_888" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_889" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_889_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_888" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_889_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockWarrantsMember" xlink:label="loc_rgti_CommonStockWarrantsMember_1333911" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_CommonStockWarrantsMember_1333911" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WarrantsToPurchaseClassACommonStockMember" xlink:label="loc_rgti_WarrantsToPurchaseClassACommonStockMember_1333921" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_WarrantsToPurchaseClassACommonStockMember_1333921" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicWarrantsMember" xlink:label="loc_rgti_PublicWarrantsMember_897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_PublicWarrantsMember_897" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerWarrantsMember" xlink:label="loc_rgti_CustomerWarrantsMember_1333926" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_CustomerWarrantsMember_1333926" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrinityWarrantsMember" xlink:label="loc_rgti_TrinityWarrantsMember_1425902" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_TrinityWarrantsMember_1425902" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333908" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_dei_LegalEntityAxis_1333908" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333909" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333908" xlink:to="loc_dei_EntityDomain_1333909" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333909_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333908" xlink:to="loc_dei_EntityDomain_1333909_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_890" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_us-gaap_StatementClassOfStockAxis_890" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_891" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_890" xlink:to="loc_us-gaap_ClassOfStockDomain_891" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_891_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_890" xlink:to="loc_us-gaap_ClassOfStockDomain_891_default" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_891" xlink:to="loc_us-gaap_CommonClassAMember_899" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_892" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_srt_RangeAxis_892" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_893" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_892" xlink:to="loc_srt_RangeMember_893" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_893_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_892" xlink:to="loc_srt_RangeMember_893_default" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_901" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_893" xlink:to="loc_srt_MinimumMember_901" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_900" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_893" xlink:to="loc_srt_MaximumMember_900" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfInvestorsAxis" xlink:label="loc_rgti_ClassOfInvestorsAxis_1333917" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_rgti_ClassOfInvestorsAxis_1333917" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfInvestorsDomain" xlink:label="loc_rgti_ClassOfInvestorsDomain_1333918" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_ClassOfInvestorsAxis_1333917" xlink:to="loc_rgti_ClassOfInvestorsDomain_1333918" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfInvestorsDomain" xlink:label="loc_rgti_ClassOfInvestorsDomain_1333918_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_ClassOfInvestorsAxis_1333917" xlink:to="loc_rgti_ClassOfInvestorsDomain_1333918_default" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1333920" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ClassOfInvestorsDomain_1333918" xlink:to="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1333920" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:label="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_894" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_894" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_895" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_894" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_895" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_895_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_894" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_895_default" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1575810" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1575810" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice_1423860" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice_1423860" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_1423861" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_1423861" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantorrightissuedduringperiodwarrants" xlink:label="loc_rgti_Classofwarrantorrightissuedduringperiodwarrants_1333912" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_Classofwarrantorrightissuedduringperiodwarrants_1333912" use="optional" order="45" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1333827" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1333827" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1333840" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_srt_StatementScenarioAxis_1333840" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1333841" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1333840" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1333841" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1333841_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1333840" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1333841_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AtinitialrecognitionMember" xlink:label="loc_rgti_AtinitialrecognitionMember_1333842" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1333841" xlink:to="loc_rgti_AtinitialrecognitionMember_1333842" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_dei_LegalEntityAxis_1333829" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333830" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333829" xlink:to="loc_dei_EntityDomain_1333830" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333830_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333829" xlink:to="loc_dei_EntityDomain_1333830_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1333832" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1333832" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1333833" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1333832" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1333833" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1333833_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1333832" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1333833_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1333834" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1333834" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1333839" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1333839" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1333838" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1333838" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1333837" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1333837" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_1333836" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_1333836" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1333835" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1333835" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1425719" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1425719" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1425721" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1425719" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1425721" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1425721_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1425719" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1425721_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateWarrantMember" xlink:label="loc_rgti_PrivateWarrantMember_1568988" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1425721" xlink:to="loc_rgti_PrivateWarrantMember_1568988" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1333828" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1333827" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1333828" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333856" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333856" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1333853" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_srt_StatementScenarioAxis_1333853" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1333854" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1333853" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1333854" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1333854_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1333853" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1333854_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333847" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_dei_LegalEntityAxis_1333847" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333848" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333847" xlink:to="loc_dei_EntityDomain_1333848" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333848_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333847" xlink:to="loc_dei_EntityDomain_1333848_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1333858" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1333858" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1333859" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1333858" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1333859" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1333859_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1333858" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1333859_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1333861" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1333861" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_1333862" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_1333862" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1333863" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1333863" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1333864" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1333864" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1333865" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1333865" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1333860" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1333860" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1333850" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1333850" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1333851" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1333850" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1333851" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1333851_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1333850" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1333851_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1333857" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333856" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1333857" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureofvestingstatusofwarrantsLineItems" xlink:label="loc_rgti_DisclosureofvestingstatusofwarrantsLineItems_1333904" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1333905" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_DisclosureofvestingstatusofwarrantsLineItems_1333904" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1333905" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureOfVestingStatusOfWarrantsTable" xlink:label="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_DisclosureofvestingstatusofwarrantsLineItems_1333904" xlink:to="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfVestingAxis" xlink:label="loc_rgti_StatusOfVestingAxis_1333899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" xlink:to="loc_rgti_StatusOfVestingAxis_1333899" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfVestingDomain" xlink:label="loc_rgti_StatusOfVestingDomain_1333900" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_StatusOfVestingAxis_1333899" xlink:to="loc_rgti_StatusOfVestingDomain_1333900" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfVestingDomain" xlink:label="loc_rgti_StatusOfVestingDomain_1333900_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_StatusOfVestingAxis_1333899" xlink:to="loc_rgti_StatusOfVestingDomain_1333900_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VestedCustomerWarrantsMember" xlink:label="loc_rgti_VestedCustomerWarrantsMember_1333901" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_StatusOfVestingDomain_1333900" xlink:to="loc_rgti_VestedCustomerWarrantsMember_1333901" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_UnvestedCustomerWarrantsMember" xlink:label="loc_rgti_UnvestedCustomerWarrantsMember_1333903" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_StatusOfVestingDomain_1333900" xlink:to="loc_rgti_UnvestedCustomerWarrantsMember_1333903" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333896" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" xlink:to="loc_dei_LegalEntityAxis_1333896" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333896" xlink:to="loc_dei_EntityDomain_1333897" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333897_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333896" xlink:to="loc_dei_EntityDomain_1333897_default" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1331448" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1331448" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockIssuedDuringPeriodWarrantsIssued" xlink:label="loc_rgti_StockIssuedDuringPeriodWarrantsIssued_1331441" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_rgti_StockIssuedDuringPeriodWarrantsIssued_1331441" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" xlink:label="loc_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod_2146632759" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod_2146632759" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_2146632682" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_2146632682" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2146632681" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2146632681" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_1331259" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_DerivativeLiabilities_1331259" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1331436" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1331436" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets_1423851" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_DerivativeAssets_1423851" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1331248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1331248" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1331248" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331250" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331250_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1331248" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331250_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiMember" xlink:label="loc_rgti_RigettiMember_1331253" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331250" xlink:to="loc_rgti_RigettiMember_1331253" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameAxis" xlink:label="loc_rgti_AgreementNameAxis_1331218" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_rgti_AgreementNameAxis_1331218" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1331219" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_AgreementNameAxis_1331218" xlink:to="loc_rgti_AgreementNameDomain_1331219" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1331219_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_AgreementNameAxis_1331218" xlink:to="loc_rgti_AgreementNameDomain_1331219_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementMember" xlink:label="loc_rgti_ForwardWarrantAgreementMember_1331220" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_AgreementNameDomain_1331219" xlink:to="loc_rgti_ForwardWarrantAgreementMember_1331220" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331233" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_dei_LegalEntityAxis_1331233" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331233" xlink:to="loc_dei_EntityDomain_1331234" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331234_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331233" xlink:to="loc_dei_EntityDomain_1331234_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AmpereComputingLlcMember" xlink:label="loc_rgti_AmpereComputingLlcMember_1575800" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1331234" xlink:to="loc_rgti_AmpereComputingLlcMember_1575800" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_1331459" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_us-gaap_VestingAxis_1331459" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_1331461" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_1331459" xlink:to="loc_us-gaap_VestingDomain_1331461" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_1331461_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_1331459" xlink:to="loc_us-gaap_VestingDomain_1331461_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1331463" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_1331461" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1331463" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1331467" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_1331461" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1331467" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1331446" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1331446" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1331447" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1331447" use="optional" order="28" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1331295" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1331295" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1331267" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1331267" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1331268" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1331267" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1331268" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1331268_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1331267" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1331268_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1331269" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1331268" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1331269" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1331270" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1331268" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1331270" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1331275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1331268" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1331275" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" xlink:label="loc_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember_1331274" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1331268" xlink:to="loc_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember_1331274" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_dei_LegalEntityAxis_1331282" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331282" xlink:to="loc_dei_EntityDomain_1331283" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331283_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331282" xlink:to="loc_dei_EntityDomain_1331283_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1331288" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_srt_RangeAxis_1331288" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1331290" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1331288" xlink:to="loc_srt_RangeMember_1331290" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1331290_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1331288" xlink:to="loc_srt_RangeMember_1331290_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1331292" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1331290" xlink:to="loc_srt_MinimumMember_1331292" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1331291" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1331290" xlink:to="loc_srt_MaximumMember_1331291" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1331276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1331276" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1331277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1331276" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1331277" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1331277_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1331276" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1331277_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementMember" xlink:label="loc_rgti_ForwardWarrantAgreementMember_1331279" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1331277" xlink:to="loc_rgti_ForwardWarrantAgreementMember_1331279" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_1331296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1331295" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_1331296" use="optional" order="21" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1037" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1039" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1037" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1039" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1048" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1039" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1048" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ContingentEarnOutLiabilityFairValueDisclosure" xlink:label="loc_rgti_ContingentEarnOutLiabilityFairValueDisclosure_1423770" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1039" xlink:to="loc_rgti_ContingentEarnOutLiabilityFairValueDisclosure_1423770" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1038" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1037" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1038" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_1047" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1038" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_1047" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementFairValueDisclosure" xlink:label="loc_rgti_ForwardWarrantAgreementFairValueDisclosure_1423763" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1038" xlink:to="loc_rgti_ForwardWarrantAgreementFairValueDisclosure_1423763" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1037" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1031" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1031" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1031" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1031" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1044" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1044" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1043" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1043" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1042" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1042" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1033" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1033" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1033" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1033" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ContingentEarnOutLiabilityMember" xlink:label="loc_rgti_ContingentEarnOutLiabilityMember_1423775" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034" xlink:to="loc_rgti_ContingentEarnOutLiabilityMember_1423775" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMember" xlink:label="loc_us-gaap_DerivativeMember_1045" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034" xlink:to="loc_us-gaap_DerivativeMember_1045" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423782" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_dei_LegalEntityAxis_1423782" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423783" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1423782" xlink:to="loc_dei_EntityDomain_1423783" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423783_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1423782" xlink:to="loc_dei_EntityDomain_1423783_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1029" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1029" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1029" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1030_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1029" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1030_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateWarrantMember" xlink:label="loc_rgti_PrivateWarrantMember_1041" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" xlink:to="loc_rgti_PrivateWarrantMember_1041" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrinityWarrantsMember" xlink:label="loc_rgti_TrinityWarrantsMember_1423772" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" xlink:to="loc_rgti_TrinityWarrantsMember_1423772" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" xlink:label="loc_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember_1569042" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" xlink:to="loc_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember_1569042" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicWarrantsMember" xlink:label="loc_rgti_PublicWarrantsMember_1040" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" xlink:to="loc_rgti_PublicWarrantsMember_1040" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_1035" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_1035" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_1035" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_1035" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036_default" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1046" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1046" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_1701477" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" xlink:to="loc_us-gaap_CommercialPaperMember_1701477" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701476" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701476" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_1701475" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_1701475" use="optional" order="35" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1147" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1147" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1144" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1144" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1136" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1136" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1137" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1137_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1136" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1137_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1137" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1141" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334986" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_dei_LegalEntityAxis_1334986" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334987" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334986" xlink:to="loc_dei_EntityDomain_1334987" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334987_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334986" xlink:to="loc_dei_EntityDomain_1334987_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1334995" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1334995" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1334995" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1334995" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ContingentEarnOutLiabilityMember" xlink:label="loc_rgti_ContingentEarnOutLiabilityMember_1423778" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" xlink:to="loc_rgti_ContingentEarnOutLiabilityMember_1423778" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementMember" xlink:label="loc_rgti_ForwardWarrantAgreementMember_1335014" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" xlink:to="loc_rgti_ForwardWarrantAgreementMember_1335014" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DerivativeWarrantLiabilitiesMember" xlink:label="loc_rgti_DerivativeWarrantLiabilitiesMember_1335013" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" xlink:to="loc_rgti_DerivativeWarrantLiabilitiesMember_1335013" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1138" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1138" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1139" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1139_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1138" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1139_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrinityWarrantsMember" xlink:label="loc_rgti_TrinityWarrantsMember_1423779" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1139" xlink:to="loc_rgti_TrinityWarrantsMember_1423779" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivatePlacementWarrantsMember" xlink:label="loc_rgti_PrivatePlacementWarrantsMember_1143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1139" xlink:to="loc_rgti_PrivatePlacementWarrantsMember_1143" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1575796" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1575796" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_1146" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_1146" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_2146632648" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_2146632648" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335264" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1424348" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1424348" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335261" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_StatementTable_1335261" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335265" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335261" xlink:to="loc_dei_LegalEntityAxis_1335265" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335266" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1335265" xlink:to="loc_dei_EntityDomain_1335266" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335266_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1335265" xlink:to="loc_dei_EntityDomain_1335266_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1424362" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1424362" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1424340" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1424340" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1424211" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1424211" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1424229" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1424229" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1424338" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1424338" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1424238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1424238" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1424230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1424230" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1424216" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1424216" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1424236" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1424236" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1424335" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1424335" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1424232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1424232" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1424218" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1424218" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1424213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1424213" use="optional" order="18" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" xlink:label="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1424070" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1424070" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2146632689" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2146632689" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1424059" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1424059" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1424056" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1424056" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2146632687" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2146632687" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1424061" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1424061" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RestrictedStockUnitsTable" xlink:label="loc_rgti_RestrictedStockUnitsTable_1424048" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_rgti_RestrictedStockUnitsTable_1424048" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1424049" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_RestrictedStockUnitsTable_1424048" xlink:to="loc_us-gaap_AwardTypeAxis_1424049" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1424051" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1424049" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1424051" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1424051_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1424049" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1424051_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1424052" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1424051" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1424052" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2146632688" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2146632688" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1424057" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1424057" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1332078" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1332086" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1332078" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1332086" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1332078" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" xlink:to="loc_dei_LegalEntityAxis_1335243" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335244" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1335243" xlink:to="loc_dei_EntityDomain_1335244" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335244_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1335243" xlink:to="loc_dei_EntityDomain_1335244_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1332079" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1332079" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1332081" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1332079" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1332081" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1332081_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1332079" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1332081_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1424390" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1332081" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1424390" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1332082" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1332081" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1332082" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_1424389" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1332081" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_1424389" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335250" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1332120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1332120" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_StatementTable_1335247" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2146632643" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335247" xlink:to="loc_us-gaap_AwardTypeAxis_2146632643" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2146632643" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2146632643" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TimeBasedVestingAwardMember" xlink:label="loc_rgti_TimeBasedVestingAwardMember_2146632641" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642" xlink:to="loc_rgti_TimeBasedVestingAwardMember_2146632641" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_MarketBasedVestingAwardMember" xlink:label="loc_rgti_MarketBasedVestingAwardMember_2146632640" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642" xlink:to="loc_rgti_MarketBasedVestingAwardMember_2146632640" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335247" xlink:to="loc_dei_LegalEntityAxis_1335251" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1335251" xlink:to="loc_dei_EntityDomain_1335252" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335252_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1335251" xlink:to="loc_dei_EntityDomain_1335252_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1335281" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1335247" xlink:to="loc_srt_RangeAxis_1335281" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1335282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1335281" xlink:to="loc_srt_RangeMember_1335282" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1335282_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1335281" xlink:to="loc_srt_RangeMember_1335282_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1332123" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1332123" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1332112" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1332112" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1332124" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1332124" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1332115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1332115" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1331849" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331846" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_StatementTable_1331846" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_1331851" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_us-gaap_PlanNameAxis_1331851" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1331853" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1331851" xlink:to="loc_us-gaap_PlanNameDomain_1331853" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1331853_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1331851" xlink:to="loc_us-gaap_PlanNameDomain_1331853_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:label="loc_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember_1575795" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1331853" xlink:to="loc_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember_1575795" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember_1331855" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1331853" xlink:to="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember_1331855" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1424373" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1424373" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1424374" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1424373" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1424374" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1424374_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1424373" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1424374_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331847" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_dei_LegalEntityAxis_1331847" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331848" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1331847" xlink:to="loc_dei_EntityDomain_1331848" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331848_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1331847" xlink:to="loc_dei_EntityDomain_1331848_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1331865" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_us-gaap_AwardTypeAxis_1331865" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1331865" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1331865" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_1569061" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" xlink:to="loc_us-gaap_RestrictedStockMember_1569061" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CeoAwardMember" xlink:label="loc_rgti_CeoAwardMember_2146632707" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" xlink:to="loc_rgti_CeoAwardMember_2146632707" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1331869" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1331869" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_2146632713" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_srt_TitleOfIndividualAxis_2146632713" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2146632712" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_2146632713" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2146632712" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2146632712_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_2146632713" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2146632712_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_2146632711" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2146632712" xlink:to="loc_srt_ChiefExecutiveOfficerMember_2146632711" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1331929" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1331929" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1569062" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1569062" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1424367" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1424367" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1331918" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1331918" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1331901" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1331901" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1331927" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1331927" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockOptionCommonShareExercisePrice" xlink:label="loc_rgti_StockOptionCommonShareExercisePrice_2146632717" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_rgti_StockOptionCommonShareExercisePrice_2146632717" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" xlink:label="loc_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear_1575793" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear_1575793" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2146633053" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2146633053" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1331906" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1331906" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1331890" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1331890" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1331878" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1331878" use="optional" order="34" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1331132" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_1331140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_EarningsPerShareBasic_1331140" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1331141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1331141" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NetIncomeLossRelationToCommonStock" xlink:label="loc_rgti_NetIncomeLossRelationToCommonStock_1331133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_rgti_NetIncomeLossRelationToCommonStock_1331133" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1569194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1569194" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1569195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1569195" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_StatementTable_1331129" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334613" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331129" xlink:to="loc_dei_LegalEntityAxis_1334613" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334614" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334613" xlink:to="loc_dei_EntityDomain_1334614" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334614_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334613" xlink:to="loc_dei_EntityDomain_1334614_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331129" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331130" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331130" xlink:to="loc_us-gaap_ClassOfStockDomain_1331131" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331131_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331130" xlink:to="loc_us-gaap_ClassOfStockDomain_1331131_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1331143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1331131" xlink:to="loc_us-gaap_CommonClassAMember_1331143" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1331163" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1331179" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331163" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1331179" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331160" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1331163" xlink:to="loc_us-gaap_StatementTable_1331160" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1331166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331160" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1331166" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1331166" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1331166" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1331178" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1331178" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConvertibleSeriesCPreferredStockMember" xlink:label="loc_rgti_ConvertibleSeriesCPreferredStockMember_1331174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_rgti_ConvertibleSeriesCPreferredStockMember_1331174" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1331176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_us-gaap_WarrantMember_1331176" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConvertibleSeriesC1PreferredStockMember" xlink:label="loc_rgti_ConvertibleSeriesC1PreferredStockMember_1331168" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_rgti_ConvertibleSeriesC1PreferredStockMember_1331168" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1331177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1331177" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334591" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331160" xlink:to="loc_dei_LegalEntityAxis_1334591" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334592" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334591" xlink:to="loc_dei_EntityDomain_1334592" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334592_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334591" xlink:to="loc_dei_EntityDomain_1334592_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331161" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331160" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331161" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331161" xlink:to="loc_us-gaap_ClassOfStockDomain_1331162" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331162_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331161" xlink:to="loc_us-gaap_ClassOfStockDomain_1331162_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1331164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1331162" xlink:to="loc_us-gaap_CommonClassAMember_1331164" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_2561" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2558" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2561" xlink:to="loc_us-gaap_StatementTable_2558" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2559" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2558" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2559" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_2560" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2559" xlink:to="loc_us-gaap_ClassOfStockDomain_2560" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_2560_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2559" xlink:to="loc_us-gaap_ClassOfStockDomain_2560_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_UnvestedCustomerWarrantsMember" xlink:label="loc_rgti_UnvestedCustomerWarrantsMember_2146632656" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2560" xlink:to="loc_rgti_UnvestedCustomerWarrantsMember_2146632656" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2146632651" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2561" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2146632651" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1331305" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_1425159" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_1425159" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1580797" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1580797" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1580798" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1580798" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1425158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1425158" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_StatementTable_1331302" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331303" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331303" xlink:to="loc_us-gaap_ClassOfStockDomain_1331304" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331304_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331303" xlink:to="loc_us-gaap_ClassOfStockDomain_1331304_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1425140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1425140" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1425142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1425140" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1425142" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1425142_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1425140" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1425142_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334594" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_dei_LegalEntityAxis_1334594" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334595" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334594" xlink:to="loc_dei_EntityDomain_1334595" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334595_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334594" xlink:to="loc_dei_EntityDomain_1334595_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1425133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1425133" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1425135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1425133" xlink:to="loc_us-gaap_EquityComponentDomain_1425135" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1425135_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1425133" xlink:to="loc_us-gaap_EquityComponentDomain_1425135_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1425137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1425135" xlink:to="loc_us-gaap_WarrantMember_1425137" use="optional" order="18" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333047" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1331739" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333047" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1331739" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1331734" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333047" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1331734" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333044" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1333047" xlink:to="loc_us-gaap_StatementTable_1333044" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333045" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333044" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333045" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333046" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333045" xlink:to="loc_us-gaap_ClassOfStockDomain_1333046" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333046_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333045" xlink:to="loc_us-gaap_ClassOfStockDomain_1333046_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333048" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333044" xlink:to="loc_dei_LegalEntityAxis_1333048" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333049" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333048" xlink:to="loc_dei_EntityDomain_1333049" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333049_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333048" xlink:to="loc_dei_EntityDomain_1333049_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1331736" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333047" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1331736" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333056" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333056" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="loc_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization_2146632754" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" xlink:to="loc_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization_2146632754" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1331886" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1331886" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="loc_rgti_DeferredTaxLiabilitiesRightOfUseAssets_2146632755" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" xlink:to="loc_rgti_DeferredTaxLiabilitiesRightOfUseAssets_2146632755" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333053" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1333056" xlink:to="loc_us-gaap_StatementTable_1333053" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333054" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333053" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333054" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333055" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333054" xlink:to="loc_us-gaap_ClassOfStockDomain_1333055" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333055_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333054" xlink:to="loc_us-gaap_ClassOfStockDomain_1333055_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333057" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333053" xlink:to="loc_dei_LegalEntityAxis_1333057" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333058" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333057" xlink:to="loc_dei_EntityDomain_1333058" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333058_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333057" xlink:to="loc_dei_EntityDomain_1333058_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1335544" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333056" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1335544" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333056" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1331850" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1331850" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1331858" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1331858" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="loc_rgti_DeferredTaxAssetsRightOfUseLiabilities_2146632756" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_rgti_DeferredTaxAssetsRightOfUseLiabilities_2146632756" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1331842" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1331842" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1331872" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1331872" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1331844" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1331844" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1331854" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1331854" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_1331856" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_1331856" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1331868" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1331868" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333067" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1332398" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1332398" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333064" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_StatementTable_1333064" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333065" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333064" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333065" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333066" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333065" xlink:to="loc_us-gaap_ClassOfStockDomain_1333066" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333066_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333065" xlink:to="loc_us-gaap_ClassOfStockDomain_1333066_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333068" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333064" xlink:to="loc_dei_LegalEntityAxis_1333068" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333069" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333068" xlink:to="loc_dei_EntityDomain_1333069" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333069_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333068" xlink:to="loc_dei_EntityDomain_1333069_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts_2146632659" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts_2146632659" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment_2146632763" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment_2146632763" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1332386" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1332386" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1332399" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1332399" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_2146632660" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_2146632660" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_1332392" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_1332392" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment_2146632762" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment_2146632762" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1332388" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1332388" use="optional" order="16" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333075" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1332421" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333075" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1332421" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1332425" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333075" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1332425" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_1332426" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1333075" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_1332426" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333072" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1333075" xlink:to="loc_us-gaap_StatementTable_1333072" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333076" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333072" xlink:to="loc_dei_LegalEntityAxis_1333076" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333077" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333076" xlink:to="loc_dei_EntityDomain_1333077" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333077_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333076" xlink:to="loc_dei_EntityDomain_1333077_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodAxis" xlink:label="loc_rgti_PeriodAxis_2146632767" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333072" xlink:to="loc_rgti_PeriodAxis_2146632767" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodDomain" xlink:label="loc_rgti_PeriodDomain_2146632766" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_PeriodAxis_2146632767" xlink:to="loc_rgti_PeriodDomain_2146632766" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodDomain" xlink:label="loc_rgti_PeriodDomain_2146632766_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_PeriodAxis_2146632767" xlink:to="loc_rgti_PeriodDomain_2146632766_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentYearMember" xlink:label="loc_rgti_CurrentYearMember_2146632765" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_PeriodDomain_2146632766" xlink:to="loc_rgti_CurrentYearMember_2146632765" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PreviousYearMember" xlink:label="loc_rgti_PreviousYearMember_2146632764" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_PeriodDomain_2146632766" xlink:to="loc_rgti_PreviousYearMember_2146632764" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333073" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1333072" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333073" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333074" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333073" xlink:to="loc_us-gaap_ClassOfStockDomain_1333074" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333074_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333073" xlink:to="loc_us-gaap_ClassOfStockDomain_1333074_default" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfIncomeTaxesInformationLineItems" xlink:label="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1332545" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1332545" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfIncomeTaxesInformationTable" xlink:label="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333079" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" xlink:to="loc_dei_LegalEntityAxis_1333079" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333080" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1333079" xlink:to="loc_dei_EntityDomain_1333080" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333080_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1333079" xlink:to="loc_dei_EntityDomain_1333080_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiComputingIncMember" xlink:label="loc_rgti_RigettiComputingIncMember_1333081" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1333080" xlink:to="loc_rgti_RigettiComputingIncMember_1333081" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_1332495" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_1332495" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_1332496" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_1332495" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_1332496" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_1332496_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_1332495" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_1332496_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember_1332497" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_1332496" xlink:to="loc_us-gaap_ResearchMember_1332497" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1332501" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1332501" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1332502" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1332501" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1332502" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1332502_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1332501" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1332502_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1332508" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1332502" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_1332508" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_1332503" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1332502" xlink:to="loc_us-gaap_DomesticCountryMember_1332503" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2146632737" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2146632737" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_2146632741" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_2146632741" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_1332534" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_OperatingLossCarryforwards_1332534" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1332531" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1332531" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_2146632743" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_2146632743" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1332540" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_1332540" use="optional" order="21" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1331022" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1331022" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334475" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_dei_LegalEntityAxis_1334475" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334476" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334475" xlink:to="loc_dei_EntityDomain_1334476" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334476_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334475" xlink:to="loc_dei_EntityDomain_1334476_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1423910" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1423910" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1423911" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1423910" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1423911" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1423911_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1423910" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1423911_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:label="loc_us-gaap_RevenueFromRightsConcentrationRiskMember_1423912" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1423911" xlink:to="loc_us-gaap_RevenueFromRightsConcentrationRiskMember_1423912" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1331025" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_srt_StatementGeographicalAxis_1331025" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1331026" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1331025" xlink:to="loc_srt_SegmentGeographicalDomain_1331026" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1331026_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1331025" xlink:to="loc_srt_SegmentGeographicalDomain_1331026_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_country_US_1331027" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1331026" xlink:to="loc_country_US_1331027" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_2146632788" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1331026" xlink:to="loc_srt_EuropeMember_2146632788" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1426692" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1426692" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1426693" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1426692" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1426693" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1426693_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1426692" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1426693_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1426695" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1426693" xlink:to="loc_us-gaap_SalesRevenueNetMember_1426695" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1331023" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1331022" xlink:to="loc_us-gaap_Revenues_1331023" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1423909" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1331022" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1423909" use="optional" order="19" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1330898" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1330592" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_1330898" xlink:to="loc_us-gaap_SubsequentEventTable_1330592" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_1330884" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_VestingAxis_1330884" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_1330885" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_1330884" xlink:to="loc_us-gaap_VestingDomain_1330885" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_1330885_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_1330884" xlink:to="loc_us-gaap_VestingDomain_1330885_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1330595" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1330595" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1330597" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1330595" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1330597" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1330597_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1330595" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1330597_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1330891" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1330891" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1330892" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1330891" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1330892" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1330892_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1330891" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1330892_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1330602" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1330602" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1330603" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1330602" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1330603" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1330603_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1330602" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1330603_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1330604" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1330603" xlink:to="loc_us-gaap_SubsequentEventMember_1330604" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTIAgreementNameAxis" xlink:label="loc_rgti_RGTIAgreementNameAxis_1581961" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_rgti_RGTIAgreementNameAxis_1581961" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_1581962" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_RGTIAgreementNameAxis_1581961" xlink:to="loc_rgti_RgtiAgreementNameDomain_1581962" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_1581962_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_RGTIAgreementNameAxis_1581961" xlink:to="loc_rgti_RgtiAgreementNameDomain_1581962_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WeightedAverageSharePriceAxis" xlink:label="loc_rgti_WeightedAverageSharePriceAxis_1330956" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_rgti_WeightedAverageSharePriceAxis_1330956" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WeightedAverageSharePriceDomain" xlink:label="loc_rgti_WeightedAverageSharePriceDomain_1330957" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_WeightedAverageSharePriceAxis_1330956" xlink:to="loc_rgti_WeightedAverageSharePriceDomain_1330957" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WeightedAverageSharePriceDomain" xlink:label="loc_rgti_WeightedAverageSharePriceDomain_1330957_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_WeightedAverageSharePriceAxis_1330956" xlink:to="loc_rgti_WeightedAverageSharePriceDomain_1330957_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameAxis" xlink:label="loc_rgti_AgreementNameAxis_1330935" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_rgti_AgreementNameAxis_1330935" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1330937" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rgti_AgreementNameAxis_1330935" xlink:to="loc_rgti_AgreementNameDomain_1330937" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1330937_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rgti_AgreementNameAxis_1330935" xlink:to="loc_rgti_AgreementNameDomain_1330937_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1569045" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1569045" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1569046" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1569045" xlink:to="loc_us-gaap_ClassOfStockDomain_1569046" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1569046_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1569045" xlink:to="loc_us-gaap_ClassOfStockDomain_1569046_default" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1330869" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_AwardTypeAxis_1330869" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1330870" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1330869" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1330870" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1330870_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1330869" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1330870_default" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334406" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_dei_LegalEntityAxis_1334406" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334407" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1334406" xlink:to="loc_dei_EntityDomain_1334407" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334407_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1334406" xlink:to="loc_dei_EntityDomain_1334407_default" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_2146632791" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1330898" xlink:to="loc_us-gaap_RestructuringCharges_2146632791" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfEmployees" xlink:label="loc_rgti_NumberOfEmployees_2146632793" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1330898" xlink:to="loc_rgti_NumberOfEmployees_2146632793" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfReductionInEmployees" xlink:label="loc_rgti_PercentageOfReductionInEmployees_2146632792" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1330898" xlink:to="loc_rgti_PercentageOfReductionInEmployees_2146632792" use="optional" order="35" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaap_LiabilitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_Liabilities" order="1.0" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_Assets" order="1.0" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>rgti-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 05-April-2023 [05:05:55] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract" xml:lang="en-US">Cover [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode" xml:lang="en-US">City Area Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber" xml:lang="en-US">Local Phone Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber" xml:lang="en-US">Entity Tax Identification Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressStateOrProvince" xml:lang="en-US">Entity Address, State or Province</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityPrimarySicNumber" xml:lang="en-US">Entity Primary SIC Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPrimarySicNumber" xlink:to="lab_dei_EntityPrimarySicNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelName" xml:lang="en-US">Contact Personnel Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AddressTypeDomain" xml:lang="en-US">Address Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_BusinessContactMember" xml:lang="en-US">Business Contact [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCurrent" xlink:label="loc_us-gaap_DeferredCostsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCostsCurrent" xml:lang="en-US">Deferred Costs, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredCostsCurrent" xml:lang="en-US">Deferred offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCurrent" xlink:to="lab_us-gaap_DeferredCostsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardContractAssetsCurrent" xlink:label="loc_rgti_ForwardContractAssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ForwardContractAssetsCurrent" xml:lang="en-US">Forward Contract Assets Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ForwardContractAssetsCurrent" xml:lang="en-US">Forward contract&#8212;assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ForwardContractAssetsCurrent" xlink:to="lab_rgti_ForwardContractAssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ForwardContractAssetsCurrent" xml:lang="en-US">Forward contract assets current.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xml:lang="en-US">Marketable Securities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xml:lang="en-US">Available-for-sale&#160;investments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCash" xml:lang="en-US">Restricted Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RestrictedCash" xml:lang="en-US">Restricted cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedCash" xml:lang="en-US">Restricted Cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Total assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating lease&#160;right-of-use&#160;assets, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating Lease Right Of Use Asset</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Goodwill" xml:lang="en-US">Goodwill</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Goodwill" xml:lang="en-US">Goodwill</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_Goodwill" xml:lang="en-US">Beginning balance, goodwill</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_Goodwill" xml:lang="en-US">Ending balance, goodwill</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssets" xml:lang="en-US">Other Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssets" xml:lang="en-US">Other assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xml:lang="en-US">Accrued expenses and other current liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xml:lang="en-US">Accounts payable and other accrued liabilities current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtCurrent" xml:lang="en-US">Debt, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtCurrent" xml:lang="en-US">Debt&#8212;current portion</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredRevenue" xml:lang="en-US">Deferred Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredRevenue" xml:lang="en-US">Deferred revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating Lease, Liability, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating lease liabilities&#8212;current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating lease liabilities, current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardContractLiabilities" xlink:label="loc_rgti_ForwardContractLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ForwardContractLiabilities" xml:lang="en-US">Forward contract Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ForwardContractLiabilities" xml:lang="en-US">Forward contract&#8212;liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ForwardContractLiabilities" xlink:to="lab_rgti_ForwardContractLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ForwardContractLiabilities" xml:lang="en-US">Forward contract liabilities.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtNetOfCurrentPortion" xlink:label="loc_rgti_DebtNetOfCurrentPortion" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DebtNetOfCurrentPortion" xml:lang="en-US">Debt net of current portion</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DebtNetOfCurrentPortion" xml:lang="en-US">Debt - net of current portion</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DebtNetOfCurrentPortion" xlink:to="lab_rgti_DebtNetOfCurrentPortion" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DebtNetOfCurrentPortion" xml:lang="en-US">Debt net of current portion.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaap_OtherLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilities" xml:lang="en-US">Other Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherLiabilities" xml:lang="en-US">Other liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Total Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' equity (deficit):</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Total stockholders' equity (deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Ending balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Beginning balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional paid-in capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common stock*, par value $0.0001 per share; 1,000,000,000 shares and 134,050,472 shares authorized at December 31, 2022 and December 31, 2021, respectively; 125,257,233 shares and 18,221,069 shares issued and outstanding at December 21, 2022 and December 31, 2021, respectively</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Accumulated other comprehensive gain (loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xml:lang="en-US">Preferred Stock, Value, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xml:lang="en-US">Preferred Stock, par value $0.0001 per share; 10,000,000 shares and 0 shares authorized at December 31, 2022 and December 31, 2021, respectively; 0 shares and 0 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xml:lang="en-US">Earn-out liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Operating lease liabilities - noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Operating lease liabilities, noncurrent</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xml:lang="en-US">Derivative Liability, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xml:lang="en-US">Derivative warrant liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and contingencies (Note 9)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Redeemable convertible preferred stock*, par value $0.0001 per share; 0 shares and 80,974,757 shares authorized at December 31, 2022 and December 31, 2021, respectively; 0 shares and 77,696,679 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock, shares authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock shares authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock par or stated value per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock par or stated value per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock, Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock, outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted average shares used in computing net loss per share attributable to common stockholders&#8212;diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted-average Class A Common Stock outstanding, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted-average common shares outstanding - Diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Earnings Per Share, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Net loss per share attributable to common stockholders&#8212;diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">&#8212; Diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating Expenses [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating expenses:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xml:lang="en-US">Selling and Marketing Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xml:lang="en-US">Sales and marketing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xml:lang="en-US">Goodwill, Impairment Loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xml:lang="en-US">Goodwill impairment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xml:lang="en-US">Goodwill, impairment loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xml:lang="en-US">Impairment charge</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and Development Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other income (expense), net:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xml:lang="en-US">Change in fair value of earn-out liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xml:lang="en-US">Change in fair value of earnout liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TransactionCosts" xlink:label="loc_rgti_TransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TransactionCosts" xml:lang="en-US">Transaction Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_rgti_TransactionCosts" xml:lang="en-US">Transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TransactionCosts" xlink:to="lab_rgti_TransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TransactionCosts" xml:lang="en-US">Transaction costs.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xml:lang="en-US">Investment Income, Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xml:lang="en-US">Interest income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Change in fair value of derivative warrant liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Change in fair value of derivative warrant liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair value adjustment of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestExpense" xml:lang="en-US">Interest Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_InterestExpense" xml:lang="en-US">Interest expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InterestExpense" xml:lang="en-US">Interest expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherIncome" xml:lang="en-US">Other Income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherIncome" xml:lang="en-US">Other income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Nonoperating Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Total other income (expense), net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted average shares used in computing net loss per share attributable to common stockholders&#8212;basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted-average Class A Common Stock outstanding, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted-average common shares outstanding - Basic</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Net loss before provision for income taxes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss, as restated</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Provision for income taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfRevenue" xml:lang="en-US">Cost of Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CostOfRevenue" xml:lang="en-US">Cost of revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xml:lang="en-US">Revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Loss from operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Earnings Per Share, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Net loss per share attributable to common stockholders&#8212;basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">&#8212; Basic</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">Gross Profit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">Total gross profit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US">Comprehensive loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xml:lang="en-US">Other comprehensive gain (loss):</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xml:lang="en-US">Change in unrealized loss on&#160;available-for-sale&#160;securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xml:lang="en-US">Foreign currency translation gain (loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xml:lang="en-US">Foreign currency translation gain (loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-In Capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Accumulated Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">Accumulated Other Comprehensive Gain (Loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockMember" xml:lang="en-US">Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Ending balance, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Beginning balance, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xml:lang="en-US">Stock-Based Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" xlink:label="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" xml:lang="en-US">Issuance Of Common Stock Through Business Combination And Private Investment Of Public Equity Net Of Transaction Costs And Derivative Liabilities Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" xml:lang="en-US">Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, as restated</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" xlink:to="lab_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" xml:lang="en-US">Issuance of common stock through business combination and private investment of public equity net of transaction costs and derivative liabilities value.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xlink:label="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xml:lang="en-US">Issuance Of Common Stock Upon Exercise Of Common Stock Warrants, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xml:lang="en-US">Issuance of common stock upon exercise of common stock warrants (Share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xlink:to="lab_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xml:lang="en-US">Issuance of common stock upon exercise of common stock warrants, Shares.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xlink:label="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xml:lang="en-US">Issuance Of Common Stock Upon Exercise Of Common Stock Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xml:lang="en-US">Issuance of common stock upon exercise of common stock warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xlink:to="lab_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xml:lang="en-US">Issuance of common stock upon exercise of common stock warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Issuance of common stock upon exercise of stock options, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" xlink:label="loc_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" xml:lang="en-US">Issuance Of Common Stock Pursuant To The Common Stock Purchase Agreement Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" xml:lang="en-US">Issuance of common stock pursuant to the Common Stock Purchase Agreement (Share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" xlink:to="lab_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" xml:lang="en-US">Issuance of common stock pursuant to the common stock purchase agreement shares.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ReclassificationOfTemporaryEquityShares" xlink:label="loc_rgti_ReclassificationOfTemporaryEquityShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ReclassificationOfTemporaryEquityShares" xml:lang="en-US">Reclassification Of Temporary Equity Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ReclassificationOfTemporaryEquityShares" xml:lang="en-US">Issuance&#160;of&#160;common&#160;stock upon conversion of legacy Series C and Series&#160;C-1&#160;preferred stock in connection with the Business Combination, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ReclassificationOfTemporaryEquityShares" xlink:to="lab_rgti_ReclassificationOfTemporaryEquityShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ReclassificationOfTemporaryEquityShares" xml:lang="en-US">Reclassification of temporary equity shares.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xml:lang="en-US">Capitalization of deferred costs to equity upon share issuance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" xlink:label="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" xml:lang="en-US">Issuance Of Common Stock Through Business Combination And Private Investment Of Public Equity Net Of Transaction Costs And Derivative Liabilities Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" xml:lang="en-US">Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, as restated, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" xlink:to="lab_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" xml:lang="en-US">Issuance of common stock through business combination and private investment of public equity net of transaction costs and derivative liabilities shares.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" xlink:label="loc_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" xml:lang="en-US">Adjustments To Additional Paid In Capital Exercise Of Loan And Security Agreement Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" xml:lang="en-US">Reclassification of loan and security agreement warrants to equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" xlink:to="lab_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" xml:lang="en-US">Adjustments to additional paid in capital exercise of loan and security agreement warrants.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" xlink:label="loc_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" xml:lang="en-US">Adjustments To Additional Paid In Capital Settlement Of The First Tranche Of Forward Contract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" xml:lang="en-US">Settlement of the first tranche of forward contract</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" xlink:to="lab_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" xml:lang="en-US">Adjustments to additional paid in capital settlement of the first tranche of forward contract.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xml:lang="en-US">Issuance of common stock upon release of RSUs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xml:lang="en-US">Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Issuance of common stock upon exercise of stock options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xml:lang="en-US">Issuance of common stock upon release of RSUs (Share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" xlink:label="loc_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" xml:lang="en-US">Increase Decrease In Unrealized Loss On Available For Sale Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" xml:lang="en-US">Change in unrealized loss on&#160;available-for-sale&#160;securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" xlink:to="lab_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" xml:lang="en-US">Increase decrease in unrealized loss on available for sale securities.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RestatementAxis" xml:lang="en-US">Revision of Prior Period [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RestatementDomain" xml:lang="en-US">Revision of Prior Period [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental disclosure of cash flow information:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestPaidNet" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InterestPaidNet" xml:lang="en-US">Cash paid for interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash flows from operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xml:lang="en-US">Amortization of Debt Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xml:lang="en-US">Amortization of debt issuance costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xml:lang="en-US">Amortization of debt issuance cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AmortizationOfDebtCommitmentFeeAsset" xlink:label="loc_rgti_AmortizationOfDebtCommitmentFeeAsset" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AmortizationOfDebtCommitmentFeeAsset" xml:lang="en-US">Amortization of debt commitment fee asset</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_rgti_AmortizationOfDebtCommitmentFeeAsset" xml:lang="en-US">Amortization of debt commitment fee asset</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AmortizationOfDebtCommitmentFeeAsset" xlink:to="lab_rgti_AmortizationOfDebtCommitmentFeeAsset" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AmortizationOfDebtCommitmentFeeAsset" xml:lang="en-US">Amortization of debt commitment fee asset.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ChangeInFairValueOfForwardContract" xlink:label="loc_rgti_ChangeInFairValueOfForwardContract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ChangeInFairValueOfForwardContract" xml:lang="en-US">Change In Fair Value Of Forward Contract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_ChangeInFairValueOfForwardContract" xml:lang="en-US">Change in fair value of forward contract</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ChangeInFairValueOfForwardContract" xlink:to="lab_rgti_ChangeInFairValueOfForwardContract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ChangeInFairValueOfForwardContract" xml:lang="en-US">Change in fair value of forward contract.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation and amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccretionOfDebtEndOfTermLiabilities" xlink:label="loc_rgti_AccretionOfDebtEndOfTermLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AccretionOfDebtEndOfTermLiabilities" xml:lang="en-US">Accretion of debt end of term liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_rgti_AccretionOfDebtEndOfTermLiabilities" xml:lang="en-US">Accretion of debt end of term liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AccretionOfDebtEndOfTermLiabilities" xlink:to="lab_rgti_AccretionOfDebtEndOfTermLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AccretionOfDebtEndOfTermLiabilities" xml:lang="en-US">Accretion of debt end of term liabilities.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock-based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Gain (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xml:lang="en-US">Accretion of available-for-sale securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NonCashLeaseExpense" xlink:label="loc_rgti_NonCashLeaseExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_NonCashLeaseExpense" xml:lang="en-US">Non Cash Lease Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_NonCashLeaseExpense" xml:lang="en-US">Non-cash&#160;lease expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_NonCashLeaseExpense" xlink:to="lab_rgti_NonCashLeaseExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_NonCashLeaseExpense" xml:lang="en-US">Non cash lease expense.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Changes in operating assets and liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xml:lang="en-US">Increase Decrease In Accrued Expenses And Other Current Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xml:lang="en-US">Accrued expenses and other current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xml:lang="en-US">Increase decrease in accrued expenses and other current liabilities.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xml:lang="en-US">Increase (Decrease) in Other Current Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xml:lang="en-US">Other assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Other liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xml:lang="en-US">Deferred revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Cash flows from Investing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net cash used in investing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US">Purchases of property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xml:lang="en-US">Purchases of available-for-sale securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash flows from financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xml:lang="en-US">Proceeds from Notes Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xml:lang="en-US">Proceeds from issuance of notes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfDeferredOfferingCosts" xlink:label="loc_rgti_PaymentOfDeferredOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PaymentOfDeferredOfferingCosts" xml:lang="en-US">Payment of Deferred Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_rgti_PaymentOfDeferredOfferingCosts" xml:lang="en-US">Payments on deferred offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PaymentOfDeferredOfferingCosts" xlink:to="lab_rgti_PaymentOfDeferredOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PaymentOfDeferredOfferingCosts" xml:lang="en-US">Payment of deferred offering costs.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xml:lang="en-US">Payments of Debt Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xml:lang="en-US">Payments on debt issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xml:lang="en-US">Repayments of Notes Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xml:lang="en-US">Payments on principal of notes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xml:lang="en-US">Proceeds From Business Combination Net Of Transaction Costs Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xml:lang="en-US">Proceeds from Business Combination, net of transaction costs paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xml:lang="en-US">Net Proceeds from Business Combination and PIPE</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xml:lang="en-US">Proceeds from business combination net of transaction costs paid</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:to="lab_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xml:lang="en-US">Proceeds from business combination net of transaction costs paid.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TransactionCostsPaid" xlink:label="loc_rgti_TransactionCostsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TransactionCostsPaid" xml:lang="en-US">Transaction Costs Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_rgti_TransactionCostsPaid" xml:lang="en-US">Transaction costs paid directly by Rigetti</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TransactionCostsPaid" xlink:to="lab_rgti_TransactionCostsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TransactionCostsPaid" xml:lang="en-US">Transaction costs paid.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfLoanAndSecurityAgreementExitFees" xlink:label="loc_rgti_PaymentOfLoanAndSecurityAgreementExitFees" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PaymentOfLoanAndSecurityAgreementExitFees" xml:lang="en-US">Payment Of Loan And Security Agreement Exit Fees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_rgti_PaymentOfLoanAndSecurityAgreementExitFees" xml:lang="en-US">Payment on loan and security agreement exit fees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PaymentOfLoanAndSecurityAgreementExitFees" xlink:to="lab_rgti_PaymentOfLoanAndSecurityAgreementExitFees" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PaymentOfLoanAndSecurityAgreementExitFees" xml:lang="en-US">Payment of loan and security agreement exit fees.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" xlink:label="loc_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" xml:lang="en-US">Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options And Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options and warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" xlink:to="lab_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options and warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xml:lang="en-US">Supplemental disclosure of non-cash financing activity:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." xlink:label="loc_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." xml:lang="en-US">Fair Value Of Loan And Security Agreement And Warrant Liability.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." xml:lang="en-US">Fair value of loan and security agreement warrant liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." xlink:to="lab_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." xml:lang="en-US">Fair value of loan and security agreement and warrant liability.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ExerciseOfLoanAndSecurityAgreementWarrants" xlink:label="loc_rgti_ExerciseOfLoanAndSecurityAgreementWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ExerciseOfLoanAndSecurityAgreementWarrants" xml:lang="en-US">Exercise of loan and security agreement warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ExerciseOfLoanAndSecurityAgreementWarrants" xml:lang="en-US">Reclassification of loan and security agreement warrants to equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ExerciseOfLoanAndSecurityAgreementWarrants" xlink:to="lab_rgti_ExerciseOfLoanAndSecurityAgreementWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ExerciseOfLoanAndSecurityAgreementWarrants" xml:lang="en-US">Exercise of loan and security agreement warrants.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xlink:label="loc_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xml:lang="en-US">Deferred Offering Costs In Accounts Payable And Accrued Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xml:lang="en-US">Deferred offering costs in accounts payable and accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xlink:to="lab_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xml:lang="en-US">Deferred offering costs in accounts payable and accrued expenses.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xml:lang="en-US">Unrealized Gain (Loss) on Investments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xml:lang="en-US">Unrealized loss short term investments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" xlink:label="loc_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" xml:lang="en-US">Capitalization of deferred costs to equity upon share issuance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" xlink:to="lab_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" xml:lang="en-US">Capitalization of deferred costs to equity upon share issuance.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xml:lang="en-US">Purchases of property and equipment recorded in accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SettlementOfTheFirstTrancheOfForwardContract" xlink:label="loc_rgti_SettlementOfTheFirstTrancheOfForwardContract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SettlementOfTheFirstTrancheOfForwardContract" xml:lang="en-US">Settlement of the first tranche of forward contract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_SettlementOfTheFirstTrancheOfForwardContract" xml:lang="en-US">Settlement of the first tranche of forward contract</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SettlementOfTheFirstTrancheOfForwardContract" xlink:to="lab_rgti_SettlementOfTheFirstTrancheOfForwardContract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SettlementOfTheFirstTrancheOfForwardContract" xml:lang="en-US">Settlement of the first tranche of forward contract.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" xlink:label="loc_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" xml:lang="en-US">Initial Fair Value Of Earnout Liability Acquired In Mergera</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" xml:lang="en-US">Initial fair value of earn-out liability acquired in merger</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" xlink:to="lab_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" xml:lang="en-US">Initial fair value of earn-out liability acquired in merger.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" xlink:label="loc_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" xml:lang="en-US">Initial Fair Value Of Private Placement And Public Warrants Liability Acquired In Merger</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" xml:lang="en-US">Initial fair value of private placement and public warrants liability acquired in merger</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" xlink:to="lab_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" xml:lang="en-US">Initial fair value of private placement and public warrants liability acquired in merger.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" xlink:label="loc_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" xml:lang="en-US">Right Of Use Assets Recorded On Adoption Of ASU 201602</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" xml:lang="en-US">Right-of-use&#160;assets recorded on adoption of ASU&#160;2016-02</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" xlink:to="lab_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" xml:lang="en-US">Right of use assets recorded on adoption Of ASU 2016-02.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" xlink:label="loc_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" xml:lang="en-US">Operating Lease Liabilities Recorded On Adoption Of ASU 201602</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" xml:lang="en-US">Operating lease liabilities recorded on adoption of ASU&#160;2016-02</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" xlink:to="lab_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" xml:lang="en-US">Operating lease liabilities recorded on adoption of ASU 2016-02.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xlink:label="loc_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xml:lang="en-US">Lease Liabilities Arising From Obtaining Right Of Use Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xml:lang="en-US">Lease liabilities arising from obtaining right-of-use assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xlink:to="lab_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xml:lang="en-US">Lease liabilities arising from obtaining right of use assets.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" xlink:label="loc_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" xml:lang="en-US">Purchases of property and equipment recorded in accrued expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" xml:lang="en-US">Purchases of property and equipment recorded in accrued expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" xlink:to="lab_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" xml:lang="en-US">Purchases of property and equipment recorded in accrued expense.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Effect of changes in exchange rate on cash and restricted cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xml:lang="en-US">Description of Business</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Summary of Significant Accounting Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xml:lang="en-US">Business Combinations [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xml:lang="en-US">Business Combination Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xml:lang="en-US">Business Combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US">INVESTMENTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xml:lang="en-US">Goodwill Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xml:lang="en-US">GOODWILL</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xml:lang="en-US">Disaggregation of Revenue [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xml:lang="en-US">Disaggregation of Revenue [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xml:lang="en-US">Revenue Recognition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupplementalFinancialStatementInformationAbstract" xlink:label="loc_rgti_SupplementalFinancialStatementInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SupplementalFinancialStatementInformationAbstract" xml:lang="en-US">Supplemental Financial Statement information [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SupplementalFinancialStatementInformationAbstract" xlink:to="lab_rgti_SupplementalFinancialStatementInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SupplementalFinancialStatementInformationAbstract" xml:lang="en-US">Supplemental financial statement information.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupplementalFinancialStatementInformationTextBlock" xlink:label="loc_rgti_SupplementalFinancialStatementInformationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SupplementalFinancialStatementInformationTextBlock" xml:lang="en-US">Supplemental Financial Statement information [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_SupplementalFinancialStatementInformationTextBlock" xml:lang="en-US">Supplemental Financial Statement information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SupplementalFinancialStatementInformationTextBlock" xlink:to="lab_rgti_SupplementalFinancialStatementInformationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SupplementalFinancialStatementInformationTextBlock" xml:lang="en-US">Supplemental Financial statement information.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesAbstract" xml:lang="en-US">Leases [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeasesAbstract" xml:lang="en-US">Schedule of operating lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xml:lang="en-US">Leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xml:lang="en-US">Debt Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US">Debt Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xml:lang="en-US">Debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xml:lang="en-US">Temporary Equity [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RedeemableConvertiblePreferredStockTextBlock" xlink:label="loc_rgti_RedeemableConvertiblePreferredStockTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RedeemableConvertiblePreferredStockTextBlock" xml:lang="en-US">Redeemable Convertible preferred stock [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_RedeemableConvertiblePreferredStockTextBlock" xml:lang="en-US">Redeemable Convertible Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RedeemableConvertiblePreferredStockTextBlock" xlink:to="lab_rgti_RedeemableConvertiblePreferredStockTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RedeemableConvertiblePreferredStockTextBlock" xml:lang="en-US">Redeemable convertible preferred stock text block.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityAbstract" xml:lang="en-US">Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockLineItems" xml:lang="en-US">Class of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockTextBlock" xlink:label="loc_rgti_CommonStockTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockTextBlock" xml:lang="en-US">COMMON STOCK [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockTextBlock" xml:lang="en-US">Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockTextBlock" xlink:to="lab_rgti_CommonStockTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockTextBlock" xml:lang="en-US">Common stock text block.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class of Warrant or Right [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class Of Warrant Or Right [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class Of Warrant Or Right [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WarrantsTextBlock" xlink:label="loc_rgti_WarrantsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_WarrantsTextBlock" xml:lang="en-US">Warrants [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_WarrantsTextBlock" xml:lang="en-US">Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_WarrantsTextBlock" xlink:to="lab_rgti_WarrantsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_WarrantsTextBlock" xml:lang="en-US">Warrants.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementDisclosure" xlink:label="loc_rgti_ForwardWarrantAgreementDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ForwardWarrantAgreementDisclosure" xml:lang="en-US">Forward Warrant Agreement Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ForwardWarrantAgreementDisclosure" xml:lang="en-US">Forward Warrant Agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ForwardWarrantAgreementDisclosure" xlink:to="lab_rgti_ForwardWarrantAgreementDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ForwardWarrantAgreementDisclosure" xml:lang="en-US">Forward warrant agreement disclosure [Text block].</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">Fair Value Measurements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Equity Plans</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Earnings Per Share [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Net Loss Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingAbstract" xml:lang="en-US">Segment Reporting [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xml:lang="en-US">Segments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xml:lang="en-US">Derivative Warrant Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration of Credit Risk</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SalesAndMarketingPolicyTextBlock" xlink:label="loc_rgti_SalesAndMarketingPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SalesAndMarketingPolicyTextBlock" xml:lang="en-US">Sales and Marketing [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_SalesAndMarketingPolicyTextBlock" xml:lang="en-US">Sales and Marketing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SalesAndMarketingPolicyTextBlock" xlink:to="lab_rgti_SalesAndMarketingPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SalesAndMarketingPolicyTextBlock" xml:lang="en-US">Sales and marketing.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" xlink:label="loc_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" xml:lang="en-US">Costs of Obtaining and Fulfilling Contracts [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" xml:lang="en-US">Costs of Obtaining and Fulfilling Contracts</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" xlink:to="lab_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" xml:lang="en-US">Costs of obtaining and fulfilling contracts.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredOfferingCostsPolicyTextBlock" xlink:label="loc_rgti_DeferredOfferingCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DeferredOfferingCostsPolicyTextBlock" xml:lang="en-US">Deferred Offering Costs [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DeferredOfferingCostsPolicyTextBlock" xml:lang="en-US">Deferred Offering Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DeferredOfferingCostsPolicyTextBlock" xlink:to="lab_rgti_DeferredOfferingCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DeferredOfferingCostsPolicyTextBlock" xml:lang="en-US">Deferred offering costs..</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicAndPrivateWarrantsPolicyTextBlock" xlink:label="loc_rgti_PublicAndPrivateWarrantsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PublicAndPrivateWarrantsPolicyTextBlock" xml:lang="en-US">Public And Private Warrants [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PublicAndPrivateWarrantsPolicyTextBlock" xml:lang="en-US">Public and Private Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PublicAndPrivateWarrantsPolicyTextBlock" xlink:to="lab_rgti_PublicAndPrivateWarrantsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PublicAndPrivateWarrantsPolicyTextBlock" xml:lang="en-US">Public And Private Warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xml:lang="en-US">Segments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xml:lang="en-US">Reclassifications</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xml:lang="en-US">Goodwill</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="loc_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xml:lang="en-US">Prepaid expenses and other current assets [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:to="lab_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xml:lang="en-US">Prepaid expenses and other current assets.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xml:lang="en-US">Comprehensive Loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Net income (loss) per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property and Equipment, Net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CapitalizedSoftwarePolicyTextBlock" xlink:label="loc_rgti_CapitalizedSoftwarePolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CapitalizedSoftwarePolicyTextBlock" xml:lang="en-US">Capitalized Software [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CapitalizedSoftwarePolicyTextBlock" xml:lang="en-US">Capitalized Software</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CapitalizedSoftwarePolicyTextBlock" xlink:to="lab_rgti_CapitalizedSoftwarePolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CapitalizedSoftwarePolicyTextBlock" xml:lang="en-US">Capitalized software.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredFinancingCostsPolicyTextBlock" xlink:label="loc_rgti_DeferredFinancingCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DeferredFinancingCostsPolicyTextBlock" xml:lang="en-US">Deferred Financing Costs [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DeferredFinancingCostsPolicyTextBlock" xml:lang="en-US">Deferred Financing Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DeferredFinancingCostsPolicyTextBlock" xlink:to="lab_rgti_DeferredFinancingCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DeferredFinancingCostsPolicyTextBlock" xml:lang="en-US">Deferred financing costs.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xml:lang="en-US">Investments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xml:lang="en-US">General and Administrative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xml:lang="en-US">Foreign Currency</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xml:lang="en-US">Stock-Based Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Principals of Consolidation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="loc_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xml:lang="en-US">Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xml:lang="en-US">Recently Issued Accounting Pronouncements Not Yet Adopted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:to="lab_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xml:lang="en-US">Recently issued accounting pronouncements not yet adopted.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xml:lang="en-US">Cost of Revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_rgti_EmergingGrowthCompanyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EmergingGrowthCompanyPolicyTextBlock" xml:lang="en-US">Emerging Growth Company Policy [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_EmergingGrowthCompanyPolicyTextBlock" xml:lang="en-US">Emerging Growth Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EmergingGrowthCompanyPolicyTextBlock" xlink:to="lab_rgti_EmergingGrowthCompanyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_EmergingGrowthCompanyPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for emerging growth company.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recently Issued Accounting Pronouncements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US">Fair Value Measurements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xml:lang="en-US">Accounts Receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" xlink:label="loc_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" xml:lang="en-US">Business Acquisition Contingent Consideration Liability [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" xml:lang="en-US">Earn-Out Liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" xlink:to="lab_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" xml:lang="en-US">Business Acquisition Contingent Consideration Liability.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" xml:lang="en-US">Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" xml:lang="en-US">Schedule of Inputs Into the Respective Models</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" xlink:to="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" xml:lang="en-US">Disclosure in tabular form of assumptions based on significant unobservable inputs used in the valuation of earn out liability arising out of business combination.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xml:lang="en-US">Cash, Cash Equivalents and Investments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" xml:lang="en-US">Disclosure In Tabular Form Of Concentration Of Accounts Receivable [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" xml:lang="en-US">Schedule of Customers Accounts Receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" xlink:to="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" xml:lang="en-US">Disclosure in tabular form of concentration of accounts receivable.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" xml:lang="en-US">Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" xml:lang="en-US">Summary of consummation of the business combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" xlink:to="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" xml:lang="en-US">Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" xml:lang="en-US">Disclosure In Tabular Form Of Net Proceeds From Business Combination [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" xml:lang="en-US">Summary of net proceeds from business combination and PIPE financing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" xlink:to="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" xml:lang="en-US">Disclosure in tabular form of net proceeds from business combination.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xml:lang="en-US">Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xml:lang="en-US">Schedule of Goodwill</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" xml:lang="en-US">Schedule of Change in Contract with Customer, Asset and Liability [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" xml:lang="en-US">Summary of Change in Contract with Customer, Asset and Liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" xml:lang="en-US">Schedule of Change in Contract with Customer, Asset and Liability</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xml:lang="en-US">Summary of Disaggregation of Revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xml:lang="en-US">Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Summary Of Property, Plant and Equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xml:lang="en-US">Summary of Components of Lease Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xml:lang="en-US">Summary of Maturities of the Company's Operating Lease Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" xlink:label="loc_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" xml:lang="en-US">Schedule Of Future Minimum Lease Payments Under Non Cancelable Operating Leases [Table Text Block]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" xlink:to="lab_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" xml:lang="en-US">Schedule of future minimum lease payments under non cancelable operating leases.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xml:lang="en-US">Schedule of Debt [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xml:lang="en-US">Long term debt and the unamortized discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xml:lang="en-US">Scheduled principal payments on total outstanding debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US">Schedule of Stock by Class [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:label="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfConversionsOfStockTextBlock" xml:lang="en-US">Schedule of Conversions of Stock [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfConversionsOfStockTextBlock" xml:lang="en-US">Summary of Conversions of Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:to="lab_us-gaap_ScheduleOfConversionsOfStockTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" xlink:label="loc_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" xml:lang="en-US">Disclosure Of Vesting Status Of Warrants [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" xml:lang="en-US">Summary of vesting status of the Customer Warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" xlink:to="lab_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" xml:lang="en-US">Disclosure of vesting status of warrants .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Schedule Of Fair Value Of The Common Stock Warrant Liabilities Measured Using Black Scholes Approach</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateWarrantMember" xlink:label="loc_rgti_PrivateWarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PrivateWarrantMember" xml:lang="en-US">Private Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_PrivateWarrantMember" xml:lang="en-US">Private Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PrivateWarrantMember" xlink:to="lab_rgti_PrivateWarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PrivateWarrantMember" xml:lang="en-US">Private warrant.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Fair value liabilities measured on recurring and nonrecurring basis valuation techniques</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xml:lang="en-US">Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Change in Fair Value of Derivative Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xml:lang="en-US">Schedule of Activity Related to Restricted Stock Units</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xml:lang="en-US">Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xml:lang="en-US">Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value [Table Text Block]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xml:lang="en-US">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule Computation Of Earnings Per Share Basic And Diluted [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share Basic Aand Diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule computation of earnings per share basic and diluted.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xml:lang="en-US">Schedule of Antidilutive Securities Excluded From Computation of Earnings</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Summary Of Components Of Deferred Tax Assets And Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xml:lang="en-US">Summary Of Domestic And Foreign Components Of Loss Before Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xml:lang="en-US">Summary Of Unrecognized Tax Benefits Affecting The Effective Tax rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US">Summary Of Effective Income Tax Rate Reconciliation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xml:lang="en-US">Summary of Revenue by Geography</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:label="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xml:lang="en-US">Description Of Organization Business Operations And Basis Of Presentation [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xml:lang="en-US">Description Of Organization Business Operations And Basis Of Presentation [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="lab_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xml:lang="en-US">Description of organization business operations and basis of presentation.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_RangeAxis" xml:lang="en-US">Statistical Measurement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember" xml:lang="en-US">Statistical Measurement [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_RangeMember" xml:lang="en-US">Statistical Measurement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US">Business Acquisition [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US">Business Acquisition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xml:lang="en-US">Business Acquisition, Acquiree</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:label="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xml:lang="en-US">Description Of Organization Business Operations And Basis Of Presentation [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xml:lang="en-US">Description Of Organization Business Operations And Basis Of Presentation [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="lab_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xml:lang="en-US">Description of organization business operations and basis of presentation.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonClassBMember" xml:lang="en-US">Common Class B [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonClassBMember" xml:lang="en-US">Class B Ordinary Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Common Class A [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Class A Ordinary Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventAxis" xlink:label="loc_rgti_EventAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EventAxis" xml:lang="en-US">Event [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EventAxis" xlink:to="lab_rgti_EventAxis" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventDomain" xlink:label="loc_rgti_EventDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EventDomain" xml:lang="en-US">Event [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EventDomain" xlink:to="lab_rgti_EventDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" xlink:label="loc_rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" xml:lang="en-US">Conversion Of Common Stock Shares From The Previous Company To The Current Company [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" xlink:to="lab_rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Title of Individual [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Title of Individual</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheAxis" xlink:label="loc_rgti_TrancheAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TrancheAxis" xml:lang="en-US">Tranche [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TrancheAxis" xlink:to="lab_rgti_TrancheAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TrancheAxis" xml:lang="en-US">Tranche.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheDomain" xlink:label="loc_rgti_TrancheDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TrancheDomain" xml:lang="en-US">Tranche [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TrancheDomain" xlink:to="lab_rgti_TrancheDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TrancheDomain" xml:lang="en-US">Tranche.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementAxis" xlink:label="loc_rgti_AgreementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AgreementAxis" xml:lang="en-US">Agreement [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AgreementAxis" xlink:to="lab_rgti_AgreementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AgreementAxis" xml:lang="en-US">Agreement.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementDomain" xlink:label="loc_rgti_AgreementDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AgreementDomain" xml:lang="en-US">Agreement [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AgreementDomain" xlink:to="lab_rgti_AgreementDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AgreementDomain" xml:lang="en-US">Agreement.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_rgti_SummaryOfSignificantAccountingPoliciesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_SummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_rgti_SummaryOfSignificantAccountingPoliciesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SummaryOfSignificantAccountingPoliciesTable" xml:lang="en-US">Summary of significant accounting policies.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_SummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_rgti_SummaryOfSignificantAccountingPoliciesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SummaryOfSignificantAccountingPoliciesLineItems" xml:lang="en-US">Summary of significant accounting policies.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xml:lang="en-US">Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xml:lang="en-US">Cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xml:lang="en-US">Cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NumberOfReportableSegments" xml:lang="en-US">Number of Reportable Segments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NumberOfReportableSegments" xml:lang="en-US">Number of reporting segments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredOfferingCosts" xml:lang="en-US">Deferred Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredOfferingCosts" xml:lang="en-US">Deferred offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Concentration Risk, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Concentration Risk, Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Class of warrants or rights outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Warrants outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xml:lang="en-US">Number of Operating Segments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xml:lang="en-US">Number of operating segments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Class of warrants or rights exercise price of warrants or rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise price of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise price common stock of warrants or rights outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeLiabilities" xml:lang="en-US">Derivative Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeLiabilities" xml:lang="en-US">Derivative liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of warrants or rights number of securities covered by each warrant or right</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodOfEarnoutShares" xlink:label="loc_rgti_PeriodOfEarnoutShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PeriodOfEarnoutShares" xml:lang="en-US">Period Of Earnout Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PeriodOfEarnoutShares" xml:lang="en-US">Period of earnout shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PeriodOfEarnoutShares" xlink:to="lab_rgti_PeriodOfEarnoutShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PeriodOfEarnoutShares" xml:lang="en-US">Period Of Earnout Shares.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Class of warrants or rights maturity period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Warrants and rights outstanding, term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xml:lang="en-US">Share based compensation by share based award requisite service period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OfferingCostsIncurred" xlink:label="loc_rgti_OfferingCostsIncurred" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_OfferingCostsIncurred" xml:lang="en-US">Offering costs incurred</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_OfferingCostsIncurred" xml:lang="en-US">Offering costs incurred</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_OfferingCostsIncurred" xlink:to="lab_rgti_OfferingCostsIncurred" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_OfferingCostsIncurred" xml:lang="en-US">Offering costs incurred.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Operating Lease, Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Operating Lease Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Present value of lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInDeferredRent" xlink:label="loc_rgti_IncreaseDecreaseInDeferredRent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_IncreaseDecreaseInDeferredRent" xml:lang="en-US">Increase Decrease In Deferred Rent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_IncreaseDecreaseInDeferredRent" xml:lang="en-US">Adjustments To Deferred Rent</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_IncreaseDecreaseInDeferredRent" xlink:to="lab_rgti_IncreaseDecreaseInDeferredRent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_IncreaseDecreaseInDeferredRent" xml:lang="en-US">Increase decrease in deferred rent.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAdditions" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xml:lang="en-US">Capitalized Computer Software, Additions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xml:lang="en-US">Capitalized Software</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAdditions" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xml:lang="en-US">Financial liabilities at fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xml:lang="en-US">Accounting Standards Update [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xml:lang="en-US">Accounting Standards Update</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xml:lang="en-US">Accounting Standards Update [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xml:lang="en-US">Accounting Standards Update</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="loc_us-gaap_RetirementPlanNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xml:lang="en-US">Retirement Plan Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="loc_us-gaap_RetirementPlanNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xml:lang="en-US">Retirement Plan Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementScenarioAxis" xml:lang="en-US">Scenario [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xml:lang="en-US">Scenario [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xml:lang="en-US">Concentration Risk Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xml:lang="en-US">Concentration Risk Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US">Customer Concentration Risk [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:label="loc_us-gaap_RevenueFromRightsConcentrationRiskMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromRightsConcentrationRiskMember" xml:lang="en-US">Revenue from Rights Concentration Risk [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:to="lab_us-gaap_RevenueFromRightsConcentrationRiskMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiComputingIncMember" xlink:label="loc_rgti_RigettiComputingIncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RigettiComputingIncMember" xml:lang="en-US">Rigetti Computing, Inc [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RigettiComputingIncMember" xlink:to="lab_rgti_RigettiComputingIncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RigettiComputingIncMember" xml:lang="en-US">Rigetti computing, Inc.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfCustomersAxis" xlink:label="loc_rgti_NumberOfCustomersAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_NumberOfCustomersAxis" xml:lang="en-US">Number Of Customers [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_NumberOfCustomersAxis" xlink:to="lab_rgti_NumberOfCustomersAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_NumberOfCustomersAxis" xml:lang="en-US">Number Of Customers.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfCustomersDomain" xlink:label="loc_rgti_NumberOfCustomersDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_NumberOfCustomersDomain" xml:lang="en-US">Number Of Customers [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_NumberOfCustomersDomain" xlink:to="lab_rgti_NumberOfCustomersDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_NumberOfCustomersDomain" xml:lang="en-US">Number Of Customers.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CriteriaAxis" xlink:label="loc_rgti_CriteriaAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CriteriaAxis" xml:lang="en-US">Criteria [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CriteriaAxis" xlink:to="lab_rgti_CriteriaAxis" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CriteriaDomain" xlink:label="loc_rgti_CriteriaDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CriteriaDomain" xml:lang="en-US">Criteria [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CriteriaDomain" xlink:to="lab_rgti_CriteriaDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableMember" xml:lang="en-US">Accounts Receivable [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesRevenueNetMember" xml:lang="en-US">Revenue Benchmark [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SalesRevenueNetMember" xml:lang="en-US">Revenue [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SalesRevenueNetMember" xml:lang="en-US">Revenue Benchmark [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">Award Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" xlink:label="loc_rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" xml:lang="en-US">Service Based And Performance Based Restricted Stock Units [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" xlink:to="lab_rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Stock-Based Awards&#8212;Options Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xml:lang="en-US">Stock Options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xml:lang="en-US">Liability Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xml:lang="en-US">Fair Value by Liability Class [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorMember" xlink:label="loc_rgti_SponsorMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SponsorMember" xml:lang="en-US">Sponsor [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SponsorMember" xlink:to="lab_rgti_SponsorMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SponsorMember" xml:lang="en-US">Sponsor.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicWarrantsMember" xlink:label="loc_rgti_PublicWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PublicWarrantsMember" xml:lang="en-US">Public Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PublicWarrantsMember" xml:lang="en-US">Public Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PublicWarrantsMember" xlink:to="lab_rgti_PublicWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PublicWarrantsMember" xml:lang="en-US">Public Warrants.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivatePlacementWarrantsMember" xlink:label="loc_rgti_PrivatePlacementWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PrivatePlacementWarrantsMember" xml:lang="en-US">Private Placement Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PrivatePlacementWarrantsMember" xml:lang="en-US">Private Placement Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PrivatePlacementWarrantsMember" xlink:to="lab_rgti_PrivatePlacementWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PrivatePlacementWarrantsMember" xml:lang="en-US">Private placement warrants.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConditionAxis" xlink:label="loc_rgti_ConditionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ConditionAxis" xml:lang="en-US">Condition [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ConditionAxis" xlink:to="lab_rgti_ConditionAxis" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConditionDomain" xlink:label="loc_rgti_ConditionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ConditionDomain" xml:lang="en-US">Condition [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ConditionDomain" xlink:to="lab_rgti_ConditionDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTIAgreementNameAxis" xlink:label="loc_rgti_RGTIAgreementNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RGTIAgreementNameAxis" xml:lang="en-US">RGTI Agreement Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RGTIAgreementNameAxis" xlink:to="lab_rgti_RGTIAgreementNameAxis" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RgtiAgreementNameDomain" xml:lang="en-US">RGTI Agreement Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RgtiAgreementNameDomain" xlink:to="lab_rgti_RgtiAgreementNameDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTICommonStockPurchaseAgreementMember" xlink:label="loc_rgti_RGTICommonStockPurchaseAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RGTICommonStockPurchaseAgreementMember" xml:lang="en-US">RGTI Common Stock Purchase Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_RGTICommonStockPurchaseAgreementMember" xml:lang="en-US">RGTI Common Stock Purchase Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RGTICommonStockPurchaseAgreementMember" xlink:to="lab_rgti_RGTICommonStockPurchaseAgreementMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TwoThousandThirteenEquityIncentivePlanMember" xml:lang="en-US">Two Thousand Thirteen Equity Incentive Plan [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_TwoThousandThirteenEquityIncentivePlanMember" xml:lang="en-US">2013 Equity Incentive Plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember" xlink:to="lab_rgti_TwoThousandThirteenEquityIncentivePlanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TwoThousandThirteenEquityIncentivePlanMember" xml:lang="en-US">Two thousand Thirteen Equity Incentive Plan</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductOrServiceAxis" xml:lang="en-US">Product and Service [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductsAndServicesDomain" xml:lang="en-US">Product and Service [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_GovernmentEntitiesMember" xlink:label="loc_rgti_GovernmentEntitiesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_GovernmentEntitiesMember" xml:lang="en-US">Government Entities [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_GovernmentEntitiesMember" xlink:to="lab_rgti_GovernmentEntitiesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_GovernmentEntitiesMember" xml:lang="en-US">Government entities.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Restricted cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Total cash and restricted cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" xml:lang="en-US">Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" xlink:to="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" xml:lang="en-US">Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" xml:lang="en-US">Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" xlink:to="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" xml:lang="en-US">Disclosure in tabular form of assumptions based on significant Unobservable inputs used in the valuation of earn out liability arising out of business combination.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xml:lang="en-US">Measurement Input Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xml:lang="en-US">Measurement Input Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Risk-free Rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US">Measurement Input, Price Volatility [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US">Volatility (annual)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US">Measurement Input, Price Volatility (annual) [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SimulatedTradingDaysMember" xlink:label="loc_rgti_SimulatedTradingDaysMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SimulatedTradingDaysMember" xml:lang="en-US">Simulated Trading Days [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_SimulatedTradingDaysMember" xml:lang="en-US">Simulated trading days</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SimulatedTradingDaysMember" xlink:to="lab_rgti_SimulatedTradingDaysMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SimulatedTradingDaysMember" xml:lang="en-US">Simulated trading days.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US">Measurement Input, Share Price [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US">Stock Price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EstimatedPeriodOfExpirationMember" xlink:label="loc_rgti_EstimatedPeriodOfExpirationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EstimatedPeriodOfExpirationMember" xml:lang="en-US">Estimated Period Of Expiration [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_EstimatedPeriodOfExpirationMember" xml:lang="en-US">Estimated time to expiration</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EstimatedPeriodOfExpirationMember" xlink:to="lab_rgti_EstimatedPeriodOfExpirationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_EstimatedPeriodOfExpirationMember" xml:lang="en-US">Estimated period of expiration.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" xml:lang="en-US">Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" xlink:to="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" xml:lang="en-US">Disclosure in tabular form of assumptions based on significant unobservable inputs used in the valuation Of earn out liability arising out of business combination.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xml:lang="en-US">Valuation Assumptions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfTransitionPeriodComparativeDataTable" xlink:label="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ScheduleOfTransitionPeriodComparativeDataTable" xml:lang="en-US">Schedule Of Transition Period Comparative Data [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable" xlink:to="lab_rgti_ScheduleOfTransitionPeriodComparativeDataTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ScheduleOfTransitionPeriodComparativeDataTable" xml:lang="en-US">Schedule of transition period comparative data table.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MajorCustomersAxis" xml:lang="en-US">Customer [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_NameOfMajorCustomerDomain" xml:lang="en-US">Customer [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerDMember" xlink:label="loc_rgti_CustomerDMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CustomerDMember" xml:lang="en-US">Customer D [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CustomerDMember" xlink:to="lab_rgti_CustomerDMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerCMember" xlink:label="loc_rgti_CustomerCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CustomerCMember" xml:lang="en-US">Customer C [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CustomerCMember" xml:lang="en-US">Customer C [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CustomerCMember" xlink:to="lab_rgti_CustomerCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CustomerCMember" xml:lang="en-US">Customer c.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerEMember" xlink:label="loc_rgti_CustomerEMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CustomerEMember" xml:lang="en-US">Customer E [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CustomerEMember" xlink:to="lab_rgti_CustomerEMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerFMember" xlink:label="loc_rgti_CustomerFMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CustomerFMember" xml:lang="en-US">Customer F [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CustomerFMember" xlink:to="lab_rgti_CustomerFMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CustomerFMember" xml:lang="en-US">Customer F.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerAMember" xlink:label="loc_rgti_CustomerAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CustomerAMember" xml:lang="en-US">Customer A [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CustomerAMember" xml:lang="en-US">Customer A [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CustomerAMember" xlink:to="lab_rgti_CustomerAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CustomerAMember" xml:lang="en-US">Customer a.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerBMember" xlink:label="loc_rgti_CustomerBMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CustomerBMember" xml:lang="en-US">Customer B [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CustomerBMember" xml:lang="en-US">Customer B [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CustomerBMember" xlink:to="lab_rgti_CustomerBMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CustomerBMember" xml:lang="en-US">Customer b.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" xlink:label="loc_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" xml:lang="en-US">Schedule of Transition Period Comparative Data [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" xlink:to="lab_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" xml:lang="en-US">Schedule of transition period comparative data line items.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" xml:lang="en-US">Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" xlink:to="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" xml:lang="en-US">Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Table].</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" xml:lang="en-US">Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" xlink:to="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" xml:lang="en-US">Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items].</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" xml:lang="en-US">Disclosure In Tabular Form Of Net Proceeds From Business Combination [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" xlink:to="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" xml:lang="en-US">Disclosure In Tabular Form Of Net Proceeds From Business Combination.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" xml:lang="en-US">Disclosure In Tabular Form Of Net Proceeds From Business Combination [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" xlink:to="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" xml:lang="en-US">Disclosure In Tabular Form Of Net Proceeds From Business Combination.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AggregateTransactionCostsPaid" xlink:label="loc_rgti_AggregateTransactionCostsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AggregateTransactionCostsPaid" xml:lang="en-US">Aggregate Transaction Costs Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AggregateTransactionCostsPaid" xml:lang="en-US">Cash&#8212;SNII operating account</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AggregateTransactionCostsPaid" xlink:to="lab_rgti_AggregateTransactionCostsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AggregateTransactionCostsPaid" xml:lang="en-US">Aggregate transaction costs paid.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CashReceivedFromPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_CashReceivedFromPrivateInvestmentInPublicEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CashReceivedFromPrivateInvestmentInPublicEquity" xml:lang="en-US">Cash Received From Private Investment In Public Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CashReceivedFromPrivateInvestmentInPublicEquity" xml:lang="en-US">Cash&#8212;PIPE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CashReceivedFromPrivateInvestmentInPublicEquity" xlink:to="lab_rgti_CashReceivedFromPrivateInvestmentInPublicEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CashReceivedFromPrivateInvestmentInPublicEquity" xml:lang="en-US">Cash Received From Private Investment In Public Equity.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CashReceivedFromTrustNetOfRedemptions" xlink:label="loc_rgti_CashReceivedFromTrustNetOfRedemptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CashReceivedFromTrustNetOfRedemptions" xml:lang="en-US">Cash Received From Trust Net Of Redemptions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CashReceivedFromTrustNetOfRedemptions" xml:lang="en-US">Cash&#8212;SNII trust and cash (net of redemption)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CashReceivedFromTrustNetOfRedemptions" xlink:to="lab_rgti_CashReceivedFromTrustNetOfRedemptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CashReceivedFromTrustNetOfRedemptions" xml:lang="en-US">Cash Received From Trust Net Of Redemptions.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfTransactionCostsThroughCash" xlink:label="loc_rgti_PaymentOfTransactionCostsThroughCash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PaymentOfTransactionCostsThroughCash" xml:lang="en-US">Payment Of Transaction Costs Through Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PaymentOfTransactionCostsThroughCash" xml:lang="en-US">Payment of transaction costs through cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PaymentOfTransactionCostsThroughCash" xlink:to="lab_rgti_PaymentOfTransactionCostsThroughCash" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PaymentOfTransactionCostsThroughCash" xml:lang="en-US">Payment of transaction costs through cash.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" xlink:label="loc_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" xml:lang="en-US">Adjustment To Additional Paid In Capital Business Combination Transaction Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" xml:lang="en-US">Adjustment to additional paid in capital business combination transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" xlink:to="lab_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" xml:lang="en-US">Adjustment to additional paid in capital business combination transaction costs.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xml:lang="en-US">Business combination transaction costs expensed</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xml:lang="en-US">Business combination transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" xml:lang="en-US">Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" xlink:to="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" xml:lang="en-US">Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" xml:lang="en-US">Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" xlink:to="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" xml:lang="en-US">Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" xml:lang="en-US">Stock Shares Issued Aggregate Business Combination Private Investment In Public Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" xml:lang="en-US">Business Combination and PIPE shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" xlink:to="lab_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" xml:lang="en-US">Stock shares issued aggregate business combination private investment in public equity.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedInTheNewCompany" xlink:label="loc_rgti_CommonStockSharesIssuedInTheNewCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockSharesIssuedInTheNewCompany" xml:lang="en-US">Common Stock Shares Issued In The New Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockSharesIssuedInTheNewCompany" xml:lang="en-US">Common Stock&#8212;Legacy Rigetti</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockSharesIssuedInTheNewCompany" xlink:to="lab_rgti_CommonStockSharesIssuedInTheNewCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockSharesIssuedInTheNewCompany" xml:lang="en-US">Common stock shares issued in the new company.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" xlink:label="loc_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" xml:lang="en-US">Common Stock Shares Issued Due To Exercise Of Warrants Immediately Before Closing</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" xml:lang="en-US">Common Stock&#8212;exercise of Legacy Rigetti warrants immediately prior to the closing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" xlink:to="lab_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" xml:lang="en-US">Common stock shares issued due to exercise of warrants immediately before closing.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" xlink:label="loc_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" xml:lang="en-US">Common Stock Shares Issued Due To Exercise Of Stock Options Immediately Before Closing</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" xml:lang="en-US">Common Stock&#8212;exercise of Legacy Rigetti stock options immediately prior to the closing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" xlink:to="lab_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" xml:lang="en-US">Common stock shares issued due to exercise of stock options immediately before closing.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" xml:lang="en-US">Common Stock Shares Issued Pursuant To Private Investment In Public Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" xml:lang="en-US">Shares issued in PIPE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" xlink:to="lab_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" xml:lang="en-US">Common stock shares issued pursuant to private investment in public equity.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" xlink:label="loc_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" xml:lang="en-US">Redemption Of Common Stock Shares Of The Predecessor Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" xml:lang="en-US">Less: redemption of SNII Class&#160;A ordinary shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" xlink:to="lab_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" xml:lang="en-US">Redemption of common stock shares of the predecessor company.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" xlink:label="loc_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" xml:lang="en-US">Common Stock Shares Newly Issued In The Predecessor Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" xml:lang="en-US">Common Stock&#8212;SNII Class ordinary shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" xlink:to="lab_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" xml:lang="en-US">Common stock shares newly issued in the predecessor company.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" xlink:label="loc_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" xml:lang="en-US">Common Stock Shares Issued In The New Company Upon Conversion Of Temporary Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" xml:lang="en-US">Common Stock&#8212;upon conversion of Legacy Rigetti Series preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" xlink:to="lab_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" xml:lang="en-US">Common stock shares issued in the new company upon conversion of temporary equity.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" xlink:label="loc_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" xml:lang="en-US">Status Of Shares Outstanding Before Business Combination [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" xlink:to="lab_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" xml:lang="en-US">Status Of Shares Outstanding Before Business Combination.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" xml:lang="en-US">Series C One Redeemable Convertible Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" xlink:to="lab_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SeriesCRedeemableConvertiblePreferredStockMember" xml:lang="en-US">Series C Redeemable Convertible Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember" xlink:to="lab_rgti_SeriesCRedeemableConvertiblePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SeriesCRedeemableConvertiblePreferredStockMember" xml:lang="en-US">Series C Redeemable Convertible Preferred Stock .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesExchangeRatio" xlink:label="loc_rgti_CommonStockSharesExchangeRatio" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockSharesExchangeRatio" xml:lang="en-US">Common Stock Shares Exchange Ratio</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockSharesExchangeRatio" xml:lang="en-US">Common stock shares exchange ratio</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockSharesExchangeRatio" xlink:to="lab_rgti_CommonStockSharesExchangeRatio" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockSharesExchangeRatio" xml:lang="en-US">Common stock shares exchange ratio.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" xlink:label="loc_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" xml:lang="en-US">Conversion From Temporary Equity To Permanent Equity Exchange Ratio</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" xml:lang="en-US">Conversion from temporary equity to permanent equity exchange ratio</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" xlink:to="lab_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" xml:lang="en-US">Conversion from temporary equity to permanent equity exchange ratio.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PromoteSponsorVestingSharesMember" xlink:label="loc_rgti_PromoteSponsorVestingSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PromoteSponsorVestingSharesMember" xml:lang="en-US">Promote Sponsor Vesting Shares [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PromoteSponsorVestingSharesMember" xlink:to="lab_rgti_PromoteSponsorVestingSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PromoteSponsorVestingSharesMember" xml:lang="en-US">Promote Sponsor Vesting Shares.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorRedemptionBasedVestingSharesMember" xlink:label="loc_rgti_SponsorRedemptionBasedVestingSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SponsorRedemptionBasedVestingSharesMember" xml:lang="en-US">Sponsor Redemption Based Vesting Shares [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SponsorRedemptionBasedVestingSharesMember" xlink:to="lab_rgti_SponsorRedemptionBasedVestingSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SponsorRedemptionBasedVestingSharesMember" xml:lang="en-US">Sponsor Redemption Based Vesting Shares.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockNumberOfVotesPerShare" xlink:label="loc_rgti_CommonStockNumberOfVotesPerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockNumberOfVotesPerShare" xml:lang="en-US">Common Stock Number Of Votes Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockNumberOfVotesPerShare" xml:lang="en-US">Common stock number of votes per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockNumberOfVotesPerShare" xlink:to="lab_rgti_CommonStockNumberOfVotesPerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockNumberOfVotesPerShare" xml:lang="en-US">Common Stock Number Of Votes Per Share.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedAsAResultOfExchange" xlink:label="loc_rgti_CommonStockSharesIssuedAsAResultOfExchange" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockSharesIssuedAsAResultOfExchange" xml:lang="en-US">Common stock shares issued as a result of exchange</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockSharesIssuedAsAResultOfExchange" xml:lang="en-US">Common stock shares issued as a result of exchange</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockSharesIssuedAsAResultOfExchange" xlink:to="lab_rgti_CommonStockSharesIssuedAsAResultOfExchange" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockSharesIssuedAsAResultOfExchange" xml:lang="en-US">Common stock shares issued as a result of exchange.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" xlink:label="loc_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" xml:lang="en-US">Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" xml:lang="en-US">Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" xlink:to="lab_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" xml:lang="en-US">Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VolumeWeightedAveragePricePerShare" xlink:label="loc_rgti_VolumeWeightedAveragePricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_VolumeWeightedAveragePricePerShare" xml:lang="en-US">Volume Weighted Average Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_VolumeWeightedAveragePricePerShare" xml:lang="en-US">Volume weighted average price per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_VolumeWeightedAveragePricePerShare" xlink:to="lab_rgti_VolumeWeightedAveragePricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_VolumeWeightedAveragePricePerShare" xml:lang="en-US">Volume weighted average price per share.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xml:lang="en-US">Number Of Trading Days For Determining The Share Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xml:lang="en-US">Number of trading days for determining the share price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xml:lang="en-US">Number of trading days for determining the share price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xlink:to="lab_rgti_NumberOfTradingDaysForDeterminingTheSharePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xml:lang="en-US">Number Of Trading Days For Determining The Share Price.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SharesSubjectToVestingMaximumPeriod" xlink:label="loc_rgti_SharesSubjectToVestingMaximumPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SharesSubjectToVestingMaximumPeriod" xml:lang="en-US">Shares Subject To Vesting Maximum Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_SharesSubjectToVestingMaximumPeriod" xml:lang="en-US">Shares subject to vesting maximum period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SharesSubjectToVestingMaximumPeriod" xlink:to="lab_rgti_SharesSubjectToVestingMaximumPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SharesSubjectToVestingMaximumPeriod" xml:lang="en-US">Shares subject to vesting maximum period.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SharesSubjectToVestingBasedOnCertainConditions" xlink:label="loc_rgti_SharesSubjectToVestingBasedOnCertainConditions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SharesSubjectToVestingBasedOnCertainConditions" xml:lang="en-US">Shares Subject To Vesting Based On Certain Conditions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_SharesSubjectToVestingBasedOnCertainConditions" xml:lang="en-US">Shares subject to vesting</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SharesSubjectToVestingBasedOnCertainConditions" xlink:to="lab_rgti_SharesSubjectToVestingBasedOnCertainConditions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SharesSubjectToVestingBasedOnCertainConditions" xml:lang="en-US">Shares subject to vesting based on certain conditions.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaap_CommonStockSharesSubscribedButUnissued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesSubscribedButUnissued" xml:lang="en-US">Common Stock, Shares Subscribed but Unissued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesSubscribedButUnissued" xml:lang="en-US">Common stock shares subscribed but not issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesSubscribedButUnissued" xlink:to="lab_us-gaap_CommonStockSharesSubscribedButUnissued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares Issued, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares issued price per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xml:lang="en-US">Number Of Consecutive Trading Days For Determining The Share Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xml:lang="en-US">Number of consecutive trading days for determining the share price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xml:lang="en-US">Number of consecutive trading days for determining the share price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xlink:to="lab_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xml:lang="en-US">Number of consecutive trading days for determining the share price.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" xlink:label="loc_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" xml:lang="en-US">Class Of Warrants Or Rights Outstanding Exercise Price Per Share Of The Resulting Company Due To Business Combination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" xml:lang="en-US">Class of warrants or rights outstanding exercise price per share of the resulting company due to business combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" xlink:to="lab_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" xml:lang="en-US">Class of warrants or rights outstanding exercise price per share of the resulting company due to business combination.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" xlink:label="loc_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" xml:lang="en-US">Class Of Warrants Or Rights Number Of Shares Covered By Each Warrants Or Right In The Resulting Company Due To Business Combinations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" xml:lang="en-US">Class of warrants or rights number of shares covered by each warrant or right in the resulting company due to business combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" xlink:to="lab_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" xml:lang="en-US">Class of warrants or rights number of shares covered by each warrant or right in the resulting company due to business combination.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaap_CommonStockSharesSubscriptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesSubscriptions" xml:lang="en-US">Common Stock, Value, Subscriptions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesSubscriptions" xml:lang="en-US">Common stock shares subscribed but not issued value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_CommonStockSharesSubscriptions" xml:lang="en-US">Common Stock, Value, Subscriptions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesSubscriptions" xlink:to="lab_us-gaap_CommonStockSharesSubscriptions" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OneTimeBonus" xlink:label="loc_rgti_OneTimeBonus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_OneTimeBonus" xml:lang="en-US">One Time Bonus</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_OneTimeBonus" xml:lang="en-US">One-time bonus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_OneTimeBonus" xlink:to="lab_rgti_OneTimeBonus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_OneTimeBonus" xml:lang="en-US">&#160;One-time bonus.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" xlink:label="loc_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock Of Previous Company Converted Into Current Company Common Stock Par Or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock of previous company converted into current company common stock par or stated value per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" xlink:to="lab_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock of previous company converted into current company common stock par or stated value per share.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorAgreementMember" xlink:label="loc_rgti_SponsorAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SponsorAgreementMember" xml:lang="en-US">Sponsor Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SponsorAgreementMember" xlink:to="lab_rgti_SponsorAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SponsorAgreementMember" xml:lang="en-US">Sponsor Agreement.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialSubscriptionAgreementMember" xlink:label="loc_rgti_InitialSubscriptionAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_InitialSubscriptionAgreementMember" xml:lang="en-US">Initial Subscription Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_InitialSubscriptionAgreementMember" xlink:to="lab_rgti_InitialSubscriptionAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_InitialSubscriptionAgreementMember" xml:lang="en-US">Initial Subscription Agreement.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SubsequentSubscriptionAgreementMember" xlink:label="loc_rgti_SubsequentSubscriptionAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SubsequentSubscriptionAgreementMember" xml:lang="en-US">Subsequent Subscription Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SubsequentSubscriptionAgreementMember" xlink:to="lab_rgti_SubsequentSubscriptionAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SubsequentSubscriptionAgreementMember" xml:lang="en-US">Subsequent Subscription Agreement.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheOneMember" xlink:label="loc_rgti_TrancheOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TrancheOneMember" xml:lang="en-US">Tranche One [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TrancheOneMember" xlink:to="lab_rgti_TrancheOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TrancheOneMember" xml:lang="en-US">Tranche One.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheTwoMember" xlink:label="loc_rgti_TrancheTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TrancheTwoMember" xml:lang="en-US">Tranche Two [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TrancheTwoMember" xlink:to="lab_rgti_TrancheTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TrancheTwoMember" xml:lang="en-US">Tranche Two.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupernovaAcquistionMember" xlink:label="loc_rgti_SupernovaAcquistionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SupernovaAcquistionMember" xml:lang="en-US">Supernova Acquistion [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SupernovaAcquistionMember" xlink:to="lab_rgti_SupernovaAcquistionMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorAxis" xlink:label="loc_rgti_InvestorAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_InvestorAxis" xml:lang="en-US">Investor [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_InvestorAxis" xlink:to="lab_rgti_InvestorAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_InvestorAxis" xml:lang="en-US">Investor.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorDomain" xlink:label="loc_rgti_InvestorDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_InvestorDomain" xml:lang="en-US">Investor [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_InvestorDomain" xlink:to="lab_rgti_InvestorDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_InvestorDomain" xml:lang="en-US">Investor.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateInvestmentInPublicEquityInvestorsMember" xlink:label="loc_rgti_PrivateInvestmentInPublicEquityInvestorsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PrivateInvestmentInPublicEquityInvestorsMember" xml:lang="en-US">Private Investment In Public Equity Investors [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PrivateInvestmentInPublicEquityInvestorsMember" xlink:to="lab_rgti_PrivateInvestmentInPublicEquityInvestorsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PrivateInvestmentInPublicEquityInvestorsMember" xml:lang="en-US">Private Investment In Public Equity Investors.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xml:lang="en-US">Financial Instrument [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xml:lang="en-US">Financial Instrument</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US">Financial Instruments [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US">Financial Instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xml:lang="en-US">US Treasury Securities [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xml:lang="en-US">United States Treasury Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xml:lang="en-US">US Treasury Securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommercialPaperMember" xml:lang="en-US">Commercial Paper [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommercialPaperMember" xml:lang="en-US">Commercial Papers</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommercialPaperMember" xml:lang="en-US">Commercial Paper</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xml:lang="en-US">Money Market Funds [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xml:lang="en-US">Money Market Funds</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xml:lang="en-US">Money Market Fund</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xml:lang="en-US">Corporate Bonds</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xml:lang="en-US">US Government Corporations and Agencies Securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xml:lang="en-US">Amortized&#160;Cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xml:lang="en-US">Gross Unrealized Holding&#160;Loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xml:lang="en-US">Fair&#160;Value&#160;as</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xml:lang="en-US">Investment securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xml:lang="en-US">Debt Securities, Available-for-Sale</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xml:lang="en-US">Available-for-Sale Securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtSecuritiesAvailableForSaleMaturityYear" xlink:label="loc_rgti_DebtSecuritiesAvailableForSaleMaturityYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DebtSecuritiesAvailableForSaleMaturityYear" xml:lang="en-US">Debt Securities Available For Sale Maturity Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DebtSecuritiesAvailableForSaleMaturityYear" xml:lang="en-US">Available For Sale Maturity Year</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DebtSecuritiesAvailableForSaleMaturityYear" xlink:to="lab_rgti_DebtSecuritiesAvailableForSaleMaturityYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DebtSecuritiesAvailableForSaleMaturityYear" xml:lang="en-US">Debt securities available for sale maturity year.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xml:lang="en-US">Goodwill, Period Increase (Decrease)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xml:lang="en-US">Change</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xml:lang="en-US">Transaction price allocated to remaining performance obligations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RevenuePerformanceObligationTransactionPriceAxis" xlink:label="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RevenuePerformanceObligationTransactionPriceAxis" xml:lang="en-US">Revenue Performance Obligation Transaction Price [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis" xlink:to="lab_rgti_RevenuePerformanceObligationTransactionPriceAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RevenuePerformanceObligationTransactionPriceAxis" xml:lang="en-US">Revenue performance obligation transaction price [Axis].</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RevenuePerformanceObligationTransactionPriceDomain" xlink:label="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RevenuePerformanceObligationTransactionPriceDomain" xml:lang="en-US">Revenue Performance Obligation Transaction Price [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain" xlink:to="lab_rgti_RevenuePerformanceObligationTransactionPriceDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RevenuePerformanceObligationTransactionPriceDomain" xml:lang="en-US">Revenue performance obligation transaction price.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RemainderoftwothousandandtwentythreeMember" xlink:label="loc_rgti_RemainderoftwothousandandtwentythreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RemainderoftwothousandandtwentythreeMember" xml:lang="en-US">RemainderOfTwoThousandAndTwentyThree [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_RemainderoftwothousandandtwentythreeMember" xml:lang="en-US">Remainder Of Two Thousand And Twenty Three [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RemainderoftwothousandandtwentythreeMember" xlink:to="lab_rgti_RemainderoftwothousandandtwentythreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RemainderoftwothousandandtwentythreeMember" xml:lang="en-US">Remainder of two thousand and twenty three.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwothousandandtwentyfourMember" xlink:label="loc_rgti_TwothousandandtwentyfourMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TwothousandandtwentyfourMember" xml:lang="en-US">TwoThousandAndTwentyFour [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_TwothousandandtwentyfourMember" xml:lang="en-US">2024[Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TwothousandandtwentyfourMember" xlink:to="lab_rgti_TwothousandandtwentyfourMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_TwothousandandtwentyfourMember" xml:lang="en-US">Two thousand and twenty three member.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccessToQuantumComputingSystemsMember" xlink:label="loc_rgti_AccessToQuantumComputingSystemsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AccessToQuantumComputingSystemsMember" xml:lang="en-US">Access to quantum computing systems [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AccessToQuantumComputingSystemsMember" xlink:to="lab_rgti_AccessToQuantumComputingSystemsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AccessToQuantumComputingSystemsMember" xml:lang="en-US">Access to quantum computing systems</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CollaborativeResearchAndOtherProfessionalServicesMember" xlink:label="loc_rgti_CollaborativeResearchAndOtherProfessionalServicesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CollaborativeResearchAndOtherProfessionalServicesMember" xml:lang="en-US">Collaborative research and other professional services [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CollaborativeResearchAndOtherProfessionalServicesMember" xlink:to="lab_rgti_CollaborativeResearchAndOtherProfessionalServicesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CollaborativeResearchAndOtherProfessionalServicesMember" xml:lang="en-US">Collaborative research and other professional services</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xml:lang="en-US">Transferred at Point in Time [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xml:lang="en-US">Revenue recognized at a point in time [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredAtPointInTimeMember" xlink:to="lab_us-gaap_TransferredAtPointInTimeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaap_TransferredOverTimeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TransferredOverTimeMember" xml:lang="en-US">Transferred over Time [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TransferredOverTimeMember" xml:lang="en-US">Revenue recognized over time [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTable" xlink:label="loc_us-gaap_CapitalizedContractCostTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalizedContractCostTable" xml:lang="en-US">Capitalized Contract Cost [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostTable" xlink:to="lab_us-gaap_CapitalizedContractCostTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostLineItems" xlink:label="loc_us-gaap_CapitalizedContractCostLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalizedContractCostLineItems" xml:lang="en-US">Capitalized Contract Cost [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems" xlink:to="lab_us-gaap_CapitalizedContractCostLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xml:lang="en-US">Accounts and Other Receivables, Net, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xml:lang="en-US">Trade receivables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred Revenue, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Balance at beginning of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Balance at end of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xml:lang="en-US">Unbilled Receivables, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xml:lang="en-US">Unbilled receivables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledReceivablesCurrent" xlink:to="lab_us-gaap_UnbilledReceivablesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract" xlink:label="loc_us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract" xml:lang="en-US">Change in Contract with Customer, Asset and Liability [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RecognitionOfDeferredRevenues" xlink:label="loc_rgti_RecognitionOfDeferredRevenues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RecognitionOfDeferredRevenues" xml:lang="en-US">Recognition of deferred revenues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_RecognitionOfDeferredRevenues" xml:lang="en-US">Recognition of deferred revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RecognitionOfDeferredRevenues" xlink:to="lab_rgti_RecognitionOfDeferredRevenues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RecognitionOfDeferredRevenues" xml:lang="en-US">Recognition of deferred revenues</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferralOfRevenue" xlink:label="loc_rgti_DeferralOfRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DeferralOfRevenue" xml:lang="en-US">Deferral of revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DeferralOfRevenue" xml:lang="en-US">Deferral of revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DeferralOfRevenue" xlink:to="lab_rgti_DeferralOfRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DeferralOfRevenue" xml:lang="en-US">Deferral of revenue</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FurnitureAndOtherAssetsMember" xlink:label="loc_rgti_FurnitureAndOtherAssetsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_FurnitureAndOtherAssetsMember" xml:lang="en-US">Furniture and other assets [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_FurnitureAndOtherAssetsMember" xml:lang="en-US">Furniture and other assets [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_FurnitureAndOtherAssetsMember" xlink:to="lab_rgti_FurnitureAndOtherAssetsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_FurnitureAndOtherAssetsMember" xml:lang="en-US">Furniture and other assets.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US">Leasehold Improvements [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US">Leasehold Improvements [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ItHardwareMember" xlink:label="loc_rgti_ItHardwareMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ItHardwareMember" xml:lang="en-US">IT hardware [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ItHardwareMember" xml:lang="en-US">IT hardware [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ItHardwareMember" xlink:to="lab_rgti_ItHardwareMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ItHardwareMember" xml:lang="en-US">It hardware.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_QuantumComputingFridgesMember" xlink:label="loc_rgti_QuantumComputingFridgesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_QuantumComputingFridgesMember" xml:lang="en-US">Quantum computing fridges [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_QuantumComputingFridgesMember" xml:lang="en-US">Quantum computing fridges [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_QuantumComputingFridgesMember" xlink:to="lab_rgti_QuantumComputingFridgesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_QuantumComputingFridgesMember" xml:lang="en-US">Quantum computing fridges.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProcessEquipmentMember" xlink:label="loc_rgti_ProcessEquipmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ProcessEquipmentMember" xml:lang="en-US">Process equipment [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ProcessEquipmentMember" xml:lang="en-US">Process equipment [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ProcessEquipmentMember" xlink:to="lab_rgti_ProcessEquipmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ProcessEquipmentMember" xml:lang="en-US">Process equipment.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Less: Accumulated depreciation and amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xml:lang="en-US">Accrued Liabilities and Other Liabilities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedDeferredOfferingCosts" xlink:label="loc_rgti_AccruedDeferredOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AccruedDeferredOfferingCosts" xml:lang="en-US">Accrued Deferred Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_AccruedDeferredOfferingCosts" xml:lang="en-US">Deferred offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AccruedDeferredOfferingCosts" xlink:to="lab_rgti_AccruedDeferredOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AccruedDeferredOfferingCosts" xml:lang="en-US">Accrued deferred offering costs.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xml:lang="en-US">Accrued Payroll Taxes, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xml:lang="en-US">Payroll and other payroll costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedPayrollTaxesCurrent" xlink:to="lab_us-gaap_AccruedPayrollTaxesCurrent" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedPropertyAndOtherTaxes" xlink:label="loc_rgti_AccruedPropertyAndOtherTaxes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AccruedPropertyAndOtherTaxes" xml:lang="en-US">Accrued Property And Other Taxes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AccruedPropertyAndOtherTaxes" xml:lang="en-US">Property and other taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AccruedPropertyAndOtherTaxes" xlink:to="lab_rgti_AccruedPropertyAndOtherTaxes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AccruedPropertyAndOtherTaxes" xml:lang="en-US">Accrued property and other taxes.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US">Accrued Professional Fees, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xml:lang="en-US">Professional &amp; subscription fees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US">Other Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US">Others</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaap_InterestPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestPayableCurrent" xml:lang="en-US">Interest Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InterestPayableCurrent" xml:lang="en-US">Accrued interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedUtilitiesCurrent" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xml:lang="en-US">Accrued Utilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xml:lang="en-US">Utilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedUtilitiesCurrent" xlink:to="lab_us-gaap_AccruedUtilitiesCurrent" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedSubcontractorCost" xlink:label="loc_rgti_AccruedSubcontractorCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AccruedSubcontractorCost" xml:lang="en-US">Accrued Subcontractor Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AccruedSubcontractorCost" xml:lang="en-US">Subcontractor cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AccruedSubcontractorCost" xlink:to="lab_rgti_AccruedSubcontractorCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AccruedSubcontractorCost" xml:lang="en-US">Accrued subcontractor cost.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedPropertyPlantAndEquipmentCost" xlink:label="loc_rgti_AccruedPropertyPlantAndEquipmentCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AccruedPropertyPlantAndEquipmentCost" xml:lang="en-US">Accrued Property Plant And Equipment Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AccruedPropertyPlantAndEquipmentCost" xml:lang="en-US">Property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AccruedPropertyPlantAndEquipmentCost" xlink:to="lab_rgti_AccruedPropertyPlantAndEquipmentCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AccruedPropertyPlantAndEquipmentCost" xml:lang="en-US">Accrued property plant and equipment cost.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementGeographicalAxis" xml:lang="en-US">Geographical [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_SegmentGeographicalDomain" xml:lang="en-US">Geographical [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_country_US" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_US" xml:lang="en-US">UNITED STATES</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_US" xml:lang="en-US">US</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB" xlink:label="loc_country_GB" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_GB" xml:lang="en-US">UNITED KINGDOM</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_GB" xml:lang="en-US">GB</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTotalGrossPropertyAndEquipment" xlink:label="loc_rgti_PercentageOfTotalGrossPropertyAndEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PercentageOfTotalGrossPropertyAndEquipment" xml:lang="en-US">Percentage Of Total Gross Property And Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PercentageOfTotalGrossPropertyAndEquipment" xml:lang="en-US">Percentage of total gross property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PercentageOfTotalGrossPropertyAndEquipment" xlink:to="lab_rgti_PercentageOfTotalGrossPropertyAndEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PercentageOfTotalGrossPropertyAndEquipment" xml:lang="en-US">Percentage of total gross property and equipment.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OperatingLeaseRentExpenses" xlink:label="loc_rgti_OperatingLeaseRentExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_OperatingLeaseRentExpenses" xml:lang="en-US">Operating Lease Rent Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_OperatingLeaseRentExpenses" xml:lang="en-US">Rent expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_OperatingLeaseRentExpenses" xlink:to="lab_rgti_OperatingLeaseRentExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_OperatingLeaseRentExpenses" xml:lang="en-US">Operating lease rent expenses.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaap_LeaseCostAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseCostAbstract" xml:lang="en-US">Lease, Cost [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xml:lang="en-US">Weighted average remaining lease term - operating leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xml:lang="en-US">Weighted average discount rate - operating leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseCost" xml:lang="en-US">Operating Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseCost" xml:lang="en-US">Operating lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableLeaseCost" xml:lang="en-US">Variable Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_VariableLeaseCost" xml:lang="en-US">Variable lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseCost" xml:lang="en-US">Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseCost" xml:lang="en-US">Total lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasePayments" xml:lang="en-US">Operating Lease, Payments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeasePayments" xml:lang="en-US">Operating cash flows from operating leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xml:lang="en-US">Operating cash flows from operating leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermLeaseCost" xml:lang="en-US">Short-Term Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShortTermLeaseCost" xml:lang="en-US">Short-term lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US">2023</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US">2024</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US">2024</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US">2025</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US">2025</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US">2026</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xml:lang="en-US">2026</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xml:lang="en-US">2027</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Total minimum future lease payments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Total lease payments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xml:lang="en-US">2022</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xml:lang="en-US">2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiHoldingsMember" xlink:label="loc_rgti_RigettiHoldingsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RigettiHoldingsMember" xml:lang="en-US">Rigetti Holdings [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RigettiHoldingsMember" xlink:to="lab_rgti_RigettiHoldingsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RigettiHoldingsMember" xml:lang="en-US">Rigetti holdings member.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xml:lang="en-US">Less: Imputed interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" xml:lang="en-US">Maturities of Long-term Debt [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongTermDebtAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xml:lang="en-US">2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xml:lang="en-US">2026</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xml:lang="en-US">2025</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebt" xml:lang="en-US">Long-term Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LongTermDebt" xml:lang="en-US">Loan payable, long term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xml:lang="en-US">Long-Term Debt, Maturity, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xml:lang="en-US">2022</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xml:lang="en-US">2024</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract" xml:lang="en-US">Long-term Debt, by Current and Noncurrent [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xml:lang="en-US">Long-term Debt, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xml:lang="en-US">Outstanding principal amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentPortionOfOutstandingPrincipalAmount" xlink:label="loc_rgti_CurrentPortionOfOutstandingPrincipalAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CurrentPortionOfOutstandingPrincipalAmount" xml:lang="en-US">Current Portion Of Outstanding Principal Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CurrentPortionOfOutstandingPrincipalAmount" xml:lang="en-US">Current portion of long term debt&#8212;principal</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CurrentPortionOfOutstandingPrincipalAmount" xlink:to="lab_rgti_CurrentPortionOfOutstandingPrincipalAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CurrentPortionOfOutstandingPrincipalAmount" xml:lang="en-US">Current Portion Of Outstanding Principal Amount.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaap_LongTermLoansPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermLoansPayable" xml:lang="en-US">Loans Payable, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LongTermLoansPayable" xml:lang="en-US">Debt&#8212;net of current portion</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="lab_us-gaap_LongTermLoansPayable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xml:lang="en-US">Less: current portion of unamortized debt discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedFinalPaymentFee" xlink:label="loc_rgti_AccruedFinalPaymentFee" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AccruedFinalPaymentFee" xml:lang="en-US">Accrued Final Payment Fee</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AccruedFinalPaymentFee" xml:lang="en-US">Add: accreted liability of final payment fee</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AccruedFinalPaymentFee" xlink:to="lab_rgti_AccruedFinalPaymentFee" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AccruedFinalPaymentFee" xml:lang="en-US">Accrued final payment fee.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaap_LoansPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LoansPayableCurrent" xml:lang="en-US">Loans Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LoansPayableCurrent" xml:lang="en-US">Debt&#8212;current portion</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableCurrent" xlink:to="lab_us-gaap_LoansPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xml:lang="en-US">Debt Issuance Costs, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xml:lang="en-US">Less: unamortized debt discount, long term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xml:lang="en-US">Debt issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentPortionOfLongTermDebtGross" xlink:label="loc_rgti_CurrentPortionOfLongTermDebtGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CurrentPortionOfLongTermDebtGross" xml:lang="en-US">Current Portion of Long Term Debt Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CurrentPortionOfLongTermDebtGross" xml:lang="en-US">Less: current portion of long term debt-principal</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CurrentPortionOfLongTermDebtGross" xlink:to="lab_rgti_CurrentPortionOfLongTermDebtGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CurrentPortionOfLongTermDebtGross" xml:lang="en-US">Current portion of long term debt gross.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xml:lang="en-US">Schedule of Short-term Debt [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentAxis" xml:lang="en-US">Debt Instrument [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheAMember" xlink:label="loc_rgti_TrancheAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TrancheAMember" xml:lang="en-US">Tranche A [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TrancheAMember" xlink:to="lab_rgti_TrancheAMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheBMember" xlink:label="loc_rgti_TrancheBMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TrancheBMember" xml:lang="en-US">Tranche B [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TrancheBMember" xlink:to="lab_rgti_TrancheBMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheCMember" xlink:label="loc_rgti_TrancheCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TrancheCMember" xml:lang="en-US">Tranche C [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TrancheCMember" xlink:to="lab_rgti_TrancheCMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xml:lang="en-US">Long-term Debt, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xml:lang="en-US">Long-term Debt, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_LoanAndSecurityAgreementMember" xlink:label="loc_rgti_LoanAndSecurityAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_LoanAndSecurityAgreementMember" xml:lang="en-US">Loan and Security Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_LoanAndSecurityAgreementMember" xlink:to="lab_rgti_LoanAndSecurityAgreementMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xml:lang="en-US">Income Statement Location [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xml:lang="en-US">Income Statement Location [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xml:lang="en-US">Line of Credit Facility [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaap_AccretionExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccretionExpense" xml:lang="en-US">Accretion Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccretionExpense" xml:lang="en-US">Accretion Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionExpense" xlink:to="lab_us-gaap_AccretionExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xml:lang="en-US">unamortized issuance cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtInstrumentPaymentFeepercentage" xlink:label="loc_rgti_DebtInstrumentPaymentFeepercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DebtInstrumentPaymentFeepercentage" xml:lang="en-US">Debt instrument payment fee,Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DebtInstrumentPaymentFeepercentage" xml:lang="en-US">Debt instrument payment fee, Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DebtInstrumentPaymentFeepercentage" xlink:to="lab_rgti_DebtInstrumentPaymentFeepercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DebtInstrumentPaymentFeepercentage" xml:lang="en-US">Debt instrument payment fee, Percentage.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Debt Instrument, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Debt Instrument, Term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WithdrawnCreditFacility" xlink:label="loc_rgti_WithdrawnCreditFacility" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_WithdrawnCreditFacility" xml:lang="en-US">Withdrawn Credit Facility</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_WithdrawnCreditFacility" xml:lang="en-US">Withdrawn Credit Facility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_WithdrawnCreditFacility" xlink:to="lab_rgti_WithdrawnCreditFacility" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_WithdrawnCreditFacility" xml:lang="en-US">Withdrawn credit facility.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xml:lang="en-US">Debt Related Commitment Fees and Debt Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xml:lang="en-US">Debt Related Commitment Fees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xml:lang="en-US">Debt Instrument, Frequency of Periodic Payment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xml:lang="en-US">Debt Instrument, Frequency of Periodic Payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="loc_us-gaap_DebtInstrumentPaymentTerms" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentPaymentTerms" xml:lang="en-US">Debt Instrument, Payment Terms</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentPaymentTerms" xml:lang="en-US">Debt Instrument, Payment Terms</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPaymentTerms" xlink:to="lab_us-gaap_DebtInstrumentPaymentTerms" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfadvancedFundsUnderTheAmendment" xlink:label="loc_rgti_PercentageOfadvancedFundsUnderTheAmendment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PercentageOfadvancedFundsUnderTheAmendment" xml:lang="en-US">Percentage of Advanced Funds Under the Amendment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PercentageOfadvancedFundsUnderTheAmendment" xml:lang="en-US">Percentage of &#160;advanced funds under the amendment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PercentageOfadvancedFundsUnderTheAmendment" xlink:to="lab_rgti_PercentageOfadvancedFundsUnderTheAmendment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PercentageOfadvancedFundsUnderTheAmendment" xml:lang="en-US">Percentage of &#160;advanced funds under the amendment.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" xlink:label="loc_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" xml:lang="en-US">Percentage Of Debt Related Cost Paid Upon The Consummation Of Merger</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" xml:lang="en-US">Percentage of debt related cost paid upon the consummation of merger</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" xlink:to="lab_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" xml:lang="en-US">Percentage Of Debt Related Cost Paid Upon The Consummation Of Merger.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xml:lang="en-US">Debt Instrument, Repurchase Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xml:lang="en-US">Debt instrument, repurchase amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US">Debt Instrument, Variable Rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xml:lang="en-US">Class of warrants issued during period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xml:lang="en-US">Debt Instrument, Fee Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xml:lang="en-US">Debt instrument, fee amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Debt Instrument, Face Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Debt Instrument, Face Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xml:lang="en-US">Debt Instrument, Maturity Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xml:lang="en-US">Debt Instrument, Maturity Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorNameAxis" xlink:label="loc_rgti_InvestorNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_InvestorNameAxis" xml:lang="en-US">Investor Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_InvestorNameAxis" xlink:to="lab_rgti_InvestorNameAxis" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorNameDomain" xlink:label="loc_rgti_InvestorNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_InvestorNameDomain" xml:lang="en-US">Investor Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_InvestorNameDomain" xlink:to="lab_rgti_InvestorNameDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xml:lang="en-US">Lender Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VentureCapitalMember" xlink:label="loc_rgti_VentureCapitalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_VentureCapitalMember" xml:lang="en-US">Venture Capital [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_VentureCapitalMember" xlink:to="lab_rgti_VentureCapitalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_VentureCapitalMember" xml:lang="en-US">Venture Capital</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockWarrantsMember" xlink:label="loc_rgti_CommonStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockWarrantsMember" xml:lang="en-US">Common Stock warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_CommonStockWarrantsMember" xml:lang="en-US">Common Stock Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockWarrantsMember" xlink:to="lab_rgti_CommonStockWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockWarrantsMember" xml:lang="en-US">Common stock warrants member.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableRateAxis" xml:lang="en-US">Variable Rate [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableRateDomain" xml:lang="en-US">Variable Rate [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="loc_us-gaap_PrimeRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrimeRateMember" xml:lang="en-US">Prime Rate [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCOnePreferredStockMember" xlink:label="loc_rgti_SeriesCOnePreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SeriesCOnePreferredStockMember" xml:lang="en-US">Series C One Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_SeriesCOnePreferredStockMember" xml:lang="en-US">Series C-1 Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SeriesCOnePreferredStockMember" xlink:to="lab_rgti_SeriesCOnePreferredStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xml:lang="en-US">Series C Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xml:lang="en-US">Series C Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_us-gaap_SeriesCPreferredStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockTable" xlink:label="loc_us-gaap_ConversionOfStockTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockTable" xml:lang="en-US">Conversion of Stock [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockTable" xlink:to="lab_us-gaap_ConversionOfStockTable" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EquityAxis" xlink:label="loc_rgti_EquityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EquityAxis" xml:lang="en-US">Equity [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EquityAxis" xlink:to="lab_rgti_EquityAxis" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EquityDomain" xlink:label="loc_rgti_EquityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EquityDomain" xml:lang="en-US">Equity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EquityDomain" xlink:to="lab_rgti_EquityDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xml:lang="en-US">Stock-Based Awards&#8212;RSUs Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xml:lang="en-US">Restricted Stock Units</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockLineItems" xlink:label="loc_us-gaap_ConversionOfStockLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockLineItems" xml:lang="en-US">Conversion of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockLineItems" xlink:to="lab_us-gaap_ConversionOfStockLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xml:lang="en-US">Common stock, capital shares reserved for future issuance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" xlink:label="loc_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" xml:lang="en-US">Percentage of Total Aggregate Number (or volume) of shares of Common Stock traded on The Nasdaq Capital Market</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" xml:lang="en-US">Percentage of total aggregate number (or volume) of shares of Common Stock traded on The Nasdaq Capital Market</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" xlink:to="lab_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" xml:lang="en-US">Percentage of total aggregate number (or volume) of shares of common stock traded on the nasdaq capital market.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaap_CommonStockVotingRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockVotingRights" xml:lang="en-US">Common Stock, Voting Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockVotingRights" xml:lang="en-US">Common Stock, Voting Rights</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockVotingRights" xlink:to="lab_us-gaap_CommonStockVotingRights" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" xlink:label="loc_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" xml:lang="en-US">Percentage Of The Aggregate Number Of Shares Of Common Stock Issued And Outstanding Immediately Prior To The Execution Of The Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" xml:lang="en-US">Percentage of the aggregate number of shares of common stock issued and outstanding immediately prior to the execution of the agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" xlink:to="lab_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" xml:lang="en-US">Percentage of the aggregate number of shares of common stock issued and outstanding immediately prior to the execution of the agreement.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Stock issued during period, shares, issued for services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of Stock, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of Stock, Price Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameAxis" xlink:label="loc_rgti_AgreementNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AgreementNameAxis" xml:lang="en-US">Agreement Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AgreementNameAxis" xlink:to="lab_rgti_AgreementNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AgreementNameAxis" xml:lang="en-US">Agreement Name [</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AgreementNameDomain" xml:lang="en-US">Agreement Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AgreementNameDomain" xlink:to="lab_rgti_AgreementNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AgreementNameDomain" xml:lang="en-US">Agreement name</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockPurchaseAgreementMember" xlink:label="loc_rgti_CommonStockPurchaseAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CommonStockPurchaseAgreementMember" xml:lang="en-US">Common Stock Purchase Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CommonStockPurchaseAgreementMember" xlink:to="lab_rgti_CommonStockPurchaseAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CommonStockPurchaseAgreementMember" xml:lang="en-US">Common Stock purchase agreement.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WarrantsToPurchaseClassACommonStockMember" xlink:label="loc_rgti_WarrantsToPurchaseClassACommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_WarrantsToPurchaseClassACommonStockMember" xml:lang="en-US">Warrants To Purchase Class A Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_WarrantsToPurchaseClassACommonStockMember" xlink:to="lab_rgti_WarrantsToPurchaseClassACommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_WarrantsToPurchaseClassACommonStockMember" xml:lang="en-US">Warrants to purchase class A common stock .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerWarrantsMember" xlink:label="loc_rgti_CustomerWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CustomerWarrantsMember" xml:lang="en-US">Customer Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CustomerWarrantsMember" xlink:to="lab_rgti_CustomerWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CustomerWarrantsMember" xml:lang="en-US">Customer Warrants .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrinityWarrantsMember" xlink:label="loc_rgti_TrinityWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TrinityWarrantsMember" xml:lang="en-US">Trinity Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_TrinityWarrantsMember" xml:lang="en-US">Trinity Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TrinityWarrantsMember" xlink:to="lab_rgti_TrinityWarrantsMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfInvestorsAxis" xlink:label="loc_rgti_ClassOfInvestorsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ClassOfInvestorsAxis" xml:lang="en-US">Class Of Investors [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ClassOfInvestorsAxis" xlink:to="lab_rgti_ClassOfInvestorsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ClassOfInvestorsAxis" xml:lang="en-US">Class Of Investors .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfInvestorsDomain" xlink:label="loc_rgti_ClassOfInvestorsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ClassOfInvestorsDomain" xml:lang="en-US">Class Of Investors [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ClassOfInvestorsDomain" xlink:to="lab_rgti_ClassOfInvestorsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ClassOfInvestorsDomain" xml:lang="en-US">Class Of Investors .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:label="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xml:lang="en-US">Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xml:lang="en-US">Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:to="lab_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xml:lang="en-US">Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xml:lang="en-US">Financial Instruments Subject to Mandatory Redemption, Financial Instrument</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:to="lab_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" xlink:label="loc_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" xml:lang="en-US">ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" xml:lang="en-US">ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" xlink:to="lab_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" xml:lang="en-US">Class Of Warrants Or Rights Warrants Issued During The Period Units .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Adjustment to additional paid in capital warrants issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" xlink:label="loc_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" xml:lang="en-US">ClassOfWarrantsOrRightsAggregateFairValueOfWarrantsAtTheTimeOfGrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" xml:lang="en-US">Class of Warrants or Rights Aggregate Fair Value of Warrants at the Time of Grant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" xlink:to="lab_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" xml:lang="en-US">Class of warrants or rights aggregate fair value of warrants at the time of grant .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInDerivativeLiabilities" xml:lang="en-US">Increase (Decrease) in Derivative Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInDerivativeLiabilities" xml:lang="en-US">Warrant liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInDerivativeLiabilities" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" xlink:label="loc_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" xml:lang="en-US">Waiting Period After Which The Share Trading Days Are Considered</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" xml:lang="en-US">Waiting period after which the share trading days are considered</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" xlink:to="lab_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" xml:lang="en-US">Waiting Period After Which The Share Trading Days Are Considered.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharePrice" xml:lang="en-US">Share Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharePrice" xml:lang="en-US">Share price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsvestingpercentage" xlink:label="loc_rgti_Classofwarrantsvestingpercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_Classofwarrantsvestingpercentage" xml:lang="en-US">ClassOfWarrantsVestingPercentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_Classofwarrantsvestingpercentage" xml:lang="en-US">Class Of Warrants Vesting Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_Classofwarrantsvestingpercentage" xlink:to="lab_rgti_Classofwarrantsvestingpercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_Classofwarrantsvestingpercentage" xml:lang="en-US">Class Of Warrants Vesting Percentage .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantOrRightGrandDateFairValue" xlink:label="loc_rgti_ClassOfWarrantOrRightGrandDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ClassOfWarrantOrRightGrandDateFairValue" xml:lang="en-US">Class of warrant or right, Grand date fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ClassOfWarrantOrRightGrandDateFairValue" xlink:to="lab_rgti_ClassOfWarrantOrRightGrandDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ClassOfWarrantOrRightGrandDateFairValue" xml:lang="en-US">Class of warrant or right, Grand date fair value.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">Warrants and Rights Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">Warrants Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantorrightissuedduringperiodwarrants" xlink:label="loc_rgti_Classofwarrantorrightissuedduringperiodwarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_Classofwarrantorrightissuedduringperiodwarrants" xml:lang="en-US">ClassOfWarrantOrRightIssuedDuringPeriodWarrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_Classofwarrantorrightissuedduringperiodwarrants" xml:lang="en-US">Class of warrant or right issued during period, Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_Classofwarrantorrightissuedduringperiodwarrants" xlink:to="lab_rgti_Classofwarrantorrightissuedduringperiodwarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_Classofwarrantorrightissuedduringperiodwarrants" xml:lang="en-US">Class Of Warrant Or Right Issued During Period Warrants .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="lab_us-gaap_FairValueInputsQuantitativeInformationAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AtinitialrecognitionMember" xlink:label="loc_rgti_AtinitialrecognitionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AtinitialrecognitionMember" xml:lang="en-US">AtInitialRecognition [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AtinitialrecognitionMember" xlink:to="lab_rgti_AtinitialrecognitionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AtinitialrecognitionMember" xml:lang="en-US">AtInitial Recognition .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xml:lang="en-US">Warrants and rights outstanding, measurement input</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xml:lang="en-US">Measurement Input, Expected Term [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember" xml:lang="en-US">Measurement Input, Exercise Price [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExercisePriceMember" xlink:to="lab_us-gaap_MeasurementInputExercisePriceMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureofvestingstatusofwarrantsAbstract" xlink:label="loc_rgti_DisclosureofvestingstatusofwarrantsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureofvestingstatusofwarrantsAbstract" xml:lang="en-US">DisclosureOfVestingStatusOfWarrants [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DisclosureofvestingstatusofwarrantsAbstract" xml:lang="en-US">Disclosure Of Vesting Status Of Warrants [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureofvestingstatusofwarrantsAbstract" xlink:to="lab_rgti_DisclosureofvestingstatusofwarrantsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureofvestingstatusofwarrantsAbstract" xml:lang="en-US">Disclosure of vesting status of warrants .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureOfVestingStatusOfWarrantsTable" xlink:label="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureOfVestingStatusOfWarrantsTable" xml:lang="en-US">Disclosure Of Vesting Status Of Warrants [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable" xlink:to="lab_rgti_DisclosureOfVestingStatusOfWarrantsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureOfVestingStatusOfWarrantsTable" xml:lang="en-US">Disclosure Of Vesting Status Of Warrants .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfVestingAxis" xlink:label="loc_rgti_StatusOfVestingAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_StatusOfVestingAxis" xml:lang="en-US">Status Of Vesting [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_StatusOfVestingAxis" xlink:to="lab_rgti_StatusOfVestingAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_StatusOfVestingAxis" xml:lang="en-US">Status Of Vesting .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfVestingDomain" xlink:label="loc_rgti_StatusOfVestingDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_StatusOfVestingDomain" xml:lang="en-US">Status Of Vesting [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_StatusOfVestingDomain" xlink:to="lab_rgti_StatusOfVestingDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_StatusOfVestingDomain" xml:lang="en-US">Status Of Vesting .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VestedCustomerWarrantsMember" xlink:label="loc_rgti_VestedCustomerWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_VestedCustomerWarrantsMember" xml:lang="en-US">Vested Customer Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_VestedCustomerWarrantsMember" xlink:to="lab_rgti_VestedCustomerWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_VestedCustomerWarrantsMember" xml:lang="en-US">Vested customer warrants .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_UnvestedCustomerWarrantsMember" xlink:label="loc_rgti_UnvestedCustomerWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_UnvestedCustomerWarrantsMember" xml:lang="en-US">Unvested Customer Warrants [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_UnvestedCustomerWarrantsMember" xlink:to="lab_rgti_UnvestedCustomerWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_UnvestedCustomerWarrantsMember" xml:lang="en-US">Unvested customer warrants .</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureofvestingstatusofwarrantsLineItems" xlink:label="loc_rgti_DisclosureofvestingstatusofwarrantsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DisclosureofvestingstatusofwarrantsLineItems" xml:lang="en-US">DisclosureOfVestingStatusOfWarrants [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DisclosureofvestingstatusofwarrantsLineItems" xml:lang="en-US">Disclosure Of Vesting Status Of Warrants [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DisclosureofvestingstatusofwarrantsLineItems" xlink:to="lab_rgti_DisclosureofvestingstatusofwarrantsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DisclosureofvestingstatusofwarrantsLineItems" xml:lang="en-US">DisclosureOfVestingStatusOfWarrants .</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xml:lang="en-US">Share based compensation arrangement share based payment award options vested and exercisable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockIssuedDuringPeriodWarrantsIssued" xlink:label="loc_rgti_StockIssuedDuringPeriodWarrantsIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_StockIssuedDuringPeriodWarrantsIssued" xml:lang="en-US">Stock Issued During Period Warrants Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_StockIssuedDuringPeriodWarrantsIssued" xml:lang="en-US">Stock issued during period number of warrants issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_StockIssuedDuringPeriodWarrantsIssued" xlink:to="lab_rgti_StockIssuedDuringPeriodWarrantsIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_StockIssuedDuringPeriodWarrantsIssued" xml:lang="en-US">Stock issued during period warrants issued.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" xlink:label="loc_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" xml:lang="en-US">Class Of Warrants Or Rights Warrants Issued During The Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" xml:lang="en-US">Warrants Issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" xlink:to="lab_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" xml:lang="en-US">Class of warrants or rights warrants issued during the period.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeAssets" xml:lang="en-US">Derivative Asset</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeAssets" xml:lang="en-US">Derivative asset</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xml:lang="en-US">Business combination consideration to be paid</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiMember" xlink:label="loc_rgti_RigettiMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RigettiMember" xml:lang="en-US">Rigetti [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RigettiMember" xlink:to="lab_rgti_RigettiMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RigettiMember" xml:lang="en-US">Rigetti member.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementMember" xlink:label="loc_rgti_ForwardWarrantAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ForwardWarrantAgreementMember" xml:lang="en-US">Forward Warrant Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ForwardWarrantAgreementMember" xlink:to="lab_rgti_ForwardWarrantAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ForwardWarrantAgreementMember" xml:lang="en-US">Forward warrant agreement member.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AmpereComputingLlcMember" xlink:label="loc_rgti_AmpereComputingLlcMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_AmpereComputingLlcMember" xml:lang="en-US">Ampere Computing LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_AmpereComputingLlcMember" xml:lang="en-US">Ampere</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_AmpereComputingLlcMember" xlink:to="lab_rgti_AmpereComputingLlcMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_AmpereComputingLlcMember" xml:lang="en-US">Ampere Computing LLC [Memebr]</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VestingAxis" xml:lang="en-US">Vesting [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VestingDomain" xml:lang="en-US">Vesting [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" xlink:label="loc_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" xml:lang="en-US">Measurement Input Probability of occurring the contingency</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" xlink:to="lab_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" xml:lang="en-US">Measurement input probability of occurring the contingency member.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xml:lang="en-US">Derivative Liability, Measurement Input</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xml:lang="en-US">Fair Value By Balance Sheet Grouping [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value Hierarchy and NAV</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value Hierarchy and NAV</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Fair Value, Inputs, Level 3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Fair Value, Inputs, Level 2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Fair Value, Inputs, Level 1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xml:lang="en-US">Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xml:lang="en-US">Liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US">Derivative liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ContingentEarnOutLiabilityFairValueDisclosure" xlink:label="loc_rgti_ContingentEarnOutLiabilityFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ContingentEarnOutLiabilityFairValueDisclosure" xml:lang="en-US">Contingent Earn Out Liability Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_rgti_ContingentEarnOutLiabilityFairValueDisclosure" xml:lang="en-US">Earn-out Liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ContingentEarnOutLiabilityFairValueDisclosure" xlink:to="lab_rgti_ContingentEarnOutLiabilityFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ContingentEarnOutLiabilityFairValueDisclosure" xml:lang="en-US">Contingent Earn Out Liability Fair Value Disclosure.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" xml:lang="en-US">Investments, Fair Value Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" xml:lang="en-US">Assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xml:lang="en-US">Investments, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xml:lang="en-US">Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementFairValueDisclosure" xlink:label="loc_rgti_ForwardWarrantAgreementFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ForwardWarrantAgreementFairValueDisclosure" xml:lang="en-US">Forward Warrant Agreement Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ForwardWarrantAgreementFairValueDisclosure" xml:lang="en-US">Forward Warrant Agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ForwardWarrantAgreementFairValueDisclosure" xlink:to="lab_rgti_ForwardWarrantAgreementFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ForwardWarrantAgreementFairValueDisclosure" xml:lang="en-US">Forward Warrant Agreement Fair Value Disclosure.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ContingentEarnOutLiabilityMember" xlink:label="loc_rgti_ContingentEarnOutLiabilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ContingentEarnOutLiabilityMember" xml:lang="en-US">Earn out Liability [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ContingentEarnOutLiabilityMember" xml:lang="en-US">Earn out Liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ContingentEarnOutLiabilityMember" xlink:to="lab_rgti_ContingentEarnOutLiabilityMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMember" xlink:label="loc_us-gaap_DerivativeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeMember" xml:lang="en-US">Derivative [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeMember" xml:lang="en-US">Derivative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeMember" xlink:to="lab_us-gaap_DerivativeMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" xlink:label="loc_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" xml:lang="en-US">Forward Warrant Agreement Liability Fair Value Disclosure [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" xml:lang="en-US">Forward warrant agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" xlink:to="lab_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" xml:lang="en-US">Forward warrant agreement liability fair value disclosure.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xml:lang="en-US">Cash and Cash Equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xml:lang="en-US">Cash and Cash Equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DerivativeWarrantLiabilitiesMember" xlink:label="loc_rgti_DerivativeWarrantLiabilitiesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DerivativeWarrantLiabilitiesMember" xml:lang="en-US">Derivative Warrant Liabilities [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DerivativeWarrantLiabilitiesMember" xlink:to="lab_rgti_DerivativeWarrantLiabilitiesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DerivativeWarrantLiabilitiesMember" xml:lang="en-US">Derivative warrant liabilities.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xml:lang="en-US">Initial measurement on March 2, 2022 upon Business Combination (Note 3)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Ending Balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Beginning Balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xml:lang="en-US">Exercise of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xml:lang="en-US">Change in fair values</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xml:lang="en-US">Issuance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xml:lang="en-US">Exercisable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US">Exercisable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US">Exercisable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Forfeited and expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US">Exercisable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Forfeited and expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share based compensation stock options granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" xlink:label="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" xml:lang="en-US">Schedule Of Share based Compensation Restricted Stock And Restricted Stock Units Activity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" xlink:to="lab_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" xml:lang="en-US">Schedule of share based compensation restricted stock and restricted stock units activity.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RestrictedStockUnitsTable" xlink:label="loc_rgti_RestrictedStockUnitsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_RestrictedStockUnitsTable" xml:lang="en-US">Restricted Stock Units [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_RestrictedStockUnitsTable" xlink:to="lab_rgti_RestrictedStockUnitsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_RestrictedStockUnitsTable" xml:lang="en-US">Restricted Stock Units.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" xlink:label="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock And Restricted Stock Units Activity [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" xlink:to="lab_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" xml:lang="en-US">Schedule of share based compensation restricted stock and restricted stock units activity..</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted-Average Fair Value Per Share, Granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted-Average Fair Value Per Share, Ending balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted-Average Fair Value Per Share, Beginning balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US">Number of Restricted Stock Units, Vested</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US">Vested</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US">Ending balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xml:lang="en-US">Beginning balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted-Average Fair Value Per Share, Forfeited</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xml:lang="en-US">Number of Restricted Stock Units, Forfeited</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted-Average Fair Value Per Share, Vested</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US">Number of Restricted Stock Units, Granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Share-based Payment Arrangement, Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Share-based Payment Arrangement, Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Stock-based compensation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xml:lang="en-US">General and Administrative Expense [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US">Research and Development Expense [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xml:lang="en-US">Research And Development Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TimeBasedVestingAwardMember" xlink:label="loc_rgti_TimeBasedVestingAwardMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TimeBasedVestingAwardMember" xml:lang="en-US">Time Based Vesting Award [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TimeBasedVestingAwardMember" xlink:to="lab_rgti_TimeBasedVestingAwardMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_MarketBasedVestingAwardMember" xlink:label="loc_rgti_MarketBasedVestingAwardMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_MarketBasedVestingAwardMember" xml:lang="en-US">Market Based Vesting Award [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_MarketBasedVestingAwardMember" xlink:to="lab_rgti_MarketBasedVestingAwardMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Expected dividend yield</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Expected term (in years)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Expected volatility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xml:lang="en-US">Exercise price/Stock price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Weighted-average risk-free interest rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Weighted-average period over which cost not yet recognized&#160;</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US">Amount of cost not yet recognized for nonvested award</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockOptionCommonShareExercisePrice" xlink:label="loc_rgti_StockOptionCommonShareExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_StockOptionCommonShareExercisePrice" xml:lang="en-US">Stock Option Common Share Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_StockOptionCommonShareExercisePrice" xml:lang="en-US">Common stock exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_StockOptionCommonShareExercisePrice" xlink:to="lab_rgti_StockOptionCommonShareExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_StockOptionCommonShareExercisePrice" xml:lang="en-US">Common stock exercise price.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" xlink:label="loc_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" xml:lang="en-US">Percentage Of The Common Stock Of All Classes Outstanding On Preceding Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" xml:lang="en-US">Percentage of the common stock of all classes outstanding on preceding year</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" xlink:to="lab_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" xml:lang="en-US">Percentage of the common stock of all classes outstanding on preceding year.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xml:lang="en-US">weighted-average grant date fair value of options granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US">Share based compensation stock options vesting period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:label="loc_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" xml:lang="en-US">Two Thousand Twenty Two Equity Incentive Plan [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" xml:lang="en-US">2022 Equity Incentive Plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:to="lab_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedStockMember" xml:lang="en-US">Restricted Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RestrictedStockMember" xml:lang="en-US">Restricted Stock Awards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CeoAwardMember" xlink:label="loc_rgti_CeoAwardMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CeoAwardMember" xml:lang="en-US">CEO Award [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CeoAwardMember" xlink:to="lab_rgti_CeoAwardMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CeoAwardMember" xml:lang="en-US">CEO award member.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NetIncomeLossRelationToCommonStock" xlink:label="loc_rgti_NetIncomeLossRelationToCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_NetIncomeLossRelationToCommonStock" xml:lang="en-US">Net Income Loss Relation To Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_NetIncomeLossRelationToCommonStock" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_NetIncomeLossRelationToCommonStock" xlink:to="lab_rgti_NetIncomeLossRelationToCommonStock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_NetIncomeLossRelationToCommonStock" xml:lang="en-US">Net income (loss) relation to common stock.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US">Antidilutive Securities [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConvertibleSeriesCPreferredStockMember" xlink:label="loc_rgti_ConvertibleSeriesCPreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ConvertibleSeriesCPreferredStockMember" xml:lang="en-US">Convertible Series C Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ConvertibleSeriesCPreferredStockMember" xml:lang="en-US">Convertible Series C Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ConvertibleSeriesCPreferredStockMember" xlink:to="lab_rgti_ConvertibleSeriesCPreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ConvertibleSeriesCPreferredStockMember" xml:lang="en-US">Convertible Series C Preferred Stock</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Common Stock Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConvertibleSeriesC1PreferredStockMember" xlink:label="loc_rgti_ConvertibleSeriesC1PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_ConvertibleSeriesC1PreferredStockMember" xml:lang="en-US">Convertible Series C1 Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_ConvertibleSeriesC1PreferredStockMember" xml:lang="en-US">Convertible Series C-1 Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_ConvertibleSeriesC1PreferredStockMember" xlink:to="lab_rgti_ConvertibleSeriesC1PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_ConvertibleSeriesC1PreferredStockMember" xml:lang="en-US">Convertible Series C-1 Preferred Stock Member</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xml:lang="en-US">Weighted Average Number of Shares, Contingently Issuable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xml:lang="en-US">Weighted average number of shares Contingently Issuable shares under earnout arrangement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xml:lang="en-US">Domestic</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xml:lang="en-US">Foreign</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xml:lang="en-US">Deferred tax liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="loc_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" xml:lang="en-US">Depreciation&#160;and amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" xml:lang="en-US">Deferred tax liabilities depreciation and amortization.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xml:lang="en-US">Deferred Tax Liabilities, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xml:lang="en-US">Total deferred tax liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="loc_rgti_DeferredTaxLiabilitiesRightOfUseAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DeferredTaxLiabilitiesRightOfUseAssets" xml:lang="en-US">Deferred Tax Liabilities Right Of Use Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DeferredTaxLiabilitiesRightOfUseAssets" xml:lang="en-US">ROU Asset</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="lab_rgti_DeferredTaxLiabilitiesRightOfUseAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DeferredTaxLiabilitiesRightOfUseAssets" xml:lang="en-US">Deferred tax liabilities right of use assets.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xml:lang="en-US">Deferred Tax Assets, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xml:lang="en-US">Total net deferred tax assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Deferred tax assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xml:lang="en-US">Stock-based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xml:lang="en-US">Deferred Tax Assets, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xml:lang="en-US">Gross deferred assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="loc_rgti_DeferredTaxAssetsRightOfUseLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_DeferredTaxAssetsRightOfUseLiabilities" xml:lang="en-US">Deferred Tax Assets Right Of Use Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_DeferredTaxAssetsRightOfUseLiabilities" xml:lang="en-US">ROU liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_DeferredTaxAssetsRightOfUseLiabilities" xlink:to="lab_rgti_DeferredTaxAssetsRightOfUseLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_DeferredTaxAssetsRightOfUseLiabilities" xml:lang="en-US">Deferred tax assets right of use liabilities.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US">Net operating loss carryforwards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xml:lang="en-US">Accruals and reserves</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xml:lang="en-US">Research and development credits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xml:lang="en-US">Intangible assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Net deferred tax assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Change in valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" xml:lang="en-US">Effective Income Tax Rate Reconciliation Transaction Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" xml:lang="en-US">Transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" xlink:to="lab_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" xml:lang="en-US">Effective income tax rate reconciliation transaction costs.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" xml:lang="en-US">Effective Income Tax Rate Reconciliation Fair Market Value Adjustment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" xml:lang="en-US">Fair market value adjustment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" xlink:to="lab_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" xml:lang="en-US">Effective income tax rate reconciliation fair market value adjustment</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xml:lang="en-US">Total&#160;pre-tax&#160;book income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Total:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xml:lang="en-US">Non-deductible executive compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xml:lang="en-US">Other</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" xml:lang="en-US">Effective Income Tax Rate Reconciliation Goodwill Impairment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" xml:lang="en-US">Goodwill impairment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" xlink:to="lab_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" xml:lang="en-US">Effective income tax rate reconciliation goodwill impairment</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xml:lang="en-US">State and local income taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US">Unrecognized Tax Benefits</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US">Ending balance at December 31, 2022</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US">Beginning balance at January 1, 2022</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US">Unrecognized tax benefits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xml:lang="en-US">Current year increase(decrease)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xml:lang="en-US">Prior year adjustment&#8212;increase (decrease)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodAxis" xlink:label="loc_rgti_PeriodAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PeriodAxis" xml:lang="en-US">Period [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PeriodAxis" xlink:to="lab_rgti_PeriodAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PeriodAxis" xml:lang="en-US">Period.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodDomain" xlink:label="loc_rgti_PeriodDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PeriodDomain" xml:lang="en-US">Period [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PeriodDomain" xlink:to="lab_rgti_PeriodDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PeriodDomain" xml:lang="en-US">Period.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentYearMember" xlink:label="loc_rgti_CurrentYearMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_CurrentYearMember" xml:lang="en-US">Current Year [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_CurrentYearMember" xlink:to="lab_rgti_CurrentYearMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_CurrentYearMember" xml:lang="en-US">Current year.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PreviousYearMember" xlink:label="loc_rgti_PreviousYearMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PreviousYearMember" xml:lang="en-US">Previous Year [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PreviousYearMember" xlink:to="lab_rgti_PreviousYearMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PreviousYearMember" xml:lang="en-US">Previous year.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfIncomeTaxesInformationTable" xlink:label="loc_rgti_SummaryOfIncomeTaxesInformationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SummaryOfIncomeTaxesInformationTable" xml:lang="en-US">Summary Of Income Taxes Information [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationTable" xlink:to="lab_rgti_SummaryOfIncomeTaxesInformationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SummaryOfIncomeTaxesInformationTable" xml:lang="en-US">Summary Of Income Taxes Informatio.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xml:lang="en-US">Tax Credit Carryforward [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchMember" xml:lang="en-US">Research Tax Credit Carryforward [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfIncomeTaxesInformationLineItems" xlink:label="loc_rgti_SummaryOfIncomeTaxesInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_SummaryOfIncomeTaxesInformationLineItems" xml:lang="en-US">Summary Of Income Taxes Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems" xlink:to="lab_rgti_SummaryOfIncomeTaxesInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_SummaryOfIncomeTaxesInformationLineItems" xml:lang="en-US">Summary Of Income Taxes Information</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xml:lang="en-US">Operating Loss Carryforwards</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xml:lang="en-US">Operating loss carryforwards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US">Change in valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US">Tax Credit Carryforward, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xml:lang="en-US">Tax credit carryforwards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xml:lang="en-US">Income Tax Authority [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xml:lang="en-US">Income Tax Authority [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DomesticCountryMember" xml:lang="en-US">Domestic Tax Authority [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xml:lang="en-US">Geographic Areas, Revenues from External Customers [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:to="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_EuropeMember" xml:lang="en-US">Europe [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Revenues" xml:lang="en-US">Revenues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Revenues" xml:lang="en-US">Revenues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable" xml:lang="en-US">Subsequent Event [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems" xml:lang="en-US">Subsequent Event [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestructuringCharges" xml:lang="en-US">Restructuring Charges</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfEmployees" xlink:label="loc_rgti_NumberOfEmployees" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_NumberOfEmployees" xml:lang="en-US">Number Of Employees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_NumberOfEmployees" xml:lang="en-US">Number Of Employees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_NumberOfEmployees" xlink:to="lab_rgti_NumberOfEmployees" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_NumberOfEmployees" xml:lang="en-US">Number Of Employees</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfReductionInEmployees" xlink:label="loc_rgti_PercentageOfReductionInEmployees" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_PercentageOfReductionInEmployees" xml:lang="en-US">Percentage Of Reduction In Employees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_rgti_PercentageOfReductionInEmployees" xml:lang="en-US">Percentage Of Reduction In Employees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_PercentageOfReductionInEmployees" xlink:to="lab_rgti_PercentageOfReductionInEmployees" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_PercentageOfReductionInEmployees" xml:lang="en-US">Percentage of reduction In employees.</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WeightedAverageSharePriceAxis" xlink:label="loc_rgti_WeightedAverageSharePriceAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_WeightedAverageSharePriceAxis" xml:lang="en-US">Weighted Average Share Price [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_WeightedAverageSharePriceAxis" xlink:to="lab_rgti_WeightedAverageSharePriceAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_WeightedAverageSharePriceAxis" xml:lang="en-US">Weighted Average Share Price</label>
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WeightedAverageSharePriceDomain" xlink:label="loc_rgti_WeightedAverageSharePriceDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_rgti_WeightedAverageSharePriceDomain" xml:lang="en-US">Weighted Average Share Price [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rgti_WeightedAverageSharePriceDomain" xlink:to="lab_rgti_WeightedAverageSharePriceDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_rgti_WeightedAverageSharePriceDomain" xml:lang="en-US">Weighted Average Share Price</label>
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>rgti-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 05-April-2023 [05:05:55] {PM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CoverPage" roleURI="http://www.rigetti.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.rigetti.com/role/ConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfOperations" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfComprehensiveLoss" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DescriptionOfBusiness" roleURI="http://www.rigetti.com/role/DescriptionOfBusiness" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombination" roleURI="http://www.rigetti.com/role/BusinessCombination" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Investments" roleURI="http://www.rigetti.com/role/Investments" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Goodwill" roleURI="http://www.rigetti.com/role/Goodwill" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognition" roleURI="http://www.rigetti.com/role/RevenueRecognition" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformation" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformation" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Leases" roleURI="http://www.rigetti.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommitmentsAndContingencies" roleURI="http://www.rigetti.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Debt" roleURI="http://www.rigetti.com/role/Debt" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RedeemableConvertiblePreferredStock" roleURI="http://www.rigetti.com/role/RedeemableConvertiblePreferredStock" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommonStock" roleURI="http://www.rigetti.com/role/CommonStock" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Warrants" roleURI="http://www.rigetti.com/role/Warrants" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ForwardWarrantAgreement" roleURI="http://www.rigetti.com/role/ForwardWarrantAgreement" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#FairValueMeasurements" roleURI="http://www.rigetti.com/role/FairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlans" roleURI="http://www.rigetti.com/role/EquityPlans" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShare" roleURI="http://www.rigetti.com/role/NetLossPerShare" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxes" roleURI="http://www.rigetti.com/role/IncomeTaxes" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#Segments" roleURI="http://www.rigetti.com/role/Segments" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SubsequentEvents" roleURI="http://www.rigetti.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationTables" roleURI="http://www.rigetti.com/role/BusinessCombinationTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#InvestmentsTables" roleURI="http://www.rigetti.com/role/InvestmentsTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#GoodwillTables" roleURI="http://www.rigetti.com/role/GoodwillTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionTables" roleURI="http://www.rigetti.com/role/RevenueRecognitionTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformationTables" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesTables" roleURI="http://www.rigetti.com/role/LeasesTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtTables" roleURI="http://www.rigetti.com/role/DebtTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommonStockTables" roleURI="http://www.rigetti.com/role/CommonStockTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsTables" roleURI="http://www.rigetti.com/role/WarrantsTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ForwardWarrantAgreementTables" roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#FairValueMeasurementsTables" roleURI="http://www.rigetti.com/role/FairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansTables" roleURI="http://www.rigetti.com/role/EquityPlansTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareTables" roleURI="http://www.rigetti.com/role/NetLossPerShareTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesTables" roleURI="http://www.rigetti.com/role/IncomeTaxesTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SegmentsTables" roleURI="http://www.rigetti.com/role/SegmentsTables" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DescriptionOfBusinessAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail" roleURI="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#BusinessCombinationAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail" roleURI="http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#InvestmentsAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#GoodwillSummaryOfScheduleOfGoodwillDetail" roleURI="http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#GoodwillAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/GoodwillAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail" roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail" roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail" roleURI="http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SupplementalFinancialStatementsInformationAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/LeasesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesSummaryOfComponentsOfLeaseCostsDetail" roleURI="http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail" roleURI="http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail" roleURI="http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail" roleURI="http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtLongTermDebtAndTheUnamortizedDiscountDetail" roleURI="http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#DebtAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/DebtAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#RedeemableConvertiblePreferredStockAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommonStockSummaryOfConversionsOfStockDetail" roleURI="http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#CommonStockAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/CommonStockAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/WarrantsAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail" roleURI="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail" roleURI="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail" roleURI="http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ForwardWarrantAgreementAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail" roleURI="http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" roleURI="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail" roleURI="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail" roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail" roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail" roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail" roleURI="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#EquityPlansAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail" roleURI="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#NetLossPerShareAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#IncomeTaxesAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SegmentsSummaryOfRevenueByGeographyDetail" roleURI="http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail" />
<roleRef xlink:type="simple" xlink:href="rgti-20221231.xsd#SubsequentEventsAdditionalInformationDetail" roleURI="http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail" />
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_1323689" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1423363" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1323689" xlink:to="loc_dei_DocumentInformationTable_1423363" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1423364" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1423363" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1423364" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423365" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423364" xlink:to="loc_us-gaap_ClassOfStockDomain_1423365" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423442" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1423363" xlink:to="loc_dei_LegalEntityAxis_1423442" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423445" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423442" xlink:to="loc_dei_EntityDomain_1423445" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_2146632636" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1423363" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_2146632636" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_2146632635" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_2146632636" xlink:to="loc_dei_AddressTypeDomain_2146632635" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_2146632634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_2146632635" xlink:to="loc_dei_BusinessContactMember_2146632634" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_1423368" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1423363" xlink:to="loc_dei_DocumentInformationLineItems_1423368" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_1323692" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_DocumentType_1323692" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_1323693" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_AmendmentFlag_1323693" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1323696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityRegistrantName_1323696" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_1323698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityCentralIndexKey_1323698" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1423371" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1423371" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_1423370" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityTaxIdentificationNumber_1423370" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_1423377" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityAddressAddressLine1_1423377" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_1423378" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityAddressCityOrTown_1423378" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_1423379" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityAddressStateOrProvince_1423379" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_1423376" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityAddressPostalZipCode_1423376" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_1423251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_CityAreaCode_1423251" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_1423252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_LocalPhoneNumber_1423252" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_2146632633" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_ContactPersonnelName_2146632633" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber_2146632637" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1423368" xlink:to="loc_dei_EntityPrimarySicNumber_2146632637" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_132" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_132" xlink:to="loc_us-gaap_StatementTable_133" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_133" xlink:to="loc_us-gaap_StatementClassOfStockAxis_134" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_134" xlink:to="loc_us-gaap_ClassOfStockDomain_135" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_135" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329032" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329072" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_133" xlink:to="loc_dei_LegalEntityAxis_1329072" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329073" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329072" xlink:to="loc_dei_EntityDomain_1329073" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_133" xlink:to="loc_us-gaap_StatementLineItems_136" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_136" xlink:to="loc_us-gaap_AssetsAbstract_137" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_AssetsCurrentAbstract_138" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1701611" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1701611" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_1701613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_1701613" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1329018" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1329018" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1329019" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1329019" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardContractAssetsCurrent" xlink:label="loc_rgti_ForwardContractAssetsCurrent_1423382" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_rgti_ForwardContractAssetsCurrent_1423382" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCurrent" xlink:label="loc_us-gaap_DeferredCostsCurrent_1335848" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_DeferredCostsCurrent_1335848" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_138" xlink:to="loc_us-gaap_AssetsCurrent_146" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1329020" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1329020" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2146632823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2146632823" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_1329021" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_RestrictedCash_1329021" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets_1329022" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_OtherAssets_1329022" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_1329023" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_Goodwill_1329023" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_137" xlink:to="loc_us-gaap_Assets_150" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_136" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_140" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_AccountsPayableCurrent_151" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1329024" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1329024" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue_1329026" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_DeferredRevenue_1329026" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent" xlink:label="loc_us-gaap_DebtCurrent_1329027" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_DebtCurrent_1329027" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2146632822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2146632822" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardContractLiabilities" xlink:label="loc_rgti_ForwardContractLiabilities_1423383" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_140" xlink:to="loc_rgti_ForwardContractLiabilities_1423383" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_LiabilitiesCurrent_153" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtNetOfCurrentPortion" xlink:label="loc_rgti_DebtNetOfCurrentPortion_1329028" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_rgti_DebtNetOfCurrentPortion_1329028" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2146632821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2146632821" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_155" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1423425" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1423425" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaap_OtherLiabilities_1329030" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_OtherLiabilities_1329030" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_Liabilities_156" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_157" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_CommitmentsAndContingencies_157" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_PreferredStockValue_159" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_StockholdersEquityAbstract_141" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_1423430" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_1423430" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_160" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_CommonStockValue_160" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_161" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1329033" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1329033" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_162" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_141" xlink:to="loc_us-gaap_StockholdersEquity_163" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_139" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_164" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_187" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_188" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_187" xlink:to="loc_us-gaap_StatementTable_188" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_189" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_188" xlink:to="loc_us-gaap_StatementClassOfStockAxis_189" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_189" xlink:to="loc_us-gaap_ClassOfStockDomain_190" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329063" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_190" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329063" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329065" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_188" xlink:to="loc_dei_LegalEntityAxis_1329065" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329067" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329065" xlink:to="loc_dei_EntityDomain_1329067" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_188" xlink:to="loc_us-gaap_StatementLineItems_191" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_197" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_197" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_198" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_PreferredStockSharesIssued_199" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_200" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_200" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_201" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_201" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_202" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_202" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_CommonStockSharesIssued_205" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_206" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_191" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_206" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_229" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_229" xlink:to="loc_us-gaap_StatementTable_230" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_231" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_230" xlink:to="loc_us-gaap_StatementClassOfStockAxis_231" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_231" xlink:to="loc_us-gaap_ClassOfStockDomain_232" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_230" xlink:to="loc_dei_LegalEntityAxis_1329141" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329141" xlink:to="loc_dei_EntityDomain_1329142" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_233" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_230" xlink:to="loc_us-gaap_StatementLineItems_233" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1329098" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1329098" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_1329101" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_CostOfRevenue_1329101" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1329105" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_GrossProfit_1329105" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1329107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1329107" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1329109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1329107" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1329109" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_1329113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1329107" xlink:to="loc_us-gaap_SellingAndMarketingExpense_1329113" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_237" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1329107" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_237" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2146632820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1329107" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2146632820" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_1329116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_OperatingExpenses_1329116" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_OperatingIncomeLoss_238" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_1329119" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_InterestExpense_1329119" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1329122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1329122" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_239" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_239" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1423459" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1423459" use="optional" order="21" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TransactionCosts" xlink:label="loc_rgti_TransactionCosts_1423460" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_rgti_TransactionCosts_1423460" use="optional" order="22" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaap_OtherIncome_1329126" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_OtherIncome_1329126" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1329131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_234" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1329131" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1329134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1329134" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1329136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1329136" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_NetIncomeLoss_242" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_245" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_246" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/presentationGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_EarningsPerShareBasic_247" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_233" xlink:to="loc_us-gaap_EarningsPerShareDiluted_248" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/presentationGuidance" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1329163" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1329164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1329163" xlink:to="loc_us-gaap_StatementTable_1329164" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1329164" xlink:to="loc_dei_LegalEntityAxis_1329179" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329179" xlink:to="loc_dei_EntityDomain_1329180" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1329165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1329164" xlink:to="loc_us-gaap_StatementLineItems_1329165" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1329167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1329165" xlink:to="loc_us-gaap_NetIncomeLoss_1329167" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1329168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1329165" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1329168" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1329171" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1329168" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1329171" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1701644" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1329168" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1701644" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1329172" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1329165" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1329172" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_272" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_273" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_272" xlink:to="loc_us-gaap_StatementTable_273" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_274" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_274" xlink:to="loc_us-gaap_EquityComponentDomain_275" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_CommonStockMember_279" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_280" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1329198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1329198" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_281" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_RetainedEarningsMember_281" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_1426616" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_275" xlink:to="loc_us-gaap_PreferredStockMember_1426616" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_us-gaap_StatementClassOfStockAxis_276" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_276" xlink:to="loc_us-gaap_ClassOfStockDomain_277" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_277" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_1329194" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1423466" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_srt_RestatementAxis_1423466" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1423467" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_1423466" xlink:to="loc_srt_RestatementDomain_1423467" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_278" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_273" xlink:to="loc_us-gaap_StatementLineItems_278" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockholdersEquity_284" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_285" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_SharesOutstanding_285" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_1329245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_1329245" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ReclassificationOfTemporaryEquityShares" xlink:label="loc_rgti_ReclassificationOfTemporaryEquityShares_1423471" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_ReclassificationOfTemporaryEquityShares_1423471" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1336565" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1336565" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1333709" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1333709" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue" xlink:label="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue_1423474" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue_1423474" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares" xlink:label="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares_1423475" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares_1423475" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1569131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1569131" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1569135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1569135" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares" xlink:label="loc_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares_1701947" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares_1701947" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares" xlink:label="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares_1569160" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares_1569160" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants" xlink:label="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants_1569173" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants_1569173" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants" xlink:label="loc_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants_1569152" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants_1569152" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1333717" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1333717" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract" xlink:label="loc_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract_1569174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract_1569174" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1569176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1569176" use="optional" order="31" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1333716" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1333716" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities" xlink:label="loc_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities_2146632805" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities_2146632805" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_NetIncomeLoss_290" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_291" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_StockholdersEquity_291" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278" xlink:to="loc_us-gaap_SharesOutstanding_292" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_325" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1332568" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_325" xlink:to="loc_us-gaap_StatementTable_1332568" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1332569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1332568" xlink:to="loc_dei_LegalEntityAxis_1332569" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1332570" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1332569" xlink:to="loc_dei_EntityDomain_1332570" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334717" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1332568" xlink:to="loc_us-gaap_StatementLineItems_1334717" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_332" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" xlink:to="loc_us-gaap_ProfitLoss_332" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_1332435" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_Depreciation_1332435" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1332445" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_ShareBasedCompensation_1332445" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1423480" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1423480" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_1332484" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_1332484" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ChangeInFairValueOfForwardContract" xlink:label="loc_rgti_ChangeInFairValueOfForwardContract_1332509" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_rgti_ChangeInFairValueOfForwardContract_1332509" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_1332526" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_1332526" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AmortizationOfDebtCommitmentFeeAsset" xlink:label="loc_rgti_AmortizationOfDebtCommitmentFeeAsset_1332555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_rgti_AmortizationOfDebtCommitmentFeeAsset_1332555" use="optional" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1710893" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1710893" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccretionOfDebtEndOfTermLiabilities" xlink:label="loc_rgti_AccretionOfDebtEndOfTermLiabilities_1332559" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_rgti_AccretionOfDebtEndOfTermLiabilities_1332559" use="optional" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NonCashLeaseExpense" xlink:label="loc_rgti_NonCashLeaseExpense_2146632803" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_rgti_NonCashLeaseExpense_2146632803" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2146632794" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_327" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2146632794" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1332563" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1332563" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_336" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_336" use="optional" order="21" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_1332579" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_1332579" use="optional" order="22" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1332584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1332584" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_337" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_337" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_1424488" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_1424488" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1332594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_328" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1332594" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_339" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_326" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_339" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1332646" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1332646" use="optional" order="29" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1701646" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1701646" use="optional" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_341" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_329" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_341" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423483" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423483" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TransactionCostsPaid" xlink:label="loc_rgti_TransactionCostsPaid_1423484" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_TransactionCostsPaid_1423484" use="optional" order="34" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_1332768" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_1332768" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_343" use="optional" order="36" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_1332772" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_1332772" use="optional" order="37" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfLoanAndSecurityAgreementExitFees" xlink:label="loc_rgti_PaymentOfLoanAndSecurityAgreementExitFees_1423485" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_PaymentOfLoanAndSecurityAgreementExitFees_1423485" use="optional" order="38" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfDeferredOfferingCosts" xlink:label="loc_rgti_PaymentOfDeferredOfferingCosts_1332777" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_PaymentOfDeferredOfferingCosts_1332777" use="optional" order="39" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants" xlink:label="loc_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants_1423486" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants_1423486" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_347" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_330" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_347" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1332805" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1332805" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_348" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_348" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_349" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_349" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_350" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_350" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_331" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_331" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_1332811" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_331" xlink:to="loc_us-gaap_InterestPaidNet_1332811" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334717" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera" xlink:label="loc_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera_2146632680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera_2146632680" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xlink:label="loc_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses_1332842" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses_1332842" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability." xlink:label="loc_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability._1332857" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability._1332857" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger" xlink:label="loc_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger_2146632679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger_2146632679" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ExerciseOfLoanAndSecurityAgreementWarrants" xlink:label="loc_rgti_ExerciseOfLoanAndSecurityAgreementWarrants_1569178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_ExerciseOfLoanAndSecurityAgreementWarrants_1569178" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SettlementOfTheFirstTrancheOfForwardContract" xlink:label="loc_rgti_SettlementOfTheFirstTrancheOfForwardContract_1569180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_SettlementOfTheFirstTrancheOfForwardContract_1569180" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance" xlink:label="loc_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance_1569181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance_1569181" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1569182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1569182" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense" xlink:label="loc_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense_2146632795" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense_2146632795" use="optional" order="57" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_1701647" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_1701647" use="optional" order="58" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602" xlink:label="loc_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602_2146632798" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602_2146632798" use="optional" order="59" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602" xlink:label="loc_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602_2146632797" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602_2146632797" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xlink:label="loc_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets_2146632796" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2146632691" xlink:to="loc_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets_2146632796" use="optional" order="61" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DescriptionOfBusiness">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_359" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334420" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_359" xlink:to="loc_us-gaap_StatementTable_1334420" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334421" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334420" xlink:to="loc_dei_LegalEntityAxis_1334421" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334421" xlink:to="loc_dei_EntityDomain_1334422" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334423" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334420" xlink:to="loc_us-gaap_StatementLineItems_1334423" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_360" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334423" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_360" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_365" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334430" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_365" xlink:to="loc_us-gaap_StatementTable_1334430" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1392700" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334430" xlink:to="loc_dei_LegalEntityAxis_1392700" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1392701" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1392700" xlink:to="loc_dei_EntityDomain_1392701" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334433" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334430" xlink:to="loc_us-gaap_StatementLineItems_1334433" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_366" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334433" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_366" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombination">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1423540" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1423541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1423540" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1423541" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Investments">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1701695" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1701696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1701695" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1701696" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Goodwill">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632784" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_2146632783" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632784" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_2146632783" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognition">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1329350" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1329436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1329350" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1329436" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329436" xlink:to="loc_dei_LegalEntityAxis_1329437" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329439" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329437" xlink:to="loc_dei_EntityDomain_1329439" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1329444" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329436" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1329444" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1329356" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329444" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1329356" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformation">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupplementalFinancialStatementInformationAbstract" xlink:label="loc_rgti_SupplementalFinancialStatementInformationAbstract_1330542" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334779" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SupplementalFinancialStatementInformationAbstract_1330542" xlink:to="loc_us-gaap_StatementTable_1334779" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334784" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334779" xlink:to="loc_dei_LegalEntityAxis_1334784" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334785" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334784" xlink:to="loc_dei_EntityDomain_1334785" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334780" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334779" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334780" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334781" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334780" xlink:to="loc_us-gaap_ClassOfStockDomain_1334781" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334782" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334779" xlink:to="loc_us-gaap_StatementLineItems_1334782" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupplementalFinancialStatementInformationTextBlock" xlink:label="loc_rgti_SupplementalFinancialStatementInformationTextBlock_1330546" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334782" xlink:to="loc_rgti_SupplementalFinancialStatementInformationTextBlock_1330546" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Leases">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_2146632733" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_2146632732" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2146632733" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_2146632732" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1569232" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1569234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1569232" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1569234" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Debt">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1331474" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335048" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1331474" xlink:to="loc_us-gaap_StatementTable_1335048" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335053" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335048" xlink:to="loc_dei_LegalEntityAxis_1335053" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335054" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1335053" xlink:to="loc_dei_EntityDomain_1335054" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1335049" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335048" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1335049" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335050" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335049" xlink:to="loc_us-gaap_ClassOfStockDomain_1335050" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335051" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335048" xlink:to="loc_us-gaap_StatementLineItems_1335051" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1331477" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335051" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1331477" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RedeemableConvertiblePreferredStock">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_1330629" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331506" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_1330629" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331506" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331509" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331506" xlink:to="loc_dei_LegalEntityAxis_1331509" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331510" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331509" xlink:to="loc_dei_EntityDomain_1331510" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1331551" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331506" xlink:to="loc_us-gaap_TemporaryEquityLineItems_1331551" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RedeemableConvertiblePreferredStockTextBlock" xlink:label="loc_rgti_RedeemableConvertiblePreferredStockTextBlock_1330631" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331551" xlink:to="loc_rgti_RedeemableConvertiblePreferredStockTextBlock_1330631" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommonStock">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1330967" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331531" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1330967" xlink:to="loc_us-gaap_StatementTable_1331531" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331532" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331531" xlink:to="loc_dei_LegalEntityAxis_1331532" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331533" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331532" xlink:to="loc_dei_EntityDomain_1331533" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_1331540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331531" xlink:to="loc_us-gaap_ClassOfStockLineItems_1331540" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockTextBlock" xlink:label="loc_rgti_CommonStockTextBlock_1330973" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1331540" xlink:to="loc_rgti_CommonStockTextBlock_1330973" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Warrants">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_389" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1333769" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_389" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1333769" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333770" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1333769" xlink:to="loc_dei_LegalEntityAxis_1333770" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333771" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333770" xlink:to="loc_dei_EntityDomain_1333771" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333774" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1333769" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333774" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WarrantsTextBlock" xlink:label="loc_rgti_WarrantsTextBlock_390" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333774" xlink:to="loc_rgti_WarrantsTextBlock_390" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ForwardWarrantAgreement">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1331184" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331589" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1331184" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331589" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331589" xlink:to="loc_dei_LegalEntityAxis_1331594" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331594" xlink:to="loc_dei_EntityDomain_1331595" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1331591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331589" xlink:to="loc_us-gaap_TemporaryEquityLineItems_1331591" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementDisclosure" xlink:label="loc_rgti_ForwardWarrantAgreementDisclosure_1331187" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331591" xlink:to="loc_rgti_ForwardWarrantAgreementDisclosure_1331187" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/FairValueMeasurements">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_407" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334874" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_407" xlink:to="loc_us-gaap_StatementTable_1334874" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334878" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334874" xlink:to="loc_dei_LegalEntityAxis_1334878" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334879" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334878" xlink:to="loc_dei_EntityDomain_1334879" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334875" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334874" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334875" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334876" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334875" xlink:to="loc_us-gaap_ClassOfStockDomain_1334876" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334877" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334874" xlink:to="loc_us-gaap_StatementLineItems_1334877" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_408" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334877" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_408" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlans">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1331520" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1331529" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1331520" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1331529" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShare">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1331096" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334566" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1331096" xlink:to="loc_us-gaap_StatementTable_1334566" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334570" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334566" xlink:to="loc_dei_LegalEntityAxis_1334570" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334572" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334570" xlink:to="loc_dei_EntityDomain_1334572" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334567" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334566" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334567" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334568" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334567" xlink:to="loc_us-gaap_ClassOfStockDomain_1334568" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334566" xlink:to="loc_us-gaap_StatementLineItems_1334569" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1331099" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334569" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1331099" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxes">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1331665" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333027" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1331665" xlink:to="loc_us-gaap_StatementTable_1333027" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333027" xlink:to="loc_dei_LegalEntityAxis_1333032" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333034" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333032" xlink:to="loc_dei_EntityDomain_1333034" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333028" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333027" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333028" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333029" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333028" xlink:to="loc_us-gaap_ClassOfStockDomain_1333029" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333030" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333027" xlink:to="loc_us-gaap_StatementLineItems_1333030" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1331666" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333030" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1331666" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/Segments">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_1331014" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1331014" xlink:to="loc_us-gaap_StatementTable_1334458" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334459" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334458" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334459" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334460" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334459" xlink:to="loc_us-gaap_ClassOfStockDomain_1334460" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334463" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334458" xlink:to="loc_dei_LegalEntityAxis_1334463" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334464" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334463" xlink:to="loc_dei_EntityDomain_1334464" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334458" xlink:to="loc_us-gaap_StatementLineItems_1334461" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1331015" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334461" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1331015" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SubsequentEvents">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_413" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_414" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_413" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_414" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_433" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334493" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_433" xlink:to="loc_us-gaap_StatementTable_1334493" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1392708" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334493" xlink:to="loc_dei_LegalEntityAxis_1392708" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1392710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1392708" xlink:to="loc_dei_EntityDomain_1392710" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334496" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334493" xlink:to="loc_us-gaap_StatementLineItems_1334496" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_rgti_EmergingGrowthCompanyPolicyTextBlock_435" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_EmergingGrowthCompanyPolicyTextBlock_435" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_UseOfEstimates_436" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_1331316" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_1331316" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1331319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1331319" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_1331328" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_1331328" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1423673" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1423673" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1331330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_1331330" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1331332" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1331332" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_1701735" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_1701735" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_1334542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_1334542" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" xlink:label="loc_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_1331340" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_1331340" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredOfferingCostsPolicyTextBlock" xlink:label="loc_rgti_DeferredOfferingCostsPolicyTextBlock_1331321" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_DeferredOfferingCostsPolicyTextBlock_1331321" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1331347" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1331347" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_1334548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_1334548" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredFinancingCostsPolicyTextBlock" xlink:label="loc_rgti_DeferredFinancingCostsPolicyTextBlock_1331322" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_DeferredFinancingCostsPolicyTextBlock_1331322" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicAndPrivateWarrantsPolicyTextBlock" xlink:label="loc_rgti_PublicAndPrivateWarrantsPolicyTextBlock_1423671" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_PublicAndPrivateWarrantsPolicyTextBlock_1423671" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_442" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_442" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock" xlink:label="loc_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock_1423674" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock_1423674" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_1331351" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_1331351" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock" xlink:label="loc_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock_1331353" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock_1331353" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_1331354" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_1331354" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1331355" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1331355" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_1331362" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_1331362" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SalesAndMarketingPolicyTextBlock" xlink:label="loc_rgti_SalesAndMarketingPolicyTextBlock_1331367" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_SalesAndMarketingPolicyTextBlock_1331367" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CapitalizedSoftwarePolicyTextBlock" xlink:label="loc_rgti_CapitalizedSoftwarePolicyTextBlock_1331374" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_CapitalizedSoftwarePolicyTextBlock_1331374" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_446" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_446" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_447" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_447" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_1331396" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_1331396" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_441" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_441" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_437" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_448" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_448" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="loc_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2146632817" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334496" xlink:to="loc_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_2146632817" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1334730" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334732" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1334730" xlink:to="loc_us-gaap_StatementTable_1334732" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1434183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334732" xlink:to="loc_dei_LegalEntityAxis_1434183" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1434184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1434183" xlink:to="loc_dei_EntityDomain_1434184" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334735" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334732" xlink:to="loc_us-gaap_StatementLineItems_1334735" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1331888" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1331888" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination_1423493" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination_1423493" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_454" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_454" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock_1423494" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334735" xlink:to="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock_1423494" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1423543" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock_1423544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1423543" xlink:to="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock_1423544" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock_1423545" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1423543" xlink:to="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock_1423545" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/InvestmentsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1701698" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_1701699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1701698" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_1701699" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/GoodwillTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632781" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_2146632780" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632781" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_2146632780" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1329428" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1329459" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1329428" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1329459" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329460" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329459" xlink:to="loc_dei_LegalEntityAxis_1329460" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329460" xlink:to="loc_dei_EntityDomain_1329461" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329459" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1329465" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1329465" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1329466" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_1329466" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:label="loc_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock_1329467" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329463" xlink:to="loc_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock_1329467" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupplementalFinancialStatementInformationAbstract" xlink:label="loc_rgti_SupplementalFinancialStatementInformationAbstract_1330558" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334816" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SupplementalFinancialStatementInformationAbstract_1330558" xlink:to="loc_us-gaap_StatementTable_1334816" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334816" xlink:to="loc_dei_LegalEntityAxis_1334820" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334820" xlink:to="loc_dei_EntityDomain_1334821" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334817" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334816" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334817" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334818" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334817" xlink:to="loc_us-gaap_ClassOfStockDomain_1334818" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334819" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334816" xlink:to="loc_us-gaap_StatementLineItems_1334819" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1334826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334819" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1334826" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1334829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334819" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_1334829" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/LeasesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_2146632730" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock" xlink:label="loc_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock_2146632678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2146632730" xlink:to="loc_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock_2146632678" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_2146632729" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2146632730" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_2146632729" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2146632696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2146632730" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2146632696" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1331502" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_1331508" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1331502" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_1331508" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1331519" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1331502" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1331519" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommonStockTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1330992" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1331544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1330992" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1331544" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331546" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1331544" xlink:to="loc_dei_LegalEntityAxis_1331546" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331546" xlink:to="loc_dei_EntityDomain_1331547" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_1331550" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1331544" xlink:to="loc_us-gaap_ClassOfStockLineItems_1331550" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfConversionsOfStockTextBlock" xlink:label="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock_1330990" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1331550" xlink:to="loc_us-gaap_ScheduleOfConversionsOfStockTextBlock_1330990" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1333783" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1333783" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333786" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" xlink:to="loc_dei_LegalEntityAxis_1333786" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333787" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333786" xlink:to="loc_dei_EntityDomain_1333787" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1333800" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1333800" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1333801" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1333800" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1333801" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateWarrantMember" xlink:label="loc_rgti_PrivateWarrantMember_1569644" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1333801" xlink:to="loc_rgti_PrivateWarrantMember_1569644" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333785" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1333784" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333785" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1333796" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333785" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1333796" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock" xlink:label="loc_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock_1333806" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333785" xlink:to="loc_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock_1333806" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ForwardWarrantAgreementTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1331191" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331602" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1331191" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331602" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331605" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331602" xlink:to="loc_dei_LegalEntityAxis_1331605" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331606" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331605" xlink:to="loc_dei_EntityDomain_1331606" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1331603" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1331602" xlink:to="loc_us-gaap_TemporaryEquityLineItems_1331603" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1331195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1331603" xlink:to="loc_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1331195" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/FairValueMeasurementsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_467" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334906" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_467" xlink:to="loc_us-gaap_StatementTable_1334906" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334923" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334906" xlink:to="loc_dei_LegalEntityAxis_1334923" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334925" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334923" xlink:to="loc_dei_EntityDomain_1334925" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334907" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334906" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334907" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334908" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334907" xlink:to="loc_us-gaap_ClassOfStockDomain_1334908" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334906" xlink:to="loc_us-gaap_StatementLineItems_1334909" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1334910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334909" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_1334910" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1334917" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334909" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1334917" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1335217" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1335217" xlink:to="loc_us-gaap_StatementTable_1335220" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335225" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335220" xlink:to="loc_dei_LegalEntityAxis_1335225" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1335225" xlink:to="loc_dei_EntityDomain_1335226" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335223" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335220" xlink:to="loc_us-gaap_StatementLineItems_1335223" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_1331576" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_1331576" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_1424001" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_1424001" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1331586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1331586" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1332094" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335223" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1332094" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1331107" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334576" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1331107" xlink:to="loc_us-gaap_StatementTable_1334576" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334577" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334576" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334577" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334578" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334577" xlink:to="loc_us-gaap_ClassOfStockDomain_1334578" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334576" xlink:to="loc_dei_LegalEntityAxis_1334582" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334582" xlink:to="loc_dei_EntityDomain_1334584" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334579" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334576" xlink:to="loc_us-gaap_StatementLineItems_1334579" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock_1331108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334579" xlink:to="loc_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock_1331108" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1331115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334579" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1331115" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1331704" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335631" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1331704" xlink:to="loc_us-gaap_StatementTable_1335631" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2146632686" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335631" xlink:to="loc_dei_LegalEntityAxis_2146632686" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2146632685" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2146632686" xlink:to="loc_dei_EntityDomain_2146632685" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335631" xlink:to="loc_us-gaap_StatementLineItems_1335634" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1331707" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1331707" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1331708" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1331708" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1331709" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1331709" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1331710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335634" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1331710" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SegmentsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_1331018" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334468" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1331018" xlink:to="loc_us-gaap_StatementTable_1334468" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334472" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334468" xlink:to="loc_dei_LegalEntityAxis_1334472" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334473" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334472" xlink:to="loc_dei_EntityDomain_1334473" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334471" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334468" xlink:to="loc_us-gaap_StatementLineItems_1334471" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1331019" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334471" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1331019" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_538" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:label="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_538" xlink:to="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_StatementClassOfStockAxis_540" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_540" xlink:to="loc_us-gaap_ClassOfStockDomain_541" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_541" xlink:to="loc_us-gaap_CommonClassAMember_555" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_567" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_541" xlink:to="loc_us-gaap_CommonClassBMember_567" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_542" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_543" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_542" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_543" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_544" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_545" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_544" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_545" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_546" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_srt_RangeAxis_546" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_546" xlink:to="loc_srt_RangeMember_547" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_548" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_549" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_548" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_549" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_550" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_us-gaap_TypeOfArrangementAxis_550" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_551" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_550" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_551" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_552" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_srt_TitleOfIndividualAxis_552" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_553" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_552" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_553" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventAxis" xlink:label="loc_rgti_EventAxis_1423429" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_rgti_EventAxis_1423429" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventDomain" xlink:label="loc_rgti_EventDomain_1423431" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_EventAxis_1423429" xlink:to="loc_rgti_EventDomain_1423431" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember" xlink:label="loc_rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember_1423432" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_EventDomain_1423431" xlink:to="loc_rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember_1423432" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423443" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_dei_LegalEntityAxis_1423443" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423444" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423443" xlink:to="loc_dei_EntityDomain_1423444" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_2146632875" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_srt_RestatementAxis_2146632875" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_2146632876" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_2146632875" xlink:to="loc_srt_RestatementDomain_2146632876" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementAxis" xlink:label="loc_rgti_AgreementAxis_2146632882" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_rgti_AgreementAxis_2146632882" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementDomain" xlink:label="loc_rgti_AgreementDomain_2146632883" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementAxis_2146632882" xlink:to="loc_rgti_AgreementDomain_2146632883" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheAxis" xlink:label="loc_rgti_TrancheAxis_2146632885" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_rgti_TrancheAxis_2146632885" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheDomain" xlink:label="loc_rgti_TrancheDomain_2146632886" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_TrancheAxis_2146632885" xlink:to="loc_rgti_TrancheDomain_2146632886" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:label="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_554" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_539" xlink:to="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_554" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1423427" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_554" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1423427" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_632" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfSignificantAccountingPoliciesTable" xlink:label="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_632" xlink:to="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_StatementClassOfStockAxis_634" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_635" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_634" xlink:to="loc_us-gaap_ClassOfStockDomain_635" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_636" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_636" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_637" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_636" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_637" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_639" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_638" xlink:to="loc_us-gaap_TypeOfAdoptionMember_639" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1332678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_dei_LegalEntityAxis_1332678" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1332680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1332678" xlink:to="loc_dei_EntityDomain_1332680" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiComputingIncMember" xlink:label="loc_rgti_RigettiComputingIncMember_1332681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1332680" xlink:to="loc_rgti_RigettiComputingIncMember_1332681" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1332787" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1332787" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1332788" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1332787" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1332788" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1332790" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_srt_RangeAxis_1332790" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1332791" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1332790" xlink:to="loc_srt_RangeMember_1332791" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1332792" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1332791" xlink:to="loc_srt_MaximumMember_1332792" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1332793" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1332791" xlink:to="loc_srt_MinimumMember_1332793" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1332946" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1332946" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1332947" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1332946" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1332947" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1332948" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1332947" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1332948" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:label="loc_us-gaap_RevenueFromRightsConcentrationRiskMember_1580587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1332947" xlink:to="loc_us-gaap_RevenueFromRightsConcentrationRiskMember_1580587" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1332949" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1332949" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1332949" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_1332951" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950" xlink:to="loc_us-gaap_AccountsReceivableMember_1332951" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1332953" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1332950" xlink:to="loc_us-gaap_SalesRevenueNetMember_1332953" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfCustomersAxis" xlink:label="loc_rgti_NumberOfCustomersAxis_1332957" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_NumberOfCustomersAxis_1332957" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfCustomersDomain" xlink:label="loc_rgti_NumberOfCustomersDomain_1332958" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_NumberOfCustomersAxis_1332957" xlink:to="loc_rgti_NumberOfCustomersDomain_1332958" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis" xlink:label="loc_us-gaap_RetirementPlanNameAxis_1333008" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_RetirementPlanNameAxis_1333008" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain" xlink:label="loc_us-gaap_RetirementPlanNameDomain_1333009" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_1333008" xlink:to="loc_us-gaap_RetirementPlanNameDomain_1333009" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1333015" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1333015" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1333016" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1333015" xlink:to="loc_us-gaap_EquityComponentDomain_1333016" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CriteriaAxis" xlink:label="loc_rgti_CriteriaAxis_1423678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_CriteriaAxis_1423678" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CriteriaDomain" xlink:label="loc_rgti_CriteriaDomain_1423679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_CriteriaAxis_1423678" xlink:to="loc_rgti_CriteriaDomain_1423679" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1423681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_srt_StatementScenarioAxis_1423681" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1423682" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1423681" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1423682" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1423689" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1423689" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1423689" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivatePlacementWarrantsMember" xlink:label="loc_rgti_PrivatePlacementWarrantsMember_1423691" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690" xlink:to="loc_rgti_PrivatePlacementWarrantsMember_1423691" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicWarrantsMember" xlink:label="loc_rgti_PublicWarrantsMember_1423692" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1423690" xlink:to="loc_rgti_PublicWarrantsMember_1423692" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConditionAxis" xlink:label="loc_rgti_ConditionAxis_1423695" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_ConditionAxis_1423695" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConditionDomain" xlink:label="loc_rgti_ConditionDomain_1423696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ConditionAxis_1423695" xlink:to="loc_rgti_ConditionDomain_1423696" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1423711" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1423711" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1423712" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1423711" xlink:to="loc_us-gaap_RelatedPartyDomain_1423712" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorMember" xlink:label="loc_rgti_SponsorMember_1423713" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1423712" xlink:to="loc_rgti_SponsorMember_1423713" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1423714" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1423714" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1423715" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1423714" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1423715" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1423717" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_AwardTypeAxis_1423717" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1423717" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1423719" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1423719" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember" xlink:label="loc_rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember_1423720" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1423718" xlink:to="loc_rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember_1423720" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_1575832" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_us-gaap_PlanNameAxis_1575832" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1575833" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1575832" xlink:to="loc_us-gaap_PlanNameDomain_1575833" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember_1575834" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1575833" xlink:to="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember_1575834" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1580591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_srt_ProductOrServiceAxis_1580591" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1580592" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1580591" xlink:to="loc_srt_ProductsAndServicesDomain_1580592" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_GovernmentEntitiesMember" xlink:label="loc_rgti_GovernmentEntitiesMember_1580593" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1580592" xlink:to="loc_rgti_GovernmentEntitiesMember_1580593" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTIAgreementNameAxis" xlink:label="loc_rgti_RGTIAgreementNameAxis_2146632967" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_RGTIAgreementNameAxis_2146632967" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_2146632969" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RGTIAgreementNameAxis_2146632967" xlink:to="loc_rgti_RgtiAgreementNameDomain_2146632969" use="optional" order="57" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTICommonStockPurchaseAgreementMember" xlink:label="loc_rgti_RGTICommonStockPurchaseAgreementMember_2146632970" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RgtiAgreementNameDomain_2146632969" xlink:to="loc_rgti_RGTICommonStockPurchaseAgreementMember_2146632970" use="optional" order="58" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesTable_633" xlink:to="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" use="optional" order="59" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_647" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_647" use="optional" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_1332691" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_NumberOfOperatingSegments_1332691" use="optional" order="61" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_1332696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_NumberOfReportableSegments_1332696" use="optional" order="62" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1332698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1332698" use="optional" order="63" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts_1332724" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_DeferredOfferingCosts_1332724" use="optional" order="64" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1332808" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1332808" use="optional" order="65" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1423686" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1423686" use="optional" order="66" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1423687" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1423687" use="optional" order="67" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1423688" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1423688" use="optional" order="68" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1423694" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1423694" use="optional" order="69" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_1423698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_DerivativeLiabilities_1423698" use="optional" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_1423704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_1423704" use="optional" order="71" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodOfEarnoutShares" xlink:label="loc_rgti_PeriodOfEarnoutShares_1423706" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_rgti_PeriodOfEarnoutShares_1423706" use="optional" order="72" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1423710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1423710" use="optional" order="73" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OfferingCostsIncurred" xlink:label="loc_rgti_OfferingCostsIncurred_1569198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_rgti_OfferingCostsIncurred_1569198" use="optional" order="74" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2146632807" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2146632807" use="optional" order="75" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_IncreaseDecreaseInDeferredRent" xlink:label="loc_rgti_IncreaseDecreaseInDeferredRent_2146632808" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_rgti_IncreaseDecreaseInDeferredRent_2146632808" use="optional" order="76" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_2146632809" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_OperatingLeaseLiability_2146632809" use="optional" order="77" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2146632810" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2146632810" use="optional" order="78" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAdditions" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions_2146632811" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAdditions_2146632811" use="optional" order="79" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_2146632816" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfSignificantAccountingPoliciesLineItems_640" xlink:to="loc_us-gaap_RestrictedCash_2146632816" use="optional" order="80" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1332130" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_2146632815" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1332130" xlink:to="loc_us-gaap_Cash_2146632815" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_2146632814" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1332130" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_2146632814" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1332137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1332130" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1332137" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1332141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1332130" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1332141" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract_1423502" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract_1423502" xlink:to="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423504" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" xlink:to="loc_dei_LegalEntityAxis_1423504" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423505" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423504" xlink:to="loc_dei_EntityDomain_1423505" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1423508" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1423508" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1423509" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1423508" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1423509" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1423510" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1423510" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SimulatedTradingDaysMember" xlink:label="loc_rgti_SimulatedTradingDaysMember_1423511" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_rgti_SimulatedTradingDaysMember_1423511" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_1423512" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_1423512" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1423514" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1423514" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EstimatedPeriodOfExpirationMember" xlink:label="loc_rgti_EstimatedPeriodOfExpirationMember_1423518" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1423509" xlink:to="loc_rgti_EstimatedPeriodOfExpirationMember_1423518" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems_1423507" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable_1423503" xlink:to="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems_1423507" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1423519" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems_1423507" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_1423519" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1424729" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfTransitionPeriodComparativeDataTable" xlink:label="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1424729" xlink:to="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1424741" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1424741" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1424743" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1424741" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1424743" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1424745" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1424743" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1424745" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1424747" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1424747" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1424749" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1424747" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1424749" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1424751" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1424749" xlink:to="loc_us-gaap_SalesRevenueNetMember_1424751" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1424752" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" xlink:to="loc_srt_MajorCustomersAxis_1424752" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1424753" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_1424752" xlink:to="loc_srt_NameOfMajorCustomerDomain_1424753" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerAMember" xlink:label="loc_rgti_CustomerAMember_1424754" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerAMember_1424754" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerBMember" xlink:label="loc_rgti_CustomerBMember_1424755" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerBMember_1424755" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerCMember" xlink:label="loc_rgti_CustomerCMember_1424757" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerCMember_1424757" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerDMember" xlink:label="loc_rgti_CustomerDMember_1568564" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerDMember_1568564" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerEMember" xlink:label="loc_rgti_CustomerEMember_1581084" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerEMember_1581084" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerFMember" xlink:label="loc_rgti_CustomerFMember_1701742" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1424753" xlink:to="loc_rgti_CustomerFMember_1701742" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfTransitionPeriodComparativeDataLineItems" xlink:label="loc_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems_1424734" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataTable_1424730" xlink:to="loc_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems_1424734" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1424735" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems_1424734" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1424735" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1332297" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1332297" xlink:to="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1332303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1332303" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1332304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1332303" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1332304" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1423742" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1332304" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1423742" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1334703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1334703" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1334704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1334703" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1334704" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_1423741" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1334704" xlink:to="loc_us-gaap_AccountsReceivableMember_1423741" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_1334710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_srt_MajorCustomersAxis_1334710" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_1334711" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_1334710" xlink:to="loc_srt_NameOfMajorCustomerDomain_1334711" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerAMember" xlink:label="loc_rgti_CustomerAMember_1332305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1334711" xlink:to="loc_rgti_CustomerAMember_1332305" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerBMember" xlink:label="loc_rgti_CustomerBMember_1332308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1334711" xlink:to="loc_rgti_CustomerBMember_1332308" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerCMember" xlink:label="loc_rgti_CustomerCMember_1332310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1334711" xlink:to="loc_rgti_CustomerCMember_1332310" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerDMember" xlink:label="loc_rgti_CustomerDMember_1334749" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1334711" xlink:to="loc_rgti_CustomerDMember_1334749" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334714" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_dei_LegalEntityAxis_1334714" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334715" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334714" xlink:to="loc_dei_EntityDomain_1334715" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems_1332325" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable_1332301" xlink:to="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems_1332325" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1332327" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems_1332325" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1332327" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1423547" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1423547" xlink:to="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423548" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423550" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423548" xlink:to="loc_dei_LegalEntityAxis_1423550" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423551" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423550" xlink:to="loc_dei_EntityDomain_1423551" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423548" xlink:to="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CashReceivedFromTrustNetOfRedemptions" xlink:label="loc_rgti_CashReceivedFromTrustNetOfRedemptions_1423553" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_CashReceivedFromTrustNetOfRedemptions_1423553" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CashReceivedFromPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_CashReceivedFromPrivateInvestmentInPublicEquity_1423554" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_CashReceivedFromPrivateInvestmentInPublicEquity_1423554" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AggregateTransactionCostsPaid" xlink:label="loc_rgti_AggregateTransactionCostsPaid_1423555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_AggregateTransactionCostsPaid_1423555" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423557" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423549" xlink:to="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423557" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1423559" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1423559" xlink:to="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423562" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" xlink:to="loc_dei_LegalEntityAxis_1423562" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423563" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423562" xlink:to="loc_dei_EntityDomain_1423563" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1423565" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1423565" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1423566" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1423565" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1423566" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable_1423560" xlink:to="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_1423569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_1423569" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts" xlink:label="loc_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts_1423570" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts_1423570" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_1423571" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_1423571" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PaymentOfTransactionCostsThroughCash" xlink:label="loc_rgti_PaymentOfTransactionCostsThroughCash_1423572" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_rgti_PaymentOfTransactionCostsThroughCash_1423572" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid" xlink:label="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423574" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems_1423561" xlink:to="loc_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid_1423574" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1423578" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1423578" xlink:to="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423581" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" xlink:to="loc_dei_LegalEntityAxis_1423581" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423581" xlink:to="loc_dei_EntityDomain_1423582" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1423584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1423584" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423585" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423584" xlink:to="loc_us-gaap_ClassOfStockDomain_1423585" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1423586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423585" xlink:to="loc_us-gaap_CommonClassAMember_1423586" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1423587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423585" xlink:to="loc_us-gaap_CommonClassBMember_1423587" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1423588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423585" xlink:to="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1423588" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember_1423589" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423585" xlink:to="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember_1423589" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventAxis" xlink:label="loc_rgti_EventAxis_1426380" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" xlink:to="loc_rgti_EventAxis_1426380" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EventDomain" xlink:label="loc_rgti_EventDomain_1426381" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_EventAxis_1426380" xlink:to="loc_rgti_EventDomain_1426381" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember" xlink:label="loc_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember_1426382" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_EventDomain_1426381" xlink:to="loc_rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember_1426382" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423579" xlink:to="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1426379" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_us-gaap_SharesOutstanding_1426379" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany" xlink:label="loc_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany_1423591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany_1423591" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany" xlink:label="loc_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany_1423592" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany_1423592" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity_1423593" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity_1423593" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity" xlink:label="loc_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity_1423594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity_1423594" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedInTheNewCompany" xlink:label="loc_rgti_CommonStockSharesIssuedInTheNewCompany_1423595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedInTheNewCompany_1423595" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing" xlink:label="loc_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing_1423596" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing_1423596" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing" xlink:label="loc_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing_1423597" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing_1423597" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity" xlink:label="loc_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity_1423598" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity_1423598" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1423599" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423580" xlink:to="loc_us-gaap_SharesOutstanding_1423599" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1423601" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1423601" xlink:to="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423604" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" xlink:to="loc_dei_LegalEntityAxis_1423604" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423605" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423604" xlink:to="loc_dei_EntityDomain_1423605" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1423607" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1423607" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423608" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423607" xlink:to="loc_us-gaap_ClassOfStockDomain_1423608" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1423609" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423608" xlink:to="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1423609" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCOneRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember_1423610" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423608" xlink:to="loc_rgti_SeriesCOneRedeemableConvertiblePreferredStockMember_1423610" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PromoteSponsorVestingSharesMember" xlink:label="loc_rgti_PromoteSponsorVestingSharesMember_1423614" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423608" xlink:to="loc_rgti_PromoteSponsorVestingSharesMember_1423614" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorRedemptionBasedVestingSharesMember" xlink:label="loc_rgti_SponsorRedemptionBasedVestingSharesMember_1423615" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423608" xlink:to="loc_rgti_SponsorRedemptionBasedVestingSharesMember_1423615" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems" xlink:label="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable_1423602" xlink:to="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1423611" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" xlink:to="loc_us-gaap_SharesOutstanding_1423611" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesExchangeRatio" xlink:label="loc_rgti_CommonStockSharesExchangeRatio_1423612" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" xlink:to="loc_rgti_CommonStockSharesExchangeRatio_1423612" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio" xlink:label="loc_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio_1423613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems_1423603" xlink:to="loc_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio_1423613" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1423617" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1423617" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423620" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_dei_LegalEntityAxis_1423620" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423621" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423620" xlink:to="loc_dei_EntityDomain_1423621" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupernovaAcquistionMember" xlink:label="loc_rgti_SupernovaAcquistionMember_1423627" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1423621" xlink:to="loc_rgti_SupernovaAcquistionMember_1423627" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1423623" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1423623" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1423624" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1423623" xlink:to="loc_us-gaap_ClassOfStockDomain_1423624" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1423625" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423624" xlink:to="loc_us-gaap_CommonClassAMember_1423625" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1423626" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1423624" xlink:to="loc_us-gaap_CommonClassBMember_1423626" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementAxis" xlink:label="loc_rgti_AgreementAxis_1423628" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_rgti_AgreementAxis_1423628" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementDomain" xlink:label="loc_rgti_AgreementDomain_1423629" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementAxis_1423628" xlink:to="loc_rgti_AgreementDomain_1423629" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SponsorAgreementMember" xlink:label="loc_rgti_SponsorAgreementMember_1423630" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementDomain_1423629" xlink:to="loc_rgti_SponsorAgreementMember_1423630" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InitialSubscriptionAgreementMember" xlink:label="loc_rgti_InitialSubscriptionAgreementMember_1423631" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementDomain_1423629" xlink:to="loc_rgti_InitialSubscriptionAgreementMember_1423631" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SubsequentSubscriptionAgreementMember" xlink:label="loc_rgti_SubsequentSubscriptionAgreementMember_1423632" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementDomain_1423629" xlink:to="loc_rgti_SubsequentSubscriptionAgreementMember_1423632" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheAxis" xlink:label="loc_rgti_TrancheAxis_1423633" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_rgti_TrancheAxis_1423633" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheDomain" xlink:label="loc_rgti_TrancheDomain_1423634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_TrancheAxis_1423633" xlink:to="loc_rgti_TrancheDomain_1423634" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheOneMember" xlink:label="loc_rgti_TrancheOneMember_1423635" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_TrancheDomain_1423634" xlink:to="loc_rgti_TrancheOneMember_1423635" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheTwoMember" xlink:label="loc_rgti_TrancheTwoMember_1423636" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_TrancheDomain_1423634" xlink:to="loc_rgti_TrancheTwoMember_1423636" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorAxis" xlink:label="loc_rgti_InvestorAxis_1423637" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_rgti_InvestorAxis_1423637" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorDomain" xlink:label="loc_rgti_InvestorDomain_1423638" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_InvestorAxis_1423637" xlink:to="loc_rgti_InvestorDomain_1423638" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateInvestmentInPublicEquityInvestorsMember" xlink:label="loc_rgti_PrivateInvestmentInPublicEquityInvestorsMember_1423639" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_InvestorDomain_1423638" xlink:to="loc_rgti_PrivateInvestmentInPublicEquityInvestorsMember_1423639" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1423618" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1423640" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1423640" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1423641" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1423641" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1423980" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1423980" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockNumberOfVotesPerShare" xlink:label="loc_rgti_CommonStockNumberOfVotesPerShare_1423986" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_CommonStockNumberOfVotesPerShare_1423986" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1423989" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1423989" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1423994" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1423994" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1424053" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1424053" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare" xlink:label="loc_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare_1424106" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare_1424106" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination" xlink:label="loc_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination_1424109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination_1424109" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations" xlink:label="loc_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations_1424112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations_1424112" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare" xlink:label="loc_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare_1424130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare_1424130" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesExchangeRatio" xlink:label="loc_rgti_CommonStockSharesExchangeRatio_1424219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_CommonStockSharesExchangeRatio_1424219" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockSharesIssuedAsAResultOfExchange" xlink:label="loc_rgti_CommonStockSharesIssuedAsAResultOfExchange_1424226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_CommonStockSharesIssuedAsAResultOfExchange_1424226" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SharesSubjectToVestingBasedOnCertainConditions" xlink:label="loc_rgti_SharesSubjectToVestingBasedOnCertainConditions_1424296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_SharesSubjectToVestingBasedOnCertainConditions_1424296" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VolumeWeightedAveragePricePerShare" xlink:label="loc_rgti_VolumeWeightedAveragePricePerShare_1424312" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_VolumeWeightedAveragePricePerShare_1424312" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice_1424324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice_1424324" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SharesSubjectToVestingMaximumPeriod" xlink:label="loc_rgti_SharesSubjectToVestingMaximumPeriod_1424336" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_SharesSubjectToVestingMaximumPeriod_1424336" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscribedButUnissued" xlink:label="loc_us-gaap_CommonStockSharesSubscribedButUnissued_1424376" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_CommonStockSharesSubscribedButUnissued_1424376" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1424380" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_1424380" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaap_CommonStockSharesSubscriptions_1424383" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_us-gaap_CommonStockSharesSubscriptions_1424383" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_1426242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_1426242" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OneTimeBonus" xlink:label="loc_rgti_OneTimeBonus_1580599" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1423619" xlink:to="loc_rgti_OneTimeBonus_1580599" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1701701" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1701701" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701702" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1701708" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701702" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1701708" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1701708" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_1701710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_1701710" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701711" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701711" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_1701712" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" xlink:to="loc_us-gaap_CommercialPaperMember_1701712" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1701713" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701709" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1701713" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701702" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1701704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1701704" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_1701705" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_1701705" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1701707" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701703" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1701707" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1701718" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701720" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1701718" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701720" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1701722" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701720" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1701722" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1701722" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_1701724" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_1701724" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701725" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701725" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_1701726" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" xlink:to="loc_us-gaap_CommercialPaperMember_1701726" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1701727" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1701723" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1701727" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_1701720" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1701719" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1701719" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtSecuritiesAvailableForSaleMaturityYear" xlink:label="loc_rgti_DebtSecuritiesAvailableForSaleMaturityYear_2146632789" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" xlink:to="loc_rgti_DebtSecuritiesAvailableForSaleMaturityYear_2146632789" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2146632790" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1701721" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2146632790" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632776" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_2146632771" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632776" xlink:to="loc_us-gaap_Goodwill_2146632771" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_2146632644" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632776" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_2146632644" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2146632772" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632776" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2146632772" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_2146632773" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632776" xlink:to="loc_us-gaap_Goodwill_2146632773" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/GoodwillAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632769" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_2146632768" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2146632769" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_2146632768" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1329366" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1329367" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1329366" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1329367" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1329368" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329367" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1329368" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1329369" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1329368" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1329369" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RevenuePerformanceObligationTransactionPriceAxis" xlink:label="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis_1423534" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329367" xlink:to="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis_1423534" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RevenuePerformanceObligationTransactionPriceDomain" xlink:label="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceAxis_1423534" xlink:to="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RemainderoftwothousandandtwentythreeMember" xlink:label="loc_rgti_RemainderoftwothousandandtwentythreeMember_2146632758" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536" xlink:to="loc_rgti_RemainderoftwothousandandtwentythreeMember_2146632758" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwothousandandtwentyfourMember" xlink:label="loc_rgti_TwothousandandtwentyfourMember_2146632757" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RevenuePerformanceObligationTransactionPriceDomain_1423536" xlink:to="loc_rgti_TwothousandandtwentyfourMember_2146632757" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329448" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329367" xlink:to="loc_dei_LegalEntityAxis_1329448" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329449" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329448" xlink:to="loc_dei_EntityDomain_1329449" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1329372" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329367" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1329372" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_1423533" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329372" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_1423533" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1329503" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1329527" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1329503" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1329527" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1329533" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329527" xlink:to="loc_srt_ProductOrServiceAxis_1329533" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1329534" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1329533" xlink:to="loc_srt_ProductsAndServicesDomain_1329534" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CollaborativeResearchAndOtherProfessionalServicesMember" xlink:label="loc_rgti_CollaborativeResearchAndOtherProfessionalServicesMember_1329538" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1329534" xlink:to="loc_rgti_CollaborativeResearchAndOtherProfessionalServicesMember_1329538" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccessToQuantumComputingSystemsMember" xlink:label="loc_rgti_AccessToQuantumComputingSystemsMember_1329539" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1329534" xlink:to="loc_rgti_AccessToQuantumComputingSystemsMember_1329539" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1329541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329527" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1329541" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1329541" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_1329544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_1329544" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaap_TransferredOverTimeMember_1329545" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1329542" xlink:to="loc_us-gaap_TransferredOverTimeMember_1329545" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_1329529" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1329527" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_1329529" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1329548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_1329529" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_1329548" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityAbstract" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_1329622" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTable" xlink:label="loc_us-gaap_CapitalizedContractCostTable_1329684" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityAbstract_1329622" xlink:to="loc_us-gaap_CapitalizedContractCostTable_1329684" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329686" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostTable_1329684" xlink:to="loc_dei_LegalEntityAxis_1329686" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329687" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329686" xlink:to="loc_dei_EntityDomain_1329687" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostLineItems" xlink:label="loc_us-gaap_CapitalizedContractCostLineItems_1329685" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostTable_1329684" xlink:to="loc_us-gaap_CapitalizedContractCostLineItems_1329685" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_1329623" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329685" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_1329623" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_1329624" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329685" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_1329624" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_1329634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329685" xlink:to="loc_us-gaap_DeferredRevenueCurrent_1329634" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract" xlink:label="loc_us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract_1329663" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTable" xlink:label="loc_us-gaap_CapitalizedContractCostTable_1329695" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract_1329663" xlink:to="loc_us-gaap_CapitalizedContractCostTable_1329695" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1329698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostTable_1329695" xlink:to="loc_dei_LegalEntityAxis_1329698" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1329699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1329698" xlink:to="loc_dei_EntityDomain_1329699" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostLineItems" xlink:label="loc_us-gaap_CapitalizedContractCostLineItems_1329696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostTable_1329695" xlink:to="loc_us-gaap_CapitalizedContractCostLineItems_1329696" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_1329664" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329696" xlink:to="loc_us-gaap_DeferredRevenueCurrent_1329664" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferralOfRevenue" xlink:label="loc_rgti_DeferralOfRevenue_1329665" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329696" xlink:to="loc_rgti_DeferralOfRevenue_1329665" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RecognitionOfDeferredRevenues" xlink:label="loc_rgti_RecognitionOfDeferredRevenues_1329667" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329696" xlink:to="loc_rgti_RecognitionOfDeferredRevenues_1329667" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_1329668" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostLineItems_1329696" xlink:to="loc_us-gaap_DeferredRevenueCurrent_1329668" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupplementalFinancialStatementInformationAbstract" xlink:label="loc_rgti_SupplementalFinancialStatementInformationAbstract_1330575" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SupplementalFinancialStatementInformationAbstract_1330575" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1330607" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1330607" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1330607" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_QuantumComputingFridgesMember" xlink:label="loc_rgti_QuantumComputingFridgesMember_1330610" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_rgti_QuantumComputingFridgesMember_1330610" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ProcessEquipmentMember" xlink:label="loc_rgti_ProcessEquipmentMember_1330611" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_rgti_ProcessEquipmentMember_1330611" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_1330613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_1330613" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ItHardwareMember" xlink:label="loc_rgti_ItHardwareMember_1330614" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_rgti_ItHardwareMember_1330614" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_FurnitureAndOtherAssetsMember" xlink:label="loc_rgti_FurnitureAndOtherAssetsMember_1330616" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1330608" xlink:to="loc_rgti_FurnitureAndOtherAssetsMember_1330616" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" xlink:to="loc_dei_LegalEntityAxis_1333274" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333274" xlink:to="loc_dei_EntityDomain_1333275" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330577" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1330618" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1330618" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1330620" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1330620" use="optional" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1330621" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330578" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1330621" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_1330628" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1334848" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_1330628" xlink:to="loc_us-gaap_StatementTable_1334848" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1334849" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334848" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1334849" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1334850" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1334849" xlink:to="loc_us-gaap_ClassOfStockDomain_1334850" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334853" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334848" xlink:to="loc_dei_LegalEntityAxis_1334853" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334855" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334853" xlink:to="loc_dei_EntityDomain_1334855" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1334851" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1334848" xlink:to="loc_us-gaap_StatementLineItems_1334851" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedUtilitiesCurrent" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_2146632753" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_2146632753" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_1330664" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_1330664" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedPropertyAndOtherTaxes" xlink:label="loc_rgti_AccruedPropertyAndOtherTaxes_2146632739" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_rgti_AccruedPropertyAndOtherTaxes_2146632739" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedSubcontractorCost" xlink:label="loc_rgti_AccruedSubcontractorCost_2146632749" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_rgti_AccruedSubcontractorCost_2146632749" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_1330634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_1330634" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedPropertyPlantAndEquipmentCost" xlink:label="loc_rgti_AccruedPropertyPlantAndEquipmentCost_2146632747" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_rgti_AccruedPropertyPlantAndEquipmentCost_2146632747" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2146632746" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2146632746" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaap_InterestPayableCurrent_1330630" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_InterestPayableCurrent_1330630" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedDeferredOfferingCosts" xlink:label="loc_rgti_AccruedDeferredOfferingCosts_2146632742" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_rgti_AccruedDeferredOfferingCosts_2146632742" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2146632740" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1334851" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2146632740" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SupplementalFinancialStatementInformationAbstract" xlink:label="loc_rgti_SupplementalFinancialStatementInformationAbstract_1330704" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SupplementalFinancialStatementInformationAbstract_1330704" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1330731" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" xlink:to="loc_srt_StatementGeographicalAxis_1330731" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1330732" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1330731" xlink:to="loc_srt_SegmentGeographicalDomain_1330732" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_country_US_1330734" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1330732" xlink:to="loc_country_US_1330734" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB" xlink:label="loc_country_GB_1330766" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1330732" xlink:to="loc_country_GB_1330766" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" xlink:to="loc_dei_LegalEntityAxis_1334862" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334862" xlink:to="loc_dei_EntityDomain_1334863" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330769" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1330726" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330769" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTotalGrossPropertyAndEquipment" xlink:label="loc_rgti_PercentageOfTotalGrossPropertyAndEquipment_1330777" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330769" xlink:to="loc_rgti_PercentageOfTotalGrossPropertyAndEquipment_1330777" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1330807" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1330769" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1330807" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/LeasesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_2146632694" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_OperatingLeaseRentExpenses" xlink:label="loc_rgti_OperatingLeaseRentExpenses_2146632693" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2146632694" xlink:to="loc_rgti_OperatingLeaseRentExpenses_2146632693" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="loc_us-gaap_LeaseCostAbstract_2146632658" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_2146632726" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2146632658" xlink:to="loc_us-gaap_OperatingLeaseCost_2146632726" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaap_ShortTermLeaseCost_2146632725" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2146632658" xlink:to="loc_us-gaap_ShortTermLeaseCost_2146632725" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_2146632724" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2146632658" xlink:to="loc_us-gaap_VariableLeaseCost_2146632724" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_2146632722" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2146632658" xlink:to="loc_us-gaap_LeaseCost_2146632722" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_2146632721" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2146632658" xlink:to="loc_us-gaap_OperatingLeasePayments_2146632721" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2146632720" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2146632658" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2146632720" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2146632719" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2146632658" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2146632719" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2146632718" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_2146632658" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2146632718" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632676" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2146632675" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632676" xlink:to="loc_us-gaap_StatementTable_2146632675" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_2146632674" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2146632675" xlink:to="loc_dei_LegalEntityAxis_2146632674" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_2146632673" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2146632674" xlink:to="loc_dei_EntityDomain_2146632673" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiHoldingsMember" xlink:label="loc_rgti_RigettiHoldingsMember_2146632671" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2146632673" xlink:to="loc_rgti_RigettiHoldingsMember_2146632671" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_2146632670" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2146632675" xlink:to="loc_us-gaap_StatementLineItems_2146632670" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2146632664" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2146632664" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2146632669" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2146632669" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2146632668" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2146632668" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2146632667" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2146632667" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2146632666" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2146632666" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2146632665" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2146632670" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2146632665" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2146632714" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2146632714" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2146632710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2146632710" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2146632708" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2146632708" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2146632706" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2146632706" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2146632705" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2146632705" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2146632704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2146632704" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2146632703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2146632703" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2146632702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2146632702" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_2146632697" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_OperatingLeaseLiability_2146632697" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2146632700" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2146632700" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2146632699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_2146632715" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2146632699" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongTermDebtAbstract" xlink:label="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_1331599" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongTermDebtAbstract_1331599" xlink:to="loc_us-gaap_StatementTable_1335137" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335137" xlink:to="loc_dei_LegalEntityAxis_1335141" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1335141" xlink:to="loc_dei_EntityDomain_1335142" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiComputingIncMember" xlink:label="loc_rgti_RigettiComputingIncMember_1335143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1335142" xlink:to="loc_rgti_RigettiComputingIncMember_1335143" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1335138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335137" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1335138" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335138" xlink:to="loc_us-gaap_ClassOfStockDomain_1335139" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335137" xlink:to="loc_us-gaap_StatementLineItems_1335140" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1331607" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1331607" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1331610" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1331610" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1331614" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1331614" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1331619" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1331619" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1423809" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1423809" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_1331623" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335140" xlink:to="loc_us-gaap_LongTermDebt_1331623" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract_1331650" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract_1331650" xlink:to="loc_us-gaap_StatementTable_1335127" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335127" xlink:to="loc_dei_LegalEntityAxis_1335131" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1335131" xlink:to="loc_dei_EntityDomain_1335132" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1335128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335127" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1335128" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1335129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1335128" xlink:to="loc_us-gaap_ClassOfStockDomain_1335129" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335127" xlink:to="loc_us-gaap_StatementLineItems_1335130" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1331653" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1331653" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AccruedFinalPaymentFee" xlink:label="loc_rgti_AccruedFinalPaymentFee_1331657" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_rgti_AccruedFinalPaymentFee_1331657" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_1331660" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_1331660" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentPortionOfLongTermDebtGross" xlink:label="loc_rgti_CurrentPortionOfLongTermDebtGross_1432171" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_rgti_CurrentPortionOfLongTermDebtGross_1432171" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaap_LongTermLoansPayable_1423785" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_LongTermLoansPayable_1423785" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentPortionOfOutstandingPrincipalAmount" xlink:label="loc_rgti_CurrentPortionOfOutstandingPrincipalAmount_1423786" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_rgti_CurrentPortionOfOutstandingPrincipalAmount_1423786" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_1423787" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_1423787" use="optional" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaap_LoansPayableCurrent_1423788" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335130" xlink:to="loc_us-gaap_LoansPayableCurrent_1423788" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/DebtAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1331747" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1331747" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1331829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_DebtInstrumentAxis_1331829" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1331832" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1331829" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1331832" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheAMember" xlink:label="loc_rgti_TrancheAMember_1331852" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1331832" xlink:to="loc_rgti_TrancheAMember_1331852" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheBMember" xlink:label="loc_rgti_TrancheBMember_1331892" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1331832" xlink:to="loc_rgti_TrancheBMember_1331892" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrancheCMember" xlink:label="loc_rgti_TrancheCMember_1423802" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1331832" xlink:to="loc_rgti_TrancheCMember_1423802" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1331860" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1331860" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1331862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1331860" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1331862" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_LoanAndSecurityAgreementMember" xlink:label="loc_rgti_LoanAndSecurityAgreementMember_1331863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1331862" xlink:to="loc_rgti_LoanAndSecurityAgreementMember_1331863" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1331896" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_srt_RangeAxis_1331896" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1331897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1331896" xlink:to="loc_srt_RangeMember_1331897" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1331898" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1331897" xlink:to="loc_srt_MaximumMember_1331898" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1331899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1331897" xlink:to="loc_srt_MinimumMember_1331899" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331911" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331911" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331912" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331911" xlink:to="loc_us-gaap_ClassOfStockDomain_1331912" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1331936" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1331936" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1331937" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1331936" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1331937" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorNameAxis" xlink:label="loc_rgti_InvestorNameAxis_1331951" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_rgti_InvestorNameAxis_1331951" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_InvestorNameDomain" xlink:label="loc_rgti_InvestorNameDomain_1331954" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_InvestorNameAxis_1331951" xlink:to="loc_rgti_InvestorNameDomain_1331954" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335066" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_dei_LegalEntityAxis_1335066" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335067" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1335066" xlink:to="loc_dei_EntityDomain_1335067" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_1335069" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_1335069" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_1335070" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_1335069" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_1335070" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VentureCapitalMember" xlink:label="loc_rgti_VentureCapitalMember_1335071" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_1335070" xlink:to="loc_rgti_VentureCapitalMember_1335071" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_1568991" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_VariableRateAxis_1568991" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_1568992" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_1568991" xlink:to="loc_us-gaap_VariableRateDomain_1568992" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="loc_us-gaap_PrimeRateMember_1568993" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1568992" xlink:to="loc_us-gaap_PrimeRateMember_1568993" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1575827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1575827" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1575828" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1575827" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1575828" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockWarrantsMember" xlink:label="loc_rgti_CommonStockWarrantsMember_1575829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1575828" xlink:to="loc_rgti_CommonStockWarrantsMember_1575829" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_1331828" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1331994" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1331994" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_1331997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_1331997" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1331998" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1331998" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WithdrawnCreditFacility" xlink:label="loc_rgti_WithdrawnCreditFacility_1335074" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_rgti_WithdrawnCreditFacility_1335074" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_1332000" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_1332000" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1332001" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentTerm_1332001" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1332003" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1332003" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DebtInstrumentPaymentFeepercentage" xlink:label="loc_rgti_DebtInstrumentPaymentFeepercentage_1332006" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_rgti_DebtInstrumentPaymentFeepercentage_1332006" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_1332023" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_InterestExpense_1332023" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaap_AccretionExpense_1332042" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_AccretionExpense_1332042" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_1332044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_1332044" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_1332047" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_1332047" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1332049" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1332049" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1335082" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1335082" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1575824" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1575824" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1423789" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1423789" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="loc_us-gaap_DebtInstrumentPaymentTerms_1423790" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentPaymentTerms_1423790" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_1423792" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_1423792" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_1423793" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_1423793" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger" xlink:label="loc_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger_1423798" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger_1423798" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1568990" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_1568990" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1569027" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1569027" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_1580600" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_1580600" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_1580601" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_1580601" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfadvancedFundsUnderTheAmendment" xlink:label="loc_rgti_PercentageOfadvancedFundsUnderTheAmendment_1580602" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1331992" xlink:to="loc_rgti_PercentageOfadvancedFundsUnderTheAmendment_1580602" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_1423817" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_1423817" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423824" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" xlink:to="loc_dei_LegalEntityAxis_1423824" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423825" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423824" xlink:to="loc_dei_EntityDomain_1423825" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1425169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1425169" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1425170" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1425169" xlink:to="loc_us-gaap_ClassOfStockDomain_1425170" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_1425172" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1425170" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_1425172" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCOnePreferredStockMember" xlink:label="loc_rgti_SeriesCOnePreferredStockMember_1425173" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1425170" xlink:to="loc_rgti_SeriesCOnePreferredStockMember_1425173" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_1425193" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1425170" xlink:to="loc_us-gaap_PreferredStockMember_1425193" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1423821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1423820" xlink:to="loc_us-gaap_TemporaryEquityLineItems_1423821" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1423822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1423821" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1423822" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1423823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1423821" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1423823" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1331004" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockTable" xlink:label="loc_us-gaap_ConversionOfStockTable_1331006" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1331004" xlink:to="loc_us-gaap_ConversionOfStockTable_1331006" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331030" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331030" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331031" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331030" xlink:to="loc_us-gaap_ClassOfStockDomain_1331031" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1331034" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1331034" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1331035" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1331034" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1331035" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockWarrantsMember" xlink:label="loc_rgti_CommonStockWarrantsMember_1331036" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1331035" xlink:to="loc_rgti_CommonStockWarrantsMember_1331036" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1331037" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_us-gaap_AwardTypeAxis_1331037" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1331037" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1331039" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1331039" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1331040" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331038" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1331040" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331554" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_dei_LegalEntityAxis_1331554" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331554" xlink:to="loc_dei_EntityDomain_1331555" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EquityAxis" xlink:label="loc_rgti_EquityAxis_1335300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_rgti_EquityAxis_1335300" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EquityDomain" xlink:label="loc_rgti_EquityDomain_1335301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_EquityAxis_1335300" xlink:to="loc_rgti_EquityDomain_1335301" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockLineItems" xlink:label="loc_us-gaap_ConversionOfStockLineItems_1331043" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331006" xlink:to="loc_us-gaap_ConversionOfStockLineItems_1331043" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1331044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331043" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1331044" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/CommonStockAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1331047" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockTable" xlink:label="loc_us-gaap_ConversionOfStockTable_1331048" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1331047" xlink:to="loc_us-gaap_ConversionOfStockTable_1331048" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331049" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331049" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331050" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331049" xlink:to="loc_us-gaap_ClassOfStockDomain_1331050" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1331051" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1331050" xlink:to="loc_us-gaap_CommonClassAMember_1331051" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331558" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_dei_LegalEntityAxis_1331558" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331559" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331558" xlink:to="loc_dei_EntityDomain_1331559" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameAxis" xlink:label="loc_rgti_AgreementNameAxis_1701483" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_rgti_AgreementNameAxis_1701483" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1701484" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementNameAxis_1701483" xlink:to="loc_rgti_AgreementNameDomain_1701484" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockPurchaseAgreementMember" xlink:label="loc_rgti_CommonStockPurchaseAgreementMember_1701485" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementNameDomain_1701484" xlink:to="loc_rgti_CommonStockPurchaseAgreementMember_1701485" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTIAgreementNameAxis" xlink:label="loc_rgti_RGTIAgreementNameAxis_1701488" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_rgti_RGTIAgreementNameAxis_1701488" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_1701489" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RGTIAgreementNameAxis_1701488" xlink:to="loc_rgti_RgtiAgreementNameDomain_1701489" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockLineItems" xlink:label="loc_us-gaap_ConversionOfStockLineItems_1331053" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_1331048" xlink:to="loc_us-gaap_ConversionOfStockLineItems_1331053" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1331064" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1331064" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaap_CommonStockVotingRights_1331067" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_CommonStockVotingRights_1331067" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1423835" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1423835" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1423838" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1423838" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1423839" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1423839" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1701468" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1701468" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket" xlink:label="loc_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket_1701471" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket_1701471" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_1701473" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_1701473" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaap_CommonStockSharesSubscriptions_1701482" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_CommonStockSharesSubscriptions_1701482" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/presentationGuidance" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement" xlink:label="loc_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement_1701486" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement_1701486" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1701487" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1701487" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts_2146632663" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_1331053" xlink:to="loc_us-gaap_DeferredOfferingCosts_2146632663" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_886" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_887" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_886" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_887" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333908" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_dei_LegalEntityAxis_1333908" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333908" xlink:to="loc_dei_EntityDomain_1333909" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_888" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_888" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_889" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_888" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_889" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicWarrantsMember" xlink:label="loc_rgti_PublicWarrantsMember_897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_PublicWarrantsMember_897" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CommonStockWarrantsMember" xlink:label="loc_rgti_CommonStockWarrantsMember_1333911" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_CommonStockWarrantsMember_1333911" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WarrantsToPurchaseClassACommonStockMember" xlink:label="loc_rgti_WarrantsToPurchaseClassACommonStockMember_1333921" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_WarrantsToPurchaseClassACommonStockMember_1333921" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CustomerWarrantsMember" xlink:label="loc_rgti_CustomerWarrantsMember_1333926" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_CustomerWarrantsMember_1333926" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrinityWarrantsMember" xlink:label="loc_rgti_TrinityWarrantsMember_1425902" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_889" xlink:to="loc_rgti_TrinityWarrantsMember_1425902" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_890" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_us-gaap_StatementClassOfStockAxis_890" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_891" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_890" xlink:to="loc_us-gaap_ClassOfStockDomain_891" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_891" xlink:to="loc_us-gaap_CommonClassAMember_899" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfInvestorsAxis" xlink:label="loc_rgti_ClassOfInvestorsAxis_1333917" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_rgti_ClassOfInvestorsAxis_1333917" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfInvestorsDomain" xlink:label="loc_rgti_ClassOfInvestorsDomain_1333918" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ClassOfInvestorsAxis_1333917" xlink:to="loc_rgti_ClassOfInvestorsDomain_1333918" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SeriesCRedeemableConvertiblePreferredStockMember" xlink:label="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1333920" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ClassOfInvestorsDomain_1333918" xlink:to="loc_rgti_SeriesCRedeemableConvertiblePreferredStockMember_1333920" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_892" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_srt_RangeAxis_892" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_893" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_892" xlink:to="loc_srt_RangeMember_893" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_900" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_893" xlink:to="loc_srt_MaximumMember_900" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_901" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_893" xlink:to="loc_srt_MinimumMember_901" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:label="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_894" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_894" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_894" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_895" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_887" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_906" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_906" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_907" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_907" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantorrightissuedduringperiodwarrants" xlink:label="loc_rgti_Classofwarrantorrightissuedduringperiodwarrants_1333912" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_Classofwarrantorrightissuedduringperiodwarrants_1333912" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant" xlink:label="loc_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant_1333914" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant_1333914" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_1333915" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_1333915" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits" xlink:label="loc_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits_1333916" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits_1333916" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1333922" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1333922" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1333923" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1333923" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1333925" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1333925" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_Classofwarrantsvestingpercentage" xlink:label="loc_rgti_Classofwarrantsvestingpercentage_1333927" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_Classofwarrantsvestingpercentage_1333927" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_1423859" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_SharePrice_1423859" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice_1423860" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_NumberOfTradingDaysForDeterminingTheSharePrice_1423860" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice" xlink:label="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_1423861" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice_1423861" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered" xlink:label="loc_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered_1423862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered_1423862" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantOrRightGrandDateFairValue" xlink:label="loc_rgti_ClassOfWarrantOrRightGrandDateFairValue_1425925" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_rgti_ClassOfWarrantOrRightGrandDateFairValue_1425925" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1575810" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1575810" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_1575813" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_896" xlink:to="loc_us-gaap_IncreaseDecreaseInDerivativeLiabilities_1575813" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_1333825" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_1333825" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_dei_LegalEntityAxis_1333829" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333830" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333829" xlink:to="loc_dei_EntityDomain_1333830" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1333840" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_srt_StatementScenarioAxis_1333840" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1333841" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1333840" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1333841" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AtinitialrecognitionMember" xlink:label="loc_rgti_AtinitialrecognitionMember_1333842" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1333841" xlink:to="loc_rgti_AtinitialrecognitionMember_1333842" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1333832" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1333832" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1333833" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1333832" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1333833" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1333834" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1333834" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1333835" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1333835" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_1333836" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_1333836" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1333837" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1333837" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1333838" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1333838" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1333839" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333833" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1333839" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1425719" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1425719" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1425721" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1425719" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1425721" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateWarrantMember" xlink:label="loc_rgti_PrivateWarrantMember_1568988" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1425721" xlink:to="loc_rgti_PrivateWarrantMember_1568988" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1333827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333826" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1333827" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1333828" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1333827" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1333828" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:label="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_1333845" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsQuantitativeInformationAbstract_1333845" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333847" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_dei_LegalEntityAxis_1333847" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333848" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333847" xlink:to="loc_dei_EntityDomain_1333848" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1333850" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1333850" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1333851" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1333850" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1333851" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1333853" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_srt_StatementScenarioAxis_1333853" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1333854" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1333853" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1333854" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1333858" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1333858" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1333859" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1333858" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1333859" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1333860" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1333860" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1333861" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1333861" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_1333862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_1333862" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1333863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1333863" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1333864" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1333864" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1333865" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1333859" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1333865" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333856" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1333846" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333856" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1333857" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1333856" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1333857" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureofvestingstatusofwarrantsAbstract" xlink:label="loc_rgti_DisclosureofvestingstatusofwarrantsAbstract_1333894" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureOfVestingStatusOfWarrantsTable" xlink:label="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureofvestingstatusofwarrantsAbstract_1333894" xlink:to="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333896" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" xlink:to="loc_dei_LegalEntityAxis_1333896" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333896" xlink:to="loc_dei_EntityDomain_1333897" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfVestingAxis" xlink:label="loc_rgti_StatusOfVestingAxis_1333899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" xlink:to="loc_rgti_StatusOfVestingAxis_1333899" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StatusOfVestingDomain" xlink:label="loc_rgti_StatusOfVestingDomain_1333900" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_StatusOfVestingAxis_1333899" xlink:to="loc_rgti_StatusOfVestingDomain_1333900" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_VestedCustomerWarrantsMember" xlink:label="loc_rgti_VestedCustomerWarrantsMember_1333901" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_StatusOfVestingDomain_1333900" xlink:to="loc_rgti_VestedCustomerWarrantsMember_1333901" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_UnvestedCustomerWarrantsMember" xlink:label="loc_rgti_UnvestedCustomerWarrantsMember_1333903" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_StatusOfVestingDomain_1333900" xlink:to="loc_rgti_UnvestedCustomerWarrantsMember_1333903" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DisclosureofvestingstatusofwarrantsLineItems" xlink:label="loc_rgti_DisclosureofvestingstatusofwarrantsLineItems_1333904" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureOfVestingStatusOfWarrantsTable_1333895" xlink:to="loc_rgti_DisclosureofvestingstatusofwarrantsLineItems_1333904" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1333905" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_DisclosureofvestingstatusofwarrantsLineItems_1333904" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1333905" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1331216" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1331216" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameAxis" xlink:label="loc_rgti_AgreementNameAxis_1331218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_rgti_AgreementNameAxis_1331218" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1331219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementNameAxis_1331218" xlink:to="loc_rgti_AgreementNameDomain_1331219" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementMember" xlink:label="loc_rgti_ForwardWarrantAgreementMember_1331220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementNameDomain_1331219" xlink:to="loc_rgti_ForwardWarrantAgreementMember_1331220" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331233" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_dei_LegalEntityAxis_1331233" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331233" xlink:to="loc_dei_EntityDomain_1331234" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AmpereComputingLlcMember" xlink:label="loc_rgti_AmpereComputingLlcMember_1575800" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1331234" xlink:to="loc_rgti_AmpereComputingLlcMember_1575800" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1331248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1331248" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1331248" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331250" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiMember" xlink:label="loc_rgti_RigettiMember_1331253" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1331250" xlink:to="loc_rgti_RigettiMember_1331253" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_1331459" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_us-gaap_VestingAxis_1331459" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_1331461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_1331459" xlink:to="loc_us-gaap_VestingDomain_1331461" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1331467" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_1331461" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1331467" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1331463" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_1331461" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1331463" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1331217" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_1331259" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_DerivativeLiabilities_1331259" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_2146632682" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_2146632682" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1331436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1331436" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockIssuedDuringPeriodWarrantsIssued" xlink:label="loc_rgti_StockIssuedDuringPeriodWarrantsIssued_1331441" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_rgti_StockIssuedDuringPeriodWarrantsIssued_1331441" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1331446" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1331446" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1331447" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1331447" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1331448" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1331448" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets_1423851" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_DerivativeAssets_1423851" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2146632681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_2146632681" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod" xlink:label="loc_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod_2146632759" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1331255" xlink:to="loc_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod_2146632759" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1331265" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1331265" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1331267" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1331267" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1331268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1331267" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1331268" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1331269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1331268" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1331269" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1331270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1331268" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1331270" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember" xlink:label="loc_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember_1331274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1331268" xlink:to="loc_rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember_1331274" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1331275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1331268" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1331275" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1331276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1331276" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1331277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1331276" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1331277" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementMember" xlink:label="loc_rgti_ForwardWarrantAgreementMember_1331279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1331277" xlink:to="loc_rgti_ForwardWarrantAgreementMember_1331279" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_dei_LegalEntityAxis_1331282" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331282" xlink:to="loc_dei_EntityDomain_1331283" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1331288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_srt_RangeAxis_1331288" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1331290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1331288" xlink:to="loc_srt_RangeMember_1331290" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1331291" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1331290" xlink:to="loc_srt_MaximumMember_1331291" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1331292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1331290" xlink:to="loc_srt_MinimumMember_1331292" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1331295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1331266" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1331295" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_1331296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1331295" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_1331296" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1027" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1027" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1029" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1029" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1029" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrinityWarrantsMember" xlink:label="loc_rgti_TrinityWarrantsMember_1423772" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" xlink:to="loc_rgti_TrinityWarrantsMember_1423772" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PublicWarrantsMember" xlink:label="loc_rgti_PublicWarrantsMember_1040" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" xlink:to="loc_rgti_PublicWarrantsMember_1040" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivateWarrantMember" xlink:label="loc_rgti_PrivateWarrantMember_1041" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" xlink:to="loc_rgti_PrivateWarrantMember_1041" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember" xlink:label="loc_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember_1569042" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1030" xlink:to="loc_rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember_1569042" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1031" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1031" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1031" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1042" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1042" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1043" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1043" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1032" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1044" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1033" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1033" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1033" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMember" xlink:label="loc_us-gaap_DerivativeMember_1045" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034" xlink:to="loc_us-gaap_DerivativeMember_1045" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ContingentEarnOutLiabilityMember" xlink:label="loc_rgti_ContingentEarnOutLiabilityMember_1423775" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1034" xlink:to="loc_rgti_ContingentEarnOutLiabilityMember_1423775" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_1035" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_1035" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_1035" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1046" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1046" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_1701475" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_1701475" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701476" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1701476" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_1701477" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1036" xlink:to="loc_us-gaap_CommercialPaperMember_1701477" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1423782" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_dei_LegalEntityAxis_1423782" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1423783" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1423782" xlink:to="loc_dei_EntityDomain_1423783" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1037" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1028" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1037" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1038" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1037" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1038" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementFairValueDisclosure" xlink:label="loc_rgti_ForwardWarrantAgreementFairValueDisclosure_1423763" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1038" xlink:to="loc_rgti_ForwardWarrantAgreementFairValueDisclosure_1423763" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_1047" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1038" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_1047" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1039" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1037" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1039" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1048" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1039" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1048" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ContingentEarnOutLiabilityFairValueDisclosure" xlink:label="loc_rgti_ContingentEarnOutLiabilityFairValueDisclosure_1423770" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1039" xlink:to="loc_rgti_ContingentEarnOutLiabilityFairValueDisclosure_1423770" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1134" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1134" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1136" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1136" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1137" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1137" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1141" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1138" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1138" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1139" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TrinityWarrantsMember" xlink:label="loc_rgti_TrinityWarrantsMember_1423779" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1139" xlink:to="loc_rgti_TrinityWarrantsMember_1423779" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PrivatePlacementWarrantsMember" xlink:label="loc_rgti_PrivatePlacementWarrantsMember_1143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1139" xlink:to="loc_rgti_PrivatePlacementWarrantsMember_1143" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334986" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_dei_LegalEntityAxis_1334986" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334987" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334986" xlink:to="loc_dei_EntityDomain_1334987" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1334995" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1334995" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1334995" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DerivativeWarrantLiabilitiesMember" xlink:label="loc_rgti_DerivativeWarrantLiabilitiesMember_1335013" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" xlink:to="loc_rgti_DerivativeWarrantLiabilitiesMember_1335013" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ForwardWarrantAgreementMember" xlink:label="loc_rgti_ForwardWarrantAgreementMember_1335014" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" xlink:to="loc_rgti_ForwardWarrantAgreementMember_1335014" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ContingentEarnOutLiabilityMember" xlink:label="loc_rgti_ContingentEarnOutLiabilityMember_1423778" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1334997" xlink:to="loc_rgti_ContingentEarnOutLiabilityMember_1423778" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1135" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1144" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_2146632648" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_2146632648" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1147" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1147" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_1146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_1146" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1575796" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1575796" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1140" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1148" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1331680" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335261" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1331680" xlink:to="loc_us-gaap_StatementTable_1335261" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335265" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335261" xlink:to="loc_dei_LegalEntityAxis_1335265" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335266" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1335265" xlink:to="loc_dei_EntityDomain_1335266" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335264" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335261" xlink:to="loc_us-gaap_StatementLineItems_1335264" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1424211" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1424211" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1424213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1424213" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1424216" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1424216" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1424218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1424218" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1424221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1424221" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1424229" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1424229" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1424230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1424230" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1424232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1424232" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1424236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1424236" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1424238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1424238" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1424334" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1424334" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1424335" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1424335" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1424338" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1424338" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1424340" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1424340" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1424362" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1424362" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1424348" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335264" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1424348" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail">
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract" xlink:label="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract_1424036" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RestrictedStockUnitsTable" xlink:label="loc_rgti_RestrictedStockUnitsTable_1424048" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract_1424036" xlink:to="loc_rgti_RestrictedStockUnitsTable_1424048" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1424049" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RestrictedStockUnitsTable_1424048" xlink:to="loc_us-gaap_AwardTypeAxis_1424049" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1424051" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1424049" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1424051" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1424052" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1424051" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1424052" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems" xlink:label="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RestrictedStockUnitsTable_1424048" xlink:to="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1424056" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1424056" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1424057" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1424057" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1424059" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1424059" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1424061" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1424061" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1424062" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1424062" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2146632689" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2146632689" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1424070" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1424070" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2146632688" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2146632688" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2146632687" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2146632687" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2146632690" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems_1424055" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2146632690" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1332074" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1332074" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1332079" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1332079" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1332081" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1332079" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1332081" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1332082" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1332081" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1332082" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_1424389" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1332081" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_1424389" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1424390" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1332081" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1424390" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" xlink:to="loc_dei_LegalEntityAxis_1335243" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1335243" xlink:to="loc_dei_EntityDomain_1335244" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1332078" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1332076" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1332078" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1332086" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1332078" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1332086" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1332102" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1335247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1332102" xlink:to="loc_us-gaap_StatementTable_1335247" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1335251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335247" xlink:to="loc_dei_LegalEntityAxis_1335251" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1335252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1335251" xlink:to="loc_dei_EntityDomain_1335252" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1335281" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335247" xlink:to="loc_srt_RangeAxis_1335281" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1335282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1335281" xlink:to="loc_srt_RangeMember_1335282" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2146632643" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335247" xlink:to="loc_us-gaap_AwardTypeAxis_2146632643" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2146632643" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_MarketBasedVestingAwardMember" xlink:label="loc_rgti_MarketBasedVestingAwardMember_2146632640" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642" xlink:to="loc_rgti_MarketBasedVestingAwardMember_2146632640" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TimeBasedVestingAwardMember" xlink:label="loc_rgti_TimeBasedVestingAwardMember_2146632641" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2146632642" xlink:to="loc_rgti_TimeBasedVestingAwardMember_2146632641" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1335250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1335247" xlink:to="loc_us-gaap_StatementLineItems_1335250" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1332112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1332112" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1332115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1332115" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1332120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1332120" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1332123" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1332123" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1332124" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1335250" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1332124" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1331843" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331846" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1331843" xlink:to="loc_us-gaap_StatementTable_1331846" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_1331851" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_us-gaap_PlanNameAxis_1331851" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1331853" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1331851" xlink:to="loc_us-gaap_PlanNameDomain_1331853" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember_1331855" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1331853" xlink:to="loc_rgti_TwoThousandThirteenEquityIncentivePlanMember_1331855" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:label="loc_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember_1575795" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1331853" xlink:to="loc_rgti_TwoThousandTwentyTwoEquityIncentivePlanMember_1575795" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1331847" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_dei_LegalEntityAxis_1331847" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1331848" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1331847" xlink:to="loc_dei_EntityDomain_1331848" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1331865" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_us-gaap_AwardTypeAxis_1331865" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1331865" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1331869" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1331869" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_1569061" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" xlink:to="loc_us-gaap_RestrictedStockMember_1569061" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CeoAwardMember" xlink:label="loc_rgti_CeoAwardMember_2146632707" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1331866" xlink:to="loc_rgti_CeoAwardMember_2146632707" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_2146632713" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_srt_TitleOfIndividualAxis_2146632713" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2146632712" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_2146632713" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2146632712" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_2146632711" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_2146632712" xlink:to="loc_srt_ChiefExecutiveOfficerMember_2146632711" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1424373" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1424373" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1424374" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1424373" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1424374" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1331849" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331846" xlink:to="loc_us-gaap_StatementLineItems_1331849" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear" xlink:label="loc_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear_1575793" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear_1575793" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1331878" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1331878" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1331890" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1331890" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1331901" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1331901" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1331906" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_1331906" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1331918" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1331918" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1331927" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1331927" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1331929" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1331929" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1424367" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1424367" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1569062" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1569062" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_StockOptionCommonShareExercisePrice" xlink:label="loc_rgti_StockOptionCommonShareExercisePrice_2146632717" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_rgti_StockOptionCommonShareExercisePrice_2146632717" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2146633053" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331849" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2146633053" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_1331126" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_1331126" xlink:to="loc_us-gaap_StatementTable_1331129" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331129" xlink:to="loc_dei_LegalEntityAxis_1334613" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334614" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334613" xlink:to="loc_dei_EntityDomain_1334614" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331129" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331130" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331130" xlink:to="loc_us-gaap_ClassOfStockDomain_1331131" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1331143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1331131" xlink:to="loc_us-gaap_CommonClassAMember_1331143" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1331132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331129" xlink:to="loc_us-gaap_StatementLineItems_1331132" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NetIncomeLossRelationToCommonStock" xlink:label="loc_rgti_NetIncomeLossRelationToCommonStock_1331133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_rgti_NetIncomeLossRelationToCommonStock_1331133" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1569194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1569194" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1569195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1569195" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_1331140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_EarningsPerShareBasic_1331140" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/presentationGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1331141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331132" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1331141" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_1331158" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331160" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_1331158" xlink:to="loc_us-gaap_StatementTable_1331160" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1331166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331160" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1331166" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1331166" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConvertibleSeriesC1PreferredStockMember" xlink:label="loc_rgti_ConvertibleSeriesC1PreferredStockMember_1331168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_rgti_ConvertibleSeriesC1PreferredStockMember_1331168" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_ConvertibleSeriesCPreferredStockMember" xlink:label="loc_rgti_ConvertibleSeriesCPreferredStockMember_1331174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_rgti_ConvertibleSeriesCPreferredStockMember_1331174" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1331176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_us-gaap_WarrantMember_1331176" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1331177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1331177" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1331178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1331167" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1331178" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331160" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331161" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331161" xlink:to="loc_us-gaap_ClassOfStockDomain_1331162" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1331164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1331162" xlink:to="loc_us-gaap_CommonClassAMember_1331164" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331160" xlink:to="loc_dei_LegalEntityAxis_1334591" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334592" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334591" xlink:to="loc_dei_EntityDomain_1334592" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1331163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331160" xlink:to="loc_us-gaap_StatementLineItems_1331163" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1331179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331163" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1331179" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_2146632657" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2558" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_2146632657" xlink:to="loc_us-gaap_StatementTable_2558" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2559" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2558" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2559" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_2560" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2559" xlink:to="loc_us-gaap_ClassOfStockDomain_2560" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_UnvestedCustomerWarrantsMember" xlink:label="loc_rgti_UnvestedCustomerWarrantsMember_2146632656" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2560" xlink:to="loc_rgti_UnvestedCustomerWarrantsMember_2146632656" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_2561" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2558" xlink:to="loc_us-gaap_StatementLineItems_2561" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2146632651" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2561" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2146632651" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1331286" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1331302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1331286" xlink:to="loc_us-gaap_StatementTable_1331302" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1331303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1331303" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1331304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1331303" xlink:to="loc_us-gaap_ClassOfStockDomain_1331304" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_dei_LegalEntityAxis_1334594" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334594" xlink:to="loc_dei_EntityDomain_1334595" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1425133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1425133" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1425135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1425133" xlink:to="loc_us-gaap_EquityComponentDomain_1425135" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1425137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1425135" xlink:to="loc_us-gaap_WarrantMember_1425137" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1425140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1425140" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1425142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1425140" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1425142" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1331305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1331302" xlink:to="loc_us-gaap_StatementLineItems_1331305" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1425158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1425158" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_1425159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_1425159" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1580797" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1580797" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1580798" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1331305" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1580798" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1331732" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1331732" xlink:to="loc_us-gaap_StatementTable_1333044" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333045" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333044" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333045" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333046" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333045" xlink:to="loc_us-gaap_ClassOfStockDomain_1333046" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333048" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333044" xlink:to="loc_dei_LegalEntityAxis_1333048" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333049" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333048" xlink:to="loc_dei_EntityDomain_1333049" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333047" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333044" xlink:to="loc_us-gaap_StatementLineItems_1333047" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1331734" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333047" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1331734" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1331736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333047" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1331736" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1331739" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333047" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1331739" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1331834" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333053" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1331834" xlink:to="loc_us-gaap_StatementTable_1333053" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333054" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333053" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333054" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333055" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333054" xlink:to="loc_us-gaap_ClassOfStockDomain_1333055" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333057" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333053" xlink:to="loc_dei_LegalEntityAxis_1333057" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333058" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333057" xlink:to="loc_dei_EntityDomain_1333058" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333056" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333053" xlink:to="loc_us-gaap_StatementLineItems_1333056" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333056" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1331842" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1331842" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1331844" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1331844" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1331850" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1331850" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1331854" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1331854" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_1331856" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_1331856" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1331858" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1331858" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1331872" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1331872" use="optional" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1331868" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1331868" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxAssetsRightOfUseLiabilities" xlink:label="loc_rgti_DeferredTaxAssetsRightOfUseLiabilities_2146632756" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1331836" xlink:to="loc_rgti_DeferredTaxAssetsRightOfUseLiabilities_2146632756" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333056" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1331886" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1331886" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="loc_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization_2146632754" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" xlink:to="loc_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization_2146632754" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="loc_rgti_DeferredTaxLiabilitiesRightOfUseAssets_2146632755" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_1331880" xlink:to="loc_rgti_DeferredTaxLiabilitiesRightOfUseAssets_2146632755" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1335544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333056" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1335544" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1332385" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333064" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_1332385" xlink:to="loc_us-gaap_StatementTable_1333064" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333065" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333064" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333065" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333066" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333065" xlink:to="loc_us-gaap_ClassOfStockDomain_1333066" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333068" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333064" xlink:to="loc_dei_LegalEntityAxis_1333068" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333069" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333068" xlink:to="loc_dei_EntityDomain_1333069" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333067" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333064" xlink:to="loc_us-gaap_StatementLineItems_1333067" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1332386" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_1332386" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1332388" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1332388" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment_2146632763" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment_2146632763" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_2146632660" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_2146632660" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment_2146632762" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment_2146632762" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts" xlink:label="loc_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts_2146632659" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts_2146632659" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_1332392" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_1332392" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1332398" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1332398" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1332399" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333067" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1332399" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract_1332419" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1333072" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract_1332419" xlink:to="loc_us-gaap_StatementTable_1333072" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodAxis" xlink:label="loc_rgti_PeriodAxis_2146632767" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333072" xlink:to="loc_rgti_PeriodAxis_2146632767" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PeriodDomain" xlink:label="loc_rgti_PeriodDomain_2146632766" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_PeriodAxis_2146632767" xlink:to="loc_rgti_PeriodDomain_2146632766" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PreviousYearMember" xlink:label="loc_rgti_PreviousYearMember_2146632764" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_PeriodDomain_2146632766" xlink:to="loc_rgti_PreviousYearMember_2146632764" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_CurrentYearMember" xlink:label="loc_rgti_CurrentYearMember_2146632765" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_PeriodDomain_2146632766" xlink:to="loc_rgti_CurrentYearMember_2146632765" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1333073" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333072" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1333073" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1333074" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1333073" xlink:to="loc_us-gaap_ClassOfStockDomain_1333074" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333076" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333072" xlink:to="loc_dei_LegalEntityAxis_1333076" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333077" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333076" xlink:to="loc_dei_EntityDomain_1333077" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1333075" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1333072" xlink:to="loc_us-gaap_StatementLineItems_1333075" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1332421" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333075" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1332421" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1332425" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333075" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1332425" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_1332426" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333075" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_1332426" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1332428" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1333075" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1332428" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1332488" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfIncomeTaxesInformationTable" xlink:label="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1332488" xlink:to="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_1332495" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_1332495" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_1332496" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_1332495" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_1332496" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember" xlink:label="loc_us-gaap_ResearchMember_1332497" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_1332496" xlink:to="loc_us-gaap_ResearchMember_1332497" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1332501" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1332501" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1332502" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1332501" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1332502" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_1332503" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1332502" xlink:to="loc_us-gaap_DomesticCountryMember_1332503" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1332508" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1332502" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_1332508" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1333079" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" xlink:to="loc_dei_LegalEntityAxis_1333079" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1333080" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1333079" xlink:to="loc_dei_EntityDomain_1333080" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RigettiComputingIncMember" xlink:label="loc_rgti_RigettiComputingIncMember_1333081" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1333080" xlink:to="loc_rgti_RigettiComputingIncMember_1333081" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_SummaryOfIncomeTaxesInformationLineItems" xlink:label="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationTable_1332493" xlink:to="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1332531" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1332531" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_1332534" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_OperatingLossCarryforwards_1332534" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1332540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_1332540" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1332545" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1332545" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2146632737" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2146632737" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_2146632741" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_2146632741" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_2146632743" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_SummaryOfIncomeTaxesInformationLineItems_1332525" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_2146632743" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_1331020" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_1331020" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1331025" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_srt_StatementGeographicalAxis_1331025" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1331026" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1331025" xlink:to="loc_srt_SegmentGeographicalDomain_1331026" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_country_US_1331027" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1331026" xlink:to="loc_country_US_1331027" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_2146632788" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1331026" xlink:to="loc_srt_EuropeMember_2146632788" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334475" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_dei_LegalEntityAxis_1334475" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334476" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334475" xlink:to="loc_dei_EntityDomain_1334476" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1423910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1423910" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1423911" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1423910" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1423911" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRightsConcentrationRiskMember" xlink:label="loc_us-gaap_RevenueFromRightsConcentrationRiskMember_1423912" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1423911" xlink:to="loc_us-gaap_RevenueFromRightsConcentrationRiskMember_1423912" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1426692" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1426692" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1426693" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1426692" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1426693" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1426695" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1426693" xlink:to="loc_us-gaap_SalesRevenueNetMember_1426695" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1331022" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1331021" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1331022" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1331023" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1331022" xlink:to="loc_us-gaap_Revenues_1331023" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1423909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1331022" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1423909" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1330590" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1330592" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1330590" xlink:to="loc_us-gaap_SubsequentEventTable_1330592" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1330595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1330595" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1330597" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1330595" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1330597" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1330602" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1330602" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1330603" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1330602" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1330603" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1330604" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1330603" xlink:to="loc_us-gaap_SubsequentEventMember_1330604" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1330869" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_AwardTypeAxis_1330869" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1330870" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1330869" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1330870" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_1330884" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_VestingAxis_1330884" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_1330885" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_1330884" xlink:to="loc_us-gaap_VestingDomain_1330885" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1330891" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1330891" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1330892" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1330891" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1330892" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameAxis" xlink:label="loc_rgti_AgreementNameAxis_1330935" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_rgti_AgreementNameAxis_1330935" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_AgreementNameDomain" xlink:label="loc_rgti_AgreementNameDomain_1330937" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_AgreementNameAxis_1330935" xlink:to="loc_rgti_AgreementNameDomain_1330937" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WeightedAverageSharePriceAxis" xlink:label="loc_rgti_WeightedAverageSharePriceAxis_1330956" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_rgti_WeightedAverageSharePriceAxis_1330956" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_WeightedAverageSharePriceDomain" xlink:label="loc_rgti_WeightedAverageSharePriceDomain_1330957" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_WeightedAverageSharePriceAxis_1330956" xlink:to="loc_rgti_WeightedAverageSharePriceDomain_1330957" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1334406" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_dei_LegalEntityAxis_1334406" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1334407" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1334406" xlink:to="loc_dei_EntityDomain_1334407" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1569045" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1569045" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1569046" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1569045" xlink:to="loc_us-gaap_ClassOfStockDomain_1569046" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RGTIAgreementNameAxis" xlink:label="loc_rgti_RGTIAgreementNameAxis_1581961" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_rgti_RGTIAgreementNameAxis_1581961" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_RgtiAgreementNameDomain" xlink:label="loc_rgti_RgtiAgreementNameDomain_1581962" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rgti_RGTIAgreementNameAxis_1581961" xlink:to="loc_rgti_RgtiAgreementNameDomain_1581962" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1330898" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1330592" xlink:to="loc_us-gaap_SubsequentEventLineItems_1330898" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_2146632791" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1330898" xlink:to="loc_us-gaap_RestructuringCharges_2146632791" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_PercentageOfReductionInEmployees" xlink:label="loc_rgti_PercentageOfReductionInEmployees_2146632792" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1330898" xlink:to="loc_rgti_PercentageOfReductionInEmployees_2146632792" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="rgti-20221231.xsd#rgti_NumberOfEmployees" xlink:label="loc_rgti_NumberOfEmployees_2146632793" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1330898" xlink:to="loc_rgti_NumberOfEmployees_2146632793" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g483086g00g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g483086g00g02.jpg
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M 0$! 0$! 0$! 0$! ?_  !$( "( 8 ,!$0 "$0$#$0'_Q  =   " @(# 0
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8 XDN,F;G-3V^%"/A$?"(^$1\(CX1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g483086g11g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g483086g11g01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[20B4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ) :^DB(X0DE-! 0      &D< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  (<G(V,3,R-S(< @4 0$UI8W)O<V]F="!7;W)D("T@,#$N82!2:6=E='1I
M($-O;7!U=&EN9R!);F,N("T@,3 M2R @1')A9G0@36%S=&4 .$))300E
M   0EYU2_0J6UGX/O):2W %?1SA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!8
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      T$    &
M  &I   "30    8 9P Q #$ 9P P #$    !
M  $              DT   &I                      $
M            $     $       !N=6QL     @    9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   &I     %)G:'1L;VYG   "30    9S;&EC97-6
M;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI
M8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI
M8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M   !J0    !29VAT;&]N9P   DT    #=7)L5$585     $       !N=6QL
M5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M 0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
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M971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M  $! #A"24T$%       !     0X0DE-! P     &5D    !    GP   ',
M  '@  #7H   &3T &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( ', GP,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
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MIKQ&UM-M;;#[9(W?F[OZW[E:6^R-MVO6W.?)8VTZ:$;D_J756&M^\$Z65N)
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M6_2T62_#_7+#8\7%UX]0M@,=+FM/N_M_F_0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( :D"30,!$0 "$0$#$0'_Q  ?   !!0$  P$!           '! 4&" D#
M  (* 0O_Q !O$  ! P,"! 0#!00%!@<'!2$! @,$!081$B$ !S%!"!,B410R
M814C0G&!"18SD212H;'!%S1#8G+P&"4F-8+1X413<W:2LK4G*#8W16-G='6S
MM+;Q"CA&559D97>#DZ+"&4=49GB$AJ.DMY6EQ?_$ !L!  (# 0$!
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M3;TX/?B_<J8L!#OXC[(Y<LN\[&HY$J"UC];6TRR.8_-I*TD<T^9B0%)R#?\
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M&DJ6M:[T-27/I'WC91H:_G,_M#[!IM>\;_C*4N/%FON^*3Q!REHB3"U,9/\
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M^]M$"/YWDHU^PSG.<8&,]LX]^_TQQMJ:9:G'\QX+QJ&1D'&^",CZ;8Q]>_0
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ML)"Y:9/WUC7M!IOQ!*#T;]6^V"G?&^^V!U!_D.&S0;;H)L$/QS"!'6=;@4@
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MIBITFK4[R)],U#2]%ETS;ST!.I#M6('EI"GCLG(A[*>$#VF?A?$Y.F5OC?=
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MT]RJ#5Y,F>\F#(+0=89;!V2HJ(2-78#WZ[' WZ$\5.I! DW5O5$?H8&H.&R
M3<@0)F_WG2G]SJQ%8%953O@4L@ZGDX)6EL$JQOUP#@=/H.*CM>&+0.\.;LPR
M-^BWU_PY)L2&L", N5N>=R=,<FXA1V/C8;,AN2I[RGZ:>LI*E *6 ,J&M.-A
ML<XP>A'^*!'=#!/PW$L+=N45@PLBKLYI!J(L.\$)&3YB)OD:XTNH1GIM0?9;
M?0)!9>=CJ/I;D9U;D[Z0K<_0';L:_>WV=_<ZS(@<R@06V[DCFF-R58:>9-.=
M5+9K%(D>7)0E(=:.P7I()0<8W5@CKU.Y!(XM05727:H&!9'R73RLP"1!!\/A
M6'8#SSLIL%8]ZTZ[Z,;8NE?EU&/EEIS&-""- 7[$MZM73L/8D.=\HD&?662K
M^(CD6(MR/GO8-'?QP)%0!C=R41=#E&(^,QE'S699&/Z*,**CG?*49U8V/;&X
M JJ@J&"G-P1W8B\RB('2J8Z$%@@(9B^&"0^JD0UJZZ;2F)#<-SSG<K"E8Z$
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MJ.F-D&FMO-I\HR-_ATDN8PD9TX';.)0:1S%U8F0RP!Z7\:\;\/H1(N _$"2
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M*VKT4FKA5U/Y:*JIR@2F"^<8Z/0YJ7[1R2ZEY5$Y?,)2"M055IP3@X."H['
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M1)(SA().-^V/?K].)JI5-D-]R.6YZZ%E;YB(9=6Q%'FI (U#&PWRI1(.P'7
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M;EJ16W9MPL7 [/$'%'I<=:B'?X_F*!5]WD;.  ^7UPLIS@8XU\EGZYV_N-6
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MK"N.H\]^1M &D#CTO(\)P_'4%J+_ #(EJ)>O*V:9JR,0Z+5IH0",$AQP!M)
MP=;F4@[K. <$U'<VZ#TC[YZT%7+/589)GQND[S"Y%&K;SR_M/FS4&5'(4FF1
MC&00=U89(]94#LCHK.GN>!L5S'/$L&')')<M UL%'! !O*:E<K;IZ1N6Y:BT
MK15;[NJJ%:5)5BH_ :PH$*&C4G=0.,'^L-\= #5LKYS#!O'G:1JA('4#HCT6
M/"95R>\6A<M6D^<*35JUY9\H.2W1-5TT@E8'0'IC&_T&U@9IYD?>=E]=P?E4
MONE(B28D !$YY7U(8*;&A%'V78,-YU:DI4J9!+BM1(QEHX#N#@Z/Q;I.2K W
MS/V\_?A?6&UGLCY$(3ARI,P-$^IN5"AVY$N"@6C%FP]:#56'F#3W(<-.\IRE
MLC)5-98#BXB0-WDMIT[@\17M]^F/9:C/*0+-EI""\X"5H THO2Y^8W[E"\N4
MC%*N5I@,BIP2,U90:&MUY:2#ERF)2I:1C=;8)('4C8V-^2\/;><Z!5Q!GP$Y
M><M>6O7DW<G/;FE0:A7&+7EM(ICRHTYD14!:EIV6A"EDM!2L%*2YZ HIU@)S
MQ4V)&!Y%.<:-(^(; AN,AM6^Q= V.E^'OGG)M6=<UTPZ2Q;5-IDV?6&A<=*J
M4]E"(KLAM;]+;^\BEMI!4?+/F)WT'(.,"28<=3%[?86^F#%PH5ST)CQQF7FG
MG)JDKLNMWA8,Y<=V!2E1ZO2F$YR[%J$X.S6TC'5QM:P.NYQL>)N_[\O+4M.<
MD3)=S/+U1!>G&/"58G.A-89GB/%O&%5*LU)'^AN>DU%B0Y'(VR"RTE(R"!L/
M?&O#L>I^FJG$8Z;K$_9=M;@^(BU&_$GX:!<TK[ZKQ8% YJTM6,_#RHL9NS>:
MEN%(^;[.KJX51QC?.,#..&N"E)!D!!2"2>>9?6XT,'DQ$P(<RW@ ZS LCEC
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M8C8N>N+*T>UKW!6:U"JE?J<B;'I:0^W3T,C4ZEJ*A13.:2.KK24I=;3D:U@
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M*I8).!OR.#VC_P :<_'2V"9-2@8#)L';PZ':.PT<?L%9 N:J1*'Q B &8*.
M0-P76CE_RSY@W3S;YF7=$MRH1Z'1J;$@E,D#S'E.LG5* SU )4,=2 ,;C/H^
MV]H([/P9#8B5#@OF2R1%B=>6[%^&?X?M?$XA"-#J)!@&D R3=(=9.^K*LV=<
M+2& ]2I.S:<J(!2 < Y/7  RH8^4=!L..9_B@.0\03M<R+VY7QW^&0Z>9 L1
M8_H=F29WT^1K<JLE!C+A+;24Z%+2 I24*!!6A(SK6 24I!&2,9&=ZU=I%0-*
M9J8L7(0GRY:=I@62\ ]KCQ"?*^K9^'+PQQ[[3/N*[JG)IT*F38I@TJG1O+?E
M.1W4NMKEKQZ4+4@!>-P"K)[\9"2AMM>+7NWL@DSH >[S;P#5GL]K/W*.-9E^
M7-?;%Q3"S:M,NRXJ1;SL-0;FMR*=.::<=>6.FA: O5C (QMC@TH$#F/,VPQ=
MF[.48!D%H0<,V(=]P0X S+!A7/6GW9X8+3K7-ZA7$NO<N6:Y!H]Q46Y87Q*(
MUI5)Y#34N&^2/+=:*W%MNGY%!*R0-N-OO/TGT\-9 'F7;Q>\3A,P $!$0MJ1
M:E0<H5SVU+@7-:U6I+U:8?82%)@//MF1,@Z 25  J21N",@;<0E ]/*#(D2-
M B3A?KB^"\Q.K 46AVO>-KIGBWHU',X2F$MF($_$*;24"0%>G2=RO40 D]CC
MA?HE4.4SGR!^I>B3AF%!N6)<GHG8[O4PL&S[?JG+FH4.O0H\V)'N*HHBN#I!
M(96E$E)VW95AT9[)QD]CCV/,8Z27O%M0@90FUR 1#RJ8CKXYO>(NLWAR$JKK
M#?+6X[IMMV3_ ,5UVF$%"%25Z6F<DC2-2D@XR,G<;<6HO8D\N4RX]?5:*@6B
M;;H)(^9!<+039Y[W]48#;]-Y852.MT8;%3R'-:AA&2#@'5I&3T]\ 8=X=1%!
M%XJNV>BVP%C;10E'S ,#,@=",%LDQI]I?,[G)+^T%56UZ3 CZ&O);F225%03
MZ<I(4%=O3MGIGMQ0,[(O8A9&#+DLR+(Z!S?#)<VD_-U4$")U%X/-#G5-<F^?
M$M^,6GU,PTH1E?EGT)"$XP3G&E.X*MMP<@BHL/N^8.8C+$[3;!@$BP99Z38A
MH"6(W9L%IO+Q"SP40J?37D-C.M44 ( QZU*R E*>I5V V)&#Q85%P/%#GRBW
MK.M<[\\;/!.Y@GK.OU-N^)NLE*9%S4>B,*4'P@)U%(&%$@*'J4!N>N3ML-@'
M5,[CI-L CE%DFT3RM<3;ID6YGG;3PWR1YR5A*%U/FS4F"HX*:3&\M)"AA02X
M#A"MQA9/H)U9V&):YYD7#NQTE?L-3E ]V+ @7?1,#+(ZL^%&X)_F.5;F?><@
MA*R3\:-PE.2-LC< _IWR<\ R$ZN:&^X08Z:@(& '?]09(7C^CK%\'U'6C7,N
M.X*@I(!U29I\PD;^@?*%*. G">I^NU$"8<E&,^)<7(+M.@?+H .;M+_=ZF4'
MPF6*YAJ6U-E.)9(2)4K4M1 )T@;ZBKL.^XZJ&+02BSDM 1#^D(W=EJ&Q7@ U
M[@[?74KI_A6Y20TGXRVHCSB=P91.L*&-T[9SD=,8R-NIS$(0$C9^?I+EF\*@
M!R4O$]02T,9M>^IA3^0W+"GI"(MKTU+6P6H[X0?F)Z;!(R=NW0XXL2326,&$
MM^9?(LXT4I V%[!L\O >"U8>A7==EHT>-;5NURK4NBTD(0Q%3Z8C:'1@?#*Z
MI4 <(43L0#C?C @9E>7[ZM/3I!^_(CV<W^9%]OH2E=W5HH5LM/Q@3E"AA0*O
MPY&?4<8SD8X@I$ 1/N=YOH&6\9+*\U;D8+ZEG>NRNO B3<]84E60M"JMZ5H(
MPM"DYPH*!*5#&XVZ''&O<"0'=Y1Z97B.@U42/G!ES!Z7MR2Y+4>E5NFE69U4
M223C,J7G?./8#WW&=L[[<'\K85#PSO;]-!@$NI^#1WSMXZ:)%S6VQJS5*:-C
MZA-W3A).K? P.OY]LYX'<M)AFT$9]&#>W):'>$@DD_TJ;9 2.QW,7TS2;_LV
M,VM3]<I@*$.*R)HV*4DY.,Y((]\G]=["E5=\1W2"CA':ZMR'2-6%88$71@[]
M4>O>.=16;SCY<1@E;UQ4[4C*P/BBHY3ZAZ<#(.-TY&K&._&@XY=Q:>8'B9&Y
MQ: =:,*Q&TD6F>ERYY@1K2+P0WI0[[Y47!5Z!,8G0XW,&ITUUUCY$R6+7M"0
MML]?4EJ6RH_12>$^T5"NL$?R >IBPQK2BQZ_0:^=;QC-%OQ&>(-_(WYF7B?Y
M7/4/TZCI_;C895CX1_2HV72\\]"@?%6?]QZ27'13S=M8J>+9M2>3_,"3W324
M.  8&I-=2L'?KLD=>G3/3C T]Y4(S4I$%JD 2 8_7?3(J[M)J)M22E_+#P;#
MS\%A,J-,F2Z?#A-J>>DZR6D8UNE9TEI&-PM>0A.XW(! X:/#'"H#@4I]!=^>
MTHG2M7$/%-*$U$D[!E#E?;<O5Y/#Y<'.?E_0*%?EDPZ-=4+[3K,.1;E57Y3J
M5L1UI,9+N_EJ>TEH+.R2O((P".)Q.U44]JI%B>)0!_[@BMT58^)>N[PNQUU=
MDK);'#K?-4DVFQV1$)#6A]L>,^U([463S4L;F#RKG!+;$BIU:A?:UFO2%8&N
M%4!@1F YO\3OY"!YGX >/1\/C?F<.FS-G= PI$J)+WUR*N%^662(,![2Y%O'
MD8C6D'@LYG\O>8EW51%B7I;UV!JCR'9#%+FEB7%0_662I;\?_3:4J*EM[Z\:
M <*SQS^/_JTLR*LW_@,WL!)QSR%W@8)RVC=OUZL9SM9:<4)9:(_ UJ^H &1O
M]=@<=>N?:P:F^=#.;>!^^>BY2AF4T/< ?S*>#J56/0^VIQ%E_>*8R-MNW<X_
M,GIM@XWW'4WX>;_V/UQRTO\ MZ&;]9SZ:E$092L'H0D']5'ANGY%R/N=6HCN
M_P!=7N-.S;61T&,# Z #MT_W]]^)2"/J?TV QOTOOIP89Z=,DCWQUVZ?[_W
M&I0/$[>\[F?/0-CT.G9D^4DH.>X.V.N<[=L9Z>V1P".\B)C^PF6C<WO&<3'V
M#X@[7CI=:]$L%Q:G,G(]7TR!T]\?KO\ 7B5&$,@> B^"? +&H@+\QUNB+0^O
M-6+Y#>T)*1^-.CW^;8_EOT/N.X..,LXY]#^XY]=&DR!N1YN_OI6KH?R/]W!U
MMIGG?/\ J?\ 'C4?/5T_32^F]70_D?[N+56/0^VII&OJ/R_Q/%:+'K]!J:[1
MAES'N4C^9XUIEC[^6K4TSU%D^<Y@Z=B"=AI !&K'?&,DY.V, [\"K)O#Y[[+
M*ZN,:-3Z0O*/IJO?.&GL57EG=,&2IMR-(M>IQWT/-><RMEZ/*:=;>:S]ZTIM
M1"V\Y6DZ.F.%*Y%2@AKG\)LQ,=,G&JM$+!]<>[][Z^1GQ(6I2>7WB?F4FV+,
MID"DP9MDR40F8WP4>'\:TVJ<\ZWT+4T*67!C!258QJX5)LLH %J]V#"02)Z2
M]7,=T""J8M+RI%A'M+O=XUZVJU.5_*&XZ+!A09L&J-.%<+.4+53D.:DD]"A0
MU _09Z<41$3(AVD0O$[N4QJ EFQ9)1D7Y1L ?/?6-%Z7O<W.Z\9,BYJA*J,"
MF)CLS5.[4%3R2/A(--&0/@WBD-5? )\E3VY.<ZTTI$W$@8C/F.EYMJ%M;;Q*
MEDGPNHC3A]GQ:I.6[43+IU@VDPRY4U1FRNHW%5V,.P8\9'1=.:>2ALHR=31.
M>N.&#6Z")D5)!&TDSL;EG $Z #Y" 9N3'G=(1ZZ-W)2P[[YG5:IWC0F:4Y<5
MKQG;IHEHU)QR)'@T.,A13]GLM_>+KT]I@)@(0 M4U302=1&%^Z/L>(:"Q#B9
MU.[T8Q"S@$"$27E07J^-CWCSHYSPGHEL\TJM;DZAM.4VJVW/K%5B5V,N,A3;
MC4!ES[I<3 (2VX E2<)5E.1Q.[2)#^&;S'CN<)WU.Z"; $Q"*[P$Y?6+H]ZP
MNAX2>65!Y(\U(7-/F;S#JEP3'J96*3/MN.TW,HS;\N1;T.A5"8MST":U2*-)
M=*G#IUI)60G@?FHM%QSV\@.6'H_E! 1<MDH$,0FP<*,YC<>VN;/)>YHT]RA7
M=9RBQ$\V7$-1I,"=$9;:*G7)#+?WBTMIU%:6QK5C"0"K' _."D$,)/R86 WS
M#8<6' D$$"=B;%B18D3#"NPM"FZ>=G*2^[7O&U[-N^DW!66(,U$R!"1\7Y1C
MU1L+0EW\)RG <'R;G?&.!^;1-\GS;;"+<;G%M;]P\O7+Y,6S[Z$=Y5[[&H%7
MKM1IRS3J!;RZB\&B4.&/382Y3R6E$;++3)2DC&Y![G)_-H(@ED'V;Y?8*,Z'
M<(V,BYYM=<^V@QX-/&KR(YW1*E MF8N@W'&D/0IM,G0_B?/5!G%M3JI'^A!*
M?X@V0E17N4XXR)..=K-=8#"++8EWT322IF03!L<HG$-1!L0=7HJ51@&YF:@Z
MXS(A1("VU*C?(&7T>O5M_5*B0<' 'U)IWTPSNPA(>9@^-ST$[I1L5L\A_2.I
MUG%X@O#;/\0G,"\JW+@3*?6H5!A-675E(U0)U92K$B!,3G*HLF,$,R0<:F7%
M#\6#I1QV@F72"6@#&X))WR)N#H=W(,$PS+(8S&WJ@-8B778%T\A;NK#4VBU>
M'1DU0,77:RXF)M#DAT!NX*0O\#! ,ED]L).<C/#??=)!+^&J;M@N1//J"[D$
M"DDD9V^XQJZG*?F1 J2J;"JU1A*CU6,U\%6V/\S::1I2(-7QG,L@Z' -NI&Q
M/"P*!+9\5,SNU;(S=3KZBU[ \_48T&OVB'AY0W9EN\R: J%-B7A$E09;<7I1
M[[HC*JQ#/8_TL5EG).0-0 W '&9L>A]09\^F=6%P(O*!P6.L9. 2G)S]M:NL
M7C9U)G$J'VQ2!$J:D;+3)#JJ2HIZC6DYT@Y!.W49X-!MB$SBPBXW=DC8G6F"
M;H$W@A,]1>[Y8&K)?L_K[BV?S2I=GUNH)A4"NU2M\M;@\[9V%3ZTV8E!JK8_
M[Y$FS$R$$=2V-CCABFKNJK^63$P02 /!+/OG5 J(RQ%BV9,(HA$.VVKX>(>C
M:.;%KWBB(^S'O"R8;]1;/RT^O1IR:=.H9QDD"<F%4SD]%$G;;AFCM*-.P0A-
M;>"ZQN3I2LE&;BKZL!EAB,6D1K4JS]2;=H:'6RAIR-9B7'$]6VU4\Y4G.22$
MDK'<D=SPS5VE\*L?[*EN8@[68-MXDZ2,U@(LU4TS[E;VB)WU,Y%@\BHK#KT^
MKQ9N"IQF%(QYOG/95,:0,?.LZDC ZGIL>.-QNT20Q8Y(+,!3!:G?R#E'  3
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M:=R]@#2_-B+&,%,J45*P,YR@?-MMC !)QW &7YW#PAU:/A#G,VY01PP7)*V
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M-TJ$^(=LPWE)!#%+M9U0*2L$-TEQS!3^('!!2.NXSOLZ.S?#5)L?_P!:)OL
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M>B*M2(2DEZ2$D*22<:E#!!R,CKOD'H3@XXM3PZ14!*!!=I;RX@R>EC(JK/Q
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MY2NOU4XQT&@DDC'L=L?IV/%^%1^57Q:FC6*IF728Z> $@W.L^+5^=P^'2O\
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M5 DV@)^!!RA<D\[\OO2Y:7'3Z9R-Y:O3H=5AU)NR+;;;?BP\H>0(4? R,Y!
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M[B0E,:Q+\5GG_P"2;F ^AP(4+8E*$-1(#I%6RF41D9 ^=1VV&0<D\+\2Z\'
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M)D9."[$G4VYG^&KEI3>:'AQ_=3ES0HE(5=LU^Y# A:G),)-&CN(;G)/SL.3
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M^VDZR&-W,#[Z8U:'FK5C;_-7E7=3+(=HM+=32*BXKY7V:I+:9?0KILMMQ25
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M9!]>!D\6,TYL?UR UO<AWG4^OV?O&EB*!9ZD$)H5Z511Z>L(\Q6#Z0=PG60
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M-+KQ(T@>7ES*CI)#?JP1Y>58X(([P1J3M.\GI[FZT=WT9Q](M(-M)+P_:?\
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M1Y3HD43GMR7N%N-(HO-'E_4&G0Z 85WT=1.K(]/U .1CIMGKOV.%VDFDU/\
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M\PK"C7CS"Y,O5!M$VG6_"D37673]VE;49#Y\P'\'HPHY&Q41]>1V@.N@"YJ
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MR%!,F/+I5YT]JNMK^53;K[ 923UTJ&4_EVWXGWR]=3PW?6Y)^_,ZUYM_SO\
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M%H07WZZ^?;QLTUB1XA.<[N-13>UR+4,X]274+(SC;.,;YV_4\7J/RC:D>O\
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M<[[CK=S4/EW(<N(KKCQGO3JN^Z&FX@>_ J(\A+25'=*@%;:>.5VK@<7B5AF
M0WS,Q+F#"(8DG7JN!VKA4<("FZ #3;@VL7@A$X1UI_R>HSD.O<P7"/+>>O5#
M;S&/X:&8C:89P3C* E!2!@8]NO'I/POA]SA'84U74!$BWDRV]]>/_%JOS.-7
M5F0!9R&SA#HDYT6;JM2\KE,&1:U#%0BL(?3(61J3K2-U*&P((U:D]QL!CBG:
MX2'3,S%S%LKG<ZG82.Z1%IY >8]6=SD95"T>8-.6$R[0<+@P4B+$6D9!R/4W
MEP;XRI'J'5)U#A?@E DF0H!ZP3Y;V+P=6XTU)"\&HF[PX]8W4 7WY'N%$FB1
MJC8]SQTOU=YAQ45560A]+K:4+05.Y;3K25))64M@$E9T]&Q6Z#*8-NAV(=P9
M:]U:Q_F4_P!0>3F&$%C:?#6=U!K]-KW(>%05563'JUH774)S$2JN*EJ2*!=-
M?@H@&+@"7YOFI9,<;.ZO*'S#CS'XMP?S:>)2/XJ*Z$!O20^DC%AX:]/^%\<\
M*JBX(JHJ#ZCRW)C?09MBB6U$YKS[SJ%L3ZO4K(N9V'-3%CF79[L(1$4B0B5
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M<#PMO<OZ<[;-R7*J[*)\4E-*7Y8:5";"@I"R4AM22!A9.4D9.,;\GM9GV@D
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M*>Y.IS2*)\"VTN+1I*6$-!EHIBZ2"1I20L@A)RKJ3D'.3MP1$D,WPPIY&PC
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MN76>A9.4(!"ZX]=:#>%"RKCY<<NZ'0;D>A"H-IN&3),0>D(J$B08GYD%:#C
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MS[@76H)46&3S"Y>NAG25&Y#GZ_%,$'/7(V_+![<.\'!R#01O<<P_7,2=4(#
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M?E?9=?7V-SHGR$@$Y!@(E6%@2\:F?,?Q4VWXP;*H=8HUL_855M&?2[8K2DY
MF9HCD6.\ 0#ZB00!MC?8G -)D%0#RP9L?TT"&"!!-)1O)^%7(6 3RQH,\I:+
M\1):!0M'PTF6T7&A]XC[Q0UM')^\1U1O\P&-]^->\#%]H_7+G;6'Y67 >$HB
MS@E'PY:L;<SL!VE0&H52>GR(\EIF0U*!ULH*TI6M)W(*03@9P"/ZNW!-8-)
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M!\6\1",<MM?-#2Y#<^:ZM)8UK;2V@H4&UA3,T:2A>X0O(&E1'IR#VQP: SS
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M$2"-U8386D:4N>*:IQVT%=&K*$I.5J^QM6E*=U82"=6 -AC)P ,$\%FS"8"
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M*2%*5D:4C3ZE8V&K)R,ERDQ")291LQSZLCW(TL'WZ*23\]+9M\6;$BQDR,3
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M0\2@W[M=!;Q26@Q!0M$OQGXGVRBJ@B6:2 YDP2)P"AR P-!+Q(29,U5F3:A
M>I$AZI4+S:;)&5Q4FX*K\$\#OO/U)(WVUG<XQQ]B_"1^5V04R72:9><RCZ3D
M/7S[M7Q<8D8(?H2/:5]3H<U/_P!FE@?^&G?_ !%7'4X?S#^H>U6DJ['^D?\
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M #L8L;D3M-[<M2NGX"+%5(78&8P2+4_H-?4E1:F:DTZZN!\ A%0D1FFSU?\
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MMN.]4>[V7B?_ .0V/_XZJ7Y^UGKF#_S- _\ TG#CD:G/78SYC79ZU+N0'G1
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MDCX?X**5#)Z'0-B/8Y(._ U8PY.9+YM_6>6CKRR;QSFYVGSM1,^T"1WVHRL
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MI'IK%=I=3B4H5"2"W+F*C.-.M0DD>IUUPZ603NLI3[<<[C_ZE7IXD \YMEV
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M8M"HOP[$1<S^B""&T !4K^C!'J>^Z*AQZ2K\6[W9>(0)'"KJ (L102!!660
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MZL[9Z]<\>T[..[PA3U'M;DQKS7%)XHJJV!+Q",> (7[,0UD9N&R![U*NC_\
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MW5:W*Q+IPE",EJ',&&7Y/IR#G<I)&, Y.,]^.QP2P!?O C]$;&(VT*B0#5<
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MK[N+$?KK&E2BPP+2+DXF\/?KH*>(RY[[LFSC<'+:Z'[0K].<9=$JGMH<<?!
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MCH#D\=FOM/#/>%(/Q @$$&[ *(@YN,,@SK+\HQ\32W#\<R-LR)T4+9\<G-*
M[$MF"S1XM.J$^*F2B+%"6BN0^AM>5!)PDA1"E Y2G.>APG56SW<D^C DA&R\
MXN]#\I2Q F$#>"$O!G#U]+_)>J2ZYRNMVMS"Q\=4:-#>D?"@:/6P@J_Z)!P=
MN@VZ;&?"R\4"WF'?ST$!;<S,E ^?ZC$Z)-!.+AM\^UQMG^2V>+T?/3_53[C1
M/S^-?_&K6??/AP_\*3FN.RJ:O'ZSF"?K^G_5PS4V=F/,C]M4IGN_TGT-(T;_
M  @ZOW0KFGYOMJXM/^UHN'']O%1?PJ]CJA^0=#_R&L'?$_SIN&-XH;UI% F5
M*@KIW,:I4R6ZW@QYK<R?$86RY@9#3J%J0YT.E9VZ83XHGJY9#GTZOQC5N&6W
M@;.)5I]_&=&7F3+$SFUX=:*I6I[][J;.DR3G#S[QBK(ZG&I1[>YQCA*M"L7_
M (79Q4$86Y^QIJJ*!D!91(!@@HJ</GS/T$T-!3S.EM'JW6:.?T$BFG\ST]L[
M[^PFJT+XA*N'=PP86_EHP<HDZN:O/1.,ZKFMQ..F<VO1!C.W7@51PZSR^E6G
M.%\GA7]-?D=6GQ(\PTG8-<JK46.O1$_( (WZX&_\^-^RE=PF#WNLL0?4?II'
MCX _D!/6_L!J$NNN.1Y:V5)0X*Y6U-K<)2E"Q'7H4M0W2E*L%1&X ZY''H*_
MA[)Q3_\ H>)'_:0/O'-:Y0*[13_ZE)\JJ?UT%/$Q>\BV[,C3$T1VK2E%ACSH
M4#XW0M0"4J#G;"CD$X((R#UX\J>*>_6\$F)>3A@;EG+@A=SAU"$3*\#TQR\&
M[ZH5;]<J%W<\N2DP0'J?1I=Z+4\B32M"_BF5QC@. 80K. ',>@^L @',HXG>
MKH#0-0&SP3<P)SUTSW@:2&F&")%[ 6'KN=:[\P8YBU:(A7\;[.8"1_\ 6Y;3
MDYQTT_W9[CARLL&3GS9M>)]3KE\8,DH7!\$ QR:]'R]:3_ ;_P#"#_S4<"JQ
MZ'VUKP/D_P#=['1*MTX<01V4D_RQQAHUV'7]=$>,\H.-%(RK6C2-QZBH#I[$
MD;9]QN#DZ5KN-F*0^D@'-IL?.-)\0JH  (D/)OFP>V]WHIT%;JO*2=@IQ*"=
MLD*4!UP.Q_7)SCAZD?Y)?\INT+V=T\#PC5B;5)$&;>(W&8+O?6?_ #^/F<^+
M&0=PB?7\_P"R*-1<GM_;O]#W>_#([)VS8CB>:K'ZCW6J<3_3J&57R4);<[QH
M3QI#1YY7*\D94BR*(R!W)^."0.Y.<_3_  XMPK#I-PD$/N08(Y+<,LB1B -E
M>4/+88B*UBZX]0YX5VWFH526]2**U(75&A_1T:D$^2Z"<>7D>KJ-&3@]TNUV
MJLNZ>C(8B5<+FU9EZB])?\8/..<,!RADG?5L+3<\V/&/Q 5A">F3D@@XR-MQ
MMN>BACA#AVJ]OVPKL3&P>FJA-)M,%+P'4+KF4SQ23I#"O9K/\M^&N'_IU_TG
M_P"6C3_'X?\ QT8**-:0OIADG'Z$^_; _//Z$T#Y;X=K_I9YOJM1D*)?L#[Z
M*-*"5-LA7REA05_LD. _V<-T_+5X^PTIQ[?]A_XC5!N>$Y3O.NH*9V0U0*<W
MWZ>>D=A_NK&/;A/CW&W]U:V=7[.B%RGT"/EJNKM8G4WE/S=JD56A^C\K;Y=C
M+ W0\E4MQI9_):0?<8. 1MP]V4_Y=<_PU"^2E.8GGYZSXS[U._>!,,%$DBWA
M?;QK;R&JDRL\K850J#P?DR:!2PM7U*)0)Z]_?'3!Z\8\-GB'E/06 ]???6D
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M.V$'O'=KR'T>F+/I'BNN'U&QT/X2=2@G^L-/\R1P>!_IGQ_Y#4-_"GV&M0/
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M73=%7=CF1):JK0;<\M;LH'X1"4YU*C#<92"5(P3@@ 93GC'B<7N/QQMS9]O
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MRYQ'7YGE>,OF"R%?[/)#P[KQ_P#S,_KPY33W0N;LL >PT"7]_:=USU:FN_\
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M$38WF2V?OGMSTJE>#N=#;<2Q6S_#6 "04G*2!G ^4G8DG&,C.QXU/;'DGJC
M<8]_?6R/*;W'C#6V_/&EW+7D9S-M.LLS*:Y'0PREU+3I'\<I5E*3V!62$C&/
M?/O?A]L-7$H%^]533 +DJ9?_ "OC4K'P$!1247=HR<VSB"=7EB46YYUNQ8M5
M$;[:0X@ +! \M)S@[9"<#U;9P2=]N+=KJNRAW:DI-ECI$^.2GDED6$!8V. I
M!04O0+YP<HKNNNS9-*@?9WQ!4\=MU:E(6$Z1@'()&!D')&P&.%N#4J34Q\([
MQ Y(EF\D7G=D6E1"J-G34+[ X%\HLVZ#5 9/A)YJ"6HBGQ9)R-)W"L]1@C(!
MSNDY]L=.&>%VP0 2$1S #A, ^?((O2K*3',-/=9(Y><W^Z'_ .9@.7]Q<M_
M-S>M^YHHB3W?%_?M1:;&?5$?Y+>'^.VX<@;EZ(^@[?@_0=/L_$_-HJJVK-(Y
MA4E[YS[:'IRV^\<LZ*5<NF"?$7SGLI:*FF:YS&YC53S7XX^SFX_[S5-Q3C:S
MV"0H^8/ZI/49XZ=(=-,_PTVO86RP4;;"=)U!UU7)[U6Y '>/1#F"5,/45YLW
MG<EB4FCU*TK&E7Q4)]\VM;M8I['\&B4*KU>%!J%RND$^BEPWWIR@-BE@]".+
MPZ;W22@PAM($RB1@ZJ?E.X!+B( #NEM (#N%IXO15Q/6I7G;6^%8N@6U47*"
MB<-<%FY9%.D&C1)H&"J*JI&,B0G&[)<Z9QQKDA D_*&+ 7'*0O=Z;[,/@^V4
M]XDD$S*26A7RP;YD(Y=VFOG!]BCF&B+/76542+IC_$(D+5(*R=TM_9P)4<DA
M.H[$#B3W:FK9M-)2%I@%0B,E''M'STY50W99'T,;Y)!0]*E09RY*I*G6"I%9
M=F$)ZF,TT'7 ,]RV"!CW /;.6RWDK8SMGW*&=98DV'BY$WZ;),@@#7K&"E5*
MJ)3\RE10G_:*D@?V\7I^:G^H>^JP+VST\Q[CKJE_C?81(Y8T,2.K->;4?5IV
M^QWP?7@Z<Y/J/38D  \<WMZ[QY@#;'E"L5U&NEV&!3A54D1*8"ZH_KOKYG;N
MY/\ ,&YKHE7%0ZCY#L&9(>A-*EE2%ICN%UM"D_B"U)2E0QZ@0/;CF]G=-9)1
M2(=XOBVPV).[Z=<E%XB)).60?6?#4OI%+J%+8M"EU6!$I\M-6J#L]"]T274M
M97(7U].=2E'.XS[;3M!_,!C&,A'UY7!YZE-(!!&]-4N XIOY"S"SJVE.FRZ1
MRZY>PJK6JA!GU?FQ8M53<"TERIJHE3IRJ<_3(S0'WD!V,MQI2 #J;5I(P>.'
MQNQ#M-8X-9"XW=X))'\/$/=*+%Q4T#<A,K72X7:_R:>])[CJ(_I!+)+'B5D"
M(#!R2YK716* _5G;VAR9MOKJU+FRHX\F!58C<:H-T93L7_352#=HI@;8'\5Y
M*49R2#QOQ7_HSLQ#(P9$. W;DRXB^.OV/MXX]5+0 JI8(!*B;AS"7([Z.5!\
M1?.VEQ*XVBXJ#.=,%8C+F45*I,-!K,<)D- #=YC9QI)/J6 "3UX\^/\ HSL[
M Y@0=RKELP?T>O2\#MGY8 YWGECG%.[1!@J)2/VD7.VGW'RUH[2^5<^K.WRB
MK5-V?;(7*?6Y4ZK$BHFM@C6TXL)2\C?6E2QOG!]!V#_I'LW"[I"BH$P22&"F
ML#H+:\_^,]N)KJLB(!NP*7(9)ZQ#+0&K4>(/Q"\U[^B<WZC54T!-3MBLVX:>
MQ2J W#\NG5*7 ^T/M1IT^6HAE3GV:AST9\L+!23QV/\ Z#V:FNBFJW>%C$D<
MN>7>$@!R.%VW_)XI!/\ IUERHI,3^I=AJDG,:7S=Y,7.U HUWLN2HG+&F\Q*
M0EJC4EQQA-=<4J1$0A'K6LG+:4-D+6<!.5$#A;\2_ ^Q]T6+W! ;@NXY(V9L
M-=?\&[:2%(;!#P?,E'EN-0.S/$AS[KU6E-W'9]#OLOSI+,1N](AB4P//1]#(
M,7 #S)<4"ZR"/-;*D)V4..7P_P 'X'#![HD D-00()R5 #!21)-GNU=J^,$%
MHB W!W!'S-EB5S!+3=W+3G#"+5QW4Y;EOP7G'ZE I]OS!4:;&<42^W#BTK&8
MI*L(1D922!U''6_#NP'O$BY@E&)R8$GZD00=<SM/XG^6*@6@#!Z$Q=BW(*XM
MJ><MK3N&794NK.,5ZHUBJ4FJ17%//?9T;XW[(NQNF?!M?,ISSO++2002H!)&
M_'3XG8(J10(ODQ.$=SX+7$XOXCWS45RDS+Y0%<,6/71^L2-2Z5/N"F1Z7";"
M?CG45'X'XRH)B(6PJWXSTG&&<QQ)2I\?PR2O;2,6[#V;N5&><"!S);G#Z=.3
MVGB_F/SD/%K*<':>>O;G:G73XBNFE^DJ_47)!)']GYCOCCT_#*X1!N:5[CZV
MUQZJ?\P[ B^\>J;^FH16CBHV<?:LU(_R@CBO _U#X_\ $:8-J.M/MK6VP%E:
M;F1O]Y9=G)/MZJ8Z#CKCJ??^W;L\ _)R-)]OTTMQ?F>_1RCSW^WJ+7%+4U1J
M*\T2'$4AIE&GYBLPI824^RLX(&/J=M^$_P 0"-0/^YV_VGG]XQHT<Y$8-G5'
M[_8C?A6HMSVW;]Q-70*@'JI?4R=314]XXB%06/A<;>9I_A[_ #=!QS*#+00J
M!"/C$D6VB=;\8/AU+-),)ONE&1TW@.R.K>10$.U9Q6E27%-I6%@:""-]8_JX
M)U#VVW'&XK!(*BX?/SW.?'(/9?@H%.334 L0!>,6;$ZKSXFZ=7J[RHN5NVG7
M$U9BEM+:9AMN.)<2DK4AI*&AYCA604Z&\K4/2G"SO<&FNJFBKY:C3359$%4D
M^ BZ9/AQ/Q3@?F5W_B84AKZPFID'6$PO'Q'6C'*5/\Q*/1J:SY:G JLPX"U.
M2R"([)3A:B,E+?XSA/7/'?['^&=CXE+5B/AV<V94^;YC7)'8ZIYN69YA$_PY
M0#"+)"8:W6^?-?=CFJM\PZGY*4OPY-7%5,)EIWU!YGS1Y0T#"QYF$82-6P)#
M%78>R<"L5H*@_F!WCX@5:3$%EX&I5V2M?")IM+F2)9-P,L-Y6G5Y4N+$J<I7
MGFJQH"GWOB0%.&:RRIU 2G\2O-2D ;ZM@.Y'E_QVNCB54CAR*C2#S:9&$?28
MN1Z3\)HKH%/Y@#-03N%*)M#1?3?5@?"]6:Y>W+&[:]6W_B&8-V4NF,1_A"G0
MHS$- :NP!'S]?Q XQQR>Q5=T+)MFY-V\1YL#3_:5^9XM\T"Q8WFUGC5^8=&@
M(99<<U!3C$9*8[>RG%*&S2<]5JSI2<9!)[9XZ= N>0]_U"Y[3I;B500+HLEH
M !]<CVYDAJ;#%J%IVEQ(#BU*1YL<GXIZ,M)2L2-AE*D9+AQL%9&=^&^!)I,?
M,#ZTB//2O\0DF0 <WR-Y(3%DMK46.VAVUJ8^?D0RAIK.^2!A/7ION3D\8]K@
MA7[I-[?$K(B4 ,[RM,ECO$$7 ZQSQ+29G3U16<UR&HY&FJ0B-NN);?\ /HD_
M3((Z\5[+<<^Z%Y']?+0JGD@_5+:X#O*YZS$YT[^)7FT#T\K_ /Z+'#=?S'P]
MAJ]-AT'MJ8>'%_R[5FMG("JO<@)QG&I-P#IG?;/ZXW'400 3_,/1_MUU*K'H
M?OZ:R*OB338'B!N"549Q:34KWJP;IB<ZLHK$8"4GZH*@H8WU=NF5N(W!_8Y;
M'+GB0+#AEC83DL@+O+UY7:U>+EC5!??/BZ+C9?D*IEJ1K2LRD)5D##3L9Z0%
M [@*]8/8#<[CA:O^)EE'VGRMK:KY1X$9E;@=>K;QK4BF.:>8WDD?+4Z.3^:3
M''Z]_P"0]\\+G^W+1H@DC>/#^_CX'1"Y-/?\O.>^3M_E#IF_7_Z#:.?[<D_G
MGW&!58_TGZ^?7PTYP_DK(&(!Y4KRA?OIFIKO_K@>=A*=>.6MHG1_6(A2AHR0
M>H!&"",;=1PQV5?#CXH\P1C;/E.D..3W0(2J'H2_!DW$<UJJW,JE2;AY=W;3
M85Q"VY=1%QB'7BZ&!"E(-&3'/F[>4&'"ESS-R@)U'.GCT_9;'I Y%LVV7W.N
M+QXJ)1?=,#,AFZ)<0 V@%JE/**RN9UN7W;E:JG-C][[;CO%B9:_G&H_%LI?2
M)#_3UZVM0.#N5 #.<<<[\0'Q&&69FP!4-79<78!(1;_#Y%15W! #D.,&_)#
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MH4E5SL3'G&Z_'SY"E-,!UMAP[8;UI 61T'78$%;M=<D 'G96D;,@MO),0G<
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M2A  M9W!-M$"VJ=%E)+R4!]M23Y2MP$J(&@@CZ[$YS@]=QP?U$$ B/L+^X,
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MZ'(RG&C_ !6U.)0%MC'F))3W)XYGXA<@$%&>2CE.<NW(,_A]ZH(YAKQN(WZ
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MI?;=MUN-4*/\0\?^<Z+\5%9^*B_]TQPXSN%X(J^>@_[F+;B/%3"GEJ22!O4
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M8)*6@M>^D9M3\U %B:65CO9+YR%<H76K=XTCO0>Z"6+_  @+D0PXL+@C5E_
M["J7*M^[N7E=OFRZW;-<7'D46@T^J!UU=VO%,6:XTT20XX6:,D-H2 5K4E.^
M<CY__P!8U\6@U#AQ2.\R,CNU N!C>+HZ]1^ =I55,/XJ:33_ -P@=3)P1%R=
M7(JLV%;TZK7#3;>EW$S;T"7$D,1Z^FF-0W:NPNU?.4%C0$MF=J5J.G R2!GC
MPO8.-Q*N+328[]5%)8D]XAJQ\^42]?2N%QR>!)P8 F&V6KDQ'TU3*H4J[+HN
M.PJ0Q7Z_;O+J;'N2[XE5E4NM/V?"I;Z7&+EJZ?@?^+:'.M^&)$U(E_T6K+CC
MX@>2M?'UW\+I([$_]A)432"<GG4Y7/;Y?^.U?F=NJC^,+_W2$ FMB"@,09+7
MV^8?/BRYE@>"&RK^J=#MZF:)E9H\2M"[*_1(*UFK/L3:?_Q?0+?NN0A^L.T2
M4/AJY'95&=(9?40[V'B$<3B$"PJ/ZB"]NL]-+=I H[,*E\@-2!A@'*8LRQ*D
M!DZ"%@\K^;O*A;MP<QV:[:%U7!1785L6G7VY#%V*8C.+15*C.B1#\59U(;&M
MR4_%)?F1TK6SEP@I5[?VDU5=V)8(?)(@ G:!,MP'M^'\;OT0%9*2=B0S$;]
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M-GYR8L\Q ZN+[N)01[TFE 8^I>&_]_Y^_%.VQ4!AB>@/ZZMP]]OHR/,E:M7
MJ)GQ+>0D[QZ8AH' Z^6$C\QMMTZ]STYW GBC-@K_ $Y@9?):8GN%A0=]DQC
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M0&NH2X%X+:L;*P?8<<WMO9N'0*N[! *:0*,,V/28*T]V3A\0&DFP,AF"YY0
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MC$MVGOMS9@J56AZHSM<C5R;)?+Z%J:#D>'*?&H+9C/N:65V_#*.)2: 1%55
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M(L,H0!DEW".==GW>14Q*#/Y("&2<E=)EX2@=-0PD[I&5 ;;COG@DQ5-V)_\
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MHCON$DC.H9 ./8;]3V)[B69D&X'@9SYP-3WB/'Q&/T.F5$JH(;<07GUE25)
M5H"<E) "@%#8D[@Y(&V>!%GW; _-/5@#T6C]W^UX:^G/]B4IY?A7YB%[Y_\
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M:@3%IA7VDA #II;M!=03D[\Q?;I+?/4OJ#13?%?0UTARHQ4?<.1VRK?/US]
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M&4@94/ZPQD@_0@'."-R,;<0M$V@D(\ONWGHD <^L6*ZXY1AV<T086D@1QG!
MSVZ_KC)QOM^F_&$_OX_?[:DB$/(1RD/S]0M=VZ8RH$".#G4",9'0Y'YXZ?7
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M3'8#@889$]],>2XZ]D%EM <*U/;%M"=6^,BPXI-0$(D &<IYO:".IE:!L5<
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M_('6[&YTW+S(F1),B)6F)3;<Y0PB.'$J'DGL4@'?.>A( Q@$$A#!M!:R[I=
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M6_?)!_F.,P1;_:0>H9'C;F=:D;Y-O>+"8N+6V;Y;JHZ65+EB.V[=,@-@]/4
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M;.DU66XI^:8<G4#()"E$(.QRK; .#N/FSCSO;*UQ&[+("R(1!OX!KEVN%\I
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MZ\&2X&FT?UUD!".@R<=@.'(F<>/WSUG:PL@9N<[[%*7:4-4=J-P<LYCL!_\
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ML:UGJ??W,!_F77GZ[7JA'KYA_9J:=2JBMU46D&F'!?%/:4E'V@"=(;*\8V(
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M7*YEKVROF37>_M)C@8.#^FWMMUPH9)',^^FZ"C3R[GJ4/WU%K-F:[S\0!!
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M$/%V*Z\B&M)ZO1+NJ40L1ZB5Y0M"6PGS3'*DE(6&S\V@D*#8V40$D'/%J>Q
M5T5!GNU4&!_*01L.<^>H2#9P"I*VYXZ#!UC]?G@ YYS*[7*C2KQM^?$GU274
M$TZH4U+4A@2'%.@-O@CRW 2=#A/W:M*M].SIX+<W)-B#G>V+A>FJTB:08# V
M%P]M,-'\)7BQH51BTY%P0U453C+4N7"D!Q34);B42(R&@0'%%DN)2C!*UD
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M![XQ]=_KD#'0YXH.*R(.[^Q)ZRA*TVMR!Y?KT5VV&-(70WN!@$@C;W_ZS_\
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M:BU))<><H]5IWGM2#_1H4.-+9<>C1#L X&DK2W[JQMQ!CSFU_4>&A41W:D
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MIVE]P"$ "T01BV#> -@=5:IP4QS,OMD;%OX CWRD#&!MOL-L=N/2\6F>S_\
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M+Z8K5O\ <K,:V6VVIKS,NCP5S9DN+I4S,<0V"SJ!P,*P K<C/3 '"? _$O\
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MJ,7VSK@M&E6#VP01_O\ H?\ <\5FDD;A'8_V]]57=-*,5;_?/29XX6@^V_\
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M+MJ';MG;&2=OR H (JDD$' LSUY7/OJM= [M2'\)O:U_VMINF0Z9*RT&O+C
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M:E= #G..N,^*MHPGF\H@L]+KV,#0/K7)WF5;#/E5BSZMYH<ZQ&S. (/S:QN
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M*Q;*O@L(EZ@?]WZ1@OJ%("U]+G[%K2/"W?P2K4!S_NL9^O\ D]Y69'^/Z\:
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MW-_O+\N3.P_^FC70GKCW[[\2J*:GBD^WAISA135T/JAIFL]S^E\^!_\ K;*
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MCL#@#AU?E]EK3/\ EUY,?";&4%;"@AI&DBHTB;@(Y_>0<I1HB5"XJ_Y],J=
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M20<C&0?RZ?\ 5OT.Q'M:CYZ?ZJ?<:M1\]/\ 53[C3]:8UW+0E[>FL4SK]9K
MV_EW[==P.%K]K"M^92_ TE>8ORTQQ_E'7T^UYZU!MQ6BL<Q5_P!2:A7_ )-)
MS_AQV>U_)P?ZA[#7%J^?_P!WN-1^S'O+H=KN=W:_4!GJ<JDXWR#GJ=^O$/\
MIC,#E_!;E]-;\&P(:(@=&8#R(6X:UI.N:0&<8(TMX.X(5\&$CKL=QGH3D#CA
M]M"J6TER9/+GRMK:D_#:1 S@(^1F>I&NK,Z0%(&Q*B, C!))].X(&!D;$ $?
MGJ*W#O29^81T-XQA6>YC5Q]^'[[?V>TR@6E!Y*BLI5AMM0#JC@X0VH$ .*Z(
M4""%8/;AHGNTU5)]VDU9"0;5XVU";D_?GH0W[>KL&E_#TB\++MVJHD9>9NIW
MXI[X9)RYF+D?$^C4 QG[T_=$D'/'@?QW\7)XOY5)9I) # +>=ANY\4-=/L?#
M-=#*M!<S-D6,80 Q?G9D&Y)*#5JA==OW-39C"T@6W33 C,OK04H4I)*AH2M0
M)WTXSCZ._@?8OS_R^T<0JH54UT\R"*@2NB+3CIK3MU/<X547IJ$1A2'B A<)
MVT0&&PL%O)RTDJS]4[X[[=N_;?CV85(JI(3"\X^IZQKBT'O?";PK<O[_ *+7
M9Z, $*.<C2O.>IQJZ=L9(()/O].*?E=[XX I+5II7AS\9UMW8/)X@IB#?!].
MNN6"KTCJK8?F=AQ;5-)V6P'U$Y(!"E@=2E/J5CZA(/\ ?].)H+EOZR7]^FO:
M0_&4%,Z<)=26SJ))PL:#WP.I&X(/Z$<2^IRV^Q]XB)TB3;+L0B;2)J&RLA:V
M5_(X!\S:LD^A>"E><;$YP<CB:L][&Z^FNDBI2%)0Q-AEHHTY>8!T*[D*W^4C
MYM@,#L .!X;_ 'XXU$[;PT]A;)?(7G3G'7 >WW'W"LG(P5:3N,YWZX!.-L :
MB,G5>L'[!^R,C-OU;3B,NQ<J2VDN!1*024C)!SUZ$$8Z'!&QXFHI)W 'W]^Y
MU&ZW76Z*VA;:_BYLC[MN)N"MUSTH:).<ZEJ"2<=5#J>DT:;@[D;;JZ]2\0M,
MM B&)$EO2$>4_+=5.7''^CQZSW_#@X_/!/;@GW"WL]WA\T >>M^14_M"EN3O
M/DZ^<PX-9SMN?;(WWQMU_F<]>O 50"I(%,-DQZ-^):"MH(B ESE=(]R?#4/F
M/N.RG P=F IPYR1E U$8.,G;'UQWXL;VDO#(;(!>ZOF%,&[4/F?''ZVL;H:B
M]2K8C)5#2D%>%/NI_K #4L9P#Z@,=>X^H 7@A9V0-A<2"YAA#<&J .>RE[J,
M1E"4]0V2)%3<2I!4RRI0#J4_.4$@+"1_6*20 >AQQ4]5O_?'5:G+I;]-M--3
MC1T,N-_"(DE*%DN2OG](SJ!& ",;''4;<9U?*5L1)EJK<7+9%\$(Z"MRD#SW
MZ^@T+:A#:=BR%? Q]@L^D[@ $JT[G<)!P-M_RQQC0&+7(^BOYW4XT! I+-Q?
M+"YYE=>FOJ9_88LI8\)%_H0UY(/B'NU6GW)Y;<I1JZ#KC'3MQT:0J0.0^_WU
MG467X7=HW*Z>]SC-=E:G4K]H5SX7 I_QTB1XC><D)Z.<X9@N\T;E9=J!^C+*
ME/$#&P/8$C6B_7[]+^<,C2]7_P CSF >GZ<M6R?Y56T6N93C+]4:_P IL$P:
MHJE.EB1!3)B.1'I,9\?P7V$/*<:>P2AQ"%_A!+= @J6\-@6-RHA0I@DZ .QV
MY(WG^^Q>-3"U+0HUF6S0;.MYAX4BVZ.S1*0Y4G_CZG"IE&?$1I+[W5!GSY&%
M*P=.LG<#)'#7YI#MDR23XPQ"0WSJH!9Y_I/]_92Y/K6I*W5* ?0E3+)(V#VD
MALJ]@%D$@>V.F<-QW:CM20.A '3JV_,Z/W]_74.+5R"[)L]4UA-JHB(1!IJ1
MZC)* ),@=3D*!(!('\\A>=HF-R/3^^,R7FQ\1!]%I!/>S5[=<)R4%]?Y:5 C
M/YA/OL.FV.,PN]2L&H7. ^5B2.>@;&([N0G=L<N2.;Z$GB*;U\G;M;_KP&WL
M_4%Q73W]NV3QCQBST8'A^K]-:<*WKXG^WKK'9R+Z\D D$'<]A[=.G7/7KMTX
M1XHD'+$[8VM9Z=X9/<.TA'S*W0O;%])7&L'IW_+?^1]@?KC([YR(?(BX$^0V
M/HT82()%OO;RQI$XT I*Q^%0./R()'Y'^6#T["I@P>8/W[:LA5R(Q]X?ES"7
M!U[!S^NWTW_E[GOVVX@!+Y7?W>_ZZ!($ ]39\G@;SOC7ZB42A6,ZM) /3WZ@
M[$9QG/<9/UL&$(()'-'R!!VQ.9U")1"/F/4QYGPTD#KY*]1V4"#DYR#]#MN.
MG<]1OCC74-OI@.8VM$EC:VO&"0I1'4:R/S R/?\ NXFA3?P/L=*A(=R,DD9&
M1@[C.X^0=1]1Q-%4[^I__9'N.NNQDC!] Z'L. ;'H=".9Y)/UUT,Q(#9]E).
M#C;!WSN<XZ=-OKU&3.!(O'.(QL5?.BAOT_4K;UQ&O1<G6M*NF"DZM.H8!!R4
MY]0!R=)^;ID#&"/BKI&]0'-D@3;86MU>H$'DF!@3#)OZ:::C1:!6G$.U:D4V
M7(:6EV+(=BXD-/(4%M.-+WT.I< 4@CHI(.-B>.5^(_AQXE;$(L.&0U(Z82.=
M5/6^R8Y2F;FUM--_R9CUH5%E3WG)B4J>AMG.S,9,-X%0]L)R?S&.O#GX=V/B
M<*D%%4R\H&0]@ESG1'/>ROM#VYS$70^KCFJTJ8-L*GT<9Z;E]D#K]0!]=L?7
MKT500;RP0Y 8#$9ZQN=9\4@FDA_*I1M_>]_35Q^7+/PM6I:\?/:#PWSC!JC'
MY_XX.#GV8#IX?$(VJJ3M-74V O&^=*US6/Z@2L]<>WF!I Q3OM.EQ,SD(\MB
M>KX9S=*\25J+:NP2Z,)5L?F]B#QYOM_'^(05.'"%X//W5];TJ=SN_',) XM<
M-Z -3YE4*G7";;JC,J!44OIC1W9/^:/)<<#:$QO92BL!&>^,D8&,NS=K_+7$
M7R'O^-!!/B@PGG35"[I+84\_%*QM;F'J5S&C"BMS9'EQXI 2Q(<SH<,G9)6,
M?P\GUC?"<]3U8XO;SQR, E0FJF-XBVK&6D9(1+%P X RSDPBM>K:FYK""RXS
M(W2/,C;(1GHI6!DI2=S@9">F,'AVBH_D%)#AU& Y42(;%SXO56D9 3#F>3.Q
MSY-:X.4]T9*GLIP2=QG3@Y!P 1TQC&#N>A/ ['Q?BJ!N+R"O'"O'3&K/QD(H
MB^9>Y%THRBC,5+JA(,7S0C#>O;(WP3^8';)X9/%X8KH.!4#<P01)F+ )7S?4
M 2!3VB1/]SS&NOV5'D'.H,[X+9P KV!^AZ'!S@[_ %V(HXWQ""9^H?CLCL0]
M'Z8MTRO-7%EKHFDJ9(#(C$>Q&Y[:0,8.<8]N,Z@>&"0BJ3 2,%MRN;^NJDP0
MB-K#PN'X.$IMT%-2HX>8C!0QU0%#\@G'J/\ J]\:1MN,"35)_9/U!]1J@)E'
M8[\\X!+>#O?7NQ*3"84R(T53"G0AULQ2E*FR=*DJ(V2"@D%1!P#WP.!^9W?A
M.5)"NAOY0G&@F060:2%O%HN\("UR=0>OT.!,,@/4_P#H_ENR!':;#T=X(0I7
ME.LX/F-N :'&^BTJ*0,'@ZU>6R!@[F( *9V$,K&LX^8=]LRG:Q:S] I](@1I
MRVD/-M? K=0HE!"4@8"BDG23L5XXA/I'UR1C]= (PYJI[N_S#NG&_,EQR,'M
M2ZJ_;M0^+MFXZK34+3Y#8B2M:4J5Z4$H.QPHYP-U8(&Y( )\SXGJ'M<W6J#L
MH)N%3NV3SL0S[3<ZM9:_B1YOL46ETRGUNIO553Q:UK_C2D.*#6AK;9YT'2G?
MYE $8'%J2202Q-K<K!"VH>S#A_$:H !@FX&UD@(1M((>KDT*H>-M^BT^XS:%
MJW?3I#;;D>A3?16'8@ *G"O25!Y:=@2-G% [#?C?69J%YCPLP9R&D//*_9/.
M2YJ$XEOFQX;;CI;@4GXF51(#DE@-I.7UJ=:^]0VE!*E.-C6E(U)R=/%:OE.8
M)M^IOSA;1H'B,$!H@CZ*_GTMM/+$YQ\J[[J\.C6JBIT:O,-.NNT>IQJJ'&V@
M%91J<PV@G! 4X- (]0T9XQC[^^GV$<Y7+Z_87F-]3+EJK12:@H=4W5=BA_T:
M@P?\.*FU?C_Q&C3\U/\ 4/?Q]M<;,?\ *3S9>_[Y>E<&X!'5O'3MV/U'89QT
M>Q-4Q(QY=/U?/5^T8Y)<['&2X(T$>?"_B+)9R,A8I@*>Y"IH!3OW."!V_(8
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MFN&000%#F$%+):Z#;TY351YT#[)DE<BF2T%CX=]6F*TR$E"C%5^%S024'\)
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MCU7)03Z@.FY3D#<;]^(CL?(Z&D7_  %/&$MU2#X9.= ;3_!4;%K.D*WTE62
M!G!.X '??B(['R.K%8/O#CQ&\ J_+HKP&>,<I4/^#7S?.01C]QJMOD?^$/\
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MYL^13G?"YS\@.-K\D.SN4]X"GN(*@C+=9<M]E$D$')6MU"" 2IU"<J':HIJ
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1KSB:FO.)J:\XFIKSB:FO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g483086g12g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g483086g12g01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2&$4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (6B^A5(X0DE-! 0      %D< @   @  ' )0  AR<C8Q,S(W,AP"!0!
M36EC<F]S;V9T(%=O<F0@+2 P,2YA(%)I9V5T=&D@0V]M<'5T:6YG($EN8RX@
M+2 Q,"U+("!$<F%F="!-87-T90 X0DE-!"4      !#L2_<)<Y, ,'7[\0)+
MAE)^.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M             #^    X0DE- _(       H  /_______P  .$))300-
M   $    6CA"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #00    8              8@   )0    !@!G #$
M,@!G #  ,0    $                          0             "4
M 8@                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M 8@     4F=H=&QO;F<   )0    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M:J3&>,2H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MOE3=5&DIO5222\R3VQ 6J['W%076G]7=R*/Y5'[U:]7W],')2I#;-< 4D@2
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M!Q='2O=/OG9&&F[KWO[FW.Z+80EUM[7FJZRB8D G8MZYKWJ0/Q+62LJ"CN,
M'FV;_:9XCS=8T:''^-4O,P-/BN>06%R2G, WV+ :,<1CPUP!IX%PB)GAF2V8
M#_4!QH(NV^"YOOEWG]0I'=7N"L)41(UE?-ICV"ZXD\<'YCT+3\?>*DK*%^)O
M$"N13/\ OGB$]WS.Y@]KWQE/A3@!G]Q\) (</PW)0)&E"/GT;$!ZG^(7X@*6
M^5S=)WK[I(:;J(2TG6VIPV$^0E(N&W:(\"(F>3U8\IX\\1*4D*X_QHR'/[US
MMC%C7F;[WM@U'A'P^03^X^# Z']V9%W8Q_J.TW?UQ\H?B<[YVZSW2[W'O+W1
M>I;72U-PJO\ RRU,XY]WI6E.NI;W5Y^8H0H) _B(CCIPGQ3XCKU$ >(.-!UA
M+#BN>3<V89@&'%]#;7 ];P[X>H)45<"X,2E!/_)>1NQ8/\"6W9KD]>4'<W[3
MKXLNXMZ=5I/OQW:T3IBD+S-NI+9K;5%#77!+*U)57UE>S<6ZA"2$DAHN%).-
MN1UU+@]3CB\NC,5>,\5J)0 XJ9_-K"GB>:L1<]=3>,4/.9?@0JKIHX-PE+DM
MR\.R:6FP:C=MFVUQ!-Z^T4^,"F0::A^*7OZ_4>F0E]'=O7"D[Q@I4C]M!/UW
M<B(S/5GH9W/O_P =SBG&N:KD!V_]H>L[:7P@S?#^&D^3A^12 "_)E,N!IM3&
M[?H#$.._:#_'&Y4.K'Q>_$<A)5"D([QZ_;2A8)W)2#?=L1( &!TWIYO.MYLW
MF3 O7J7C_?TUW](2IR62^(L?9,KV^STH)/1 W])&"NA^/WXWWFFVZ;XKOB+>
MJ5<NO=XM>%I (CYMU[@G!,QP<=0U>*9I!Y1F<P.IK5-_^N.G;YXF'",DH<QR
MN6 .GP*0DM+E-M&<SUP1/?&W\9[M$M#WQ>?$N[=UP:=BV=X]?AL+.3ZVR^ !
M.1/'GP#T../5J:V7F:ZE B/C+(D=5,;]9ZQB;]SY55(-D\J"7/,<O1F8()1M
M8P.^!RJ^.+X_[,ZTJM^++XAZ.B4UO#[W>#7=27"#!:_>WI92HQ!5((/!P.M\
MQQW,U$_PZ]=):Z:JP>Y*5 NP)DN!M#Z4>$9.D2:F3RJB\A67I$"7  *3TAIM
MW,=._:-?%G5T@I:GXIOB'IJYMPA]^L[M:\4AY",;VMU[_"HR1L.1'4:,]G%)
M23G<W-WS%8 DA_\ /T![^P,/#^'AO] R-A_Z+E_7_9^GZ? _>OC\^.BLK0F@
M^++O]2VQ,E=4QW8UWE(5\X*C>I$(R(,CQ[C4Y[/24YW-@.T9BL(:)YW??01O
MC/[OX<S'(9(PW_%,OKVIZ6];1C]_R]/C74VTD_%K\12*=L[G*M?>#N CU&QE
M1G]NR)  QP3P,]24LWQ D/G<V27)_P!(JZ?^_(VN_1PT1X=PX!_L&2<.0/LM
M&'-_N?H X;+M]I#\:-2G[E9?BJ[^M,I 1][5W?UTZ\M8$$!9O94"K(F<0(,Q
MT8,UGD#F&:S*S9C7JJ!ZL5$=H?YXAJ</R(2?]!R8 (_]&H "-S3<[$_489&/
MM!/C;I0%7/XP_B(925 E/^F37JEP2,2;Z5A//!&<>XZ@J\1XFQY:]<2++J"V
MS'7:0;GI!]BR G[%E( G[/1]X0\./0C!;</M$?BZIZ!MQOXM_B$=W ;5,=Y=
M?%?(GU-U\G((CS,Q'G6GG>(E-3GS69YB/*U>J&.I;FVF'MIKM3R61,')9-G9
MCEJ%[Z(>^_Y817/[03XNZJUM.47Q>?$BQ7*0# [R=Q8,_P 1#5^"0)^A,<^W
M4:<[GTK!.=S9:Z3F:Q<;D%37+&-XC&YX=D"8R63U!;+48NW\C/(=]HPP4?QX
M_'6?F_Y7OQ&&G0F5.N=YNX.Y495\KE^*L1^H\<=-/WO5IT>==>J2RO\ :*AH
M:]RVEF-\0KX3E5K(1D\LD1_Z/2 !/_N/-KZB7G!WI[XWOCNO=2TU:?BH^(VI
M:<*6E/U'>+7RE*)@%QAHWPI4E4R@J$G'!YK&<\4YKGY:69KI#$>2M4#L=2%"
M6F)G#SAOA?)J3S+RF762 ?/EZ)BY#*0P[](O%G['\47Q9:/MG[>U[\7GQ!+0
M4A9HGN[VO9@B0%(5?<$^P$1[8Z!3Q7BM=1;/YU()\H3FZZ8?_KAAU_KAFOP_
MPRFX/#\CLYRF7()&Y^'(:\:3TKEW ^TX^+^OKJZFTU\3??*UVVC46VJEONAK
M0.U$ @)]07?>%*X2J9!.23TURE3B:E4UJXCGU *0HA6;S+%(,N#48C0@P1W?
M"K,\/X8E*P.'9!*N13$93+A4A3$-2<6@@@AX.,=#?:%?%>:!ZMOGQ3_$Q=JM
ME*W&J6G[QZZ;9*DG"%E5[VP?^\(GF2>B.)\2SJPH4<WFJ:DL!\.O51L"Q2H?
M3Y8WX;PGAII U>'Y%3 $\V5H*(!D2:9U@EW[8NQ\-?VRG>_0U^;TSWBU_P!R
M]6:"OKC*J2_7#5=WK]3:=?<4AMQ53<7:QQZIM[<J4YO6M2%% 0,]<ZXV?$XI
MJJ4..<9IR%-2XIGT\H +CR5@S]@]](W3PWA S82.'9 N".564RY!E+EE4V<2
M 888[!J^)#N#JJEHM2:*[S:ZN^G;O3-U5O?IM8WIK:TXG>$N)37@;QNA0Y$=
M</XWXL\;<+KD?XF\0\H)'*.,<1 +-'_&6 U=FN=\=&X;X8X#7RWQ%<$X0H\H
M))X=DE/=_P#8&7V_/&I/?'O84*)[I=Q.01&M+Y)Y$9KI'_C/0>6_:#XMK4RJ
MIXE\0)(@']\\1&I_^<3M-V]BJ7ACP_34H'@?"%R#/#,DH--GHEF>V_S_ '^G
M#O7L,]T^X8,G\>M-0[OYM5\ >P/S3_0K_'?BPLWB7CY'_;7$0[=LP!]1[8)/
MAKPX6_X X+_^2LA^.7<;:>^,6^]_>5:PE?=?N,DG!"=9ZF@>T']H9QDY/Z=1
M*\=^*^;_ )S>(/\ \L<1 /2<S#/:^N/?X8\.$$CP_P $[_NO(MII\$8UO]\N
M\[:BE/=KN% ,?-K:_@X.)FO*@8YW9]^>O#QWXK,?XG\0CMQKB!^7VG^NU\9_
MPOX<"01P#@AM?A61[3_H\]8,Z1A,YWT[TI:W#NWW$D$'&N+_ "1N_P#X[SQ^
MOGJ0^//%;C_SGX_%_P#ACB-VU'VD1<_A#XV_PAX?(?\ <'!MW_=F2'I_J&;O
M_3"7_3SWJ./]+/<<?4ZXOP _,_?1'\^L'Q[XJ;_G/Q_>.,<1??\ Z5K\\>'@
M_P /$@#P_P &=Q_\G9,_(T6,?TQFGOMWIW#_ ,[G<0Q,@:ZOY/\ (U\?SZT_
MQYXK_P#XFX^.W&<_OTS+XG_P;X>$G@/!&_[*R?XY<C&M/?GO4IS:.[7<<F%&
M#KF^A/ZG[_ (D8$>W7O\=>*R9\3>(!$/QCB+F3_\Y>?7UC&R/!_AU)=7A[@A
M#$,>%Y&YZ&A:]^LOA4SWV[T+6EM7=GN++A2F4ZXOJHR>)K\?G@GCVZERWCCQ
M6:C'Q-X@(T2>,\0W:2<SOOU$2<!U_"_AQ((' ."B6=/"LB&ZO\!V.EL>@_M-
M5UE?VPT!6W&KJ*ZOJ](V&HK*VK>74U554NVZG6\_45#BE+>>=<*EN.*4I2U$
MJ)),]?='@W,5LWX3\.9K,5:E>OF.#</K5JU:HJK5JU*F6IJ6NI462NHM1)*E
MJ)4HER23CY.\34:67\0\:H4*=.E1H\3SE.E2I(33ITT(KK2E*$) 2A*0 $I
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M'#AB06!AG8MTUTPC-O0RT !@#F3DCW_VCXF?ZGIE152!" WF(3=S,>TQ;J,
M5:E<I45$_=)D2=^LV;Y%L$&@ZE:ZVLH4 $KI'TE"H"8(7^+Z8@2#R.@\U03]
MH2D %)<$3L;;AYBT6N9\I7JC+\W*H<H8$AP?=KNVD@ =(8U'W%NMENCMB?4B
MGI*%UU2"D))G>%?41$R?!X!F!9,ID*9X>M9H<[I5Y5AP"QF6Z3BK9WC*Z6?0
MDJY2X%^6Y LVG72[3CTK_9KZ^_MSV$IG%OIJU6RK^[IV@$MH](*Y3P#'G,B/
M]KKX_P#VK5$9;B"D*RPI@J6' 8*Y57.^SP-7MCZ$\'9I68X8X)/E0=W>-(<
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M'T#L=,6&GP6G72@J2'2' ZGU8S^M[)V_2MBTE;G:NCMU+3@HE%74-MH6MP)
M2I"705*)Q^'SP)SU6LUQ"M73]]0/^7\CTB^@UQ9LAPNC1*7 802[FVFI)T8
M3@B!H;39'=2:IJ77Z9NE<J&@MQ;#+:V@2RDM)*$JD!,#:2HCC,=:Y*C5J+14
M45$E3N2QU@?6<%YFK1RREI!3R@>4ZEP-7?MTWQ076%]J^Y=ZK;D^\Y2VIMPB
MF9^9AIYA+A+>U!@E'IQ!$3R(,D]!X:BHA"0Q+I#/VZZGN>KXIO$:M/,*+GF\
MQ@![$QZ$7F[&XP*U]VM=G8]%DH2V!$I3@$3/S1',S@^?U(IY:JNJ5+<.JY+P
M7;J^KQ:7PNJU4( "6)  Z MKZ: ]M7BJ[ZOJJI18MBW7"9 4V@[ 3B2L#;\O
MD \3..K)D\C3!2I24EBDN=@8/RE_0.3BO9O-57(22JXBTEM_1[1#QAT[=M)=
MU*%:AORJ5LL_O0W4EE384%%.4J3N,1*<DYG$1MF\H@U.9"0Z26(TZVCUZM=\
M,,CG%)H%%11 Y68^8:.&U),/^-P37NEK1<-87 6ZI-=;O53OJ0XM;H"B%*.X
MJ)("02H"?!$X'1M.LNEE%H)8<I9X$AH(87+ :WQ6,YED9CB"5L#(+V,$,>CA
MB6W;OZ%_LFF*6SZ#U=8:-U:Z1EZFJV@5J(],LC>0DF01( \Y,'KY._;-D_B9
MBE5Y7++NPV)+F[=&?;'T%X+J)I<.Y$GE)Y   \#KT=]C,XZZE""03'R-H*2<
MX5)!/&,CG^_KAZE 4Z2?\J6 8OU&ER]WF<6=14I:G=W(+$#;\ 3%^V-*Q\AX
M'S$1(&<$X]A'OUM2!\SZJ+.1IW,=,%4=-M]XN?<#J<)5.H;*@LP=N(!(,@1Q
MU.%A("=6C8N8G\+]L$$]'-P(]V=SZ?+'U#BU!," 1B2!^7(GKWQ0[.?0@CWY
M3]<8)#<SENC?B,?5'<!'^S']/^/4!223$.=M^_Y8D?R@//,_;Y?GC6AMM2T^
MH8.X!..3@^?KG/(\>.L)?F VZ#Y_KMC8%A$N',E_SFT6-\*''PPA:4GQR"<D
M^/8Y^L#/4UY.K^^/:3#"!J!ON&G9V ,P6E;GJ(*?XS)CZ>_^?ZGG"R.0]TQV
MN?4_IL1U)$$ER YW>WMC25*9+'B7 ,'$1!GZ<D3[?R.R8D6+)3\B2X]R/0L^
M#G>D2Q<!(]2#!@W%_P PV/3%V5)/:+MH3R=$:;_]UTW7Z$^!H\&^%QMP/AO_
M (6GCXE\8AO%?B(?_3/$+_\ VFICS4?$XTE/?#O$LI)]3N9K&!B9&I*\3S@$
MS'].<_'?C"JA/BKQ"LI)Y..<520));/UP6!;7ZX^L/"])7^'> JWX)PHP!;[
M#09S]?P@8%+/:FG++;@&P%?=VO5!!^9:P"(&<<3]<D'S0^*YK[0I/P^9/PR%
M*"F$ N68L[:,+]L.C7116$J2HS<-!,7+&?<-$X';W3I9N9:!A"$("H)(!_(0
M#!]X X,]'\/K!5-!5S&]^Q( N1L2'UQ.*B5ATI5[ 3T'78==HQ);]-(3N4H0
M#,XQSDQ_21_7J;,\HG<@!I/5[:@6DO;&5_=<.Q.K;/IZ?.X#XW,/O,*3M64I
M)X)(X]OIG$>1'D]+JB0IM#/H0 SL^_7IIC5$@AX^?ST."ZSU;E0\$*65)2G<
M3,@ $ CZ$G \<YZ!KTF3_*7>PZ@7:'&S2[L6QLE@A?,EI3+."?-IMVCY-(K"
MV-Z ,!32>?=4@F"3&1[Y\](,T%\WE=N7K<$AW'S+ L/3"G-GE!(!V^M]&V]'
MPYFCIG&\@%0R1)!^D<#] )]_)Z%"ZZ4 I5#6EQKZ#K /;"Y-8L"01)<LUWV.
MQM\L)56]A(*MBB![*.9^DB/Z=:*S55(\Q-M&UB(_'&XJ@FY9G)@"+Z#ZVPC?
MIW$K!; 2DP3@D@C$#D1!&!CWZFRX^*1SE])BY8O9W'5XZR304%$<B@):='N6
MWVVUMAM?2Y_%NC,D2/UQ $#'/F..FGV.F4+9@Z5,05 @MH;@]1VPSITB0RU!
M5,_? 9R@_> '7O,]\: -@E*U%0&$JDC^<XC$9Y',=#HRM1#DU%5=DU%J*3.H
M,.!8R>NN/*IT4/\ "24@ L3^C#.&_%\*$U+X&U(001!G!VGD3!D<8/\ 3HM(
M(/\ "0BC$J06*F(($'?;VP/4YZB.2J$5*8D) 2_,/YCKN&DVPK:JZJE4TY2/
MNT[J?XV75LG/!"FB"3G!/1:.(\2HL*696GJ%J%K?H7Z#"G,<)R&8<5:"'EF2
M-9F;%[ Q.D8E_3_>ONIIIML6[6]W#5.@(9HGWA4L;$Y"27D..;3E(&Z(!\GI
MYP[QOX@X>M-.EFE*1S<Y"BY<LDID.0\]\),SX3X4M"@C*40" 22"_-NT_JV)
M@L/V@]9I>JI;=KS3YO#1*0Y<K<PI:VYP5+:E#<IS)!D\P1QU;@O[2.-(2DY@
MTU"\!(,D%I F?21&*)Q3P$NJI:LL$I23#.1\D&-MF8ZG%V^V7Q.=K^YM&FJM
M&HZ2AJ'7?1505ZC252' $F"E0V;8, A62.8&.B<'\?*SRDJKU44^:%(/*"&+
M!A;0$V%Q,8YYQ+P;GLC66DTN802I#L'2"'</[:DN^M@&GA5,JJ&G&*]K,/(=
M0ZSM\"1N)!&00DB"/UZ%EU93BE+XHK9<I2P(J<H/70O +3)DL",5BOELQE5,
MJG6=RP ,-U>TOTN!(PEJ=*Z7NB6C<+/2!#@E*BUY5^*5,EM3>?XR(!F"(Z!S
M7A?PUGT<B,G2-P5<CP8=@>_N^",M6SU!?/\ %6D!C]XPQ!AS'H;N6,8B?5'8
MG3UZ0^S0/L@.*.VDJF!4T_(( +OJ D9 D".09'5 XE^S/A5>JM.4R])"V)02
ME3" 8OH))!ZL^'M/Q%GZ"1RYNIS%+@)6YAWU@@3H^Q88K%KCX5[:6'RYIID+
M0E2DU]H]1I7N%%M"DHGW&V/J< <^XQ^SNMEN?X2*?,"26*V8/LD-[;O=\67@
MGC+.(J(%6OF"',%B#%G)>UNID;TFUYVGJM)5"U(KG7J5#2G#3U:74K0 >%.%
M!&(B-_G$9ZY)Q+A=7+5ZN7JH*6$%((2X(#!P/9CI <C'7N%>(TYHTD5%5'6R
M$\W*?,7()=3B-G.F(-U);455BNE(ZR5,55#4,N-JW%KTU)A0@* 62"2F9]L<
M$7A*E4,Y3'.OE*TN 8)#B!ZW#2VHQ>TY6F:::E0)8@$-K$QI;T?2<<^M2]H+
M(IM\L4@85+@;4TE3>V2H_.W)05&29R3Q]>NT\/SH110A!5RJE0)<N0 0-=OQ
MVP#Q"AEDK2!3+J1!(MHY.\.S/T+3 %U[45;"B_2,"J2B8<+BV*A2AP!Z83E$
M0"3,#,>'M):%@%7*226('</UOZP>]>K9>HZN0D&]]PS$!QJ&+=Q@43<-96-'
MHHK[I2K95M]"K3ZK+@0=H 4X%2GV).><=2%%!9(" %#_ #-RG<[^X#:DO B:
M6;IJ*C4)#G[JB&:=F@:RV)7TEW732A#>I;/4[BE(-=2!3GD#<0(2.=V$<<*B
M) K<.29'("7((M=V(((]'82&C!U/-U$L_.\:!M1+-?VN6?%D=-W>T:B92]9*
MZEJSS]V#B0Z0).U29B3Q$\F/'5;XC34FHH)#V Y;/ G^LD%VP]Y@D278$ZZ"
M (Z>YP-=R^Z;6DFF],V"EJ+MK&N8W,4#+*76Z .**4*JW J&VTJ!=VC<E0$$
M02.I<G0!HE=4MRAV498F#(D.1?<S@>I53\-;..HC7[H/2 2"-0)G!SV3['OW
MM+6N.Z -[OU>I#OWFK'JMM4R?F30T=,H(9IJ9@P$I:0DKR5?-P@XQQ)&6*DT
MB?B @%0 Y1!<)EQOI=R^L"*%6HU1*@$ 6!/,J=AI9B\DR[L;E-TM'0,L4M*P
MEEM&\-I9 2@) 2!(!@&,'WYZYAG<YF:N8'/444J<)<EA(!)D@0UG$Z-@L54%
MJ9'G#R+"Y.H?U&]Q.-Z]K#:G7'$@(@)22=[I5PE  RKB<^<SD=8-!)225.XU
M/ZO=]A88P*56%E20AW8OW.X@>F^) TG9K<XTNYZA:?52[$JH:19+;:JA7X'%
M>FH*62!\R"2@8QG,)73I.GE/,9#,  QO+N\V,:$SA1Q?B'P@*-+G"BA*N80Q
MD&[D[_E@FN=GL6K+$Y;+SI[3M50KK6V:JEKK/15#-8U/[KU$5-(O?L;@25F2
M)/,='9+.+R[J25D$%F(-NL0&G2'9PYIM6IG%5.85%<MV4HO[.0U]8P(I^&_L
MA75*FW^TO;]RB^0@TND+4E96WRM:F:9*@21PDC/@2>G66XYG4"HDU5*"R2D0
M6268%Y!8ZN)U;$2ZJBE@*O.[*-DEF=0#DR;?GB6J70.A*:D3;6]'TE)0,LL,
M4%+2-O4J:)+0@>AZ3L"204A7T!3(Z!YZE6M5JU%.*@82'23#F( :=Q@C+\0S
ME$.%+# S<""QZ")(D,6PPW+M-:707[,NKMH"276JA)=:6D E22XYO*$*!@J
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M@20XB 6U&^\E@&P(7%JWMW!#E#4+6?E5M;1@J!D \@!2N3F.<#J?XJ$I4DI
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MCVZ=T,MEJ03S!-A]TV8,WXZ][81)JYE)YEJ406U+_.7^=S><#=;^Q[=N>O\
M=GK@]N.^C+H0R%3,'8I.[,X Z9TU9:HW)1+AY4@!VB&>._X865Z]1!)J5"Q)
M:?75I_HQ.-6G*W^U]15-V9^FM=OHU[  EIHN1S"E)*EI/&[GD^W0]8+IGR.
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M_P#V(TW_ .ZJ;K]"_ T^#?"__8?#?_"T\?$?C+_G9XC_ .V>(?\ B:F/-_\
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M^@P) \= U<L'4>4"7,.W30]=1/KC'V<$BXAK0>[6[WMIA0U7AS\1 / $ SG
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M1-4(IIYY*E)#+ )9G=B9)GJ+<?['IC5USOFI:S[\X]IB@M%0^&'E;T-K;;5
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M5,EF))3$:](?3L#BP=/I/0G;ZF:JKV:>X7':E)I X5NE0(PE!"MI)D9P1.#
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M $#!F3/5:J<;J)JJY5D)9@GFOS#9K#^D1A[EN$4Z@3SH"IN4R#9Q?]'%]?A
MJ[?HGN[9*>@;13LU]*_1*2P0TTN"C8,2%;3, @2#/CKF'C@5<_24L*)=%2+E
M)9W@[O[-H^+YP6F,F BFD NDP#IM>[F?KKWLI*@NH+BDD%2&E$$X'R@$S&9C
M/'/'O\T5,NJCF*R502NY@P2)<LX?1O7%ZI*6M/G-R&V 82+.+_W@:7' E8.W
M=S(F//'!X_+_  /4C E];/MOZ_KIB9>AUD=FV[3_ 'QBH^J"I(V8&!G(,$SC
MF/ZQ/7FAG-_Q_#]1&(2_,5.2VF\#7"=2E*$%7]/\.HQ*DG<$E]P_Y1M@JE_+
MZWFS_KM&/D3@XG$^T]:8V_F_][\<:'T*2%)0=Q. >/UY\>WGK9)Y2#L?SUM^
M>)4*<@L((N=-W;OAM^Y..+2%.E*<S$F1''XA_DGCJ3XQ.FD2WO8.VK>CSB=P
M'/,_M\AM[X7NL-4[:0D[EE0!49\\XDYQS_A$Z55DH9W#6V_3_)GVWIJ=7H6<
MW#Z;3/X:X2K$K9^C@/\ +HK)%C3-_P"G_P#U\L&U"U$=4MV9S^./2]V5$=HN
MV@]M$:;'_P#2Z;K]#_ A?P7X6._ >&'_ /-*6/AWQ@7\5>(O^V>(#VS-08XS
M_$-V\I4=R-;WVFJ:*I<J-=W]]^GW!;C:ZB\53RTJ2% I6E:R#()D?4=?!'[2
MB<MXN\2"D214X_QA12J2E2N(9A18Z)<GEV#78OW7PIQ"LCA7"TU%<J4\/R24
M,D_<3EJ8227;[H:-M)Q#+NE:A2]M,TZ\\V=IV"4>GX4 $DD@&/Q0?8=4%64J
MI53K>;F*@2WW7>?*"-M#KL^+:KB5*B>>HJ$$&3<)()G6S;C9C@=?T/<6G5C[
MNK<HJ6 MI25GSR? $3$SCZ'IG1JYH ( 0 =65IL02).XL.AP50\1\-+<U0 %
MW90@B['<%F@>ALPO::KFGE^HP$H2)C:5'=X$ _0^P^OM,A%8+*Y)(+P0EKP"
MS&-][X9IXUD:Z>6BL%7WB%$$!.K/KZ,?;"%RC=2%[6E*6G"N4I3R 8(\F>#X
MZD-2HDZ3=Y@=2K].YZ[IS2%N$E)9F8@F9EKQ-XP@<8=@+4KTR-V$*P>,*D'C
MD3[^>HU54U/ODI(8 IU>;/,]!Z/B0YCD(#I!+L\>KDVL[/:=L?:<%Q6[>5 8
M&01 R8@1P<^1CK*%T0)6IP2_F <0S@MONWXD45K624E%NC3)UOWDCMAZIZ,K
M^< 21\I,_3DR/IQ]/KUN,TER@$<NF\O,%K]+:Q,-1:PM19!+[.8$ZC1CH&<:
M835!9;"D*2<*VJ(Y)!.1B8D>0?H>.M@JDO[QN9Z>H?IMUC$B74QY1S ;1L2Q
M.O=_7"8J)4/3($D8GZC('$P/,Y^D]%<].1RILPCY$M;J_P">)KO_  TB"VOX
MXR(6 223$DY'Z\1_DGK0\LMR@M%OQ.(RDESRCT;UU^6, X3@%0P<^WU\_ICG
MJ-NWN/SQH4#5+>C8_ J0D)0 8/\ %[>>".L8R(E@3U^GZ_OM4ZVE,J)"B. )
MGB8QXGJ:F 0SF8,LQ;1Q&F_1\84MFA.L"'Z>]YB=<"ES0E<NE.[YB4[B8&9X
M!'C,3])Z-I)2A# O<DW8EG;I'JV)J=3R$@)@S<$0-1/?0SI&/ELID%?K; 5$
M@[LR(B()/ @ 9Z@S'+4=)$-!MZR3UN-H;&JE$LW,DD:'K'O.G:,/RW5D\S&)
M_3Z1QQT#RE#I2HA(L#/?I=_QQ/30%(25#F,R;F3=@/3IC653/XLS_%[_ *<?
M3KW(-7)ZG&&I_P#JTG4$W!WTZ>V,TI*<!:@,_*F$@?E Q$GZ_P NIETT5&(2
MFFXDTPQ-M2_TP$JDDJ)45*N&)<-K%Y[QIC>VX4$3!(X602L$9!"AF9\F>I$5
M*U!+4Z]5*7F3'LT/TUQJ,KE5/ST*:^BP"DV%CV?TM@HL^OM8:66*C3VI;Q;'
M=PG[O75(0H<0IM:U-D<8"1XZ;Y+Q#Q/) IHYM9"@0.8KC6);H(_'"[->'N$Y
MO[^1H.[E@B=;-^NE\)]6=R];ZP2PC4E\J[NEM<I]<I*TJ2%$*20D2LY2"1,*
M(B<]),W6S.>S7VBOF:ZE*!! 7Y)(8@&06C^I@KA?AKAN4JJJY?+H0I%,F -3
M8LD/IW(!>3C[9NXUDLNB]661=NJ&[M=K544].^)@N00HF4F3&$[2.?:(-I%2
M0SE3M*KZ-:TL"[V.IPOS]-=?,!/($I0HCRAC,#7V#0_J:[+92_3\A*E-C>%@
M;BLC), 3D\_SG'3C+E/*%$ LHWVA['4NT^L8=Y6D:= )=3W+P1 Z1,?+#73V
M%M)*@D+WR9(!3YR)&#/G/L/'3:EG4)!!"8'E&G_Z7U@7OCU6DEOO$0T'86]0
M8E^N%#EE9I&7''EHIVF4&I?4Y"4AK*RLNGY$)Y(!&/,Q/0R1F,U6/,G^&I9(
M(!^Z3<20 VKBSB[8U)Y4)D_= =VL&O'TFP @XK%<+QKCNS?JK3NBDU-DTI3U
MZJ:XWZF;VJN3*%;"6'"%!6Z##B!M,S $19LIF<OD$@(4@<J6)60ZF$[>IGJ[
MX55ZM9*^4*"G,)%F<L+P(G4LX%WN+VY[1Z:T+:6!2T%(;D?WKM8IGU:E;RB5
M..K>="E*6N25%1V@D[ F!U1..\6JYRJM-"J4(D-3)%KD[E^F@F^&=!""1S@$
MN%$,+F2UH?I]8EAML':F"IR0$I$)P8!@ 0 !_=Y,=5H5 E"@M2JE14?Q/,9(
M#2VCOH^&H4@(*4)3S%RE]X,V),-##NS8:KO=*&T4]15U%0AAFE2\JJJGE>FQ
M2(0C=Z[BU%(4A!@*2""22 I(!AEP_A1SAY_A*8V* P?9V5%^L"(PFS:TH)4H
MI!9F#"3-N][#8[U9T_W/N??'O';^W6@;DHZ3TXVB]ZWU(T 6*Q#"MR;13/;B
M*<U)!V()65@J$_+/5MI\,HY'+K-<J25)#.6^X"X<I(9E G4N<),QQ&JOE0CD
M2E)-@02"P\Q<C0L(>26G%Z*]2:@HMU"A-(AQQNC994E2_2],)W!*MTR4%*I,
MP22,&.N8<8*3F5BF73S$B9OT=M7C26P/2?G"S)$D%R'+Z=.^C  8?:RW4=(:
M:FK:@4=#1-CU5J:W&I?2F3L,@E9F."( $>>HLO3/P[F"_L.NOIOOB>I\6LI)
M2R8Y?(&!:X-S8Z$?08&+AK!9931Z8L[BW6G3MJZ]M104I405-L+'IMD^%;?F
MR2/'184I+<H:3)?67O(D0-\2T\K4+%143?W>;"S_ $ZC#<$ZQN+@>JZX4=.N
M%/(82BF!6H;B 60V%)F,JR1]9ZC2:O,7.IAKZ,1NW<1KAFC*Y9*$E5"FHE/F
M*D.2;N2XONT]Y"2MO1T^5+I[]5UM4D&*1EU3F]0X3"]RQ*O(4#S! X9(2&91
M(C2X^O5MR_KJ<MEY;+TP9(+$D-;ULU[89!KC7E]>2Q35550TZ5)"A^\0M*)
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M #7?8 -U"^#?M93]KNSC-P^ZM_VDUZ!?KC7K0K[V*/T]EM84M<PAIM;BD[0
M2LJ())(Y%XVXI\:LG+98E!I_%"N6/O%/*.4.[,0Q+"6WQ-E*96%+6YYB  9M
M>8-H##8O88MC05KS*T^@$+J*5EI7WA^/D4LG<N52%*(P5*E1$ $ =<Y3046-
M4$W?F)!-[V(]HVPUITH, 6)8NTVDSZMKN'9M17LU-0FG0X:EY*MRUK5*6U@
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MSC\6_K.-BL$6$ G^K&98]#?#:^V0O<2>??V\?U]N/S@>8-!]#WT_+OC(6Z0
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ML&VL=ML.!FT-%VW>+WOL'?Y89QH#3"75OL-5M$%)('W&O<;*7)GY@H[=AC(
MG &,=3T,\H$IS;KIA+CF/,RW9) T8.S=.N,#-^A9W&VYG2\,"WNJ:L=QI E-
MMU5<&2G+:*UEJK:1' 6H)! , &2?IG/1/VW(BR$L01*0'&D$:O!-IEAC89@+
MNTL\$PS0X#M!EB_L=*JWN)0K64.6N^M$ALAII5.\GV4E,PDG.! )Q[=8.;HU
M3R4$)3!YV !+LTNT,=?ICWV>G4=2H*9&ERYLVPOW-BZBE[A7.B5Z>H=/5S"&
MS'J,MK=;/$!13@J R9,\2??!R1K2I[1YH_%K]6>PL=@BDAU,&M;N;7T:S'M8
MDI.X6G*Y207&J8J!/IO(+;J-H"?G0<#&1,8.>>L?NQ%$?$*B9U/7>#W(UP/F
M%TU)8(#!@8$022["\P_T@BI;K:JD%='4 .2"E:% '."1&8C^G'@@=5>K0)Y8
M8EGEQH8?]  ;805J)45!@SF'AG%WW&V">FNU6R :.Z+0I,%)E13N&03F,GF<
M?E.9:>>)*7&HUYF8@6=PQ^DPSQ5,GD:D?!0[$6:]K-UP66W6^JJ( )KV'4I,
MK2II*E.)'(D\;L <_IY8)S9203/+/F','!?NU]3[MA;F.!9&LA0II3S%*@DA
MKD$ @RS7Z=89>]W4=*@Q66.BK*QTI;:#;*4.$J(25R %?()4<&8(GSU(<W\4
M\O*DO(\I^ICW5;NV%]/@YRX^\IDP27+$=RPEM6,;X05%HM-"7J^L*D*JUARH
M* "IE3DK*$R/E@8GZCZ3ZG2H<W/62"EC 9^9WUZ.6LP-GP=0^(2*84_*':"[
M%G(^6D3)N24VF.V%X90HU3B5J;1O]=0!*R,[< DR#/(@@3[86.'H?RCF-N9+
MR!#08T<&XOOFKQ/,99) )2Y/0Q+@@'WUT.IA?7^@*>P'[[;*QERA<45-).5[
M2LD92!@#/M(S[]*Z]6GSD4@0@B6#!_K(:-OFWX7Q>OF4 JDI7R/N  =;$NVW
M66Q&B&OE4K C@;I'',SC.8CF8]NH#4)=BSN8+0[:F8:S-&+3EZREI!5+V $?
M3Z6V8X2ELR8*HD\*$?E^G'15&H3323-R[S))GK@E2_,0"1 @.1;HX]H=\:BW
MDG<9GZ_X&)^OOGJ4!)DF3+ BY],:%[N1K%_H^-?HI\$Y_P"Z1_,QU)B?XCD7
MT'?O,OKOC-=,@H1*4F=W(]HSY_3'62?Z1;Y[MN3?O)3J K $2=-&)+,8&]B<
M-[E,@&( _(#_ (C\_P#(ZU<"\;?K]?5BN8@/?]0]C(L8M:7QK4P$I4H)*@(W
M$0-H) "B1F K:#'O/ /6% D,'?I<^NF-%52 "8G0?69])VQ'VL[\FQ(^[4I9
MKKX\ U2TC3JE;%O*"4+>1)BGC+I$* !@\GIOD*(5RN'B20[O;<Q$SH6Q$JLY
M<AG@=-B 6MMN98/@3M/;&KNE:Q?M<5"[B\A)?IF65$4-'C<ANG;.%!*C^-0*
MB<$D 07G.('ASA(;F0[N?;?31YMMB.I4D\MF8EF+:3J[=!!!#DO9JE2E-OI6
M&6_NWI,H2E*(2=I2(!@9W#,GZ8ZJ>=K'/OYH(!%W=@"6)>=F][X6U*A<]W)T
M;ZF]X.-#[[-/3+?4Y3I"$?O2O"Y3^(*48.))()CSY)Z RN1^)53042HI/+S2
M[@_7?788R!\(!;MS *-M>@M<%]FMCG]WI^*VHH:BNTQVZ+7[1HW5T55=ZM'J
MM)6DE"C;63"'%H(,J7,$9Z[%X?\  ^7S5)/-*O*9!AY+N+]^I=FP%6XW5H.>
M4,78B>;1P=+6O9IQS&U7J]^NOESO%9=UW:_U;BDW2LK5E2O45A0IT*^5$<)
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M?O\ 3<U2ETM!UV(W/Z F;G"I%PH6=S+%2U4F(4W(42?I)(&1S'OSCHM'#LV
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MN F3&_\ &H_PS]),$=2_O1;!EL3LQ,=X^6\6P=2X4D)#H> SACT+%E$C0ZO
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ME=1W,?(OC!=4N!M)F1]<>?'^>//6%J44L^HV'X=FF^-%%98*+@FSF3H_;O\
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M;H;C54B&EW*Y5H;]95OM[CR5,MLIIU(4HI!6DE:@00.JSQOQ8K*T:YIJIFH
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M8(:!';"D2_05OI.NTKHHWG*"N+KM.]^)MIY*%J]->X!(#@!]R,](!P_-9-@
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ML2"1:?T"7N""/3I)C-7IR]TU135KC]8U3M_=7&VTK0H5"$;2IYE4AN5)D$
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MA3*:''.+4TDD>9%+/YA )\PORZNQTQWW@7@+@G$N"<(S%0J-7,<*X?F*H\P
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MJ'8$QJY-E:M!WZW-A.G>XUZ8;2=@IKQ3LW!M*?"5*"/46""$S,F"3SU*O/\
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MGY6Q C+I542H0 ]PQL683H1MH'+/B1M/5Z:5V\5[C2:NK&QJE"IVLJ"4^I[
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M5)^4> %*A,F3B1U;Z/[2^"9TA%>G2(6>51(#3M/ULVV$=?P1Q7+@D(6P!L\
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MJ@"9)$<=<.\8?L]/#J:RE2@!S$%2B8*C9F^Z 8@STGHWAGQ0KBE<.R7/*4@
M& &+B!)N)( (Q26DN%-=J!UQM'K!%4NC62WN27T)"U ;Q^ !0$B25 X]J)P_
M+YG+4E(IU"0DD,YO,3H&FV@QTE*0JO34HW8[D1/X#^CC#!7:>LU;(K+93..
M<AIM/.0"0 3 CDXX!(@=3HS==">59YE!1))ERY[2 6TD1!PXJ\OQ5!,) 2S_
M /52\,\'407]A9[M_IQ]2RW3OT1F2*:H<2%$F<)P$Q.$CC'@1UM]M6=;S8,[
ML2Q<]([R^):8@.S%W(['5FM]'.F!R\:=8TW2*N#>H[I;*=A+BU.//)4D*;25
M);E1(6H@82F9S//5@X=3354I:PX8'K&FWUA@7&(TZJOT%^MR]QONU\1-;Z#6
MG=QQ3"M5W.CTM1/K34+IV&F%W0'<$->N&PXG\,J4DC$I)ST]S.;HY6B"AOB
M!M3IN2;$AF?TG'B"7=F[Z.[,.DDW8L,64T5HFQ:,MZ:&ST*6$G:7G59==7@K
M6M9E2UK.3N/G\^J'Q3BU594+NJ W7]6?\@ZJC+&Q@MZ6[W^K8D%"PXD);!!3
MD$B/F!\1./IX_N2_:U+!YS%_6+ZAFF_YBA7*I2B;IT$NX8ERS:::QAR0V"E)
M<)*N3''B"?)Q,>??H"K6=R'+O,.'&EM=X!W?$-2JR9%P>P:;!NA]XP]6NWBJ
MJ$K0H@H.9 G!]_\ >>M$4^=JK>9+7>P+_B22Q<?-17S'PZB2\<H#]26E]AIZ
MVQ13XB:6KM/=UFHI%(6I^P4OJAQ*%#]TM8$ C!*2/8F#SQU] >%*Y/#2Y+%
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MGWW)^''NSVW%2_?M.NUU&QO":EE@J<(28"E )*OF ]_.23U;<KXRH\0\BB@
MAX YH#ZD^SF=9Q/3J4ETP'8L[EF8;M<M:W5FQ4JX.T:ZA;+M'4T*AN]1NJ0X
MW+Z2,)283'($Q!@=6+)YS)9H@@H))#@MV>'DV>-<!U7!5R)=W .AEQN-.KO;
M7#?045517>FN=.^E+3;[%0M+@*/3^[.H6")&TE0D)@\C/OT?FLOE?@GX8#L
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MH ]&/<@GYDXS24#13T)EM-]]G_*WI0[+ CM'VU!$$:)TX"/K^RZ;K]$/ O\
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ML2M.H,-M9_GCR>0/_#40?]\;?B?EOC)#*B2=R\1R"?\ =B?'MUDDN.0I2UR
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MLU]+4 A+BZIZJ%+N$>I34]2IQE*D94A(1,C&<]$4>)YSXB4?$)',&@6+ F"
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ME*(@$*W)F?&??J[4N'U\W1%.B4DMS0Q8]2^C6UC!:$)I4QS.QT< VUMM?:7
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MP[&R#!*2/;ZQU:JG'$Y;+_&4D$) #'7F8 N&B7AKZ83KX)\0<Y!=P?TT:O\
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M?(4J^2J$J2A160@'[KD!K,1$@D7Q[A/C+/97-#[44J^*L<I! 869@""3N&_
M<G^]W8ZZ5%][M]O%L5BJBKTJY?:/[FA2G:A5 TMQU32""# 4K='X09\":[X:
M7G:/$3E%I+""H@$EF!8D0S.PNW1L=@H\7^U94507"P%&UY#AFO WL;VY9_#W
MI"V56M*JTZAME7>33VJO134I6I3E-4T)5^]=:,B6FT*"D*24'*BF>NG>(JB^
M'<'R^90@?$74"0Z1!4J1: S@L0VDO@:A5H5*Q546026(>2P/+L.HZ7D8P[DV
M;1M7J.DNM-8UVRVMU:@[7I<0-X9)"VRVE(2V%$&0 % 8,9Z;<%S]8\(IYCX8
M34Y4>9K)N021)#&2!-S@^O1RI0_._-N7A_<WVC8,^ +OWK?M-8]/T L3C+]Q
M90A2VTNIW+4 DP1L)$J$$ C(PH<],N$Y'/5J@(YO,OF=B7!4[P)9W$3'7"/-
M\1%.DI08EC <N$P!+[21?KBB5V[W*25&CMZ4@R)05*]Y_$29&( 5GCQF[TN"
MYDJ3\?F^&.4K) )Y8)CK.A?K(Q2\UQNJI?(B"=@/1G!/K=M1B*[MW5U#6+6&
M$,M,J)!.U16 3(VD$8GQ/'GIM2X'D"0GG,L2Z0$M[?/NT6#7Q//,0.:UG#]9
M#^UQ'3 ?4ZCO53^\=K'-JU;=K9452>#MW?YQ^K.AD,AD5?%1RE3<@8&QO<@:
M-!=K' 1S.<S2C36E3#S7@$-: +G9]]<(:>QWF\53/H,7%];U52E;GINE.PO#
MC. 8(GDQCH.MQ'*T\Q9+AP!J3$Q\WV'7'CD:]0$G6;CJ8=]>EVC']3GX%:9R
MB^#+X6Z1U"FW*;L1VQ8<0L$+2MK2=L0I*@K(4"#(.0>N@9)8J9/+5$V70I+%
MK*0"+18XYCQ)!I9_.4U71F*J#K*5D'Z8K_J75Z+9J_6E*M+9*=7:G$EQ0 '[
M5JIGV,R2/K['KXG\5\25E/$WB#E/*W'.+ D*Y7;B&8<1=]3K:]KXC(+K\/R)
M;G"LGE2 H.P-"F7<@L!9G]&G";^VM.I"O7;(D'Y/5 "AY3! F)^I_/'0>6X^
MM=-:TDDA)("BI0)T/3M\L:T^"UETE)0 @*04LF 7#3#/TAQ=K8<*36]$E"$E
MH-MI&&S^\ D"(F$F3&?^'3/+<=J+#KRZ*G0IDW:2(L= ^!_W!7I$<U]VC]>O
M:1A>=:V\I3*64IW##C20"#_7/(^G$R>HE^(!3JD+RJ4.&<I!#["/:/G?U3)5
M<N 4DI),J2Z2W0@D7 @F"):!C?\ VFM-2DI4FWQ "DJ90"L*$ 209 SY\_EU
MN.*4ZX"OA((U@.]Q_+??TZ/$:>:'^UJ]/,0/?UT<&#&B!YNPUZVU*I[<AMO<
M%)*$*+F_;MVC;\NV"<GE0\ CH7,IR>:Y+I*.8EF;S,;/T8,YTOB2EF\WE"6*
MJOQ&/F> G8@D23-G;KA-4:5T74ME3M.V"H+E:%%&(P $0F!/)SGG'0:N'9!0
MEBXL4A0!%G!U#EOGIB8<9S@CD(!T!6^_U%HP N]O=%5Y6P%@(W*(]4(=;!G)
M'J@J_,E7F!B(59K@>1J%7(HH<N & $: $ !V+-U+X*I>(L[2 = 40" "51.N
M]X^8,X'+GV9T<I)6W4BG+G[M*J="D $$?.-B@$YDX"?; Z7K\-91<"NL!Y9@
M9U(EY$D09V;#.GXOSH2D&FD0+DL=VF^\1TC&@]C2W3%-LU#5QMD)^^.%,'P4
MJ609\A2?TQUZMX4RH!":RTENC#31@=6<^NI)RWBD@I(0(+W$L7EF+W#NQP W
MCX=JM];E0FN>J'T)4HG>A0E GCDS$!(.2!]!TGK^%^0%:<PL\J5$!V<@%QY2
M;]_746&AXQ 9T"^YENV@V]FQ&-R^&^K4E#CZJMX))/I%GY22(Y20?E)D00<3
MD8Z 3P^K1(4%J)#0%GKH_P I%I&&]+QO3! 5227>7<_B^S,Q=L!-=V0J*97[
MM*DJ0H (<:<2 /8*4HA1$8&"1$^>HLTNJ:8"Z:JH2KF"23!:]MF[.;7PW'C#
M*YBGR%(I$,>=@5:@C7ZW!-CB-]3=L=3UE,]06ZYIM*5I6A]UEI2G'6C@MI6%
M(+1@D I)!D3[]3Y+BARX ^RH0;>8<P\L!H[.')>_0^AQ;)54(/Q>9[L&.SJ+
MN=&V?8MAMTMVY9T=;TTU!;W4K5*ZNM6%.5%2Z2=RZA8,K*B H DP"..I\YQ1
M6<92D)3RIY  P!#OJV^[Q[M4YG)*2$BLD%0AR##7$V9H%I[X)-I:4GUBM*00
M3((2,8P22( _D.01U7ZM52%J^&.0D!B VFA!#]"Y [XW&4I5@Z,WR@BX+&"1
M<.3ZX)*5JEJ6$.MU;2U %QU"20\G:K:$E)@1M *1[$8SF KS50\QJ+4[.ZR2
M18ZG6+^V%V;5]C4JFFH:G( RWN_F,,79V$F)>(++7IVGKZ3]H75UZFMJ72FG
MHD':Y5F?QJ)_A(*8!28.X?E($I('.D&1*@%$F";NXWVAHO7LSQ525,"IR2'!
MF2QLTN'G6"\G#K7W2BH&VZ*E:*D4I@M*(+23( 6$ ;=P@P8//L>B#F$4PR4A
M+"R VQ<L/ET;$B4E;J7YW@$NX=[%W+QJ+7P.KNS]<^&VG%M+5(0A"R$S!F4@
M@8$Q'O/0YK?%4"74"+$V(]/ZF&M@RFNGED\ZD)9+\T = "0[W=F<M?!=;K0F
MSL"_7-U;BF?F;9624.*5^$$&9R<X,<R(/1=$I2KF2E(>T -O[2'MT,'"/-*J
MYJJ!1)0@DV)D$V8-%M9V<EA._:EJ+NZO=#+1$M@$QM'RA$8G!$Q'TB1U-F<U
MR40.4/S,]BS&?38=&VP\R/"2$I6L!4,Y +&SZ%MGMZ8"5H=<6 'UE!6-R05!
M.?!R01!XQC^J.I4YB_H6D%]@WL)8V.'"<HE !#.+0 XZ]3/0[M@CIG&:$M^J
MLH]2 5<)2E1B2.)G,@Y\_7&7KIIJ"2 KS<SF\7GLUP+ Q; &=(4"P<<I$R3\
MM'MV<'$R:2:MS"#]TJD5B=N\J>2#!5N4H"9B"2)YP<<=6;*9CXG*!J2>A!($
MBQ:&NT/.*=Q!%0*@D 0)+6-P##S#8(ZZ^6YBG*G'&E!LPI)0-I4)!P9&2"8S
M]8STR-2B/+R@<I+Q$7V[N&P%3RRE,Q> 2T3$Z?4;OIAA<U9:RZA:VF3M *2T
MLH@'ZIQC,@C)_EUM\6@?Y1;J/1VOZ^KX.1E%;ERDV>"U[;P)_!]+]_14TP<'
MHO,JW)]-:00E))D))D \&0/RYZ]S!;_=EV9MM!%NS=8G3[/5IDA3DB>OY]XT
MO&,#;[?56(.+;#"WGW$A02/ER((( _"3\I/&#X/492@.2@$!A8  1)>7L^"<
MOF#0JHYU%2$GS!1_W;LS7]?KBK_=#MLU=PND>2\%-LNNVZL;$+]58)+JC(((
M!5!D$D D YZVIYJG36E(2 DP0S!X9P(8ARPCK##H7"\Y1JT@D  L6)O8!B"!
M83!A]26Q%';)N\V6XWW2=U*:X4C=+5VNL5*W'*;8XE[U"I2BI04 3&3QST3G
MZF7JTZ7PZ5/G(5_('=DN;6)EH,;8:*12"2HI"N8 N1:Y\L%HGKM+8F]EQEX,
MI+JT;$A3*@B4%SDMK!@8( &<<1U73DJY65<Q2DF  4I,F2P8_P!YT*M1"5F
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M*RA6^T5 A,\@62D2&_F&D=)<W&'R>/9N@'33 00 +V,Z"(#@G3MB%-8_9VZ
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M&?3*_2"U@ )3(,F>BZ_C3B)I*HJ4H(60"!45V%V2)T80PZ8J.8\!952TU$*
M4D^7R)A[0PW)!+L-,"JN_6@:KN'8==:PIW*"Z/\ W[2-T89:+U _:[]2.-)]
M-Z 2MLIW_-((/,P.L<"S S><"TCE4%.M22 HZEE .5.=R;MUF3P/.96F:2:R
MP&!0ER0)V?< FPV9L<A^R%+9#\<6LK-8W2[IU^^:KHV%J3M":&KVRK83 +8=
M4/ @J'!CJW>(LTHY.A1J*540DNRW4(+@L7#L+[G6^&67R*J:$KJRLDN\F'()
M+SO:!&F('[U:::LO</5VA4U6ZP45[K*VEK%F7O2?4\I*,D) ,R0,0!].F/AS
M.%63-,@JIBFED%^6V@+V$7&@>,$& UP%%@>AC2UXB9&N*VWCL?9=2-5"*IUU
M) EMTM*4K=RGYEN$@*,2)X/F>KQ1X_5RG*4T4#E8!@Q8 7*6ONU^^%^:X4JJ
ME3*(YDDL':7L/71WF&G$.7/X3JD.>M0W8I;5RTM"1.9B9( CZ?W]-Z7CBH"$
M+H(()8OYF?5F#]3MV?%?K>&:W-\1R2DNX!'UZ]</UA^#VE?6R_>+XEUEY6UQ
MJG2VI30'^RD$%2BH03\I(C/4>9\9J2%!%)((!Y6@%]X/L"P?O@S*\&5Y2M(+
M&Y0Y,PQ+F8T[MK+%L^&3MC:'%,U+3]8Z@@A;K \1]2?H,F9P.D2?%N8K*4@@
MI$NZU,"+,X&^WT;%C3P&BL) IH!$NE"1U() D.1'RQ*-J[>:(L?HBW62GW M
M)*WF4!0#2TJ0M)6DPH$\B,&)'F#]Y5J]9)))F7)FS"/75]NAZ>&9*E3Y5TZ8
M(@$(2[V+W#=QH-9Q[QOA>0AOX<>QJ&DA#:.UFB4H2#(2D6"A  ,# 'TZ^B.
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MSX7GN/4L$%%6HG&T!Q)SB,SX,2/ GZ]1_OO,J=)4AK%UER+6YM'>+D7)P/\
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M K(6O>XD%1)&XB4SP2(ZL6:R'&,CYD(JJ-R1349'9B-Q8:8KAJYGGJ,@_>(
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M=TCA*0YM$ ?Q$S)@ X&35H<K<BRH:D"1,WT<6!BSD/AC4R-8) "0(>Q=B_\
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MO@1=6JJS-Z@ L_XZW^0<FEJ<4H+22F3$#V_J203@X\ <=>%$@W2Q]VZQ#%K
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MOEJQ6E25) <G5V]@/G[Z)7"VIX*9RTB840#*N/>(@_Y/4"$J2IPX!EPWH6,
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M<W+=>TV]@)>33J4W6O,IJ&F5@0E99G<Z4J(/IH*5*@D$8ZUR]0!0-<*4G_=
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MF,P#X'\YZU X:L<Q6F;I)9FUEFTOU])>;B; E))+NIU3I#GL"^CVQBO3>DG
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MY<J*Y-+6/O0;JF:A:JAI?S[P7Y_Z03)$#R,=9R=')55 ("1$0G2-;B (.O7
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MD?)QM@HTPZ2P(DV:[/';22?3#775"T,)!NX'[T0%E049@^\0#QS@?IT.3;S
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MF KP8\C@'ZX,<^%$FQYG()<$]R.IU)OMBP</X=]G 8'1X(87]MKEW#/AE=J
M00E22K^&3.<@3[C^GU]V5(NEAH!L-)U_5IPR2@O8 7M?TCYMAI-U11K<+L[A
M!!P,F./IXQ^0XGHA(!20XG3^CWU]M V#Z;!$D"]VL+%BWH_<@ZN='>67VP6G
M %A0G=$$#)'ZXF1 ]NAJJ($ 2"Q$GT+>A!?6,+\PDK<!^A:#/X@MI,ZX>6[G
M;RIM3Q<I:G*4N-?O&UP$CYPF  DY&.21//0O+)8&6T]G,,6,]O7"I63J**E
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M]M,=N?A=^%.R_#QH=RVE::W5E_J?VEJ2Z4*_307G4AS]GTZH)6PP3EPF"I(
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M)91=]6G>P<8T*@7$AXZ#35OPQ+/9*]+T[KJUUS3A:^=NDW" M(=W#< 09DJ
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M5%5>3E4[O?>Y8]K&[0TG&PI5&=GLP!VO,DZW[:X2.T;UN<0M4K]; Y^:,8)
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M*)9:2&APY!G87V)ZZ[(XW2JCEII(4)V@,_F?4FQ$XS1H#4:T$J=H&_\ UJH
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M,/T(P&N:]I*A93ZDDDRDJ2DB? DDB?)\\P2.L_N2G3(+I)!=A/N8:-B<2_%
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M],]:_9#5>HA?*F  1<@$6F[/>;G$:BM*@E,[2>[L->G>^GQH+ 8;9;=><<>
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MZ))4HJW$_(LA.<D!)Q_,_F0>HRI"5..9@\6$L#O[-[,<$_NNAN6T>&^9UO\
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M()J&0L0-02Q-F[0XW:V"4J34#,T.Y#A_3K<C>1#8(+8@[4RX7CM'R%6XR.?
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M0-L5+U56O( (J''"%$S($%7 XYXSU.O,_#9DD 1Z 02+O+ZD=-)0H)8$@F1
M D-JYOM%VF776MO2%'4(M=_LM*AV0&Z\NJG=/RJ7M$2D1R?/F.A*E=1YB"2D
M))BVK];W["0,8 )8")Z=WEY>[R2''4O=T[IYU/\ J%%2*;7'IO#Y@8R283MR
M!C,R8SR5"L_4I9A"2E3EY!@."US#=XQ+\)8!62 !+:W:/69$#U86K=(!;^]G
MTF$H_ HH&P*'@^3B8CQR! AM2XBM5/E\W_WU]C\_H1;& HP;G;W%N[%G#Q$
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MRXQQ:[V+K6N[?<\MK*$G7VKR/F E)O-:1 CRD\ @@^\]?G3X_'_GAXL8D?\
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MS??UP>E?(A*6L"X>0[EQ/3=_;!K9=--VFF1<;BE*67"(43N<!4,0F)5!CYH
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MH)6E0<@.7#/K:!H9ZL6.,BF H*$S<BX!&@;;5]=CA2="6)A)05K)5D*34G<
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M>N:ZGH;98ZJHKV$*^ZL53II%(21\A0'CO(,R"E.V 02.E&:S^3J+J^<*)02
M&$WN8?O=W%Y)I\/XN4TW0H)"T$^]X#: :CTQV%^%+MYW"T_I#^PVH;'4.ZCN
M#51MI0\BH4:=#124>IZB4 $G:"53@RD1/7).*Y^IEN(FIS<M *))=@$DO;YL
M"SG';. Y8*X2I"_]>4@!P\@"3UMUV,8K1?\ X-OBLM&H=87&R=J:]=H<N%9<
MJ-[[Y:T^FTI2U%Q"?OH=48 (2A!)," 3'3VCXNX3F4T*2*P*TLE8YF8O>1N"
M]MH?%6S7!.()K5EFFLI424%B/*Y.^@$^SZXHKJ_0'?YVYU%!>]'ZS#R7E);;
M<H:E;3BPHI*6G IU.T9 2E201,1.;?PW-\*6>:I5I!RY#.PW+M+P;XK'$,IQ
M8NBFBHPB[2'ZN-I9]7O@1=[.=ZPPY6.]O]64C#"2IRL5;JBE:0!C<7'EM-$C
M@[%*)/B<=/OMW"5JY$KID"VT=.PT9P]\5]65XMEGK5$5 J09(]7!.C-#Z6G"
MO1>HN^6@+FFLTVO5-MJV98>^[MNI;?3PH.25H</ W@D$B,XZW&7X962:B5TY
M\T,7=V@6DV;46QJ.(<5Y@GSL0S/8:!V%KWTU(<68H_B3U_>&ONW=CM-:]?4Z
MP$5+]QM%,Q<E-I $HK*9Q"T+ $A0^:3,@\+:F2RB 2FN@$ J #.Y=F+F.A&V
M@PXHYW.*#*IK26$D]AL#J]VTWQHJ;S\-.H%L4U?V.U98'WEE3J;7<"ZE;CA^
M4H^\N**0DD';.2![#H%"/A5 KXG.D%RE^IB28MOTU<VJJIFJ"J)HH^(1R\[
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M@@D"&TNDHE4I.X [U_+^'(R8Z:TJ*Z_W4N=(@.-2Q;337ICQK)2"I:@@$WM
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MPI5?+3)DNY28W8 ?+6\82M]I:R870MKQ,J?2<\D[2 3*I,?TYZ'7Q6H2YK$
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M+32G0\J1K9SHT-8N[88:/XPM;M74WZS5R;6BBJFUIH'F$>I4AIP*%,IQ!_\
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ME@>@&_6]I@8*+;4,4H>:) J/3.Z!! )P)]O\?)YZ5KI)^+SI0D$ ),7+NYW
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MTJDA(I5:B5%2BI(40"ZB XU>'&NL8SL-=>-/:>5>TO5S53=%(IJ"L;)D-@
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M6<1=U\[DL"0!;1]6UD7<.<18]WM[D:G+[53JZ\U!@.N&LN3Z)($$EPO J(\
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MW@XCKGU7Q3Q'-9A50DDE3L;L^[LVK"Q+6 Q?J.71EZ":;.4I8;]0\[[ZPV*
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MG_="BY_'%$++K6ZZ(U+J2[Z"U)>[2S>KS<KNS3.5ZWJ>G37.J<^ZMLO*4VA
M"BE,3P,GJ[Y_P_D Q<!22_+RZM @-#B2_P".*_E<_GN6/-$DG<%S-G#VL27?
M51J/N_JS5]RI:_55P5<GJ)@)I7:I*GDLK3_$I*"49 Y3QDB#'45/@N1I(%0
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M=I*92 E=+H#34I2#(*K</&/>.!YXCKX9\;53F?%I )/WB 3#!RQ8V$MT'O\
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MJ^X%KI;Q=;76.AA5'6%AOU$*2E9"0O:%>001!.)/YD6)/!D5T%2$J/E?S0S
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M7T^\^PL_? Y=-.ZIH5@.Z1O+6[(4Y2.@'D$X0HQCS$<2>C_WID*@ 140D<K
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MH%PK,52#N"LD'UQX*_CL#*_C.^*M)2G_ .D+W9F)D*&N+T9/,YYGKD?$T_\
M".?#"<[FY<O_ *^J06 :SQV&.T<+)_=O#NF0R;M'_H](&]Q;<&[-BEU4XN5
MJPDD# X$G.//^<YZ#06(>66UM 'CK^>##*5?]4_488:LA:'!@2!@?0CW_P F
M.C452X( 8%K:-)@]?Z:8&*B"8_E,^A_7J-\"5Q4$.5\A1V6Q:$D#$O("96?
M!\@>>.F.77S$"-@UR[_C^M@:X=*CJJX^C"_ZOB)/2<:# 4/F])(($D !2P 8
M\[8)_/QU9* 9((V8]#'SZ$:;%\(JCJK"" /U^HT]K!=ATJ^_:N7MCTM,UBI
MQM"5R>9@$C/N>#TISKC,4>O/;9Z<D[MIL&&&=J"P[^75R;%IZ D=?;%%[XYZ
MUTKW8 !K:D")R/67F3GQ_AXZM&1FF[O"1\OZ>N*=G/\ 65._X]/[[SAAW%3Q
MF,$G'Y1_CT;F213H]"_K/Y85UI*AL_YX+]%-J>UCIAL"?7O5MIT@#DIK:<^_
M.23B.#CI1QX-PFL9?X1@;%S\\-^$-]II]AVM_0_H3[E[ @,:6TI39^336GFU
MD""A;5O:@0!Y$S.?H,=? GBX_P#" O\ ZPLSM_K%!KV:-M7)C'U+P!QP[K\.
MSF?(&O:1N?QP\.$H+)&2H^?$D#$1[>9X'5;JC[E_O#;0O<@GZMIAK0E%4?YD
M*[M9A?88V;S,P/SC/]_64EC&L3-SZ8@^!YG\W9O3"@%N4#>9)R,8QF.>/,^.
MI$KV$@//IUL>IL?;=*.4D^Q(:+C=_P"^F-)4D.+4%$@$ >Y&<\3)QG'CJ1WO
M$ >6![7[;0^)!(LS7T@-)&I@C4#;&,I422HS)X_3V!'6?*7))$QVTT.-@QNH
MIZ.! BVEIZOC4HI"L*..,>X_+Z]:EG@N/G]!C#'1E ZDSV=QJ-,1IK\!YRGW
M$Y92)'_[Q?O/33A1:N#$ CY?UQ@V (9N;Y ']?HXK%J%H,/DDJRM1\2 58B!
M[XZZ;E#_  B"S "=R"P?I9Q?;08!J02! YG]3S?E@;<*%)))D0<'@_G^?T/Y
M=.0F7=(,$S(9W'S+@XTY5=A>XTPC?0A#84VD!6-Q.[!)'&8/GR?K!Z\HNDC0
M_=;4:N]FC2^XQ&L$)=RQM;<;!\,]6%#:(/OYY@X_/)G\NHP7MZ_@VC-/M@=3
M&"_]6M:8>VV,$4X()<*@!_L^_@21GZ^WUZ\_YS$?K^K8U"!J3Z8UH<0RZG:%
M$$P9S !\0 2?/&>('62'#;C&P 2\]WZ/^M<$3#C:RA9 #@.T A1!'()@3]",
M_I@="UP0#V)>(?;6[V(Z[XE2[%AH9LWK\],2YI\"GHD.': \5[N9 "B(2"<&
M #F02?IU7LV?,>I $V8 _/;3!] >2 2223KJWX6TZ8D>RO(6VM$N9$(4A&_Y
M8@%02#$@Y&))/ CI)4H5%$\H4740&%[LT&9/OTPU16I!* 2'2E(/0@#<Z?KK
MM<#38J/46AN.77W44[0B"/QIW# \JG\^LCAU==J9)/3]6.L/9P"^,G,T@">9
M+"[D=_S?^N(CU5?]#4[E0]=M46.D4XE146ZQIUV0#.Y"2X50") $ST^X7PS.
MT@DK0M!=V;U#D_CA+6S=-R.8':[")MT9V9P\[0+J#N5VR89-.Q?EWAT+*66K
M91ONK)W A.\H@',D!!F",1(L"&IJ2*RN5+N7(9IU#R[3NS.+K:^8-1"DT^4*
M5RA+DN2#+"P+6VB7? (O^U>IZUI6B^UVI[NETI:9N1M]0PV%$3)>6&T$#Y>4
M@G$'J6KQ'A-%8^-70P'F<IU9S(C5R;:7?$-(UI#I![N6>"1WEY:7ZR'9^QWQ
M1:L0::J*='4"5;/3JZT(<0T1_P!(IM#BE*@".1[ GI7G?%/ \JI'V6O17S<P
M48404@ <W* &8QW.&.7*T\Q(8AF 3>^I#GVZVQ)=C^!1NK4Q5Z[U]579U"PI
MVGM[;FTJP5H6[4%R2<B4B#/&,UC.>,Z"5%5):5$@QY@#H& )OWT=Q?&*E*M4
M4%!P-_GO9]"Y=WOBR^A/AJ[6:,=?<H=-,5=2MM/I/UR$OK2L;?WX!"6P1M!C
M;R,D2.D9\99A94$$ARX"14&[7)+&(Z%AC9&54"Y<PPYF$,Q#-(TUW=W F=&E
MK6B@J+:BI^XM%I?JNV]EJG>2D20E/H-H6-H,23F,R>AJG'^*UR?A\ZA!/E5)
M;H=-#<QO@RDB@@-4N06$-?0 :-9[FSX8;7I;1UA2JJ?O%0T61ZRZZ[5#@;(,
M\>LI *E23$J_D".E]9'$LQYRBH34)4K[VK$F;F&/7IB==6BD!B+%G$MH'AI+
MDQJ\SA%<NYG9VT6^H_;6MK6Z%)*DTU(M575;DG< CT4J ^8>08CGQTTR? N)
M5PI(IU'*5 $,&Y@0[D,+W^=SA<O.4^;E"@05<MG$Q=^NL".V(2K?BQT9I:BK
M*33-+==0J=<6:=QT>DA!,[8W-MK"$R)_B !$G'3K)>$<^DI*TU(*7E%HLX;2
M[FPZXU^)2+R 0S.2S0]G&IN!-]<5SU+\4G="^J*J4TUD:<4M/I,>L7$-Y*%;
MUN* 4<3F,^_5LROAJLAB2K_WE P;_=AXZF#UQX5*"2%DLVNY9FD;_B)Q6S4>
MK;S<JEZLOMP75U2MRA4.+6' 29VC*4[8/E,XYR1U:,MP-=/E=1# ,72WU):_
M:]CA=F,[0(*0MCL6=QK[L?6V(2K=94Z'GDOUJ#!6!*B5"(QB8X,[??WB;!2X
M-5J,4KJ/JRD@-W;IZER1LM5Q>CEQ4<H/,]@38G5[L;!F^L/7S7S%-4U)I'U+
M27#O2HA:2J3F52L?+M/RF#$P#/3K*^'ZSMSU9DL4W@&X Z=]]*WGO$%(N.6F
MSDV+$/I)(]A?M@:8[C6[<I5;6)81DEL**2)))X/DF1&<F?H6K@]="R"M89FD
M/O,[Z=C&%R>,TEHY@E <EI(ESU!$:&_5L9'NC865)4Q6LD@G*U+<\C)"C] ?
M.1Q[&4^%5>4.5@O9TV>&-Q+_ $TP-5XM2=3)0Y&QT#78B>CZ[80U?<6DK5EQ
MI5(LY,K:0H'<2<!0/L3 @?KUX4<ZA9I@**4DA+O80";!K&.K;".I6R682E14
M 2RB'%S)OH+,WS? [6ZET]4I)K&K8XH@CYZ=GSDC*<F3 &3'&3T:@9\OY5$:
MF?G^8M&!UT<FHE34]C:S:0SEK$?B\0:W1HVY62O4Q;J#[VEMQ3"D-(0H. S@
MI',3YB#[QT[X6<T%-4! &_,W<]6_40MXA2R_PFIM8V#,WH&@^^I+-2YVEJ X
M*9"2D;E+V 82%$A.WZ#^F8X,71^7+"Y)*27@P9!O<CH]KXYG6H+7FU)2%-YF
M N2')^75VZ/C<Y;'"QZ?[R2H'<0)2<R4X\ Q[Q^O6M*LA!)5R@:/#D-U<C7I
MMIC49*K\0$!3C2&$,>LOV.DG!A8^WRKJQO6Z\E<)@K2#)43) " <G&21&>MZ
MW%LO2Y0R"\ZZ,WT/>V'2>#YC-(3=)0S@@:QJ;!B?POA>_P!I[FE1]%QM20("
ME)*5 S^7Y&2(_/'0YXW0+>5%C!!BT09<MI\PV,_X;S#_ 'B1K($]'#-I!O,/
MB0.T53J#L_J>OOPM-)J)FOT_=;'46ZJ4D- 76F73&KA8$NTJ5^HT6R-JDC<"
M29'K<0R]8$D( -V!#,P.L]#WT&"*'"\SE2*8YR$R=07D6?=GW>8Q'^HK?=[D
MY0^E:DT#U+3)IR65K]*KVD_ODE2B5;Y!!^7\ACJ;(JRJE.2D@Q+=.P[3T9WQ
M#G_M20W*IQ"F%NC-8W?N3T&/V3J]A\>E2W ;8$(6K:2!C@B?$>_GJ>K4R1)!
M4D,X=P?1V]-G?> 4?;=!4D;'\8<B_P".CBU7=R*!Q'W9N[I^9,;0H@&<$G,P
M?'GZ]!KH</J$<_PPEP[,0TO!=M2_SP:E?$$I=*:I4P*7<SH!)W8;8)6.Y'=:
MW#:Y^U5I0<AYATIYS"DP(GS/Y>>M*G#^$K)":B)$,I(+%RS !XTT+=L9I9[C
M""DKHU(N"E;=H;>>DW.%Z.^FN:=835TRY2 "'&7A]025*(F1](G$]"+X'P^J
M>4+"MO,C3TL.[/&F"_WUQ)"0U-:51I4ZC>/;H-<.J/B+O#80BKH0N3$H0X"G
M_:4K/! C,@D$\<1'P[D-.4_^\DZL+#O[1IB:CXBSZ'^(%M%TJ+R8'-WL_2<$
M%)\0=*]":AA;<@3$@@><9QCR#].@<WP-%(H&70E0+\W*Q8BQ.OMM8@X/I^(/
MC BNOEY2P!"A!N7.@(]-,/3/>_3+Z%J<=?\ 41P%21!_).!SR)GST'^Z*X,4
MSKMOL^L]L3?OO+F2M) T)4Y.X@W-X],*D=V=.5)4$O[92#\^Y,&!CD#(^G]_
M6XX57_RD781&H:^K]8UG&1QF@[_$2'#$ F[%O;UMM&/U-W)TZ7=QN+:2)P59
M&.#'MC.!^G&?W57$\IACH&8]IW)'=M,>_?-'_P!:"+W,COUP9)UOI5]I:S>:
M4+<"<)).<0,@GF)_7C(Z 7P/.CS"D8)/_P"$[O87M86F^&8K\-AZZ'+$>80\
MZO:7=]<8-ZFT^\"A-WI%$\)+H!/T!($G_@.M/W=G:2@L4UJ8N 1=FT<M[OC(
MJ\/48K4YZB.P#7M8^CX1U%TM*U?NKA2J\?*ZG=^@W08G_".IA]N(G+J<N)"@
M#L\_)]=SCQ^Q.?XR6ZJ@PVB?I!PF=J:5;8(JF2-R>'$2.8,C@>_/Z=>-#-U?
M*ND4INX"A8QJ7]&][:J3D%#_ %J&FRIC0N"+[:V?'YM*'?32RZ'5^O3J*$+2
MI7RO)(\\$R#&<<8,DTLC6!#A3VD#KT]M!J\8#JTLB 2*X,FY22)[-/HWT_J(
M_ H5GX,?A:*QM7_H'[8[A['^R=LGJ^Y1)1E<NDP4TD C8A(<>EL<USX2,[F@
MDND5ZG*=T\Q8^WICP5_'2A1^-+XK#DC_ )0O=H__ -\WLCZ?XP??KC_$R1Q'
M/W!^V9I]C_&6\O)ZWT>V.U<& 7P[A_,Q R64:]OL]. U]7-G>XQ3.K;4"LY,
M?,/?</)B<>8C'GQT$)8&Q43)O:_7:=>QP56=*BE+!U,>Q_E'7;M@>>"OW@4@
M@;%F3/(E0_P\Y_IT4@P&ZOOT_71NPQ'F+EKL-X#CY%Q<7VP,UA!1>BM24_\
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MZ$!_KA<MTJ]+>A0"5  Q@<&>)@?K(_+-=S'E51 EUID3<CV.C;##7+CRU/\
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M+Y="OA4PF%BY+!E3.MIWP,JDB5,7$@N8(8C7<6M[!MGSJ4M)@@)4!@ 9! B
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MZ#174@)99C_>,;7,N#_5V9PJAEE@@I07@Z#T8PQZ7^0M=]%Z=JG5EZVT* 8
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M X3GG',#'N#!B>B$<6"DS5!=P! <O!V(]=,#KX$*2C3^$HM+A1EYOI:\V;7
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MSJ004.O$%I*TGRE?(,R0) (@QU+3R5;-N0DW =I/,-MA9[^N-Q30DN6!/LS
M$NP_M@0KNZ[J'7&*>MHJ9I39(IJ1EM*Q,C#@"8)'$<8D]'9?P_7IYA)/-RL'
MN06(=VYCZ:RS"\2<TBA6%$%RKS @!A)$F-M'$ /?%/OBOKT7WL]?[FZMUW:X
MA!^\D.K"0"F%23 Q\L9XY@=7[PYDZ=//H342API)8@?[I#AKG?J1&$OB2I_
M64D@\KN_0&&,O#SH(?'%-FXUU&X%T5?5-*1&U3#[C92!,)&TS@X XQS[]OK9
M&C4II("?,D%@)=GZZZCO$8Y%]IJ(6LL7"C.IFY+LH[N_>^#NR=YNX5B6G[MJ
M&IJFA +545.@1C9^\69Q(!',G..D%?@Y749(ARP@AG-@;7[#:V&M+COPF"E%
MP T_5M8N'GT:9+'\4=>EOT]2:?H:]&1ZC++;;RTDP?4402D$')/O^HTK^'JA
M2KR!F+@,"7T$@F==?7!*/$B'3) )F3'66#,V_P!,2I:^^79^]4Z?V@FLTY5O
M+E8]-UQI*X WI#"5@@I$2G,'P.DE7@%9!YZ=,H*0X(9WD.]YD7]Q8]/'\O59
M-1<*$DN8W#NT]Q8#3![17;MG>_0<M'<>TM-$%(9K5.4Y"O*#ZK205&?PX)&1
M@=#+X?FJ<A*E$P1W(.I(80TPYZX:97/</4R@I!<'Y-MVU<&3K@B:T&_<VEJM
M==9KRV2=BZ:OI%+ (P$)4XA4JY &3_>OKY9,#,T6ORE(!!9N8F!TT,Z"<&55
MT*@0J@1<\S3$,[^K$$_)\?$:'U#:00]8ZP(.0XJG#R% 3)0I'J CZ3_B.H/A
MY2E 2$DSYA(M:(MB6B"H.Y+0PVU=IVD^F^,VZ=VF(4JG=84GY2EQLM*GZ)('
MRGS C$'HNCF:*$E+(47)TC<%[6.S;8E5EU+(()$-KI,ZO9X.F'!H-J"5+4E"
MY)VCD',YP3(.?UZ\JM1J&&&K!M#%^[[;-C7[,3<DRY>X:)<Z&Q;48V*1+C<9
MP8B<@C'_ !YG^\;XA#LLL'%^K:;M!OM?&Z4E("7+B'UBV^%](AS ))DP.8 X
M@^1QCQ^<=:\[QS$O>8E_3I%B6Q@V+G1OE>_U_NJ<0I,B2E6.#SF!_GVZR]@;
M _WF_P \1VEW=P7O/O[A^NV$M0P"I,'8E1&X^_G/Z>^ <_3J9 YF$$S86U,0
MQO&K0^,TVYTO:>Q@[Z/AENME%8HJ00/E,P ,9@9R9QT2*J:8:['\)O!MOW%\
M;U*)J;,H,0.WT+?HL,1+=]*I(>E"%;B9P"<$X)B9R/K^D]%4<X4FY+:.2PF;
M/^F,87U<GRI5Y RA$,Q#'?1W]().(9OFE4@.%6V"YM(.#F#G' )C^7M'3[+9
MSF8$E))=K!VCH^^CL^F*MGLGYB0D,0;AS#SL7T87ZQB$-1:=IJ=;@"T"%F&Q
M! )Y'!G/)_03TYI9CRAE.SR_4]M]^N*Y4RPYU I'9KQTGO.O0C 4JU4ZS"4H
MW" 2$CB.9_4?J,>W1]+,ZN1=I).Q:X:_KJ[XT^S*!!2(9NHU8A_5^UWPG<LZ
M404G8?, "<B"8'(SG//&1U(<SU)U$F6?IU[3C'V97^75[2\WF;[[]'^FU4\A
M2E)44@9('C,?SZRG-J<#S,XAPS6VV_+&1EYN"'$-+;:8T/L!M)2RK;,P$PG,
M_EQQQY$#F>ITYD\S@%_I?:6G5Q,Z8TJY=/*62&LXU_4QN8+LXVY2.&HR%*.3
M@3X/,Y)_*?Z]$4LRI2V/EO)< ,=V:;/-\ 5*(2/N %_>#_?T?3&UJ@67/PE,
M8W%.? "8'C^G/Z;5:L$N[Q!TT/=OS%L;TD)!A-P]OZ=_T,/=+;DJ4"8*DP4_
M+ )!\$8,@GZYF.@BHJ)<D[R_Z]A;!"D$@.[;#<Z-O'X84+I74J4G\ )X$?,!
MY/(^GZ9ZQZ ]W_ C&G))=]Q81^N@Z/A$_2J"8Y*>">1(G!C^4GZX'6/B>?V=
MC';M'OC')-X^?Z?]'&E+#ZDI.]P"!R0!_+D<\'HI%0;.0&V+=3+XUY%$L 3Z
M,^,DM*2023N]^23CGV/&.O5%\P;FAB&)CY/[-]<:)(=GES![G]1AZI+B_2I'
MXDXG),1DP8G$#Z?UPKK9?XI8)OV[OZ'3;!],\H< =F/RM.D1\\/3.HJH %+L
M$@Y2OD \"1QC@>W4(X>K8$;$#Z0?T<2?'41 4_4GY-Z'MZ8W#4#RR2XI2H\R
M203Q^7]!Q^1T7D% .$B2!_;73M[XQ]I*6*QRB \MZ_/WN,(ZB^A:@7%D'P=Q
MS$CV/'M_7K>ED5]FV<EKZ==#;'OMJ'@O^KV';\+$HG+H'5)*%Y1@E2C/T_(>
M<C,<3'1)R:PF;#T_$=9;;?'CF:BR#1=F\W*2SZ._X=;R,.=#7%:_G5NVI$$*
MD >\@C_=QP3E9FD*01R@LUY@R&/>\2/3&#5S9_E61U,"S]B)O-RV@<TO*>4I
M(4J2(.8@# $F3SB//D^.A$U*H 'F]YO(9QH9?TQLE:BEUI(78O$7$C\&VTQH
M4V&EE:D@Y.8!G\SC\\3YXZV^)6?[IWF .S7]OQQL2D@$B=&Z2QC6UB+X?Z-Q
M);G$D@8R3..0,<^8C'GB"J*FBE0'("MI#S[]MC@Q*J+ GE&C[Q^,A@^""CH3
M4$ SM4(4#/!Q!]Y^D_UCJ%&8J(6EPIB;#KU<M\AVQJHT5)+$.UA>>WYC8[8$
M+U;Q15:B&R$K*H( ]B('/'.>G5#-++ DL=7N(+RVTX$J4J1$\I)EB +FQZ>O
MO&!A5&Y5OBGI:=3[[IV(;#/J*5,"$IC\7&>1(Z9_:A00*BE:\H+EGF P;;Z7
MP-3H(-0@A(\IEFUWV<]!#N,'3'8KN*ZQ35@TI4MTSA0L%ZG2RIUM:D2%;B"M
M!3F#QSGS!5XVE) 29!/\QBTSUMMM,'UN&)K4" !( TAHM!+WAW9M,?TP/@CH
M:JV?!]\,ENK6BQ64/8_MM2U+)B6GF-*VUMQLP2/E4DC!C&.NC<.J?&R&3JN3
M\7+4:DW\Z J??''.)4_@\0SM+_U69K4__O%E/X8\$'QWGT_C1^*PQS\0G=>?
MK.N+WGW''Y_3KD_&HSV=+S]LS'_XY9%G!NW7U)QU[AI(X=D&<?Z#DS$?^CT[
M^^*>5;H)6,9"H XSY_.)]I'0V7+TV@O>QG7K.OZ8X72Y<=?-T[R=^AG P^M"
M=Q<44@1PHR9@X$\2<GB"9P.LE!^H.C,^TB/5\!UB>=IL WS]W_#$U]O]#4^H
M^U7=;5"&=[MK;:!<W@I])MEHD $\\;MHP ?UPM0I!)43]]B2][QI!WE_;!]#
M+_::2T@%PE2KL2 &(/I U&*7U"E..I4AI0'I)R!*2 I0"@!(*1MP?;WD=6K)
M9D? L"&Z'2P)^CW+/&*AG\L<OF2"27+@/L=)G9IF-6Q+W;I?IZ3[HN$D)3IE
M()\273_0GQ,_4^$V95\7.T@'/*5,0&#DAW8,;3>"V^'>65S9*H''E2E]0))[
M6UOBA%2 'W/PB2LP2$Q*R1@P 8'\CCGKI/#F1ED@P6>;6 :=)?ZZ/SO/3F%[
M\QMW8?K?#>3O4M!\.('Z8.3XCG)_D.M,^DBB5I>3#':\C4V<,]KO@-+_ &A!
M+@;*U<02#$@#23/?TI?8KHM5C[1]RM3)T]055U3KMI@7XT8>N@93:TS2T-<4
M M;9@)03M)$2H@]?./[6^)5:.0J)YE>5( /,H$#F#:_6)D-;N/@7AJ<R$E*4
MEP#"4F_4"P=G>-,=LF]4:.U454U51?<E.)*2^H*15I4<%2X&T@&5*^:2)]SU
M\S9P5,RQ\Q@*)!+Z'28AF=\="SE#,4FY.8!.B3$.XB-I+.VS8T5&F*1+:EVV
M^6^J82"4,K<0:AL@&(!S,\3B0!X/0E)(I\H/_P"$=XCF$%G^>K8:9'B8R^74
MBK]Y2"+?S$%G<>A AG+VP/NVJX(!2FG6Z/\ \5#94!!\E (',01Y\9/1/. 7
M<$6NG7O#/T[#8E'$$U& Y9]+3L#K=FO+'#=5*?9:]-T%,&,I(,@'W$X\SXF>
MMD5$I))(^Z0'(-S[&W3JV"7! 4 ',F7,ZM8?,3&F$%4@_LYXHE1^4P@%2@!)
M^8)D@*\?7\CT3EZU,U99GL#UG\MF),#& H="9%FN6O\ )H9QHV !-:W]Y0RM
M82M*((/RK!"C (P9@9Q(_+E]\3+J4@**0>0."6ZZGOTN+XQS68LSR^G3L7F8
M./E54^M5-)2%*5N2(A2CS/CYL>.2?;@=19NEE5 ?Q$N!9*I<Z.-?[[/GF.]I
MG3J7_'5]7PMU!9;I<44Z:2BJGMK*-Q""AL$DG\:]J4X,Y(]^.A\MF$4$II(+
MA)4SEW=RWJYL6C<OC0J)7>[ /MZ,_2"'-PY!9&='>E!NMSH[4VH J#CR%.3!
M*A 4HRD\D>1TSIYNJ0  ;$P#T9F'HS.^P&/,)@."&8!V?79_D.V'(*T'9D>J
M'S=G2,G>?1.V#!((24*X(QCZ\3"C6JLWQ#_]]K#%]?DQ,XV6())2(-RD%@[:
MZ'J69NN&.X=TK50-.L6A%)1X*3]V'K.(X,)* K:3&08@<9YU5P_,F13J%M0D
MQI=C?O? P "TN2;R[Z%K.'&ATG4G$<73N?5+:2Z:A]:OF"2Z5)2>?"R)@03'
M&>)/33)\#KUBD*IK8@G[JG/4P6+Z$>U\:5,U3H D$.#/,0P]7,B(O(F,1AJ+
MNU2I:*KA=[:P4IE:15(0Z$ID[50H@$C.?(SF)LE'PN4!*S3(L)2Y(:?Y>:&N
M\S&!#QNDD*!*(&@#BUM01MI?$%:@[[:4I4*<I[@*NI0HX]7UDI,B G:( ,R2
M1F//3[*\$Y&=)'*4B4LSC2)<_P!6;"[,\;I*8(4"9<2S.&B)[DZ/B,7^\]_O
M50IJR6JLJO64IL+IV%K$+P "$'.?I].F(H_9E*20G_5NY U>UV]QZX6*KG,)
M%4<Q(7RN"8[; /U?$D]Y''VOAJO=5>6':>K4V''VGDJWH$&%$$$I B9\'G/,
M7"5C]Y()Y94 VK@AG[P^FS$MC?C"2KAYU:D;O</H7,Z#1HQQHIJMNK89>:(#
M0J'2%$%/[O.V9]TQ$P3['GKLN8844B Z$]-/UWQRQ (0D'8?IS?]=\;4D*2#
MC!$^<'W_ )_TZ7T%L=6D$7.[S^BVV-B'&G1]\8E2I.$G\XG&,_+T;]I!AR='
M+M[NTM\L"?9R/Q:WL\]F],92HB?;S''C!'$S'7OBA9Y6#GH"20[:F8/9BTXD
MHTU)J)4; G?4$6,7/<:6PMIB$EM1$PH$9(VJVX5 \^)CSU!70"+#MR@LWXW/
MIMA@"UO8%A[#^AM@GMFI[[:5K<M]WNE,H+!VL/+0D;9*2/G^8<P>,?G"]>0^
MU@@)!Y!L-6V$"+"7&M\$4,PJB2>94@:J:#JQBY^>)BT[\2W=33I:VZ@K*NE3
MMEBL/K2!'O) (YC^>.DV9\.U"2Z.:Y^Z"XZ. 1)>]]-VE/BD>94!P3S$=G+A
MR"7U@]&$XV;XP_O6P:PL-)<D$;-[;:4.H3 ,R$I,969GDXXD+QX=J!)>FH$D
MF$D%FB-1I8_AAC1X_21Y2HS+W9](5TT#>\G5N^('L[?'$4]2IRP[_F+KB5[4
M'. H)(,DQR?TZ6YGP[7*R$H6T$,2XB0T;N([ VP;2\14096&ZBWN7EOE@TH=
M5]LKJL)M6N;$3$H+]8A"]I!PL+*861@C$3GH8\&KT$\O*LD!B"%&TR8U+N/Z
MX+3QW+U"1S(-V8@$F-BVT:=@<$S"670105]NJPH$C[I4L+W)SD?.%&0/ \S)
M\@KIUT,%)5,%TD1W9AOVP<C,4ZC$J2'/^9(CJQO/?ZCXJBJD_BI7%Q)*DI4L
M"(R2D* C!R8_2>LH-1( Y21%MOUK&"&ID-S)<Q]X/T=^]@WI&&RX-/ME*UT[
MC8P I25 9_,<?IGHQ%5+!-0,EF,$$"9=O8D@7QI4RZDH*J:@I2= 7V#09+[$
MF2V$XJ&@PZM2T@!!SNF2.03,28D#!YZ& RRU@?$$O_.(V8 E^C][%\9-7-)I
MS37 =R@C30L1^K0,0[JC5E+3.N(;J$+,$;4D&"GZ)F""")/')CJP9?*TDI"J
M2DJ@.>8%F]-7F Y$#%?KY^J"L5@L)!\H*2 Y,WEY8D[BP.(#O>JUO%_8=PW*
M$!)C=R!QS&<>,DX'3&E2"6#!]"?FVH]9EM\5_-<1<J8GL ;/,B(;2.M\0Y=*
MY52^XI0.XJ,SQC B1 CC,F>G66HA2$F "[2^I>7]G^6%"ZQ6HK(,D6N0&U8'
M\(WPSJ2"HJ'T/ZP,^/Y8'TZ:4J,,X:UG+:R''NV,?'"6=DM8%WC]?TQ@ZC]W
M)@'D2<^Y.9@9_P .MB&*@$B"7+ R'U,#1]0TXP2#Y@0QG]?KYX1'V.)_K^7O
MU&JQ['Z8\;'L?=BWSPG*9!!$"(DX 'YF(\=1TDD* )( ES%AH\=A@?\ 6^&Y
M^E+L) )&X$* / S$B?$>_P"O'1PK"F[$.>S_ -O;Z8TJ(*TE(U(_MZ_VPLH[
M6L*_C,XF%23(]\'V)'/D>XU;-@_S@F[ B#-B"_I'><8IY93R]G9CT>6]O88)
M*6UN*,AAQ60!"50#[3M'MX.(^O0*ZX@<S![D]-GM+0^QVP9\(L&!>9;4'K[D
M$6U8'"]=J=$?ZNX/ES\JL&3]# _X]:?'&J^LD'IUVQK\)8+!)(WY7<](,,Q]
M<(WJ%8D>BHP 22@GGQD>_&.8ZE1F4I2)!()<]B[QT_0QD42?O!CLPT<6.A!<
MQ9]VPG%(L 0@"  ,' CCG'6_VD;0=U-:SAL;_ 3^G_/"1ZB)Y009P0@SYSQ[
MB>?Z'HBGF$G4=7(-V&Y?]3& U4B# !!+L WS%G_N21C1]R('S!<P>4F/UD?Y
M_//1HJTN4GRNQ8Q!;T;NX/ICW(H$,"!$3ZZ8^"B4B5)3/L )^G@9@?0]"FL)
M',D'JH>D?3$O*H%P&]0?[X0U#-0F3Z:P#B0E0Q^?!_GB3CSUFG422!S)(8W-
MWWN79VAQB',)*J;,2>=)L2[<PO<N-@ /7#74,O*"?D<P3X)''GD?S^O4_P 1
M";%+QJ3ONVMM\+U4S'*DZO?IC!IE:4JE"LD<I@1^8$ >YYXC,=2(J @AT^AC
M2;W#'\<82*J(2%!^IGYZ=.YC#O;VU*4#E/SQ$'Q&3B8CR?UZ69NH'TL\RU]M
MH#F<'4!44/._WKGFM/X[_+0U88RF1MQ[Y\_F3X^GCH!*TA+@R)C=][;/TP:*
M9Y0XUL8,VT!UWOTQO>1"1 F/,8X,"3/^?.3UD5 =-=&/?3Y,>V,_"!B!?N>W
M1Q?8'>=E(PIJ3M))DP),\X]\8&/SXX#K6O\ /6_TZ2VIQBJDL !9I OOW^L[
M-B5+#3"J52I*=R2$A42!&,&, G,@P9\>.@U@ .]AZP[2SN[&_P".#,O2)062
M2=(VV@]3L]^H[KVVN6ZO!#"T-K0/F(, *&" 1D$F)XYD]3T:B3RR#N 0X:^I
M+68-;0ASC6I19PS:NVD&Q9O4;Q? 5;[J_8:MJNIDMK>;4%HW *"3((4DQR"!
M _GT?4I4\U2324H <P4Y4TAX=W<N1UP.FJFD28@%G ]+N!;^^'Z^=[.YES4E
M"]0O-,?NF664/>FAI(6@$ #'X0!B"('//1-#@V6)234! 9F4DB?7^W:T53/6
M/,P?=HG9A)=M-]L?TJ_@:JZNN^#;X7JVO=+];5=BNV;]4\H[E.ONZ4MBW7"K
MR5K)5/F>NH</IIHY'*4D$%-/+TD):0R4 "?3'(N**Y^)9Y?^;-5U0S3448:,
M>!OX]7TI^-#XK)4 !\0O=A).29&N+T#//GGKD_&?-GLZ$A_],S,";5EC2UAT
M^>.N<.4!P[(!Y^PY.YVR]._5Q^.*9.O_ (CP<P<C\IG,#/,1QYZ%R\ !4=%3
MO[GKO@T*2"/,(9SUUT OJ/1VP-5SF]2SG:(5(R2$Y@&)S!$1[1T:E(5U<D^]
M]C^M6&!ZY'-S P][7ZR/U9WQ*G;CNZ=$:,[F:7KV$KM.J;>IBD4 3Z=4]3H2
M"L ':J4J$GZ#!,]8K9551"0$D^8$!G!9WLP@$3TO&"*>>10IJY5@JY2&!D./
M0L=MVT8BLQ0IE320#L53H"1!@ @J2D@"?)$<F,CJP9++)1E@E<$.[F'WLTOV
M87G%3S=:IF<P2$$LHL0-')WEF<@'4ZWE31:/1[>=U'\_]7V4;O91>68R)\>8
M.(X Z75:(&;IE+,Y,:AX^HL^EVP\HA*,G4"H)"(L\V;:??TQ0&M4%5#AYS_Q
M]I)R?'\^KUEE!5!(3) <@7L [;?KH.=Y[_C"B-S?62?:>KCWPC&?6GC<"/$C
MB<YB/;R,9Z(J@')!:SRH02%JL$%RP4>OH#; N9'*E%0$$GEMT@/\_P"K''=_
M[&-S5#Z.\3M/J6I8TWIYJV+5I9X)%%6W:ZN$HK65.0A+@IV%@D$*$03/'SQ^
MU_(TZF0=P#4 Y)^^5$$ 02YZ0S$S?M?[,L\L%"6/W3\@>Y9R'9B\O&.Z-KNE
M,2_45]O+)80IQRIIQO2UL!5N5M*@4CD\8D^>OF.G3(_UGE9Q+M#@F-AVFPQV
MRHFA6^\4I?4D03HWHQD@O:6+U1W.W5S@=MU2AQ2R5*45!HI P5%*MLQR8F (
M\@] YE!YO)YI@C1K%OT)]PE9*@>;S))D=XV]PDP^Q(P1L7FOHU@-D/; J6YW
M@A0@DQ($9(,XB3T*I-0"4*#]&D:W9_T)QA&613+@ D1 LX:W6T;=L**B[T#[
M80^RENH<,J)1N2D>3!$#)Y$?43GJ)55*#)+D-N9ZB+LSEX#'$PYP#Y3I*7D2
M8&]AV=NK'4#30"J==VID.NX45.!!1$R$A.51Y!&(! F.I\NBLM8^&A9! D Z
M]F%^H)EHMXJ6Q=!@.W<S:=YAY?5XYN]Q[<69U J[BJK?#BOF8;<2"X8'I;E)
M (^7F2(/@\6>CPK,9M=-;J3R@)EQ8O,S!T?WG&AJ%+A7EAR]V!/1R[W/T9Q&
MH[N6RDJT4=@L=-\[NT552 M?S$9 (.1('N,8CIX?#J_A@J5,CT&ACVAOGCP5
MS, YTL1W9Y]/4:G"+6NN]0--M'U'0W5-)7LI@IM*83$)(($B)Q[P<]:9?@:_
MBBF$N$EBIG$AW!?1Y?;$P!"03!;H-9&_4,Y$G;$*7+5-P<:]6HJJ:F $I6^^
M7%*2<A2A*H)@8(!!D 2.K7E/#Z$@%2"'9P?D8.QOKC!J)EBP (<G6=YTB0VM
ML1I?.ZNE[0C;7W05KZ@I)9;>])E)(P(D$ Q' P??A_E^$44EBD .'C27)[/^
MGPCK9][*=B?<2Q);3:!#8AN\_$!1M-JI=-T;16XX0ZMEMVK?2D^VQ*U9484>
M(]XGIO1X7DPD@K2&$;._;E@:]P[O@*KQ%9?D/,N.5( T$AIAN]G#"1$UXU3W
M1U0\K[E05R*8SZ2UARE3M)(D%>S@$F(&)'1",O0HET%) #B6<] VWZTPMJU\
MS6+*28L]A+S9@18'#50=L]3W1T+U!>%TX=5+C1=4YNF#LG(R)DSXSGF56:0A
M!!)8%W # :7^H+] T1(H+6ME@E]-W+'9X,Q+G$CVCMII*U'>JC%;4(*%2\O>
M%*1,D-DRH#D@ Q DC!,)XBDGR=?P;V]-,$?NTEE%,%R=8T<%RY9V<6)%\25:
MDLL ,T-'2,H)"4)IJ8;P21_$E .^.4Q/!B>ALQF#45S$,0BS72Y<O,8-HY4H
MH@ $O58EX=@PO^&N^#;O';D.]C=34E4RM]"[:^I >0I1"T[EJ!D$@)R2#$1Y
M('0'",RG]Z)+@>9+G3L)9[09UQ/QFD_#U,Y\BGT<@-J9)?\ (XX:^E34Z54X
M2D))4X0G\ 43^$'Z$$ <#@QUV^JL*HTR""Z$D,;#E#;?KKCCX8'E#."0UV(/
MZWZ/A$]+#"E@'"2X?;:!ND_I'Z?E/0V7H+4IP"0_NSLTZZSTQJNHA$+4$][B
M_P"IPSLW^G60AQ&V:=3RSB?E$D@>/IY_2>F?V%08\NVD"7T)ZW#0-\!_:F_F
M!#VZ2Q)-V!V,V;1S;K:-]M!:>A2D>H6R8^43*O>,?W>_7CEB@A7+;4:QHW?7
M<XDHY@*J(!6&/6'9^V]H'MAQIW&U)1M6D[H(@C(QD?R/\CT-50H)(Y2_;H<'
MI(NX9F^2?R,VC"[<%**DDD*"8(!@B2#P,YZ'IJJ4N;E0HDLX /4[,7<_GB8<
MC$J4! 9S?M!LVL,>V,E*/"I$0<I*<YXW >.?K](ZE^TJ(/.""; S'S;]-KB%
M:4NZ#S S&G]/EC &<S@"![>_'O\ 4Y/]3'4S(+ ))8!X9KM>1N\/&CXC1245
M$DLY+!I,ZOH<9$!7I@B849D3&><@CZ'\_>.HQ509(8M+B=QW@..WN4BFD?>4
M/R)W#PW3KU?XO<V262ZPJ?\ I&E09S/$8_SYZE5E*-5(46\S$OUUT?VO>QQ@
M*^&24@F2[7(<G2_1XP\VW6.I;2ZRY27NI;#7S2EUX1M!@1NB>(\>#]0ZW LJ
ML$[ ]='T-K>KOB=/%,Q2#@K+6@BUWTAK%_2&DFU?$+W M("$5[E2T2 YZZ\E
M'\6#DX)Q/T$=!*X%02DA %B!TCKUV?KO@FCQ[, IYC8AWL&)=Y:=^HN;3#:?
MBT6MAIB]43#H! <7&8 S!B(X$2/H?/057P^*B2EBE_YB P[]^Q.AN^'"/$2D
MAQYU ADAP3U8<MMNCVO)]M[_ /;:\(<;JW6J%+DDC_O'R !  !Y&<#'5:S/A
MJK37S4Y/,!#@3OJ7LQ'J-'=#Q)273Y:C @6,&&&C;[$D/WP@J[=VNU I3UOU
M52-OU!4M2'*EM 25CY0-Q!Y/$X$#P!U+0R.;RP(Y%J<" "P">A8-I_9\05LU
MD<V#S5*88DR0'YO4OU'0ZA\ %U[,.NE2[7>*6O2ZLO->B^TL!)@ 0E1@R).,
M3'1::M9 93N[D$%XN#\KSOU5U<AEJA*J:DL;D?6((8^^(RNO9S63 <=:M;M3
M"E0IM"E[@%&/PR# \P?S X99?B=.F@(542"Y+/(E[#0@BYDX@_=G*@<K$M8,
M3?J3)&EX)WP!UNC-34#H^]V:M:VI!(-,\ $@QF4 Q(\XF>1TVH<2!$+!.SL7
M]6T#%C[X69CA684I1%)9!,<H)TDAGU+FWIAAJJ)]N4.L.M*420A;:TF#[$I$
M_IY ]\&_:D*#\SD@/.OS;IO.!#E:M,<BJ:@SB0WW>W7^N&MUL;P%?*?8X@_D
M>/ZGQ[=2)J4R1YTD$@$O WD=+],1*#.#!8B8Q\]%*E;,0<<^W@B?/']V>LU%
M4T@\BPJPB;]O7$( ) -ORG#I26Q3JD@(!$3Q$_23$<_IC/GH"M49)EDN)GY_
MVOB2DDE;,9?3\X[],'-OL3*0A;D3MQE).[ XDY]O'].@5U0SI(*B9Z7G]#V.
M&5.F SQT)ZO'>]SHV"!JW(1 2DA.(D0#']0<'CW^G0JUK41Y23N 2]@XG0!S
MK@M%-#&RB&>06DW:W]-<.2;8E:#.V1@3@P1_6/8]>\R@[%_?T=L;&F/Y0 &V
MN?U?;J^$#MEF=J ?S ,_R^H\R/Z=2)4M*6Y7^ERQ8_.?PP#6ID5"PT$VN--6
MV^6&ZIM!0G#;<@ 1P0![_7'MSSR>LFJH7"GY9@>S:CUERSSB+X9T2=;2S]K0
M^MATPR.V@&"I&2)^H.? \2?S]SU)3K:$MIM ])/ZL3C3X:MB22='>>L=+$7(
M<V;GK,]R4KB1!@B>)YGB3YYY]NBQ7-BH-8F+?WU_OC'(H/Y#(.CL9M:+:/[8
M:*BD4RYLS^4$GQ'\_P Y^G6140;$?WT_7OC3E5M],)7&-XV'F9@C./I])ZEI
MDNX>W8MT=O[8T4'B+O?Z->^&JHIPB1P2!()GS'TC\\GGJ;F)ND_W<OVE^K-=
MGA^'J!H##CJ-&)Z3:=,:D4TI!*20! ($\^?;&/''@=3TB>19:7$QV>"_K=YW
MQJ::E$%FO![[0;F;8<*)B%R 2!@G/.,?K[3S'2[-$$'WB;$Q\\$4T!)8ML=
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M<G/$2,<=9_P=XC;_ )*J/'^WRDW?_;B'ZO/1L##QGX9"TG]ZTV2;_9\WV?\
MU!)AANV%J_LSOCL=(;5V"OZ$ X*=6=N4I $Q@:PGS],]>_P?XDUX74+"/X^4
M;LWQ^UFC4B,$#QMX7UXM3,-_Q?.38NWV:#VTUQL8^S!^.)2T!78J](SE;VJN
MWJDI&?F 1JY1GC@''UZ@K^#/$ZJ9".%5"2W^WRG;_I W)],;I\;^%N8?\+4Q
M_P#T^<V_^S8-K5]E=\6=$PJMNW:B^UKB4E?[-MNH-")J7" 26A45&IVVD;S
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M.)V_U5=VC_V6FV%JOL7/M-C'I_"CJ1(C(.O.T>3[B>X/4/[EXG_T57_>4?\
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M3_\ VH^N,HX_PY"@H9M)(=OX=47#?^KPK'V*GVGH2 GX4-0((\C77:28]O\
MK_'MS_+SUHO@>95_L#O]^GUC[_XXF_Q+D;_:T^J*Q_\ U9Q]9^Q=^U'845-?
M"GJ="L9'<#M()CVCN%B/K'TZ@/A_,%WRQM_GI_\ Q!HT#MC9/B;( A\TEA_[
M.K^%-_Q;UP4VS[)#[6FT*2JA^&'53829V_Z0>TA!(@ F>X9!$8B.!QTLK^%\
MZM1*<JLP0_Q*('L:@+G\;VPRH>+>%H'FSZ4E[?!S!!#&(I0']M2,2E8_LUOM
M;;<4(J_A6U)5(3R5:_[1A*I,QM_T@"(XR(,?7H0^#<Z?/]D5SN8YZ+@.PGXA
M#, X>>AG!R?&?" Q_>" 8?\ @YB&[4I[8DZW?9U?:7OMA-[^#R_.*4=BC_;G
MM&N&R9G=_;Y6[DDCD@Q'N/4\,<:I.*/#UK L16R_XU@?T;8+I>-^!@,OB"/*
M0Q^#FM;LU%XM+M&P9]5]E/\ &G>$$7;X1[\PX1/J)UEVM)!5E0EO6Y, Q]8&
M(Z@'A_Q*"?\ @VJP,?QLJ7$S_KW:9$.'#8EJ^+/"U5()XK2YE!U Y?.&6W.7
MN#Z?7 ;=/L5OC"ND.(^'*_T3GS1&L.W"H))(48UBJ8\B<^TYZ,3P/Q&!_P G
MKT@ULN/D*[>[_AA76X[X6404<409<_P<V_N<O]/33$>7;[$'X]6W ;5V'O3B
M!)A6KNW*0?:0O64SY'MC]-_W'X@N.'K!%P:V7+O'_KV[R^(CQ[PUIQ*GO-#-
M Q_]PN^FW?#,G[&+[1^B< 9^'"\5+8!$C6/:\&?>5ZW0?R_WB.MD\!X\ORKR
M"@F\ULN9#LP^.0(UER<:GQ#X=3*.((*K#^#F1!_^X_UN,+F?L?/M)&S\_P ,
M=]4D<!&M>UG/O_UZQC^L?KG_  YQ?_H*_P#O:/\ \7&/\3<$C_A!$2/X.8_^
M#A<G[(7[2 1_\6+44"(!UKVLC'Y:ZQ^O6#X=XTP;)5(_]IEQV_VHT+1?$M/Q
M3P))+Y] !:U',^MJ-GEM-.J]'V17VC8$'X9=0#__ #7M89__ +Y/^?YG8>'^
M,M.16#+CXE#W_P!;K.-_\5\!<_\ ""2-/X6:'TH_KY#+_P""*^T://PS:A__
M -U[7#^[7/6X\/<6:<E4!_\ K*'_ ,0X'J>)>!*45#B  +?[/,[=:.-3_P!D
M)]HNXB!\,NH"KZZT[6X/YG7(GS_/KQ\.\6+@9);-K5H!_P#_ &]YC3N<#Q-P
M,?\ R@CUI9CY_P '#:Y]C[]HX1CX8M0$?36O:P?W:Z_O_3ZZ?X<XP(^PK[BI
MEW]Q5_6N,_XFX&__ !^GU'PLRVO_ +'\FTPG>^Q^^T@6@)3\+NH2?_;?M4(]
MCG78\^WC](R/#7%Q/V14?^UH7'>J+[[QC!\3<#:,_3=BQ^#F;_\ <MACJ_L;
M/M(W4K4GX7=0E<#:!KCM2#,B<G7?!YR?R&.I$^'N+B^24X<O\;+[,W^M[_HX
M@/B/@KQGT,8_U68B['_5#Y-]&95_8S?:7%94/A9U&828_P#+KM-^*,?_ &]_
M/QT92X)Q4'SY,AP03\2B>UJOZT;$!\0\'YO^.I9M*5=GT'^J^;[.8PV*^QA^
MTU45J5\*NHU$C$Z[[2Y@X_\ M_\ XC_=)^YN*&/LA$_YZ(9[VJ?F^-_\0\&$
MG/(,6^%F+RUJ78G"MC[&7[3 )"5_"KJ(#ZZY[3'$<8U]P./^'4J>#\1Y% Y4
M@D?^LHO?3^),?A&-3X@X-?[:CI_"KNPL/]4#Z>F%K?V,WVE2#CX6=1)$D_\
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4BJM"@" I*EDI+$ AP78@'</C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g483086g18g01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g483086g18g01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[19<4&AO=&]S:&]P(#,N,  X0DE-! 0
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M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q 6             IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
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M0DE-! T       0   !:.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         !.$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      -!    !@             !S    DD
M   & &< ,0 X &< ,  Q     0                         !
M      ))   !S                      !
M !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG   !S     !29VAT;&]N9P   DD    &<VQI8V5S5FQ,<P    %/
M8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '
M9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90
M  !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P
M(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   <P
M4F=H=&QO;F<   ))     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M        37-G951%6%0    !       &86QT5&%G5$585     $       YC
M96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH
M;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M"79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0
M   +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO
M;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M    #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M    .$))300H       ,     C_P        .$))3001       ! 0 X0DE-
M!!0       0    $.$))300,      N<     0   *    !^   !X   [$
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MD_%(()7U\4TGQ3_!*$E+2?%+
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M%A<E,S5UDI2TU.$D-#:"E:2ELO%#15-B8T14HK72&"9D97.$XG2%PL35_\0
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M#'PP1%I@%U!$B=C@BAF/2Y L.PL-E[8(F&P^ P1/@B6")8(F8$BQB_P^[!%
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MW[=YGVP%%51N2TPP[G)6FL _47!B:1?2\]%3J.*)TN%!!!-@28F+^T_$6V.
MX=1%ZGM=IV/NM\X8%J6).%[[P/A0'SU(0"M-3,ZM(!:QM) ,$W(F)$Q,8OY5
M<R6U,W%IOVCL7YE+6#[;Q;'4G1E1S/$LO3)U!'$6! (!Z, 9@B\F) )]\3\N
MH7)9\:A/B/DXP_,I:PZ4Z;8&==,<#F>8!M3%AM%E @W%X(^$QU$#%HI()?ZH
M(Y2=1GCN!>-<<3B4D0PD/!!L8U'3R6OU>./5=E! .DDV)%M(L9 -C^VP$$'J
MU7[ SP8]7#_STX<].?@?98VKFJE0D$,-<A3)!!:8@]/8"+B=\**"Y>@$-+LS
MN).^+X.(%N7%K^D<I(/,'9Q@=M%2J134+4&IBVK4WJ:""(DZC%N^\_+M312Y
M_P#CI ;(>UY/1NO#FJ_=5W/NK?#,RE/,; #08!'IG6AF('2;BX$[W!Z"B@.>
M2DP?T@L[:?+*CB5B>>K_ )'W^6LO2,KF%JT5"P" #808ZB1TDC?<WQQJII%1
M@=ADO9154:0Y)Q>7QSGH5:DZ=S];O[8\8)YR'AK=EZ5&3W.-HIH229)-N_N,
M$0\R2*8@D>L"Q(M#6M@BQY)-R9/<X(D"1<&#W&"(K$M3!8DG4!),F/5:3?H/
MLP1"P1.68B"Q([$DC[,%BNPW]"FP7)R+%DL%TH))+DF,]0E@NB<&)) -NO3W
M_B,$0O,&J.D?,[7^'\?"LP!SL,6SV5Y28%\LNKWT]84@P)@3B(:2+CR4L%$L
M$8&X=+!1AD.P2P1@+ #HLMP"W'.#Q:>+<,!]Q^7Y>Q[BPQ1<;A8K  @ 3ENN
MFL=US7./&_\ +/%?\[<7_P!N;'"JYW/FNU'VCKYE8W$6DL$4TW/P_$8(BX(E
M@B6"(X)\MFDZA !DR 6N)WP11#,:=26)^KN2=R9^WKWP1-336& @$%3,?UI^
MTW/PP1%6F4DSTBTCJ/W8(JY).Y)^-\$3 D7!@]Q@B1]1DW/<W/[<$2P1,=C\
M#@BBA)!DS?\ =@B)Y+_7]4=I^<Q-@/\ UM@B<-   69F2 21VN#;;!%.FQ);
M;ZO15'ZR]0 ?E@B5$ L9 /I.XGJ.^"*SH3^:O^B/W8(H5B0@@D>H"UK0;6Z8
M(JH)!D$@Q$BQCM(Z8(I>IPPU$P"UR3M:WO>V")4Z3,LD]>LG[/;\9P1$\@_S
MA]AP132EI)+0PB((ZR+WP1$T)_-7_1'[L$4'IAA"A5,S,#:]K8(A^0?YP^PX
M(HM291,@WCMW[X(F13K74+$Q>#@BM+Y:5+TT8&FP *J1J++! ,#4!,'[Q;!$
M5*4'S-("L"! @7.H B ) C8G]N"(H4'91]@P1/I1;U*(J+L%M8][3TD?/!$.
MJU *-% 4C-VN9$'T[=3!^6"*%-@6,'I[]Q@BO995:H0P##03! (F5O?!$;,
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M-CYB"1?L2/@3@B0:LR-H+LP=/UFD BI.P8Q,3TV]L$4"E>H(J'0 0P-0L5+
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MDF2P(6T$$3\YC?XQ.+^7\MM#'T8+ASB[XZCW-O@6-S%:M6T&M4UL:@+"2>C
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M -[L).=A:%K6=YGJ'T4M3 -N7,6!! $DS<;V,[[8Z\H'Z7-I_DQV?1<3Q/\
M4VVD82M<S'%LW7)TMIZS)L+B#<]^P%]\*:7,T#6 <1@)\<^D%8,.^A?UQ\<E
MB@^;J5&-2LJH%8B&:9D6F>H)MUMCI^73/+3<XA@T28&/714D#1VDYMBWQE$9
MNG39B]:FWI(]1#=09/P@_M [XW3PZJ7JHIY21?%C.%(Q]8Q7.NND 3C+/,&(
MPU6/S',&4H:O-:GI%E%OK1(L28L&[_AC7+68YC=]+27#"^O4KG^8Q.T!WO9@
MY,^[@0M9S_.E&F&%((]R(@=0Q O:=A[&_2_3ATD&22PL3CF!WG7=6D\]3&1]
MTL1$6)<26MHM/S?,N:K%S2&DZ2>MP-K]XB(_;$8Z_/=;'#&--(Z!\NN%B+F'
M8C CB'$,P&+LRZC9E+:M5[6.T;_U0>DXH )EAN =,=^SKEQ::::0S \PLP..
M3&3N,(LL;4:NA*568DR=99B2)NLDSIF\3T!C%,6:7D.-QDPL!IK/'FJ_<>Y3
M4P6)74P &J 3$@P#&TW-\ <#40,&)TW4)-7W$G>?-&\L_P#Q'^T_OQIZ?WU=
MS[*,,AV"=*"AB;,8-V [B\P3-L2IFBHF<7]ENBFDDO2#&0S".*;22J*Y(@RH
M8@=Q*FXM!QCUBSKH:*/VTQ-@%6K4=-]4-,%";#O8=H VM)O>Y44TB0 -0 (Z
M*N5($F,%42A]<_U3]XQOAD@EBT>H6*[#?T*.P7<J3?\ 5!GKOIO'[)QTJ=HS
MU_\ &?1<W.9[E04*M2F55EAP3(8 @ DB_P  ?EB4N\_^7_E"S554P:JIW:"1
M=QFM^Y?X@M8/EVJ$E 6&IFL RJ>IBYDQ\]X'*N'N,F:!.!AO$WQ5I-1N27FY
M+XEKG2/)R=@H*V3S:YBF[LA,%);1)8-K*W4GTP&@%9($3?S,*B>9C$<P!#OK
MC@+L'>"NM3\HARX+7EC>Y;1^J]HX/Q"GGLL@&ZI)4F8@@'Y@F]AO[X\]8IYZ
M@ (.0F!/5>F@GE!D%O6RRC$J;$B1>#'4]L>0$\Y#PUNR]%9($$B<]"HZW_G-
M_I']^-K-!))<DQGJ$Q9CNQ/Q)/WX+HFP1+!%#5#F3:/?VP7$5$&7/5)JBJ)W
MO'7]V-4D S9LGR5-9(B.JAYR_P 3^[&WHT[?PLN<SW*8U ]A\>O[AWQFHTD0
MSODV>B[<$DU%R3])N=0FQA>E+!$L$2P1.NX^(^_!9K^T]/-%_6_ZOXXW0 27
M#QZA>>N*8CZAY5*6.C#(=@N3G,]RE@PR'8(Y-R3U65X%_ES@O^=^&?[;0P89
M#L%%TWBHN<>-_P"6N*?YSXL?G^<:PGXP /@!VQPJN=SYKK3AMZ4^Y[J@FY^'
MXC$6T7!$L$2P1+!$X)&Q(^!C[L$2+,=V)^))^_!$W8]1<'L>XP19!"56%)4$
M D*2 3:Y B?G@B(A))DDV[^XP1$#,I!5BI)@D$@D03%ND@?9@BMYJFU5E05/
M+ 77]8J"02.G6_[,$57\B2#YN:TJ 2(J,=3"X4W%HD];@6P1 :F1J$%T$P=.
MK:!(D%@8,7(.[  R01,<LCB95&"EM/U2;@0(!!B;[]Q&V"*G3!%9J;("@4D,
M0"9U*!TFX).^"*\F_P OQ&"(TD3!(D0?<=CW%A@B/E@&=E8 KI)@B1(( ,&T
M@$B=X)[X(CUPE- 1326;3]4#=6-H&XB?V],$5 TM8#%=2[7@K/P-M0O?>">F
M")UHJ#LE.WUHB?;TW]^UOA@BDU$$>E]<&2JEMAU,V@&/G'2<$1\L5)-(JL:2
MQD"3#+N-B 3:Q@GWP17-" $!% ,2-(@QM(B\=)P1 K@4Z8*#02X!*>DD0UC$
M3@BI^8O_ +=W*=!JGU=-S&TX(DU3+VT*SF;AG""(-Y!,D&+&QZG!%1S6?I4@
M="*ATGZU4BQ%]V$$$0) ()-QMC5(<[2LUV&_O?1:\_'VRX9P[-)T1YVN)!,A
M22!]7?<$P#N,;)I&7^V_@1"X_)^><+$9CF+,N"$DB19V+*=Y,:B![>G;W.+3
M]1:D %GMA%[>!.RS76* YQ+,,<?182OQ#-5@0[JBS,@E 3<1Z;WF0"8[WOCI
M^5629#9,\?,VZ+G^<,C9_P"+?QJL4U4.Y%6JBA06E'*MKF()47!!O>28,V!Q
M:.!4"Y+N(PR-SH%FOBPP$OGH;CS!;R5>KG<M3)T5=3 [%]-N\DF;Q8B_RQV/
M!>&9GWU!@_PUUS_,; 'J1\;&=G6)SG,5'+TY4TE(8 EW#@B&L%86)(!!@0)%
M@3CIPN".;$N&9AIH9^.J*W?FC&/Y+^;VNM/SG/"$FDM)R1^M_P"SM:P L3((
MB3$VN3CK^6TD ,V$O&6N/@M\U+!@_:2QMCAB0!@Q#K5,WS'G*[,U*HV7!)AI
M,$7],"PDF;=!&**)$6Q((]'W'C,8XM8%(P/,+,]CDV>4Q;' OG<Y7<^=FFJK
M<@ LL-($W$Q$B/>PQ?RP;^D^&[:'!<07D=9?:Q(WZ(98GJWS8G\!B54"D.,3
M-M=%Z."2:BY)^DW.H5G+:ZCE2[0$)@L8^LHVOWQA=ZBS%GED>O39*9*.RD&1
MI)%X/;3\?CBC&2(P^93N(E<.+5S4B&GT.BJ40[@M6=JIN :A+]NK$FP '[,;
MI WOA&#WG*[:.N"N4J(=B% !"D^E9,2!TBUQC53 6IOB/8).'FWH48T#3$M)
M!M=2!._4GMCF2X_3T!!\0I.('=_0)A;:WPM]V,KI1<[>H4T)U7J,@-I!(U?_
M "D@['<S:UQBC=H[Z:/F870[//;75LA*5:G3#38L=U(U?.3/M8WO.T8M0Z')
MWZOZ7Q4I/49LW1O6V"J5E4*(51ZAT'8^V,K2#3 !, "W;W&-T7.WJ%BNPW]"
MC8ZL#<.N2A4LC$6(%CU&(P%@!T6:OT_Y#U5S@-<T<R7))!6#))F7!)-[[3OT
M';'*MOJWI\021E+,<UNF#8,!(TQ;HO4Z9_*::&D)L+ ;0.L3W'VC' "2\.#<
M 'T$7Z+I583+WM@<G\%M7*W$#EJM3*U#I8-.MCLNI05G?23#1)%M1 &WDXD<
M1XE@<W;///-L87HX?V@9#OZ^ R7I[A2JU%=6#0($2+$S;I[]9!ZX\@^\[>P\
M+'7)>BNPW]TJ(!8R ?2=Q/4=\;7)R+%D,[GXG[\%UI)YKG[1Y!1) $G!= ";
M*!J*!,'^/A."SQ!52 ;2U]#DH>:G8?Q_U<%P3,Z,K" +3,;?L'VXS4>4.SRR
M*HC6,F\]3^_&!Q+XASC;1%,'L?L/[L:IJYBS-#W_ (6^&2"6+1ZA/)[G[3C:
M[.<SW*4GN?M.".<SW*FA))DDV[^XP6Z"22Y)C/4(F"Z)UW'Q'WX+-?VGIYA%
M_7_ZOXXW1<[>H7GK^S_=3Y5*6.JXI8(LKP+_ "YP7_._#/\ ;:&"+IO!%SWQ
MK0>*<3]*ZOSMQ:6($Q^75;3$Q,F.I)(QP/W5;GS*[TB =!Y>L=EBH V 'RQ%
M4^")8(E@B6")8(BT0"QD ^D[B>H[X(K.A/YJ_P"B/W8(H5B0H@D>H"QBT&UL
M$1Z73^K^[!%*H2%)!@WN/@<$64I@.$+@,=!NP#']3O/<_:>^"(AI4C$TJ9@R
M)13![B1O[X(I!5 @*H'8  ?8!'08(H-01@T(H,78*-0 [$";$[>YVWP186H&
MI5(":F!(@QM<D21!@@0!T@S$C!$96=E.JFJB0=0IA3-_3J  (.\#;3@B*F7J
M&6)@$$@,;R3(^ (D"0+7F-R*>55EKO),:&L9D'4LB-H[=1M[X(K[*K !E5@#
M(# $ C8B08(DWWP1 S'HIC1Z/6/J^G<-.T;P)^ P155+U#I)9P!,,QCM-YO?
M]N(7P+='6:BPNTY YYI]#*U,@:9< PQN"#((ZB!L;&,6@3]53C ,+N%*:I<D
MD#,#,9%/5 IU@4*T_P!&1JDB?4"03!)Z$3[XZU"D&X$#]+C',?&6Q6#T&%+W
M?#UV3>>J M5S "@'ZK$F=^PZ _NQ !5#OH*0#Y>"SQ*ARP2)OR\N>/HL+G>9
M.&Y>5;,"H4:7!:0% ,M[08$FPGY8OY1R(>SD$Q>![G:[<><?N,C,AGS<?,UI
MG$O$#AZ:UHHM2FIT@J).OX@&($C=0?;?%'#J'Z7U) S%I,Q)W3\T#]5\2_AA
MM#ZK55YVS&9JZ:*NH+$RS$#3M 4V&XZB8.VPIX=3.U(Z ^?LXU6?S-:O%6:V
M<S>:G6Z!2I:YZV@1:!<F2021;>!**"27 'TG)C.+;Y2(A2NL\H8U%SKK;MA*
MK(*=,!WS-*2\, 0)#2>_2(WV'?';\G_3_P#K_']Z/''GA^8ZS;QG^V=5LWQ/
M)Y<_I*Z%=@$(^M$B1MW^'M<8Q7PS0'!Y2[. 069R(GX,XIK%5VJT+-=G#&?.
MX:SZKG><,K24J13(!],JI]4&))W)^&US88[<*BH&:ZC%GM(Q^##59)IJM2!>
MP&<G$WL"-,UJ.;YQJU69,N@426#'TB.T" ;M)$0>XC'II$PP+22;VAS?8W6:
MP!2& !YAU#%QI;29E8#-<9SV8$.?06E=#&=4&-C[D[$;;D8VS7!(D4LQB3KN
MX&/1<FU\L'T^8,L+F?/J*'8E1KWDDDP3<@[]8M\,#N*6B#/5OX95 1*K'2U5
MV $A=3$ VO!D=3TZX DQS$Z U>Q16Z-%BQ#$L-)LYD3(O<1._O!.-.1<GJ:F
M_P"V_P#*AUF8AYS_ )5KR5'U@D?]4W^SXX<SV;NW_=2WJ@; -T(]%7S"(J K
M$Z@+1M#=A\,9J)(G/.D^0"Z<,D$L6CU"CDR?/2^]C[BUCW'MC(N-QYKK42QD
MV..BR=<#S%6/248D=)U 3&TP2)[' X;>I4N[S..P34:=,L046()@"+R.T8!W
M@/W]"%"*=!T'J%8T+3]2#238D$@QO&_<#[,4DM((_P"7J2@%.AZ4^@422PAB
M6&\$DB>]\9589#L$"M91%O4-K=#VP1@+ #HJTGN?MP54D)),F;?B,$1" =P#
M\1/WX(FTJ-E4?(?NP<BQ9&!N'3.FH0+7F1;OV&*YS/<J,,AV"$:)(C4?F3^$
M8.<SW*U3323(ISD4WZ@IJ=$TJE(JQ6:@!"DB1I8W$P1:8((/:^(9O.^ENRVU
M(<@4DL<*?0#1>A\O\1!1Z)8ZB=(>;K) )6+@S&V_>!A&0'MELL$!A].9D7U8
MDC%RS[-)S%8/D\Y1J)4=U9];,78R0&:+DFP^(V[X\]0!)@8X!_$#QVLL.7I8
MD"0P)&$1#6> O5N7^)'.4"&7ZM@6$W! @3<"_>+>TX\58I%@ 7+$"2)/F;.N
MU%3U'F)JC-VD9OV6U4D@:^XVBU[_ (8PNU6@  +:PJ=0D3!CU'\<%UX0!K+A
M_H'_ (JNY,"YW[GL<%VK@1$X1GDA23N2?G@N1F\[SYIL%&&0[!+&*[#?T*Q6
M !  G+=- [#[!CBP%@ N:<%4N0.VW_ ]L5R+%DG D:@L4^M6L  =_P"+#OBN
M<SW*!Q^JH[U$IL'.9[E5SF>Y2DC8Q@YS/<IS5"U1'4HB$DF23;O[C&Z"22Y)
MC/4+MP:JC47J)^DW).(S1,=%Z4\GN?MP<BQ93EI-Z0>@2D]S]IQ7.9[E3DH_
M;3_Q'LE)[G[3C=!))<DQGJ%RXU-(I#4@?4+ # Y++<!)_/O!;G_+'"NI_I#+
M#[K8Z+S+J'!%SKQ8D\8XL"3 XOQB!.W_ "]\<*KG<^:[TV&P\E1Q%4L$2P13
M2F*A*E]$"9)B;@1^V?E@B=Z(IC4*@>3$3,;F=_:/G@B>B 6,@'TG<3U'?!%:
M"J-E ^  ^[!$.L2%$$CU#8QT/;!$.D2Q8,2P"@@-< ZT$WF\$CX$CK@BRV75
M32J$JI(T02!(EC,'IL,$0&,:20"-0D&(B\S/0;GO$=<$63IU%9]*"P29B(^J
M-('_ )CU( V P10S9<4UT,4.L D$@QI:=M^A@P)&"(=,9@*"K,Q( TNTG3_.
M.HQ)MUF\Q!P16*1KZCYEE*G8K<R+'29B)]L$0\P@T JH#:Q)  .S=;>V"*HQ
M>/46(F8+2)[Q)O[X(CT\TL&FPBPD@:AZ?3[:3W]1B-H-B*34F+ETJ:0UY]0,
M-ZHL/G$^]M@1-H8?7S# ="&>9_9TG!$-S34 FL]0!A*L21 DS#$CI%KP2-IP
M4J=HCOC&&ZDW%\E24*M/+!U^LSTT.I1,P8F20#>=C83@*B&^FFV/M;Q.)&*Y
M-5^HQN7>,"&Q_=Y%:]Q#F?AT:0_E.K@ZD.A?JL(!!$$S,'H#[XM!',781%VA
MLX<8E[WR6*JJ:'>08RUU#AL#,8$+4<YS5I,J[UU)*KJJ%R+3,,9%A$])VQVQ
MZ7^?.RY?G4C^W\@M=SO,'$*M.HU U!(F-3!0L7@ F_Q@7^$[X5)JK8G])M@7
M'4.-7<PLU\4-]-WSC'*^&-\(7GM;\LSM6IY^9JTPRD$TZKJS74:6(8%E.Y#;
MD#>!'J_+8 !H_G<O/7%<_P PW;YKGK"H^5E<J!3JUR &#'4YDF"(N2;W-Y^P
MX?EG/OEGC=3GT#.#&%K6MYZ0K'YSX9EJ8+59 (  ;K!OM.P]HL! OAR:^'\_
M,5>9F@"6@O&PR^!4\QSMEJ2^6BU:HF +F!T,&1L(D=XN)QJCA 5&WVG!G!:_
MP^BS74X&$P\ P>MV%V+$W"UG-\W9BK(HE:08[A=3#>Y[=Y'PC;';D=W:=/0V
MEC&H7(5G2=6G)I;JPAWF,#6SV;S#BJ^>JU06'Z+4ZCN6B8(@$&W4VWGGQJ!R
MC'Z@ "',@XZLAK,206))!? P[B;>" ZO5JZ9#@*6(JD%;D"8:TWBT&#&TXO"
MI!,@ D.S/D&L3KYJBO<.\"?+?+-$2@T^H48BP4IO(CICT5T\E()%+.WVL'8X
M@%S&2O.\.3BS5>75-70TT!&E?4!Z2 ;ANWPQQ-0:&$O#Y'0([Y]B/,*%#558
MHS%@%+ .TJ""!(!D3!CO$XE)SD9%VPT."KM_1/DK!I!+P@FWIB>_3I;'2D@F
M +8/[!1WS[$>83J"3 ,&.IC%J( EKX_T57;^B?)3\MSNP/\ UL8Y@+"D=_\
MU4<:]C[)#+FH=)*VO<S[=/C@3S!G QN?4#-;HJDP3&1S&;)-E_( <%09@%9!
M$@F9Z;8P0TN#L974%X8C<0DI+>86)8BF8)))'K38G;Y8"QT$:2$-QJ9U@JU0
M17H$MN*@]0C5&EK203'MW Q0S%WN+,^.:A=PS6-W;#)$%$ V+3\C_P#XX-2;
M$C_)@/#%6EP?J (; D2BTZ*R=3$"/UM,3(]A??$(;$'8NMN,*6\? HWY/3<A
M05:\D0IMW O]O0'Y$ [O9G.=Q;7!8J)C-X8 8&[!VQ410I4LP^NG3*>4P"LB
ME02Z$$ S+0& M, C];&F!EV'BWJ;CILLN1#.?!_06/7= -.GK+*B@&1ITJ!!
M,@P! (%O_2]IY2;9X!F=QU#MLI5S 7RQ+NS'H6?=)J:,(@"\RH /W;8M0I D
M-. #XJ4FHF"\8DM@H>0G=OM'[L8^C_5X+?U_Z?%194I:2;AF"'5! D$R!&XC
MWM/Q &D8$O!=K9AL4(J.(#2&>^1?!/Y<5BT H4(B!I#2O3:8&\#<[WPJ#&+6
MZB.\*T%R ;N(T)?M*KU[&UH-HM'UMHQE=:0',"]7HK'#*S4<R&#,!IDPQ ^L
MMS<7][F)L</FZM; #MT8QMHO7N&Y1>(TED >G43I61M?<'K;V]SCSUEB6F"7
M?(;^71K+D9?/WQQU6V9!7X;IR]-04'J-01+,#.DP9A@28VL+" <>+B& ?]3.
M,+AB"9F[,[:!:X8D[$X9CYFMRHYIZJ*MQ U2"1M:+'WQS!</FN[_ #7X2JSL
MVH^IOM/;%6^&3S&3;V4))W)/SP75R;DGJFU!;D3TC_U^&#BF:@XMC?HH[?T#
MYJ#U PA1I,S-MKVMC%==)'TP7S-I5=\NP'D$.3W/VG'-R;DGJN==AOZ%*3W/
MVG$7)26YO>W6_;O@B) &P ^6")\$2P1*2-C&-T7.WJ%OAD@EBT>H3R>Y^TXZ
MKLYS/<J:$DF23;O[C!;H))+DF,]0B8+HEJ"W(D;?Q8]L;HN=O4+CQ_L'^0\B
MLQR^ZOQW@H '^5N&';MGLO[#K!QU7E74&"+G3BW^6>+_ .=^,?[>^.%5SN?-
M=Z;#8>2I8BJ9@3$&+]R._;?X8(K-*G E@#(@ B3TN9&Y_C?!%*J J@J IU 2
MMC$&TB+8(H4B68AB6&DF&N)D7@S?!%.J J@J IU 2MC$&TB+8(@"HPF68R($
MD[R+CWP1&%)V22QW&Y) L3&YO$&;;VF^")Z=,H2209$?M!_#!%D*)(IM!(FF
MA-]SK2_QN;^Y[X(@)ZBP-Q"V-Q^MWP17LK_C&_J'_P RX(K5<#RFMM!'L9W'
M8^^")\N3Y :;R!/6)J6G>+"WL.V"*3AF  9A>3!O$'W_ (_;@J*A3-5K6>?3
M>4?\G?0#)N>\'KW^[IUO.)RU$ !W$F0_61G9RGYO#_;&P?T'B4"ME_3+M !D
M29$@'I\)QKAT5 DU.S&Y#/&51P?!#Q:,*>X$Z0;[PJ[#)H+LJDF=1"B=[7MU
MOWL6DWQV^C_2<8!)\*2!XK/Y@NP@2.7SC3/-F5#-<>R620Z2KDD+#08 5K@S
M,V F)@][8Q6.:D"D"D\PE@"S%QG-_"!;-==+">4O) =X,9,7F6<"P"U?.\VY
M=@1( #2(,"8(  F]O:=SUD<.2O,[.Y[.#JS6QSY<XAJJGB[SAY_ RU^OS)F:
MDBC"C?4Q)!$$:0)$$D[].@QOATU DD<P(+ D9W8DM;+&ZAKB:O$YF<>]H6%S
M'$,U7)\QX5C"E6@AX.Q%YTR=X]L;--1#&D7>P4YZ<_ ^RH.:0TT\TX(UZ@:I
MUG4 =M1:!!N>E^FV^%PZC4S8$X9A8KJI( ,SEH=,E4S.=R-%H0425$D:%T]0
M8E2)%@+=3!C'<\(X/E-^T9CO=<B:0?M#[!K:OZW#!8+-<T9.DK4V:BHO9($G
MMN9^$=MHMUX5'*2=,@+^)MGEHGTFP';;34;+1.(\V"FS'*TEJ$M$JH$*09(B
M#TB9B_RQWM#OM8'UZ=RC _I#:@3[87G0+5L[Q.OG6U.S*=0("LP L=K^_P"[
M GH/E\S\#)RTX@%]!V P'PNL:[U8&AF)G8L;B#[CK&QG$589#L$DUM4(J$HN
MFQ#&296 38D;] +=8!QJF27)$7=LL5BL!A OD,BG<4J4.K2S$(3$F#>YO:0,
M:)816>X([>L^*Y,,AV"LTD,:F,R+ W GX];'[3BT@&YYH< R!W%^KW1AD.P4
M<PI*KI)4ZQ)6Q(AK2()$Q;_U"H,S07N(..7QT89#L%.BC)ZBQDB(DG>#?WM_
M$8H<EJJC5#L2:@-9A]=8 %S 6 '1&TFI8P8O#&W;KUO@>4!V';V!5=OZ)\E(
M42IE="G:00#':V,\U.5/C_ZJ.->Q]D1:+N8F;3;U'[ ???\ ?AS 6Y1W]*0C
MY#NX]$JE%J0#$M<Q=2NX)WGVVQ*JB1<7P?U6Z))<"V;XC,!00DDR2;=_<8PN
MK#(=@CTW"$D]00/C8CX;?\,4,#(?37710C]K XEL-$[4JE826(!,A2S1[$ ;
M"Y ]OM-Y29@/9X[:)S 1):[3WU3)EJB$E60R-)#2PB0=F!&X&,U  20SM%7]
M.(M.R N;$;ANVO\ *O4\O55 2R%3^J@ $W@^D=I%QU.,M@Y O<N>^$YK(K N
M[R+!KX6/=$%)[Q:!/4?+;[[8U13)8N6+"HN,+1=#4#^X2Y;+5C:5($NN@"'6
MY.Q(%H)WDDB0;2)D;8V)'VAQ$V/0_J^')4P?N+&8N.H_3\&:)2>?3$,HN8@V
MM<[R9N.XGVQJEC<6#'(VOK\R6:G%C<N,Q>VGS-6:2J[DNJN=)NP#=1W!PK
M##'W2@DDN</9&>G3T@:$B=M*QUZ1CFYS/==&&0[+%UP!4@  1L  -SVQ:B?I
MG](/694I ^J/U$=(A#1"Y@1M-_EV![X4@DP 8QM@E1 $DB<+XJ9H"WFE=,B+
M:K_,0+3ZNF-MGR@9@/YP-RL/ES$Y$MY2=@@. M4Z&+6/I+$")'JBXD'TR  T
MR.N,U G[3+OH1^YG#'!\;A:I+86Q )(.43KI8RH%-<AT4=9!!,_Z([SOC/+4
M+L'+?)*WS&6YL[$;W950E2F[%2$.D^H[ 2"2+0=A?<"=C?&J1)!$L6>SN).E
M][2J*GQ)&,^AQ\KKT3E3CK4"F4>NFHP2SF=2:E!'VFP$? QCGQ*0QBE\>Q<8
MOY-D;6H"['=K@N6@"V6L. %ZC5=7T5:;:B5#!0T4R9O G3]HVGN8\PHIYOLI
M,. :00XQ9KL=,+X7AMS/IOET^:K*9/.,U-5==#LX018@&3<B(V!OW '3'G/*
M*C3R@2&@"#Z#3M!74[-\U618>4?4=4CJ9/X]H'S^?DJ)%1#D:.A?,TZ@L3_"
MCYJ?S1]G_P#+C+G,]RHQ_?7_ ,BH5'5@   9G]A]A@Y-R3U6^&[EZJC%B7%P
MAJP4DD!K& 8@&U[XU00"20#!8&9<-&*[*NU34Q M%[6_CX?;?;8I%R!.#0/<
MYGLC W#II/<_:<5AD.P489#L$O,9;R>V_P"_X8<M)P'EY(PR'8)"LS6U-WWC
M[CB<M(P]?-&&0[!'#E4!))^J.^X)Z_#  -8&3?<Z%&&0[!2IU-9(OM-P.X[?
M'!AC33Y^@1AD.P4ZC: #[QT['O\ #%9K >7D"C 6 '10IU-9(OM-P.X[?'"<
M0.[^@51I(V,8S62!!:?=9K) @D3@6SR1$)),DFW?W&.;G,]RN%==8$5U"?W'
M75-5V7^N/N.)S5 AJJA.!.16::ZZBU55509V-1(>)DK,<N?](>"_YSX;_MV5
MQVHJJ)X;U$N2\F9Q6AZGS*ZEQZE5SGQ?_+G&1T_.G$S'23G')/S._?'"JYW/
MFN]-AL/)4\15%H@%C(!])-Q-Y%\$5O!$Q .X!^(G[\$0JH"@: %)8"5L8(-I
M'3;!%-*1),DO N'G2#;:0;_*P-R)$D15H4R8J:$7NH),SM "VB3OTVP131ZG
M^+%-6I@68JO0P&N+D DANH) @&,$5S+4Z3,2P5FTD:"H( D>J#:>DQ-XZ8(K
M@ITP("(!$0%4"+&-MI M[#!%7S%%= -- I#@G0H4D!6^L0!*@F8)B8G!%'*L
M-12%G2S:OUB)41\!(^?QP1%S1(IB"1+@'W$-8]Q88(IHZTDNR(NE(U_4DK)^
M!^L9B=^Y.(7P?HWK"A?!^C>L*O\ E2AR6J*0HU :S3%HB"I )BVGO)Z8!P=!
M:^>./5VLRY\0\H#NQ+ WS,O.!EV(L)0,QS/D<M2<5"JD Z2*VLZH)&Y!$F;Q
M\^F-@S :#+DD/G$@/<R[2N%5=(9B6<.2&(QU?Q>1B'TC.<[*ZLE%R\/J!UL;
M!6$C?<D#YVC;%$F3S"+DZ3:;LQNI^?1'*._\AO):O7YDSV8:HM)F$*6@NPD
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MG3ILS%D1CH/UE4]1W!Q%4O+IBD"$0'5$A5!B#:0)CVP<BQ9&!N'4/*5Y!T*
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M&_H4:2-C&.:Y,#<.F8DZ9)/J'7XX*,!8 =%G.6_\O\&_SKPW_;LMCM1_^/\
MR]U5U+CU(N=.+_Y<XU_G7B/^UU,<*KG<^:[TV&P\E2Q%5)&*&1VC[O8]L$5B
MG4+L0>Q/3N/8=\$4JCZ #W(7[03^&")Z>7<RY+NH$P?4H:8$R;-$B8 !OWDB
MR.3*L6ILJF 6$@$[C:1&[7B>A.^"*\:-)MZ5,P9$HIOWN-\$4PJ@0%4"(@
M1O$;1-\$0*M(0#3&AI$M3A&*P;$@25F#&TP<4 FRS42 XS]T)?,I3J:HWF#0
MNMR0&)#2.S0A$]B1UQH AWI=PPM!)$Z;],5S-51T:8<:3-I[HE)QEP:688$P
M6U5222!N+ST?;J!VQ*Z20:8I+BIP&AB.48S=L2$>JH\U)+9 N.W3S5?,<1R]
M%6-&GERZB"RA4.F)(U SOI,=[Q(QS'#XAN3W/JWR,4',7)K(O#AQT8,1E.6+
MK7<WS-1%+0XIH5J AE<,Q.E[&#[WV%@!TC?#X9YCS%PUN87A\?GG.?EQ)%I<
M_+8SFY6LYCFUF+)3</&PJ/J61Z1 G<20 .\6$D=6B*(:"6OZ]\U/S?\ 5X?P
MM4XCQSB-=-0?02X 16*KIAB2%F-X!))B8M))O#HYJB*J0 Q:V8'7L_DN/&XC
MTAJB?J&=F/R)R6*05\Q35Z]6S.-F,ZH8P;R1U@VVZWQW'" _2(#?:,(<0V]^
MR\J,'RF78EB@ 0J9 (+2"1MN8)B\ $S?$_*R !TI:#;H^).6J&[/(PRGY:%B
M\WS%PO*3K-*-AITAB2) E;Q DK:2!UVIX3C4&\,&.+,-<Q=VE.EV^=?D+5,W
MSQE:6O\ )5EA($>DC>^X(@@28[CWQUX= I,R&(M>7$LQ[D8LMTAR00#%CN'A
M:IFN;LYG494+ ABVIW=O2 1 #& ?4#(]Q]4QCV<.FF'H!(:.4"'$XEWTO+.M
M$4D6IL0" '<.<A:[D^"UG-9W-U:6I\PYU5!(6HU[-8P=K"VQ-]QCIQJ:1P@1
M32":P'  +-5!([M:Q7+MNV71_CW6.&NK*LY(^M#$L)VF"3>^^^/+>YUE[^,H
MI^0VVH1VOA:U0'_+V1@;AT2G3*NLD$3$?MZVZ8T"7'U/(Q/J HPR'8*_ \[3
M TZ"=/ZLRHF-I@D3V.-WJ8R.5VP=[JB+1M'DIM31A$ 7F5 !^[;"H "*<< /
M8JN<SW*9:"DV)-NL1T]L<S:Q'0>E(6Z"22Y)C/4(]/+:C (L)N3&X'0#$ ?$
M#>%LEL"=I2K4&H*'#02P7TE@;@G[/3@0V(.Q=1P8-)ZB$%7=C#,S")@L2)M>
MYQ'(L6589#L$="28), 6$[7&"Q6 !  G :%%!4?6 (]X-_G\\4!_@]2%S1*:
MTZC%5$$"?2%F) Z3:_W8E4!P1?%FQRJ*U2 2QR]D<9< - /U3]8 @;7%A<?'
M&')Q!:6I)?8Z&W;!;Y:1U@.Q#_ HK0BG#&?5]8;W!@21<==A?X8U202YYF9@
MWGZ1E-T9@P%+WF8W;/0>"7Y.&LI:=^]O^K!_;C;4FW-V!\F1FN*/+S!1:.6=
M&)#,"5(DZE&X.\GMMC5((,/;]08>!,J'E:0/]I!/D(_A6UHNYAWD1/UB;_,'
MN<6IV^IF?]-WZX74I9_I=V_59NF-D[9<H)1B#,78BU^RCL,2EG^EW;]5FZ8V
M5J=OJ9G_ $W?KA=*FM122SR(CZS&\CO&-,3]PI(ZWZK+@?::@>ENB-)[G[3B
M\M)O2#T"CDW)/526YO>W6_;OC%=-($4@3@ ,\EJ@ DN'CU")I7^:+;6&.:Z,
M,AV"F&8" S =@3'V3@JI4Y+=2%&HB3$ @7]KX(IU3JAP-(G3Z;+,$["!-NW?
M!$(-$DE8 _7N/V]?PG!B;!T<"Y98ZOQWA^2EGS%%B91E]/I!N6&XD%5ZV!)V
M.*V?A.F>:CY>,:Y9+1N*^)/"J!-"@E6L5<,K4F(E@&$$H?JW.I9,G28&-"@O
M;NVF$ZXSGGDU"0['KYM':""%IF;YVYBXH&R^0RM:DA;S*=52RL2HTA"P8$@Z
MPP62"5!B8&+R@23J0!J.K/A99-1,-A$FSZW<1$F=EC*'*W.G&ZH&>S39>F2*
MNCS:@+!2$"N=0# JYD1!(66 @XHJ BD'IH<3D^-@K)FSXF^$ ,#> 'F3BMQX
M=X<4:;_\KJD/H)8@V<@I:VXO/4VWG:_F<0P#5!B20W?#$@Q:$  EVB7OBUQ?
M !@XZ@[=0Y6R>6IHF7IHS@C4?+2"@F3<;S!O N=B23FKF9ZJB2\N7SUDW[G4
MJTF6&[EW)B7P?YDK[Y=\H%120#"JJRJ@[@J 8!L0=HF(OC)&1=XM.%M<)G1B
MZTY-X:;QC?SB-7"WWEGC RKKEY;4P)*@D:H91,B)-QWB8N)F54ARP ?(9&<G
M=I&JM#PQ<MB9F<_/(Q8CU&HU.O36J" "-8($$VWD=??KMTC'EXO#!GE .;":
MIC"#>=\0JYS/<HF1SM-SY0?4US<DD $+:9D7&P(/PQY#32&)IIP?Z<WE_P"'
M,:+5!))EXSQ<++U?0 _1B% V$D$]B)L?VXX\6F2P  :  &B3AY7W*ZV5<U-9
M*Q$7F9GIV]^^.?#!YB7CEMU"W1?IZA-CLNJ@Y(%C%_WX(AR3N2?G@B+1 +&1
M/I._Q&,U.SC N=0%BLD""T^ZL5&IL@4*@(:9"B2 "-XVD[?#&:JW$.)OWR*Y
M\Q_<>ZK/86M?I;OVPH))+DF,]0MT$DER3&>H4PVE0W4Z1T)N">OPQH@$@&S$
M^7NNB=:LGJ;>P[=L9KI $#'758XE7* 7:6QR.2(&#&"/?O\ A[XYN18LN0K>
MU1\5,,J&8%[=O?H/;&A5/U.1E>>JKDW)/5%2LI)D3;W[CVQL&DEA3X!13+JU
M@!(OM_P'?&F&0[!%F^6_\O\ !O\ .O#?]NR^-4@/3&(\T74N.Z+G/BX(X[Q@
MDV/$^)0.G_/'O\8/\=.%5SN?-=Z;#8>2IXBJ< G;!$1&\K4S#=2!L;R#[QL;
MV,3%[$B-3IZZ7FO+KK&\L 88BQGH"9CV)'4BR.2)+O3)E"C-H-Q.I 3!,?LF
M3O@BN5*=)5!!%$S&M!I8B#Z96#!B2)B0.H&"(!<4H9:[5+P5<L0%W)]1@; 3
M8P3?!$U?-4C3&FL4J!PQ$QZ &E?2022=/4CYX(A?G?(T:96O765!((*R6 @
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M:0I(839C[$J#: "Y& (IZ8A^EOZ=[1AD,,!.>O?^\!5JYBJY-6I5(Z$NQO\
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M8Y#K<ED62"22"2;C<L3/?!SF5*JHBGEF_**<X<>2.20%4$A=0L+#KTVQ022
M22'LY:;K#G,]RCZ :8("@R), &-.T@3O?&B3RNY=Q.]()\96Z"22Y)C/4*!1
MCN0?B2?O&,.<SW*Z)"F!O ^%OO&#DW)/5%-4#$@-TO<;?(8 D6)&Q9$9*)GZ
MQV[GN/;%-=9#&NHC(U$CS489#L$0T9W,_$S]XQ')N2>J,,AV"0RXG93\8C]H
M&+20#+6Q_HK%; ",<!H<@BIER20 H,?J $[CH(,?\,:Y@+<H[^E(7)\AW<>B
M.M H98$@B/4D"=^LWMB&HD7'1P?%;HDEP+9OB,P%,*JF0 "-B  ?M&,N3<D]
M5U89#L$26>S.]K_6/XSWP#8OHV:A&0I>Q<890D**@E@SACN00"9WDQ-X'V8T
M].=?@HU65'BHG+![+J)WVG]@@]<1J3;F[ ^3*O4+\O<CS=23+FD2T&XTW4C<
M@]2>V(0V?4-ZE4%\NA?T"M4E+,0-])/[1VQDLTEM792LL+ SC.:/Y3]OV']V
M,L/WG_D%SYO]-/91>BY'07ZR._MC= !)8BJ+5'F%Q+9_RG,,0VM,'^OX2IT&
MU E@ +F"9-Q;86[]]O<;-(I8FFD3^D,3H=,[K0:IP"3'ZI U&N5ED6%,TU&A
M-08&=(FP/6)W._PZC&%MAD.P0' %P #M($&+F)%XF\8W1)+S&,X_R5FN &B<
M(^6"2*7)!)L)N?<#W[XW5](< 7:WMLL4_46)-GO[[HZ4+F_3O[CVQS-1(8LN
M@I +AU*I3* $7O&_L?;VQE*@2(+3MY(6IA( NPTR&,B>MAM:^'5OEO;59Y:L
MWZGO[Z.C>90R],C,9F@HNT/4",OO,WZVF>O008]# R.KL.N"U2&N7.(DMI<^
M2U+B?.O >%!GK9I:A!@4Z=<,22&(,23I&DR0( ZG8Z8F!+9 -WA]>\H[3@<R
M?*PAR,<+EEYYQ#Q;&;)H\)X3FZK!_345&*L &4R8"W+*;=H)&-BDB7:)Q\Q;
MYJH2X+BS&8B+@$EYR6(3,^(''JJ2K93*UCZ:6NHKB9TR-0@A222 3/L/2/*(
M))8V<FWAOUR80 W$6P #'+.69VP>"LUD/"S.9HO6XCF2:S,2VMR\AMXU:C%I
MZ3,P#O#7D!UOCETB_F@HSDYX8-D;:D+?^$\A<"X<HG+>?5":84*BBX.J0 2!
M$$$FYL+6R:G.)W<3F #!ZGHM"G8; ;9-V \2MER^4HY7]'1\M::@Z:0HHKJ?
M3ZC4503%P1UD']7$PQ]/D>&BL::=/[Z=5<D]SVW.W;$53$DB"9&\&XG:8VVP
M1-I69@3W@3@B:H3I DQ.TVV/3!$&"9TD@@38P>WX[8H+&P.ZA#BY&RJO7\MF
M626 @D>]XU&_W[]]NAY;@&&+86Q#M9G8;KF.:Q(EP^-\"SW=G.RJMYEZI)!8
MQ,G40;[[Z3I$ GH#$ '&"[ P'+AH,WZ?+,MAG(DL&+R(MU_G%U3JN].IJ1=3
MNFFV]VF2=XE1-\=N%]__ /K!/<25 2 6+?40+VT \H&<.#M' ^(U*1IT:KNH
M'J^LPEI4:=X][SM(-SAQ@0'%B6+-=C!Q])G!6DV>#<3?%QAZAMUM>84YAO-H
MG40I+:KP)^L.LV6^X,WQY6!J(J (9V,@$8S#S#87$A<R:G+D]S81?&VFLK.\
M&XAI44:M4,01I0DF!/:\ 3$ 3)CVQY.-32"XI#.!  +SD)[[N3/:@U$#ZC.9
M.;+:364J&4 '8P![V/OM[=K0<>0AC8", SC/JO71<[>H3"H6M?OL!]V"ZIH'
M8?8,$47L+6OTMW[8(H:FB-31VDQ]^",#<.I(229)-N_N,%&&0[!'0 DR)M^(
MP1@+ #HI/86M?I;OVP50]3?SC]IP1@;AU-26/J):WZQ)[=YP489#L$5 -0L.
MO0=L9J_3_D/58K  @ 3ENCL 'L +'81_-QBL & T>I7-*5%V (]Q-_L.,TD
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M !20@ $Z9( D^D]<6K]/^(]5SJL?\SY*65_QC?U#_P"9<97,V.Q3P]2H5ER
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M,6($L2XR!>6$NIS/8&VH[00&<%WL0JAX+X@\><-F<[Y&7K,&,!Q64$Q=IG2
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MX'7'I=$J9<EXZ!=4$ B00.T7D7D1<=3@M<HL #!()8Z0<P;'!RGJ.- IV!#
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M<%YD$-N"8D*3T,8T+F07N(:8B)#OC>#))/2ES(? 6)%QB^3.T,%Y)EG\YI8
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M,XJ'^DX-ZE6A= 3<R+FYV[G&_P!38<K]79^T;+FFDS,WVGK':<5AD.R*+OI
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MIWBPM,6';$54T DVW6#[B18]Q86/;!$[H&   $&;6M>WM<X(A.0%"@!6FY
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MD"8-IBV-T26,AK&<AY0BO&DA581 8!)(43<]8Q P,@6%]AH5'O>^IP&2%4H
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M+1NQF_I.]^H[X+%8 $ "<MT2M91%O4-K=#VP4H )+AX]0@H229)-N_N,%:P
M( $Y;IW4L('0R>DBXC[2,4%G@&,<-5R(=I(G#'1"948:817W+%1)46()WN3)
M!L2)PEGPM_"U2 2PNSW;$38JO5I*BA@5)U 6 G8_NQ%JJEIUS?T"%2\CS *X
ME7!018EMP#%R(!,>P.XQJD.2SVP;3.V3YE9#//CZYYMCO!M\&S@RN>>FM,^5
MJ%G!TZ0X &D@KM&W_P PZXE0.,[A]2SF\MXJD9%PYA\G8[D/A8=O<LK7IULJ
ME6C^C#(%*)Z1L)D*(LP W]_<>'B4E]'D&SL7(ALI>9U606M&&2QM97HU!5UN
M$F&4,0#UF 8/N(/QF<<32/V@N[. 1AIB,S@PA5SF>Y1?-%1 ZGK>)'?X==_>
MVT8Y<5N4, )$  ,P+[7 ;39;H))+DF,]0HR3N2?GCSKHFP6Z+G;U"DI@S -N
MH!^\'%#//F1Y KL&Q#]64P0Q@HMK[+^X=\4D#[8.AJMU 6>(0P8,7NYR*)JB
M 2T3  )W^[[OC@*B,7W<KCS59GN4< Q,>F8'?YGW@G;YXZ4BQ)))#MAT"<QS
M/<I21L8QI'.9[E35R#))-NM_OP6Z"22Y)C/4(@>3 M\@/NP716*))8R2?2=S
M[C&Z+G;U"Q78;^A6>X!_TAY>_P ^\)_VZCC=7Z?\AZKDNL\:1<_\1)_/?&[F
MW%>( 7-@<U4) [ GMCA5<[GS7>FPV'D@AW$Z7921$JQ!CX@XYUV&_NM#]6WJ
M%>I4PRJ^:JU"E,!E(=B6<- $$D1H+23'V8M)',1@TT@6, RU[VC5<:C)%,DN
M&:!$N;X6D$ZV\O\ $/@Y?_".5I:*=$"JS*-(( 8%B1NTF9()Z#:,>JS,X \\
M>V&C+QL>8DF0"#-IA_4DW.2TFA4H-ELNU4(WFI%0% Q*" 0T@R++(;VD6M:<
M&L[P[2?9W.(3YMW:,H7B'B3P4Y7B%'BV14/ESIHOH4:55@:DD 0(-, D@#]N
M/>"0)B)Z:^-]W585!F?E(O(=BU\9B[DYK22/12=00&BH2+&P(*WO'JDC:P/P
M.<T-  !8=AK[7[.$9F\Q5>Y&T-)$Q[VD"WP]MRQ6 S@ 2!#9'S9U.@3J(FVD
MV^8P7)6L$1:(!8R ?2=Q/4=\;H )+AX]0BM!5&R@?  ?=CHP%@!T161]5/ZH
M^\XXF_2GR"@O5OZ!2"%PP&ZJ6V)V('38WMW-NN #_/G35@MT%CT]1\.CE.M4
MFD%F&5A>\P PB9][CX=CBO#/;RGW(.C:KHTNU_./8$:OHHDEHU$F-I,Q\)QE
M:4E)+*"21J6Q,C>-C;:V*"20"7#B#90@ $@,6,XJTU-&$0!>94 '[ML4LY=V
M<V;-26#,["[Y*=#+([D$:@%+0T$6(':QD[_$6F</HC[NK>B?7/V]']5>J%-'
MESY9!U +Z9B1!B+'43!M(D7&%8D3<N ^;VTVOJ'6'+?:Y! ,/8=W^8JJ35#1
M3I!YW:+J+=8)@G<#L.V.(^T$MB7(=Y,7$^;[K1 >[&S<S-:W8/[LK:HP0,P@
MFVT>]_L_CKL,]@"V']!QF;/$RW,G4D8.GDC8QBL#<.HIHGFL%9V4;R"1,6@^
MU_;XC ?27  PM@M4 $SE[?)1*RT 4IBH%;4!_BQ4/4[08VG6;#:;QC3DW<X]
ML1ECIV71@+,,.^!SPU[JOFLUE\GI%>IE@-4:ZN:6CI.EC+*Q TB#:^XM88/+
M@L[^N/9R9>9*$ !B' ;TPZP!&$!>?\P>*O)W B]+,\66K6 (6GD4_*"7@L$
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MEXB6PU_G'9KBW"\E2;,YC-T,MEV<-JS>8H+4!TL0E.FK:@" ?3 6TWC =XP
MQ ;##&Q#DN90@9 !\;02^SX.X,!A"\KX_P".'*?"6-+*5GS]5'@4\EEQ7J,0
MKFS*#*V43JN6$CL8 ;@>+EF&;"^ZCARP$/8 0VLN)@#<M*T@>(WB?S158\K<
MMU,CEVEDS6:HFB[TR0@DZ4+*2RM$D$J.HMI@S%S9G>]I%PSBQ((U8(3,"9&
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MS@/A%R3R^U.KD."T:=14"MFLXM"O4<DH2 '1G74R!@T_JE9AKN9I<81:V9Q
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M-Q,8K9Q#B?/REI5>E\"(-NIV$V8G!:74\1/$#FRFU'EOEKR*-4S1S%>D*%0
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MZB]X8P")Q$A[8,<[_2;.0\$>.\6K4ZO.?,^?S+57%2IDZ+U%RRN>ATN5/I+
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MZE3UB&V!A&VC9@!CI0Y%M?/YB2X-RM AW?=PQEFQRZ "TNL!2N2T!0HTTR
M:B&#K,1)!TPQ'4P8,8TNBR-.ZP;B%L;]/?!8KL-_0H@55LH '8 #[L;HN=O9
M<D1/+D^8K,(,:9D&U[$6 G>1>XQNMFG/WU'KLM4.\9>VA]-T89G+4DK/7S=*
ME0%)K5J]*@  RP#5K$!"5!O3/F1L0NHXYP]R< '+ME8WLPS726L!B2P9\[BU
MW.2\XYI\9_#+E*CY>8YFX<:Z#UY#(5*W%,VY*L?T;T"X+R -.TL-RL8LBT29
M:JY#,+F-;D#)2YG#;"7/\. YLZ\J'CQS=S5-+PW\.^8,[1S-04*/&^.TZO#<
MB)OJIH0E1VU!&4&%:GK,!M((.<2(?:6ZQB+NPR(Q/*&\XT>Q?.1@S@Y\+_&[
MG1J3<X^(-#EK(U/77X;RZ*IS,00*+,KJ!%-G_2+-0.J0(9H6M>^X8%LXB 3!
M,IJ3%F.<ARQ:2[VWSW+EOZ-/AOPC-+Q#-4,QS#FJ-3S*F?XWG\QF:[O.HZ:&
M:-5%1F$ZA)](4'2;20VQ.<3&1$/U)5#88%L!=GPB]LP-5[CPW@W">'4*N5X=
MDLCE*6L-3I9:FH94564FR*H4%E%I,D$]<4W>X(:2"<RUV;5]Y4#LUB-#80 3
MB#\"S5'+E,L*=+]&GFABB$JK,58%F584F.I! ^S$< P'#,'\SGC_  JQ(DL7
M<MY#+#^5;IT$Z*H8CU,% )%A!($D;6VD8RM*?E!!T([=)O>('O\ :<$3P(B+
M=NF")$DB"9&\&XG:8VVP10>PM:_2W?M@B').Y)^>"*:,Q,%B1$P22)L)C;;!
M%#7IJ&28@P)M.KW,;8(I&H"(4W^(V^1P1);F][=;]N^"(D ; #Y8(HN2!8Q?
M]^"(<D[DGYX(I)N?A^(P1$@3,">\7^W&*[#?T*)\<D2QNBYV]0B6.J(E, L)
M /QOU&"*%2U5@+"-AMOVP1-@B8@$0<0@&Z)@BCW^,'Y[;X"D"PT12Q42!((A
M0TV,B8'?[8^W!%-31436JBDK@HS-HA ;ZY>RD%0-0]5R-F."+6.-<Y<L<OI5
MJ<5XSD,C3I>D5*^8I.U5=+.=-*DS/YGZ,PY$!0RS+"= &(#',@#$7/7SR7+B
M5<H$D'F:-B2\@69M6;)>&<7^DKP%ZK\,Y-X+QGFC/NPITSP_(/4ID7!<UZJE
M*=,/Y:FHAU@N (4DXK8AL2S/RD/!</X'#0KE^86?F/<L"SZ0;.6M9G*PSYGQ
MRYU5!2I</Y-RM2/T%=JE?B'EE2/5!"4B%:2PTNK*H$!B<&@;F;PP+NP!=BSF
M!<8K5-9J)#DEC,M)Y<R20[]<UG^%> .3KLF9YRX[Q'CF9<:JE*KQ#-^1K+ G
MTM4(*@2H2Z7)@Q&)S883XY9&3F'L&77E>[]_CV&18#%W]?X)R'REP#0O"N!9
M"BU.F46OY=*K4B4-@U*Q)4'S/KB"H,.1B<S8L]VCR;*W7$H6IF181UN#'6ZV
MY:24R(0!6]++I #+$P1 !%A8VMB<_P#JQSSZH*QJ;W; /@I.!2A:0%)>JTQH
M!/>%@=<.8DL[P]WTB<&;LK34^#7]/-T&!>PN9/N>Y]_?!:4')T@3:=OD<%NB
MYV]0A8+JP-PZF@!)D3;\1@N=8 $ "<MT>F "8 %NWN,%S0W:H&)23I!8K)C3
M)!M\Q\MN^(< <3_/IW:XA9K=@1@?0_(W6.K%JS!P@19@E5TW[& !TW/X1C)#
MGJ\L7\78/ 8:R7&!4 ,SD';J^.9G2$>FR(I#(I:/K:03]IO_ .GOC=(:HD#!
MF U!EMIS$1=9=X)?=S\OI;H:56BU5E4E2NN0KP4)TM TM(M,[&8V QT)<"08
M=L7 [WG%] Y5IOX'N/ZPT<K;N6L[41CEZ]3RLKJT 4V84PP8 0@($:0_0>UA
M.,<0##4M.#@78B>L$8K8<WP(D,"09(<6P+BXP6U\0R0K54IT'1:!'F5*K$0H
M ((#"#JN-AW ZXP##L9MZ0Y \L5MAA(C;IEX.JN0SBFG6RKTR6I5AY;M='0!
ME+001J)("G>-6P,'S_BOLITKG_B6Z-AG+.MT147RF^GP]2CNA"ZP(!.FVQW_
M '7_ (GPKK\^?/X:FS"0&(&\28FUXVGWP1%UQ=KCWO?]N"*:9BFFIBJDZ2!(
M%C(@W%NT^^(0\.TSM,*&VF/PQW1LJ[.[/J)E#N2;%AUDVMC-8 $!I]"KZK(!
MC(DG?OCDBMK4!  @F9]_?VCL#N=_?I36  #A"(Y9600H# B8 $B#\]]QWWQH
M N2[@B)^!E)Z>.WS9L5F^5?^DO /\\\+_P!NRY^_&L:?\J?^X(?4>878./0J
MN=.+@'C/%B0"1Q?BX!-R ,^\"_028^..%5SN?-=Z;#8>2I@E=B1(@P8MVMT]
ML152-04T#E0Q9@A)%X;43??IWW]\$613,FI30,+*;-:5(!$S:T&YWL !%@5!
M(L2-BRL^74914UL"?2"-1;3.TR(4E=IW ,;' U5"SG"[0H2=3.>\S\E83CW"
M!Q'A>>HL"]4Y=C28)ZPX(B&,D6+6MVQOAU\0DN:F:QK,EPPN,^BX<::0#2 ]
M0R,R6;4_'7A^3<)Y>6BI3KY1FHU 20&.L2S;$MT!/0GH;^JES)D&SDO@PGJ+
M89,O,PF!T ](V6+YUX*.-<"SE%*5-\S3+9BBY12X>FK*L/!9;5")!$ F\3CM
M22!5.0O>\=+C9*P  0 _*):<9<!USYD,P]6DM#,46%?)!J#K2""HP!^L^J)@
M@"3)N!,",:X;D%R27WT!C/X,%Y:ZJ@&%1!? D1.31Y9*Y6XCP[)*]?-<0R65
MH4U)J4L]G,ODVHA?5YQ<LI<*+>5)8AM6GT8]E%--ZV8.6 &8T?N&DSEPX==9
MJ(-550%+AZB1<6!,G2+M%EXGS7](WPMY=K-E*7&ZW'>*M4&7RW"^ 9;/9ZOF
MLRP9EHT7HAJ&IO+90U0A!-X)&.XIX+DL!I _@PU1AA,DAEW#P]_@P 'QP[!:
MPWB-X[<Z4TH\@^'%7E')9J5J<:YXK4J>8I4))-2AEJ!^N6%.HJM)*)4$";B.
M&! %4LQ#G&;/]/4.SL(6J9+Q]NK97@;P][V*I> ?.W.E5*GB9XJ\6XE0JU5K
M/P+EZG7X7PNHM-33:FII5*:,=-2HFHT[AB9!OCF] 8<M(<%R +AV-B^>#G"R
MZL6<7U!)DC4$-D_7%>M<I>"?AER:Y7A'*/"WK4QI-7B9I\3XIY@97.8\W-TZ
MHH@LJRR,'5V"@D,3CGQ&8<H%WA@0 (EH&Y/0P*==I!())P$.S1HQE>QTPE*G
M36C1>@*85:9%0Z54 ^E%4Z5@W],1<"Q,<Q^IG;E(\]2.S:!9/Z79^8'RT![O
MJ5=6ZH3<@K4!-R*@4J'D_K@,PU?6@D3!.- !A L,-%DDN9-SCJI5&9] =F<:
MYAB6$A'@P21(Z8$!Q OD,B@)F3;,YA92F 4 (D   &\"!83T]L>>LEKF_NNR
M(+"!8=AM]F.3G,]RB4D;&,;H))+DF,]0B>2=R3\\=$38(E@B4 [B<$30.P^P
M8(I JH8D#ZI L-S&WOVP15 ADLUQL)D[F>MI_?@B(@$FPV[#N,$18 V 'RP1
M/@B<%1]8 R( (!O\]C8B?>V")BGZ\  VB+7N"!TV/\;D30!L /E@B?!@;AT2
MQ&&0[!$L& L .B)8J)P2-B1\+8Q62!!:?=%!R=Y,SOUZ]=\<W.9[E8K) @M/
MNFIL QU&1!WO>1WQN@DDN28SU"E!))<DQGJ$<,&.E%!)ML+#O[=+])QT715<
MQ5I9:$J5A39B+LU-5((/I-2H8I@[ZP01 $B3BM#X6^?-U'EL;_/FRTSCWB9R
M/RG1J5.,<=X=3J(LG+-FQF&DAF#(^6+N]2$(%%CI*LQ(U*@-9\ID8:6'E>(?
M&.,)T!?!WS.F!);;Q#-?2/SG'JKY/P]Y.XSQVO5J>30SM3)U<GD),C5YCJA(
MU:(F1H+$FV#:$X7#;OAL1[*N=O-@V )SGP$NK!Y:\=^=UI+S#QG(\G9:H07R
M.1H"M6\N& !K*!IJ:6+ @ZP5Z7( @9&"Q9^A#P>^&%\L3F/#*6F!&+OS;+.<
M&^C7REE*K9[C_$.(\S9MO15J<7JM7IW9:C*BUFJ$)^CTK3(T:9D2!%YI)9XC
M$VQS F2'(N4- ( +7#P-<@+ZV>#G[/PGE?EO@%),MP3@_#<A2IBWY+0I4X:T
MG0E-55K26 ##86)Q*K3GT<N^)%P^%[6;---),TT&#A(D->?9A*SO2.DS'2;B
M8[P2)WN<9<FY=;%---J:0]V 'DD59]B01>>I Z3V)CM@MT@EV:QOZ:I,X "#
MTL&68L8 (OUBXD;3B'#?T*I8T@&F0;MIYIR2=R3\<&&0[!889#L$QOO?XWQ6
M&01@+ !0=-0M:#)BTB]I'N1@JADJ0%*B09V$P+?'K]N".18LA. !8 7[?'!5
MSF>Y3)N?A^(P1R;DGJCJP4DGJ('QW^6V^"B8K4NZ@DL""+_5-Y]A;^-\$8&X
M=23+(0-3G8G1^KN),3$CH3T)O?",@^>/=3E&0V8-\NJM3*J&E3?:\D6Z]I[&
MYCK$#$KJ( P+WI/*<<H\,EQXM+4CE?[A;8XW\643ER=RI@R)&Q[_ !QRYCG5
M_P OX7#Z_P#5XH%<9C+K3J4&8^776HZ(2 RA7G4H(#"2#>1,3CKPB*JB"Y^D
M_<7#DC1Q)N.QLNO"-?,7YK.Q=H(SBT>$+T7AV9'$^&@NNEZ:AC25RBE0"I)T
MQJNP[3O&TN(P=HFX8;V(P&KD9V[5_;!:<(.)^/YJG4=Z&<HU#2T9>FDL \TV
MAE.DH/20;R2"+7L<>7B UCEN;L<+AYQGY#W@DFHS86)NY QR?=9S,$/26JMD
MJLK*@$*HTML!8=38#?ICPU V%P?@\EZE2DC8QC%!+ER;8[A$\D[DGYXZ(G1/
M,.D@$;P?B!^/2_;!/19BA1\I08B1  @ ==A\/E$8XU5/ L/%3Y_)]N^0LH 2
M9$V_$8RJC+I!F!MV^'8'%I(!D/&_FB)K4;B1_P#+,S_HXWSTY'I'D46=Y7J
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M6S[7QN\TIE"3,R#UZDB^P[8R9O,O,SGNMBFD%Q32"S.  6R@6T5A?5Z6NHN
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MK"X,#8G!G>UC?YX>BAZW%OELT/.<4X;PM&?.9W*4$1"6.8BJ*5IUM2HU*;(
M 0:CS3$Z2-3*1UX+<QY@"#26</+@ CRQ7/BORAJN5J@Y!; P=X7A/-?TD_"_
MEZO4X>O%*W&N*J^A,KP#+9;B55SI/H&42BU;+RP"G-&JWEL11(FL#CO_ /'^
MRDQ^T>8+:6Q>0N!YR8JKAK$EW>1H78LY&#KS^KXH>-_/M-7Y \.:? N!UJM.
MC^=N9\W4R#Z?,!-49>DRUFK%!J577R] >\A9S4*(^F@%W!Y<&T#SIEF%TX?,
MY%1)>FQ)+%QG$? 5]"N1.*9W-<N<-I<5:G7XKD,K0RV?S-!56@V:-,,R42?T
MA25:YD$CX3XZP _*  ^3EM/D9XKK42 ')W'EAWSPL%L'$,I^5T&9@"Z'S!*R
M39A"FYB&D S,? CR<8/1L7\#FM<$DUE_VGQ(LM-6F%#+51%JJY&F!]2\&.TP
M)^$W./*0+AV]<EZ56S@"TE*@*?, E;&-+6D1:PQ$5*BS%C+$^D[DGJ.^"*S@
MBFF_R_$8(K JU (%1P.P=@/L!Q&&0[!%NO)Y+<R<NZB3_AKA)N9O^<,M>_7'
M.G_[!_F/^Y0>I\RNT,>U5<]\:C\[\5]1)_.G$?222!_RNK?\+;;8X57.Y\UW
MIL-AY+%%580P##>" 1/>^(JD !L /@(P1'H@%B" 1I-C?J,$4ZP 00 /4-@!
MT;M@BA1NQG^:?O&"*TA"E_3(E0  +68[$@=_MP1%0)6>G1=2*-0LE96TZ&I&
MF_I99AEU!#I(B0#T&,5V&_NL5VZX[$6QU&2YAYKH9K@'''X<,VN2R6;>KFZ.
M9=2R*PJ!$H4A 6F2CN5*P0JL! 8C'HHFD.<(>[/E.(??43Y:Q-68;3N,[.SW
MF4N'9_.<7R=?(5LSE%R#E\D];2A2I3J*3YCTR-.L,JG5&H&T^HD^ZG,!V9I:
M]_A@@=%Y^'%1UI,Z.(ZMJQR(#<^IE&Y>X[Q#EJMG&S-05JF:HUZFHZZ;.H15
M=]1*@5/2@;2 /2(%O3PP201 8 1BX;MKM#,M5LU\;=YLTF\N(B5L"HM1#49D
M4TZ@I,J0HDAFU$ "8"Q>29Z8[<;[!_D'RL?YA<N'_P#87CZ(G!Q\/PF[3HT"
MLEA,]P(C;??O/O[8X 4D26.X'FNM1J!@.-B?)6$HT?5Z]E,>H-%QT'X7Z"YQ
M332+%SE?RL]GUS98KJJ8/3B,#\^.H.B+2#*TMK [&(8_>!?;Y@XR<P<8(#=<
MKAFT?-\2[-#7UR^>JGEF9G*L20$) )) ,K< VZG[<<ZOT_Y!;I_5_B?19BFJ
ME "!?V'\T>V,U$O$P#UYKMX=5ESG>Z/0I,KZR3H(T@28F09TS&P[>TQC0()U
M:1=NK>1;1UTH?(-GCMLLD54*I  -K@ ';&ET4,$2P1. ;Q$@3ZA;_A\<$5<E
MQ44%@1,0O7>9@_+[,$4G)#""1Z3U]Q@B$[!$=ST7?KN.MS]F* Y^6Q4);YC@
M@9C-"E30ZLHA=-,YJLE"28)-%G(IG,  E14(0*')-L&9W-BWFY\$=V87#^3#
MQ7F'.OC+X9\@T@W-7/? ."5J2ZVRV8SO#\QGF8H[JCY;*)F$J461')%)1F#4
M%(*P!8,:SC7I@3E-[0S(]V.0]VB6ZL7>%SCF_I=Y_G"M5R?@EX6<Y<]$OY2<
MP9O(UN7.4_.,J*PXQQA-52D&9/\ DN3H)5J4V>LCA*%0&PT9M@WBS_I)<1>'
M4.O2]_2Y FQ;!1J\@_2Z\3J"IS=XF\"\)N%9HCS.$<AT^+<5XDZ[?D=;C=:L
MM.@6I-4=WRX2IYM&F58(7Q8&8VN&+22S90 +:A(.N]BX<#(YXMXK?>4_H>>$
M?#,S1XES.G%_$#F(JM0\7YPSE7CM?73:F*K4SQ8YPTJ1J1Z$90 VG8G$)(R>
M+E[C>Q<G) ':3!=@&$')O!\'73'#>5^ \!H4\GP;(9#AF41 B93AN4R^4RX
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M+L\/ZAI+9.N9^._2RY)H9RKD>2LEQKQ#SY8Y?+_W+Y#.-PKSYMYF<S5,, &
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MLSRS41J=/(5ZC</"@H&R#D_XQ0=)<LU/O !^?IYC52">SZ-;HT&&L'7/@_\
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M$:-&N8,V;=UN7+?T4>3:.<H<6YUXKQWGW.TT)K5.-Y^MF,H:FM&A*6:J5@R
M*P6D5"E6,B5&(2^'KV%FTM)T;=(+F<,!+]WF!_#KWS@_)O*G+J>1P+@'">&9
M=2/*I97*Y="@'ZP5*2JL0/4/4-NIF+H QU(>S$86P@L;6QEMFI *Q*@*8-U
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ME53-3F?I!$M@TXPV;LAL&FQNW]O:<U::F!I<!0"P%@(O)!'L0/F/V[_$"@4
M4TT@BH D"D/]-6(G?5027D%I'J \2X^3>.GRU+!B JGTS((&]B"($F9'VQC@
M6Y:2SL!F[-HWB66 _-4'9R<F=]7\ Z-2#U*0\A"^EIKFI2K57_)P"&-,4F1E
MJ^9Y8#EM(!8;F!@M<>-\;FV!^13THNQ;:XAGAPP .,,)S.+X_P Q<#Y1R=?B
MW'>,\.Y?X=EJ)J5,SQ[.T.&T*=-89JU2OFLS4(4!6E:M*K382625$978\H-A
M.8B,-,R; ,9QY)YC^GOX,Y;/OP/PSH\T>-_,SHU&CDO#GA=3C7!TSFH)^GXW
M0R.4X,*:5--%Z34S5+5DJ!]*/,J>+DN'N]F-B^.$Q("Y5@<L<H#O89&P;,B(
MT<DE:EGN;/IV^+6;RN7Y2Y Y7\"^6LV!4S?$N<O-XUS?2I']&#E.#9&HN4H:
MEK><,P\HC411(#5@<8=QW%R;O$R3 B&@V) YM)8LQ%V$1<AH.#96<A;!P+Z%
M]#F*K5S7C?XJ>('BEQ+3KJ</J\6/+?!14+(21P+)5D3,9>F#4I 9E7ID5I92
M^B-TP[L8,2P,9=VAI9*9LXS)8OG,7-RQ,"RZEY'\(_#KPXX?1X?R?R=R_P "
MH4B%4Y3(9%,XTF2]6K1RU-G+%06=F9RT23..@_5$<IP;;KXZE6K"9-0A_D0.
MPQ7I:HE!&:BBT6(#%J2BF2W<E "3<W-[GOCF;C?T*5D@06GW5<E1JKLH:LQ%
M-JI -1D(U%"Y]14E02I)!(!B0,0W'U$0;%L1[E<WJ-B3G=26O5J**2U:B4PP
M<HKL$,2(TAM.[=N^TXM+.YJ-6C@OOZF5JGFD2(:7BUM<K*]19=.D  B]@ ;?
M\3O^[%75&-][_&^")M*G=0?D,$2"J-E ^  ^[!$^")&^]_C@B6")8(E@B6")
M8(E@B6")8(E@B6"*: $F1-OQ&"(D#L/L&")0!L /E@B9BJ@%N]MM[]_G@B&S
MJVV_>TQ]OPP11P1* =Q.")F=QI"I4J^H>A-,Q!OZSI $1.]XVG!$GTJR,6K4
MC(L]*I6I$&3IJ?DU6F:"VDUZI-)8TLI9T(NEW/7ID^RFMF!VZYMNO+N>_&GP
MZ\.Z;9SFOFS@.1IT7%-LA2XQPO-9NH[)5910R5.C6SU7,Z:;:*#,$:3/K"2;
M=HDAO4OXP^2.?X!?9W ;PL+NN?6^E)S%SL:E/P5\'N=^=_*++3XMQCAM;EO@
M@5SI%>MFZ[TJ=>BKFF M*CYQ1S4IDI3J#%893E888DXN,\8L5'+L"-<3L68#
MO+;JE1\./I0^*%9VY\\2^"^&?#ZM,UZG*O(]*OQ'.BD&6GY3\5J%7RU4I6.I
MZ3AEJ!-) U3*K B&(,.[-M>U@U3Z*B[&1-YQ['K(;(A>C\J_1-\*^ 5\OQ+B
MN6XOS;Q=6&OB/-N?K\5S39B5<U4?/G--3I?HS%,/"@@6&^0[RYP=X-B[$^6+
MDW5V^?WCX,N@N&\*X;PT#+9'*</RJ9<A:%')TD0TT7TCZJ*!'I'I N>DG"79
MS&;VR>Q$F)\$89#LRSY0I3<DF6B1-KD SW)%B?B+C%^?-OF*) !32"@*&4$A
M1 )C<@6/SP6J/N'7R1*A.I1)C2;3;?\ XG[<%NG].U7F$)R0+$B_0QW[8)78
M;^A0];_SF_TC^_!<D6B2S$,2PTDP22)D7O@CD6+*Q [#[!@JYS/<H-8 *( '
MJ'3V.".3<D]5"CZF(:X"D@&X!D7 -NIP45C0G\U?]$?NP1,421Z5W_FCL?;!
M%7=$-4*94 2HIROJM%EWL3:#>^ BT;1Y(MNY9XF-3\/IY5,Q6JDTP^9"L$0Q
M+2X-@0IB0+G3B<QQJ,;R780"<7U<!)[P9;YU5GB66K91ZV6?+I4S%5BU-T(J
M4Z2L"2M-;BFP$ %8*KJ ,$X'ZJ0YY@)'-(L0Y?S73AS5)_22'F7#1+SY=JF4
M*U*7DUD1JE(^K4 QFX,AIN)'60# $8^;Q:0*B0S.T!A;X^KYLNGSY9U6955S
MI51ZV%@!;U6MTQYP3SD/#6[+!^SH/16S]1?C^_&UM0P1;/R42.;N6H._'>%
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M[#]NVV(7P+$'OH44E8,+>Q_C^.TX ON+C(HI8J)8(E@B6"*: $F1-OQ&"(D
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M@DDF1O?I@P%4!OI]5P49(V,8ZT $EP\>H1R+%DBSCZJ^8>Q.P[W^SYXW4 !
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M=IW_ ''%I_5_B5FLD""T^ZR+JHHR  ?,B8$QI)B=XGIB&_0>07(55,)-AB4
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M<DQGJ%--S\/Q&"Z(N")201!(OT^!QFK[3\Q6:OM/S%$:R@BQ, GJ01)!/62
M3[C&E1ZGP);M@L1QG@U/C_"L]PIG\M\Q0<Y9Q9DS*>JFU,P2M0@,H98:&*R
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M'_GOT'UCM(MOM[8TN@)<2;A6#=9-SJW.^W??&Z+G;U"SQ;4Z@$ZEC)U3IO\
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MF!;K>_V8L^G\+I'K_*D54JR%04;ZRD JW]9=C\P<$42B ,0J@D7(4 G2"!)
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MN"(M'ZX^!Q#AOZ%47&X\U:ZCX'[QAB-CYA#AMZE/BJ)PT1-Q.QN.^W??!$[
MAI%@1TL.GRZ?MP3Y\^?P$F&,F!&TF28%E]^HB_;$Q&Q]/Y5-SN?-"JY[)9>G
M4;-YREE*=-"SFJ::%%6)>M6J5Z/Y/0 ^M7+,%;2I4ECI:CQ<>#?,U.GGVO\
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MJ945,QFORZO1%'+(735FGIU0I*J:9\R1@EK4@27+V@M]LN2+9S>0I(<V&6\
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M@V(B0/B+Q,?LQ#Q!5 N)Q]AFNW!^X_XGS"968N"22>Y))V/4XQ5]IZ>87HJ
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M@$@;#J+D6WB2,1AD%W80X!QL#^FG/<[7,.CM4!K%5](T$P+3<7B??Y6'QW0
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M!F5D &JH$ B8(!Q \D DG<D_&^*PR'8+?+3^VGL/9$H@%C(!])W$]1WP8"P
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M5\\J^3XAEJ^5HY9LPS5O1I*5JA@ 5ZA/"O@U$<X-3$M+G>7P:P&#"RZCC"G
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M)R!R8MZP,U-00P19JTP"[5"=400L7 CZVPC:>N.Y_#U/$;$#W[;'%8_ZBDC
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MXM--1YVJ@Q5(<D3,.V*&U-$5B&HT@&-5Y*TU8]7)V+[F29/JG<SOA<"JDN7
M (8WTQ,=XAL%FO\ $<(P*:0?\0#8Y,!U'FXPO$.;>7.'*S\2XI3#((5:%;S*
M^H20@"DM!CV (47)OZ:^44T\S,*A)EH.36EC':%YB348) T)!ZC"+LWFO/\
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M@> U\]D*C97+9VCQ+-9JFN:IU11'EY>O69&"LYG]&98E# +A7C4JD>TM#[C
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MT\?X9Q#A_!]3U- JHQIJ]8JSTG2D\TWHBLQED QY^/\ C12,"26;NY\C=IQ
M=<A^!-+GE#V 8.)#?I)[#&#BM=X;]%_^5\^E[4K9KQ7\23X'<B<3J9:G6X1R
MO2R/!8R-12:S><M1*F9S #%& 05W1GA](<-\_P#_ ,G4*B\N&9RPD- UIQZ:
M=_P_"' KJK(_0:1])!FJDC/]M@7&8*[:\"OY"_Z,W)+'COC#5XOXQ<Y9NO2K
MUL_QA^*U,DB4RCU*)5\Q4R@:M55:A"4E9M+,9 .(?Q-7&<$202&B<VABWB+/
M)]9XX;*98>IBYEC?8KZK^'?T>_!OP<R]/AW(/AQRORQ2HA/)7+<'IG.!$TC4
M,_5HL  4I^E'%0L P(56GQ<:FNFD5$FD\P$&;$W&TM%U#Q::@T!@# N 6D@E
MQ@7VR7L-2IJJTZM)8J)8.!#I:-2O$J0+2(]-MC?GP^'5Q#?!W?H_2(C>%R)E
MQ$X!OZLBNR)3-5F0MY@=_,K>5>#^F+DC54$Z02=4,QZ$X]G"X1X9)+"X:'OC
MVZ8W6*C532#(<B9&9C^[+7N+<[<#X<G_ "OC*%Z;@-EZ;',5"0K-I"W*SI@-
M87B#,8['Y\ /719%=M1NYC4 ="TK0<YXE\4SI9>6."5\Q)TK7SP(H@&VO2Y*
MR#IZ=6BV)S<KDN,V,![8LSC0Z!PCU50"!B[L>K9N[='<%:[F*7/'&&U\:XPF
M2I5#;*9!G0+-@2M,A00NL:K;D203CA7^-II!;JQ+-)NXO;H!@NU/ YVI>0Y+
M"=)Q@V!R)P:2<H<'H%*E3*OG,SJ#'-5F%1G.Y67+-!,-<W(MN,>3B_C/S0*1
M40U3W)9@1%B#)/ZAC9>JG\+512:B)M,FU\Q(N+,,EG*=*K344O+2A1 ]-)6$
M"+ Z 8V)$Q;:;QCA^<P<5,3E41XXR/C)^47M;%G/D&=WZXW2-+2 %TKZ@;"+
MWC8;^^,U<8U  U&_[B9GXZ5454@F=8:.I\$JE,O]90W23!,;P)WN!8V/L8(Z
MTD'8CYMN/&RS26O8X8=?</ULJ!HL"5!/E_6 !A9.UMIB2#&WO;'7\DD ZP&G
M=O7J(*W3R"IC'TD-#01<&'&+.,0TA,*,;&/@8_#$_))N'_VKH_"%B1_Q4UIP
M?4=0C8W$]X(QFKA\@=FEOM;Y9'H/VDD[BW1-41-(F$N+A9Z&UOXMC*B ::,+
M-KB\:#8;3<P8G:^\Q;!$B?3$ &9$;@&;&U]QUZ 1V(HJI8P 2=[?CT ]S]F"
M*ZB%%O>3)(%I-XGV$6^9C;%9@^>&.[9(I8U1<[>H1+'5%-%+&!&W7I<"8Z[[
M8A?![X1XX#-I6:BPQOAC>'PZ*UY'I73 (,S%R(.\$&#\?D<&<,<?F+],ESYC
M+N0<'UP=U%@455!-C'8_5;?YXE44F9SW,J7YCH_B$7&E%-!)/P[D=1VP1$"B
M9B_S-\$5[+T':X[$Q)[CH-_B;?CBNPW]"LW>XP<-ZSVM+EX%H+IL=^O[+?#;
MX[XY+2BX $@ &8D6,7M(Z8(HK<WO;K?MWP1._IT:?3+J#%I!F08Z'MC=%SMZ
MA0W&_H4>H 0 0"+F")$][_$XZJH851LH'P 'W8(K95= .D3.\#WP10&6:0YU
M:38 V%[@Q\MQ??Y1P[/:2IG.N@:#/F'61I94!02HD^P%NVX_X1&.9K+Q;S23
M8MT?N]OCY GY-[?Q_I8G/5GX#V4:K]W_ .H1*5$(Q)&X(_:#W/;$-1-SY*@'
M$OT 17L+6OTMW[8BJS?*-.HO-/ '9W96XSPH!6)(!_..5V$](_:1CI2031#$
M5TRVOFH/G\ZZKM#'L57-7,('YWXH8$_GCB]XO_SU^N.%5SN?-;M0"(+W'7V'
M98I@!20@"21)@2;'KB+5)/-5)Q\T'!;2P1+!$L$2P1+!8J@1$X1GDE@N;G,]
MRE@J"3S.7^DF9G-6:>@4]3!=S<@$_ 2,%:2SL'+@#J_A\P0&J#5(A.P408]X
MP3F @_5J3#Z._?%0U!S<ZC[R?OP4)!$4@?-E%["UK]+=^V"RIX+K2!RB!CAJ
M5)55C# ,(F" 1-KWQCB $!P\X[%2L " !.6Z)I4;*H^0_=CDN:Q/&>%Y?BO#
MLUPRH%IKGT:CYH50*=32SH[F(TZT"R;:F'6,;HJ-)BHTQ@3:'MF!.BQ7;KZ'
M->2<N97+96G6RCT5I9[A>8;+<26H@U5BH/D5)(!:F5$RUI(((V'LYJV!YJG
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MJK3;_F]$)6J>8 UH!,"-2Z[>HQ.TSB54UT@#E(!=F) @AP)TM@Z[_AZ6K/,
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M6RZEO0JF\@#<7]QT.-TTR7-)C-^JQ48@@3@=] A2>Y^TXVPR'8+#G,]RHNY
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M146BWD$34U-2FH))AIN?=Q^.%4$@1;T*A#QACKHK@72HWW_>?M^[8F=HQ ?
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MG7(N>@AS8'W*YD'B?2"2Q=G>SZWG^%J.=YWX)DZCTZ=6IQ#,(#I7)Y76K,
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MYRA$ B" 1,P;B>\'KCFY-R3U4Y:?VCL%4W<@W$;';ITQGADU5U"H\P ) JD
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M>TQ\+^QQH/5#OC)15JJLA!#, 3%B1,J3T/M\#OB#]6WJ%FIP"03AYB1EZHP
M":@(8B"18Q.T[Q86]L1:0Z :I3 DF#-S/5AU.-5?<?F"(WEE;FXVV'[SVQE$
MBI,!+$F+6M>9B)'<?/IBC6S3\PZ.< MT!R;0'G<?(E6$72L$D]3/?_ATZXZT
M@W,789/COD,!&:ZD4Y"- YW^0B!@ VJXTD ;^H[$#O<QUZ=<4BTLQ<[8CR7.
ML  , )NV$OY>N">G39P3($'3>3<;_M^T1C/,!=R\[ V^;KD^A/;U(1/+*7)!
MZ?Q]F**A5#:R!\Q6Z))<88L<1J4^*PR'8+JPR'8*: $F1-OQ&##(=@L5@ 0
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D:E)]%3./3;2Z@Z75E,0RD$@P44"12!8]BX\0I\[+;L;1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726988416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">POS AM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RIGETTI COMPUTING, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001838359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0950636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">775 Heinz Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Berkeley<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">210-5550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPrimarySicNumber', window );">Entity Primary SIC Number</a></td>
<td class="text">7374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">775 Heinz Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Berkeley<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">210-5550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Rick Danis<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPrimarySicNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Primary Standard Industrial Classification (SIC) Number for the Entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPrimarySicNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sicNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723782320">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 57,888<span></span>
</td>
<td class="nump">$ 11,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Available-for-sale&#160;investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">84,923<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,235<span></span>
</td>
<td class="nump">1,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,450<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ForwardContractAssetsCurrent', window );">Forward contract&#8212;assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,229<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrent', window );">Deferred offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">742<span></span>
</td>
<td class="nump">3,449<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">154,467<span></span>
</td>
<td class="nump">18,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">39,530<span></span>
</td>
<td class="nump">22,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease&#160;right-of-use&#160;assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,316<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">129<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,377<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">203,442<span></span>
</td>
<td class="nump">46,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,938<span></span>
</td>
<td class="nump">1,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,205<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">961<span></span>
</td>
<td class="nump">985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt&#8212;current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,303<span></span>
</td>
<td class="nump">575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities&#8212;current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ForwardContractLiabilities', window );">Forward contract&#8212;liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,752<span></span>
</td>
<td class="nump">7,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DebtNetOfCurrentPortion', window );">Debt - net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,635<span></span>
</td>
<td class="nump">24,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - noncurrent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,858<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">4,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Earn-out liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53,218<span></span>
</td>
<td class="nump">36,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred Stock, par value $0.0001 per share; 10,000,000 shares and 0 shares authorized at December 31, 2022 and December 31, 2021, respectively; 0 shares and 0 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock*, par value $0.0001 per share; 1,000,000,000 shares and 134,050,472 shares authorized at December 31, 2022 and December 31, 2021, respectively; 125,257,233 shares and 18,221,069 shares issued and outstanding at December 21, 2022 and December 31, 2021, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">12<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">429,025<span></span>
</td>
<td class="nump">135,549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive gain (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(161)<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(278,652)<span></span>
</td>
<td class="num">(207,131)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">150,224<span></span>
</td>
<td class="num">(71,528)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">203,442<span></span>
</td>
<td class="nump">46,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Redeemable convertible preferred stock*, par value $0.0001 per share; 0 shares and 80,974,757 shares authorized at December 31, 2022 and December 31, 2021, respectively; 0 shares and 77,696,679 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 81,523<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible Series C-1 Preferred Stock, legacy Class A Common Stock, and legacy Class B Common Stock have been retroactively restated to give effect to the Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DebtNetOfCurrentPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DebtNetOfCurrentPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ForwardContractAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forward contract assets current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ForwardContractAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ForwardContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forward contract liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ForwardContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723765168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">134,050,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="nump">125,257,233<span></span>
</td>
<td class="nump">18,221,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">125,257,233<span></span>
</td>
<td class="nump">18,221,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">80,974,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">77,696,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">77,696,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725980256">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8,196<span></span>
</td>
<td class="nump">$ 13,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,623<span></span>
</td>
<td class="nump">2,873<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross profit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,573<span></span>
</td>
<td class="nump">10,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26,928<span></span>
</td>
<td class="nump">59,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,475<span></span>
</td>
<td class="nump">6,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,299<span></span>
</td>
<td class="nump">47,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,377<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40,702<span></span>
</td>
<td class="nump">119,309<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(34,129)<span></span>
</td>
<td class="num">(109,080)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense), net:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,465)<span></span>
</td>
<td class="num">(5,286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,664)<span></span>
</td>
<td class="nump">22,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of earn-out liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_TransactionCosts', window );">Transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(927)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,112)<span></span>
</td>
<td class="nump">37,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(38,241)<span></span>
</td>
<td class="num">(71,521)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (38,241)<span></span>
</td>
<td class="num">$ (71,521)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used in computing net loss per share attributable to common stockholders&#8212;basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">23,337,127<span></span>
</td>
<td class="nump">102,300,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used in computing net loss per share attributable to common stockholders&#8212;diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">23,337,127<span></span>
</td>
<td class="nump">102,300,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders&#8212;basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.64)<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders&#8212;diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.64)<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Weighted-average shares have been retroactively restated to give effect to the Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723685024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (38,241)<span></span>
</td>
<td class="num">$ (71,521)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive gain (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation gain (loss)</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in unrealized loss on&#160;available-for-sale&#160;securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(314)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (38,246)<span></span>
</td>
<td class="num">$ (71,734)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836727009584">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th" colspan="2"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Gain (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th" colspan="2">
<div>Preferred Stock [Member] </div>
<div>Redeemable Convertible Preferred Stock [Member]</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jan. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (35,425)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 133,406<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="num">$ (168,890)<span></span>
</td>
<td class="nump">$ 81,523<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jan. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,582,525<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,696,679<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,404,966<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares', window );">Issuance of common stock upon exercise of common stock warrants (Share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,578<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants', window );">Issuance of common stock upon exercise of common stock warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-Based Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation gain (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss, as restated</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(38,241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(71,528)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">135,549<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="num">(207,131)<span></span>
</td>
<td class="nump">$ 81,523<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,221,069<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,696,679<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">81,523<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">81,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (81,523)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ReclassificationOfTemporaryEquityShares', window );">Issuance&#160;of&#160;common&#160;stock upon conversion of legacy Series C and Series&#160;C-1&#160;preferred stock in connection with the Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,380,563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77,696,679)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,768,568<span></span>
</td>
<td class="nump">2,768,568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue', window );">Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, as restated</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 159,538<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">159,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares', window );">Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, as restated, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,850,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon release of RSUs (Share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,046,689<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon release of RSUs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares', window );">Issuance of common stock pursuant to the Common Stock Purchase Agreement (Share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares', window );">Issuance of common stock upon exercise of common stock warrants (Share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,818,630<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants', window );">Issuance of common stock upon exercise of common stock warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants', window );">Reclassification of loan and security agreement warrants to equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-Based Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">44,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract', window );">Settlement of the first tranche of forward contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Capitalization of deferred costs to equity upon share issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation gain (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities', window );">Change in unrealized loss on&#160;available-for-sale&#160;securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss, as restated</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(71,521)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71,521)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 150,224<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 429,025<span></span>
</td>
<td class="num">$ (161)<span></span>
</td>
<td class="num">$ (278,652)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">113,810,285<span></span>
</td>
<td class="nump">125,257,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;C-1</div> Preferred Stock, legacy Class&#160;A Common Stock, and legacy Class&#160;B Common Stock have been retroactively restated to give effect to the Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital exercise of loan and security agreement warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital settlement of the first tranche of forward contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in unrealized loss on available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock pursuant to the common stock purchase agreement shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock through business combination and private investment of public equity net of transaction costs and derivative liabilities shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock through business combination and private investment of public equity net of transaction costs and derivative liabilities value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon exercise of common stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon exercise of common stock warrants, Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ReclassificationOfTemporaryEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of temporary equity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ReclassificationOfTemporaryEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90193-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723796592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (38,241)<span></span>
</td>
<td class="num">$ (71,521)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">4,651<span></span>
</td>
<td class="nump">7,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,765<span></span>
</td>
<td class="nump">44,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of earnout liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,207)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="nump">1,664<span></span>
</td>
<td class="num">(22,132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ChangeInFairValueOfForwardContract', window );">Change in fair value of forward contract</a></td>
<td class="nump">230<span></span>
</td>
<td class="num">(5,764)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AmortizationOfDebtCommitmentFeeAsset', window );">Amortization of debt commitment fee asset</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Accretion of available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(949)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AccretionOfDebtEndOfTermLiabilities', window );">Accretion of debt end of term liabilities</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NonCashLeaseExpense', window );">Non-cash&#160;lease expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,063)<span></span>
</td>
<td class="num">(4,692)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(1,099)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other assets</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">493<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(389)<span></span>
</td>
<td class="num">(707)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="nump">4,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Other liabilities</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(295)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(29,044)<span></span>
</td>
<td class="num">(62,689)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(7,008)<span></span>
</td>
<td class="num">(22,737)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(84,287)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(7,008)<span></span>
</td>
<td class="num">(107,024)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid', window );">Proceeds from Business Combination, net of transaction costs paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">225,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_TransactionCostsPaid', window );">Transaction costs paid directly by Rigetti</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,842)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of notes payable</a></td>
<td class="nump">27,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments on principal of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments on debt issuance costs</a></td>
<td class="num">(247)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PaymentOfLoanAndSecurityAgreementExitFees', window );">Payment on loan and security agreement exit fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PaymentOfDeferredOfferingCosts', window );">Payments on deferred offering costs</a></td>
<td class="num">(1,548)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants', window );">Proceeds from issuance of common stock upon exercise of stock options and warrants</a></td>
<td class="nump">378<span></span>
</td>
<td class="nump">6,068<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">25,583<span></span>
</td>
<td class="nump">215,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of changes in exchange rate on cash and restricted cash</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(10,474)<span></span>
</td>
<td class="nump">45,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">22,520<span></span>
</td>
<td class="nump">12,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">12,046<span></span>
</td>
<td class="nump">57,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,489<span></span>
</td>
<td class="nump">3,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of non-cash financing activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera', window );">Initial fair value of earn-out liability acquired in merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses', window );">Deferred offering costs in accounts payable and accrued expenses</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability.', window );">Fair value of loan and security agreement warrant liability</a></td>
<td class="nump">2,691<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger', window );">Initial fair value of private placement and public warrants liability acquired in merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ExerciseOfLoanAndSecurityAgreementWarrants', window );">Reclassification of loan and security agreement warrants to equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SettlementOfTheFirstTrancheOfForwardContract', window );">Settlement of the first tranche of forward contract</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance', window );">Capitalization of deferred costs to equity upon share issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment recorded in accounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense', window );">Purchases of property and equipment recorded in accrued expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss short term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602', window );">Right-of-use&#160;assets recorded on adoption of ASU&#160;2016-02</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602', window );">Operating lease liabilities recorded on adoption of ASU&#160;2016-02</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets', window );">Lease liabilities arising from obtaining right-of-use assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,892<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AccretionOfDebtEndOfTermLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion of debt end of term liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AccretionOfDebtEndOfTermLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AmortizationOfDebtCommitmentFeeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of debt commitment fee asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AmortizationOfDebtCommitmentFeeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalization of deferred costs to equity upon share issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ChangeInFairValueOfForwardContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of forward contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ChangeInFairValueOfForwardContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ExerciseOfLoanAndSecurityAgreementWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of loan and security agreement warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ExerciseOfLoanAndSecurityAgreementWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of loan and security agreement and warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial fair value of earn-out liability acquired in merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial fair value of private placement and public warrants liability acquired in merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liabilities arising from obtaining right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_NonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_NonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease liabilities recorded on adoption of ASU 2016-02.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PaymentOfDeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PaymentOfDeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PaymentOfLoanAndSecurityAgreementExitFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of loan and security agreement exit fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PaymentOfLoanAndSecurityAgreementExitFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from business combination net of transaction costs paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock upon exercise of stock options and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases of property and equipment recorded in accrued expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right of use assets recorded on adoption Of ASU 2016-02.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_SettlementOfTheFirstTrancheOfForwardContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement of the first tranche of forward contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_SettlementOfTheFirstTrancheOfForwardContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_TransactionCostsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction costs paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_TransactionCostsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728114336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">1. DESCRIPTION OF BUSINESS </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rigetti Computing, Inc. and its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Rigetti&#8221;), builds quantum computers and the superconducting quantum processors that power them. Through the Company&#8217;s Quantum Computing as a Service (&#8220;QCaaS&#8221;) platform, the Company&#8217;s machines can be integrated into any public, private or hybrid cloud. The Company offers product types of Platform, Research and Software Tools usage in application areas of benchmarking, chemical simulation, education/entertainment, machine learning, and optimization. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is located and headquartered in Berkeley, California. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Munich, Germany. The Company&#8217;s revenue is derived primarily from operations in the United States and the United Kingdom. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Basis of Presentation </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;2, 2022 (the &#8220;Closing Date&#8221;), a merger transaction between Rigetti Holdings, Inc. (&#8220;Legacy Rigetti&#8221;) and Supernova Partners Acquisition Company II, Ltd. (&#8220;SNII&#8221;) was completed (the &#8220;Business Combination&#8221;, see Note 3). In connection with the closing of the Business Combination, the Company changed its name to Rigetti Computing, Inc. and all of SNII Class&#160;A ordinary shares and SNII Class&#160;B ordinary shares automatically converted into shares of Common Stock, par value $0.0001, of the Company (the &#8220;Common Stock&#8221;) on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis. The SNII Public Warrants and the Private Warrants held by SNII became warrants for Common Stock. The Company&#8217;s Common Stock and Public Warrants trade on the Nasdaq Capital Market under the ticker symbols &#8220;RGTI&#8221; and &#8220;RGTIW,&#8221; respectively. For more information on this transaction, see Note 3. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company determined that Legacy Rigetti was the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification (ASC) 805, Business Combination. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The determination was primarily based on the following facts: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Former Legacy Rigetti stockholders have a controlling voting interest in the Company; </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The Company&#8217;s board of directors as of immediately after the closing is comprised of eight board members, six seats occupied by previous Rigetti board members and one seat being occupied by a previous Supernova representative. The final eighth seat was filled by an individual who did not have ties to either Rigetti or Supernova <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-merger;</div> and </div></td></tr></table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Legacy Rigetti management continues to hold executive management roles for the post-combination company and be responsible for the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-to-day</div></div> operations. </div></td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Rigetti issuing stock for the net assets of SNII, accompanied by a recapitalization. The primary asset acquired from SNII was cash. Separately, the Company also assumed warrants that were deemed to be derivatives and meet liability classification subject to fair value adjustment measurements upon closing of the Business Combination (the &#8220;Closing&#8221;). No goodwill or other intangible assets were recorded as a result of the Business Combination.</div></div><br/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">While SNII was the legal acquirer in the Business Combination, because Legacy Rigetti was deemed the accounting acquirer, the historical financial statements of Legacy Rigetti became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the financial statements included in this report reflect (i)&#160;the historical operating results of Legacy Rigetti prior to the Business Combination; (ii)&#160;the combined results of SNII and Legacy Rigetti following the closing of the Business Combination; (iii)&#160;the assets and liabilities of Legacy Rigetti at their historical cost; and (iv)&#160;the Company&#8217;s equity structure for all periods presented. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><br/></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The equity structure has been retroactively restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company&#8217;s Common Stock, $0.0001 par value per share, issued to Legacy Rigetti shareholders and Legacy Rigetti convertible preferred shareholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Rigetti redeemable convertible preferred stock and Legacy Rigetti Common Stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying consolidated financial statements of the Company and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. All dollar amounts in tables, except share and per share amounts, in the notes to the consolidated financial statements are presented in thousands unless otherwise noted. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Risks and Uncertainties</div></div> &#8212; The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including, but not limited to, the need for successful development of products, the need for additional capital (or financing) to fund operating losses, competition from substitute products and services from larger companies, protection of proprietary technology, patent litigation, dependence on key individuals, and risks associated with changes in information technology. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Based on our forecasts, we believe that our existing cash and cash equivalents and available for sale investments will be sufficient to meet our anticipated operating cash needs for at least the next 12 months from the issuance of these financial statements based on our current business plan and expectations and assumptions considering current macroeconomic conditions. </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> and Macroeconomic Conditions</div></div> &#8212; As of December&#160;31, 2022, and December&#160;31, 2021, the Company&#8217;s financial position was not significantly impacted by the effects of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19.</div> However, the duration and intensity of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and any resulting disruption to the Company&#8217;s operations remains somewhat uncertain. Global economic conditions have been worsening, with disruptions to, and volatility in, the credit and financial markets, disruption to banking systems, and rising inflation and interest rates in the U.S. and worldwide resulting from the effects of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> and otherwise. If these conditions persist and deepen, the Company could experience an inability to access additional capital or our liquidity could otherwise be impacted. If the Company is unable to raise capital when needed or on attractive terms, it would be forced to delay, reduce or eliminate its research and development programs and other efforts. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in Fiscal Year</div></div> &#8212; In October 2021, the board of directors of Rigetti approved a change to Rigetti&#8217;s fiscal <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> from January&#160;31 to December&#160;31, effective December&#160;31, 2021. The Company believes the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">year-end</div> change is important and useful to its financial statement users to allow for increased comparability with its industry peers. As a result of this change, the Company&#8217;s fiscal year now begins on January&#160;1 and ends on December&#160;31 of each year, starting on January&#160;1, 2022. Rigetti&#8217;s fiscal year 2021 covers a period of 11 months starting from February&#160;1, 2021 and ending on December&#160;31, 2021.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728316128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Emerging Growth Company</div></div> &#8212; Following the Business Combination, the Company qualifies as an emerging growth company (&#8216;&#8216;EGC&#8217;&#8217;) as defined in the Jumpstart our Business Startups (&#8216;&#8216;JOBS&#8217;&#8217;) Act. The JOBS Act permits companies with EGC status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company intends to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">earlier of the date the Company (i)&#160;is no longer an EGC or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div> &#8212; The </div> preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Such management estimates include, but are not limited to, the fair value of share-based awards, the fair value of the convertible preferred stock warrants, the fair value of the Forward Warrant Agreement (as defined below) , the fair value of derivative warrant liabilities, the fair value of Sponsor Vesting Shares issued in connection with the business combination (See Note 3), goodwill and intangible assets, accrued liabilities and contingencies, depreciation and amortization periods, revenue recognition and accounting for income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from those estimates.</div><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principals of Consolidation</div></div> &#8212;The consolidated financial statements include the accounts of Rigetti and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reclassifications</div></div> &#8212; Certain amounts reported previously have been reclassified to conform to current presentation, with no effect on stockholders&#8217; equity or net loss as previously presented. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Segments</div></div> &#8212; Operating segments are defined as components of an entity for which discrete financial information is available and that information is regularly reviewed by the Chief Operating Decision Maker (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM, who has ultimate responsibility for the operating performance of the Company and the allocation of resources. The Company&#8217;s CODM reviews financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. </div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign Currency</div></div> &#8212; The Company&#8217;s reporting currency is the US dollar. The functional currencies of the Company&#8217;s foreign subsidiaries are the local currencies (UK pounds sterling, Australian dollar and Canadian Dollar), which are the monetary unit of account of the principal economic environment in which the Company&#8217;s foreign subsidiaries operate. All assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollars is reflected as a foreign currency cumulative translation adjustment and reported as a component of accumulated other comprehensive gain (loss). Foreign currency transaction gains and losses resulting from or expected to result from transactions denominated in a currency other than the functional currency are recognized in other income (expense), net in the consolidated statements of operations and are de minimis for the year ended December 31, 2022 and 11 months ended December 31, 2021. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>  <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><br/></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Comprehensive Loss</div></div> &#8212; Comprehensive loss consists of two components including net loss and other comprehensive loss. The Company&#8217;s other comprehensive loss consists of foreign currency translation adjustments that result from consolidation of its foreign subsidiaries and unrealized loss on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities. </div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash, Cash Equivalents and Restricted Cash</div></div> &#8212; As of December&#160;</div>31, 2022 and December&#160;31, 2021, cash consists primarily of checking and savings deposits. As of December&#160;31, 2022, cash equivalents consist primarily of money market funds. There were no cash equivalents as of December&#160;31, 2021. The Company considers all highly liquid investment securities with remaining maturities at the date of purchase of three months or less to be cash equivalents. These cash equivalents are stated at cost, which approximates fair value.</div><div style="margin-top: 1em; margin-bottom: 1em"/> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>  <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s restricted cash balance includes cash whose use is limited by contractual provisions. As of December&#160;31, 2022, there was no restricted cash. As of December&#160;31, 2021, restricted cash consists of cash secured as collateral for letters of credit in favor of the Company&#8217;s landlord and its corporate credit card program. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,542</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,729</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash <div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>quivalents</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">317</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents and restricted cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57,888</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,046</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table>   <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investments </div></div>&#8212;<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>The Company classifies its investments in fixed income securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments. The Company&#8217;s investments consist of U.S Treasury securities, commercial paper, and corporate bonds that have a maturity of one year or less. These investments are recorded in the consolidated balance sheets at fair value. The fair value of our underlying investments is based on observable inputs and classified as Level&#160;1 and Level&#160;2. Unrealized gains and losses on these investments are included as a separate component of Accumulated Other Comprehensive Loss. The Company evaluates its investments to assess whether those with unrealized loss positions are other than temporarily impaired. Impairments are considered other than temporary if they are related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of the cost basis. Realized gains and losses and declines in value determined to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the statements of operations. See Note 15 for further information on fair value. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accounts Receivable</div></div> &#8212; Accounts receivable are recorded at invoice value, net of allowance for doubtful accounts. Unbilled receivables are included in accounts receivable and include amounts that were invoiced subsequent to the period end for which revenue was recognized in advance of the right to invoice. On a periodic basis, management evaluates its accounts receivable and determines whether to provide an allowance or if any accounts should be written off based on a past history of write-offs, collections, and current credit conditions. A receivable is considered past due if the Company has not received payments based on agreed-upon terms. As of December&#160;31, 2022 and December&#160;31, 2021, the Company does not have any allowances for doubtful accounts. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Prepaid Expenses and Other Current Assets </div></div>&#8212; Prepaid expenses and other current assets include prepaid software, prepaid insurance, other prepaid expenses, all of which are expected to be recognized or realized within the next 12 months. </div>  <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;<br/></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deferred Offering Costs</div></div> &#8212;The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with the Business Combination or issuance of shares under a registration statement filed with the SEC. After consummation of the Business Combination or issuance of shares, costs allocated to equity-classified instruments are recorded as a reduction to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. Costs allocated to liability-classified instruments are expensed. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The </div></div> Company incurred $2.3&#160;million of offering costs for the year ended December&#160;31, 2022, which related to filing new registration statements with the SEC after the close of the Business Combination. These costs are incremental to those disclosed in Note 3. A portion of the offering costs amounting to $0.7&#160;million relates to the Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC. As of December&#160;31, 2022, while the registration statement related to the Common Stock Purchase Agreement with B. Riley Principal Capital II, </div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;">LLC was filed with the SEC, there were no shares issued other than the commitment shares referred to in Note&#160;12. As such $0.7&#160;million of the offering costs were classified as deferred offering costs. As of December&#160;31, 2021, the Company had recorded deferred offering costs of $3.4&#160;million, all of which are related to the Business Combination as discussed in Note 3. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Property and Equipment, Net </div></div>&#8212; Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets. The Company uses an estimated useful life of three years for furniture and other assets and information technology hardware (&#8220;IT hardware&#8221;), seven years for process equipment, and three to ten years for quantum computing fridges. Leasehold improvements are amortized over the shorter of the lease-term or the estimated useful life of the related asset. Expenditures for repairs and maintenance are expensed as incurred. Upon disposition, the cost and related accumulated depreciation are removed and any resulting gain or loss is reflected in other income (expense) in the consolidated statements of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Long-lived assets, which consist of property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset (asset group) may not be recoverable. When such events or changes in circumstances occur, the Company performs an undiscounted cash flow analysis to determine if an impairment exists and, if so, an impairment loss would be recorded based on the excess of the carrying amount of the asset (asset group) over its fair value. During the year ended December&#160;31, 2022 the Company determined there was a triggering event and an undiscounted cash flow analysis was performed. Based on the results of this analysis, the Company&#8217;s long-lived assets were not impaired and no impairment charge was recorded. During the 11 months ended December&#160;31, 2021 no triggering events were noted. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill </div></div>&#8212; Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed in a business combination. Goodwill has an indefinite useful life and is not amortized. The Company reviews its goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value of the Company may exceed its fair value. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the Company is less than its carrying amount, including goodwill. If that is the case, the Company performs a quantitative impairment test, and, if the carrying amount of the Company exceeds its fair value, then the Company will recognize an impairment charge for the amount by which its carrying amount exceeds its fair value, not to exceed the carrying amount of the goodwill. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company determined a triggering event existed in the fourth quarter of 2022 resulting from the sustained decline in the Company&#8217;s stock price. A quantitative impairment test was performed and as a result, the Company recognized a $5.4&#160;million goodwill impairment charge for the year ended December&#160;31, 2022. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deferred Financing Costs</div></div> &#8212; The incremental cost, including the fair value of warrants, directly associated with obtaining <div style="letter-spacing: 0px; top: 0px;;display:inline;">debt</div> financing is capitalized as deferred financing costs upon the issuance of the debt and amortized over the term of the related debt agreement using the effective-interest metho<div style="letter-spacing: 0px; top: 0px;;display:inline;">d</div> with such amortized amounts included as a component of interest expense in the consolidated statements of operations. Unamortized deferred financing costs are presented on the consolidated balance sheets as a direct deduction from the carrying amount of the related de<div style="display:inline;">b</div>t<div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:rgba(255, 255, 255, .0);;display:inline;">obligation.<div style="letter-spacing: 0px; top: 0px;;display:inline;"/> </div></div></div></div> <div style="background-color:rgba(255, 255, 255, .0);;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:rgba(255, 255, 255, .0);;display:inline;">&#160;</div></div></div><br/></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"/>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public and Private Warrants</div></div> &#8212; At the Closing Date of the Business Combination, SNII </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> had 4,450,000 Private Warrants and&#160;</div>8,625,000<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;Public warrants outstanding. Each whole warrant entitles the holder to purchase one share of the Company&#8217;s Common Stock at a price of $</div>11.50<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> per share, subject to adjustments, and will expire </div>five years<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> after the Business Combination or earlier upon redemption or liquidation.</div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">fixed-for-fixed</div></div> option on equity shares. Therefore, the Private Warrants are not considered indexed to the Company&#8217;s stock and should be </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">classified as a liability. Since the Private Warrants meet the definition of a derivative, the Company recorded the Private Warrants as liabilities in the consolidated balance sheet at fair value upon the closing, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date. The fair value of the Private Warrants are measured using the Black-Scholes option-pricing model. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Public Warrants also fail to meet the indexation guidance in ASC 815 and are accounted for as liabilities because they include a provision whereby if there is not an effective registration statement, the warrant holders have a cap of 0.361 shares of Common Stock per warrant (subject to adjustment), on the issuable number of shares in a cashless exercise. Subsequent to the separate listing and trading of the Public Warrants, their fair value has been measured based on the observable listed prices for such warrants. Upon consummation of the Business Combination, the Company recorded a liability related to the Public Warrants of $16.3&#160;million, with an offsetting entry to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. On December&#160;31, 2022, the fair value of the Public Warrants decreased to $0.7&#160;million with the corresponding gain from the change in fair value recorded in the consolidated statement of operations for the year ended December&#160;31, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See Note 13 and 15 for further information on fair value. </div>   <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative Warrant Liabilities </div></div>&#8212; The<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;) at the initial recognition date. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than the Public and Private Warrants noted above, the Company also issued warrants to Trinity Capital which are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period until exercised. The fair value of the warrant liabilities issued were initially measured using the Black- Scholes model and are subsequently remeasured at each reporting period with changes recorded as a component of other (expense) income in the Company&#8217;s consolidated statements of operations. During the year ended December&#160;31, 2022 these warrants were exercised and are no longer outstanding. </div>   <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Liability &#8212;</div></div> At the closing of the Business Combination, the SPAC Sponsor subjected certain Sponsor Vesting Shares to forfeiture and vesting as of the Closing Date if thresholds related to the weighted average price of Common Stock are not met for the duration of various specified consecutive day trading periods during the five-year period following the Closing (the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Earn-Out</div> Triggering Events&#8221;). Any such shares held by the Sponsor that remain unvested after the fifth anniversary of the Closing will be forfeited. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These Sponsor Vesting Shares are accounted for as liability classified instruments because the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Triggering Events that determine the number of Sponsor Vesting Shares to be earned back by the Sponsor include outcomes that are not solely indexed to the Common Stock of the Company. The aggregate fair value of the Sponsor Vesting Shares on the Closing Date was estimated using a Monte Carlo simulation model and was determined to be $20.4&#160;million at the Closing Date. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2022, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Triggering Events were not achieved for any of the tranches, and as such, the Company adjusted the carrying amount of the liability to its estimated fair value of $1.2&#160;million. The change in the fair value of $19.2&#160;million for the year ended December&#160;31, 2022 is included in gain on fair value change, net in the condensed consolidated statements of operations. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant inputs into the respective valuation models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows:</div></div></div> <div style="null;text-indent: 0px;"> <div> <div style="display: inline; background-color: white;"> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 54%;"/>
<td style="width: 20%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 20%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Assumptions</div></div></div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"> <div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial Recognition on<br/>March 2, 2022</div></div></div> </div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"> <div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></div> </div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Price</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.73</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Simulated trading days</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,198</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,050</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility (annual)</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30.50</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109.30</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.74</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.04</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Estimated time to expiration (years)</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> </div> </div> </div>    <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue Recognition</div></div> &#8212; The Company recognizes revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Revenue from Contracts with Customers </div></div>and accounts for certain contract costs in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;340-40,</div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Other Assets and <div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred</div> Costs&#8212;Contracts with Customers.</div></div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes revenue from contracts <div style="letter-spacing: 0px; top: 0px;;display:inline;">with</div> customers by applying the following five-step model: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identify the contract with a customer </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identify the performance obligations in the contract </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Determine the transaction price </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocate the transaction price to the performance obligations in the contract </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recognize revenue when (or as) performance obligations are satisfied </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company generates revenue through its Quantum Computing as a Service (&#8220;QCaaS&#8221;) and development contracts and other services. Access to Rigetti quantum computing systems can be purchased as a quantum computing subscription, or on a usage basis for a specified quantity of hours. Revenue related to subscription-based access to (&#8220;QCaaS&#8221;) is recognized over time as access to the systems is provided on a ratable basis over the subscription term, which can range from six months to two years. This time-based input measure of progress provides a faithful depiction of the transfer of the services because the benefits the customer obtains generally equals the benefit from its access to the systems throughout the subscription term. Revenue related to usage-based access to Rigetti quantum computing systems is recognized over time as the systems are accessed using an output method based on compute credit hours expended. This output method provides a faithful depiction of the transfer of the services because the customer has purchased a specified quantity of hours of usage that diminishes each time an hour is expended and therefore each hour of access to the systems is considered a discrete delivery of underlying services in these arrangements. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Development contracts are generally multi-year, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> arrangements in which the Company provides professional services regarding practical applications of quantum computing to technology and business problems within the customer&#8217;s industry or organization and assists the customer in developing quantum algorithms and applications that will provide commercial value to the customer in areas of business interest. Development contracts are typically fixed fee arrangements invoiced on a milestone basis but may also be invoiced on a time and materials or cost reimbursement basis in certain cases. Revenue related to development contracts and other services is recognized over time based on completed milestones or hours or costs incurred as appropriate. Revenue for partially completed milestones deemed probable of being met is recognized using an input measure based on actual labor hours incurred to date relative to total estimated labor hours needed to complete the milestone. This input measure of progress provides a faithful depiction of the transfer of the services because it closely depicts the Company&#8217;s efforts or inputs to the satisfaction of the performance obligation. Revenue related to the sale of custom quantum computing components is recognized at a point in time upon acceptance by the customer. </div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">When the Company&#8217;s contracts with customers contain multiple performance obligations, the transaction price is allocated on a relative standalone selling price basis to each performance obligation. The Company typically </div></div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"/> <div/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">determines standalone selling price based on observable selling prices of our products and services. In instances where standalone selling price is not directly observable, standalone selling price is determined using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price, which includes fixed consideration and estimates of variable consideration. The amount of variable consideration included in the transaction price is constrained and is included only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s contracts with customers may include renewal or other options at fixed prices. Determining whether such options are considered distinct performance obligations that provide the customer with a material right and therefore should be accounted for separately requires significant judgment. Judgment is required to determine the standalone selling price for each renewal option to determine whether the renewal pricing is reflective of standalone selling price or is reflective of a discount that would provide the customer with a material right. Based on the Company&#8217;s assessment of standalone selling prices, the Company determined that there were no significant material rights provided to its customers requiring separate recognition. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The timing of revenue recognition may not align with the right to invoice the customer. The Company records accounts receivable when it has the unconditional right to issue an invoice and receive payment, regardless of whether revenue has been recognized. If revenue has not yet been recognized, a contract liability (deferred revenue) is also recorded. If revenue is recognized in advance of the right to invoice, a contract asset or unbilled receivable is recorded, depending on whether the Company&#8217;s right to consideration is considered conditional or unconditional. Unbilled receivables are included within accounts receivable in the consolidated balance sheets. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In instances where the timing of revenue recognition differs from the timing of the right to invoice, the Company has determined that a significant financing component generally does not exist. The primary purpose of the Company&#8217;s invoicing terms is to provide customers with simplified and predictable ways of purchasing the products and services and not to receive financing from or provide financing to the customer. Additionally, the Company has elected the practical expedient that permits an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment terms on invoiced amounts are typically net 30 days. The Company does not offer rights of return for its products and services in the normal course of business, and contracts generally do not include service-type warranties that provide any incremental service to the customer beyond providing assurance that the goods and services conform to applicable specifications or customer-specific or subjective acceptance provisions. The Company also excludes from revenue government-assessed and imposed taxes on revenue-generating activities that are invoiced to customers. </div>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Costs of Obtaining and Fulfilling Contracts</div></div> &#8212; The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less. The Company capitalizes incremental costs incurred to fulfill its contracts that (i)&#160;relate directly to the contract, (ii)&#160;are expected to generate resources that will be used to satisfy the Company&#8217;s performance obligation(s) under the contract, and (iii)&#160;are expected to be recovered through revenue generated under the contract. </div></div>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost of Revenue</div></div> &#8212; Cost of revenue consists primarily of all direct and indirect cost associated with providing QCaaS offerings and development contracts and other services, including employee salaries and employee </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">related costs, including compensation, bonuses, employee taxes and benefit costs of program management and personnel associated with the delivery of goods and services to customers. Cost of revenue also includes an allocation of facility costs, depreciation and amortization directly related to providing the QCaaS offerings and development contracts and other services.</div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Research and Development </div></div>&#8212; Research and development costs are expensed as incurred. Research and development expenses include compensation, employee benefits, stock-based compensation, outside consultant fees, allocation of facility costs, depreciation and amortization, materials and components purchased for research and development. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">General and Administrative</div></div> &#8212; General and administrative expenses include compensation, employee benefits, stock-based compensation, legal, insurance, finance administration and human resources, an allocation of facility costs (including leases), bad debt costs, professional service fees, and an allocation of other general overhead costs including depreciation and amortization to support Rigetti&#8217;s operations, which consists of operations other than associated with providing QCaaS offerings and development contracts and other services. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sales and Marketing &#8212;</div></div> Sales and marketing expenses consist primarily of compensation including stock-based compensation, employee benefits of sales and marketing employees, outside consultants fees, travel and marketing and promotion costs. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capitalized Software &#8212;</div></div> The Company capitalizes the costs to develop <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">its&#160;internal-use&#160;software</div> when preliminary development efforts are successfully completed, management has authorized and committed project funding, and it is probable that the project will be completed and the software will be used as intended. Such costs are included in property and equipment in the consolidated balance sheets and are amortized on a straight-line basis over the estimated useful life of the related asset. These capitalized costs are primarily related to the software infrastructure supporting the quantum computing services purchased by customers. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. During the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, no capitalized software has been recorded. </div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes </div></div>&#8212; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of December&#160;31, 2022 and December&#160;31, 2021, the Company has recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of income tax positions only if it is more likely than not that those positions will be sustained. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in income tax expense.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Loss Per Share</div></div> &#8212; Basic net loss per common share is computed by dividing the net loss available to Common Stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to Common Stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">of common shares and potential common shares outstanding when the impact is not antidilutive. Potential common shares from stock options, unvested restricted stock units and Common Stock warrants are computed using the treasury stock method, while those from convertible Series C and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock are computed using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. Contingently issuable shares are included in basic net loss per share only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration shall be considered outstanding common shares and included in the computation of basic net loss per share. </div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/><div style="margin-top: 1em; margin-bottom: 1em"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock-Based Compensation</div></div> &#8212; The Company accounts for share-based compensation in accordance with ASC 718, Compensation &#8211; Stock Compensation. The Company&#8217;s share-based compensation awards are all equity-classified and consist of stock options, restricted stock units (&#8220;RSU&#8221;) and restricted stock awards (&#8220;RSA&#8221;). Most stock options have service vesting conditions ranging from 1 to 5 years. RSAs are fully vested on grant date. RSUs granted under the Rigetti&#160;&amp; Co., Inc. 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;) have a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4-year</div> service vesting condition and a performance condition linked to the occurrence of a liquidity event defined as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">change-in-control</div></div> event, successful initial public offering or successful merger with a special purpose acquisition company, which was satisfied at the Closing. RSUs granted under the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) have a service vesting condition only. The Company occasionally issues awards that might have different vesting conditions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compensation expense is based on the grant-date fair value of the awards and recognized over the requisite service period using a straight-line method for awards that have a service only condition. Compensation expense for awards with service and performance and/or market conditions is recognized using a graded vesting method. Compensation expense for RSAs is recognized fully on grant date. Compensation expenses for awards with a market condition are recognized over the requite service period regardless of whether the market condition is met unless the service requirement is not met. The Company has elected to account for forfeitures of employee stock awards as they occur. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div>&#8212; The Company reports all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis... Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 1&#8212;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 2&#8212;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 3&#8212;Inputs are unobservable for the asset or liability. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentrations of Credit Risk</div></div> &#8212; Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments in the form of commercial paper and corporate bonds, and trade accounts receivable. The Company&#8217;s cash and cash equivalents and short-term investments are placed with high-credit-quality financial institutions, and at times exceed federally insured limits. To date, the Company has not experienced any credit loss relating to its cash and cash equivalents or short-term investments. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/>  <div style="font-family: Times New Roman; font-size: 10pt; margin-bottom: 0pt; text-indent: 0px; margin-top: 1em"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant </div></div> customers that represent 10% or more of revenue are set forth in the <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">following tables: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year<br/>Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the 11<br/>months<br/>ended<br/>December&#160;31,</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer A</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">33%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">16%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer B</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">18%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">20%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer C</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">15%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">15%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer D</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">14%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">29%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer E</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">11%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer F</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">*</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">17%</td></tr></table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*Customer accounted for less than 10% of revenue in the respective period </div></div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer A</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">65%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer B</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">13%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">35%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer C</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">10%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">34%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer D</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">29%</td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*Customer accounted for less than 10% of accounts receivable in the respective period</div></div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales to government entities comprised 81.3% and 80.0% of the Company&#8217;s total revenue for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recently Adopted Accounting Pronouncements </div></div>&#8212; In February 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-0</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2,</div> Leases and related subsequently issued ASUs (collectively, &#8220;Topic 842&#8221;), which supersedes Topic 840. From a lessee perspective, the core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (&#8220;ROU&#8221;) asset representing its right to use the underlying asset for the lease term. There continues to be a differentiation between finance leases (which replace capital leases as so identified under Topic 840) and operating leases. However, the principal difference from the previous guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the statement of financial position. The updated guidance also requires additional quantitative and qualitative disclosures and allows various practical expedients.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/><div style="margin-top: 1em; margin-bottom: 1em"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted Topic 842 effective January&#160;1, 2022, using the modified retrospective transition option of applying the new standard at the adoption date for all leases with an original term greater than 12 months. The Company elected the package of practical expedients requiring no reassessment of (i)&#160;whether any expired or existing contracts are or contain leases, (ii)&#160;the lease classification of any expired or existing leases, or (iii)&#160;initial direct costs for any existing leases. Adoption of the standard had a material impact on the Company&#8217;s consolidated balance sheet by recognizing operating lease ROU assets and operating lease liabilities but did not<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>have an impact on its consolidated statement of operations or cash flows on the date of adoption. The adoption of Topic 842 was recorded as of January&#160;1, 2022 and resulted in the recognition of operating lease ROU assets and operating lease liabilities of $6.3&#160;million and $6.6&#160;million respectively and a $0.3&#160;million adjustment to deferred rent, with no impact to accumulated deficit as of January&#160;1, 2022. The period ended December&#160;31, 2021 continues to be reported in accordance with the Company&#8217;s historic accounting under previous lease guidance, Topic 840.</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company determines if an arrangement includes a lease at inception. Operating leases are included in the Company&#8217;s balance sheet as operating lease ROU assets and operating lease liabilities as of December&#160;31, 2022. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. In determining the net present value of its lease payments, the Company uses an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date, or the date of adoption of Topic 842. The operating lease ROU assets also include any lease payments made less lease incentives. The Company&#8217;s leases may include options to extend or terminate the lease, which is considered in the lease term when it is reasonably certain that the Company will exercise any such options. Lease expense is recognized on a straight-line basis over the expected lease term, taking into account adjustments for provisions such as free rent, escalating base monthly rental payments or deferred payment terms such as rent holidays that defer the commencement date of required payments. The Company has elected not to apply the recognition requirements of Topic 842 for short-term leases. The Company considers leases with a term of 12 months or less at the date of commencement to be short-term. </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2021, the FASB issued&#160;ASU No. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04,&#160;Earnings</div> Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-50),</div> Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#160;(&#8220;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#8221;).</div> The guidance in&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#160;clarifies</div> and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December&#160;15, 2021.The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Company&#160;adopted&#160;ASU&#160;2021-04&#160;as</div> of&#160;January 1, 2022. The adoption of&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#160;did</div> not have an impact on the Company&#8217;s financial position and results of operations. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,&#160;Income</div> Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> removes certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. The Company adopted this ASU on January&#160;1, 2022. Adoption did not have a significant impact on the Company&#8217;s financial statements or related disclosures. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recently Issued Accounting Pronouncements Not Yet Adopted </div></div>&#8212; In June 2022, the FASB issued&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2022-03,&#160;ASC</div> Subtopic 820&#160;&#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The FASB issued this update (1)&#160;to clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2)&#160;to amend a related illustrative example, and (3)&#160;to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The ASU is effective for the Company after December&#160;15, 2024, and interim periods within those fiscal years, with early adoption permitted. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In August 2020, the FASB issued&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06,</div> Debt - (Topic 815) (&#8220;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06&#8221;),</div> which simplifies an issuer&#8217;s accounting for convertible instruments and its application of the derivatives scope exception for contracts in its own equity. The amendments in&#160;ASU No. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06&#160;are</div> effective for public companies, other than smaller reporting companies, for fiscal years beginning after December&#160;15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December&#160;15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December&#160;15, 2020, including interim periods within those fiscal years. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In April 2019, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU&#160;2019-04,&#160;Codification&#160;Improvements</div> to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU&#160;No.&#160;2019-04&#160;was</div> issued as part of the FASB&#8217;s ongoing project to improve upon its Accounting Standards Codification (ASC), and to clarify and improve areas of guidance related to recently issued standards on credit losses, hedging, and recognition and measurement. For entities that have not yet adopted the guidance in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Update&#160;2016-13,&#160;the</div> effective dates and the transition requirements for these amendments are the same as the effective date and transition requirements in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Update&#160;2016-13.&#160;The</div> amendments related to ASC 326 are effective for the Company as of January&#160;1, 2023.&#160;The adoption of the ASU is not expected to have a material impact on its consolidated financial statements. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728287312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">3. BUSINESS COMBINATION </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed in Note 1, on March&#160;2, 2022, the Business Combination was completed. Pursuant to the Company&#8217;s certificate of incorporation, as amended on March&#160;2, 2022, the Company is authorized to issue 1,000,000,000 shares of Common Stock and 10,000,000 shares of preferred stock, par value $0.0001, of the Company (the &#8220;Preferred Stock&#8221;). The holders of shares of Common Stock are entitled to <div style="letter-spacing: 0px; top: 0px;;display:inline;">one</div> vote for each share of Common Stock held. The Preferred Stock is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting.</div> No shares of Preferred Stock were issued and outstanding as of December&#160;31, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;1, 2022, prior to the Closing, as contemplated by the Merger Agreement and following approval by SNII&#8217;s shareholders at an extraordinary general meeting of shareholders held on February&#160;28, 2022 (the &#8220;Extraordinary General Meeting&#8221;), SNII filed a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filed a certificate of incorporation (the &#8220;Certificate of Incorporation&#8221;) and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which SNII was domesticated and continues as a Delaware corporation, changing its name to &#8220;Rigetti Computing, Inc.&#8221;<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of and upon the effective time of the Domestication (which occurred on March&#160;1, 2022), among other things:(1) each then issued and outstanding Class&#160;A ordinary share, par value $0.0001 per share, of SNII (&#8220;SNII Class&#160;A ordinary share&#8221;) converted automatically, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into a share of Common Stock; (2)&#160;each then issued and outstanding Class&#160;B ordinary share, par value $0.0001 per share, of SNII (&#8220;SNII Class&#160;B ordinary share&#8221;) converted automatically, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into a share of Common Stock; (3)&#160;each then issued and outstanding whole warrant of SNII to purchase one SNII Class&#160;A ordinary share converted automatically into a Public Warrant to acquire one share of Common Stock at an exercise price of $11.50 per share pursuant to the Warrant Agreement, dated March&#160;1, 2021, between SNII and American Stock Transfer&#160;&amp; Trust Company, as warrant agent; (4)&#160;and each then issued and outstanding unit of SNII (the &#8220;SNII Units&#8221;) was separated and converted automatically into one share of Common Stock and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-fourth</div> of one Warrant. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immediately prior to the effective time of the Business Combination, each share of Legacy Rigetti&#8217;s Series C preferred stock and Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock (collectively, the &#8220;Legacy Rigetti Preferred Stock&#8221;) with Par Value of $0.000001 converted into shares of Common Stock of Legacy Rigetti (&#8220;Legacy Rigetti Common Stock&#8221;) in accordance with the Amended and Restated Certificate of Incorporation of Legacy Rigetti (such conversion, the &#8220;Legacy Rigetti Preferred Conversion&#8221;). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the Business Combination, among other things (1)&#160;all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (in<div style="background-color:#ffffff;;display:inline;">cluding Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of </div><div style="background-color:#ffffff;;display:inline;">0.7870</div><div style="background-color:#ffffff;;display:inline;"> (the &#8220;Exchange Ratio&#8221;) for an aggregate of </div><div style="background-color:#ffffff;;display:inline;">78,959,579</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:#ffffff;;display:inline;">&#160;</div></div><div style="background-color:#ffffff;;display:inline;">shares of Common Stock; (2)&#160;each warrant to purchase Legacy Rigetti Common Stock converted into a warrant to purchase shares of Common Stock (&#8220;Assumed Warrant&#8221;), with each Assumed Warrant subject to the same terms and conditions as were applicable to the original Legacy Rigetti warrant and having an exercise price and number of shares of Common Stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement; (3)&#160;each option to purchase Legacy Rigetti Common Stock converted into an option to purchase shares of Common Stock (&#8220;Assumed Option&#8221;), with each Assumed Option subject to the same terms and conditions as were applicable to the original Legacy Rigetti</div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">option and with an exercise price and number of shares of Common Stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement, and; (4)&#160;each Legacy Rigetti restricted stock unit award converted into a restricted stock unit award to receive shares of Common Stock (&#8220;Assumed RSU Award&#8221;), with each Assumed RSU Award subject to the same terms and conditions as were applicable to the Legacy Rigetti restricted stock unit award, and with the number of shares of Common Stock to which the Assumed RSU Award converted based on the Exchange Ratio and other terms contained in the Merger Agreement. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connectio</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">n with the execution of the Merger Agreement, SNII entered into a sponsor support agreement (the &#8220;Sponsor Support Agreement&#8221;) with the Sponsor, Legacy Rigetti and SNII&#8217;s directors and officers. Pursuant to the Sponsor Support Agreement, the Sponsor and SNII&#8217;s directors and officers (&#8220;Sponsor Holders&#8221;), among other things, agreed to vote all of their shares of SNII capital stock in favor of the approval of the Business Combination. In addition, pursuant to the Sponsor Support Agreement, (i) </div>2,479,000<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">five year </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">period following the Closing, the volume weighted average price of Common Stock equals or exceeds $</div>12.50<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> for any </div><span style="-sec-ix-hidden:hidden73805546">twenty trading days</span><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> within a period of </div><span style="-sec-ix-hidden:hidden73805503">thirty consecutive trading days</span><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, and (ii) </div>580,273<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the </div>five year<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> period following the Closing, the volume weighted average price of Common Stock equals or exceeds $</div>15.00<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> for any</div><span style="-sec-ix-hidden:hidden73805545"> twenty trading days</span><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> within a period of </div><span style="-sec-ix-hidden:hidden73805504">thirty consecutive trading days</span><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">. Any such shares held by the Sponsor Holders that remain unvested after the fifth anniversary of the Closing will be forfeited. (Refer to Note 2 for related significant accounting policy for the Sponsor </div><div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Liability).</div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div> <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Concurrently with the execution of the Merger Agreement, SNII entered into Subscription Agreements (the &#8220;Initial Subscription Agreements&#8221;) with certain investors (together, the &#8220;Initial PIPE Investors&#8221;), pursuant to which the Initial PIPE Investors agreed to subscribe for and purchase, and SNII agreed to issue and sell to the Initial PIPE Investors, an aggregate of 10,251,000 shares of Common Stock at a price of $10.00 per share, for aggregate gross proceeds of $102.5 Million (the &#8220;Initial PIPE Financing&#8221;). <div style="letter-spacing: 0px; top: 0px;;display:inline;">On December 23, 2021, SNII entered into Subscription Agreements (the &#8220;Subsequent Subscription Agreements&#8221;, and together with the Initial Subscription Agreements, the &#8220;Subscription Agreements&#8221;) with two&#160;investors (the &#8220;Subsequent PIPE Investors&#8221;, and together with the Initial PIPE Investors, the &#8220;PIPE Investors&#8221;) pursuant to which the Subsequent PIPE Investors agreed to subscribe for and purchase, and SNII agreed to issue and sell to the Subsequent PIPE Investors, an aggregate of&#160;</div>4,390,244 shares of Common Stock at a price of $10.25 per share, for aggregate gross proceeds of $45.0 Million (the &#8220;Subsequent PIPE Financing&#8221;, and together with the Initial PIPE Financing, the &#8220;PIPE Financing&#8221;). Pursuant to the Subscription Agreements, Rigetti agreed to provide the PIPE Investors with certain registration rights with respect to the shares purchased as part of the PIPE Financing. The PIPE Financing was consummated immediately prior to the Merger. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Business Combination is accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, SNII was treated as the &#8220;acquired&#8221; company for financial reporting purposes. </div></div><br/></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;">In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $225.6&#160;million. The table below shows the net proceeds from business combination and PIPE financing: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;SNII trust and cash (net of redemption)</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;PIPE</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">147,510</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;SNII operating account</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Net Proceeds from Business Combination and PIPE</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">225,604</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction costs consist of direct legal, accounting and other fees relating to the consummation of the Merger. Legacy Rigetti transaction costs specific and directly attributable to the business combination totaled </div></div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$20.65&#160;million. These costs were initially capitalized as incurred in deferred offering assets on the consolidated balance sheets. Upon the Closing, transaction costs related to the issuance of shares were recognized in stockholders&#8217; equity (deficit) while costs associated with the Public Warrants, Private Warrants and Sponsor Vesting Shares were expensed in the consolidated statements of operations. Of the total transaction cost of<div style="letter-spacing: 0px; top: 0px;;display:inline;"><br/></div>$20.65&#160;million, $19.75&#160;million was recorded to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital as a reduction of proceeds and the remaining $0.9&#160;million was recognized in the consolidated statements of operations during the year ended December&#160;31, 2022. Transaction cost paid through cash during the year ended December&#160;31, 2022, equals $16.7&#160;million. For the year ended December&#160;31, 2022, the Company also paid a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-time</div> bonus to certain employees related to the business combination of $2.1&#160;million. </div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The number of shares of Common Stock issued immediately following the consummation of the Business Combination was as follows: </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:79%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div>SNII Class&#160;A, outstanding prior to Business Combination</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: redemption of SNII Class&#160;A ordinary shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22,915,538</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div>SNII Class&#160;A ordinary shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,584,462</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;SNII Class&#160;B ordinary shares*</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in PIPE</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,641,244</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Business Combination and PIPE shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,850,706</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;Legacy Rigetti**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,221,069</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;exercise of Legacy Rigetti stock options immediately prior to the closing**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,123,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;exercise of Legacy Rigetti warrants immediately prior to the closing**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,234,408</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;upon conversion of Legacy Rigetti Series C preferred stock**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,478,261</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;upon conversion of Legacy Rigetti Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,902,302</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares of Common Stock immediately after Business Combination</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113,810,285</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">*</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes (i) 2,479,000 shares of Common Stock held by the Sponsor (the &#8220;Promote Sponsor Vesting Shares&#8221;) and (ii) 580,273 shares of Common Stock held by the Sponsor (&#8220;Sponsor Redemption-Based Vesting Shares&#8221;). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">**</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">(i) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of 0.7870 (the &#8220;Exchange Ratio&#8221;). (ii) the conversion ratio to Legacy Rigetti Common Stock for the Legacy Series C Preferred Stock was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> and for Legacy <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;C-1</div> Preferred Stock was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">eight-for-one.</div></div> </div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728186912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4. INVESTMENTS </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, investment securities in the Company&#8217;s Trust Account consisted of $36.3&#160;million in money market funds, $58.2&#160;million in United States Treasury securities, $3.6&#160;million in corporate bonds and $23.1&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;">million in commercial paper. The money market funds are classified as cash equivalents in the consolidated balance sheets. The Company classifies its investments in fixed income securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale.</div></div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> marketable securities are recorded at their estimated fair value. The amortized cost, gross unrealized holding loss included in other comprehensive income, and fair value of the </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">investment securities on December&#160;31, 2022 are presented in the table below. The Company did not hold investment securities at December&#160;31, 2021. </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 49%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized&#160;Cost&#160;as&#160;of<br/>December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross&#160;Unrealized<br/>Holding Loss</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;Value&#160;as&#160;of<br/>December&#160;31,&#160;2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash <div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>quivalents</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money Market Funds</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments:</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States Treasury Securities</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,514</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(304</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,210</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,571</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commercial Papers</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,142</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,142</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">121,583</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(314</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">121,269</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the Company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities have final maturities of one year or less. The Company reviews the individual securities that have unrealized losses in its short-term investment portfolio on a regular basis. The Company evaluates whether it has the intention to sell any of these investments and whether it is more likely than not that it will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met as of December&#160;31, 2022. The Company additionally evaluates whether the decline in fair value of the securities below their amortized cost basis is related to credit losses or other factors. Based on this evaluation, the Company determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-credit-related</div> factors. Accordingly, the Company determined that the unrealized losses were not other-than-temporary and that recording an impairment was therefore unnecessary for its short-term investments as of December&#160;31, 2022. All of the Company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities have been in an unrealized loss position for less than one year because they were all acquired in 2022. The Company did not have any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities as of December&#160;31, 2021. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728127232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">GOODWILL</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">5. GOODWILL </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the change in the carrying amount of goodwill for the Company for the year ended December&#160;31, 2022: </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 86%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 86%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">January 1, 2021</div></div></div></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,377</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 86%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Change</div><br/></div></div></div></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 86%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:86%"/>
<td style="vertical-align: bottom; width: 6%;"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December&#160;31, 2021</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment charge</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,377</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 86%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December&#160;31, 2022</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 86%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On the Company&#8217;s annual goodwill impairment testing date of November&#160;1, 2022 management performed an impairment evaluation of goodwill after assessing qualitative factors that indicated a possible impairment of goodwill. Under the qualitative assessment, management considers relevant events and circumstances including but not limited to macroeconomic conditions, industry and market considerations, overall Company performance and events directly affecting the Company. It was noted during our assessment that the Company has experienced a sustained decline in stock price, however as of November&#160;1, 2022 the Company determined that goodwill was not impaired. Subsequently in December 2022, the Company&#8217;s stock price continued to decline, resulting in a triggering event to evaluate goodwill for impairment as of December&#160;31, 2022. As a result, further quantitative analysis was conducted to determine the extent to which, if any, the Company&#8217;s carrying value exceeded its fair value as of December&#160;31, 2022. The quantitative analysis used fair value based on market capitalization adjusted for a control premium based on market comparable transactions. This quantitative analysis resulted in the Company&#8217;s fair value being significantly below its carrying value, resulting in a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> goodwill impairment charge of $5.4&#160;million being recorded for the year ended December&#160;31, 2022. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728247312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6. REVENUE RECOGNITION </div></div></div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables depict the disaggregation of revenue according to the type of good or service and timing of transfer of goods or services for the year ended December&#160;31, 2022, and the 11 months ended December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Type of Goods or Service</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Collaborative research and other professional services</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,849</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Access to quantum computing systems</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,185</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,347</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Timing of Revenue Recognition</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue recognized at a point in time</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue recognized over time</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>  <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Selected consolidated balance sheet line items that reflect accounts receivable, contract assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021 were as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 65%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 65%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trade receivables</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,143</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unbilled receivables</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">92</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(961</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(985</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in deferred revenue from contracts with customers were as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at beginning of period</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(985</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(492</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferral of revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(545</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(904</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recognition of deferred revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">569</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">411</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at end of period</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(961</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(985</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Remaining performance obligations represent the portion of the transaction price that has not yet been satisfied or achieved. As of December&#160;31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $9.7&#160;million. The Company expects to recognize estimated revenues related to performance obligations that are unsatisfied (or partially satisfied) in the amounts of approximately $7.9&#160;million during the year ended December&#160;31, 2023, and $1.8&#160;million during the years ended December&#160;31, 2024 and December&#160;31, 2025. <br/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred Contract Acquisition and Fulfillment Costs&#8212;The Company has not identified any costs that are incremental to the acquisition of customer contracts that would be capitalized as deferred costs on the balance sheet in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40.</div> Incremental costs incurred to fulfill the Company&#8217;s contracts that meet the capitalization criteria in ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">340-40</div> have historically been immaterial. Accordingly, the Company has not capitalized any contract fulfillment costs as of December&#160;31, 2022 and December&#160;31, 2021. </div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728344848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statements Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SupplementalFinancialStatementInformationTextBlock', window );">Supplemental Financial Statement information</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">7. SUPPLEMENTAL FINANCIAL STATEMENTS INFORMATION </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Property and Equipment, Net </div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment as of December&#160;31, 2022 and December&#160;31, 2021 are composed of the following: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Quantum computing fridges</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,218</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,190</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Process equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,330</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,561</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,297</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IT Hardware</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,035</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,428</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and other assets</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,246</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,246</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65,390</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,330</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation and amortization</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(25,860</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18,832</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment - net</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39,530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,497</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022 and December&#160;31, 2021, 98% of the total gross property and equipment was located in the United States, and 2% of the total gross property and equipment was located in the United Kingdom. Total depreciation and amortization expense for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $7.0&#160;million and $4.7&#160;million, respectively. </div>  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued Expenses and Other Current Liabilities </div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Utilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,818</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Professional&#160;&amp; subscription fees</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,044</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and other taxes</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,161</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">571</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subcontractor cost</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">804</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payroll and other payroll costs</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">781</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">626</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;">Accrued interest</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">314</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,205</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,806</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_SupplementalFinancialStatementInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial statement information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_SupplementalFinancialStatementInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728176720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">8. LEASES </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company leases a building, offices and equipment under various lease agreements with terms extending through 2029. Under the terms of the building and office leases the Company bears the costs for certain insurance, property taxes and maintenance, and the lease agreements provide for increasing rental payments at fixed intervals. <br/></div> <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Components of lease costs, the weighted average remaining lease term and weighted average discount rate were as follows as of and for the year ended December&#160;31, 2022: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 15%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/>Lease cost<div style="letter-spacing: 0px; top: 0px;;display:inline;"/></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 15%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-size: 0px;">
<td style="width:87%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term lease cost</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Sub-lease income</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(194</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease cost</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;">2,355</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr> </table>  <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash paid for amounts included in the measurement of lease liabilities:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating cash flows from operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">$2,128</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets obtained in exchange for new and modified operating lease liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">$4,892</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average remaining lease term - operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">5.87&#160;years</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate - operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center; text-indent: 0px;">7.93<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0px;;text-align:center;">&#160;</td> </tr> </table>  <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the net present value of its lease payments, the Company used an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date or the date of Adoption of Topic 842. As of December&#160;31, 2022, the maturities of the Company&#8217;s operating lease liabilities were as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"/>
<td style="width: 7%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">2,422</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,288</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">2,198</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">1,524</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,566</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,841</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease payments</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">12,839</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Imputed interest</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(2,636</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Present value of lease liabilities</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">10,203</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,345</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, noncurrent</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">7,858</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;">10,203</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the adoption of Topic 842 on January&#160;1, 2022, the Company accounted for its leases under Topic 840. The Company recognized rent expense on a straight-line basis over the lease term, taking into account adjustments for provisions such as free or escalating monthly rental payments or deferred payment terms such as rent holidays that defer the commencement date of required payments. The Company recorded the difference between cash rent payments and the recognition of rent expense as deferred rent. Rent expense under the Company&#8217;s operating leases was $1.5&#160;million for the 11 months ended December&#160;31, 2021.<br/></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future minimum lease payments under non-cancelable operating leases as of December 31, 2021 are <div style="letter-spacing: 0px; top: 0px;;display:inline;">as</div> follows: </div></div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 87%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,808</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">901</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">928</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">956</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">81</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total minimum future lease payments</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4,674</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr> </table>  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728384368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9. COMMITMENTS AND CONTINGENCIES</div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is periodically involved in legal proceedings, legal actions and claims arising in the normal course of business. Management believes that the outcome of such legal proceedings, legal actions and claims will not have a significant adverse effect on the Company&#8217;s financial position, results of operations or cash flows.</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728358752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">10. DEBT </div></div></div><br/></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2021, the Company entered into an agreement (the &#8220;Loan Agreement&#8221;) with Trinity Capital Inc. (&#8220;Trinity&#8221;) to secure a debt commitment of $12.0&#160;million (the &#8220;Tranche A&#8221;) which was drawn at the closing. The term loan is collateralized by a first-priority, senior secured interest in substantially all of the Company&#8217;s assets. In conjunction with the Loan Agreement, the Company issued Trinity a warrant to purchase shares of Common Stock (the &#8220;Trinity Warrants&#8221;) which is recorded at fair value using the Black-Scholes model, see Note 15 for the fair value assumptions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreement contains customary representations, warranties and covenants; however, the debt agreement does not include any financial covenants. In May 2021, the debt agreement was modified to increase the overall debt commitment by $15.0&#160;million (the &#8220;Tranche B&#8221; or the &#8220;Amendment&#8221;) and $8.0&#160;million of the additional commitment was drawn at the closing and the remaining commitment of $7.0&#160;million was available at the Company&#8217;s option at any time through March&#160;10, 2022 subject to certain conditions. The Company drew the $7.0&#160;million in November 2021. In conjunction with the Amendment, the Company cancelled the Initial Warrants and issued 995,099 (783,129 shares post conversion upon the closing of the Business Combination) warrant shares to purchase the Common Stock which was an incremental cost allocated between Tranche A and Tranche B, see Note 13 for further information on these warrants. The Amendment to the debt agreement was considered a modification for accounting purposes. The Company capitalized $2.8&#160;million of debt issuance costs which consist of incremental costs incurred for the lenders and third-party legal firms as well as the fair value of the warrant issued in conjunction with the term loan. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Amendment, the maturity date was modified to be the date equal to 48 months from the first payment date of each specific cash advance. Subject to an interest only period of 19 months following each specific cash advance date, the term loan incurs interest at a rate of the greater of 11% <div style="letter-spacing: 0px; top: 0px;;display:inline;">or </div>the US Prime Rate plus 7.50% per annum, payable monthly. The Term Loan includes certain negative covenants, primarily consisting of restrictions on the Company&#8217;s ability to incur indebtedness, pay dividends, execute fundamental change transactions, and other specified actions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2022, the debt agreement was modified to increase the overall debt commitment by $5.0&#160;million (the &#8220;Tranche C&#8221; or the &#8220;Third Amendment&#8221;) which was drawn on January&#160;27, 2022. Subject to an interest only period of 19 months, Tranche C incurs interest at a rate of the greater of 11% and the US Prime Rate plus 7.50% per annum, payable monthly, until the maturity date, February 1, 2026. Other modifications per the amendment included an extension of the requirement to raise an additional $75&#160;million of equity until April&#160;1, 2022, and a defined exit fee for the additional $5.0&#160;million to be at 20% of the advanced funds under the amendment. The company met the requirement to raise additional equity of $75<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million through the business combination mentioned in Note 3. The Company paid an exit fee of $</div>1.0&#160;million which is 20<div style="letter-spacing: 0px; top: 0px;;display:inline;">% of the Tranche C amount upon the consummation of the merger. The exit fee was capitalized as a debt issuance cost and is amortized using the effective interest method over the life of Tranche C. The exit fee is not applicable to Tranche A and Tranche B. In conjunction with the amendment, the Company also guaranteed payment of all monetary amounts owed and performance of all covenants, obligations and liabilities.&#160;</div> </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In addition, the Company is required to pay a final payment fee equal to 2.75% of the aggregate amount of all term loan advances. The final payment fee is being accreted and amortized into interest expense using the effective interest rate method over the term of the loan. The effective interest was between 20.75<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% </div></div> &#8211; 26.83% for all tranches of the debt as of December&#160;31, 2022.<br/></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the debt is classified as Level 2. Given the maturity and variable interest rate on the debt, the book value approximates its fair value. Long term debt and the unamortized discount balances are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 74%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding principal amount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Add: accreted liability of final payment fee</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">407</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: unamortized debt discount, long term</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(990</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,618</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: current portion of long term debt-principal</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,491</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,291</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Debt&#8212;net of current portion</div><br/></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">20,635</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">24,216</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Current portion of long term debt&#8212;principal</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,491</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,291</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: current portion of unamortized debt discount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,188</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(716</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt&#8212;current portion</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">575</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the year ended December&#160;31, 2022, the Company recorded interest expense of $</div>5.3<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, which includes the accretion of the end of term liability of $</div>0.3<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, the amortization of commitment fee asset of $</div>0.3<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million and the amortization of debt issuance cost of $</div>0.9<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, respectively. The unamortized debt discount of $</div>2.2<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million as of December&#160;31, 2022 is offset against the carrying value of the term loan in the consolidated balance sheet.</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the 11 months ended December&#160;31, 2021, the Company recorded interest expense of $</div>2.5<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, which includes the accretion of the end of term liability of $</div>0.1<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million, the amortization of commitment fee asset of $</div>0.1<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million and the amortization of debt issuance cost of $</div>0.5<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million. The unamortized debt discount of $</div>2.3<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million as of December&#160;31, 2021 is offset against the carrying value of the term loan in the consolidated balance sheet.</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Scheduled principal payments on total outstanding debt as of December&#160;31, 2022 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 85%;"/>
<td style="vertical-align: bottom; width: 6%;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,491</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,007</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scheduled principal payments on total outstanding debt as of December 31, 2021 are as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">702</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8,682</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">11,008</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">6,608</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">27,000</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728141680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_RedeemableConvertiblePreferredStockTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">11. REDEEMABLE CONVERTIBLE PREFERRED STOCK </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Legacy Rigetti was authorized to issue 73,389,000 shares of Series C preferred stock and 62,537,577 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock with a par value of $0.000001 per share for each class of preferred Stock. Legacy Rigetti&#8217;s board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, option or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Immediately prior to the effective time of the Business Combination (Note&#160;3), all Legacy Rigetti preferred stock outstanding converted into shares of Common Stock of Legacy Rigetti (the shares in this note do not factor in the exchange ratio). </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_RedeemableConvertiblePreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redeemable convertible preferred stock text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_RedeemableConvertiblePreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728112144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockTextBlock', window );">Common Stock</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">12. COMMON STOCK </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As discussed in Note 3, on March&#160;2, 2022, the Company consummated a Business Combination which has been accounted for as a reverse recapitalization. Pursuant to the certificate of incorporation as amended on March&#160;2, </div>2022, the Company is authorized to issue 1,000,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock. The holders of shares of Common Stock are entitled to one vote for each share of Common Stock held. The Preferred Stock is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting.</div> No shares of Preferred Stock were issued and outstanding as of December&#160;31, 2022.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, and after payment to the holders of shares of Preferred Stock of their liquidation preferences, the holders of the Common Stock are entitled to the entire remaining assets of the Company on a pro rata basis. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the warrants and stock-based awards outstanding prior to March&#160;2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company has reserved the following shares of Common Stock for issuance upon the conversion, exercise or vesting of the underlying instruments: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:78%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common&#160;Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,243,811</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Stock-Based Awards&#8212;RSUs Outstanding</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,332,591</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Stock-Based Awards&#8212;Options Outstanding</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,845,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">37,422,305</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table>  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common Stock Purchase Agreement </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Company entered into a Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC (&#8220;B.&#160;Riley&#8221;) on August&#160;11, 2022 pursuant to which the Company may issue and sell to B. Riley the lesser of i)&#160;$</div>75.0<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;million in aggregate gross purchase price of newly issued shares of the Company&#8217;s Common Stock or ii)&#160;an amount not to exceed </div>23,648,889<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock (such number of shares equal to approximately </div>19.99<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the aggregate number of shares of Common Stock issued and outstanding immediately prior to the execution of the agreement and inclusive of </div>171,008<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares of Common Stock issued to B. Riley on August&#160;11, 2022 as consideration for entering into the Common Stock Purchase Agreement).&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In consideration of the parties entering into the foregoing agreement, the parties also entered into a Registration Rights Agreement on August&#160;11, 2022 pursuant to which the Company provides B. Riley with registration rights with respect to such Common Stock and pursuant to which the Company has filed a registration statement covering the resale of such Common Stock. </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the initial satisfaction of the conditions to B. Riley&#8217;s purchase obligation set forth in the Purchase Agreement, on September&#160;14, 2022 (the &#8220;Commencement Date&#8221;) the Company will have the right, but not the </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></div></div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">obligation, from time to time at the Company&#8217;s sole discretion over the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">24-month</div> period from and after the Commencement, to direct B. Riley to purchase a specified amount of shares not to exceed the lesser of (i)&#160;1,000,000 shares of Common Stock </div> and (ii) 20% of the total aggregate number (or volume) of shares of Common Stock traded on The Nasdaq Capital Market (&#8220;Nasdaq&#8221;) during the applicable period beginning at the official open (or &#8220;commencement&#8221;) of the regular trading session on the applicable purchase date for such purchase and ending at such time that the total aggregate volume of shares of common stock traded on Nasdaq reaches the Purchase Share Volume Maximum (as defined herein) for such purchase (as applicable) (such period for each purchase, the &#8220;Purchase Valuation Period&#8221;). &#8220;Purchase Share Volume Maximum&#8221; means, with respect to a purchase made pursuant to the Purchase Agreement, the number of shares of Common Stock equal to the quotient obtained by dividing the (i)&#160;total number of shares of Common Stock to be purchased by B. Riley in the relevant purchase (the &#8220;Purchase Share Amount&#8221;), by (ii) 0.20 (subject to certain adjustments). <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not identify any feature that needs to be bifurcated and recorded as a derivative within the Purchase Agreement. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recorded $0.7<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">million of additional paid-in capital with a corresponding entry to the deferred offering cost asset in the accompanying consolidated balance sheet as of December 31, 2022 with respect to the fair value of the<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>171,008 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">common stock commitment shares issued to B. Riley which will be offset against future proceeds from the sale of the Company&#8217;s common stock under the Purchase Agreement. The Company did not issue or sell any shares to B. Riley under the Purchase Agreement during the year ended December 31, 2022 other than the </div>171,008 <div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">shares issued as consideration for entering into the Purchase Agreement.</div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728232816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_WarrantsTextBlock', window );">Warrants</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13. WARRANTS </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the number and corresponding strike price of Rigetti warrants outstanding prior to March&#160;2, 2022, the date of the Business Combination, to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Liability Classified Warrants </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public Warrants </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Public Warrant entitles the holder to the right to purchase one share of Common Stock at an exercise price of $11.50 per share. No fractional shares will be issued upon exercise of the Public Warrants. The Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, and (ii)&#160;the last reported sale price of the Company&#8217;s Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders. Upon issuance of a redemption notice by the Company, the warrant holders have a period of 30 days to exercise for cash, or on a cashless basis. As of December&#160;31, 2022, there were 8,625,000 Public Warrants issued and outstanding (Refer to Note 15 for fair value measurement). </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Private Warrants </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Warrants may not be redeemed by the Company so long as the Private Warrants are held by the initial purchasers, or such purchasers&#8217; permitted transferees. The Private Warrants have terms and provisions identical to those of the Public Warrants, including as to exercise price, exercisability and exercise period, except if the Private Warrants are held by someone other than the initial purchasers&#8217; permitted transferees, then the Private Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. On August 18, 2022, the Private Placement Warrants were transferred from the initial purchasers to permitted transferees and remain unredeemable by the Company as of December&#160;31, 2022. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Private Warrant was measured using the Black Scholes model approach. Significant inputs into the respective models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 61%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Assumptions</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial&#160;Recognition<br/>on March 2, 2022</div></div></div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 61%;"/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock Price</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$0.73</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$9.43</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike Price</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$11.50</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$11.50</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility (annual)</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">109.26%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30.66%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4.04%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1.74%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated time to expiration (years)</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4.172</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5.000</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;%</div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Trinity Warrants </div></div></div></div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Trinity Warrants were issued in March of 2021 for the purchase of 313,252 shares of Common Stock, and additional warrants to purchase 469,877 shares of Common Stock were issued in connection with the Tranche B Amendment, see Note 10. Therefore, there were total of 783,129 Common Stock warrants issued in conjunction with the Loan and Security Agreement in 2021. The Company utilized a Black-Scholes model to determine the grant date fair value of the warrants which was approximately $2.7&#160;million and was recorded as a debt issuance cost. The outstanding Common Stock warrants were subsequently remeasured at each reporting period using the Black-Scholes models with changes recorded as a component of other income in the Company&#8217;s consolidated statement of <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">operations. </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The liability related </div></div>to the Trinity Warrants was $6.4&#160;million as of June&#160;2, 2022, at which time all 783,129 warrants outstanding were exercised and the fair value of the warrant liability was reclassified to equity. The Company recorded a loss for the change in the fair value of the warrant liability in the consolidated statements of operations for the year ended December&#160;31, 2022 and the 11 months ended December&#160;31, 2021, of $2.0&#160;million and $1.7&#160;million, respectively.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The warrant issued in conjunction with the Loan and Security Agreement was classified as a liability under ASC&#160;480, &#8220;Distinguishing Liabilities from Equity&#8221;. See Deferred Financing Cost disclosure at Note 2 Summary of Significant Accounting Policies. </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant inputs into the Black Scholes model used to value the Trinity Warrant liabilities at June&#160;2, 2022, the exercise date, are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 82%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"/> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 82%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Assumptions - Trinity Warrant Liability</div></div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;2,&#160;2022</div></div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$8.23</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$0.27</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility (annual)</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">105.10%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2.94%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated time to expiration (years)</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">9.000</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;%</div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Equity Classified Warrants </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C Preferred Stock Financing Warrants </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In conjunction with a prior Series C Preferred Stock Financing the Company issued a total of&#160;</div>5,248,183 Warrants to purchase Class&#160;A Common Stock to the Series C investors. The Warrants have a $0.01 exercise price per share and have a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-year</div> term to expiration. The Warrants can be exercised for cash or on a cashless basis. The Company determined that the Warrants met the requirements for equity classification under ASC 480 and ASC<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>815. The Company estimated the fair value of the Warrants using the Black-Scholes model and allocated approximately $1.2&#160;million in proceeds from the Series C Preferred Stock to the value of the Warrants on a relative fair value basis, which was recorded to additional paid in <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">capital. </div></div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div>  <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Customer Warrants </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">In February 2020, the Company issued a Warrant to purchase 2,680,607 shares of Class&#160;A Common Stock to a customer in conjunction with a revenue arrangement (the &#8220;Customer Warrants&#8221;). The Customer Warrants have a $1.152 exercise price per share and have a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-year</div> term to expiration. The Warrants vest upon the achievement of certain performance conditions (i.e., sales milestones) defined in the agreement, and upon a change of control, either 50% or 100% of the then unvested Customer Warrants will become fully vested, dependent on the acquiring party in the change of control transaction. The Warrants can be exercised for cash or on a cashless basis. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company followed the guidance in ASC 718 and ASC 606 for the accounting of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> consideration payable to a customer. The Company determined that the Customer Warrants met the requirements for equity classification under ASC 718 and measured the Customer Warrants based on their grant date fair value, estimated to be $0.2&#160;million. The Company recorded this amount as a deferred asset and additional paid in capital as of the issuance date, as the Company believes it is probable that all performance conditions (i.e., sales milestones) in the Customer Warrants will be met.&#160;</div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The vesting status of the Customer Warrant is as follows at December&#160;31, 2022 and December&#160;31, 2021:</div></div><br/></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 76%; border: 0px; margin: 0px auto; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested Customer warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,340,297</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,072,237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested Customer warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,340,310</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,608,370</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,680,607</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,680,607</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_WarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_WarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728100048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Forward Warrant Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ForwardWarrantAgreementDisclosure', window );">Forward Warrant Agreement</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">14. FORWARD WARRANT AGREEMENT </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the execution of the Merger Agreement in October 2021, Rigetti entered into a warrant subscription agreement (&#8220;Forward Warrant Agreement&#8221;) with a strategic partner, Ampere Computing LLC (&#8220;Ampere&#8221;) for the purchase of a warrant for an aggregate purchase price (including amounts from exercise) of $</div>10.0&#160;million. The Forward Warrant Agreement provides for the issuance of a warrant for the purchase of an aggregate of 1,000,000 shares of Common Stock at an exercise price of $0.0001. The purchase of the warrant was conditioned upon, among other things, the consummation of the Business Combination and the entry into a collaboration agreement between Rigetti and Ampere. The parties entered into the collaboration agreement in January 2022. Ampere was required to pay $5.0&#160;million to Rigetti no later than the later of (i)&#160;the Closing and (ii)&#160;June&#160;30, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2022, pursuant to the Warrant Subscription Agreement, the Company issued the warrant to Ampere upon receipt of an aggregate of $5.0&#160;million (including the exercise price), and upon such payment and issuance, 500,000 shares of the Company&#8217;s Common Stock vested under the warrant and were immediately exercised by Ampere pursuant to the terms of the warrant. Ampere is required to pay an additional $5.0&#160;million to Rigetti no later than the closing date of the listing of Ampere&#8217;s capital stock, provided that if the listing has not occurred by the second anniversary of the Warrant Subscription Agreement, Ampere is not obligated to make the additional payment. Upon the payment of such additional amounts, the warrant will vest and be exercisable with respect to the remaining 500,000 shares underlying the warrant. The Warrant Subscription Agreement further provides that the Company will use commercially reasonable efforts to file a registration statement to register the resale of the remaining shares underlying the warrant. The Company filed a registration statement registering the resale of the initial 500,000 shares issued under the warrant during the year ended December&#160;31, 2022.<br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated the Forward Warrant Agreement as a derivative in conjunction with the guidance of ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221;. The Company calculated the fair value of the Forward Warrant </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="background: none; letter-spacing: 0px; top: 0px; text-decoration: none;;display:inline;"> </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div>  <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Agreement by using the Forward Contract Pricing methodology at inception and at December&#160;31, 2022. The fair value of the Forward Warrant Agreement was estimated based on the following key inputs and assumptions 1) Assumed holding period 2) Related risk-free rate and 3) Likelihood of the outcome of the various contingencies outlined below. Based on these inputs and assumption, the Company calculated the fair value of the Forward Warrant Agreement to be a </div></div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> $</div>2.2&#160;million <span style="-sec-ix-hidden:hidden73805685">derivative asset</span> and a ($0.2 million) <span style="-sec-ix-hidden:hidden73805686">derivative liability</span> <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at December&#160;31, 2022 and December&#160;31, 2021, respectively. The Company has included the derivative asset as a forward contract asset and the derivative liability separately in other liabilities (current) on the balance sheet line in the accompanying consolidated balance sheets as of December&#160;31, 2022 and December&#160;31, 2021, respectively. The change in fair value is recorded as part of the general and administrative operating activities in the Company&#8217;s consolidated statements of operations. The following table represents key valuation assumptions as of the year ended December&#160;31, 2022 and 11 months ended December 31, 2021: </div></div></div> <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 64%;"/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td style="width: 7%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Assumptions</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Holding period (in years)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.767</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.5-1.13</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk free rate</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4.69%</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.19%-0.43%</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Probability of occurring the contingency</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">50%</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">50%-100%</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying value per share</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$0.73</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$10.29</div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ForwardWarrantAgreementDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forward warrant agreement disclosure [Text block].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ForwardWarrantAgreementDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728389024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15. FAIR VALUE MEASUREMENTS</div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 87%;"/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value measurements of financial assets and liabilities that <div style="letter-spacing: 0px; top: 0px;;display:inline;">are </div>measured at fair value at December&#160;31, 2022 and December&#160;31, 2021 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 68%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:68%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash equivalents: </div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money Market Funds</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States Treasury Securities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,210</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,571</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commercial Paper</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,142</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward warrant agreement</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,229</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">94,556</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">26,713</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,229</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Public Warrants</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">699</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Private Warrants</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;;text-align:right;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">1,068</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-out</div> liability</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">699</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,274</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;;text-indent: 0px;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Trinity Warrants</div><br/></div></td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$<div style="display:inline;">&#160; &#160; &#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$<div style="display:inline;">&#160; &#160; &#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;">4,355</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward warrant agreement</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">230</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Liabilities</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; width: 4%;"><div style="font-weight:bold;display:inline;">&#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4,585</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company has recorded the following <div style="letter-spacing: 0px; top: 0px;;display:inline;">financial </div>instruments subject to fair value measurements: 1) Derivative warrant liabilities&#8212;Public Warrants liability and Private Warrants, 2) Forward Warrant Agreement, and 3) Earnout liability. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company also has long-term debt and a line of credit that provides for variable interest, and therefore, the carrying value approximates the fair value. The carrying values as of December 31, 2022 and December 31, 2021, represent the original principal amounts borrowed less principal payments and debt issuance costs. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Public Warrants has been measured based on the observable listed prices for such warrants, a Level&#160;1 measurement. The Company&#8217;s money market funds and U.S. Treasury securities are classified within Level I due to the highly liquid nature of these assets with quoted prices in active markets. The investments in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities (i.e., commercial paper and corporate debt securities) and corporate debt issued by the Company are classified within Level II. The fair value of the Company&#8217;s Level II financial assets and liabilities is determined by using inputs based quoted market prices for similar instruments. All other financial instruments are classified as Level&#160;3 liabilities as they all include unobservable inputs. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Warrants were initially measured at fair value using a Black Scholes model. The Company estimated the fair value of the Forward Warrant Agreement using a forward analysis with unobservable inputs which included selected risk-free rate and probability outcomes. The Company has further discussed the key aspects of the fair value measurements described above in Notes 13 and 14 to the financial statements. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate fair value of the Sponsor Vesting Shares on the Closing date was estimated using a Monte Carlo simulation model. The Company has further discussed the key aspect of the valuation inputs in Note 2 significant accounting policy for Sponsor <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Liability. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2021, the Company recorded a derivative warrant liability for the Trinity Warrants at fair value using a Black-Scholes option model with unobservable inputs including volatility. The Company estimates the volatility of its ordinary share warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s ordinary shares that matches the expected remaining life of the warrants. On June&#160;2, 2022, all outstanding Trinity Warrants were exercised into shares of the Company&#8217;s Common Stock </div></div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There have been no changes in fair value measurement techniques (other than the change in valuation assumptions described in Note 1) during the year ended December&#160;31, 2022. There were no transfers between Level&#160;1 or Level&#160;2, or transfers in or out of Level&#160;3 of the fair value hierarchy during the year end December&#160;31, 2022. The fair value estimates are based on pertinent information available to management as of December 31, 2022 and December 31, 2021. Although management is not aware of any factors, other than those noted above, that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for the purpose of these financial statements. Current estimates of fair value may differ from the amounts presented.</div></div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of the changes in the fair value of the Company&#8217;s Level&#160;3 financial instruments as of December&#160;31, 2022 and December&#160;31, 2021 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">warrant&#160;liability&#160;-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Trinity Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">warrant&#160;liability&#160;-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward<br/>Warrant</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Agreement</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-out</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">liability</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;January 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,691</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">400</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair values</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,664</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(170</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 45%;"/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;December 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4,355</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">230</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Initial measurement on March&#160;2, 2022 upon Business Combination (Note 3)</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">9,612</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">20,413</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair values</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,015</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(8,544</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(5,764</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(19,207</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Exercise of warrants</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(6,370</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">3,305</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;December 31, 2022</div><br/></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,068</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;(2,229</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/>)</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,206</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr>
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;;text-align:right;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836729239296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Plans</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">16. EQUITY PLANS </div></div></div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2013 Equity Incentive Plan</div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2013, the Company adopted the 2013 Plan which provides for the grant of qualified incentive stock options (&#8220;ISO&#8221;) and nonqualified stock options (&#8220;NSO&#8221;), restricted stock, restricted stock units (&#8220;RSU&#8221;) or other awards to the Company&#8217;s employees, officers, directors, advisors, and outside consultants. After the Closing Date and consummation of the Business Combination effective March&#160;2, 2022, no additional awards were issued under the 2013 Plan. Awards outstanding under the 2013 Plan will continue to be governed by such plan; however, the Company will not grant any further awards under the 2013 Plan. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 Equity Incentive Plan</div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination (Note 3), the shareholders approved the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) in February, 2022, which became effective immediately upon the Closing Date. The 2022 Plan provides for the grant of ISOs, NSOs, stock appreciation rights, restricted stock awards (&#8220;RSA&#8221;), restricted stock unit awards, performance awards and other forms of awards to employees, directors, and consultants, including employees and consultants of the Company&#8217;s affiliates. The aggregate number of shares of common stock reserved for issuance under the 2022 Plan is 18,332,215 shares as of December&#160;31, 2022. As of December&#160;31, 2022, 4,748,116 shares were available for future issuance under the 2022 Plan. The number of shares reserved for issuance under the 2022 Plan will automatically increase on January 1st of each year for a period of nine years commencing on January&#160;1, 2023 and ending on (and including) January&#160;1, 2032, in an amount equal to 5% of the common stock of all classes outstanding on December&#160;31 of the preceding year; provided, however, that the board of directors of the Company may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of Common Stock. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Stock Options</div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of activity related to stock option is summarized as below:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 54%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;Options</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Exercise</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Contractual</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life&#160;(in&#160;years)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intrinsic<br/>Value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Outstanding&#8212;December 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,468,275</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.36</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,750,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.96</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,768,568</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited and expired</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,603,804</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 54%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Outstanding&#8212;December 31, 202<div style="display:inline;">2</div></div><br/></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,845,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,103</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; width: 54%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 0pt; font-family: &quot;Times New Roman&quot;; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; padding-bottom: 0.375pt; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Exercisable&#8212;December 31, 2022</div><br/></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">5,464,027</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;">0.40</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;">7.2</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;">1,780</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;12, 2022 the Company granted to the CEO an equity award (&#8220;CEO award&#8221;) under its 2022 Plan that consisted of options to purchase a total of 1,750,000 shares of its common stock with an exercise price of $0.96 per share. Of the total stock options granted to the CEO, 1,250,000 have time-based vesting over 3 years and the remaining 500,000 have market-based vesting conditions. Compensation expense for the CEO award for the year ending December&#160;31, 2022 was insignificant. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted-average grant date fair value of options granted during the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $0.81 and $3.43 respectively. The total intrinsic value of options exercised during the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 is $9.9&#160;million and $5.7&#160;million, respectively. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2022, there was $2.4&#160;million of unrecognized compensation cost related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-vested</div> stock options granted under the 2013 and 2022 Plan, which is expected to be recognized over a weighted-average period o</div>f approximately 1.96 years.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>   <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="null;text-indent: 0px;;font-style:italic;display:inline;">Restricted Stock Units</div></div></div></div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of activity related to RSUs is summarized as below:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSUs</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Fair<br/>Value&#160;Per&#160;Share</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-vested</div> shares at December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,388,455</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.93</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,782,607</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.92</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,007,789</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.99</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,830,682</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-vested</div> shares at December&#160;31, 2022</div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">11,332,591</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;">4.36</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:right;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;2, 2022, the performance condition of all outstanding RSUs was met due to the closing of the Business Combination. As a result, the Company recorded a cumulative <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">catch-up</div> compensation expense for the vesting period that was satisfied as of March&#160;2, 2022 and continues amortizing compensation expenses for unvested RSUs over their remaining vesting period.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fair value of the RSUs vested during the twelve months ending December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $35.0&#160;million and $0 respectively.</div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock-based compensation <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">expense related to RSUs granted to employees was $</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">42.7</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;million and $</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">0</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> for the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. As of</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31, 2022, the unrecognized compensation expense related to unvested RSUs was approximately $</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">41.9</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;million which is expected to be recognized over a weighted-average period of approximately </div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">2.85</div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> years.</div></div> <br/></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Restricted Stock Awards</div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the twelve months ended December&#160;31, 2022, 120,000 restricted stock awards (&#8220;RSAs&#8221;) were issued and vested immediately on the grant date as part of transaction bonuses in recognition of efforts in connection with the Business Combination. The total compensation expense related to RSAs was $0.6&#160;million for the twelve months ended December&#160;31, 2022.</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below summarizes the total stock-based compensation expenses for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;14,092</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Selling and marketing expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,109</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">106</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,611</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">684</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total stock-based compensation expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,812</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;1,765</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Common Stock and Options</div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model that uses the assumptions noted in the table below. Expected volatility for the Company&#8217;s Common Stock was determined based on an average of the historical volatility of a peer group of similar public companies. The expected term of options granted was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">upon which to estimate expected term. The assumed dividend yield is based upon the Company&#8217;s expectation of not paying dividends in the foreseeable future. The risk-free rate is based upon the U.S. Treasury yield curve in effect at the time of grant for the period equivalent to the expected life of the option.</div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">In determining the exercise prices for options granted, the Company&#8217;s board of directors has considered the fair value of the Common Stock as of the grant date. Before the Company&#8217;s common stock was publicly traded, the fair value of the Common Stock has been determined by the board of directors at each award grant date based upon a variety of factors, including the results obtained from an independent third-party valuation, the Company&#8217;s financial position and historical financial performance, the status of technological developments within the Company&#8217;s products, the composition and ability of the current engineering and management team, an evaluation or benchmark of the Company&#8217;s competition, the current business climate in the marketplace, the illiquid nature of the Common Stock, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">arm&#8217;s-length</div> sales of the Company&#8217;s capital stock (including redeemable convertible preferred stock), the effect of the rights and preferences of the preferred shareholders, and the prospects of a liquidity event, among others.</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock options issued in 2022, including the options that are based on market conditions, did not have significant </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">impact on the stock-based compensation expense during the year ended December 31, 2022. The range of assumptions used in the Black-Scholes option-pricing model for time based options issued to employees and in Monte Carlo simulation model for market based options during the 12 months ended December 31, 2022 and 11 months ended December 31, 2021 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width:55%"/>
<td style="vertical-align: bottom; width: 12%;"/>
<td/>
<td/>
<td/>
<td style="vertical-align: bottom; width: 12%;"/>
<td/>
<td/>
<td/>
<td style="vertical-align: bottom; width: 12%;"/>
<td style="width:12%;"/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12&#160;Months&#160;ended&#160;December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">ended<br/>December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Time&#160;based&#160;vesting</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Market&#160;based&#160;vesting<br/>awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-size: 0px;">
<td style="width: 55%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="vertical-align: bottom; width: 12%;"/>
<td style="width:12%;"/>
<td/>
<td/></tr>
<tr style="font-size: 0px;">
<td style="width: 55%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="vertical-align: bottom; width: 12%;"/>
<td style="width:12%;"/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">150</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%&#160;</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;">150</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div>&#160;</div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">46.8</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3.77</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">3.76<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">1.07</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;">0</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">0</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; text-indent: 0px; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (in years)</div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5.85</div></div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;">5.0</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: right;">6.1&#160;years<div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: center;"><div style="font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Exercise price/Stock price</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.96</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;">0.96</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">0.21</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr></table>  <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726812880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">17. NET LOSS PER SHARE </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the weighted average shares outstanding prior to March&#160;2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of basic and diluted net loss per share of Common Stock for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11 Months<br/>ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(71,521)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,241)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average Class&#160;A Common Stock outstanding</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102,300,852</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,337,127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss per share for Class&#160;A Common Stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#8212; Basic</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.70)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.64)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#8212; Diluted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.70)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.64)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table>  <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There </div></div>are 3,059,273 shares of contingently <div style="letter-spacing: 0px; top: 0px;;display:inline;">issuable </div>Common Stock pursuant to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">earn-out</div> arrangement that were not included in the computation of basic net loss per share since the contingencies for the issuance of <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">these </div></div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;">shares have not been met as of December&#160;31, 2022. The weighted-average common shares outstanding for the twelve months ended December&#160;31, 2022 and December&#160;31, 2021 include 2,541,856 and 5,116,058 weighted-average shares of warrants with an exercise price of $0.01, respectively. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s potential dilutive securities, which include stock options, restricted stock units, convertible preferred stock and warrants have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. </div></div><br/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company excluded the following potential common shares from the computation of diluted net loss per share as of December&#160;31, 2022 and December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31,</div></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,218,320</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible Series C Preferred Stock</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,478,033</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock Warrants</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,444,127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,822,319</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Options</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,845,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,468,227</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted Stock Units</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,332,591</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,622,621</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90,986,899</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 1px;">
<td/></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The number of outstanding shares as of December&#160;31, 2021 have been retrospectively adjusted to reflect the Exchange Ratio. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The number of outstanding warrants as of December&#160;31, 2022 and December&#160;31, 2021 does not include 1,340,310 and 1,608,359 shares, respectively, of Unvested Customer Warrants. </div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728309808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">18. INCOME TAXES </div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents domestic and foreign components of loss before income taxes for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;ended</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Domestic</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(67,677)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,787)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,844</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,454</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(71,521)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,241)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not pay any income taxes for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021. </div></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021, are as follows: </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred <div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div>ax <div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>ssets:</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,313</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals and reserves</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">147</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,233</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,509</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">ROU <div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div>iability</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,507</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross deferred assets <div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">80,733</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">47,487</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred <div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div>ax <div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div>iabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ROU <div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>sset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,289</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Depreciation and amortization</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,063</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,420</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total deferred tax liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,352</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,420</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total net deferred tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,381</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,067</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(76,381</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(46,067</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Net deferred tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The effective<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">tax rate differs from the statutory rate, primarily due to </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Company&#8217;s history of incurring losses which have not been benefited and other permanent differences.&#160;</div><br/></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"/>
<td style="width: 22%; vertical-align: bottom;"/>
<td/>
<td style="width: 21%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;Ended<br/>December&#160;31,&#160;2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,&#160;2021</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt; width: 55%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Component</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rate Impact</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rate Impact</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total pre-tax book income</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">21%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">21%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State and local income taxes</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">11%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Fair market value adjustments</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">14%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Non-deductible executive compensation</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(4)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill impairment</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction <div style="letter-spacing: 0px; top: 0px;;display:inline;">c</div>osts</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Change in valuation allowance</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(42)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(21)%</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total:</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net U.S. federal and state deferred tax assets have been fully offset by a valuation allowance. The net change in the total valuation allowance was an increase of approximately $30.3<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>million and $8.0<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>million for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">As of December&#160;31, 2022, the Company had net operating loss carryforwards for federal income tax purposes of $230.9&#160;million, of which $189.4<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>million does not expire; federal research and development tax credits of $2.3&#160;million, which will start to expire in <div style="letter-spacing: 0px; top: 0px;;display:inline;">2035</div>; net operating loss carryforwards for state income tax purposes of $168.1<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>million, which will start to expire in 2033; and state research and development tax credits of $2.3&#160;million, which do&#160;not expire.</div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Utilization of the net operating losses and credits may be subject to substantial annual limitation due to federal and state ownership change limitations provided by the Internal Revenue Code and similar state provisions. Such </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">annual limitations could result in the expiration of the net operating losses and credits before their utilization. The Company has not performed a Section&#160;382 analysis to determine if an ownership change occurred and whether the use of net operating loss carryforwards and credits carryforwards will be limited to offset future taxable income. For financial statement purposes, the Company has included the federal and state net operating losses and credits in the deferred tax assets with a full valuation allowance. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company files U.S., various state income tax returns as well as foreign income tax returns within Australia, Canada and the United Kingdom with varying statutes of limitations. The tax years from inception in 2013 forward remain open to examination due to the carryover of unused net operating losses and tax credits. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company had unrecognized tax benefits of $4.7&#160;million as of December&#160;31, 2022 all of which is offset by a full valuation allowance. These unrecognized tax benefits, if recognized, would not affect the effective tax rate. There were no interest or penalties accrued as of December&#160;31, 2022. </div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">A reconciliation of the beginning and ending amounts of unrecognized income tax benefits during the year is as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 68%; border: 0px; margin: 0px auto; text-indent: 0px; border-spacing: 0px;">
<tr style="font-size: 0px;;text-indent: 0px;">
<td style="width:87%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance at January&#160;1, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,672</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Current year increase (decrease)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;">
<td>Prior year adjustment&#8212;increase (decrease)&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px;text-indent: 0px;">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,672</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px;text-indent: 0px;">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728341952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">19. SEGMENTS </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, and 11 months ended 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 52%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended <br/>December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11 Months Ended <br/>December&#160;31, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85.0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,826</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71.1%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Europe</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,965</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15.0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,370</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28.9%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenues from external customers are attributed to individual countries based on the physical location in which the services are provided or the particular customer location with whom the Company has contracted.</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728141680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">20. SUBSEQUENT EVENTS</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In February 2023, the Company announced an updated business strategy, including revisions to the Company&#8217;s technology roadmap. In connection with this updated strategy, the Company has implemented a workforce reduction in order to focus the organization and its resources on nearer-term strategic priorities. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The reduction</div></div><div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;">&#160;in workforce impacted approximately </div>50 <div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;">employees or approximately </div>28<div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;">% of the Company&#8217;s workforce. The Company began implementing activities with respect to the revised business plan, updated technology roadmap and reduction in workforce in February 2023. Affected employees were offered separation benefits, including severance payments and temporary healthcare coverage assistance. The Company currently expects to incur restructuring charges of approximately $</div>1.4&#160;<div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;">million for severance payments and temporary healthcare coverage to employees with respect to eliminated positions. Such restructuring charges are expected to be incurred and recorded in the first quarter of 2023.</div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720288368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Emerging Growth Company</div></div> &#8212; Following the Business Combination, the Company qualifies as an emerging growth company (&#8216;&#8216;EGC&#8217;&#8217;) as defined in the Jumpstart our Business Startups (&#8216;&#8216;JOBS&#8217;&#8217;) Act. The JOBS Act permits companies with EGC status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company intends to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">earlier of the date the Company (i)&#160;is no longer an EGC or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates. </div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div> &#8212; The </div> preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Such management estimates include, but are not limited to, the fair value of share-based awards, the fair value of the convertible preferred stock warrants, the fair value of the Forward Warrant Agreement (as defined below) , the fair value of derivative warrant liabilities, the fair value of Sponsor Vesting Shares issued in connection with the business combination (See Note 3), goodwill and intangible assets, accrued liabilities and contingencies, depreciation and amortization periods, revenue recognition and accounting for income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from those estimates.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principals of Consolidation</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principals of Consolidation</div></div> &#8212;The consolidated financial statements include the accounts of Rigetti and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reclassifications</div></div> &#8212; Certain amounts reported previously have been reclassified to conform to current presentation, with no effect on stockholders&#8217; equity or net loss as previously presented. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Segments</div></div> &#8212; Operating segments are defined as components of an entity for which discrete financial information is available and that information is regularly reviewed by the Chief Operating Decision Maker (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM, who has ultimate responsibility for the operating performance of the Company and the allocation of resources. The Company&#8217;s CODM reviews financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Foreign Currency</div></div> &#8212; The Company&#8217;s reporting currency is the US dollar. The functional currencies of the Company&#8217;s foreign subsidiaries are the local currencies (UK pounds sterling, Australian dollar and Canadian Dollar), which are the monetary unit of account of the principal economic environment in which the Company&#8217;s foreign subsidiaries operate. All assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollars is reflected as a foreign currency cumulative translation adjustment and reported as a component of accumulated other comprehensive gain (loss). Foreign currency transaction gains and losses resulting from or expected to result from transactions denominated in a currency other than the functional currency are recognized in other income (expense), net in the consolidated statements of operations and are de minimis for the year ended December 31, 2022 and 11 months ended December 31, 2021. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Comprehensive Loss</div></div> &#8212; Comprehensive loss consists of two components including net loss and other comprehensive loss. The Company&#8217;s other comprehensive loss consists of foreign currency translation adjustments that result from consolidation of its foreign subsidiaries and unrealized loss on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities. </div></div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash, Cash Equivalents and Restricted Cash</div></div> &#8212; As of December&#160;</div>31, 2022 and December&#160;31, 2021, cash consists primarily of checking and savings deposits. As of December&#160;31, 2022, cash equivalents consist primarily of money market funds. There were no cash equivalents as of December&#160;31, 2021. The Company considers all highly liquid investment securities with remaining maturities at the date of purchase of three months or less to be cash equivalents. These cash equivalents are stated at cost, which approximates fair value.</div><div style="margin-top: 1em; margin-bottom: 1em"/> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s restricted cash balance includes cash whose use is limited by contractual provisions. As of December&#160;31, 2022, there was no restricted cash. As of December&#160;31, 2021, restricted cash consists of cash secured as collateral for letters of credit in favor of the Company&#8217;s landlord and its corporate credit card program. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,542</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,729</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash <div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>quivalents</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">317</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents and restricted cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57,888</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,046</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Investments </div></div>&#8212;<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>The Company classifies its investments in fixed income securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt investments. The Company&#8217;s investments consist of U.S Treasury securities, commercial paper, and corporate bonds that have a maturity of one year or less. These investments are recorded in the consolidated balance sheets at fair value. The fair value of our underlying investments is based on observable inputs and classified as Level&#160;1 and Level&#160;2. Unrealized gains and losses on these investments are included as a separate component of Accumulated Other Comprehensive Loss. The Company evaluates its investments to assess whether those with unrealized loss positions are other than temporarily impaired. Impairments are considered other than temporary if they are related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of the cost basis. Realized gains and losses and declines in value determined to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the statements of operations. See Note 15 for further information on fair value. </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accounts Receivable</div></div> &#8212; Accounts receivable are recorded at invoice value, net of allowance for doubtful accounts. Unbilled receivables are included in accounts receivable and include amounts that were invoiced subsequent to the period end for which revenue was recognized in advance of the right to invoice. On a periodic basis, management evaluates its accounts receivable and determines whether to provide an allowance or if any accounts should be written off based on a past history of write-offs, collections, and current credit conditions. A receivable is considered past due if the Company has not received payments based on agreed-upon terms. As of December&#160;31, 2022 and December&#160;31, 2021, the Company does not have any allowances for doubtful accounts. </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock', window );">Prepaid expenses and other current assets</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Prepaid Expenses and Other Current Assets </div></div>&#8212; Prepaid expenses and other current assets include prepaid software, prepaid insurance, other prepaid expenses, all of which are expected to be recognized or realized within the next 12 months. </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DeferredOfferingCostsPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deferred Offering Costs</div></div> &#8212;The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with the Business Combination or issuance of shares under a registration statement filed with the SEC. After consummation of the Business Combination or issuance of shares, costs allocated to equity-classified instruments are recorded as a reduction to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. Costs allocated to liability-classified instruments are expensed. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The </div></div> Company incurred $2.3&#160;million of offering costs for the year ended December&#160;31, 2022, which related to filing new registration statements with the SEC after the close of the Business Combination. These costs are incremental to those disclosed in Note 3. A portion of the offering costs amounting to $0.7&#160;million relates to the Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC. As of December&#160;31, 2022, while the registration statement related to the Common Stock Purchase Agreement with B. Riley Principal Capital II, </div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>    <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;">LLC was filed with the SEC, there were no shares issued other than the commitment shares referred to in Note&#160;12. As such $0.7&#160;million of the offering costs were classified as deferred offering costs. As of December&#160;31, 2021, the Company had recorded deferred offering costs of $3.4&#160;million, all of which are related to the Business Combination as discussed in Note 3. </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Property and Equipment, Net </div></div>&#8212; Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets. The Company uses an estimated useful life of three years for furniture and other assets and information technology hardware (&#8220;IT hardware&#8221;), seven years for process equipment, and three to ten years for quantum computing fridges. Leasehold improvements are amortized over the shorter of the lease-term or the estimated useful life of the related asset. Expenditures for repairs and maintenance are expensed as incurred. Upon disposition, the cost and related accumulated depreciation are removed and any resulting gain or loss is reflected in other income (expense) in the consolidated statements of operations. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Long-lived assets, which consist of property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset (asset group) may not be recoverable. When such events or changes in circumstances occur, the Company performs an undiscounted cash flow analysis to determine if an impairment exists and, if so, an impairment loss would be recorded based on the excess of the carrying amount of the asset (asset group) over its fair value. During the year ended December&#160;31, 2022 the Company determined there was a triggering event and an undiscounted cash flow analysis was performed. Based on the results of this analysis, the Company&#8217;s long-lived assets were not impaired and no impairment charge was recorded. During the 11 months ended December&#160;31, 2021 no triggering events were noted. </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill </div></div>&#8212; Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed in a business combination. Goodwill has an indefinite useful life and is not amortized. The Company reviews its goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value of the Company may exceed its fair value. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the Company is less than its carrying amount, including goodwill. If that is the case, the Company performs a quantitative impairment test, and, if the carrying amount of the Company exceeds its fair value, then the Company will recognize an impairment charge for the amount by which its carrying amount exceeds its fair value, not to exceed the carrying amount of the goodwill. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">The Company determined a triggering event existed in the fourth quarter of 2022 resulting from the sustained decline in the Company&#8217;s stock price. A quantitative impairment test was performed and as a result, the Company recognized a $5.4&#160;million goodwill impairment charge for the year ended December&#160;31, 2022. </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DeferredFinancingCostsPolicyTextBlock', window );">Deferred Financing Costs</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deferred Financing Costs</div></div> &#8212; The incremental cost, including the fair value of warrants, directly associated with obtaining <div style="letter-spacing: 0px; top: 0px;;display:inline;">debt</div> financing is capitalized as deferred financing costs upon the issuance of the debt and amortized over the term of the related debt agreement using the effective-interest metho<div style="letter-spacing: 0px; top: 0px;;display:inline;">d</div> with such amortized amounts included as a component of interest expense in the consolidated statements of operations. Unamortized deferred financing costs are presented on the consolidated balance sheets as a direct deduction from the carrying amount of the related de<div style="display:inline;">b</div>t<div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:rgba(255, 255, 255, .0);;display:inline;">obligation.<div style="letter-spacing: 0px; top: 0px;;display:inline;"/> </div></div></div></div> <div style="background-color:rgba(255, 255, 255, .0);;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color:rgba(255, 255, 255, .0);;display:inline;">&#160;</div></div></div><br/></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PublicAndPrivateWarrantsPolicyTextBlock', window );">Public and Private Warrants</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public and Private Warrants</div></div> &#8212; At the Closing Date of the Business Combination, SNII </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> had 4,450,000 Private Warrants and&#160;</div>8,625,000<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;Public warrants outstanding. Each whole warrant entitles the holder to purchase one share of the Company&#8217;s Common Stock at a price of $</div>11.50<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> per share, subject to adjustments, and will expire </div>five years<div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> after the Business Combination or earlier upon redemption or liquidation.</div><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">fixed-for-fixed</div></div> option on equity shares. Therefore, the Private Warrants are not considered indexed to the Company&#8217;s stock and should be </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>    <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">classified as a liability. Since the Private Warrants meet the definition of a derivative, the Company recorded the Private Warrants as liabilities in the consolidated balance sheet at fair value upon the closing, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date. The fair value of the Private Warrants are measured using the Black-Scholes option-pricing model. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Public Warrants also fail to meet the indexation guidance in ASC 815 and are accounted for as liabilities because they include a provision whereby if there is not an effective registration statement, the warrant holders have a cap of 0.361 shares of Common Stock per warrant (subject to adjustment), on the issuable number of shares in a cashless exercise. Subsequent to the separate listing and trading of the Public Warrants, their fair value has been measured based on the observable listed prices for such warrants. Upon consummation of the Business Combination, the Company recorded a liability related to the Public Warrants of $16.3&#160;million, with an offsetting entry to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. On December&#160;31, 2022, the fair value of the Public Warrants decreased to $0.7&#160;million with the corresponding gain from the change in fair value recorded in the consolidated statement of operations for the year ended December&#160;31, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See Note 13 and 15 for further information on fair value. </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Warrant Liabilities</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative Warrant Liabilities </div></div>&#8212; The<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;) at the initial recognition date. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than the Public and Private Warrants noted above, the Company also issued warrants to Trinity Capital which are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period until exercised. The fair value of the warrant liabilities issued were initially measured using the Black- Scholes model and are subsequently remeasured at each reporting period with changes recorded as a component of other (expense) income in the Company&#8217;s consolidated statements of operations. During the year ended December&#160;31, 2022 these warrants were exercised and are no longer outstanding. </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock', window );">Earn-Out Liability</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Liability &#8212;</div></div> At the closing of the Business Combination, the SPAC Sponsor subjected certain Sponsor Vesting Shares to forfeiture and vesting as of the Closing Date if thresholds related to the weighted average price of Common Stock are not met for the duration of various specified consecutive day trading periods during the five-year period following the Closing (the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Earn-Out</div> Triggering Events&#8221;). Any such shares held by the Sponsor that remain unvested after the fifth anniversary of the Closing will be forfeited. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These Sponsor Vesting Shares are accounted for as liability classified instruments because the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Triggering Events that determine the number of Sponsor Vesting Shares to be earned back by the Sponsor include outcomes that are not solely indexed to the Common Stock of the Company. The aggregate fair value of the Sponsor Vesting Shares on the Closing Date was estimated using a Monte Carlo simulation model and was determined to be $20.4&#160;million at the Closing Date. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2022, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Triggering Events were not achieved for any of the tranches, and as such, the Company adjusted the carrying amount of the liability to its estimated fair value of $1.2&#160;million. The change in the fair value of $19.2&#160;million for the year ended December&#160;31, 2022 is included in gain on fair value change, net in the condensed consolidated statements of operations. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant inputs into the respective valuation models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows:</div></div></div> <div style="null;text-indent: 0px;"> <div> <div style="display: inline; background-color: white;"> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 54%;"/>
<td style="width: 20%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 20%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Assumptions</div></div></div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"> <div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial Recognition on<br/>March 2, 2022</div></div></div> </div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"> <div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></div> </div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Price</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.73</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Simulated trading days</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,198</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,050</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility (annual)</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30.50</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109.30</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.74</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.04</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Estimated time to expiration (years)</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> </div> </div> </div>  <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue Recognition</div></div> &#8212; The Company recognizes revenue in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606,<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Revenue from Contracts with Customers </div></div>and accounts for certain contract costs in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;340-40,</div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Other Assets and <div style="letter-spacing: 0px; top: 0px;;display:inline;">Deferred</div> Costs&#8212;Contracts with Customers.</div></div> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes revenue from contracts <div style="letter-spacing: 0px; top: 0px;;display:inline;">with</div> customers by applying the following five-step model: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identify the contract with a customer </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Identify the performance obligations in the contract </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Determine the transaction price </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Allocate the transaction price to the performance obligations in the contract </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recognize revenue when (or as) performance obligations are satisfied </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company generates revenue through its Quantum Computing as a Service (&#8220;QCaaS&#8221;) and development contracts and other services. Access to Rigetti quantum computing systems can be purchased as a quantum computing subscription, or on a usage basis for a specified quantity of hours. Revenue related to subscription-based access to (&#8220;QCaaS&#8221;) is recognized over time as access to the systems is provided on a ratable basis over the subscription term, which can range from six months to two years. This time-based input measure of progress provides a faithful depiction of the transfer of the services because the benefits the customer obtains generally equals the benefit from its access to the systems throughout the subscription term. Revenue related to usage-based access to Rigetti quantum computing systems is recognized over time as the systems are accessed using an output method based on compute credit hours expended. This output method provides a faithful depiction of the transfer of the services because the customer has purchased a specified quantity of hours of usage that diminishes each time an hour is expended and therefore each hour of access to the systems is considered a discrete delivery of underlying services in these arrangements. </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Development contracts are generally multi-year, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> arrangements in which the Company provides professional services regarding practical applications of quantum computing to technology and business problems within the customer&#8217;s industry or organization and assists the customer in developing quantum algorithms and applications that will provide commercial value to the customer in areas of business interest. Development contracts are typically fixed fee arrangements invoiced on a milestone basis but may also be invoiced on a time and materials or cost reimbursement basis in certain cases. Revenue related to development contracts and other services is recognized over time based on completed milestones or hours or costs incurred as appropriate. Revenue for partially completed milestones deemed probable of being met is recognized using an input measure based on actual labor hours incurred to date relative to total estimated labor hours needed to complete the milestone. This input measure of progress provides a faithful depiction of the transfer of the services because it closely depicts the Company&#8217;s efforts or inputs to the satisfaction of the performance obligation. Revenue related to the sale of custom quantum computing components is recognized at a point in time upon acceptance by the customer. </div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">When the Company&#8217;s contracts with customers contain multiple performance obligations, the transaction price is allocated on a relative standalone selling price basis to each performance obligation. The Company typically </div></div></div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"/> <div/>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">determines standalone selling price based on observable selling prices of our products and services. In instances where standalone selling price is not directly observable, standalone selling price is determined using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price, which includes fixed consideration and estimates of variable consideration. The amount of variable consideration included in the transaction price is constrained and is included only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s contracts with customers may include renewal or other options at fixed prices. Determining whether such options are considered distinct performance obligations that provide the customer with a material right and therefore should be accounted for separately requires significant judgment. Judgment is required to determine the standalone selling price for each renewal option to determine whether the renewal pricing is reflective of standalone selling price or is reflective of a discount that would provide the customer with a material right. Based on the Company&#8217;s assessment of standalone selling prices, the Company determined that there were no significant material rights provided to its customers requiring separate recognition. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The timing of revenue recognition may not align with the right to invoice the customer. The Company records accounts receivable when it has the unconditional right to issue an invoice and receive payment, regardless of whether revenue has been recognized. If revenue has not yet been recognized, a contract liability (deferred revenue) is also recorded. If revenue is recognized in advance of the right to invoice, a contract asset or unbilled receivable is recorded, depending on whether the Company&#8217;s right to consideration is considered conditional or unconditional. Unbilled receivables are included within accounts receivable in the consolidated balance sheets. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In instances where the timing of revenue recognition differs from the timing of the right to invoice, the Company has determined that a significant financing component generally does not exist. The primary purpose of the Company&#8217;s invoicing terms is to provide customers with simplified and predictable ways of purchasing the products and services and not to receive financing from or provide financing to the customer. Additionally, the Company has elected the practical expedient that permits an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment terms on invoiced amounts are typically net 30 days. The Company does not offer rights of return for its products and services in the normal course of business, and contracts generally do not include service-type warranties that provide any incremental service to the customer beyond providing assurance that the goods and services conform to applicable specifications or customer-specific or subjective acceptance provisions. The Company also excludes from revenue government-assessed and imposed taxes on revenue-generating activities that are invoiced to customers. </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock', window );">Costs of Obtaining and Fulfilling Contracts</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Costs of Obtaining and Fulfilling Contracts</div></div> &#8212; The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less. The Company capitalizes incremental costs incurred to fulfill its contracts that (i)&#160;relate directly to the contract, (ii)&#160;are expected to generate resources that will be used to satisfy the Company&#8217;s performance obligation(s) under the contract, and (iii)&#160;are expected to be recovered through revenue generated under the contract. </div></div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost of Revenue</div></div> &#8212; Cost of revenue consists primarily of all direct and indirect cost associated with providing QCaaS offerings and development contracts and other services, including employee salaries and employee </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/>  <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">related costs, including compensation, bonuses, employee taxes and benefit costs of program management and personnel associated with the delivery of goods and services to customers. Cost of revenue also includes an allocation of facility costs, depreciation and amortization directly related to providing the QCaaS offerings and development contracts and other services.</div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Research and Development </div></div>&#8212; Research and development costs are expensed as incurred. Research and development expenses include compensation, employee benefits, stock-based compensation, outside consultant fees, allocation of facility costs, depreciation and amortization, materials and components purchased for research and development. </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">General and Administrative</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">General and Administrative</div></div> &#8212; General and administrative expenses include compensation, employee benefits, stock-based compensation, legal, insurance, finance administration and human resources, an allocation of facility costs (including leases), bad debt costs, professional service fees, and an allocation of other general overhead costs including depreciation and amortization to support Rigetti&#8217;s operations, which consists of operations other than associated with providing QCaaS offerings and development contracts and other services. </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SalesAndMarketingPolicyTextBlock', window );">Sales and Marketing</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sales and Marketing &#8212;</div></div> Sales and marketing expenses consist primarily of compensation including stock-based compensation, employee benefits of sales and marketing employees, outside consultants fees, travel and marketing and promotion costs. </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CapitalizedSoftwarePolicyTextBlock', window );">Capitalized Software</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capitalized Software &#8212;</div></div> The Company capitalizes the costs to develop <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">its&#160;internal-use&#160;software</div> when preliminary development efforts are successfully completed, management has authorized and committed project funding, and it is probable that the project will be completed and the software will be used as intended. Such costs are included in property and equipment in the consolidated balance sheets and are amortized on a straight-line basis over the estimated useful life of the related asset. These capitalized costs are primarily related to the software infrastructure supporting the quantum computing services purchased by customers. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. During the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, no capitalized software has been recorded. </div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes </div></div>&#8212; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of December&#160;31, 2022 and December&#160;31, 2021, the Company has recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of income tax positions only if it is more likely than not that those positions will be sustained. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in income tax expense.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net income (loss) per share</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net Loss Per Share</div></div> &#8212; Basic net loss per common share is computed by dividing the net loss available to Common Stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to Common Stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">of common shares and potential common shares outstanding when the impact is not antidilutive. Potential common shares from stock options, unvested restricted stock units and Common Stock warrants are computed using the treasury stock method, while those from convertible Series C and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock are computed using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. Contingently issuable shares are included in basic net loss per share only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration shall be considered outstanding common shares and included in the computation of basic net loss per share. </div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock-Based Compensation</div></div> &#8212; The Company accounts for share-based compensation in accordance with ASC 718, Compensation &#8211; Stock Compensation. The Company&#8217;s share-based compensation awards are all equity-classified and consist of stock options, restricted stock units (&#8220;RSU&#8221;) and restricted stock awards (&#8220;RSA&#8221;). Most stock options have service vesting conditions ranging from 1 to 5 years. RSAs are fully vested on grant date. RSUs granted under the Rigetti&#160;&amp; Co., Inc. 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;) have a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4-year</div> service vesting condition and a performance condition linked to the occurrence of a liquidity event defined as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">change-in-control</div></div> event, successful initial public offering or successful merger with a special purpose acquisition company, which was satisfied at the Closing. RSUs granted under the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) have a service vesting condition only. The Company occasionally issues awards that might have different vesting conditions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compensation expense is based on the grant-date fair value of the awards and recognized over the requisite service period using a straight-line method for awards that have a service only condition. Compensation expense for awards with service and performance and/or market conditions is recognized using a graded vesting method. Compensation expense for RSAs is recognized fully on grant date. Compensation expenses for awards with a market condition are recognized over the requite service period regardless of whether the market condition is met unless the service requirement is not met. The Company has elected to account for forfeitures of employee stock awards as they occur. </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div>&#8212; The Company reports all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis... Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 1&#8212;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 2&#8212;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level 3&#8212;Inputs are unobservable for the asset or liability. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety. </div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentrations of Credit Risk</div></div> &#8212; Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments in the form of commercial paper and corporate bonds, and trade accounts receivable. The Company&#8217;s cash and cash equivalents and short-term investments are placed with high-credit-quality financial institutions, and at times exceed federally insured limits. To date, the Company has not experienced any credit loss relating to its cash and cash equivalents or short-term investments. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/>   <div style="font-family: Times New Roman; font-size: 10pt; margin-bottom: 0pt; text-indent: 0px; margin-top: 1em"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant </div></div> customers that represent 10% or more of revenue are set forth in the <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">following tables: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year<br/>Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the 11<br/>months<br/>ended<br/>December&#160;31,</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer A</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">33%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">16%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer B</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">18%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">20%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer C</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">15%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">15%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer D</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">14%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">29%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer E</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">11%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer F</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">*</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">17%</td></tr></table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*Customer accounted for less than 10% of revenue in the respective period </div></div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div>   <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer A</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">65%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer B</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">13%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">35%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer C</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">10%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">34%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer D</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">29%</td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*Customer accounted for less than 10% of accounts receivable in the respective period</div></div>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales to government entities comprised 81.3% and 80.0% of the Company&#8217;s total revenue for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recently Adopted Accounting Pronouncements </div></div>&#8212; In February 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-0</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2,</div> Leases and related subsequently issued ASUs (collectively, &#8220;Topic 842&#8221;), which supersedes Topic 840. From a lessee perspective, the core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (&#8220;ROU&#8221;) asset representing its right to use the underlying asset for the lease term. There continues to be a differentiation between finance leases (which replace capital leases as so identified under Topic 840) and operating leases. However, the principal difference from the previous guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the statement of financial position. The updated guidance also requires additional quantitative and qualitative disclosures and allows various practical expedients.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><br/><div style="margin-top: 1em; margin-bottom: 1em"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted Topic 842 effective January&#160;1, 2022, using the modified retrospective transition option of applying the new standard at the adoption date for all leases with an original term greater than 12 months. The Company elected the package of practical expedients requiring no reassessment of (i)&#160;whether any expired or existing contracts are or contain leases, (ii)&#160;the lease classification of any expired or existing leases, or (iii)&#160;initial direct costs for any existing leases. Adoption of the standard had a material impact on the Company&#8217;s consolidated balance sheet by recognizing operating lease ROU assets and operating lease liabilities but did not<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div>have an impact on its consolidated statement of operations or cash flows on the date of adoption. The adoption of Topic 842 was recorded as of January&#160;1, 2022 and resulted in the recognition of operating lease ROU assets and operating lease liabilities of $6.3&#160;million and $6.6&#160;million respectively and a $0.3&#160;million adjustment to deferred rent, with no impact to accumulated deficit as of January&#160;1, 2022. The period ended December&#160;31, 2021 continues to be reported in accordance with the Company&#8217;s historic accounting under previous lease guidance, Topic 840.</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company determines if an arrangement includes a lease at inception. Operating leases are included in the Company&#8217;s balance sheet as operating lease ROU assets and operating lease liabilities as of December&#160;31, 2022. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. In determining the net present value of its lease payments, the Company uses an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date, or the date of adoption of Topic 842. The operating lease ROU assets also include any lease payments made less lease incentives. The Company&#8217;s leases may include options to extend or terminate the lease, which is considered in the lease term when it is reasonably certain that the Company will exercise any such options. Lease expense is recognized on a straight-line basis over the expected lease term, taking into account adjustments for provisions such as free rent, escalating base monthly rental payments or deferred payment terms such as rent holidays that defer the commencement date of required payments. The Company has elected not to apply the recognition requirements of Topic 842 for short-term leases. The Company considers leases with a term of 12 months or less at the date of commencement to be short-term. </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2021, the FASB issued&#160;ASU No. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04,&#160;Earnings</div> Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-50),</div> Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#160;(&#8220;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#8221;).</div> The guidance in&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#160;clarifies</div> and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December&#160;15, 2021.The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Company&#160;adopted&#160;ASU&#160;2021-04&#160;as</div> of&#160;January 1, 2022. The adoption of&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04&#160;did</div> not have an impact on the Company&#8217;s financial position and results of operations. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,&#160;Income</div> Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> removes certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. The Company adopted this ASU on January&#160;1, 2022. Adoption did not have a significant impact on the Company&#8217;s financial statements or related disclosures. </div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock', window );">Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recently Issued Accounting Pronouncements Not Yet Adopted </div></div>&#8212; In June 2022, the FASB issued&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2022-03,&#160;ASC</div> Subtopic 820&#160;&#8220;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#8221;. The FASB issued this update (1)&#160;to clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2)&#160;to amend a related illustrative example, and (3)&#160;to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The ASU is effective for the Company after December&#160;15, 2024, and interim periods within those fiscal years, with early adoption permitted. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In August 2020, the FASB issued&#160;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06,</div> Debt - (Topic 815) (&#8220;ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06&#8221;),</div> which simplifies an issuer&#8217;s accounting for convertible instruments and its application of the derivatives scope exception for contracts in its own equity. The amendments in&#160;ASU No. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06&#160;are</div> effective for public companies, other than smaller reporting companies, for fiscal years beginning after December&#160;15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December&#160;15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December&#160;15, 2020, including interim periods within those fiscal years. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;">In April 2019, the FASB issued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU&#160;2019-04,&#160;Codification&#160;Improvements</div> to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASU&#160;No.&#160;2019-04&#160;was</div> issued as part of the FASB&#8217;s ongoing project to improve upon its Accounting Standards Codification (ASC), and to clarify and improve areas of guidance related to recently issued standards on credit losses, hedging, and recognition and measurement. For entities that have not yet adopted the guidance in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Update&#160;2016-13,&#160;the</div> effective dates and the transition requirements for these amendments are the same as the effective date and transition requirements in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Update&#160;2016-13.&#160;The</div> amendments related to ASC 326 are effective for the Company as of January&#160;1, 2023.&#160;The adoption of the ASU is not expected to have a material impact on its consolidated financial statements. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Contingent Consideration Liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CapitalizedSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CapitalizedSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs of obtaining and fulfilling contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DeferredFinancingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DeferredFinancingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DeferredOfferingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DeferredOfferingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for emerging growth company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PublicAndPrivateWarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public And Private Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PublicAndPrivateWarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recently issued accounting pronouncements not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_SalesAndMarketingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales and marketing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_SalesAndMarketingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726093248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Cash, Cash Equivalents and Investments</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,542</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,729</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash <div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>quivalents</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">317</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents and restricted cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57,888</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,046</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination', window );">Schedule of Inputs Into the Respective Models</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant inputs into the respective valuation models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows:</div></div></div> <div style="null;text-indent: 0px;"> <div> <div style="display: inline; background-color: white;"> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 54%;"/>
<td style="width: 20%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 20%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Assumptions</div></div></div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"> <div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial Recognition on<br/>March 2, 2022</div></div></div> </div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"> <div style="top: 0px; letter-spacing: 0px; display: inline;"> <div style="display: inline;"> <div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></div> </div> </div> </td>
<td style="padding-bottom: 0.5pt; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Price</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.73</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Simulated trading days</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,198</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,050</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility (annual)</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30.50</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109.30</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.74</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.04</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Estimated time to expiration (years)</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> </div> </div> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Shares</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-bottom: 0pt; text-indent: 0px; margin-top: 1em"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant </div></div> customers that represent 10% or more of revenue are set forth in the <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">following tables: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year<br/>Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the 11<br/>months<br/>ended<br/>December&#160;31,</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer A</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">33%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">16%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer B</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">18%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">20%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer C</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">15%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">15%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer D</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">14%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">29%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer E</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">11%</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer F</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;">*</td>
<td style="vertical-align: bottom; width: 12%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">17%</td></tr></table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*Customer accounted for less than 10% of revenue in the respective period </div></div></div> <div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock', window );">Schedule of Customers Accounts Receivable</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer A</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">65%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer B</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">13%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">35%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer C</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">10%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">34%</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer D</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">*</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">29%</td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*Customer accounted for less than 10% of accounts receivable in the respective period</div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of assumptions based on significant unobservable inputs used in the valuation of earn out liability arising out of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of concentration of accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726883568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock', window );">Summary of net proceeds from business combination and PIPE financing</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;">In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $225.6&#160;million. The table below shows the net proceeds from business combination and PIPE financing: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;SNII trust and cash (net of redemption)</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,769</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;PIPE</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">147,510</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Cash&#8212;SNII operating account</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Net Proceeds from Business Combination and PIPE</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">225,604</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock', window );">Summary of consummation of the business combination</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The number of shares of Common Stock issued immediately following the consummation of the Business Combination was as follows: </div></div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:79%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div>SNII Class&#160;A, outstanding prior to Business Combination</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: redemption of SNII Class&#160;A ordinary shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22,915,538</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div>SNII Class&#160;A ordinary shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,584,462</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;SNII Class&#160;B ordinary shares*</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in PIPE</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,641,244</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Business Combination and PIPE shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,850,706</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;Legacy Rigetti**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,221,069</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;exercise of Legacy Rigetti stock options immediately prior to the closing**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,123,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;exercise of Legacy Rigetti warrants immediately prior to the closing**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,234,408</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;upon conversion of Legacy Rigetti Series C preferred stock**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,478,261</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Common Stock&#8212;upon conversion of Legacy Rigetti Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock**</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,902,302</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares of Common Stock immediately after Business Combination</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113,810,285</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">*</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes (i) 2,479,000 shares of Common Stock held by the Sponsor (the &#8220;Promote Sponsor Vesting Shares&#8221;) and (ii) 580,273 shares of Common Stock held by the Sponsor (&#8220;Sponsor Redemption-Based Vesting Shares&#8221;). </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">**</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">(i) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of 0.7870 (the &#8220;Exchange Ratio&#8221;). (ii) the conversion ratio to Legacy Rigetti Common Stock for the Legacy Series C Preferred Stock was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> and for Legacy <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;C-1</div> Preferred Stock was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">eight-for-one.</div></div> </div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of net proceeds from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728362064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value</a></td>
<td class="text">The amortized cost, gross unrealized holding loss included in other comprehensive income, and fair value of the<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">investment securities on December&#160;31, 2022 are presented in the table below. The Company did not hold investment securities at December&#160;31, 2021. </div></div></div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 49%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized&#160;Cost&#160;as&#160;of<br/>December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross&#160;Unrealized<br/>Holding Loss</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;Value&#160;as&#160;of<br/>December&#160;31,&#160;2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash <div style="letter-spacing: 0px; top: 0px;;display:inline;">e</div>quivalents</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money Market Funds</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments:</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States Treasury Securities</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,514</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(304</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,210</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,571</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 49%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commercial Papers</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,142</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,142</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">121,583</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(314</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">121,269</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 49%;">&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 11%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728170544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the change in the carrying amount of goodwill for the Company for the year ended December&#160;31, 2022: </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 86%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 86%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">January 1, 2021</div></div></div></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,377</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 86%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Change</div><br/></div></div></div></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 86%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom; width: 6%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:86%"/>
<td style="vertical-align: bottom; width: 6%;"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December&#160;31, 2021</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment charge</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,377</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 86%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 86%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December&#160;31, 2022</div></td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 86%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728353136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Disaggregation of Revenue</a></td>
<td class="text"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables depict the disaggregation of revenue according to the type of good or service and timing of transfer of goods or services for the year ended December&#160;31, 2022, and the 11 months ended December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Type of Goods or Service</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Collaborative research and other professional services</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,849</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Access to quantum computing systems</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,185</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,347</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Timing of Revenue Recognition</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue recognized at a point in time</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue recognized over time</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Selected consolidated balance sheet line items that reflect accounts receivable, contract assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021 were as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 65%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 65%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trade receivables</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,143</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unbilled receivables</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">92</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(961</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(985</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Change in Contract with Customer, Asset and Liability</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in deferred revenue from contracts with customers were as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at beginning of period</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(985</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(492</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferral of revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(545</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(904</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Recognition of deferred revenue</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">569</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">411</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance at end of period</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(961</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(985</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Change in Contract with Customer, Asset and Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728206288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statements Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary Of Property, Plant and Equipment</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment as of December&#160;31, 2022 and December&#160;31, 2021 are composed of the following: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Quantum computing fridges</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,218</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,190</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Process equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,330</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,561</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,297</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IT Hardware</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,035</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,428</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and other assets</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,246</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,246</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65,390</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,330</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Accumulated depreciation and amortization</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(25,860</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18,832</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment - net</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39,530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,497</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued Expenses and Other Current Liabilities </div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Utilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,818</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Professional&#160;&amp; subscription fees</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,044</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and other taxes</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,161</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">571</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Subcontractor cost</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">804</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payroll and other payroll costs</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">781</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">626</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;">Accrued interest</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">314</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,205</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,806</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728378176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock', window );">Schedule Of Future Minimum Lease Payments Under Non Cancelable Operating Leases [Table Text Block]</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future minimum lease payments under non-cancelable operating leases as of December 31, 2021 are <div style="letter-spacing: 0px; top: 0px;;display:inline;">as</div> follows: </div></div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 87%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,808</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">901</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">928</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">956</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">81</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total minimum future lease payments</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4,674</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Components of Lease Costs</a></td>
<td class="text"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Components of lease costs, the weighted average remaining lease term and weighted average discount rate were as follows as of and for the year ended December&#160;31, 2022: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 15%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/>Lease cost<div style="letter-spacing: 0px; top: 0px;;display:inline;"/></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 15%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-size: 0px;">
<td style="width:87%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Short-term lease cost</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Sub-lease income</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(194</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease cost</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;">2,355</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr> </table>  <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div>   <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;Ended<br/>December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash paid for amounts included in the measurement of lease liabilities:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating cash flows from operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">$2,128</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets obtained in exchange for new and modified operating lease liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">$4,892</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average remaining lease term - operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;">5.87&#160;years</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate - operating leases</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center; text-indent: 0px;">7.93<div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0px;;text-align:center;">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Maturities of the Company's Operating Lease Liabilities</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the net present value of its lease payments, the Company used an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date or the date of Adoption of Topic 842. As of December&#160;31, 2022, the maturities of the Company&#8217;s operating lease liabilities were as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"/>
<td style="width: 7%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">2,422</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,288</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">2,198</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">1,524</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">1,566</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,841</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total lease payments</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">12,839</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Imputed interest</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(2,636</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Present value of lease liabilities</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">10,203</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,345</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, noncurrent</div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">7,858</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;">10,203</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size:1pt;;display:inline;">&#160;</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of future minimum lease payments under non cancelable operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725954736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long term debt and the unamortized discount</a></td>
<td class="text"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the debt is classified as Level 2. Given the maturity and variable interest rate on the debt, the book value approximates its fair value. Long term debt and the unamortized discount balances are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 74%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding principal amount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Add: accreted liability of final payment fee</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">407</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: unamortized debt discount, long term</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(990</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,618</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: current portion of long term debt-principal</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,491</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,291</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Debt&#8212;net of current portion</div><br/></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">20,635</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">24,216</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Current portion of long term debt&#8212;principal</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,491</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,291</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: current portion of unamortized debt discount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,188</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(716</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt&#8212;current portion</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">575</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Scheduled principal payments on total outstanding debt</a></td>
<td class="text"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Scheduled principal payments on total outstanding debt as of December&#160;31, 2022 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 85%;"/>
<td style="vertical-align: bottom; width: 6%;"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,491</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,007</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,020</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,709</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scheduled principal payments on total outstanding debt as of December 31, 2021 are as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 85%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Year ending December 31,</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">702</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8,682</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">11,008</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">6,608</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">27,000</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728375440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfConversionsOfStockTextBlock', window );">Summary of Conversions of Stock</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company has reserved the following shares of Common Stock for issuance upon the conversion, exercise or vesting of the underlying instruments: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:78%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common&#160;Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,243,811</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Stock-Based Awards&#8212;RSUs Outstanding</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,332,591</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Stock-Based Awards&#8212;Options Outstanding</div><br/></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,845,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">37,422,305</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfConversionsOfStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfConversionsOfStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836729194400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule Of Fair Value Of The Common Stock Warrant Liabilities Measured Using Black Scholes Approach</a></td>
<td class="text"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant inputs into the Black Scholes model used to value the Trinity Warrant liabilities at June&#160;2, 2022, the exercise date, are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 82%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"/> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 82%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Assumptions - Trinity Warrant Liability</div></div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;2,&#160;2022</div></div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock price</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$8.23</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$0.27</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility (annual)</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">105.10%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2.94%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated time to expiration (years)</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">9.000</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;%</div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock', window );">Summary of vesting status of the Customer Warrant</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The vesting status of the Customer Warrant is as follows at December&#160;31, 2022 and December&#160;31, 2021:</div></div><br/></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 76%; border: 0px; margin: 0px auto; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested Customer warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,340,297</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,072,237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested Customer warrants</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,340,310</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,608,370</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,680,607</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,680,607</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember', window );">Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule Of Fair Value Of The Common Stock Warrant Liabilities Measured Using Black Scholes Approach</a></td>
<td class="text"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Private Warrant was measured using the Black Scholes model approach. Significant inputs into the respective models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 61%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Assumptions</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Initial&#160;Recognition<br/>on March 2, 2022</div></div></div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 61%;"/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Stock Price</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$0.73</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$9.43</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike Price</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$11.50</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$11.50</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility (annual)</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">109.26%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30.66%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4.04%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1.74%</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated time to expiration (years)</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4.172</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5.000</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></div> </td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;%</div></td>
<td style="vertical-align: bottom; width: 10%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;%</div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of vesting status of warrants .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728387152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Forward Warrant Agreement (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques</a></td>
<td class="text">The following table represents key valuation assumptions as of the year ended December&#160;31, 2022 and 11 months ended December 31, 2021:
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 64%;"/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td style="width: 7%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Assumptions</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Holding period (in years)</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.767</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.5-1.13</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk free rate</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4.69%</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.19%-0.43%</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Probability of occurring the contingency</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">50%</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">50%-100%</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underlying value per share</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$0.73</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$10.29</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value liabilities measured on recurring and nonrecurring basis valuation techniques</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836828313120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value measurements of financial assets and liabilities that <div style="letter-spacing: 0px; top: 0px;;display:inline;">are </div>measured at fair value at December&#160;31, 2022 and December&#160;31, 2021 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 68%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:68%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash equivalents: </div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money Market Funds</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td>
<td colspan="4" style="height:6pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term investments:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States Treasury Securities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,210</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,571</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Commercial Paper</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,142</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward warrant agreement</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,229</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">94,556</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">26,713</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,229</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Public Warrants</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">699</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Private Warrants</div><br/></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;;text-align:right;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">1,068</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-out</div> liability</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,206</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">699</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,274</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="display:inline;"/></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;;text-indent: 0px;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Derivative warrant liability&#8212;Trinity Warrants</div><br/></div></td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$<div style="display:inline;">&#160; &#160; &#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$<div style="display:inline;">&#160; &#160; &#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;;text-indent: 0px;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;">4,355</td>
<td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward warrant agreement</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">230</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Liabilities</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; width: 4%;"><div style="font-weight:bold;display:inline;">&#160;&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4,585</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Change in Fair Value of Derivative Liabilities</a></td>
<td class="text"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of the changes in the fair value of the Company&#8217;s Level&#160;3 financial instruments as of December&#160;31, 2022 and December&#160;31, 2021 are as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">warrant&#160;liability&#160;-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Trinity Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Derivative</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">warrant&#160;liability&#160;-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Warrants</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Forward<br/>Warrant</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Agreement</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-out</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">liability</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;January 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">2,691</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">400</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair values</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,664</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(170</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size: 0px;">
<td style="width: 45%;"/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;December 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4,355</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">230</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Initial measurement on March&#160;2, 2022 upon Business Combination (Note 3)</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">9,612</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">20,413</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair values</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">2,015</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(8,544</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(5,764</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;">(19,207</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Exercise of warrants</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(6,370</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">3,305</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgba(255, 255, 255, 0);">&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Balance&#8212;December 31, 2022</div><br/></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,068</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;(2,229</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/>)</td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">1,206</div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr>
<td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><br/></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;;text-align:right;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;">&#160;</div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726967728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Plans - (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock', window );">Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value [Table Text Block]</a></td>
<td class="text"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of activity related to stock option is summarized as below:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 54%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;Options</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Exercise</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/>Contractual</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life&#160;(in&#160;years)</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intrinsic<br/>Value</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Outstanding&#8212;December 31, 2021</div><br/></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,468,275</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.36</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,750,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.96</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,768,568</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 54%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Forfeited and expired</div></div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,603,804</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.27</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 54%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Outstanding&#8212;December 31, 202<div style="display:inline;">2</div></div><br/></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,845,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,103</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; width: 54%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 0pt; font-family: &quot;Times New Roman&quot;; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"> <div style="font-size: 0pt; line-height: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; padding-bottom: 0.375pt; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Exercisable&#8212;December 31, 2022</div><br/></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">5,464,027</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;">0.40</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;">7.2</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;">1,780</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 54%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Activity Related to Restricted Stock Units</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A summary of activity related to RSUs is summarized as below:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">RSUs</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average&#160;Fair<br/>Value&#160;Per&#160;Share</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-vested</div> shares at December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,388,455</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.93</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,782,607</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.92</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,007,789</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.99</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,830,682</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.03</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; padding-bottom: 0.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-vested</div> shares at December&#160;31, 2022</div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">11,332,591</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">$</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;">4.36</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td> </tr>
<tr>
<td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &quot;Times New Roman&quot;; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:right;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"> <div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs</a></td>
<td class="text"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below summarizes the total stock-based compensation expenses for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;14,092</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Selling and marketing expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,109</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">106</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,611</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">684</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total stock-based compensation expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,812</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#160;1,765</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions</a></td>
<td class="text"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width:55%"/>
<td style="vertical-align: bottom; width: 12%;"/>
<td/>
<td/>
<td/>
<td style="vertical-align: bottom; width: 12%;"/>
<td/>
<td/>
<td/>
<td style="vertical-align: bottom; width: 12%;"/>
<td style="width:12%;"/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12&#160;Months&#160;ended&#160;December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">ended<br/>December&#160;31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Time&#160;based&#160;vesting</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Market&#160;based&#160;vesting<br/>awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-size: 0px;">
<td style="width: 55%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="vertical-align: bottom; width: 12%;"/>
<td style="width:12%;"/>
<td/>
<td/></tr>
<tr style="font-size: 0px;">
<td style="width: 55%;"/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 12%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="vertical-align: bottom; width: 12%;"/>
<td style="width:12%;"/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">150</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%&#160;</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;">150</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div>&#160;</div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">46.8</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average risk-free interest rate</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3.77</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">3.76<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">1.07</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;">0</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%</div><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">0</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">%<br/></div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; text-indent: 0px; width: 55%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (in years)</div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5.85</div></div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;">5.0</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; text-indent: 0px; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; text-indent: 0px;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: right;">6.1&#160;years<div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: center;"><div style="font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Exercise price/Stock price</div></td>
<td style="vertical-align: bottom; width: 12%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.96</div></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div><br/></div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;">0.96</div></td>
<td style="vertical-align: bottom;;width:5%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><br/></div></td>
<td style="vertical-align: bottom; width: 12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td>
<td style="vertical-align: bottom;;width:12%;"><div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right;">0.21</td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: center;"><div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;">&#160;</div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836828313120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Basic Aand Diluted</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the computation of basic and diluted net loss per share of Common Stock for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: </div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11 Months<br/>ended<br/>December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(71,521)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,241)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted-average Class&#160;A Common Stock outstanding</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102,300,852</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,337,127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss per share for Class&#160;A Common Stock</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#8212; Basic</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.70)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.64)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">&#8212; Diluted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.70)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.64)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded From Computation of Earnings</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company excluded the following potential common shares from the computation of diluted net loss per share as of December&#160;31, 2022 and December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">December&#160;31,</div></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,218,320</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible Series C Preferred Stock</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,478,033</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock Warrants</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,444,127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,822,319</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Options</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,845,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,468,227</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 66%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted Stock Units</div></td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,332,591</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,622,621</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90,986,899</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 66%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 1px;">
<td/></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The number of outstanding shares as of December&#160;31, 2021 have been retrospectively adjusted to reflect the Exchange Ratio. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The number of outstanding warrants as of December&#160;31, 2022 and December&#160;31, 2021 does not include 1,340,310 and 1,608,359 shares, respectively, of Unvested Customer Warrants. </div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule computation of earnings per share basic and diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728184256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Summary Of Domestic And Foreign Components Of Loss Before Income Taxes</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents domestic and foreign components of loss before income taxes for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 62%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;ended</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-size: 0px;">
<td style="width:66%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Domestic</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(67,677)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,787)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,844</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,454</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(71,521)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,241)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary Of Components Of Deferred Tax Assets And Liabilities</a></td>
<td class="text">the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021, are as follows: <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred <div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div>ax <div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>ssets:</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating loss carryforwards</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,313</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals and reserves</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">147</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock-based compensation</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,233</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">744</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development credits</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,509</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">ROU <div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div>iability</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,507</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; padding-bottom: 0.375pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross deferred assets <div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">80,733</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;">47,487</td>
<td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred <div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div>ax <div style="letter-spacing: 0px; top: 0px;;display:inline;">l</div>iabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ROU <div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>sset</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,289</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Depreciation and amortization</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,063</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,420</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total deferred tax liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,352</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,420</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Total net deferred tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76,381</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,067</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Valuation allowance</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(76,381</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(46,067</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Net deferred tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Summary Of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Company&#8217;s history of incurring losses which have not been benefited and other permanent differences.&#160;</div><br/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"/>
<td style="width: 22%; vertical-align: bottom;"/>
<td/>
<td style="width: 21%; vertical-align: bottom;"/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;Ended<br/>December&#160;31,&#160;2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11&#160;Months&#160;Ended<br/>December&#160;31,&#160;2021</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt; width: 55%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Component</div></div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rate Impact</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rate Impact</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total pre-tax book income</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">21%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">21%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State and local income taxes</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">11%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Fair market value adjustments</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">14%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Non-deductible executive compensation</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(4)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill impairment</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(2)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction <div style="letter-spacing: 0px; top: 0px;;display:inline;">c</div>osts</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Change in valuation allowance</div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(42)%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(21)%</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 55%;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total:</div></div></div></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0%</div></td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; width: 55%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align: bottom; width: 22%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; width: 21%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summary Of Unrecognized Tax Benefits Affecting The Effective Tax rate</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">A reconciliation of the beginning and ending amounts of unrecognized income tax benefits during the year is as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;">&#160;</div>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 68%; border: 0px; margin: 0px auto; text-indent: 0px; border-spacing: 0px;">
<tr style="font-size: 0px;;text-indent: 0px;">
<td style="width:87%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance at January&#160;1, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,672</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Current year increase (decrease)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;">
<td>Prior year adjustment&#8212;increase (decrease)&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;"/></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px;text-indent: 0px;">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance at December&#160;31, 2022</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,672</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px;text-indent: 0px;">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table>  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836728398752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Summary of Revenue by Geography</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, and 11 months ended 2021: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 52%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended <br/>December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11 Months Ended <br/>December&#160;31, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">%</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85.0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,826</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71.1%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Europe</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,965</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15.0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,370</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28.9%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,196</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100.0%</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836727456192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Business - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 02, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares | Conversion Of Common Stock Shares From The Previous Company To The Current Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares | Conversion Of Common Stock Shares From The Previous Company To The Current Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of organization business operations and basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_EventAxis=rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_EventAxis=rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836721280048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>OperatingSegment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 36,346,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | OperatingSegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reporting segments | OperatingSegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">3,400,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrants or rights outstanding | shares</a></td>
<td class="nump">2,680,607<span></span>
</td>
<td class="nump">2,680,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_OfferingCostsIncurred', window );">Offering costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="num">$ (207,131,000)<span></span>
</td>
<td class="num">(278,652,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_IncreaseDecreaseInDeferredRent', window );">Adjustments To Deferred Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,203,000<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease Right Of Use Asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,316,000<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAdditions', window );">Capitalized Software</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="nump">$ 317,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_RGTIAgreementNameAxis=rgti_RGTICommonStockPurchaseAgreementMember', window );">RGTI Common Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_OfferingCostsIncurred', window );">Offering costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember', window );">Service Based And Performance Based Restricted Stock Units [Member] | 2013 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Share based compensation by share based award requisite service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rgti_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PeriodOfEarnoutShares', window );">Period of earnout shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrants or rights exercise price of warrants or rights | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrants or rights maturity period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrants or rights outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrants or rights exercise price of warrants or rights | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrants or rights maturity period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrants or rights number of securities covered by each warrant or right | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember', window );">Revenue from Rights Concentration Risk [Member] | Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember', window );">Revenue from Rights Concentration Risk [Member] | Revenue [Member] | Government Entities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">81.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Share based compensation by share based award requisite service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Share based compensation by share based award requisite service period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rgti_RigettiComputingIncMember', window );">Rigetti Computing, Inc [Member] | Minimum [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_IncreaseDecreaseInDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in deferred rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_IncreaseDecreaseInDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_OfferingCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_OfferingCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PeriodOfEarnoutShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period Of Earnout Shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PeriodOfEarnoutShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions made to capitalized computer software costs during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_RGTIAgreementNameAxis=rgti_RGTICommonStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_RGTIAgreementNameAxis=rgti_RGTICommonStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rgti_TwoThousandThirteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rgti_TwoThousandThirteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rgti_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rgti_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rgti_GovernmentEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rgti_GovernmentEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rgti_RigettiComputingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rgti_RigettiComputingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726934720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Cash Cash Equivalents and Short Term Investments (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 21,542,000<span></span>
</td>
<td class="nump">$ 11,729,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">36,346,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">317,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash and restricted cash</a></td>
<td class="nump">$ 57,888,000<span></span>
</td>
<td class="nump">$ 12,046,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726171936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Inputs Into the Respective Models (Detail)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>d </div>
<div>shares </div>
<div>yr</div>
</th>
<th class="th">
<div>Mar. 02, 2022 </div>
<div>shares </div>
<div>d </div>
<div>yr</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Valuation Assumptions | shares</a></td>
<td class="nump">0.73<span></span>
</td>
<td class="nump">9.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=rgti_SimulatedTradingDaysMember', window );">Simulated trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Valuation Assumptions | d</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">1,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility (annual)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Valuation Assumptions</a></td>
<td class="nump">109.3<span></span>
</td>
<td class="nump">30.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Valuation Assumptions</a></td>
<td class="nump">4.04<span></span>
</td>
<td class="nump">1.74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=rgti_EstimatedPeriodOfExpirationMember', window );">Estimated time to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Valuation Assumptions | yr</a></td>
<td class="nump">4.17<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of assumptions based on significant unobservable inputs used in the valuation Of earn out liability arising out of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=rgti_SimulatedTradingDaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=rgti_SimulatedTradingDaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=rgti_EstimatedPeriodOfExpirationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=rgti_EstimatedPeriodOfExpirationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836721188592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary Of Earnings Per Share Basic And Diluted (Detail) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems', window );"><strong>Schedule of Transition Period Comparative Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems', window );"><strong>Schedule of Transition Period Comparative Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems', window );"><strong>Schedule of Transition Period Comparative Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems', window );"><strong>Schedule of Transition Period Comparative Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer E [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems', window );"><strong>Schedule of Transition Period Comparative Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer F [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems', window );"><strong>Schedule of Transition Period Comparative Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ScheduleOfTransitionPeriodComparativeDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of transition period comparative data line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ScheduleOfTransitionPeriodComparativeDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720003520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Customers Accounts Receivable (Detail) - Customer Concentration Risk [Member] - Accounts Receivable [Member]<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems', window );"><strong>Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems', window );"><strong>Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems', window );"><strong>Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems', window );"><strong>Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rgti_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rgti_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726819760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Net Proceeds From Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CashReceivedFromTrustNetOfRedemptions', window );">Cash&#8212;SNII trust and cash (net of redemption)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CashReceivedFromPrivateInvestmentInPublicEquity', window );">Cash&#8212;PIPE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AggregateTransactionCostsPaid', window );">Cash&#8212;SNII operating account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid', window );">Net Proceeds from Business Combination and PIPE</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 225,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AggregateTransactionCostsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate transaction costs paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AggregateTransactionCostsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CashReceivedFromPrivateInvestmentInPublicEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Received From Private Investment In Public Equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CashReceivedFromPrivateInvestmentInPublicEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CashReceivedFromTrustNetOfRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Received From Trust Net Of Redemptions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CashReceivedFromTrustNetOfRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure In Tabular Form Of Net Proceeds From Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from business combination net of transaction costs paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836727303216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Parenthetical) (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Net Proceeds From Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts', window );">Business combination transaction costs</a></td>
<td class="nump">$ 20,650<span></span>
</td>
<td class="nump">$ 20,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts', window );">Adjustment to additional paid in capital business combination transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed', window );">Business combination transaction costs expensed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PaymentOfTransactionCostsThroughCash', window );">Payment of transaction costs through cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid', window );">Proceeds from business combination net of transaction costs paid</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 225,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital business combination transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure In Tabular Form Of Net Proceeds From Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PaymentOfTransactionCostsThroughCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of transaction costs through cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PaymentOfTransactionCostsThroughCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from business combination net of transaction costs paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs which have been expensed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723880448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Summary of Consummation of the Business Combination (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity', window );">Shares issued in PIPE</a></td>
<td class="nump">14,641,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity', window );">Business Combination and PIPE shares</a></td>
<td class="nump">34,850,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesIssuedInTheNewCompany', window );">Common Stock&#8212;Legacy Rigetti</a></td>
<td class="nump">18,221,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing', window );">Common Stock&#8212;exercise of Legacy Rigetti stock options immediately prior to the closing</a></td>
<td class="nump">1,123,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing', window );">Common Stock&#8212;exercise of Legacy Rigetti warrants immediately prior to the closing</a></td>
<td class="nump">2,234,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares</a></td>
<td class="nump">113,810,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany', window );">Less: redemption of SNII Class&#160;A ordinary shares</a></td>
<td class="num">(22,915,538)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany', window );">Common Stock&#8212;SNII Class ordinary shares</a></td>
<td class="nump">11,584,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Status Of Shares Outstanding Before Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares</a></td>
<td class="nump">34,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany', window );">Common Stock&#8212;SNII Class ordinary shares</a></td>
<td class="nump">8,625,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCRedeemableConvertiblePreferredStockMember', window );">Series C Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity', window );">Common Stock&#8212;upon conversion of Legacy Rigetti Series preferred stock</a></td>
<td class="nump">54,478,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCOneRedeemableConvertiblePreferredStockMember', window );">Series C One Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity', window );">Common Stock&#8212;upon conversion of Legacy Rigetti Series preferred stock</a></td>
<td class="nump">2,902,302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares issued due to exercise of stock options immediately before closing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares issued due to exercise of warrants immediately before closing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesIssuedInTheNewCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares issued in the new company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesIssuedInTheNewCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares issued in the new company upon conversion of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares issued pursuant to private investment in public equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares newly issued in the predecessor company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption of common stock shares of the predecessor company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock shares issued aggregate business combination private investment in public equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_EventAxis=rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_EventAxis=rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rgti_SeriesCRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCOneRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rgti_SeriesCOneRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836721260096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combination - Summary of Consummation of the Business Combination (Parenthetical) (Detail)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">113,810,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesExchangeRatio', window );">Common stock shares exchange ratio</a></td>
<td class="nump">0.787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCRedeemableConvertiblePreferredStockMember', window );">Series C Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio', window );">Conversion from temporary equity to permanent equity exchange ratio</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCOneRedeemableConvertiblePreferredStockMember', window );">Series C One Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio', window );">Conversion from temporary equity to permanent equity exchange ratio</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rgti_PromoteSponsorVestingSharesMember', window );">Promote Sponsor Vesting Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">2,479,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rgti_SponsorRedemptionBasedVestingSharesMember', window );">Sponsor Redemption Based Vesting Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems', window );"><strong>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">580,273<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion from temporary equity to permanent equity exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rgti_SeriesCRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCOneRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rgti_SeriesCOneRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rgti_PromoteSponsorVestingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rgti_PromoteSponsorVestingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rgti_SponsorRedemptionBasedVestingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rgti_SponsorRedemptionBasedVestingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720426336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Additional Information (Detail)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 02, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 23, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 01, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized | shares</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,050,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock shares authorized | shares</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockNumberOfVotesPerShare', window );">Common stock number of votes per share</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, Outstanding | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination', window );">Class of warrants or rights outstanding exercise price per share of the resulting company due to business combination</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations', window );">Class of warrants or rights number of shares covered by each warrant or right in the resulting company due to business combination</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare', window );">Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share</a></td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesExchangeRatio', window );">Common stock shares exchange ratio</a></td>
<td class="nump">0.787<span></span>
</td>
<td class="nump">0.787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockSharesIssuedAsAResultOfExchange', window );">Common stock shares issued as a result of exchange | shares</a></td>
<td class="nump">78,959,579<span></span>
</td>
<td class="nump">78,959,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NumberOfTradingDaysForDeterminingTheSharePrice', window );">Number of trading days for determining the share price</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_OneTimeBonus', window );">One-time bonus | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare', window );">Common stock of previous company converted into current company common stock par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare', window );">Common stock of previous company converted into current company common stock par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rgti_SupernovaAcquistionMember', window );">Supernova Acquistion [Member] | Sponsor Agreement [Member] | Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SharesSubjectToVestingBasedOnCertainConditions', window );">Shares subject to vesting | shares</a></td>
<td class="nump">2,479,000<span></span>
</td>
<td class="nump">2,479,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_VolumeWeightedAveragePricePerShare', window );">Volume weighted average price per share</a></td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SharesSubjectToVestingMaximumPeriod', window );">Shares subject to vesting maximum period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice', window );">Number of consecutive trading days for determining the share price</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rgti_SupernovaAcquistionMember', window );">Supernova Acquistion [Member] | Sponsor Agreement [Member] | Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SharesSubjectToVestingBasedOnCertainConditions', window );">Shares subject to vesting | shares</a></td>
<td class="nump">580,273<span></span>
</td>
<td class="nump">580,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_VolumeWeightedAveragePricePerShare', window );">Volume weighted average price per share</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SharesSubjectToVestingMaximumPeriod', window );">Shares subject to vesting maximum period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice', window );">Number of consecutive trading days for determining the share price</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rgti_SupernovaAcquistionMember', window );">Supernova Acquistion [Member] | Initial Subscription Agreement [Member] | Private Investment In Public Equity Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscribedButUnissued', window );">Common stock shares subscribed but not issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,251,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Common stock shares subscribed but not issued value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rgti_SupernovaAcquistionMember', window );">Supernova Acquistion [Member] | Subsequent Subscription Agreement [Member] | Private Investment In Public Equity Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscribedButUnissued', window );">Common stock shares subscribed but not issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,390,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Common stock shares subscribed but not issued value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights number of shares covered by each warrant or right in the resulting company due to business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights outstanding exercise price per share of the resulting company due to business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Number Of Votes Per Share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock of previous company converted into current company common stock par or stated value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares exchange ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CommonStockSharesIssuedAsAResultOfExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares issued as a result of exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CommonStockSharesIssuedAsAResultOfExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of consecutive trading days for determining the share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_NumberOfTradingDaysForDeterminingTheSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Trading Days For Determining The Share Price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_NumberOfTradingDaysForDeterminingTheSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_OneTimeBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>&#160;One-time bonus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_OneTimeBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_SharesSubjectToVestingBasedOnCertainConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares subject to vesting based on certain conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_SharesSubjectToVestingBasedOnCertainConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_SharesSubjectToVestingMaximumPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares subject to vesting maximum period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_SharesSubjectToVestingMaximumPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_VolumeWeightedAveragePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Volume weighted average price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_VolumeWeightedAveragePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscribedButUnissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscribedButUnissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscriptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscriptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rgti_SupernovaAcquistionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rgti_SupernovaAcquistionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AgreementAxis=rgti_SponsorAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AgreementAxis=rgti_SponsorAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_TrancheAxis=rgti_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_TrancheAxis=rgti_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_TrancheAxis=rgti_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_TrancheAxis=rgti_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AgreementAxis=rgti_InitialSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AgreementAxis=rgti_InitialSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_InvestorAxis=rgti_PrivateInvestmentInPublicEquityInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_InvestorAxis=rgti_PrivateInvestmentInPublicEquityInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AgreementAxis=rgti_SubsequentSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AgreementAxis=rgti_SubsequentSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726178384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments  - Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;Cost</a></td>
<td class="nump">$ 121,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross Unrealized Holding&#160;Loss</a></td>
<td class="num">(314)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair&#160;Value&#160;as</a></td>
<td class="nump">121,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">United States Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;Cost</a></td>
<td class="nump">58,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross Unrealized Holding&#160;Loss</a></td>
<td class="num">(304)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair&#160;Value&#160;as</a></td>
<td class="nump">58,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;Cost</a></td>
<td class="nump">3,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross Unrealized Holding&#160;Loss</a></td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair&#160;Value&#160;as</a></td>
<td class="nump">3,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Papers</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;Cost</a></td>
<td class="nump">23,142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross Unrealized Holding&#160;Loss</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair&#160;Value&#160;as</a></td>
<td class="nump">23,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized&#160;Cost</a></td>
<td class="nump">36,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Gross Unrealized Holding&#160;Loss</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair&#160;Value&#160;as</a></td>
<td class="nump">$ 36,346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726177376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Investment securities</a></td>
<td class="nump">$ 121,269,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DebtSecuritiesAvailableForSaleMaturityYear', window );">Available For Sale Maturity Year</a></td>
<td class="text">one year or less<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-Sale Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Investment securities</a></td>
<td class="nump">$ 58,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">Corporate Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Investment securities</a></td>
<td class="nump">3,571,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Investment securities</a></td>
<td class="nump">23,142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Investment securities</a></td>
<td class="nump">$ 36,346,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DebtSecuritiesAvailableForSaleMaturityYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt securities available for sale maturity year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DebtSecuritiesAvailableForSaleMaturityYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720249024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Summary of Schedule of Goodwill (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance, goodwill</a></td>
<td class="nump">$ 5,377<span></span>
</td>
<td class="nump">$ 5,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Change</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charge</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,377)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance, goodwill</a></td>
<td class="nump">$ 5,377<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836729188752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,377<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836944339008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="nump">$ 9.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_RevenuePerformanceObligationTransactionPriceAxis=rgti_RemainderoftwothousandandtwentythreeMember', window );">Remainder Of Two Thousand And Twenty Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_RevenuePerformanceObligationTransactionPriceAxis=rgti_TwothousandandtwentyfourMember', window );">2024[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_RevenuePerformanceObligationTransactionPriceAxis=rgti_RemainderoftwothousandandtwentythreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_RevenuePerformanceObligationTransactionPriceAxis=rgti_RemainderoftwothousandandtwentythreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_RevenuePerformanceObligationTransactionPriceAxis=rgti_TwothousandandtwentyfourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_RevenuePerformanceObligationTransactionPriceAxis=rgti_TwothousandandtwentyfourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723725856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Summary of Disaggregation of Revenue (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 8,196<span></span>
</td>
<td class="nump">$ 13,102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Revenue recognized at a point in time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Revenue recognized over time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">8,196<span></span>
</td>
<td class="nump">13,102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rgti_CollaborativeResearchAndOtherProfessionalServicesMember', window );">Collaborative research and other professional services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">5,849<span></span>
</td>
<td class="nump">9,917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rgti_AccessToQuantumComputingSystemsMember', window );">Access to quantum computing systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 2,347<span></span>
</td>
<td class="nump">$ 3,185<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rgti_CollaborativeResearchAndOtherProfessionalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rgti_CollaborativeResearchAndOtherProfessionalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rgti_AccessToQuantumComputingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rgti_AccessToQuantumComputingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836727528736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue Recognition - Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostLineItems', window );"><strong>Capitalized Contract Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 6,143<span></span>
</td>
<td class="nump">$ 962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="num">$ (961)<span></span>
</td>
<td class="num">$ (985)<span></span>
</td>
<td class="num">$ (492)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723657168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Summary of Change in Contract with Customer, Asset and Liability (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostLineItems', window );"><strong>Capitalized Contract Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Balance at beginning of period</a></td>
<td class="num">$ (492)<span></span>
</td>
<td class="num">$ (985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DeferralOfRevenue', window );">Deferral of revenue</a></td>
<td class="num">(904)<span></span>
</td>
<td class="num">(545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_RecognitionOfDeferredRevenues', window );">Recognition of deferred revenue</a></td>
<td class="nump">411<span></span>
</td>
<td class="nump">569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Balance at end of period</a></td>
<td class="num">$ (985)<span></span>
</td>
<td class="num">$ (961)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DeferralOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferral of revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DeferralOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_RecognitionOfDeferredRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recognition of deferred revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_RecognitionOfDeferredRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836721284640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Statements Information - Summary Of  Property Plant And Equipment Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 65,390<span></span>
</td>
<td class="nump">$ 41,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(25,860)<span></span>
</td>
<td class="num">(18,832)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">39,530<span></span>
</td>
<td class="nump">22,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_QuantumComputingFridgesMember', window );">Quantum computing fridges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">30,218<span></span>
</td>
<td class="nump">17,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_ProcessEquipmentMember', window );">Process equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">23,330<span></span>
</td>
<td class="nump">16,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">7,561<span></span>
</td>
<td class="nump">4,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_ItHardwareMember', window );">IT hardware [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">3,035<span></span>
</td>
<td class="nump">2,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_FurnitureAndOtherAssetsMember', window );">Furniture and other assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 1,246<span></span>
</td>
<td class="nump">$ 1,246<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_QuantumComputingFridgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_QuantumComputingFridgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_ProcessEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_ProcessEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_ItHardwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_ItHardwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_FurnitureAndOtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rgti_FurnitureAndOtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720304992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Statements Information - Schedule of Accounts Payable and Accrued Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedUtilitiesCurrent', window );">Utilities</a></td>
<td class="nump">$ 1,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional &amp; subscription fees</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="nump">$ 1,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AccruedPropertyAndOtherTaxes', window );">Property and other taxes</a></td>
<td class="nump">1,161<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AccruedSubcontractorCost', window );">Subcontractor cost</a></td>
<td class="nump">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Payroll and other payroll costs</a></td>
<td class="nump">781<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AccruedPropertyPlantAndEquipmentCost', window );">Property and equipment</a></td>
<td class="nump">639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Others</a></td>
<td class="nump">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">314<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AccruedDeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other accrued liabilities current</a></td>
<td class="nump">$ 8,205<span></span>
</td>
<td class="nump">$ 3,806<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AccruedDeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AccruedDeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AccruedPropertyAndOtherTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AccruedPropertyAndOtherTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AccruedPropertyPlantAndEquipmentCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued property plant and equipment cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AccruedPropertyPlantAndEquipmentCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AccruedSubcontractorCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued subcontractor cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AccruedSubcontractorCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedUtilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedUtilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836721133376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statements Information - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation, Depletion and Amortization</a></td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PercentageOfTotalGrossPropertyAndEquipment', window );">Percentage of total gross property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">GB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PercentageOfTotalGrossPropertyAndEquipment', window );">Percentage of total gross property and equipment</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PercentageOfTotalGrossPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of total gross property and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PercentageOfTotalGrossPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836730701888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_OperatingLeaseRentExpenses', window );">Rent expenses</a></td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_OperatingLeaseRentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease rent expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_OperatingLeaseRentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723881504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of Components of Lease Costs (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">2,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">2,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 4,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term - operating leases</a></td>
<td class="text">5 years 10 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - operating leases</a></td>
<td class="nump">7.93%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836727009584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary Of Lessee Operating Lease Liability Maturity (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 2,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">2,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">2,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">1,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">1,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum future lease payments</a></td>
<td class="nump">$ 12,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rgti_RigettiHoldingsMember', window );">Rigetti Holdings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum future lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,674<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rgti_RigettiHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rgti_RigettiHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723727872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Maturities of the Company's Operating Lease Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, to be Paid [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">1,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">1,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">12,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(2,636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">10,203<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">2,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, noncurrent</a></td>
<td class="nump">$ 7,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726176816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Scheduled principal payments on total outstanding debt (Detail) - Rigetti Computing, Inc [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">$ 9,491<span></span>
</td>
<td class="nump">8,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">13,007<span></span>
</td>
<td class="nump">11,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">8,020<span></span>
</td>
<td class="nump">6,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan payable, long term</a></td>
<td class="nump">$ 30,709<span></span>
</td>
<td class="nump">$ 27,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rgti_RigettiComputingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rgti_RigettiComputingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725337568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt -  Long term debt and the unamortized discount (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="nump">$ 30,709<span></span>
</td>
<td class="nump">$ 27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AccruedFinalPaymentFee', window );">Add: accreted liability of final payment fee</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: unamortized debt discount, long term</a></td>
<td class="num">(990)<span></span>
</td>
<td class="num">(1,618)<span></span>
</td>
<td class="num">$ (2,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CurrentPortionOfLongTermDebtGross', window );">Less: current portion of long term debt-principal</a></td>
<td class="num">(9,491)<span></span>
</td>
<td class="num">(1,291)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Debt&#8212;net of current portion</a></td>
<td class="nump">20,635<span></span>
</td>
<td class="nump">24,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_CurrentPortionOfOutstandingPrincipalAmount', window );">Current portion of long term debt&#8212;principal</a></td>
<td class="nump">9,491<span></span>
</td>
<td class="nump">1,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Less: current portion of unamortized debt discount</a></td>
<td class="num">(1,188)<span></span>
</td>
<td class="num">(716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Debt&#8212;current portion</a></td>
<td class="nump">$ 8,303<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AccruedFinalPaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued final payment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AccruedFinalPaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CurrentPortionOfLongTermDebtGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current portion of long term debt gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CurrentPortionOfLongTermDebtGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_CurrentPortionOfOutstandingPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Portion Of Outstanding Principal Amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_CurrentPortionOfOutstandingPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836719879040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 01, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 1,618<span></span>
</td>
<td class="nump">$ 990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,465<span></span>
</td>
<td class="nump">5,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">$ 917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember', window );">Common Stock warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">783,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rgti_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DebtInstrumentPaymentFeepercentage', window );">Debt instrument payment fee, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Debt Related Commitment Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">unamortized issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt Instrument, Frequency of Periodic Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">payable monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rgti_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Prime Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">US Prime Rate plus 7.50% per annum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rgti_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rgti_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rgti_TrancheAMember', window );">Tranche A [Member] | Loan and Security Agreement [Member] | Venture Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rgti_TrancheBMember', window );">Tranche B [Member] | Loan and Security Agreement [Member] | Venture Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of Credit Facility, Current Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_WithdrawnCreditFacility', window );">Withdrawn Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of warrants issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">995,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rgti_TrancheBMember', window );">Tranche B [Member] | Loan and Security Agreement [Member] | Maximum [Member] | Venture Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt Instrument, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rgti_TrancheBMember', window );">Tranche B [Member] | Loan and Security Agreement [Member] | Minimum [Member] | Venture Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Debt Instrument, Payment Terms</a></td>
<td class="text">19 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rgti_TrancheCMember', window );">Tranche C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Debt Related Commitment Fees</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Debt Instrument, Payment Terms</a></td>
<td class="text">19 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt Instrument, Frequency of Periodic Payment</a></td>
<td class="text">payable monthly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Feb.  01,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger', window );">Percentage of debt related cost paid upon the consummation of merger</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt instrument, repurchase amount</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt instrument, fee amount</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PercentageOfadvancedFundsUnderTheAmendment', window );">Percentage of &#160;advanced funds under the amendment</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rgti_TrancheCMember', window );">Tranche C [Member] | Prime Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">US Prime Rate plus 7.50% per annum<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Variable Rate</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DebtInstrumentPaymentFeepercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument payment fee, Percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DebtInstrumentPaymentFeepercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Debt Related Cost Paid Upon The Consummation Of Merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PercentageOfadvancedFundsUnderTheAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of &#160;advanced funds under the amendment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PercentageOfadvancedFundsUnderTheAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_WithdrawnCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Withdrawn credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_WithdrawnCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reference rate used for variable rate of debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rgti_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rgti_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rgti_TrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rgti_TrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rgti_VentureCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rgti_VentureCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rgti_TrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rgti_TrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rgti_TrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rgti_TrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720404960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 02, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">73,389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCOnePreferredStockMember', window );">Series C-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">62,537,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rgti_SeriesCOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rgti_SeriesCOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720331088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Summary of Conversions of Stock (Detail)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">37,422,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock-Based Awards&#8212;Options Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">8,845,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Stock-Based Awards&#8212;RSUs Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">11,332,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="nump">17,243,811<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725961744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 14, 2022</div></th>
<th class="th"><div>Aug. 11, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 02, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,050,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one vote<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,648,889<span></span>
</td>
<td class="nump">125,257,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,221,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket', window );">Percentage of total aggregate number (or volume) of shares of Common Stock traded on The Nasdaq Capital Market</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement', window );">Percentage of the aggregate number of shares of common stock issued and outstanding immediately prior to the execution of the agreement.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period, shares, issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AgreementNameAxis=rgti_CommonStockPurchaseAgreementMember', window );">Common Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued during period, shares, issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,008<span></span>
</td>
<td class="nump">171,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Common Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Common Stock, Value, Subscriptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the aggregate number of shares of common stock issued and outstanding immediately prior to the execution of the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of total aggregate number (or volume) of shares of common stock traded on the nasdaq capital market.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscriptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscriptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AgreementNameAxis=rgti_CommonStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AgreementNameAxis=rgti_CommonStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720897072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">2,680,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,680,607<span></span>
</td>
<td class="nump">2,680,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,664,000<span></span>
</td>
<td class="num">$ (22,132,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustment to additional paid in capital warrants issued | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NumberOfTradingDaysForDeterminingTheSharePrice', window );">Number of trading days for determining the share price</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="nump">0.361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NumberOfTradingDaysForDeterminingTheSharePrice', window );">Number of trading days for determining the share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice', window );">Number of consecutive trading days for determining the share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered', window );">Waiting period after which the share trading days are considered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="nump">783,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">783,129<span></span>
</td>
<td class="nump">313,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember', window );">Common Stock Warrants | Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ClassOfWarrantOrRightGrandDateFairValue', window );">Class of warrant or right, Grand date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_WarrantsToPurchaseClassACommonStockMember', window );">Warrants To Purchase Class A Common Stock [Member] | Series C Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits', window );">ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,248,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CustomerWarrantsMember', window );">Customer Warrants [Member] | Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,680,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CustomerWarrantsMember', window );">Customer Warrants [Member] | Class A Ordinary Shares | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_Classofwarrantsvestingpercentage', window );">Class Of Warrants Vesting Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CustomerWarrantsMember', window );">Customer Warrants [Member] | Class A Ordinary Shares | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_Classofwarrantsvestingpercentage', window );">Class Of Warrants Vesting Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember', window );">Trinity Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_Classofwarrantorrightissuedduringperiodwarrants', window );">Class of warrant or right issued during period, Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant', window );">Class of Warrants or Rights Aggregate Fair Value of Warrants at the Time of Grant | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="nump">783,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">783,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants Outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 783,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities', window );">Warrant liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ClassOfWarrantOrRightGrandDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right, Grand date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ClassOfWarrantOrRightGrandDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_Classofwarrantorrightissuedduringperiodwarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right Issued During Period Warrants .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_Classofwarrantorrightissuedduringperiodwarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights aggregate fair value of warrants at the time of grant .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrants Or Rights Warrants Issued During The Period Units .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_Classofwarrantsvestingpercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrants Vesting Percentage .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_Classofwarrantsvestingpercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of consecutive trading days for determining the share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_NumberOfTradingDaysForDeterminingTheSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Trading Days For Determining The Share Price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_NumberOfTradingDaysForDeterminingTheSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Waiting Period After Which The Share Trading Days Are Considered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_WarrantsToPurchaseClassACommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_WarrantsToPurchaseClassACommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ClassOfInvestorsAxis=rgti_SeriesCRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ClassOfInvestorsAxis=rgti_SeriesCRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_CustomerWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_CustomerWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720230512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Schedule Of Fair Value Of The Private Placement Warrant Measured Using Black Scholes Approach (Detail)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>yr</div>
</th>
<th class="th">
<div>Jun. 02, 2022 </div>
<div>yr</div>
</th>
<th class="th">
<div>Mar. 02, 2022 </div>
<div>yr</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">9.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility (annual) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility (annual) [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">30.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">1.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=rgti_AtinitialrecognitionMember', window );">AtInitialRecognition [Member] | Measurement Input, Share Price [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=rgti_AtinitialrecognitionMember', window );">AtInitialRecognition [Member] | Measurement Input, Exercise Price [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=rgti_AtinitialrecognitionMember', window );">AtInitialRecognition [Member] | Measurement Input, Price Volatility (annual) [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109.26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=rgti_AtinitialrecognitionMember', window );">AtInitialRecognition [Member] | Measurement Input, Risk Free Interest Rate [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.04<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=rgti_AtinitialrecognitionMember', window );">AtInitialRecognition [Member] | Measurement Input, Expected Term [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=rgti_AtinitialrecognitionMember', window );">AtInitialRecognition [Member] | Measurement Input, Expected Dividend Rate [Member] | Private Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=rgti_AtinitialrecognitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=rgti_AtinitialrecognitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725347648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Schedule Of Fair Value Of The Trinity Warrant liabilities Measured Using Black Scholes Approach (Detail)<br></strong></div></th>
<th class="th">
<div>Jun. 02, 2022 </div>
<div>yr</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">8.23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility (annual) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">105.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">2.94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836726190720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Summary of Vesting Status of the Customer Warrant (Detail) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureofvestingstatusofwarrantsLineItems', window );"><strong>Disclosure Of Vesting Status Of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">2,680,607<span></span>
</td>
<td class="nump">2,680,607<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_StatusOfVestingAxis=rgti_VestedCustomerWarrantsMember', window );">Vested Customer Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureofvestingstatusofwarrantsLineItems', window );"><strong>Disclosure Of Vesting Status Of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">1,340,297<span></span>
</td>
<td class="nump">1,072,237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_StatusOfVestingAxis=rgti_UnvestedCustomerWarrantsMember', window );">Unvested Customer Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DisclosureofvestingstatusofwarrantsLineItems', window );"><strong>Disclosure Of Vesting Status Of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">1,340,310<span></span>
</td>
<td class="nump">1,608,370<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DisclosureofvestingstatusofwarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DisclosureOfVestingStatusOfWarrants .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DisclosureofvestingstatusofwarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_StatusOfVestingAxis=rgti_VestedCustomerWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_StatusOfVestingAxis=rgti_VestedCustomerWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_StatusOfVestingAxis=rgti_UnvestedCustomerWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_StatusOfVestingAxis=rgti_UnvestedCustomerWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836721115312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Forward Warrant Agreement - Additional Information (Detail) - Forward Warrant Agreement [Member] - Rigetti [Member] - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AgreementNameAxis=rgti_ForwardWarrantAgreementMember', window );">Ampere</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from Issuance of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_StockIssuedDuringPeriodWarrantsIssued', window );">Stock issued during period number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AgreementNameAxis=rgti_ForwardWarrantAgreementMember', window );">Ampere | Share-based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business combination consideration to be paid</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Share based compensation arrangement share based payment award options vested and exercisable</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_AgreementNameAxis=rgti_ForwardWarrantAgreementMember', window );">Ampere | Share-based Payment Arrangement, Tranche Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business combination consideration to be paid</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Share based compensation arrangement share based payment award options vested and exercisable</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_StockIssuedDuringPeriodWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_StockIssuedDuringPeriodWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_AgreementNameAxis=rgti_ForwardWarrantAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_AgreementNameAxis=rgti_ForwardWarrantAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rgti_RigettiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rgti_RigettiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rgti_AmpereComputingLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rgti_AmpereComputingLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720220560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Forward Warrant Agreement - Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques (Detail) - Forward Warrant Agreement [Member]<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>yr</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>yr</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="nump">0.767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="nump">0.0469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0043<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember', window );">Measurement Input Probability of occurring the contingency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember', window );">Measurement Input Probability of occurring the contingency | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember', window );">Measurement Input Probability of occurring the contingency | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative Liability, Measurement Input</a></td>
<td class="nump">0.73<span></span>
</td>
<td class="nump">10.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=rgti_ForwardWarrantAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=rgti_ForwardWarrantAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725664224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">$ 94,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="nump">699<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">36,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">58,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | US Government Corporations and Agencies Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 | Earn out Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ContingentEarnOutLiabilityFairValueDisclosure', window );">Earn-out Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">26,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | US Government Corporations and Agencies Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">3,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">23,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 | Earn out Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ContingentEarnOutLiabilityFairValueDisclosure', window );">Earn-out Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">2,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="nump">2,274<span></span>
</td>
<td class="nump">4,585<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Money Market Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | US Treasury Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | US Government Corporations and Agencies Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Earn out Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ContingentEarnOutLiabilityFairValueDisclosure', window );">Earn-out Liability</a></td>
<td class="nump">1,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember', window );">Trinity Warrants | Fair Value, Inputs, Level 1 | Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember', window );">Trinity Warrants | Fair Value, Inputs, Level 2 | Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember', window );">Trinity Warrants | Fair Value, Inputs, Level 3 | Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember', window );">Public Warrants | Fair Value, Inputs, Level 1 | Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="nump">699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember', window );">Public Warrants | Fair Value, Inputs, Level 2 | Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember', window );">Public Warrants | Fair Value, Inputs, Level 3 | Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember', window );">Private Warrants | Fair Value, Inputs, Level 2 | Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember', window );">Private Warrants | Fair Value, Inputs, Level 3 | Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="nump">1,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember', window );">Forward warrant agreement | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ForwardWarrantAgreementFairValueDisclosure', window );">Forward Warrant Agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember', window );">Forward warrant agreement | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ForwardWarrantAgreementFairValueDisclosure', window );">Forward Warrant Agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember', window );">Forward warrant agreement | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ForwardWarrantAgreementFairValueDisclosure', window );">Forward Warrant Agreement</a></td>
<td class="nump">$ 2,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ContingentEarnOutLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Earn Out Liability Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ContingentEarnOutLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ForwardWarrantAgreementFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forward Warrant Agreement Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ForwardWarrantAgreementFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=rgti_ContingentEarnOutLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=rgti_ContingentEarnOutLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivateWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720182064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Summary Of Change in Fair Value of Derivative Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Forward Warrant Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues', window );">Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair values</a></td>
<td class="num">(5,764)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Exercise of warrants</a></td>
<td class="nump">3,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="num">(2,229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Earn out Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3', window );">Initial measurement on March 2, 2022 upon Business Combination (Note 3)</a></td>
<td class="nump">20,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair values</a></td>
<td class="num">(19,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Trinity Warrants [Member] | Derivative Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues', window );">Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair values</a></td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">1,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Exercise of warrants</a></td>
<td class="num">(6,370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 | Private Placement Warrants | Derivative Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3', window );">Initial measurement on March 2, 2022 upon Business Combination (Note 3)</a></td>
<td class="nump">9,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair values</a></td>
<td class="num">(8,544)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="nump">$ 1,068<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=rgti_ForwardWarrantAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=rgti_ForwardWarrantAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=rgti_ContingentEarnOutLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=rgti_ContingentEarnOutLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_TrinityWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=rgti_DerivativeWarrantLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=rgti_DerivativeWarrantLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rgti_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720338944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Plans - Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding | shares</a></td>
<td class="nump">11,468,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(2,768,568)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited and expired | shares</a></td>
<td class="num">(1,603,804)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding | shares</a></td>
<td class="nump">8,845,903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable | shares</a></td>
<td class="nump">5,464,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding | $ / shares</a></td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">0.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited and expired | $ / shares</a></td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding | $ / shares</a></td>
<td class="nump">0.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable | $ / shares</a></td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding | $</a></td>
<td class="nump">$ 3,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable | $</a></td>
<td class="nump">$ 1,780<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725413056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Plans - Schedule of Activity Related to Restricted Stock Units (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems', window );"><strong>Schedule Of Share Based Compensation Restricted Stock And Restricted Stock Units Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Fair Value Per Share, Beginning balance | $ / shares</a></td>
<td class="nump">$ 3.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-Average Fair Value Per Share, Granted | $ / shares</a></td>
<td class="nump">4.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-Average Fair Value Per Share, Vested | $ / shares</a></td>
<td class="nump">4.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted-Average Fair Value Per Share, Forfeited | $ / shares</a></td>
<td class="nump">5.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Fair Value Per Share, Ending balance | $ / shares</a></td>
<td class="nump">$ 4.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems', window );"><strong>Schedule Of Share Based Compensation Restricted Stock And Restricted Stock Units Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance | shares</a></td>
<td class="nump">5,388,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Restricted Stock Units, Granted | shares</a></td>
<td class="nump">17,782,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Restricted Stock Units, Vested | shares</a></td>
<td class="num">(7,007,789)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Restricted Stock Units, Forfeited | shares</a></td>
<td class="num">(4,830,682)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance | shares</a></td>
<td class="nump">11,332,591<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of share based compensation restricted stock and restricted stock units activity..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725368848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Plans -Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 1,765<span></span>
</td>
<td class="nump">$ 44,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research And Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">14,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and Marketing Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">2,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 684<span></span>
</td>
<td class="nump">$ 28,611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836725148656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Plans -Schedule Of Share Based Payment Award Stock Options Valuation Assumptions (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">46.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rate</a></td>
<td class="nump">1.07%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price/Stock price</a></td>
<td class="nump">$ 0.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rgti_MarketBasedVestingAwardMember', window );">Market Based Vesting Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.76%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price/Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rgti_TimeBasedVestingAwardMember', window );">Time Based Vesting Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted-average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.77%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 10 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price/Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rgti_MarketBasedVestingAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rgti_MarketBasedVestingAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rgti_TimeBasedVestingAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rgti_TimeBasedVestingAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836720096896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Plans - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 12, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,765<span></span>
</td>
<td class="nump">$ 44,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">weighted-average grant date fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.43<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="nump">$ 9,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Amount of cost not yet recognized for nonvested award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which cost not yet recognized&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 11 months 15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,422,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,422,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Amount of cost not yet recognized for nonvested award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which cost not yet recognized&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,007,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,332,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,332,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rgti_CeoAwardMember', window );">CEO Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based compensation stock options vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation stock options granted</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_StockOptionCommonShareExercisePrice', window );">Common stock exercise price</a></td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rgti_CeoAwardMember', window );">CEO Award [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation stock options granted</a></td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rgti_TwoThousandThirteenEquityIncentivePlanMember', window );">Two Thousand Thirteen Equity Incentive Plan [Member] | CEO Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation stock options granted</a></td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rgti_TwoThousandTwentyTwoEquityIncentivePlanMember', window );">2022 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear', window );">Percentage of the common stock of all classes outstanding on preceding year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,332,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,332,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,748,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,748,116<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the common stock of all classes outstanding on preceding year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_StockOptionCommonShareExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_StockOptionCommonShareExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rgti_CeoAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rgti_CeoAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rgti_TwoThousandThirteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rgti_TwoThousandThirteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rgti_TwoThousandTwentyTwoEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rgti_TwoThousandTwentyTwoEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836731380528">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Earnings Per Share Basic and Diluted (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NetIncomeLossRelationToCommonStock', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (38,241)<span></span>
</td>
<td class="num">$ (71,521)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average Class A Common Stock outstanding, Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">23,337,127<span></span>
</td>
<td class="nump">102,300,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average Class A Common Stock outstanding, Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">23,337,127<span></span>
</td>
<td class="nump">102,300,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">&#8212; Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.64)<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">&#8212; Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.64)<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average Class A Common Stock outstanding, Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,337,127<span></span>
</td>
<td class="nump">102,300,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average Class A Common Stock outstanding, Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,337,127<span></span>
</td>
<td class="nump">102,300,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">&#8212; Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.64)<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">&#8212; Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1.64)<span></span>
</td>
<td class="num">$ (0.7)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Weighted-average shares have been retroactively restated to give effect to the Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_NetIncomeLossRelationToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net income (loss) relation to common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_NetIncomeLossRelationToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836723864256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) - Common Class A [Member] - shares<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</a></td>
<td class="nump">90,986,899<span></span>
</td>
<td class="nump">34,622,621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rgti_ConvertibleSeriesC1PreferredStockMember', window );">Convertible Series C-1 Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</a></td>
<td class="nump">23,218,320<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rgti_ConvertibleSeriesCPreferredStockMember', window );">Convertible Series C Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</a></td>
<td class="nump">54,478,033<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</a></td>
<td class="nump">1,822,319<span></span>
</td>
<td class="nump">14,444,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</a></td>
<td class="nump">11,468,227<span></span>
</td>
<td class="nump">8,845,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,332,591<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rgti_ConvertibleSeriesC1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rgti_ConvertibleSeriesC1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rgti_ConvertibleSeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=rgti_ConvertibleSeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836730654480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Detail) - shares<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rgti_UnvestedCustomerWarrantsMember', window );">Unvested Customer Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</a></td>
<td class="nump">1,608,359<span></span>
</td>
<td class="nump">1,340,310<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rgti_UnvestedCustomerWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rgti_UnvestedCustomerWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836727327664">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable', window );">Weighted average number of shares Contingently Issuable shares under earnout arrangement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,059,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">23,337,127<span></span>
</td>
<td class="nump">102,300,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">23,337,127<span></span>
</td>
<td class="nump">102,300,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price common stock of warrants or rights outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - Basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,541,856<span></span>
</td>
<td class="nump">5,116,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - Diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,541,856<span></span>
</td>
<td class="nump">5,116,058<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Weighted-average shares have been retroactively restated to give effect to the Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836731384976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Domestic and Foreign Components of Loss Before Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (36,787)<span></span>
</td>
<td class="num">$ (67,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(1,454)<span></span>
</td>
<td class="num">(3,844)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total</a></td>
<td class="num">$ (38,241)<span></span>
</td>
<td class="num">$ (71,521)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836729004912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Components of Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 61,313<span></span>
</td>
<td class="nump">$ 46,553<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">5,233<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development credits</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">11,509<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred assets</a></td>
<td class="nump">80,733<span></span>
</td>
<td class="nump">47,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(76,381)<span></span>
</td>
<td class="num">(46,067)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DeferredTaxAssetsRightOfUseLiabilities', window );">ROU liability</a></td>
<td class="nump">2,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(4,352)<span></span>
</td>
<td class="num">(1,420)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation&#160;and amortization</a></td>
<td class="num">(2,063)<span></span>
</td>
<td class="num">(1,420)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_DeferredTaxLiabilitiesRightOfUseAssets', window );">ROU Asset</a></td>
<td class="num">(2,289)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total net deferred tax assets</a></td>
<td class="nump">$ 76,381<span></span>
</td>
<td class="nump">$ 46,067<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DeferredTaxAssetsRightOfUseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets right of use liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DeferredTaxAssetsRightOfUseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836731327696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Total&#160;pre-tax&#160;book income</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment', window );">Fair market value adjustment</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Non-deductible executive compensation</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment', window );">Goodwill impairment</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(42.00%)<span></span>
</td>
<td class="num">(21.00%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total:</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation fair market value adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation goodwill impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836731197776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Unrecognized Tax Benefits Affecting the Effective Tax rate (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance at December 31, 2022</a></td>
<td class="nump">$ 4,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PeriodAxis=rgti_PreviousYearMember', window );">Previous Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Prior year adjustment&#8212;increase (decrease)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PeriodAxis=rgti_CurrentYearMember', window );">Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Current year increase(decrease)</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PeriodAxis=rgti_PreviousYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PeriodAxis=rgti_PreviousYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PeriodAxis=rgti_CurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PeriodAxis=rgti_CurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836727348944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfIncomeTaxesInformationLineItems', window );"><strong>Summary Of Income Taxes Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">$ 30,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,672<span></span>
</td>
<td class="nump">$ 4,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfIncomeTaxesInformationLineItems', window );"><strong>Summary Of Income Taxes Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfIncomeTaxesInformationLineItems', window );"><strong>Summary Of Income Taxes Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Deferred Tax Assets, Tax Credit Carryforwards, Research</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member] | Rigetti Computing, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfIncomeTaxesInformationLineItems', window );"><strong>Summary Of Income Taxes Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward [Member] | Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfIncomeTaxesInformationLineItems', window );"><strong>Summary Of Income Taxes Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_SummaryOfIncomeTaxesInformationLineItems', window );"><strong>Summary Of Income Taxes Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_SummaryOfIncomeTaxesInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Income Taxes Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_SummaryOfIncomeTaxesInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rgti_RigettiComputingIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rgti_RigettiComputingIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836721320368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Summary of Revenue by Geography (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 8,196<span></span>
</td>
<td class="nump">$ 13,102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember', window );">Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,826<span></span>
</td>
<td class="nump">$ 11,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">US | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">71.10%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 2,370,000<span></span>
</td>
<td class="nump">$ 1,965,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member] | Revenue from Rights Concentration Risk [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">28.90%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_RevenueFromRightsConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139836731381888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Detail) - Subsequent Event [Member]<br> $ in Millions</strong></div></th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($) </div>
<div>Numberofemployees</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges | $</a></td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_PercentageOfReductionInEmployees', window );">Percentage Of Reduction In Employees</a></td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rgti_NumberOfEmployees', window );">Number Of Employees | Numberofemployees</a></td>
<td class="nump">50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_NumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Employees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_NumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rgti_PercentageOfReductionInEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reduction In employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rgti_PercentageOfReductionInEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rgti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>d483086dposam_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rgti="http://www.rigetti.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rgti-20221231.xsd" xlink:type="simple"/>
    <context id="P01_01_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn05_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn03_02_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="P12_31_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn08_11_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2022-08-11</instant>
        </period>
    </context>
    <context id="P09_14_2022To09_14_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <startDate>2022-09-14</startDate>
            <endDate>2022-09-14</endDate>
        </period>
    </context>
    <context id="PAsOn09_14_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2022-09-14</instant>
        </period>
    </context>
    <context id="P08_11_2022To08_11_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="PAsOn01_01_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:WarrantsToPurchaseClassACommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:ClassOfInvestorsAxis">rgti:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FurnitureAndOtherAssetsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rgti:FurnitureAndOtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ItHardwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rgti:ItHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ProcessEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rgti:ProcessEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_QuantumComputingFridgesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rgti:QuantumComputingFridgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_USsrtStatementGeographicalAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rgti:RigettiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rgti:MeasurementInputProbabilityOfOccurringTheContingencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rgti:RigettiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:AmpereComputingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:RigettiComputingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rgti:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:MarketBasedVestingAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:TimeBasedVestingAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ResearchMemberusgaapTaxCreditCarryforwardAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ResearchMemberusgaapTaxCreditCarryforwardAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:StatusOfVestingAxis">rgti:VestedCustomerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_UnvestedCustomerWarrantsMemberRGTIStatusOfVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:StatusOfVestingAxis">rgti:UnvestedCustomerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimatedPeriodOfExpirationMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rgti:EstimatedPeriodOfExpirationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SimulatedTradingDaysMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rgti:SimulatedTradingDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_TwothousandandtwentyfourMemberRGTIRevenuePerformanceObligationTransactionPriceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:RevenuePerformanceObligationTransactionPriceAxis">rgti:TwothousandandtwentyfourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RemainderoftwothousandandtwentythreeMemberRGTIRevenuePerformanceObligationTransactionPriceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:RevenuePerformanceObligationTransactionPriceAxis">rgti:RemainderoftwothousandandtwentythreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_PromoteSponsorVestingSharesMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:PromoteSponsorVestingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SponsorRedemptionBasedVestingSharesMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:SponsorRedemptionBasedVestingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesCOneRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:SeriesCOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesCOnePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:SeriesCOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesCPreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_PreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:AgreementAxis">rgti:SponsorAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:TrancheAxis">rgti:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:SupernovaAcquistionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:AgreementAxis">rgti:SponsorAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:TrancheAxis">rgti:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:SupernovaAcquistionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:RigettiComputingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:ForwardWarrantAgreementLiabilityFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FurnitureAndOtherAssetsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rgti:FurnitureAndOtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ItHardwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rgti:ItHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ProcessEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rgti:ProcessEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_QuantumComputingFridgesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rgti:QuantumComputingFridgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_GBsrtStatementGeographicalAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rgti:MeasurementInputProbabilityOfOccurringTheContingencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rgti:MeasurementInputProbabilityOfOccurringTheContingencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:RigettiComputingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:StatusOfVestingAxis">rgti:VestedCustomerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_UnvestedCustomerWarrantsMemberRGTIStatusOfVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:StatusOfVestingAxis">rgti:UnvestedCustomerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:RigettiHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CollaborativeResearchAndOtherProfessionalServicesMembersrtProductOrServiceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rgti:CollaborativeResearchAndOtherProfessionalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccessToQuantumComputingSystemsMembersrtProductOrServiceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rgti:AccessToQuantumComputingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TransferredOverTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_USsrtStatementGeographicalAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EuropeMembersrtStatementGeographicalAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesC1PreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rgti:ConvertibleSeriesC1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesCPreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rgti:ConvertibleSeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RestrictedStockUnitsRSUMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rgti:RigettiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:AmpereComputingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rgti:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_RestrictedStockMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:MarketBasedVestingAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:TimeBasedVestingAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CurrentYearMemberRGTIPeriodAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:PeriodAxis">rgti:CurrentYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PreviousYearMemberRGTIPeriodAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:PeriodAxis">rgti:PreviousYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_RigettiComputingIncMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:RigettiComputingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_GovernmentEntitiesMembersrtProductOrServiceAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rgti:GovernmentEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:WarrantsToPurchaseClassACommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:ClassOfInvestorsAxis">rgti:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SeriesCOneRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:SeriesCOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rgti:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EuropeMembersrtStatementGeographicalAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_USsrtStatementGeographicalAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerEMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMemberusgaapAwardTypeAxis_TwoThousandThirteenEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rgti:TwoThousandThirteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:CommonStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:UnvestedCustomerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_RGTICommonStockPurchaseAgreementMemberRGTIRGTIAgreementNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:RGTIAgreementNameAxis">rgti:RGTICommonStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CollaborativeResearchAndOtherProfessionalServicesMembersrtProductOrServiceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rgti:CollaborativeResearchAndOtherProfessionalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_AccessToQuantumComputingSystemsMembersrtProductOrServiceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rgti:AccessToQuantumComputingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_TransferredOverTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_USsrtStatementGeographicalAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_EuropeMembersrtStatementGeographicalAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesC1PreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rgti:ConvertibleSeriesC1PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesCPreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">rgti:ConvertibleSeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_RestrictedStockUnitsRSUMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_RigettiComputingIncMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:RigettiComputingIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_GovernmentEntitiesMembersrtProductOrServiceAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rgti:GovernmentEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_EuropeMembersrtStatementGeographicalAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_USsrtStatementGeographicalAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:RevenueFromRightsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerFMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rgti:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P02_01_2021To12_31_2021_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rgti:UnvestedCustomerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rgti:RigettiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:AmpereComputingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">rgti:AtinitialrecognitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">rgti:AtinitialrecognitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">rgti:AtinitialrecognitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">rgti:AtinitialrecognitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">rgti:AtinitialrecognitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">rgti:AtinitialrecognitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivateWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:EventAxis">rgti:ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:EventAxis">rgti:ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_EstimatedPeriodOfExpirationMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rgti:EstimatedPeriodOfExpirationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_SimulatedTradingDaysMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">rgti:SimulatedTradingDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="PAsOn03_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-02</instant>
        </period>
    </context>
    <context id="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:AgreementAxis">rgti:SponsorAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:TrancheAxis">rgti:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:SupernovaAcquistionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:AgreementAxis">rgti:SponsorAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:TrancheAxis">rgti:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:SupernovaAcquistionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn12_01_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-01</instant>
        </period>
    </context>
    <context id="PAsOn12_01_2021_InitialSubscriptionAgreementMemberRGTIAgreementAxis_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SupernovaAcquistionMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:AgreementAxis">rgti:InitialSubscriptionAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:InvestorAxis">rgti:PrivateInvestmentInPublicEquityInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:SupernovaAcquistionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-01</instant>
        </period>
    </context>
    <context id="PAsOn12_23_2021_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SubsequentSubscriptionAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:AgreementAxis">rgti:SubsequentSubscriptionAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:InvestorAxis">rgti:PrivateInvestmentInPublicEquityInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:SupernovaAcquistionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-23</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheAMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rgti:TrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rgti:VentureCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2021_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rgti:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rgti:VentureCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-31</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MaximumMembersrtRangeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rgti:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rgti:VentureCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-31</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-31</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_PrimeRateMemberusgaapVariableRateAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-31</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rgti:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rgti:VentureCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rgti:TrancheCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-31</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="P01_31_2022To01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MinimumMembersrtRangeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rgti:TrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rgti:VentureCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-31</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="P01_31_2022To01_31_2022_PrimeRateMemberusgaapVariableRateAxis_TrancheCMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rgti:TrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-31</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rgti:TrancheCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rgti:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="P08_11_2022To08_11_2022_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:CommonStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="PAsOn08_11_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:CommonStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-11</instant>
        </period>
    </context>
    <context id="PAsOn06_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="PAsOn06_02_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="PAsOn06_02_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="PAsOn06_02_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="PAsOn06_02_2022_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="PAsOn06_02_2022_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="PAsOn06_02_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:CustomerWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:CustomerWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:CustomerWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="P06_30_2022To06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheTwoMemberusgaapVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rgti:RigettiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:AmpereComputingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P06_30_2022To06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rgti:RigettiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:AmpereComputingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="PAsOn06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rgti:RigettiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:AmpereComputingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheTwoMemberusgaapVestingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rgti:RigettiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:AgreementNameAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rgti:AmpereComputingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="P02_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-28</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="PAsOn02_28_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-28</instant>
        </period>
    </context>
    <context id="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:CeoAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-12</startDate>
            <endDate>2022-12-12</endDate>
        </period>
    </context>
    <context id="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:CeoAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-12</startDate>
            <endDate>2022-12-12</endDate>
        </period>
    </context>
    <context id="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis_TwoThousandThirteenEquityIncentivePlanMemberusgaapPlanNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:CeoAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rgti:TwoThousandThirteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-12</startDate>
            <endDate>2022-12-12</endDate>
        </period>
    </context>
    <context id="PAsOn12_12_2022_CeoAwardMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rgti:CeoAwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-12</instant>
        </period>
    </context>
    <context id="P06_02_2022To06_02_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-02</startDate>
            <endDate>2022-06-02</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_StatusOfSharesOutstandingBeforeBusinessCombinationMemberRGTIEventAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rgti:EventAxis">rgti:StatusOfSharesOutstandingBeforeBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:TrinityWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ForwardWarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:ContingentEarnOutLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001838359</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rgti:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">rgti:DerivativeWarrantLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Year">
        <measure>utr:Year</measure>
    </unit>
    <unit id="Unit_Month">
        <measure>utr:Month</measure>
    </unit>
    <unit id="Unit_Day">
        <measure>utr:Day</measure>
    </unit>
    <unit id="Unit_USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_OperatingSegment">
        <measure>rgti:OperatingSegment</measure>
    </unit>
    <unit id="Unit_Numberofemployees">
        <measure>rgti:Numberofemployees</measure>
    </unit>
    <unit id="Unit_Y">
        <measure>utr:Y</measure>
    </unit>
    <unit id="Unit_D">
        <measure>utr:D</measure>
    </unit>
    <dei:DocumentType contextRef="P01_01_2022To12_31_2022" id="hidden73986025">POS AM</dei:DocumentType>
    <dei:AmendmentFlag contextRef="P01_01_2022To12_31_2022">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="P01_01_2022To12_31_2022">0001838359</dei:EntityCentralIndexKey>
    <dei:EntityAddressStateOrProvince
      contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"
      id="hidden73986034">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressStateOrProvince contextRef="P01_01_2022To12_31_2022" id="hidden73986036">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityRegistrantName contextRef="P01_01_2022To12_31_2022">RIGETTI COMPUTING, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="P01_01_2022To12_31_2022">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityPrimarySicNumber contextRef="P01_01_2022To12_31_2022">7374</dei:EntityPrimarySicNumber>
    <dei:EntityTaxIdentificationNumber contextRef="P01_01_2022To12_31_2022">88-0950636</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="P01_01_2022To12_31_2022">775 Heinz Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P01_01_2022To12_31_2022">Berkeley</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="P01_01_2022To12_31_2022">94710</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_01_2022To12_31_2022">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_01_2022To12_31_2022">210-5550</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Rick Danis</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">775 Heinz Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Berkeley</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">94710</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_01_2022To12_31_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">210-5550</dei:LocalPhoneNumber>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
      contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis"
      id="hidden73805686">http://fasb.org/us-gaap/2022#Liabilities</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <rgti:NumberOfTradingDaysForDeterminingTheSharePrice contextRef="P12_31_2022To12_31_2022" id="hidden73805545">P20D</rgti:NumberOfTradingDaysForDeterminingTheSharePrice>
    <rgti:NumberOfTradingDaysForDeterminingTheSharePrice contextRef="P12_31_2022To12_31_2022" id="hidden73805546">P20D</rgti:NumberOfTradingDaysForDeterminingTheSharePrice>
    <rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice
      contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis"
      id="hidden73805503">P30D</rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice>
    <rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice
      contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis"
      id="hidden73805504">P30D</rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
      contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis"
      id="hidden73805685">http://fasb.org/us-gaap/2022#Assets</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">57888000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">11729000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">84923000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="PAsOn12_31_2021"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6235000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1543000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2450000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1351000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <rgti:ForwardContractAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2229000</rgti:ForwardContractAssetsCurrent>
    <rgti:ForwardContractAssetsCurrent
      contextRef="PAsOn12_31_2021"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:DeferredCostsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">742000</us-gaap:DeferredCostsCurrent>
    <us-gaap:DeferredCostsCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3449000</us-gaap:DeferredCostsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">154467000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">18072000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">39530000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">22497000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">9316000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCash
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">317000</us-gaap:RestrictedCash>
    <us-gaap:OtherAssets
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">129000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">165000</us-gaap:OtherAssets>
    <us-gaap:Goodwill
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">5377000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">203442000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">46428000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1938000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1971000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8205000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3806000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">961000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">985000</us-gaap:DeferredRevenue>
    <us-gaap:DebtCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8303000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">575000</us-gaap:DebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2345000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <rgti:ForwardContractLiabilities
      contextRef="PAsOn12_31_2022"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <rgti:ForwardContractLiabilities
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">230000</rgti:ForwardContractLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">21752000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">7567000</us-gaap:LiabilitiesCurrent>
    <rgti:DebtNetOfCurrentPortion
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">20635000</rgti:DebtNetOfCurrentPortion>
    <rgti:DebtNetOfCurrentPortion
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">24216000</rgti:DebtNetOfCurrentPortion>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7858000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1767000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4355000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1206000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">295000</us-gaap:OtherLiabilities>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">53218000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">36433000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn12_31_2022"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn12_31_2021"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">80974757</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">77696679</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">77696679</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="PAsOn12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      id="Fact_73804637"
      unitRef="Unit_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="PAsOn12_31_2021_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      id="Fact_73804636"
      unitRef="Unit_USD">81523000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">134050472</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">125257233</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">125257233</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">18221069</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">18221069</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      id="Fact_73804635"
      unitRef="Unit_USD">12000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      id="Fact_73804634"
      unitRef="Unit_USD">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">429025000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">135549000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-161000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">52000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-278652000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-207131000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">150224000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-71528000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">203442000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">46428000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">13102000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">8196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2873000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1623000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">10229000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">6573000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">59952000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">26928000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6348000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2475000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">47632000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">11299000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5377000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:OperatingExpenses
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">119309000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">40702000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-109080000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-34129000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5286000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2465000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2433000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">10000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-22132000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1664000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-19207000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rgti:TransactionCosts
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">927000</rgti:TransactionCosts>
    <rgti:TransactionCosts
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:TransactionCosts>
    <us-gaap:OtherIncome
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">7000</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">37559000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-4112000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-71521000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38241000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-71521000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38241000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.7</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.7</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P02_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">-1.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P02_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">-1.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      id="Fact_73804579"
      unitRef="Unit_shares">102300852</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      id="Fact_73804581"
      unitRef="Unit_shares">102300852</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P02_01_2021To12_31_2021"
      decimals="0"
      id="Fact_73804580"
      unitRef="Unit_shares">23337127</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P02_01_2021To12_31_2021"
      decimals="INF"
      id="Fact_73804582"
      unitRef="Unit_shares">23337127</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-71521000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38241000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-314000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-71734000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38246000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn01_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      id="Fact_73804565"
      unitRef="Unit_shares">77696679</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn01_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      id="Fact_73804567"
      unitRef="Unit_USD">81523000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn01_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73804566"
      unitRef="Unit_shares">16582525</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn01_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      id="Fact_73804572"
      unitRef="Unit_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn01_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">133406000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn01_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">57000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn01_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-168890000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn01_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-35425000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P02_01_2021To12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73804970"
      unitRef="Unit_shares">1404966</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P02_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">375000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">375000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares
      contextRef="P02_01_2021To12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73805486"
      unitRef="Unit_shares">233578</rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares>
    <rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants
      contextRef="P02_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3000</rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants>
    <rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3000</rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="P02_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">1765000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1765000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="P02_01_2021To12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="P02_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-38241000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38241000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      id="Fact_73804547"
      unitRef="Unit_shares">77696679</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      id="Fact_73804559"
      unitRef="Unit_USD">81523000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73804546"
      unitRef="Unit_shares">18221069</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      id="Fact_73804558"
      unitRef="Unit_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">135549000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">52000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-207131000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-71528000</us-gaap:StockholdersEquity>
    <rgti:ReclassificationOfTemporaryEquityShares
      contextRef="P01_01_2022To12_31_2022_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      id="Fact_73805338"
      unitRef="Unit_shares">-77696679</rgti:ReclassificationOfTemporaryEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="P01_01_2022To12_31_2022_PreferredStockMemberusgaapStatementEquityComponentsAxis_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="-3"
      id="Fact_73804742"
      unitRef="Unit_USD">-81523000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <rgti:ReclassificationOfTemporaryEquityShares
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73805339"
      unitRef="Unit_shares">57380563</rgti:ReclassificationOfTemporaryEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      id="Fact_73804741"
      unitRef="Unit_USD">6000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">81517000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">81523000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73804971"
      unitRef="Unit_shares">2768568</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">1020000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1020000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73805487"
      unitRef="Unit_shares">4818630</rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares>
    <rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">5048000</rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants>
    <rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5048000</rgti:IssuanceOfCommonStockUponExerciseOfCommonStockWarrants>
    <rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73805344"
      unitRef="Unit_shares">34850706</rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares>
    <rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      id="Fact_73805341"
      unitRef="Unit_USD">3000</rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue>
    <rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">159535000</rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue>
    <rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">159538000</rgti:IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73805492"
      unitRef="Unit_shares">7046689</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      id="Fact_73805491"
      unitRef="Unit_USD">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <rgti:AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">6370000</rgti:AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants>
    <rgti:AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6370000</rgti:AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants>
    <rgti:AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-3305000</rgti:AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract>
    <rgti:AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-3305000</rgti:AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">1520000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1520000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <rgti:IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares
      contextRef="P01_01_2022To12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73805710"
      unitRef="Unit_shares">171008</rgti:IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="P01_01_2022To12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">44812000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">44812000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <rgti:IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities
      contextRef="P01_01_2022To12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-314000</rgti:IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities>
    <rgti:IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-314000</rgti:IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-71521000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-71521000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_73804545"
      unitRef="Unit_shares">125257233</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      id="Fact_73804549"
      unitRef="Unit_USD">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">429025000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-161000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="-3"
      unitRef="Unit_USD">-278652000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">150224000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-71521000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38241000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7017000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">4651000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">44812000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1765000</us-gaap:ShareBasedCompensation>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-19207000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-22132000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1664000</us-gaap:FairValueAdjustmentOfWarrants>
    <rgti:ChangeInFairValueOfForwardContract
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-5764000</rgti:ChangeInFairValueOfForwardContract>
    <rgti:ChangeInFairValueOfForwardContract
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">230000</rgti:ChangeInFairValueOfForwardContract>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">949000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">917000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">513000</us-gaap:AmortizationOfFinancingCosts>
    <rgti:AmortizationOfDebtCommitmentFeeAsset
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-266000</rgti:AmortizationOfDebtCommitmentFeeAsset>
    <rgti:AmortizationOfDebtCommitmentFeeAsset
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-94000</rgti:AmortizationOfDebtCommitmentFeeAsset>
    <rgti:AccretionOfDebtEndOfTermLiabilities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-285000</rgti:AccretionOfDebtEndOfTermLiabilities>
    <rgti:AccretionOfDebtEndOfTermLiabilities
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-122000</rgti:AccretionOfDebtEndOfTermLiabilities>
    <rgti:NonCashLeaseExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">537000</rgti:NonCashLeaseExpense>
    <rgti:NonCashLeaseExpense
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:NonCashLeaseExpense>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5377000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4692000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1063000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1099000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">315000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-34000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">35000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-24000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">493000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-707000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-389000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <rgti:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4456000</rgti:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <rgti:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1554000</rgti:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-295000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-87000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-62689000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-29044000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">22737000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">7008000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">84287000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-107024000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-7008000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">225604000</rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid>
    <rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid>
    <rgti:TransactionCostsPaid
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">18842000</rgti:TransactionCostsPaid>
    <rgti:TransactionCostsPaid
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:TransactionCostsPaid>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">27000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1291000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">85000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">247000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <rgti:PaymentOfLoanAndSecurityAgreementExitFees
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1000000</rgti:PaymentOfLoanAndSecurityAgreementExitFees>
    <rgti:PaymentOfDeferredOfferingCosts
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:PaymentOfDeferredOfferingCosts>
    <rgti:PaymentOfDeferredOfferingCosts
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1548000</rgti:PaymentOfDeferredOfferingCosts>
    <rgti:ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6068000</rgti:ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants>
    <rgti:ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">378000</rgti:ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">215454000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">25583000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">101000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-5000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">45842000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-10474000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">12046000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn01_31_2021"
      decimals="-3"
      unitRef="Unit_USD">22520000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">57888000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">12046000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3819000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1489000</us-gaap:InterestPaidNet>
    <rgti:InitialFairValueOfEarnoutLiabilityAcquiredInMergera
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">20413000</rgti:InitialFairValueOfEarnoutLiabilityAcquiredInMergera>
    <rgti:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses>
    <rgti:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1900000</rgti:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses>
    <rgti:FairValueOfLoanAndSecurityAgreementAndWarrantLiability.
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:FairValueOfLoanAndSecurityAgreementAndWarrantLiability.>
    <rgti:FairValueOfLoanAndSecurityAgreementAndWarrantLiability.
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">2691000</rgti:FairValueOfLoanAndSecurityAgreementAndWarrantLiability.>
    <rgti:InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">22932000</rgti:InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger>
    <rgti:InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger>
    <rgti:ExerciseOfLoanAndSecurityAgreementWarrants
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6370000</rgti:ExerciseOfLoanAndSecurityAgreementWarrants>
    <rgti:ExerciseOfLoanAndSecurityAgreementWarrants
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:ExerciseOfLoanAndSecurityAgreementWarrants>
    <rgti:SettlementOfTheFirstTrancheOfForwardContract
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3305000</rgti:SettlementOfTheFirstTrancheOfForwardContract>
    <rgti:SettlementOfTheFirstTrancheOfForwardContract
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:SettlementOfTheFirstTrancheOfForwardContract>
    <rgti:CapitalizationOfDeferredCostsToEquityUponShareIssuance
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1520000</rgti:CapitalizationOfDeferredCostsToEquityUponShareIssuance>
    <rgti:CapitalizationOfDeferredCostsToEquityUponShareIssuance
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:CapitalizationOfDeferredCostsToEquityUponShareIssuance>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">673000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <rgti:PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">639000</rgti:PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">314000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <rgti:RightOfUseAssetsRecordedOnAdoptionOfAsu201602
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6270000</rgti:RightOfUseAssetsRecordedOnAdoptionOfAsu201602>
    <rgti:RightOfUseAssetsRecordedOnAdoptionOfAsu201602
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:RightOfUseAssetsRecordedOnAdoptionOfAsu201602>
    <rgti:OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6620000</rgti:OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602>
    <rgti:OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602>
    <rgti:LeaseLiabilitiesArisingFromObtainingRightOfUseAssets
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4892000</rgti:LeaseLiabilitiesArisingFromObtainingRightOfUseAssets>
    <rgti:LeaseLiabilitiesArisingFromObtainingRightOfUseAssets
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:LeaseLiabilitiesArisingFromObtainingRightOfUseAssets>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1. DESCRIPTION OF BUSINESS &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Rigetti Computing, Inc. and its subsidiaries (collectively, the &#x201c;Company&#x201d; or &#x201c;Rigetti&#x201d;), builds quantum computers and the superconducting quantum processors that power them. Through the Company&#x2019;s Quantum Computing as a Service (&#x201c;QCaaS&#x201d;) platform, the Company&#x2019;s machines can be integrated into any public, private or hybrid cloud. The Company offers product types of Platform, Research and Software Tools usage in application areas of benchmarking, chemical simulation, education/entertainment, machine learning, and optimization. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company is located and headquartered in Berkeley, California. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Munich, Germany. The Company&#x2019;s revenue is derived primarily from operations in the United States and the United Kingdom. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Basis of Presentation &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On March&#160;2, 2022 (the &#x201c;Closing Date&#x201d;), a merger transaction between Rigetti Holdings, Inc. (&#x201c;Legacy Rigetti&#x201d;) and Supernova Partners Acquisition Company II, Ltd. (&#x201c;SNII&#x201d;) was completed (the &#x201c;Business Combination&#x201d;, see Note 3). In connection with the closing of the Business Combination, the Company changed its name to Rigetti Computing, Inc. and all of SNII Class&#160;A ordinary shares and SNII Class&#160;B ordinary shares automatically converted into shares of Common Stock, par value $0.0001, of the Company (the &#x201c;Common Stock&#x201d;) on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-for-one&lt;/div&gt;&lt;/div&gt; basis. The SNII Public Warrants and the Private Warrants held by SNII became warrants for Common Stock. The Company&#x2019;s Common Stock and Public Warrants trade on the Nasdaq Capital Market under the ticker symbols &#x201c;RGTI&#x201d; and &#x201c;RGTIW,&#x201d; respectively. For more information on this transaction, see Note 3. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company determined that Legacy Rigetti was the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification (ASC) 805, Business Combination. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The determination was primarily based on the following facts: &lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Former Legacy Rigetti stockholders have a controlling voting interest in the Company; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;The Company&#x2019;s board of directors as of immediately after the closing is comprised of eight board members, six seats occupied by previous Rigetti board members and one seat being occupied by a previous Supernova representative. The final eighth seat was filled by an individual who did not have ties to either Rigetti or Supernova &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-merger;&lt;/div&gt; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Legacy Rigetti management continues to hold executive management roles for the post-combination company and be responsible for the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;day-to-day&lt;/div&gt;&lt;/div&gt; operations. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Rigetti issuing stock for the net assets of SNII, accompanied by a recapitalization. The primary asset acquired from SNII was cash. Separately, the Company also assumed warrants that were deemed to be derivatives and meet liability classification subject to fair value adjustment measurements upon closing of the Business Combination (the &#x201c;Closing&#x201d;). No goodwill or other intangible assets were recorded as a result of the Business Combination.&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;While SNII was the legal acquirer in the Business Combination, because Legacy Rigetti was deemed the accounting acquirer, the historical financial statements of Legacy Rigetti became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the financial statements included in this report reflect (i)&#160;the historical operating results of Legacy Rigetti prior to the Business Combination; (ii)&#160;the combined results of SNII and Legacy Rigetti following the closing of the Business Combination; (iii)&#160;the assets and liabilities of Legacy Rigetti at their historical cost; and (iv)&#160;the Company&#x2019;s equity structure for all periods presented. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The equity structure has been retroactively restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company&#x2019;s Common Stock, $0.0001 par value per share, issued to Legacy Rigetti shareholders and Legacy Rigetti convertible preferred shareholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Rigetti redeemable convertible preferred stock and Legacy Rigetti Common Stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accompanying consolidated financial statements of the Company and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. All dollar amounts in tables, except share and per share amounts, in the notes to the consolidated financial statements are presented in thousands unless otherwise noted. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Risks and Uncertainties&lt;/div&gt;&lt;/div&gt; &#x2014; The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including, but not limited to, the need for successful development of products, the need for additional capital (or financing) to fund operating losses, competition from substitute products and services from larger companies, protection of proprietary technology, patent litigation, dependence on key individuals, and risks associated with changes in information technology. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Based on our forecasts, we believe that our existing cash and cash equivalents and available for sale investments will be sufficient to meet our anticipated operating cash needs for at least the next 12 months from the issuance of these financial statements based on our current business plan and expectations and assumptions considering current macroeconomic conditions. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; and Macroeconomic Conditions&lt;/div&gt;&lt;/div&gt; &#x2014; As of December&#160;31, 2022, and December&#160;31, 2021, the Company&#x2019;s financial position was not significantly impacted by the effects of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19.&lt;/div&gt; However, the duration and intensity of the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; pandemic and any resulting disruption to the Company&#x2019;s operations remains somewhat uncertain. Global economic conditions have been worsening, with disruptions to, and volatility in, the credit and financial markets, disruption to banking systems, and rising inflation and interest rates in the U.S. and worldwide resulting from the effects of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; and otherwise. If these conditions persist and deepen, the Company could experience an inability to access additional capital or our liquidity could otherwise be impacted. If the Company is unable to raise capital when needed or on attractive terms, it would be forced to delay, reduce or eliminate its research and development programs and other efforts. &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Change in Fiscal Year&lt;/div&gt;&lt;/div&gt; &#x2014; In October 2021, the board of directors of Rigetti approved a change to Rigetti&#x2019;s fiscal &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; from January&#160;31 to December&#160;31, effective December&#160;31, 2021. The Company believes the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;year-end&lt;/div&gt; change is important and useful to its financial statement users to allow for increased comparability with its industry peers. As a result of this change, the Company&#x2019;s fiscal year now begins on January&#160;1 and ends on December&#160;31 of each year, starting on January&#160;1, 2022. Rigetti&#x2019;s fiscal year 2021 covers a period of 11 months starting from February&#160;1, 2021 and ending on December&#160;31, 2021.&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn03_02_2022_CommonClassBMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn03_02_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Emerging Growth Company&lt;/div&gt;&lt;/div&gt; &#x2014; Following the Business Combination, the Company qualifies as an emerging growth company (&#x2018;&#x2018;EGC&#x2019;&#x2019;) as defined in the Jumpstart our Business Startups (&#x2018;&#x2018;JOBS&#x2019;&#x2019;) Act. The JOBS Act permits companies with EGC status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company intends to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;earlier of the date the Company (i)&#160;is no longer an EGC or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Use of Estimates&lt;/div&gt;&lt;/div&gt; &#x2014; The &lt;/div&gt; preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Such management estimates include, but are not limited to, the fair value of share-based awards, the fair value of the convertible preferred stock warrants, the fair value of the Forward Warrant Agreement (as defined below) , the fair value of derivative warrant liabilities, the fair value of Sponsor Vesting Shares issued in connection with the business combination (See Note 3), goodwill and intangible assets, accrued liabilities and contingencies, depreciation and amortization periods, revenue recognition and accounting for income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from those estimates.&lt;/div&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Principals of Consolidation&lt;/div&gt;&lt;/div&gt; &#x2014;The consolidated financial statements include the accounts of Rigetti and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reclassifications&lt;/div&gt;&lt;/div&gt; &#x2014; Certain amounts reported previously have been reclassified to conform to current presentation, with no effect on stockholders&#x2019; equity or net loss as previously presented. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Segments&lt;/div&gt;&lt;/div&gt; &#x2014; Operating segments are defined as components of an entity for which discrete financial information is available and that information is regularly reviewed by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company&#x2019;s Chief Executive Officer is its CODM, who has ultimate responsibility for the operating performance of the Company and the allocation of resources. The Company&#x2019;s CODM reviews financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. &lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Foreign Currency&lt;/div&gt;&lt;/div&gt; &#x2014; The Company&#x2019;s reporting currency is the US dollar. The functional currencies of the Company&#x2019;s foreign subsidiaries are the local currencies (UK pounds sterling, Australian dollar and Canadian Dollar), which are the monetary unit of account of the principal economic environment in which the Company&#x2019;s foreign subsidiaries operate. All assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollars is reflected as a foreign currency cumulative translation adjustment and reported as a component of accumulated other comprehensive gain (loss). Foreign currency transaction gains and losses resulting from or expected to result from transactions denominated in a currency other than the functional currency are recognized in other income (expense), net in the consolidated statements of operations and are de minimis for the year ended December 31, 2022 and 11 months ended December 31, 2021. &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;  &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Comprehensive Loss&lt;/div&gt;&lt;/div&gt; &#x2014; Comprehensive loss consists of two components including net loss and other comprehensive loss. The Company&#x2019;s other comprehensive loss consists of foreign currency translation adjustments that result from consolidation of its foreign subsidiaries and unrealized loss on &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/div&gt;&lt;/div&gt; &#x2014; As of December&#160;&lt;/div&gt;31, 2022 and December&#160;31, 2021, cash consists primarily of checking and savings deposits. As of December&#160;31, 2022, cash equivalents consist primarily of money market funds. There were no cash equivalents as of December&#160;31, 2021. The Company considers all highly liquid investment securities with remaining maturities at the date of purchase of three months or less to be cash equivalents. These cash equivalents are stated at cost, which approximates fair value.&lt;/div&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s restricted cash balance includes cash whose use is limited by contractual provisions. As of December&#160;31, 2022, there was no restricted cash. As of December&#160;31, 2021, restricted cash consists of cash secured as collateral for letters of credit in favor of the Company&#x2019;s landlord and its corporate credit card program. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:9%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:9%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21,542&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,729&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;e&lt;/div&gt;quivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Restricted cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;317&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total cash, cash equivalents and restricted cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;57,888&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;12,046&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;   &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Investments &lt;/div&gt;&lt;/div&gt;&#x2014;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;The Company classifies its investments in fixed income securities as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; debt investments. The Company&#x2019;s investments consist of U.S Treasury securities, commercial paper, and corporate bonds that have a maturity of one year or less. These investments are recorded in the consolidated balance sheets at fair value. The fair value of our underlying investments is based on observable inputs and classified as Level&#160;1 and Level&#160;2. Unrealized gains and losses on these investments are included as a separate component of Accumulated Other Comprehensive Loss. The Company evaluates its investments to assess whether those with unrealized loss positions are other than temporarily impaired. Impairments are considered other than temporary if they are related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of the cost basis. Realized gains and losses and declines in value determined to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the statements of operations. See Note 15 for further information on fair value. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accounts Receivable&lt;/div&gt;&lt;/div&gt; &#x2014; Accounts receivable are recorded at invoice value, net of allowance for doubtful accounts. Unbilled receivables are included in accounts receivable and include amounts that were invoiced subsequent to the period end for which revenue was recognized in advance of the right to invoice. On a periodic basis, management evaluates its accounts receivable and determines whether to provide an allowance or if any accounts should be written off based on a past history of write-offs, collections, and current credit conditions. A receivable is considered past due if the Company has not received payments based on agreed-upon terms. As of December&#160;31, 2022 and December&#160;31, 2021, the Company does not have any allowances for doubtful accounts. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Prepaid Expenses and Other Current Assets &lt;/div&gt;&lt;/div&gt;&#x2014; Prepaid expenses and other current assets include prepaid software, prepaid insurance, other prepaid expenses, all of which are expected to be recognized or realized within the next 12 months. &lt;/div&gt;  &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;br/&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Deferred Offering Costs&lt;/div&gt;&lt;/div&gt; &#x2014;The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with the Business Combination or issuance of shares under a registration statement filed with the SEC. After consummation of the Business Combination or issuance of shares, costs allocated to equity-classified instruments are recorded as a reduction to additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital. Costs allocated to liability-classified instruments are expensed. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The &lt;/div&gt;&lt;/div&gt; Company incurred $2.3&#160;million of offering costs for the year ended December&#160;31, 2022, which related to filing new registration statements with the SEC after the close of the Business Combination. These costs are incremental to those disclosed in Note 3. A portion of the offering costs amounting to $0.7&#160;million relates to the Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC. As of December&#160;31, 2022, while the registration statement related to the Common Stock Purchase Agreement with B. Riley Principal Capital II, &lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;LLC was filed with the SEC, there were no shares issued other than the commitment shares referred to in Note&#160;12. As such $0.7&#160;million of the offering costs were classified as deferred offering costs. As of December&#160;31, 2021, the Company had recorded deferred offering costs of $3.4&#160;million, all of which are related to the Business Combination as discussed in Note 3. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property and Equipment, Net &lt;/div&gt;&lt;/div&gt;&#x2014; Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets. The Company uses an estimated useful life of three years for furniture and other assets and information technology hardware (&#x201c;IT hardware&#x201d;), seven years for process equipment, and three to ten years for quantum computing fridges. Leasehold improvements are amortized over the shorter of the lease-term or the estimated useful life of the related asset. Expenditures for repairs and maintenance are expensed as incurred. Upon disposition, the cost and related accumulated depreciation are removed and any resulting gain or loss is reflected in other income (expense) in the consolidated statements of operations. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;Long-lived assets, which consist of property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset (asset group) may not be recoverable. When such events or changes in circumstances occur, the Company performs an undiscounted cash flow analysis to determine if an impairment exists and, if so, an impairment loss would be recorded based on the excess of the carrying amount of the asset (asset group) over its fair value. During the year ended December&#160;31, 2022 the Company determined there was a triggering event and an undiscounted cash flow analysis was performed. Based on the results of this analysis, the Company&#x2019;s long-lived assets were not impaired and no impairment charge was recorded. During the 11 months ended December&#160;31, 2021 no triggering events were noted. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Goodwill &lt;/div&gt;&lt;/div&gt;&#x2014; Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed in a business combination. Goodwill has an indefinite useful life and is not amortized. The Company reviews its goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value of the Company may exceed its fair value. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the Company is less than its carrying amount, including goodwill. If that is the case, the Company performs a quantitative impairment test, and, if the carrying amount of the Company exceeds its fair value, then the Company will recognize an impairment charge for the amount by which its carrying amount exceeds its fair value, not to exceed the carrying amount of the goodwill. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;The Company determined a triggering event existed in the fourth quarter of 2022 resulting from the sustained decline in the Company&#x2019;s stock price. A quantitative impairment test was performed and as a result, the Company recognized a $5.4&#160;million goodwill impairment charge for the year ended December&#160;31, 2022. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Deferred Financing Costs&lt;/div&gt;&lt;/div&gt; &#x2014; The incremental cost, including the fair value of warrants, directly associated with obtaining &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;debt&lt;/div&gt; financing is capitalized as deferred financing costs upon the issuance of the debt and amortized over the term of the related debt agreement using the effective-interest metho&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;d&lt;/div&gt; with such amortized amounts included as a component of interest expense in the consolidated statements of operations. Unamortized deferred financing costs are presented on the consolidated balance sheets as a direct deduction from the carrying amount of the related de&lt;div style="display:inline;"&gt;b&lt;/div&gt;t&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color:rgba(255, 255, 255, .0);;display:inline;"&gt;obligation.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="background-color:rgba(255, 255, 255, .0);;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color:rgba(255, 255, 255, .0);;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"/&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Public and Private Warrants&lt;/div&gt;&lt;/div&gt; &#x2014; At the Closing Date of the Business Combination, SNII &lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; had 4,450,000 Private Warrants and&#160;&lt;/div&gt;8,625,000&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;Public warrants outstanding. Each whole warrant entitles the holder to purchase one share of the Company&#x2019;s Common Stock at a price of $&lt;/div&gt;11.50&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; per share, subject to adjustments, and will expire &lt;/div&gt;five years&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; after the Business Combination or earlier upon redemption or liquidation.&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;fixed-for-fixed&lt;/div&gt;&lt;/div&gt; option on equity shares. Therefore, the Private Warrants are not considered indexed to the Company&#x2019;s stock and should be &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;classified as a liability. Since the Private Warrants meet the definition of a derivative, the Company recorded the Private Warrants as liabilities in the consolidated balance sheet at fair value upon the closing, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date. The fair value of the Private Warrants are measured using the Black-Scholes option-pricing model. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Public Warrants also fail to meet the indexation guidance in ASC 815 and are accounted for as liabilities because they include a provision whereby if there is not an effective registration statement, the warrant holders have a cap of 0.361 shares of Common Stock per warrant (subject to adjustment), on the issuable number of shares in a cashless exercise. Subsequent to the separate listing and trading of the Public Warrants, their fair value has been measured based on the observable listed prices for such warrants. Upon consummation of the Business Combination, the Company recorded a liability related to the Public Warrants of $16.3&#160;million, with an offsetting entry to additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital. On December&#160;31, 2022, the fair value of the Public Warrants decreased to $0.7&#160;million with the corresponding gain from the change in fair value recorded in the consolidated statement of operations for the year ended December&#160;31, 2022. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;See Note 13 and 15 for further information on fair value. &lt;/div&gt;   &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Derivative Warrant Liabilities &lt;/div&gt;&lt;/div&gt;&#x2014; The&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;) at the initial recognition date. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Other than the Public and Private Warrants noted above, the Company also issued warrants to Trinity Capital which are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period until exercised. The fair value of the warrant liabilities issued were initially measured using the Black- Scholes model and are subsequently remeasured at each reporting period with changes recorded as a component of other (expense) income in the Company&#x2019;s consolidated statements of operations. During the year ended December&#160;31, 2022 these warrants were exercised and are no longer outstanding. &lt;/div&gt;   &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Liability &#x2014;&lt;/div&gt;&lt;/div&gt; At the closing of the Business Combination, the SPAC Sponsor subjected certain Sponsor Vesting Shares to forfeiture and vesting as of the Closing Date if thresholds related to the weighted average price of Common Stock are not met for the duration of various specified consecutive day trading periods during the five-year period following the Closing (the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x201c;Earn-Out&lt;/div&gt; Triggering Events&#x201d;). Any such shares held by the Sponsor that remain unvested after the fifth anniversary of the Closing will be forfeited. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;These Sponsor Vesting Shares are accounted for as liability classified instruments because the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Triggering Events that determine the number of Sponsor Vesting Shares to be earned back by the Sponsor include outcomes that are not solely indexed to the Common Stock of the Company. The aggregate fair value of the Sponsor Vesting Shares on the Closing Date was estimated using a Monte Carlo simulation model and was determined to be $20.4&#160;million at the Closing Date. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&#160;31, 2022, the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Triggering Events were not achieved for any of the tranches, and as such, the Company adjusted the carrying amount of the liability to its estimated fair value of $1.2&#160;million. The change in the fair value of $19.2&#160;million for the year ended December&#160;31, 2022 is included in gain on fair value change, net in the condensed consolidated statements of operations. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant inputs into the respective valuation models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="null;text-indent: 0px;"&gt; &lt;div&gt; &lt;div style="display: inline; background-color: white;"&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 54%;"/&gt;
&lt;td style="width: 20%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 20%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation Assumptions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt; &lt;div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Initial Recognition on&lt;br/&gt;March 2, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt; &lt;div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December 31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock Price&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.43&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.73&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Simulated trading days&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,198&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,050&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Volatility (annual)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;109.30&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free rate&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.74&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.04&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Estimated time to expiration (years)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.170&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;    &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Revenue Recognition&lt;/div&gt;&lt;/div&gt; &#x2014; The Company recognizes revenue in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 606,&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;Revenue from Contracts with Customers &lt;/div&gt;&lt;/div&gt;and accounts for certain contract costs in accordance with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASC&#160;340-40,&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;Other Assets and &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;/div&gt; Costs&#x2014;Contracts with Customers.&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company recognizes revenue from contracts &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;with&lt;/div&gt; customers by applying the following five-step model: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Identify the contract with a customer &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Identify the performance obligations in the contract &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Determine the transaction price &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Allocate the transaction price to the performance obligations in the contract &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Recognize revenue when (or as) performance obligations are satisfied &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company generates revenue through its Quantum Computing as a Service (&#x201c;QCaaS&#x201d;) and development contracts and other services. Access to Rigetti quantum computing systems can be purchased as a quantum computing subscription, or on a usage basis for a specified quantity of hours. Revenue related to subscription-based access to (&#x201c;QCaaS&#x201d;) is recognized over time as access to the systems is provided on a ratable basis over the subscription term, which can range from six months to two years. This time-based input measure of progress provides a faithful depiction of the transfer of the services because the benefits the customer obtains generally equals the benefit from its access to the systems throughout the subscription term. Revenue related to usage-based access to Rigetti quantum computing systems is recognized over time as the systems are accessed using an output method based on compute credit hours expended. This output method provides a faithful depiction of the transfer of the services because the customer has purchased a specified quantity of hours of usage that diminishes each time an hour is expended and therefore each hour of access to the systems is considered a discrete delivery of underlying services in these arrangements. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Development contracts are generally multi-year, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-recurring&lt;/div&gt; arrangements in which the Company provides professional services regarding practical applications of quantum computing to technology and business problems within the customer&#x2019;s industry or organization and assists the customer in developing quantum algorithms and applications that will provide commercial value to the customer in areas of business interest. Development contracts are typically fixed fee arrangements invoiced on a milestone basis but may also be invoiced on a time and materials or cost reimbursement basis in certain cases. Revenue related to development contracts and other services is recognized over time based on completed milestones or hours or costs incurred as appropriate. Revenue for partially completed milestones deemed probable of being met is recognized using an input measure based on actual labor hours incurred to date relative to total estimated labor hours needed to complete the milestone. This input measure of progress provides a faithful depiction of the transfer of the services because it closely depicts the Company&#x2019;s efforts or inputs to the satisfaction of the performance obligation. Revenue related to the sale of custom quantum computing components is recognized at a point in time upon acceptance by the customer. &lt;/div&gt;&lt;/div&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;When the Company&#x2019;s contracts with customers contain multiple performance obligations, the transaction price is allocated on a relative standalone selling price basis to each performance obligation. The Company typically &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"/&gt; &lt;div/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;determines standalone selling price based on observable selling prices of our products and services. In instances where standalone selling price is not directly observable, standalone selling price is determined using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price, which includes fixed consideration and estimates of variable consideration. The amount of variable consideration included in the transaction price is constrained and is included only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s contracts with customers may include renewal or other options at fixed prices. Determining whether such options are considered distinct performance obligations that provide the customer with a material right and therefore should be accounted for separately requires significant judgment. Judgment is required to determine the standalone selling price for each renewal option to determine whether the renewal pricing is reflective of standalone selling price or is reflective of a discount that would provide the customer with a material right. Based on the Company&#x2019;s assessment of standalone selling prices, the Company determined that there were no significant material rights provided to its customers requiring separate recognition. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The timing of revenue recognition may not align with the right to invoice the customer. The Company records accounts receivable when it has the unconditional right to issue an invoice and receive payment, regardless of whether revenue has been recognized. If revenue has not yet been recognized, a contract liability (deferred revenue) is also recorded. If revenue is recognized in advance of the right to invoice, a contract asset or unbilled receivable is recorded, depending on whether the Company&#x2019;s right to consideration is considered conditional or unconditional. Unbilled receivables are included within accounts receivable in the consolidated balance sheets. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In instances where the timing of revenue recognition differs from the timing of the right to invoice, the Company has determined that a significant financing component generally does not exist. The primary purpose of the Company&#x2019;s invoicing terms is to provide customers with simplified and predictable ways of purchasing the products and services and not to receive financing from or provide financing to the customer. Additionally, the Company has elected the practical expedient that permits an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Payment terms on invoiced amounts are typically net 30 days. The Company does not offer rights of return for its products and services in the normal course of business, and contracts generally do not include service-type warranties that provide any incremental service to the customer beyond providing assurance that the goods and services conform to applicable specifications or customer-specific or subjective acceptance provisions. The Company also excludes from revenue government-assessed and imposed taxes on revenue-generating activities that are invoiced to customers. &lt;/div&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Costs of Obtaining and Fulfilling Contracts&lt;/div&gt;&lt;/div&gt; &#x2014; The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less. The Company capitalizes incremental costs incurred to fulfill its contracts that (i)&#160;relate directly to the contract, (ii)&#160;are expected to generate resources that will be used to satisfy the Company&#x2019;s performance obligation(s) under the contract, and (iii)&#160;are expected to be recovered through revenue generated under the contract. &lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost of Revenue&lt;/div&gt;&lt;/div&gt; &#x2014; Cost of revenue consists primarily of all direct and indirect cost associated with providing QCaaS offerings and development contracts and other services, including employee salaries and employee &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;related costs, including compensation, bonuses, employee taxes and benefit costs of program management and personnel associated with the delivery of goods and services to customers. Cost of revenue also includes an allocation of facility costs, depreciation and amortization directly related to providing the QCaaS offerings and development contracts and other services.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Research and Development &lt;/div&gt;&lt;/div&gt;&#x2014; Research and development costs are expensed as incurred. Research and development expenses include compensation, employee benefits, stock-based compensation, outside consultant fees, allocation of facility costs, depreciation and amortization, materials and components purchased for research and development. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;General and Administrative&lt;/div&gt;&lt;/div&gt; &#x2014; General and administrative expenses include compensation, employee benefits, stock-based compensation, legal, insurance, finance administration and human resources, an allocation of facility costs (including leases), bad debt costs, professional service fees, and an allocation of other general overhead costs including depreciation and amortization to support Rigetti&#x2019;s operations, which consists of operations other than associated with providing QCaaS offerings and development contracts and other services. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Sales and Marketing &#x2014;&lt;/div&gt;&lt;/div&gt; Sales and marketing expenses consist primarily of compensation including stock-based compensation, employee benefits of sales and marketing employees, outside consultants fees, travel and marketing and promotion costs. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Capitalized Software &#x2014;&lt;/div&gt;&lt;/div&gt; The Company capitalizes the costs to develop &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;its&#160;internal-use&#160;software&lt;/div&gt; when preliminary development efforts are successfully completed, management has authorized and committed project funding, and it is probable that the project will be completed and the software will be used as intended. Such costs are included in property and equipment in the consolidated balance sheets and are amortized on a straight-line basis over the estimated useful life of the related asset. These capitalized costs are primarily related to the software infrastructure supporting the quantum computing services purchased by customers. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. During the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, no capitalized software has been recorded. &lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income Taxes &lt;/div&gt;&lt;/div&gt;&#x2014; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of December&#160;31, 2022 and December&#160;31, 2021, the Company has recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of income tax positions only if it is more likely than not that those positions will be sustained. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in income tax expense.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net Loss Per Share&lt;/div&gt;&lt;/div&gt; &#x2014; Basic net loss per common share is computed by dividing the net loss available to Common Stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to Common Stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;of common shares and potential common shares outstanding when the impact is not antidilutive. Potential common shares from stock options, unvested restricted stock units and Common Stock warrants are computed using the treasury stock method, while those from convertible Series C and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;C-1&lt;/div&gt; Preferred Stock are computed using the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;if-converted&lt;/div&gt; method. Contingently issuable shares are included in basic net loss per share only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration shall be considered outstanding common shares and included in the computation of basic net loss per share. &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock-Based Compensation&lt;/div&gt;&lt;/div&gt; &#x2014; The Company accounts for share-based compensation in accordance with ASC 718, Compensation &#x2013; Stock Compensation. The Company&#x2019;s share-based compensation awards are all equity-classified and consist of stock options, restricted stock units (&#x201c;RSU&#x201d;) and restricted stock awards (&#x201c;RSA&#x201d;). Most stock options have service vesting conditions ranging from 1 to 5 years. RSAs are fully vested on grant date. RSUs granted under the Rigetti&#160;&amp;amp; Co., Inc. 2013 Equity Incentive Plan (the &#x201c;2013 Plan&#x201d;) have a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;4-year&lt;/div&gt; service vesting condition and a performance condition linked to the occurrence of a liquidity event defined as a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;change-in-control&lt;/div&gt;&lt;/div&gt; event, successful initial public offering or successful merger with a special purpose acquisition company, which was satisfied at the Closing. RSUs granted under the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;) have a service vesting condition only. The Company occasionally issues awards that might have different vesting conditions. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Compensation expense is based on the grant-date fair value of the awards and recognized over the requisite service period using a straight-line method for awards that have a service only condition. Compensation expense for awards with service and performance and/or market conditions is recognized using a graded vesting method. Compensation expense for RSAs is recognized fully on grant date. Compensation expenses for awards with a market condition are recognized over the requite service period regardless of whether the market condition is met unless the service requirement is not met. The Company has elected to account for forfeitures of employee stock awards as they occur. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&#x2014; The Company reports all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis... Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Level 1&#x2014;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Level 2&#x2014;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Level 3&#x2014;Inputs are unobservable for the asset or liability. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Concentrations of Credit Risk&lt;/div&gt;&lt;/div&gt; &#x2014; Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments in the form of commercial paper and corporate bonds, and trade accounts receivable. The Company&#x2019;s cash and cash equivalents and short-term investments are placed with high-credit-quality financial institutions, and at times exceed federally insured limits. To date, the Company has not experienced any credit loss relating to its cash and cash equivalents or short-term investments. &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-bottom: 0pt; text-indent: 0px; margin-top: 1em"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant &lt;/div&gt;&lt;/div&gt; customers that represent 10% or more of revenue are set forth in the &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;following tables: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the Year&lt;br/&gt;Ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the 11&lt;br/&gt;months&lt;br/&gt;ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;33%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;16%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer B&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;18%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;20%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer C&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;15%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;15%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer D&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;14%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;29%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer E&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;11%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer F&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;*&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;17%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;*Customer accounted for less than 10% of revenue in the respective period &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;65%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer B&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;13%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;35%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer C&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;10%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;34%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer D&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;29%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;*Customer accounted for less than 10% of accounts receivable in the respective period&lt;/div&gt;&lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Sales to government entities comprised 81.3% and 80.0% of the Company&#x2019;s total revenue for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recently Adopted Accounting Pronouncements &lt;/div&gt;&lt;/div&gt;&#x2014; In February 2016, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-0&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,&lt;/div&gt; Leases and related subsequently issued ASUs (collectively, &#x201c;Topic 842&#x201d;), which supersedes Topic 840. From a lessee perspective, the core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; (&#x201c;ROU&#x201d;) asset representing its right to use the underlying asset for the lease term. There continues to be a differentiation between finance leases (which replace capital leases as so identified under Topic 840) and operating leases. However, the principal difference from the previous guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the statement of financial position. The updated guidance also requires additional quantitative and qualitative disclosures and allows various practical expedients.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company adopted Topic 842 effective January&#160;1, 2022, using the modified retrospective transition option of applying the new standard at the adoption date for all leases with an original term greater than 12 months. The Company elected the package of practical expedients requiring no reassessment of (i)&#160;whether any expired or existing contracts are or contain leases, (ii)&#160;the lease classification of any expired or existing leases, or (iii)&#160;initial direct costs for any existing leases. Adoption of the standard had a material impact on the Company&#x2019;s consolidated balance sheet by recognizing operating lease ROU assets and operating lease liabilities but did not&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;have an impact on its consolidated statement of operations or cash flows on the date of adoption. The adoption of Topic 842 was recorded as of January&#160;1, 2022 and resulted in the recognition of operating lease ROU assets and operating lease liabilities of $6.3&#160;million and $6.6&#160;million respectively and a $0.3&#160;million adjustment to deferred rent, with no impact to accumulated deficit as of January&#160;1, 2022. The period ended December&#160;31, 2021 continues to be reported in accordance with the Company&#x2019;s historic accounting under previous lease guidance, Topic 840.&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company determines if an arrangement includes a lease at inception. Operating leases are included in the Company&#x2019;s balance sheet as operating lease ROU assets and operating lease liabilities as of December&#160;31, 2022. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. In determining the net present value of its lease payments, the Company uses an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date, or the date of adoption of Topic 842. The operating lease ROU assets also include any lease payments made less lease incentives. The Company&#x2019;s leases may include options to extend or terminate the lease, which is considered in the lease term when it is reasonably certain that the Company will exercise any such options. Lease expense is recognized on a straight-line basis over the expected lease term, taking into account adjustments for provisions such as free rent, escalating base monthly rental payments or deferred payment terms such as rent holidays that defer the commencement date of required payments. The Company has elected not to apply the recognition requirements of Topic 842 for short-term leases. The Company considers leases with a term of 12 months or less at the date of commencement to be short-term. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In May 2021, the FASB issued&#160;ASU No. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-04,&#160;Earnings&lt;/div&gt; Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;470-50),&lt;/div&gt; Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-40):&lt;/div&gt; Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#160;(&#x201c;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-04&#x201d;).&lt;/div&gt; The guidance in&#160;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-04&#160;clarifies&lt;/div&gt; and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December&#160;15, 2021.The &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Company&#160;adopted&#160;ASU&#160;2021-04&#160;as&lt;/div&gt; of&#160;January 1, 2022. The adoption of&#160;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-04&#160;did&lt;/div&gt; not have an impact on the Company&#x2019;s financial position and results of operations. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;In December 2019, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12,&#160;Income&lt;/div&gt; Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12&lt;/div&gt; removes certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. The Company adopted this ASU on January&#160;1, 2022. Adoption did not have a significant impact on the Company&#x2019;s financial statements or related disclosures. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &lt;/div&gt;&lt;/div&gt;&#x2014; In June 2022, the FASB issued&#160;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022-03,&#160;ASC&lt;/div&gt; Subtopic 820&#160;&#x201c;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#x201d;. The FASB issued this update (1)&#160;to clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2)&#160;to amend a related illustrative example, and (3)&#160;to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The ASU is effective for the Company after December&#160;15, 2024, and interim periods within those fiscal years, with early adoption permitted. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;In August 2020, the FASB issued&#160;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&#160;2020-06,&lt;/div&gt; Debt - (Topic 815) (&#x201c;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&#160;2020-06&#x201d;),&lt;/div&gt; which simplifies an issuer&#x2019;s accounting for convertible instruments and its application of the derivatives scope exception for contracts in its own equity. The amendments in&#160;ASU No. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-06&#160;are&lt;/div&gt; effective for public companies, other than smaller reporting companies, for fiscal years beginning after December&#160;15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December&#160;15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December&#160;15, 2020, including interim periods within those fiscal years. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;In April 2019, the FASB issued &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU&#160;2019-04,&#160;Codification&#160;Improvements&lt;/div&gt; to Topic 326, Financial Instruments&#x2014;Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU&#160;No.&#160;2019-04&#160;was&lt;/div&gt; issued as part of the FASB&#x2019;s ongoing project to improve upon its Accounting Standards Codification (ASC), and to clarify and improve areas of guidance related to recently issued standards on credit losses, hedging, and recognition and measurement. For entities that have not yet adopted the guidance in &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Update&#160;2016-13,&#160;the&lt;/div&gt; effective dates and the transition requirements for these amendments are the same as the effective date and transition requirements in &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Update&#160;2016-13.&#160;The&lt;/div&gt; amendments related to ASC 326 are effective for the Company as of January&#160;1, 2023.&#160;The adoption of the ASU is not expected to have a material impact on its consolidated financial statements. &lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <rgti:EmergingGrowthCompanyPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Emerging Growth Company&lt;/div&gt;&lt;/div&gt; &#x2014; Following the Business Combination, the Company qualifies as an emerging growth company (&#x2018;&#x2018;EGC&#x2019;&#x2019;) as defined in the Jumpstart our Business Startups (&#x2018;&#x2018;JOBS&#x2019;&#x2019;) Act. The JOBS Act permits companies with EGC status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company intends to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;earlier of the date the Company (i)&#160;is no longer an EGC or (ii)&#160;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</rgti:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="P01_01_2022To12_31_2022">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Use of Estimates&lt;/div&gt;&lt;/div&gt; &#x2014; The &lt;/div&gt; preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Such management estimates include, but are not limited to, the fair value of share-based awards, the fair value of the convertible preferred stock warrants, the fair value of the Forward Warrant Agreement (as defined below) , the fair value of derivative warrant liabilities, the fair value of Sponsor Vesting Shares issued in connection with the business combination (See Note 3), goodwill and intangible assets, accrued liabilities and contingencies, depreciation and amortization periods, revenue recognition and accounting for income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. These estimates are based on information available as of the date of the consolidated financial statements; therefore, actual results could differ from those estimates.&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Principals of Consolidation&lt;/div&gt;&lt;/div&gt; &#x2014;The consolidated financial statements include the accounts of Rigetti and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Reclassifications&lt;/div&gt;&lt;/div&gt; &#x2014; Certain amounts reported previously have been reclassified to conform to current presentation, with no effect on stockholders&#x2019; equity or net loss as previously presented. &lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Segments&lt;/div&gt;&lt;/div&gt; &#x2014; Operating segments are defined as components of an entity for which discrete financial information is available and that information is regularly reviewed by the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company&#x2019;s Chief Executive Officer is its CODM, who has ultimate responsibility for the operating performance of the Company and the allocation of resources. The Company&#x2019;s CODM reviews financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. &lt;/div&gt; </us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_OperatingSegment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_OperatingSegment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Foreign Currency&lt;/div&gt;&lt;/div&gt; &#x2014; The Company&#x2019;s reporting currency is the US dollar. The functional currencies of the Company&#x2019;s foreign subsidiaries are the local currencies (UK pounds sterling, Australian dollar and Canadian Dollar), which are the monetary unit of account of the principal economic environment in which the Company&#x2019;s foreign subsidiaries operate. All assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollars is reflected as a foreign currency cumulative translation adjustment and reported as a component of accumulated other comprehensive gain (loss). Foreign currency transaction gains and losses resulting from or expected to result from transactions denominated in a currency other than the functional currency are recognized in other income (expense), net in the consolidated statements of operations and are de minimis for the year ended December 31, 2022 and 11 months ended December 31, 2021. &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; </us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Comprehensive Loss&lt;/div&gt;&lt;/div&gt; &#x2014; Comprehensive loss consists of two components including net loss and other comprehensive loss. The Company&#x2019;s other comprehensive loss consists of foreign currency translation adjustments that result from consolidation of its foreign subsidiaries and unrealized loss on &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities. &lt;/div&gt;&lt;/div&gt; </us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="P01_01_2022To12_31_2022">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/div&gt;&lt;/div&gt; &#x2014; As of December&#160;&lt;/div&gt;31, 2022 and December&#160;31, 2021, cash consists primarily of checking and savings deposits. As of December&#160;31, 2022, cash equivalents consist primarily of money market funds. There were no cash equivalents as of December&#160;31, 2021. The Company considers all highly liquid investment securities with remaining maturities at the date of purchase of three months or less to be cash equivalents. These cash equivalents are stated at cost, which approximates fair value.&lt;/div&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"/&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s restricted cash balance includes cash whose use is limited by contractual provisions. As of December&#160;31, 2022, there was no restricted cash. As of December&#160;31, 2021, restricted cash consists of cash secured as collateral for letters of credit in favor of the Company&#x2019;s landlord and its corporate credit card program. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:9%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:9%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21,542&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,729&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;e&lt;/div&gt;quivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Restricted cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;317&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total cash, cash equivalents and restricted cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;57,888&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;12,046&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RestrictedCash>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets to the total amount shown in the consolidated statements of cash flows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:9%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:9%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt; 2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;21,542&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,729&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;e&lt;/div&gt;quivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Restricted cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;317&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total cash, cash equivalents and restricted cash&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;57,888&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;12,046&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:Cash
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">21542000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">11729000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">36346000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">317000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">57888000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">12046000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InvestmentPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Investments &lt;/div&gt;&lt;/div&gt;&#x2014;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;The Company classifies its investments in fixed income securities as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; debt investments. The Company&#x2019;s investments consist of U.S Treasury securities, commercial paper, and corporate bonds that have a maturity of one year or less. These investments are recorded in the consolidated balance sheets at fair value. The fair value of our underlying investments is based on observable inputs and classified as Level&#160;1 and Level&#160;2. Unrealized gains and losses on these investments are included as a separate component of Accumulated Other Comprehensive Loss. The Company evaluates its investments to assess whether those with unrealized loss positions are other than temporarily impaired. Impairments are considered other than temporary if they are related to deterioration in credit risk or if it is likely the Company will sell the securities before the recovery of the cost basis. Realized gains and losses and declines in value determined to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the statements of operations. See Note 15 for further information on fair value. &lt;/div&gt; </us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accounts Receivable&lt;/div&gt;&lt;/div&gt; &#x2014; Accounts receivable are recorded at invoice value, net of allowance for doubtful accounts. Unbilled receivables are included in accounts receivable and include amounts that were invoiced subsequent to the period end for which revenue was recognized in advance of the right to invoice. On a periodic basis, management evaluates its accounts receivable and determines whether to provide an allowance or if any accounts should be written off based on a past history of write-offs, collections, and current credit conditions. A receivable is considered past due if the Company has not received payments based on agreed-upon terms. As of December&#160;31, 2022 and December&#160;31, 2021, the Company does not have any allowances for doubtful accounts. &lt;/div&gt; </us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <rgti:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Prepaid Expenses and Other Current Assets &lt;/div&gt;&lt;/div&gt;&#x2014; Prepaid expenses and other current assets include prepaid software, prepaid insurance, other prepaid expenses, all of which are expected to be recognized or realized within the next 12 months. &lt;/div&gt; </rgti:PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock>
    <rgti:DeferredOfferingCostsPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Deferred Offering Costs&lt;/div&gt;&lt;/div&gt; &#x2014;The Company capitalizes certain legal, accounting and other third-party fees that are directly associated with the Business Combination or issuance of shares under a registration statement filed with the SEC. After consummation of the Business Combination or issuance of shares, costs allocated to equity-classified instruments are recorded as a reduction to additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital. Costs allocated to liability-classified instruments are expensed. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The &lt;/div&gt;&lt;/div&gt; Company incurred $2.3&#160;million of offering costs for the year ended December&#160;31, 2022, which related to filing new registration statements with the SEC after the close of the Business Combination. These costs are incremental to those disclosed in Note 3. A portion of the offering costs amounting to $0.7&#160;million relates to the Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC. As of December&#160;31, 2022, while the registration statement related to the Common Stock Purchase Agreement with B. Riley Principal Capital II, &lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;    &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;LLC was filed with the SEC, there were no shares issued other than the commitment shares referred to in Note&#160;12. As such $0.7&#160;million of the offering costs were classified as deferred offering costs. As of December&#160;31, 2021, the Company had recorded deferred offering costs of $3.4&#160;million, all of which are related to the Business Combination as discussed in Note 3. &lt;/div&gt; </rgti:DeferredOfferingCostsPolicyTextBlock>
    <rgti:OfferingCostsIncurred
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">2300000</rgti:OfferingCostsIncurred>
    <rgti:OfferingCostsIncurred
      contextRef="P01_01_2022To12_31_2022_RGTICommonStockPurchaseAgreementMemberRGTIRGTIAgreementNameAxis"
      decimals="-5"
      unitRef="Unit_USD">700000</rgti:OfferingCostsIncurred>
    <us-gaap:DeferredOfferingCosts
      contextRef="PAsOn12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">700000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="PAsOn12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">3400000</us-gaap:DeferredOfferingCosts>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property and Equipment, Net &lt;/div&gt;&lt;/div&gt;&#x2014; Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets. The Company uses an estimated useful life of three years for furniture and other assets and information technology hardware (&#x201c;IT hardware&#x201d;), seven years for process equipment, and three to ten years for quantum computing fridges. Leasehold improvements are amortized over the shorter of the lease-term or the estimated useful life of the related asset. Expenditures for repairs and maintenance are expensed as incurred. Upon disposition, the cost and related accumulated depreciation are removed and any resulting gain or loss is reflected in other income (expense) in the consolidated statements of operations. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;Long-lived assets, which consist of property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset (asset group) may not be recoverable. When such events or changes in circumstances occur, the Company performs an undiscounted cash flow analysis to determine if an impairment exists and, if so, an impairment loss would be recorded based on the excess of the carrying amount of the asset (asset group) over its fair value. During the year ended December&#160;31, 2022 the Company determined there was a triggering event and an undiscounted cash flow analysis was performed. Based on the results of this analysis, the Company&#x2019;s long-lived assets were not impaired and no impairment charge was recorded. During the 11 months ended December&#160;31, 2021 no triggering events were noted. &lt;/div&gt; </us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Goodwill &lt;/div&gt;&lt;/div&gt;&#x2014; Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed in a business combination. Goodwill has an indefinite useful life and is not amortized. The Company reviews its goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying value of the Company may exceed its fair value. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the Company is less than its carrying amount, including goodwill. If that is the case, the Company performs a quantitative impairment test, and, if the carrying amount of the Company exceeds its fair value, then the Company will recognize an impairment charge for the amount by which its carrying amount exceeds its fair value, not to exceed the carrying amount of the goodwill. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;The Company determined a triggering event existed in the fourth quarter of 2022 resulting from the sustained decline in the Company&#x2019;s stock price. A quantitative impairment test was performed and as a result, the Company recognized a $5.4&#160;million goodwill impairment charge for the year ended December&#160;31, 2022. &lt;/div&gt; </us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">5400000</us-gaap:GoodwillImpairmentLoss>
    <rgti:DeferredFinancingCostsPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Deferred Financing Costs&lt;/div&gt;&lt;/div&gt; &#x2014; The incremental cost, including the fair value of warrants, directly associated with obtaining &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;debt&lt;/div&gt; financing is capitalized as deferred financing costs upon the issuance of the debt and amortized over the term of the related debt agreement using the effective-interest metho&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;d&lt;/div&gt; with such amortized amounts included as a component of interest expense in the consolidated statements of operations. Unamortized deferred financing costs are presented on the consolidated balance sheets as a direct deduction from the carrying amount of the related de&lt;div style="display:inline;"&gt;b&lt;/div&gt;t&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color:rgba(255, 255, 255, .0);;display:inline;"&gt;obligation.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="background-color:rgba(255, 255, 255, .0);;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color:rgba(255, 255, 255, .0);;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;</rgti:DeferredFinancingCostsPolicyTextBlock>
    <rgti:PublicAndPrivateWarrantsPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Public and Private Warrants&lt;/div&gt;&lt;/div&gt; &#x2014; At the Closing Date of the Business Combination, SNII &lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; had 4,450,000 Private Warrants and&#160;&lt;/div&gt;8,625,000&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;Public warrants outstanding. Each whole warrant entitles the holder to purchase one share of the Company&#x2019;s Common Stock at a price of $&lt;/div&gt;11.50&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; per share, subject to adjustments, and will expire &lt;/div&gt;five years&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; after the Business Combination or earlier upon redemption or liquidation.&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Private Warrants do not meet the derivative scope exception and are accounted for as derivative liabilities. Specifically, the Private Warrants contain provisions that cause the settlement amounts to be dependent upon the characteristics of the holder of the warrant which is not an input into the pricing of a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;fixed-for-fixed&lt;/div&gt;&lt;/div&gt; option on equity shares. Therefore, the Private Warrants are not considered indexed to the Company&#x2019;s stock and should be &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;    &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;classified as a liability. Since the Private Warrants meet the definition of a derivative, the Company recorded the Private Warrants as liabilities in the consolidated balance sheet at fair value upon the closing, with subsequent changes in the fair value recognized in the consolidated statements of operations at each reporting date. The fair value of the Private Warrants are measured using the Black-Scholes option-pricing model. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Public Warrants also fail to meet the indexation guidance in ASC 815 and are accounted for as liabilities because they include a provision whereby if there is not an effective registration statement, the warrant holders have a cap of 0.361 shares of Common Stock per warrant (subject to adjustment), on the issuable number of shares in a cashless exercise. Subsequent to the separate listing and trading of the Public Warrants, their fair value has been measured based on the observable listed prices for such warrants. Upon consummation of the Business Combination, the Company recorded a liability related to the Public Warrants of $16.3&#160;million, with an offsetting entry to additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital. On December&#160;31, 2022, the fair value of the Public Warrants decreased to $0.7&#160;million with the corresponding gain from the change in fair value recorded in the consolidated statement of operations for the year ended December&#160;31, 2022. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;See Note 13 and 15 for further information on fair value. &lt;/div&gt; </rgti:PublicAndPrivateWarrantsPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_shares">8625000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2022_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn12_31_2022_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="3"
      unitRef="Unit_shares">0.361</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-5"
      unitRef="Unit_USD">16300000</us-gaap:DerivativeLiabilities>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-5"
      unitRef="Unit_USD">700000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:DerivativesPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Derivative Warrant Liabilities &lt;/div&gt;&lt;/div&gt;&#x2014; The&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;) at the initial recognition date. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Other than the Public and Private Warrants noted above, the Company also issued warrants to Trinity Capital which are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period until exercised. The fair value of the warrant liabilities issued were initially measured using the Black- Scholes model and are subsequently remeasured at each reporting period with changes recorded as a component of other (expense) income in the Company&#x2019;s consolidated statements of operations. During the year ended December&#160;31, 2022 these warrants were exercised and are no longer outstanding. &lt;/div&gt; </us-gaap:DerivativesPolicyTextBlock>
    <rgti:BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Liability &#x2014;&lt;/div&gt;&lt;/div&gt; At the closing of the Business Combination, the SPAC Sponsor subjected certain Sponsor Vesting Shares to forfeiture and vesting as of the Closing Date if thresholds related to the weighted average price of Common Stock are not met for the duration of various specified consecutive day trading periods during the five-year period following the Closing (the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x201c;Earn-Out&lt;/div&gt; Triggering Events&#x201d;). Any such shares held by the Sponsor that remain unvested after the fifth anniversary of the Closing will be forfeited. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;These Sponsor Vesting Shares are accounted for as liability classified instruments because the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Triggering Events that determine the number of Sponsor Vesting Shares to be earned back by the Sponsor include outcomes that are not solely indexed to the Common Stock of the Company. The aggregate fair value of the Sponsor Vesting Shares on the Closing Date was estimated using a Monte Carlo simulation model and was determined to be $20.4&#160;million at the Closing Date. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&#160;31, 2022, the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Triggering Events were not achieved for any of the tranches, and as such, the Company adjusted the carrying amount of the liability to its estimated fair value of $1.2&#160;million. The change in the fair value of $19.2&#160;million for the year ended December&#160;31, 2022 is included in gain on fair value change, net in the condensed consolidated statements of operations. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant inputs into the respective valuation models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="null;text-indent: 0px;"&gt; &lt;div&gt; &lt;div style="display: inline; background-color: white;"&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 54%;"/&gt;
&lt;td style="width: 20%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 20%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation Assumptions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt; &lt;div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Initial Recognition on&lt;br/&gt;March 2, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt; &lt;div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December 31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock Price&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.43&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.73&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Simulated trading days&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,198&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,050&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Volatility (annual)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;109.30&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free rate&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.74&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.04&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Estimated time to expiration (years)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.170&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;  </rgti:BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock>
    <rgti:PeriodOfEarnoutShares contextRef="P01_01_2022To12_31_2022_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">P5Y</rgti:PeriodOfEarnoutShares>
    <rgti:DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant inputs into the respective valuation models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="null;text-indent: 0px;"&gt; &lt;div&gt; &lt;div style="display: inline; background-color: white;"&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 54%;"/&gt;
&lt;td style="width: 20%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 20%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation Assumptions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt; &lt;div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Initial Recognition on&lt;br/&gt;March 2, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid rgb(0, 0, 0);"&gt; &lt;div style="top: 0px; letter-spacing: 0px; display: inline;"&gt; &lt;div style="display: inline;"&gt; &lt;div style="top: 0px; text-indent: 0px; letter-spacing: 0px; display: inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December 31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/td&gt;
&lt;td style="padding-bottom: 0.5pt; vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock Price&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.43&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.73&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Simulated trading days&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,198&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,050&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Volatility (annual)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;109.30&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free rate&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.74&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.04&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Estimated time to expiration (years)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.170&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </rgti:DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn03_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_shares">9.43</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_shares">0.73</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn03_02_2022_SimulatedTradingDaysMemberusgaapMeasurementInputTypeAxis"
      decimals="0"
      unitRef="Unit_D">1198</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_SimulatedTradingDaysMemberusgaapMeasurementInputTypeAxis"
      decimals="0"
      unitRef="Unit_D">1050</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn03_02_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">30.5</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">109.3</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn03_02_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">1.74</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">4.04</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn03_02_2022_EstimatedPeriodOfExpirationMemberusgaapMeasurementInputTypeAxis"
      decimals="3"
      unitRef="Unit_Y">5</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_EstimatedPeriodOfExpirationMemberusgaapMeasurementInputTypeAxis"
      decimals="3"
      unitRef="Unit_Y">4.17</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Revenue Recognition&lt;/div&gt;&lt;/div&gt; &#x2014; The Company recognizes revenue in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 606,&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;Revenue from Contracts with Customers &lt;/div&gt;&lt;/div&gt;and accounts for certain contract costs in accordance with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASC&#160;340-40,&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;Other Assets and &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred&lt;/div&gt; Costs&#x2014;Contracts with Customers.&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company recognizes revenue from contracts &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;with&lt;/div&gt; customers by applying the following five-step model: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Identify the contract with a customer &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Identify the performance obligations in the contract &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Determine the transaction price &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Allocate the transaction price to the performance obligations in the contract &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Recognize revenue when (or as) performance obligations are satisfied &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company generates revenue through its Quantum Computing as a Service (&#x201c;QCaaS&#x201d;) and development contracts and other services. Access to Rigetti quantum computing systems can be purchased as a quantum computing subscription, or on a usage basis for a specified quantity of hours. Revenue related to subscription-based access to (&#x201c;QCaaS&#x201d;) is recognized over time as access to the systems is provided on a ratable basis over the subscription term, which can range from six months to two years. This time-based input measure of progress provides a faithful depiction of the transfer of the services because the benefits the customer obtains generally equals the benefit from its access to the systems throughout the subscription term. Revenue related to usage-based access to Rigetti quantum computing systems is recognized over time as the systems are accessed using an output method based on compute credit hours expended. This output method provides a faithful depiction of the transfer of the services because the customer has purchased a specified quantity of hours of usage that diminishes each time an hour is expended and therefore each hour of access to the systems is considered a discrete delivery of underlying services in these arrangements. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Development contracts are generally multi-year, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-recurring&lt;/div&gt; arrangements in which the Company provides professional services regarding practical applications of quantum computing to technology and business problems within the customer&#x2019;s industry or organization and assists the customer in developing quantum algorithms and applications that will provide commercial value to the customer in areas of business interest. Development contracts are typically fixed fee arrangements invoiced on a milestone basis but may also be invoiced on a time and materials or cost reimbursement basis in certain cases. Revenue related to development contracts and other services is recognized over time based on completed milestones or hours or costs incurred as appropriate. Revenue for partially completed milestones deemed probable of being met is recognized using an input measure based on actual labor hours incurred to date relative to total estimated labor hours needed to complete the milestone. This input measure of progress provides a faithful depiction of the transfer of the services because it closely depicts the Company&#x2019;s efforts or inputs to the satisfaction of the performance obligation. Revenue related to the sale of custom quantum computing components is recognized at a point in time upon acceptance by the customer. &lt;/div&gt;&lt;/div&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;When the Company&#x2019;s contracts with customers contain multiple performance obligations, the transaction price is allocated on a relative standalone selling price basis to each performance obligation. The Company typically &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/&gt; &lt;div style="color: rgb(0, 0, 0); font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; top: 0px; display: inline !important;;display:inline;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"/&gt; &lt;div/&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;determines standalone selling price based on observable selling prices of our products and services. In instances where standalone selling price is not directly observable, standalone selling price is determined using information that may include market conditions and other observable inputs. Standalone selling price is typically established as a range. In situations in which the stated contract price for a performance obligation is outside of the applicable standalone selling price range and has a different pattern of transfer to the customer than the other performance obligations in the contract, the Company will reallocate the total transaction price to each performance obligation based on the relative standalone selling price of each. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Revenue is recorded based on the transaction price, which includes fixed consideration and estimates of variable consideration. The amount of variable consideration included in the transaction price is constrained and is included only to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s contracts with customers may include renewal or other options at fixed prices. Determining whether such options are considered distinct performance obligations that provide the customer with a material right and therefore should be accounted for separately requires significant judgment. Judgment is required to determine the standalone selling price for each renewal option to determine whether the renewal pricing is reflective of standalone selling price or is reflective of a discount that would provide the customer with a material right. Based on the Company&#x2019;s assessment of standalone selling prices, the Company determined that there were no significant material rights provided to its customers requiring separate recognition. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The timing of revenue recognition may not align with the right to invoice the customer. The Company records accounts receivable when it has the unconditional right to issue an invoice and receive payment, regardless of whether revenue has been recognized. If revenue has not yet been recognized, a contract liability (deferred revenue) is also recorded. If revenue is recognized in advance of the right to invoice, a contract asset or unbilled receivable is recorded, depending on whether the Company&#x2019;s right to consideration is considered conditional or unconditional. Unbilled receivables are included within accounts receivable in the consolidated balance sheets. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In instances where the timing of revenue recognition differs from the timing of the right to invoice, the Company has determined that a significant financing component generally does not exist. The primary purpose of the Company&#x2019;s invoicing terms is to provide customers with simplified and predictable ways of purchasing the products and services and not to receive financing from or provide financing to the customer. Additionally, the Company has elected the practical expedient that permits an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Payment terms on invoiced amounts are typically net 30 days. The Company does not offer rights of return for its products and services in the normal course of business, and contracts generally do not include service-type warranties that provide any incremental service to the customer beyond providing assurance that the goods and services conform to applicable specifications or customer-specific or subjective acceptance provisions. The Company also excludes from revenue government-assessed and imposed taxes on revenue-generating activities that are invoiced to customers. &lt;/div&gt; </us-gaap:RevenueRecognitionPolicyTextBlock>
    <rgti:CostsOfObtainingAndFulfillingContractsPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Costs of Obtaining and Fulfilling Contracts&lt;/div&gt;&lt;/div&gt; &#x2014; The Company has elected to apply the practical expedient to expense contract acquisition costs as incurred when the expected amortization period is one year or less. The Company capitalizes incremental costs incurred to fulfill its contracts that (i)&#160;relate directly to the contract, (ii)&#160;are expected to generate resources that will be used to satisfy the Company&#x2019;s performance obligation(s) under the contract, and (iii)&#160;are expected to be recovered through revenue generated under the contract. &lt;/div&gt;&lt;/div&gt; </rgti:CostsOfObtainingAndFulfillingContractsPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost of Revenue&lt;/div&gt;&lt;/div&gt; &#x2014; Cost of revenue consists primarily of all direct and indirect cost associated with providing QCaaS offerings and development contracts and other services, including employee salaries and employee &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;related costs, including compensation, bonuses, employee taxes and benefit costs of program management and personnel associated with the delivery of goods and services to customers. Cost of revenue also includes an allocation of facility costs, depreciation and amortization directly related to providing the QCaaS offerings and development contracts and other services.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Research and Development &lt;/div&gt;&lt;/div&gt;&#x2014; Research and development costs are expensed as incurred. Research and development expenses include compensation, employee benefits, stock-based compensation, outside consultant fees, allocation of facility costs, depreciation and amortization, materials and components purchased for research and development. &lt;/div&gt; </us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;General and Administrative&lt;/div&gt;&lt;/div&gt; &#x2014; General and administrative expenses include compensation, employee benefits, stock-based compensation, legal, insurance, finance administration and human resources, an allocation of facility costs (including leases), bad debt costs, professional service fees, and an allocation of other general overhead costs including depreciation and amortization to support Rigetti&#x2019;s operations, which consists of operations other than associated with providing QCaaS offerings and development contracts and other services. &lt;/div&gt; </us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <rgti:SalesAndMarketingPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Sales and Marketing &#x2014;&lt;/div&gt;&lt;/div&gt; Sales and marketing expenses consist primarily of compensation including stock-based compensation, employee benefits of sales and marketing employees, outside consultants fees, travel and marketing and promotion costs. &lt;/div&gt; </rgti:SalesAndMarketingPolicyTextBlock>
    <rgti:CapitalizedSoftwarePolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Capitalized Software &#x2014;&lt;/div&gt;&lt;/div&gt; The Company capitalizes the costs to develop &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;its&#160;internal-use&#160;software&lt;/div&gt; when preliminary development efforts are successfully completed, management has authorized and committed project funding, and it is probable that the project will be completed and the software will be used as intended. Such costs are included in property and equipment in the consolidated balance sheets and are amortized on a straight-line basis over the estimated useful life of the related asset. These capitalized costs are primarily related to the software infrastructure supporting the quantum computing services purchased by customers. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional features and functionality. Maintenance costs are expensed as incurred. During the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, no capitalized software has been recorded. &lt;/div&gt; </rgti:CapitalizedSoftwarePolicyTextBlock>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="P02_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income Taxes &lt;/div&gt;&lt;/div&gt;&#x2014; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. As of December&#160;31, 2022 and December&#160;31, 2021, the Company has recorded a full valuation allowance against its deferred tax assets. The Company recognizes the effect of income tax positions only if it is more likely than not that those positions will be sustained. Recognized income tax positions are measured at the largest amount that has a greater than 50% likelihood of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest related to unrecognized tax benefits in interest expense and penalties in income tax expense.&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net Loss Per Share&lt;/div&gt;&lt;/div&gt; &#x2014; Basic net loss per common share is computed by dividing the net loss available to Common Stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Diluted net loss per common share is computed by dividing the net loss available to Common Stockholders adjusted by any preferred stock dividends declared during the period by the weighted average number &lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;of common shares and potential common shares outstanding when the impact is not antidilutive. Potential common shares from stock options, unvested restricted stock units and Common Stock warrants are computed using the treasury stock method, while those from convertible Series C and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;C-1&lt;/div&gt; Preferred Stock are computed using the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;if-converted&lt;/div&gt; method. Contingently issuable shares are included in basic net loss per share only when there is no circumstance under which those shares would not be issued. Shares issuable for little or no cash consideration shall be considered outstanding common shares and included in the computation of basic net loss per share. &lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stock-Based Compensation&lt;/div&gt;&lt;/div&gt; &#x2014; The Company accounts for share-based compensation in accordance with ASC 718, Compensation &#x2013; Stock Compensation. The Company&#x2019;s share-based compensation awards are all equity-classified and consist of stock options, restricted stock units (&#x201c;RSU&#x201d;) and restricted stock awards (&#x201c;RSA&#x201d;). Most stock options have service vesting conditions ranging from 1 to 5 years. RSAs are fully vested on grant date. RSUs granted under the Rigetti&#160;&amp;amp; Co., Inc. 2013 Equity Incentive Plan (the &#x201c;2013 Plan&#x201d;) have a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;4-year&lt;/div&gt; service vesting condition and a performance condition linked to the occurrence of a liquidity event defined as a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;change-in-control&lt;/div&gt;&lt;/div&gt; event, successful initial public offering or successful merger with a special purpose acquisition company, which was satisfied at the Closing. RSUs granted under the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;) have a service vesting condition only. The Company occasionally issues awards that might have different vesting conditions. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Compensation expense is based on the grant-date fair value of the awards and recognized over the requisite service period using a straight-line method for awards that have a service only condition. Compensation expense for awards with service and performance and/or market conditions is recognized using a graded vesting method. Compensation expense for RSAs is recognized fully on grant date. Compensation expenses for awards with a market condition are recognized over the requite service period regardless of whether the market condition is met unless the service requirement is not met. The Company has elected to account for forfeitures of employee stock awards as they occur. &lt;/div&gt; </us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_MinimumMembersrtRangeAxis">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis_MaximumMembersrtRangeAxis">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="P01_01_2022To12_31_2022_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMemberusgaapAwardTypeAxis_TwoThousandThirteenEquityIncentivePlanMemberusgaapPlanNameAxis">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&#x2014; The Company reports all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis... Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Level 1&#x2014;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Level 2&#x2014;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Level 3&#x2014;Inputs are unobservable for the asset or liability. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="P01_01_2022To12_31_2022">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Concentrations of Credit Risk&lt;/div&gt;&lt;/div&gt; &#x2014; Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments in the form of commercial paper and corporate bonds, and trade accounts receivable. The Company&#x2019;s cash and cash equivalents and short-term investments are placed with high-credit-quality financial institutions, and at times exceed federally insured limits. To date, the Company has not experienced any credit loss relating to its cash and cash equivalents or short-term investments. &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-bottom: 0pt; text-indent: 0px; margin-top: 1em"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant &lt;/div&gt;&lt;/div&gt; customers that represent 10% or more of revenue are set forth in the &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;following tables: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the Year&lt;br/&gt;Ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the 11&lt;br/&gt;months&lt;br/&gt;ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;33%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;16%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer B&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;18%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;20%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer C&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;15%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;15%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer D&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;14%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;29%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer E&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;11%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer F&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;*&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;17%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;*Customer accounted for less than 10% of revenue in the respective period &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;65%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer B&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;13%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;35%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer C&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;10%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;34%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer D&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;29%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;*Customer accounted for less than 10% of accounts receivable in the respective period&lt;/div&gt;&lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Sales to government entities comprised 81.3% and 80.0% of the Company&#x2019;s total revenue for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-bottom: 0pt; text-indent: 0px; margin-top: 1em"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant &lt;/div&gt;&lt;/div&gt; customers that represent 10% or more of revenue are set forth in the &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;following tables: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the Year&lt;br/&gt;Ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the 11&lt;br/&gt;months&lt;br/&gt;ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;33%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;16%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer B&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;18%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;20%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer C&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;15%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;15%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer D&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;14%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;29%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer E&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;11%&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer F&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;;width:12%;"&gt;*&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;17%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;*Customer accounted for less than 10% of revenue in the respective period &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; </us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_MinimumMembersrtRangeAxis_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerEMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerFMembersrtMajorCustomersAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <rgti:DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant customers that represent 10% or more of accounts receivable are set forth in the following tables: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer A&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;65%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer B&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;13%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;35%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer C&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;10%&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;34%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Customer D&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;*&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;29%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;*Customer accounted for less than 10% of accounts receivable in the respective period&lt;/div&gt;&lt;/div&gt; </rgti:DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.65</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerBMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerCMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_CustomerDMembersrtMajorCustomersAxis"
      decimals="2"
      unitRef="Unit_pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_GovernmentEntitiesMembersrtProductOrServiceAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="3"
      unitRef="Unit_pure">0.813</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_GovernmentEntitiesMembersrtProductOrServiceAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="3"
      unitRef="Unit_pure">0.80</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recently Adopted Accounting Pronouncements &lt;/div&gt;&lt;/div&gt;&#x2014; In February 2016, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2016-0&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,&lt;/div&gt; Leases and related subsequently issued ASUs (collectively, &#x201c;Topic 842&#x201d;), which supersedes Topic 840. From a lessee perspective, the core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; (&#x201c;ROU&#x201d;) asset representing its right to use the underlying asset for the lease term. There continues to be a differentiation between finance leases (which replace capital leases as so identified under Topic 840) and operating leases. However, the principal difference from the previous guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the statement of financial position. The updated guidance also requires additional quantitative and qualitative disclosures and allows various practical expedients.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="margin-top: 1em; margin-bottom: 1em"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company adopted Topic 842 effective January&#160;1, 2022, using the modified retrospective transition option of applying the new standard at the adoption date for all leases with an original term greater than 12 months. The Company elected the package of practical expedients requiring no reassessment of (i)&#160;whether any expired or existing contracts are or contain leases, (ii)&#160;the lease classification of any expired or existing leases, or (iii)&#160;initial direct costs for any existing leases. Adoption of the standard had a material impact on the Company&#x2019;s consolidated balance sheet by recognizing operating lease ROU assets and operating lease liabilities but did not&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;have an impact on its consolidated statement of operations or cash flows on the date of adoption. The adoption of Topic 842 was recorded as of January&#160;1, 2022 and resulted in the recognition of operating lease ROU assets and operating lease liabilities of $6.3&#160;million and $6.6&#160;million respectively and a $0.3&#160;million adjustment to deferred rent, with no impact to accumulated deficit as of January&#160;1, 2022. The period ended December&#160;31, 2021 continues to be reported in accordance with the Company&#x2019;s historic accounting under previous lease guidance, Topic 840.&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company determines if an arrangement includes a lease at inception. Operating leases are included in the Company&#x2019;s balance sheet as operating lease ROU assets and operating lease liabilities as of December&#160;31, 2022. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. In determining the net present value of its lease payments, the Company uses an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date, or the date of adoption of Topic 842. The operating lease ROU assets also include any lease payments made less lease incentives. The Company&#x2019;s leases may include options to extend or terminate the lease, which is considered in the lease term when it is reasonably certain that the Company will exercise any such options. Lease expense is recognized on a straight-line basis over the expected lease term, taking into account adjustments for provisions such as free rent, escalating base monthly rental payments or deferred payment terms such as rent holidays that defer the commencement date of required payments. The Company has elected not to apply the recognition requirements of Topic 842 for short-term leases. The Company considers leases with a term of 12 months or less at the date of commencement to be short-term. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In May 2021, the FASB issued&#160;ASU No. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-04,&#160;Earnings&lt;/div&gt; Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;470-50),&lt;/div&gt; Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-40):&lt;/div&gt; Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#160;(&#x201c;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-04&#x201d;).&lt;/div&gt; The guidance in&#160;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-04&#160;clarifies&lt;/div&gt; and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity classified after modification or exchange. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December&#160;15, 2021.The &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Company&#160;adopted&#160;ASU&#160;2021-04&#160;as&lt;/div&gt; of&#160;January 1, 2022. The adoption of&#160;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2021-04&#160;did&lt;/div&gt; not have an impact on the Company&#x2019;s financial position and results of operations. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;In December 2019, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12,&#160;Income&lt;/div&gt; Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2019-12&lt;/div&gt; removes certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. The Company adopted this ASU on January&#160;1, 2022. Adoption did not have a significant impact on the Company&#x2019;s financial statements or related disclosures. &lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn01_01_2022"
      decimals="-5"
      unitRef="Unit_USD">6300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="PAsOn01_01_2022"
      decimals="-5"
      unitRef="Unit_USD">6600000</us-gaap:OperatingLeaseLiability>
    <rgti:IncreaseDecreaseInDeferredRent
      contextRef="PAsOn01_01_2022"
      decimals="-5"
      unitRef="Unit_USD">300000</rgti:IncreaseDecreaseInDeferredRent>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn01_01_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <rgti:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &lt;/div&gt;&lt;/div&gt;&#x2014; In June 2022, the FASB issued&#160;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022-03,&#160;ASC&lt;/div&gt; Subtopic 820&#160;&#x201c;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&#x201d;. The FASB issued this update (1)&#160;to clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2)&#160;to amend a related illustrative example, and (3)&#160;to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The ASU is effective for the Company after December&#160;15, 2024, and interim periods within those fiscal years, with early adoption permitted. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;In August 2020, the FASB issued&#160;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&#160;2020-06,&lt;/div&gt; Debt - (Topic 815) (&#x201c;ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&#160;2020-06&#x201d;),&lt;/div&gt; which simplifies an issuer&#x2019;s accounting for convertible instruments and its application of the derivatives scope exception for contracts in its own equity. The amendments in&#160;ASU No. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2020-06&#160;are&lt;/div&gt; effective for public companies, other than smaller reporting companies, for fiscal years beginning after December&#160;15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December&#160;15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December&#160;15, 2020, including interim periods within those fiscal years. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;In April 2019, the FASB issued &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU&#160;2019-04,&#160;Codification&#160;Improvements&lt;/div&gt; to Topic 326, Financial Instruments&#x2014;Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASU&#160;No.&#160;2019-04&#160;was&lt;/div&gt; issued as part of the FASB&#x2019;s ongoing project to improve upon its Accounting Standards Codification (ASC), and to clarify and improve areas of guidance related to recently issued standards on credit losses, hedging, and recognition and measurement. For entities that have not yet adopted the guidance in &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Update&#160;2016-13,&#160;the&lt;/div&gt; effective dates and the transition requirements for these amendments are the same as the effective date and transition requirements in &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Update&#160;2016-13.&#160;The&lt;/div&gt; amendments related to ASC 326 are effective for the Company as of January&#160;1, 2023.&#160;The adoption of the ASU is not expected to have a material impact on its consolidated financial statements. &lt;/div&gt;&lt;/div&gt;</rgti:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3. BUSINESS COMBINATION &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As discussed in Note 1, on March&#160;2, 2022, the Business Combination was completed. Pursuant to the Company&#x2019;s certificate of incorporation, as amended on March&#160;2, 2022, the Company is authorized to issue 1,000,000,000 shares of Common Stock and 10,000,000 shares of preferred stock, par value $0.0001, of the Company (the &#x201c;Preferred Stock&#x201d;). The holders of shares of Common Stock are entitled to &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;one&lt;/div&gt; vote for each share of Common Stock held. The Preferred Stock is &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-voting.&lt;/div&gt; No shares of Preferred Stock were issued and outstanding as of December&#160;31, 2022. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On March&#160;1, 2022, prior to the Closing, as contemplated by the Merger Agreement and following approval by SNII&#x2019;s shareholders at an extraordinary general meeting of shareholders held on February&#160;28, 2022 (the &#x201c;Extraordinary General Meeting&#x201d;), SNII filed a notice of deregistration with the Cayman Islands Registrar of Companies, together with the necessary accompanying documents, and filed a certificate of incorporation (the &#x201c;Certificate of Incorporation&#x201d;) and a certificate of corporate domestication with the Secretary of State of the State of Delaware, under which SNII was domesticated and continues as a Delaware corporation, changing its name to &#x201c;Rigetti Computing, Inc.&#x201d;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As a result of and upon the effective time of the Domestication (which occurred on March&#160;1, 2022), among other things:(1) each then issued and outstanding Class&#160;A ordinary share, par value $0.0001 per share, of SNII (&#x201c;SNII Class&#160;A ordinary share&#x201d;) converted automatically, on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-for-one&lt;/div&gt;&lt;/div&gt; basis, into a share of Common Stock; (2)&#160;each then issued and outstanding Class&#160;B ordinary share, par value $0.0001 per share, of SNII (&#x201c;SNII Class&#160;B ordinary share&#x201d;) converted automatically, on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-for-one&lt;/div&gt;&lt;/div&gt; basis, into a share of Common Stock; (3)&#160;each then issued and outstanding whole warrant of SNII to purchase one SNII Class&#160;A ordinary share converted automatically into a Public Warrant to acquire one share of Common Stock at an exercise price of $11.50 per share pursuant to the Warrant Agreement, dated March&#160;1, 2021, between SNII and American Stock Transfer&#160;&amp;amp; Trust Company, as warrant agent; (4)&#160;and each then issued and outstanding unit of SNII (the &#x201c;SNII Units&#x201d;) was separated and converted automatically into one share of Common Stock and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-fourth&lt;/div&gt; of one Warrant. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Immediately prior to the effective time of the Business Combination, each share of Legacy Rigetti&#x2019;s Series C preferred stock and Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;C-1&lt;/div&gt; preferred stock (collectively, the &#x201c;Legacy Rigetti Preferred Stock&#x201d;) with Par Value of $0.000001 converted into shares of Common Stock of Legacy Rigetti (&#x201c;Legacy Rigetti Common Stock&#x201d;) in accordance with the Amended and Restated Certificate of Incorporation of Legacy Rigetti (such conversion, the &#x201c;Legacy Rigetti Preferred Conversion&#x201d;). &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As a result of the Business Combination, among other things (1)&#160;all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (in&lt;div style="background-color:#ffffff;;display:inline;"&gt;cluding Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of &lt;/div&gt;&lt;div style="background-color:#ffffff;;display:inline;"&gt;0.7870&lt;/div&gt;&lt;div style="background-color:#ffffff;;display:inline;"&gt; (the &#x201c;Exchange Ratio&#x201d;) for an aggregate of &lt;/div&gt;&lt;div style="background-color:#ffffff;;display:inline;"&gt;78,959,579&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color:#ffffff;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="background-color:#ffffff;;display:inline;"&gt;shares of Common Stock; (2)&#160;each warrant to purchase Legacy Rigetti Common Stock converted into a warrant to purchase shares of Common Stock (&#x201c;Assumed Warrant&#x201d;), with each Assumed Warrant subject to the same terms and conditions as were applicable to the original Legacy Rigetti warrant and having an exercise price and number of shares of Common Stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement; (3)&#160;each option to purchase Legacy Rigetti Common Stock converted into an option to purchase shares of Common Stock (&#x201c;Assumed Option&#x201d;), with each Assumed Option subject to the same terms and conditions as were applicable to the original Legacy Rigetti&lt;/div&gt;&lt;/div&gt; &lt;div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;option and with an exercise price and number of shares of Common Stock purchasable based on the Exchange Ratio and other terms contained in the Merger Agreement, and; (4)&#160;each Legacy Rigetti restricted stock unit award converted into a restricted stock unit award to receive shares of Common Stock (&#x201c;Assumed RSU Award&#x201d;), with each Assumed RSU Award subject to the same terms and conditions as were applicable to the Legacy Rigetti restricted stock unit award, and with the number of shares of Common Stock to which the Assumed RSU Award converted based on the Exchange Ratio and other terms contained in the Merger Agreement. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In connectio&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;n with the execution of the Merger Agreement, SNII entered into a sponsor support agreement (the &#x201c;Sponsor Support Agreement&#x201d;) with the Sponsor, Legacy Rigetti and SNII&#x2019;s directors and officers. Pursuant to the Sponsor Support Agreement, the Sponsor and SNII&#x2019;s directors and officers (&#x201c;Sponsor Holders&#x201d;), among other things, agreed to vote all of their shares of SNII capital stock in favor of the approval of the Business Combination. In addition, pursuant to the Sponsor Support Agreement, (i) &lt;/div&gt;2,479,000&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares of Common Stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the &lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;five year &lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;period following the Closing, the volume weighted average price of Common Stock equals or exceeds $&lt;/div&gt;12.50&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; for any &lt;/div&gt;&lt;span style="-sec-ix-hidden:hidden73805546"&gt;twenty trading days&lt;/span&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; within a period of &lt;/div&gt;&lt;span style="-sec-ix-hidden:hidden73805503"&gt;thirty consecutive trading days&lt;/span&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;, and (ii) &lt;/div&gt;580,273&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares of Common Stock held by the Sponsor Holders became unvested and subject to forfeiture as of the Closing and will only vest if, during the &lt;/div&gt;five year&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; period following the Closing, the volume weighted average price of Common Stock equals or exceeds $&lt;/div&gt;15.00&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; for any&lt;/div&gt;&lt;span style="-sec-ix-hidden:hidden73805545"&gt; twenty trading days&lt;/span&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; within a period of &lt;/div&gt;&lt;span style="-sec-ix-hidden:hidden73805504"&gt;thirty consecutive trading days&lt;/span&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;. Any such shares held by the Sponsor Holders that remain unvested after the fifth anniversary of the Closing will be forfeited. (Refer to Note 2 for related significant accounting policy for the Sponsor &lt;/div&gt;&lt;div style="font-size: 10pt; white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liability).&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;Concurrently with the execution of the Merger Agreement, SNII entered into Subscription Agreements (the &#x201c;Initial Subscription Agreements&#x201d;) with certain investors (together, the &#x201c;Initial PIPE Investors&#x201d;), pursuant to which the Initial PIPE Investors agreed to subscribe for and purchase, and SNII agreed to issue and sell to the Initial PIPE Investors, an aggregate of 10,251,000 shares of Common Stock at a price of $10.00 per share, for aggregate gross proceeds of $102.5 Million (the &#x201c;Initial PIPE Financing&#x201d;). &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;On December 23, 2021, SNII entered into Subscription Agreements (the &#x201c;Subsequent Subscription Agreements&#x201d;, and together with the Initial Subscription Agreements, the &#x201c;Subscription Agreements&#x201d;) with two&#160;investors (the &#x201c;Subsequent PIPE Investors&#x201d;, and together with the Initial PIPE Investors, the &#x201c;PIPE Investors&#x201d;) pursuant to which the Subsequent PIPE Investors agreed to subscribe for and purchase, and SNII agreed to issue and sell to the Subsequent PIPE Investors, an aggregate of&#160;&lt;/div&gt;4,390,244 shares of Common Stock at a price of $10.25 per share, for aggregate gross proceeds of $45.0 Million (the &#x201c;Subsequent PIPE Financing&#x201d;, and together with the Initial PIPE Financing, the &#x201c;PIPE Financing&#x201d;). Pursuant to the Subscription Agreements, Rigetti agreed to provide the PIPE Investors with certain registration rights with respect to the shares purchased as part of the PIPE Financing. The PIPE Financing was consummated immediately prior to the Merger. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Business Combination is accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, SNII was treated as the &#x201c;acquired&#x201d; company for financial reporting purposes. &lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $225.6&#160;million. The table below shows the net proceeds from business combination and PIPE financing: &lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"/&gt;
&lt;td style="vertical-align:bottom;width:7%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash&#x2014;SNII trust and cash (net of redemption)&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;77,769&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash&#x2014;PIPE&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;147,510&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash&#x2014;SNII operating account&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;325&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net Proceeds from Business Combination and PIPE&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;225,604&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Transaction costs consist of direct legal, accounting and other fees relating to the consummation of the Merger. Legacy Rigetti transaction costs specific and directly attributable to the business combination totaled &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;$20.65&#160;million. These costs were initially capitalized as incurred in deferred offering assets on the consolidated balance sheets. Upon the Closing, transaction costs related to the issuance of shares were recognized in stockholders&#x2019; equity (deficit) while costs associated with the Public Warrants, Private Warrants and Sponsor Vesting Shares were expensed in the consolidated statements of operations. Of the total transaction cost of&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;br/&gt;&lt;/div&gt;$20.65&#160;million, $19.75&#160;million was recorded to additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital as a reduction of proceeds and the remaining $0.9&#160;million was recognized in the consolidated statements of operations during the year ended December&#160;31, 2022. Transaction cost paid through cash during the year ended December&#160;31, 2022, equals $16.7&#160;million. For the year ended December&#160;31, 2022, the Company also paid a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-time&lt;/div&gt; bonus to certain employees related to the business combination of $2.1&#160;million. &lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The number of shares of Common Stock issued immediately following the consummation of the Business Combination was as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:79%"/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Common Stock&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&lt;/div&gt;SNII Class&#160;A, outstanding prior to Business Combination&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;34,500,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: redemption of SNII Class&#160;A ordinary shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(22,915,538&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Common Stock&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&lt;/div&gt;SNII Class&#160;A ordinary shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,584,462&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;SNII Class&#160;B ordinary shares*&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,625,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Shares issued in PIPE&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,641,244&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Business Combination and PIPE shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;34,850,706&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;Legacy Rigetti**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18,221,069&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;exercise of Legacy Rigetti stock options immediately prior to the closing**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,123,539&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;exercise of Legacy Rigetti warrants immediately prior to the closing**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,234,408&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;upon conversion of Legacy Rigetti Series C preferred stock**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;54,478,261&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;upon conversion of Legacy Rigetti Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;C-1&lt;/div&gt; preferred stock**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,902,302&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total shares of Common Stock immediately after Business Combination&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113,810,285&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;*&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Includes (i) 2,479,000 shares of Common Stock held by the Sponsor (the &#x201c;Promote Sponsor Vesting Shares&#x201d;) and (ii) 580,273 shares of Common Stock held by the Sponsor (&#x201c;Sponsor Redemption-Based Vesting Shares&#x201d;). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;**&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;(i) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of 0.7870 (the &#x201c;Exchange Ratio&#x201d;). (ii) the conversion ratio to Legacy Rigetti Common Stock for the Legacy Series C Preferred Stock was &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-for-one&lt;/div&gt;&lt;/div&gt; and for Legacy &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Series&#160;C-1&lt;/div&gt; Preferred Stock was &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;eight-for-one.&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <rgti:CommonStockNumberOfVotesPerShare
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_pure">1</rgti:CommonStockNumberOfVotesPerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <rgti:CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</rgti:CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare>
    <rgti:CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</rgti:CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare>
    <rgti:ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination
      contextRef="PAsOn12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.5</rgti:ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination>
    <rgti:ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD_per_Share">1</rgti:ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations>
    <rgti:TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022"
      decimals="6"
      unitRef="Unit_USD_per_Share">0.000001</rgti:TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare>
    <rgti:CommonStockSharesExchangeRatio
      contextRef="PAsOn12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.787</rgti:CommonStockSharesExchangeRatio>
    <rgti:CommonStockSharesIssuedAsAResultOfExchange
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_shares">78959579</rgti:CommonStockSharesIssuedAsAResultOfExchange>
    <rgti:SharesSubjectToVestingBasedOnCertainConditions
      contextRef="PAsOn12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis"
      decimals="INF"
      unitRef="Unit_shares">2479000</rgti:SharesSubjectToVestingBasedOnCertainConditions>
    <rgti:SharesSubjectToVestingMaximumPeriod contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis">P5Y</rgti:SharesSubjectToVestingMaximumPeriod>
    <rgti:VolumeWeightedAveragePricePerShare
      contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheOneMemberRGTITrancheAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">12.5</rgti:VolumeWeightedAveragePricePerShare>
    <rgti:SharesSubjectToVestingBasedOnCertainConditions
      contextRef="PAsOn12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis"
      decimals="INF"
      unitRef="Unit_shares">580273</rgti:SharesSubjectToVestingBasedOnCertainConditions>
    <rgti:SharesSubjectToVestingMaximumPeriod contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis">P5Y</rgti:SharesSubjectToVestingMaximumPeriod>
    <rgti:VolumeWeightedAveragePricePerShare
      contextRef="P12_31_2022To12_31_2022_SponsorAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis_TrancheTwoMemberRGTITrancheAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">15</rgti:VolumeWeightedAveragePricePerShare>
    <us-gaap:CommonStockSharesSubscribedButUnissued
      contextRef="PAsOn12_01_2021_InitialSubscriptionAgreementMemberRGTIAgreementAxis_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SupernovaAcquistionMemberdeiLegalEntityAxis"
      decimals="INF"
      unitRef="Unit_shares">10251000</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn12_01_2021_InitialSubscriptionAgreementMemberRGTIAgreementAxis_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SupernovaAcquistionMemberdeiLegalEntityAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="PAsOn12_01_2021_InitialSubscriptionAgreementMemberRGTIAgreementAxis_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SupernovaAcquistionMemberdeiLegalEntityAxis"
      decimals="-5"
      unitRef="Unit_USD">102500000</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:CommonStockSharesSubscribedButUnissued
      contextRef="PAsOn12_23_2021_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SubsequentSubscriptionAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis"
      decimals="INF"
      unitRef="Unit_shares">4390244</us-gaap:CommonStockSharesSubscribedButUnissued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn12_23_2021_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SubsequentSubscriptionAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="PAsOn12_23_2021_PrivateInvestmentInPublicEquityInvestorsMemberRGTIInvestorAxis_SubsequentSubscriptionAgreementMemberRGTIAgreementAxis_SupernovaAcquistionMemberdeiLegalEntityAxis"
      decimals="-5"
      unitRef="Unit_USD">45000000</us-gaap:CommonStockSharesSubscriptions>
    <rgti:DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;In accounting for the Business Combination and after redemptions, net proceeds received by the Company totaled $225.6&#160;million. The table below shows the net proceeds from business combination and PIPE financing: &lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"/&gt;
&lt;td style="vertical-align:bottom;width:7%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash&#x2014;SNII trust and cash (net of redemption)&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;77,769&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash&#x2014;PIPE&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;147,510&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash&#x2014;SNII operating account&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;325&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net Proceeds from Business Combination and PIPE&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;225,604&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rgti:DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock>
    <rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">225600000</rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid>
    <rgti:CashReceivedFromTrustNetOfRedemptions
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">77769000</rgti:CashReceivedFromTrustNetOfRedemptions>
    <rgti:CashReceivedFromPrivateInvestmentInPublicEquity
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">147510000</rgti:CashReceivedFromPrivateInvestmentInPublicEquity>
    <rgti:AggregateTransactionCostsPaid
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">325000</rgti:AggregateTransactionCostsPaid>
    <rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">225604000</rgti:ProceedsFromBusinessCombinationNetOfTransactionCostsPaid>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts
      contextRef="PAsOn12_31_2021"
      decimals="-4"
      unitRef="Unit_USD">20650000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts
      contextRef="PAsOn12_31_2022"
      decimals="-4"
      unitRef="Unit_USD">20650000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts>
    <rgti:AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts
      contextRef="P01_01_2022To12_31_2022"
      decimals="-4"
      unitRef="Unit_USD">19750000</rgti:AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">900000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed>
    <rgti:PaymentOfTransactionCostsThroughCash
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">16700000</rgti:PaymentOfTransactionCostsThroughCash>
    <rgti:OneTimeBonus
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">2100000</rgti:OneTimeBonus>
    <rgti:DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The number of shares of Common Stock issued immediately following the consummation of the Business Combination was as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:79%"/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Common Stock&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&lt;/div&gt;SNII Class&#160;A, outstanding prior to Business Combination&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;34,500,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: redemption of SNII Class&#160;A ordinary shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(22,915,538&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Common Stock&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&lt;/div&gt;SNII Class&#160;A ordinary shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,584,462&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;SNII Class&#160;B ordinary shares*&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,625,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Shares issued in PIPE&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,641,244&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Business Combination and PIPE shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;34,850,706&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;Legacy Rigetti**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18,221,069&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;exercise of Legacy Rigetti stock options immediately prior to the closing**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,123,539&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;exercise of Legacy Rigetti warrants immediately prior to the closing**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,234,408&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;upon conversion of Legacy Rigetti Series C preferred stock**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;54,478,261&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Common Stock&#x2014;upon conversion of Legacy Rigetti Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;C-1&lt;/div&gt; preferred stock**&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,902,302&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total shares of Common Stock immediately after Business Combination&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;113,810,285&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;*&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Includes (i) 2,479,000 shares of Common Stock held by the Sponsor (the &#x201c;Promote Sponsor Vesting Shares&#x201d;) and (ii) 580,273 shares of Common Stock held by the Sponsor (&#x201c;Sponsor Redemption-Based Vesting Shares&#x201d;). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;**&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;(i) all outstanding shares of Legacy Rigetti Common Stock as of immediately prior to the Closing (including Legacy Rigetti Common Stock resulting from the Legacy Rigetti Preferred Stock Conversion), were exchanged at an exchange ratio of 0.7870 (the &#x201c;Exchange Ratio&#x201d;). (ii) the conversion ratio to Legacy Rigetti Common Stock for the Legacy Series C Preferred Stock was &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-for-one&lt;/div&gt;&lt;/div&gt; and for Legacy &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Series&#160;C-1&lt;/div&gt; Preferred Stock was &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;eight-for-one.&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rgti:DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_StatusOfSharesOutstandingBeforeBusinessCombinationMemberRGTIEventAxis"
      decimals="INF"
      unitRef="Unit_shares">34500000</us-gaap:SharesOutstanding>
    <rgti:RedemptionOfCommonStockSharesOfThePredecessorCompany
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">22915538</rgti:RedemptionOfCommonStockSharesOfThePredecessorCompany>
    <rgti:CommonStockSharesNewlyIssuedInThePredecessorCompany
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">11584462</rgti:CommonStockSharesNewlyIssuedInThePredecessorCompany>
    <rgti:CommonStockSharesNewlyIssuedInThePredecessorCompany
      contextRef="P01_01_2022To12_31_2022_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">8625000</rgti:CommonStockSharesNewlyIssuedInThePredecessorCompany>
    <rgti:CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">14641244</rgti:CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity>
    <rgti:StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">34850706</rgti:StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity>
    <rgti:CommonStockSharesIssuedInTheNewCompany
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">18221069</rgti:CommonStockSharesIssuedInTheNewCompany>
    <rgti:CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">1123539</rgti:CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing>
    <rgti:CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">2234408</rgti:CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing>
    <rgti:CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity
      contextRef="P01_01_2022To12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">54478261</rgti:CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity>
    <rgti:CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity
      contextRef="P01_01_2022To12_31_2022_SeriesCOneRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">2902302</rgti:CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">113810285</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2022_PromoteSponsorVestingSharesMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">2479000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="PAsOn12_31_2022_SponsorRedemptionBasedVestingSharesMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">580273</us-gaap:SharesOutstanding>
    <rgti:CommonStockSharesExchangeRatio
      contextRef="PAsOn12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.787</rgti:CommonStockSharesExchangeRatio>
    <rgti:ConversionFromTemporaryEquityToPermanentEquityExchangeRatio
      contextRef="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_pure">1</rgti:ConversionFromTemporaryEquityToPermanentEquityExchangeRatio>
    <rgti:ConversionFromTemporaryEquityToPermanentEquityExchangeRatio
      contextRef="PAsOn12_31_2022_SeriesCOneRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_pure">8</rgti:ConversionFromTemporaryEquityToPermanentEquityExchangeRatio>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;4. INVESTMENTS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As of December&#160;31, 2022, investment securities in the Company&#x2019;s Trust Account consisted of $36.3&#160;million in money market funds, $58.2&#160;million in United States Treasury securities, $3.6&#160;million in corporate bonds and $23.1&#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;million in commercial paper. The money market funds are classified as cash equivalents in the consolidated balance sheets. The Company classifies its investments in fixed income securities as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale.&lt;/div&gt;&lt;/div&gt; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Available-for-sale&lt;/div&gt;&lt;/div&gt; marketable securities are recorded at their estimated fair value. The amortized cost, gross unrealized holding loss included in other comprehensive income, and fair value of the &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;investment securities on December&#160;31, 2022 are presented in the table below. The Company did not hold investment securities at December&#160;31, 2021. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 49%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortized&#160;Cost&#160;as&#160;of&lt;br/&gt;December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Gross&#160;Unrealized&lt;br/&gt;Holding Loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;Value&#160;as&#160;of&lt;br/&gt;December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;e&lt;/div&gt;quivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Money Market Funds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Short-term investments:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;United States Treasury Securities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;58,514&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(304&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;58,210&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Corporate Bonds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,581&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(10&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,571&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Commercial Papers&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,142&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,142&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 49%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: bottom; width: 49%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;121,583&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(314&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;121,269&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 49%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;All of the Company&#x2019;s &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities have final maturities of one year or less. The Company reviews the individual securities that have unrealized losses in its short-term investment portfolio on a regular basis. The Company evaluates whether it has the intention to sell any of these investments and whether it is more likely than not that it will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met as of December&#160;31, 2022. The Company additionally evaluates whether the decline in fair value of the securities below their amortized cost basis is related to credit losses or other factors. Based on this evaluation, the Company determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-credit-related&lt;/div&gt; factors. Accordingly, the Company determined that the unrealized losses were not other-than-temporary and that recording an impairment was therefore unnecessary for its short-term investments as of December&#160;31, 2022. All of the Company&#x2019;s &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities have been in an unrealized loss position for less than one year because they were all acquired in 2022. The Company did not have any &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities as of December&#160;31, 2021. &lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">36300000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">58200000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">3600000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">23100000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock contextRef="P01_01_2022To12_31_2022">The amortized cost, gross unrealized holding loss included in other comprehensive income, and fair value of the&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;investment securities on December&#160;31, 2022 are presented in the table below. The Company did not hold investment securities at December&#160;31, 2021. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 49%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amortized&#160;Cost&#160;as&#160;of&lt;br/&gt;December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Gross&#160;Unrealized&lt;br/&gt;Holding Loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;Value&#160;as&#160;of&lt;br/&gt;December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;e&lt;/div&gt;quivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Money Market Funds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Short-term investments:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;United States Treasury Securities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;58,514&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(304&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;58,210&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Corporate Bonds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,581&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(10&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,571&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 49%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Commercial Papers&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,142&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,142&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 49%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: bottom; width: 49%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;121,583&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(314&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;121,269&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 49%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 11%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">36346000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022_MoneyMarketFundsMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">36346000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">58514000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">304000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022_USTreasurySecuritiesMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">58210000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">3581000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">10000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">3571000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">23142000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">23142000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">121583000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">314000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">121269000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <rgti:DebtSecuritiesAvailableForSaleMaturityYear contextRef="P01_01_2022To12_31_2022">one year or less</rgti:DebtSecuritiesAvailableForSaleMaturityYear>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5. GOODWILL &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table sets forth the change in the carrying amount of goodwill for the Company for the year ended December&#160;31, 2022: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 86%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;January 1, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;5,377&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; width: 86%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:86%"/&gt;
&lt;td style="vertical-align: bottom; width: 6%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,377&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Impairment charge&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,377&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 86%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 86%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;On the Company&#x2019;s annual goodwill impairment testing date of November&#160;1, 2022 management performed an impairment evaluation of goodwill after assessing qualitative factors that indicated a possible impairment of goodwill. Under the qualitative assessment, management considers relevant events and circumstances including but not limited to macroeconomic conditions, industry and market considerations, overall Company performance and events directly affecting the Company. It was noted during our assessment that the Company has experienced a sustained decline in stock price, however as of November&#160;1, 2022 the Company determined that goodwill was not impaired. Subsequently in December 2022, the Company&#x2019;s stock price continued to decline, resulting in a triggering event to evaluate goodwill for impairment as of December&#160;31, 2022. As a result, further quantitative analysis was conducted to determine the extent to which, if any, the Company&#x2019;s carrying value exceeded its fair value as of December&#160;31, 2022. The quantitative analysis used fair value based on market capitalization adjusted for a control premium based on market comparable transactions. This quantitative analysis resulted in the Company&#x2019;s fair value being significantly below its carrying value, resulting in a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cash&lt;/div&gt; goodwill impairment charge of $5.4&#160;million being recorded for the year ended December&#160;31, 2022. &lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table sets forth the change in the carrying amount of goodwill for the Company for the year ended December&#160;31, 2022: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 86%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;January 1, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;5,377&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; width: 86%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:86%"/&gt;
&lt;td style="vertical-align: bottom; width: 6%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;December&#160;31, 2021&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,377&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Impairment charge&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(5,377&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 86%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 86%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 86%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="PAsOn01_31_2021"
      decimals="-3"
      unitRef="Unit_USD">5377000</us-gaap:Goodwill>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">5377000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5377000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">5400000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;6. REVENUE RECOGNITION &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following tables depict the disaggregation of revenue according to the type of good or service and timing of transfer of goods or services for the year ended December&#160;31, 2022, and the 11 months ended December&#160;31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Type of Goods or Service&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Collaborative research and other professional services&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9,917&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,849&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Access to quantum computing systems&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,185&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,347&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,102&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,196&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Timing of Revenue Recognition&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Revenue recognized at a point in time&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Revenue recognized over time&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,102&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,196&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,102&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,196&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;  &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Selected consolidated balance sheet line items that reflect accounts receivable, contract assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021 were as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 65%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 65%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Trade receivables&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,143&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;962&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Unbilled receivables&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;92&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;581&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred revenue&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(961&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(985&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;   &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Changes in deferred revenue from contracts with customers were as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 14%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 14%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 14%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 14%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Balance at beginning of period&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(985&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(492&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferral of revenue&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(545&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(904&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Recognition of deferred revenue&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;569&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;411&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Balance at end of period&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(961&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(985&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Remaining performance obligations represent the portion of the transaction price that has not yet been satisfied or achieved. As of December&#160;31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $9.7&#160;million. The Company expects to recognize estimated revenues related to performance obligations that are unsatisfied (or partially satisfied) in the amounts of approximately $7.9&#160;million during the year ended December&#160;31, 2023, and $1.8&#160;million during the years ended December&#160;31, 2024 and December&#160;31, 2025. &lt;br/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred Contract Acquisition and Fulfillment Costs&#x2014;The Company has not identified any costs that are incremental to the acquisition of customer contracts that would be capitalized as deferred costs on the balance sheet in accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;340-40.&lt;/div&gt; Incremental costs incurred to fulfill the Company&#x2019;s contracts that meet the capitalization criteria in ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;340-40&lt;/div&gt; have historically been immaterial. Accordingly, the Company has not capitalized any contract fulfillment costs as of December&#160;31, 2022 and December&#160;31, 2021. &lt;/div&gt;&lt;/div&gt; </us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following tables depict the disaggregation of revenue according to the type of good or service and timing of transfer of goods or services for the year ended December&#160;31, 2022, and the 11 months ended December&#160;31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Type of Goods or Service&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Collaborative research and other professional services&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9,917&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,849&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Access to quantum computing systems&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,185&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,347&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,102&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,196&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Timing of Revenue Recognition&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Revenue recognized at a point in time&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Revenue recognized over time&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,102&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,196&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,102&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,196&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; </us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P01_01_2022To12_31_2022_CollaborativeResearchAndOtherProfessionalServicesMembersrtProductOrServiceAxis"
      decimals="-3"
      unitRef="Unit_USD">9917000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P02_01_2021To12_31_2021_CollaborativeResearchAndOtherProfessionalServicesMembersrtProductOrServiceAxis"
      decimals="-3"
      unitRef="Unit_USD">5849000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P01_01_2022To12_31_2022_AccessToQuantumComputingSystemsMembersrtProductOrServiceAxis"
      decimals="-3"
      unitRef="Unit_USD">3185000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P02_01_2021To12_31_2021_AccessToQuantumComputingSystemsMembersrtProductOrServiceAxis"
      decimals="-3"
      unitRef="Unit_USD">2347000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">13102000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">8196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P01_01_2022To12_31_2022_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P02_01_2021To12_31_2021_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P01_01_2022To12_31_2022_TransferredOverTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis"
      decimals="-3"
      unitRef="Unit_USD">13102000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P02_01_2021To12_31_2021_TransferredOverTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis"
      decimals="-3"
      unitRef="Unit_USD">8196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">13102000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">8196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Selected consolidated balance sheet line items that reflect accounts receivable, contract assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021 were as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 65%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 65%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Trade receivables&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,143&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;962&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Unbilled receivables&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;92&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;581&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred revenue&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(961&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(985&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">6143000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">962000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">92000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">581000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">961000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">985000</us-gaap:DeferredRevenueCurrent>
    <rgti:ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Changes in deferred revenue from contracts with customers were as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 14%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 14%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 14%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 14%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Balance at beginning of period&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(985&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(492&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferral of revenue&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(545&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(904&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Recognition of deferred revenue&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;569&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;411&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Balance at end of period&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(961&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(985&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </rgti:ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">985000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="PAsOn01_31_2021"
      decimals="-3"
      unitRef="Unit_USD">492000</us-gaap:DeferredRevenueCurrent>
    <rgti:DeferralOfRevenue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-545000</rgti:DeferralOfRevenue>
    <rgti:DeferralOfRevenue
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-904000</rgti:DeferralOfRevenue>
    <rgti:RecognitionOfDeferredRevenues
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">569000</rgti:RecognitionOfDeferredRevenues>
    <rgti:RecognitionOfDeferredRevenues
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">411000</rgti:RecognitionOfDeferredRevenues>
    <us-gaap:DeferredRevenueCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">961000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">985000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="PAsOn12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">9700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="PAsOn12_31_2022_RemainderoftwothousandandtwentythreeMemberRGTIRevenuePerformanceObligationTransactionPriceAxis"
      decimals="-5"
      unitRef="Unit_USD">7900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="PAsOn12_31_2022_TwothousandandtwentyfourMemberRGTIRevenuePerformanceObligationTransactionPriceAxis"
      decimals="-5"
      unitRef="Unit_USD">1800000</us-gaap:RevenueRemainingPerformanceObligation>
    <rgti:SupplementalFinancialStatementInformationTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7. SUPPLEMENTAL FINANCIAL STATEMENTS INFORMATION &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property and Equipment, Net &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment as of December&#160;31, 2022 and December&#160;31, 2021 are composed of the following: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Quantum computing fridges&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,218&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;17,190&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Process equipment&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,330&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;16,170&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Leasehold improvements&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,561&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,297&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;IT Hardware&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,035&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,428&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Furniture and other assets&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,246&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,246&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total property and equipment&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;65,390&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;41,330&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: Accumulated depreciation and amortization&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(25,860&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(18,832&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Property and equipment - net&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;39,530&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;22,497&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As of December&#160;31, 2022 and December&#160;31, 2021, 98% of the total gross property and equipment was located in the United States, and 2% of the total gross property and equipment was located in the United Kingdom. Total depreciation and amortization expense for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $7.0&#160;million and $4.7&#160;million, respectively. &lt;/div&gt;  &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued Expenses and Other Current Liabilities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Utilities&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,818&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Professional&#160;&amp;amp; subscription fees&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,044&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,377&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Property and other taxes&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,161&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;571&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Subcontractor cost&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;804&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Payroll and other payroll costs&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;781&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;962&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Property and equipment&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;639&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Others&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;626&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;"&gt;Accrued interest&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;314&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred offering costs&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;648&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,205&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,806&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </rgti:SupplementalFinancialStatementInformationTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment as of December&#160;31, 2022 and December&#160;31, 2021 are composed of the following: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Quantum computing fridges&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,218&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;17,190&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Process equipment&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,330&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;16,170&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Leasehold improvements&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7,561&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,297&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;IT Hardware&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,035&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,428&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Furniture and other assets&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,246&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,246&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total property and equipment&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;65,390&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;41,330&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: Accumulated depreciation and amortization&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(25,860&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(18,832&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Property and equipment - net&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;39,530&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;22,497&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022_QuantumComputingFridgesMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">30218000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2021_QuantumComputingFridgesMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">17190000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022_ProcessEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">23330000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2021_ProcessEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">16170000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">7561000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2021_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">4297000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022_ItHardwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">3035000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2021_ItHardwareMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">2428000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022_FurnitureAndOtherAssetsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">1246000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2021_FurnitureAndOtherAssetsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">1246000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">65390000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">41330000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">25860000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">18832000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">39530000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">22497000</us-gaap:PropertyPlantAndEquipmentNet>
    <rgti:PercentageOfTotalGrossPropertyAndEquipment
      contextRef="PAsOn12_31_2022_USsrtStatementGeographicalAxis"
      decimals="2"
      unitRef="Unit_pure">0.98</rgti:PercentageOfTotalGrossPropertyAndEquipment>
    <rgti:PercentageOfTotalGrossPropertyAndEquipment
      contextRef="PAsOn12_31_2021_GBsrtStatementGeographicalAxis"
      decimals="2"
      unitRef="Unit_pure">0.02</rgti:PercentageOfTotalGrossPropertyAndEquipment>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">7000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="P02_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">4700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued Expenses and Other Current Liabilities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Utilities&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,818&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Professional&#160;&amp;amp; subscription fees&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,044&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,377&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Property and other taxes&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,161&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;571&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Subcontractor cost&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;804&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Payroll and other payroll costs&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;781&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;962&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Property and equipment&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;639&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Others&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;626&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;"&gt;Accrued interest&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;314&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;248&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred offering costs&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;18&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;648&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,205&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,806&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1818000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2044000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1377000</us-gaap:AccruedProfessionalFeesCurrent>
    <rgti:AccruedPropertyAndOtherTaxes
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1161000</rgti:AccruedPropertyAndOtherTaxes>
    <rgti:AccruedPropertyAndOtherTaxes
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">571000</rgti:AccruedPropertyAndOtherTaxes>
    <rgti:AccruedSubcontractorCost
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">804000</rgti:AccruedSubcontractorCost>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">781000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">962000</us-gaap:AccruedPayrollTaxesCurrent>
    <rgti:AccruedPropertyPlantAndEquipmentCost
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">639000</rgti:AccruedPropertyPlantAndEquipmentCost>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">626000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">314000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">248000</us-gaap:InterestPayableCurrent>
    <rgti:AccruedDeferredOfferingCosts
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">18000</rgti:AccruedDeferredOfferingCosts>
    <rgti:AccruedDeferredOfferingCosts
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">648000</rgti:AccruedDeferredOfferingCosts>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8205000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">3806000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8. LEASES &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company leases a building, offices and equipment under various lease agreements with terms extending through 2029. Under the terms of the building and office leases the Company bears the costs for certain insurance, property taxes and maintenance, and the lease agreements provide for increasing rental payments at fixed intervals. &lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Components of lease costs, the weighted average remaining lease term and weighted average discount rate were as follows as of and for the year ended December&#160;31, 2022: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 78%;"/&gt;
&lt;td style="width: 15%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;Lease cost&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 78%;"/&gt;
&lt;td style="width: 15%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:87%"/&gt;
&lt;td style="vertical-align:bottom;width:6%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease cost&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,513&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term lease cost&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Sub-lease income&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(194&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total lease cost&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;2,355&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 78%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&#160;Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Operating cash flows from operating leases&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;$2,128&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; assets obtained in exchange for new and modified operating lease liabilities&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;$4,892&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted average remaining lease term - operating leases&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;5.87&#160;years&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted average discount rate - operating leases&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center; text-indent: 0px;"&gt;7.93&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0px;;text-align:center;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the net present value of its lease payments, the Company used an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date or the date of Adoption of Topic 842. As of December&#160;31, 2022, the maturities of the Company&#x2019;s operating lease liabilities were as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 85%;"/&gt;
&lt;td style="width: 7%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;2,422&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;2,288&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;2,198&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;1,524&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;1,566&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Thereafter&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;2,841&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total lease payments&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;12,839&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: Imputed interest&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;(2,636&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Present value of lease liabilities&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;10,203&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Operating lease liabilities, current&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;2,345&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Operating lease liabilities, noncurrent&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;7,858&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;10,203&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Prior to the adoption of Topic 842 on January&#160;1, 2022, the Company accounted for its leases under Topic 840. The Company recognized rent expense on a straight-line basis over the lease term, taking into account adjustments for provisions such as free or escalating monthly rental payments or deferred payment terms such as rent holidays that defer the commencement date of required payments. The Company recorded the difference between cash rent payments and the recognition of rent expense as deferred rent. Rent expense under the Company&#x2019;s operating leases was $1.5&#160;million for the 11 months ended December&#160;31, 2021.&lt;br/&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Future minimum lease payments under non-cancelable operating leases as of December 31, 2021 are &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;as&lt;/div&gt; follows: &lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 87%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year ending December 31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,808&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;901&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;928&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;956&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;81&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total minimum future lease payments&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4,674&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  </us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Components of lease costs, the weighted average remaining lease term and weighted average discount rate were as follows as of and for the year ended December&#160;31, 2022: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 78%;"/&gt;
&lt;td style="width: 15%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;Lease cost&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 78%;"/&gt;
&lt;td style="width: 15%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:87%"/&gt;
&lt;td style="vertical-align:bottom;width:6%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease cost&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,513&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Short-term lease cost&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Sub-lease income&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(194&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total lease cost&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;2,355&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;   &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 78%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&#160;Ended&lt;br/&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Operating cash flows from operating leases&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;$2,128&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Right-of-use&lt;/div&gt;&lt;/div&gt; assets obtained in exchange for new and modified operating lease liabilities&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;$4,892&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted average remaining lease term - operating leases&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;5.87&#160;years&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted average discount rate - operating leases&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center; text-indent: 0px;"&gt;7.93&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0px;;text-align:center;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2513000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">36000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">194000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2355000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2128000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4892000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="PAsOn12_31_2022">P5Y10M13D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="PAsOn12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.0793</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the net present value of its lease payments, the Company used an estimated incremental borrowing rate that is applicable to the Company based on the information available at the later of the lease commencement date, lease modification date or the date of Adoption of Topic 842. As of December&#160;31, 2022, the maturities of the Company&#x2019;s operating lease liabilities were as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 85%;"/&gt;
&lt;td style="width: 7%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;2,422&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;2,288&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;2,198&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;1,524&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2027&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;1,566&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Thereafter&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;2,841&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total lease payments&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;12,839&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: Imputed interest&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;(2,636&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Present value of lease liabilities&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;10,203&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Operating lease liabilities, current&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;2,345&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgb(204, 238, 255);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Operating lease liabilities, noncurrent&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;7,858&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;10,203&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 85%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size:1pt;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2422000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2288000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2198000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1524000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1566000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2841000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">12839000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2636000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">10203000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2345000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">7858000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">10203000</us-gaap:OperatingLeaseLiability>
    <rgti:OperatingLeaseRentExpenses
      contextRef="P02_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">1500000</rgti:OperatingLeaseRentExpenses>
    <rgti:ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Future minimum lease payments under non-cancelable operating leases as of December 31, 2021 are &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;as&lt;/div&gt; follows: &lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 87%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year ending December 31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,808&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;901&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;928&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;956&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;81&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total minimum future lease payments&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4,674&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </rgti:ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">1808000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">901000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">928000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">956000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">81000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">4674000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;9. COMMITMENTS AND CONTINGENCIES&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company is periodically involved in legal proceedings, legal actions and claims arising in the normal course of business. Management believes that the outcome of such legal proceedings, legal actions and claims will not have a significant adverse effect on the Company&#x2019;s financial position, results of operations or cash flows.&lt;/div&gt; </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10. DEBT &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In March 2021, the Company entered into an agreement (the &#x201c;Loan Agreement&#x201d;) with Trinity Capital Inc. (&#x201c;Trinity&#x201d;) to secure a debt commitment of $12.0&#160;million (the &#x201c;Tranche A&#x201d;) which was drawn at the closing. The term loan is collateralized by a first-priority, senior secured interest in substantially all of the Company&#x2019;s assets. In conjunction with the Loan Agreement, the Company issued Trinity a warrant to purchase shares of Common Stock (the &#x201c;Trinity Warrants&#x201d;) which is recorded at fair value using the Black-Scholes model, see Note 15 for the fair value assumptions. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Loan Agreement contains customary representations, warranties and covenants; however, the debt agreement does not include any financial covenants. In May 2021, the debt agreement was modified to increase the overall debt commitment by $15.0&#160;million (the &#x201c;Tranche B&#x201d; or the &#x201c;Amendment&#x201d;) and $8.0&#160;million of the additional commitment was drawn at the closing and the remaining commitment of $7.0&#160;million was available at the Company&#x2019;s option at any time through March&#160;10, 2022 subject to certain conditions. The Company drew the $7.0&#160;million in November 2021. In conjunction with the Amendment, the Company cancelled the Initial Warrants and issued 995,099 (783,129 shares post conversion upon the closing of the Business Combination) warrant shares to purchase the Common Stock which was an incremental cost allocated between Tranche A and Tranche B, see Note 13 for further information on these warrants. The Amendment to the debt agreement was considered a modification for accounting purposes. The Company capitalized $2.8&#160;million of debt issuance costs which consist of incremental costs incurred for the lenders and third-party legal firms as well as the fair value of the warrant issued in conjunction with the term loan. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Under the Amendment, the maturity date was modified to be the date equal to 48 months from the first payment date of each specific cash advance. Subject to an interest only period of 19 months following each specific cash advance date, the term loan incurs interest at a rate of the greater of 11% &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;or &lt;/div&gt;the US Prime Rate plus 7.50% per annum, payable monthly. The Term Loan includes certain negative covenants, primarily consisting of restrictions on the Company&#x2019;s ability to incur indebtedness, pay dividends, execute fundamental change transactions, and other specified actions. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In January 2022, the debt agreement was modified to increase the overall debt commitment by $5.0&#160;million (the &#x201c;Tranche C&#x201d; or the &#x201c;Third Amendment&#x201d;) which was drawn on January&#160;27, 2022. Subject to an interest only period of 19 months, Tranche C incurs interest at a rate of the greater of 11% and the US Prime Rate plus 7.50% per annum, payable monthly, until the maturity date, February 1, 2026. Other modifications per the amendment included an extension of the requirement to raise an additional $75&#160;million of equity until April&#160;1, 2022, and a defined exit fee for the additional $5.0&#160;million to be at 20% of the advanced funds under the amendment. The company met the requirement to raise additional equity of $75&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million through the business combination mentioned in Note 3. The Company paid an exit fee of $&lt;/div&gt;1.0&#160;million which is 20&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;% of the Tranche C amount upon the consummation of the merger. The exit fee was capitalized as a debt issuance cost and is amortized using the effective interest method over the life of Tranche C. The exit fee is not applicable to Tranche A and Tranche B. In conjunction with the amendment, the Company also guaranteed payment of all monetary amounts owed and performance of all covenants, obligations and liabilities.&#160;&lt;/div&gt; &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;In addition, the Company is required to pay a final payment fee equal to 2.75% of the aggregate amount of all term loan advances. The final payment fee is being accreted and amortized into interest expense using the effective interest rate method over the term of the loan. The effective interest was between 20.75&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;% &lt;/div&gt;&lt;/div&gt; &#x2013; 26.83% for all tranches of the debt as of December&#160;31, 2022.&lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of the debt is classified as Level 2. Given the maturity and variable interest rate on the debt, the book value approximates its fair value. Long term debt and the unamortized discount balances are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt; &lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 74%;"/&gt;
&lt;td style="width: 5%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 5%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding principal amount&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,709&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;27,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Add: accreted liability of final payment fee&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;407&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: unamortized debt discount, long term&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(990&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,618&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: current portion of long term debt-principal&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(9,491&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,291&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;Debt&#x2014;net of current portion&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;20,635&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;24,216&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;Current portion of long term debt&#x2014;principal&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9,491&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,291&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: current portion of unamortized debt discount&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,188&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(716&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Debt&#x2014;current portion&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,303&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;575&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;During the year ended December&#160;31, 2022, the Company recorded interest expense of $&lt;/div&gt;5.3&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million, which includes the accretion of the end of term liability of $&lt;/div&gt;0.3&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million, the amortization of commitment fee asset of $&lt;/div&gt;0.3&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million and the amortization of debt issuance cost of $&lt;/div&gt;0.9&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million, respectively. The unamortized debt discount of $&lt;/div&gt;2.2&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million as of December&#160;31, 2022 is offset against the carrying value of the term loan in the consolidated balance sheet.&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;During the 11 months ended December&#160;31, 2021, the Company recorded interest expense of $&lt;/div&gt;2.5&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million, which includes the accretion of the end of term liability of $&lt;/div&gt;0.1&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million, the amortization of commitment fee asset of $&lt;/div&gt;0.1&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million and the amortization of debt issuance cost of $&lt;/div&gt;0.5&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million. The unamortized debt discount of $&lt;/div&gt;2.3&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million as of December&#160;31, 2021 is offset against the carrying value of the term loan in the consolidated balance sheet.&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Scheduled principal payments on total outstanding debt as of December&#160;31, 2022 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 85%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year ending December 31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 85%;"/&gt;
&lt;td style="vertical-align: bottom; width: 6%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9,491&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,007&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,020&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;191&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,709&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Scheduled principal payments on total outstanding debt as of December 31, 2021 are as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 85%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year ending December 31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;702&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;8,682&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;11,008&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;6,608&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;27,000&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="PAsOn03_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheAMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis"
      decimals="-5"
      unitRef="Unit_USD">12000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis"
      decimals="-5"
      unitRef="Unit_USD">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis"
      decimals="-5"
      unitRef="Unit_USD">8000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis"
      decimals="-5"
      unitRef="Unit_USD">7000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <rgti:WithdrawnCreditFacility
      contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis"
      decimals="-5"
      unitRef="Unit_USD">7000000</rgti:WithdrawnCreditFacility>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis"
      decimals="0"
      unitRef="Unit_shares">995099</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn12_31_2022_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">783129</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="PAsOn05_31_2021"
      decimals="-5"
      unitRef="Unit_USD">2800000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentTerm contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MaximumMembersrtRangeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis">P48M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentPaymentTerms contextRef="P01_31_2022To01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MinimumMembersrtRangeAxis_TrancheBMemberusgaapDebtInstrumentAxis_VentureCapitalMemberusgaapLineOfCreditFacilityAxis">19 months</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.11</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_PrimeRateMemberusgaapVariableRateAxis">US Prime Rate plus 7.50% per annum</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_PrimeRateMemberusgaapVariableRateAxis"
      decimals="4"
      unitRef="Unit_pure">0.075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="P05_31_2021To05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis">payable monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPaymentTerms contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis">19 months</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.11</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis contextRef="P01_31_2022To01_31_2022_PrimeRateMemberusgaapVariableRateAxis_TrancheCMemberusgaapDebtInstrumentAxis">US Prime Rate plus 7.50% per annum</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="P01_31_2022To01_31_2022_PrimeRateMemberusgaapVariableRateAxis_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="4"
      unitRef="Unit_pure">0.075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis">payable monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentMaturityDate contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis">2026-02-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="-6"
      unitRef="Unit_USD">75000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</us-gaap:DebtInstrumentFeeAmount>
    <rgti:PercentageOfadvancedFundsUnderTheAmendment
      contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</rgti:PercentageOfadvancedFundsUnderTheAmendment>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="PAsOn01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="-6"
      unitRef="Unit_USD">75000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="-5"
      unitRef="Unit_USD">1000000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <rgti:PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger
      contextRef="P01_31_2022To01_31_2022_TrancheCMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_pure">20</rgti:PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger>
    <rgti:DebtInstrumentPaymentFeepercentage
      contextRef="PAsOn05_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="4"
      unitRef="Unit_pure">0.0275</rgti:DebtInstrumentPaymentFeepercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MinimumMembersrtRangeAxis"
      decimals="4"
      unitRef="Unit_pure">0.2075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis_MaximumMembersrtRangeAxis"
      decimals="4"
      unitRef="Unit_pure">0.2683</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of the debt is classified as Level 2. Given the maturity and variable interest rate on the debt, the book value approximates its fair value. Long term debt and the unamortized discount balances are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt; &lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 74%;"/&gt;
&lt;td style="width: 5%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 5%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Outstanding principal amount&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,709&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;27,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Add: accreted liability of final payment fee&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;407&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;125&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: unamortized debt discount, long term&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(990&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,618&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: current portion of long term debt-principal&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(9,491&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,291&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;Debt&#x2014;net of current portion&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;20,635&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;24,216&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;Current portion of long term debt&#x2014;principal&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9,491&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,291&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less: current portion of unamortized debt discount&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,188&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(716&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Debt&#x2014;current portion&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,303&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;575&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">30709000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">27000000</us-gaap:DebtInstrumentCarryingAmount>
    <rgti:AccruedFinalPaymentFee
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">407000</rgti:AccruedFinalPaymentFee>
    <rgti:AccruedFinalPaymentFee
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">125000</rgti:AccruedFinalPaymentFee>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">990000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1618000</us-gaap:DeferredFinanceCostsNet>
    <rgti:CurrentPortionOfLongTermDebtGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-9491000</rgti:CurrentPortionOfLongTermDebtGross>
    <rgti:CurrentPortionOfLongTermDebtGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-1291000</rgti:CurrentPortionOfLongTermDebtGross>
    <us-gaap:LongTermLoansPayable
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">20635000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">24216000</us-gaap:LongTermLoansPayable>
    <rgti:CurrentPortionOfOutstandingPrincipalAmount
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">9491000</rgti:CurrentPortionOfOutstandingPrincipalAmount>
    <rgti:CurrentPortionOfOutstandingPrincipalAmount
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1291000</rgti:CurrentPortionOfOutstandingPrincipalAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1188000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">716000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">8303000</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">575000</us-gaap:LoansPayableCurrent>
    <us-gaap:InterestExpense
      contextRef="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">5300000</us-gaap:InterestExpense>
    <us-gaap:AccretionExpense
      contextRef="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:AccretionExpense>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">300000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="P01_01_2022To12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">900000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="PAsOn12_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">2200000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:InterestExpense
      contextRef="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">2500000</us-gaap:InterestExpense>
    <us-gaap:AccretionExpense
      contextRef="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:AccretionExpense>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">100000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="P02_01_2021To12_31_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">500000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="PAsOn12_01_2021_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Scheduled principal payments on total outstanding debt as of December&#160;31, 2022 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 85%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year ending December 31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 85%;"/&gt;
&lt;td style="vertical-align: bottom; width: 6%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2023&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9,491&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2024&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,007&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2025&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,020&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;2026&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;191&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;30,709&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Scheduled principal payments on total outstanding debt as of December 31, 2021 are as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 85%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Year ending December 31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;702&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;8,682&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;11,008&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;6,608&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;27,000&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">9491000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">13007000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">8020000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">191000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebt
      contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">30709000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">702000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">8682000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">11008000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">6608000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebt
      contextRef="PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis"
      decimals="-3"
      unitRef="Unit_USD">27000000</us-gaap:LongTermDebt>
    <rgti:RedeemableConvertiblePreferredStockTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11. REDEEMABLE CONVERTIBLE PREFERRED STOCK &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Legacy Rigetti was authorized to issue 73,389,000 shares of Series C preferred stock and 62,537,577 shares of Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;C-1&lt;/div&gt; Preferred Stock with a par value of $0.000001 per share for each class of preferred Stock. Legacy Rigetti&#x2019;s board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, option or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. Immediately prior to the effective time of the Business Combination (Note&#160;3), all Legacy Rigetti preferred stock outstanding converted into shares of Common Stock of Legacy Rigetti (the shares in this note do not factor in the exchange ratio). &lt;/div&gt; </rgti:RedeemableConvertiblePreferredStockTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesCPreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">73389000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2022_SeriesCOnePreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">62537577</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_PreferredStockMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.000001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <rgti:CommonStockTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12. COMMON STOCK &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As discussed in Note 3, on March&#160;2, 2022, the Company consummated a Business Combination which has been accounted for as a reverse recapitalization. Pursuant to the certificate of incorporation as amended on March&#160;2, &lt;/div&gt;2022, the Company is authorized to issue 1,000,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock. The holders of shares of Common Stock are entitled to one vote for each share of Common Stock held. The Preferred Stock is &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-voting.&lt;/div&gt; No shares of Preferred Stock were issued and outstanding as of December&#160;31, 2022.&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, and after payment to the holders of shares of Preferred Stock of their liquidation preferences, the holders of the Common Stock are entitled to the entire remaining assets of the Company on a pro rata basis. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the warrants and stock-based awards outstanding prior to March&#160;2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As of December&#160;31, 2022, the Company has reserved the following shares of Common Stock for issuance upon the conversion, exercise or vesting of the underlying instruments: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:78%"/&gt;
&lt;td style="vertical-align:bottom;width:7%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Common&#160;Stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Common Stock Warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;17,243,811&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;Stock-Based Awards&#x2014;RSUs Outstanding&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,332,591&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;Stock-Based Awards&#x2014;Options Outstanding&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,845,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;37,422,305&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Common Stock Purchase Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Company entered into a Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC (&#x201c;B.&#160;Riley&#x201d;) on August&#160;11, 2022 pursuant to which the Company may issue and sell to B. Riley the lesser of i)&#160;$&lt;/div&gt;75.0&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million in aggregate gross purchase price of newly issued shares of the Company&#x2019;s Common Stock or ii)&#160;an amount not to exceed &lt;/div&gt;23,648,889&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares of Common Stock (such number of shares equal to approximately &lt;/div&gt;19.99&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;% of the aggregate number of shares of Common Stock issued and outstanding immediately prior to the execution of the agreement and inclusive of &lt;/div&gt;171,008&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; shares of Common Stock issued to B. Riley on August&#160;11, 2022 as consideration for entering into the Common Stock Purchase Agreement).&#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In consideration of the parties entering into the foregoing agreement, the parties also entered into a Registration Rights Agreement on August&#160;11, 2022 pursuant to which the Company provides B. Riley with registration rights with respect to such Common Stock and pursuant to which the Company has filed a registration statement covering the resale of such Common Stock. &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Upon the initial satisfaction of the conditions to B. Riley&#x2019;s purchase obligation set forth in the Purchase Agreement, on September&#160;14, 2022 (the &#x201c;Commencement Date&#x201d;) the Company will have the right, but not the &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;obligation, from time to time at the Company&#x2019;s sole discretion over the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;24-month&lt;/div&gt; period from and after the Commencement, to direct B. Riley to purchase a specified amount of shares not to exceed the lesser of (i)&#160;1,000,000 shares of Common Stock &lt;/div&gt; and (ii) 20% of the total aggregate number (or volume) of shares of Common Stock traded on The Nasdaq Capital Market (&#x201c;Nasdaq&#x201d;) during the applicable period beginning at the official open (or &#x201c;commencement&#x201d;) of the regular trading session on the applicable purchase date for such purchase and ending at such time that the total aggregate volume of shares of common stock traded on Nasdaq reaches the Purchase Share Volume Maximum (as defined herein) for such purchase (as applicable) (such period for each purchase, the &#x201c;Purchase Valuation Period&#x201d;). &#x201c;Purchase Share Volume Maximum&#x201d; means, with respect to a purchase made pursuant to the Purchase Agreement, the number of shares of Common Stock equal to the quotient obtained by dividing the (i)&#160;total number of shares of Common Stock to be purchased by B. Riley in the relevant purchase (the &#x201c;Purchase Share Amount&#x201d;), by (ii) 0.20 (subject to certain adjustments). &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company did not identify any feature that needs to be bifurcated and recorded as a derivative within the Purchase Agreement. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company recorded $0.7&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;million of additional paid-in capital with a corresponding entry to the deferred offering cost asset in the accompanying consolidated balance sheet as of December 31, 2022 with respect to the fair value of the&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;171,008 &lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;common stock commitment shares issued to B. Riley which will be offset against future proceeds from the sale of the Company&#x2019;s common stock under the Purchase Agreement. The Company did not issue or sell any shares to B. Riley under the Purchase Agreement during the year ended December 31, 2022 other than the &lt;/div&gt;171,008 &lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;shares issued as consideration for entering into the Purchase Agreement.&lt;/div&gt;&lt;/div&gt; </rgti:CommonStockTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn03_02_2022"
      decimals="INF"
      unitRef="Unit_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockVotingRights contextRef="P01_01_2022To12_31_2022">one vote</us-gaap:CommonStockVotingRights>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:ScheduleOfConversionsOfStockTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As of December&#160;31, 2022, the Company has reserved the following shares of Common Stock for issuance upon the conversion, exercise or vesting of the underlying instruments: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:78%"/&gt;
&lt;td style="vertical-align:bottom;width:7%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Common&#160;Stock&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Common Stock Warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;17,243,811&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;Stock-Based Awards&#x2014;RSUs Outstanding&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,332,591&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;Stock-Based Awards&#x2014;Options Outstanding&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,845,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;37,422,305&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfConversionsOfStockTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="PAsOn12_31_2022_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_shares">17243811</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="PAsOn12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="0"
      unitRef="Unit_shares">11332591</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="PAsOn12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis"
      decimals="0"
      unitRef="Unit_shares">8845903</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_shares">37422305</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="PAsOn08_11_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis"
      decimals="-5"
      unitRef="Unit_USD">75000000</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn08_11_2022"
      decimals="0"
      unitRef="Unit_shares">23648889</us-gaap:CommonStockSharesOutstanding>
    <rgti:PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement
      contextRef="P08_11_2022To08_11_2022"
      decimals="4"
      unitRef="Unit_pure">0.1999</rgti:PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="P08_11_2022To08_11_2022_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis"
      decimals="0"
      unitRef="Unit_shares">171008</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <rgti:PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket
      contextRef="P09_14_2022To09_14_2022"
      decimals="2"
      unitRef="Unit_pure">0.20</rgti:PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="PAsOn09_14_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.2</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:DeferredOfferingCosts
      contextRef="PAsOn12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">700000</us-gaap:DeferredOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="P01_01_2022To12_31_2022_CommonStockPurchaseAgreementMemberRGTIAgreementNameAxis"
      decimals="0"
      unitRef="Unit_shares">171008</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">171008</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <rgti:WarrantsTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;13. WARRANTS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the number and corresponding strike price of Rigetti warrants outstanding prior to March&#160;2, 2022, the date of the Business Combination, to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Liability Classified Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Public Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Each Public Warrant entitles the holder to the right to purchase one share of Common Stock at an exercise price of $11.50 per share. No fractional shares will be issued upon exercise of the Public Warrants. The Company may elect to redeem the Public Warrants subject to certain conditions, in whole and not in part, at a price of $0.01 per Public Warrant if (i) 30 days&#x2019; prior written notice of redemption is provided to the holders, and (ii)&#160;the last reported sale price of the Company&#x2019;s Common Stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;30-trading&lt;/div&gt; day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders. Upon issuance of a redemption notice by the Company, the warrant holders have a period of 30 days to exercise for cash, or on a cashless basis. As of December&#160;31, 2022, there were 8,625,000 Public Warrants issued and outstanding (Refer to Note 15 for fair value measurement). &lt;/div&gt; &lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Private Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Private Warrants may not be redeemed by the Company so long as the Private Warrants are held by the initial purchasers, or such purchasers&#x2019; permitted transferees. The Private Warrants have terms and provisions identical to those of the Public Warrants, including as to exercise price, exercisability and exercise period, except if the Private Warrants are held by someone other than the initial purchasers&#x2019; permitted transferees, then the Private Warrants are redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. On August 18, 2022, the Private Placement Warrants were transferred from the initial purchasers to permitted transferees and remain unredeemable by the Company as of December&#160;31, 2022. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of the Private Warrant was measured using the Black Scholes model approach. Significant inputs into the respective models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 61%;"/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 61%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation Assumptions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Initial&#160;Recognition&lt;br/&gt;on March 2, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 61%;"/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock Price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$0.73&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$9.43&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Strike Price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$11.50&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$11.50&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Volatility (annual)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;109.26%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;30.66%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk-free rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.04%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.74%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated time to expiration (years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.172&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;5.000&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Trinity Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Trinity Warrants were issued in March of 2021 for the purchase of 313,252 shares of Common Stock, and additional warrants to purchase 469,877 shares of Common Stock were issued in connection with the Tranche B Amendment, see Note 10. Therefore, there were total of 783,129 Common Stock warrants issued in conjunction with the Loan and Security Agreement in 2021. The Company utilized a Black-Scholes model to determine the grant date fair value of the warrants which was approximately $2.7&#160;million and was recorded as a debt issuance cost. The outstanding Common Stock warrants were subsequently remeasured at each reporting period using the Black-Scholes models with changes recorded as a component of other income in the Company&#x2019;s consolidated statement of &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;operations. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The liability related &lt;/div&gt;&lt;/div&gt;to the Trinity Warrants was $6.4&#160;million as of June&#160;2, 2022, at which time all 783,129 warrants outstanding were exercised and the fair value of the warrant liability was reclassified to equity. The Company recorded a loss for the change in the fair value of the warrant liability in the consolidated statements of operations for the year ended December&#160;31, 2022 and the 11 months ended December&#160;31, 2021, of $2.0&#160;million and $1.7&#160;million, respectively.&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;The warrant issued in conjunction with the Loan and Security Agreement was classified as a liability under ASC&#160;480, &#x201c;Distinguishing Liabilities from Equity&#x201d;. See Deferred Financing Cost disclosure at Note 2 Summary of Significant Accounting Policies. &lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant inputs into the Black Scholes model used to value the Trinity Warrant liabilities at June&#160;2, 2022, the exercise date, are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 82%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 82%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation Assumptions - Trinity Warrant Liability&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;2,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$8.23&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Strike price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$0.27&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Volatility (annual)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;105.10%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk-free rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.94%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated time to expiration (years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;9.000&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;;text-indent: 0px;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Equity Classified Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Series C Preferred Stock Financing Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;In conjunction with a prior Series C Preferred Stock Financing the Company issued a total of&#160;&lt;/div&gt;5,248,183 Warrants to purchase Class&#160;A Common Stock to the Series C investors. The Warrants have a $0.01 exercise price per share and have a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-year&lt;/div&gt; term to expiration. The Warrants can be exercised for cash or on a cashless basis. The Company determined that the Warrants met the requirements for equity classification under ASC 480 and ASC&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;815. The Company estimated the fair value of the Warrants using the Black-Scholes model and allocated approximately $1.2&#160;million in proceeds from the Series C Preferred Stock to the value of the Warrants on a relative fair value basis, which was recorded to additional paid in &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;capital. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;  &lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Customer Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;In February 2020, the Company issued a Warrant to purchase 2,680,607 shares of Class&#160;A Common Stock to a customer in conjunction with a revenue arrangement (the &#x201c;Customer Warrants&#x201d;). The Customer Warrants have a $1.152 exercise price per share and have a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-year&lt;/div&gt; term to expiration. The Warrants vest upon the achievement of certain performance conditions (i.e., sales milestones) defined in the agreement, and upon a change of control, either 50% or 100% of the then unvested Customer Warrants will become fully vested, dependent on the acquiring party in the change of control transaction. The Warrants can be exercised for cash or on a cashless basis. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;The Company followed the guidance in ASC 718 and ASC 606 for the accounting of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cash&lt;/div&gt; consideration payable to a customer. The Company determined that the Customer Warrants met the requirements for equity classification under ASC 718 and measured the Customer Warrants based on their grant date fair value, estimated to be $0.2&#160;million. The Company recorded this amount as a deferred asset and additional paid in capital as of the issuance date, as the Company believes it is probable that all performance conditions (i.e., sales milestones) in the Customer Warrants will be met.&#160;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The vesting status of the Customer Warrant is as follows at December&#160;31, 2022 and December&#160;31, 2021:&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 76%; border: 0px; margin: 0px auto; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:5%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:5%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vested Customer warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,340,297&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,072,237&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Unvested Customer warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,340,310&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,608,370&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,680,607&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,680,607&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </rgti:WarrantsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharePrice
      contextRef="PAsOn12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">18</us-gaap:SharePrice>
    <rgti:NumberOfTradingDaysForDeterminingTheSharePrice contextRef="P01_01_2022To12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P20D</rgti:NumberOfTradingDaysForDeterminingTheSharePrice>
    <rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice contextRef="P01_01_2022To12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P30D</rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice>
    <rgti:WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered contextRef="P01_01_2022To12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P30D</rgti:WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">8625000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="P01_01_2022To12_31_2022_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis">&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of the Private Warrant was measured using the Black Scholes model approach. Significant inputs into the respective models at March&#160;2, 2022 (the initial recognition) and December&#160;31, 2022 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 61%;"/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 61%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation Assumptions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Initial&#160;Recognition&lt;br/&gt;on March 2, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 61%;"/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock Price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$0.73&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$9.43&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Strike Price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$11.50&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$11.50&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Volatility (annual)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;109.26%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;30.66%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk-free rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.04%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.74%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated time to expiration (years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.172&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;5.000&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 61%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 10%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; </us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">0.73</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">9.43</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">109.26</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">30.66</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">4.04</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">1.74</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="3"
      unitRef="Unit_Y">4.172</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="3"
      unitRef="Unit_Y">5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn03_02_2022_AtinitialrecognitionMembersrtStatementScenarioAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn03_31_2021_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">313252</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <rgti:Classofwarrantorrightissuedduringperiodwarrants
      contextRef="P01_01_2022To12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">469877</rgti:Classofwarrantorrightissuedduringperiodwarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">783129</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <rgti:Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant
      contextRef="P01_01_2022To12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-5"
      unitRef="Unit_USD">2700000</rgti:Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities
      contextRef="P06_02_2022To06_02_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-5"
      unitRef="Unit_USD">6400000</us-gaap:IncreaseDecreaseInDerivativeLiabilities>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="PAsOn06_02_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">783129</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2022To12_31_2022_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-5"
      unitRef="Unit_USD">2000000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P02_01_2021To12_31_2021_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-5"
      unitRef="Unit_USD">1700000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Significant inputs into the Black Scholes model used to value the Trinity Warrant liabilities at June&#160;2, 2022, the exercise date, are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 82%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"/&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 82%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation Assumptions - Trinity Warrant Liability&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;2,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$8.23&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Strike price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$0.27&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Volatility (annual)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;105.10%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk-free rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.94%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated time to expiration (years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;9.000&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend yield&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;%&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">8.23</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_02_2022_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.27</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_02_2022_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">105.1</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_02_2022_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">2.94</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_02_2022_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis"
      decimals="3"
      unitRef="Unit_Y">9</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_02_2022_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis"
      decimals="0"
      unitRef="Unit_pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <rgti:Classofwarrantsorrightswarrantsissuedduringtheperiodunits
      contextRef="P01_01_2022To12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_shares">5248183</rgti:Classofwarrantsorrightswarrantsissuedduringtheperiodunits>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberRGTIClassOfInvestorsAxis_WarrantsToPurchaseClassACommonStockMemberusgaapClassOfWarrantOrRightAxis">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">1200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">2680607</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="3"
      unitRef="Unit_USD_per_Share">1.152</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <rgti:Classofwarrantsvestingpercentage
      contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis_MinimumMembersrtRangeAxis"
      decimals="0"
      unitRef="Unit_pure">50</rgti:Classofwarrantsvestingpercentage>
    <rgti:Classofwarrantsvestingpercentage
      contextRef="PAsOn01_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CustomerWarrantsMemberusgaapClassOfWarrantOrRightAxis_MaximumMembersrtRangeAxis"
      decimals="0"
      unitRef="Unit_pure">100</rgti:Classofwarrantsvestingpercentage>
    <rgti:ClassOfWarrantOrRightGrandDateFairValue
      contextRef="PAsOn02_28_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</rgti:ClassOfWarrantOrRightGrandDateFairValue>
    <rgti:DisclosureOfVestingStatusOfWarrantsTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The vesting status of the Customer Warrant is as follows at December&#160;31, 2022 and December&#160;31, 2021:&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 76%; border: 0px; margin: 0px auto; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:5%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:5%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vested Customer warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,340,297&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,072,237&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Unvested Customer warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,340,310&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,608,370&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,680,607&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,680,607&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rgti:DisclosureOfVestingStatusOfWarrantsTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2022_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis"
      decimals="0"
      unitRef="Unit_shares">1340297</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2021_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis"
      decimals="0"
      unitRef="Unit_shares">1072237</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2022_UnvestedCustomerWarrantsMemberRGTIStatusOfVestingAxis"
      decimals="0"
      unitRef="Unit_shares">1340310</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2021_UnvestedCustomerWarrantsMemberRGTIStatusOfVestingAxis"
      decimals="0"
      unitRef="Unit_shares">1608370</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_shares">2680607</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_shares">2680607</us-gaap:ClassOfWarrantOrRightOutstanding>
    <rgti:ForwardWarrantAgreementDisclosure contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14. FORWARD WARRANT AGREEMENT &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In connection with the execution of the Merger Agreement in October 2021, Rigetti entered into a warrant subscription agreement (&#x201c;Forward Warrant Agreement&#x201d;) with a strategic partner, Ampere Computing LLC (&#x201c;Ampere&#x201d;) for the purchase of a warrant for an aggregate purchase price (including amounts from exercise) of $&lt;/div&gt;10.0&#160;million. The Forward Warrant Agreement provides for the issuance of a warrant for the purchase of an aggregate of 1,000,000 shares of Common Stock at an exercise price of $0.0001. The purchase of the warrant was conditioned upon, among other things, the consummation of the Business Combination and the entry into a collaboration agreement between Rigetti and Ampere. The parties entered into the collaboration agreement in January 2022. Ampere was required to pay $5.0&#160;million to Rigetti no later than the later of (i)&#160;the Closing and (ii)&#160;June&#160;30, 2022. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On June&#160;30, 2022, pursuant to the Warrant Subscription Agreement, the Company issued the warrant to Ampere upon receipt of an aggregate of $5.0&#160;million (including the exercise price), and upon such payment and issuance, 500,000 shares of the Company&#x2019;s Common Stock vested under the warrant and were immediately exercised by Ampere pursuant to the terms of the warrant. Ampere is required to pay an additional $5.0&#160;million to Rigetti no later than the closing date of the listing of Ampere&#x2019;s capital stock, provided that if the listing has not occurred by the second anniversary of the Warrant Subscription Agreement, Ampere is not obligated to make the additional payment. Upon the payment of such additional amounts, the warrant will vest and be exercisable with respect to the remaining 500,000 shares underlying the warrant. The Warrant Subscription Agreement further provides that the Company will use commercially reasonable efforts to file a registration statement to register the resale of the remaining shares underlying the warrant. The Company filed a registration statement registering the resale of the initial 500,000 shares issued under the warrant during the year ended December&#160;31, 2022.&lt;br/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company evaluated the Forward Warrant Agreement as a derivative in conjunction with the guidance of ASC 480, &#x201c;Distinguishing Liabilities from Equity&#x201d;. The Company calculated the fair value of the Forward Warrant &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="background: none; letter-spacing: 0px; top: 0px; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;  &lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"/&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Agreement by using the Forward Contract Pricing methodology at inception and at December&#160;31, 2022. The fair value of the Forward Warrant Agreement was estimated based on the following key inputs and assumptions 1) Assumed holding period 2) Related risk-free rate and 3) Likelihood of the outcome of the various contingencies outlined below. Based on these inputs and assumption, the Company calculated the fair value of the Forward Warrant Agreement to be a &lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt; $&lt;/div&gt;2.2&#160;million &lt;span style="-sec-ix-hidden:hidden73805685"&gt;derivative asset&lt;/span&gt; and a ($0.2 million) &lt;span style="-sec-ix-hidden:hidden73805686"&gt;derivative liability&lt;/span&gt; &lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;at December&#160;31, 2022 and December&#160;31, 2021, respectively. The Company has included the derivative asset as a forward contract asset and the derivative liability separately in other liabilities (current) on the balance sheet line in the accompanying consolidated balance sheets as of December&#160;31, 2022 and December&#160;31, 2021, respectively. The change in fair value is recorded as part of the general and administrative operating activities in the Company&#x2019;s consolidated statements of operations. The following table represents key valuation assumptions as of the year ended December&#160;31, 2022 and 11 months ended December 31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 64%;"/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 7%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation Assumptions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Holding period (in years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.767&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.5-1.13&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.69%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.19%-0.43%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Probability of occurring the contingency&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;50%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;50%-100%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying value per share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$0.73&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$10.29&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </rgti:ForwardWarrantAgreementDisclosure>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="P01_01_2022To12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <rgti:StockIssuedDuringPeriodWarrantsIssued
      contextRef="P01_01_2022To12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_shares">1000000</rgti:StockIssuedDuringPeriodWarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="P01_01_2021To12_31_2021_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="P06_30_2022To06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="PAsOn06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheOneMemberusgaapVestingAxis"
      decimals="0"
      unitRef="Unit_shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="P06_30_2022To06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheTwoMemberusgaapVestingAxis"
      decimals="-5"
      unitRef="Unit_USD">5000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="PAsOn06_30_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis_ShareBasedCompensationAwardTrancheTwoMemberusgaapVestingAxis"
      decimals="0"
      unitRef="Unit_shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <rgti:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod
      contextRef="P01_01_2022To12_31_2022_AmpereComputingLlcMemberdeiLegalEntityAxis_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_shares">500000</rgti:ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis"
      decimals="-5"
      unitRef="Unit_USD">2200000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis"
      decimals="-5"
      unitRef="Unit_USD">200000</us-gaap:DerivativeLiabilities>
    <rgti:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="P01_01_2022To12_31_2022">The following table represents key valuation assumptions as of the year ended December&#160;31, 2022 and 11 months ended December 31, 2021:
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 64%;"/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 7%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation Assumptions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Holding period (in years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.767&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.5-1.13&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk free rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.69%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.19%-0.43%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Probability of occurring the contingency&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;50%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;50%-100%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Underlying value per share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$0.73&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$10.29&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rgti:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis"
      decimals="3"
      unitRef="Unit_Y">0.767</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis"
      decimals="1"
      unitRef="Unit_Y">0.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_Y">1.13</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis"
      decimals="4"
      unitRef="Unit_pure">0.0469</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis"
      decimals="4"
      unitRef="Unit_pure">0.0019</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis"
      decimals="4"
      unitRef="Unit_pure">0.0043</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis_MinimumMembersrtRangeAxis"
      decimals="2"
      unitRef="Unit_pure">0.50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MaximumMembersrtRangeAxis_MeasurementInputProbabilityOfOccurringTheContingencyMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">1</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.73</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">10.29</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;15. FAIR VALUE MEASUREMENTS&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 87%;"/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value measurements of financial assets and liabilities that &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;are &lt;/div&gt;measured at fair value at December&#160;31, 2022 and December&#160;31, 2021 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 68%;"/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Assets:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash equivalents: &lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Money Market Funds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:6pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:6pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:6pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:6pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Short-term investments:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;United States Treasury Securities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;58,210&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Corporate Bonds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,571&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Commercial Paper&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,142&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Forward warrant agreement&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,229&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total Assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;94,556&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;26,713&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,229&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Liabilities:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative warrant liability&#x2014;Public Warrants&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;699&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative warrant liability&#x2014;Private Warrants&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;;text-align:right;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;1,068&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-out&lt;/div&gt; liability&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,206&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total Liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;699&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,274&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;;text-indent: 0px;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative warrant liability&#x2014;Trinity Warrants&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;;text-indent: 0px;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;$&lt;div style="display:inline;"&gt;&#160; &#160; &#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;;text-indent: 0px;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;$&lt;div style="display:inline;"&gt;&#160; &#160; &#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;;text-indent: 0px;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"&gt;4,355&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Forward warrant agreement&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;230&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total Liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4,585&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As of December&#160;31, 2022, the Company has recorded the following &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;financial &lt;/div&gt;instruments subject to fair value measurements: 1) Derivative warrant liabilities&#x2014;Public Warrants liability and Private Warrants, 2) Forward Warrant Agreement, and 3) Earnout liability. &lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company also has long-term debt and a line of credit that provides for variable interest, and therefore, the carrying value approximates the fair value. The carrying values as of December 31, 2022 and December 31, 2021, represent the original principal amounts borrowed less principal payments and debt issuance costs. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The fair value of the Public Warrants has been measured based on the observable listed prices for such warrants, a Level&#160;1 measurement. The Company&#x2019;s money market funds and U.S. Treasury securities are classified within Level I due to the highly liquid nature of these assets with quoted prices in active markets. The investments in &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities (i.e., commercial paper and corporate debt securities) and corporate debt issued by the Company are classified within Level II. The fair value of the Company&#x2019;s Level II financial assets and liabilities is determined by using inputs based quoted market prices for similar instruments. All other financial instruments are classified as Level&#160;3 liabilities as they all include unobservable inputs. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Private Warrants were initially measured at fair value using a Black Scholes model. The Company estimated the fair value of the Forward Warrant Agreement using a forward analysis with unobservable inputs which included selected risk-free rate and probability outcomes. The Company has further discussed the key aspects of the fair value measurements described above in Notes 13 and 14 to the financial statements. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The aggregate fair value of the Sponsor Vesting Shares on the Closing date was estimated using a Monte Carlo simulation model. The Company has further discussed the key aspect of the valuation inputs in Note 2 significant accounting policy for Sponsor &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-Out&lt;/div&gt; Liability. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&#160;31, 2021, the Company recorded a derivative warrant liability for the Trinity Warrants at fair value using a Black-Scholes option model with unobservable inputs including volatility. The Company estimates the volatility of its ordinary share warrants based on implied volatility from the Company&#x2019;s traded warrants and from historical volatility of select peer company&#x2019;s ordinary shares that matches the expected remaining life of the warrants. On June&#160;2, 2022, all outstanding Trinity Warrants were exercised into shares of the Company&#x2019;s Common Stock &lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;There have been no changes in fair value measurement techniques (other than the change in valuation assumptions described in Note 1) during the year ended December&#160;31, 2022. There were no transfers between Level&#160;1 or Level&#160;2, or transfers in or out of Level&#160;3 of the fair value hierarchy during the year end December&#160;31, 2022. The fair value estimates are based on pertinent information available to management as of December 31, 2022 and December 31, 2021. Although management is not aware of any factors, other than those noted above, that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for the purpose of these financial statements. Current estimates of fair value may differ from the amounts presented.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of the changes in the fair value of the Company&#x2019;s Level&#160;3 financial instruments as of December&#160;31, 2022 and December&#160;31, 2021 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 44%;"/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Derivative&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;warrant&#160;liability&#160;-&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Trinity Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Derivative&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;warrant&#160;liability&#160;-&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Private Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Forward&lt;br/&gt;Warrant&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Agreement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-out&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;liability&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Balance&#x2014;January 31, 2021&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Issuance&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,691&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;400&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change in fair values&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,664&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(170&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 45%;"/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Balance&#x2014;December 31, 2021&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4,355&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;230&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; background-color: rgb(204, 238, 255);"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Initial measurement on March&#160;2, 2022 upon Business Combination (Note 3)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;9,612&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;20,413&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change in fair values&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;2,015&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;(8,544&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;(5,764&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;(19,207&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; background-color: rgb(204, 238, 255);"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Exercise of warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;(6,370&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;3,305&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Balance&#x2014;December 31, 2022&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,068&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;(2,229&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;)&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,206&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;;text-align:right;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value measurements of financial assets and liabilities that &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;are &lt;/div&gt;measured at fair value at December&#160;31, 2022 and December&#160;31, 2021 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 68%;"/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="10" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:68%"/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Assets:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Cash equivalents: &lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Money Market Funds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;36,346&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:6pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:6pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:6pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:6pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Short-term investments:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;United States Treasury Securities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;58,210&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Corporate Bonds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,571&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Commercial Paper&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,142&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Forward warrant agreement&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,229&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total Assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;94,556&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;26,713&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,229&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Liabilities:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative warrant liability&#x2014;Public Warrants&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;699&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative warrant liability&#x2014;Private Warrants&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;;text-align:right;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;1,068&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-out&lt;/div&gt; liability&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,206&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total Liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;699&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,274&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="10" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;;text-indent: 0px;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative warrant liability&#x2014;Trinity Warrants&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;;text-indent: 0px;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;$&lt;div style="display:inline;"&gt;&#160; &#160; &#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;;text-indent: 0px;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;$&lt;div style="display:inline;"&gt;&#160; &#160; &#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;;text-indent: 0px;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;;text-align:right;"&gt;4,355&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-indent: 0px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Forward warrant agreement&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;230&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total Liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4,585&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">36346000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MoneyMarketFundsMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">58210000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_USTreasurySecuritiesMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">3571000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_USGovernmentCorporationsAndAgenciesSecuritiesMemberusgaapCashAndCashEquivalentsAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">23142000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_CommercialPaperMemberusgaapCashAndCashEquivalentsAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <rgti:ForwardWarrantAgreementFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:ForwardWarrantAgreementFairValueDisclosure>
    <rgti:ForwardWarrantAgreementFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:ForwardWarrantAgreementFairValueDisclosure>
    <rgti:ForwardWarrantAgreementFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">2229000</rgti:ForwardWarrantAgreementFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">94556000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">26713000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">2229000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">699000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">1068000</us-gaap:LiabilitiesFairValueDisclosure>
    <rgti:ContingentEarnOutLiabilityFairValueDisclosure
      contextRef="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:ContingentEarnOutLiabilityFairValueDisclosure>
    <rgti:ContingentEarnOutLiabilityFairValueDisclosure
      contextRef="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">0</rgti:ContingentEarnOutLiabilityFairValueDisclosure>
    <rgti:ContingentEarnOutLiabilityFairValueDisclosure
      contextRef="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">1206000</rgti:ContingentEarnOutLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">699000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">2274000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_DerivativeMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">4355000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementLiabilityFairValueDisclosureMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">230000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">4585000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of the changes in the fair value of the Company&#x2019;s Level&#160;3 financial instruments as of December&#160;31, 2022 and December&#160;31, 2021 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 44%;"/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Derivative&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;warrant&#160;liability&#160;-&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Trinity Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Derivative&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;warrant&#160;liability&#160;-&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Private Warrants&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Forward&lt;br/&gt;Warrant&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Agreement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Earn-out&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;liability&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Balance&#x2014;January 31, 2021&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Issuance&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2,691&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;400&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change in fair values&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,664&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(170&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 45%;"/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 8%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Balance&#x2014;December 31, 2021&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;4,355&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;230&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; background-color: rgb(204, 238, 255);"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Initial measurement on March&#160;2, 2022 upon Business Combination (Note 3)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;9,612&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;20,413&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change in fair values&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;2,015&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;(8,544&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;(5,764&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);;text-align:right;"&gt;(19,207&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; background-color: rgb(204, 238, 255);"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Exercise of warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;(6,370&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;3,305&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="background-color: rgba(255, 255, 255, 0);"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="break-inside: avoid; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt;"&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Balance&#x2014;December 31, 2022&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x2014;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,068&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;(2,229&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;)&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;1,206&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); padding-bottom: 0.375pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;;text-align:right;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); border-bottom: 0.75pt solid black; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; background-color: rgba(255, 255, 255, 0); line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="line-height: 1pt; font-size: 1pt;;font-weight:bold;display:inline;width:100%;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
      contextRef="P01_01_2021To12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">2691000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues
      contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="P01_01_2021To12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">1664000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">-170000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2020_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">4355000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">9612000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
      contextRef="P01_01_2022To12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">20413000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">2015000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">-8544000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="P01_01_2022To12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">-5764000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="P01_01_2022To12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">-19207000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="P01_01_2022To12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TrinityWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">-6370000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="P01_01_2022To12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">3305000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022_DerivativeWarrantLiabilitiesMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-3"
      unitRef="Unit_USD">1068000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis"
      decimals="-3"
      unitRef="Unit_USD">-2229000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022_ContingentEarnOutLiabilityMemberusgaapFinancialInstrumentAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="-3"
      unitRef="Unit_USD">1206000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;16. EQUITY PLANS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2013 Equity Incentive Plan&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In 2013, the Company adopted the 2013 Plan which provides for the grant of qualified incentive stock options (&#x201c;ISO&#x201d;) and nonqualified stock options (&#x201c;NSO&#x201d;), restricted stock, restricted stock units (&#x201c;RSU&#x201d;) or other awards to the Company&#x2019;s employees, officers, directors, advisors, and outside consultants. After the Closing Date and consummation of the Business Combination effective March&#160;2, 2022, no additional awards were issued under the 2013 Plan. Awards outstanding under the 2013 Plan will continue to be governed by such plan; however, the Company will not grant any further awards under the 2013 Plan. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2022 Equity Incentive Plan&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In connection with the Business Combination (Note 3), the shareholders approved the Rigetti Computing, Inc. 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;) in February, 2022, which became effective immediately upon the Closing Date. The 2022 Plan provides for the grant of ISOs, NSOs, stock appreciation rights, restricted stock awards (&#x201c;RSA&#x201d;), restricted stock unit awards, performance awards and other forms of awards to employees, directors, and consultants, including employees and consultants of the Company&#x2019;s affiliates. The aggregate number of shares of common stock reserved for issuance under the 2022 Plan is 18,332,215 shares as of December&#160;31, 2022. As of December&#160;31, 2022, 4,748,116 shares were available for future issuance under the 2022 Plan. The number of shares reserved for issuance under the 2022 Plan will automatically increase on January 1st of each year for a period of nine years commencing on January&#160;1, 2023 and ending on (and including) January&#160;1, 2032, in an amount equal to 5% of the common stock of all classes outstanding on December&#160;31 of the preceding year; provided, however, that the board of directors of the Company may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of Common Stock. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Stock Options&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of activity related to stock option is summarized as below:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 54%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;Options&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Exercise&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Contractual&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Life&#160;(in&#160;years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Aggregate&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Intrinsic&lt;br/&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Outstanding&#x2014;December 31, 2021&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,468,275&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.36&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Granted&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,750,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.96&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercised&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,768,568&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.27&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Forfeited and expired&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,603,804&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.27&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 54%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Outstanding&#x2014;December 31, 202&lt;div style="display:inline;"&gt;2&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,845,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.38&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7.2&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,103&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 54%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; padding-bottom: 0.375pt; width: 54%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercisable&#x2014;December 31, 2022&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;5,464,027&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"&gt;0.40&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"&gt;7.2&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"&gt;1,780&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 54%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On December&#160;12, 2022 the Company granted to the CEO an equity award (&#x201c;CEO award&#x201d;) under its 2022 Plan that consisted of options to purchase a total of 1,750,000 shares of its common stock with an exercise price of $0.96 per share. Of the total stock options granted to the CEO, 1,250,000 have time-based vesting over 3 years and the remaining 500,000 have market-based vesting conditions. Compensation expense for the CEO award for the year ending December&#160;31, 2022 was insignificant. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The weighted-average grant date fair value of options granted during the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $0.81 and $3.43 respectively. The total intrinsic value of options exercised during the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021 is $9.9&#160;million and $5.7&#160;million, respectively. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&#160;31, 2022, there was $2.4&#160;million of unrecognized compensation cost related to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-vested&lt;/div&gt; stock options granted under the 2013 and 2022 Plan, which is expected to be recognized over a weighted-average period o&lt;/div&gt;f approximately 1.96 years.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 8pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;   &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="null;text-indent: 0px;;font-style:italic;display:inline;"&gt;Restricted Stock Units&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of activity related to RSUs is summarized as below:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;RSUs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&#160;Fair&lt;br/&gt;Value&#160;Per&#160;Share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-vested&lt;/div&gt; shares at December&#160;31, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,388,455&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.93&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Granted&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;17,782,607&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.92&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vested&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(7,007,789&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.99&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Forfeited&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,830,682&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.03&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-vested&lt;/div&gt; shares at December&#160;31, 2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;11,332,591&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"&gt;4.36&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:right;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On March&#160;2, 2022, the performance condition of all outstanding RSUs was met due to the closing of the Business Combination. As a result, the Company recorded a cumulative &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;catch-up&lt;/div&gt; compensation expense for the vesting period that was satisfied as of March&#160;2, 2022 and continues amortizing compensation expenses for unvested RSUs over their remaining vesting period.&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Total fair value of the RSUs vested during the twelve months ending December&#160;31, 2022 and 11 months ended December&#160;31, 2021 was $35.0&#160;million and $0 respectively.&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Stock-based compensation &lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;expense related to RSUs granted to employees was $&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;42.7&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million and $&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;0&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; for the twelve months ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. As of&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;December&#160;31, 2022, the unrecognized compensation expense related to unvested RSUs was approximately $&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;41.9&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;million which is expected to be recognized over a weighted-average period of approximately &lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.85&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt; years.&lt;/div&gt;&lt;/div&gt; &lt;br/&gt;&lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Restricted Stock Awards&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;During the twelve months ended December&#160;31, 2022, 120,000 restricted stock awards (&#x201c;RSAs&#x201d;) were issued and vested immediately on the grant date as part of transaction bonuses in recognition of efforts in connection with the Business Combination. The total compensation expense related to RSAs was $0.6&#160;million for the twelve months ended December&#160;31, 2022.&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The table below summarizes the total stock-based compensation expenses for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 61%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;Ended&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;14,092&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;975&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Selling and marketing expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,109&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;106&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;General and administrative expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;28,611&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;684&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Total stock-based compensation expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;44,812&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;1,765&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Fair Value of Common Stock and Options&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model that uses the assumptions noted in the table below. Expected volatility for the Company&#x2019;s Common Stock was determined based on an average of the historical volatility of a peer group of similar public companies. The expected term of options granted was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted-average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"&gt;upon which to estimate expected term. The assumed dividend yield is based upon the Company&#x2019;s expectation of not paying dividends in the foreseeable future. The risk-free rate is based upon the U.S. Treasury yield curve in effect at the time of grant for the period equivalent to the expected life of the option.&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;In determining the exercise prices for options granted, the Company&#x2019;s board of directors has considered the fair value of the Common Stock as of the grant date. Before the Company&#x2019;s common stock was publicly traded, the fair value of the Common Stock has been determined by the board of directors at each award grant date based upon a variety of factors, including the results obtained from an independent third-party valuation, the Company&#x2019;s financial position and historical financial performance, the status of technological developments within the Company&#x2019;s products, the composition and ability of the current engineering and management team, an evaluation or benchmark of the Company&#x2019;s competition, the current business climate in the marketplace, the illiquid nature of the Common Stock, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;arm&#x2019;s-length&lt;/div&gt; sales of the Company&#x2019;s capital stock (including redeemable convertible preferred stock), the effect of the rights and preferences of the preferred shareholders, and the prospects of a liquidity event, among others.&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Stock options issued in 2022, including the options that are based on market conditions, did not have significant &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;impact on the stock-based compensation expense during the year ended December 31, 2022. The range of assumptions used in the Black-Scholes option-pricing model for time based options issued to employees and in Monte Carlo simulation model for market based options during the 12 months ended December 31, 2022 and 11 months ended December 31, 2021 are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;br/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:55%"/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td style="width:12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12&#160;Months&#160;ended&#160;December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Time&#160;based&#160;vesting&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Market&#160;based&#160;vesting&lt;br/&gt;awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td style="width:12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td style="width:12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected volatility&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;150&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"&gt;150&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;46.8&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average risk-free interest rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;3.77&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;3.76&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;1.07&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"&gt;0&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;0&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; text-indent: 0px; width: 55%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected term (in years)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;5.85&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"&gt;5.0&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: right;"&gt;6.1&#160;years&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: center;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Exercise price/Stock price&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.96&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"&gt;0.96&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;0.21&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="clear:both;max-height:0pt;"/&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="PAsOn12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">18332215</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="PAsOn12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">4748116</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <rgti:PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear
      contextRef="P01_01_2022To12_31_2022_TwoThousandTwentyTwoEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="2"
      unitRef="Unit_pure">0.05</rgti:PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of activity related to stock option is summarized as below:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 54%;"/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 6%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;Options&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Exercise&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Price&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&lt;br/&gt;Contractual&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Life&#160;(in&#160;years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Aggregate&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Intrinsic&lt;br/&gt;Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Outstanding&#x2014;December 31, 2021&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,468,275&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.36&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Granted&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,750,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.96&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercised&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,768,568&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.27&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Forfeited and expired&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,603,804&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.27&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 54%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 54%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Outstanding&#x2014;December 31, 202&lt;div style="display:inline;"&gt;2&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,845,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.38&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;7.2&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,103&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 54%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 2.5pt double black; line-height: 0pt; font-size: 0pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 0pt; font-size: 0pt; padding-bottom: 1.25pt;"&gt; &lt;div style="font-size: 0pt; line-height: 0pt;"&gt;&lt;div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; padding-bottom: 0.375pt; width: 54%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercisable&#x2014;December 31, 2022&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;5,464,027&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"&gt;0.40&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"&gt;7.2&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"&gt;1,780&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 54%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt; width: 6%;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.375pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_shares">11468275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="PAsOn12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">1750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">2768568</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="P01_01_2022To12_31_2022"
      decimals="0"
      unitRef="Unit_shares">1603804</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_shares">8845903</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="PAsOn12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="P01_01_2022To12_31_2022">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">3103000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_shares">5464027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="PAsOn12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="P01_01_2022To12_31_2022">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">1780000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis_TwoThousandThirteenEquityIncentivePlanMemberusgaapPlanNameAxis"
      decimals="INF"
      unitRef="Unit_shares">1750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rgti:StockOptionCommonShareExercisePrice
      contextRef="PAsOn12_12_2022_CeoAwardMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.96</rgti:StockOptionCommonShareExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis"
      decimals="INF"
      unitRef="Unit_shares">1250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="P12_12_2022To12_12_2022_CeoAwardMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.81</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="P02_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">3.43</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">9900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="P02_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">5700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="PAsOn12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">2400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2022To12_31_2022">P1Y11M15D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;A summary of activity related to RSUs is summarized as below:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 10%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;RSUs&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average&#160;Fair&lt;br/&gt;Value&#160;Per&#160;Share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-vested&lt;/div&gt; shares at December&#160;31, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,388,455&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3.93&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Granted&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;17,782,607&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.92&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Vested&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(7,007,789&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4.99&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Forfeited&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,830,682&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.03&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; padding-bottom: 0.375pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-vested&lt;/div&gt; shares at December&#160;31, 2022&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;11,332,591&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;$&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;;text-align:right;"&gt;4.36&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 1pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;;text-align:right;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; line-height: 1pt; font-size: 1pt;"&gt; &lt;div style="font-size: 1pt; line-height: 1pt;"&gt;&lt;div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="PAsOn12_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">5388455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="PAsOn12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">3.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">17782607</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">4.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">7007789</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">4.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">4830682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">5.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="PAsOn12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="INF"
      unitRef="Unit_shares">11332591</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="PAsOn12_31_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">4.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">35000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="P02_01_2021To12_31_2021_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">42700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P02_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="PAsOn12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">41900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2022To12_31_2022_RestrictedStockUnitsRSUMemberusgaapAwardTypeAxis">P2Y10M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="P01_01_2022To12_31_2022_RestrictedStockMemberusgaapAwardTypeAxis"
      decimals="0"
      unitRef="Unit_shares">120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_RestrictedStockMemberusgaapAwardTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The table below summarizes the total stock-based compensation expenses for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 61%;"/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 11%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;Ended&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;14,092&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;975&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Selling and marketing expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,109&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;106&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;General and administrative expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;28,611&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;684&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Total stock-based compensation expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;44,812&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#160;1,765&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">14092000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P02_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">975000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">2109000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P02_01_2021To12_31_2021_SellingAndMarketingExpenseMemberusgaapIncomeStatementLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">106000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">28611000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P02_01_2021To12_31_2021_GeneralAndAdministrativeExpenseMemberusgaapIncomeStatementLocationAxis"
      decimals="-3"
      unitRef="Unit_USD">684000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">44812000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1765000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;br/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:55%"/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td style="width:12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12&#160;Months&#160;ended&#160;December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" rowspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Time&#160;based&#160;vesting&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Market&#160;based&#160;vesting&lt;br/&gt;awards&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td style="width:12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 12%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align: bottom; width: 12%;"/&gt;
&lt;td style="width:12%;"/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected volatility&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;150&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"&gt;150&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;46.8&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average risk-free interest rate&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;3.77&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;3.76&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;1.07&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividend yield&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"&gt;0&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;0&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; text-indent: 0px; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;%&lt;br/&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; text-indent: 0px; width: 55%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected term (in years)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;5.85&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"&gt;5.0&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; text-indent: 0px;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: right;"&gt;6.1&#160;years&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-indent: 0px; text-align: center;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Exercise price/Stock price&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.96&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px; text-align: right;"&gt;0.96&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:12%;"&gt;&lt;div style="line-height: normal; margin-bottom: 0px; margin-top: 0px;"&gt;&lt;div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"&gt;$&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right;"&gt;0.21&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; text-align: center;"&gt;&lt;div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis"
      decimals="2"
      unitRef="Unit_pure">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis"
      decimals="2"
      unitRef="Unit_pure">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="P02_01_2021To12_31_2021"
      decimals="3"
      unitRef="Unit_pure">0.468</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis"
      decimals="4"
      unitRef="Unit_pure">0.0377</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis"
      decimals="4"
      unitRef="Unit_pure">0.0376</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="P02_01_2021To12_31_2021"
      decimals="4"
      unitRef="Unit_pure">0.0107</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="P02_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2022To12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis">P5Y10M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2022To12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P02_01_2021To12_31_2021">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="PAsOn12_31_2022_TimeBasedVestingAwardMemberusgaapAwardTypeAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="PAsOn12_31_2022_MarketBasedVestingAwardMemberusgaapAwardTypeAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="PAsOn12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:EarningsPerShareTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17. NET LOSS PER SHARE &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As a result of the Business Combination (see Note 3), the Company has retroactively adjusted the weighted average shares outstanding prior to March&#160;2, 2022 to give effect to the Exchange Ratio used to determine the number of shares of Common Stock into which they were converted. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table sets forth the computation of basic and diluted net loss per share of Common Stock for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11 Months&lt;br/&gt;ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(71,521)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(38,241)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Basic and diluted shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average Class&#160;A Common Stock outstanding&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;102,300,852&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,337,127&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Loss per share for Class&#160;A Common Stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#x2014; Basic&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.70)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1.64)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#x2014; Diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.70)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1.64)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;There &lt;/div&gt;&lt;/div&gt;are 3,059,273 shares of contingently &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;issuable &lt;/div&gt;Common Stock pursuant to the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;earn-out&lt;/div&gt; arrangement that were not included in the computation of basic net loss per share since the contingencies for the issuance of &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;these &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;shares have not been met as of December&#160;31, 2022. The weighted-average common shares outstanding for the twelve months ended December&#160;31, 2022 and December&#160;31, 2021 include 2,541,856 and 5,116,058 weighted-average shares of warrants with an exercise price of $0.01, respectively. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&#x2019;s potential dilutive securities, which include stock options, restricted stock units, convertible preferred stock and warrants have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. &lt;/div&gt;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company excluded the following potential common shares from the computation of diluted net loss per share as of December&#160;31, 2022 and December&#160;31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td rowspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;C-1&lt;/div&gt; Preferred Stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,218,320&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible Series C Preferred Stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;54,478,033&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Common Stock Warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,444,127&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,822,319&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock Options&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,845,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,468,227&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Restricted Stock Units&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,332,591&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;34,622,621&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;90,986,899&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The number of outstanding shares as of December&#160;31, 2021 have been retrospectively adjusted to reflect the Exchange Ratio. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The number of outstanding warrants as of December&#160;31, 2022 and December&#160;31, 2021 does not include 1,340,310 and 1,608,359 shares, respectively, of Unvested Customer Warrants. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </us-gaap:EarningsPerShareTextBlock>
    <rgti:ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table sets forth the computation of basic and diluted net loss per share of Common Stock for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11 Months&lt;br/&gt;ended&lt;br/&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net loss&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(71,521)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(38,241)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Basic and diluted shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Weighted-average Class&#160;A Common Stock outstanding&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;102,300,852&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,337,127&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Loss per share for Class&#160;A Common Stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#x2014; Basic&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.70)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1.64)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&#x2014; Diluted&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.70)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1.64)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </rgti:ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <rgti:NetIncomeLossRelationToCommonStock
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-71521000</rgti:NetIncomeLossRelationToCommonStock>
    <rgti:NetIncomeLossRelationToCommonStock
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38241000</rgti:NetIncomeLossRelationToCommonStock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">102300852</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">102300852</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">23337127</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">23337127</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.7</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-1.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.7</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-1.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_shares">3059273</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">2541856</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">2541856</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">5116058</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">5116058</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2021_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2022_WarrantMemberusgaapStatementEquityComponentsAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company excluded the following potential common shares from the computation of diluted net loss per share as of December&#160;31, 2022 and December&#160;31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td rowspan="2" style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;C-1&lt;/div&gt; Preferred Stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;23,218,320&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible Series C Preferred Stock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;54,478,033&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Common Stock Warrants&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;14,444,127&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,822,319&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock Options&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,845,903&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,468,227&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Restricted Stock Units&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,332,591&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;34,622,621&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;90,986,899&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 66%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The number of outstanding shares as of December&#160;31, 2021 have been retrospectively adjusted to reflect the Exchange Ratio. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The number of outstanding warrants as of December&#160;31, 2022 and December&#160;31, 2021 does not include 1,340,310 and 1,608,359 shares, respectively, of Unvested Customer Warrants. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesC1PreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesC1PreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">23218320</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesCPreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleSeriesCPreferredStockMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">54478033</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">14444127</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_WarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">1822319</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">8845903</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_EmployeeStockOptionMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">11468227</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_RestrictedStockUnitsRSUMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">11332591</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_RestrictedStockUnitsRSUMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">34622621</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">90986899</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2022To12_31_2022_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1340310</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P02_01_2021To12_31_2021_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1608359</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18. INCOME TAXES &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents domestic and foreign components of loss before income taxes for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:7%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:7%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Domestic&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(67,677)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(36,787)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,844&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,454&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(71,521)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(38,241)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company did not pay any income taxes for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#x2019;s deferred income tax assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021, are as follows: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;t&lt;/div&gt;ax &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;a&lt;/div&gt;ssets:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net operating loss carryforwards&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;61,313&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;46,553&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accruals and reserves&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;160&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;147&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock-based compensation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,233&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;744&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development credits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,509&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;32&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;ROU &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;l&lt;/div&gt;iability&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,507&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; padding-bottom: 0.375pt;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Gross deferred assets &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;80,733&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;47,487&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;t&lt;/div&gt;ax &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;l&lt;/div&gt;iabilities:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;ROU &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;a&lt;/div&gt;sset&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,289&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Depreciation and amortization&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,063&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,420&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Total deferred tax liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,352&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,420&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Total net deferred tax assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;76,381&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;46,067&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Valuation allowance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(76,381&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(46,067&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Net deferred tax assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The effective&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;tax rate differs from the statutory rate, primarily due to &lt;/div&gt;&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the Company&#x2019;s history of incurring losses which have not been benefited and other permanent differences.&#160;&lt;/div&gt;&lt;br/&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"/&gt;
&lt;td style="width: 22%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 21%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 55%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&#160;Ended&lt;br/&gt;December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;Ended&lt;br/&gt;December&#160;31,&#160;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt; width: 55%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Component&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Rate Impact&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Rate Impact&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total pre-tax book income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;21%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;21%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State and local income taxes&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;11%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Fair market value adjustments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;14%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Non-deductible executive compensation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(4)%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill impairment&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(2)%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Transaction &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;c&lt;/div&gt;osts&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;3%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Change in valuation allowance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(42)%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(21)%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; width: 55%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; width: 55%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net U.S. federal and state deferred tax assets have been fully offset by a valuation allowance. The net change in the total valuation allowance was an increase of approximately $30.3&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;million and $8.0&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;million for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021, respectively. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;As of December&#160;31, 2022, the Company had net operating loss carryforwards for federal income tax purposes of $230.9&#160;million, of which $189.4&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;million does not expire; federal research and development tax credits of $2.3&#160;million, which will start to expire in &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;2035&lt;/div&gt;; net operating loss carryforwards for state income tax purposes of $168.1&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;million, which will start to expire in 2033; and state research and development tax credits of $2.3&#160;million, which do&#160;not expire.&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Utilization of the net operating losses and credits may be subject to substantial annual limitation due to federal and state ownership change limitations provided by the Internal Revenue Code and similar state provisions. Such &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;annual limitations could result in the expiration of the net operating losses and credits before their utilization. The Company has not performed a Section&#160;382 analysis to determine if an ownership change occurred and whether the use of net operating loss carryforwards and credits carryforwards will be limited to offset future taxable income. For financial statement purposes, the Company has included the federal and state net operating losses and credits in the deferred tax assets with a full valuation allowance. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;The Company files U.S., various state income tax returns as well as foreign income tax returns within Australia, Canada and the United Kingdom with varying statutes of limitations. The tax years from inception in 2013 forward remain open to examination due to the carryover of unused net operating losses and tax credits. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;The Company had unrecognized tax benefits of $4.7&#160;million as of December&#160;31, 2022 all of which is offset by a full valuation allowance. These unrecognized tax benefits, if recognized, would not affect the effective tax rate. There were no interest or penalties accrued as of December&#160;31, 2022. &lt;/div&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;A reconciliation of the beginning and ending amounts of unrecognized income tax benefits during the year is as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 68%; border: 0px; margin: 0px auto; text-indent: 0px; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;;text-indent: 0px;"&gt;
&lt;td style="width:87%"/&gt;
&lt;td style="vertical-align:bottom;width:6%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Beginning balance at January&#160;1, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,672&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Current year increase (decrease)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;"&gt;
&lt;td&gt;Prior year adjustment&#x2014;increase (decrease)&#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px;text-indent: 0px;"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Ending balance at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,672&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px;text-indent: 0px;"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents domestic and foreign components of loss before income taxes for the year ended December&#160;31, 2022 and 11 months ended December&#160;31, 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 62%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;ended&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:66%"/&gt;
&lt;td style="vertical-align:bottom;width:7%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="vertical-align:bottom;width:7%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Domestic&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(67,677)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(36,787)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Foreign&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(3,844&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,454&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(71,521)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(38,241)&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-67677000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-36787000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-3844000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-1454000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-71521000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-38241000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="P01_01_2022To12_31_2022">the Company&#x2019;s deferred income tax assets and liabilities as of December&#160;31, 2022 and December&#160;31, 2021, are as follows: &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 66%;"/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 9%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;t&lt;/div&gt;ax &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;a&lt;/div&gt;ssets:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Net operating loss carryforwards&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;61,313&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;46,553&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accruals and reserves&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;160&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;147&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock-based compensation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,233&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;744&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Research and development credits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,509&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;32&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;ROU &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;l&lt;/div&gt;iability&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,507&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; padding-bottom: 0.375pt;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Gross deferred assets &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;80,733&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; border-bottom: 0.75pt solid black;;text-align:right;"&gt;47,487&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Deferred &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;t&lt;/div&gt;ax &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;l&lt;/div&gt;iabilities:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;ROU &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;a&lt;/div&gt;sset&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,289&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Depreciation and amortization&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(2,063&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,420&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Total deferred tax liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(4,352&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(1,420&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Total net deferred tax assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;76,381&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;46,067&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Valuation allowance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(76,381&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(46,067&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Net deferred tax assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">61313000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">46553000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">160000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">147000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">5233000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">744000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">11000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">11000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">11509000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">32000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <rgti:DeferredTaxAssetsRightOfUseLiabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">2507000</rgti:DeferredTaxAssetsRightOfUseLiabilities>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">80733000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">47487000</us-gaap:DeferredTaxAssetsGross>
    <rgti:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-2289000</rgti:DeferredTaxLiabilitiesRightOfUseAssets>
    <rgti:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">-2063000</rgti:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <rgti:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">-1420000</rgti:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4352000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">1420000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">76381000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">46067000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">76381000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">46067000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="PAsOn12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="P01_01_2022To12_31_2022">&lt;div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the Company&#x2019;s history of incurring losses which have not been benefited and other permanent differences.&#160;&lt;/div&gt;&lt;br/&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"/&gt;
&lt;td style="width: 22%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td style="width: 21%; vertical-align: bottom;"/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 55%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year&#160;Ended&lt;br/&gt;December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11&#160;Months&#160;Ended&lt;br/&gt;December&#160;31,&#160;2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt; width: 55%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Component&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Rate Impact&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="1" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Rate Impact&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total pre-tax book income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;21%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;21%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State and local income taxes&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;11%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Fair market value adjustments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;14%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Non-deductible executive compensation&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(4)%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill impairment&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(2)%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Transaction &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;c&lt;/div&gt;osts&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;3%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Change in valuation allowance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(42)%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;(21)%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; width: 55%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 55%;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; text-align: center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;0%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; width: 55%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 22%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 21%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0.11</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <rgti:EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0.14</rgti:EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment>
    <rgti:EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</rgti:EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">-0.04</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <rgti:EffectiveIncomeTaxRateReconciliationGoodwillImpairment
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">-0.02</rgti:EffectiveIncomeTaxRateReconciliationGoodwillImpairment>
    <rgti:EffectiveIncomeTaxRateReconciliationGoodwillImpairment
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</rgti:EffectiveIncomeTaxRateReconciliationGoodwillImpairment>
    <rgti:EffectiveIncomeTaxRateReconciliationTransactionCosts
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0.03</rgti:EffectiveIncomeTaxRateReconciliationTransactionCosts>
    <rgti:EffectiveIncomeTaxRateReconciliationTransactionCosts
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</rgti:EffectiveIncomeTaxRateReconciliationTransactionCosts>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">-0.42</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">-0.21</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="P01_01_2022To12_31_2022"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="P01_01_2022To12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">30300000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="P02_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">8000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">230900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="PAsOn12_31_2022_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">189400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="PAsOn12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis_ResearchMemberusgaapTaxCreditCarryforwardAxis"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="PAsOn12_31_2022_RigettiComputingIncMemberdeiLegalEntityAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">168100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="PAsOn12_31_2022_ResearchMemberusgaapTaxCreditCarryforwardAxis_StateAndLocalJurisdictionMemberusgaapIncomeTaxAuthorityAxis"
      decimals="-5"
      unitRef="Unit_USD">2300000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="PAsOn12_31_2022"
      decimals="-5"
      unitRef="Unit_USD">4700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="PAsOn12_31_2022"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="PAsOn12_31_2022"
      decimals="-6"
      unitRef="Unit_USD">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"&gt;A reconciliation of the beginning and ending amounts of unrecognized income tax benefits during the year is as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; width: 68%; border: 0px; margin: 0px auto; text-indent: 0px; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;;text-indent: 0px;"&gt;
&lt;td style="width:87%"/&gt;
&lt;td style="vertical-align:bottom;width:6%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Beginning balance at January&#160;1, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,672&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Current year increase (decrease)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff;text-indent: 0px;"&gt;
&lt;td&gt;Prior year adjustment&#x2014;increase (decrease)&#160;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px;text-indent: 0px;"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;text-indent: 0px;"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Ending balance at December&#160;31, 2022&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;4,672&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px;text-indent: 0px;"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  </us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="PAsOn01_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4672000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="P01_01_2022To12_31_2022_CurrentYearMemberRGTIPeriodAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="P01_01_2022To12_31_2022_PreviousYearMemberRGTIPeriodAxis"
      decimals="-3"
      unitRef="Unit_USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="PAsOn12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">4672000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;19. SEGMENTS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, and 11 months ended 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 52%;"/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended &lt;br/&gt;December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11 Months Ended &lt;br/&gt;December&#160;31, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;United States&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,137&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;85.0%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,826&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;71.1%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Europe&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,965&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;15.0%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,370&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;28.9%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,102&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100.0%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,196&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100.0%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Revenues from external customers are attributed to individual countries based on the physical location in which the services are provided or the particular customer location with whom the Company has contracted.&lt;/div&gt; </us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents a summary of revenue by geography for the year ended December&#160;31, 2022, and 11 months ended 2021: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 52%;"/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td style="width: 4%; vertical-align: bottom;"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended &lt;br/&gt;December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11 Months Ended &lt;br/&gt;December&#160;31, 2021&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;United States&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;11,137&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;85.0%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5,826&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;71.1%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Europe&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,965&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;15.0%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;2,370&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;28.9%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;13,102&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100.0%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;8,196&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;100.0%&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear:both;max-height:0pt;;text-indent: 0px;"/&gt; </us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="P01_01_2022To12_31_2022_USsrtStatementGeographicalAxis"
      decimals="-3"
      unitRef="Unit_USD">11137000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_USsrtStatementGeographicalAxis"
      decimals="3"
      unitRef="Unit_pure">0.85</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="P02_01_2021To12_31_2021_USsrtStatementGeographicalAxis"
      decimals="-3"
      unitRef="Unit_USD">5826000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis_USsrtStatementGeographicalAxis"
      decimals="3"
      unitRef="Unit_pure">0.711</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="P01_01_2022To12_31_2022_EuropeMembersrtStatementGeographicalAxis"
      decimals="-6"
      unitRef="Unit_USD">1965000000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_EuropeMembersrtStatementGeographicalAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="3"
      unitRef="Unit_pure">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="P02_01_2021To12_31_2021_EuropeMembersrtStatementGeographicalAxis"
      decimals="-6"
      unitRef="Unit_USD">2370000000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_EuropeMembersrtStatementGeographicalAxis_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="3"
      unitRef="Unit_pure">0.289</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="P01_01_2022To12_31_2022"
      decimals="-3"
      unitRef="Unit_USD">13102000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="3"
      unitRef="Unit_pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="P02_01_2021To12_31_2021"
      decimals="-3"
      unitRef="Unit_USD">8196000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P02_01_2021To12_31_2021_RevenueFromRightsConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="3"
      unitRef="Unit_pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SubsequentEventsTextBlock contextRef="P01_01_2022To12_31_2022"> &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20. SUBSEQUENT EVENTS&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In February 2023, the Company announced an updated business strategy, including revisions to the Company&#x2019;s technology roadmap. In connection with this updated strategy, the Company has implemented a workforce reduction in order to focus the organization and its resources on nearer-term strategic priorities. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The reduction&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;in workforce impacted approximately &lt;/div&gt;50 &lt;div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;"&gt;employees or approximately &lt;/div&gt;28&lt;div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;"&gt;% of the Company&#x2019;s workforce. The Company began implementing activities with respect to the revised business plan, updated technology roadmap and reduction in workforce in February 2023. Affected employees were offered separation benefits, including severance payments and temporary healthcare coverage assistance. The Company currently expects to incur restructuring charges of approximately $&lt;/div&gt;1.4&#160;&lt;div style="font-size: 10pt; text-indent: 4%; letter-spacing: 0px; top: 0px;;display:inline;"&gt;million for severance payments and temporary healthcare coverage to employees with respect to eliminated positions. Such restructuring charges are expected to be incurred and recorded in the first quarter of 2023.&lt;/div&gt;&lt;/div&gt; </us-gaap:SubsequentEventsTextBlock>
    <rgti:NumberOfEmployees
      contextRef="P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="0"
      unitRef="Unit_Numberofemployees">50</rgti:NumberOfEmployees>
    <rgti:PercentageOfReductionInEmployees
      contextRef="P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.28</rgti:PercentageOfReductionInEmployees>
    <us-gaap:RestructuringCharges
      contextRef="P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">1400000</us-gaap:RestructuringCharges>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_73804545"
          xlink:label="Fact_73804545"
          xlink:type="locator"/>
        <link:footnote id="FN_254682" xlink:label="FN_254682" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible <xhtml:div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series&#160;C-1</xhtml:div> Preferred Stock, legacy Class&#160;A Common Stock, and legacy Class&#160;B Common Stock have been retroactively restated to give effect to the Business Combination.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804545"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804546"
          xlink:label="Fact_73804546"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804546"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804547"
          xlink:label="Fact_73804547"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804547"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804549"
          xlink:label="Fact_73804549"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804549"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804558"
          xlink:label="Fact_73804558"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804558"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804559"
          xlink:label="Fact_73804559"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804559"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804565"
          xlink:label="Fact_73804565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804565"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804566"
          xlink:label="Fact_73804566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804566"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804567"
          xlink:label="Fact_73804567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804567"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804572"
          xlink:label="Fact_73804572"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804572"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804579"
          xlink:label="Fact_73804579"
          xlink:type="locator"/>
        <link:footnote id="FN_254680" xlink:label="FN_254680" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Weighted-average shares have been retroactively restated to give effect to the Business Combination. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804579"
          xlink:to="FN_254680"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804580"
          xlink:label="Fact_73804580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804580"
          xlink:to="FN_254680"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804581"
          xlink:label="Fact_73804581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804581"
          xlink:to="FN_254680"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804582"
          xlink:label="Fact_73804582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804582"
          xlink:to="FN_254680"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804634"
          xlink:label="Fact_73804634"
          xlink:type="locator"/>
        <link:footnote id="FN_254681" xlink:label="FN_254681" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shares of legacy Redeemable Convertible Series C Preferred Stock, Redeemable Convertible Series C-1 Preferred Stock, legacy Class A Common Stock, and legacy Class B Common Stock have been retroactively restated to give effect to the Business Combination.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804634"
          xlink:to="FN_254681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804635"
          xlink:label="Fact_73804635"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804635"
          xlink:to="FN_254681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804636"
          xlink:label="Fact_73804636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804636"
          xlink:to="FN_254681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804637"
          xlink:label="Fact_73804637"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804637"
          xlink:to="FN_254681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804741"
          xlink:label="Fact_73804741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804741"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804742"
          xlink:label="Fact_73804742"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804742"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804970"
          xlink:label="Fact_73804970"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804970"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73804971"
          xlink:label="Fact_73804971"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73804971"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805338"
          xlink:label="Fact_73805338"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805338"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805339"
          xlink:label="Fact_73805339"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805339"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805341"
          xlink:label="Fact_73805341"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805341"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805344"
          xlink:label="Fact_73805344"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805344"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805486"
          xlink:label="Fact_73805486"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805486"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805487"
          xlink:label="Fact_73805487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805487"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805491"
          xlink:label="Fact_73805491"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805491"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805492"
          xlink:label="Fact_73805492"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805492"
          xlink:to="FN_254682"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_73805710"
          xlink:label="Fact_73805710"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_73805710"
          xlink:to="FN_254682"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>114
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "0@8564>E[;A8$  !)$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;*V876^C.!2&_XK%2G/5*>!\=Y-(">W,1C-M49+9E7:T%RZ<)*A@9VTG:??7
MKX$$,EIR(*.]2;#Q>7EL[/?8# ]"OJH-@"9O2<S5R-IHO;VS;15L(&'J5FR!
MFSLK(1.F35&N;;65P,(L*(EMZCA=.V$1M\;#K,Z7XZ'8Z3CBX$NB=DG"Y/L4
M8G$86:YUJIA'ZXU.*^SQ<,O6L #];>M+4[(+E3!*@*M(<")A-;(F[MV4=M*
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M)?#R?5OY1O!P_WE!)H\(1Z?@Z*!"$P,19B"?8K:N L'C5RQ6@'!T"XXNJO/
M=:3?R1S6D=*2&9XGEE0.#*XSGWU^6"YGQ'M^]+\M9T^?;\CLR;M%"'L%8:\)
MH6?&2K+83+00WL@7>*]BQ)4<QW'[K7ZK,T"P^@56OPG6C =";H7,9OX-66BF
M@0A)/+$SO 9;A)6CB8O?/R"$@X)PT(1PR=[(+#2C%ZVB(%^@3[OD!605%J[8
M[W]T!AVGV^HB>*Y3.J/3!' 2AF:=JYO3!<GLXYE7&R8NV>MUB$D4_!\RV0/?
M82O$/7-P]RI.+RV9=[P4!U[)B,M-0;Z:I/F.L=&2C5[%5DQ 7XI]Q(/J0<0U
MO0F&5J8&%S7R_Z#Y0FFS@/^,MA=718WBH-US'8RMS (N[N/9*YR87=9E%%R@
M@X.4:<#%??RK",R8^!MAIOSE95DC0EWG8Z?308G*A. VR@B^C-)=)%G,/ P,
MU^JU>FT,JLP!+F[=TYTR-<8;/+,?,AM-\OT14J;*_06N]9,;#+=,#&[__]\3
MN6A"^%GF,E6XC7+%=5:,2UYAQ;1,&?2ZE%%GQ35R#:R8EFF"7I<F&EEQC29J
MQ;3,$O2Z+-' BFL4ZZR8EFF"XJ9>;\4U K@5TS(G4-S2FUEQC4@#*Z9E<J"X
MKY_,S@>I!.<07]R<UPC-H^"5W#,>J2HN^^QTFX!<9V=X18)T"YL?=(O:XCO!
M)#\=E\WSCPR/3*XCKD@,*Q/JW/8,E\S/[7E!BVUV5GX1VIR\L\L-L!!DVL#<
M7PFA3X7T <77D_&_4$L#!!0    ( )"!A59S&$N).0@  ,DE   8    >&PO
M=V]R:W-H965T<R]S:&5E=#(N>&ULM5K;<MLX$OT5E"8UFVQ)%@'P)L=6E2UY
M=Z8JD[BLS.[#U#[ $F2Q0A$: I+C_?IMD+0H$1?9&>^#;5X:C=,-H,\!S(M'
M47Z3*\X5^K[."WG96RFU.1\.Y7S%UTR>B0TOX,U2E&NFX+9\&,I-R=FB:K3.
MAR0(XN&:945O?%$]NRW'%V*K\JS@MR62V_6:E4_7/!>/ESW<>WYPESVLE'XP
M'%]LV .?<?7[YK:$N^'>RR);\T)FHD E7U[VKO#Y-*2Z067QKXP_RH-KI$.Y
M%^*;OOEU<=D+-"*>\[G2+AC\V?$)SW/M"7#\V3CM[?O4#0^OG[W_HPH>@KEG
MDD]$_N]LH5:7O;2'%GS)MKFZ$X^_\":@2/N;BUQ6O]%C8QOTT'PKE5@WC0'!
M.BOJO^Q[DXB#!I@Z&I"F >DV"!T-:-. OK1!V#0(J\S4H51YF#+%QA>E>$2E
MM@9O^J)*9M4:PL\*/>XS5<+;#-JI\>3+Y]F73[].K[[>3-'UU:>KSY,;-/OE
MYN;K# W0[[,I>O_N WJ'L@)]78FM9,5"7@P5]*S;#^=-+Y.Z%^+H9<KG9XCB
M/B(!(9;FTY<WQ\?-AQ#O/FBR#YI4_J@KZ&U9\D(A)B57\MP63^T@M#O0B_%<
M;MB<7_9@M4E>[GAO_/-/. X^VJ)[(V='L=)]K-3G?3QA<H5@U-!<7_ _M]F.
MY1"\=11K5U'E2E>,W3A*TC2]&.X.PS&M,$[(:&]UA#/<XPR].*]V+,O9?<X'
M4,P&$C#6*<B*'9=J[4)<.XT/L*3AB- .8F_7]@% GMQ'^Y@B?TSSN=@"<"B0
M<PYYA^AL,41&##&A42<$TPA'(;7G/-[CB[WX;DN^8=D"\>] (Y++:IX(M>(E
ME)[#)6)#'1N 2!@%'=2F$:81MJ-.]J@3+VJH]X^LA DM"E4";_S\4THP^>A&
MFIA(R<%TK9%Z^WS]%$GWP:3>8*9\R2'3D/8E7&3% X0E[6&D1AA)2#I1F#8T
M#!TK<[2'./)"_"H4RU\P(4:V&1K&20>BQ2P-$F+'B(.6QX(3<QFT4*F>JCFL
MR]Q&UXP^*KBR\E5@9FH4T>[\M9@1$HX2!]H#UL5>M%\ *U-ZN',.JJ4N=:76
M* .Q'&R?G]3)=@>!#70CBN-N#*95X,#?$BCV<M;X#FIRF<T5KWG%"HYXNFV0
MF284NW+;$A[V,]Z7JH"YYVG3_&@&&N7 9A1'#F@MQV$_R?U3B,5CEN=66":5
M&?DR32*:N!+6LA3VTU2]P#T),[F'!%!7NL7'8A?&(4D=^%J6PO&+Y%J>L?LL
MSU3&[9H->]GNM:+MK;P=!]V2'/:SW%X[;-B32SA@D]GPB';EFM4J<9 P;HD+
M^YD+ )9;[A4/!P-FA6^R54J"KO"Q6-$TB!WP6U+#?E;;$V_)=[S8VO-K<M4H
MQEU\%J/442E(2V?$3V=3?O\L;)ZSN1&EWBI;=RLF3:4TZ*I@BU64N)"V5$9>
M166'@WX<@!6XR4V$AMTI8+%R,!@YV +Z&<RA(D],6;_3%\G$)B23^@AU!=52
M'_%3W[%4.Q6+27$$)U&WJEO,DBAVD YIJ9#XJ5!/<#30R@:D+WK)'#?)CP2Q
ML4^RF84$.^H%:4F2^$G2,\UU&*+PS7*3&),TZM9IBY5K0K342?P[O"GL*79,
M'ZTAF.TE>\&LL&S9$D/$6ZQ"&KEJ24MZQ$]Z-ZPL!F)[&J2%TDC0%;X6*U="
M6]8C?M:KQ>4I>"9E=:6<Q82,7/EK28V\9*OVZ00ZD[ B2K Q'4TS&H?4<>1
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MB_HCI]]8^9 5$E*PA.Z"LP3F05E_-U3?*+&IOJ2Y%TJ)=76YX@R(1AO ^Z6
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MD)1?^2E_9/&^^)[+8YQE\:XXW%*RHDG>@%U?QW'V\B-74']KZ?I_4$L#!!0
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MOS.-=A@$0\=)F([O1)TS5G0A>+^5\+V4Z+I>+R <>L/RIFFRZ9V*H)6D[7E
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MM %\OZQK]?)&_\#N_T',_@=02P,$%     @ D(&%5A9@R@Y-"@  @QD  !@
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M2NQ _ D$\*G_  4F ]O7/C?8,:)L%'51E\A7I"1H%2H\W)'%%IB$AY(K,)$
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M+WW*GAI*'0CB%W^33\9$4Y3'PCV*?1-$E*"MXR&E@-OF,,H'==4%$TZ27-6
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M01A$'Y<*3*O% 7!_;DP5ON "\2? 7OT/4$L#!!0    ( )"!A5;HBYWS& P
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M#<N-7H&E-L7ECOL)F_5FP3D^Q[UI-.M<QSAK*3L_"JY<D;%89WGA*!%V:TF
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M'%16@<Z74IK=QCK8?S6-_P902P,$%     @ D(&%5AT<C[4 !@  @ X  !D
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MDH[&2!>E*//[".X-+U'8[*I3OI:P:,,MRPW? +GSAF5*6UFN1NP>-["M8(K
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M]0,A3N9S@CY+3K>!/T<\'T[&$_R?SJ8'MTC$6#E/@AM&(VJ^%?'>'-101'M
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M>5;2NB,(Q*-$G(%2HX/W-4F*9TUUQ+61O'V]>OAB";;G=7;;6N3\JQLCLB>
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MN1>Q2E&N9+[NY>9C;P)/C7*S4I6OJ]R(Q,JZQ.6,!(-6#;6(I*VRM]#J148
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MWM18JZS/2*M75G/BI35"<><&)Q!%J'>(F-N%4"4.*P38#M]8VX56=YSP!8?
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M(E"E-0W ^UB!X_H'+=!>O5[] U!+ P04    " "0@856Z?J^_<D,  "U(P
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M-[TI4V@$,<)WXB.O1J+:*/'2%%M9W@J9F6T%5=([/LM;=QN=;L36FAN=*2<
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M[?PZ6R(1BV@QF4;GH[%G:R'FPP2/XR@>C1M.**[OH9"(*>2:1*-DS@0FHT
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MEC9@?6509H8/=$'[2YV+_P)02P,$%     @ D(&%5N6<AQ4]!0  B P  !D
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MX<J9-U5%=3;'?3'#V-H'PH 7 _)1K+'B@+D<]J&VDM39*/M8L+WB2;)<.ON
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M[1SN@U\B!_ 8OD@?+[C(K9.0PVE8TGTB8F8.T]<89<]ZC?^;EZC+<P$>E<T
MKLH28\B/06Z06&E>)\DA-HHZO9=HL63!#^O&XQI)<:E!H[9U[%%Q'QC-D7BI
M4)E0Y9P4KA4YNT)0WFL?Q.I'<?*6B"%$\0>1(!8C^VI)1 G$$;4D7O-*T4K2
M41ZEXQ>^:XT1LASO_R/'+@^D.$H(&LV7>12^<5Z++%Q1BS:OGF$HT%TPDBO'
M&G8!4>Q-R5,N95Y(9B3;I28?X)X3Q!4L\<4L/74_I0>/1XWL3)Y(SW&T-G3O
M2+_:O\)7W>/S>+Q[PC\Q5\VM;[!DT^'@[>L$J'L6NTEP37R*EB[PPQ:'+!UW
MIQS@_=*YL)^(@_Z_R>Q?4$L#!!0    ( )"!A58.^.<]'QP  $]?   9
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MQ)7TYT:!*:AP +Q?&5/['[A ^(;^+_\'4$L#!!0    ( )"!A5:EN-&+HP0
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M5\, =#,E&L.JTG?F4EGJ<[_,:;"B=@'D7REEMX9+T(WJY!=02P,$%     @
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MF]1[:6_J'BMD@TSK%#1=!11")F2H4G"R9$O:=48HNT:SL[0=4TM4C,=Z1&$
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MJ*P"G9=2FOW&!AC^,"S^ U!+ P04    " "0@8565D3]B>@$  "4#   &0
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R-5U%OVS80?O>O.+A9EP**;=&R
M++N)@21=L0+)&C3IBF'8 RU1-E&)5$DJ;O[]CJ2DV(YC]"4A1=['[^X['L_G
M&ZF^ZS5C!GZ6A= 7_;4QU7PXU.F:E50/9,4$KN12E=3@5*V&NE*,9LZH+(9D
M-(J')>6BOSAWW^[4XES6IN""W2G0=5E2]73%"KFYZ(?]]L,7OEH;^V&X.*_H
MBMTS\[6Z4S@;=B@9+YG07 I0++_H7X;SJ]CN=QO^YFRCM\9@/5E*^=U./F47
M_9$EQ J6&HM \=\CNV9%88&0QH\&L]\=:0VWQRWZ1^<[^K*DFEW+XAO/S/JB
MG_0A8SFM"_-%;OYDC3\3BY?*0KN_L&GVCOJ0UMK(LC%&!B47_C_]V<3A5PQ(
M8T <;W^08_F!&KHX5W(#RNY&-#MPKCIK),>%%>7>*%SE:&<6-PQ=TG#Z0)<%
MT^_.AP9![=(P;0"N/ !Y!2 D<"N%66OX0V0LVP48(IN.$FDI79&CB!]8.H!Q
M&  9$7($;]RY.'9XX^,N_GNYU$9A%OQWR$D/$1V&L#=CKBN:LHL^IKYFZI'U
M%V_?A/'H_1&"44<P.H:^N,>;EM4%@\\Y?*Q-K1C<<L'+N@3''>[H$]X#H^$K
MAEC!7YC-UU2DK+"BP>>**6JX6$'KJ1,3'MA/ U>%3+\?]/@HI\,>M^S*AEWA
MV%4MN]JQ$U*<I<_L9,>N\.RH!ID#BLS*)6YOA Z!(C#5O7\85<!$9BVV-_5L
M-L )A$$R2NQD#+-1: <1S(C[,H'9)+:#&)*P]R -+3JJN6>^Q_@$HB">1D<T
MG'0:3HYKZ(N:=>U:EI44#A]G7L%KJ8T^I,)1U,,J[.)[CU*+'X!9,]BX0L0R
MH(\8^17#TFF+<Z< &*9*H")[N3/C.I6U,("*62"G".2RP-+="F<-\2UP1STU
M6B'$OIYDWMM1[_-N&CC"&'X23,)Q[WXME3ESO+96QW'OOEZ>^2]<I+)D<!K.
M(GC7:+N'-)Y,?/:X0M2[IGJ-2G-/EY;6,6UQBMH2YL*Y4"(&)H9-A^=H%IPN
M><$-9WJ^Q3RUB+F+1:YD^3*U3T@08BJZE^U,YF<U8IU$03(CO6^_I,K92\S)
M()FZ0.N7&+MZ'3">#F9C^ V.Y'?<Y7?\J_E]2_$JN>#8F0VBS4@JGG[7^[4(
M;IXC>2C[CY[Y2@W:SZ0ML5P-L6]T!M++*["M<;88I$=:U*REO!_^KB1(C.W!
M'5:@ 7P2^.;;H5]Z]0R.4+O(P7:HH+8DJ0"F#<?>PB5DZO,0,WLI%>IC#W#*
MFC4UP-&]JBIXZLJJD3MP.TYSX9LUU_4\4NX+,4+8Q0(!51N%]@:5>&[J+T&&
MZT&S4,J,YWB@0[(+T%Q\/\[A,I.56\3Q@ZQX"DE$!G!YL,03'X'RM?1Y^R8A
MX?2]WD_C'87WBM+<W7C_'-@:$!'BGP02D*1Y%/!2SA+_+(3!A$1V.+7#..X]
MK!&/YC8D)$BB<*>R=#D1XMIXUKMA6L_A4UG57B^T0OG@E 3Q.,:J=+>?!"_I
MX_LU"LAH_*(>;FT*L.]3R@*YJA9-CF_&][;=/PV22=)KSSATZX=;G6+)U,KU
MPQI<%?%-8_>U:[DO?:?YO-WWZ[=4K;BP69ZCZ6@PQ:=,^1[83XRL7-^YE :[
M6#=<X\\&INP&7,^E-.W$'M#]$%G\#U!+ P04    " "0@856/.F7",L#  !]
M"0  &0   'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6RU5MMNXS80??=7#+3!
M(@'4Z&);OJQM()?>@"P:;+8MBJ(/M#2RB:5(E:3BI%_?(24K3IJX6*!]D8:7
M.7.&/$-RL5/ZB]DB6GBHA#3+8&MM/8\BDV^Q8N9<U2AII%2Z8I::>A.96B,K
MO%,EHC2.LZAB7 :KA>^[U:N%:JS@$F\UF*:JF'Z\1*%VRR )]AV?^&9K74>T
M6M1L@W=H?ZYO-;6B'J7@%4K#E02-Y3*X2.:78S??3_B%X\X<V. R62OUQ35^
M+)9![ BAP-PZ!$:_>[Q"(1P0T?BSPPSZD,[QT-ZC?^=SIUS6S."5$K_RPFZ7
MP32  DO6"/M)[7[ +A]/,%?"^"_LVKGC<0!Y8ZRJ.F=B4''9_ME#MPX'#M/X
M#8>T<T@][S:09WG-+%LMM-J!=K,)S1D^5>]-Y+ATFW)G-8UR\K.K:UQ;./W,
MU@+-V2*R!.D&HKQSOVS=TS?<DQ0^*FFW!KZ5!1;/ 2+BTA-*]X0NTZ.(UYB?
MPS )(8W3] C>L$]PZ/&&QQ*\YB87RC0:X?>+M;&:Q/#':]FV6*/7L5R!S$W-
M<EP&5 $&]3T&J_?ODBS^<(3IJ&<Z.H:^NE%R Q9U1:HBSDP68+<(C625TI;_
MA044E(=JI'V-^G'PSX14,J[AGHD&094>VP?B!G+!C.$EIQ#,P W>HX#T'+ZG
M@I%^(LF_T=P^>E;W3',G&."2Z**QH)DE3-ECAMYRM=C%8W6MU0,G&#3 K3G@
M<@Y?D3A5H& R)Q!&>TE<2R7H7#'S >D&JS5JKYW#QL )R:DI&?S46&,)GE.\
M6G.9\YH)H"@.^02&<3B)9V2DDS".X\%%4<SIV,@U6J(@*&<NW!K0XI5<DF?-
M'NE\LE BPBB>0)*.!S=HS/PY=Y?4/H$01)_MZ6P6PQF<)F&63.&L<\T;K1UH
M[?QI32F:>+9 WSQ1/YV%HUG28J3.&#BYOW\W39/T@Z0CG9Q?XE%Z<9@-Q\X8
MA6F2#:[^+6('^!3W!-K )^#COLW\S75PC)/IU%&?)-ESXO]D/ V'\9#^X\GX
M2*&-^T(;'ZV%.[K9BD80I:>,NJTT7L7*4H\Z$(NC_EK-_1]QG*IIY9[IV4OX
MI>)_0Z8!6\>7@A_NM\@U1I ,2= 39X]I+>,T=F8&"8WO93_X3]DF7\4V);:3
M.&V)3\-LFG:T$Z(];6EG8=::&70R&>P+]35)1 =78H5ZXR]^.NB<]MK;L>_M
MWQ87[97Z-+U]F'QD>L.E 8$EN<;G$]IUW5[V;<.JVE^P:V7INO;FEMY'J-T$
M&B^5LON&"]"_N%9_ U!+ P04    " "0@8561WEBXL$"   *!@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970S-RYX;6Q]5-M.VT 0?><K5D9"K>3B6P(A)):2
MT*I(12 "Y:'JP\:>Q!9[<7?72?C[SJX=$Z20%WMG9\Z9,V//C#92O>H"P) M
M9T*/O<*8:A@$.BN 4WTN*Q#H64K%J4%3K0)=*:"Y W$6Q&%X$7!:"B\=N;L'
ME8YD;5@IX$$177-.U=L4F-R,O<C;73R6J\+8BR =570%<S#/U8-"*^A8\I*#
MT*441,%R[$VBX;1GXUW [Q(V>N],;"4+*5^M<9N/O= * @:9L0P47VN8 6.6
M"&7\:SF]+J4%[I]W[#]<[5C+@FJ82?92YJ88>P./Y+"D-3./<O,3VGKZEB^3
M3+LGV32Q2>R1K-9&\A:,"G@IFC?=MGW8 PS"3P!Q"XB=[B:14WE##4U'2FZ(
MLM'(9@^N5(=&<:6P'V5N%'I+Q)ET)CG'YLR-S%[)ER>Z8*"_C@*#U#8@R%J:
M:4,3?T(3Q>1."E-H\EWDD'\D"%!3)RS>"9O&1QEO(#LG2>23.(SC(WQ)5VCB
M^)+/"F54:R*7;:E_?J&?W!K@^N^A<ANRWF$R.RE#7=$,QAZ.@@:U!B\].XTN
MPNLC4GN=U-XQ]G3>#(@5.Y-B#<I.P+OV0W*/$AZ62R:.$OL,? &JZ[5/3 &8
MF%=4O)&":M)"<N=82H:#7(H5T05%3Z-R[R?"14%*K6LJ,B!UA?<6EG6%^ 2V
MH+)2 \'(-6ACR9#%AM7X]RCV9F]*H8VJ<?Z-'I[L9_A@D!>J%,48$EWZ<2_Q
M!U%TXCS?ICBL.9ELJ,KUV>D@CN+KQ_FS)O>UT8:*W":)(C])8K]_=01T7QG7
M_WW<P!_T^OY5F)P\24,922[]'K8N"?N'OG^P-Y\<U,IM(8T]J85I1K6[[1;=
MI)GO]_!F2]Y1M<+.$ 9+A(;GEWV/J&;S-(:1E9OVA32X.]RQP&4-R@:@?RFE
MV1DV0;?^T_]02P,$%     @ D(&%5CL%D)5"!   $0P  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S@N>&ULS5?;;MLX$'WW5PS<ID@ 5Y;DBYS4-I!+B\VB
MP09)FCX4^T!+8YL():HD92=_OT/J4J=UM,$"!?;%XF7FS)D9\H">;J5ZT&M$
M X^IR/2LNS8F/^GW=;S&E&E/YIC1SE*JE!F:JE5?YPI9XIQ2T0]]?]Q/&<^Z
M\ZE;NU;SJ2R,X!E>*]!%FC+U=(9";F?=H%LOW/#5VMB%_GR:LQ7>HOF27RN:
M]1N4A*>8:2XS4+B<=4^#D[.)M7<&]QRW>F<,-I.%E ]V<IG,NKXEA )C8Q$8
M?39XCD)8(*+QO<+L-B&MX^ZX1O_D<J=<%DSCN11?>6+6L^ZD"PDN62',C=S^
M@54^(XL72Z'=+VPK6[\+<:&-3"MG8I#RK/RRQZH.KW$(*X?0\2X#.987S+#Y
M5,DM*&M-:';@4G7>1(YGMBFW1M$N)S\S_\J48IG1<'C'%@+UT;1O"-9N]N,*
MXJR$"%^ "$*XDIE9:_B8)9@\!^@3GX946),Z"UL1+S#V8!#T(/3#L 5OT"0Y
M<'B#%_#.!=,:Y!*J;$$J<,</OGTF4[@TF.J_]V5>X@[WX]H+<Z)S%N.L2S="
MH]I@=_[N33#V/[2P'C:LAVWH\UNZ@$DA$/Y:PB?&%=PS4;C9W1KA7*8IG>I;
M(^.')J_/G"VXX(:CABMDNE"8P!?-LQ6<"4:&A"FIRW":YTJR>+TOYW]AQ5<9
M7_+8AN-97M#1X9F18(C3\QBI3%! H8D"[6\<>6MUIWC&S5-#6NR09@;^+*@C
M8=G[GG/ 1U0QUP@),]@#IA"8AJ44I"CZI&/+PMP5/]6D+;D=:GC_2YRZ.$_/
M0G3*"N:*QPAO)UXXH!7%'[!>\KTPZMQ+02&<\R'+LH*)(PC\D1?X!YT;KA_>
M+Q4B*.('H7<\/.A\U(:39MC<2<-L ? QYZKD>?B$3.DC./9\W^]<\ U/,$O@
MB:-(X-V;21B$'PY:3M"H.4&C]EZ52FM/_@:)$!T#;9@IW%VPE3UW H.JKM&^
MX] :8O\5< ?T=1&!ZYUFVO[3Y<=T01:U  "CVOR\&IQTGBWM3CK.RQIU[HD$
M]:")NJWE+N@-AGXO/(YHY$=A+QQ$G2_9IMU\$/@T&ON3WB#R.V%O//%I%D$S
M:NG9N.G9N+5GUXIO[#&JZ_/MRN6U5YU:D?ZC.D4-S^@W:6KT&UA/&M:3_Z6F
MMK.RL9>632F2U57Y^21LZ9ZD-8'"$7A)=%E%Q8,VN:;RYNA>1:6;NWY73,7K
M6ASAT-I9&>5,D'TL5W8LLZ.]ES)\I38_\[NLT&]^H%>:?%T+<#2 M\?>L%'F
M:B,(O)%??5Y0Z&,O'!_ P/?&XU^$>NCYPP,(O.BU<CWT@BB$49MHMZIW?^>9
M1NJR<H]1#;$L,E.^V)K5YKU[6C[S?IB7CV7JTHI3)04NR94J1"JMR@=H.3$R
M=X^^A30D96ZXIC<[*FM ^TLI33VQ 9I_ ?-_ %!+ P04    " "0@856N12J
M9_X"  !9!@  &0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6R-56UOTS 0
M_MY?<0H4#8DU+^T&&VVEEA>!Q&#:!GQ ?'"3:V/-L;.SLZ[_GK/3AB%*Q8<D
M9_ONN>>Q?9?QVM"M+1$=/%1*VTE4.E>?Q['-2ZR$'9@:-:\L#57"\9!6L:T)
M11&"*A5G27(:5T+J:#H.<Y<T'9O&*:GQDL V525H,T=EUI,HC7835W)5.C\1
M3\>U6.$UNJ_U)?$H[E *6:&VTF@@7$ZB67H^'WG_X/!-XMH^LL$K61ASZP<?
MBTF4>$*H,'<>0?#G'M^@4AZ(:=QM,:,NI0]\;._0WP?MK&4A++XQZKLL7#F)
M7D50X%(TREV9]0?<ZCGQ>+E1-KQAO?5-(L@;ZTRU#68&E=3M5SQL]^%_ K)M
M0!9XMXD"R[?"B>F8S!K(>S.:-X+4$,WDI/:'<NV(5R7'N2E+6PLJX+L@$MK!
M;$6(O.D.CF[$0J%]/HX=Y_'><;[%G+>8V3\PTPPNC':EA7>ZP.)/@)@)=BRS
M'<MY=A#Q+>8#&*8O($NR[ #>L%,]#'C#?^#=8%4;XDL([^X:Z3;PXQ-[P$>'
ME?VY3W +-]H/YPOGW-8BQTG$E6&1[C&:/GN2GB:O#Y ==61'A]"GUVV]@%G"
M>R$)O@G5('R28B&5=!(M7*"P#6$!7S1<8=X02;V"F2[@L]'43<R%E3:$BU 1
M-YB76MXU:/=)/DSJID18&L4U[9&=ORI<HT&]=A9N<0/W72)AN>9K;UJVO1#'
MX1L4!.AO"/#Y8K5 ZLX8!)-/4ZC:>[3?*SWO_18S>Y3C;[B_0GL?C"H\]1I)
MF@*.I Z$['-(!B]/7_+[Y#@=I,/>E;2WL.2J !(.830X/>OS:GK6/TX&HV&_
M=TEFT9Y%.".3[_;;B\Q9 -NH\PV<)'W_'*=)TN]]94FD-M[O/APH$P%;"D)X
MR@R&\#1-!MG9OOL3/RKW"FD5FIKE5(UV;>5WLUW?G+7MXK=[VW0O!*TD[YC"
M)8=RWI,(J&UD[<"9.C2/A7'<BH)9<N]'\@Z\OC3&[08^0?<WF?X"4$L#!!0
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M$ACT?!H&CN<&6TM,'(\@^!"17Z'C^@,+$+H- 'F5N"=X'+8\#E_'8XK>>$N
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MLGZUUA,M*OM2G E-[TX[7-)#'Z41H/VY$'H[,0>T_SJ,_@-02P,$%     @
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M[E^AR;4W8<8E?DN<4L@, =KCIB\,T-[<1\7>)#IL*944 OWUMRLY3C*$3#\
MDKPOS^X^NQ*G*Z4?S!S LJ>ZDN:L,[=V<=+KF6(.-3?':@$2OTR5KKG%K9[U
MS$(#+YU27?62*!KT:BYD9W3JSF[TZ%0M;24DW&AFEG7-]?,8*K4ZZ\2=]<&M
MF,TM'?1&IPL^@SNPWQ<W&G>]UDHI:I!&*,DT3,\ZY_')>$#R3N"'@)796C.*
M9*+4 VVNR[-.1("@@L*2!8Y_'N$"JHH,(8R?C<U.ZY(4M]=KZQ]=[!C+A!NX
M4-4_HK3SL\ZPPTJ8\F5E;]7J+VCBZ9.]0E7&_68K+YNCQV)IK*H;9=S70OJ_
M_*G)PY;",'I%(6D4$H?;.W(H+[GEHU.M5DR3-%JCA0O5:2,X(:DH=U;C5X%Z
M=G0M"U4#N^=/8%CWGD\J,$>G/8NF2:!7-&;&WDSRBIDX85^4M'/#KF0)Y:Z!
M'F)J@25K8./DH,5+*(Y9&H<LB9+D@+VT#31U]K)7[-UYUK%O4W:)$1LK"G8N
M2X:UQ<I)=J'JA9(@K2&1S\H8-@8D/;#M%.W+S$&_U%0G9L$+..M@UQC0C] 9
ML?LYL*FJL"6$G#%+:6?N,_DOU_@XXILV^(H-/C5E%>&;>'S"X[.NA'C"+!I_
M!JX94"T89A+J">@VF\YN'+/:5VR_5'P2_$LV7#U)^LN6=+ CO;T)G /2#]HT
MOV'=01X.\OR(END@S(?Y4;!.?#<-AUG&CE@W#K,^+@(4RN.PG\1>?A@F67QT
M@ )92X'L=RFP6^U+F(+6&";6F)T; WA,W/@L^$14PHK]A3_LC:I ;KA\_O./
M81+G'PR-"^]H4S/&O3^J2;7QA\=4Y_VU>U&KD'$D C<-I\S)@0*UP5K&@Z\X
M]G' :VZ)AXY5!=?Z&6FTXKHT6(!!'*9QBHML$/;[:7!>%'K)*X^X8;1A\2!B
M<98'=U85#^]H3I:.LCB^N1N__3!)4Y9G67"+.EP7<V>@A$>\&!8XYBTK$)7
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M85 @J$R^G3B7_6V=CF8+?^@'0\?9:QB"@WFCJX.=JP/0U7_ER0/A*M>PYPA
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MQ95NKG98ZNL/A$G0\8)S]3PQ';:[4-,_4$L#!!0    ( )"!A58-R&0,[@,
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M)M<R7O&DR/SK*UXCMP9B_7>3%D&76G0$5M.B7VG1;UUS^\DZG/=_RY7=1+W
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M'%XFW[G=CEE1KMXD1VA-SK4UPIV;"MBIB7*%UNQ-;:.PU8U\1,#=UK/WX53
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MR(,P!GH_YESM)N8!Q5\#X1]02P,$%     @ D(&%5B2$XL[] @  Y @  !D
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M2>'XNW%JM6-JP\/VD_=?JN!5,&LJX)*E?R:QW$VMT$(Q;&B9RENV_PI-0!7
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M)B7+JN8.: Q<?Z#>;QB33P]Z@/:F=/8O4$L#!!0    ( )"!A5;[ $ *@@,
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M-BE:UNW#]#XX<)-8!9O9)MG>KW\V4& *\*0JO"^)#=QSS[T^/L&9'X5\4GL
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M"W)Z\HZ<$";(UU06FHI$CUV#BBRO&S?99W7VX)7LOD]NI#"I)A]% DD'P?P
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M"%U"(""WCH'ALH$Y".&(,(V?/6<PA'3 W?V6_9.O'6M9,@-S);[QPI;3X'U
M"EBQ1M@[U7Z&OIZQX\N5,/Y+VLYW@LYY8ZRJ>C!F4''9K>RIUV$'$$V> <0]
M('XM(.D!B2^TR\R7M6"69:E6+='.&]G<QFOCT5@-E^X5[ZW&6XXXFUTI5;1<
M"/*.S(J".VF9(->R^S^<T,<+L(R+$_1XN%^0XZ,3<D2X)%]*U1@F"Y-2BXDX
M.IKW02^[H/$S0:.(W"AI2T,^R@**/03S%PCB P04)1ATB+<Z7,8'&1>0GY$D
M.B5Q&$?[$GH]/#Z03C(\2^+YDI>>!07&U[!,KOE2 )D9 ]:0!3>Y4*;10+[/
MEL9J[(8?^]ZABS+:'\5-B M3LQRF 8X  WH#0?;V330)/^R3X#^1_27(:!!D
M=(A]$.24\*IF7.,@L00EV/OW=51C3^7&V"8+4[K9+>5?CW%R?CXX=2G2G;:J
M0*_]M#$D5XVT78<-I\- F_D^IG_<NVEXP_2:2T,$K! :GIUC:-U-F,ZPJO9-
MNE066]YO2QS*H)T#WJ^4LEO#!1C&?/8;4$L#!!0    ( )"!A59T9N.KJ0(
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MEZ.:P;.9^9X[=B;V9K>RPZ@!=-TZJD%Y4%$>=%+^0*2\ M=!D"59K)L^U$-
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M(X)#(DR ?K_B7#W<F'.HZMQQ]C]02P,$%     @ D(&%5C!,YIA6 P  P@H
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M/WR'2M#8Y$LXE?87':I8ST%)(17/*K!FD!%6_N/'RH@&P!\= 005('@K(*P
MH15:,K.REECAQ4SP Q(F6F<S#>N-16LUA)EE7"NAOQ*-4XMUD><4]+HH3-$W
MPC!+B&ZM%59V5*)K5A:+,?T+6NLZVA84$$_1UR3AA0E9X2>\T6.8;<V@*&"+
M?A"\(90H A)]7(+"A'[2^-OU$GT\^81.$&'H]YX74H/DS%5:BV'D)A7ORY)W
M<(3W$I(S%/J?4> %00_\ZNUP_R7<U0[6-@:UC8'--SJ2[U956ON4E-"QA9IM
M];#P8S^>N0]-OH/YS68^ESE.8.[HW2I!/("S./W@1][% /NP9A\.LE\)GH(T
M.U,O_2G.\@N]K3<R$22WRYY"O[ R:]00%GBC44M8V%4?3B9UT O"HYKPZ#7"
M.0CU9"N.JST(I/!C/\E1AZ3O1WZ+9#=H//'[.8YKCN-!CNMBDW"FA#ZHN$ )
MEZJ/W;@S<>RU'1R<YYVE$=4JHF&G\9/@E#:,SJL1HZC7\*@C:1*W_>[&3*.@
MW^])S73R]IJ ^X+DYOSJ(SCI3!Z%TQ;!P;G>Z7E<*XD'E?PR/O=:&W>9!U&+
M^6#N=S*?ULRG@\R?#W_"%.CLO>Y/.QI"OUWQW9A@%/>7A^_]O^F\07)+2$$(
MS8ZGND'8[G@)5YE>'!KM [LG)CI*LG$=^Z\Y6-ZI>>-.+3<>KLREC9LU*;2B
M_BJO)FH>O''@C=LJNE%A[$4M&6[C@6%>=S^QV!$F$854P[RSB<:+\L%4=A3/
M[9MCPY5^P=CF7C\R09@ _3WE7#UWS#.F?K8N_@%02P,$%     @ D(&%5L(>
M\B\4 P  MPL  !D   !X;"]W;W)K<VAE971S+W-H965T-C8N>&ULM59K3]LP
M%/TK5H8FD%CSZ)NUD?J #6E(%17;AVD?3'+;6CAVL-T6]NMG.VE(4<BH5+XT
M?MQ[?,[QK74'6RX>Y I H:>$,CET5DJE%ZXKHQ4D6#9X"DSO++A(L-)3L71E
M*@#'-BFA;N!Y'3?!A#GAP*[-1#C@:T4)@YE <ITD6#R/@?+MT/&=W<(M6:Z4
M67##08J7, =UE\Z$GKD%2DP28))PA@0LAL[(OYCXGDFP$3\);&5IC(R4>\X?
MS.0Z'CJ>8004(F4@L/YL8 *4&B3-XS$'=8HS36)YO$._LN*UF'LL8<+I+Q*K
MU=#I.2B&!5Y3=<NWWR$7U#9X$:?2_J)M'NLY*%I+Q9,\63-(",N^^"DWHI3@
M=]Y("/*$X+T)S3RA:85FS*RL*58X' B^1<)$:S0SL-[8;*V&,'.-<R7T+M%Y
M*IROTY2"OA>%*;HB#+.(Z-%<8657);IF6;$8T[^@41P3,]0QY8W3*2A,Z)F.
MN)M/T>G)&3I!A*$;0JG>EP-7:;+F2#?*B8TS8L$;Q'P?W7"F5A)=LACB"H#)
M?P""&@!7VU1X%>R\&@>UB%.(&JCIGZ/ "_PJ0N]/#VKH-(NK:UJ\YAMX,Z'_
MS$(]GZ,9Q4PAS&)T^;@FJ;DW]/N'#D?7^A;EGRKW,^Q6-;9Y/"YDBB,8.OIU
MD" VX(2?/_D=[VN5\".![=G0*FQHU:%K6S6H+EI3A^=(SRAD#X2V8Y1PH<A?
MNU=E0H;<M\CFP=N$K49WX&[*VK*8=BGF)6*/<+L@W*XE?#>OHE*;<^A]' EL
M3UZGD-?YP++L'-.&(X'MV= M;.C6WO(,1&1>U24@OD"*F_=U*;B4*,T-LL[
MSIDJ,VI/.-2,#,SW2X7L-?J]ZEKN%2I[M2J_C:MXU^8<ROM(8'OR^H6\_@?6
M<O^8-AP);,\&WWOI$KP/K^;\B%<5Z 6OWMMZ)H<J=4NM40)B:3M&B2*^9BKK
MDHK5HBL=V5[,?0G/6MH;+):$241AH5.]1E>_LB+K$K.)XJEMM.ZYTFV;':YT
M9PW"!.C]!>=J-S$'%+UZ^ ]02P,$%     @ D(&%5IDA0TDG @  G00  !D
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M1H,/=M156(9@&-GX =Q(8\?9'RO[_P#E NS]5DIS,ER"_H^4_P502P,$%
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MPO^NCQ;DP!TT_A?;2FQD=BTQ$N:-FM6SG+T*CYK_L=9XK\#(G6(@F%;@\;;
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M;]HP$,>_BI5-TR:UY D(=!"I)9M6:950V<.+:B\,.<!J$F>V@7:??G:2AJ1
M2B3S@MC)W>]\__@L.Z,=98]\#2#04QPE?&RLA4BO3),OUA!CWJ$I)/+)DK(8
M"]EE*Y.G#'"8.<61Z5A6WXPQ20Q_E-V;,G]$-R(B"4P9XILXQNSY!B*Z&QNV
M\7+CGJS60MTP_5&*5S #\3.=,MDS2TI(8D@XH0EBL!P;U_958+O*(;/X16#'
M*VVD4IE3^J@ZM^'8L-2(((*%4 @L+UN80!0IDAS'WP)JE#&58[7]0O^:)2^3
MF6,.$QK])J%8CXV!@4)8XDTD[NGN&Q0)]11O02.>_:-=86L9:+'A@L:%LQQ!
M3)+\BI\*(2H.=O>$@U,X..<ZN(6#>ZY#MW#H9LKDJ60Z!%A@?\3H#C%E+6FJ
MD8F9><OT2:+>^TPP^91(/^'?0PAR)LTC0!.:;($)HMI3J3XP!B&:";IX1)?H
M.@R)>E,X0K=)/M_4>_L8@, D^B0MWB,3\35FP$>FD$-3 <Q%,8R;?!C.B6$$
ML.@@U[Y CN4X1]PGS>YWF'60Y9QT#\Z/;M?=3:EG*:I3BNID//<$[P?$*66R
MC-"7OQLBGM'#=VF!;@7$_,\Q<7)<]SA.E?X53_$"QH:L;0YL"X;_X9W=MSX?
MDTHG+- $J\GHEC*Z371_/PFYFH07"&_$FC+R#\)C(N:P?@93R]W6MZW\-S*W
M58'.-0P.#?<6M8RZ94;==AFEF*$MCC9P+*&<Y57#=^0@[5?I-(9L^[[?C%G+
MNU?FW6O,>P:, $>3@W7EX0[B.;"C1=&(;%L4.F&!)EA-RGXI95_OVM+7*:-.
M6* )5I/1*V7T=*XMWL%*X+GN8'BXMC1&;2N0)EA-H$$IT."LDKVT6Q5M([3M
M;-,)"S3!:F(.2S&'>HMVJ%-&G;! $ZPFHVWM=ZN6SK(M:-6Z[3L]U^MYWJNZ
M;8[;5B1=M+I*E3V]?:9*;Q=L,ZKM5--*"W31ZC+N=_&VYFV\K74?KY46Z*+5
MM=QOY>V6>_G&G6\!DZ?URAX=+JW^ZZIM#-I:(DVT7"*S<BA7GU#D&75%$HXB
M6$J\U?%D<BS_*I%W!$VS<_J<"GGJSYIKP"$P92"?+RD5+QUU]"^_#?G_ 5!+
M P04    " "0@8567P*QWLX"  !R"@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970W-2YX;6R]EM%NFS 4AE_%HE*U26W!)B2D39":5-4J;6J4J.O%M L73@(J
M8&:;T+W];$-HNM)LBM+>)#;X_.?SX0>?4<7XHX@!)'K*TER,K5C*XMRV11A#
M1L49*R!7=Y:,9U2J*5_9HN! (Q.4I39QG+Z=T22W@I&Y-N/!B)4R37*8<23*
M+*/\]P125HTM;&TNS)-5+/4%.Q@5= 4+D'?%C*N9W:I$20:Y2%B.."S'UB4^
MGV"B \R*[PE48FN,]%8>&'O4DYMH;#F:"%((I9:@ZF\-4TA3K:0X?C6B5IM3
M!VZ/-^K79O-J,P]4P)2E]TDDX['E6RB")2U3.6?5%V@VY&F]D*7"_**J7NNI
MQ6$I),N:8$60)7G]3Y^:0FP%$/Q& &D"3"'L.I&AO**2!B/.*L3U:J6F!V:K
M)EK!);E^*@O)U=U$Q<E@RK),%6<A6?B(3M&B?CB(+=&4Y6O@NOI"3^L5GZY
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M0_*7@:9@>VN$M54&$^::F\EU2'GA"IIF&F8U/"183<MAI>70V,@'_08%0D!
M9"$G,\XR(ZRMEI@P=WAVEIW,L4L+>F\+VLWS9E3U]:A=7^]?7*1,F[O;R&O;
MW9@P=V3HG**?,=UY)G<U+<:5%N-V6OR1*JE8$NA8UJ2$D=96"4R8._ZA$ICN
M/).[FA*32HE)Z[7^AW(8D6WEF+QIDM,;]L?C\:3>D>[;@M09.(.1T^N==#EF
M_;P&MV/'H?9PTMSSU#[LNFSS+ #A0Z+TWCU[EU9<Z0T7VVP$;)@"DJ3Q$PAR
MQ85>!Z,TAO=9J3)HZ:O:IDT)IO=*1-__N07R.Y,!^TH6;!=F3+V%> ;5)&19
M04J/!U37J7?GPMR,MC,&E;9$I7E8M/J .-J&4^. 6+$(JFW5-7D0H0]$CY)B
M7C8*6  G9OV,7EOKATE;HM(\+%I=/^>@G]-F0NN9^&8ZUZ:P7TSA? TLWT.(
MCKJ$'\(O">,8@E 3HN]D)T(=#13/T? -_%25&_'"EP"(M?]NXT@Q5KUMT"YI
MU*D-/#J9G 9M5+=+5)J'1:N/ED,FA1HW\;/5L>Q!*C*U=Z E#O;OIM?[;]=:
M]JP".AXT;O+,GEJ+BYIC*6FU!72D7_K')XLVJE</BU;7]I!!H>84BKM_O^5K
M?9$IZW/9O$$WDUIKAYH\*6GUY65T*AQJWJ3!9:_;/_.J=<B9T,N3)N0A%?Z6
M22#S?<0D7^XA"\^-Z4LSNK5 J#D45-H2E>9AT>J2'U(K=(B>J::H&194FHM*
M6Z+2/"Q:7>I#9H>:4SN8*REJTH>^S9PTK7WNA>66J+7SL&AUU0XY(&I. I4Q
M>1$Q*<F\"L'D7_*_HC5JK@B5YJ+2EJ@T#XM6'PR'-!2=X$=KU#P4*LU%I2U1
M:1X6K?YC_"'MY9C37B<_8+$HA6NR2I^D+\*=.G-HX-8,;2MV21L<!=S1X"0H
MHWI<HM(\+%HAH75T="0&L<D/^4B]94D359PBJ9Y6!XGF^?$9ZU"\.(5TS\0F
M3"2)8*U-]69!=[$H#O84-XKO\H,H3UPI'N>76V !B*R _G[-N=K?9 ZJXU6S
M_P!02P,$%     @ D(&%5E61, RP"@  2G<  !D   !X;"]W;W)K<VAE971S
M+W-H965T-S<N>&ULM9U=<^(X&H7_BHKMVIJMZ@G8!D)ZDU2E8UOJK<UVJM/3
M?3$U%PH6X&UCL[)).E7SX]=?((L8@3.'FX0/ZWDE.%CR>R3Y\CF1/]*%$!GY
MN8SB]*JWR++5AWX_G2[$DJ=GR4K$^3NS1"YYEC^5\WZZDH('9:%EU+<'@W%_
MR<.X=WU9OG8OKR^3=1:%L;B7)%TOEUR^?!11\GS5LWJ;%[Z$\T56O-"_OESQ
MN7@0V6^K>YD_ZV\I0;@4<1HF,9%B=M6[L3ZPX:0H4![Q+13/:>,Q*9KRF"0_
MBB>?@JO>H*B1B,0T*Q \__<D;D44%:2\'O^KH;UMS*)@\_&&[I>-SQOSR%-Q
MFT3?PR!;7/4F/1*(&5]'V9?DF8FZ0:."-TVBM/Q+GNMC!STR7:=9LJP+YS58
MAG'UG_^L/XA& <?>4\"N"]@[!>Q]!9RZ@+-;X&)/@6%=8+A38+BO#:.ZP&@W
M@K6GP+@N,#ZVT>=U@?-C&SVI"Y1RZ5=?1_E=NCSCUY<R>2:R.#JG%0]*092E
M\Z\PC OM/F0R?S?,RV77W[F4/,Y2\BNY"8*PT!./R*>X^E44ZOK%%1D/HW]<
M]K,\7E&J/ZW9;L6V][ MB]PE<;9(B1<'(F@!> < M@'0SUNZ;:Z]:>Y'VTAT
MQ?2,.-9[8@]LF[PC?9(NN!1I_:^EBK=FX+_6\1D9V#7PMP>7_/*N]:,ZOE[6
M!K._4EZ75FYHQ[36-X/ON&Q4<R^%'OC,>-R@'%,M9@;ZXO&,V),2.&C_$C2U
M.-L?AU-RG3W<VXBG*?D\(_6OA'R6I#R[D]__G1]*/F5BF?[14M^/%7?8SBWZ
MHP_IBD_%52_O<%(AGT3O^N]_L\:#?[8I$ ESD3 /"?.1,(J$,1!,T^!PJ\&A
MB:Y.T/G (\UX'(3QO$UQ%65<4HH!R].U/9X,QH/SR_Y34TS&:%W%=&10[\CC
M?&3E*!+&0#!- J.M!$9&"?@\E.2)1VM!>/#??$R0CQTSDLS(\T8;?Y)W;9HP
M8KN>A9 PMX*-&H*PQN/A8##8$<[KXWZU;<NQ7QWI(ZM'D3 &@FG2&6^E,S9*
MYT;I)4MR]6Q'>"L>!B2,R92OPBQ_OI52F*9K$>Q3E#%:5T4A82X2YHU?R[.0
MW"O1(8-2)(R!8)KHSK>B.S>*[J$8QI&5#*>BT-%V?-<FJ(HT:7S2@[.!M=-G
M&<-U%0H2YAU3?1\9D2)A# 335#+9JF1B5,E_ULM'(8MN+).\&-60@+^D)+_P
M)('(A,PO=HL7LX6HY%,)JDU#YCCY%4$!;CL!&0MVU142YB%A/A)&D3 &@FGZ
MN]CJ[\*HB_OU8Q1.-Y=VK2<G(Z!K;X>$N4B8AX3Y2!A%PA@(IHG-&J@\V^!$
MN80:#)(AE.9":1Z4YD-I%$IC*)HNQD;2UX(D%6I,\\)],K9'KP;"M^9XG56%
MI'G'-L*'AJ50&D/1=,'82C"V43#>3R&G8;H9U>_D'HPC_)I\T;R8LLY&NP(R
MQN\L("3-.ZH%/C0FA=(8BJ:K1Z71+6.&5)UN\C,-D46GIYUYWI-BN-^J'3-W
M1%X$EZU#>W/)SGJ"9LW?W"H?6@\*I3$43=>82I-;YCQY-;Y*U/@JJ<=7[XFZ
MTGP0T[4,LU"DY)9'D0C(XPM1G6%=HOTT5H4O.N[&M;XSWLU5F*O967A(FG=D
M&WQH5 JE,11-EYE*Q5OF7'R7W);5DN6>[,H%FE:'TKPCZN]#(U(HC:%HNE14
MZMTRY]YQ"2YSH,Y7@-"\.Y3F'?A(]^?R?&@]*)3&4#1=B"H=;YGS\4J(TR1.
M\RZPF"[VUT6)S$3?0FDNE.8=^'@=@RBAJ7\HC:%HNBA5]M\RI^6_\WP<EBMM
M)628!(3/<O&1YT4X733$IVFT>*$0<!@(V3J;[*,Y9&=)0NT!*,T[\.&:) EU
M Z TAJ+IDE2&@&5V!&Z3Y3*)R4.63'\8?0$SI[/.H,X E.9!:3Z41J$TAJ+I
MTU*5/6"?RAZPH?8 E.9":1Z4YD-I%$IC*)HN1F4/V&9[X-2Y%/MU1OY\XECV
MQ<[%L;F:G<4(=16.;(/?<IQC.?;(UH^CT-HQ%$T7D+(+;+-=T-J3DC])):R;
M_.26#^NX?"$/>Y,GY@B=3VM0>P%*\Z T'TJC4!I#T715*AO"/M5T?ALZGQ]*
M<Z$T#TKSH30*I3$431>C\BOL(_V*9]7'RJJ/I;+PR0*>"3)34[_WS,@UA^DL
M3:A[ :5Y4)H/I5$HC=6T9N)]9_JQ+CKE7MAF]V+;%7]-R/U:3A<\%=M.6>NT
M?[\3Q4#OCUQV#T*6@SSR101"+/ECE)=)XB<AL[!X?"_%3$B9#P#UHJUJA2Y)
M@-)<*,V#TGPHC4)I#$73-:UL%GM\JEX=:JM :2Z4YD%I/I1&H32&HNEB5%:+
M;?8"_L(\*?NHI1#F^)U5!O5)CFJ!#XU)H32&HNGJ49Z(;4[;EZ>RS[--+_U9
M5BF4S?-/Y=(L=RW#>/YU(>Y+YZ152E ?!$ISH32OIC6S*R-[.+$FSJ[JH+8'
ME,90-%UURO:PS;;'FV?G'>!:@_W3\\Q%.VL*ZGF\O5D^M"(42F,HFKZ3@C(X
M'&/.^OJVW,M$2)4.;%QB=,@+FL-T/;=!:2Z4YD%I/I1&H32&HNG25':'8YWH
M"L)!)NUOH3072O.@-!]*HU :0]%T,2KKQ#G92@LSN;,:H98)E.9!:3Z41FN:
MU1R36F?6KN''4%%UG36V-CK1F@PSM[/*L)L;87<WPFYOA-W?R/SM&@:I#%41
M77C*^'".-#Y.-+G '+ZS/J&&")3F06D^E$9KVL$MGQ@JK*Y&Y8@X9D?D+9<E
M^3MW_&>X7"^-7H<Y<F<A0KT.*,V#TGPHC4)I#$73U:J\#N=47H<#]3J@-!=*
M\Z T'TJC4!I#T70Q*J_#,7L=NV),R3>1EG/Z[_-+&!%G?-ZZ<,2,[2Q%J"$"
MI7E0F@^ET9JF7:7L[HC 4"%UA2D_Q#G@A[RQ<P[CPYTSU"*!TEPHS8/2?"B-
M0FD,1=/5JGP4Y^)4G3-T/0F4YD)I'I3F0VD42F,HFKYIL+);A@?LEC=VSF9L
M5RE":2Z4YD%I/I1&:YIF:^_VS:B(NL"4:3(TKQ'Y*O->-GMYW36WJ@KJDT!I
M+I3F06D^E$:A-(:BZ?I3/LG0/E%O.X3:)%":"Z5Y4)H/I5$HC:%HNAB5F3(T
MI]OW3N;?;*<=E).VZL7N[XV+B\VA.LL3ZJ] :5Y-:_9RP_'%Y/S570&@S@F4
MQE T77B-FT-T,U,:W@BYF<^EF!>K2,H;"'PK5Y$T#^59N=7"UW!9ODY+Y>Y9
M9F*N1V=50ET5*,VK:=KBB_.VS=^A82F4QE T79;*51F>Z(X59FYGF4$]DV'+
M=EAMPO!:#JR6[[Q2$-3I@-(8BJ8K2#D=0_-.3Z=VB>OP!Y>@FZO964)0I^/(
M-OC0J!1*8RB:+C/E80S-'L96+)_5U)>]YR:H;U'31@>^/!<:U8/2?"B-0FD,
M1=.%I:R+X:'MK:K35A3RQS J$B7[5 4U(FI:4U7E;95VNQX7&M:#TGPHC4)I
M#$6K9-5OW+AS*>2\O(EK2J;).LZJ>WAN7]W>*/:FO#UJ7QU>W67VCLMY&*<D
M$K.\Z.#L/-> K&[<6CW)DE5Y&]#'),N29?EP(7@@9'% _OXL2;+-DR+ ]O:Y
MU_\'4$L#!!0    ( )"!A5;/L7^Q.P<  (=.   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<X+GAM;,6<6V_;-AS%OPKA 4,+=+:N=M(E!MIPQ3(L6)#T\E#L
M@;&96(@N'D4G+; //TI61-%QV# [MEX2RS8/Z2/QA+_P;QW=%^*V7' NR;<L
MS<OCP4+*Y=O1J)PM>,;*8;'DN7KENA 9D^I0W(S*I>!L7C?*TE'@>>-1QI)\
M,#VJGSL7TZ-B)=,DY^>"E*LL8^+[>YX6]\<#?_#PQ$5RLY#5$Z/IT9+=\$LN
M/RW/A3H:M2KS).-YF10Y$?SZ>/#.?TOCN&I0O^-SPN_+SF-2?92KHKBM#D[G
MQP.O&A%/^4Q6$DS]NN,G/$TK)36.?QK10=MGU;#[^$']0_WAU8>Y8B4_*=(O
MR5PNC@<' S+GUVR5RHOB_G?>?*!Z@+,B+>N?Y+YYKS<@LU4IBZQIK$:0)?GZ
M-_O6&-%IX$^>:! T#8+G-@B;!N%S&T1-@ZAV9OU1:A\HDVQZ)(I[(JIW*[7J
M06UFW5I]_"2OSONE%.K51+63TR],");+DOQ"+M4U-5^EG/QU33ZP1)#/+%W5
M1Q\7G)R+Y(Y)]3ME,ZY.O"1-4W+&6;D2?$X^E4E^0]ZK-]Q68D7*2_)NN10%
MFRW(*\HE2]+71R.IAEUU/IHU0WR_'F+PQ! IGPU)Z+\A@1<$Y+O8HG!B5_AC
ME0^)%]@4J%WAC F+PDB9WCH?M,X'M63TE.3:MMK*TWRYDF_(Y8*)VND9)U_/
M>';%Q=_;_+(*5TGQMERJLW0\4%%0<G''!].??_+'WJ_;K$.*49"886C8&AK6
MZN$3AG:NV4?>EH3E\_I%5L?-1SY;Y,D_*W6%?OU3Z9!3R;-RJ]DATFRD& 6)
M&69'K=F1]>IM<Z/R553A6A+U9Z64ZEBEP!N2=4Y!4IV";=Y:^W#U=BWFKR^/
MZN_=W?1@&(1'H[NN:: N#=/BUK08,>7)OVW:/F2L+0VL?;J:B!2C(#'#ZW'K
M];B/-!@CS4:*49"88?:D-7NRAS28/)[ A\-H8P*?6$?B:AI(S##MH#7MP#4-
M?OO&Q2PIG[,&L&J[7HA(,0H2,SP];#T][&/6'R+-1HI1D)AAMN]I>/#V,._M
MG;C:VZ@9,>(-@\G&.@#5J>E<![M\T.1W7 W8^W4V$ZE&46JFYQJX_*"/</"A
M. 95HR@UTW%-9+Z505#YL.[$CSHSVO>'\<;"P#X69^=V05>^QBO?SE=;\F$=
M"Y^+5%VA:2*_DU<LSU<L?6W/ RAC0=4H2LWT6-.8'_>2!U @@ZI1E)KIN&8R
MWTHAJ#R 0EBC9J:+%P_]S07#+@#+UX3EVQ'K18'@NG9 LM4)5(VBU$S[-:OY
M![UD!13CH&H4I68ZKDG.M[(+*BL.']- Z W'X\W% Y3*4&KFQH+&LL".95NR
MXB(I;\D'P=7%F$NN.I7DHHH%ZS8#E,N@:A2E9CJL\2WP^XB#  IO4#6*4C,=
M[^R6V;?+,'%@[\39X.!QN 3#PVACY8#JU'1.0UA@A[ 7I('CNL$^ &=7H1R'
M4C/-UQP71+T$!93JH&H4I68ZKJDNL&^R@8(B?CRU_>%D8VJ?V,?B[-PNZ"S0
M=!;8Z6SK_R27?";Y7%V;(K-G !3*H&H4I6;ZJM$MF/22 5!:@ZI1E)KIN*:U
MP+ZU!LH *)PU:N/N[N;F0F$7Q!5HX@KLQ/7L^>^Z/(!NGT'5*$K-K%C2I!9Z
MO=0L0<D-JD91:J;CFMQ"^\8;)AJ:3KJ3>7,[PCX.9]=V05^AIJ_0N5BQC0::
MW"5SKMS\X3\4[)TX7Y;0G3*4FFEPIW:QG^)%;/4BMGQQ%V06:C(+]U'!:._$
MV>#H4:QX&VL$5(>F:YJN0N<2QA\$@>-BP=Z_LZ%0/D.IF=YK/@M[*6D,H>0&
M5:,H-=-Q36[A/NH:FTXLL_K$/@YGUW9!7Z&FK]!.7^_D:9[(A*47?%;<5 _5
M!=F)@]V40=L'Y7P90[?24&KF"=%@%_92%1E"N0ZJ1E%JYI<C--=%^RB,M'?B
M_/T(*,9%6\LL)[I:VW1.\UEDY[,7A >F<-(^+F>SH?2'4C//B::_J)?"R0B*
M@U UBE(S'=<X&.VC<-+>B;/!4/J+?E34:3K7^5Z:'>M>D!_P.BK[$)U]A^[.
MH=3,TZ/Y,>JEYC*"4B-4C:+43,<U-4;[J+FT=^)L,!02&S5SK]8[' ;C)\)$
M\U]DY[\7A FXM,(^0&??H9B)4C-/CL;,J)>2S C*D5 UBE(S'=<<&>VC)-/>
MB;/!4&R,MI2+1D,OVAXDL>;!V,Z#+Z(:P-:K?5C.7PZ'$B1*S3PE&C3C7DHX
M8RA&0M4H2LUT7&-DO(\23GLGS@9#J;%1J[Y;VHD/?Q(\D1^:!V,[#_Z?_(!L
MR]C'Y^PZ%"51:N:YT<09]U+B&4,A$JI&46JFXYW;J.RCQ-/>B;/!V#NGQ)8M
MH[5KH\Y-OZI;M)TQ<9/D)4GYM6KC#2=*0JSO>K8^D,6RO@_852%ED=4/%YS-
MN:C>H%Z_+@KY<%#=6JR]]]ST/U!+ P04    " "0@856%5L G7@#  "E#P
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M-"JWP,ZOI#0O ]?:U9WYXF]02P,$%     @ D(&%5D_.U]"X @  I H  !D
M  !X;"]W;W)K<VAE971S+W-H965T.# N>&ULO59=;]HP%/TK5B9-F[0U7Y
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MS79?H:YGJ/D2E@OSBW95;#BV4+(1DA4U6&50$%K]XX=:ASV .S@"\&J ]UR
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M<@D4O5Q7P.=SSM7KC6Z@.+T<_0-02P,$%     @ D(&%5I L\X?&!   \B(
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M>L%BM:/X/']'8<25XDF^.0,Z!I&=H+^?<*[>=K+7'LK77(;_ 5!+ P04
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M(Y6 6@$>7IU>U+B0\<.3BWY^++PW\N, 8"K 8>IV=Y\F*RH P3LSMCP%G 4
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M*8M*3??9V4$)C\!>U[\]K[&KU_4?=#Y^$1'OSM8.<%1X7FH5DJ965&KZQE
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MX]Q +DQIY,O[</49,D&=&,\)?9'\1:NLK6D@)Q(R#+)@Q2#P6/J?/F6)6 O
M]I8 D@60:D![2X"5!5B)T)19(NN*2CKL\W"%>-Q:H<4?DMPDT4J-Q^)A?)!<
M?>NI.#G\1#V.OE,_ G0+5$0<U!A)@4[10SJPZ.L4C>>4S0!Y#*TU#Z?H"KBW
MI/$XH!N/3CS?DQX(='0%DGK^L0+Y]G"%CCX<HP]Q\.,\C 1EKNBWI*(>$V@Y
M&<U12I-LH8D)N@V9G OTD;G@E@%:2G,NG#P+'Q$MXA4X9\C")XB8A-00&N\>
MCC5TK'P<K 3/>GD<+H4 -0*7S"UE-1L>%WUEZ!Z<B'./S9)67T+&\Q<C*CR1
M(-%DG3R",V?>[T@A_+Q1G:)K"8'XMVX(4H;M>H9Q/;D0"^K P% %0P!?@C'\
M^R]LF__4I:\AL%(RVWDRVSKTX0AF'F-I-GS*'*A3FT)T$HBXV"V'9K^U7)>@
M[>25$CJYA(Y6@IKF+_#7QN\[6AU-,DK\[9R_K>5?S.<3=,T6D10GZ :6X",+
M_8=4!5Y1[J(?E'/*)+J<<4@*#_IY"\$$>.W\U/:XK^*&P$K)Z>;)Z;[[Q=YM
M,ID-@962>9XG\_SMBUT+L:_:%,Q>6RS$VK)<>KF(GE;$M1#1-N[:R'VY]S:X
MM\TMW+%9> A3R[[P!]-X9B_CF5V_R9L;W9]VNG:[4GCKFN'N-IIK5@?K:^H3
M<,<3B759I96GGB7>Z-ZRS$Z5I+:S5TYZ3 HQY(T;1 90RB(AI%?5H>WGM3H*
MWX.U3N"%C>(CY0RI7Q]Y<?RCW2'T?>V[5II"*V>F,#&X_>YW"=R0!\H2>@A'
MA0M+A?6>:J>=(L.P:ZU0)J,AZU6643@KK+=6UTR-/O514/Q>0VI4;REWYHBD
M/VA0M%"O1I%0L4*@<1A,/):._M&74 *RCFO%VYM;F]G&5C4!AS!/N'!/6.LG
M]MANNC7[2(^8W:J>0_@77!@8K'<P.Y3R3<N!B6E796RVVK9G%KX$ZXV)OCP_
MJOH2U^3,QXN\.*OOU@X'GFW^>NW2EO%&+4]3:.5CAL(<$?/=EW&B]6_[)K0I
MM')""QM']#9NIS*NQ]A;\:8C;%N=3OWB(H6'(WH/IW/]^M"]!6QZ06+W\!8!
MA7DC>O.V<R7.<,H;"ZY:ZII6V%[[=5!F61@IHC\.VM7W9S"E[<*VNM7M7]_;
M:Z=_X6*(WL7H*_)=4G0!W?F*06(-\MK\II*L)[7W=#R$@R*%@R+V^R_)C9YF
M-8563FCAR(C>D>U6DC?=V,;2.H01(X41(WHC=D!G33:]6<_&I*J_H7.JLO["
M[!&]V=N]G&\>(YV>=]K5<QQ]=Z^48Q7.R](?2[WLJS. ]7-O;-KG%1DUK:J^
MNK5V Q< GR47DP(Y8<1D>B>5O\TO/R^3*[_*^Q&^&*=7F 5,>J.J9J%:9 +Y
M,%60YEE7\>'I)67Z(,-%<L\W":4,@^3C'*@+/&Z@OI^&:GIF#W$'^57Q\']0
M2P,$%     @ D(&%5C@/4[6, P  8PP  !D   !X;"]W;W)K<VAE971S+W-H
M965T.#4N>&ULK5?;;MLX$/V5@9"'%F@C47<7MH$X22\/18QZTWUF)-HF*HDN
M2<4QL!^_0\F1Y+4LQ\7ZP2(ISIPS,^+1:+P5\I=:,Z;A)<\*-;'66F\^V;9*
MUBRGZEIL6(%WED+F5.-4KFRUD8RFE5&>V:[CA'9.>6%-Q]7:7$['HM09+]A<
M@BKSG,K=C&5B.[&(];KP@Z_6VBS8T_&&KMB"Z<?-7.+,;KRD/&>%XJ( R983
MZX9\FI'8&%0[?G*V59TQF%">A/AE)M_2B>481BQCB38N*%Z>V2W+,N,)>?S>
M.[4:3&/8';]Z_UP%C\$\4<5N1?8W3_5Z8L46I&Q)RTS_$-NO;!]08/PE(E/5
M/VSW>QT+DE)ID>^-D4'.B_I*7_:)Z!CXIPS<O8%;\:Z!*I9W5-/I6(HM2+,;
MO9E!%6IEC>1X8:JRT!+O<K33T_O?)=<[F&>T4/ 1%ECUM,P8/"QAL::2P0Q#
M3N%6Y/@<*%IE\D9*6JP8UD;#;'>P;TYWU?+-ELH4'C9FOX(ON%\K^%; G$DN
MTGH!D###12TY%CF!GS0K&;R[8YKR[#U<@0W*N%; "W@LN%8?<!''?ZU%J6B1
MJK&M,04F$#O9ASNKPW5/A$M<^"X*O59P7Z0L/71@8^Z:!+JO"9RY@Q[O6'(-
M'OD KN.Z\+BX@W=7!^3KRP"2UY3*JY#\$T@/I58:P^;%"O[I=5OSK;V$E1=S
M*)^GA/AA[$;!V'[NP?<;?'\0ORH:UG@(VS_&C@('?_W000,=#$+?OS"9<'4&
M/#@"_^A&81R$<3]ZV*"'@^AX_)>,F] Q^\!>-ER>81(>,R&AX\6.W\\D:IA$
M_\LC$!WAQ[$?C!RO'SYNX..WE($^H4 ,P<='\($?^HX;]<./&OC1!=&W1ZR/
M0NTI[E!PKKVP'Y\XK5@Z;SP"P^A[-\0[P!^=PN^(-7GS.3C#@/0Q.%4!XK8,
MW#\Z"V?8N!>Q:1617"*)9SAX?1R\$]I 6E4DP[)X>"C.<*A=C0XHG- $THHC
M&5;'3A9Z08>M(]@Q*A6XD-=O1GQ'IG0W],8BK7*28>GL)*>7VK#UGU!KI91<
MHJ57O?1J#T&G7!XY):*D55%RB8SV(\='R"2*__L6M3M]7\[DJNIN%22B+'3=
M C:K30=]4_>-[?:Z_?Y.Y0K;,,C8$DV=ZPBA9=W1UA,M-E47^20T]J35<(U?
M 4R:#7A_*81^G1B YKMB^B]02P,$%     @ D(&%5DA8-8R% P  A@P  !D
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M;"]W;W)K<VAE971S+W-H965T.#@N>&ULM9A?<^(V%,6_RAVWT]F=:;!E_J?
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MF)Q%)K''?&H@O?.^*29EOK<_/]%BD6U>?Q1:BR0[G',VX=(V,-]/A= O)];
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MZG31H.T^5'TPR06L2>+4=F#Z[VL[(<-'R P2$CP0?]Q[?,\]B>T[W'+Q(M<
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M9LZM(K.T'JFBXZ'@6R2,M48S#9L;ZZW9L-S(.%="SS+MI\9_ZC?E#RXEFH%
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MFVM=4((P!GI^R;G:=<P"38DZ_A]02P,$%     @ D(&%5FX A%^. @  9@8
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M.GW\!9!E8U(.M%C;RGLA--;Q]C/!9@ZD$<#UI1!Z-S .ZO9P_!U02P,$%
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M<9_4<9]8XWY@ F(^9_1?2) BS^@1&,RHZLQ^J]2^4Z<4&ZRQZ0].PPTT)UL
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MIJ5Y'5%: W->"*'?%K9CN_<V_0M02P,$%     @ D(&%5KBKQVMT P  G1@
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MLX<E +V=ZNT >CO5VP'T=JJW ^CM5&\'T-NIW@Z@MU.]'4!OKWI[@-Y>]?8
MO;WJ[0%Z>]7; _3VLX?= +V]ZNT!>GO5VP/T]JJW!^CM56\/T-NKWAZ@=U"]
M T#OH'H'@-Y!]0X O8/J'0!Z!]4[ /0.LY>5 +V#ZAT >@?5.P#T#JIW .@=
M5.\ T#NJWA&@=U2](T#OJ'I'@-Y1]8X O:/J'0%Z1]4[ O2.L\TF +VCZAT!
M>D?5.P+TCJIW!.B=5.\$T#NIW@F@=U*]$T#OI'HG@-Y)]4X O9/JG0!Z)]4[
M ?1.L\V" +V3ZIT >B?5.P'TSJIW!NB=5>\,T#NKWAF@=U:],T#OK'IG@-Y9
M]<X O;/JG0%Z9]4[ _3.L\W> +VSZIT!>A?5NP#T+JIW >A=5.\"T+NHW@6@
M=U&]"T#OHGH7@-Y%]2X O8OJ70!Z%]6[ /0NL\,Z +U-,S^N\YU^C]/GH1MO
M15_K6<!W:CU=[NUNOW]=?EV<'1%JKD#7]QGCTU]02P,$%     @ D(&%5H6?
M)TI8 @  PS@  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS=O+;MLP$(7A5S&T
M#2Q9)$5219Q-VVV;15] E>A8L&X0F=1Y^]+*!6B1&@U<H/_&@DURSH@#?#M?
M?WN<G%\=^V[PVV0?PO0ARWR]=WWETW%R0US9C7-?A?AUOLNFJCY4=RX3FXW.
MZG$(;@CK<*J1W%Q_<KOJO@NKS\?XLV_'89O,KO/)ZN/3QE/6-JFFJ6OK*L3U
M[&%H?DM9/R>D\>2RQ^_;R5_%#4GV9L)IY<\!S^>^/KAY;ANWNJWF\*7JXZ[L
MV&4^/';.I^=+O-'CN-NUM6O&^KZ/1U(_S:YJ_-ZYT'?I4]&K\\DAWK![^LPO
MSE_*G N,.V_G<?)Q8K-[?]S+2$ZGUU,LY.;0GG_%U\18^N+W<Z=I-Z[YR^QX
MO3_&^;#,PV?+X_([_G7&K_7?V8> ]"$A?2A('P6D#PWIPT#ZL) ^2D@?^8;2
M"$74G$)J3C$UIZ":4U3-*:SF%%=S"JPY159!D5509!44605%5D&155!D%119
M!45609%54&25%%DE159)D5529)44625%5DF155)DE119)45619%54615%%D5
M159%D5519%44615%5D6155%D+2BR%A19"XJL!476@B)K09&UH,A:4&0M*+(6
M%%DU159-D5539-44635%5DV155-DU119-45639'54&0U%%D-159#D=509#44
M60U%5D.1U5!D-119+4562Y'54F2U%%DM159+D=529+4462U%5DN1M:3(6E)D
M+2FREA192XJL)476DB)K29&UI,A:4F3--_^3UN_C>/C'\<LS[:MV>,G/EO\N
MWOP$4$L! A0#%     @ D(&%5@=!36*!    L0   !               ( !
M     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "0@856PT]!X>\    K
M @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M    " "0@856F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE
M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )"!A591Z7MN%@0  $D1   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "0@856<QA+B3D(  #))0  &               @(%:#   >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ D(&%5I._'Q10 P  EPP
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M965T-RYX;6Q02P$"% ,4    " "0@856%F#*#DT*  "#&0  &
M    @(%B-@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
MD(&%5A?G/_G>&0  #DP  !@              ("!Y4   'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( )"!A5;HBYWS& P  -0F   9
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M970Q-"YX;6Q02P$"% ,4    " "0@856'1R/M0 &  " #@  &0
M    @($/>@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M )"!A59D!_Y%TP(  $0&   9              " @4:   !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ D(&%5O.YA55N"0  01H  !D
M             ("!4(,  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " "0@856YIF4C7H"  !Q!0  &0              @('UC   >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( )"!A58PVRV;%@<
M +<1   9              " @::/  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ D(&%5I5'$Q[M"   EA8  !D              ("!
M\Y8  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "0@856
M?5=G8\X&   9$0  &0              @($7H   >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( )"!A59-EA\E6P@  (85   9
M      " @1RG  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ D(&%5NGZOOW)#   M2,  !D              ("!KJ\  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "0@856Y9R'%3T%  "(#
M&0              @(&NO   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( )"!A5;=-316!@@  (,3   9              " @2+"  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ D(&%5D/R[$'F
M @  V@4  !D              ("!7\H  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " "0@856."%6Z;<#  "G"   &0
M@(%\S0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( )"!
MA58.^.<]'QP  $]?   9              " @6K1  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ D(&%5J6XT8NC!   E0L  !D
M         ("!P.T  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    " "0@8563!.PI/P$   _#0  &0              @(&:\@  >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( )"!A58IG;$U50,  ! '
M   9              " @<WW  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ D(&%5N-VDKJ4 @  M@4  !D              ("!6?L
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " "0@856<!NL
M5$,$  #<"@  &0              @($D_@  >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( )"!A58#>S;PV0,  #P(   9
M  " @9X" 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
MD(&%5E9$_8GH!   E P  !D              ("!K@8! 'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " "0@856/.F7",L#  !]"0  &0
M            @('-"P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( )"!A59'>6+BP0(   H&   9              " @<\/ 0!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ D(&%5CL%D)5"!
M$0P  !D              ("!QQ(! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " "0@856N12J9_X"  !9!@  &0              @(%
M%P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( )"!A59X
MJNYN@00  (H+   9              " @74: 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ D(&%5MWB)U(2!0  1@P  !D
M     ("!+1\! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )"!A59O;!WX&0D  $M#   9              "
M@8HT 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ D(&%
M5O)-I;RG @  7 <  !D              ("!VCT! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " "0@856#<AD#.X#  !Q$P  &0
M        @(&X0 $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( )"!A5:\(6$,V@,  %P5   9              " @=U$ 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ D(&%5H3?!T93 P  )A
M !D              ("![D@! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " "0@856)(3BSOT"  #D"   &0              @(%X3 $
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( )"!A589X.F%
M, ,  /X)   9              " @:Q/ 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ D(&%5@,T[)>B!   -14  !D
M ("!$U,! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "0
M@856^P! "H(#  "Z#@  &0              @('L5P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( )"!A58-,N#?$@H  (%B   9
M          " @:5; 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#
M%     @ D(&%5@B8$06\ P  7A$  !D              ("![F4! 'AL+W=O
M<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "0@8566-]6P+$#  #8
M$@  &0              @('A:0$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM
M;%!+ 0(4 Q0    ( )"!A58\N"#AN (  /8'   9              " @<EM
M 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ D(&%5C.R
ME*%I @  \@4  !D              ("!N' ! 'AL+W=O<FMS:&5E=',O<VAE
M970U.2YX;6Q02P$"% ,4    " "0@856=&;CJZD"  "-"   &0
M    @(%8<P$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M )"!A5:JZ#ROFP,  )40   9              " @3AV 0!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ D(&%5M6J,T&T @  $0@  !D
M             ("!"GH! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " "0@85645,=NN8"   0"   &0              @('U? $ >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( )"!A5:36.B*& 0
M (,4   9              " @1*  0!X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ D(&%5C!,YIA6 P  P@H  !D              ("!
M880! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " "0@856
MPA[R+Q0#  "W"P  &0              @('NAP$ >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( )"!A5:9(4-))P(  )T$   9
M      " @3F+ 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ D(&%5F;N4[S_ @  M @  !D              ("!EXT! 'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "0@856E7"^<RT#  !]#0
M&0              @('-D $ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( )"!A5::*^MRL ,  -(0   9              " @3&4 0!X
M;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ D(&%5EZUHT6G
M @  3@<  !D              ("!&)@! 'AL+W=O<FMS:&5E=',O<VAE970W
M,2YX;6Q02P$"% ,4    " "0@856A>Z3_%0#  #@"P  &0
M@('VF@$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( )"!
MA597/FX]K0L  /V$   9              " @8&> 0!X;"]W;W)K<VAE971S
M+W-H965T-S,N>&UL4$L! A0#%     @ D(&%5I^B9&Q8 P  )Q(  !D
M         ("!9:H! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4
M    " "0@8567P*QWLX"  !R"@  &0              @('TK0$ >&PO=V]R
M:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( )"!A5:60&<DOP4  &HE
M   9              " @?FP 0!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL
M4$L! A0#%     @ D(&%5E61, RP"@  2G<  !D              ("![[8!
M 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " "0@856S[%_
ML3L'  "'3@  &0              @('6P0$ >&PO=V]R:W-H965T<R]S:&5E
M=#<X+GAM;%!+ 0(4 Q0    ( )"!A5856P"=> ,  *4/   9
M  " @4C) 0!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @
MD(&%5D_.U]"X @  I H  !D              ("!]\P! 'AL+W=O<FMS:&5E
M=',O<VAE970X,"YX;6Q02P$"% ,4    " "0@856,8!S,2 %  #)'   &0
M            @('FSP$ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4
M Q0    ( )"!A5:0+/.'Q@0  /(B   9              " @3W5 0!X;"]W
M;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ D(&%5EKN&G$N"0
MUET  !D              ("!.MH! 'AL+W=O<FMS:&5E=',O<VAE970X,RYX
M;6Q02P$"% ,4    " "0@856^K<\9EP%   V'@  &0              @(&?
MXP$ >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( )"!A58X
M#U.UC ,  &,,   9              " @3+I 0!X;"]W;W)K<VAE971S+W-H
M965T.#4N>&UL4$L! A0#%     @ D(&%5DA8-8R% P  A@P  !D
M     ("!]>P! 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )"!A58F^-_NA ,  *X.   9              "
M@?4# @!X;"]W;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ D(&%
M5FX A%^. @  9@8  !D              ("!L <" 'AL+W=O<FMS:&5E=',O
M<VAE970Y,BYX;6Q02P$"% ,4    " "0@856;7;&S<0#   J#@  &0
M        @(%U"@( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0
M   ( )"!A58Y#CF?:@(  #<&   9              " @7 . @!X;"]W;W)K
M<VAE971S+W-H965T.30N>&UL4$L! A0#%     @ D(&%5M6SJ=CB P  2 X
M !D              ("!$1$" 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q0
M2P$"% ,4    " "0@856L6K,<R<#   L"@  &0              @($J%0(
M>&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( )"!A5;G2B+Q
MK (  *P&   9              " @8@8 @!X;"]W;W)K<VAE971S+W-H965T
M.3<N>&UL4$L! A0#%     @ D(&%5DN5XX["!    1T  !D
M ("!:QL" 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"% ,4    " "0
M@856FG[2.>L#  !7%   &0              @(%D( ( >&PO=V]R:W-H965T
M<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( )"!A59P813I:0(  'L%   :
M          " @88D @!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4
M Q0    ( )"!A5:XJ\=K= ,  )T8   -              "  2<G @!X;"]S
M='EL97,N>&UL4$L! A0#%     @ D(&%5I>*NQS     $P(   L
M     ( !QBH" %]R96QS+RYR96QS4$L! A0#%     @ D(&%5J#Y5++=!@
M'D$   \              ( !KRL" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( )"!A5;#*Q\]U@(  ,<Z   :              "  ;DR @!X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( )"!A5:%GR=*6 (  ,,X
M   3              "  <<U @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0  !L &P K!T  % X @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>311</ContextCount>
  <ElementCount>473</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>130</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/DescriptionOfBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - Business Combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/BusinessCombination</Role>
      <ShortName>Business Combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure - Supplemental Financial Statements Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SupplementalFinancialStatementsInformation</Role>
      <ShortName>Supplemental Financial Statements Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/RedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - Forward Warrant Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ForwardWarrantAgreement</Role>
      <ShortName>Forward Warrant Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - Equity Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/EquityPlans</Role>
      <ShortName>Equity Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/Segments</Role>
      <ShortName>Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - Business Combination (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/BusinessCombinationTables</Role>
      <ShortName>Business Combination (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/BusinessCombination</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>1031 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/Investments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>1032 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/Goodwill</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>1033 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/RevenueRecognition</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>1034 - Disclosure - Supplemental Financial Statements Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables</Role>
      <ShortName>Supplemental Financial Statements Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/SupplementalFinancialStatementsInformation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>1035 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>1036 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/Debt</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>1037 - Disclosure - Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/CommonStockTables</Role>
      <ShortName>Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/CommonStock</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>1038 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/Warrants</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>1039 - Disclosure - Forward Warrant Agreement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ForwardWarrantAgreementTables</Role>
      <ShortName>Forward Warrant Agreement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/ForwardWarrantAgreement</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>1040 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/FairValueMeasurements</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>1041 - Disclosure - Equity Plans - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/EquityPlansTables</Role>
      <ShortName>Equity Plans - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/EquityPlans</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>1042 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/NetLossPerShare</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>1043 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/IncomeTaxes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>1044 - Disclosure - Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SegmentsTables</Role>
      <ShortName>Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rigetti.com/role/Segments</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>1045 - Disclosure - Description of Business - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail</Role>
      <ShortName>Description of Business - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>1046 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>1047 - Disclosure - Summary of Significant Accounting Policies - Summary of Cash Cash Equivalents and Short Term Investments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Cash Cash Equivalents and Short Term Investments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>1048 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inputs Into the Respective Models (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Inputs Into the Respective Models (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>1049 - Disclosure - Summary of Significant Accounting Policies - Summary Of Earnings Per Share Basic And Diluted (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary Of Earnings Per Share Basic And Diluted (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Customers Accounts Receivable (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Customers Accounts Receivable (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>1051 - Disclosure - Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail</Role>
      <ShortName>Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>1052 - Disclosure - Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail</Role>
      <ShortName>Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>1053 - Disclosure - Business Combination - Summary of Consummation of the Business Combination (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail</Role>
      <ShortName>Business Combination - Summary of Consummation of the Business Combination (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>1054 - Disclosure - Business Combination - Summary of Consummation of the Business Combination (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail</Role>
      <ShortName>Business Combination - Summary of Consummation of the Business Combination (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>1055 - Disclosure - Business Combination - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail</Role>
      <ShortName>Business Combination - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>1056 - Disclosure - Investments  - Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail</Role>
      <ShortName>Investments  - Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>1057 - Disclosure - Investments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail</Role>
      <ShortName>Investments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>1058 - Disclosure - Goodwill - Summary of Schedule of Goodwill (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail</Role>
      <ShortName>Goodwill - Summary of Schedule of Goodwill (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>1059 - Disclosure - Goodwill - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/GoodwillAdditionalInformationDetail</Role>
      <ShortName>Goodwill - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>1060 - Disclosure - Revenue Recognition - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail</Role>
      <ShortName>Revenue Recognition - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>1061 - Disclosure - Revenue Recognition - Summary of Disaggregation of Revenue (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail</Role>
      <ShortName>Revenue Recognition - Summary of Disaggregation of Revenue (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>1062 - Disclosure - Revenue Recognition - Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail</Role>
      <ShortName>Revenue Recognition - Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>1063 - Disclosure - Revenue Recognition - Summary of Change in Contract with Customer, Asset and Liability (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail</Role>
      <ShortName>Revenue Recognition - Summary of Change in Contract with Customer, Asset and Liability (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>1064 - Disclosure - Supplemental Financial Statements Information - Summary Of  Property Plant And Equipment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail</Role>
      <ShortName>Supplemental Financial Statements Information - Summary Of  Property Plant And Equipment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>1065 - Disclosure - Supplemental Financial Statements Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail</Role>
      <ShortName>Supplemental Financial Statements Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>1066 - Disclosure - Supplemental Financial Statements Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail</Role>
      <ShortName>Supplemental Financial Statements Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>1067 - Disclosure - Leases - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/LeasesAdditionalInformationDetail</Role>
      <ShortName>Leases - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>1068 - Disclosure - Leases - Summary of Components of Lease Costs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail</Role>
      <ShortName>Leases - Summary of Components of Lease Costs (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>1069 - Disclosure - Leases - Summary Of Lessee Operating Lease Liability Maturity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail</Role>
      <ShortName>Leases - Summary Of Lessee Operating Lease Liability Maturity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>1070 - Disclosure - Leases - Summary of Maturities of the Company's Operating Lease Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail</Role>
      <ShortName>Leases - Summary of Maturities of the Company's Operating Lease Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>1071 - Disclosure - Debt - Scheduled principal payments on total outstanding debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail</Role>
      <ShortName>Debt - Scheduled principal payments on total outstanding debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>1072 - Disclosure - Debt -  Long term debt and the unamortized discount (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail</Role>
      <ShortName>Debt -  Long term debt and the unamortized discount (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>1073 - Disclosure - Debt - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/DebtAdditionalInformationDetail</Role>
      <ShortName>Debt - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>1074 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>1075 - Disclosure - Common Stock - Summary of Conversions of Stock (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail</Role>
      <ShortName>Common Stock - Summary of Conversions of Stock (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>1076 - Disclosure - Common Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/CommonStockAdditionalInformationDetail</Role>
      <ShortName>Common Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>1077 - Disclosure - Warrants - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/WarrantsAdditionalInformationDetail</Role>
      <ShortName>Warrants - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>1078 - Disclosure - Warrants - Schedule Of Fair Value Of The Private Placement Warrant Measured Using Black Scholes Approach (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail</Role>
      <ShortName>Warrants - Schedule Of Fair Value Of The Private Placement Warrant Measured Using Black Scholes Approach (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>1079 - Disclosure - Warrants - Schedule Of Fair Value Of The Trinity Warrant liabilities Measured Using Black Scholes Approach (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail</Role>
      <ShortName>Warrants - Schedule Of Fair Value Of The Trinity Warrant liabilities Measured Using Black Scholes Approach (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>1080 - Disclosure - Warrants - Summary of Vesting Status of the Customer Warrant (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail</Role>
      <ShortName>Warrants - Summary of Vesting Status of the Customer Warrant (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>1081 - Disclosure - Forward Warrant Agreement - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail</Role>
      <ShortName>Forward Warrant Agreement - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>1082 - Disclosure - Forward Warrant Agreement - Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail</Role>
      <ShortName>Forward Warrant Agreement - Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>1083 - Disclosure - Fair Value Measurements - Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>1084 - Disclosure - Fair Value Measurements - Summary Of Change in Fair Value of Derivative Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail</Role>
      <ShortName>Fair Value Measurements - Summary Of Change in Fair Value of Derivative Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>1085 - Disclosure - Equity Plans - Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail</Role>
      <ShortName>Equity Plans - Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>1086 - Disclosure - Equity Plans - Schedule of Activity Related to Restricted Stock Units (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail</Role>
      <ShortName>Equity Plans - Schedule of Activity Related to Restricted Stock Units (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>1087 - Disclosure - Equity Plans -Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail</Role>
      <ShortName>Equity Plans -Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>1088 - Disclosure - Equity Plans -Schedule Of Share Based Payment Award Stock Options Valuation Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail</Role>
      <ShortName>Equity Plans -Schedule Of Share Based Payment Award Stock Options Valuation Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>1089 - Disclosure - Equity Plans - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail</Role>
      <ShortName>Equity Plans - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>1090 - Disclosure - Net Loss Per Share - Schedule of Earnings Per Share Basic and Diluted (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail</Role>
      <ShortName>Net Loss Per Share - Schedule of Earnings Per Share Basic and Diluted (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>1091 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>1092 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>1093 - Disclosure - Net Loss Per Share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail</Role>
      <ShortName>Net Loss Per Share - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>1094 - Disclosure - Income Taxes - Summary of Domestic and Foreign Components of Loss Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Summary of Domestic and Foreign Components of Loss Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>1095 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Summary of Components of Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>1096 - Disclosure - Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail</Role>
      <ShortName>Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>1097 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits Affecting the Effective Tax rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail</Role>
      <ShortName>Income Taxes - Summary of Unrecognized Tax Benefits Affecting the Effective Tax rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>1098 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>1099 - Disclosure - Segments - Summary of Revenue by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail</Role>
      <ShortName>Segments - Summary of Revenue by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="d483086dposam.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>1100 - Disclosure - Subsequent Events - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail</Role>
      <ShortName>Subsequent Events - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: rgti:NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice, rgti:NumberOfTradingDaysForDeterminingTheSharePrice -  d483086dposam.htm 9347</Log>
  </Logs>
  <InputFiles>
    <File doctype="POS AM" original="d483086dposam.htm">d483086dposam.htm</File>
    <File>d483086dex1030.htm</File>
    <File>d483086dex231.htm</File>
    <File>rgti-20221231.xsd</File>
    <File>rgti-20221231_cal.xml</File>
    <File>rgti-20221231_def.xml</File>
    <File>rgti-20221231_lab.xml</File>
    <File>rgti-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g483086g00g02.jpg</File>
    <File>g483086g11g01.jpg</File>
    <File>g483086g12g01.jpg</File>
    <File>g483086g18g01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="854">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>120
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d483086dposam.htm": {
   "axisCustom": 10,
   "axisStandard": 33,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 854,
    "http://xbrl.sec.gov/dei/2022": 20
   },
   "contextCount": 311,
   "dts": {
    "calculationLink": {
     "local": [
      "rgti-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rgti-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d483086dposam.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rgti-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rgti-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rgti-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 821,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://www.rigetti.com/20221231": 4,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 11
   },
   "keyCustom": 127,
   "keyStandard": 346,
   "memberCustom": 68,
   "memberStandard": 51,
   "nsprefix": "rgti",
   "nsuri": "http://www.rigetti.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "1001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.rigetti.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1010 - Disclosure - Business Combination",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.rigetti.com/role/BusinessCombination",
     "shortName": "Business Combination",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1100 - Disclosure - Subsequent Events - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
     "shortName": "Subsequent Events - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_28_2023To02_28_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1011 - Disclosure - Investments",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.rigetti.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1012 - Disclosure - Goodwill",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.rigetti.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1013 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.rigetti.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:SupplementalFinancialStatementInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1014 - Disclosure - Supplemental Financial Statements Information",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.rigetti.com/role/SupplementalFinancialStatementsInformation",
     "shortName": "Supplemental Financial Statements Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:SupplementalFinancialStatementInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1015 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.rigetti.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1016 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.rigetti.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1017 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.rigetti.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:RedeemableConvertiblePreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1018 - Disclosure - Redeemable Convertible Preferred Stock",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.rigetti.com/role/RedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:RedeemableConvertiblePreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:CommonStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1019 - Disclosure - Common Stock",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.rigetti.com/role/CommonStock",
     "shortName": "Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:CommonStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:WarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1020 - Disclosure - Warrants",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.rigetti.com/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:WarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:ForwardWarrantAgreementDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1021 - Disclosure - Forward Warrant Agreement",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.rigetti.com/role/ForwardWarrantAgreement",
     "shortName": "Forward Warrant Agreement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:ForwardWarrantAgreementDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1022 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.rigetti.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1023 - Disclosure - Equity Plans",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.rigetti.com/role/EquityPlans",
     "shortName": "Equity Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1024 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.rigetti.com/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1025 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.rigetti.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1026 - Disclosure - Segments",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.rigetti.com/role/Segments",
     "shortName": "Segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1027 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.rigetti.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:EmergingGrowthCompanyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1028 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "28",
     "role": "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:EmergingGrowthCompanyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1029 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1030 - Disclosure - Business Combination (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.rigetti.com/role/BusinessCombinationTables",
     "shortName": "Business Combination (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1031 - Disclosure - Investments (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.rigetti.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1032 - Disclosure - Goodwill (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.rigetti.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1033 - Disclosure - Revenue Recognition (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.rigetti.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "rgti:SupplementalFinancialStatementInformationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1034 - Disclosure - Supplemental Financial Statements Information (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables",
     "shortName": "Supplemental Financial Statements Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "rgti:SupplementalFinancialStatementInformationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1035 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.rigetti.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1036 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.rigetti.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "rgti:CommonStockTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfConversionsOfStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1037 - Disclosure - Common Stock (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.rigetti.com/role/CommonStockTables",
     "shortName": "Common Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "rgti:CommonStockTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfConversionsOfStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1038 - Disclosure - Warrants (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.rigetti.com/role/WarrantsTables",
     "shortName": "Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1039 - Disclosure - Forward Warrant Agreement (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.rigetti.com/role/ForwardWarrantAgreementTables",
     "shortName": "Forward Warrant Agreement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1040 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.rigetti.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1041 - Disclosure - Equity Plans - (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.rigetti.com/role/EquityPlansTables",
     "shortName": "Equity Plans - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1042 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.rigetti.com/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rgti:ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1043 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.rigetti.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1044 - Disclosure - Segments (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.rigetti.com/role/SegmentsTables",
     "shortName": "Segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1045 - Disclosure - Description of Business - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
     "shortName": "Description of Business - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "div",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn03_02_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMemberRGTIEventAxis",
      "decimals": "4",
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1046 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_OperatingSegment",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1047 - Disclosure - Summary of Significant Accounting Policies - Summary of Cash Cash Equivalents and Short Term Investments (Detail)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail",
     "shortName": "Summary of Significant Accounting Policies - Summary of Cash Cash Equivalents and Short Term Investments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "rgti:DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1048 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inputs Into the Respective Models (Detail)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Inputs Into the Respective Models (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "rgti:DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1049 - Disclosure - Summary of Significant Accounting Policies - Summary Of Earnings Per Share Basic And Diluted (Detail)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail",
     "shortName": "Summary of Significant Accounting Policies - Summary Of Earnings Per Share Basic And Diluted (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1050 - Disclosure - Summary of Significant Accounting Policies - Schedule of Customers Accounts Receivable (Detail)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Customers Accounts Receivable (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CustomerAMembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "rgti:CashReceivedFromTrustNetOfRedemptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1051 - Disclosure - Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Detail)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail",
     "shortName": "Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "rgti:CashReceivedFromTrustNetOfRedemptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-4",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1052 - Disclosure - Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail",
     "shortName": "Business Combination - Summary of Net proceeds from Business Combination and PIPE financing (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-4",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "rgti:CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1053 - Disclosure - Business Combination - Summary of Consummation of the Business Combination (Detail)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
     "shortName": "Business Combination - Summary of Consummation of the Business Combination (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "rgti:CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1054 - Disclosure - Business Combination - Summary of Consummation of the Business Combination (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail",
     "shortName": "Business Combination - Summary of Consummation of the Business Combination (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "rgti:DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_SeriesCRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis",
      "decimals": "0",
      "lang": null,
      "name": "rgti:ConversionFromTemporaryEquityToPermanentEquityExchangeRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1055 - Disclosure - Business Combination - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
     "shortName": "Business Combination - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-5",
      "lang": null,
      "name": "rgti:OneTimeBonus",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1056 - Disclosure - Investments  - Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value (Detail)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail",
     "shortName": "Investments  - Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1057 - Disclosure - Investments - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
     "shortName": "Investments - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "lang": "en-US",
      "name": "rgti:DebtSecuritiesAvailableForSaleMaturityYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn01_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1058 - Disclosure - Goodwill - Summary of Schedule of Goodwill (Detail)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail",
     "shortName": "Goodwill - Summary of Schedule of Goodwill (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn01_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1059 - Disclosure - Goodwill - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.rigetti.com/role/GoodwillAdditionalInformationDetail",
     "shortName": "Goodwill - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn01_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
     "shortName": "CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn01_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1060 - Disclosure - Revenue Recognition - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail",
     "shortName": "Revenue Recognition - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1061 - Disclosure - Revenue Recognition - Summary of Disaggregation of Revenue (Detail)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail",
     "shortName": "Revenue Recognition - Summary of Disaggregation of Revenue (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021_TransferredAtPointInTimeMemberusgaapTimingOfTransferOfGoodOrServiceAxis",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1062 - Disclosure - Revenue Recognition - Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable (Detail)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail",
     "shortName": "Revenue Recognition - Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn01_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredRevenueCurrent",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1063 - Disclosure - Revenue Recognition - Summary of Change in Contract with Customer, Asset and Liability (Detail)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail",
     "shortName": "Revenue Recognition - Summary of Change in Contract with Customer, Asset and Liability (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "lang": null,
      "name": "rgti:DeferralOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "rgti:SupplementalFinancialStatementInformationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1064 - Disclosure - Supplemental Financial Statements Information - Summary Of  Property Plant And Equipment Information (Detail)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail",
     "shortName": "Supplemental Financial Statements Information - Summary Of  Property Plant And Equipment Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "rgti:SupplementalFinancialStatementInformationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "rgti:SupplementalFinancialStatementInformationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedUtilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1065 - Disclosure - Supplemental Financial Statements Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail",
     "shortName": "Supplemental Financial Statements Information - Schedule of Accounts Payable and Accrued Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "rgti:SupplementalFinancialStatementInformationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedUtilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "rgti:SupplementalFinancialStatementInformationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1066 - Disclosure - Supplemental Financial Statements Information - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail",
     "shortName": "Supplemental Financial Statements Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "rgti:SupplementalFinancialStatementInformationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "rgti:OperatingLeaseRentExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1067 - Disclosure - Leases - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.rigetti.com/role/LeasesAdditionalInformationDetail",
     "shortName": "Leases - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "rgti:OperatingLeaseRentExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1068 - Disclosure - Leases - Summary of Components of Lease Costs (Detail)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail",
     "shortName": "Leases - Summary of Components of Lease Costs (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1069 - Disclosure - Leases - Summary Of Lessee Operating Lease Liability Maturity (Detail)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
     "shortName": "Leases - Summary Of Lessee Operating Lease Liability Maturity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "rgti:ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021_RigettiHoldingsMemberdeiLegalEntityAxis",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1070 - Disclosure - Leases - Summary of Maturities of the Company's Operating Lease Liabilities (Detail)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail",
     "shortName": "Leases - Summary of Maturities of the Company's Operating Lease Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1071 - Disclosure - Debt - Scheduled principal payments on total outstanding debt (Detail)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail",
     "shortName": "Debt - Scheduled principal payments on total outstanding debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021_RigettiComputingIncMemberdeiLegalEntityAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1072 - Disclosure - Debt -  Long term debt and the unamortized discount (Detail)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail",
     "shortName": "Debt -  Long term debt and the unamortized discount (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn05_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1073 - Disclosure - Debt - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
     "shortName": "Debt - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn01_31_2022_LoanAndSecurityAgreementMemberusgaapLongtermDebtTypeAxis",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1074 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail",
     "shortName": "Redeemable Convertible Preferred Stock - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "rgti:RedeemableConvertiblePreferredStockTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_SeriesCPreferredStockMemberusgaapStatementClassOfStockAxis",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "rgti:CommonStockTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1075 - Disclosure - Common Stock - Summary of Conversions of Stock (Detail)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
     "shortName": "Common Stock - Summary of Conversions of Stock (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfConversionsOfStockTextBlock",
       "rgti:CommonStockTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1076 - Disclosure - Common Stock - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
     "shortName": "Common Stock - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "rgti:CommonStockTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1077 - Disclosure - Warrants - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail",
     "shortName": "Warrants - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn06_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1078 - Disclosure - Warrants - Schedule Of Fair Value Of The Private Placement Warrant Measured Using Black Scholes Approach (Detail)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
     "shortName": "Warrants - Schedule Of Fair Value Of The Private Placement Warrant Measured Using Black Scholes Approach (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivateWarrantMemberusgaapClassOfWarrantOrRightAxis",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn06_02_2022_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "reportCount": 1,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1079 - Disclosure - Warrants - Schedule Of Fair Value Of The Trinity Warrant liabilities Measured Using Black Scholes Approach (Detail)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail",
     "shortName": "Warrants - Schedule Of Fair Value Of The Trinity Warrant liabilities Measured Using Black Scholes Approach (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1008 - Disclosure - Description of Business",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.rigetti.com/role/DescriptionOfBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1080 - Disclosure - Warrants - Summary of Vesting Status of the Customer Warrant (Detail)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail",
     "shortName": "Warrants - Summary of Vesting Status of the Customer Warrant (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_VestedCustomerWarrantsMemberRGTIStatusOfVestingAxis",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1081 - Disclosure - Forward Warrant Agreement - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
     "shortName": "Forward Warrant Agreement - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_ForwardWarrantAgreementMemberRGTIAgreementNameAxis_RigettiMemberusgaapBusinessAcquisitionAxis",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Y",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1082 - Disclosure - Forward Warrant Agreement - Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques (Detail)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
     "shortName": "Forward Warrant Agreement - Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Y",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1083 - Disclosure - Fair Value Measurements - Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1084 - Disclosure - Fair Value Measurements - Summary Of Change in Fair Value of Derivative Liabilities (Detail)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
     "shortName": "Fair Value Measurements - Summary Of Change in Fair Value of Derivative Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_ForwardWarrantAgreementMemberusgaapFinancialInstrumentAxis",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1085 - Disclosure - Equity Plans - Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value (Detail)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail",
     "shortName": "Equity Plans - Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1086 - Disclosure - Equity Plans - Schedule of Activity Related to Restricted Stock Units (Detail)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail",
     "shortName": "Equity Plans - Schedule of Activity Related to Restricted Stock Units (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1087 - Disclosure - Equity Plans -Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs (Detail)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail",
     "shortName": "Equity Plans -Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021_ResearchAndDevelopmentExpenseMemberusgaapIncomeStatementLocationAxis",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1088 - Disclosure - Equity Plans -Schedule Of Share Based Payment Award Stock Options Valuation Assumptions (Detail)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
     "shortName": "Equity Plans -Schedule Of Share Based Payment Award Stock Options Valuation Assumptions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1089 - Disclosure - Equity Plans - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
     "shortName": "Equity Plans - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1009 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "rgti:NetIncomeLossRelationToCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1090 - Disclosure - Net Loss Per Share - Schedule of Earnings Per Share Basic and Diluted (Detail)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail",
     "shortName": "Net Loss Per Share - Schedule of Earnings Per Share Basic and Diluted (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rgti:ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "rgti:NetIncomeLossRelationToCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1091 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1092 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Detail)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021_UnvestedCustomerWarrantsMemberusgaapStatementClassOfStockAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1093 - Disclosure - Net Loss Per Share - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
     "shortName": "Net Loss Per Share - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1094 - Disclosure - Income Taxes - Summary of Domestic and Foreign Components of Loss Before Income Taxes (Detail)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail",
     "shortName": "Income Taxes - Summary of Domestic and Foreign Components of Loss Before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1095 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets and Liabilities (Detail)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail",
     "shortName": "Income Taxes - Summary of Components of Deferred Tax Assets and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1096 - Disclosure - Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail",
     "shortName": "Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1097 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits Affecting the Effective Tax rate (Detail)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail",
     "shortName": "Income Taxes - Summary of Unrecognized Tax Benefits Affecting the Effective Tax rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P01_01_2022To12_31_2022_PreviousYearMemberRGTIPeriodAxis",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1098 - Disclosure - Income Taxes - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1099 - Disclosure - Segments - Summary of Revenue by Geography (Detail)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
     "shortName": "Segments - Summary of Revenue by Geography (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d483086dposam.htm",
      "contextRef": "P02_01_2021To12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 130,
   "tag": {
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "GB"
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "US"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail",
      "http://www.rigetti.com/role/CommonStock",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/CommonStockTables",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/CoverPage",
      "http://www.rigetti.com/role/Debt",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail",
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail",
      "http://www.rigetti.com/role/DescriptionOfBusiness",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
      "http://www.rigetti.com/role/EquityPlansTables",
      "http://www.rigetti.com/role/FairValueMeasurements",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsTables",
      "http://www.rigetti.com/role/ForwardWarrantAgreement",
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementTables",
      "http://www.rigetti.com/role/IncomeTaxes",
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail",
      "http://www.rigetti.com/role/IncomeTaxesTables",
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/NetLossPerShare",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail",
      "http://www.rigetti.com/role/NetLossPerShareTables",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStock",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/RevenueRecognition",
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail",
      "http://www.rigetti.com/role/RevenueRecognitionTables",
      "http://www.rigetti.com/role/Segments",
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SegmentsTables",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformation",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables",
      "http://www.rigetti.com/role/Warrants",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail",
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail",
      "http://www.rigetti.com/role/CommonStock",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/CommonStockTables",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/CoverPage",
      "http://www.rigetti.com/role/Debt",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail",
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail",
      "http://www.rigetti.com/role/DescriptionOfBusiness",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
      "http://www.rigetti.com/role/EquityPlansTables",
      "http://www.rigetti.com/role/FairValueMeasurements",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsTables",
      "http://www.rigetti.com/role/ForwardWarrantAgreement",
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementTables",
      "http://www.rigetti.com/role/IncomeTaxes",
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail",
      "http://www.rigetti.com/role/IncomeTaxesTables",
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/NetLossPerShare",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail",
      "http://www.rigetti.com/role/NetLossPerShareTables",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStock",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/RevenueRecognition",
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail",
      "http://www.rigetti.com/role/RevenueRecognitionTables",
      "http://www.rigetti.com/role/Segments",
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SegmentsTables",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformation",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables",
      "http://www.rigetti.com/role/Warrants",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail",
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.rigetti.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "rgti_AccessToQuantumComputingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Access to quantum computing systems",
        "label": "Access to quantum computing systems [Member]"
       }
      }
     },
     "localname": "AccessToQuantumComputingSystemsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_AccretionOfDebtEndOfTermLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion of debt end of term liabilities.",
        "label": "Accretion of debt end of term liabilities",
        "negatedLabel": "Accretion of debt end of term liabilities"
       }
      }
     },
     "localname": "AccretionOfDebtEndOfTermLiabilities",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AccruedDeferredOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued deferred offering costs.",
        "label": "Accrued Deferred Offering Costs",
        "verboseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "AccruedDeferredOfferingCosts",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AccruedFinalPaymentFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermLoansPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued final payment fee.",
        "label": "Accrued Final Payment Fee",
        "terseLabel": "Add: accreted liability of final payment fee"
       }
      }
     },
     "localname": "AccruedFinalPaymentFee",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AccruedPropertyAndOtherTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued property and other taxes.",
        "label": "Accrued Property And Other Taxes",
        "terseLabel": "Property and other taxes"
       }
      }
     },
     "localname": "AccruedPropertyAndOtherTaxes",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AccruedPropertyPlantAndEquipmentCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued property plant and equipment cost.",
        "label": "Accrued Property Plant And Equipment Cost",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "AccruedPropertyPlantAndEquipmentCost",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AccruedSubcontractorCost": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued subcontractor cost.",
        "label": "Accrued Subcontractor Cost",
        "terseLabel": "Subcontractor cost"
       }
      }
     },
     "localname": "AccruedSubcontractorCost",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital business combination transaction costs.",
        "label": "Adjustment To Additional Paid In Capital Business Combination Transaction Costs",
        "terseLabel": "Adjustment to additional paid in capital business combination transaction costs"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalBusinessCombinationTransactionCosts",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital exercise of loan and security agreement warrants.",
        "label": "Adjustments To Additional Paid In Capital Exercise Of Loan And Security Agreement Warrants",
        "terseLabel": "Reclassification of loan and security agreement warrants to equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfLoanAndSecurityAgreementWarrants",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid in capital settlement of the first tranche of forward contract.",
        "label": "Adjustments To Additional Paid In Capital Settlement Of The First Tranche Of Forward Contract",
        "terseLabel": "Settlement of the first tranche of forward contract"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSettlementOfTheFirstTrancheOfForwardContract",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AggregateTransactionCostsPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate transaction costs paid.",
        "label": "Aggregate Transaction Costs Paid",
        "terseLabel": "Cash\u2014SNII operating account"
       }
      }
     },
     "localname": "AggregateTransactionCostsPaid",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AgreementAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement.",
        "label": "Agreement [Axis]"
       }
      }
     },
     "localname": "AgreementAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_AgreementDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement.",
        "label": "Agreement [Domain]"
       }
      }
     },
     "localname": "AgreementDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_AgreementNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement Name [",
        "label": "Agreement Name [Axis]"
       }
      }
     },
     "localname": "AgreementNameAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_AgreementNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement name",
        "label": "Agreement Name [Domain]"
       }
      }
     },
     "localname": "AgreementNameDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_AmortizationOfDebtCommitmentFeeAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of debt commitment fee asset.",
        "label": "Amortization of debt commitment fee asset",
        "negatedLabel": "Amortization of debt commitment fee asset"
       }
      }
     },
     "localname": "AmortizationOfDebtCommitmentFeeAsset",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_AmpereComputingLlcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ampere Computing LLC [Memebr]",
        "label": "Ampere Computing LLC [Member]",
        "terseLabel": "Ampere"
       }
      }
     },
     "localname": "AmpereComputingLlcMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_AtinitialrecognitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AtInitial Recognition .",
        "label": "AtInitialRecognition [Member]"
       }
      }
     },
     "localname": "AtinitialrecognitionMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition Contingent Consideration Liability.",
        "label": "Business Acquisition Contingent Consideration Liability [Policy Text Block]",
        "terseLabel": "Earn-Out Liability"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLiabilityPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_CapitalizationOfDeferredCostsToEquityUponShareIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalization of deferred costs to equity upon share issuance.",
        "label": "Capitalization of deferred costs to equity upon share issuance"
       }
      }
     },
     "localname": "CapitalizationOfDeferredCostsToEquityUponShareIssuance",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_CapitalizedSoftwarePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software.",
        "label": "Capitalized Software [Policy Text Block]",
        "terseLabel": "Capitalized Software"
       }
      }
     },
     "localname": "CapitalizedSoftwarePolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_CashReceivedFromPrivateInvestmentInPublicEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail": {
       "order": 2.0,
       "parentTag": "rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Received From Private Investment In Public Equity.",
        "label": "Cash Received From Private Investment In Public Equity",
        "terseLabel": "Cash\u2014PIPE"
       }
      }
     },
     "localname": "CashReceivedFromPrivateInvestmentInPublicEquity",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_CashReceivedFromTrustNetOfRedemptions": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail": {
       "order": 1.0,
       "parentTag": "rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Received From Trust Net Of Redemptions.",
        "label": "Cash Received From Trust Net Of Redemptions",
        "terseLabel": "Cash\u2014SNII trust and cash (net of redemption)"
       }
      }
     },
     "localname": "CashReceivedFromTrustNetOfRedemptions",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_CeoAwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CEO award member.",
        "label": "CEO Award [Member]"
       }
      }
     },
     "localname": "CeoAwardMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ChangeInFairValueOfForwardContract": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of forward contract.",
        "label": "Change In Fair Value Of Forward Contract",
        "verboseLabel": "Change in fair value of forward contract"
       }
      }
     },
     "localname": "ChangeInFairValueOfForwardContract",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ClassOfInvestorsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Investors .",
        "label": "Class Of Investors [Axis]"
       }
      }
     },
     "localname": "ClassOfInvestorsAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_ClassOfInvestorsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Investors .",
        "label": "Class Of Investors [Domain]"
       }
      }
     },
     "localname": "ClassOfInvestorsDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ClassOfWarrantOrRightGrandDateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right, Grand date fair value.",
        "label": "Class of warrant or right, Grand date fair value"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightGrandDateFairValue",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrants or rights number of shares covered by each warrant or right in the resulting company due to business combination.",
        "label": "Class Of Warrants Or Rights Number Of Shares Covered By Each Warrants Or Right In The Resulting Company Due To Business Combinations",
        "terseLabel": "Class of warrants or rights number of shares covered by each warrant or right in the resulting company due to business combination"
       }
      }
     },
     "localname": "ClassOfWarrantsOrRightsNumberOfSharesCoveredByEachWarrantsOrRightInTheResultingCompanyDueToBusinessCombinations",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "rgti_ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrants or rights outstanding exercise price per share of the resulting company due to business combination.",
        "label": "Class Of Warrants Or Rights Outstanding Exercise Price Per Share Of The Resulting Company Due To Business Combination",
        "terseLabel": "Class of warrants or rights outstanding exercise price per share of the resulting company due to business combination"
       }
      }
     },
     "localname": "ClassOfWarrantsOrRightsOutstandingExercisePricePerShareOfTheResultingCompanyDueToBusinessCombination",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "rgti_ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrants or rights warrants issued during the period.",
        "label": "Class Of Warrants Or Rights Warrants Issued During The Period",
        "terseLabel": "Warrants Issued"
       }
      }
     },
     "localname": "ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_Classofwarrantorrightissuedduringperiodwarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right Issued During Period Warrants .",
        "label": "ClassOfWarrantOrRightIssuedDuringPeriodWarrants",
        "terseLabel": "Class of warrant or right issued during period, Warrants"
       }
      }
     },
     "localname": "Classofwarrantorrightissuedduringperiodwarrants",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrants or rights aggregate fair value of warrants at the time of grant .",
        "label": "ClassOfWarrantsOrRightsAggregateFairValueOfWarrantsAtTheTimeOfGrant",
        "terseLabel": "Class of Warrants or Rights Aggregate Fair Value of Warrants at the Time of Grant"
       }
      }
     },
     "localname": "Classofwarrantsorrightsaggregatefairvalueofwarrantsatthetimeofgrant",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_Classofwarrantsorrightswarrantsissuedduringtheperiodunits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrants Or Rights Warrants Issued During The Period Units .",
        "label": "ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriodUnits",
        "terseLabel": "ClassOfWarrantsOrRightsWarrantsIssuedDuringThePeriod"
       }
      }
     },
     "localname": "Classofwarrantsorrightswarrantsissuedduringtheperiodunits",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_Classofwarrantsvestingpercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrants Vesting Percentage .",
        "label": "ClassOfWarrantsVestingPercentage",
        "terseLabel": "Class Of Warrants Vesting Percentage"
       }
      }
     },
     "localname": "Classofwarrantsvestingpercentage",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "rgti_CollaborativeResearchAndOtherProfessionalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative research and other professional services",
        "label": "Collaborative research and other professional services [Member]"
       }
      }
     },
     "localname": "CollaborativeResearchAndOtherProfessionalServicesMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CommonStockNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Number Of Votes Per Share.",
        "label": "Common Stock Number Of Votes Per Share",
        "terseLabel": "Common stock number of votes per share"
       }
      }
     },
     "localname": "CommonStockNumberOfVotesPerShare",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "rgti_CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock of previous company converted into current company common stock par or stated value per share.",
        "label": "Common Stock Of Previous Company Converted Into Current Company Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock of previous company converted into current company common stock par or stated value per share"
       }
      }
     },
     "localname": "CommonStockOfPreviousCompanyConvertedIntoCurrentCompanyCommonStockParOrStatedValuePerShare",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "rgti_CommonStockPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock purchase agreement.",
        "label": "Common Stock Purchase Agreement [Member]"
       }
      }
     },
     "localname": "CommonStockPurchaseAgreementMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CommonStockSharesExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares exchange ratio.",
        "label": "Common Stock Shares Exchange Ratio",
        "terseLabel": "Common stock shares exchange ratio"
       }
      }
     },
     "localname": "CommonStockSharesExchangeRatio",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "rgti_CommonStockSharesIssuedAsAResultOfExchange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares issued as a result of exchange.",
        "label": "Common stock shares issued as a result of exchange",
        "terseLabel": "Common stock shares issued as a result of exchange"
       }
      }
     },
     "localname": "CommonStockSharesIssuedAsAResultOfExchange",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares issued due to exercise of stock options immediately before closing.",
        "label": "Common Stock Shares Issued Due To Exercise Of Stock Options Immediately Before Closing",
        "terseLabel": "Common Stock\u2014exercise of Legacy Rigetti stock options immediately prior to the closing"
       }
      }
     },
     "localname": "CommonStockSharesIssuedDueToExerciseOfStockOptionsImmediatelyBeforeClosing",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares issued due to exercise of warrants immediately before closing.",
        "label": "Common Stock Shares Issued Due To Exercise Of Warrants Immediately Before Closing",
        "terseLabel": "Common Stock\u2014exercise of Legacy Rigetti warrants immediately prior to the closing"
       }
      }
     },
     "localname": "CommonStockSharesIssuedDueToExerciseOfWarrantsImmediatelyBeforeClosing",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_CommonStockSharesIssuedInTheNewCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares issued in the new company.",
        "label": "Common Stock Shares Issued In The New Company",
        "terseLabel": "Common Stock\u2014Legacy Rigetti"
       }
      }
     },
     "localname": "CommonStockSharesIssuedInTheNewCompany",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares issued in the new company upon conversion of temporary equity.",
        "label": "Common Stock Shares Issued In The New Company Upon Conversion Of Temporary Equity",
        "terseLabel": "Common Stock\u2014upon conversion of Legacy Rigetti Series preferred stock"
       }
      }
     },
     "localname": "CommonStockSharesIssuedInTheNewCompanyUponConversionOfTemporaryEquity",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares issued pursuant to private investment in public equity.",
        "label": "Common Stock Shares Issued Pursuant To Private Investment In Public Equity",
        "terseLabel": "Shares issued in PIPE"
       }
      }
     },
     "localname": "CommonStockSharesIssuedPursuantToPrivateInvestmentInPublicEquity",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_CommonStockSharesNewlyIssuedInThePredecessorCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares newly issued in the predecessor company.",
        "label": "Common Stock Shares Newly Issued In The Predecessor Company",
        "terseLabel": "Common Stock\u2014SNII Class ordinary shares"
       }
      }
     },
     "localname": "CommonStockSharesNewlyIssuedInThePredecessorCompany",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_CommonStockTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock text block.",
        "label": "COMMON STOCK [Text Block]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_CommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock warrants member.",
        "label": "Common Stock warrants [Member]",
        "terseLabel": "Common Stock Warrants"
       }
      }
     },
     "localname": "CommonStockWarrantsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ConditionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condition [Axis]"
       }
      }
     },
     "localname": "ConditionAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_ConditionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condition [Domain]"
       }
      }
     },
     "localname": "ConditionDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ContingentEarnOutLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Earn Out Liability Fair Value Disclosure.",
        "label": "Contingent Earn Out Liability Fair Value Disclosure",
        "verboseLabel": "Earn-out Liability"
       }
      }
     },
     "localname": "ContingentEarnOutLiabilityFairValueDisclosure",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ContingentEarnOutLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earn out Liability [Member]",
        "terseLabel": "Earn out Liability"
       }
      }
     },
     "localname": "ContingentEarnOutLiabilityMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ConversionFromTemporaryEquityToPermanentEquityExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion from temporary equity to permanent equity exchange ratio.",
        "label": "Conversion From Temporary Equity To Permanent Equity Exchange Ratio",
        "terseLabel": "Conversion from temporary equity to permanent equity exchange ratio"
       }
      }
     },
     "localname": "ConversionFromTemporaryEquityToPermanentEquityExchangeRatio",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "rgti_ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion Of Common Stock Shares From The Previous Company To The Current Company [Member]"
       }
      }
     },
     "localname": "ConversionOfCommonStockSharesFromThePreviousCompanyToTheCurrentCompanyMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ConvertibleSeriesC1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Series C-1 Preferred Stock Member",
        "label": "Convertible Series C1 Preferred Stock [Member]",
        "terseLabel": "Convertible Series C-1 Preferred Stock"
       }
      }
     },
     "localname": "ConvertibleSeriesC1PreferredStockMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ConvertibleSeriesCPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Series C Preferred Stock",
        "label": "Convertible Series C Preferred Stock [Member]",
        "terseLabel": "Convertible Series C Preferred Stock"
       }
      }
     },
     "localname": "ConvertibleSeriesCPreferredStockMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CostsOfObtainingAndFulfillingContractsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of obtaining and fulfilling contracts.",
        "label": "Costs of Obtaining and Fulfilling Contracts [Policy Text Block]",
        "terseLabel": "Costs of Obtaining and Fulfilling Contracts"
       }
      }
     },
     "localname": "CostsOfObtainingAndFulfillingContractsPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_CriteriaAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Criteria [Axis]"
       }
      }
     },
     "localname": "CriteriaAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_CriteriaDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Criteria [Domain]"
       }
      }
     },
     "localname": "CriteriaDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CurrentPortionOfLongTermDebtGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermLoansPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current portion of long term debt gross.",
        "label": "Current Portion of Long Term Debt Gross",
        "terseLabel": "Less: current portion of long term debt-principal"
       }
      }
     },
     "localname": "CurrentPortionOfLongTermDebtGross",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_CurrentPortionOfOutstandingPrincipalAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LoansPayableCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Portion Of Outstanding Principal Amount.",
        "label": "Current Portion Of Outstanding Principal Amount",
        "terseLabel": "Current portion of long term debt\u2014principal"
       }
      }
     },
     "localname": "CurrentPortionOfOutstandingPrincipalAmount",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_CurrentYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current year.",
        "label": "Current Year [Member]"
       }
      }
     },
     "localname": "CurrentYearMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer a.",
        "label": "Customer A [Member]",
        "terseLabel": "Customer A [Member]"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CustomerBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer b.",
        "label": "Customer B [Member]",
        "terseLabel": "Customer B [Member]"
       }
      }
     },
     "localname": "CustomerBMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CustomerCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer c.",
        "label": "Customer C [Member]",
        "terseLabel": "Customer C [Member]"
       }
      }
     },
     "localname": "CustomerCMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CustomerDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer D [Member]"
       }
      }
     },
     "localname": "CustomerDMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CustomerEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer E [Member]"
       }
      }
     },
     "localname": "CustomerEMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CustomerFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer F.",
        "label": "Customer F [Member]"
       }
      }
     },
     "localname": "CustomerFMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_CustomerWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Warrants .",
        "label": "Customer Warrants [Member]"
       }
      }
     },
     "localname": "CustomerWarrantsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_DebtInstrumentPaymentFeepercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument payment fee, Percentage.",
        "label": "Debt instrument payment fee,Percentage",
        "terseLabel": "Debt instrument payment fee, Percentage"
       }
      }
     },
     "localname": "DebtInstrumentPaymentFeepercentage",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_DebtNetOfCurrentPortion": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 30.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt net of current portion.",
        "label": "Debt net of current portion",
        "terseLabel": "Debt - net of current portion"
       }
      }
     },
     "localname": "DebtNetOfCurrentPortion",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_DebtSecuritiesAvailableForSaleMaturityYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities available for sale maturity year.",
        "label": "Debt Securities Available For Sale Maturity Year",
        "terseLabel": "Available For Sale Maturity Year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityYear",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DeferralOfRevenue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferral of revenue",
        "label": "Deferral of revenue",
        "terseLabel": "Deferral of revenue"
       }
      }
     },
     "localname": "DeferralOfRevenue",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_DeferredFinancingCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred financing costs.",
        "label": "Deferred Financing Costs [Policy Text Block]",
        "terseLabel": "Deferred Financing Costs"
       }
      }
     },
     "localname": "DeferredFinancingCostsPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred offering costs in accounts payable and accrued expenses.",
        "label": "Deferred Offering Costs In Accounts Payable And Accrued Expenses",
        "terseLabel": "Deferred offering costs in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DeferredOfferingCostsInAccountsPayableAndAccruedExpenses",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_DeferredOfferingCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred offering costs..",
        "label": "Deferred Offering Costs [Policy Text Block]",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredOfferingCostsPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_DeferredTaxAssetsRightOfUseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 12.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets right of use liabilities.",
        "label": "Deferred Tax Assets Right Of Use Liabilities",
        "terseLabel": "ROU liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsRightOfUseLiabilities",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities depreciation and amortization.",
        "label": "Deferred Tax Liabilities Depreciation And Amortization",
        "terseLabel": "Depreciation\u00a0and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_DeferredTaxLiabilitiesRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities right of use assets.",
        "label": "Deferred Tax Liabilities Right Of Use Assets",
        "terseLabel": "ROU Asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_DerivativeWarrantLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative warrant liabilities.",
        "label": "Derivative Warrant Liabilities [Member]"
       }
      }
     },
     "localname": "DerivativeWarrantLiabilitiesMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of organization business operations and basis of presentation.",
        "label": "Description Of Organization Business Operations And Basis Of Presentation [Line Items]",
        "terseLabel": "Description Of Organization Business Operations And Basis Of Presentation [Line Items]"
       }
      }
     },
     "localname": "DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of organization business operations and basis of presentation.",
        "label": "Description Of Organization Business Operations And Basis Of Presentation [Table]",
        "terseLabel": "Description Of Organization Business Operations And Basis Of Presentation [Table]"
       }
      }
     },
     "localname": "DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of assumptions based on significant unobservable inputs used in the valuation of earn out liability arising out of business combination.",
        "label": "Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination",
        "terseLabel": "Schedule of Inputs Into the Respective Models"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombination",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination.",
        "label": "Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Abstract]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationAbstract",
     "nsuri": "http://www.rigetti.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of assumptions based on significant unobservable inputs used in the valuation Of earn out liability arising out of business combination.",
        "label": "Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Line Items]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of assumptions based on significant Unobservable inputs used in the valuation of earn out liability arising out of business combination.",
        "label": "Disclosure In Tabular Form Of Assumptions Based On Significant Unobservable Inputs Used In The Valuation Of Earn out Liability Arising Out Of Business Combination [Table]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfAssumptionsBasedOnSignificantUnobservableInputsUsedInTheValuationOfEarnOutLiabilityArisingOutOfBusinessCombinationTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of concentration of accounts receivable.",
        "label": "Disclosure In Tabular Form Of Concentration Of Accounts Receivable [Table Text Block]",
        "terseLabel": "Schedule of Customers Accounts Receivable"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfConcentrationOfAccountsReceivableTableTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items].",
        "label": "Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Line Items]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfConcentrationOfAccountsRecievableLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Table].",
        "label": "Disclosure In Tabular Form Of Concentration Of Accounts Recievable [Table]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfConcentrationOfAccountsRecievableTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Net Proceeds From Business Combination.",
        "label": "Disclosure In Tabular Form Of Net Proceeds From Business Combination [Line Items]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfNetProceedsFromBusinessCombinationLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Net Proceeds From Business Combination.",
        "label": "Disclosure In Tabular Form Of Net Proceeds From Business Combination [Table]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of net proceeds from business combination.",
        "label": "Disclosure In Tabular Form Of Net Proceeds From Business Combination [Table Text Block]",
        "terseLabel": "Summary of net proceeds from business combination and PIPE financing"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfNetProceedsFromBusinessCombinationTableTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.",
        "label": "Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Line Items]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.",
        "label": "Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Table]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination.",
        "label": "Disclosure In Tabular Form Of Reconciliation Of Common Stock Shares Issued Following Business Combination [Table Text Block]",
        "terseLabel": "Summary of consummation of the business combination"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfReconciliationOfCommonStockSharesIssuedFollowingBusinessCombinationTableTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_DisclosureOfVestingStatusOfWarrantsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Vesting Status Of Warrants .",
        "label": "Disclosure Of Vesting Status Of Warrants [Table]"
       }
      }
     },
     "localname": "DisclosureOfVestingStatusOfWarrantsTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureOfVestingStatusOfWarrantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of vesting status of warrants .",
        "label": "Disclosure Of Vesting Status Of Warrants [Table Text Block]",
        "terseLabel": "Summary of vesting status of the Customer Warrant"
       }
      }
     },
     "localname": "DisclosureOfVestingStatusOfWarrantsTableTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_DisclosureofvestingstatusofwarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of vesting status of warrants .",
        "label": "DisclosureOfVestingStatusOfWarrants [Abstract]",
        "terseLabel": "Disclosure Of Vesting Status Of Warrants [Abstract]"
       }
      }
     },
     "localname": "DisclosureofvestingstatusofwarrantsAbstract",
     "nsuri": "http://www.rigetti.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rgti_DisclosureofvestingstatusofwarrantsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DisclosureOfVestingStatusOfWarrants .",
        "label": "DisclosureOfVestingStatusOfWarrants [Line Items]",
        "terseLabel": "Disclosure Of Vesting Status Of Warrants [Line Items]"
       }
      }
     },
     "localname": "DisclosureofvestingstatusofwarrantsLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation fair market value adjustment",
        "label": "Effective Income Tax Rate Reconciliation Fair Market Value Adjustment",
        "terseLabel": "Fair market value adjustment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationFairMarketValueAdjustment",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_EffectiveIncomeTaxRateReconciliationGoodwillImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation goodwill impairment",
        "label": "Effective Income Tax Rate Reconciliation Goodwill Impairment",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGoodwillImpairment",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_EffectiveIncomeTaxRateReconciliationTransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation transaction costs.",
        "label": "Effective Income Tax Rate Reconciliation Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransactionCosts",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_EmergingGrowthCompanyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for emerging growth company.",
        "label": "Emerging Growth Company Policy [Text Block]",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_EquityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Axis]"
       }
      }
     },
     "localname": "EquityAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_EquityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Domain]"
       }
      }
     },
     "localname": "EquityDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_EstimatedPeriodOfExpirationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period of expiration.",
        "label": "Estimated Period Of Expiration [Member]",
        "terseLabel": "Estimated time to expiration"
       }
      }
     },
     "localname": "EstimatedPeriodOfExpirationMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_EventAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event [Axis]"
       }
      }
     },
     "localname": "EventAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_EventDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event [Domain]"
       }
      }
     },
     "localname": "EventDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ExerciseOfLoanAndSecurityAgreementWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of loan and security agreement warrants.",
        "label": "Exercise of loan and security agreement warrants",
        "terseLabel": "Reclassification of loan and security agreement warrants to equity"
       }
      }
     },
     "localname": "ExerciseOfLoanAndSecurityAgreementWarrants",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value liabilities measured on recurring and nonrecurring basis valuation techniques",
        "label": "Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table Text Block]",
        "terseLabel": "Summary of Fair Value Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_FairValueOfLoanAndSecurityAgreementAndWarrantLiability.": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of loan and security agreement and warrant liability.",
        "label": "Fair Value Of Loan And Security Agreement And Warrant Liability.",
        "terseLabel": "Fair value of loan and security agreement warrant liability"
       }
      }
     },
     "localname": "FairValueOfLoanAndSecurityAgreementAndWarrantLiability.",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ForwardContractAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward contract assets current.",
        "label": "Forward Contract Assets Current",
        "terseLabel": "Forward contract\u2014assets"
       }
      }
     },
     "localname": "ForwardContractAssetsCurrent",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ForwardContractLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 25.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward contract liabilities.",
        "label": "Forward contract Liabilities",
        "terseLabel": "Forward contract\u2014liabilities"
       }
      }
     },
     "localname": "ForwardContractLiabilities",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ForwardWarrantAgreementDisclosure": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward warrant agreement disclosure [Text block].",
        "label": "Forward Warrant Agreement Disclosure",
        "terseLabel": "Forward Warrant Agreement"
       }
      }
     },
     "localname": "ForwardWarrantAgreementDisclosure",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_ForwardWarrantAgreementFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Warrant Agreement Fair Value Disclosure.",
        "label": "Forward Warrant Agreement Fair Value Disclosure",
        "terseLabel": "Forward Warrant Agreement"
       }
      }
     },
     "localname": "ForwardWarrantAgreementFairValueDisclosure",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ForwardWarrantAgreementLiabilityFairValueDisclosureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward warrant agreement liability fair value disclosure.",
        "label": "Forward Warrant Agreement Liability Fair Value Disclosure [Member]",
        "terseLabel": "Forward warrant agreement"
       }
      }
     },
     "localname": "ForwardWarrantAgreementLiabilityFairValueDisclosureMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ForwardWarrantAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward warrant agreement member.",
        "label": "Forward Warrant Agreement [Member]"
       }
      }
     },
     "localname": "ForwardWarrantAgreementMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_FurnitureAndOtherAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture and other assets.",
        "label": "Furniture and other assets [Member]",
        "terseLabel": "Furniture and other assets [Member]"
       }
      }
     },
     "localname": "FurnitureAndOtherAssetsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_GovernmentEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government entities.",
        "label": "Government Entities [Member]"
       }
      }
     },
     "localname": "GovernmentEntitiesMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 30.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in accrued expenses and other current liabilities.",
        "label": "Increase Decrease In Accrued Expenses And Other Current Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_IncreaseDecreaseInDeferredRent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in deferred rent.",
        "label": "Increase Decrease In Deferred Rent",
        "verboseLabel": "Adjustments To Deferred Rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRent",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in unrealized loss on available for sale securities.",
        "label": "Increase Decrease In Unrealized Loss On Available For Sale Securities",
        "verboseLabel": "Change in unrealized loss on\u00a0available-for-sale\u00a0securities"
       }
      }
     },
     "localname": "IncreaseDecreaseInUnrealizedLossOnAvailableForSaleSecurities",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_InitialFairValueOfEarnoutLiabilityAcquiredInMergera": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial fair value of earn-out liability acquired in merger.",
        "label": "Initial Fair Value Of Earnout Liability Acquired In Mergera",
        "terseLabel": "Initial fair value of earn-out liability acquired in merger"
       }
      }
     },
     "localname": "InitialFairValueOfEarnoutLiabilityAcquiredInMergera",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial fair value of private placement and public warrants liability acquired in merger.",
        "label": "Initial Fair Value Of Private Placement And Public Warrants Liability Acquired In Merger",
        "terseLabel": "Initial fair value of private placement and public warrants liability acquired in merger"
       }
      }
     },
     "localname": "InitialFairValueOfPrivatePlacementAndPublicWarrantsLiabilityAcquiredInMerger",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_InitialSubscriptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Subscription Agreement.",
        "label": "Initial Subscription Agreement [Member]"
       }
      }
     },
     "localname": "InitialSubscriptionAgreementMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_InvestorAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investor.",
        "label": "Investor [Axis]"
       }
      }
     },
     "localname": "InvestorAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_InvestorDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investor.",
        "label": "Investor [Domain]"
       }
      }
     },
     "localname": "InvestorDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_InvestorNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor Name [Axis]"
       }
      }
     },
     "localname": "InvestorNameAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_InvestorNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor Name [Domain]"
       }
      }
     },
     "localname": "InvestorNameDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock pursuant to the common stock purchase agreement shares.",
        "label": "Issuance Of Common Stock Pursuant To The Common Stock Purchase Agreement Shares",
        "terseLabel": "Issuance of common stock pursuant to the Common Stock Purchase Agreement (Share)"
       }
      }
     },
     "localname": "IssuanceOfCommonStockPursuantToTheCommonStockPurchaseAgreementShares",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock through business combination and private investment of public equity net of transaction costs and derivative liabilities shares.",
        "label": "Issuance Of Common Stock Through Business Combination And Private Investment Of Public Equity Net Of Transaction Costs And Derivative Liabilities Shares",
        "terseLabel": "Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, as restated, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesShares",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock through business combination and private investment of public equity net of transaction costs and derivative liabilities value.",
        "label": "Issuance Of Common Stock Through Business Combination And Private Investment Of Public Equity Net Of Transaction Costs And Derivative Liabilities Value",
        "terseLabel": "Issuance of common stock through Business Combination and PIPE financing, net of transaction costs and derivative liabilities, as restated"
       }
      }
     },
     "localname": "IssuanceOfCommonStockThroughBusinessCombinationAndPrivateInvestmentOfPublicEquityNetOfTransactionCostsAndDerivativeLiabilitiesValue",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon exercise of common stock warrants.",
        "label": "Issuance Of Common Stock Upon Exercise Of Common Stock Warrants",
        "terseLabel": "Issuance of common stock upon exercise of common stock warrants"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponExerciseOfCommonStockWarrants",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon exercise of common stock warrants, Shares.",
        "label": "Issuance Of Common Stock Upon Exercise Of Common Stock Warrants, Shares",
        "terseLabel": "Issuance of common stock upon exercise of common stock warrants (Share)"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponExerciseOfCommonStockWarrantsShares",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_ItHardwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It hardware.",
        "label": "IT hardware [Member]",
        "terseLabel": "IT hardware [Member]"
       }
      }
     },
     "localname": "ItHardwareMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_LeaseLiabilitiesArisingFromObtainingRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease liabilities arising from obtaining right of use assets.",
        "label": "Lease Liabilities Arising From Obtaining Right Of Use Assets",
        "terseLabel": "Lease liabilities arising from obtaining right-of-use assets"
       }
      }
     },
     "localname": "LeaseLiabilitiesArisingFromObtainingRightOfUseAssets",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan and Security Agreement [Member]"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_MarketBasedVestingAwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market Based Vesting Award [Member]"
       }
      }
     },
     "localname": "MarketBasedVestingAwardMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_MeasurementInputProbabilityOfOccurringTheContingencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input probability of occurring the contingency member.",
        "label": "Measurement Input Probability of occurring the contingency"
       }
      }
     },
     "localname": "MeasurementInputProbabilityOfOccurringTheContingencyMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_NetIncomeLossRelationToCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income (loss) relation to common stock.",
        "label": "Net Income Loss Relation To Common Stock",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLossRelationToCommonStock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_NonCashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 31.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash lease expense.",
        "label": "Non Cash Lease Expense",
        "verboseLabel": "Non-cash\u00a0lease expense"
       }
      }
     },
     "localname": "NonCashLeaseExpense",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of consecutive trading days for determining the share price.",
        "label": "Number Of Consecutive Trading Days For Determining The Share Price",
        "terseLabel": "Number of consecutive trading days for determining the share price",
        "verboseLabel": "Number of consecutive trading days for determining the share price"
       }
      }
     },
     "localname": "NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "rgti_NumberOfCustomersAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Customers.",
        "label": "Number Of Customers [Axis]"
       }
      }
     },
     "localname": "NumberOfCustomersAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_NumberOfCustomersDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Customers.",
        "label": "Number Of Customers [Domain]"
       }
      }
     },
     "localname": "NumberOfCustomersDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_NumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Employees",
        "label": "Number Of Employees",
        "terseLabel": "Number Of Employees"
       }
      }
     },
     "localname": "NumberOfEmployees",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "rgti_NumberOfTradingDaysForDeterminingTheSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Trading Days For Determining The Share Price.",
        "label": "Number Of Trading Days For Determining The Share Price",
        "terseLabel": "Number of trading days for determining the share price",
        "verboseLabel": "Number of trading days for determining the share price"
       }
      }
     },
     "localname": "NumberOfTradingDaysForDeterminingTheSharePrice",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "rgti_OfferingCostsIncurred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering costs incurred.",
        "label": "Offering costs incurred",
        "terseLabel": "Offering costs incurred"
       }
      }
     },
     "localname": "OfferingCostsIncurred",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_OneTimeBonus": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-time bonus.",
        "label": "One Time Bonus",
        "terseLabel": "One-time bonus"
       }
      }
     },
     "localname": "OneTimeBonus",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease liabilities recorded on adoption of ASU 2016-02.",
        "label": "Operating Lease Liabilities Recorded On Adoption Of ASU 201602",
        "terseLabel": "Operating lease liabilities recorded on adoption of ASU\u00a02016-02"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesRecordedOnAdoptionOfAsu201602",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_OperatingLeaseRentExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease rent expenses.",
        "label": "Operating Lease Rent Expenses",
        "terseLabel": "Rent expenses"
       }
      }
     },
     "localname": "OperatingLeaseRentExpenses",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/LeasesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_PaymentOfDeferredOfferingCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of deferred offering costs.",
        "label": "Payment of Deferred Offering Costs",
        "negatedLabel": "Payments on deferred offering costs"
       }
      }
     },
     "localname": "PaymentOfDeferredOfferingCosts",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_PaymentOfLoanAndSecurityAgreementExitFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of loan and security agreement exit fees.",
        "label": "Payment Of Loan And Security Agreement Exit Fees",
        "negatedLabel": "Payment on loan and security agreement exit fees"
       }
      }
     },
     "localname": "PaymentOfLoanAndSecurityAgreementExitFees",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_PaymentOfTransactionCostsThroughCash": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of transaction costs through cash.",
        "label": "Payment Of Transaction Costs Through Cash",
        "terseLabel": "Payment of transaction costs through cash"
       }
      }
     },
     "localname": "PaymentOfTransactionCostsThroughCash",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Debt Related Cost Paid Upon The Consummation Of Merger.",
        "label": "Percentage Of Debt Related Cost Paid Upon The Consummation Of Merger",
        "terseLabel": "Percentage of debt related cost paid upon the consummation of merger"
       }
      }
     },
     "localname": "PercentageOfDebtRelatedCostPaidUponTheConsummationOfMerger",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "rgti_PercentageOfReductionInEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reduction In employees.",
        "label": "Percentage Of Reduction In Employees",
        "terseLabel": "Percentage Of Reduction In Employees"
       }
      }
     },
     "localname": "PercentageOfReductionInEmployees",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the aggregate number of shares of common stock issued and outstanding immediately prior to the execution of the agreement.",
        "label": "Percentage Of The Aggregate Number Of Shares Of Common Stock Issued And Outstanding Immediately Prior To The Execution Of The Agreement",
        "verboseLabel": "Percentage of the aggregate number of shares of common stock issued and outstanding immediately prior to the execution of the agreement."
       }
      }
     },
     "localname": "PercentageOfTheAggregateNumberOfSharesOfCommonStockIssuedAndOutstandingImmediatelyPriorToTheExecutionOfTheAgreement",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the common stock of all classes outstanding on preceding year.",
        "label": "Percentage Of The Common Stock Of All Classes Outstanding On Preceding Year",
        "terseLabel": "Percentage of the common stock of all classes outstanding on preceding year"
       }
      }
     },
     "localname": "PercentageOfTheCommonStockOfAllClassesOutstandingOnPrecedingYear",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of total aggregate number (or volume) of shares of common stock traded on the nasdaq capital market.",
        "label": "Percentage of Total Aggregate Number (or volume) of shares of Common Stock traded on The Nasdaq Capital Market",
        "terseLabel": "Percentage of total aggregate number (or volume) of shares of Common Stock traded on The Nasdaq Capital Market"
       }
      }
     },
     "localname": "PercentageOfTotalAggregateNumberOrVolumeOfSharesOfCommonStockTradedOnTheNasdaqCapitalMarket",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_PercentageOfTotalGrossPropertyAndEquipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of total gross property and equipment.",
        "label": "Percentage Of Total Gross Property And Equipment",
        "terseLabel": "Percentage of total gross property and equipment"
       }
      }
     },
     "localname": "PercentageOfTotalGrossPropertyAndEquipment",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_PercentageOfadvancedFundsUnderTheAmendment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of \u00a0advanced funds under the amendment.",
        "label": "Percentage of Advanced Funds Under the Amendment",
        "terseLabel": "Percentage of \u00a0advanced funds under the amendment"
       }
      }
     },
     "localname": "PercentageOfadvancedFundsUnderTheAmendment",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "rgti_PeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period.",
        "label": "Period [Axis]"
       }
      }
     },
     "localname": "PeriodAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_PeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period.",
        "label": "Period [Domain]"
       }
      }
     },
     "localname": "PeriodDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_PeriodOfEarnoutShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period Of Earnout Shares.",
        "label": "Period Of Earnout Shares",
        "terseLabel": "Period of earnout shares"
       }
      }
     },
     "localname": "PeriodOfEarnoutShares",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "rgti_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses and other current assets.",
        "label": "Prepaid expenses and other current assets [Policy Text Block]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_PreviousYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previous year.",
        "label": "Previous Year [Member]"
       }
      }
     },
     "localname": "PreviousYearMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_PrivateInvestmentInPublicEquityInvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Investment In Public Equity Investors.",
        "label": "Private Investment In Public Equity Investors [Member]"
       }
      }
     },
     "localname": "PrivateInvestmentInPublicEquityInvestorsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_PrivatePlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private placement warrants.",
        "label": "Private Placement Warrants [Member]",
        "terseLabel": "Private Placement Warrants"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_PrivateWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private warrant.",
        "label": "Private Warrant [Member]",
        "verboseLabel": "Private Warrants"
       }
      }
     },
     "localname": "PrivateWarrantMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ProceedsFromBusinessCombinationNetOfTransactionCostsPaid": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from business combination net of transaction costs paid.",
        "label": "Proceeds From Business Combination Net Of Transaction Costs Paid",
        "positiveLabel": "Proceeds from business combination net of transaction costs paid",
        "terseLabel": "Proceeds from Business Combination, net of transaction costs paid",
        "totalLabel": "Net Proceeds from Business Combination and PIPE"
       }
      }
     },
     "localname": "ProceedsFromBusinessCombinationNetOfTransactionCostsPaid",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of common stock upon exercise of stock options and warrants.",
        "label": "Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options And Warrants",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options and warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptionsAndWarrants",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_ProcessEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Process equipment.",
        "label": "Process equipment [Member]",
        "terseLabel": "Process equipment [Member]"
       }
      }
     },
     "localname": "ProcessEquipmentMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_PromoteSponsorVestingSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Promote Sponsor Vesting Shares.",
        "label": "Promote Sponsor Vesting Shares [Member]"
       }
      }
     },
     "localname": "PromoteSponsorVestingSharesMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_PublicAndPrivateWarrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public And Private Warrants.",
        "label": "Public And Private Warrants [Policy Text Block]",
        "terseLabel": "Public and Private Warrants"
       }
      }
     },
     "localname": "PublicAndPrivateWarrantsPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Warrants.",
        "label": "Public Warrants [Member]",
        "terseLabel": "Public Warrants"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of property and equipment recorded in accrued expense.",
        "label": "Purchases of property and equipment recorded in accrued expense",
        "verboseLabel": "Purchases of property and equipment recorded in accrued expense"
       }
      }
     },
     "localname": "PurchasesOfPropertyAndEquipmentRecordedInAccruedExpense",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_QuantumComputingFridgesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quantum computing fridges.",
        "label": "Quantum computing fridges [Member]",
        "terseLabel": "Quantum computing fridges [Member]"
       }
      }
     },
     "localname": "QuantumComputingFridgesMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_RGTIAgreementNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RGTI Agreement Name [Axis]"
       }
      }
     },
     "localname": "RGTIAgreementNameAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_RGTICommonStockPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RGTI Common Stock Purchase Agreement [Member]",
        "terseLabel": "RGTI Common Stock Purchase Agreement [Member]"
       }
      }
     },
     "localname": "RGTICommonStockPurchaseAgreementMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recently issued accounting pronouncements not yet adopted.",
        "label": "Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block]",
        "verboseLabel": "Recently Issued Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_ReclassificationOfTemporaryEquityShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of temporary equity shares.",
        "label": "Reclassification Of Temporary Equity Shares",
        "terseLabel": "Issuance\u00a0of\u00a0common\u00a0stock upon conversion of legacy Series C and Series\u00a0C-1\u00a0preferred stock in connection with the Business Combination, shares"
       }
      }
     },
     "localname": "ReclassificationOfTemporaryEquityShares",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_RecognitionOfDeferredRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition of deferred revenues",
        "label": "Recognition of deferred revenues",
        "terseLabel": "Recognition of deferred revenue"
       }
      }
     },
     "localname": "RecognitionOfDeferredRevenues",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_RedeemableConvertiblePreferredStockTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable convertible preferred stock text block.",
        "label": "Redeemable Convertible preferred stock [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_RedemptionOfCommonStockSharesOfThePredecessorCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption of common stock shares of the predecessor company.",
        "label": "Redemption Of Common Stock Shares Of The Predecessor Company",
        "negatedLabel": "Less: redemption of SNII Class\u00a0A ordinary shares"
       }
      }
     },
     "localname": "RedemptionOfCommonStockSharesOfThePredecessorCompany",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_RemainderoftwothousandandtwentythreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remainder of two thousand and twenty three.",
        "label": "RemainderOfTwoThousandAndTwentyThree [Member]",
        "terseLabel": "Remainder Of Two Thousand And Twenty Three [Member]"
       }
      }
     },
     "localname": "RemainderoftwothousandandtwentythreeMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_RestrictedStockUnitsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units.",
        "label": "Restricted Stock Units [Table]"
       }
      }
     },
     "localname": "RestrictedStockUnitsTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_RevenuePerformanceObligationTransactionPriceAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue performance obligation transaction price [Axis].",
        "label": "Revenue Performance Obligation Transaction Price [Axis]"
       }
      }
     },
     "localname": "RevenuePerformanceObligationTransactionPriceAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_RevenuePerformanceObligationTransactionPriceDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue performance obligation transaction price.",
        "label": "Revenue Performance Obligation Transaction Price [Domain]"
       }
      }
     },
     "localname": "RevenuePerformanceObligationTransactionPriceDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_RgtiAgreementNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RGTI Agreement Name [Domain]"
       }
      }
     },
     "localname": "RgtiAgreementNameDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_RigettiComputingIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rigetti computing, Inc.",
        "label": "Rigetti Computing, Inc [Member]"
       }
      }
     },
     "localname": "RigettiComputingIncMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail",
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_RigettiHoldingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rigetti holdings member.",
        "label": "Rigetti Holdings [Member]"
       }
      }
     },
     "localname": "RigettiHoldingsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_RigettiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rigetti member.",
        "label": "Rigetti [Member]"
       }
      }
     },
     "localname": "RigettiMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_RightOfUseAssetsRecordedOnAdoptionOfAsu201602": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right of use assets recorded on adoption Of ASU 2016-02.",
        "label": "Right Of Use Assets Recorded On Adoption Of ASU 201602",
        "terseLabel": "Right-of-use\u00a0assets recorded on adoption of ASU\u00a02016-02"
       }
      }
     },
     "localname": "RightOfUseAssetsRecordedOnAdoptionOfAsu201602",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_SalesAndMarketingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales and marketing.",
        "label": "Sales and Marketing [Policy Text Block]",
        "terseLabel": "Sales and Marketing"
       }
      }
     },
     "localname": "SalesAndMarketingPolicyTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule computation of earnings per share basic and diluted.",
        "label": "Schedule Computation Of Earnings Per Share Basic And Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Earnings Per Share Basic Aand Diluted"
       }
      }
     },
     "localname": "ScheduleComputationOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Change in Contract with Customer, Asset and Liability",
        "label": "Schedule of Change in Contract with Customer, Asset and Liability [Table Text Block]",
        "terseLabel": "Summary of Change in Contract with Customer, Asset and Liability"
       }
      }
     },
     "localname": "ScheduleOfChangeInContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of future minimum lease payments under non cancelable operating leases.",
        "label": "Schedule Of Future Minimum Lease Payments Under Non Cancelable Operating Leases [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableOperatingLeasesTableTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share based compensation restricted stock and restricted stock units activity.",
        "label": "Schedule Of Share based Compensation Restricted Stock And Restricted Stock Units Activity [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityAbstract",
     "nsuri": "http://www.rigetti.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rgti_ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share based compensation restricted stock and restricted stock units activity..",
        "label": "Schedule Of Share Based Compensation Restricted Stock And Restricted Stock Units Activity [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockAndRestrictedStockUnitsActivityLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_ScheduleOfTransitionPeriodComparativeDataLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of transition period comparative data line items.",
        "label": "Schedule of Transition Period Comparative Data [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfTransitionPeriodComparativeDataLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_ScheduleOfTransitionPeriodComparativeDataTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of transition period comparative data table.",
        "label": "Schedule Of Transition Period Comparative Data [Table]"
       }
      }
     },
     "localname": "ScheduleOfTransitionPeriodComparativeDataTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_SeriesCOnePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C One Preferred Stock [Member]",
        "terseLabel": "Series C-1 Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesCOnePreferredStockMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_SeriesCOneRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series C One Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesCOneRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_SeriesCRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C Redeemable Convertible Preferred Stock .",
        "label": "Series C Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesCRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service Based And Performance Based Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "ServiceBasedAndPerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_SettlementOfTheFirstTrancheOfForwardContract": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settlement of the first tranche of forward contract.",
        "label": "Settlement of the first tranche of forward contract",
        "terseLabel": "Settlement of the first tranche of forward contract"
       }
      }
     },
     "localname": "SettlementOfTheFirstTrancheOfForwardContract",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_SharesSubjectToVestingBasedOnCertainConditions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares subject to vesting based on certain conditions.",
        "label": "Shares Subject To Vesting Based On Certain Conditions",
        "verboseLabel": "Shares subject to vesting"
       }
      }
     },
     "localname": "SharesSubjectToVestingBasedOnCertainConditions",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_SharesSubjectToVestingMaximumPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares subject to vesting maximum period.",
        "label": "Shares Subject To Vesting Maximum Period",
        "verboseLabel": "Shares subject to vesting maximum period"
       }
      }
     },
     "localname": "SharesSubjectToVestingMaximumPeriod",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "rgti_SimulatedTradingDaysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simulated trading days.",
        "label": "Simulated Trading Days [Member]",
        "terseLabel": "Simulated trading days"
       }
      }
     },
     "localname": "SimulatedTradingDaysMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_SponsorAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsor Agreement.",
        "label": "Sponsor Agreement [Member]"
       }
      }
     },
     "localname": "SponsorAgreementMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsor.",
        "label": "Sponsor [Member]"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_SponsorRedemptionBasedVestingSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsor Redemption Based Vesting Shares.",
        "label": "Sponsor Redemption Based Vesting Shares [Member]"
       }
      }
     },
     "localname": "SponsorRedemptionBasedVestingSharesMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_StatusOfSharesOutstandingBeforeBusinessCombinationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status Of Shares Outstanding Before Business Combination.",
        "label": "Status Of Shares Outstanding Before Business Combination [Member]"
       }
      }
     },
     "localname": "StatusOfSharesOutstandingBeforeBusinessCombinationMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_StatusOfVestingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status Of Vesting .",
        "label": "Status Of Vesting [Axis]"
       }
      }
     },
     "localname": "StatusOfVestingAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_StatusOfVestingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status Of Vesting .",
        "label": "Status Of Vesting [Domain]"
       }
      }
     },
     "localname": "StatusOfVestingDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_StockIssuedDuringPeriodWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period warrants issued.",
        "label": "Stock Issued During Period Warrants Issued",
        "terseLabel": "Stock issued during period number of warrants issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodWarrantsIssued",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_StockOptionCommonShareExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock exercise price.",
        "label": "Stock Option Common Share Exercise Price",
        "terseLabel": "Common stock exercise price"
       }
      }
     },
     "localname": "StockOptionCommonShareExercisePrice",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "rgti_StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock shares issued aggregate business combination private investment in public equity.",
        "label": "Stock Shares Issued Aggregate Business Combination Private Investment In Public Equity",
        "terseLabel": "Business Combination and PIPE shares"
       }
      }
     },
     "localname": "StockSharesIssuedAggregateBusinessCombinationPrivateInvestmentInPublicEquity",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "rgti_SubsequentSubscriptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsequent Subscription Agreement.",
        "label": "Subsequent Subscription Agreement [Member]"
       }
      }
     },
     "localname": "SubsequentSubscriptionAgreementMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_SummaryOfIncomeTaxesInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Income Taxes Information",
        "label": "Summary Of Income Taxes Information [Line Items]"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxesInformationLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_SummaryOfIncomeTaxesInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Income Taxes Informatio.",
        "label": "Summary Of Income Taxes Information [Table]"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxesInformationTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_SupernovaAcquistionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supernova Acquistion [Member]"
       }
      }
     },
     "localname": "SupernovaAcquistionMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_SupplementalFinancialStatementInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental financial statement information.",
        "label": "Supplemental Financial Statement information [Abstract]"
       }
      }
     },
     "localname": "SupplementalFinancialStatementInformationAbstract",
     "nsuri": "http://www.rigetti.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rgti_SupplementalFinancialStatementInformationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Financial statement information.",
        "label": "Supplemental Financial Statement information [Text Block]",
        "terseLabel": "Supplemental Financial Statement information"
       }
      }
     },
     "localname": "SupplementalFinancialStatementInformationTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share.",
        "label": "Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share",
        "terseLabel": "Temporary equity of previous company converted into permanent equity of the resultant company par or stated value per share"
       }
      }
     },
     "localname": "TemporaryEquityOfPreviousCompanyConvertedIntoPermanentEquityOfTheResultantCompanyParOrStatedValuePerShare",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "rgti_TimeBasedVestingAwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Time Based Vesting Award [Member]"
       }
      }
     },
     "localname": "TimeBasedVestingAwardMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TrancheAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche A [Member]"
       }
      }
     },
     "localname": "TrancheAMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TrancheAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche.",
        "label": "Tranche [Axis]"
       }
      }
     },
     "localname": "TrancheAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_TrancheBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche B [Member]"
       }
      }
     },
     "localname": "TrancheBMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TrancheCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tranche C [Member]"
       }
      }
     },
     "localname": "TrancheCMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TrancheDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche.",
        "label": "Tranche [Domain]"
       }
      }
     },
     "localname": "TrancheDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche One.",
        "label": "Tranche One [Member]"
       }
      }
     },
     "localname": "TrancheOneMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche Two.",
        "label": "Tranche Two [Member]"
       }
      }
     },
     "localname": "TrancheTwoMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TransactionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 13.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction costs.",
        "label": "Transaction Costs",
        "negatedLabel": "Transaction costs"
       }
      }
     },
     "localname": "TransactionCosts",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_TransactionCostsPaid": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction costs paid.",
        "label": "Transaction Costs Paid",
        "negatedLabel": "Transaction costs paid directly by Rigetti"
       }
      }
     },
     "localname": "TransactionCostsPaid",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rgti_TrinityWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trinity Warrants [Member]",
        "terseLabel": "Trinity Warrants"
       }
      }
     },
     "localname": "TrinityWarrantsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TwoThousandThirteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand Thirteen Equity Incentive Plan",
        "label": "Two Thousand Thirteen Equity Incentive Plan [Member]",
        "terseLabel": "2013 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandThirteenEquityIncentivePlanMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TwoThousandTwentyTwoEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Two Equity Incentive Plan [Member]",
        "terseLabel": "2022 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyTwoEquityIncentivePlanMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_TwothousandandtwentyfourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty three member.",
        "label": "TwoThousandAndTwentyFour [Member]",
        "terseLabel": "2024[Member]"
       }
      }
     },
     "localname": "TwothousandandtwentyfourMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_UnvestedCustomerWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested customer warrants .",
        "label": "Unvested Customer Warrants [Member]"
       }
      }
     },
     "localname": "UnvestedCustomerWarrantsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail",
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_VentureCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Venture Capital",
        "label": "Venture Capital [Member]"
       }
      }
     },
     "localname": "VentureCapitalMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_VestedCustomerWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vested customer warrants .",
        "label": "Vested Customer Warrants [Member]"
       }
      }
     },
     "localname": "VestedCustomerWarrantsMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_VolumeWeightedAveragePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Volume weighted average price per share.",
        "label": "Volume Weighted Average Price Per Share",
        "terseLabel": "Volume weighted average price per share"
       }
      }
     },
     "localname": "VolumeWeightedAveragePricePerShare",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "rgti_WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Waiting Period After Which The Share Trading Days Are Considered.",
        "label": "Waiting Period After Which The Share Trading Days Are Considered",
        "terseLabel": "Waiting period after which the share trading days are considered"
       }
      }
     },
     "localname": "WaitingPeriodAfterWhichTheShareTradingDaysAreConsidered",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "rgti_WarrantsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants.",
        "label": "Warrants [Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsTextBlock",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rgti_WarrantsToPurchaseClassACommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants to purchase class A common stock .",
        "label": "Warrants To Purchase Class A Common Stock [Member]"
       }
      }
     },
     "localname": "WarrantsToPurchaseClassACommonStockMember",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_WeightedAverageSharePriceAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Share Price",
        "label": "Weighted Average Share Price [Axis]"
       }
      }
     },
     "localname": "WeightedAverageSharePriceAxis",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "rgti_WeightedAverageSharePriceDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Share Price",
        "label": "Weighted Average Share Price [Domain]"
       }
      }
     },
     "localname": "WeightedAverageSharePriceDomain",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "rgti_WithdrawnCreditFacility": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Withdrawn credit facility.",
        "label": "Withdrawn Credit Facility",
        "verboseLabel": "Withdrawn Credit Facility"
       }
      }
     },
     "localname": "WithdrawnCreditFacility",
     "nsuri": "http://www.rigetti.com/20221231",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r325",
      "r718",
      "r800",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r449",
      "r636",
      "r664",
      "r694",
      "r695",
      "r715",
      "r728",
      "r737",
      "r796",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r449",
      "r636",
      "r664",
      "r694",
      "r695",
      "r715",
      "r728",
      "r737",
      "r796",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r325",
      "r718",
      "r800",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r321",
      "r638",
      "r716",
      "r735",
      "r791",
      "r792",
      "r800",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r321",
      "r638",
      "r716",
      "r735",
      "r791",
      "r792",
      "r800",
      "r916"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r438",
      "r449",
      "r478",
      "r479",
      "r480",
      "r612",
      "r636",
      "r664",
      "r694",
      "r695",
      "r715",
      "r728",
      "r737",
      "r788",
      "r796",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r438",
      "r449",
      "r478",
      "r479",
      "r480",
      "r612",
      "r636",
      "r664",
      "r694",
      "r695",
      "r715",
      "r728",
      "r737",
      "r788",
      "r796",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r206",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r283",
      "r347",
      "r348",
      "r512",
      "r540",
      "r544",
      "r545",
      "r546",
      "r581",
      "r599",
      "r600",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r206",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r283",
      "r347",
      "r348",
      "r512",
      "r540",
      "r544",
      "r545",
      "r546",
      "r581",
      "r599",
      "r600",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r271",
      "r454",
      "r742",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r322",
      "r323",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r717",
      "r736",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r322",
      "r323",
      "r680",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r717",
      "r736",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r271",
      "r454",
      "r742",
      "r743",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r770",
      "r901"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Accounts and Other Receivables, Net, Current",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 22.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities",
        "verboseLabel": "Accounts payable and other accrued liabilities current"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r14",
      "r734"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 21.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r327",
      "r328"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r709",
      "r790"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion Expense",
        "terseLabel": "Accretion Expense"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Payroll Taxes, Current",
        "terseLabel": "Payroll and other payroll costs"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional &amp; subscription fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedUtilitiesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Utilities, Current",
        "terseLabel": "Utilities"
       }
      }
     },
     "localname": "AccruedUtilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r87",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r221",
      "r660",
      "r672",
      "r676"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 17.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive gain (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r27",
      "r30",
      "r143",
      "r600",
      "r667",
      "r668",
      "r752",
      "r753",
      "r754",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Gain (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 15.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r487",
      "r488",
      "r489",
      "r762",
      "r763",
      "r764",
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r257",
      "r258",
      "r259",
      "r260",
      "r271",
      "r332",
      "r333",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r487",
      "r488",
      "r489",
      "r509",
      "r510",
      "r511",
      "r512",
      "r523",
      "r524",
      "r525",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r573",
      "r574",
      "r578",
      "r579",
      "r580",
      "r581",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r639",
      "r640",
      "r641",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r104",
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "negatedLabel": "Capitalization of deferred costs to equity upon share issuance"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r93",
      "r104",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Adjustment to additional paid in capital warrants issued"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Share-based Payment Arrangement, Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r36",
      "r409",
      "r576",
      "r756"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance cost",
        "verboseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r171",
      "r189",
      "r216",
      "r248",
      "r302",
      "r312",
      "r317",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r528",
      "r532",
      "r555",
      "r734",
      "r794",
      "r795",
      "r903"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r209",
      "r222",
      "r248",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r528",
      "r532",
      "r555",
      "r734",
      "r794",
      "r795",
      "r903"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r335",
      "r354"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Amortized\u00a0Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r76",
      "r334",
      "r354",
      "r655"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Available-for-Sale Securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r521",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r131",
      "r132",
      "r521",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r134",
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "verboseLabel": "Business combination consideration to be paid"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r526",
      "r755"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 23.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 12.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedLabel": "Change in fair value of earn-out liability",
        "terseLabel": "Change in fair value of earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "verboseLabel": "Valuation Assumptions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r133",
      "r136"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 29.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Earn-out liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r138",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombination"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs which have been expensed.",
        "label": "Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed",
        "terseLabel": "Business combination transaction costs expensed"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.",
        "label": "Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs",
        "terseLabel": "Business combination transaction costs"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r0",
      "r60",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r56",
      "r57",
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property and equipment recorded in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAdditions": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions made to capitalized computer software costs during the period.",
        "label": "Capitalized Computer Software, Additions",
        "verboseLabel": "Capitalized Software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAdditions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Capitalized Contract Cost [Line Items]"
       }
      }
     },
     "localname": "CapitalizedContractCostLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostTable": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Table]"
       }
      }
     },
     "localname": "CapitalizedContractCostTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r678",
      "r679",
      "r734",
      "r745"
     ],
     "calculation": {
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r54",
      "r211",
      "r698"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r55",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r49",
      "r54",
      "r59"
     ],
     "calculation": {
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "totalLabel": "Total cash and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r49",
      "r54",
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r49",
      "r162"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r745"
     ],
     "calculation": {
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents",
        "verboseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerAssetAndLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Asset and Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerAssetAndLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r218",
      "r219",
      "r220",
      "r248",
      "r274",
      "r275",
      "r277",
      "r279",
      "r286",
      "r287",
      "r342",
      "r378",
      "r380",
      "r381",
      "r382",
      "r385",
      "r386",
      "r416",
      "r417",
      "r419",
      "r420",
      "r422",
      "r555",
      "r696",
      "r741",
      "r758",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/CoverPage",
      "http://www.rigetti.com/role/Debt",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail",
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/FairValueMeasurements",
      "http://www.rigetti.com/role/FairValueMeasurementsTables",
      "http://www.rigetti.com/role/IncomeTaxes",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail",
      "http://www.rigetti.com/role/NetLossPerShare",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail",
      "http://www.rigetti.com/role/NetLossPerShareTables",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/Segments",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformation",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStock",
      "http://www.rigetti.com/role/CommonStockTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail",
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfNetProceedsFromBusinessCombinationAndPipeFinancingParentheticalDetail",
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "disclosureGuidance": "Exercise price common stock of warrants or rights outstanding",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants",
        "verboseLabel": "Class of warrants or rights exercise price of warrants or rights"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class Of Warrant Or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/Warrants",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Class of warrants issued during period",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Class of warrants or rights number of securities covered by each warrant or right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding",
        "verboseLabel": "Class of warrants or rights outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsSummaryOfVestingStatusOfTheCustomerWarrantDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class Of Warrant Or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/Warrants",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper",
        "verboseLabel": "Commercial Papers"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r24",
      "r177",
      "r194"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 32.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 9)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r89",
      "r372",
      "r373",
      "r682",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Class A Ordinary Shares"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Class B Ordinary Shares"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, capital shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r762",
      "r763",
      "r895"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock par or stated value per share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "positiveLabel": "Common stock shares authorized",
        "verboseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Common stock, issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r8",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Common stock, outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesSubscribedButUnissued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.",
        "label": "Common Stock, Shares Subscribed but Unissued",
        "terseLabel": "Common stock shares subscribed but not issued"
       }
      }
     },
     "localname": "CommonStockSharesSubscribedButUnissued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesSubscriptions": {
     "auth_ref": [
      "r8",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.",
        "label": "Common Stock, Value, Subscriptions",
        "presentationGuidance": "Common Stock, Value, Subscriptions",
        "terseLabel": "Common stock shares subscribed but not issued value"
       }
      }
     },
     "localname": "CommonStockSharesSubscriptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r8",
      "r734"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 14.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock*, par value $0.0001 per share; 1,000,000,000 shares and 134,050,472 shares authorized at December 31, 2022 and December 31, 2021, respectively; 125,257,233 shares and 18,221,069 shares issued and outstanding at December 21, 2022 and December 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common Stock, Voting Rights",
        "terseLabel": "Common Stock, Voting Rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r31",
      "r229",
      "r231",
      "r238",
      "r656",
      "r661"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r325",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r325",
      "r677",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r325",
      "r681",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r185",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "verboseLabel": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r325",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r141",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principals of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary of Contract with Customer, Contract Asset, Contract Liability, and Receivable"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Conversion of Stock [Line Items]"
       }
      }
     },
     "localname": "ConversionOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConversionOfStockTable": {
     "auth_ref": [
      "r56",
      "r57",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This table may be used to disclose all the information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction. It may include a description sufficient information to understand the nature and purpose of the conversion, as well as the financial instruments converted from and to (for example, preferred, common, treasury, etc.) the amounts converted, the new shares issued, and the value of the new shares issued, if applicable. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock [Table]"
       }
      }
     },
     "localname": "ConversionOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r38",
      "r248",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r555",
      "r794"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r64",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfCustomersAccountsReceivableDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 24.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Debt\u2014current portion"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r94",
      "r247",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r403",
      "r410",
      "r411",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r172",
      "r174",
      "r187",
      "r253",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r577",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r4",
      "r174",
      "r187",
      "r414"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermLoansPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of reference rate used for variable rate of debt instrument.",
        "label": "Debt Instrument, Description of Variable Rate Basis"
       }
      }
     },
     "localname": "DebtInstrumentDescriptionOfVariableRateBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r164",
      "r166",
      "r387",
      "r577",
      "r711",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Debt instrument, fee amount"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r23",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument, Frequency of Periodic Payment",
        "terseLabel": "Debt Instrument, Frequency of Periodic Payment"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r20",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r223",
      "r710",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r23",
      "r253",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r577",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPaymentTerms": {
     "auth_ref": [
      "r21",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.",
        "label": "Debt Instrument, Payment Terms",
        "terseLabel": "Debt Instrument, Payment Terms"
       }
      }
     },
     "localname": "DebtInstrumentPaymentTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Debt instrument, repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt Instrument, Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r163",
      "r166",
      "r797"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "verboseLabel": "unamortized issuance cost"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r163",
      "r166"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LoansPayableCurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Current",
        "negatedLabel": "Less: current portion of unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses.",
        "label": "Debt Related Commitment Fees and Debt Issuance Costs",
        "terseLabel": "Debt Related Commitment Fees"
       }
      }
     },
     "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 33.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Unrealized Gain (Loss)",
        "negatedLabel": "Accretion of available-for-sale securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r339",
      "r355",
      "r707"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "terseLabel": "Fair\u00a0Value\u00a0as",
        "verboseLabel": "Investment securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r340",
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "negatedLabel": "Gross Unrealized Holding\u00a0Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r338",
      "r707",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Summary of Available For Sale Securities Continuous Unrealized Loss Position Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCostsCurrent": {
     "auth_ref": [
      "r750"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.",
        "label": "Deferred Costs, Current",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r165",
      "r797"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermLoansPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Less: unamortized debt discount, long term",
        "verboseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r5",
      "r6",
      "r173",
      "r186",
      "r503"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r776"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r747"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 23.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r746"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "negatedLabel": "Deferred revenue",
        "negatedPeriodEndLabel": "Balance at end of period",
        "negatedPeriodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfChangeInContractWithCustomerAssetAndLiabilityDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r504"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "terseLabel": "Gross deferred assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r129",
      "r892"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Research and development credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r891"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r891"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r129",
      "r892"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r129",
      "r892"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r127",
      "r129",
      "r892"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r129",
      "r892"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r129",
      "r892"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Accruals and reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r505"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r52",
      "r85"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r52",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation, Depletion and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative asset.",
        "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r224",
      "r225",
      "r554",
      "r699"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r224",
      "r225",
      "r554",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 27.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Derivative warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes derivative liability.",
        "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeMember": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).",
        "label": "Derivative [Member]",
        "terseLabel": "Derivative"
       }
      }
     },
     "localname": "DerivativeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Warrant Liabilities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognition",
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail",
      "http://www.rigetti.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r435",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognition",
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail",
      "http://www.rigetti.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Summary of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r455",
      "r483",
      "r484",
      "r486",
      "r490",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Equity Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r239",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r272",
      "r274",
      "r277",
      "r278",
      "r279",
      "r283",
      "r545",
      "r546",
      "r657",
      "r662",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Net loss per share attributable to common stockholders\u2014basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "presentationGuidance": "\u2014 Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r239",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r274",
      "r277",
      "r278",
      "r279",
      "r283",
      "r545",
      "r546",
      "r657",
      "r662",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "\u2014 Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "presentationGuidance": "Net loss per share attributable to common stockholders\u2014diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r62",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of changes in exchange rate on cash and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total:"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r889",
      "r893"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r889",
      "r893"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "terseLabel": "Non-deductible executive compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r889",
      "r893"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Total\u00a0pre-tax\u00a0book income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r889",
      "r893"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Amount of cost not yet recognized for nonvested award"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period over which cost not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Stock Options",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock-Based Awards\u2014Options Outstanding"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r104",
      "r205",
      "r233",
      "r234",
      "r235",
      "r254",
      "r255",
      "r256",
      "r258",
      "r267",
      "r270",
      "r285",
      "r346",
      "r424",
      "r487",
      "r488",
      "r489",
      "r511",
      "r512",
      "r544",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r600",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r52",
      "r95"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 11.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "negatedLabel": "Change in fair value of derivative warrant liabilities",
        "terseLabel": "Fair value adjustment of warrants",
        "verboseLabel": "Change in fair value of derivative warrant liabilities"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "verboseLabel": "Schedule Of Fair Value Of The Common Stock Warrant Liabilities Measured Using Black Scholes Approach"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r151",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Summary of Information About Assets and Liabilities Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r151",
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value By Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r401",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r549",
      "r609",
      "r610",
      "r611",
      "r711",
      "r712",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r401",
      "r439",
      "r444",
      "r549",
      "r609",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r401",
      "r439",
      "r444",
      "r549",
      "r610",
      "r711",
      "r712",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r401",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r549",
      "r611",
      "r711",
      "r712",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsQuantitativeInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]"
       }
      }
     },
     "localname": "FairValueInputsQuantitativeInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r154",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "verboseLabel": "Change in Fair Value of Derivative Liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3",
        "terseLabel": "Initial measurement on March 2, 2022 upon Business Combination (Note 3)"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances",
        "terseLabel": "Issuance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "terseLabel": "Change in fair values"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "verboseLabel": "Exercise of warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r401",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r609",
      "r610",
      "r611",
      "r711",
      "r712",
      "r723",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r336",
      "r337",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r357",
      "r358",
      "r359",
      "r412",
      "r421",
      "r535",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r707",
      "r771",
      "r772",
      "r773",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities at fair value"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Areas, Revenues from External Customers [Abstract]"
       }
      }
     },
     "localname": "GeographicAreasRevenuesFromExternalCustomersAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r214",
      "r361",
      "r654",
      "r708",
      "r734",
      "r777",
      "r784"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 11.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance, goodwill",
        "periodStartLabel": "Beginning balance, goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r366",
      "r367",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r364",
      "r365",
      "r367",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "GOODWILL"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r52",
      "r362",
      "r363",
      "r366",
      "r708"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 32.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Impairment charge",
        "terseLabel": "Goodwill, impairment loss",
        "verboseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/GoodwillAdditionalInformationDetail",
      "http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Change"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/GoodwillSummaryOfScheduleOfGoodwillDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r37",
      "r248",
      "r302",
      "r311",
      "r316",
      "r319",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r555",
      "r706",
      "r794"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Total gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r249",
      "r515"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r33",
      "r167",
      "r178",
      "r196",
      "r302",
      "r311",
      "r316",
      "r319",
      "r658",
      "r706"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 9.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Net loss before provision for income taxes",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r249",
      "r515"
     ],
     "calculation": {
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r250",
      "r496",
      "r501",
      "r507",
      "r513",
      "r516",
      "r518",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r251",
      "r269",
      "r270",
      "r301",
      "r494",
      "r514",
      "r517",
      "r663"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r232",
      "r492",
      "r493",
      "r501",
      "r502",
      "r506",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r889"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 25.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 26.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r637",
      "r755"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 28.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDerivativeLiabilities": {
     "auth_ref": [
      "r755"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).",
        "label": "Increase (Decrease) in Derivative Liabilities",
        "terseLabel": "Warrant liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInDerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 29.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r755"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 27.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 24.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r165",
      "r180",
      "r236",
      "r299",
      "r575"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 14.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r241",
      "r244",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r40",
      "r298"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 15.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r341",
      "r915"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r83",
      "r168",
      "r183",
      "r198",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "INVESTMENTS"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r592",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r899"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Components of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Schedule of operating lease liabilities"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Maturities of the Company's Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total minimum future lease payments",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r17",
      "r248",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r529",
      "r532",
      "r533",
      "r555",
      "r705",
      "r794",
      "r903",
      "r904"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 19.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r13",
      "r175",
      "r192",
      "r734",
      "r760",
      "r774",
      "r898"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r210",
      "r248",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r529",
      "r532",
      "r533",
      "r555",
      "r734",
      "r794",
      "r903",
      "r904"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r15",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Current Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r15",
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.",
        "label": "Loans Payable, Current",
        "totalLabel": "Debt\u2014current portion"
       }
      }
     },
     "localname": "LoansPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r4",
      "r174",
      "r190",
      "r400",
      "r415",
      "r711",
      "r712"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-term Debt",
        "totalLabel": "Loan payable, long term"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, by Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r91",
      "r253",
      "r405"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r91",
      "r253",
      "r405"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r91",
      "r253",
      "r405"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r91",
      "r253",
      "r405"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r91",
      "r253",
      "r405"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLoansPayable": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Loans Payable, Noncurrent",
        "totalLabel": "Debt\u2014net of current portion"
       }
      }
     },
     "localname": "LongTermLoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r23",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Available-for-sale\u00a0investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaturitiesOfLongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-term Debt [Abstract]"
       }
      }
     },
     "localname": "MaturitiesOfLongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset.",
        "label": "Measurement Input, Exercise Price [Member]"
       }
      }
     },
     "localname": "MeasurementInputExercisePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Measurement Input, Price Volatility (annual) [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "verboseLabel": "Volatility (annual)"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Risk-free Rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Stock Price"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfInputsIntoTheRespectiveModelsDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Fund",
        "verboseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r49",
      "r50",
      "r53"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r34",
      "r53",
      "r179",
      "r195",
      "r208",
      "r228",
      "r230",
      "r235",
      "r248",
      "r257",
      "r261",
      "r262",
      "r264",
      "r265",
      "r269",
      "r270",
      "r276",
      "r302",
      "r311",
      "r316",
      "r319",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r546",
      "r555",
      "r706",
      "r794"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss, as restated"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reporting segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r302",
      "r311",
      "r316",
      "r319",
      "r706"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r585",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r583"
     ],
     "calculation": {
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of lease liabilities",
        "verboseLabel": "Operating Lease Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r583"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 26.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities\u2014current",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r583"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 31.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities - noncurrent",
        "verboseLabel": "Operating lease liabilities, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/LeasesSummaryOfMaturitiesOfTheCompanySOperatingLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r584",
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 12.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease\u00a0right-of-use\u00a0assets, net",
        "verboseLabel": "Operating Lease Right Of Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r591",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r590",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term - operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r170",
      "r188",
      "r215"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r139",
      "r140",
      "r142"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation gain (loss)",
        "verboseLabel": "Foreign currency translation gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive gain (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r226",
      "r227"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Change in unrealized loss on\u00a0available-for-sale\u00a0securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 16.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r176"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 28.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r18",
      "r734"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense), net:"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payments on debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r43",
      "r75",
      "r240"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedLabel": "Purchases of available-for-sale securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value",
        "verboseLabel": "Preferred stock par or stated value per share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "positiveLabel": "Preferred stock shares authorized",
        "terseLabel": "Preferred stock, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r7",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r7",
      "r734"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 33.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Redeemable convertible preferred stock*, par value $0.0001 per share; 0 shares and 80,974,757 shares authorized at December 31, 2022 and December 31, 2021, respectively; 0 shares and 77,696,679 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "auth_ref": [
      "r7"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 18.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.",
        "label": "Preferred Stock, Value, Outstanding",
        "terseLabel": "Preferred Stock, par value $0.0001 per share; 10,000,000 shares and 0 shares authorized at December 31, 2022 and December 31, 2021, respectively; 0 shares and 0 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively"
       }
      }
     },
     "localname": "PreferredStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r751"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Notes Payable",
        "verboseLabel": "Proceeds from issuance of notes payable"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r208",
      "r228",
      "r230",
      "r242",
      "r248",
      "r257",
      "r269",
      "r270",
      "r302",
      "r311",
      "r316",
      "r319",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r527",
      "r530",
      "r531",
      "r546",
      "r555",
      "r658",
      "r706",
      "r731",
      "r732",
      "r754",
      "r794"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r86",
      "r212"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, Plant and Equipment, Gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r88",
      "r193",
      "r659",
      "r734"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r88",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Summary Of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "auth_ref": [
      "r101",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.",
        "label": "Reclassifications of Temporary to Permanent Equity",
        "terseLabel": "Issuance of common stock upon conversion of legacy Series C and Series C-1 preferred stock in connection with the Business Combination"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r445",
      "r601",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r445",
      "r601",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Payments on principal of notes payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r123",
      "r199",
      "r911"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research And Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r745",
      "r757",
      "r912",
      "r914"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r54",
      "r59",
      "r211"
     ],
     "calculation": {
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndShortTermInvestmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units",
        "verboseLabel": "Stock-Based Awards\u2014RSUs Outstanding"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r52",
      "r370",
      "r371",
      "r789"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r10",
      "r111",
      "r191",
      "r671",
      "r676",
      "r734"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 16.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Accumulated Deficit",
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r205",
      "r254",
      "r255",
      "r256",
      "r258",
      "r267",
      "r270",
      "r346",
      "r487",
      "r488",
      "r489",
      "r511",
      "r512",
      "r544",
      "r667",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r728",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r728",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r296",
      "r297",
      "r310",
      "r314",
      "r315",
      "r321",
      "r322",
      "r325",
      "r434",
      "r435",
      "r638"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r432",
      "r433",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Summary of Revenue by Geography"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRightsConcentrationRiskMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that license fee or royalty revenues during the period from other parties from use of a specified patent, trademark, or other form of right granted to such parties are to a specified benchmark, such as total license fees, total revenues, segment revenues or product line revenues. May also reflect the percentage contribution the revenue made to operating results. Risk is materially adverse effects of a loss of such revenues, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Revenue from Rights Concentration Risk [Member]"
       }
      }
     },
     "localname": "RevenueFromRightsConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r701",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Transaction price allocated to remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r237",
      "r248",
      "r296",
      "r297",
      "r310",
      "r314",
      "r315",
      "r321",
      "r322",
      "r325",
      "r342",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r555",
      "r658",
      "r794"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r589",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "verboseLabel": "Sale of Stock, Price Per Share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r325",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue [Member]",
        "verboseLabel": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded From Computation of Earnings"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Investments"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfConversionsOfStockTextBlock": {
     "auth_ref": [
      "r56",
      "r57",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction.",
        "label": "Schedule of Conversions of Stock [Table Text Block]",
        "terseLabel": "Summary of Conversions of Stock"
       }
      }
     },
     "localname": "ScheduleOfConversionsOfStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Long term debt and the unamortized discount"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Summary Of Components Of Deferred Tax Assets And Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Shares"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Summary Of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r119",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r708",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Summary Of Domestic And Foreign Components Of Loss Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Scheduled principal payments on total outstanding debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationAdditionalInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationSummaryOfPropertyPlantAndEquipmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r32",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SegmentsSummaryOfRevenueByGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.",
        "label": "Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Activity Related to Restricted Stock Units"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis": {
     "auth_ref": [
      "r96",
      "r97",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents settlement terms for the group of mandatorily redeemable securities, including the description and the details of all terms for each outstanding financial instrument and each settlement option.",
        "label": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]",
        "terseLabel": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms"
       }
      }
     },
     "localname": "ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r99",
      "r102",
      "r103",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r110",
      "r111",
      "r218",
      "r219",
      "r220",
      "r286",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r715",
      "r741",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r730",
      "r890"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Summary Of Unrecognized Tax Benefits Affecting The Effective Tax rate"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r293",
      "r294",
      "r295",
      "r302",
      "r303",
      "r313",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/Segments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [
      "r748",
      "r749",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C preferred stock.",
        "label": "Series C Preferred Stock [Member]",
        "verboseLabel": "Series C Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Share based compensation by share based award requisite service period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "verboseLabel": "Share based compensation stock options vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of Restricted Stock Units, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Fair Value Per Share, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Number of Restricted Stock Units, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-Average Fair Value Per Share, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted-Average Fair Value Per Share, Ending balance",
        "periodStartLabel": "Weighted-Average Fair Value Per Share, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Vested",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Number of Restricted Stock Units, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Fair Value Per Share, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Exercise price/Stock price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Weighted-average risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited and expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted",
        "verboseLabel": "Share based compensation stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding",
        "periodStartLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding",
        "periodStartLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Share based compensation arrangement share based payment award options vested and exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfActivityRelatedToRestrictedStockUnitsDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited and expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "weighted-average grant date fair value of options granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares",
        "terseLabel": "Shares outstanding"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain": {
     "auth_ref": [
      "r97",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifying description of each financial instrument that embodies an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur. Examples are preferred stock or trust preferred securities, each of which has redemption rights beyond the control of the issuer on a specified date or upon an event that is certain to occur.",
        "label": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]",
        "terseLabel": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r586",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r60",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r218",
      "r219",
      "r220",
      "r248",
      "r274",
      "r275",
      "r277",
      "r279",
      "r286",
      "r287",
      "r342",
      "r378",
      "r380",
      "r381",
      "r382",
      "r385",
      "r386",
      "r416",
      "r417",
      "r419",
      "r420",
      "r422",
      "r555",
      "r696",
      "r741",
      "r758",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/BusinessCombinationAdditionalInformationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationDetail",
      "http://www.rigetti.com/role/BusinessCombinationSummaryOfConsummationOfTheBusinessCombinationParentheticalDetail",
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/CommonStockSummaryOfConversionsOfStockDetail",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/CoverPage",
      "http://www.rigetti.com/role/Debt",
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail",
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail",
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail",
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/FairValueMeasurements",
      "http://www.rigetti.com/role/FairValueMeasurementsTables",
      "http://www.rigetti.com/role/IncomeTaxes",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail",
      "http://www.rigetti.com/role/NetLossPerShare",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail",
      "http://www.rigetti.com/role/NetLossPerShareTables",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.rigetti.com/role/Segments",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformation",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r26",
      "r104",
      "r205",
      "r233",
      "r234",
      "r235",
      "r254",
      "r255",
      "r256",
      "r258",
      "r267",
      "r270",
      "r285",
      "r346",
      "r424",
      "r487",
      "r488",
      "r489",
      "r511",
      "r512",
      "r544",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r600",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/Debt",
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail",
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail",
      "http://www.rigetti.com/role/DescriptionOfBusiness",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
      "http://www.rigetti.com/role/EquityPlansTables",
      "http://www.rigetti.com/role/FairValueMeasurements",
      "http://www.rigetti.com/role/FairValueMeasurementsTables",
      "http://www.rigetti.com/role/IncomeTaxes",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail",
      "http://www.rigetti.com/role/IncomeTaxesTables",
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/NetLossPerShare",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail",
      "http://www.rigetti.com/role/NetLossPerShareTables",
      "http://www.rigetti.com/role/Segments",
      "http://www.rigetti.com/role/SegmentsTables",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformation",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r285",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStock",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfComprehensiveLoss",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/Debt",
      "http://www.rigetti.com/role/DebtLongTermDebtAndTheUnamortizedDiscountDetail",
      "http://www.rigetti.com/role/DebtScheduledPrincipalPaymentsOnTotalOutstandingDebtDetail",
      "http://www.rigetti.com/role/DescriptionOfBusiness",
      "http://www.rigetti.com/role/EquityPlansAdditionalInformationDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsDetail",
      "http://www.rigetti.com/role/EquityPlansTables",
      "http://www.rigetti.com/role/FairValueMeasurements",
      "http://www.rigetti.com/role/FairValueMeasurementsTables",
      "http://www.rigetti.com/role/IncomeTaxes",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfDomesticAndForeignComponentsOfLossBeforeIncomeTaxesDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfEffectiveIncomeTaxRateReconciliationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail",
      "http://www.rigetti.com/role/IncomeTaxesTables",
      "http://www.rigetti.com/role/LeasesSummaryOfLesseeOperatingLeaseLiabilityMaturityDetail",
      "http://www.rigetti.com/role/NetLossPerShare",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareParentheticalDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail",
      "http://www.rigetti.com/role/NetLossPerShareTables",
      "http://www.rigetti.com/role/Segments",
      "http://www.rigetti.com/role/SegmentsTables",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesTables",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformation",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationScheduleOfAccountsPayableAndAccruedLiabilitiesDetail",
      "http://www.rigetti.com/role/SupplementalFinancialStatementsInformationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "verboseLabel": "Stock issued during period, shares, issued for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/CommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r104",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock upon release of RSUs (Share)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r8",
      "r104",
      "r111",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Issuance of common stock upon exercise of stock options, shares",
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
      "http://www.rigetti.com/role/EquityPlansScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r7",
      "r8",
      "r111",
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock upon release of RSUs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r26",
      "r104",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "verboseLabel": "Issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r8",
      "r11",
      "r12",
      "r74",
      "r734",
      "r760",
      "r774",
      "r898"
     ],
     "calculation": {
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets": {
       "order": 13.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets",
      "http://www.rigetti.com/role/ConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r571",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r571",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r571",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r571",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r603",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail",
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash financing activity:"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r1",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreement",
      "http://www.rigetti.com/role/ForwardWarrantAgreementTables",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStock",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreement",
      "http://www.rigetti.com/role/ForwardWarrantAgreementTables",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStock",
      "http://www.rigetti.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r721",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r721",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r200",
      "r201",
      "r202",
      "r329",
      "r330",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred at Point in Time [Member]",
        "terseLabel": "Revenue recognized at a point in time [Member]"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Revenue recognized over time [Member]"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfDisaggregationOfRevenueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r336",
      "r337",
      "r412",
      "r421",
      "r535",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r771",
      "r772",
      "r773",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfChangeInFairValueOfDerivativeLiabilitiesDetail",
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/ForwardWarrantAgreementSummaryOfFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesDetail",
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r257",
      "r258",
      "r259",
      "r260",
      "r271",
      "r332",
      "r333",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r487",
      "r488",
      "r489",
      "r509",
      "r510",
      "r511",
      "r512",
      "r523",
      "r524",
      "r525",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r573",
      "r574",
      "r578",
      "r579",
      "r580",
      "r581",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r639",
      "r640",
      "r641",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r894"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DescriptionOfBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "US Government Corporations and Agencies Securities",
        "verboseLabel": "Corporate Bonds"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r703",
      "r723",
      "r725",
      "r913"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US Treasury Securities",
        "verboseLabel": "United States Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/FairValueMeasurementsSummaryOfInformationAboutAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail",
      "http://www.rigetti.com/role/InvestmentsAdditionalInformationDetail",
      "http://www.rigetti.com/role/InvestmentsSummaryOfAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
        "label": "Unbilled Receivables, Current",
        "terseLabel": "Unbilled receivables"
       }
      }
     },
     "localname": "UnbilledReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/RevenueRecognitionSummaryOfContractWithCustomerContractAssetContractLiabilityAndReceivableDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized loss short term investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r491",
      "r497"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance at December 31, 2022",
        "periodStartLabel": "Beginning balance at January 1, 2022",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense [Abstract]"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Current year increase(decrease)"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Prior year adjustment\u2014increase (decrease)"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesSummaryOfUnrecognizedTaxBenefitsAffectingTheEffectiveTaxRateDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r288",
      "r289",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r587",
      "r733"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "negatedLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/LeasesSummaryOfComponentsOfLeaseCostsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/DebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ForwardWarrantAgreementAdditionalInformationDetail",
      "http://www.rigetti.com/role/SubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Common Stock Warrants",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrants Outstanding"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Warrants and rights outstanding, measurement input"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfThePrivatePlacementWarrantMeasuredUsingBlackScholesApproachDetail",
      "http://www.rigetti.com/role/WarrantsScheduleOfFairValueOfTheTrinityWarrantLiabilitiesMeasuredUsingBlackScholesApproachDetail"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants and rights outstanding, term",
        "verboseLabel": "Class of warrants or rights maturity period"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.rigetti.com/role/WarrantsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r273",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Weighted-average Class A Common Stock outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "presentationGuidance": "Weighted average shares used in computing net loss per share attributable to common stockholders\u2014diluted",
        "terseLabel": "Weighted-average common shares outstanding - Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares, Contingently Issuable",
        "terseLabel": "Weighted average number of shares Contingently Issuable shares under earnout arrangement"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesContingentlyIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r272",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Weighted average shares used in computing net loss per share attributable to common stockholders\u2014basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average common shares outstanding - Basic",
        "verboseLabel": "Weighted-average Class A Common Stock outstanding, Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.rigetti.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rigetti.com/role/NetLossPerShareAdditionalInformationDetail",
      "http://www.rigetti.com/role/NetLossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetail"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r738": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r739": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=118255708&loc=SL5909891-110878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22026-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>121
<FILENAME>0001193125-23-092237-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-092237-xbrl.zip
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M:1S\'MR;AI?QUJ"(P\^PG4C=Y^%5GD3RX)'Y\</?W*(NCFI?/OKM7O"'J"9
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M5S@9,(Y P .-6,LJXLL<_NH9RL=7R,35.*S4O4!G58M_&!AVH. -P#-?$/O
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M%8C+(^-*EQI<V=#Z&9%6CQ8CK?;OOSPY^@=\^/;B_;N#_P502P,$%     @
MD(&%5H/%:X0E @  .P8  !$   !D-#@S,#@V9&5X,C,Q+FAT;;55VV[B0 Q]
MK]1_L%BI3X$4NE4K")$(9%NDM" NV^WC$";$:C(3S3AJNU^_S@7M:F]/Y26*
M'8_M<X['\>XW#Y'OW8>3F7]^YFWFFRCTPV_=P56O[[F-R7ZW#0 O6,R>(;B;
M+J+%:MQYNI]OPD[U <[/.&XJ%4GC>[/Y5UAOGJ-PW'G%/:7#V]XUJ@Z(# ]J
MW,ED0O4I;WD,RX4YH.J2+H:7!8V@M7>:2.>-*]&*NA:_RV'_IYV('+/WX09S
M:>%1OL)*YX(K3:+YW>.X8_"0<BDO\,.W%'=(4"$#SPU\SUU6T/[607_P@2W$
M-2?<P]:?:F79 IW 7.UE(?G!YDH>T'*,W,.RW&48PR2.=:D(U0&^H,FYW^W)
M^_57>)!$"%.=%V55V^$NXQY4A4^GE!](\R(S^>[ E,<CT4:A@).#?9*0,N.[
M=XA;44@#I1)**P%5_;HTVA8RIM+60814TP(""F%J%2E%V\IG!*%6L"9!,F]%
MUJ4!(PO-P7MV[^%!F#B]4#M;C 8W#@PN!U<.1V2BSMMT<'Y6%=,9-D<25$+%
M*#*PQ]2VROT/M1QX33%. >N>2:#B'#4>0;\ ^I^J'T:PR*S^G5XC$Z9=Q;)R
M,+$E7P'3PA9%3>'%I_[GFU'X5DA#MC)N1W\J<GH KG4AF"U@NYXX$$7+T\_D
MNM O0DD'GH1-65%B,DY\^2:%P:P9R.MF'H\P7=[AO'/:C<Z[NO)5VY^=]4_C
M!U!+ P04    " "0@856172"UAGK! "U]R\ $0   &0T.#,P.#9D<&]S86TN
M:'1M[+UK<^,XDB[\?2/V/_!X9O9T1\@NR;>Z==<)E2U7:\=E>RVY>_O]4@&1
MD,4IBE3S8EOSZ]_,!$""%*F;)14E<:*GVY) $$!>D$AD/OG+_WL9.L83]P/;
M<W\]:!S5#PSNFIYENX^_'D1A__#=@?'_/OWG?_PR"*$A-':##_YC:/]Z, C#
MT8<W;YZ?GX]\^Y&'H7UD>L,WQ_7CX\;Q2>- -G9L]WNJ\4O/=XX\_Q%:UD_>
MX,\]%G#5''^UDM[UQN=OQ(]QTXFNGT^H;>/]^_=OZ->X:6#G-81.&V_^]^MU
MQQSP(3NTW2!DKID:BSUE[-GV%L\,/.#FT:/W] 9^H'51#>W .SUNO)W6M6B1
M]#SRN<E";A4^\_X-\TW?<_B;I+%ZW/0B-_3'^8.3/Z8&:$:^#VQ0](3\-?4(
M?S$'^<WQEU13E]EFD-^6?DHU#FPSORG\D&X8COR"EO!+JFD4'#XR-HI;]UG0
MHW64/Z0:OSA3Z/2_UQJ71:$_A3SP:^;]AT$T&CE\R-VP<"C8AH;SUTD\43^<
M^J3\??*IW*9IQGPIFD #V1U$BO_OY_OKI'F8WSYI^B;TF1OT/7_(0E Q^+;Z
M8?WXL'&L2]FT)<YJ"'CI(5 V]82B]+3W-LX.Z^\.8\54K#A0TQV0RN/,PO^&
M=NCP3W>W':/Y]9<WXA-\/>0A,TS/#8D*(7\)W^"C'PUSP/R A[\^=*]0?>)[
M#OE?D?WTZ\&%:'[8'8_XP1OLY8UZ2\^SQD80CAW^ZX%X_=FG7Y@Q\'G_UX._
MA9YY\*G+>@XWO+XANPE^><,^00]GV-RRG^3C_]>R@Y'#QA\,UW/Y__WTB_WR
M =_"??&G;5G<I3_A]YMHR'W;-%PVA!>#IOIPZ9D1<A:-T;!1Y= 3;T_>OSNO
M'Y\=B$F_A/<XLKMZXQO\@US4]1K'WT[$WP?Q>J5>4_S6)KS2PM=>.>QQSE?T
MF1/PN=_0<H%TXPMXA<^<MFOQEW_R\9QOJL-.\>[DW<G9^P5?U[0LGP=!)P1]
M?.O?^=Z333M&=EE/3N<:R;?/40 <'@3( <P,O_)AC_OPNM3;>"#_0!(V7^S@
MX--%<UT#/Y]S"?-'T/>\T/5"3OU>W7P[/CL]?U<G&?W@,#1"N'OXT#GX] >W
M'P>PIQTRL%;8(S<"D#(>& /X;/0X=PV?A[X':V(_<6<,GP(<NF6$GO$(7QF\
MW^=FB!_# 3?4.H(H#7NV2TKBR* 1QD,J'F C9X =,1Z03H<_,G-LW'.+@UF!
M(@O4@E&'-O[=@;E#NPOC#B2;PTYJ&1V0[N^U60\<-B8?D:^Z<!A,I8F3&7JN
M^I&Y5KK!YU2#E2Y==N7>I!4-C1ML!AY\^@45^H> 3"[@&(,,M0\A<.JO!X$]
MA&WM0'XG5!]:FX?*JCQZ"<"J>2,[45O#PMU\ POI""BHFJ#=-&4+(K,*'@E
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MEK9KL?^_);Y3S74:NTO)WRE\Y5& UVKDUL;;!G*,WO:I 7G*-[!L4N;Y(PY
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M,SGRW@Z^7\'S;7@;PM+=@QF]CYQ9O X5A_Y8#H7C>$^FM=SV;TW$1H:3=G>
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MBJ'U*T#<Q7:D3:#^KW6W*\O>OWLR_L5[XKY+KF:<@ST#8N3;/7_B;L0Q0)#
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MZ^+AOMUM UF:-Y=&ZW\O?FO>?&D9%[=?O[8[G?;MS8;)5=\7<M67(=<?+!A
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MPB@7^O]46.8U>LIA02B#AF5><""U,2R8EQWK,^P)?\>DT[?O=97[ P0#$]2
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MY]N'KM']K=W1;HN$1APMO."%7*'GTLI4VD79<>XN%'^1FCWXU%C5<-8AIKO
M1,=8.>2AV[ZE*\>;VV[+N&]]:=Y?MF^^&%>W]W_ GX?7M[?_Q,^=;K/;^HK;
MRR[QV$G%8^OEL1/@L=9]M]F^,2Y;5^V;UJ71;=U_W2DF.JN8:+U,=(K!$7%
M1.?AZU=06+O$0>\J#EHO!YW!,>DW/"1=M>YA-]LEWFE4ZF?-S(..Y7;GG\95
M\Z)[>[]36U?CO&*>]3+/VX-/#QURS\ 6=M%J7>X4_YQ7RF?-_//NX--E"TWF
M]DT3CVK(26H; Y9J7[1VBI\J?;1F?GI_\ FLYW^VND;[!L[X7P53P5]&IW7Q
M<-_NMEL=HWES:5RV?V]?MN"/N]OK]L5.F=OG;RLN6[-_LHYL=M/\0BXCO(9O
MO/W8 9[J7#QT.LAQR&+0X/K/3IL"CZ] O]U<M)O7>(UQV>ZJ-O>MSL-UEYK<
MWK7NB5UW:PNM#G_K9L;&P:?/#YWV3:NS4YSSKN*<=7/.L:[&=HEW&O7W%?.L
MF7E.#CZU_A>,JF[[]Q8FUMRU;CJT?^T4(U4NA+4STFERB7+?NA8FT&_MNXXT
MD.";%ICIS?ONGT;WO@E,=K%S5E+CY+1BLS6SV1F82:V;UE6;S/#;/VY:]\AF
M:'HG9\/=8JKJ(+ANICH_^-1I75^+$(+;BW_^=GM]V;K?+2ZJ3*EU<]%;]()V
M+N[;=\H'NJ,:Z;2*>EHW+[U+K*FO8#G=XV9'2597+=!,\*%] \9ZR^@V_Q=]
M49W6_SRT;BY:'7*2WMS>'%)CH<=VB_G.JG"H=3/?^X-/=]=-TF"7[4[WOOWY
M8>=.A&>55;7NR,WZP:?KUA?05:#!NKNFAL[K%?^LF7\:Z)JZ@UVPXIR*<Q;B
MG).#3W_\UKIO&7_>/A@7L)-=M6\NC:^W\(UVH5QQU;24EE\D\G25AOFC,X,/
M/J7RU!'4Q:5_42JM#G6(:;6,8!D2T,,D'??&@V<XI0#W$)\(YC7P?!@"X3!(
M[&AC#.\B_ 2]8P618-E4O1C!"@G8BL"9IKXTB]& G6A 2J'*)@TXE7.$]\IY
MF1ZP*H$?>_U4IC[A& 9!A)A: EQX_D6@?&-*7Q9@OIZHYBSR666N-9/3Q2]E
M)O*T-,H)6I<&C]!6@__/*H%VJQ-H9R74_7 ,//S$?,(%8T7HIO"!:M&F$C(G
M-ZB#3YW#ALS(%'+XS)= 1DT!V[4N$GB?  $V=-2\ 7?Z"M<F-71"L0I A3U(
M2""8);7.;58KA*(;LG%M$@>P%N.O*L@N51A>X)D-LR C&;U:!,&5QMX2Q7$=
MKD#2\L:7!@Y;ZRBR&&4Z -]T4)*UL_0TB%]ML0B]2-LX8;*XI^;MG[@.^K[D
M$7KND'T72Y0&Q@C2VX\7\.G[F(3Z0#0CL.908VH_)H OJET?<6^>?0'FF[0D
M;"H.HBL(#HUAG#T^8,#D"!D9R$$+>/]G+J8/RIK[^ A,=3HVLK9P(<X;)CQ"
M",&>[=CA&/=[ 3 BEXYF!#N[3U!I+,;41$AC)I_Q^C4!-4<OG;!1Z&N!POR(
MS+C($(F3)7UFP22_%N]XX_A>N"+,"1(^9<4<4U@I/*9'KH9'4"W+2M/$(P)'
M(U620FKJ(GNM-JD(4K8OL[#:SF!"'' ;F%<>EI[=HRBV'6]#""R!C9B3F7,B
M+R0JI!+20%%!'GI*%F;O#^(GG/\%,.05$-_X"G:7T4Y>]N-0]US$T3-EC:9C
M@FLY3NVZ%XY'>RUB6">0I<^DU\!X'](A -NGX"B1&?APY-"OM =I\*\Q!"K1
M6Z$0?N7^(_?G@&=%Z*.AJ+\#9+J$[6H8-T+X/FQ%/?\W<R,$)VK4U;R21VNZ
M\2!?G0/-*J%@V="#)>A$(/NN]\1JR9]JV)VH5P.*FD=8@OV2.^P9D?A,SQ]Y
MD@6I'SAY^0@0_@RZ"L]^SR@OB%1K6S8.%=$;XZX5M.&5[0>A]J)D>$E;H"?W
M4H.YOKY(C07AY'%I$QVL</F6'QE8<!ZR<\[0L%,%F?L;*&;$-9NQ0JK7-."N
MZO+(:.;Q%3>RU*LA6VA<W9#43X:/<(T6+%@04BDH8K<I5)/U PC7V67"]E-P
MDG*&,0:TF*(29UV0+N,74CD9-:E;H5!T,:L9/]D_B[%G26\@L*&RH0GCWX7!
MI!=,F;!@#Z"V5K-!B%S$TW0%AN5$SR9G 5E"5A;Q&';R)_M)+=,4!BE8C;05
M3YWA5"^298X!*1%BDH!F:9Y^2DKU$<<' 1SN3[9:+GLXY!9BW#IHE3B.]ZR.
M"?K#HM?<@>2OKSRLI%E]OF4N?I.VWA-]OW[)Y^3;-AY/Y9JAQH@95R."KME3
M!$D-.T7"R4UV<OU3NK>6>MR$Z8IM72&*X@,I 1)]W+7O6KBC8C$U6-X":&XR
MY819/GV/RM,EVE _XZD3SHBXV#UX:5J0$5#-E%(L"9_W )J1:!# /A@;X&AQ
M!>HMFC;X86:!!)(5)A3WE1"!W3]Y_&.!@F>-5W$Z\/GF[>8'UT$J*,1"Z"HN
M R@/;,]V &J7"(*2&^2=U:0B4':1Q,)7)$H+5L'7FIAF&CSS[#=1D/W&BW0I
MBU%#48(#::+"& N5</_-]S=,VP7OF!^Z>,IJFD ^6<90P:^WVV!!A-:1D"#4
M(&COH2^>Q"560C8"3=\GZY:HF/A%B5=&CA#A7>&\:E$9.UDO47@;;'%.E802
MYJ4&BIXK3SG&JJY-$M>T[&3>CE.BGV<%%\P[UWJ9)$_:)DK/78G_-GNM&Y77
M>N->ZY4Z@^5Y'H_=("V^+2M"R#,<N1^">!^-'5P!5EU4%T*>&0FXXL3[*+8^
M.%A%8:)N<4\<,DM!V6,MQ@A.X\GS<555K.RE'=+A3(#U$\3KDG'BWO47]&#W
M[1C;V?;I8.YS./C(;2K[FB.@^DC.,W\>^HXM-W%RI=$]''FW:PK,7SJ[O1C=
M'^L**!N1=LID^EAI]F5@]^PPF.&]@!$)IT3>A1@Y[\7)"UT55'BB1]0RXWD)
MGV0R(Z83AVPFB4FML*\G<!?I[P\(P6^#P,SCW)#7 "EC9CN5VG&EU';K*FY)
M6,(??E,7*V=@FV?F6X>.YWV71:1#B1&/!R?IKAQRYLIS2:J>[?';YO2*NREO
M6^H8GVJ>=OND7]%HY;PBONM+WG5:^"Z]L7[>L@-9JP4!SG&V'FPJY.:2!IRV
M&***BSK()/6W1YXP?'%'DC8@J5W^.(ZM1S@BRE(L'I7WLY^$+@7*@ 2+FH^@
MY_M1&('F\\#L%7=!=";$^X9D&&A\AG:(E7^ FO^27F0J <5-%H2R=DTA4<4"
MX_Z&5Q&/$<-S%A?#@?>2SH4=A6[TQ,Y$3@9Q[S&%5SQ1= 'H0U$A6$G'5#=:
M^$9ML ;KX3K+V?(GL7,V%6"]5J,CMGD+IHKW5'0L!_+ZL!G#0?/?ZA:MGWX!
MW3G8/NQ:6*7*E'M\\82.8 ,2>SB\"MD#-T03:X6@_-G]\;3%0/. BCN#S@4V
M(%=(<CZ'!;=->X1^NLSY#+9/&X:;_1IEU7:CG.\CQ\I^B1Z.84[?@B+9;VW4
MY];$01&OJK-?H4[,?HF,/?&=%P0V[!>3W^/6 2(S\0/80_;DT"3-LU^+*Z"Y
ME@+MIHGOL&&F;IZ+!<"HQ'=?T$H<B&/N4N=D6$*?B[I*/Z0ZV'0)1'X.DO*A
MWUWOV94E0L3?5,2DEJE@0MH @ZA&NFQ&4@#1 C19A$790+BEN0MK$#FH21S@
M54?$3J%.L\-Q3=<A=.=L#I"CXYHC/;R 1#FETO"9*#*ZH!9"N_0[)(V$X6Q3
M&2"RE8FNT\0=]@@^"NG>2/ES4FXI[4;18<]T@85UM1QFBX%;44CEA.05)\UE
MFA86QPYABR/IY,!A59*#APK62(BLO$KR^A =I:@ET=E9K.CZH:P=4E"N@90]
MD)F."JCG5#C=0@SGPH' ][ 09GZQG)HQ]((P/6ED -L$2@LE3WI %EX65>22
MICT^1E^QJ)SEAK[G;%X&KXH7(\?=A\(CS0M1HI&_,#R!ILP*DK</*ZR;BW&_
MQ*6RJ]74.(@+&^BGA6Q5A4S5A?DBTK,QYN(%6 ZA.#::FIS\(QO## L4AT/C
M&>) G!C/B_MHY/:1\V:]UX+8<'IRT5#X16B0.2T=?!(^"Y0@F[NB] Z)!PNP
M@EH ?YM4N2?R=7LL#J83 5M<."-\A@I/BV0P994\T$%XP8$WH*>H6SCS04?!
MIS-AT.*^(*^#IW7S/. NO8Q;X@"?A)A/#3"O^+_B_R+^S_">M ,,Z R,8,]%
MW@^Y.2 K' <*?/F$6Z+<@B?*=)+BQI[X"QPT0UF!#=\2=S,V?(]90S82A371
M./%&(I8.[1-ZB3 4R)RJ6+UB]96I^O@ A8K^+PR8C8;DU!:LB@RI#G^6*N"+
M74J#BC[+<I;%K(_<[GCNXR&>@7)<&FC'Y+P;G<<!]Y^HVK0\:OV/;':1;M81
MS6K:(4P]<,%81_EG*M&I1&>%5I*)5\7*0AK)B^N!/1('%8P7 4O<K[1VQ7KK
M-%"  )Q"O/ 7:3VH:[DA'(-M.!X:C]Q5#F!=T\O\$L^O^+/BS]7PIQF!G3SD
MY%'!VRTM9%55/9;%LL&0>'1M.&EB5!85X1:Q+\C'/CJ>(JY\_^C7XR/T*ALR
MJ!]-8ZT6MRSJC2XLSZ]XN>+EE6WS7A2:,NP"_8<.?\0+.I&"1F6Q8Z<V15/(
MBS28T"->A88RSTFF#F4MX\+XL?B> "QOL)HK]5RQ]%K,!^&5X,HG,7$VTST:
M0\_EH;P,C:U>W[,BT,05?U;\N3+^U (ADENYFO(S"'B%Q/W@C=!VB%S@Z(H+
M*RY<AY8T(YE[JT)1,)]#7I!DMG01"T,WJ(\BR!'OB^E:.4[?&>+M);-E,+=C
M!Z$,@Q(7D<,A15=ZYG<1Y2),VV>1OH &L'CNA@46^\NXD)<A7TD::DE\4.S9
M<^R_(MO"J=!O/K/DZ^C^.LD[KJ2GDIZ5F<WZ_1TW/3CH_5N(4!*IA*&]+@A2
M&(/UY&<\B/MZ:6$SRJVF.(::S(!5X 8B<0$%#LP4\6A&CG$'4:$ 0'6UHX 1
M Z, YH0NE6PB+H#PEY!#CV17'6V%?X\2OVWUR>?T%+Y0B\##7[[SL8$97=Z8
M5S)6R=BJW"Q>0 &D(E$0+UE$A*>Z$9&[ALQBJMBN8KMU&$8^5VFZ%- MH_",
M9UAQU..4LEA3MXC (G:0M8 2K P,&_4IO$.$8L&N@"!MR6' Y^0D=!\+N7D[
M\S=.JOR-5>1O5%IH;[20R+P00$FI$%KRM<+)*W*J6]>*XU8>*Q/$Z&(JWE&=
M2BP888# $-KY1!Y,$(_"&]IFDLQ#L%7Q.06VOC[#:ZN*6RMN71VW\B?/B70X
M >$N):490X@))N05XU6,MX[C >;*R!3QR%=W2G JM5W0>Y0>!;J0O\ )E7!5
MDY1&E9U&G;B(UR'C6PC&B-(D1,1?I3,KUET-ZT9N'Y;0)VHC@I0M@J6D3\]V
MK0CX=RQ<[X^.UX,#J=C9"=I4?D,^P3&FCL)S/R57IQ@YD/H-)(,"6&((6\]]
M].B2%84'8;2@[[Z#J4NV"YJ<@+KN(S! & G(PW<?T2V$(Q+.QV*PL3L(\0]"
M[V?]]M:&[I)0G.143>*&65*ANE#K.Q$FY54&="5>U9&MXKAMY3@R.62,-MWG
MH,.1;CZ1WTP_L@4.60P<K$'&V?+NR,-$.#C9U=*W./B,0":M3FT5PZZ2856R
MC8X-@GF6+N%%J(M*,K!K25X[Q<K6XKQ(R<8R&1CV=U? Y6->>Y)%V5<(E14#
M5PR\\M,?:DAN2C V"C0<46JOG]RPI\YS<=@X8L,(C,2**RNN7)$S3/H32)N2
M@S8..;FX_;U]>=AX;R![\J%MROM)T_>4XU8[#J82?&'OYV10I(Z#F?:6'?B1
MQ$'!=!WH'(YS8.HZ*B K ;08*R!_>1Y+']2D_XZ&X"-,,YDUZ6,=W:'"'D)!
MDA*7"4NGR%"4)"9,;AWZZ- R%]828JHP]SNF7" 0%9D[#G=IUAB>9H<20%$X
M:*AMG]D.]!C45(DMO'JD(^W1;$%>.\C&%QNV2(D^4@@E,DZ7 1LYS.2(.QC)
M(B$$#>/.Q# Y,IHZ5 'Y8/% KP-;^83S$@G<'V3%@D&I(F@X)G&S(+-C",E&
M80UI8#6*K5-86:DR.U/ 5^(R'KU,@1C"XS=E+$FZRHM6_V+SV"D=02TLDH,;
M"T(\ROF+]<3J(*GEG%9PB$X"DOZ$-NF,131- F2$^*(2,A.-_UH&O4C(&#DQ
M!<D$%I&.3B3]/0AWF: *R16>DZ4RY4U@>JY$D N$/TA<.\D[I20]1;B<A+,I
M1H.;P%&3?!F#HA(^&0*'>I&K4$L54M!$49%[3.ZZ$B_6T8[E9@]OM3T+%&3?
M=BAU)BFZU;HX,FZA"?P1_XH(/>P)](HHN4(!34EI0EEXJ_'V(_3#>Z"GH'5H
MS((&?7Y^/H+A'SUZ3Q(!=/-LFZTZ4UAP9J;(Q?BSCMA+X@4E!D:P)HDNR$(=
M;6LV();@"PT3B^$J.TZ,9:60H<A]F(*&DE>BQ9!<S_+N5.@H HH2\%1CA6!%
M20#3H?"(VW.UZU8#5)]6L4"[A>5Z<O#IHG7?;;9OC,O65?NF=6ET6_=?-P_6
MFE-N8 *4+IA=;6 "5DP;^/DZQET(^:Q1X>#39P]T10;2&?</F6/9PY^106.O
MW;0R)>DB+?-"\V^^(,:<2Y,SUN*5RJEG(LN/)*;%$@5+].(I^B%JLEY*69=1
MEC\H7KDYRJR4?&Y42")_@E\GZK%M?BXS)J$/?.:,]2RKS(R]*3#SZ543?71R
M^M#8(E"E3U.9737$BS&>F .'R[_7C^KU>@/-+=&Z-D4YE96%4GJC>#5(=>"9
M"#3%,QN+92'?3.+$ ,M5KS.0JO$6WY=?L#&,SF@'<-RR@CCK;;(S?5SIOBA/
M0B^KEJJ%((\ZG5#BF\:%V&3P%)9'H!-Y1,USJ[N5E5@Q=OD]3CR?6O6CM^_.
MW[][7S\[?O?VY/3D/2&AF\PQ(Z'KTQ5V)Y7^YL]5\TW^2[-YES]E 9*#)Q9T
MA(T(Q0&.8)$K*]L"?R"83J!XX\&EVH7$(H$ BA\)<&!D/C(<J.A:B$YM.R@K
M-XAH+$>E#%%]V<F=;FZUV+Z[S5_>5.TE.K<7O%E&U[(@5<XS+6&GHJ1F6=<T
M76\I?ST6*T19FUWSRH!-W.2%1FOF?7%5K7ON^8_,C9$=W'2)TS.M>.E2Q;#B
ME.BX^A1V^U]L./H(S;32@-,G-_/=KYO?=G"2L=1!)]U'N6<JYY;CR$LU5NLQ
MQ9#3;7,]J7[+%B0F_5U<Z*G8Y,R>M-(6Z"CNH< (G31#LU5<8_QTV6M2:<KB
MB.>E*M=V. GM17;4LA8+_9B:/O0:\D.\&.4?7._99R.PL \;BATRW9259%DC
MJ(@EM<+3DX=EH?SRZTPO4_MY1D'FZ56176O^VM;]R"<'@=9:EKN69G&]W':Q
M@-3(IUFW"'*CM)/YL],JUHC8W9^>_UU*I3H1E'4R:1_1C/.EYIJ*K4>"8G%=
M>7%%]R3*ZY$]R.07B*6+][C.G?1:M=TGA 7W@W1UX$#T@/>,%'0%IX''1PSH
M$D?)QFGM_+11.SX]+? .3#X%8P0"!5B@R18UG/_>.'U;.P.) J6]U>7KSJHK
MC^VJR;E*/QRP,^7V4+ %W6@JG*-ECY]WLL<_\OO1=,5I[?2,Q,<H'H5*]/2Q
M'&@0":B-9#_MC/"XXN,.B?C/<37?Q!4\>>B%\W%-JT&#NB)D%)4#FD-4 D/(
M?SG(+/H3'(ZL[.L0^XR<$@4OTPKJ**.#"M+!;#A5*$KB[K?5GYM9IJ691W0S
MFW>P4#0?D@Z(2?.3?JV!$1[$.R*4Q.9R:U&<0S3[66,O<GZ@[8P9/4ADL/22
MYACI%1(Y5=!/W@@TM['D5O)Q"@Q1_-5AST8TDA$4L!]BUK(HWP+OQNM_$1\2
MVDF=V<R%$ OBZT-U:5A6FT$M!47PP%H4,(=&U43JO63'S9S"4ONT2J3%2!7Y
M%IF^B&&/9'9@T)_J.-5OP=:?8ZA,@<;"GSF#,11,5I=].@N":2Y+T<F!JD0W
M"O# >239.?(9#[8:&R./,BNA7H$=P3%0Y+DAHJAOVK&E0N'G$9X7"'$N?\YR
M3>BEHC:D9-&THUJ_@J0II(+4\GS0V\*:GM#!Q9SI)2&DJV1,5W:\0<:4+UPC
M7\HW5&SY:K:\[SQ,W0.#$!8S5.XD:8>L6G?FOL9 _[C$V30Y8FBLEVMA)=;)
MLM/FJ*XV9[(KO",YGN9-0*0'!_O%R]-O XJY>R"?DR&8L'BI6P3=:2!6_2?[
M9W&"GG;-$<.@\2*76\H;U\;#HH)82]QVTC='G(K,!F/%P-AG-WMGDAB$>:.I
MP9CMGXLN1&JI.3+-%4)#O',8W;S(4>FEL;-+GF4958XI[<R<.M#EUTKU8"G/
M-(PY?[IS=60,\0LK ?,E+35U[-1T&E,$D?]DTT9%B+Q#&6^%IGL^:<>ZI9_U
MV(J1B4!:6< @#@1&BST<:YB_,S@$SX>D'80C*SF=3NLHCTC :$H\LNQVGEG_
MW''(R^#TSA!?DZK3K&.K]#,EM3J82*#5RRYXU_7UA63.LJJU3NNB6&=IM>QQ
MXK%JQT@EFY)-2CNM9.1-L_#6)#7#IDD.D,;[DY.:=D51VAFJL_R<%YP7#FS=
MLNU\GI(9K02O-\$& >&DD'DR(XK7FD90\-3L^#7M;DJW]")8<T8ZQ!DG$ET3
M$3,S+P1G-O!<?@B:ZA#^JU9%+C>%X-2$ZD@,J%S+M,!F3'E"*C:;RF:?EV*S
MB:<68#/E4LUGL+EH6B8F+#U_*=_WC%@OXT[6133:;=Q>,;PI$[L)1_,A!=NE
MP*I+.'7I[(>Y(1#Q0I?\ZMF)6_X<@W3&7;_J2[_7QV;92 WMUIY2FCW+[F-L
MH@BA10\O#A+^N]6WA^?5[>%VW1XN)FN_<P$/T9FQB9S4ZF?O:\=O3XK]0+:\
M8AOP[.5*?(M'51UB)\^3?#=%MGA^G]N8-5E:[90?M5"\9&T9?%OP8.QWPM_A
MN(?G_L+("&)+=3!+K2UAOZ.?0IY&,V$3!=OR=J0$96VMV7M@TX1S<T!NPM@[
MTF[#N3.TCN;8&6O+!>"6?OVF1;5.WFE/QKB6=8+R'KG04IC[7CJ^:IME<L1Q
M#Y.6QD1Z"EH8/'S&V,VTO#:'W,>JK#(VK"MS=G1G2=>/@E"Q,-D:R1#)*:P
M?+8UH."UD02S0PBRD1UQX:["8)2R9M0HELO?'I9=P2L! ##)T'.8V]KM=S(B
MMH3MK02D.1R1^V+"SMYJM(&WE?&\ N,Y_4*))/;YMMN]_?JA<51'@E-*B_$W
MBK"O?Y1-KEM7W:D-[MM??IO>HGM[E__[U^;]E_:->$4=EM607X@N\9LA>SG4
M%CMG5=Z__4=,9Z+[T=D_LH1/?4<KE?I&K-1AX^@8H<I*!<QP>O#I[OZV<]>Z
MZ#YTC,[#5UBA/TNP9:7A:KH(P$!&G@\G%YB=@S,,LB! \HJ6.P%_'E"PXB1V
M@\B&A=<CN)5\1K\GTKLD9:KA85$JH\41!QN6@/!8Q@(6&PWYH2B)*=#^CHS/
M)/SR-P$]+?#?8]]]"FO+! 7>C_!DEH#AX#63SU/@3$EPG:B2J:6))1AI&DA,
M7'!>8F+#K E/BY"QXU_U20>(?>WY< 1)PQS!4W.A',F?O\;E_V*+]3(&^Q+V
ME<N<<6#3[G,5C_U"!1"(6TT%\04;5(S6=*1>-R>8QS,WHD!$'HK;_/3M5TUU
M)[]6YESFZV>>_2;*FS>017V;BQPBH$7TQ,<L[@;%'@!Q"^^S<;.5_M1",7VW
M!F5R\.GV">L-0(,-HY_\P8U>9(.4_(47\=&03H)1J*I.$I>B[8[1)Y%)TJ9:
M4HWZ((@QP$;>,Y7)Y$."7.IQ!T'C,AUC!SY'8#(!5.?&<:!##PQ^D;XO) :>
MY7A534$2;"1N7NTD._K9\QV,T+'8&'3"F$"F?/:H#W'(\8+2-@6KJA$A"TQ.
M5TXG);$(9Q>Y%KHY0_+MN/RY)G#@:+:@5A!E@!8 ]"1>--#M==SKYBUJ6'G"
M-3,4+B8&?8,$/PK4 7G0)PH!_PN1(/GGH')ZAPWT$D2N_5>$T:I]PGGK^>K^
MHL],<?UM<0N_$^'JL'*A%XY'RI<E:K8K33K)+D=&=^![T>- O?%9C(6X@#-7
MIA)2X7>M%#Q9?J%\<@C*RSXT!_9H\@6P@.; !0/P4<Q3,H8@O$GE5E4WS,"=
M ?9$AN%XXI4PN2?N>",1B3*";YDYJ FW=LPV^&*1D*CJO48(B!?)]'+1N^EX
M$<)-.,#+_OB'\(*>/HG@XEFJ)/R/&+H(#QG@!ZJ,*#,-8 HB[_NXWG@K&(=0
M!PE$+5F]23E'S!Z4)0F$(7H2954,$;4,6[[A4P0!T'CFM1<,[Y"&5U/77<)!
MXXSC%<<Q*>W_/Q>=> @RSQ"Q)]/$4>-!Y$4T0'Z,Q!*5)-M1B)[OZ9#%Z5+!
M(N3$<5B/,O?AR9%T_PG6]@A=PA$RC334^1G6&9'F8PE!?8J1-VCZ'8I[T(B
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MN%^9!JHLT(+]07G=5,?<I;!B]((HLTLZ/]'S)Z!4:">3#VKS\+%MJC3Y(ZQ
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M7N92+U/WF8O3MHY:U2=OPMS4QA"TIM3^)H*N,ARKLG(Q)=J6Q IQB&)L[ZC
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M/>#9RE-17^2LP>E:._8G2U/:C+-I2^:6Y_ ?Y>FN./+5#.)/I9R3WD];H%*
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MVY,@'FIX7FX=A4NN^8E/16<;?0I?],\2YYE%J%VR"B,"N^5P /,U0X<GZF3
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MDZ&0A](W;RL1G(3=$I/WNS\";J_<<+JK.G$SCA(!-T@;XN.A-A_7Y$,>;+*
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M_+EE,1NE/LS*-231*!8;ZG<U >2/)MC^C(;<GD_>4.7C%^UE;7VQ[192S)-
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MU!B/(J<<EC?&@E*R)5R74HJ"<WW$D8'3OKNQ2??JS?^^_O[LZ9^U21<;J-8
M0& >H5*B!\N%>4>-X=%4T]UV?0=5!;EG^J>JD0D( D$S\EJE8H0S,K^@,:I>
M__C145JG==KLU27<EOL]2/ALV(,ZP&F[A]JN%P=[-:O#DG(483^+U%!TL\N\
M?H=42,NZU+&@GFDWKGMHI]Q5(1XG! PGIW-R.G?B=%QAOFW"*]\AA!3LYZ3P
M-SU&3\??R1+OQA)=D%@='#9\TZ+B1R=9B])JTI"49E];8G"UJ(I5#Y'RQ1X\
M6M(:-C2T LT)$4%@(3HW# JMI;J329],^FYJ2 DQWK(X-(+9=$BXB&-GF,,^
M1"4\[!OY112%@O:\ZY3<IK_OJK<B;>"@H!A'/IG[R=SO*-%W@%[M#IB=:BX2
M+A56GMG%/'6+M.+:H>SEO]'[B]#K$*!L@G<&PN!DM">C_0.,-E\7P=Y "I$/
M_;9IB5YMI-@<86'2_32.SU%9J&E/-GJRT;NW42-Z)3-=T4AS!3"5HB&HQ++^
M;>BF)7TZ[XOU>#P"0(+N(1#TOMZX\:X0Z#1\W\'C4QX@8=15H6,H#@]::ON>
ML?0\Q;[-J]Z7<*5I?TUO6BE?"7Q15A@=3])@#R^<SI=ZB-H(GC:"PTUP %PY
M.S9P.KG\.M\1[GB>G.P!XC#>.#!C'"6DERQSP3I5Z#$7?=-4BJ0!$3!9\MY$
M<=V+W17!5Z^/$-"(^Q;(3,0O)!?GH2B[/G$Q#V6U3NS%YI9I@R5?L:9I@R2P
MYK>64",@ULX$60P4L4Q@X?K"=9S@FI-Q+..DX1%4;W<.>.*L;82I5..[+\1)
MI#A5\;:9"=(N;4WR0PHN/;X[E?J9;NW(A8?IASPA3W)@%QNJ:'1NI1YVR["1
MDO;IQ@D'&8$&0>_+\)=7X\M73?-.A.R*^H*VIQL.=@ [0WW6S>)B(+GHOBCF
M2%Z+CCQPV6UYFDJ&[F:F$WEZ>N;+L,D(=B#X<GC0 ^>!YXN?L1Y4DZ]Y[&XT
M5>.!8XK%'Y=-E@4+]=KTPA(WF>XUEX(N"W;0?OX++QBMA,\9]_KG$^[UH>->
MQ^>XTS2CD5MBWQ^6OPEQ=JIYT&V'GMC +$(0I^3!YQ.]#U=W7.4],0,U^^#1
MA.;^?/&6D):&6-/X1JY,FZ8J$.,U0Z\.3H=^C\U.)I/W2B\Z>]9HE#6[3?VX
M<-/.D_Q,HY+(R.'.F@<6B?P 2*N%"4XK-$8?9!TS0:(;QBC>%ZO!!M,A:U=<
M8%C,1M2U!6IH!<S7K+:L]6"LJROA*7PG(&,]]%IBU6B/Q:MR*\TR1*[$HXI>
M\8;&_S!I)?AL&PRZ/S8FG;\P9G>>2N=1=8X$K7'MY_*9_+=(YO*GZ^"H;[W%
MBGW*G#L;+7Z,F2/>;7%Q?BT)+=[K'T?>8?_E+$1[4_9@PRK\]BC5<F^HHF=V
MTV\8AR+LMB<)H?HOZ$&$\D0/3-FM8Q!R[DS.Y)[K A(B";/OKTYH1#@A#D=H
M@#D0D;R15O6HL2Y&*!MK(6I+G@*[E?"2DEA)+K#V_?;0E:N. QOGE#6X*GN>
ME=/HZVI;P*01Z5R[>>C6@02**/GW_:(#PW.U.!2Y$E.LFZ+3@CL3.?/H+@WR
MB!W2QV[\1G[G<.D#O""^G4'.'[3-G3'?;E\?(T/X$#JC8YR0#]!S_SHS+.OF
M4S'K /!6,D(WT4;(7%8Q'L,SCO)IUN<W;G6XQR3*O*=$!)Y"?R1 8<L27BN/
MF"NT#0]Y6;3'=H@@4J;"$OGZ,G<LPZ4K*?'9QJSE,7"2X1]!IF+LVSF'=;%#
MW4.&)_5[8JJ=[J"1;PYY;],G@D=^B('^M_/#?5P<D#:;GL0S]]<HN4;R(%C(
M+J<'O'8D.;%/_9:<M:)&;\.05)&,\?H39GJ$@$& :=/9+<0Y2!^+Q"+277"@
M'7<:WP]2FENUC8U];8M\?14LGLL;8\R80<9L5!-D.@88BT  *;Q%$-=8ZX:)
M/5QMZ"&Z,=K"TS=L46+)TV=A:<-&K$#9<B'E*1FT%OKF<@,V?CW%Q.UE^G/^
M9Y?HB1G5PN13PFN L"D]'34,</Q]UT1 >N'PYI@OKK/BE+"=R9BX4-:98<?G
M:%E=0F<HI);"\1?D'#F.''L_+9Y0#L(\Q??EG^N\6S&Q$L)-H6P:^='PFKL>
M85:^+]?A/1="%),!YQ+BH8)Z3S* SQ^Q6-$':UGB#O0 DS%]^[GDEIE]C==X
MBM+Q*F?#IFAL06QPTU"5O;>4%XNPL4.8PG[6^?699Z^5K&9BOG3PZ%![QM5.
ML5#$EV3,U8&-V7TL<5@F'76<OW%*]V"!>S2?3SL[/Z%N<.F2@&A'9Z6-'I9,
M<3O5GV(V<I'^6!YT+;4PX=A]-W-ADD>G3A*T<#-</NDY^KK,JZ&87DCJH2/N
MDN^YA$TR?/QH; Z"8IYS,@(_A.$C$I!^&/A(."J>?C']5UY']@74G95BOEY%
M/E)Q0N?AA4Q\E>BS6JJO#DM*T-=X<D",K[9-5=SZ^UV2-KTP/!P873AY _7.
M&8<LFGB=+_Y#N9V0N%A"AA%M^@6J7.$BB%""45R75&,KX]U5I8&8;>I;\4K!
M3Q>E, 0MPXO<E'TW?K3L%CY_5Z "/_+W]5&[UZES<QV8JE/^?\@\R&]FST \
M7$(FJ>J3E+^YCN(?&S&]!I;\HF6^\RNP_.D[0; -@B&\N0Z$&%S__[R+Y<^?
MG(KE#[U8+E'XJE?.9=L0L;<M@]C(HH<B/58PPD'##ZLB(6*!=IOT\ JH7&5*
M74E_+DI]N@7"2UUS*5G5_'[9A@/O2G8FU9M%>$UI@XMX.SIAQK1H;!K3S?4
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M-D1S* JG Z[6QSB-$GTW#62I0A<6/\6WT75B==9=T?K$JQ![XI<2.,B&TYU
MP3AW]!E &AQ$C>J^/+U3X. 'BV-DV=$[LOM@UBU>H_#;'0%*:ARB]!5X:IVP
MF$"J9[C\[C-9'?FKN>K_K>R#^8/5.!K:LRC[I^L6U]/-X87/$>M]=;YX"<[M
M")6/T>"R6!&Z$;L9;020+SKT<PQ!(_>M;UE'A3$KXU.R:GR>I3 -NKMQ_/&)
MQGS"I\_>,KR!,OQH ,J<CM1)40O=$PZ4=/(K:3AJV*9YJ+^BD;]+D,7KR9,+
M43DC$\4KYI^6PA?QJX?[T6J7O0GB)H[T]5(K1[HWV0TL"J![(BZD?[.HY1!I
M&)K,T*6*BY^,&S.1.8LZY\DQ0#C76$3[P>"A8IKDB8EY';T3(CFFJQ$S2TN<
M_NH&C%8T.@2'8 VIR= 6$<47%7>)B#M85$C@+R2FV#4-'88FO=4Y]8W4J"4A
M*0UZ)>\R)%YVPP[E29V9B=H%G47AK_\:SADDT?B#5\%<-HL?;%>]X5V5+;YO
MS[G4_FH;(JJ?RXMP()88V@JY/ M),!LF%5]HJ[4]/^.S)\^>2<[5L1*&4,M'
MF(>0^7[HG;P=ELUZN_BOH7J7MW6XF<^YG_#TU$]XZ/V$R/2:NTVJQ7E1CN)R
M1[F[G35/15Q"QJ'<"74S %[$3+[D[I#7;/SNY>O^:"&D[9+OVI A+-X2A#?/
MC&@JY$Y-N$$]#OXSN*4V.);O0M975,$1*VR.@NNCER[C+9.'N_GV?HDIG5WD
MIQ!4Y46U^(^\70YMG2GH:==HVO%]'@ZCX&DN<QZO0C=8J/<)G$K<IC+L[%^'
M! 9N1A_0+$"08TW,BC]6.$=:%&YCUU"C',<-<?!=4-&LQ/PL<DN]JD&50V#"
M YZ+_(JZ0JI$YV)V.<SMNRBWS(>.+6E=]$#'YGKW(>#(J^M[.G^D&"?%.YFP
MDFD'A?#+3?LNO-15U+R)!AI^_6.Q; <J'@=W_QPK?BB+<$0-->T'R&M2#3B\
M+L:%ZW1AERIG:GQ G&=E/\@T6'I,(K/NRX[2;XT%*#KDU^\H2NR;DP?!0V3@
M3G,_Y477MX^A8YI7 R-/3 5$]>B,<KJS,;2RXYG'(ZI*)1V\& 6&5G/! GN#
MH,;C#HVAY%64T;:A"P]0,$M+KJ0[,EB"L'XC&2I7[ZJ#",QX5A8:'+0RITVQ
M?4"1<SY+C3(J/JW50#.]8=9^X@(>QS4<L*7:28S3:B:;&Q8Q3M92Z2(X*-K"
MG2MHS.UD?RGCH['MS6H;J2+MGG8N&BI33P[\!C5#+A622#<2]U&TOYBBI"L3
MUKQI551+E<ZC*D$4.]\/;3<4\-K-GL+3H8Y='K^^G#TI'M*RD)@926R&I;6\
MQ /.T[^>2,C2%Z1S9Y&_2@OUG]ZUS62=B.5'I3*IC\$O3S+/+ )4Z8RZY.T3
ML]%)EH^0_EUX=<7:)T&4XCE@I?R9?I#,0ZL 4N[0T/IZR&U8'BJ050>?X, H
M8YY$I8A61L/&F?""((< @J?2+V/&FUBJT!P# D8IV(Y/3RNFA&V\V6A-JZ!2
MZW@PR=W'3*$E$2"8Z!H<A?1J_S@=4DPX>+@ZE;?P$\%C\5N3S6L0X-$8NRQO
MC#5TG^IVHOK,^>(G1P0QK@/@2+#N%U^RB-JHHU<#GZR*>]&O)FY#AL\5(;9N
MV-)BWFG>.9'.DQ?L*^)<-@B[7 (JXC;0%^(&++GW;E*6MWXM*?27!SP4*EW^
M,Y\K.L__L5G#-<_(=FNZ7Q$V:Z.05:5T#D"<SE>=L@5K)LV3.D73K>=8/V1C
M\2&1*DQI@X/P\KM=>=%&##,Y LCXE23F>*6N6W'.IMR9KW?!P2/]%Y@>$I ]
MW::N!"(L7"0*M[AB,I6+RO86!;>)BW-N+6D6?L2RE>E4B%-&M</4C52L#7_[
M478G];U(1NN9,)PF"$&81QX(I;C?(KP;R*U;Z)7='VN)(I0_9'H5NHA^\C3\
MS.'M"YW QC%%*%[6E@CAD)SO]U5;CA*@3K.>=G</54#W##DI*U[S#&#[V" 9
M:J;A T*RR ,S6CZ_<K,2D]B1#D_^%B* '*MVMV"V#E][9G^N]-9<+%2>"Q,R
M%@5C865</&K:V"/3'Z)\2J-9Z%S2$CX68@Z]L1MOJ6[J,R_\I'=EZZQ$)46"
MI/_%R63R&106?#GP[=&M*]<*)>>/RL=<GXNE]Q#Z!B^*7)KY4CERHE' \$:W
ME(,N#Z/U)K]ADW?,HV!0(1%1=-(H YO(HU*_G J^%!1@:5QS'.XXLHO$3,YG
M,A"<EE!(SFR9N0OGA%*[1"O^($O0)<>7@DB6T>F<(= R%0E^W1O>[,Z@6.:P
MIY,_&/* 8O.F?$],5D7J=74%8[M,;-&E!J)6^K:P3@%RK&<O;H%#:50*#.M,
M2TC VQU06IO&WU7R_FQ2,F0IPHEGF4DR<LM]%HY^:!+17R7C$ TSTO$$$D 8
M#ZF,_D+EK2G4# \A?L&-U@/69&Y2.R5) NG>ARVN4\B6K<(V%Y6CYMXB>16*
M(X LYI$\O"-,NA7O*?("\N!J(A.L$Y]"#L@3,MA?<1K!IWH&6Y9IF"+N/;<\
M'V,"KVP)L"7_?O[V?/8\4O83SDZ]5T$^S:TB60R&>87?\$CF)5F4@<0B$S_J
MDD7- 9R\,8-R?\X=AV>GCL,G[SC\KOCF+]<&+TU[$7++?UK).2P.N^R>"D>I
M@DU!6YG3 X$>\9FAQ3S>_2'1[[<'?\XQWFB5;L:;3P[#?*(RNJ=SJ!-<39%3
M51\GDV,N,JXOS3\%E1;%EM&X5_V+3')6'.#=*F1YJ&E*!H56Q)IK9-*V!5<8
M0H)X;HVZ&@HQ-N\GSBV+?KR2=://]USG=(YR5!!40)T>Q)VYQO3%T<IM6M3)
MJ0OD%H6U05,H]8XTL_95P:"X2U0T)A4XGR)>%IF^<JW?< F!,ZIS]'N0F_*Q
MEMY<?*4H24@@9*5MMBB.B#*K%&KA0E<@P5 9F$X.L?AG MZCZH;"]Q0-D>E$
M'8PVO)8UP2U@YPB?L"&"M]GFW)#".>"N'.<7 :OH2I.S)P2^EHUS$=($DA7O
M'CJK%W6$:/%X47S"G!$2FZIX+Q0L).5:31FR5M""7-NH L>*3<PS!4*O)'52
MNII);B(O@MXW'\[QEGE+,PPM."]^O_[<?H!YZZ^%3UTB%X7%<1K^^;D/E4)'
M:3&9N#Q*H3)&G"<#%^%-" X0/JVLI\5(A\!PZ9^&/_H2Q@@Q]QQ[ J@+-BLE
M=TLQCQ:"3BKN1JLY*8_<5Q[^&J#DV*< @VE\3'E;R<A=R@@LGD[?7@3XN^(L
M.R#)#8FDF28\(&W9MRAJ6/XKN%!\S93)EEDV8U; <U&R^&MA7R7H%=U.L<J[
M.!JL3DBGPQG%XN;=(XOE7OF/ .H2FN.U0E,/7H\)7SG=Z.>+5\K3F1)P;H-G
M;U@P!/RL6+9=#B+/W\)"2D:BE;+K]X5F+LF<O'8](C>XP)0%6#NSN^82(.0;
MX>0UX69>)=T<%$78KA[3/F<I96"T@.(]8PB5T3SFGZ;+?:7[AB'.FDI:S1)!
MTH=_LT,?3+Y=MZH,!HUV]ISR<G1!L;1)0->=U=IUOXSB"O;ZV(+\XI5Y5@DT
M5#F#MD/Z*.!)QP-=4N<^5:_A%ZSU+3VW?*\>=>WP>;MB%B,@IFP=>6+$>E%_
M"6B\BY+JIW3_8R?)=W>4^%&CB2.4CSK]P48?=]D,'Q365H,]_)0K#+*OYPY=
M"P'QLI \.QJD"8GD!_!X/,"S^#OE[XN09ZT<8RM3?S&;*X*^WUM[4(; \MCZ
MF*6^Z8:.0K-2N=%F"7N32XTFJ.Y)B#Q2*!O),<.1)4H@?\'K,&D6_;W&"?:V
MIUI6YG_T7\$LULTN6[RD)F]X%ZP=^"H/CB>'%Z /$]O9@F$NWQ<K@&JYH/#\
M:1:QEVB35>A5[,*S;+OK_N0IOYU;57RI$J-E1PTYKX@WA [T]W"I856>?G7^
MY O<R+-OS__\A7%=(VVRQ$IXL(2>[GN8&/QE'2=!IO"&<=N*#53WN6]6,R+?
MVDDCMBZ]UC'S\B (K;[1E"Q[='[9J"M?A6,W6"[%.Z6)Q;N +?T"?#. *=9%
M5GQ56U@"K[D:?7E,ZEV(',?S1N>#)!+<U)]_,DTR.RF;T2-(RM1)ZSS5RZ3O
MC*7(3;Z*^-_$G#T"?@@G SK?"%VN_)[A.RF.] *F@+Q_'_O(DP3)28+D9@F2
MH5;"+8])HDD_:R17S6H"0M"Q+:Y4.)JX")@@\&FE^$T"DC0D^%<OJKR^&(S\
M+GCMO91(*!K"=RTH04) O:>XR4X,-^UW$C0_[84[WPM5OGK' [&D5YRW6HE;
M#N%E,6(94Z8'(ZF,-GW54=9QP;@NI=<+">YEOA+5D$1 V'WHB%6'J"?<P6;C
M9[66>=NRV$0"C*7 7WLQ$UHV03OJ$).,&(D@AP%&F];-T92:BMGF TU=L>/4
M7PY75)YUYO:T!T][\$[VH!@=Y!:D5":Y;5$30EA#MHH:^0/+&Q/R_<!T)AV;
MI<55M$DICZ<_,\"8;3XY59A/(VP!E#DQ<-$+2GTCT+'KO@[AH'WG:2><=L+=
MB,/5<>:?3Y9-F^\*-/ X<K+DB7\=88SCLP1F+)P*1TXDG\BQ= C1$'$GP02+
M%$NH.%%00DMJC\N'_^<(3L@=M+W$S!J,C2=(@>\KTE8?LXO518_G3,EQXK$W
M:JZ%6SJRZ3Y3%,+S$PKA+E (_QK>\L_7><M/[*9H6=W&M5&SQ+FLF]40-^>C
MF!/"-U2',XT;^_3O0F!9"K'+OB&>WJ)[/#.,I2@Z#R"4;IB5@[Q<)-%!H&>#
M@44',72S2SES2X_9 &:^_5H%R-/A?SK\[[PL$\<AKDD5WZ-.WN;K0I)1R1XS
MVAI-2XVBIL^)5AZ)X6(]]*6O1?*?8M).2K0G6S[9\IW8<I+(Z=B<'S>B!(NF
M?%319(::]F2,)V.\,V.4QE>T,BL(G,SL9&9W:&:8X17I%C>[1Z7BZ;2,_3!?
MH9C4@?6D9$4'!5&ZP9JQ6PV9&Q6IT!2=7N%DV2?+OA/+CD-F;N::[4W[\6U!
M$2?]2SLG"KLB"'!_*I*>K/$/CRVESA]^>QW&(YWOY]K^8E7E70?,GQ87"02E
M)(R*YFL25DJ&S5S0!X2L(EO$4$/*).V_6;TD57OGZ;'(L E73VG<:9^<]LD=
M>VTE94(-;:U:BZMV*)W_[H7EB?78<J#B(L5DLU==N6;HZ?7,@)Q427B5=SQ>
M3_6*_G#&LJ+A=@@^RIS#Q!&M$SI6]>"61H2D)*6/6*0 2437#:;C1=,MJ/HY
MCMAC-WG:7:?==2>[ZZ)JEM0;;BIAA!ESDTL)SZ8O="HI,>5FRG<23IK+HHHS
M'VK3)\L]6>Z=6.ZFHM:J14,T.0);7;3BQ7.5W)-!D4044N!/XM0%LGRRS9-M
MW@T42&=,*NNZ4:,CH<P<4W3Y)--9J+(TK"F0H6L\BHV/_/WC** S=LC,)+G/
M^[:T;*#(H1NJ*#QEKM9"3PI-I8^<]L-I/]S%?BA(:@7,'@D@1P:"1B666;K5
M) _>YX>V(655VA",XT8UQT"J$PC1:$@C\IS=:.%_O+A70B$7)\C*>G37)CM#
M5)?RA%W" ^%Y5".-<>T+7H8AP*"L\+N12)U0,ABQ*<.=C)/5$_\8#,'&:NG\
MU3>+A,87*J8S(S0>Q@-_!=3CVH(YGBIX/IT[:D8#IY^>9_25H839"F>)^W*:
MEESI3#N4LCFH=HN 5^90'\SX@[BDBV1()!_4</%1!NF8WQCGP&@(2444=63:
M38NCF$2F B)BXBNSLM*PU_IF,@JA>::P6R:I)G.$S']---9D_&\T'.@>-65$
M)MJ..(XI0];'!ZC282D8T=RT%*9.!:QW U/7[2;%V/X37:1U>)M-JJ'&8/6/
MT"O+;!3X&O9E%",VD%MFU6W(L,(,A&XLWAS$F'1\'7;K@!B.W25QDBK\(4$T
MDU'+V"R/\SH1#)XE2+2>)BR4DZE9#+)!)]P\ 21\F2ER)Y!E^ I^,Y#=IGMV
M],R*ZW>,=\VV7)9]E)^0UU@9$DNIZ%?%&@+M%D =W\4#C?E5_1:%(!V3,^AF
ML3YZ[;7J9T2ID-7(B?""F2O1*RD+@(B&U@T-R@XM_HZ?EO%<23:=^:)N%N5P
M8;$7PGE753,O;/+]YXO_+1LC(]T8OR@)E>!+&K>BLM0WW@?1E?-MC)DYXEC\
M#!E+EAQ8ZK)V9=>12Y)&)*/JY;1;R117E'S,*Y@@I&(OFE:G139RIO!>Q)V7
MER77/58M!)NK.)-"\L$[5MHLZ]^$Z(8X!.1$JVC.O.7=',GPA<I535.";T'_
MDMB,4KLRP"EE\=6)-,<$<[L!] _T(^>?-=G9ER>8\4.65_E(:MOT!&:(@:-5
M<+/- I =TU%Z'8H1 [8C,N"#A4_&E$/T:G%14%5_O\7FI_W9R9FG<1@?K*M#
M6G!:^')4%LFGKL7<WM4VOB>6A!")E9=C*CHX:W9GZM@9K)Q,]LU-EULP<YN0
MK#2QRD@FQ9H:==Z"Y;D5L5!E#G#"8/_17!&AK)ZXN(HGBAJ9TH2Q8GIG<Z8Z
M1S @/#X)>X"F62-6(:(I(BKJD7"GFUCVA*>.%N#:4)Q)KHSK'\1STSYSJK:G
MWS-=B-%,*3>"0^ 0@D4O/A.)Q)4W"GD U$I[)Z8^/YIM;"+,\\;9YGQFO#S,
M4RTEE!Z1O2.+/!22&7&_SW%,1'Z/XPW#U)BOI?E0M>I+-YH$:0FF/ 4YW5]0
M+#F\6&S53/'>^8:/W:?G];ON5COC;#8=4Y"OL@'[JR3ZOT>XY,EA.EYN3G%#
M%+6,;#N68K;^#XOW9==[25CF=RV@>-*J!PCW7[9>+=RN!CXRX8."K"_S_<C6
M02F!!R\OM!Y"C%1+5#A,V5R_^WSQ2Z*Q,U7!=?3?_O#X8$:5^+0B/-^XU)I?
M 6O)K'*J3F*V;2;!\_<#2OMC&^+35TS^ OZGJ8-D8O(5.X.<T_RFBZ^,'XD+
MWZ/&SOR!2[MZ6U:%96?!>8:'*8D0F.K:>21;3(X=6/N: O>6:?B$\W$DIVR4
M?QB1C2=R6)6&J9?7OC@C]S@C"3%^FJ0+A0T:;V@AS%JC2\( (!?$E$W88GN^
M(LL;8X2(SN)IJ=,>/N4RF\G.T_M&#67EV/J8\DN1%-!VJ+O8[^6,*!:$[,^$
MINR#]PH=)LFJ*<&&6 /=#@MAZ ?#J3.SV*.^X++HKTBT<F[I):N+"S^ADZPC
M[YP8KK\&U5,N04ID*AU1(XG)<!)SX,M'-J[Y< _S7U3MB8$4VVPJ')+^;"-[
MD(*+IIV\7=87OGU$*[>JFE6PNH00DE3O*"JG\AQ'!$+;.,>R.?N<#Y I;9J2
MN-<"Z=\D&5':V F/.G4I0AR \[.\/ST-T@_*=U1[@^^AP2O:YGOFQ(VX[Z32
M[$5%1'&R<OA"^A$>#]6B#:+H)BQ'<HUQ+C;F2&MF#HQH,'32E5R,<75,^M*6
M_UZ"AN"DRTY76XI7J78.DS%HZ&&?2ZMP,QQD0F@UCJPAJT=%7E1_PE6MWLH5
M_7;?\!&B4^!2(PZWQ,I1AT1E@ 6>PETA.!_ZK2C1Z3*GKX4"&27QTOO#^.B6
MPCL0+!,%;1$NLU:5G$T3>[W);>B)B2M[8FU[+W,W3 M,BLO![HOXW-"_5$)^
MKBLWTE""_K;R+,OAT(=H<>@ULC$.RE&WX[6XT]P_7_QVB? X46^(C3>^1Y48
M!8T=Y2!=.!%#' B61V7AA8J#HXC-$X8WF5'$0@1_FJ4: L>XAV\\\9JZ.*/2
MNLE\$$)@2US7'8O,%ZW7F8X&K[P?L0J0.1D'*O#GW&!S:A5R(GA_"S$A*T#$
MTJH\B1)WML6&IC,61H]*H5Q[R>T35D/4=Z-0XM7A?/$VA+70\B9MSI%5JWA&
M3@(U?<*0YPC2Z8FQR[PQ1,(YS4T\BUV25-$%8%BQF9P)D7YXIJ*5ETWLABI?
M<:11K?(0+)F2.BJZRYX\OWD/7HU:G@[?6FY<LT@IYQ,*6X./^L,"CCF8"=DZ
MSMS1MGB0)^91Y3[/;PA_PL2@K$L$8L(630Z503S3X;;PVTU_E8L#)7D__".A
M';XQO+VW,AF,<].$0+Q8)_*"Q(,)PV$%Q]&BZ6-F7GW8%C.&O_%S>?A!V2.Q
MN-'W!%=QAC19G8\ML<&:F6$XY!F[\*Q1>=ZS[N;5!6WG[<XTQ]S=N$!!KFGG
M#E%,=HM'LNE>_O5U)SOLL:/\1+*CZ":[/:]2](YD<_4J;[__KW@5K XOE-"1
MV[W(!8R+3)]%[G''?$M*]$<7NM5BFCP6"FP76U[=S[K'\M6IQ_*0>RP@-)DU
M;(XDO9IL,--R3=4KH65BTX^%$?@H[LUO&S38.5:<V1+ISJ[*99MS*Y^V,5^7
MMN*8:_8:WX^XY*KV7T'7HN. KL2!RLRI$CNE;>$;[^O\(/* XV_:4;5\E__6
MQ.L==2P^:?E;V84?98M79?L/?L0W(?Q;_.WEVY]&/"M0**'?,<0$D6N^8#&$
MD(6$M_&(5L%]Y'&\A;YIJJZ@-5KE.R[?VA&X<?<\\]9QV\F!2,7PW#0XFQ 1
M#UU^8:54.T5W4%I81B11'H5X1C3H:/;4Q05T9R SR@KB]*6O.$%(XKX2SUX6
M*WRK?:,\7BYL7;0HD47>/V=\UX^XL-5!Y26S#PC95OC$8]62D$:#$C/PB\]4
M5YV>B1_XED_SJ>NGJHT7.3"32K0VN=2P.4C4FA;7K^:#)4V'X@%=]DXO5CJ3
MZ7 ?1V:IU&)X#VE1-8O4T7CCENJY&RRE4!G\:=&%=#Q?CUBMZ8]VZ,6%MS?4
M*P-K<,4MN5C83&$U=G*OE,@WJ?X"[D_R)SZ%TQV6U-T&Z5N@P#9!C]"R_1N1
M^YJ&$.D$HN$6NTO,!\XH;UY+(6B:6XKC\M;FSB0WNKYS/%$:&.$\K9_\Z6U8
MVK@MW?NVR"^I)D_H+G9+ ,TL&Q:O2A%+_;8,G@[ZYIQ=JG;ONP)"4N%E4EW"
M19V"OK)3"K1^4B@W#R_91Y2E#O=S6=*6NI>UX>X?:@FH!C69<7_AI_(SZ'L5
M%^7*U@A[<J1H[+6VBV.Z-<=5VC76YW-X)&K.H3C0:]TV24.E(K4)K[*Y"NM^
M8G _C05\Q%B -&2!*>[+[C1_=3*L.S6LB,HQ/+QI#D*^FL$4)[,[F=V=^K-_
M#"STQ6=P6/_J1!USLK,[I(Z1 ' F6YN,TUB><AKH/%G@W=%&3!11[W^.\M<C
M EK3X<36N-\1$0QE+TQU,<]*M$E'LK5U<='TA(+UN2S!H+05C7HJ$S62;**I
M7Q.AAC3#I< $94V>[4D&K#B)C?<I0SOC[KM*&H?_W,@?HV$ZFV.313[]YD6G
M&MJ8+.*.INEG)U]PI)7V486&^VE'OE88%)X7+\ES9TIA0!0&,D92-9WDM[X6
M,>P;A[>@RD;&I=Z680>4);?-CO G#E7@AB6U/I3,"7'EA@P%Y2)1,-<K^0+T
M<NAAA5JC15O>2%H8YE5>1$!8KD3(%'GPSU_PO%.*77A!$ J2-/6H,7O1$2SP
M8EH:>V&EL,F\;O=B6B9#O$WQ^ L'M9M;E>RVC.7W)H?,)>)P+(4]@-KUT$:(
M<JS0716&GK_9F$3#W7<*,%.W*==\G@NT@'">V-1LL=%"&*@NBA39O/*+T3ZL
M"QJ5;PDR_TC)-R]Q'_$+W*9Y?+YX18H;9WG?YRO2$=S1_@+0B\$012],*H+6
M(L=65V$A^&5O-OCO39L/87_<V$^]\0-A3<*2G#6;,TGGS!*D":OW2;BF9L<%
M</V9F7>Q(X1+W'"88F0967I KI)?ENU@6M5",^"!]TXC8+_E ^:QL_".NR$.
MQ4;\8H03K&6N(KYBUE1&XZ+4EY5?AGL<87AFWY%@RZYS="I"8A[N9L,\7[PE
MI\2WW,G ;2$85VDWN2^REJ-V&VS[R^&CG]#)60^Y;N'S&-@!8$Q8RK#S9V"F
MF98^9;8H&=Z1V>Z1H)^35Y<W++"!;3 *ZF(HQ(<?=:&3K.Y3] )IL$P_*<,2
MA9L;'?UQ'!YY%(66F5PN+-P&VF6?,T#@ZQ- X*$#!()?"^[K,77CR3U1UD#Q
M Z/7&/,G?H%_=(8?G4EEC!UZHX@"[/0RG-.=S:3("$<7HLT^9U FM>.X$#+4
M OC[)RZ$ VXT%Y1%YR3-7%:;WV\/'?CH8OE$D'_S.O> #H8[I?C+1>[)V(S-
M[T<HXQZQ2\]Q\B[X'"4("-?:1SH9LLK5%K= (R<@2D#X1U!3.@;.>0Z@RJ_2
ML?0+&200A?FU+#\8!AA@-6T$>G_*TNCDGH,'S%N#H )Z*8PM\2R&+%;JA$9]
M5OCD1,X1;!P&@HUDFQX%((=%4U\T/(<?7@A'/G4XV%>]-:!_'KI.YMW^_HY&
M"V,(I"-:75XK@GG'$T#Y14Z=??GC3]^2>PM4,M/BA@!#)[R4]",",],)H4A/
ML4ICHWCN4$6F&21JYQWG=YE^*6$;+HHF<C#2*U & .9"4NH!@;&,7X#0JA<;
M5A*R6.-\\?W B@%X:$*I)*,N#(6QJU#,FMTR8)7==3E45 E0>,*"77%!0!P5
M^)34=;H\!,NO2N&93->0YZ=EYB28/#=M)5?QR,#)S"UYK@HP^+*6$"H"^85S
MB$EQA(J^8P0Z.Y:+IA%M1>T38 SRMG'\&,&<!"8FB2?1U WY'<>:9S[6E.7Q
M,:?&$QI[ZF<>^QA]U82 WT(0B6C93087+)]%D.RN/'( &)\FT#D%-3+K()XF
M.*5P15K^QY\PN(\/%%R61-#AL@-XL\.-N)^&=!4),N'>8DP6CD:9FL;(*0E'
MSR<,;%)G,"GW4\64+ <BU ,D'GG#)M*$V&<:![B22@U4$SA)AI28L=(<">()
M34Y&DRLJN AI6[/;#76I@W+QRD4PT6TX6MX5(!G SS85&7<VDYR(0>*LB(<-
M/=,EG;C3-5D(C*L12*\+UV-Z@!@]O&K%SGB6 )QC5G>0&3&_C75ITH17/")%
M_K-4+[RCJ68@0.7P+M;AN7YXWPLM@:A1< !#DR27I6I%3J!@A%Z;/'N&O>K#
M"QI/E[)BC#50P(.!VC?RR&_&<Y3O<PI&,D\[I#-+GI7(*&10IW17NQ?D"EP<
M$'+!#9Z1I1S43X*N("2R8QTDU766":55*T><)>%.D%-K(//Y+0J;SIW261R>
M1^"A?C)\.92<+0IG0(<@U1*O>._[81D6?[&JFF'M'D#]RLM?W^K89OPEVTW7
M^.*>A8<X;F2+<*&W]+BT2 <1$7?R_.&D)ON>1ISV?>**D?#>:IB6H_6PV.HX
M0WS+)R0_GLY[$4ZTCI.]B##28-WN\4TZ%[=K:D*6R@F?'(XQWX]OT!XNTGB%
MMR5'GBFDCJ]D%7A&;&KD/GMAB^"#L02+$/PM/<+U)NL+M?%JP=&@-.-=<W1;
MMZ_SNDEU<1H@>ZA$VY$)IE2Z_/H;U9DL;BD<S,)8A9+R%KGY,XVWFV#B6AA&
MVI&AVI]?$:A8;B>$WW1LADRE[N-0%X;YE/T*A>YI2D6<77$ C*[YZ1T3P2\E
M0Z'#AR(>XAS$X;\I61Y[=-(E"-!;OW$?E<8Q/Y_D9N%?P8UCQ@M5>+X<=&;^
M,92=9&&[9FTB'40IP .B^ >=>P0I[^4H))JS57L0BPO1:G!68"1J-OH5?J/.
M>DZA8+^I.)AV/XX$N\'Y6&GPY:T7CM?,A^_J11[QKL_[HSV7^(V/Y9"X!%6E
M<_K_IB[VWV+4?D^@5TRVKI-8)])- CX97OUAU$]SM>%P:+2:JF"B7K/CR5*'
M9WPE%8")/K9]V.]^QN1BR%45K6-!!!@IZ37:$.[4KP*%/Y[.0\Q"&2LW_R=_
MY)[F%MVXM,WA/NS<J):7O;,<G^(3RL;IC7FRQJ/KK2=Q)H>3_;6;DD6G=N)*
M,]?@DUIY4A&+NWGL$KAJ-W(-!$.?1,62OFL+8;1>-#5,<6A?*'*8GQ$<#+MB
MC=A74W@ILR4![JCS/?OW-/\RN@9&/ ;AW+?F@<:%7$'4TF'8,553,B64OXRC
M(L5!V@M[%=(I#/&F)<T2Q96PF(C96E20)=@9WYV5N^2[B3MTZ/T#\X,6I.O2
M$SGDACH&<P?%-@127 4LUAHLCK^.REQ6QA!R,7'8L9<IA%E&^.-BBDB5*< ?
M9>]:%Q2S<2D%;Z.:M^U\O6ZY<2]M?G<XCF[V\V:%_.;4D/CD#8G?%[O%]/=C
M#S&27M\<XG1(1RYOVU0X!. KIP<GFIK1_7(]@RCNJH/E(4FPQ10[FWD&9&RI
MA$R9'8P-#<WF!"^Y-T^]CJ(EK4OR0IKU6:=WY@ &"TN,+#EB+&M\"\IRZ8V'
M(V</+D$<.%VAU!Q"A6MSB:.(\?@1PX68)16V4R03160"H<I&4VQ-.PKN+'%J
M> 9+%UU_SW@/<5]62N;SKY7S44+&SM_ZZ,R-\!=A>5%TI#$L$%DQ7*BE.@FP
MAEZJJ(T;QS!_TEQXBU,)1Z(6I&(8#/34Q-F_<2P B#W0A>*PYA)D*X5$&T9W
MHDLV(8VHM98["WY3/G1-'.4$1\AF!_@XV%G,\IC3 2B_Q[-=E90\*6^;?]WX
M,#-TRF!=GA3X.>#74;EKR'9BEW!Z*LYCA[2XX6C.9WBB>9[4BG I?LJ(H1W#
M2SZL,1+,]4<*D/'1QR]2701EJDZ9U7F$L$%9,CC:%Q.I%BE\\7C"7 ;WZ C.
MY[$'>/E/00B2_K?<T4V2>][53A@R>M07L>[)Y;#P&E[$:"6U]6CA+ZCXPXZ#
M:JRQZMJ]N*FXFS091O 6>:B(+J0=_V*F9$W[BASYQ+EK#2YD83EK7D:\'?B1
M$)>FI)74ZQTZ$^*3'#)C*J,1R27J;W,?1@]=EK)*2GS.N,'6&%M6Q<@O?.JD
M]<W0&G%[++313W(X3VU;,B%\=)G@<"*B1V[)HQ^^;FYDL#]V0;61>"O<1_,U
M*<W/AO_+WMLVQVTDV<)_I6-CY@DI M**DN67<=PG@I;L6<]XQEI+L_,9[$:3
M&*$!#H FW?OKG\J3+Y550#<IF1:I^_2'NW<L=J,+55E969DGSY$E<'QJ19*F
M8J-?.$I03F3=(KK()%&8^?FBU&NKO@M27DP"*L2TFI1$3]&A43,\8L-[MO(O
M$5ZY%JL:C>YT;KR6/)4JJ:!&_9!\F9J&QYN,8LPV[8)UUW:&*AL:6=)!\\\G
M>BQM+\!LWT.??$0UR"62SP4XE6G,5\SDE,,*X,(E $@^M%HZK?8 [!#RZ$I*
M[<#09C"PL[Y[K^>?5-@IY\X328=\B>YSIF1@/^$*7*1=&O[.OP.?Z4E]HQR
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M83(<9)=;K O (DB/DW@W'\C!&,]\CP=[*8VL?9VY;+?4/[7MTUG^]&%'(FM
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MY!V:7?YDS(%U#N8%)OJK_&:*SD]J\0#_X5??]>%N%)[S2ES4C^WR*6^J:V#
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M&G*N"R_R@MJ(BQDA[R(6!O0:6""^I^:@5@@.*8WL.>'N0D=[N*A(1C+8R!.
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MRR5U8%&<U%$,NFN$2MMQ&0@NK>Z$)7>M<Y2]H][L5LKGAN]*@R!F1''1E\Q
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M^UJ(Q?B :A.B8)#MQBL\Y1?<+9V;M0 PEG0\<MG2?JXG6]1BBRWE5NJOM<O
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M,Q:<[Q99W$(GXJH>]((_#8[)?F3F*5D0G-)]R#:=1@VL"?GQSV2<PT5]22]
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M796K!X*]D;J9?;>\)A *JS3>@B#QQ@^LREW8)$_"_V<AB8FD64*;S[9X=GA
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MF=<5!LO?MPQZ9"3Y]$0PMZRZ.-O><Y(XJB;XJ6DU)6&_F=V3.&=E3V(CS(_
M3NZYTVS>O@^ZS9DRR\TON:?VDA#W,TY8PICP<RMMV]G<H.DT;4=WEC9W;C(S
M@B%"R2%SN_&UETDROD.I!EL+=BOX .7$S8H][''HC=$+;I43>8WX;I@Y0@4:
M,]/!@E/*\<1@$WO-7/]GGBF1J0EUO.0ZB*$]H6SO4#AWQ/O_K%P?+LN>$O=/
MUQ(9T^%@12ZA>=VLF/#7*IL?7<"L;XMJOU& C>A[FZO)T79#T3$_61V2QW$
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M4,D[#,B=,.152;"FDZ8VS;R8&X.YQ?P&KP4S8]QB CF#P+AE%N"H<)5@=2]
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M!G B.P?['7DK_++,YQNY,"Y.[7Z(0ST<V,XX?V$'$S_C"]\'/ZEE<'9*WX5
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MDY^ZTI LO/I,[#,O53H_^Y-HU)]E\6)@&U4O1^2]\=+5YK+I=I5V"<1K2/A
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MASHS4O?H<!3WS'$M\%! NUTD'WXV<EW)=PD.I_[EH-'*9QCV1&]^-7UQEQP
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MI%^:1_R\U3[>/!!!T?82!!B@?&S_[JZTS?P?TWE)._\&3JMTIY$P<UBA>LQ
MC+1GO.-OL(13'PWD:O_V4?/V-T\&VF4X9(,OK40YC@Y(,[%?U@>&^.ZDG-KH
MF")KF.I"N8/<[HZD]G6PK*K-9G,N.UO5HMTW;$#'!Q#B<'=ETT3KP5"8/9A6
MP]3H#++!JP2AB1TU!H1?TD2\/ "#\; T:\"=-?&4PP/[;7C@L=<%-#'<0)O
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MEFS;,7=!S;D9$#ETQ&F[48F3DW149?M#1SRY;AL<64DCG6<!8-/4%.[QNU4
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M:1<B*CFC,PMBG69$::=@)059F:#9J\"=K9ES$$N"-R@IG9=S"7T38*JZ$JV
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M>/"5'\Q*3T:RMN,&,CWH9! 3O%C*X:Q.,><9//PWS2\JE]F;>A<0XFE*G9]
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MPKD=&.&%P<$ >?D$L,$TF"^0=^%^F(H&10:"(,L,WYHE\01V 6";$QVD>!*
M7NAEF'8=$ZW#'^'SHX+;;3LHR)\CT8[?P^_$@!I9CF"9 ,7$,5S<D._H?3A(
M"]PW<,+]M8AZ\IAEZ&6Q &IE%N5=Q(@E](RWYVTG7O^(@V(4(>[U^D]4T![6
M!>UA_XX%[5'S(L4-H;>=R 4.!8 # -2$+WX3GTOBS!M%&7#:C-$9_Y"%3!+!
M %;V&T0&<KLY5F+23I$W8,_Z*^03L@3=,$H ^#Q\1';'7"=(8X1W56"Y;!!6
M^6<0*UGU/!"LP GQ2'"^63&R>[TYX+Z!0N]7"3]'H0&';Y7QQ\4C]%[2&J\
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M& XUB\81YMV%:9;$<3CS'26-(\82-M0#.+LDJTI"A_-@F"8F<!C&5U&:Q!R
M=#8LH<&I,A#8$0!<M*Y*,+$-&SZ1L.&-7:Z]2@B,7:[=DSMTN9[<8PCQ+C+
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M,;''RYR.]1DW6P"WL7OPL;2[7GT.Y+1(Z(B#!)87RZ9AUACRY'F8#B, S2(
M'9G;A 5I'#HZ'Q9(%31GS%P'/3>*1N0NI7MY:'R@CN"R =SPVNVZLNH.&MBT
M_KO'PURW,C77)/>#-C/C6,(-DONK#-+I8_*-J<^[UQ[.31W6>W37_TO=]5I[
M]6O$$RFBV_0.NYVK5INVB<-@5>78->]XZ<V<+4?ESO>_)\ =>_O<G(:;4R:S
M:$3*I>3Z OEDR'F9@]Q &)OOA+,LO)Y*V5D^C; K74*"M_BV6J@'N?"-C/H=
ML-N]I# #5Q0SEH\<+S8>+*P<;&8.UH0]<-.7Z'\"Q-@.9!\:0.9_SQCXV6E5
M<"ZY**W)\ABDZIE'K8C$,>M<DV3JIE%FW'TK.P23N0S63#)4F]T0U-YP%@"]
MTH"@"(?U%(SC%#+6B9$:>,<ABJ#X<OS>(>E\FB;%9$KJ'WHAP9"I[]3]?$ZU
MR>[WYJB[#TQ5([4A4P.?=%QC[<O(3'Z*RJ,:X,+#WBH]U&X&@1M$F!T5G+;I
M44U);5-WV+FQ57P?$8EBKDK#=9>=5([A<U.5M![)KG_L1C[ [?UW)1V\\^"Q
MZ%]-2T.D>HV@?0HS$-3#,%M#(?=RTT#GT^#*N52,><\2S*7R@.T.Z2_A(C>3
M)=ULJ3B<<#(9IKUXXUERG3';EK8IH'9TO(]@,Z5Z*<TM?RA3#;42=&U@SIAY
MW6FUK!R9$"?+"LHDXX:4;AM*_TD'@$[: -!C'^T@%F#FHUI-&=AX>,Q4A%]A
M$AYH$]X@&'ZA%,*!3BZ$OQ3H#7Q[HWR?:U=+,+1)NL!QKY).L,G3B%[.@$;#
M!D/I[TI;'.-(65JR?WS2.$WVVK0)X0[^J [8N;3"+5050#S+PI!08EP@-#H@
M,1%8L7!>,WQTBWY@Z'&CP EOJ^\<)H5S O-AE@6FQS ,1PR:?O^PXKDDA680
MSB*X!YN<29FUE/D:S)"=T-O(RWSF:)@)".J@\0FR7Y5K&ZRO-ILFQ6R$FEY6
M8"U91(F8"6B682Y)JW;NJ&TH15^(:<^4&9G3;-[<]D\QDM2WP7ZRYF1VY4#!
MA>-/+7,>YL(Z*5D!&.5\P3]K=BY]O''^I<WO[7@_NY\, 4QS<A33<,WF#3A8
M@@"^#GE&*!Z1#-$!#>]T$$?R0S&Q&W$1;_8 DS*!+&84]SKTW$F@FA$K0V/7
MCY*7(NPI73B^8#:;#/[BZ 0[FH<X9S;GVTL%-YP]VMIL'7AJ7,F UC2&%4T*
MT'^TL#"(<$ZKLT+!O8DIR1N!$8X(5O-@B<N99%U*\YT%8+7S2%;,3@5#!7NG
M1C(H<50,^3 Z% /#G@5A4P,(Z'@DW!E]V$*Q5YG$)?2@D^.F<%XP'05V=YTF
M,IOD&E.2$<^+C/=@X&#N,35*3)8D,66?!#3<0Q &SL (PLC*S,%YV_:E-9&8
M8 2_#89+ZGIB/DB!#;Z048A#7CA_.%XV9;7G4YPVLU(-S*-\!K^5I*-/4?;%
M>Q^8QJ']WNM&[\8OLV2 ([GKE",0#T-J;Y2%:#U*3LLHRM)"H9TP$*X23"UB
M/U#,6C'HQ+ 6@\CX:ICUF$F\?W0N.WPM23H;@<P,G71E8SD+Q5!Z.*779UNY
MJLX__.OB;4.?4;]T MC)((AI"C)/1<XD4XD9-])W$H_!RG)G\EQ'&=--+JV\
M#-BP32IP8Z%GO%7?XIQ5.GFRN3._&&094G4#6TEX.+3;0QS7,OMPIQ>OHV5=
MSR%@6CO6V<2H 6-B.B>I7ZLTH,Y6+ETK >.4>B#Q&'G>6EX&&#=)@SG![V_X
M2;<#5H<%W!G)0?%/EN2R2:A/4\;UK E'& *F0V<CQFS7G78%UHCD;)8S<B?(
MD%+F<EP'4F;9R@U*_=NL!'[XOFDX0YLF/N_1+&P2Y27^)4Y2@SODW8$S \-C
M<:\GSLKCJOF/*Q$"?Z[S_G$:C29A]MI,)6]BJ=P N;$''8:B4*>=.,RW%(_=
M!7@QR9*AVPC8&D!I=A3H(1AM@S\&L7KL2_)R&BU 1@Q2K+2B#-Q@2)SDM7FW
M,C=^CO2R '; #?(8:>'WNB+IG5D&G)X![.IZ#BVZ\6*<4C\,9DS[_WT>!)?8
M@X#TLIUT "0Y*D#& B@PMV@X,^+;G!(/1"LF.)< 'V1LH5QQO!)XXB3A'O-K
M$-AJ8HZ7X ^ VXQCZY01S"O#)A3P86EC8D\Q&^.98W+5Y>'U,3'HTE XTS?'
MJ@CUB_#+-H]X)UC]MGI[W3F!#U13P9R,:2[S*A&;TT#2EV#-'-0_Q!\N1"JI
MH/#LSQWO4S0+E[YSJ$6"9C?%=*Q=8M[+/",[E#.(HN8"H0EP!L[TY0D&P6.^
M1[B5H;:JM4P%NQ3!;65 9N@Q9Y\/H*<I34.SK:H@ZYY<!T\6L$-!0, C_HRQ
M36:UFZGB:GMVD2(SPF)[H%(Z];4<PDG\&-L*/:X7R]0B\'E[+/511YH5.>KX
M*K5(-1 QFI4L1]2VE:&QFB(VKUX7^[9",DW%,@$@9*&5DY1N@-Z/S#UJ$I=V
MVO'>(L3LF<E6K #"IY%\JF/[LCG03U$\*#;+-HQX XR(:>HBV2Q$2R2^<N"P
MN2G:M-I:'GP)S?AWS]3V$=V;\ CMT.('WC9NIR3:2FP(V_V'PQDWP1I%5Z .
M@X%P _LLL_$>@W"C$LBRF]IO_ET8<"@(']1,PAZZ^.WIMYA);H.^[:/!]R+6
M+JRCP4<TPZ)A$A.,Y3%RXC&H<$%J)<<Y$\XEE;#";2I/\!9%BN[F7)W8:YE)
M"=@!J*Q@M^1T,0)TL:R=6M;!$BMU&ZIAS.WX*(F1FH@K '0!(7VGZMI491._
M20.Z4:XC;CH<2V7^OJ@TO(> =A<LX.K@;1*Z8M'C_@L[3;6FGKNRW'I5)D6
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MQ<=WI:PH#O#2L"!^*J#@/5X',.UYF&)1>E"6Z0'?/ J^(EV@A5?N^VQZ19>
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M9C-GE8(N6KI6.U6_R&I5O#2LX*LC,"9%7NFHL0CC8):OSUW>S1#,RV).-68
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MJ\B0^Z-6LV6;HFRJINMP"D"3(<F]7J?ON0,JP6SXY@5Y=%N0RHP[<0X/EC)
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M.&#MYSI(81GQ91S6N,_&*)Y/$K!I  ![$?8K@*$/ESOR2VY4E'OCD%*B$*L
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M8R:M/*=P?>/7)6\W\XJ,XQ1? .O-[1"] 4G-A1/SZ" JF))0"!I*L!U-.,/
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M62:5@*8%A=XY2-P$WR#Z^ WIXVE[]_=;[_[3\NY_L#(#Y\TZWI%5DLF1DXX
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MY+.^8^G/>"/:#:@'2C^YQ/S#OE(&')DH[?;;,'Q*]YL.M';O ZVO&FCUW]G
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MZD+0[)/NR\XIE(*DXG+,J2K\!JI+M)E-D^O:[KP!KN2P!P5)H=1JOL)$T?
M09KAX;V^C8X.=^&JY+UMNT>9-:,1<3]VXA9 VPD[ICRE9TC@1]%$/K(Q1/M
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MX%NT>CG4LDSYK5G=+@2V3*SK8Z6 \RZ!(C-\>P!@)VB9%#BUSJYN#RY_,9O
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M SQ ,?I?<&UO'0:(! DAUVC[.:>$Z.;)2R=<9]%ZG#LVY[)1[X24_=P[/*+
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M3U>;L*NV6(0#[C^N2(%KZ5KD[O#D>'#4I9_3+0US!$DWD&TP6X7@1K(1POH
M1MYHJ]@&#M_]?_L]"=>=B7%>'..C,_%()\__B4P?<61@H=.B69-TYC0H_>V8
MH4;NS1\'([GF$-KT03/PR'_5M-?L@-TD_ L&SSL#U(2]]^R5J#6'9^_/B]NB
M>SL[CZB1QI#+[SY,AVY.!]F<6.#SF\ZG-.P"9(_4,XV>EG!8I9\^_L$IHE'B
M?F&H/N_=?=DQI_[NXVVW\("BHGG&0T5/,G S.KZT[[YCF0^41N*-,!J;?'!G
ME2FC"QW"<H (#S)A3IWS8-J//&>"=Y+>O#/.47<^4YFX/#6E@ /NX"QE8;]#
MOQ*M:FIC(!)G8)']S!F'Q,_-FW?KETERD#<B6'_"W#7[W":*J]+T_'9R]$OR
M^O7)W;- H3[D'7+_F/1QQPV_8=&E[WZO!T=3J]ILYON3\9GG5#@P>FR9:&[Q
M2&*$LV=C&!K@-PVB?'H/HKS+($I<?&@#D.?WSV5)QO:IA$H?L]P'K%"WW:&S
M4\/>X#.$T>76+PC- JT?J/.<?EO-W+\CQY(=UXQ&_P1C\(^RW;VMT$_IO4\Y
M,(GM<L?4]C;I(GFUK-[7?%L3J>_^A'O[<=#Y>G,C!)I%,LB ;T-7C:A2SA<8
M4_)+4R_GW#/$M]U?GCEGQ$:VX9.?.OVW5]K(S&0A.B[]JP="&,YM,F(;_^E<
M+9&ZV>$;E>7@/4A8<.]1 O9)\L<#)E3Y"+!.RNP2(I/D+^8?7#C9NM#(S<&U
MA4.W#<[=Z>Z):6*OVCC2G;'YZ"MSL=?S[?UM;A?P7 DTO\?G18U&0@#DM:TD
M2_Z)\$E>^TFV+.TW#G!HLU[(Z^SR[AV>45F?B6S"S-#'G96QKE8NZR#2/!)"
M#Y^3NERWM]+D5)QNHL+5(,^]N_@$YBY[;&%M0$7_ S&>7;+07*<%WK2!AN/<
M'[1*8\\4OJ==!>[>3(19Z)B&E_:V"Q<%EHODG3M+LDFK9D@&_M-6Y,(^H<A_
M($7(!N'XV(3NF/R7QWB.4V+0>^ G3=-9#[;<_SP**2\51..DEQO8F_I]D>G7
M=W["U_=,MJ;[4GP.YH2)./GU=+\E?[1,#F9Y'/E4R'9"K3K278@!/(@F8^=Q
M<I[?9*5MH?"!.=+G)SN(YSM=5L(!R7_AJ:C+24O;6O(=1Y);X3".$AZ2+.,
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M^A1V"C&Q-\W)&T,=U>5!0FT\\PO]R0WZ#=B=P6=1'-]E+A_,1WF2:B\(#I(
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ML>]Y;F?0LW#HH '1>?5PZ)VX_4'?'5A06"O;PF0CF'@G0_=L</KJX= [=?O
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M,5^$\5*0QJS>@MZ-L$J8 U=* HO)U%7XF:-R16<&&)'O*Q7)#?F^VF6_@0B
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MD?P6[?^K?!1/9J6M(:&2 C/A8GO831"1WJRT [.M@E&37^UE4#[G:LWG4>A
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MZ$ #MW.ZL\(@ZR"RRI%E9A8F%B86)A8F^P<3K^.YP\Z958^*?GE]M]O;637
M$_J(GD5VTY_!>.:+T/F[GXSR)-K_!*?!VVX7U3.;,=KM]-V34]M<\M1SN]Y@
M)QQT\"(XJ)6S=9C8+'/%/;%*IV<A88GD46%B_50[%WMVQ*RRH;KNX,RZZWJN
MUQ_N1 TZL6K0"\41JP;9";.62%Z<&O3RM9W^V[[ML43*SM =#BW?\M!MOANG
MSZG5=EXHDEAM1_+.GNVP9&GDI2@[K]CGTV?WK:WNMZ1L86)A8F%B8?*@IN;0
M[?9VDKH]?!$VEM<[=;N#TV>N'[U\-<C6\%NV96%B86)A8F'R&.D%GCOH=G?B
M:WX95?R@%YYX_6>N!KUB-Y$M8;/\S,+$PL3"Q,+D$?2CD[[;\4YVHA^]C!(V
MSSMS3SJVS]%3WX/5@RS?LC"Q,+$PL3!Y!*_(P.UW/:L&%>*WZW:'NZWDAV7>
M9OXH%&9U?1A$XF@F\*6_#(^QEKY<;O^N7&S?1=]0G$Q$HC[Q%C^<- Y!?_J/
M#OWGW6TPR6:_>-[/Q186? A\N7KQ;Y^_?KC\>G3Q^8\_SK]<7?ZB_K&Q%N9U
M]%Y^T2_M='[^R1F+,%SXDTD07?_G3QW^&P$F_]Y,':QJ>/R"_L]5:*.JI^X.
MVP\@"AZ:]V9^MTI=W+;E0042*\%&K1#X7;S';S.!:WX7F7/CA[EPXJF31S<B
MS02<>.8G\'B0.K#%<1[Z^.%HZ<SS, L6X1+@Z&2P0)3/1R)I>A1^C#\8AW&*
M/Y9O6B3!F-X4YXDSCN?S.((3Q^/O#OSCDY]._'_COSZ(L<"%&7EZ'==!-=2E
M%4,_S9PL\?%NG8F_Q-6F00K[=);"3^0O@4;&,^?63YTWG>/3[EG76< ^:6_'
MCF[C0$2A2>(5X6?W^>/GKP"/J)WE_?3^,["M;!8DDU_?XD_?.P?>VUXR.42$
M0$21B)CFHW^),:!,3)_&BRP #$-DK6.:UR5,Z[F.'TWHYXF8^T&$J+9R.?@R
M#'G1('*R6Q%ERZ,I(OE!5P4MQ+]SP%' ^&P6+N%G:0;/S.&7*:X$MSO-1.*:
M+_B0'/.C_Y6'W_TD"DAO.'T'5 FK!%$>Y[ AD=P@466S),ZO9X[P ?'3'/X+
MM\-$D@GG '>+SW<[[S* _='(3X%:U6\2V%T AX7MT(^\=X<KZ,1 A)6R@C&C
M0(/A(BM)A-9E=HA-8SB22"@.Y4@QA&)P$MR\Y_^&X]#_P:=-V_&P9TQE._B1
M090C,8T3(,KPUE^F2";P&EAMI@E8!E#.Z#_OI*SM+7Z4>,);>F;P_E??F25B
M^I\__0<P1N#3Q)( IR_@O(@MO[[U8>?P0[5K.(1Z4<.YS:_Y=</C05 CN'=F
M_QS'S[-8?4+J"'_T$[_SU;#)WO-GD]]F(*0E%PIJ[,E'Q$2BAJ^!VE<3/C$]
M'P4E/ 4O&Z_X[;&#^L-&/W7R5!"+ PR> Z->:B[&DI]U I#4ZME9GDQ">"0&
MX,)^IL&-."+1#J\+X@F].H$GX/^SV[CVF)\Y;P9TEC=>IQ#[H!,$F62/_%/U
MYH52:&)GT/FY(C[R"-"R4'@DI*\3'Z@+MG*NU@+8ST'!N9V)J/&L2A%2FHMY
M=I(,<-[$$3_&0DP86G)A?Q[G $2 ,YQI*64+B)6.%"N&*I0ZDSS!?^,/042D
M8IQG #T'Q20^U&MXJ( JHPP@&%Y:-O,S^GNS.T;4\[,@G0;P S@5[%:B(#"A
M>1#Y!#8 [38RS35!?ALH"8M7.Q*@/>)F13(.4F)'>+UQGL&VKOUDHE^_$N49
MC<TW1'&V\BUY!#B6TK=P+4&X!8QF@.,C ?BA(>4ZX@;^#ACCUFH\Q5F4RK/9
M:ZS&^_Z@__Q9N=<_[O>'G:%D005?EY:5Q$B_@I'P@W_DX9*I"G57;.\FN5VA
MPL*-:&P!%56UNMA>*6U0/6$'A=:)VJ9%N/<'@^>/<-W.XZ":8['LH;#LY/EC
MV;<*>J6&:$U+Z 7(L@)3I#K(Z@IY?="^1L4P)5>2B!#JSGE^G:>9M.<'"D4M
M:FV-6J?[@%K"^7KUET0K]+R Y2Q6(9&!*'4_HZ?\C!9;ML:6X1YBBY9,*U#D
M3U^).\8.SV+'';#C;-^PXR"0EC)Z! !5O.Y*T105H0D9DB <H!^;"/6[&"6Y
MGRB4&C+#(8%X$)BOE'I8G%1<RZN5J7ONPZ+V74)]'8O;A%-_^LEX5I:DCX_8
M#9NP6'T7K-Z3"/8=Y+E%D)T@R!Z$D+N#[?T;9<GH#972]Y3N-%>ZFK7O_&MP
M+;*L<)U/Q,)/LCP1#2%M-H&[%F<!9_<@GJ=QMN!M*"ZCLE^CJSA7.4]A(JIB
MM7>R0JQ:QG<7)-J#2(*2C-NH6.W6P<"*R;MCRQZ$ 3SON']V-KQ#W*E16-J
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MZE=X5]"OZV#XK6'EM;:SAHNRDC=[<QNYKX9S07X:A7QE&J?;:9)M-\(K+UL
MO69[3ZMS/LB1#'UU3_2)/W>A3ZP51ELA:35OK&*T9LTL]C[B"Z#Z9G ,KP!0
MST#G%)1"Y]9V0NA*;KKRGMR=[,#KE+;@5OO@;M']MM[S5CU NDBER_!6_G+!
M2"=_B)[I68ER"4_CZ;%SCO[*.#$=9!M1(=TH\D!D]P56W(>7XPZ2LORL;USM
ML?GH"DWA;5,19&*U<^AI0E!? \ D#C#>.>BTE5Z_;D-%),2,W&JE]\DB8S+
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M5/Q7O452[MJI1?F<9BR4]D+"3>J);0GU!HIT"PVC5>$H*1@@':4;180AJJF
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MWR1SM9G&J0:;]F\=F5CK^F%<@GK^DZ.5\B=O41;Q/]^5*:F/\H4(I2_!NH<
M,JNM\M^HLIZ!PLI__4H6\5\=1BO1ZA3UG(!3,G;C:X-'>OAJA6ACS/Z!]+N7
M@!8&E1LR=%^_?G[CGMH/K*6VQ*)#0^T C3!V[EN 3.C#?HMU%O_WFR^R>(V9
MCQ3ZQ7BE>)1"A<R]Z*#O%LBT<KXD,9G2"1Q'WD"ZMMO# /^6K.!%4;J)LNVD
MQ_<J_Z__V#\X>*:BO^U&?TOF7*]%>74725K.DWQU4_:9R<J4(FNGSL^KD\OK
MLFB[ZTW1N230_G&1 E[^5NF=2 ATBK%O\E2/V6_;+JM;N6P,'RNG)H]24OL*
M\]@AZZ0XN+7>/6HA NKP^$B2P'\!Q,6,35#0)PG6MGV\PD1>+F,[WAM1N5&=
M1,\S*J_$@J.CO:/#AU9P=+@7(I#?<@3R,PJ.'C_Z\<7+L^?O7[W[\.KMF^CM
MSQB.__W]JP^O7I[=>F!LW01+/[F#"@5L2O8<4[&0YDTB."4'V- 04#3F]6#6
M53XU+ >+ N:+3-6JO:"$/2GM@G*<5#YAOVRKPE;2BJOHSP;VJ1/(S4]TG@+F
M]<.W$TD=3_-)42ZD%B&F)WY:9LF5S?N0_*^=4G%:X+28-!PJFRK.V.2D#"G@
MY@;0"8;<+M)QRKUL/B>O%@-?.J,669@9$3J "R=? 7/!6&_JBZ*$7X. 2A:$
M O_+1QC>RO%7*4N"FWGNW]TK]^Z0KGFG+%MUO0_W+I+ZKY7YWJ:X(2FCRR1K
ME"US,(T?NFLL3./&]<M0QF=O@A*6 I"(7P &?$KG7$ATC?@C[BLOAO<SH.*L
M#+=_'4QRPRB?@3Q?]O+_897I/3.36T;=E]C?1L+4[?O3)1?4(CMC?H@F!BC6
MK%]0?@G54N(J7'336]5-/6\QR0O9'O%&_<J<HO: 4S5FK^""DJT #Q)WMF%T
MX*(Z;2'&M$LL:^!2"]-_-'&'49FJ*HGDKZ10K(19(HJ#&"%E /@LI^?)R_NA
MHVLY' AQ=Z&<,B@IG9I8J:Z\6K4'[C^8$21@/YPQP!R#<ML( $;,Q%K\F"0'
M*]9RRH>88XJIU^X0Q-\ )<[:9Z5;2JCD )_B7U)S1#DK #V5W I@)\P4*#[D
MMHAI+>IMC'_,@K(D(6E3EN",/25\*Z'GEOEB58'_[-3I1TW24K*1\=%!L&SC
M9MN;>/'+\]=HJRB<L/!G4Y3-W$D,89S!_O*4&G*I!!]FV/LW^7>!2=[&1F/"
MY[Q%WX:1U1!U.2,K9H5ACHLA&C8Y'HWT FSL8?"6<KE,DA3K&<BVE[J[]%PI
M8Z%UT/9<)T1&NF^U%"(R@;9K%>ODHXHXC2>.FO8P.%06C*YCR$DT&"EY6G6C
M+-B$LG6-E,J4*8,T[5IB45/\S%*DYVB1-7 @!#H>D&R\4DD]7P3*4I.96Z(,
M=R*I.Y! +U)D;'#>NQ$#9W[!J>8L':[0YAM4,X*IXD3,Q)ZY+X^N7%Y]OQ66
MVHF9+Z4GW:2\>#4+;K%?79I'C&4J4*UL50:Z DR5#"4B3I+J(K8U%7 ((#E+
MI;K $(LD8FX!1)6&IBY+<RO=J4=Z>N>4B(:.AU+Q<;OIAI@TAJRAH@1T>#EW
MC&N].5/G1)/)99)F"5<D<B'5'2"JX"?)Z-<I\(*I7.8+T.:*K#$M\M=6T_R1
MDE3:^7VA2V>^%:0?1OA8*Q.@?.2U+I3(7#A,'3A@B0Z?$@"F#4X0#DG*3(LE
MY24\GM=D5U)"N_XSEAQ 4U3K4!@Q1*?:%A>>JK%8HPY)\B,.WV9F+-5>W X#
M'K(=48?5=3 U/[(:D7,FB"NQVK1IZ[\=@,0NJ'SHV 95#NJ;0BB0?$F:XY.Y
MJC6]:/(W%"U2:872I@UGYWL+*Z#GBO.JC4(P8;NR!0"%9CP0I&V6\64GU^O1
MT"9;OSY.JO0N9-%;@L;="")//@/J86JP0*Q*&?K((UU1XRCM/:5KXM:EPWCZ
ML[AM0$( ?U5MNN^5,UY;!J=><X6 -"GI;GT_V;V:D\P:;(>V>Z\+3PY'P>U[
MK]R^ZSVI+QU%^X7IB[C6U??5_&L\S!<U_)0K%Z2C%);H$^-& _(Y_H.)X)7_
MURN.8[F?P!/$P'DDBYU0S6( 9, EY_$GY^>*]3QXUPZV Q!+F^MN<F+<2DL/
MQRR1JEDR6:02'M?'%7:CWTWM/UM$\;!YT[5KVE;-K8N(=X;-?:[/[(MK.!DA
M=*&2>%@!(E3W@OQU6)'I4<1SN5.Q1PRX8ZZ70I1;Y<C,Q36FG1O:7T(]<Z-9
M^HD+3JP3HNW+L8*(S5X](DH;4SUZJ/9V:"/'"+E)D6,S&EN8%?OF;6P]15;"
M^@J*W5OLRUW^9:ONU):NF(8;V@VC5:FR#0"M>LD#(KEG399AO;NT,^6>"K4M
M3&7GRX>6#[U]'9.BR:9<@41$15XL]@*!,994N@*Z+A."H.DA1$$8S_%N[L$!
M=*6](YYVB)I_Q@<?<NX,Z!=PF: ;I*;#A'L1OB7>>B%6X:DL64I%'H !K1("
MO:XWXG0!-_@^<2?OW2K3^$-W*[AE;K$NL#$ZB/<>X_B8?:>A@G6;$D%AEH:T
MPY.V"N91K4?VCXNX SBO$^WO^ #.==R%4*?(PQ60A&I!5+MS*B<TR>7E'#-P
MYV\@S^V/.Z KW6D.-AKMXE0/]$O3*R5TYFCTR?3?C>XTS7Z;IJKT#+28VXXM
M65K@BQ1U#8\.9"Z0K=:38/&:]G1NR,*^2TP"MV$?]1Q1S*:2,CDOD\5%M]><
MZ?GG-&$S'SI5B"9-"'U3%ME1AZ$VF@*=#E_OE,Y_P(CP7"6Y_%K_4K^STQ^3
M[N,\!09E6D)T=DA..ES-6ZLB/BT%D^8SLLG4IP46)<_0X<=]FNP]/)<&EB\
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M=Y57ZZNZ4!R-%FM?&DBLT]]/\SK=X<@SCHZP&Q?]6]P$VSIFK6/>0.E"X7)
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M&$H2R18>U\DBJ;8':,%)1G#@*&B>Z@XO?PV7(!:>"WAW@TLPF"@/RD0)+L&
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MM1[8;TC_/'K\\/3/H\!##2P>!UA8_3/H&5;_W NP"/IGT#^#_AGTSX>G?SX
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M0R^U<D9(4W'>J(FSX)XG$[40U=S;HJ^J7.L%M*Y8SI):TB>2VSFC572A,MX
M JLEE?5"2:63_=@#K?40_MJ&?>>XTZFP),EGG*LY:"#YM)GSF;$X.6.N CA2
M3%(#?PKRB@JEF9:7HCK C]JGGE%@J<#  #+:%/65:-Q4:8Y.#M<,IA1FPPT+
MRXH'X$"I/^AT CUV6V(UD[2<-'/4BR9<!"PN/*(L_&&F/)\7WZ8DE,M]SH0W
M*<*TDAES,<,HNQN4!U".95>X&^P.M(BV\"NY$/3)D^MM%KUOLFLX\$8'TYVC
MK?'VUFA;._%L5M%+O;_32;UMC20Z!>\3%2W4ZVO)Q?9V2XBC4P;X?OFZK0'
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M&/T,JQ5E)3UD^@T.U.7.<X+.K8)5JZ"88F/36EM@D9X,V.U)8BT3T4*P:,N
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MD""#S3: !.R^ Y?"%UE)MSZQ[WJ&UK=@5)F,_:]@A\C8]=;0T56A/?@:;6G
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M49:A=M!7NGFVA:RE/50</T-G(3G%=E;$GI%49W?->1K3H1$,U]2;S,39N.$
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M9P,S?GP$ANUZMO;G'!0.ZKCDE$Q5U]#X'!W#]#VJ'XV><:DZEF$]N#?4N4.
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MXZD(GDT<"@2C&28EEF"$^"G^KJ%^X+M4)X:5JAQ\DGJ!U L*/R?M@L[)!5W
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MI/((1)CP]+M#2X^[6G*MP=R2*='IRO8 DB!W)\C<<R6Z7=DOH-96%@]+R;X
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M'Q^!.%W/UOXD_@)^I2_4T0R7?<L_MA=($GQ>Z+/J.*J5F<225L=;TF?BD<O
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MMI'@ "47O U!I>"$3#@P@H^)A^*8X,0B/_!P<:.D!>8@R!OR(<[?3)NY B\
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MOE#-QQ,8OPPD(^6&"/*/A>UZIUI,S]4"%R80^I0R"\ &)",9!O>4WZC3U5?
MU"G\2-ATD7_S;(]#'.!SP\%)"0BF:>?%1 2+B?&A>8->L >,TR!EQ RJA>\
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M$G9=W)9="\5G8!KFZZG]C*97'*3 &8#QLWAAX J-I3;P=4]5$X$;!S\U#19
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ME.I>TLJ/U>[&S6UJZ>&.F%XN4I6%5R.H)K'<U#> 8NE@=D/BZ8QM"X51]YW
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M[%U!$WT:(8I/FL$EX5E+7/T?'XZ"_\CR*WS1;M[0'["Y\'<*UAF.?,*,!@?
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MAJ<FXPV-M6H-E0Y!2E'OX^RK3Y1VJ#P%V.Y@9R/G1D8_Q@)O3+G$@5(Y\F/
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M!%HQ RW]30:(,Z<XH/2:>YA;]G3JSE62<9QR3-G)822F#*I^MXSMSY#$V<'
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M-+][YULV':N<4L4IY,91\H_=&?YW8AW$?/OD;P5(3!(2@]'B9-"T4PT3C!^
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M/LI[]-$S!:](13Y44'DVE1E:1@#O3MZ,A9;I6EEO+N^NY%6Q$82B YYLS$;
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M!SO\TB/'=\$%IAP_O31!M95<?7S"X%V AB!I\&-&J?2=1_K$+-%2Z\Z9E]?
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MJNG"^^08#)*H^%P-]B /=;N5J^T;+Q?A97L>PD#U_;X!-XNP6+CW:&'U>,0
M?/6?#/.HJG_"$&&S81RH"'"E8[WQ!&XMQ@TFH 3V" 9@V8B,"_$]_X:..!$\
MA]!:1MQ)!*<W!&5#R**-**W001TQVC<:;5K?06(,23#;X[?@TPVSQV#@<'<,
M"!0)W:3.:H3IP D&LTD8V=Y J(+AV-&'640H/M>9.!)(.;$'@2^@.7_B#+!9
M1G2&#>S\+(PDO(]+M>O7VO(9!)PBF$R!*J0@\;WT,]FGH1.(080XR=$(T=V(
MYHBGM&E=,T00N@:=&LX"?,"?!<;@8W"B>A6";\4/>*$CX&THX1"Z:Q.2T0"=
MAI$_^!.1F@/1L,;^,_0HD""J?+58!([4&B![*^=2#)O6W>PA%/^>05=AF$Y<
M<I8:;>1JL-&U&-:/<R*[WX"Y#6<NB0N1?U8$V^"C(.F08/%9A;I- ET,'5L"
MH0P)]XRO:5BC64 H6M _Z(U20,]VYPC Q3&C?LP&D>JFE Z-#A:][!)L<X,Q
MZ,\(P7?Y0]= '88#BQ_@GE%)>P3WQ##AY4CD_*[.$/QKM/.@T,!*C>TI_,9U
M_H?7MCW\%Z@._@1$9]-<!+Z+I8$GSFR2_34.)F"H;V![(>_]!!B'=^?WB$4<
M5QE."\3LK$#!A+ ].2.P'J10C(Y&Z20EEU&1[4"+[7 LD8AYYI:/Y3A3/^_M
M"-O37MO9LB-L,YOXRYH%NZ"+G>8)8"RS5(J5@&+I(L\+]MV5? QC^^U3G;B$
MYY#?6L[!I&PJ3+:VWT]__WS2V60+[^:%R1>,HIVM,=\2D\1U/B<]O+/=9WL>
M:E]GK)UD>>Z[H/^]EYX2>&KOV9G%>LX__;6P8':SCWQY<8\L7>,^T:OX8Q-X
M:A'R]*=2E>\-L._?4G^J[F4.M;2^M; M+>UEF5Q)([%Y*E>5D(.%V-T](:YR
MU'816/@;[LTS\3GP)SC3:&/^Z43C*]AB?'A^6\CAZD$GKV!JSYK6MT^_?_KZ
M_1/\]^KFUZ_7]]<W7_, OW)M+IKXCTYH/SX&XI&\BIN15 1:]Q7.^HN ]12@
M3GL] IQ*U&D%*W7?2/M#4?0<*#T<R\34&?"I:IC07=RE M9>RU:98^C:XZ/1
M?"K4R14S[T(1/#GRO!?!P1+/;B/VC$><:(A/AL:CX>H^54,FEPFKW;8F((5Q
MN.CY=AY8OVB3KPZMOQ\XOK4#//[YV=[Q^-9BT(.5"[GO: 1#[O?MSE),OF6
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M$]/38;JP8J'>#9Y"2_]->XD(LL23D&N!HJ#A$<+ Q@<Z K(![8A'Y%$S)7F
M82N6/*/2),_'.DN>T4:2YZ/<0TRRO?SZ N:DQ_0-<M0&"R5!6]N%"K,*UJZ3
ME,!8T8[?TB8,]DN6:H@@@<Q!4. G6^OW&_]1[?*%>*!KEP]72'O4#($7(5<I
M#:U":P#?HKA=@@: RQS;>Y@)<U'"[O0$[@ZJZ?^BFP12=<(=U 2X ((_$B R
MN@.*!%^Y"JCEWZ"VB8OBI$KZ.L&2WMGM\LKE!=)_!V5&9>L$#9-I$@5"-&X-
M"3 14\+\7"%H#VQQWZ:A?2P-IM4[]M($P^1Z*F^\=F[0_P+7%@9V/96+ [;
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M%-9/(SW" M,9Q*>SV])P_T669YHJ>;*R<GPUV?9065YLE09%5FGX1L492G2
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M%) +<;B-?K?7"P W?J' 3&\]^)0\3]HETH;8IV*&M%GC1S$E4;">8&9 Q.8
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M^[[BQ7KK[X-P$ZU/CE!G%!F9^= ^-<-W^2(?GP%BWO1<S.2 K_/LILA:?O)
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MDP<!0?$.%U2B2J384 )(',GH1(I+=QO-W/\*9\8H\R<#]+M]%<#D000I][%
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M H^^<3LU$/YD2#<D$9MPTY19(/]XTWM#?\O'T]^QA:77,,U;VOXJBD\FGN/
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MEFOB(8]>3Z>P8(ZXW'66=\82._!>62";#-W3S"J8=9#%K#/M$58 1-DQG5:
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M@@71NC_6-6_%<=YS;L7<@!>Z3C$KX'MR@(3G$ZG&CNPA#=[F&%QX!U.-;NS
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M^YGZ#HM?_K3"NY\WK46ID]DXGY>K'OJV(/X(CUN+'7?FJF][Q[T]\2"!OS+
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M!N756XL:$4?%<.=6SLTI>'3#X(1X&T0L=)538U8Q7/@8Z\AA&2M_"@^.? _
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M%?@ITKX&_F)[Q*(71XZ'9NAX:"Z*V<TZ'0IKG6QF\\,)HWJSY&Y';J*KT4U
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M"5N=-ZXJ=DV,0PDB&(KG"73[RX?YY_Q.6>JENL57GG@Q'@@<OSLVIJKRIVW
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MNFS.==7>3G7G+\^A8-RP_XL$50FJI,ENU04G0?600+7]2Z50-<]1H'6U_BE
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M"F-&(\QS:! KF1BIA/-^,ZTOJ>F41ZF5@B4EZI8*%8B7$I NF'"9&V@2QMO
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MS$$0IB1YCB8R,7/(PM14*V+.5DJQB.AM,;1+P3PAI 6C)9SWD*(I)8IH (W
M7@'3\!#)B96J0-$R*6AF/69!O+*7\V":GV'],$KX/0JKB&9@_NTRS+>C+UCE
MP?CM)8XQI:2,%_<"-]!@&V@MW@BD02A" >.O^!1?0N!C[B223M,.6\%=MNL2
MH7BV9 GS8,H*:@-HW^%KXY#.X) ^5/' B8"/+4 ,'?#Q.(HS4#R&28Q%<1N
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M-AL/ZW'8IDQ#"P^IUHA^*I#8#HCU.C88$&Z)IH7.P<-Z&MF.B"V-"#N8T>V
MV"2#GT PV8*#C:MV4&8Q7#@,/XC8Y@$1;,](YV!B.R+6:;%E$3$10;N#$\$D
M=:<F6G3=?O"Q<Y"!H#\R-"S#34&W<G#H #8L36A@*(!&!R%C>#9CL%HW&Q<8
MNDW;C"8LL);%^$G! ANVN=CV88$V8=%T)S\A7*#;L]+U.K8>, SH3\Z-&-#M
M;F10Q]:!13/R7!UW=A JAA=U_L@QY]8."KUN !4=YT3TV[<VUVFQI:U%QP)C
M<'RP'1A;%!AFM%.!8?YQ/<FV#@RLO;6U&AF=M+4U./3;[*VM'QD;6_W6EJ65
ME*S>Q#!T$#8&1X";FY;\R-L8@^5O==!8[5#,'9:N_LC^9+#X;<V=Z%:Y$V.'
MX6+PQN7_VID8MVU@F%O :.YO=5K\.4Q<#'=_ZR<0?K;VPSL,%L.,/8>]';YM
MPZ*9BP2;06=J8H>YD>$>SAD<-VXV,+9M-](&1OLHAKX)#3WZT\'&\,]BZ(>'
MCL'D6QT\S&L.ZG28/QEF6K+]!-=Z'5M_8[PC@3',C?'MP%BO8^L P[#&8AC0
M#MO_''SO_'\.C<$=V-;V/Y$U5@/M,+,Q>&[_Y]@8;+>V,;NQ.C_1=Q@P?N3T
M9/ !@&T,%OJF.]$W<6'L,%P,CNTW$QB#R3=__W/;!H:Q:3",Z"I/TD%9ZV#%
M;"8P!N]K_Z\=R=:>LJ*K3P2;=!VVGS',U&38>Z"FX2%CJ]_-0)O.Q-2"1C,U
M,7:0-T&'YTT&:W;SH3&\S&2PS=OJH-&*,XRKH=%!R!AFG#%8,_]K9&SMP#"L
M=B?FCMO.^)'=R3"/9FSUNQF&U>X$Z[1(8Y@[7<-V)X,/AVQKD48K.S&AJWYG
M8N@@: PS/1GL#O[7/S49C.RM$QKF-0>$T0[R*,/$QN"C/__S \*#7=I6!PYT
M-3A:+L7<0=@89O(Z;&P,TZ4,EC\\: SU/-2U*EL2-OP\T"W['.:6L#4/-75+
ME"8/=&&S'G6*K$W468\Z;=]>6'6S&M%UT++JY"=5;?5/NUP'%I;MJ-@4@RV"
M"LPRWF*Q&#L#%-AV4&R*P18!A;D)"@SK#%!T4EC6R: PM2R%N3- 8=H.BDTQ
MV"*@0%N@0#H#%)V4W'<T*#HIT.RD^XZ=# I#)P6:G?1;\$X&A;Z3 DW]=E!L
MBL&6V:CHI$"SDVY!=S(H.BK.W Z)33#8(I P;DG?L17?([!);+Z@_#3O$K1_
MGM)QC_7ZL7^>LJT_UZMU8Q;]Z2%C\"&N[< 8TF;\Y)Y+/NSG\VSCSR4?_!S
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M.<C)@)"A77BB:L_A%K>:&3/#3Q';^DWX86>Q/T<U6HQ$ 2?P_-GMYB0YFF.
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MR_LET&FP3$_F,8#)/>?/6![D]%6CU?1(/"=9-$74 9QZ,UD=W!:QV^$<+K?
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M L1%HO1^M1?6FF9Y=;'3@\'3K*:T'QZ]VSBLX,M[MJ_C7]>EROXI-5!.ZHM
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M+U_43K[U8PC5;F3-TY/FQ<C],#?@ F"S'I'&C]^=?%I^&;\#X$-K\H[KS7C
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MSLB?L) 'N%Y'7&"P-,V6ZWTJV.$'/#. /O9NY'U&E$IE5\B:>+T+N2J0)KO
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MJ*&E#6MRG1C%>;2?45S&MRMI(&749]20H'J.%N^@(,HK["(V+T.<Y'WC$/\
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M-52!85()L5MASF1J\L.[+PY=X3S!:3<ML.J\]F]K:C><^B*@A4,UR(1ZX*$
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MW $3MX  >,?:6A,HDGU&9QO\(YNVDE9J<6$43(KPCU5HAX$]9#36'/+)ZD+
MT9&>IZG.(>(%!19>!Y9YP3;4 =PV  0]\].<?#&B[:%W4F^*0JEW XIJIS&5
MQX[@ZM)TEI+@.1\I(4.NXQD=>+"HDB]R+') ,_6]RX@&,PA!+,D&T24(];:J
MSS!LVMVG69$.4W(7%#^84I0"DNM2%C2-NQ!QC VP,YVXT-OT*WDGQ9O)SH,F
M<#Q7AMRZ#;4/ #+;:FE*#^270.J4CL-L8&-^NV??'!(A)Q#S[<OVU(01F7RV
MU)J>PZTSK5DZPHJSC(U=0?\ 9&V1MGIMCC$W_36M(*#_ +9]/33VK^ ?R/\
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MTJJD\Q(Y](W&)&5=IB5-0RD!3,>0Y'0%$%*J9)5IA GKI,\@$D],CVSY3L7
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M0MJY'A]\%'A_Y<7^]4^<%"H?,6S(T)266:S5/,2Q(6%$*=1N5-C/WB>B@DC
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M::<\NRJZZA:'!KN"[-9 4"G+B,>M(!]:2!E)QT..,GY]!BP]R=R;9.D$M(3
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M"HW/RSS1."B$,%G5B:+S+K-#?8IO,*CNTR0M*&H=P1G/M:B5A"E!M,DL@_\
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M,NP-0MU1ZC.#'3N]D[9^=PJQ,TU W-P0W@,YA/3R$G(_,=E?]7">B((.VEJ
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M1R]G SHDVL0[XDSGKE&0H*=X5GJ9934%T^1Y;VZ))Z+)W&0!G22-1SN>N.G
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MM+O#E*Y;-5F?%,634I%12@=97+7FI%-KU)W.Y_XNK\RA*&V,-^W1[@\M_.1
MD)N9E#FQ@V$'%KWDM;9+WU7*JVB;6YE2*"<A-'#T!&-OZ(9IG0CA0)'I4D;G
MO^?$XT54AGYK^*S$&R8O)MI?BF*C"[I"CH)'+>U@KZW2LY7D6E2PE.H_9]HX
M2?Q$4MST_P#2V'Z]>O'0X)_RZC_M)*Z5//+^^N=Q*._350+UCNA;U0-Y9GG&
MLON?$.72KQMGF4IF5*CTVYJO3GDL@J1%9=]+JUI[I0C4M0QZ@-.#PUPJQW:M
MY#Z3AK==1$:\E^)\+B=GXE)_E(*V&).;'J9C1CY86Q#NRJM5BJ)D*MBEP_M.
MMR50_P"(XD>>S"5[I>2D-GIUZ]1QS.U<4GBTDNX-R9814H[*W.^O6_@W%![)
M_F7[JIY,<S(>>MD]3^/5ZC>-#OABI(66H<-BM6[Y$8I=HT-#BHS41M>1AV>E
MM#;9/RJ6"3@;\C@]H_\ &G/QTM@F34H& R;!V\.AVCL-''[!60+FJD2A\0(@
M!F"C@$#<%UHY?\L^8-T\V^9EW1+<J$>AT:FQ()3) \QY3K)U2@,]0"5#'4@#
M&XSZ/MO:".S\&0V(E0X+YDLD18G7ENQ?AG^'[7Q.(0C0ZB08!I ,DW2'63OJ
MRK-G7"TA@/4J3LVG*B 4@' .3UP ,J&/E'0;#CF?XH#D/$$[7,B]N5\=_AD.
MGF0+$6/Z'9DF=]/D:W*K)08RX2VTE.A2T@*4E"@05H2,ZU@$E*01DC&1G>M7
M:14#2F:F+%R$)\N6G:8%DO /:X\0GROJV?AR\,<>^TS[BNZIR:="IDV*8-*I
MT;RWY3D=U+K:Y:\>E"U( 7C< JR>_&0DH;;7BU[M[(),Z 'N\V\ U9[/:S]R
MCC69?ES7VQ<4PLVK3+LN*D6\[#4&YK<BG3FFG'7ECIH6@+U8P",;8X-*! YC
MS-L,79NSE& 9!:$'#-B'?<$. ,RP85SUI]V>&"TZUS>H5Q+KW+EFN0:/<5%N
M6%\2B-:52>0TU+AODCRW6BMQ;;I^102LD#;C;[S])]/#60!YEV\7O$X3, !
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M9EXG^5SU#].HZ?VXV&58^$?TJ-ETO//0H'Q5G_<>DEQT4\W;6*GBV;4GD_S
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M&!\/>)3?Q$F'YR]P+H 6NY!4VP'.5UN'F+'LYJZW$/R*M'J$M*W&VP2MDA)
M!PD9"3E1( Z\ <&[##"(;2$6,PUX  '6IX8&-KK$#D,0 ETU0.=<],J?B'YL
MT2VGJC*IU 9#U/B*;;>HH=2E3C2(3+F&G2I:0E+3F4.9#:SI4>!^25! -H<O
M!_N[+E4\, $V0,[_  L@]#3NLK>]E2YUT.W+9IE037[1LZ.U0'G"CS:5.J%0
MK<.(MR/&>IS678?GR&T-E2<K;*R0<])^54"%W8,E/,L[3@=,#6+("@0D$R1R
M)@\XL\:S6>OR@TF _$I= ETJ)593U7J+%'J9IJOB7YRG5S&D8(*YQ*E-@XP5
M)"3QM30C3 ^:DL3)12/B(VF0&"6##)&T,&>2/A&<FQO/?F?%Y8\E.7E+NZU8
M-U6-?%4^P+H8NA7VK(B4U32''UI!(#BVXCSA"2<DIV'LSK$"P(Y#)CJX!OF=
MM4&==Y8>&F^:A9%%O!=>Y<WXS"NWEZFA.^<P&9RDO5NAFI_Z 1D+=CFDCY])
M9V"AB  (690SUCQCTM +-)<D @D\TCUP3L+#-JK=YUUFN&GIH2H,2CLMM,1Z
M6G_/#T DR![)!UN=P,G'%>+0P8P?+FD;PQFT2+\,+FBI&,/ID#;P-UN2-6=F
MV/5WYD./'<7<4OXB2,ZE(4P=:DJ/?25$;=1TQU1[GQT=: /_ '* 9\P&8$:;
M,\.KG2AM(,@8Z89\>?B+LZFW!RNGUZ'5S378[M!;6I+7G%]29C8#26MBX7?D
M#8&7"K&=\#HT$4&F3=3]J,;H+2@X9[QV$Q;/B1O,07OG.U:-(^&<-0N*2M(4
M0XV'/@/,3^)!9(45$C(*-BK(3L!GAL<4=TR4BRQM+%DMQU&C^5YXMU)#L(-C
MS<K71FG<O8 TOS8BQC!3*E%2L#.<H'S;;8P 2<=P!E^=P\(=6CX0YS-N4$<,
M%R2M@#/7]''33@U6.6E,P6Y%':6HX;6"4K2O&RPH[ITJ.H*! 2=QT'!_-X8_
MD:Y']8@1JOY0)R+MC!6"L#I<[Z[?Y3K'IWI-;IP2G*LB5J!VWRA74$=$YP=^
M@)P?S>&1<,66^\$%0,1O;4JX0"V@R &@)%Y'5(HVU&IO/7EU3WE+?K=.TJQD
M@@*4D]1L#[8&3@^Y&, \;NARPRHQCVR2,Z I9015IGV,-X#>FI/B?Y;Q'%AF
MM0E)&K9'\0C'1L$YU]D]/5C&YXH.U$C"908P60A?H?#1-)[P",P2 <Q,F7=)
M\WJ/U7QC<NX27 %29*@A>%9&Q"2<GH1O\I[D=CN*U=L/=K0DTU. <%9ZQ&VK
M#@LV*) E<@08'A,VC4,J'CNL*(VV@-/ZC@ *!*=SC<IWP/Q$8VU*/0X2_P 8
M=E,V+8_J .POM$/3_";M##"O8R(V\D-0V9^T!H$=QPPXP6@ G2 5:@!J*0<G
M&3L.@[^W&E/;&F ?('_EJ?X;NJH%"E5"8B?YL\WTTQM>/V7.E-0:72=;KSK:
MFDD;*<4L!"3MC!5C*NJ0.OMH.U38(;O?]PQ%[W4^(!,"&FILC$7%_*-<;R\:
MG,6W RMRG1XK4MO6T$E.0I23C&/Q [C?.>G0<"KM+!(1@R7?FS_=<CJ4]YA(
M#O2/$&T(Q9&'@'0FF>-[F54"IQDJ0D J*A@D8&2LXQLG<YQMCL=^,?\ %G*8
MCY7[@\_JW&WW][],:AE5\7G-J;YAB7 (BE(6$DG)2I22$G'^J<$'.>ISDDD?
MXM!"(YP>7WX:G0D/GO\ ?ML-1T>)OFW(9<^-N93SA0L!QO.L$I.%)R#E8.2!
MG!."1G;B?XL@7WYGP>?(>JGZ9'WRV-]-=0YW<QI"VW'[IJ0\YG!*4@*.H:1I
M&1N#D^W3'7/ _P 3WF"6#%@2<73%AG]-#]O>?3]]127S0OR2L W16BDG"AJ\
MD'42DX<W#>QW<!&GYR,C@"MP0)0^AW>^-M'[^_OIJ.3[VN=Q#JGJQ67SH44E
MRKA2"H)/SI*<J3TR/Q#.^<<0]!L7)\RO?F(#U YGR!$<Y+\4(Z:8A<%9FEHR
M9LA22I&M!E!25)*AD*3D!61L1C<>G'0\02DF#YKS).YLYF^H0+'(]_#;]7C7
MU)?L0G?-\*?,17MXB+L2/TY:\I3O_/Z>_%Q:R * Z?N[>[U-?/G^U=N_FQRN
MOGQ 5FS:S#GU&?XH;L:4[*.GX.@UJXY?V+;?8X<FNIAI.>J@.F<WJ!^$[CT0
M0]S%^5M9T)U0B*C)ZF>B0UFOXFZO?$VPKL9D6PS%M2=RQ%8578:=:/MU-PPW
MY+)0<!8^(&"D@$DZ3OPKQ:NX>]BE5+8THP%L+ VWPYPJ!6.[_,Z=V"Z2W $Y
M".+G687(ZA6O<E9KD6M1V'%0*7&-$>54A39;3SKQ\UR.WU^)0LA;1/\ I$H[
MD9@[5^:#2?X@I.2$HO,@ V#A$ZG^'_+KI(!8J!1#@$',!AC8\L:F\G>7]*M3
ME1*10W7E-P*NW4X#<J09JUAMSXB6D.D@I*L* /91!S[^?[3P_P#Q(K_EJ-;$
M(@@CE<*Q@6QKT/X?6*J!PR)XBH0&:RL@X*FRC&M0*/:=OW?8<!F9%1-I=4I\
M=4MAU*%-,R4M:5%:5Y;4VDDZDK&A200KTDX[_8.(.)13483;1*DL@O<'RG7'
M_&:/RN(::0;D6YH6S9N]E=$/P><O.7MH\PZ[6+4MBW[>K5016H-<J-)I%*H4
MR?IJ++4=J1*;RY4$O>D+9;.MX*+:,*4#PQ6.^01@@R7:2(6P(8@*\ZY_ ([M
M0A]VHCHJOM \^FS=IM'#!'9+8QU.=2>WN=]QD<$0 -M5&>9/[>BT3Z8SH=<4
M/5L3CKD==SM@X!SC.>W$T*_E+MOMGW 'CJ04UC7(>4&@-(*M6=\ =?? P5$Y
MWWZ\6X<DGD(5B2<WY'HRM8F%]5)^GJ5B=2^'(U@-G?1T^F< 9]\#I^9WWP&Z
M!#Y^GCY;1;4IN(4CI?3XQV_Z'%A;QJ]SIC3PC^&G_H_^<.,:;CJ/?0JL>A]M
M=,:O3_6V_GMQN8!Z:PU[((:4A'NI*1U/4^_Z[\9E$.;5$"-Y)^H\M6WQC/\
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M^;ZF C=*A/B';,-Y200Q2[6=4"DK!#=)<<P4_B!P04CKN,[[.CLWPU2;'_\
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MDA$=V09:%['<^." 9W;.,0K(CE*-L& I<856:*VA"7YT<DD# !SDX&VPR3G
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MB? /$X/'HI/Q5<+B@''>--2).-K%9L5U_P .[4.%VGA$_+3Q>$27/P\2G:9
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MZ+=-9;!9H%R0J:[8$^(ZZTIIV=(E4LB',,5:DOZ'?N5A*@Z2C/!X?8Y%YY>
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MZ^YX2KI,3U@;_P!X+SB-="G!8Y>)FW*TST8UZ)Y77!+PX[6BI2<* 3G4<9(
MROZ>G&_3';C)@%=Y+D__ (@#P<ZV/.^?O[G2Y'*:I.-K3(JDHH6E2%H  U)4
MDA20"<Y()&V?\.#WJ3<D^8\T!H:<8_)5V5(9;$F2VPV 7%JP0EOTZU#V"$94
M=OE&^VXG>"@L]-KWW\YR=32Y/A^??GR\UHJAJ4P"VD#6M!4 H#.Q4I)( '0X
MQL.)352P2#<)R&% S,/?.=$21U'OI!7O#@WY[9CU>4PE*<D:M!P!G"5)QI4!
MD!63@GKTXT/$!D@L2@5 R0G=J;'$G6H@$1;9\@UNNIFP"TCC^&^BK1YE0K:"
M4A2E_$S<K 2 HXSU5C( VZG))SQ45AALHB[S-Q&7L2-M5J-2(#$$' ,%RF L
MOD ;Z<H?(KEJ@K;E5N*7&@I24JFC05C)2%C;TYV4.A23N!GC?OT^WWX9TO\
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M58&X& ._$[M1M L#N$1-@2$ )ZLZT%<B\'E.P2]CXZ^I?]BJE:?"S?P<W/\
MP@+LQUZ?Y/>5F.O^_P"N>-N&!325N_0#Z?8T*ZN^0>2]3_;69_C*?:9\0O/2
M*V]]_ ORZ1*/PV/AS49'VY"=*\');^TD+\SJ -6W3C:K^'H!RL/6?;6 O5>Y
M?*; C>XD)3&L2_%9Y_\ DFY@/H<"%"V)2A#42 Z15LIE$9&0/G4=MAD')/"_
M$NO!P()L(Z;Y%S#G!D)P7#.WES-C8O6*')"QQS NO]W4/36&5TOS3(B9TL2#
M*PEW P,M+/F G/R=\ \.]GH@'?<FX7UZVF="LGAMCF"' &_D2(.+'6Y_@BHL
MYFV;RH3M7EOR_MYZE-3#GXN.TEA3'Q$;88?:"@XT.RT @$$CC/M' _,J%!CO
M'NA6^(]V3B+7%^NE1V@4\2BND".(#Y$%^>59%,ZNCRKI<KEKS<K]B3ZW-N&-
M<5#IUQT^M5+(>GUN-)2]5F4[;F'!3A)Z  ]3CCS-'&_P_P"('L[O6*.H)^$F
M6""5(!)#"4^NKX1XOX>./?X*ZEDCND;0$EU**:LKR*1\1=D_!QKK-6!.!L?)
M7C8>^W;; Z'CT_XA1^4.S5_S4TC_ -R$>9V$2+:\MV&K\T]HICX:ZQT[M)J'
M4@(]8G6D5FD,MJ2.F% ;^P2E)/?H1[;]?HI2'2VB2CLQ)=X"^K6MB90L23Y0
M/?1NI+ 0AI>_WJTYZ8 )P,?I_+V]Q3\P/, 7W#Y2>5E)U*HH(%T3XHKP4^.B
M-$8RR@G&Z@?R.=M^NQ![8W(Z'>]9+Z!>=_OEI<0 -M/\9HX0E/51'7&R<@?7
MJ=AMM_;Q*!\0)_F ',N/+.IIRC-'6HG\(./Y'.1^0/ZC'UX;"<=2[@EQX?$^
MNB3XY?[6$X]2-+D#*T#W4D?S(XMJM5CT/MIQ+8 )VVWZ#MQ-8:]4]1^8_OXF
MII9V/^P/[E<6'\/]1_\ CJ:6C^&G_9/_ )R>+CY/"KZZN+CK1[:;Y';_ &CQ
MEJHM5T^HTF3U'YC^_@56/0^VAI/*.'$GV*3_ "*3Q>GYAX^QU-?D5W*U ]%;
M >WM_OWWVSOQN?E)R 0?$&T8#O\ L#]6MXSXVSG;2"J *+B5?*6G K\B% ^W
M;ZCBE/R<T?<ZAOX4^PU43Q$/*A\N+]=+*I"&;>KKC3"1ZGU(I$U2&4@[DNJ
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M "8;G=[7/W"T:22"\%;?KKYZO&V7I'/[G85N$/+OZM1649 !CL2&FPG7^'*
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M249!S49N4'N2[@Y\L9]9W].=\]+DC 8(F2 @LF.JVG1^FGB%2(Z5K3!Y24,
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M)ZE1@R2"";S^QQ^VLS)W@GYK5NHQ*=;=Q0'Y#S\K0S-<,+R6J+3Y2YQ+8R2
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M8Z$7/WPIRKO,>1:M-97>\1M0;CM)U.U%(!+41I.3EV6H)8;2.JG #N=BF:2
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M::?B8W/,7R=S@)PC<:ZW" %+&>N(9>^P@;F^JN5KE\U%<DRXH5 4%*===C1
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MFN&,>4"7B??7LNU/VB-34''+AAP6]0*FS-HS:5)& H*<(R@$9RL@E W'0\
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M/,0'F@K*O6A1U"]?#3.P<MLH\^4GQ%]1$6A]"2 #L( 9'(<Y%19G[=;Q=2V
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ME*UR*;7*HF0XIM+:54B.](3&<4Z?+"%*:"%*<]"4E17L#Q5$P&ZB0+WZK?\
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M0<Y.W!$20S?#"GD;",!0V1J!@RRXP +AR;6-N8()T0[=MFI)<5*J4=++KO\
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MU<Y94G]P>;%S38C"'(_,?F6MAQM(4IMJ/S)O)G4E/XE 4'*!WP$J&#GC'M5
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M;X0MD=RXMBV:MS6MRG7;1X4FD.5R8S/$N'ZBRN<$,#&?ZFQVZ#!WR>*TF3L
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MXUIUY3ZZ\,I#7KRG.H>6-8(!1OCCF]C?Y7:!O3Q><@$V_0C%EJM=JCL#MDU
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M8 ^(1'WSG3W"D1<'^_@O7F9IA>=-I]1N'FI*DR:FQ]@3G6J6AF+HCE:FHRI
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M4I)@P-O<X/A.(AO._F93N9DVPK@@-3$1U\QJ;'4Q4:<:<XR\S&K8!#>-U)4
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M(?H(>C7;5+B*D-%:@ H)2M1&Z4$C4?S .1]??L_2%22 SW;"&3#BWB+:5_\
MNT#_ '4DSSLK4MRY*!W.HES3@Q8%UVR(S!9$H(DA\G/F_#N)7C'^MIQG<_3K
MQRNT.HO/>.P4W^^2VTZ%)CX0R&0>HS?UU^<M'W%)O];*?,>;I]04RC^NXB(Z
MIM/3;*M([]<[[\:\ ND^'21=8^S?0J$'G2?J/IIEY5)J(I\-^IH\F4J!6"A)
MSNSYSY(S]1L#G?;\^-@21,';[MK OZ1(3WGD\LYN2K >/P\'!_\ <&6!CW+K
MN,_7.-P=OIOQ"0$,(^0&=69#(P9M+)ON<,6QJEOB)C,S7[/^'J CR6Z9(5H/
MRJ4E]12#MG?&#C/]_&!=MA#M<P<P7M!F"M:"]KF?1+P&QGIK*#F;RDORL7(W
M*H$.54%R0^%N1P/+PX2"I><'2-9UCND:<[$<"H(':;6$&'E;PPLQJSLW@- O
MFAO<@V)-Q)U3\.E)=IW(JT;3N"&XS.31I:)#3NS2@I:T+2YC8-Z58<&1A.1C
M'&=%RXB1B%F#_<V2T#ON_#E]\M%?EG1Z=0J_595.IK42%+CO*<=B*"$O.LI5
ME!7OH"B-)5MIR5</=G^>G8U +?QZ\F%E!2KY3NB[[1]B+9>J4^->];?B_:]#
MJ]DQ;LEU.V5.-U9^#\6_2F6TNZG&I)SY+C PZAX@>6IL*VT\*]NJ[M1&0"R3
M>\S8]8M=+5*# ,C("LL$VQ*1N;ZSK\(O*R1SMMF].6\:Z*O;2%/?&LR81P(S
M!F*!9!.,:4[#^8'7CFT4]X AF0C9W,W'2V1STT"%G-[Q^]\GKJXE(LNF^""W
MH-*N6_*O<]-N6>6&:I+ED&-*EN>4V@^H[I4M.2<G&<'/!K@&; VE\O&WEXZ"
M6A<")L$QO/)EKGJZUH6[ NZW:?<49^34J?4F$OLJ7+U#"TA6Z 0H@@[I.202
M,<*570_OSVJ<SF<)L\,1DXSBZL<2;$(]'IRSW(F6X<'RDJ&CS-)PC/XU9SLG
MYM\=#OOGBU[TFW6[>4,;$=!JW=I1A09+CG/TUZ-V1=$^8E"WI4>(VC*DL#2S
M*;2<J9=W TN@:%_,=)5O[ F#%\J=RX >ZLN3T$2P2[N\CG2%Y@S:0=)9=@5M
MAQWRH_W("M>K<:<$KR1U&G.=^GMC)6XA?>PZ2+!%,<D/"\X!T 0,Y8;"MR(B
MU[91.HU)L)Q;B5OQV"4+"B&SI60D@G0O?2K& DG<$@GOGG5MXY';"3:]-B'H
MD"639@2%!P>FV-M>)LF/J03"E8"TG_/1V.>R>+<-L("X!,[]=9!DE)6+(CS"
M?D=;X?LMJ:W2N0-Z1VVG&DKYS7"]I<=\U1*K)Y>(*@K P/NP G?H3G?;T'8H
MX56_YA?_ +:.OW&LN)<=(\S]7JD?B3B,Q>;7-9]B-HD3KPN"07<:@ZJ)6:PL
M#2,:@2@9'<G .2<]SA?)29^48>X4[@A7$R"M)A=ZJ;UU3*DF?"1LP<0,6?%C
M1*.]95]SUPJ9.G0+8N=N!4W8H3(BQWJ-.,QMI0W0XE)5H/9:03UXYO:XJ;W7
MF!Z8P.=]-</YJ<?%3"663]GU>OE42P55%"620A52J8)3C4$EQ8)&>X R,8R>
M_O3LI/>0AU!E\P[Y+\[76M>,/C/4@XVQL_ 1RU]"G[(]83RWOAHR)!"+]C[*
MV3C[">!U '8;#(Z >PQCN4!4D9[H;DP>C/L81*TEQ\MI5%B<%STR,K?6UU,I
M#+,J+/#I)8BR&4CL?B$$#IG<DX[8SCZ\9EH\[[VL1<!--[E.$Z2;;(?;E+EN
MC8:;+.5IK=[*U:--96K7UT8C9U8[Z>OZ<)\2U77ZZ8J^3A]!:]S;1.Y?<C[-
MYA\VK2YAW<PB<YRZI%1;M^GNC*")"2X](6DX*FP4Y4GU:AE.<')6KL $=@ =
MQ8)>WPXOHT.$-@6C:$I+S(>,A:,_8=GZ"RS1**RV&V$L(^#&5'"= [G*E:1Z
MO[>G"58'>A%D#DV=\EY6UPBS18 P6O"P]CU'1Z$?B)MWE_\ Y$>9!F4:AMPQ
M:U:5)<^$"0APOKU%2A\FG=1.<#!/;9[@\3N4HV2]+JXDW("UAQJ#W@1>PCJC
M?9%"9+5A@_<5]VS3.1?+ZEP6HB&:OR\M/EXZN&2-%Z2^3UI7E5BA1'I*:+=^
MRL[$9R<'5Q/Q;MIX?!X\)<+B/IW3YHXDXV&NY^%]CKXE?";([]#.?FI=X$-H
M3@W&JE\R*36*+>/-6FR:E(:'F5&$752BL7%4H(M.?.CE'X@S3RI&@'U;!/?C
MS78_Q1T54W%0--TV)D9*#ZW,+H\3\*[_ .*\&!_ ':>]2")W1$CG&J*W+;S]
M?J(I2%!:78\LQ&U$)2Q"6A8GN*(P4A#9=)5VTDXZ#CD]NX9XW:.%QZ8/"XE'
M%"LZ:J:L"; R[[Z^B4]C/ ["*0+\.J;$'NDO #F<78 FVG+:PZE.M2Z:-2I+
M-/?AV;*@PF*U.T0"S+<H+--FMK&R BBJE.:CDIP-AC9OLOXCQ^'VZ@,_+2!<
M$2K'GG8MJ_"_$_P_\WLSO\%70_ 90RQ9P1)*(TY\JN5=&Y6\\.5E5H<*F"8)
M\5==-*D_'(D2'J>HO2@X1L#E2P>@P3G<#AW\8_$>/Q.'32;5'NF,$A[;[WZ/
M5/\ IWL?Y%=5S2+]YFP-N1D7$DM7.DUVU.DCFU"J:Z<\T[&J/,"NN4]0PB1\
M9:$F.IQ><'"LC6=MB1OQY8]J'#K LBUNP%U:](YO]OX/YG$)3#$;!DP+<UUY
MZQF\<=NI8OJ3/CRX$V34[?C3)R*6?Z3#7Y=$<AL21T"0H!*\;8Z9Z#O_ (;Q
MOSORR%\X-MZN3E*+@J%):[.!3V?B4H3P^(#"(*/.R*ZN27IME\I.4MN<D[?Y
MF<LKAKDF_9U(BP;@I49?EI:F..:5H4H#+8#AQYAR4I45=L<>QX' %=-19)6]
M@!DO)V6VO ?CE)_,F;\Y,,(1,IJ78!HJ50.9DNEMQ>8-P-R[5FKBU9JW*352
MY.9CPRA]R16&LD.14-(6922/4R%@=\\_M/!/#XM/$*_RZA5+(5)[R?Z%XS"/
M9>S_ )W#JHMWJ*@8$$L$A,M' ZP9T4Y&VX_?O(-V+1ZI"H,&[N=D"@1ZH\?N
M:6:9R]IM51471C/E0C;"7UXQZ6SN23GS/%_%35^(4<._<XW#?_O!S%Y)S=%:
MZM/X*.#^&\3B$OO=X_U;;D[DFVZU!?%Y:$OE_5[%M.96(=QKI"[:(K-.(\N0
M9U>J:2I0.P2HJ!VWQGZ ?2.Q=J_-X7!O\1HOSJ'K#Y+:WC:1^5VCB4L22#8X
MA7^]B& U/Q_E%Y>YZ?%UO/Y?&QN&ZK5=*?<ZUJN.E7MSU]"=N8%N<VR@*4L6
MQ3="4*"5D_Y-Z?@)5T22<!*AN#@C<<=+L_RS9!OH+XW]=*<3YCX)/TRG^^LP
M?%'6[:777+:KMT)H$"IV/2XCWQ$K4ZTJ729;"EI3@ZUH#N0,[[))!)SR^V?.
M7RL9RR%SE7G+G;AB,@@OR.6A8B5CPT3O"]:5+M7D5;-+H]7%;IZ8=2D-3 <:
M_.>=4#T!P203G!V_,##@IC9T^7B];_P@V@N+1M)^UC1JM:$! EJ"%+\R4E.A
M. 5#S DH203N3W[9[;DL\6_G*F]L>,=,ZQ28D*8.; @;)6'D]5"\9@COO6-2
M)5)<GQ*H_5T2I[PU-,1OAO+>CN) ]31:)"TG!*<@9!X2XY3.RJZ($V/GT>"3
MJP*--RJJ5B 2!CVB91UFA4N1_*T.5$Q;#H[*)@><D-HA^J2_A1,E.D;J"CJ2
M=SJ((P>$?SR=D(D>UC,V%A,::[YZN\F68=P,-DR>NH50N6MNT"E29;G+BA5-
MQ%12@P),3"XM+#@\^>/JS'U.@XP=!SCB?G=^.Z'5!81):1:/*/$D#4-11&$H
M:+@X(3.XYZE5ET^ST2WYT3EE:]N+;?0FD5*CQ )JVTK^_<?5CTZ3ZRHXZ9R#
MN(:3= 18-R?'D\6UE_?1D8<CN%*@ "E05N D@@Y'12?SW*@=L G($I -5(>1
MCISZ_9U!/B5I^UL%H _,<@]#U]/ZC\\#H>N<M?E[G?'WX_341VTWRY#BJ=)3
M#;#TQI+RXK1) =E(;)8;/T6\E"5=!A6<8XE5 4,J5T/A^^CW3UW6%)!UI?X4
M7)CO)RWU5.,Q E^?4"6DXR59<.@9 ()(( W.23^>W"L<6Y6$=8%_,"=5J3 N
MS&(!O^UU:^CM13BZ;?/M/8/\I">'>#\OB?\ ^9I3C7/]5/\ RJU2_P 1$_RO
M%M?B!C>VB1UZ_&L?WY[@ YW.W#--QU'L/#RCQ>C20A.[Y*_+(VB=&7P.OIDQ
M+QRD*"[REI4E:M"%:I%<]*B,Z$D'"C^$$G?J6@?AJ!_DJ@?TG,9(YPBAJE<A
M/!"EF5=\MQO#CVYXU2[%4RHTFD717* NH"BI74:-.*?+B)@4I+S#3A^191J"
M5 >G 5@8)/+XR"Z2@IAV\X>W2_#<H"XRI<(WZAY<*127I$1-'CO29,G$REAZ
M1*D?&U"<^7VOZ1*<_"G7ZE*Z=3OCA&KYC>">C?J?N'IL2 !#GQ)WN!R/5:.\
M:(57_4'B /,J=$*B,;^F/C^_^Q0'8F"YM^G7[MHD?+49+-]PKBTOP%KZ-ECD
MN\Y>9[6V&XEGG)SOBFK.=O8]-]\[\"JQZ'VT1!?1+>JP/6SQISUZ_$%3TYQY
M5@/*'_1KK!(__!SD>_;AGLD&G/Q6EWI]9MN)C2W&0RB0.8-XY8Y-N^CJVM+L
MAUEQ)<0[S";:=0D^I;:VFFU)3CNI.0-MSMVW[U1 [-Q00Q^1Q [@NDD!R8:O
M()MKF@ <>D/^.@A?U  $XLG*T6%6/;R(ZBS2I*GUI5)6%;I.A*EX5C;! P<Y
MZGJ !QY?CW/(<V6,(W5_#)UV*4*42)?=F003!8%]AU4C023RDH]8O.ZH-<I2
M10:H]37E1W$Y0ZM"T:FUHZJ0L H4DD'!*0=QPF0150+$5.!8>H=D9-VTM$9A
MO#N80Z<F,%[ OQ4\KK.C3[&HU(MRG0J.B%66WJ?\($&0I50:072O;3JR<JZ)
MVQ@#!Z7! [IQ -_0#/(1+9-]4K[SHLUR.WALC+'@=5*KER1^7,-NG0*6JH2:
M;%IQJSD=6EJ)#7*3Y;*R ="$HZXV"1J]6-W.'\AV[IMF8Z9G9VPO5%=&"Z9S
M<*\ >_KI#2.?;50J+=-AV@N7.]#KR4R2M:XN1YB$))RI2VSI2G?4HD X/ -^
M[#5@R#N\6P5 E$ZO@5!@'*4[*,A,.XC&E$'F+>-8I[#=3I3 A/T>+598@)U5
M&,)U3,&)&=20-2CE(T]SD;].+4DFJE/!L\X(*B_,*!*@DJ$[D[3(O(P<Q:=:
M 65R:MA;<*6JF0FIKR1+=6(FF>@OPTKUOGHDC(43N$D9R!C$XP^.GJ,LWZSU
M" V.AQ'\2V(84#%C@?HQH9^(>@TZ@7'8E*@?P#?E/6K/7SS$KNDYWVUX..Q.
M3UX;X 5)*@T5!>#\6=@8:YH5/ND8QD<X&4?/4#J!#G/2PVE?*W1ZOJWZ)346
M"K?ML,9SV!R-CPUPHX9;2 %U/='ORE3;2Q!-5)<]YQE2(S(*LG;2#QO7'3Z%
MS"LM3R_+4+<J*M?]529C"@??8C._3;Z#CF=K^8&+% #F8'GE8VUV>R(4%;$9
M%Z2/"Z',8U56AWY3:ZM;R9Q66DE@)2 2I7RI2$=5$] ,D$G&P/"GWUS]]-;D
M;7GU?07+.ZR=&ZWKKI 6TT^)"M" HH5%T:L=4E0^49P"HGT@D]AQ!<=>N=L]
M,Z!8!OGPNO3UU8.W;]M6-&;;>8(*L)"0-9.K8@) ]1.V!U5MT)QPUPR 0PP_
M1@@WEW+SI>M(@$"/..>Y_;12HW-^Q:/*;$_XEM+B4H0U\+IU*5I 3K/R:QI3
MJV SG)Z</ _"A%]@#X-P97,VG2M(7$HG^.E*X^+P +\CIGYH7)3;IN&RY5+:
MDB*(ZUH40,8!U G;H,C(P-AWR 4./<"&:F!Z+H\O/33IN:BPJ43)D$F;W@*)
M#QIUY/2::Q5+SD5I]$>&),]ER0Z?NX[!@K2Z^YN/0TWEQ1WT@8VQQOV9]V !
M+,\X+ ($HI@*,O00FY!IYXVR[AME9L>3+-)I52$:C5IFMQ#0:A+1.C?(V'O.
M4(RNNQR4^Q'3;C:J83@VD#Q!,L6*.X&<TB3>QLC\PP9/5R=S(<A4REF H9"D
M4!9Q]0XL[9.>W]G4#8K<,@<4G:J/ @S&_D(OH %K8N4?J42&2+P/"LW-*DBX
M:I9;K(]3=)<<>']9 DE2Q@;8(/T/T/;?B_*5,$'D0UZ-AD#6SYJ_,@&Z<>2/
MA9!0*.Q'BQ6BQI"'7"2-@ DDY ^F K/TQ@;\)&3)RU,_K,DK9ZK8691D 7*E
MV$*[FP<";T.,9#JH[6K08DQ!QL0E32DDIWZD=,[Y /7I8V'COC<93]5K,DR3
MX@\T0O 6+$9)6A[X?[IJU5J-\Q9/Q1B4JX*U%94,=6HZPDI(&03T)R<$# &-
MS0?CI_J'C(0V*S:0;1H56O<.Q)@%G=9M+Y'4$YEV/7K_ +JNMFC(0XY!M"1&
M\J1@.K,MI]M*$[C"E*.E.-\J&.,>V?.2.0\9Y<QCSOIKLUKJZA[QF9,I"#JD
MO@-Y:<Q>7_-"\5W51C3X#[,]N&_M]XM4MP(QTSDXWW'4'KGC#LOSAYJ=_J[?
ML7OEVB2';O"]R,*42S+AJ^IM^T8JD7[(M&GR?XK<M#Z?]MMP*3[9]0!ZC&.O
M3C7MR Q!Q9IE9SMN)6M.%\IO8<B)@G%H']M:1^%Z)'D<F;,?.1JI#'?!]3>#
MG!V]OIUW[<KA$@U1>DF<H1UA>&GN$ :#T/3./O&PU8+['87ZQDZ?5I!Z@'.D
M_G],'?C4U&;3U/UMRMJRI!#9*Y(OGMSTI;C,P$*7Y&G6"DG<XR/?/;(.=\?K
MQF6:9-P3RM*F7R,KP,@""(+(ED&)*&Y\SG4;F!EUU1 "B0?2?E4"3A*M]\]Q
MW!SWX2XLO^GESZZIIJ=IL)\_>0V2H_U1@Y/3&^?R[]-^$R %:XDMOP'O'+4S
MX6QUG/(%<M(UT"F@@F& 0<@G(.<]<G<^^W4CB[!L7J>5E86UL7^SYALP>3%R
M,L)TH5S+JSA&,>HVC9*>G;TH2,?3CL?AQ? K_P#6J'E30-9<2_A]3K/_ ,2;
M(5S4YCD8WNNYR1O^*LUHYSOC<*SMUVZ'CT'#?Y=-PP/*D/ER0]<Z3!^*N/XZ
MK]3CD%>_IK';Q.4W78%_%71%MW*5#/84>8#O^63GV!''-[4N^KW"\&OH[NVF
M>& 33>32/ $^[_OKY)HRRB4VVVKRTMR02YO]V B5E8[^@#/%.R_ZEX!O;Q]/
M#6M;[^W5P)")$Q,\YC7T&?LC4EWEOS!4'522+PHY&D'45"FND#?\15A(.1DY
M_K9X[=*1%_A$PS<8<+D[;:3X\"J03W/1$Y6/;6UUKT/[$I;T5R<_/6)@E)<4
M-HWGKU".=SD#.,G&0<@'/%:S=.20<@F]X1FW)&!*8-@&19XQ/*+#S TWVJV8
ME=O9/=RJ*>'T_HY4/Y;#88(W WV3J%_&.N.73&F*S\('.[>!GPOMH\6-5C2:
MJMV*27)$525@@ >M)3^8U9QG;8DY!'"E;"//]_H,ZM0/EMCG=%V=Q9^,#1?3
M>[A0I+BCKC@N!(!!RV,]=^X ^;KUVZI\2I5 ]T!9DCDFB!=E'D]-4KX9#[R@
M+/\ ?)U3OQ[\ZY]I>'JY:8U#4XF_==I^>VK2XR&HSN76U;X6CS2I)'I"DC Z
M$5JK IJJD"FFJJXE4ORLW,SIFGA_F5T $,U!P!>J!$N+Q'*-8LW%!ATKE%RL
MMJW9=7<2SS637*%(KDGS*D]0$<CK>^,IZ&_Q4MZ707&'4YPII2DD$$<>+_%N
MT"L5\,?_ '**^'=A5@@7AF^Z5M>T_".S=VOA$V%=%3W1)< 7!,>!90T9K\Y-
M7CS(8KM[46G,UFW*_>%1?I=Q*J!AP4-K-G4ZM.S&P,*B4E'G.O@[J::4$GKQ
MY7AU_D5U0(:YDL J_ES)O/H**.%5^(\*"U2 + $5! HW/PW$DD=!^WX+.<E'
MN:?6('V-=U%I]K5!MBJTBKZU2Y,Z$]Y3*$@>I<):TZ0<94@8S@$O\'MHIKI)
M$"NDE71(9$N*3@L^>NY^*<4<+LE*)'PU4R0,'-HVN-H.IMSKK]GRK=AQZ546
M)D:1R/MZG5.+"G!%0BU6E4FGMSHCJ\8"E+0MLGJ"-QTXZ'9OQ+@'M5&_YE*\
M:@(C<WM*0!CC55FOL=1 1[E19@102V$=GD$["(#8MO<L[ <L&OVW,NF95J[4
MJ;'A1JO5@XM;LJEK;DU2L-]%_8ZU_$4]&^HLI&^1PW^,_B'9ZJ*:*3-1[HAJ
MHP);9)+@O)3UR_PKBKM/$I#I[VWH#Z20TW)B_/,9P2.:-KOPH1CMURT;KK-.
M2" J30Y%L2(/G@[!)^+UJ!'0G/8'CYM^*]I-''I EU@^!-X(ED*$.1C7IAPS
M6S(0!$9("/- )$NPE:S#\8E!LBHS*5!M.DN,<PY\"(JXWW)6IMQIN@4P,AP9
MP6QZ=:0/E!2<[<>M_ NT?^'-8"[@%1,+X0V(!N'E24'JE=/=X?$&:J:]\L&%
MG!R B2D7?DERD15.6-J4F^7Z>XJF*N.1-MQ)P9I746E1 E62I'F[(2=]U#)]
M_9=C_$72'+@S!P$ ;D0H'AKP7XSP2"0&$#@71(RFDD&)U[U_P=6Y J=8J%'N
M";1:349$*,XB++RF(NHJ0T8V2>WF%!VSD$$[',[;VH<2CB9^"H,%$NDVOY$[
M$C9+L5 H^,LFDBI"0$ 7,*&21JR/*6V!9?*!JQ(RGW&*;SCN.AM.R9F'5A/+
MF\)"9J1OZDZ@ZD;'*1ML,?,J1WOQ(U"!WZ2$2)[P((D FD.2>0,$GUG:>/\
M_N^IC_[50(ZBHVV5R[0;ZKUSYIDJD(L.+(>DONN5VANU12I96D#]Y:H8^1^(
M ?,GN#IQD\?;OP[AO@=EJABBE=1(Y=#]$=?+N-1WNU<6H7IJ)'3ETA+?"!U
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M.%\JM\O*9W^YC0K0  ,@71!DLE<^H$WU33G#7K=Y9T)=T5.@.7 NJ278?D-
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M->*<PE1Q^$]_I^7 [Y,1,9SXZFM?OV?ZM7*"[3_[]&L=\Y_Y(6/OGCN_AI?
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MKAU6O4/MY=1J,@QHL2@"MF<&/.J*$-R?L_?X(MDI4%YTM$$@X3PY2.%PP25
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M0Z;7Z!7*<PS6Z74<AB0TZ\IA$5_.Q:D,K+3V1@H6HGIC@$-943SL\@J3 WE
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M!_VDW\7XOKS@:\1VD"GBD7D>#)<@W^Y$Z#E2>Q==AY[U.L>^<_ #O^6<_7]
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MQ$UPAC2IGE?1%@XQ@HJ:E9&=R$E.H #KGKV>[-@]!:6/ _?EK#C*U_A*)O\
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MA"\HCX2]QX'W=@[0B$4]@^P1@D;Y&#@X/?;/7&#VQGFF/O>WGIH(DF=X(0"
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MX#ZZKA?Z?,YF\SCV3S%O\8[G_E'4!M^H./TX]%V;Y&-_<$'W.N;VF_,5%="
M=062UI)SC 'JU?+C&=_IC<]SO[<#B_-19"H#-N\%S8L[;W>M> NX4?X3?"A6
MDF)M&H[*#*EA(^'U*5A./FR1CTX_%TSCZ<5XEO/IXO[OJZ;&#$<SG/1S;3(Z
MH.+<:45:6P5'R3]Z0 2?*]UD?+VR4]R>%1%=(3'?I'(CO ?7Q1T*N":6B(!)
MEL7&P%F/7;4(IE#:H3%22F:\\9TI<CX>5GS&R25 #ZI)&.Y.YX=CE<^>WIX+
ME&!+L$%@>\\T3S\-,;86JLUE+8RXI4(-CW65H"1^JL#@;?U5?_+5L5=*/8:
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ML>M\OVJG:MT\OZN_"NZO727*4Y7X\NG3J-4;Q!DL%JWK=F.U"3;Q%.:T+<;
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M5MUY*E!"57'70I95H"07*^"HJ_"$C<J_#C/;@56'W_#3I,_ZE'6G_EK.B_\
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M(P>:,6B$"0QTPC>=63\*O@O<\.O/BQ[IN&Z;,UOS9$=HT:KEU<E>4)0TTTH
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MAX]LQTMF:_\ 'C(<V)=QA(]U@C (5G41G'C7!7D6YLCB,N<9._"2(] .G)=
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M*CLZJ9E5 VVZ2AGU.0Y34L,,1D3)VLC>8.-6UYENF1<R7%_PS"@H;SC.J.E
M'7KD@''4=^G%C"_NRSUQZ2$-*=H+-9!?Q'&.Z05ON_#F&ZG?P6?]H?WIX%5C
MT/MK;@V_[?\ XG1%M[YT_F/\.,-6J_A_J'UT08/^<-_^$:_\\<6K^4_^F/<:
M2XMZ>M/N=%:B_P )O_P@_P ..CP_](=*O<ZO78_U#_B-4"YXO^9SWLYO/\-5
M]D#Z_!4'^P'&W0_7?AW\*CLG;1CN<5;_ ,3?TY>&L^)\M9Y5^O>7L>4!RQH,
M,O)5SUO5*\AM5LT@*TY)T%T!6D@C< G!VW]NUN -DX\S(O%D\:5X8D7$QNV
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M*76($7XVNQ82Y+-#M4AYJHQZ;3O.G/":3F-\ AM:A(S]R$>8/EW;[-^,"D
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M1]_A^C]/^-.D^+<^/_ ZC3CP:IM#!&<TQG(VP1\+*!!S],_[]1Q >Z9(@OD
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M#D76Q>CER@<?=YI<]%'I^_5%R=]Q^YM&R=\]LCZX]^*5_)5_35'@=-\ E5;
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M7^SR0\.Z\?\ \S/Z\.4T]T+F[+ 'L- E_?VG=<]6IKO_ +:W.O\ ^VIS(_\
MDDJO#U'R#_L]J-*57JZU>_$TD"=1"?ZQT_SVXE7ST^'N=2BWC^FF^8V&MM]\
M@?R/]A(Q].QXU!,@9'M?T>MJ;5;&D^8];'4-G%29"5(^<!)1ZM/J&"GU;Z=\
M>K!QUXTXEO'Z'5*L_P!(_P"(T-:+9]M67)KG[O?T9=SUJ94JHKXO4'Y:(^M3
M>CHKS%#3C R=MN@P";&21BUR;-.-B4;EZQ+66!+=B $-KSTA6UT5_P YS/\
M;:__ !.+"2!OJAD$;@ZS@_:4T?[=Y*T)HM%_R;P@*\@#=[%*?/D)SG=T#0G.
M^2.W'([8/B+)&&L9\<0$-=/L #I&14 +."#]!Z8;P#NRK*MN68\.C1*K6':8
M_5:2)&SK428PJ%*B(/\ 76-38!'4X.>G&'"!KI[M,55 4CJ6 =U(SXZZ7$/=
MI-30 )/4!CSZ['1#Y,\ZI35!B/LT2+'C5VJU2%*0M?E)B38\930>4]G[H,N
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M>]3Q2HOQ,\?Y_'=7,2E]M0RZV2C!R,FJCB\6BNLO^(@V, XN MRD2;,:1_\
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MZQ\1Z7">, 7*7$FHRO02"$6[7W@&V@[RJ0&+ @,:XJM--H"?/3_FKH^%6,1
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M0JC9TU"^P.!?*+-N@U0&3X2>:@EJ(I\62<C2=PK/48(R <[I.?;'3AGA=L$
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M:=I<2 XM2D>;')^*>C+24K$C892I&2X<;!61G?AO@2:3'S ^M(CSTK_$))D
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M7$ -H!:I3RBLKF=;E]VY6JIS8_>^VX[Q8F6OYQJ/Q;*7TB0_T]>MK4#@[E0
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M7<[90H87MG?*2=N_]YA@,["(YBU@ATWV!?<J-H@M'+_MEDR=,U0:&Q.=@<C
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MK<8IQ%0=2DHBCX@M\=7L'%[3Q.Y) -0 YDD"?UYP)&O'_C'9_BJ4IE1 3"\
MFQ$,ZM#8W+3F!&=G7;S/O*I4^/4:?%<JMJ3[GIM/D7NI;852$5*J5)M^F17<
MZ&:72Y3+M=4M;;;#3D@)3QUJNR]J)%6003>$6R B!"/)-C7,X'# X58-NX64
M)@MF65)!V1EG1GMGF+'YJ\SVOBJY9[3ULVQ IKMJVSR^K;H@MP7DIAR:Q<U[
M4!A^L3&M"''$4!]FDOJ! =;;4%#C_B'![2ZB><0V,WV!N+)$L:]!^"\#A]2;
M4V ,)05)LR.>[M,M:VJMS[NLNVQ9T)VH7U'0]4:A=E(J#U32FFQPMI-LMH>=
MI*Y'RH6VRZXPI64-N*2$GFT</M-#JJ" ,D6 VAPHB$K9>[7V<=^ED0E$@DXI
MBQL<B3 8LIS)H-OQZ9;<",URRM1$II3<5^G-_O1=$J"V%"H-2FC;S7V73G&O
M,#TKS6C&94ISS&PG(]+^'<6 N3@G8>D.V$IUX[\7I%%9)9OM= @!F0'"&PO&
M@I$HCU+H55G-46OUJ'!:AS&*Y+?^ HKWPLH/IBPK9RDQPZ$>6BM#_-,B3^ Y
MZ9XCJII1(8%C))EW(FYY6&N9PJ.]PN(=J*S;85';,#F@.>N]@NR)<"-6$.R9
M$*I42@1XL^I0/@F'*G05/V_6&H51  G.U:CTJDW(TV#AU=72@=3PW3PT7:05
M=KQTK&+Y^X^\G4?YTO9H;>>TNWQ@_P#PS9!W_0 'KTR-^&*0542K$>9]P$+3
MZZ/=)!*@)GH0?KJ)5=[_ (QLL'?-=:3G'O071[CN/^P]K\#YCU_^/W]G52W3
ML03Y%>_IK63E_P!:S_XEVG_Z+=X[/9_X/ZJ?_CI7C?.>@U *_P#\WV]ZM/\
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M^/E.+H=U?O#L%E57AC21Z5?T=(T$>RCL<>_MGBS#V#)=[Y2Y!;<])C_4I?\
M.+G#"\]L1H&R;ZMN16ZQ2$3XYKL>:\%0T#U);^$]21E74_*COD@ X5QS^U5C
MO&396W))B<>DV#T\YJ8 P+Q83X V_82IF07V7P<G4&@.N!G'3)^FP[>PR1QG
MPJFD\ O8^<?IC4*(@E@6.V2]K);6G6>G[1J3ILNVG?\ OMQ-D?0L!"]AUV"1
MN?YYZSC$$O\ W;BRFWKX0-!3@J;W5T[\\>FA%X:7-?*>KNX4K49)(1\QRTZ
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M.XWYRPV$2QZU%HD!)VW"L$?F<]>A%1IJIJ%P6.H1!'4]V)ON]#NTU%%W'J3
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MJGL, KB9P-CL-L9X&J4F"I2F;D*;67C<!Z6<G9&+QYTJ!SIYE/8R.XI+0/\
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M#8#=BS<R.JU<FQI95:T'XAKR'S(H <'PYA9RQ'R"WWSD#3W)(S@\:<-.D"S
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M3D0-;"X'[Y\=[:IY1N;E<-CM4RFKG0*PTM+0D.DAE;?RZG%C9#>,ZU$>E()
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MX=QU'0S[[^!UL"Z#T.VW+&I(Z2'II!*2$,$*3\R2$]1]1U'UX9X]Z>A]]9B
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M3N?TT/O[_;518TH.^)CQ%LG ".</,UM6>P_RD7(,@_EU/8G?CI]G'POD%OC
M!=CM;2I/Q5?U5/\ ]V>@)/GJ?5*IQ8E.>EKE(91'A-!;KF"VTE#QUN+P=D(
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M1:MW<_ZPB:W5+:O&/ D,TB_K8?73ZHMC2I,<W+0&OO9Z4+*%0IS>%X2%(RK
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M,N(RT!#O!"D9G#6?M3B7SEG,57G)>DV)55I:FULNLS6E*2X5+:!2MM3?WB7
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ML:FTD9]N@.PWZ=#PI6($.\X@,W7E^VA388(CU/DR#Y>6,J&<-(4>H(.Y^O\
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MP4"M2:/5*>76T5)J*)K3Z5/!:8=7AY/Q<%W'ES(N/Z0P7&2,+.;=WOJ4X/\
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M2/AI)81(EV&T#PADG4.4PZ%OLO+TZ5, K(VD]@@X[+R$J&"""<:L;YGLQE@
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MX?>RQ!&\2"Q%E)O?4D<\27(B[FOLZY*923&0"\N-,4EHH?'J UE*2@Y& O\
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M5;/(WD6\=-]B'PARV$,.8V5XD7" "LCR_N']X(4R<!\05K95YF 0G=)U[ 9
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M^?,GKC_NA ^I'S?J<C&_$'.?O[].;,D&3"OS?/F>KMK)KFL_CG1SCQMEX')
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MR0M4*5"DH2A4K,2K!Q/W:2O^%@%W&G/ECYL:3G. OPZ%VRF'_FT@_P#N$KG
MN<L.=:=I?< A  M$$8M@W@#8'56J<%,<S+[9&Q;^ (]\I Q@;;[#;';CTO%I
MGL__ *W#/G52-B@/&?+7)XA)(BU24X?5SMBVH99F#2*HZM?E+;O&K.(>*PCR
ME(02E9<Z)T$!6KMC/8\7XA/Q9CIC8SX89R99X4"-JMS8G:/'/EJX4"M7PPU
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M200=L')V]^M2^X?%XQMOB_/EI.HGORP,D!^ETM@[3G7%FL/+PTMD!T;+5@@
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M4-&01MD8.QR3U[$9^F=IWQ"I\Z3%@)\.7UT/RC<$D#:'DM!,Z7L<NH[6Q"B
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M2Z>"$J5\22"RE6 4%9.C6/E*L@DC/! D9##V^[K*Q?0,@@"44<""(%0,.T#
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M=G8D7B_3^^VG1B&AE)2H[*V42"=CU P ,8 &W;(Z[\ ,D&/1JS-R2O!HSJ%
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M9U*P2"#UU DD\'ZKS,#W^[Z/\))NT.@,D2B^63)DHHQB'99:'^BEMJ!WW*7
M>V^VW\L]#Q?A_/0[=^GW&B2$PX'='@'Z*3[ZR0OTC_*GS:.^U=EG]<U\C_#C
MHBI 9D@GQGK?ST*3\?$>]^0 %]0FWW N!:K9T +86DEP@-^N:1ESI]WOE?T"
MCG;BG$J8J-_A@9@>]_:TZA JI-.>Z3',(=8(B,R]?0VY=="MBUH=4DU%F!3X
M5*9<F5JK8-)B!CX1;H.VS#:4E3G3* 1@=UX.PA%>J9!)P;6>YTO^2#X2-\WF
M8R=RT]8^>+3]J-:-MPZG0.3-0<K]PK>DPJK<ZAFF0DH0MIQ='(W,EI.IR-G
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M+!9/H6>4@);GUTM37I;2$^?39D173#&"WG(R5$$>G)&01G'8XV2XM/>=+'Q
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M)"L9#P&QXVD:[154]+CDIN.\P\X%!R2RH(><"P02RL;I>.<-G)TKP<G/&/\
M@C#V&/VL(N>J(U4$@V,(&1T5M\.>L@=W+RHL*ZKG;NB53W!<0E0'8\IN7J><
M7#=:<;^/'0M%Q"2^.Z-0[GBM78!5353 )!G(N 9$+D/-S:FHBJEB!4)R$0S!
MW14AY@:=>85OW+=%O"E6[<2;9J<5QEV+5T->>SB%A;3#K/5Y&I"4J9 'F)&C
M;(X2/8?RF2@G4VF@[F/#KF0U^9AQ8 "Y<\I@CK@1KK8T6YZ3;#M,O.JFXJLE
M11&G,-BG,J'RA2V_Q-ZMU)]0(R#D[<0<8T(.]0F9\!Y]0#,:%50--0L.[4?
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M>M^14_M"EN3O/DZ^<PX-9SMN?;(WWQMU_F<]>O 50"I(%,-DQZ-^):"MH(B
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ML:4'92CV3W(_('M[?48Y+R9/O[^22UUPWMN;OQ\5;HL<%(>2DJ5ZP 24;^H
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MX(XXW:*F462B,D[>;A7]=;TA"]YZ$_LOLZ7^6<)(U:DD$!*0I?I.VE)QJ5D
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M8'4C&,X[9SQF>K$@\N=CL6R;SJ$ C',B^Q6[LN>3KZ<OV(D=<;PGWXVYU/B
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MIY@]2OFE]',14Q8D^_*[*I( ME$0"DAO['XY=&M.>^L[IYD C].GL,#X*CA
M]2LR!>VB"[P@+)G=B"-Q-A=UY92[S!"1S388+V%D5JE5_1LZ?[X/FW;.O'/.
MM': XIB'#7:?!Z7"M\^QI! X=_M$=QV)G%F(A"^SI-* 3'/B-[A+-2M142KT
M.,T3DOLSZ9OB@ O-@B> )5@(TDB=K;$K>G6YX71H]*_J)\"O@ZJ5D!_XMI1:
M0?DB*Z\HJ"V @,/.J:6@:$U6<8L+JC D#[&<>*4)@-V6.M$L#E:LFW6,]]W0
MLUM-:A>TP%8)6'_^KL>G&LG>KI^^XT['M:HXIT#AWCBY]H%Y=$'.<@\XE2!F
M(7+K>;FJ#296C0"G3L,U2LWI61M1KP9N-]-,[8(/?F3%OW\"<"\17"X%O&VN
M'@0],#J[DN>C]Z5[T)DG:1JHFTR1LA<",AMA?^'9<S5=!W/0)O+B=DYO["1S
M<_A;<E?149NW;R<#EB;RYF+EW$20F9C_UC%_LX487\O#*:RB5\1_KR3 ASGV
MI%TM-+F8?JH#!U[3>NF*IZ_Q,H( (N@^V))S44>!IH]=-.Z[[TP62Z@3>$:]
MAS!2:NN%K5+'$4#C/E2[?BSA*[LIF\F9!\-0,K-A%85[8?[EC76Z7NUU"]1>
M6>3(@JD59-D>3=HCYDN/_YFN.=H<]?[C6FRS4X;O]"R1.SJ.DXEV< ?7C:UA
MY-\X'0@+<M1R*.36/BD-4D*TS1B4PMND6:8FH\OV"F^JH]Q!1FTS) B$N^'1
M@?HM)A3HV3#7F%9XKRL5_VR*CR-DDAF<_@Y93P8I@&RUFZJE;KU#FV8OXS#4
MN58FZU!S2R!K1N'.7 ?>T"@\ 3:J>-N*?#:*,M82I-%DTZ156"M#G-6T=.C<
MGM5:I@P6J4A;K*WHIE7P$FODDYF%CF$BZ'ND#A-@?_Q#6JO1OR;$1YOX&?[X
M9(YX;3&(K?&<VB''Z$?KPE:!"GC[7;],A:Y?T?WF8.$8@DS=O;C)5<RV:SI5
MJZ2"8ID'^-&KTQYYC%S7@BU7H!^]4V'+A<AF$N-R!;L>*8<$,SM_*)G9G3&L
M4^1>)&*$5+)O.=FY6#W;5?[R92Y!T=&. A:8JHE!N>8TU+_NB<9*%@CJH!AD
MTTC!'^_.MVI['D4=C%SA3ON^+X!+:FK]<SZWHTB78\;+\B57A2)CE8C1GJTR
M!ZBL%J]NRG:I38$DO+NR+8.]M+WS,[%B\!:"*&F$IJ>9J3N:((:2R O-=9MV
M I@2EG;Q27P_%%2T_O/R%YB^_\UB0C7IY*:;(ZXD7_I=_9:"J%?5ZA,@$BH,
MSS/'G,)Z?_I<Y8W#B&'\/L$FP-RR^<5'?)_$10$[DP>E=Y^F4L@;U)4G4W5(
M[H_$@K)W)P',#!LR070;X,/+W\MCLL1,!%U?<R;4O$IL&@>[+5QTPGI=1)BY
MB_E3AJZEFH.W(V;HI-'Z;-D8,9U(A7"I_X:<KW7V[@NX#(W-E4R\*K<0T6%B
MO>YYR9"G:33^D],IJO=SR79>+ L9H<'@D.9C]>ZWKW3?4127XSR>]2YRZN3!
M6_HX9*^//LG1RI6$$RI^W-9L^GV;DO<SY[5#Z[U7ME="<CE9/AX%H^U$"0/M
MI+PBBW4 71&2.FNV/]K=ULL>?%5#[95KX:3FC&2U3[IO:R:]+EN<M@MQJE!2
M?L27?#N5),1YTT@!B&UUP#_510>]>=<_=OF3+,'H"R<+K]/-DKW2^.<&=:S,
MO KQ)HJ\.M6#8+*_=0FX,W!/BDG>_,;?2RYZS(()/%?#!Q_=:/-R*N(S4K]Y
M=$P&ALMUZ%UK;55QSYX/F[ 2;Y>P.G;J(RSKEX:&,URIY^F,D"ZLJCS'Y2QW
M4 YT$CBE(]\+DCM8L)D-<E*ZR2TB^$WMBW)@1X4<3Q2\MK&WQC"&F9$S5)A-
MFJ*G(>9S8L'SBA[%H7' AN.K%>J W\_O[QMXBW[5T<R1&6X7*K%#6*LSHK*4
M+SEF=W[%>N..!#4*T%JK*0 62[HO[R[XD)R6IHHPW$$"^K\$ ('GV^B.^=BL
M$-HZ)]E23EE""8-0Y8(F#<TS8C#M#M5='QDQ&K2N!#.4Q9(M1J"$8Y1L&*/=
M;*JRM.D5W>EA()^8B%%EW-?;+W\?O!\DTP1+\*>V2TB&?V<PW+O!>-*O@U[8
M[7M8'F0A=DD?[9"A[/@=VUC,VQJ3@M07(@,!G<6TH%X[-9U;'O'K_5\YKGZU
MEM*C*U^]IP6/MT)/QD7M=0L3J0AN2T)52SC2"Q&(.G*S='@)O0NPN*R//S%I
M^_FS9Y?QY\6DB1-;-=_;F;-NM'-1A%6C!=8L)D27KQ,-N<$R9QWC*M'-WA:>
MS;%VZJ@IV_&)(A;YY>811'L?&B.KDE;QL##:5+ZX:UITQ,%1X+MHOEFX7*$G
MN/FQB'K9QHB)NERTT<[%#M'BN%D2%4*/?1J!^;FPIC:J6DI]79CNGL1)@<#,
MG>-T=V9,+L%!1J1:PZ^FAF)2%C><6/T\/E"#X@&6K32 <SFXU^\>UTP%P\,2
M(X#SYO#''*8X_G"75'M9E*Z#%F;*R,-J![0<H"I [EBBZ"//?B;&SA6O1);D
MK7"TF$%A/NO%2QYW>-Y\M<O#DTQ[15KSTU1>PQK=[R^I(5] DA%!.)<9F%6=
MG2 ;>[<;V^%HLV1!K@RL-H5/XB@.^SO7]M^R299I9:#FX"FST0+"0>&]%J%\
MWHH+2?7F&;LNU3]-&.,+Z'-$I1QTJX5&FB+)!F7:)&@(W:R[/5EN442)G:XH
M7!$(9+$.U%P*:W82X0X6_BU9#=&INK;&OMK<<JTOVP5]@TYQT'1&&M3;J>IQ
MDO\)_4[\2G* V#2S.+]QUN-,I;N^Z5LT!%:S9OI3\_H+!SN,4;5_X+?/5%@L
M%K9'&("M\H-U6L<W+^@.:8"7ZW"R5Y<W][A[$\/TJBS&QL?Q('@HI[R\#&3=
MWWO\C8\U1J)!^30-^KO*R(:4UIKOYS.O)S% .<#@R,8!_8'82ET+K;5*[9(3
M\YY9@X0MS0 CQ]<&LW]"8W9MZ[><JHX%4ZQ9K$/O3#[%48_U5R(LU;;/YG*[
MB]\T"F$&1==JC73OY\[N70D<>J@5B*U#2[4@Y 7=#0X"0+8ZM'[R^S5^^MVC
MW%KM2%I*?95B"AJ_E1/3J?Y#&I\V]I ^R2_IZA&^(0DDS9R]HJX9#,.DB=I_
MF\"YA$%H=N,+YWJ.7UV_RI@85ACXI(5#6F=T3C2R^<5!<N$*PS1#RBG3=H/G
M?\"13P!UCV>/*=>>.WIG.KTLBI913" +\>ZO,#$]"HBB&KZ^Q1:)36H-)K\[
M@S)D_;C!P15WWIQ8;#/VX0E@2K\*57 JB];O!$4=_.:@W=H+?/U*F@S^+K&=
M"7QK"WO)E\.+[=>I,5,MO._K*08':C49&W-8N8%E3'^8+DS/N?,.*0?)H#$$
M25%BQJ"#<\Y7:[Y;E\33&68X.$Z$NRN@R=EA8L3\C8'[6!;32C9%+;X%!IA;
M "<^B&8<M13:0,23!%B5QJNA2*),VQ7*<>%FY%OTC>M_4MY04I36N2/[4/\$
M\%J'/Y+YTJJR906-?#X?FM@*M;X3YO?K_0N4_^^KD2+S>RMD*T3"U*9;A'J3
M]+!3]@C:PG;0<4<<S$Y ZN1"\JLMUD':JLW .<#O(<K"Q$#)[H.WA*E#CI-H
MN44N[:GD%W [D+Y*J+H/O_\"-[+1%.U[>XOQV15L=+9"@=;5OW7SO_O>BM\Q
M?FH'6:?J=)O,-"J.K&:M-=5FD@V-L\LM25&1WLPBMDD"-#_N[FM,]JIM%.CR
M]DS?O(839_KXX;'3Q(6@0SEXX$U VC3NU=5!_ @PZ JILOS[F$4Y4./<;*7X
M:LF85JL<@2XOR$:OMH(<5P.(B*S Z? ',:!#<KP??;)4>6O$IF_49)+V?C9N
MANP-7@Y2$VP$?(7J8M^%H<ES.X27+F<98*!U,^6[U:K(6G+%9,E:2FS=VX\]
M3TW=MM>S3$KN-%T8YQ7U7._%^.#,2SVP/:G$E:7EQ^NOP=@TK-(?UE:_CD[\
MG<[/TP!"GO]#M!X1ZKFK!FUTV\"H>@XTEZB9D1G]FHGL^N11,Y*.]P"1EN#+
M286<IU*../*,R-]9TG;VKC W!>"^44TP,LG[K"C>1/ V)Q']3V-\BUVWF0T?
M<NN]@@'G:;4"-)/ .?E;C@7EP<5*S##C5Q[&;[!+GCSPR=45^N*M_D,T5>!J
M0Z#-WJ/94>?.H[JWP2,%:HK&ML=DLC/M#FNWH_8BR_/X-LO*?VR-KV_JMYCW
MD&_?IA#?2JU=YOWV%DJYE<Q>Y]/2C&_ 3OM1:18X7Q4A%4?EW_\NG?;D"EL<
M^9>@=L/*"!XAQ&!9QM!R6Q->:K=JTIZ[L_7=VG@F0X^)YZ"H6+[)WMW0O0ZT
M;) .52^>LAP-EXDRHK/NF]GDC_+% NI[R+C1K$)SUK$9EAV=V^[V"R@?DP!2
M7[D[-M,[TD1TAK.)FDS"[993FYAX[D"KE5,;,P=?^MIT&SC=F[2U;9\72J6\
M"(Q4.8ZPD_-#K^[DD)WF1>U "N!;,L ^((AKYUNMCG#!!=/5/DH'V&OZ12^$
M^Z/KH_N568YK<1KAM'>T2W3KFD\A79U>-E-[8Y\>F)X!S_^UII3R7L@/(]8@
M-;[^0/[W<!5L%,VQ-4,E%%GZIO24&0&+WOE6<.0JF]632YX9IP'#X*D^=JWL
M+]1Q#!O)*5[[Y3[1ZH@WCI?9(_5+%G"27 S=%A!K</"+WRO0B0>)7_D4*B:L
M</)89U@<_8;]42#;8BC'>FWKX)T&V.=0^,UNK:8-6(TJ,<\([4L"G^38LI>J
MQH'"VV>.IR;VQQ)ATL6GOFFP4MC>&+9^J*.NMBF7/8<Y2^QL70&I^Z3G),AK
M(LHV$-<SH2.MM7JK[ => M2#C97RC)@"5HI3A=GQ>NC"RV6[)\F%-/L77C>6
M!*GD"\TFB[D TG6,WS@D#$G9,8S43$+CZ05Q>Z!/!&:J6N+/KMNFY0()Q>=Q
M):.OP+7EUA]E%#0DRX*4QKLL(N)00_9O)5?^_AU13%Y5Z6\KY/3MC1=$3X)(
M/?25$R7 .G"$QW>$Q3:@G42T\7(!#_661C0H$5JFT>\!$JN2_;4(]7N:ENH<
M-1<NY4'4 =+]<([VK/LH*U[JV=R%:% B(W9?XAKQ9[.BY,%CZO4M);1.D/'\
MJQ4\<EI+6XFXS:R4D*RZV,&NT:-OUCF2&@(X>T^ 9LICS0+.8[(-"E:%1]#R
MO"G:^>/ZK(21WW??\P<OG#]^<6')@5U" V]6'@F-%RA6.&I*%R@NEZJ:YOX5
M,[A;4WWQX'Z4C0Y^BQ<$Z[46UEY@$,:*UQF2!N>(.FDE"%%?K3/7G(I2O7L"
MH*E3J+@K@BE%?E"K'VL[&(XG5)RG6 9ANZBMHJT$,(G1,Y>1A?P%B<L?XW5R
M1QU3;M 4RCX2^JV(8%I<455T*#P^?P)X_FM+X@]C5-5>06^79(S#$^"L'N9[
M4<O9_. "B_=S/NQ3L-ATIQP"^T#\,+U0D[%@JI:*,F;*FC(*I3_:?%,MX_-+
MQ?_%F,:V*JF%M6AMY%[Q25I?Q1H6-H )Q7IV1%B'/6@&DB*^L)HH&6;%'=BH
M)9YAD0$4_.)"6+IPF A[0SJ7%_%_?J#'VA=ZX9I)0HW+F5V'0L$/?1P4.TAN
M-C?[1H+.RI\ R:5=7&EQ@M7M.\Q8(D!U![B+\*(9ZU5\9<FKM <A4^3Y3';-
M/>'U6.%@+K="F)I3OQ,97A.5>M]\"KSFI?%G#@H&)%DY&:E3(>EFR.?D/@3P
MD, -I29K<75U9R<+[)J+(4?^Z=4+!SE@-=Y?\7\EKX8', @#. <Y\/ &ZI9C
MJWG5PL,")H(?G*D< KL\8ZQVZ*A:JF("+QCU- 8DR[+N#K/NW,55:?F_KS+_
M\^FHO&M=GPU9Z/2T>BS'[$ O4'.1)06!QW@G:4F XY_CM&P67ZFJ/<1H$F,<
MS^_CZP5%F3:0D^=>9">)N'GU7M8[S,,<FCA._>5DCAV(X$SV#8?$#C$'&PX3
MV:#I/A)N(1/JF2$@1PF+OG)8L>>W#+T7W<"8O0B#E+7XKQ6LN)R.Q Z&+881
MF(4,+'^44'Z$==_0\I)PF'"8!@9 BC4AG]4$T.3(\9@9937)P^(4A^9T[W&]
MFA!2)=>FVV4U2Z+1*M6O>!BGBUT7%]BX"\UMM<P!U<H*4R0+PHI]^>8\\6CN
M8@#JV?S802XE\UJIF_ F-WKU1<F@3C+$YU$=DEX>H5T5?Q6H?<A(:9^C.5R1
M*S1IE<5B1&1648E"=_#$%[<D 3<$[H&&SK+=VZMQHH]$?YF$SWQCI2X\-J ;
M=C_ZD )F%2GD*#U42+B_SIF;CRNB*M6HX.SCP!-%U_B3=EO?_KD<JR*V-XB4
M)M22COX#_X3[*VE*&Y@B6-YPEK0;FYM/Q(7AV7O6O!<\]]C7 _4V!$NI>N%.
MSLMC\AP?TUUDJP^8&J?8?@3S"8MB]\_0 (1$*#?2!_Y(Y)_M(5T.D%HZ+]G+
M/^.S![6"2K"*WFE?V5V7)!+CUGRT-!6)R8Z6OIOK7CD4JCT28ED,(&^)]5^,
M+Q>> IW>UF[I$A-72+.F$+06 -XDO%FO%7!#J83V;F@I&8OVZ?_4Z(&@B<&V
MQ^M8^$Z<"FCK;% YAK7D?^%/ /*9-B?6C\YAXVZ0'<ZWKKGRI0MDMR8Z J2-
MI)01&^_;B_;VW3")P[(@U"RYA8FY2G,]A\#XGK)3X4&HS<O<W@HL_>3C)995
MP&&.HOR[E-ZW7@_%JF[.^&"N[8E$-<^>'4D&X<7[A#]'6K_1OZWCP7E_68WX
M(Y0P:5(JIAF"E+-D7',7\S*",NPZY++5Y[T/:,EL30G;]?OE]=:> !D<>)BL
M3/UEH8T^(2$A-7N9:/-$<91%*P'6Z2T.^[87=$3M>JQX>)M" H,<&NR" A:8
MSZ4I,*A#+@ZRXH'2^#E7H_;Y="1^VK4X3X"0OP+5T,G^<DO0PQLU[#>2J:98
MNA+/&G.)":KUKZ8#CHY]UVL=7[YZ[B=Q9KM#G3E=;*@:K3==W[AOS$X+1;(4
M$$/0='MIW\H'D SO[.V*[H\#XW^\OS'X;:USE]J!U?YIDOTC_Q. 4'PC[LX]
MX^N0HRZK%4M?VAHG!8M# 8>^J**8<\OJ)#YF"-3%^QF !QEPV=+$=>%CUWB/
MXS53+-OQ?"<L#II[F^)J],-=WSUX&P5-^5R!B=B7Y@1P,(1,G7Z"9VL.TTQ<
M[;IG20]A%MNO<QD9U^MO/8/'OSA7*>+/Z P'VW?'E$&A<QJ)'W63ZI6XZ7<+
M9;<X)[3@Q.@172++<TIYU7U1003H$1S,]-ZS+-I[UTH$](AHZA< _R5=:#8!
M'6>^ HPF81L6'Q[P)V![9IATO"JA<&#%84OL^8$SP[F1&D&N<G"\*[C3Y+Z)
MBP],TH&S>"IIIA1 WJXX;:"B$T@X-V8%G-S@XV)#Q.)AON;$;5J _,AQ*WG=
M/AQQ8RSS72I_9-0?%,('[*+<3D!)YA$;2]9!UMHLN57MNV.WB+63-$KJ7QDV
MJ+N\X$UJ2GK#SZ9;6  *"A(UYZD,#&05LQO=] X(DS[ \$=SDIP?"50CSFIH
ML9]8^K#C]^MY=FU9\E[-M R<=#AA*@Z1:ZB#X-T_CY=U8@>47%U=;94\='IY
M'%^*4CZ;+US_OH=CJ_M]](-W)-&6R$A9N_8BJZSL"+?1(3^-PYJWT2$#![C8
M2$T[_3Q[5B)9O %<;'$INB0R&^.JTB4IV,)LW5^/I(GH2&%L8%VLT/S*5#_2
M@!OW!" V>A:8Y_:*4Z8;#.G1F8:^_I=W1,,M\R'G=E]I] D "F LN51UTVH7
M.PMH AL14X6JY.A?1-4W#+F*15C=4/LDT4)(=\S1)EP_Q=5\6CV6W5C?+S!%
MW#X!X)U$]L6JWS59D>]=*YM-4^5U$4J)U,-4TW[P3JYZO/8N=!>IP<N[-TT3
M*G;^YS/NI8]C/(O/U*N:.\R\!$]X%(L44UA"A%+T?.Y3:>)S6T1->NUP8,I!
M+N2S\F1[X^:/NV2="[<#116>P?&89O4AR7K^'U/=KM_O6!H)_DT^B5=*-]>U
M'8@4X=X<1*V!D#=1NK?RA;XNG T:ZCT.VP0@?[8I^>R,U \Z+_&"7,U6*JO4
M!?T$S@8VXF;:/+RX3J1';=QVQ&<__O!V-BJ:8ADTC&I/%[#<'(Y8CT]EM6 >
M@@Q1+,6S7C=9'M+F=8;4G929PVW6]#08@MXJT2 X1&UT%!6G$@5@G'WEHPF$
M/WW23K.[5D0=]XU?A26O$5]O;2G-+EN13EG-%NDNQJQR$*HG\&V5*:')K1:[
MH@WT'D]T38!*A6>F=+ S]LK:3%["B;"NE+M>$YS-V*UC*#W;QD8_'@N6F6*5
M%A7,[]F)E%I,IXG9YH5\5YZYRS58D"/)0FD$%&2BM;#%:ZD*:. PK2XJ<!"M
MM_,5?MJP-UKY8V;<N5JQKB,6IPQC8X9&R]2"Y#> :JBE@__0Q8W6;&2?O^(O
M?@=S"$/=$-@FO&9?LE4@]Z'@VW?UL>2.7\(1_XBL'/%W[%9X[F4[]W7*I$H[
M8CM2;XV^52 )6"-6#&R2?0(8_T=!X,?9Q*J>ID@=D>U72>(3NJ \PGR#X9J.
M9P76$J+G_X=EWZC6Q5][94"^I)SRI1=BLC-P_BC?PS(!O:T&PFZ@_T%X7!Z1
MF!P6OGG6C?UOR=!XDM?L.XE^*&9,FD6!)!P18 XP5^()( XE,Z)G1GIC;$LZ
M0I'7.B?\Q_9#F]9O@Z9C;<E#;:6*-6:F+8DSXYJIK?=Q2OP*3IDOIQ]0\^FU
M@CZ??'NL(Z>W5$^IT_$,737>91D,,FRQLF'^@^"LMA,L@4 .<D$QHYX[5U@9
MR=@BSK$&0#:'^(B_EBTTD.16RC>19AQO5\"0+"'SB-=5B!9W7#338YVS$['B
M;!:HJAVE\A&&3\%^1I/_[0L]7L?+8]A@AR512,)KJ@[%@54?M9U&5 #>/^[,
M_94/B/,_\+%%;W_IA3"<[#Q]-KI:4,[!=B535P,4N?&_6G$N!DP&(FXH=HY.
MW5WE5*3-%J;H[B]^F9+>JZYN)&:.C8,D-T,M*@5W8RXN5TL;P0J7/ZX]P.:W
M#.?+5;BF;$ET$&_:T=/"7%O4D;\]&T21N5CKVR_UZJ6HTK4?WE4%AUD[7\HY
M+8438#AP''<>JU@%K;5G_51ZC+()XC^''$<_3E006BN=%R3'(%=9-E=)IJ(]
M[2*$*%4^BF@Y[YF/-_S58@_R[-ZE<43_0J\JMW+LOMXP'U\(IKVI3L5?D'>X
M'8=E*Y\$09-P-2@& L%<TO/E6)V7"? (0CRX$*V967O64,L_\<3()H_EQ0#3
MB]33H9"/.[,#3X!TVE:GP&Q-HH@1Q:[3;"-9GQBGU\W)PQ_\O>U#Q;I3HQ6'
MH#Q> =M#W,(T;%>BM3E"0!=!/;]".=\ 3>+YE>OWOP)A@NW[Q$2IY!9.9NKZ
M<][_I%JW>2E2/?RW(X>*HRWNNT1#6V5.)33&U8#=S#V5-H1#56^_;_&_^4U8
ML6@50NT#)9S#_Q1N-;V],5C;/F_RSOZX;-Q1-;2C.J07KM"2-Q()MJ)[ESS2
M#-T?S=,'<;-$)K#URT:,6%U#GH,*N AM;*J+K8)S*P37%S/.(DNJA#/^_YJG
MA?\!4$L#!!0    ( )"!A58GFZA05N@" #(Y P 1    9S0X,S X-F<Q,F<P
M,2YJ<&?LO0=4%-NS-]I#SED$)0Q)).><@^0<1! D#C"DP6$(2LX*2 Z"1,E(
M,)!!@B1%@F0D9P1$@BA)X!OPZ/&<X[GKWO>_Z[WWK47A=/>NO:M^5;5K5W?/
M]&I/1D]F "(5!64%  1" =T!W0& DW6Z("U;& +F8@MS!O-Q<@/"LLKJ:&@
MDNAL&X)U_FP"AE0H (#\1X6B!6#!X8(\?+Q"O%0HZ("T.M02#G.!62/ !C"X
M%9@#S,W#:0[6@=I $ @H6 [FZ.R*@#K9@)6=+#F1O3S<'*I@L#S<'"F@;NZ"
M@'P'93I#(?JHNHOM$@=PNQYNH:B&Z/B<]8F>]2V>]B,_H+,6KC,<ZH30=$4@
MM2.;Z*<\+1>$K@4,YG V0MD) 8$XN3K^.#[=RSG 3]N$9[*Z4(_3$;)0Q*G,
MGSHA< US1XC>M1MZ/\&^"VC!83!K70C"U5G3PLX2R<8#M  X $/^60-@0!>
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ML]5T];O<:3I+;0)_\HG/#D'?JQ :V5GK=$+1SMJGXP'RMW\$+!/YL4,>S@!
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MQ^&]\>HR.\VC8X:5PP0[E@_)O=5U#!_9W>)YOQX\8/C\4E6QHG&9C2@YPC:
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M>5KG)2UA3J>/)4"LQ+G^PO]W022..?)4AESUDM9PF"/8W-G9 6II?BIUNDS
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M+F0Z7L A>@)<[]?JZ[,[[.9@XKA\,66XL)#EH74%ED5*6@Y=I:$C'7X6'0L
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MV+\S#DWFE(XGP@;/+VW[:M-.]J%*YB1U:14:WMRNUVA.7LQYP^57]#B6,"7
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M<^32C+_@\'%4B. CM"1=E92)8_Q^DN<^^O&!.. ,OIWEO OQ*8AFG0"3)CC
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M[+FEU!B_7L25K7V47+%\<).8,^\C9TA]EDI.U7%;@1<)KBTZMA9W< )*@F
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M*D.!%:QH$=Z\WM] @ZQL^,-=C"L',,5F[%QU>;)GSG/L3N,'LU_'55?)"J&
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M+6Z HA2CN*B2 D$J GP1.!T;3K+I91:"6'*6>!(:"&%RP&M\5C.99&8X@E;
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M =OK?1MO1\.9HZ9QO(!4,D20?I' _0"??R>A0NNE *50UI<:^@ZP#VPN36+
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M1])24#++#%!2TC;U*FB2T('H>D[ DD%(5] 4R.@>>I5K5:M13BH&$ATDPYB
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M,_Q>_P"G'TZ]R#5R>IQAJ?\ ZM)U!-P=].GMC-*2G 6H#/RIA('Y0,1)^O\
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M2K=,E!2J3,$DC!CKF'&"DYE8IET\Q(F;]';5XTEL#TGYPLR1)!<AR^G3OHP
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M 3@1P8',_P"&".CT9Z@L<O*E]0(<^C'U;;7"_,<+SV7 .674"R2_(272T_,
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MU$)<7=GVC3"<@'!ZTQYR6!G;NQ8Z6PF>9=VDI,"8XX^LX(P"?;D3[Y>0==F
MMZSUM@JA4-%:E$P4D .3)(C\B]^^&.L95M/K2LDRDP3$1_LS'U Q',]'TB/R
M[@ -,3^4WQJM-&HOG4@29( ?27%WEM<,XHPKU(0!(D+@S/M\P$XCGCQXZG^U
M?#/PCS%2CS 1K$,>C?(3.)#RE)Y1RA(9P'$M<%K]2=!C.L:IK-1&ZW-]J@H:
M5LEY^L.VB6Y!4AN1"RZL0$;8!)_0D)H5,R$E!4&N "WJUFN9WZX!J A[Z-('
MR!EYTDWF,1326/57=RI6ETU5GT>%#92)4II-<P%84\I)2ZOU4B5(W[!)$ 1%
MD7Q/+Y3(4Z+ 544D(46#\R$@&;F>WK+A+J%R.80P:(9VTOK+]#?%EM-Z0L.E
M;<S1V>WM,>BA"$!EA"0D( 'RGSQR<G$R9ZH6;XK6S-4@5%* <!BS))(<L-S^
MKXA%,%146=C)))+L)^5I>YPZ*FF 6H[4N8 42$IS!*AX S,1[D^>EM)%7*+:
MJI1)(#K()<]VF6;IK@\E*0=2SAA>&!'][N<1SW$[D:8[=69^]WZN%$V@DTR%
MK3]XJW D#T:1H$*4'%':@P3D3(XLG#O#5?B2J>:0"4!1!/F*;Z@=P#U<=,#G
M.&DDDJ8@?KY0Y>-9QQU[X?$/K3NA7URJ.YW#3^C\L4UE:?<IW:EL.$..7&"%
MK6_)*$E4*3@B8CM_!O#='(\-^*NBE/*"2XN>4;1+:0S=!BF\2XHJI6*4U#S.
M[!FU$.\ _P UWV #=0O@W[64_:[LXS</NK?]I->@7ZXUZT*^]BC]/9;6%+7,
M(:;6XI.T $K*B"22.1>-N*?&K)RV6)0:?Q0KEC[Q3RCE#NS$,2PEM\392F5A
M2UN>8@ &;7F#: PV+V&+8T%:\RM/H!"ZBE9:5]X?CY%+)W+E4A2B,%2I41 !
M '7.4T%%C5!-WYB03>]B/:-L-:=*# %B6+M-I,^K:[AV;45[-34)IT.&I>2K
M<M:U2EM8 ,"8 !DP<R>.F=% -,!M6M AP[0\;Z@[8.I!*  S.7$G4V!O?MN<
M,Z*G4A0V^Z^BE9*E  [0M*02E), E04 "#G'Z]2BFX8^@%H],'TUH! "0-7=
MIVO$ V&NS8VO5M?$O5*UA62=YVJ/N!@#'&)SYZ]\-"05-J01J/R?0/OMC57-
MS%@&=M1ZQ;\YPH#0J%I=0Q1!84DEP >KR)^:)R/ZGQU"NJK^4F]VTMIW/1Q+
MC'H#N[ /O^+]^D8<E%3.T^FB 0HA, J(5@0$C=/ !C/M(ZC%<WYC&A:1%GG>
M6VZX]\<7=Q,0P-^FC;VN--GHT[M4IRM:JU0$E*"ZZEL<;24H4D*2DYA6/>1(
MZVIYKD6E1@ EW+B7!VW=SUQ$O,)4@@$2= !+O_6TM./R&DNU2*J@=7:'Z5*F
MT*; 2Q4MD@J:6U!:/J0"5;)! ^;/3"HM-9!4  207)DO\A-^DX#70"[@&[Q,
M/UD;;C;!?1HMUQI'EW3T'45%.JDN%KJ$ARGJJ7*'-R%$I<#@,K"I!Q&9ZSP_
M/5\GF.9%50)*0"%6#EV!=QH-1V+!9G<K3"4)*0RN:Z22[ "78?>8VG:,>=WX
MN_AXTOV>[X:B=59#4:4URX+]H^AMM,H>FPZ NX,4X1\GIHJ_6;V$G9! A( '
MTSX,X\M>6RZ5U5*)9A<$,--9#V ]7&*XOA] **Q32"[O#B+20[Q.\1#4AU75
MZ5I[O;Z*V::5;V:5Z'Z5YM?J&3O"7B25SD$_-X(_*_YFHI=+XZ7 (=Q%@+,Q
M,@O:^$F;13%9:>4>5G&L)%Y($6G0^CAJ"X7=:?O5#:&Z73IID@,FEBE^\H3M
M+K:MI4I<@2=\A4_ET#DZM:J2GF40#]TBXF0PN[:&V!@BF)Y1,@V:+GTZMW&
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M8O\ DWZ[8V^T6(MI=O=I]7PA50C<5)0<QG(\?K'GK=)8  * F$@-?1QC<5W
MN?<:]"/IA0EE20 $@8$X//UQGK(YNNVGO]YGZM[X]\8[GV'Y_3&"_GDCQS[
MX'Z^/R_GU(&8R?0"SC\6_K.-BL$6$ G^K&98]#?#:^V0O<2>??V\?U]N/S@>
M8-!]#WT_+OC(6Z0 (9OI/=W]^F-76,:XV(420F3' '@'_,]>Q*E0/-S $<I,
M#6&-]L8/MM!QKU-H'S&(D* R9QS'1-)2E%@6.@%AJ+]C8XV2M(_E >SQ_3Z.
M\' CJ74EBT[0OUE<XVXH)/W6@$(?J7D9"409VJ.# /D8D2WR>1^/4"UDDI9G
M#^439@Y)) QBI58!*2P(<@6)W#W:0Y@8%M,:,U!KY8NNM5N5%I4H/TEC,MTC
M+!,L*=:PEY01M,J!@G'$DKB'$:/#Z2OA,E0=B&+%K:ST#;3A?5JE^8$Q+6<L
MQG9X9MVZ6!8M=';Z)%%0*2EIA +8;2&QZ82 /E&!( P?'@1FA9OBE2N2LU"2
MM7,;W)?46 =@;:M@"FI2U$%WYB'-[O!F7=CI81;$*4A(=<6H(! 2D&)2#@<9
MF8G$X/@=>R=77X8>/,Q)<D-V.I>7$C<U%!9:269^Q:W4!B+CLXQ5SOW\0VF^
MV%"[04ZQ=M4NE::.TTYWII]P/I)J@#*2 4[BL2!SR>NE<&\,5.,E-6NCG/E(
M!%R#T!@GT8-HQUXGFJ=-+4SR1<%B2!HQ9S%GW<0_)/N'W$U7W'N;][U;6/5K
MY6?NUO#JD4EHID#]TEED?NU.'A2@"1N)D0>NQ\'X?0X/0I94Y>F5%3\I#@W+
ML=F>]K,<4_-YRI40MED^7L2-7C=H9@69\!7;#2%;W$[PZ%T]>7-VG[QJ6UTM
MQ94^II:Z 5*5/)2H$%1(&T#DI) (QT9XAXC4I9%=*D@4T%#A*0P,*_+J!T#X
MJB4KJY@J*N:;_P!'W$N9UZ^G4:6H*4L4%JN-+;=,V2E8M='3JV^LJEIP66@@
MR9*/3(5Y.)/D_+^94K-<1S2J@'E6&>2>92B26/\ * P%AZXON3I+7E4A+\R7
M<R;@,[AV!Z]H;#S<[-:J.VLO6AA-[:21]^AW9482=B @$%: ,RF8/GSU!6Y4
M*E(+ N(ON&!;6[=09;:FFO3J$+6>5PPT($7M9I,[-B,+BU1UU1O-L>MX:AQ;
M"V7$?>4 PD(6!\RT$?-F=N<XZA2L+<H=(YF(%B6TG5^@AR<,$YFF620"IKR_
MN7UL^^/SCM-6M ;5)2B VB20"GY=N8)( ,@\9S/6Y*P0ZK"#=M=GAO3H^"J:
MTJ8  7,/IK8OV:^&TVVKJ'4J4ZTFG3,()@@?P@CWP)CG^9,BJJ.4 R0SOJ?=
MK]6[X*)2P#.0+A]-)ASN3J3A93-II04/J;"ID;,$X,#WSB(F<B.>@E<JG  ?
M3:39NQ(+VL^!E<PNY$$N=/YK.+..Q],?'EI]5*C^%2DQ).T?-$QN,?[0_*?$
M]:HHCR\S$/-QZ'Z&[3C3R*A( -HT>VW1].@PJ=O3+_[NF:<<:0 W4DGYCG!2
MJ1 !B1^?UDSX%&H.4H2 6G6"X +1Z"2V-Z&5:JA:DCE2[B2"&^8!D=GP#:GJ
M=8MI=<M=&R]1(; "0HEP ^1$$&)S]>FE+*T4@ J(#6YB)V<!GT!?IK@I24!^
M4 3N':;C<?K7#CVZU=<[C55%->K($L4+:PXEQ9;<=)E*$AP\;2DF28]IR>IE
MY:A325)0E2O\QNF!:!<F=RW; 55"*C\R02E^5PX<ZN-V&AQ%?Q2Z&L>N^SVJ
M*]YDL:MTK27'4&AKB$M5-59W:6E+C]M44%:ET%41ZA0HE/J+6$QU<?"?$:HK
MH0*B@E"@$I<  ,/+;N7M#D$XJO$J2J:U\I8 ,P)+AX?31Y!V)%L>=9BZ6QRK
MKKK?K<JX7O<5!3@*6GZA("5$M0("5  )&V (X,]?0&5S1J4::%.H$""(<AB=
M6DN6?34XJM:FY4M4DDR?]V+QL=)Z C 1JG5NH-1;:1RI^X4+*@&;;2(#+" #
MQ\J0"5&2KZD@].,G1!8H0E)58AA[ZS\MB<*:^832D0( NPAS!]R_3$>..*I5
MK+C_ *RE25)<(44P?PY\ Y@<8B1T^Y E"6 )"1%R3J6#_G!M.$JU_$4M1<NH
MD>I!AM+-J#MCXTVFYME%/3*JWD;@E38DI*@8!(@B">0)&,#J!2_@R2P$J=[)
M()N)UO$:VQ,: 4E0Y0ZDD)U+FS&6EN^"C2FB+;2W!+NI[8]6-U(2FGIPM2RE
MQ8@**?I,G!QSQTMS&=15(%%2AS6:"6^MC!?32Y&3RZJ:?XH2HV+=GOU.PCI;
M!#W:M]FTO;*+3U@9;9K[GZ7WE#2 E]AI4*4F0-R3M$&8SSS'4^6JK04J4LM+
MZL\27UVZ$&,;UTH0%$@:)VO+7;\==L--@M=JI;8RVBE0]ZZ$AU+X*G''D@A1
MX)).8Q XP (QQ'-M15R*Y2;\K_B0Q<=Q)WQ[(44KKH4$#G)#&(<AQWOH.F.J
M/::V*N/8FO9H*9+1MM%ZU2!N*T-;5! 47!\H!F D0(.,QUR[.+",[266YU+)
M),EPQT+F"SP[G7'4LDA5/)U 2KE53  TZGU G\@,<K^Y++C&HKQ3..%9<-0$
M;L^F3O("?;.?K,SUU#@>;4:2!S2>4]H$"[::!^V.7\=I U:A9RY!TE].WHP8
MXKQIE90Y6H4HDI&XR?X@K"C]<?Y'5CS 4I',2Y)EXT(8;N- &WUPDR/E6E)E
M(-K";QZXLIIQ:54KW[Q "@)21D I ()CP3^8.('52SB2ZS_O*OW_ *;:]\67
MR*2DI%PSZV;7:=XZP(C[O.TMRI[=2FJ4LTJB2FC0Y4K&1(4E )3 !!! C,#'
M3;A57*A*0O,(! #AP"(=F O+,_6'&$'$C442$T%7 YAK\R9 ]9?$E]O_ (D[
M]IZBTEVZ[/6IC1MW14TY=OCC:GC4W512PBX/,U$I]9 ((6I)V1(R.EW&^%T,
MRM5>G4*D-)!+D,S-\B3!#X8\$XIF,ND4>3EYU%()$@K(#--H@ -,B,&O>[1N
MH;MK!]&MM=:@UE>7:6BK+I<:FN6[1NUK],AQWTDAS:EME2O20A V@) @#'07
M#*.4H))*$$B74F1+:SV +:8(XG3S%10=:F(<CF+$;BP: =]3KB':70]-8'B^
MNWM5=*<DK;"W%*_AD\@ !7UD@3XZ89WB@.7^%39)200P9G>T1^0+"V%E/*?#
M6FHIRY""[R%&Q)DVO[-@[HV&&:;[S3-FC4H* IR-J%((^4!/)@Y.?J#T#3Y\
M[D\PFJ2I*4B"27A0FS -IVO@A66HTJ](HIA*B;I<3JQ)[_)\=\/L^=4C4/:!
M%,XH%RW5;E,E ).TH3D9))Y&,C&0,]?-OCO)BE5J*;[I6$-< &6,,&VDZ0'Q
MVOP^QR"2W,>5,DZ-RO!8?=N]WUG%]:9U1+B7B3!5L!$&!Q[<3_O/7+LL>:G4
M*G)!(!EWN!V,]&$=35%1JJ#P/I/].L]<?GH]+<#)!,'] >?//.?$=9RY*T.;
MDGY*4!$B&#8)$D]0D_7"5PDL[B221,DG_/CJ0CRDRX)8N?\ -C.$_6CG<^YQ
MMS*W^F,5_A5^7^3^G/64RH!1)23()+$8V0I7.F7FP ?"!=*7IS(/.3!B,> 9
M_6?RZ):B+:%@&&GK)'M[C!CNWE(ZQ\V/U#XVIMB6T[@@!7&  9@F1[_KU'5(
M4+!P8/3Y.^S1?M'4(2D-Y?,+/J]W-M'^IQ@=R7:>3,N$0<P DP ?; /_ (1U
M-E?Y!<@W[_U&)N1"@2P+I!W!/FGOCTM]F/\ LD[;?^Q.G/\ W73=?HAX%_YF
M>%O^PN&?^%I8^*/&  \5>(0( XQG_P#Q-3'&3O?VCU;4=T>X]SHFVWFKCK'5
M5Q9V[@H,O7>K>;085@C<F8.5$D@$]?"W[1_#&<5XM\0YA"UI37XYQ:LDA1'E
MJ9_,5 !%F5H.H),8[5X9\3BEPOAE#XJ *.0R=$@A,?"R].F6/5N\:OB$:W2N
MI+84-UMKJ0M*@#Z5-N0$CW*P?E&9$&<B/(H6<R6=HBB@5%RH)DFY+3!]=K][
MA3X[3KU$#F#K4$N"-3Z&;]/; S6:?M%8XL7"TTCE0#!#K8:=^I!0$^^9$S(C
MJ-*,]0(*E*+2[F1IL&VL=ML.!FT-%VW>+WOL'?Y89QH#3"75OL-5M$%)('W&
MO<;*7)GY@H[=AC( G &,=3T,\H$IS;KIA+CF/,RW9) T8.S=.N,#-^A9W&VY
MG2\,"WNJ:L=QI E-MU5<&2G+:*UEJK:1' 6H)! , &2?IG/1/VW(BR$L01*0
M'&D$:O!-IEAC89@+NTL\$PS0X#M!EB_L=*JWN)0K64.6N^M$ALAII5.\GV4E
M,PDG.! )Q[=8.;HU3R4$)3!YV !+LTNT,=?ICWV>G4=2H*9&ERYLVPOW-BZB
ME[A7.B5Z>H=/5S"&S'J,MK=;/$!13@J R9,\2??!R1K2I[1YH_%K]6>PL=@B
MDAU,&M;N;7T:S'M8DI.X6G*Y207&J8J!/IO(+;J-H"?G0<#&1,8.>>L?NQ%$
M?$*B9U/7>#W(UP/F%TU)8(#!@8$022["\P_T@BI;K:JD%='4 .2"E:% '."1
M&8C^G'@@=5>K0)Y88EGEQH8?]  ;805J)45!@SF'AG%WW&V">FNU6R :.Z+0
MI,%)E13N&03F,GF<?E.9:>>)*7&HUYF8@6=PQ^DPSQ5,GD:D?!0[$6:]K-UP
M66W6^JJ( )KV'4I,K2II*E.)'(D\;L <_IY8)S9203/+/F','!?NU]3[MA;F
M.!9&LA0II3S%*@DAKD$ @RS7Z=89>]W4=*@Q66.BK*QTI;:#;*4.$J(25R %
M?()4<&8(GSU(<W\4\O*DO(\I^ICW5;NV%]/@YRX^\IDP27+$=RPEM6,;X05%
MHM-"7J^L*D*JUARH* "IE3DK*$R/E@8GZCZ3ZG2H<W/62"EC 9^9WUZ.6LP-
MGP=0^(2*84_*':"[%G(^6D3)N24VF.V%X90HU3B5J;1O]=0!*R,[< DR#/(@
M@3[86.'H?RCF-N9+R!#08T<&XOOFKQ/,99) )2Y/0Q+@@'WUT.IA?7^@*>P'
M[[;*QERA<45-).5[2LD92!@#/M(S[]*Z]6GSD4@0@B6#!_K(:-OFWX7Q>OF4
M JDI7R/N  =;$NVW66Q&B&OE4K C@;I'',SC.8CF8]NH#4)=BSN8+0[:F8:S
M-&+3EZREI!5+V $?3Z6V8X2ELR8*HD\*$?E^G'15&H3323-R[S))GK@E2_,0
M"1 @.1;HX]H=\:BWDG<9GZ_X&)^OOGJ4!)DF3+ BY],:%[N1K%_H^-?HI\$Y
M_P"Z1_,QU)B?XCD7T'?O,OKOC-=,@H1*4F=W(]HSY_3'62?Z1;Y[MN3?O)3J
M K $2=-&)+,8&]B<-[E,@&( _(#_ (C\_P#(ZU<"\;?K]?5BN8@/?]0]C(L8
MM:7QK4P$I4H)*@(W$0-H) "B1F K:#'O/ /6% D,'?I<^NF-%52 "8G0?69]
M)VQ'VL[\FQ(^[4I9KKX\ U2TC3JE;%O*"4+>1)BGC+I$* !@\GIOD*(5RN'B
M20[O;<Q$SH6Q$JLY<AG@=-B 6MMN98/@3M/;&KNE:Q?M<5"[B\A)?IF65$4-
M'C<ANG;.%!*C^-0*B<$D 07G.('ASA(;F0[N?;?31YMMB.I4D\MF8EF+:3J[
M=!!!#DO9JE2E-OI6&6_NWI,H2E*(2=I2(!@9W#,GZ8ZJ>=K'/OYH(!%W=@"6
M)>=F][X6U*A<]W)T;ZF]X.-#[[-/3+?4Y3I"$?O2O"Y3^(*48.))()CSY)Z
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M&T[D_. !@9(D=7+@G'^(9O*@U\P%I(,.02+-#;/N\CI[B7 N&Y.H]*GR%)!
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MDC+U(=+!W90/K$0.FG7"M5KKZ,']GZCJ0B/D;JPA^5<@K_B* <DS$3UFGF*
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MU#U0XVR(0D!*2MP@2K:$I'G Y&TS<+X*M=0'^($DN()U(,F&?^Q;$%6O3<D
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MI:T_V;UE162N%"VR[;:^K0RI+C;:0Y$K0D09P09(P28E+Q/A%9"EYG+E3B
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M+>WHV)*:2GF<-W &\<P).HWZ82556U3[_46D--JVNK6L(*#!6.2"4PF5$?*
M,S,=-:/!LS7(0*+A3SSI22D3/,?TS],3 @)NP87OT.H?^N(8N>NW]5WQW2&D
M5)#:E^E=;TUN?IV&QE2:=:90EQ2MJ929SG Z:4LG0R"?XOE6D?=E3;ATZW8
M[G7$:EA($F==6T;TUZO<XE+1V@K-I;94EE57=JA:B_<*I?K.DF2%)*IVR0('
MXA(Y (Z XAG4<I""))"6&\"#W=]#B!=8+'*DDMT,Q-S9^PT><2& LK4%J6J%
M B8@ ^ !F8XP/$',"C5>==9U@! )EP?*[D-Z;SJ+8"J%7W@+@G3HT_([7.-+
M].E=2TW*RL@;6@%$ 2=JMP$ SR#P()QSL:U"G7I4T$\OE4HE)^\5$;3$?0'
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MU+NVA>';W>8])=LJR^:\:[?V8-_M&XUK.YX)1%'2NH0\Y4.K5"$--L.!8*R
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MR 1]>NR<)6I5"GSW4Y80+^_][XX]F%A)4D L^PU=_P!=;NV/MFJ"Y5-$&#Z
M5,B,)'G.9Q^?GQT1GLN% AGTL2QC8 -KCV3J2]G;J9[-,6%P3A3JM"7K'4OE
M!W 1  *C GCR,SDDQQT-PQ)0HI)L2ENQF_X'<'!695_HE<F0MP-7: ^C0HXK
MI9G5-W;U =J/75NG)VK4 )'!B9/CC'5GK#FH$?[I'RTCJ3UZ0_/\@ ,ZOFL%
MD&1K :;,VN.C>@-.U.H-.VJX4:TAU@-L.N) R&Q*92HQ'RC).(.) ZY/Q]9H
M5U%)#DEG?3J2+O?\!CK'!LF*U))0T:RY=^FY9NG=I.JKM<;(V6;I1 T[24E-
M4V"I)2D0?E3CW)(XCI73XBFO2^$MPQ=PTLX@/ ?5O4 X8UJ56A4^&S^4Z'L-
M!;I^;*Z!^GO%*W5TFT-N*4$DA24JP,E1!"$R(!41)D3&.M/LU&H?BQ-R3;4
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M)8L=.C1.@).^.>7<=-3J'LE1KJV6V:^Q-5UEN"&P245%O><94%  %*MJ1B,
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M):X+?FW;\:K7/(LJZA1?YL-;>LOCLM]F)<&7^X-+8*RMN-NM]YH54U4JW/\
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MK3\6>*5)4ISXBXT0[L'XGFG9V>+2=AJ,?3'AO/FAP3@R5*2 GA/#@'2ULI1
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M((EVFWL^&*XU3]XK%5S]P165#@VJ<]9ESQ$D#YC',C/&2('6P5F%*2E*FL!
M<OH;!IG7U<X>Y?*(R=#D2D)80X)(V8Q/?4Z/ABJ*=\ D+3M!$J(QF ,R3DQP
M1[9'4OP,XIB&(V*8(/N''7\,3TR%D!3LY</+@&\Z1?28PSK+C+B%*@)4K;OV
M*$SF),C/(@?EYZE32S5/S5$N%,D#E )?I/T^6"TI0D\S.2&\Y>^C?6^'N04
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MMO3UUR\VWO/*EB5!1$QN)D9P<<@CCH.IE:54DE):3$/J&:[]19FD2QHU*@#
MNF.I#'MZ[P/2'M3:05;5JJ*$J2A04HAF3Z8B=VW() ,Y'."//02\K3+CEG4@
MM(#-Z=0VQ;%FR&9YO*KE8$&1IK'<?H6BMRY"BKRW4+<<04!O>M,?B,JD$;3!
M\X_+'0J<H/B)"1+D(?0W/7TWLS XM(105EN>Y!L"UR ["Q(F_P")PZ%286X
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MM8=*3\JIE!A0A7B 09 @S'5KX9X'X:BJX0.9*F=2]06CU#_D[875<[70 I)
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M8$],.'\:*U,6+D3[D]')>+"^,\0X5\!@A1!46()@EH#W!8W9M-\0%H7M=?\
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ME4PH\F.3B+SE?$6;RM!&7IIYRA(2IU%QRP#JY+F&O+WQFGQ]597\2BA/('!
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M(0VCM9HE*$@R$I%@H0 # P!].OHC@"BK@G"E&ZLAE2>YI)Q\M^)D)1XAXTA
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MA[WT^&#XT^\?<_N3<NWW<O2]BHJ6CL/[8^_VD/M/*VJ);2EI8VE*]A*E))3
MDG(W4OCW"E<&H**2#R)6HNX<L&+,+L0T@,VS;J\.Y9/\Y#[D:!Y<DPX&D-L
M.B%%W(0I;BU0T'%EP(0^ @;DH"0"3)40F5"!M($1/7($<<S%:K6 KBGR+  <
M$$'F%HL0\E_;$*^"9-,A**S@P"ET6V&H%@3:+85O]R2&:D-U#J1Z4PEX* )F
M9.1G@9R<>\$GBN9_Z4&:[IWO>.L'8!F.-!P3+*ME@9Z%MW#=8V'0X'+9K\JI
M9=>7N+I42MP[B-RAF""< 3F/[NM4\4SCN*H4-R0'/5S #?C&-U>'\JI+_9IU
M@ B8D#4-[[3@@:[@*AL*="T>H"D!S<0DD;21NP.,G ]XZ)1Q2M<YH M(@ ,+
M#:1N8O@)7 :0'*,J;P>4F'@ @AS&LL^%Y[CU+!!15J)QM <2<XC,^#$CP)^O
M4?[[S*G25(:Q=9<BUN;1WBY%R<#_ .$Z9!(4N9:PL6#,[&T]GPH1W(N#B%'[
MY!@_^D;3Y^N9_P"/.1UD<5JN#S((U'.Y;4-S26M&-#X5 22U0,">8A02&N22
M& ;K_3<SW,K@0E51O23D*<21(&,R29C/&>MCQ 5#YDI DD/[%R\>A[[0?N+D
M8!9ASI[ZV[!NN-CG<12Q#Y86D\)+;:Y/Y*(C\Q/6HS-"GYPD+?RLE8)8S(9P
M-/7WF1P1=4LFLJFH>9P0>8C0P/J,)$ZFM56EU#]LH0%?QE+:9)F3\I,0/!C/
MTXU.<RRW!I@ _P"8I!UL2!]7;! X5F:,IK*7:"&(Y=CU>7.!JK3I"K6I#U'3
MM*RD%I:TJ@DF0I(4D')R23 GR#U M.56H*!2 (;G$D&Y?]1C= SZ5 @KA@ R
MB  "1JY_N#MABJ='Z%KYFHJ&5+@0'FR.8PI8!]@?(X&<];(RN46"/B)!F2M,
M>QO/S?#BAF>(TT@LKRO)! $PQUAN\%[.,5>D=.Z<=JJK[PMVE!:^Z,E22[4*
M 25+7MDEL*)02D$  ="YBEEZ*N1*DJ"0)21K, 7DGH=CA@,UF\R0E0\YE2@#
M8!H<!ND[O&&"MOBZ]9;2V6VFRI+;8<2E*4))@#V@")B8CF,K*M1!)9:1+21/
M3H[2)F"<2(X=S?Q5D)5_O>7F)U#M[M?Y:FK:]6O(9:IU .CY"K<4N@P"4JCY
MPGR08'G&>LT<L*I#%Y>"3LQ^>NI[G!515.F_\1/8J2/F_P"I%\/M/0V_3957
M5X0_5J_=MTJ2D!!!(EV22D"01($F.9CHM.6I4V*EI! 5"E)]0T=7($C1WQ"$
MJS'E0'2074GS >T7%^XO@4OVIJRZNA+KJ0R#M9IT&0!&!]2!X@_X=05:J:8<
M+20-E N\"SVV/SP?E\BFF0LN_9F.COKKN_0X8@DN&"%).-HB25$@)$9@$DX\
M =#!:LP>1C$P#H]P#H"XAG86PV&912ID"&%XT)L0?1Q@OL^D[K7I+R6@TA6S
M]XX@I3'E1*@!M3Y/]<]%4LDE+A19]"+7W(Z1H=B,*:_$@_*E0425 @*!+[ "
M=;:^F'6LT.S"377ZA:(2!Z3;B7%0)(6H(4=IY'S1 $Y&>BAPJFHBISAP& =/
M<_S7+[&PN;P(JUJR2!26)_F! V+0>G32XQB&:'32"^C4%/4-MB5,I4H@C)VB
M"229X\\B#'4R:::%B"1+%H?\@/9])P.K*+J$I%)2B&%E$O>Y'Y[,S'#$O5=-
M?'5TY8*&$I*VW(4 9&!*H,D<@\>?'6OQ2HDPZB2=P?1P)9B\[F,34^'J0E(4
ME0)9^9!#_1O9YUG&@,/(2%H"EH()! "@ ?$C.9@YD<QULE2Q9)+"&!)WT$MH
MWX8,&7HPY 8AWB=KO']L.5H>:=K&Z905M3 7F",@F0#/&($1C\NI*-12B'@N
M(F9LU[_79\#5\JD<S$*=_NM)GVU:_><'MQOY;4U24K2%,TS24)2K(4KG(&"K
M<<#))XY'3BD@5$>=0!+N;'U[P- UM,)EY-2J@*@J7+E)  FY:'TML1AGN5-]
M\IVGZ\%=2^DP@"&V6@%!(/\ LJ,B 8F23T(O+*%4JIZ,(#B6<N(9]1:6TP1E
M<V<K6Y$,0 0YZL"Y!9P&, QKBL/<+3.H+"LZ@TD"Q<VJ=Q)_=(>2X%*, H<(
M*]LDE*, *S&.FF4RP74IBHH)0%,2H !B9 )C1@_7%SRV=^T4?.0.4>20"KRR
M Y[3?4=*4W_XA^]V@;PVNNH+?J>P!T"ZT#MN33+IJ92X4^T^E1*5_B  21*1
MF00;_3X%D:N3"Z2TU*C?=04J4"P'W7<_B_9@U/\ $YB%@27#@ DW<@-N!9@)
M<AK8: [RV76UO:K:9!8:>IT/)IZFH2IMM),J0VX=LJ"@H>G)( )!B>JSFN%9
MC*5O+1K!#!04:2PQ+B3R[ LVTV&#J-0+#<Z>8%F<$F&$ C<R+F['$T;Z355N
M33"G"6% >H\0/4;2#A:)$@*(D*'XDY!@SUM0/(4_$9,3S0 =!\N^"F(N"&$F
M0!J\_+IUPS.:%M=J+(H7GJE*2:A:7G5;@D@R =I*4#=/.V,3'1B2*Q*1YMN4
M\VMP!&C;3Z8AS"J?(!SH!:?,Q&N^[==W!;%-/B:[[T=BMET[8:6IS5UM6U_S
MY6M0^PQ3C/W-I;04D.K(^="CO ,D&#U;.&Y0\@<0XYG$1+OL'WT+SA!F*Z5?
MS( =OO,38W'0.]A8F&-\OA9O+ET[+]N*QP% 8M5.T1)$*2%)4@S_ !)(@I,$
M$CZ=<R\6I-/B)Y$J/G'\O- -X!  N\XJW%2#RLI*FORRP!W'S_IBTMT3ZE&\
M?42TK<K*R( */()&8X^I^O2+,LL(YW2&DJAB&U)! B^XTPBHK^'4"U))99/)
M=P3%S>=C T%J(=S_ -K4.O*FIH*NLHA5M,DJ9JEHC80 4M-PH3,[B"($$^Y_
M#,\HJ10^&2AW"@DD20+R)>98&YEL=)X=D<OFJ"5*04N 6 L6L?P:^H<D#GIW
M*^([OEVZ[CWBEL.OKRND:<"T4]2XEZG0)P"%J24I))"0)"@!YB.L9#PWE%(1
MF'YRM 4I*0#R L05$,Q;4D/(PGXEPBASCX8))4H$D.#) 9HL7Z'WQ8#M+\;O
MQ27RC0TS8:/4D+V;WK:\VTXD)22I=0D*R9_$%;8R#R.@^,_N[(T5I24%0$H*
MT @B XDB /?&*'#4"FEUV:2[B6%F8"7!<^C8O1I+O5WAU);-FJ-'V2SJ=9"%
M/4KSKQ0IX?+\CB O?M(^50$*P 1UR[.<7R]8KI(I *=X\T'JQT/6+&7!]+(H
M34<*)/E@D%^A8QZS#]<0AKZH[>:%U-:-7=V6W*]A3JBPMBC0I#2W)3\R%SM+
M8Y)$X/CJ3@N4S>>J 9=12ZH !<6@I @%GN =0V#,PDTP E)5$ )/=RUVNQT$
M"<%?[6^#KN@ALN7*R4B]@;4FI%-1N@*R%KWN)!421N(E,\$B.K%FLAQC(^9"
M*JC<D4U&1V8C<6&F*X:N9YZC(/WB .104 \"UMX!#:"Z"J^"7L;K9G[WI6^-
MMEQ0"7;?6LJ:6E4E);VE2%P)4-O,'ZPOI>)>*9-9IU $.I(*%J*5D L2 MB\
MLUW]221GETW*T%#3Y@05"Y "@]@PM)+' C<?LS:2I)<M>MJBE82#N+M.BH6$
MK!2"DI(F"I,QXSP.K#E?&&8;SA >""OET9BXT9K]#+X"K<8I \WP2PZ#N))8
M-V+^L;-)_ ;0=KJJZW!-1<]0U5<U3I?>0H,L%5.^A]I:&TH4HJ2XVDB"# /B
M!TJXIQZIG:52FP!47)<D0Y > &ZV]F/H\?RBJ?(H($?=Y@# [D1K8=-,2]=[
M1?Q5KKZJDJ!6?=6:5YY3#P(IZ9HMM(4N!.U*1,SF >J%F<U6*V*3RN_-+:LT
M,Q+_ $Q-D^+9.M5%--)*U/ "TDL[$LQ+N6N^\XB35CC].M+Y;4M(IO3<:"%;
M'=R@"%1S&2 H'^>.F.1":PJ*4H%=,)Y4 R2= DN2S"UL76C0IYFDE0H&E\,$
M\W+!!%G;1BP##9WQ6_XD>WUT[R=J[AI6WWA%FJ&0:FF><8WD-HI]SJ6G"K:/
ME!0$@'YIS[=$\)\5&5SE*FLI0352746$$0'83M<7;%=XSP_XE&HP6(4\$&]^
MVF@@W./.'76^S:1H[_I>K^XU]Q%SJD-76XOI35(^[.K:@(<5PT! &,"8DGKZ
MDX3G*69-.JHI*B "RP&:!9V,=[S(QRC/\.*"M("CR@*\H)!YFD$"[0W< XJK
MK>D9I*Q)L]:BZ%2)=4P %,J4)VI*"H*CD$\@3[]7FGF,L0A":B"M@.4+!5[.
M2^C1?MB@<1R:N99FY^\(ONVNC6B;XCE%PO#M/4)"C\I*1A4C;CYH,3[D >9\
M'HY*4J;F9): IA /7>-P!H0^*RM=4$A*20"S@$VWWZSN'%\6=^'3L?W([WFN
MM>B]*LZFJZ%"JFI"W6TK8ITG:NI@RZEM!D>IM*9! /,57C?$Z?"RI:U4T!"2
ML<ZDI"N4$@>8@%VT:X.V+1P/AJ^)<@%*HLE82R4*4)(NP.IENIL^.Q_PT?9K
MZHM^H[3J74NJ::R72THIZ]ZUVMDN>BM$.MTK]4@P72DI,*"509@@@=<-\2_M
M*%>HNDFF@@#E=)"AH0Y@,T%@=1$''7>#^%EY=*5"@007!"2Y<- 9SH"+1=K]
M*;5IK]EZCIG$6J\&I=O+;%SK7;@\S27!%*VIM+B4.MQLB I<E(,#$R.69WCB
M<PHYGX!*E*Y>50AC)(;8@2(O() QT')\.6$(H@E!2.8\WE *98V,DB)(D%\;
M=1:5M%MJ[A2VI=57*U2\JHJVZBXAZEMQIED/AM;0*4AL9)4H$;=I,\14,Y3S
MA4E= ( _RS]Z^@E@X@%X<.29ZF5JH^[5!>Q)! U!=R;QVWOC]IK5=L"JJUT5
M:S<[=0(1;G'T.!09="OG!7)0K:1 ,R!]9Z%XAP7*YA 4*G(6*BDJ 46E@(42
M#<![$X'3F*E E*P5@V+,S0VMR8!8VWF4KLQ;[E9Q;@X:AY_TW;8H!*@BI9+2
MVG)R2D2L%4X$R>>D_#E?NO,D)+RPF\L+078-87[XE)IUWYP9:\:DS :3;4VZ
MT_TO4_Z-/B H>XS=&JL36U59IN^T$A 0_6,K::KFP!N 4M*5!9$*)A)\]7OB
M"3F^%4JA2KF60" DF I@=P X!.WMB"O0I%"N58<2P(!(!+L'!L;/WVQ%G?,W
M+56NM8O)M#[58;;45*5IIWB@T=.=QJ4K" %K2DC>4DA/D@=//#U"FF@4&HA*
MBB 5 %V,-<ZV'5KG"/-)^$"=B0QTF!MZ^[O%>]-W=]IQ":VJ><&R$),C>$B
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MO2+@4JN>L;]4E@M@!"7[K5O)@R9V[YSG/OU\%>./"=6OXI\25TK7_&X]QBL
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MM!7*GIF:>E89M=<EIAFF0Q3-EIE1:;;ITA*6DP 3$ DR1GI/P6I]HXH%P&J
M'K8'YEKR3U?$56G3I$@00'/X/M)UQQU:OM0U7AFY5AIV_O50TMNC:#JT;'%
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ME$H*R0+EW=M06;ZQ\\3G-<:4R0LD*/*7*@6+"#,LYUM@(U*[H:P4KBE+%;4
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MAXLW?!]*BI)8I@]';N_;YR<,->O[NV\[@I0VI1)Y\?I@R(F?Y].:"D$!@"6
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MS(Y_,Y_7K92$DS3%I_)C^/71L2"LM2"H*8@.03OLT_DV!=^H6DO(:6A0;!4
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M2I: ""4R9(@R[&\;'WP(6GN Y2U"$7NVW"WNK)#:JIIUL+4<@%9&Q ,B)43
M&!Y/_=%!;!%5E.[DC3HP/Z],3?#H*F&L!!(M #_3J6VEVV=Q5KI%H9=+*4P
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M+=Q8=+RQ8[6+>V?>BHM]2WVZ[I6^ITMJNT-EBBK:PD6K4;%.4H55T56H@*W
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M_9RK2%EN^-E(@B7"=QR,9(/MX]CUL"E@2%7W)!F &(/?5@\EL&Y<*3]T\MM
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M:.A^[-/)V,OO%)K7P3)]1R-Q$9VJ,#W@D]%U"\^P#P& ?:X#6D825\Y454Y
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M_P"<5/P-HW @ $'Y2 >(P2#,?7INHI3EUH"0YL6#Z1$ZDGJ1ALZ132H "6+
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M/,G0CLJ;_G+Q7+97(I^)1Y><@)( "85!-A 8?U#XK9<WOWCJONYIQ_LA>],
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M^-_\L<3_ /MV9_\ QJL<X^ZO?,6KN5KVTFA*OV5K74](5[D#=Z%SJF23\O\
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M,#%M3L).]VC&"=*:HW*34IHU%"24*54)(4G,%&W$'(]Y$ \=0? IJS"#55(
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MA<GIMAM^(2X$7#M4XN/4<N*_2/*$TYJ/F3 / !S_ "/3W(Y97%.!JJIA205
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M4I=R'.E@1HSZP'#G>=5L[M:4=KV5ITY?JEFG<'K4J:%#8>0XM*4@$DCY2DX
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MZ16%*D20"2#& "0,C(\3UZE1K*6H%'EYBTAX,V)+:V#OH^+;DDK0I/.&3#.
M20 T-(,7C N[4S@$&0))QQ^@F>>?S'/3=%%2 .<,R9L9&K@MV#0W4N\55  ^
M&>8D#3TF- &[[F[4_<6&E$*2)"OH?Y$#QQ[<CK-)08"9W>2[6 N;WG&X2J[!
MP>ATN'Z'YX8JYU-8YN2 !Q,CGQ&<G_>9]NF%)#J *2 7=QL#TWWUQ,H\M,E4
M$@1[B=".FIT:<:*8NM*V(Q)GD3]1@^?;D$>.IJN56I((2\[@&.Y=V8M#L1B
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M9IPFS;\RV:22/66$ ;;ZOICYJZH9HJR@>;]1ERJN+5,^A;@4F'XG:=HD[3'
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MH"502A2H.0#M2"9S'7.*@31XNA9($%),EW*8-NX.^F_2J10GA)550:C$,@"
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M0!! 4;!SRO!8PS2[-[#!J$$@+) 4H<Q#<IG1]QT%HOAO1HBVO4#;%2]55KR
M"*AQPA1,R!!5P..>,]3KS/PV9) $>@$$B[R^I'324*"6!()D0 )#:N;[1=IE
MUUK;TA1U"+7?[+2H=D!NO+JIW3\JE[1$I$<GSYCH2I74>8@DI"28MJ_6]^PD
M#& "6 B>G=Y>7N\DAQU+W=.Z>=3_ *A14BFUQZ;P^8&,DF$[<@8S,F,\E0K/
MU*680DI4Y>08#@M<PW>,2_"6 5D@ 2VMVCUF1 ]6%JW2 6_O9])A*/P**!L"
MAX/DXF(\<@0(;4N(K53Y?-_]]?8_/Z$6Q@*,&YV]Q;NQ9P\1 .".T4:+13;
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M,=3#]GQT*L'>/25H[;V?M]JRQU=5<;G3O?=*I+B&6$*4"AIU;@4HB"N=A'S
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MT+=/("&%#TWDDR%K2D DF,_-B(!@]$9'C&92I8Y%D<WE,M#F[,1U]6+!LFE
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M&9ZD32.74'(2^UP[,'ZQ],)G=":PH*M3+MAN"*BG(]5EUG8XV3,'TRK>HR.
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M!-O6^^F="M;%(&7LK*E;B! ""29&3&/?CVZ,H*YJ*$LHP6;J3)MZBV/#,T0
M%!<.Y #F3TDWD._7&%8EMYLI;!4%)"9(SM$;3R,^\>Q/GHNG2I)=2N87);U<
M6N(NPVBTPSE ,WQ"_83!U>Q[[W+XC2\:0<K?72$@-9(3N ]12IVS(!)!XR(D
M1XZ=9#B&4IJY45%+M]^6-X,#I8-B=**C$L&)W+MNXU(VZ:@XBNITSK.RON.6
M:J<05)("&ZB%%"2%!!W*" !MR)X$ GS949C+U&6J0\D,TN(L6!UUZ'&*H:BH
M@JY_*4BSAYG6)OIZECK[/K/4U,U2WZ\7JFI$N+*FE,)713M4(4M)6N#G:1DG
M)!X,U)&3-0*"U NY*2P;4V;20[ARV^ 7JFX>[.'U8V'70,S.Q# *H[&BHU#^
MQ+8':NDMMNJ$O/.DI;=65(0I)2H!0D**@1G'GR^HY^C2" E?,00"#)W#VF)+
MSMKB)5(EW3UCI<R+"S:1MB,7-+.6JX5SZ$EO:\Y"$D #<HS. 2I)!*8/U/@A
MVG,TZU)BT@6=K/WFWY%L1%/+86<21:1V;LWUQ+&B=7N4#C--5*)0VM(0N2
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M? *R6[5JRR;FD4Z'7:AI3;"@X:@/4[CJE[4DJ2=P$ D1D'W$V3YB1SV+M:Q
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MXYO_ /'KQQ [XN[>]'=0K)A/<368Q_LIOE?S&3@8\QF.>OSV\=H'^+O%/_\
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M+XZ0UI9-4(*:2I12UU.W%7;WY35,+ R4S\CJ!,RA1D\>QY+F> YBD:E52/\
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MM$6T,8U?Z7;=5U**)%"]45RA][;HJ9UE;RF&8*U^BTZXX !$%8"9@D^.A%^
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M'L<C/1B\S1KH*4 207/3U?<@[ZXRG[PF;:[;/H/PM;&U-*SO2?7;$*!E* 8
M\D;>.A_A!BS'L7/?IWQ-,R/8B?<X>&D,^BRT:D5;2*EIX,P$J2YO3"I&<^V>
M"/,]05J9'*0&(-G)'7J;?0@8P4\T*%G(()'R'3<F-+@5?^*GO#_HFTO>*IG<
MW=+Y<JBEHWT)2E-,P_1@NK"B0"[O)('XD@8(P1>/#/#OM=6FD@>920K1R6GK
MJ[#>9FK^(,[]DIU"21RH)20T,"!#2S.QF-78<F+U\;O=FZZ:?TC37FD:TRNV
MN4%06[10??%L*0I+B7:L,>J77%2=Y7O!.2DXZ[I0\+(2BBDTT/S1?4@_/H-'
MQRL^(?B"JLK4[&X&CAP7[:'7N(Y^$WN$BU?$)IG4%SK_ +C;@MVGNCS]0&FT
M,.I)+SR6R92=VY4^^>B?$GAFC^[6%)/.I 8@DSRW FS06TB V(O#O'S^\2><
MI":A=P"\]3 >PL=-\=BKI\8GP[6*N>IJGN%15CC*E"+;35=7"]QW#Y6P,'="
M02#X]^N+9+P?Q?XU2HFE_#"BQ<LQ,::CL0T 7/6J_B+AG*"JHQ,'4N ^AWWU
M[G"O3G>GMOWQH=7VS0]TJ+PI.G:U3B'Z5ZB.Y#;C:"4O $J2D<\G\^CZO#N*
MY*NBDH*"$J0XZ.Y<L"UW8B_N"G.<+S9-1^9<A$D,;))!C1SO!8B<1!IZF-\[
M-:UTZBG+S[%MJR6X2HC[LEP2-V/E].3F1G]&_"ZRTYQ(=23SD/< ,1(]&!L>
MXQ[BPRR<@%,D_P ,=R89W;\)[8AGX==8V^XZ4=[3J9KZ[5.I'ZIBS6RFIEU!
M<<I7"5E)3\B#"$IPKR<?-T9QZBM9HU'8$H$ZN5 ]!N3]&.$G!^(T.2I12PY2
MM18$P+RW43K@TT/W3[;:.[JZ8L%V566C6-LU5262IMC]*\AQ-74*>IEA]9*F
M2A9"DI"3*3*H$CI=G.&+JY!2RQ(2IY9_+!?ZDZN^#,OQ:DC-! \Q! M9R'Z;
M,YGL<=:J@$>NCY2IR2A, A+)2%-"9B2F).#&/KUQ#/43ELTM*B'*R1T8R1O$
M'5Y#3CH:*OQ:--8'\KN3IJ1?T?4[7B;5=:AJF#"3D2!NA6P#(VDGY29R1^OT
ML'#%ETOT@-)@=]/H";8$S%P2#J+#1Y)#"Y#>H?>LVI0Y5)J7%E2]OX23 $#F
M)R?[X@]7&A\10YDDR&;9B!?I?Y[C$!J)"1S>@ GW;;46>&Q%-92)<0"L%1,$
MRHQ).00<<&)&1ST=3-0L"3 'JPG]-HUW!4YBFA:U*(?S$ZP_4- MZX'A1J05
M*2D @GB# SX.!^@\>>CETJK%W+I@/N(V@ZOKZX$IK0%@ ZMJ68C4W^L:SA93
M./-+2X5PI.-R2$D)!G'MXS_/CH&I1JJ!"2056T;M>VNCX9TZE/F#CO!;L[!K
M:Q<]</U%<E;Y6]N&Z5$@2<S"E<J\').<\XZ\<K52@N'"0S[BW]#;61C156DF
MJ#8.(^8.FSP-"&-C;"VU5+7:=MI 4K:Q)R3"0DI/G'F#MS$SC%;S-/D7R@3S
M,2\FQ]K7,895,Z%9=-,*LI+1!#&7T(AYUUQ$]V32OVVLHG4)4ZS4DLA7\*''
M  /J829Y//Z6CAU84Z8TY4I 8?/3H\M!+C"RNDJ*B3"F>8/K!'2=M1'ME^%I
ML,_#=V+:$0WVJT0@1Q\NGZ$8_EU]+^'U<_ ^$K_S</RI]Z*#CY2\2CE\0\:&
MW$\Y_P#CUXX5]^%D=Y>[8!/_ &BZT SG_P"?*X"/,23[9.)GK\^/'P7_ (L\
M4D*4#_B'C1N!;B6:<7;1P3ZSCZL\)5$#@' 00/\ D?A@>Y<9.B\-<^]CB/WT
ME-OHDC ]-)"8@!7,Q[SQ' P/'52H5$J3)<M+C8"(CT]21;#;,Y@&J DW4 #^
M4/'R;3"=@.EP#<J=JA,^XSY_3J9120&8'LQUUMZ8DIJ)*7)F[GHUK3<#'Q42
MH?Q Y.-T# !Q^76A2??K^ /SP3 2"P.EM7.H-F&GTQH<WB-JHYF?T]AU@!NO
MO^).,H8O ^OU?'UDD+45G<0VLI,3$1/(B<B/UZ]S)2H<P!<%B0[,UMG+8E%1
M-)*G$*(@='T;J,*K+8J.^N5:ZQ+JS3AHHV23G?\ +@C\CQXY@#HZAF4H2KE)
M204V(!(+DZ&=SH(N#A5G*Y<%"8:S;&YD0S.^HTQRO^+Z^:,L_=VXVV\6S5;I
MIK11)0];:%MU+*$K0H!#KH"2@\JA1 )(\CKKGA<I-"E61FU4ZBJ;%"5,02HO
M! <L/7Z5ZOFR2M!HIJ2_F2#L9T$F-6TUQ!MH;T8_0,ZL<OVI]'Z>I$.N_?[T
MFW*<K3M(0U2T*725DD@H"TI@QCJ\DYI(3413%53!EJ8E1.H.CSL8V+87_;:=
M.?L8=R#RI 827)UT?:X=\!U;\0/9;2]524^G;%6:COK3_P!\IKY=W%I6[4))
M/K"WMA5(A>" HN#8,Y(@Y^Q<<XB0E>0I!/, ' 8"/,Q-@)W+8T_?B*)/+32G
M0\J1K9SHT-8N[88:/XPM;M74WZS5R;6BBJFUIH'F$>I4AIP*%,IQ!_\ DKH!
M0H8 2>#'6]7P'GLU0K?%1E44S36*@ #\I3YI9W'0NQOKC7_$Z@I(*5$<P#O>
M;1O'N7-ACL;\/GQ#:([^:<^\V>I<M^H;<Q3B[Z=>&RII:H@!VJ;J05"IHWCN
M#:4D[#!(]N,>*/!8R-1?PLQ\/D@IIEN[M?3I9L6WA7$_M2'510J7<I#AP2&[
MO#&&Z/BQ%>NBH6$(JGVV0H@^HXX!_"5$)_[T28Q(!ZY\K+4TGX2JJJBDJ8E1
M)<6<N',M/:<.:U,L%III2"T, )'Z,>[8!KCW:TS;6E(H&WZQ3)+3AIVDH*EM
MDID*61ZFXS\PP?[G&4X0G,?=8%DDL$AW@."YVUUW? HJD @H2&,L [";N/F'
MQ#M\[OWNK=>;:M+C%,\H^C451<AILB1O](*9) ^8R0HDQP!U8<OX;RHY!7K!
M"R0I(&S,]P+BY,-UQL@TUJ*EAARP" 1K,"7Z.3!G%1.[?Q3VW13-SI*1NKU)
MJI-$\U;6*"C=-JH[BX%!C[_6ELLIVJVK]/<21@@21UU#PUX?X, CX^9!2 7<
M/9HG>8T.IP@X_GJ]!!.4K_"($!)Y2X>7#%V+C5F@$''.2U-_']W>8U!?[+W$
MKZ6BM:O7J**BJ%VH(:JW3Z%/2LI: >##:T-!?"B@D3/72\KP_P +4"$_'2MF
M<*22ER'(8@!B2Y(&NFE$6OQ#F?XP4:R:G\ZUDJ4 P<DDDL T_-RX=7_#5\9=
MQ67M5=U=14A<ET"MU>FD(WG<L%-15M)3L)RA*8'$#CHS,<0\,90#DRU*IRLY
M^$""0P'1CW'<RZ^IE./'_8ECJ%N$_P"\+O+G=FN\6I^"3M-KGM+WYIK_ *O[
MG,:@=O>G:VU*I*K4K5XJ5EU@ "EI5N++8F(4@;MVTCD=5/QIFJW%.&&ID<G]
MG^&2>:D!3+<KCF( 8,'E[P\XLOAKABJ&<1\?B"ZHY00A=0J!(4##@-+C]1V@
M92^IBH<$NK"0DJ<;49 6-J8," HB!&))(QU\[4LS\*KF:6>6I68-0BF5*<P7
M5(T8&S!WTD=:K+I)7EZ-!"1Y/XBD@#F(<DJN"7#>OJ=5LIKB[4>J[2.A05\J
MM@0@@$0"H0)Q_3Z ".O5IJ<IJ*+_ ,HV-RY;UNW<@XD"4W80YEG&\?(Z"-Y-
M"A2W'14TRO\ Y(N5D"5[0-J"9W0" 1F) \]*EE 6E16Y"A<B#N^_LPAX8[\Z
M*(*RA*@04LH [38;,#WQ7BY4S;M15%#<$59DD#RN8GR3!GZD=7;AF9H?#3S*
M8E@6UBYASH+[L^@U3-)5"**+$*\I<[/O>=];X#[Y:T/,.M(0X75!1&V0@?+R
M1/)*9XCW..FM.NCXX4FJKD  8$@ [>@.I'27PN6@+/.:20H1]V D.28EW;?7
M$4-6NZTMQ9HJ>W.UES=4!1;$!2G HRH!9(@@X(S'(\=.5\5RB$DU0*G<:Q-Y
MO'YW'4\D6$1%[0WM;TQ:?2%@[BTK5.FYVAUAE(;1^^>9;A"0(295.!X(G\HS
M2N)\5R=8J 3Y>8LDI@)<L -I9B2S8*HU*A2$FHHADB[M##H&B(,$F9Q,XMCK
M; +S+:%D"8VF%1) (F<SF8(SGJE5LV$53\$FFE[TP4@C37:+?.QR2HARHFT.
M=B-=P0>K[78ZZT-5#BMNTJ<5(! RHX!X@P?/CF8Z8Y=3@$DJ (,E[$N(?9OZ
M8D8,\ QZ N"9<N8,"S$8%:^TN4[BO5DA()@'@?F?J<1@^?(Z=4JZ0GF22DZ$
M00S_ %&I(E\8, P-W%[>FC7'S$"5YH7%-)J&PM*&TDK*L0D$[B1R2,$1^O!Z
M8T,P24I427(<DNY!;ZM?TWQ&#=R"219M&;9^CN TZX8+&Y3M/K:>_>[U%;>\
M;B2K!$8@#;B. ?;HVNH$)@"#]V'8"Y<;O+Z],;.?Y8>YD$MN&[C]'!_1)(1)
M:0KU/D:2I(( _P!H9@$3&<C&8STKKI3#I!)<NSO.KO:/5K8U)/-"B !)E@>@
M&_6]I@8*+;4,4H>:) J/3.Z!! )P)]O\?)YZ5KI)^+SI0D$ ),7+NYW [6D8
MU"HGK<DB6;26EXUZX;:>]/"JK:*VTS:KCL+J7:IQIIMU4?NVD+6K<),2,9@R
M>IDU*(#+0E8$,I((O>1M Z'3&1(&Y=NHF(:!=G]+8":+1?<U6J:?4-U33.G[
MR]ZU.JO:J?N[;E.XL-I03\NTD$)& 0".#TRKYS*#*) II  2S)=B!?7YZ&1;
M RG*ELHERHA^["&9MA!)&\$IKM&:ON5'<D+HP'G4D4RTO-J=2F00EI.Z95C:
M$B3'2_+\0I"LE(2PNH ,&=B2VH]-?30\P!\S!G2W8^EX.LF^*K:K[5=Y=0-7
MVT*[;W.MMCR5,T%<NOL*F@X4E'J)I_O?WULDPI6]O<!R//71N"<<R&7"14I@
MA+,KE!$,YAC!@=7MA;FJ*\PY0J2DP]S,/MH=I()Q6G2OP8_$0S>4/W"TT5JM
M-#*FM]WHZJL=*5^HVVA <(:"B$A2<?*2 <D],,YXQX22JG42E2"&92.81T(?
M[W7<=<(!P?.4*HJ\Q9W "B;P-H;=GVTQU*[?'N NR4ENU59$6>X6UMJF"TN4
MFRKIV$A"75%"R2J "G=@>P.>N/\ B#BF5S592J-)"$A7,#R@:G8$@:"0UB&Q
M;LFM:*80HJ^ZT%QLP TBX!?0C$NH>:IFTAU:-Y3*RC8=JHE4[,Y)R9,^_5?2
MH+512H$\Q(\S&8(Z:ZM>!IB9((43)!5-KFPTW%VG8QAMK;_36YBIJZ@NH8H:
M:IKG"TV'/4HZ9M3M0X4"5DH2#\H!]IF89H\.9_/U:2<J6YV=CRAU%V([;F;,
M<>S&=R^40%U0"R7,;'66)OZ!CHU+W/M'OA(77.6TZ[NK%5359HWD?V?N:5"J
M]0H+9=](!0*@4@ Q'!/5NSG[*^/4LI0S*5$)6@+)348L+B [&Y)=P^*W5\7\
M,"_A% YU>7F^&"8! D/H=+]L60TEWK[>Z\N#%HTYJ%+MQJ:)NMIJ:KIWJ-YV
ME<3O0XP*A*?4*DD^!"B0>DF8\+9W)Y8KJ@%8=R_FU"3(_$OI#X8TJPS@2NE"
M0'+,0=99]IDAM'Q);H+:3ZW[S."YM)]IP=H_(8..>J=5%5!**P*@ET^8O:"!
M>X_IAUE6(#I!:)U#2-O4>G5M^^FC?W+;4^IQ(2BE8'R*)_"DI_"2H_+QY(XR
M":&34L<R/(@,5 %@4O+C]$XVS82DLD 21 MU'L'TPOI[F@N>E4T#U"H!:EM5
M)'IK;6E22AL_-'XMQ$\#P,&95%*%>6L4SY7<7WD=1ZB&D!2?76(V([P?<$Z8
MCO5NC+6BE-TLCBF2A2G:EEQSY#,[MB/))(B#S@&#AWD4 A(.9<%H23S>EXC\
MSC8)*BPOO;=I^@=YD8CUFC40E32" XDP'LD@1)&8 XY(/'ZOD4$0364)EC]'
M%K1]9.,BC4!@DD#_ #:VU]=_EA4TRY2!:ELH3N*"EQ(_ H+$*!DYDXR)P9@=
M$5DTJ.5K*)%112XYI*.5Y26#:2[.,34LM5622HL 21S.9>=F@.&:=,<Y?M-Z
M*H:[8T-8V2ZY0:FLOK%1^;=66DN.DY,^H=I6/XH'TZZ)^S:HBO5IE:$J(9BH
M<TN0"-88;EK:C'.O&**HH5BI:N7D5<[.P[/>'$[OCS^:EO[EIL5+:Z3>:RJ;
M345*DJ*5!HR2"J?(/ YCQSU]*96@I55)J#FIIY0DF=@=!J[:L_3'SSGLTJDA
M(I5:B5%2BI(40"ZB XU>'&NL8SL-=>-/:>5>TO5S53=%(IJ"L;)D-@  %P?,
M$%$B9R, YZ/XGELG7IA%;,H2D#[AD!M"'@CK=B+8GHYO/9?)?&H991J*4EJJ
M/*LID.5"6.@C=N4-BW/8[M9>]86E6KKM;:*IH7$FBI_O#2'$N/I&7(5)"C[F
M2)!F>E2J=.E0"<KEJ)8 !24 <S.RK:L_R%IL-'/9VK00NKDU*44I*R95S:O8
MEV]2U[BQ6A;;W%[57NNN6@UT-O1=*5VEJVU-CTE,N AQ,IF0 9&<&2"3/56S
M/!,]G,U_%30%-:@E2RW-3084H1# /U9K!\-J'%J]!/,G*J\GF 8<I*2XU]#-
MA+X&+WWI[Q]MK%J!M=QL[5#6/U+-8[^%UUJI*E+ID%2<H._;M.#,8\0Y;PC0
MR^;4I->E5"5DR"5$-82X.HTV?&N8\7YG-E-)=-5-(@I#,"VS@ .WR[X,_@&I
M=37;N9=N\-Y77T>C^U=DO6JJFJIPZW2-5;[=3]UI8CTU*J%J*DI"I(;!\82^
M*J(-2CEJ--*?AE"RH"_*3<VN0[MMH,-^!TU534JA1!J4U^4EH/*";_=T.T'&
M_2-'VMU]W1?[I=S>X L%5<M1-ZEM-&TVX*ARL9N:ZFC4XXE)W.5#*"U,DI"E
M\2>JMG59FED%CXBTNDD *<L+@A_7T!N0,-<H*:,\ETI4H*3<&P.I(&H#B[8[
MPTM8Q<&Z6M8*5TUPHZ.KI'0/QTS[#:V5?_G(@P?>/IUQ'B7\3,+4?,4J+J(F
M?PGW+Q..OY4IJ9:GRAF2 P#?R@MZ]]!MB)M>,AEXD!(WDH X )$S/Z<_W'IM
MP6K1^($K +"QL0-;1T^M\#9I)@AP)<OI!<>A/9WL<5TO;+J0M&Y4+6K<),*!
MR K@$8CGCCJZ(KTTPD,D.S "]XO=S+V=L+54U* (4_31K@?JVSG !6M84D"(
M)@""()Q^H\ ?6#T4E<O9Y<=0/81.!*M-;&2):]Y+_J#%WPP/8R!F3C($_6#Q
MXXY]^G(S-,@ AW#6Z:'UT[X'%))GE3W 9CZ;DZ2#>[X;U+<4M(#42H""!'B0
M?;B8!S&>LBMEPH%D\PD @W]1;K\HQE84$$)400'!"K/WG73?KC:XTZE_;L])
M$))"<B)C@8$G^\'J&O7!"@BQ L&!F7 [M%Y!OB*E1J$A2U%4RYD:F_3ZF^+(
M:/OU!3:,-7<*IFD8MJG/O%75+2VTVVDG_I%J&4"#\I)!('B.JYF:'Q*C\H<E
MW+ B&&LF0S2)UP9G%IHTT<H +I$0]R[F6D=KPV(FUEW-T#9K5?+O47JG?I6Z
M!NJ2];%"KJT;GQZ;]/2-DEYM2I2<$-@;_)Z<Y+AE>KRIIJ/F2&#V.C1#E]>C
MVQ$OBN531/Q$)! #D@.=#)<]O5\>XWX/[Q1Z@^%?X>+Y;W'7:&[=G>W]PI''
MT%MY=/5::M[S2G6SE"U)6"I)X,CKZ3X#251X)PJBO[]/(95"NZ:20?9O7'RQ
MXDJ)J\?XS43]U?$LXI/8UED:#3ICB%WV>2KO9W:282!W UBF3C/[;KD3F!.X
M1SR,">O@'Q\D?XK\3L1_S@XR2=/^4,RTV!G:^/JOPO33_A_@)*T#FX/PPL2
MSY&@X/?>+ZX"%M;J.A(((^[>3(4H@_*))E1(_P"'/7.DU"A12"Y;E2!<DL !
M=R^VKM)PVJTT\Y*5)/*18AF#=WCY8T4Z5--/.*$!&\%1B!*8.3@9]^,#STRR
M]+,5%.::R+D<I@L\M$ V:==\3T@X# DO</ ZM'HV[WPV&J;2TE9^9!40% 3*
MB>)S^G/)Z9&@I"$A:2D LZO*']6WB[CM)R4DND))9W2SF^P>'MCX*AA8/RN
MB(2D;2H&8@'\1)$"/_#3X3D !Y;RR_U;VQJH<K>4=73IN[1[8R96'7=GHN0$
MF2ZG8),;=LD3.22.#YS/4=;(U:BJ?\-;@J;RE_Y79AVT8:WB)7(1]Y(DGS$
M#3L.QN.E\T5-=:D/&CEI+Q*74A02(P9))!]\R8QG)ZGH\+S8'EHU6)@E"B7?
M=G+P?U$2J>7CGK4N:/YT^IOH8B?Q K[8K%>45E3>:NT4S]8AVG365CU&:NG*
MFBD*2IXF$B,;R$B9 ZL'!<KQG+9Q*DTJAH@>4)14)N#*0 Q?U+ 03.E97#$T
M5)75I<S,254Y)8AB3 T##ICG)W"^%#L=75]95ZO[^52F$O/5*K;4W.C32L+6
MYO\ N[*&B4E#9.U&T< #\NN9#C^;RE,4E\-S%:+HI*4QU+,[N)V?1\5K,UN'
M!8 4" [E("AK8@@,(UZW(Q$U/VA^!G2SZ?VIW1HZRH8D!277GO4"N0@MM$G!
M(P3GSGHA?'/$]58120*511 0FH"E22?N.D@$:>[P^!U?NRL"4U$*2 7(8MT+
M&\#1P=-MS=W^SZL!<]&K<O\ 5[MGI4]FN-8XZ20D!(]($[C@'@XST/6K^,85
MF\Y0ITW/Q JIR*4@2IDDAR4B+;3@4T,BJ4B4R2 DA+2Y4Q@:N"FW7!CI[XI/
MA:[072GU!IG2FK+)"$4BZINPN4+%0 !N92X^IM)4MO"@HE0!'Y]+JGAO/<?)
M/VE"U*AN=^8E]22^X$2_J?2XYDN'H9P>1XB3+!@F=P9,MUP_ZA^U'^'JZ/(>
M?M&K'6D!912EBF*6GLB"?6 XD!60/U/463_8GQ!-0UZBDE"P>629<*</!<;.
M8T & E_M&RBJAIJ"@$F"0P,Q[&P=B^EC!.H/M3- L%U&E^WU0I[YA3OW*K2E
MM2,_-Z;:2-Q$;AN!XCZ6[*_LJS>62%$I"?*Y?1+M=V [Z/#2!7_:'E0I00@D
M%Q(#DWN#8ZB>^(%NGVEW<6_N.4^F-*6+UZAU3#5.FW.UJRT<@!I"2M3NY1$Y
MD1!('5ERW@S@F70%<04#43=22".5@&)+ 2"XDBYF<*3XT^TU&I)4Q/+RD%R1
M(\HF\.W1V;#]:M4_'-W.0E_3NB56JCK4AQA]^P6JW,+08 6@U: ZHX/S*R#Q
MD=1YNKX-X:DHHU I9NE)25 L=((^7YLT+S7$DA1HU4@/>FMO0*%B_6_?&B_]
MKOCCIJ*JJ=4ZZLVEZ%QK][25&IZ>UO)92(+B::B0?DDD@I!$Q,&>A<DO@%:H
M<R#44EW8 JLSND/H+:Z7P'F<MQX*(RQIIH_[,*(20&\Q4&CS<S$N-GOBOZ>R
M/Q(ZWNSMHM&JJ35[X $T6H+C<4H4LJ 0M?I0%*@G:2"8D8.6V8X[X&R02<U0
MK%7*"2I!;F%I)83U-_8$9#Q;7)%,TU)MY:A5"GL 0[= QT9\3MV.^!'XM>W_
M '.T=W8U#_92U62PWFCN-6[<M6-LN/TC #50TAE]P%T^D5'TT)*H''GI/Q7Q
MCP?-\.K9?*9=94I3):F]PS@)>P[ F#K@O(\%XOPS/T:V:K I-PY<,74"]B7(
M<@.??'9VL^)3LGHYRLIKOK"F54D*)I;8BHN&VIEKUPCTFU!P%["8@$21C'7#
MJWA"KQ:M6S=+RJYR0A3I6>8EV06) LP#]FQU"KQ.G3ITE%:20@64&"BP(?0,
MYF9P/CXW>TI8524-+J.N6E14%L:=>#I3)VD+=2F 1P2!/ZP=D> <XXYO*.H5
M>"Q #:S;\X/WT@P%I.GW@?D+ZB]]Q.&*L^,'0@(?&F]?J 45;T6=E#8A)^97
MJ+22B/X1R8/&00/V>5%L5U::.4NZELYM_,1H\/;>,87QNE2#K<I)Y6!)DSM9
MQ)V],(;/\7?P[W&I;9NR[U:JY]T-OJNFG7S3'<=I+C],%I;*"1N7$20H29ZU
MS7@_,9&B54JB"""[*<'E+1<R7 +E]Q#R(\1999"337W9C+7-K]X?2UK-.O:)
MU)0,76QFWW2@J4A5$^074^@4@I2D+ 6A&?PD$@^9@=5&K5SG"ZHIU*:E%0YP
M0"0 5,-._8:-AMEZZ,[255I)/*%%!<$$$.2"+6_-],%K-HLU(ZBM-IH?O#6&
MELMI0I*C_$CQQDD'QDYCH+-\2J+2H.'(-B9_'<,2Q:UL:5*:I@@7?ETVT8[M
M=G9L+E./E:]RB05*,J4(,SQF(/T&)Z2A=1948#JAR>[W]7/X8CI@ ARPF780
M8/31IUC#35.EENH= *EXD"3\H$;HF=L09P.3(Y!E++"K!*7NQ+,7GN[->7P8
ME0=G M/2 +=X=Q;U1,58J:0D$$^FH;MH@?4GZ?X^>F)IKI_RJ# AP#+=>Y]=
M,$@I%B[@_.-79FF-=<(EVPU2$P >0.&_M4"2!RH0($Q/CSS[_7K S/)Y%%AZ
M]9OZBSF+.^JB""PD$68GU!DV>.[BY%:^UNL/%+H!;3\RHR-H!''!D$^",3C/
M1^6K!_O$@ D,7(_L1?V.\+$2QEQ8[B_3H)9IG$;WJU&WOFN825TZEI=A&2T9
M^8*"-VP&  , P>2.GE&L%I+J!(2TF^D.VC&.GKL" [@)]&!_1]AZX+[56I>0
MV^@A8+200B%<2"#R01B21..HZP+A3$@@L;C3HV\>N-2)NS;W>3=V)UN+AR^%
M**AM-<"74B4.'TB0"2>#^9X P8!Z"44J6!S"8N+S#V>T7QXGRC0#66>YEM()
M8ZZWP(-7ZSU594V<*;:N; =JE[\!H-.A84%CGY()2,#\)'1J>%KJTPM22$FZ
MB(&Q>P]268-UUYJ:E0M)T "@YW<S(O?1B'M-%HNJW*.F<+JU%UE)W!"H4K8-
MQ3(S$#ZXSYZ3<2HU$(4A#*2B$\I=P"-KOII;IC)2YT ?N#.Y@]?:"</2:EPJ
M %0=Q4(*28&0).<0><8]NJ^CXJ5 L8(+;L7T_&,8"'&@!C]0QPJ"JG\27U*C
M/R3.,Y@#)]_/OT7]IK;*2[ZJ#N[V,VD8R*0!=W:683TM#MIC]]XJB3^\*B1&
MT@RK^7D<Y\>>H54JU53N7,B7)>2\DG??T&,G^(.0I+%Y+@1,EDCI$X;JBJ=4
M2C<%+'*2KY_J")F!Y&#@'K*>'\QYJR@!J'V[^VS[X!92% )00-PEQNY'NWJQ
MP+5+SSA<I@X4>JE04H.)3$9B201GC(/D=,LKE\LJHCE6A1IEV"@2'>;F7$OK
M'3&]=10*9+^8F#&SDZAGB\D=\54[TZ(OO=K2=WT'8=:7C0UU1>&7%:CM:RIP
MTE/2U*OV=5A*PHT56MY:"$!14J04_+UU#PS6HT,]EPL>0J2222&, $%@-(EG
M(TO7?$J"K)DI(_U;%BYDDP'OU#:X\U-/I%G1_<*]VB\5HN;]@OM10N+*H0X]
M1UBFU/@K.2\I)< .1N@^0?IOB6:R=7P_EDT$J4H4E?=0\'H!8/Z#'"J-.JKB
MU11+@K0&))$=3#D@O$L,=01K2NI+KH;4-EJJABIM-%0U++3;I0G]RVD;!M@J
M!V@[9(,GY>N.\1R2<W26GE4%2P*6)&D7Z,UM#CK>2SBLKEJ8/F/,#Y223 D$
M.X$@RS"&..S_ &B[ITO<[0]#?V4NFM;0BGOJ5IAQ%P;;1ZA*1\P#BP2@J "@
M!MZX/XDX0<G5J+8@*J5#+C4P8;<!I,-OB_<+S",PE*N=+J2@D AV(L0!][H!
M?>^"FIK]J6'-Z]J'4N&$F?30L*428D  9, "/IA'PU7QTKRZ"ZU.A/+J5NG3
MJ?S+X*SWE(4HE(8ES L)&G4.=2[G!/0:IT;J9M!;N]OK6V@XVM3-8A]"7&_E
M<0HH61O;7MWI404'D>.MZ_ASB/.GG00 2#*I-M =8-X&DX7BLC12#J6*7O!8
MZ$?E(!:--?:GL>E0FENFIM+T;57!HJ2YNJ:]><I"5$B3$D$?+'!YZ<</\/9T
M%+,%$$.Y[,$LYMMN6!;&JLPE#*"DE4.D29>>CL;@SJ;XB"Y=X-&V(--7&^:(
MHW%-^HE#ET2E*VR?Q(25;B 2. 1 SCJRT?#?$5%*>5W$?>FQ[?C.N(3Q*FAS
M46!,@EB]I=K;/U[_ )SO5HU%H<O1U-H%FU-?O35KN.]I!1)$I296H'@#W_(]
M-:?A?B'V>O\ %IK/D 2.54W$;OV+$:Z83Q[+4R5)6@AI90+7 >X^>N*&?&-W
M4T'W/[1W+36DKJK55^NMZH*^IKVF#3VBU4] %K**:JJ2A+BG0 E*$%0"5"2.
M.KSX!X;6R50?$IK3JY24@LP:0!#F'=O,PC%*\49_+YO+KY:B.9:% I"DDNY9
MDAV>7Z]7QPCOW;+5EPU(:DT=.Y;&%^FH,55*Z\A*7 E(;:0[N="6>-LR8')$
M?1%/B%-&3--P*@0H6$$.4@0[V]-HQP+.<)S%3,)K)!53*TE@"2&/F)!&PT#
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M6CH'C74Z#1]/0#&?AN& =F$L_;<?AZ8$K#>&64KHW5.*=;"DJ!!^7/B<9F"
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MON+N-(K_ +[-5;:XMYYA2DB<\'KIARXI\,*5!G20VT@N>SON;,['"BG52%J
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M8];0W7L_]RL=QIKP\+S3)73VY_=4*IE)3)=;;.XI3.[]/; L'AJE2IU*:E$
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MKM\B-W]M[S[9@'$YR,\]<=XW00K/9U^5SF\P9N#\=9+SK(G7'6^'UZB>'Y
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M@UKH9IM*W;8I822[3+:@GQ+D 2")(QT,OBV7O\4$SL9>Q#@LPD'^XB>'5OB
M<AO\W,VA['MT;$R:=^'/6]V _:!I;&B/W1JEH4X".=PX.>!.1ST#4\04*0Y"
M0HCLQ?U.HNW?#NEX;K5FJJNJ#)!!! $$@_BWL">H^&34K2-J;Q:GEI^52@4
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MV]L)''T+"RXAM(2%"023 G@F#GP9_(SGJ.GPU',(#%3V$NIY!?0R_KB4<1J
M,7)C1I;<G=W%WZ-A(+F PMM*$@;#L4"J=P&-V8()Y.,$SGHX<-IJ24D!B#8N
MY_6_Y-[]X5# 47+-'6Q-I!;;T!=NJ;L7%.+6$)4YZ(<;2"IL%MO8I:-Q4 HF
M")&1]>I<OD4Y:4 @\P(;<==AKU81.!ZV976^^5$$-.QU_$1OA(W6TX 2I*'T
ME040ZV@@#Z#:((\&?I Z95,_7">1 4P8,SB.@):UM[C"Y>4R]17GY6O):!O&
MG=]<+Z&].6W?^SGW;6NJ*J5Y^WK]!UVEJE!#U(Z41N8J$PAR?P)R 9@>I5JU
M8\B@1S %R&;KT?>6UMC84J5$>4APS ![6C:"P=K:8_IG_!2ZA_X0_AH=0R*=
M#G9'MNM+"5EQ+23I6VPV'#E82,!1RKGKI?#QRY'*#;+TA[('Z^F.5<5GB6?.
M^;KGWJ*_7YWQX$OCRJU)^,[XK$B4Q\0_=I,C@@:YO0XX/B"<<8R3UR#BX55X
MAGAS<H^VYIG!EZ]378.W],=>X92'[NX>8+Y')PS_ /H].'?:#%]<4]K*A9'"
MP58_ ?.,\^<\\8QT-021RA2GD2T"1_6WJU@<:82DD%AMKMIKU(P,U:5@.DK,
M2#Q!Q&.?\,?J.F*:(4H>8"X=IMW_ !'=G?52G V2/H/P'XF,#-8VC[PZXMMM
M2T6Y]:E[0%J2A(44;LD2,#Q[@QT\RM?X*0D#F#%-VN/O$:F_70MA1FJ25J4I
M[%W(?:P_7T:'4)"5^HD8='J[?]G>HD)GR0?,9C@=,Z:>;SO)DB2S_P!].\LQ
M35$$5 D*8$0)U/<Z&]_9\3_V"1_Y27^J(,,Z;KU1GE39  5X,GDCP?)CI?Q-
M?QC1HA/*05'F)<&4Z,""&W],,\LCX*%U2>;R_= (.MSHTB)?MBE&I%ER^W4J
M!!-?5D9!D*?69Q'U_/Z=6GA2Q1ROPFYG /,"PD)TOI^FQ4.)-6S8K@A/( DH
MN[$EPH,)/3 XL$NX_P!CTX^NXKD_09&#GG\I^3X"$$GFYR6:&<DZOZGM& LP
ML&6(:]KVTVCWP_:>07K]:6.0NX6],02)<J6VIB9A.Z2 <\ C!Z4\;249"M6$
MCE*N29@ZR'_+01AMPFH#62CE() 8@AA8NS=/G[>Y?M^DL]O= -%!;2UHC3%+
ML,C:I-M0-Y^A)C:8B<G/7P;XGJBCXB.?4GG25J2:0+*#J4G[[$?_ ()?7K].
M>'Z83PY4OY52 082"8MK>;O@O;3Z:MWJ021$B,@C/(''B,^3[U182,RNOI7/
M*$NQ2%!I)^]=]"T2PP52RJN>I5^(R0DJY>4R ':]B+&3A3ZZFT*$^H%'C\)P
M?K/C/&8)\#J0IW83H-/SV9[VQE2F.Y9C< =6Z]\;DK"@#(!,0)F?RQ&,]8^'
MU]Q8=6[C\,;H!40+0"^G6+XUE06[MW1M\>Y/C]/[_&>M@AM0>C>C]->LVMB4
MT=>8.6#L;3?H_J=+8U*VA2MWS&>1C\QSX,];)0SD6.C*AHV+XR*8:Q5U (_6
M_KC%2T@)2, &<YB8SR<?GUXI#RP:SN/DSQU&[:XW%.T 3#D@O]3?YXBKN1\M
M6T[))+"8C$22/<S) /M&(\EIPM'-4%-V"B3:T^]AO[&<1+I$GF"N4*Z%X.[]
M28[=JW7RM6M:T204*4D JG()!/N28_S ZZ/D<NE%($2_*Y (-IC5B=WB[8%4
M&)#ORD@7D@]8$?3U(@X0C)@QYD@"/T^OMTU1EB&98+%VY9WWFUXTC'@EP2X#
M7[;_ %_3X3K?$2()'@ O0-"_ HSF!_LB.ITIY',$Z")Z7-_U+8R.6FZ@4G>V
MO27+MIIAIK*@GYD@_B@F3[8_,YYQP?USS<S.""UB;2T#019@)@Z8U5F )*2>
MQ!Z:1_3#<I]2A'^)/7F?^Y'TQ$K,I(;E5?<8VTREJ< "@F"#Q/\ B.M2")!@
M7!+N/5_UVQA-9[)MN8-_ZX?D*EU"'7,?*H!*3[Y,3D@"?;J%:@DN02P( >=7
M;=B-0]NV-N?F+@,S  DDL;M[#=@]\2OI E!><4K>-L!4;9'C'B(\?TYZ19ZH
M%I*0"!(>XENE]!M)&":(LOF,AB -2Y?7800=WQ,-JJ%AH+4XE6 8B#$#),F3
M!CCQ( SU6#12DJ/,))TM-IANVK7PW02$I\I8I#2 \"-8&YVWQ\74AQ2R"!L(
MQ."3G'/TYQUH*U--Y +/O+'3OV]\;2>8-N'Z;]@_SW<XK#K.T)7?;N4+EU56
MI\N+05 #T@@@@8/$DXD8QD]="X17H_#',M*G "MP3%^UV+2TQA:H*IDA^8.[
MM$DEC'4;;:0#HJ+QIUYJMIZI1;7@-M2DF 0I0&X@CDCF.#GJ;,\/R^:KA7.E
M*?\ >25-J'((!<L& ZXU36%-25*262[EQJ&NQ9WZ.=3)Q..BN]]+Z3%LK7VU
M/+7L6JH4EEQH8&_:M*BH XP4[L1D'I#Q+A%.B2*:PL%FY4,]S#J+^AB,%(SE
M-6C"2&4+WZ,7OJU\3#3W=JO4Y6,OM+:&%*14-H3$$A1*AM$_, !P!))ZI^:R
MN>4ODH9&K6:%>8)9RX,B7O!?>3@FE6IK*O.!JX/OM\[FV!&_:LT[1I?3<=0V
MN@"C!-76L@MD$$E*4G<X!D3\ID\1'3OA'",ZLI-7+*I $.%$'2SZ^VF]X:V:
MI4W9UF3>2--"Q@OUZ-BKG>#7VA+S36ZU6[4M%5(9436FW^I5/OK^8$(2TF4C
M,@%1()G$]="RB/L2"FHSEBR6(9@&@D@Q=P]F882YS,JS'W:92P8$J??0!AI!
M'J;"![#9ZU-S55:*TKJV_P!8LH-.\S:ZAIM(!.\FH6E20""0#&/<\='KXA28
MA04Y:2>5Y#7!.T:VUPE*:R%*_AE78^O4QV@8E>UZ"^(>\-?=K9IIW33+RE%;
MU8XVS4E7.XJ4LB29DEM,Y$))Z19WB>0I@DU*95S%T\Z0RC=SRFUF^K##"EE*
MU5*25<C@$ H4Z72[$N')W@'NV%]S^&GO&M+/[4><NJRE6]C]J/-MI)'\.Y1:
M6X5'Y4':%*A)(!Z6T^.<--1!6M!3S)*_.P"7#D^66&C2 Q(QY61KA*B*A@*)
M 09 !8 \Q:;./46PQ+^'[NI:X">W=>F"DBLHT4U6X^D?[:D*)$F<).XY R1T
MY''.!DNBO2EV8AP3J" 2KKT& Q0J%RYY0TLJ&?1G$_@POAO>[;]RVEQ4:-U$
MV$'"/V:_,<8"24\3SQQXGJ='%<A=&80#HPU+C1K='P1EZ%1-9"N:SF_^Z>OZ
M; )K3MI2:EM"M/ZNI*FE;.XJIJMIUAY*B% *"%).4@D<&.>!FR\,XK22M)&=
MI L#*38$.\P/39Q@+B?#%YE)!( )V>6.KC0@;7/0\WM9_!+J=RXUKM@U#9W;
M8Y4O.T3-2ZXV\U3DG8P4E8^<" 3P($  0.F9;Q/133^&O.(4%)"078!A) G=
MNTLU^;\1\)9E52G4HI^-RJJ*4$4U R S\QU8A_;?$<7_ +/=^[5I![0*!17#
M3E-4*J*>FI:I!2ET_B5M4L[E%*0! !B))ZFR_$L@:HJ'.(()<IM)TN&O+!H>
M^%N<X;GJ5 TOL50'EB1V<  WD #?UQ7]?9?NC0N.)7I.N> )E3*FW 2,F!NX
M\"")]L=6A/'>&JII1\=*6AW) >?=XGY8IU3@G%0M2A0J,2=-2-]>_0X:*CMU
MKZB</WC1=]S!*_NKBDGC,)6K\L?K'4E'B?"QYEYJF7-ON]+R/ELSLV(%\)XJ
M@_\ %EEI>U]/O/L+/WP.733NJ:%8#ND;RUNR%.4CH!Y!.$*,8\Q'$GH_]Z9"
MH $5$)'*P/.DN&$[S$O.V!*O#,VEN>@LJEP!()<FT1[0^%VF]1+TVZI5VT6[
M6!12L??*=U)0$D2?F0J0.3B8F.<!5Q1KI(1FJ=-P6)EW?_>2=;W>[8)RE962
M5RU.'5JY$A25! #7?F0;';H';$B:S[SV+4^D'--MZ&I+0\Z^PIJY-I2EUD,P
MI8!"$$;]I259 !((S(&R^2^&0H9NFMMD$>XYB.W3##-9Y.9I$?8JM)VA2TJ(
MU9Q33W-O5FQ7A3I*VTH0I+6\_O<E)') (B/U^G''39"&'*50)YF@LX[] +>F
M*K64E=0@)"""\S8GIKHS[ZX6U50IMM"4**MV"4G:5?(2 "9@R 9(Y$#F>I5+
M\A2$\Q:X(Z]+Z=L9I5DI6$W8006?T.^OKZ6U[-=Z-(Z9T:U9[[4-L7*G6HMN
MNT_J+&X\+44DP,?-.?:#U4N+93.U"GX%"HL\R[.P$,]WM;Y1BW\)SV5I(J"N
MM*.9*0ER)(!)8$:"P]@'&)%5WVTD^H[+_2A2C@A6Q/Y*0&Q!'O.!U7U<*XN7
M_P!'6-+6M&^F[G5\,T\0X8E14:],D'HXL1+D:./>^'"G[I6RYE(I+E35BFPI
MU8ITO.J#:#*W%-H25)0VD2HJ('GR(V'!LP*2370L5?,X(-G+.7VL!H3@NGQ.
MG46]"L@4H8@@RWFU&HL/7JI'<:VOE13=:5MY1*O254-I"03_  E202F(Y).?
M)R01P6K440*:A+MRD^S&VUM0^F#_ +>BF'5F27DR0'UBU_5M!@QLNL;4XV%K
MO-*ZK;E&]L*X'"B2,<@QD2>AZG"<]2)\RV!( *%   N-6M?]'#%'%:*D@?$I
MDL'5S)!TNX$F?KB1+;K.W.C:BHIE* V[DO!1!F9D'D0,#G,#@A=6H9M+A5.H
MH&"0"Q! !)!Z/;MI@NGGZ2BG^/38G5B[Z1HYVM\R7]L-O,[Q4H;)2?342259
MP0?X9&,S^8\:4\J'!*%@0923&EV/TP35S--04RJ9.C*$FYU:S]9G08&JJZH)
M(6YO.\&)$&!@B2.)P)\GHFK2":;4ZGPUA:?,H%N4W29N8+L0P$' E.HE2R*B
M M'*2P(=PS$  EIW_##947-L@J2YM6L;9E,;1P((4, \B#D\S'4:4+'WLTDM
M<$'?4A6OI$%\8K%#CDH*-^\,Q,!QT(;=K8&G7VE%2BI:E3X(/ _[H'Z#G^>#
M*0=_,"VK."Y?21TC:&P-S\C\U,H=F!(&V][Z,!,G#:[5MMJA)/'))Y^DQX_[
MOZ\]2D/ 5RP99P_U]1CR:B'<I;U$^T;]<-]56@[(5@$$DJR!$S^F8$_G&!UN
MC*4UIYUD*4IW+'1QJYZ/=^@QI4KK)(IDI3H"QO!F+W/RQ^IJ]E1+!<2%.&0L
MDPG$Y ,D\#!!/4HR%!I:9@6GKI$V VU RUYDN14#N[--XEQ^MCAMJJA2@XA,
M@(&?J"3/$ 8R)D_7J.B*9+&H$RPN>G0Z/K$WP*:U*Y6.K#5P_9C;=\-1<5$@
MD)/),Q$YD3Q_GGHX40$DH6E:YY4B"2- 27^0_*1%>AS <XZL#]7)]I]L-%34
M"2D*F>,0)Y\QF1]")CP.M0G,V-(]03)^L%^V)5KHKA-1/,Q;86[=Y=YPE%0I
MOYE$^WT (XC^[W)R?/4J H'^+04A,>;F!).@^[KW]&L!5ID J.80!N052Q#,
M%:[^^,A6@^D2J FJI(.?+O!S@C]8\=%(53L$,3<N^KG2=/3><#&HA()-=*F\
MH 21Z7M!V$=L?U ?@;5O^#?X7E_[78KMFK/UTI;#U?\ )?\ %,M_]33MT2/K
MCFW$2%9_.*!<*S%4@[@K)!]<>"OX[ ROXSOBK24I_P#I"]V9B9"AKB]&3S.>
M9ZY'Q-/_  CGPPG.YN7+_P"OJD%@&L\=ACM'"R?W;P[ID,F[1_Z/2!O<6W!N
MS8I=5.+E0*L)) P.!)SCS_G.>@T%B'EEM;0!XZ_G@PRE7_5/U&&&K(6AP8$@
M8'T(]_\ )CHU%4N" &!:VC28/7^FF!BH@F/Y3/H?UZC? E<5!#E?(4=EL6A)
M Q+R F5GP ?('GCICEU\Q C8-<N_X_K8&N'2HZJN/HPO^KXB3TG&@P%#YO22
M"!)  4L &/.V"?S\=62@&2"-F/0Q\^A&FQ?"*HZJP@@#]?J-/:P78=*OOVKE
M[8]+3-8J0,;0E<GF8!(S[G@]*<ZXS%'KSVV>G).[:;!AAG:@L._EU<FQ:>@)
M'7VQ1>^.>M=*]V  :VI B<CUEYDY\?X>.K1D9IN[PD?+^GKBG9S_ %E3O^/3
M^^\X8=Q4\9C!)Q^4?X]&YDD4Z/0OZS^6%=:2H;/^>"_13:GM8Z8; GU[U;:=
M( Y*:VG/OSDDXC@XZ4<>#<)K&7^$8&Q<_/#?A#?::?8=K?T/Z$^Y>P(#&EM*
M4V?DTUIYM9 @H6U;VH$ >1,SGZ#'7P)XN/\ P@+_ .L+,[?ZQ0:]FC;5R8Q]
M2\ <<.Z_#LYGR!KVD;G\</#A*"R1DJ/GQ) Q$>WF>!U6ZH^Y?[PVT+W()^K:
M8:T)15'^9"N[687V&-F\S,#\XS_?UE)8QK$S<^F(/@>9_-V;TPH!;E WF2<C
M&,9CGCS/CJ1*]A(#SZ=;'J;'VW2CE)/L2&BXW?\ OIC25)#BU!1(! 'N1G/$
MR<9QXZD=[Q 'E@>U^VT/B02+,U](#21J8(U VQC*5$DJ,R>/T]@1UGRER21,
M=M-#C8,;J*>C@0(MI:>KXU**0K"CCC'N/R^O6I9X+CY_08PQT90.I,]G<:C3
M$::_ ><I]Q.64B1_^\7[STTX46K@Q (^7]<8-@"&;F^0!_7Z.*Q:A:##Y)*L
MK4?$@%6(@>^.NFY0_P (@LP G<@L'Z6<7VT& :D$@0.9_4\WY8&W"A2229$'
M!X/Y_G]#^73D)EW2#!,R&=Q\RX.-.5787N-,(WT(0V%-I 5C<3NP21QF#Y\G
MZP>O*+I(T/W6U&KO9HTON,1K!"7<L;6W&P?#/5A0VB#[^>8./SR9_+J,%[>O
MX-HS3[8'4Q@O_5K6F'MMC!%.""7"H ?[/OX$D9^OM]>O/^<Q'Z_JV-0@:D^F
M-:'$,NIVA1!,&<P ?$ $GSQGB!UDAPVXQL $O/=^C_K7!$PXVLH60 X#M (4
M01R"8$_0C/Z8'0M<$ ]B7B'VUN]B.N^)4NQ8:&;-Z_/3$N:? IZ)#AV@/%>[
MF0 HB$@G!@ YD$GZ=5[-GS'J0!-F /SVTP?0'D@$DDDZZM^%M.F)'LKR%MK1
M+F1"%(1O^6(!4$@Q(.1B23P(Z25*%11/*%%U$!A>[-!F3[],-45J02@$ATI2
M#T( W.GZZ[7 TV*CU%H;CEU]U%.T(@C\:=PP/*I_/K(X=77:F23T_5CK#V<
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MEVQL>9>4D[ K:#.W;)S[^)R.<\F>L5%*%-0!=3  L'$R!#_*!\M5<Y1RN"8
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MTSJ*J !2[!(.4KY / D<8X'MU".'JV!&Q ^D']'$GQU$0%/U)^3>A[>F-PU
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M9[US9YKSBQFY>2)W".)&:6E1["SI43Y>AEUH:-TSN\ M;V\BZB#;6L1L_HF
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M>UU@)XLE:1 X^KD*% ^_*'LD#N@VO,*ZV*]CQ:=3GHEO;ACAA]JZ=A-^8DN
M]P92GD1HU$>P#K0A>00'A NB6!1O)=S ..!WD VTT^:\';_=N7XWPYM';1%>
M]+(<%7'^=.EFLJ% VXWBV.]7FZ8XP FR)+S!&2R^1]A0WX)Z1[WC\Q\2.MX
MICIQ6'/*_%EG18 #<(![0*)"'C6]!S[I?Y">EV5?X0 2ROH01,^K=:9+AQE0
MB%3#:Y*+UPU'&.4O\!C97D1C0WM5%MS3XKQ> OMPS1V/6!4SP8]&7N. IMM<
M/4C0 >Q&ZUYH^JWP'AT<O?I932G)9^$4M7F6@*#T](0ZF<%1KVS\JD6Z3Q+
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ME?(%%(_G'._[W/=_[_-]S__YF)"=/6MFK=^:-6O6S.R]V>O]ZR, FY$!U@
M@<"@8Z!C + ^S>UD<<27Y!MXQ-</(2>-!I1UL*90*$!-W%I-=NE_9@%G 9 #
M .$7W2< !@#JGP#8 H %!"ABY&259 7 -("6J0<^P#?0UXV$V.\;X(J00J Q
MTLX(*P]W HGD@=#U]?$+(GD0W1%8(EZ:6HI!2QDC$'H!SE0&4^= $N$[N.@F
M&EM18R^=^5Y97\]' @,YH^=9-\M4-LO>;I13OZ#-'*-?@ >19!Y$HDJG9FDV
M:!:!)&L77U_OS1I8(HE ( ;Y;)UO_.IZ!VSD63=YK3V.;M30\2!M\/PIDQ!@
MYNQ#L-&WM_D)]IW!(L#7U\V:0 KR,W?QQ%/)3( %$ #X4C]N  *P!@@ "0@"
M_#99&/Q^UMX2H^--(O[0B,DER,.;:I5-D=0\_69M7=,#QM^MH;I1'RSUEQ:S
M_])B<S^2AR\QD$KEV6R7'XFXU0AJ(UT"?F:LW --_RP)(.K^F2&2_LR8N'@'
M_LR8N9."?V;T?;SU?F:H=OQ3M [>R_V'(;XK"%CMT]&E_D VSUT1"%??(!<M
MWQ%@*^T+(/Z#IN/]SWHZ :XVMD22@8B5-PGX)>EXNR)^1[<*]"9MTBV.>FO9
M_R0S!!/P)-\ /6>2\T^OL'"W"-SRBHWS'[^ZFT8@N)%^)]Z&.DA^1[?&>W^G
M6P3@M0[\)+-1AX/?_B,$:N=2^XOJ^5L68]DHL*+JI.-+(OGZ>/L2W7^P,&V5
M;*CP"YUYBTX=34=^+6#<*J#J]I.\X3F0Z>\Z0)K7%*C#%;3UN^E58IME+'^V
M0#/R!]>G[P:CAH;-])T*9=ZD;L0!A\T\W\^\T";7_&:>?DL::)-+G.V'+- 6
M>;/NXN:Y(2#CYD8M\:8>:7\P?:?D9V;]I,AN'AVHQRV*PN91ZD_*ILSES7._
M+:W_GB#O-XK_^V6;MH!]M_.F7@!8Z_OW1YG03SM]S^_8.(-H_]3^>Q.ZJ#S8
M39H[@ &4J4<T]??G8/I+^H6VP;/!^R\K_$Q_A@Z &.2]X8+@#3@7WR"B:^#?
M1BZ>A-E2></=?W$UX&\^">C\]-WO:EC]=,WOS0GT]L 3 NV\338&%^@O.#2;
M9=03=NJ7;C.#U?M%-IU[@&^0WU](M+X!'NX>/^.FOO4&D_DFC9IG=@XB^>XC
M$ D!SB2"ZZ;VQ_RVPC[#]\H;E(T2K(\[XO^%]D." KS_,GEL&O^O%-- ][].
M,+3.WB0;9_>_T%CP!"H?X2@)&VAH8VJR%<)@6^2_5*8_XAL0JNWMX;YE*=;O
MC3?<(F]8UY7@YART&</H@PD!I-]4M]LB_[4ZHXN[KJ^W;\ OQH5_9]#9][-@
M0PTS7^+&+SW)UX\Z4042?C4<@S?5D/^@,KEL!L-_T!D#-D+>W\B;HVG7=[X-
M=];\"/Q)AV^>@KY'(2CG9FZC0Z&;>:9-H1=_&"R/^@VGGHX P)06E1X)\ *@
M]?[U:8!)V]77A7!8UQ0 K\\ +)LYP#5R@V]]$#@%,,%@,'H8$ST]$YR1@1'.
MQ<K$Q,K%R\'!Q<'!"V?:3#]^?I] S(R,S"S,;"PL;)PL+"R<&P<6SN\L\']'
MP'H+ (=1E<^#@)  & Z"P$'K+ZD-95AO VE2M:0!;:8?9H0 (#"4AI8.1L_
M"/I[(0@ 0[8*V0 0% 0!0\$T=+0P&@B3'+40#H'N9,?0:%LZ<R#]HV1I.5/S
MJW1$4%Q6K2YR\@'D)[ITHA3KCZ_G\($*W 773HKII=FXZM^^1%+DZ;$=)7RJ
M/G6G-VALWD#\;.'IFG-M?6\6+E]O?_IVT<XM.#J]J+;CV;LEI7W[W4/.G"^N
MZWP^_AD.@,%4;:&;.M'1TBALJK 3PPZE:N"/Y*"1C4KEW-"@U>K)1SF4R^L
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M<9[SG7O?VY:JA&@Z-M>JX7("A':\/'_9P#PPL2"+'4LQO?DM <XJ:UB$2/T
M;HO7=>A'=E),[Z4-C<2"]5M/#N%BKAI;T\2*6[";9"PZ4"?H:JA.*T>Z"Z)*
MA#KM5-/$32DM[*YTNAC/;4S30\9*8Q,6Z7$WQ&E1*<PW%CZOB4!UYFE+)H3E
MKJ\)=]ZN!@(KVZM?'++"'9:\T;BP>!K1DL$1$TV15CM;:2D)CZHG56[L>HRA
M.$G@_;4A\%#@R?;B>+^6$YUOOQP7&KW#Z43DW@/  #/'BJS.H(>!R?SK@.3<
MX?DZGG6 Z.U7-A[X[J;E4E(3 >_/36GE[ W\N&( B]\<O2+DL%H/E5. ZUV:
M"O$PN)[<CB#1V*\W*2%BX:\:/^KU]=KC$&PV71$.X52N5KA=)E:N1TJD9+4?
M68%5I80KM7)\-T>LL&5:X-#0VA!<$H[I7V&!%9Q*<:4N H-AL6^:GR_N\_C2
M91JY#CSK1_H]!D!N;H;0U(&106^XV05V1]\K3VS"KRT"PNFP<[_,?]7YFEG-
M[Y-?DG?9H1#D?26,#H]]B!G(,GI:;42;8552CPHN[E QDP('</V>JL.KS[6P
M<RHF#U"+'\2GEE;<H7J?6.?/]%,CXN5"RN/;2-@'Y.=6N+SX_/Y5^+=*?;HB
M7IW3UG)HQ<9R\LXO=%_N3"DCXZT('(A7JB&S9#%]E><659BCRLB:)@>;1GF<
M1R50EEIRK15HZ8.V?FNOU+.Y3-?5 ZY$:$4%EH 1]&!%\:61F'SM%_OZT7I?
M+7VM8DINTEQ//FZ.%5:#LURQ8)"WX$QX6>&JO3#=U_J%NCSHYT:''J>&Z<9T
M6\]3:"9Y#BA8S(ZJ8#5@K64!%8T4I:7H86+97+0P4V@]]H74H+ZR;A2S9-MI
M27IQ8XXJJ*,S\1+;RO)KM[HCDNV? 1Z(K5DQQP-K.L/B4N();=3A0'!HJ*_7
M AT\GD+/:Y)T\NE70A=Y_D!J/5./S.-1/#OMCF:AZ.!BBX(4F[B@C N9,78#
M/>)>$/7C?OL4]"!JA>G*RMP\%%E6R:J#I">&9P*@D:[Q+X9,8LZX[X&N^#LU
MU;DA>"7;$[Y1W?]S;HZZ\/D_SGQJR$&_O"J@4>GSKE)AN<ECDDL?3A/E%76T
MIKO$ :FH).O/RG!)K87.M^[ZHR5UZ.XOK=F7P@)J!%_@R_9?[7E:#1#EJS,^
M\]0=%11#8G+O7DU=]*&[,UQJ_HA/4%K87<@SWKUTIX^M!P986BV\"W8UR9YK
M$@;BXB_N>)'B[S=]>K%;P5^;N2(D\>J:BM&=YV,V'G+P-[O)"CK1(D<SH%,R
M<$38S7##M@M3_:I@H%NA>UX>,(G0&*MP&(:/,QP(.JA@=8DA4@>..(W7H,#(
MR)#ZV2-'73)OWIGL+1H_:".>X?G%8V:YN6C/GH?#Y]SAGD]+\UX$W>23S=L%
M7:3@/1JK1*Y.G#^Z(^B "Y2LLB]HPL;K4H]1#9?Q!$V^W@1<S&7,+O?XBG\9
M,5@E[ -,<,39^W5RF*-5[1IS]C&&,4.)D%=!4HUM1"B 8^0_1O]U<L=7YM!:
M8F/-B4OO%!T]LXV8,E;3:CJ/.XXG[_HV.2B42QO?EWVV1AL)$U,-UNCPORX1
M')_Q4?&IS%Z/_K:<[.-KO&%?YI^XD<V";[X*&]<T8'9[EA\E:NQSE);5M#FX
M7ZJL'VF//(9AQ]>95T--J7$ K<22SK"Q@\(ET$0*LK?:T@V.?_OH^'T_D!?)
MC8K"W&(9HRD;429_9O/7CU0$PBJ=ABY00HM;-Z9??7F"E;%T/IQ6*?7X2/7!
MBMZ*!LEF*(FHU$K.L_XR',T7*?4EB-&1^T)B9]:;PY\U(RQN. KV.8UUK ,/
MU/:O3+>O X,7!"0:AKY4])VX]$>F_9!^8:5>86("+O;-9TV/5L['%!.*S_ 0
M+L[=?XX:72I:GA?14DZE@NF9$!W]R)QS9/FK@FTP3,T*6I\=7-H###H+GJC4
M-RU#\[B)C$:$P_)X.<!^^I)P9>@T6?SQR^8CJ\M(!_ZZ:>%FJ&EAR0#= VIP
M*Z'8D[$[3&-11-61N!9;6IT2##M JVHX0=[Y#+6+&H%\/BHCN5@K(LK"Y\C(
M[R1O?/XT>6>/:$:T:#3%N4),?^3A1ST[SF?TEK=@E@':K_J1B2HL@A?9M*TJ
ML8P!1;<1;7K?4D6@=FE:"S1"%S@* <.JS\/AIQ:5D1=9[DSQ(BU462MQL5I3
M&JUD44CE-UK8V4UR5;J>YRG9/=05BH7>_5=C4(,NR^)\4J]64/QIBV!B)5I/
MH)%3@3[TR.,B!8D:OH.%O!_(>VP]*B*Y4XYZP*[NQC*\U',<?.?- BOKE;:_
MTO.);3>R+-W.+;?$GLV0;/:1E'2';>9EHYT7"M;]TIZA8/12P]2C+@TTEF-V
M-M)W:+41//[0LK/WGD[I3FV0:=LD$(G(Y,!I@U<+O<V@[(@J+:R?)Q)I^M6H
M;-8@BR'9*A/5$:D?E8:FJPD:#M.^<_5NF5).]^37/8O&69%>YUD"W(<%N%6:
M>?+/[T@]U>78@[O7D!D+N3P7(7&K>Z7FP8G079[@11M:HO%["#Y*['F&O<K0
M$^P]@Y(6L'UHS!*;>+70J9 $\P<5]AE\8^?:7,WC[E[E^5KV'GO'2T.9^7:K
MS=BBIPUA/XI>Q/INB@MNP(1BPM$XSD&I$GTQ8/I-Z-T+E8=A.FT,52ZRU,%A
M>,\Y4$T7_;8CY77TN4-YV0G9EV[=G< GU5B]TQ(!##%RM32#/"AIIZ=NQ\_9
M2EA?,OSR:%>#K,G$D9,2AN26[#8VHY/UO(N]MW%[M8J*LTJ9@OV>X,^JG(K^
M6JB9\)Z0:VLS_HEAK2PNXBJ]8N*4]C>#)T-XG23QF=+H0K:O)E^)UYB!_H,9
M,0G34V9=57MGG%_WV9?^D;_O:<];U#2;"EQL;":M25 \@_(&XRXCO6.Y9ES=
M+*J@8-K,[3:NWGEX/^X-J-B?A7C?"FJE<9R; ?4P[OKH'.T=_XBP8&+WF0O[
M+I5_>AQA6"D+<'<!+AB/R.LJ*ZVY9>U/)B[+,M%48]/\$*>'!&O9Q7G&F\V#
M)#C[&0Y)TF1,E+0U:7M]F5HB7OLZF2&CD8Z8\D%0[-ZUQ4?A'W\[./U)WNF+
MQ]T#35YEG58[7L8S[\.BKC\:"W!=F8L[(V>FO#AC4Y;2&LF.?@CG+;<Y7G%F
M/V8J>*)V'1#J;\U['?7BSC&3#UFM?NV9G1ZH(%^:&;7J]D^+1\0SO@99/>;-
M4(EU9)=AHX^IOQ73<8RI"E,:IJ:+(WZ&JA>\23T9\R)CGU]MVVA$VGZ+JS?T
M[V"JH+%#R=>8H]0Q;T?])H&^MT,M#8USQ\>X'P9Q\8,=GFO*G7 .%69X=/&N
M@63"Z6 V@U*>NII7H4.9RO,]0$F]:"MX7*Q)L</MF</XE<^V$4,G%H+2NJ+M
M":+:& 9#G@OVWTZL5O;^\3#YR,/0>M<4@>8>::=ZE=D*[M.V%?1**I^5%+F;
M)"9;K '6*U*<KFW8Q%$?]3$:CHW+%)*ND G5V$G5D9ASYW1B+-1U<72Z@U#;
M2GT:<6NG16IH102 >S[/%)-OVU-#\<DI#<VH5F)\=J-.'#%<.*;5\R;S*H,T
M(V6SD$*3</CS2-WWG:+LC]4I]]$6!EU (S_Z-&%YITCB1T/,&M]KW;=?[LAX
M.Q"5A+RZ;H0(/ME<"DKYF\_G<FMJ/E(XM8(#?834*ML&-LP?]+CC:W2B.RBQ
MS=$8NO&Q-NV^,\>+E(8EZU'>8372&L1+9LE[E)$G2YV!]O&*Y]<K]0^^3Q%[
M>*)I<!BJ([_C<KJ5NEXI6:N&788'NH+6"\6(\MFDT%- 7FPR\]3X [+QS@L#
MA(-A9VPPEH4INF!<>]XLW*=2CQ53<SI-3D[,O.[V&-0LO\SK 'Y"/ !'+O"M
MG5,7KQF).Q9J:FI6T.6FH'!WJ.W;TA1(-0%NW\KFM:J]ZOQ9  [BK$*WX["(
M5 \P$XFBX4_>@V&P3;I$4S@\^,?4].=4#7M8!L?QENP.6+*E390$\]<HZN85
MN\A)DJ 7O,=NWG9A));3[;J"2I%9BIO*(PK+&_,F6(&'G6,E3C']&70%Z[5R
M<QAJ*EGGE7C5M7O51Z0X(AU6E'BUQ;IFV+S.Y?A(3-;WB6/?@\*&OKQ$<3]8
MYJ'SU+5;X&_6;OH'/=5L%AM3X).*&B[T/%.&RQQDU(YJD2/278*:!PK!$F:M
M"2;FIHV5^N!SD[ 2$J +L:BR:HD1N@PV1)%A2/H4<:BMEQMW3*]5V;63(+VV
M5[ ^PUENVOG:M_0>FCT=S\9>A-5+F>P^UJ/'6N8ZI 4VM$0R#;CS\=SL'(SI
ME#4A-G!$I;XA26,[WM;LQ,T+=#VE-^X8_2B)=#FQ#B0UUNMF%?%PSKL8LM!U
M/#)2'\"T+X6_@-E[#KFCV[+\Q$!0ZBZ9!&TY>=QP8'E!B$M+-7)9>/HK^J7K
MS#J@X7ZCS>[1N%-U*&+HGCW_-]98S6#$:UMH-ETOZ\O8^NB._=(8^1[8ZNUO
M7,GNETKZNAHY& Q20&1#.5ES__#L8IY/26F%*:[IMY:>^JGI/&/#3\[<9II^
M4[587V27N4>_CPTU^37+X*L=:>#Y*Y6V42'8SOC#>_@H,'>5#RG'3=U*CC1E
M.&</NMF;=,I:7[JR,,D0N\!6#D>Q5QI.&G30>0@E"3,WF_MA1&HFWM5"QDZN
M QCQ 0?NTK:]'>6$.".G,SP!YD4[/F,0G1;,<^^+SA1R ^J=#Q6.1.T1<"M*
MT>Q#);3NK9]D/,SMT(%/FC-Z<]J"XEJYTP<*U]R;N(91;C[_:5!7V(#QC/+-
ML9+/BLO<2AB'ZSZTUTV]/<&WL>];+@RT1>HY^#.KY0GJ+[W,4GAEL9_E#2"7
M_4>\07C0RPCLA$53&D)K*'%4S)_BU,]\;J7K6,RDC58/X?Q@_@?-9KCOF<,*
M>H$<O$U,&.P".E'D6+W0LO2]TEYH-@)2. 6(C3[CF17JK^GM"L[-/#1EA2'6
MYP;1%D]2#!-;%(EU0JL1/G.7M!\GGQ\NDYR%/5HS=\B0;(4*@F(.:I]>Z#*]
M2XOJ,A2;?1#3(LR*N!V G"H!31_OK*U?YB%,B$ZZZ=A9=95<NW*EIPOH=3%,
M46%S>2[6>8ZDAK[9P'/K!<S-9T V8-I?>NV!_]M#\CH[@D!%'^QW'6Q$N\+Y
M?6Z!\;5J3D3A/2FM#SJ\PUYT:K,U< !53.Y5*KS'M5IT%B62/*V*/AF*>V">
MYXL?T:17?Z36\;8IY- :O/).^LLF#?6T7B ]A?G1Z/&0UI!5X9D%@\>Y#P\O
M[)MI)3!<*[%DH"OQ!MX?Q\75H[P-EWF_5>K%8U[&+E/"5^"*&ZLE:*![ J65
M@QU((^=Q$&B/<:=&G!GR<RRB,,7XL!BQF[W)S6'TIJYQ.;#\O*UVM*][[\V$
M]Y(WKMIM[?M_[*4+< V7@1EQ:(#D 7E0)>0MN9N- J&X<^0?(-*L.8TTCX?S
M?9/K$]E<TX[>\/T1;+_ONX5E'F1TWL9JLA\?.[U?-5=A(+<F:'Z-CJ -H.Y>
M"!>!>[#3.2\QP7<)GJ'N%_."A7&M[)M+:CU/!+<L:"&[;5'PHYX[,H/&!FQB
M#SHB7E<+._FN6@&#"FUK'=*NBD0=Q\7O3 6]?R8-8;O-R*QW,%@,#[6*ZC]Q
M$FID]-(6JX@HJ#S9&"-2/*>,C%&)%<M&XS](H0PTVLGD??89J>IH_1U1.DMI
M[%*/%X6_XN+BS^@&N[!T6M[ZS-$\]QRJTPKWT(A&44!612R?M$_6Q)M.(X0R
MD'4FBK6BL0;LG&D<2"9^0VAD2,., 2SA :*%70:G&D\:]J4NU.&ZNUT@DC$I
MS&VO5F<4^8^/Q#FSF2!CV9RU4OM;!@>AE@$Q"FC';"7(U8S^I59.CT9%48M=
MD>9%=);]+,O(;/,K\X=7[D -"D'YU+E$R(FW?C$5W_.LS@1NEHG,=J/E/8:#
MNX"\(O7;6G*6D8I.65%WLG$>",T2R&1]9@)<@\!F#46>O.J=1R+>@=KTG9,M
M+(TY5Y74@WS&BY2P"3"Y>2%"^;/0LJ2=(9O#B2=/,M(D.UYV^\\F/@:)WNDL
M<1IZ=_P<W)(3<Y4@G]'G"O&*56V+XFFLZB+CV+\Z3?C5Z9LX-<3S\?#55\=&
M3A;,26:)T#' /EPV*T6UJI]B?N-@T!]N>RQG';@_>;2FL;0/)(A8O#GR@.MP
M\AN/\PY!MF8?=S =4IQ4I*BF:'>4O+;!4K389:2%.=XR"IA)B<8#[5GG@5=3
MJ''G(P[/0C(GA?6E3"!$I_8H* CUL&-)KJG_PWVZB4"/-9/@$SP<;>N M4^A
M\QZG+G_OEP&DVIQJL=NCS-WA+8?#=E_N>JP0Z<]+/]==R'62Y2O/8F>G:!SK
MA5++1*/[)5PQT1Z9W)F3]'6.^.*WO6HU0Z.\\MBHY(-<*&;!PG?]=1V6?#=(
M+^*?%;VBJ.LI6;BN(-8>JXZ1/DY>GBS(L=*?PRM;8183]JM\* 0I/U!KC;EC
MF]P52&L5_8="Z02WI6\YNR0VGG9V&>]T/>.=T@DIT3N,'_HJ(C+:ID&OEG!O
MNF]&,1[HGK^\P_DT(CD 26?1QC@0+-2Q*M-[!DN+E90TVQOU*NBE@[FZB>N)
MGC8]^_/L#@-2FDI=#67M#W<63HB7MPRLCB(UO0U45CX["F 2Y9.B/GTX'=-P
MQ@4M$N//U.(R]:#DQ=G:\OW7DYXT+VI/*.>!"=$C@ICAZ@HG!X^BE"Y6=#4D
MR<1U!ATOZ6-0<>JRG8M)-B&#(O8!]2CSEKD6GK,]ZY!N8H>))&U6MY!GL_^,
MM35-[$$38$<>!SL3A-_TX4<ZB"6$5MRT#_7T,WM(KKROY#HP)SRMV;PC-.+$
MP>YK&\&$E)<?6\VK1!T771R*;:59$F+^$80;NPLI"R?YF&XK%_48%30@F4I<
MZ/PEB%)TO(OQ*N^/7%KJY<!Q>?:1AFWD6W6\5?N#(Q5K+KQZJR\?"S!K@54D
MWAJRXVDL=YT(7+7^G. ;;2@:OZ_$ON).A$Y2:XB$Z3I@P_>AZ4+GU$52Z8#<
M\W6 ;V'3H6D8KN\^9V?O9Q(-1-(CUP$@W/[LS>ZUPU]T'MK:M):5OLQ+#>$K
M_W9^F?R,];SGJ;,TT45>P/WBTOA,S/PK.HG7,[)N4<J\OAQAMH5]1.RQ!IE8
MKVR1>_?Z=^UQG??**)JY:\*9_D3TI->>(/%>4!X7!6JZTB4AGIFP#PU5_9 $
MGA(<J;BNN>N,-.,A^U=O:\*O#"AKLA7G/$#PEV&MW!"1X;@+_;ZSR>HN.:&1
M8!8=G+GM1%Z.A2OWXK7[& EOP]2CF+ZESA2.1[IW'*\M4,>MX<4%"94?]UT&
M'D(I3FE\DQS<^)L<<ZC59>F-&P+ZS!;O3"\-#]*TV6B?5[?RC"L(N16TVO\4
M!5'TSA4U=8U)*A,*6 <XOE7573(;OOW@8G= 1A^K\]R';V?"W"YAV1Y]40R5
M'F(WU;^GB6WH$^O@N2P)W_BHS&B(S+:Z-=<LS.NO^GYM3E+ZOB0_]B'.12/_
MK56Z"OIN,&,:55PZ$]4%]BJA%@\<VIHKU@9U:?E86O5[CY8T=":N ^GUQ5^Z
MXX5SQW?<#D<#RZ#![Y<_:E[77=88OY%W(??,*(;[B=^/VQO_O!7R,MG2[[C0
M&/0 5-2.\QP4K$,!*3: Q<?)R)VH3-1@<WTK'"*;8AM'P:48HK0Q1 K="_*>
M8V4^MN=HS"5IGB_&D;5%BAW7NN"V*[&(+PWE$B"D!*;O]FO3]@)SQRAO.*@T
MM42;Q$%G5IYGF&+/BPE@F0)DM3D$KBEGVN NUZQ:$:$P*.^%V2&#?F2Q"?Q
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MP>[L+,\K 8!D90]TR$0OYG-E^TJE[X0&?^T9FC:>U&>'O=B5WD?;YY3/NT2
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MYV6GN$>GUCS7@0+-8%B^?4H!O5">I,MC'V^XT'GSR;4IN%'^3BPM\XP&'?2
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MPXJR6'^[WT5OEOM2I:"XNO!GC[YV?=1"*T*1ZJR[ZR4[=R.?\DB'<.P(-DW
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MJ<Y&F-(*1LU:N]0HSSZQ YV'2;(YOMK"UM2><$G2I, CS(.&@V8Z]R[V8HG
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MA0BQ)2^@8_5FCM;EA9<,D^PG>PH-) $19XX]DQF$XAX!$H[>.>SV'-YL1=P
M$D81+:0316R\/.IVPM^AN;_\=BXL'[_!Z\>Q\_NL^M8$FINU?_Y;B/Y*H_J'
M%7GY-[I414B@.=6%9<Q+MCOW-EW2%7<5O)KZCS3U'YTL8W#)LQ\4YPWHJE^F
MQ&Z*_+B%X ,4F@[$%4\LL0M1$37BR5B)B\30[:XEY@$<-07"<\.=*HDJ@MCW
MA@5P73\F *S9UY04\IM.0&=+[HUJA] -X#F$#4\6LD^9H+P!#A]9Z:=QJ)PJ
MH7[1G+<N6"K[U!]*ON\D'\-$L0L?N"_<IZX?^+4G<#8LN](X>O^9B)2E;M>G
MGQ"P2C&=')QY:JY:%I-4%J\%O6B6HX\25OJZ;M!&[XN^P/.($Y22GOT.((B[
M\9"*\H4"4.[SK;I$HVB.KIBV(ED9@;J90+^C(Y\V&][X42.>*&@6<>T4<>ZB
M)1L,W6BU5";JA.<2E7T:TK9 [S6!X4U5[17*F(13!>:UY*^"8)7#U$H4VTPZ
MUHE&5,,VY]_)?];2"'=?::_EOVL3WA29+ZJ%.EN#_[<N>+'JREQ+X3^U.N5"
MZ'ZB6D>>M ='+Q]V4BVA[@R=*,BSY_?FKZWOS[C]0M_) V@-P*DO6M]X>KH^
M\]10GT\[[J3QRE38HL6Y 60.VF\ .EOT1.1Y8KX5K>GJ3%S7Q:?10-1]'./-
M$#8Q,)-"^J00A(H*3WSGOZ)=5% 7VMA?J?=H0,\1&(^G67\[K$@)@N7&+<RM
MYKEVQFF[Y(RX=M:>M^5^W0QQU>;.6,E@J+:,+RBKJ%)-7B$XV690!.* 8 ,Y
M?%<ZQK<=8K*99'&T;SA0+8@>?QZHD:[G=6[7' O>I'T0;Y*=R&5%>JVI]$!1
M^7N-#]CZ183AZFAQIF&+<56YDV\X# Y 3P2-1#)3?5B8)XY_>74I_[-'9-L(
M#WQ9>/@O[1TG^EC_8!<#$1V!1L 0XBCSDQ+62M4^2RHF+@!#V#2UMH+%Z6@0
M1 ;/;+,PF\P(_N!1203AIZZ-YHGHM=.B)QJ)'-H%^C[B6Y"$<]J$SIY2-I)\
M]29GB8)X:?<1R]=E6;U5JC;J"&)O1-WNHOQ4N=XT#Q(FV)WF$*?20D6QUR!Q
MO&F+-IS/DLR-D7BYY>N./>UXK  >;N&N,C3P9U Q)@IT)H:G67X*<(D>"VO5
M+SK@(^@^Y3-?9K#88;;X('Q9993WAJH\.Q4W7CW<M@BQ0V%%]V!C]"F7CD46
MCRB23E(8P+?;<6NGIAE[Z^8S^N\ 2[26N:1 3]3".SDU3X]"&RUCVH<_:27N
MLC4TRDJ*'^#K4@)XHL/:U\O&<YC066H1_X6@;\4)\=9WMK<$)Z;9,0@314%U
M-AL+DM)%<(GFL+5D/&:]>"%'!U9YY\=Z-VL3[JEW[7 #Q)SI&Z8!@'4E\2/,
M$%:4!>R=@68L["MW 5!LG[FH&,$&E]@/:7JSJL/RQ\CCH_7N6_W\Y$\T8G$$
M<E?$=D4$EM.=1\[AB\3-$@V0>%4K&HV*+0[?JQ+I0#6K>"D:OA9!"=+4%G24
MG145+HK*:7ZE60)ZJH>LP2E*T"5+)TC9J$KJ1-\WKJ@H"H\E[Z<LY(X13Z&I
M:6P0NPK]\;/VJGUN^T.JV?!CP ;;[EKKJI-],[Z*&]<Q/[D;X-Q%3)WOSU'C
MZ+VHZ>-([8#WL09]YQX/T*XJ6W@R'$@UX]O;#&\QN602-0UP#-,VQA[%.GY2
M/EO&UOUN@(8+D[N:9W,4OGX9?X(_8@\06H+(A$N-30GN9P7TEB&P3)S$?A&B
M:'\B9C;5!9125[@&#E\8GCG(W&ZA OV=),*%< ,:2NKL!9G]D'>;"=$@,=4U
M&LFZ2QFK]>')80)VO?G <DP)P]M[[RRUVB:L]F,(V5Z716](-'OXZ5)B2=2\
M*?V'\&<-#? <?7[6&5:O? ,TVQMG[?W.X/OR<)S$D4".($7\IS(BN>,U)\E@
MQI,51NT%%18-Y!I/1!DA@,/<8N)BY685%S-S&?GZ+G<!;:A<2JD(;.N#>E!L
M*[[B\XJHM@=0N%DAMLGZ;O&N\$_#"6,^2X9X',(TUIPS=@<:R6IM*%:*/*G-
MPLX[+"1T S^.@.93K]%*-BES\::(J1$P1";KI(L%+=!#8('(7:9+N!^2H6B@
M#KC]7+)YE87$PTP=@AWGQ 3T=F,^;SV2:)H#(;V9>N6;VWCC=?HY+?=BP9,5
M E@,?N'F] V,#322KU]W &0)2WEC7!09$0AU"6&V\=8;0&Y%0N8PV+")!?]C
MIN.KA]GZ*=0CO.$519UQU)#Y#)")FS^L.7C&&IH[@/X2UL,X\^(DQ<X^)/';
MJ(3!\@+S\2*S0OIAM4"S=R7Q^A_]RFZE!YR&8>5*6&6:FFG(BA2KZ9*QC)Z%
MQ]R#KG8]I5\ZW*<\!9%#+Y<MB _X(@/NUSH8RYG" R9YC(ZY/Y\^RA##KIS5
M%(0H*W=V;T*^<&72U3;7CTK*Y67-W"]9[,SEC$)^SY)4*UJ[H%&*W#&O5GKX
M".7V_=-$\;V$DX0'$' :?N&>),-V4W6IP/)V7WF0QRF,(X$U,CZ(J=;4S->!
M1AJA$@^O.SOKU3("8[37"L1*Z-D$24Z1]L)B@&5"PL9J&QOTOFH'&1+G5P\T
M-]7O=HE@29[L.9 CIO9<LV++'[S@069AB"WD]L+K!IR7?/K>?^>Q'7CYD]:0
MG" 9MD>;XD_A@5FJ'^0#!.$<B<E>>'WXW-N2W[AGR#NZO8&DOKW+I;<*\"@(
MFO_(&]9I^Y\%E.(9"TO'4HP)6RI2JT,0"L<C'>>JI)0'+<5H5C#%&.$KW3YL
M5'7[-"R6>PG-ZWX/AT>/1EP*?4V!$$MB^E=6YS9EQE,VO()7GW#("5HCF,BL
M$; WM@/=;UP_)S,5RBRS>.RU$?%WU/*^KB[[97A_'+#&13W&:N@XV9H(,E-.
M_3IL+;(:S#0DU2HZ@1@]@(]\?!DUT>)V6?F% 4-3)4Q$S=!-8@8_!<^3F#D'
M)UDE^M3-:GK[YE5^4K+Y[N)A+>S]>D G8B,UXAY?,/_6+A&<BFJ>/F[7CE26
MT;V# >8>B.)C<UFAN?!A1C#.B40XT2*_=E=5HK!>]?YPMF[K:_OCS,Y(/(R?
M&49?WY,[:OSB=F]5/CF7.$=WWF4AW6M)F5 7&K=\ONJ5:+18^EEJ^)S'$!CO
M!?4>AE8MTB )!+#>-#S]7QE74#ID2>0H RD&QJW&_DS/0@G-NL0I0E]#>P->
MZ?]K1/LSIND6/>FK]@I:NC+1@:/_5>_=Y:K<A1&5:KW]8@Q2!L^G_ Z1+-0G
M'B=3W$7_!Z"=@]K>O[P!'DK6N,I\->PI9MRCPI/ $Y]S]A$=EX(#P8]@V-("
M3I4>=1;@;O./M"OO?'ZO=I.FX2I*?7X-A',5=_>4_K^QQ/0'-:'">C SS?'[
M6.2#T$<1ECI=7E:2=\+#'5DUR[%SHJ!+9^/TB[ .[HTR<414@6 E$\_],)XC
M9RQB[UE7+51?0,@LO/?/BMG7.;I,HI'NZP*JH("A93?<M69E0A75C$EU+3D8
M,*0KB+49K-O^]"7G'[*V;.0>Z$N6%28UP+55]>EJE-WA@9E.3-T'@V5^B]2&
M^@!G.+Y^O[N%#?E<..)1VK=>40$;VJ:HK)CD_82E >C)^^'H#I,4C[BUT6^=
M_IRFOS<R@;\)?E10&'_]P+8?YS5%DMJ]U_Q6@_ ^<GF;YBE_Y]ZGQ6O_\.88
M.E?(*YU;-ZZ3R/"%N/A?%/CXAD<!].1BV!#Z_ ,7?R:/,12LY'52$P&=T+,F
M(X;X%&NJO*&T EMGCK7:5F?&;>"<DB_XL--7\YHL:<G]7W>AJ):DF.M#AZ9Y
M_VJ-G=#8YSMDOTL9%-S,0G<)(N+9W/_C5)9K)I_8]>SX;%$G>0-R:D'_1X%X
MA6]QXO>P)F_E_^FJ$GW^C9SZ3FUPK)W[=#+4R5?N$$G(1U,.H94*Y'(N#ZLH
M229H*Y*9,2'Y[)+@2>&);]3F[DSXL_+AVDGJSH9H& ]U_EK>&#PF;#Y-$A;(
MV#8Q3?4]BT1?VUJAR;O#QX]+1;7*43J=1Q RW#BY4Y<&<J531/4^%K22+'AU
MGI 9T>Q%1X;TS9M2-IA6?TRI'#=R2JYI#@9"?N:NZG;0V@N.JI/-X*S5"L!?
MI AT8/\88'9D?N3G5A>RJ_/NC\6].]&OOH9CE**,RNI<#1.ZPM^">:8AFV]Z
M>'RZ\W2$ZF .7-%GO8;6ZET=,14=8O,/N+_T6) 69*Z5,,RT3[?>#7S71/"C
M^UDXJA$\(EEC3%^37ANY[L9+.]"2-,GD%:Y&"-$VC4VE;'P4B8V^TB;9-GKK
M#9KO;VZ>:^Z] 0RL!O\\*ZAS;BY)$Y&8#>C[5YL3*W %XX1#2<ZROQS<98N4
MD;[HNI+CVZ36XJ.6K,D"@4=N (_.KH;$69YGV1'8H\./.<4<)HP=:PPK'XLG
MTZ60< H(2(!3!+4?CH5RX(W5G6[]1M2T&F>])"/3]0IZ%'G?S"S+8!C+0'?!
M<J%[KAQGEJM-/HT%\L.ECHY(]DPJAC9*L+44=3'9<52)>6EA+->S\\ZAN(Y;
M*C8<YF6(5:YXD@$--V'J2)@(VB?6SMPI>/<.2S+EI$&ZEN*AE/0T;7:0[D:1
MHTV3U\&5&%FQL5EDCWB-$**2PQ5[-T"P%UD*7KN6):+EPUU"?'AC+H4-B<%3
M?Z/.I<GT0CB$W&-!,"YK@UG"**[NS>?)LDJM&&+H5]5"PV1.&6TN0<3,4@<9
M4;>%[>F]QP/#O2_8 Y^M!LGAO[I0'VSEIYB+JK861*IHY!NI^(+(O:5K\82D
M(SN2B<&CU@QFTF[V;3CTAOK@#:V&0^$#4[?L$*;7 Q.*.MP:2+C*/2I#HF&>
M&&'.P!4JI("(W5\=(UAWE CI#=#QLW)@LB)8K]1XQZ&^]&5-74^TLXKA-T+Q
M'Y;7*!JYGL@D9PJ90DL 4,PUFVZL'R5XM89[#WB2FPP(8M&R77='8+0)WL%3
MS32O"+_LLUVPY=P <?C5[T*^!"RA+&.]!T@@G0E]W9:H'9E(D R.$&N,H&**
M2&,#D??SM\?W/E.:JW-JK:4IT"_B5NQ-?WLGEZ7RA6N?3D!#\O]'8I6_W643
MQ#[\;PRLDT;NG]8IAGA_%\P-(+EJ%%)PB%\YNJUW+B^[][W;^0.EUN/LB\42
MNM#&&X#S*"'S!C"^_F)H4V7Y%5;Z?L\^'/1+9EFK?Y@EIV"=Z)A>T*MS=JWG
M+^[/>:X8_1';$RI\9:KY?@8=[:D(0=)5QIT4NZP\PE3OD KC++\X1O= 1=?"
M)EKCU]$;-!73)?&83M"KG6U.Q 0&/J_Z=;6G%Q(CB::J.N@EQ7_9*KQ^ XRO
M=KID!\T:E1BRXP']EL[.)-5BI%'=.#1]Z?-2KD4VNQ[U!1+/4EW,2HT5+7WE
M-'4.9593..$<*'Y?92Y.3C<A^6\N\<T2 C%66<[=080LOKPI"#6CNW,R@KIM
M<NT2!+L#YQ';Q*R' [\_/:T;^]KG4]>_R"(Q'XJ2C8#9Z;E%!G<7EI7]&\#M
MZV OQYG?(<$'!1-*J(LX59#CZ^X-?B'4Y22I)N1'5J;^79@7@YX6(72 \\>?
M7@+4_\O7HA*(-ITDQD[E/+ QAZ-15%\.[RZ Z);I_GS2UT'X]Z?42_6DL5;.
M'PJ;=0$N"9-7H?T!U8\KT<46X!XF'>J5&.QMQL?RZF%E-\!@!0$G)Z>+H-_"
M9ECS?/7)GW=6:_>5C8,UX@<UDKU3.5QXO$_$T6B(=9XM4HJB^B7_.-/R\D&<
MYI7&A[SEA1#SB8K"3%S#MDSIV#JB5)EDU3/).HPS3]2U$E*\T<489]!1- 7[
M!E#)9>OUHJ%DII7ST,Q>SO[=<P]U)5[M71$#I,)K(&9G]1\=VBL-53DMU1=E
MHW@[U#!*!!0,T>W':-8, =[DP4-M^N=<^JGH -N<]QJ.ZX;86+CIR3;E8'JY
M7FE=QQ=BDJY/7XLXO*1R;4@ <"-L&'Y$.'#!FO.KS3Z2C4T-&.K+?HY6HB?1
MSX*H6_MB*UNP 7V?PAT\>:!'\S0O(#@%N?D?7M/)B=;B5SH$.+8_X?D'*QM6
MUQUV'O+;*:?]AV&\HTSWSY#[0T>C_F=?9==-*QFR](LK.TY2I9GZ4>>7"#GE
M:&@T+32)Z?>3\M+T)LZ13(M%!AUX6C-GGZ>.N:W+78@FTH_J7Q/0?\U_[K%_
M/Q7"6^*&@%')G"0E_ G_1L:]B4YG:W5@-7H%LZ2$ZTG(69,+"N-&GC'<9SYO
M*\5*O:\!8-E<=6UW[P::)[D>QNF!8+2=?\)_$*O'"^$+9:F69EZ] CC"AXGB
MQAZ'4;KBNZ !B1J.@K%"AV=D#]P[.WRMOKFZ&U3!V<M9##MB=B1F^]SL\;'A
M]<H1Y7O'H@!X'(OA=NL15O71TR(P FVE J K]69LO]Z*:X>MM2?<.#EE=)=O
M_Q=9R#@?1_/L3GHIYJ%0G&E@"<9@_;2\UNJY(CDL?+'M*2$QNDW!\ABGIN')
MDP1.HVF-G%_4R84F S(JQ5AM9U^63:U8X+CY61QY>]$?$)\$/=?SXE$U!9B@
M N\T?FT?R?O$S\QY 75\0W++ZWU0N$=OD0EM<^=5LZ_(PK*])#\?[G)-75 ?
MKF4Y[WMEP YOBJ+FHI<#BC&9-*J5QE6G'O+=#IYXSPGMS_65ZVN0&,3=+O,Q
M$5N3N0%PJ?4C^(KDF4*LP<L20HZH"% ;JPT&CABHX$D@K^ LB@#,+1:)?3Z0
M. +;G)1OO(M3WJ*,*?/$ =D'XVQ=+VFNN7;[1#P%L 25PO@12S:? 3H[6"X5
M/8H[!!ZW/047#[>Q.,MOV)\F%_PCNH4M%Q0:]OY0>N2/K$+6%S'=5[+(E2??
ME"EJ+H.SOEVA8A6!&?7. L\=SI3'X&9L]]=#RCR39>58^0GDI09RJ@3%@&IV
M79HT,B^]45$0#^&%H%.*MV 9W.1X3 L024JA.R,:\Z*<GJR\V1]LA18,269J
M"IY0.WY>+VQ\K^0*$^R@ Z'"N4J)\3D+B;#I(\SM.G_).1]OD;-VM8SZ4S)%
M'M=^%%VQ$'VO42_<VMZY<TA#Z8!YKUW[5L&0WM_ %V_0%88-S1]14N"GR2PF
M)\EJ  W+2H'^@2P=\WL2H04[5J[#ITQLW.[[?\K%N+>">74I*3*&*E*5JX3N
M5;V/N0_HX[[2S,$GIB^)CQX_ZBHQ#9-*?GN?-BR*V*.Q6MPTGVFIY+G$.Z&^
MIJE U'3&B^)3GHXF#G7?+X+::9JII(7>J9]8925O@-7W<SR:R<Q6]2":)EL5
M+DH3NPNZQ%Z"_H<&RZUA'9+2K ,'NT5L9;H+VN9Y^J1%N I5;I5NH)%$J2E[
MZAYL1\]19G&$J+2J<?J;QR)PO*->-X>>^/5&VRV.>XKV2;IH@@53G*HI?E:7
MAJD&2<HKXC;K \'(0K!!P; \K7"< *&]+53131#-'LQYS!1B$ENTOO]$:]AM
MVF,:I%>-_Z87U*U)B)KUBR,*)*8@^G^1&17)1/,Z)6X+?KT.?YZOZ<$!<8KQ
MJ49G!VK&Y$(<;%^:G^[_BU+*3Y@9^<,5>,IT\.2_5F,MX Q<6C87/TK9!I)>
MHBZ7$E7B6-$ED7#"4V0-$^K2);PPS7,/0N^5YG3$6&ZG6U&EZ"#MXOKJY.(Y
M[G2Z3 V"[^M5T%_N?TWL[UP'] ,+ZI;NCJKXP>C<*^WS;9FE_Q$CROITE2]*
M3MYR-?K_R<CN_<\$Y7XE ,&2<LW#U(1]&]AB6Y$?%U)\@;1F%#./\4WE(O9^
M9*O*8'7_G,]070]!N+ V@->-^FIZT'A0#P?5M,C-48CS?#'3B*6[SZ5+@^VK
MT$+A6&'F,_('^_Y#]F'LI@QW71642X>0)X2*N>.74(52ZI@S6',O;>.)DNS%
MU6:N=2LX""PIW+Q94C>646;:.5$L"3A JK_?P@;!'92NY.CR*=_&T0)/2HK[
M!@N7=3-99+2;Y^!TZ5.>#/N_\<*X#_)3:K+OL0T#BXOS+U^FO_Z^!I:A90-S
M^^<]4712I>=SL0T0PWWF2FF5+@2<9N&1-44<9O=1P?\4MM0B51D0(I*"D>:W
MY/6YJ"%L.V !ZG?AL[@PIRKE\31=$%L9P!%\6-_A(OY_K#7^KI&3)/TS]]\>
MV3T-RV$<UT*65D;=,7D;?^P6O&Z%)P8@H?#_CZJWCFKZ?___GQNC1S<(C#%2
MNCLD1TD+B#!2ND,0!49W23<"TH(T H)T*R4E'0+2C8H_?;W>[]_[\SW[:^?L
M[.QY]MRNZWX][M?M'N/X_4.+;Q^"J(DPO-(;]#12 0MJ=NC!GE4$XB8#P+X_
M.H_BP47\+Y9JI&9LG[]R@VKXVV('9EZA?6XV2N"]R4C".2_<44_IX3_JE[_X
M;R[OS*  4F0_\ -F&RZBE55P&HZ= EZ!R7RG4K*,8HE-?L'F><C_OV[@>5#@
M)(/9;T#F./]R3^RK^9N?$16;;1.T2A,_%?,G ERVEQY%@CQ1G@:X&+5L_TF#
MV:V=\X-%N$L\>95$6B6?$/FOQE6X<-ZCV-/OX>QTJ'[PJLN&:2[-[1.$5-&.
M&S$P'X.\UXN:4J7D@S8>V<VXEPV1#_'0%"BV=E(F:C6=_@:(K\4#C^,-TZ*]
MY"I&7ZO"L#"CZ!HRDW&_B<3Z5XVN$DD]MWC-2\=@B4S$$;2/N$ L;39D4;"+
M/.:9>2":E:1-#E7#@0B%P$>8.HI-9G-HQX\/V.:7ULFVORX(A*TS(([U4M?)
MGS4I*6R-9_$6*J<:8A4G0G"$NA!!LB[2JXFL<'_'C1=?#2FPGF[!3^ECS&EB
M6L6K$0E*;-IR=F6J=;6PZB.&<F9'C&/Q,0( ,/*A_6%>'VKKRF]PJ/QI4G&@
MHQ@_0+J9RQ!##% EGF<4\9: [,&=BQ>W^4Q3JT@H_\>T^\]2YGWY_^3=2/PE
M$2A9O]"_*_LQ+I9]_F:0G=?P+EB5R:W+I>*QI0_,:V[YZUC;*L;/FRE#?"]*
M:6F5GM>O]O6SY&UIC,S. +ZH_.<)$5;1QQ.N'%>P;PLU<3Q?SA)0RF^+HEA>
MZ["*I/ ?Y]C8(Y%<!<G*)74"HG%Q34WLB$1<MW6"5S! %6HTSCFEITP"F-G(
M81\NDM>G^WC:CB%1H]]Y;C@^C3"W0AQ Z@KRE#"?NI0/O29/B8ID#JN_Y9O^
MZF"<,2O34TF7,<;6QM_-2,*"#^CP.<.5^BFBR#Q695R=13H+9^\U+VP20Z4C
M?&^B*S2U/VLE^GTMVN.>Q47[8M0>Q#,?0)I8!GU3J,BV?U03,WQW6AJ=;4;=
M?:^NX),;A64[,US]D(U_#[T$FA@_N6?6]XYXLNDJ$^:ISO7?QW#;XRCRJZ+(
M?>4*2^*WD_ER>1V+/6D*\#7AZP,:6P>G.O>Y =V,,HI&T!V7OK36)RO[62>1
M['ZAS:_CTG4T5F]L/@?50R57/7O,]CH=A=.'=BGV;()F:/>VT^)32F+?U6&H
MAC@><EN$C*#'[UHN/6RVU8@!RWM8YSU5(&HYL\!1!LY37S"ONF!?6C4*Q\2/
M_&=!.KH;0-[G6REN[#(.3S&NG3CL?/+F?C@D#8_TB^S)<D"&^#CL+7_UQD,^
M]^'8G#<C-*,S%%B);S,+IGLC&>P302BU(T@(S#06L-QX'\3ZA0R"HF7Z-&C)
M:)]$ EOU',T.Y33-73^2$*_N%]L_YJ'3">@=L3$I^F)24(')KZ,5@JP@E4?P
MZ4SGX&)0-<:,LQP%1=)0$<:J]R@J$,U@XV='N#\?7_PH1;2U3*_CZ&XZ0+)A
MW,/@;+I&P5'+A7LA;OFPF!Y! EFR,-"$1?!MCHQB4T;8=D(>A--T<YF8C(I^
M&\!__Z'J>/SQZD^)#(T$Z/#6MVH!,DT\ 6I[8-> ^+-,(=;V,<I3>'K%W6VV
MK(=.7(*^_6.!Y4<Y D\:UQ#Q?J.G''JHX$8^E(8]B[7\.1E<OW=7)I-4'NXF
M/(V4&D-1O]_NHAOLYN!#M*<];[)>HU9&U>E&)Q(@]=RW)HI^ ]7%I&U%4^UD
MS\0\<^X?WKDP/!&/!#*3>>B>#>#LHY-!"+G(!8A73T;V-&$^KF%6:XR@PLJU
MXG^B8/H>ZWAK<Q68%V!\<"+AM Y/5.6?_/JG?]HS+\_,S+[8]T0S^:G<#!S(
MOH?H*7(B$=E*HQ<,/1"M7G2BK]N?&N"DL"?UD<F@OMC$-T;SF$H28V:T2%@;
M, *,G("CZ$@'D"BP6);W]5@%WI?TH&Q>[AJ0^4[QES:0CTE&C!,2*2>JR%:,
M0^*!(QH_<)B_X48>;+%=QF6^<U*3%-W09Y)<".PRNQ%V185(7UWUF;"",&,Q
M<F0C3I++C?79PS"F18 _5=CPWT4JO";\(IDGJ:9IBT@ZS2TWX[(@A-31=E2&
MES5(Z0*CP80.DT,H!?0:)I6*9+:B9OF[=*T([0T:NT#620\L=L[QJ$K@37,A
M6^";22V"+R[KEA'W[-(QP'R4HFGU/RX'L;*BL' ZX9^N7%UV!_&0VKU..)"'
M76B"-P$V7I!TOUAD%-G9D*7C4X$]3;5&NT]>B%U;-0<@T=@%\&MLHP3P-SZL
M#0@;@&75YW\#!LS-J6?NM(+M:S%SZC&"%^]FQ-)E/*[P*!P,UE_]/%8KTAO%
M"]LC>E2.X0 G7HI;5<T^7W=K G_DZBY(BPCY7$6L+_@;8&L.2>FHH=V?_<FV
M\SU=;'/X== TYQ--::9455W-#L4]/2P-<[^!\9^:\$3<A#)^ZG Q+^=5=:[L
MPQUG&5'TI=.R89B:BWVHG8VE4#FM' JE\@S-S"#6<1"+'\'0X:%4#?MLO(O/
MKMN%3]!UV_%'W! T#3#P8R7E"QI70;W<H__9G0_P^Z)?^X^__14R^_:%V=<:
MB9B#92(-G5@I_P3H^7-3'_H%':KIA2Y .?_A3"L]9E33+]X5RNJ@))?W5+MI
M"?%L"TPAS9F??S&1T9CJMU_<MH6?T:VTM!PQ$K;,58?E%IZ/4# =!S*F*VN;
MC9Q(.[MVQ9^(+:)!+&U-[A4UF"/WK5F#P%6#B*[<R+A2UE]UV*+\F NJ=X1S
MW&X3T_+4]YARA.8)@3G0:?\7:S5K-*KO TE(DN7(O\4]'2G5-W**_ T0NN5]
MN.M0H(4DWTN![Q@,>7=*PG?RA-1..KF+4_-8>I$AI('WGV<L_73_GY-=SDD&
MXZ]#1:=D.8OG=2D(5A<)&P*ON_B;:>106\?>2R-T<9?,"Q8E+LX\I#-'[&[[
MO1J&<-ZC[Q+%+HR,1Q/VT!8GRR&V/(G.VFN\=50.BLD\IB-"(!M<K8&Q.YP>
MAR^;H6_3*[;4]6F+P][ R(TIY8S4(J$]^F#N_;5!FL'NV+360;%//6]9%/9@
M?#2MSX7DTWI38];GH^]YHFU/I]D3Q,OJE&RP:" $L! LY&V17-[UA0*RHS;V
MU_/W.*;7UM$5.2PK?/?J!^^H0JPK;-EO,J&#,MYLG,*WD7(+BD@8?@P&(Y?7
M6@175U\MJ?2Y%K?*JZ'!%\JX@6NE#^-=DB'FW.@4B2:LCRK?\]>Q)$[LP=&J
MQ>!5,4"*H<K[>PN&WFE6%" .2684$:MS;@O5KA#1E@&(WC-X%U_#A?]-_OP'
MG:]D]\OPKOQ'O[ Q3-[^ZC^]?=4G!<.@#V7ZHHCQ1)$,5L2H<RS@@"'>J9!J
M=SJI'AP6U/Z#(\M5?:9J9=(BH?^2,NERU5YHY/+%+V):9'"XPC:[96:9JE[Q
MH482OTOZ?B3&.M9Q@SI*:S(ZTQ*79S-RCE\TZ><N_:\3(_S$P-[6DVX5UJZ$
M4Z@4OYX#QE1Q+5,P(C>4;@[L2LP6Z 1@'[A-(NUH/I*J+/6M J<>J2Y9Q(BO
M/I@UR*/ X,ZO6+.-)A#IL:',Q6VTGI_ +"68.3 K.:AGC_1-N3$DOA_6OSQ+
MW6NUO1SF!3K!>(:TEZ1D"NB??-DV1&>J<5O4L^XZ11OR,WT1Y'0O.(=#VP)"
M\XO5_5K5,]';(<X7IV?H M9J_IDAB=N6E:#OEGX59?\&JYU0NS<GN/&"(/9=
MEWBP/2\,.MC1P!LJD5AE(#4</?@J0]C061R]"[$#UU0CDCL+$""@AYI6B:7
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M =7TUC2H:D0:]$EN0<?A,O:$*6D^UL: J(KQ\ EE]/@L^9[^1:1S<*CS:UO
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M\L^Q=!CZ+V,PZ]_  _Q<% C '?'R1X%1()?E#<PQ@H4"2UVM1*.JC"D$7<#
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M4@*FSQH:F5/OUISC14]LR-+9/$JA471_&NA['MOB,[\!WC6WV]_ S'JPJ:W
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M$['Z.9$Y7L&)FZ7;%GNGBC9:L&J1U6PW7BE'?ZF]%?")=<1.*:\<-TGVDZI
M#Z^JW85_<<.,A:%ZN:/56_G[,ZRQDLN_&OSLBOTFG!UQ+,]CE><CNUWC\T9-
MTISG87ZQ?;TAP0TXZC<#J(H>$^H=0$! KI4N=>Y4D7&15'B=]U3H'^"KGDDI
MSUW8M[@U7B1!><GY<82K.E PG3/L=HM3J^$J&EGC!*%,K=)080GR.UUX F)=
MDX X2PTH:R<!R2YE9(.QY1<&O9\/S^77_:W7JJ<RI^N6?%E)M&1U-6BPPL$V
MJ#Y(%CX$/\FRD2.A08NIC%!!-P3.-VZ\AJ05^1\,_ (,W\FH"+$ N>'H#P)"
M8='DOE7K![PIOQ=9W2"BMO>#]M0ZYTNS6N,QZ!AX+0EH80L6MM31E\MJO+J#
M0U61(J9WQ^ZJ#TW"X4E>TEO^?7VM>L936QD_*'H]+K^GENM'NJN1)3+-756(
M._&\1Z/412@OUU=-"6X:2W-#H"@T9@WQ%&[XQN4..OZ:P%X/4/1Q6.SGE78%
MFV1DE?=ZK(X8Y_C"\$HXC'=4PM1LIFP=58Q:S%D\FN:%C-@-LY$K]3*E+J#V
M B*V$[-F:QPMYJB#XX]"@1"1BY?;^K.! S9EVGU4J!ZYY!X_G!\J3/JVFMT_
M3-E\2PG1'W-;C:0Y(K0RRA&)>C97IL&5#KU3MC1=)UK^)C+Q$:NG/H:^PX/+
M3T*VB\!W+WZ?BLS?:R_.7FX<PW6L(T^IEO-\QE;?1ON6PS)%I8^>OEK6J(%?
M0*EF JN<B%:9NPY8HZB+^9ED:2%$C2K$U;CUY<KFATGRI>.I?.( 4L\M:NC,
M5M,'PJT.N3CC:'>]<J8)P\H]N"Y?J(ZL+;Q95G)3!V*;T9QG-3URQE:;Y2A?
M5M"IO$9,.Z\715.*S:"I"F<IHN<'85CD@]"CD? $R+:Z;)L'>H;0^H#E\K'?
M*XA<0_.=4=NQN'O.!C7AE1+%UEQ*F7D&Y32*6M,**%!C5@4_\*X)8O$A=3\1
M$6@"%B+S$[01&1F9I[48B3)S"J&%(NJ Z33J;\C!HD$02:19'\#[;R%<^N^@
M^BD [U^_ 5H62!GTY$) R]/&3H_/Z"$@^QD8^_@ %H;^4+Q)<I.% LFTSC<Q
M8-612W3N*N/2B3F0]%NN:#_U-2Y9<C#]= M+G1,(+:^5#"RZ >LH034+(W"M
M$*=E=XY?/Z-EP5?!M\!$YQ(X"&%N1,9_.W0F1!N1F?,'L/_;!6#[33:-:0$)
M-B-^CD3IH$9'SV*IN/QU=W^P _G"5AG-N8NI)_G ^"IQN%898ON7K0P1I_<E
M<J$*& NO\,&19;*RVJ6Z02!^UYS?7<WH%!YMQ^0UKZ=^<_"LV@GJTVS*TUTP
MPG#Z2RB9^VXDP)L=GV)II/>$.M_D6^NSQ&3X618=7>#C9R$9H?>YGV[UF\+"
MK= %ANS%:4K>9^56-*LA79:=B6?J;ID,C9F1G%;$D'[$V:@VA^WY1]>FWGXJ
MUBTSJ5:5J40DS4 (HMY$R&XBMOA!)2IN; K--@ 7R;6%"CA_<S'Y>*FYLRP\
M2FZ<\Z:68G_UA(^A64TPKSI]E#1SIH#9MD(/*X@5N5B'68^'7HZ&,Z+VI>WL
MK)?S+&9&'P+GMSW4TZ-U(0F&\S*.LL3N5E3TS0QONK_Z?W1W.I^JBI"9I4KR
M"E=CI3S]$S"D13DN1]2+269,XIR9@-$/Q[#X)HGJ/B^';H(&LQ^IWA"E3=%:
M'@U9GZ0FZGRL_GG6X^F9\:/PET:1LU%1*5PPMFS=GPB>S OY@;=S+<11WLSR
M+4UCF;WK[<8_'$BT<,TJ/VD(GL6:BG%)G<D'Z[6]7X*K%#T_A6CM";C?E57Y
M]! ^$F:7?QB?@V,E\?G5 /.D<I5(WZ.E0N3ZMS2$@WP'7SL;7=OK "J7S2>X
MG2]=,\(N\-Q)O67]>KRJ\;T+YJ52I:GAB(PO+6628\\5P2_#!LI>"1S?++YD
MDVXR<;9SIS7FJON:B9TTKE5I>+#H-,%S#$-)X3'P>P$N,4(06$8+*:(,[)_Y
M PR2"RZB4+44/L>-P_2JXYH(FEDR$6KD3;A]$>L1+/W=P)(-0-Q(1'*).!D:
M3YOI<+\TH@\]7#HJ&,%(D5FP1OS;ZIW<X]Q48 2S4XKGLRZ09FEJP"MZWC?
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MQ*2%$<T$<Z1UT&SOV&-!2=W3N39NG(?@C>:D+3N+_;@B*(G.4I%"Q"H-@J!
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MV @,SAX9N'%QK"M)W><(F+ 15DYC#JEY/E^2D[\J+::3JO2A05BW*+,R365
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M&CH9OHC!0+L%[-.4V>^ U7_<N!CU-#+X8M)6%+A.1-^!I,WM>1JMJR8).*"
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MSRTTX:/-&^G+-:CSJ>2\G!7=XY_>'"N<H8R&J-/  M(%,.FGRN5=3658<\I
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M41R<H19GM-0L>Q:[U>0\YHGA<F/XXB55ZD%>OJ'N8Z6\\V$$DU$GPG$6?10
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MN#B(;4=F3=41*:CB\"5*[U[+HJR,W)<0 R42]=70HJ>91=,.V;S@X==-),G
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M\4DBK-;/R0RIL1,_;.5<F,3?E ]>2LF*Y^P7$^BQF4QF3AC[5>!FUM5;EJ,
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MQ">Q< B-@%=HOX9+<)EX?(H1WBWLRIIT<%F:D":I+-X*BI[T9H9%&MF6WI)
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M]?[K+'2(SIS5ZS#!K[1Y#B)<98QS$@EVAN-YB4Y<L_K*D*/O_M*GKWXF_S4
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M7*D*_IP\=*B$-M\ C7!=+6'E]J>H5WA>Q7FA[/5-/44]LO\W[KS3DKX346&
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M65MVK]'A%8'M?(&X$7#7]]P,N6_'>5+D<_<+R\B<TGESTWDOEH[:9J^W>A,
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M*XJ9H?YUB]C:Y-=(L6)%JTAQRN3&Z#@9(2G(?-Z=TCI*%:0BF0'S +ZGRYH
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M/9K>DQDE4^(@&@P<AZUH(':EL?BX0["_;04?AO]>_6=%GI 'U RH>S]G/'C
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MQ+H$2F8I86F6LFQ%0MD5PG2@K;&:KFNCW[3 @>UOWW C(WZBZ9+?&7F+;UE
M?#N=LFC)]1\?\2V+W!S2"?YZF_B$;A^Q@)%$>=0W(?R7*Y2B*;XSCAA5Z>QY
MCM84<MHZ0^[P37,<,!%MHO8R0Q'J:_9Q/_K5^R>4S?)H-==SKVF\K[-O]+5
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M$JUGE?SZN_<D5YY[+B805!#>4(J/89+=:-E3?&_P:J#N+I1&0$%X.T%8 O&
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MT2Q:W.))5+X#K:<:GN(P[2S"+JVG-NS?$980@O'J-G*F,S+ QD?[CW!7C:5
M(FF[*2'W#AG=3+GQ C/6N.R[LY0!=LN:2CDN] )<U]8)?2:L$(*7O0P&H15]
M;V>%D&(T4>'%A-UW@E!<W&%&?,U*I!!O 0VA\_G<TD6@FZXAE05H%Y8@E=1O
MZ1(QQ14=DA'$NF".I_B_@L1DA5&,<%L]>%V*2 LL("6WUA]UW$;V4ZQ8?  Q
MM\4-2-R/U8<E]:G6\Q:,XC,Z1,];VQU6!2P@3+>6FT>T6M.J>%!"0_ 4]1K6
M9%:$8I1 @0\3M8FW3^>&3(;&0MNDN!%X=+9\'T]O^  B-<0&0.8F>JOIR%-
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M/E=*W1.[Y?5,HSL]'3I6#QB;'M$JRTDK:CW%3F$T4_*/+875=VO3/80+;^L
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M6['[X,OIH&<G:A/]@ 1,V(=NERB?$7TKS[Z7<W(;BU(%G[?R6 R@)U8&34A
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MP>R@]H1IL<Y)&Z$^Y!G>K<KWAP79>]*8F(-6Y.RX>B=57R2;J\)HIM)>>.Q
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M!HC.<;"8+=&%LH_:E*%T)S61O_50O>+M@I,A<14V/<N)]5)656L]--SXQ7@
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M,HC6O \2^9 *<^/I#F7"FE+@\QR*KP*3,OX>2D,!B37G@FNA^#ZC+$C'J.\
MJG-??UEL']E[C"2<79P-O1CV%2=V@R('@C!@M9>P]UJ-O=<[9YJ7A/3N[#T
M8=%\7G_S5HV_MYLB;L='%SV=O@<@3!C&)?R]4^/O74W:^='Q^:D7YU!W_AZ
ML&BPKK\Y4N/O:&=I]73^'H"06)U-\/=*C;]7.Z19BL2SS=\#$ !_'=<W/-3=
M%4+$!*.XMNB]1K)M4^(A7D">CCL2[E.J%!(D&,7Q^2[?KR0!1>$U@0.$Y[BJ
MH2WA^=;"W$A1II@=.TXQKR_>^Y1+3862D1ROEW-0:U$!DE1%!TC1<7U"&Z6<
MZ6GC17Z&/;%Z< &!UAI]('$,:^9L3$;LH>(135!"0\AM)Q3O\',\W2(@092
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MDSFZFBPU@0+"'7BSZJ\+_0",^' &_C.];BC!&OC/++E$NQOXSPY;=.BA"LO
M7^3EEISQOS8RQO]X><BSN)J4XYPY#2'+%?0H0QU"_P]%V>S(58[*F@U?32P;
M;RZ" ]:$SW,HOAJ"R#D,2D2$Q9JAWK58?%_]K,C'A35^-,&?+9ZS_[.*TK):
MDG*%%:F.^/1>D)U<;!Y0&LS1>,D-45P&#88 36CV[.O7V0*SG8;SO>$;6X$P
M]#G&,B[G*,?8IIA,^M4:G%AD+5_'D7JQS[478F>P081I)TL:@E1')HVGG[(L
MEETT-$8SN*=VTJ:MWSU: 0TA1%I"L#RN7F4\AVRI!(9RJ(&6<%K)=Q]N""'-
M3B7L^P;D2]2R2Y);-;\F.4?QJ'S($E*EGQ00ET;%B@=RL'XC8_46("!:19A!
MA#=O$3M^0[FN''?'<&Q^$U(,BQ!":-QET,%V?8>Y0&J4Y]&D_",IY]=5469+
ME-^GDT5%>BF,B@)? U'\'/V06[)UWL;YX>7.;,I2UPFVQ(7AT<K=A*7^'8%2
MUO_XG$2OR8(X<](8OP@E;^0NZMP:?AVMDI)5DJ@I(P7(5:SALJ%47,,+MUG,
M6+O.JI2J<U07V["V^(J9SUHG"$ IC6?(;.4=JZT_=>XWKS]-H"&$MP.099X.
MT3#.)3O7'Z&GHZO\U% 9]'2T-ZG;C#\97MB)T=2R+BC*8D>.0D"FK>=V B.&
M%Y:BLUJ'GU#F'?*YF7+355.L,=FW FZ VS)=VNTEX8:W0./W./FMH'D  V?+
M<^?F&B!#%H*=^EN*;\H+M'5-+N0B@P?Q2TVOQ::"3FR*]JDCS:-TAN[3)EV)
MZDCX3KI6CSZ>1G3I=O58NS5?VK$X&;@U7QZ<2WJH@H@/LGIKO@P@:EM1%FJW
MYDL+Z;R6+G2V^IBVOS5?JD41#^$.I<&I)I?!QFQK<-MHF$Y8M^9A#ZY?\#$B
M0V8S*79]GQI/]\@0)#0+!G&JO=8_:BL/'73VLEC9-Z/%V@D"R>'@04Z=5]==
M)]X+$/E5/YZJU8K=VZ+%NHX2[8U,RRAM51A:JR4/>89O+^7[PR)*B0IR^U>5
MK,C3/LL1@42IZ"/RP5A<@Z.S<[?1*R!9GW)QEUCQ0(IE>.S5*ZK#\>:C115C
M" Z9K6ZS-VB5([S&V"+!2X\R/HUY6^.(I<H"T,3^.".?8(RS5%'<V>0PSXT0
M2B"!9'Y%HJDA&L8!>FW88W$OV$$81$VD=:ETD&;UY@#B5W"F>4A.ZRY0?8Q!
M] .P9XH:#$[. ZB;U$(N"F8I#LZTQ\N&Q820:DD+:6F6XLR3&DHXY:;]5-:8
M'*992HO;816$!U?LU;M" 4R%T>RD/;)SX#C=IEJ!#B'? 8:K4GQ1832':TEW
M5,YFT1*,IFR;P(:0V.!,MKYW7C]"EM9]T<I\ "R@=U6.65GEJ(XFI6Y\2<*H
M<! W='CMMZ"UE!J,HXH @\AI^(RB LVS17R_7.79&[.22G-2!*,X/J\QTAT$
MJ(701$4E8&7=E_\1Y?'W*)?41-Q_CA/GU<O6=?W F"15CKHP?#\M_RY/XIDL
M]UTXB),=INE1412*  &YF"@G@1&0N@EKPL4":7Z:$QJF55!1$C)D@ C.PO.[
M;;HK\E24A^B=:"_$B#V9Y!5:!P'2#LBNNW;7-*LXV@X?)@(YO3C3.L3A0BJ$
M&;5G>SS%_\5+D#AI08^_:,RZUJBMY'W%KKH"GC7,>V5$@3C&"+%X0F..+)ZC
M'RH1R_ @MKK]!IJKBTL'3PCNIS4RJ8=BYT$&WU(2KKA'L;8H(,H->A<<^YMJ
M0->+J"C&TZ<RF_PIZW4#C>'\L!.6J6?@@^0DEBH,*(2XP6WJI/:<PX?YW+9T
M?5;O:2-G=K.41(A"2(8R))Y0K&L6Y"0SH=GT,K5VK&+" ZCYJ;:A"2&8]C%9
M\>QA4@-SGS+FR1UZC'+33AYK3/:]S1C@MM&Z4F*=L38VU 9H>@F7Z(R-8]8:
MEI]JF]UT1CFB((I";:A=5X^\0SJ*8_- IFSYS;=HKSS*, 7A/*&S:LM8)1<9
M,&)CR/#J^-(7EPJ>(/I.W&---T=%R6V-<DDU#^ 6#*\V?7TIR;"8<*L8J^"T
ML08SW^F!25B]F)/JJS;3M6>"[034A-/&U.'WK=01;M.(32<MKZ[GUB>>$(_$
MN6/@QOA4O4YX%EB6$^.ZY+9X\/QF:O7PIBA& W#?1 KAWDWUP#FH( GAV T.
MKWF>W>[O<F2 A,)+.AS%<<*H_.C)A>=#M^&$KC-1SD_L7-5-9*)0W@.^ VV,
M'[PH"MZ%AG;\X?9"O)E<U$RI0] U'E:!%$*JI9M;>U/J\*!F-4QY'PJD4%*#
M-:6J<]M!@11)OZGUZ?X)9;,\6LV32;00M&@#GV<+>A! KY2N6Y B3&N^3YG$
MV(&U39BP0QCX/(?BJP.*(IL;9",'9*WJHVO9^-[C[ G)7A)>?>!0DU+^SN3%
M_[$1%__%R[>G!MEL_LC)]>)]4)SLN\QO(MV6=U2-PY^N!!S^=,5O^EX<!ITX
MO$UZ"(EH*A4U!%JCRG *^,)2*JG9LA0"W5$/J<6TLP=\J2'&EAF^JSQG9;2@
M-7*VW+VB"C.:;V!,L51VPKKH6H.5^%=M6]1H^E6Q+M'UF;2"06-,;T2R4.A?
MUY6"OT1EE?NH&-PU58!;,(?G;N,-VL8]K\GU4/]7PCW U@73_Z&-6FN@(518
M$<A :L#:!A*^#6M-;4AFK&T62FPKV_2';\S:4.M;US/&=A?=N1_92?L?V8(T
M69.DMS8^O"'82SZE<-HV7'[D&$((QA=><!ZB=^I'O*G0?Z(H?_Z>"0YMS3>M
M.3$,S6TO/]^[0 VAOXD6_?B;HKN:]KLVW/!:.-6^X _ AE"\2@?!75:):W'H
MO6K#B]!"0LP*_@!K" 6MM  D;Z96/'G5AA>AQ1@;EOL^UA!LC*H #,A[@]UK
M>7FK<M[!&$02ARKE7]&/\OD[6KRA+UE:SD46H[:OW# GM-P/<Q- B-FS[?(&
MO9:U+SU^R)-TDJRB14W\.*4FV'%5%F64$IV$/-\[V^7Q8'!V?.IXC67I[!GE
M2\(P;O1-4/&(5C5KIVMNWZ<*FE*+UQ'<QYYK.HFD :RJ3DA#**S2H5;'V?'
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M_R@47@.YZR*'7L/9V=_;5CNP@+A]UIJXR]%?%4HG[^,IUL>2+$XFW"*FK//
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M:Q L"I$YLAD'(!6;):VZ)-[:41<MGCA"* #SV^OSMG)"+<5R=,B\;61T,^4
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MC<1(+A]84;#%Q5\U/V.ORLU)'N0L6S1L"7. .^"O2/R(%[<P#1L0,#2#:>4
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M--AI -X7&8[X#P$Q]C+2!VOK^H'@ +FW>TSO?3RF8!T*K3\J_;,DZZ=:W-;
M> R[7+Y)T=_S)?_,4I1C10B:[/YZB_<(:!,85-A$!\PP2N3[:0S<JL'ZHW*:
M Q%W!S+LE'@,N]Z]2M&;M/SS<\'895:Q@I55S$5/]=MR9I/L#!)I[)EAL53&
MCT@+F2T6:2O&9?:0%\\M"V: 7(_1A]/(I4.Z1]JYK B94B;<7"/MK>0!(^UQ
MV1$K-[(ET+[]6*LU3=>KM(;2=FH=*- =G .7^R5!&B6 [G'.$6TUKF8;["M
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M\VO^."L*6QTPC[>E'J@QWJZ&ZJ0FA2+@?R2"S599I]C.<U(%5")RWRFE42A
M",1Y"HWZS2'EZU+M0:YVW?2D$#Y9I[QM$J6L,TK[CAR,J EB?6>7@W((E;^[
MA]''9S0;52DNET85AE$(G,N*5>7,B)Y#9+>1/'A0 PQE[*M2 +BI=?D.'TD'
M*I0+Z-AR4(A$X>P@D5JH@D:A(ND3?0C0H!&):M.![(.]R@$:RKKZQ2VH$B22
M/D%U 9@FA5\D?:)OBAVK(S%4)/V:_U]6/;$JG2?+P875C\>3841)C\=CF)N\
M;XBT1<PI/MK*'# XBF2J(.<W#@8,1Z'/X4U:R//DUJI"(7[=]U3 !S-0/F6
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MU(1HH#S<W".2%?1*L7ZB&6+M:D##H-B6YFQ'?DC2)Q33#I!@UJ&CCV4=-+Q
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MS=S_X>8>]4=!K_SR6C0;V0?X1)!.U'VPZ.3LYVROGW9*=YXGM_5YAC= J71
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M9QQKNRQ'N)JY)SYS,1_<OX/V$7]6>:6V+Z7LA_*XSDW@4WXG\5F]^0IO673
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M/VQVZZ(X'5BJRH)%'6_2^^0I94DMT_)3FCT6.&?>RG5Z/)7%)]*$C/",Z<:
MJ?UF1Q<$LA[4ZK_.B:E(G\BO-KO*@EQDA\<D';1@]7/8D$CT]D8[)*9U5P'7
M*1+T(4H@VNQ0BT3$(]8W*6I1B=ID(DXGHH2RP9XQJFFEHU%J4=9V*Y @&%%G
M@[2H5Z,6T1#OSX.>LOOX&6]/>W9W(T1^G989(EL0&EIYQ#%[F_@AV^(]X-/W
MH&0H>X!!T>?]&7](S.ML4I*B4MBD';5)]+JR99,>F4TBUJ5HV:13VR8E7$%.
MM!T=C.C(2VV3R&BXLDG[VB9%PB;1WY(6CY5-BANB 8H8"*7G\FVG#R/SQ(HT
MO$_VIQ)O'RC;1F^YIX[H\S'W9*YU1G,H21X;C_N;?$3T,QL3WH5>1@87T3X^
M[6LUD-FG.??$3=%7-RSG'I76)M\2%<A?N=A@JRW,TPCI#?@\=?!L!.CC@=X#
M D+A_7.6EP\X/[329DRP!],'!S$-,V1A\6BE-4R IL&[#,+0_+EJH#8"<W5@
MB8U\IX0X\=6DZX9177<\/O@6VEXB=OO?;OUYNB$>NI #M@9+BZCC-IR*DK@$
M>3$DB?#VFA,UQFRC"*DN\W9Y3M5F8(L6=]2F"3$M4%Y_PEDZ1Q63M-)D&I,M
MG>"2[#D/6<JR+W#GE8<,7F7[??:9^'L#>].9]G0!"L M[A)2M;/)70JXE:8T
M($:$V)A4\: U'8-'BX&;;A^ROC\=#G0_Q[6VH/^JE):>E0P=?H1GYA=3=;.%
M(&P]G[=4_*?2]\77G(^XO,VS&.-M<46PZWY)L?\ ^(HQ029V *$G5=47$/W$
M6[3U#J34,N4I$<FQ$@FUHH.&G)=0OKZ];++RAF?;IZJ4F>D&U:=YEMFM7@UX
M\68@\G\5\AX_EO<X/N5)F>!B_1(E>\HHD0I]3_TIS3'/'$]/K6\S'M)4!SH;
M'X<Z_8K'<U&WTI'S>#^6J!E^A>H/G!'8G-%/K%#S$5;<"E6?6:%6##VT.?8C
MKY9-KH>F"Q>B@[<$*4+N3MFI4(JO)3W(T]<%U*]_#+N [GF^GZEJE]I=O ST
M KE1&:)>=RI8U]\-1:GGLQ+&_8821NJ+"R6&9NQW6M<BST1PQ!.AYBJ/XO*G
MI'RNSH19-<YUNJTC/\SV.HX&][7/<24+[2D[&YGZ9-78Z'-"LR>(T5>\LC7S
MWUL/$D+8X"PFGF8AG20=L(V-4]WI;&K"4QRC#4VP"N1_(Y,4T=-3CI_$V9K(
M9&6^13'K[W/S8<C1P$:TU:^5U0O<J,WEK&6WE$R">O,V&)3\=!L ^LKZ[< O
MF36:WQSA#@RGRD36OV=#MOY=#[T2Z7R#"85P*YBVS^%,1L#YR^=Z'@Y4 [:P
ML8G>FW0.H9BQ#KS:,L8^%'4D'?$LYBK-W.R0EL\@RQB/ZI8Y_#R?:E6!0K?1
M*X4/+905Q_D)UQJ?X"GQQE.&!3D7F\2_;I]2!]&)$7F5-3XF:@T:D+X&((TP
MSN:F*X/Z\&ZZ)GBQ!#<X*C!-76RLY,H>'O57374?C*SEBI6<"L:5-:>^XZX>
MCEG*XO;)O]@0<)60#='3UXH1Z'@"/'%I\>;(\E^D3XRDVKO]$)7TALI\.SEI
M-*^*,H5;68GH*"M4CX.$6K6V1-5@ 6F9"]9;&BCZT+5;A%**[+S_5/0E$\K2
M-@/LLNY.1KJ3:ZJK$_D$_I"DR>%T8%\G*RI[K?,IW>+\8Y9>1$0F[%:Y2^6X
M_[K<I_Q?8;F4D]*S(YLT_ATD/B1@7WT*L6^ACS3Q4/VUOI*8N,  =SK.@::X
MX0D399;W/5[01JSMCJ/M(-"V9V@[5F@[,;2E!&UQ@[:L1AMK74 ^\*?1+Q-V
MT4/=0';)@_3KYHL%E87B"5CR<9,1S)"!#VA+N: [5KK8G]+HD.4E"^+:)@7;
MU86Q;56C2[TM54/+LVHT7M5F1R5/G^).5!?3H4!4R)A/G5IU75 ZS!D#:J#J
M-IOG+3I696,;:T_,?)F5Y#?9J2Q*HI[4QE-5#4,;[0"MUE [-'O66O90Y_SU
M8A\5?"$W4M"!7B"Z.$2]3NWXLZ3'5\1Z"$4#\54M9D*-+.4T^,YXDJ4OQ*#0
MM$^"*,ND)KK^,'E+M!QIPYN:G@WBPK/HE@QV;MLE_L)0( ,4:G**C$/0R:/$
MS>XON*";F7NR,SN1;_T4Y7EDD@MHZD#^'QF:\ZAY]+39(3$*XL/0WU0#@2N4
M,XY;FO4BV"TXN]71I C@J'@/X!6@)885K_T@ &SYJL\)D =G]G,%9/^'&?5C
M'!825+1B@HB'*FJ-;#?I'7WC0WSV)]+@8Y;FU3]IQK6B3BGY@./G-/GE9!%;
MX.G[$-5Y%I:H6=6;*N\L/>YH4OPVPP84KP EN,[Q=R-$\J\'?AG4I# 0&M\)
M^*@H0Y]8+M+S?41S'<3/A/,"K8_'/(OBYR!J#_E0<67=(A_Z[2=PF>ZO:N._
MR>^2I^=R_271%676]/$9A*RA7 HU9EOBK':R4)8CUA[]3'M 10N[X  TKG<,
M/%+T[AARX##_/CM$R5 % :->T+BOJ;= /N\3$O;MN0@._5T8&>&_BZ$9._';
M/'F)2BQ&_X /CS@? +2FK:_]M()2.9:<-:MG_6?>TKM/-X-FN$((.C1TMJV+
M0\%H9VHI7K')=)59JW;L_.P7/7S3ERHO+#G-OG!PV[))4?U-1#Z*VE]EZ>8+
ML)WC^*F;9V&V#NB6DBN8^?.AT1TS^F;4V<@<0ZCU"X/?O@6_0P4_@JD&;?3T
M)VW#[Y'!KZFO4@["#^($<D!D3$83#A,-AH([%S3A4VW*15J$EKG)VN:&6Y=@
MC_:F\-ZRO-<I37S'@;M^I,5_A##:22(ZMC@JV^9:%E5 QW/&^!\Y:3,&OU\E
MUQM'1J%4O*J;5];*$#C]'(2Q<"LOG4$95!Q9558#E03[F7\#-#S+RK')8M,V
M,S1>EFV^:)&_0)Z.+*F(2HNT@!;Z#HRCN:M9#3OZ. BG!:/J#A=EGL0EWK+K
M(>+:]7[S*4W*8DVK/-J\/EOVLS"A>4O(3W(1Z$?.>*5!\5X!K>FAQQ.["EVA
M9G1QG\<3?O1^23]*_"OQ5?!M+I0P.\^]A2SN\#ZB@BJS8;$%\N![.6W51%\N
MIJH0INZ\STA+C\Y?FR9"S=:?HWR[X:4^?V2'N-?I+5G[LBW[UWL"FNN4L)T6
M26R7W!F8+CACZ7T&M)'2+<O:IJEM7FD@]: %II311\:,MA7BU%%?B=,G?H,H
MB:BF,;#<T\%.SD9,CBCZK9R<\]=.N\[D5'-33<UU-37S9@;0]L.8KY'% <9V
M@:T>;3;84B=XJ0\[6Q6L9RT'<SX$;-]GR<C48/<,,??6:G/<7$&TOA6TW5U&
M:#U#VC60'9D-BRPTZS=?_4S,V7S=\UV3_7#<9Z\8W^/\)8FQPC#O&1DB4VJ<
M/:7T>3 WOBPYCYVI<OY-F+KNSB5GO7^__$(_1,_SR;[](CHF):\N07;K!_IN
M.T"SY4%J+0M6?0V)SVE\P_J35>4V_M'*\P//0;6XRFK*RB^CKP[RY5 "3J7X
MZF64ITGZ5)!O5B0F\3K=OD_VIQ)O[=+CS!G9=S:<65)0JD]K5*9*8ERJ$(T:
MD>T/#>40@P=PT>%!,)E.&%$C#? D/_.U8S"G3R"J897"9QDDQ"T5(:C %2J.
M!!4%0\4C0P4%Q98/#IF>9YV6"2,C><%-D:K++_'^M,5;6HI/*R;+U+C./@:3
M,->=K+0W":W/M(NJ51_BU0LONC@;L#[A.7JA"/!*(\ P_#G7:JE)TNM8)[VG
M%]OA/*<&^LO0Z[E)F<>L1@1*2F;'M3Y?&1\+D<%406+AF9+9$FAR[K?2"V^&
MQ;%. \S8/0GYNJQH$V#O6=FO4^)=X7.\RVC]8/HSH?8]^4]1,F?MBOP^>1JO
M2NYL9!#EGRH%G1'@XZ!'-FCU+S+L"E4#,YL@A@[0'C@32F,7:L[7+<Z[QH)5
MM#WO"RT4"S%+7=268I:N>+88M+IN=>Y$J#S'*=XE97&7[?>$3'HB/\%8V \*
M8B<F\*XS$>WAV.)8#8CHB$@,&:!I<"&'QBJHQ;#>[7#,LM;0G!B7_%\OS"*@
M/"I!:V7-UPBU/9BJ#KYOM:H)J6W6'9F47@BMO3&8,BS,W=04_K4'GC7"FZ4/
MT3$!0MUM;YR<R*(Q"J:B",,$3-<$S7W09#7P8@9$+4]ZG''YA8 EC?95FKCB
M_/5'G#WET?&9N"\YCLP/#6:-ZM$(S..^C_NJF"T[AJS&J[/N%33&L1D2L3&#
M,0%N)=%Z;U<)I<4\2)5NAX#O*[L#M,])"(J+.$^._!1RDS]%Q-]@5N7\5"0I
M+@I18R%+Z<D%>R^SV=T2(%770:I<S4Y']Y8ZU)4TI#2,S<!T86L/C:JQ43,X
MVQOSE[2L>F7S 56JZ&7U_(T+QU]J4J?:U,U7&IXJF24Q]8$:LE)D;=0\5JC)
M&M30@S:>>X"T/K8^X.B>N,C+ELM$_M6X2^0?_W%'8\D4N?IZ?_=@[?H424LP
M%0T]>"(N2#NE)T0&OHFT0AB!P8FNU'APEI?%FS*MF-3")^:4^:*4J /)?C>9
M7E#D#><.4\RWETUB9>C7\2^GI$A8!*,^9ZFRA\?-G9KJ/@IJ%Z75%#15Z3S2
M(;=7(U#I;YU&< *&;OICCO%HEE*#OL"([W-B J 5JKH!IRUUSU!HNC$(-!,M
M&429%WUY(&-O=JVW%2-K@:*]1[U042QE8LGVI%N6\Z0K[1>PK$1]Z]^;\AGG
MJ'R.Z,5WNQ/DJN&/34@MTL*OKSE:['G1EM:W"YZ^+VI^\T!^*J*8;6^5GO[D
MD3QJF#V72^@>Z%H5@@@@]7(BT/L:.Q'ED ?H-Z35=8D/0XN@\R^\F8/TME06
M/"^FGT'L.V_R1!U>2F_G:%W2,[?'Z\LHF9\C=E,8A7#,;N$\\?I)K(S#^:A_
M--389Z&0(5KE)9X5A.(%-LZ7J[!@5A3$B&)!ZB;?)BF]TV>O6T #>=6HD J
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M\O36VO#J;B-OH;H]V@;BY/C?P2.LAX38C=,=DJ"+:1L)LNXW\SYUNB#':O+
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M(LVNUH"0N93E>,A/14G<B\WN#F^Q>*EC:B\4G:&LA(H7@QE@79F;1;RM5N\
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M7QN0%".A.WR5IKL9'QT5&NB;IB]07$K&B38^Q1-,UKU\+%BUM&6I%[#"LM0
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ML'M<!Y0VN[L\2;?),=K?I 8Y89.&\[DR3.-W9!HI(!]K0*Y0-=0;>!Z8&_;
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MI'5(0'=%/"#41[C18'T$&@"PUR]77Q$/U!CN_4Y@@!_0KD5-W1Y=!;)!<LH
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MMX9[C$X'E?XC=%YP8O;XG+W(BSY>#JRY_URB[DY5XX..FWKT(@1TCLQ7+\0
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MN<NSI^H\>[/;;*M2BX\O]#%(:LAQNGU3;T[FC.AK^S*+:VU5(=09CIZB9?6
M+'UFVPX)MK.8/^N]O4<@4VZT.UELZEDU1W0TG/JI$80ELJ@LRI,:]8;-@3*H
MTBE.<=)6( 7.73*MR&DQ1WXKAE^\741[>A#_\()Q^3G/3D>J:J;/=2B[0U3N
M5O,CKRB]HI>5JJZ(]45UYT!>RYC*&;JP90RDSK4!$*6UJ@U0Z%NKFG_^>X)S
M(I.7MUO\2D2KCF.9#@"C66J>% ALVK/3\"_K7R0A,>\:Y8ZC0'3( '8*+3+
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M"7 @@>&\M4/21\;)H(V1X(9CA\C J!H9=89&&^+1UX,C.CJ "5E6(&3!+XE
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M%*';*8A32,.)&8+*<%;\[%((O(LRV5[2M3)_TR)*TM[G_D)"\6CS4+4;6J$
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MN,I;YW@'V9[\'7DKV'.)F)/O@9#K/"=P?*Q!WXH YS^(-EZ#+(U3XF%'+S*
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M_ P@4(IG^J4B34;,K4RH"E5Q95W4\^9CW680??"Z 8P*:U(D(^/(FS8^)]B
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M[YOO'I07&DE[08\#V6XT$($RP*&8,1_B)$J&<33; +=Z^W(7Y\-9RMZ\*$3
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MKBWA,":)CYGUKR>3C)ZO!>%/':@"'+-LCWF1#Z)X! F%LI/ ZZ5QQY4(&!(
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MANA;E;TV=ZB5/P?# +[C3/J!CX&.J>Q'7KQ:UKO=5:VRVNVVK98XEJ\%@]&
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M6=FP1SYK5^]4#B @^/CJ&#MNHL$%P ":*W],D/'!E 3(ZK\!A^2L50$">!I
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M62*$2$!KS?52*O!D/(#V=+20F 8DT*XB M&MQ_J<KH.=:<;4!ARY*+4?0'F
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M)94[6Y['+;Z#@02RUVGRS['8Z""":F;?>7_/9BVBQ=5&]!F_2Y$4)[J%K4W
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MSGA&^!@>?%#E_E=K0(U?P96PMK.*$W]M9VN1M;"=K9%!A5]"1E4/@:.P("8
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MR^6Y7K)[&% @+X2. #@BTP,$%5<BD-S/Y*.%[.1W,;! )N&6TM.%!!5+TOY
M(S/>&#^#$0%DX;6W +;#;"E Q*<>?7I-&52W,HH\/S9R)&I@J^/"M11( F*%
MN4DSS,R,H9R\9:@R-#5]*S>2:7I/%-NSBMVE!6IDK)$AIOD$(LO!<=VS&/!3
M5"5VB6]B&(#-H,:$&WQ\.S"A+#6B.KGK;^<N6HD"-/D7,D@^5C?8H9RSB$K0
M0)EC= 0D/T%R+F6P($_]$JI5@MG%X)E!1K *R0\@TILHU&/(X[Y4 !R!:>+Q
M(AO)H8$::X:/W9RD,Z$4BA<)14ZLTA@?T"%02KC:*DT'[ID99K)Z1Z31X^J]
M) >7[\NIHLR^X'K:*PS*TBFFF[=&*2%8,K4 G;8ORAP?-_-\,OVGC//J1*5(
MW1'<05F$2KAN/S%JPPHV[8:'C/P3K][*[!OEO90?Z/1LI?#T92Y !Y6*(YB)
M'ZF51#[];EW$H !O7 P8YTS& D#A)LK(W;N<JRK0I] Y;^UG62Z4<!-<5,Y>
M[G44.'3R$E<24J'MCC[<^M]5SMU%E*,9V=BA)*?DD[/M,];HZ0+=)^K8<H.G
M,-* +9\".?*%W@I=N"DG:KC/_Z865*)^"B,->#VVK!(<=.$FH#C,,<#[%N!$
MD_9+N"ZZ<)-+3!O!"_JA5T3XN%/C"(LO:@4P6SD@0*:/?72?=5F7^_E-G. I
M+8Z6#RD]IUP3SW4>XR_D.BE7**M$::05YH]_.<:3Z.CD>'0.G-YL6X\Z4A%N
M1?*'+)TB-,MO,,6W>5Z2Q.LF(DBB3O(;Z7H+W:2JFY;H(@2KQBV,_$VGO\B
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M7)"2,[=)D^@_YW8?/XQ\_T$=H]4SB$/J9#/P)J!!+&.%Y<$=+V'7)>@M16L
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M!;+VMUOC^N'#4C:6ATNEZ NF!YJ-XK;WQ0)ESXLH88>ZN[3JJXYF[F)U3<?
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M9;24Y-QPKZVQ#WQQFTKWG'HX;+GE@63X=UPL*K,^\9(MXO?G5''L:_&4AB_
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MX;U&.?K?_Q]02P$"% ,4    " "0@8568+\>1:8]  #/(P$ $@
M    @ $     9#0X,S X-F1E>#$P,S N:'1M4$L! A0#%     @ D(&%5H/%
M:X0E @  .P8  !$              ( !UCT  &0T.#,P.#9D97@R,S$N:'1M
M4$L! A0#%     @ D(&%5D5T@M89ZP0 M?<O !$              ( !*D
M &0T.#,P.#9D<&]S86TN:'1M4$L! A0#%     @ D(&%5NTE<NMD+0  -L,
M !$              ( !<BL% &<T.#,P.#9G,#!G,#(N:G!G4$L! A0#%
M  @ D(&%5O0D.H(X8@, '+4# !$              ( !!5D% &<T.#,P.#9G
M,3%G,#$N:G!G4$L! A0#%     @ D(&%5B>;J%!6Z ( ,CD# !$
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M+3(P,C(Q,C,Q7V1E9BYX;6Q02P$"% ,4    " "0@856M<-H<\R^   1%@L
M%0              @ %2-@X <F=T:2TR,#(R,3(S,5]L86(N>&UL4$L! A0#
M%     @ D(&%5G(H, \[K0  [L(+ !4              ( !4?4. ')G=&DM
F,C R,C$R,S%?<')E+GAM;%!+!08     #  ,  4#  "_H@\    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
